PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Dong, N; Diao, Y; Ding, MH; Cao, BQ; Jiang, DH				Dong, Nan; Diao, Yi; Ding, Maohua; Cao, Baoqiang; Jiang, Dehua			The effects of 7-nitroindazole on serum neuron-specific enolase and astroglia-derived protein (S100 beta) levels after traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						traumatic brain injury; 7-nitroindazole; nitric oxide; nitric oxide synthase; neuron-specific enolase; S100 beta; oxidative stress	MODEL; S100B; RAT	We investigated the possible role of 7-nitroindazole (7-NI) in regulating serum neuron-specific enolase (NSE) and S100 beta levels in a rat model of traumatic brain injury (TBI). We also explored the possible mechanism by which 7-NI may affect the level of NSE and S100 beta. A total of 160 healthy adult male Sprague-Dawley rats were randomly divided into 2 groups: i) The saline-treated group and ii) the 7-NI-treated group. Using the random number table, the groups were further divided into four subgroups: i) The sham-injured group; ii) the TBI 6 h group; iii) the TBI 12 h group; and iv) the TBI 24 h group (n= 20). Controlled cortical impact in rats was established. Serum NSE and S100 beta levels, nitric oxide (NO) level, water content, Evans blue (EB) content, malondialdehyde (MDA) level and total superoxide dismutase (T-SOD) level in the brain tissue were measured. NO synthase (NOS) activity was measured at 6, 12 and 24 h after TBI. Pathological changes in brain tissue were studied by hematoxylin and eosin (H& E) staining at each time-point. NSE and S100 beta levels, NO content, water content, EB content and MDA level in the brain tissue increased significantly after TBI. NOS activity was also increased significantly after TBI while T-SOD content in brain tissue was significantly reduced after TBI. H& E staining showed that brain damage was aggravated gradually after TBI. We concluded that the early application of 7-NI significantly reduced serum NSE and S100 beta levels after TBI. The neuroprotective effects of 7-NI may be associated with reduced NOS activity, reduced NO content, alleviated brain edema, lower blood-brain barrier permeability and oxidative stress. Serum NSE and S100 beta levels can reflect the therapeutic effect of 7-NI, which suggest a good diagnostic value.	[Dong, Nan; Diao, Yi; Ding, Maohua; Cao, Baoqiang; Jiang, Dehua] Xuzhou Cent Hosp, Dept Neurosurg, 199 Jiefang Rd, Xuzhou 221009, Jiangsu, Peoples R China		Jiang, DH (corresponding author), Xuzhou Cent Hosp, Dept Neurosurg, 199 Jiefang Rd, Xuzhou 221009, Jiangsu, Peoples R China.	jingdehua1963@163.com					Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Cojocaru Inimioara Mihaela, 2013, Rom J Intern Med, V51, P97; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liu KZ, 2014, NITRIC OXIDE-BIOL CH, V38, P17, DOI 10.1016/j.niox.2014.02.002; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7	16	7	9	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2017	13	6					3183	3188		10.3892/etm.2017.4411			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EU5NW	WOS:000401080000085	28587392	Green Published, gold, Green Submitted			2022-02-06	
J	Gainza-Lein, M; Fernandez, IS; Loddenkemper, T				Gainza-Lein, Marina; Sanchez Fernandez, Ivan; Loddenkemper, Tobias			Use of EEG in critically ill children and neonates in the United States of America	JOURNAL OF NEUROLOGY			English	Article						EEG; Video EEG; Critical care; Pediatric; Health services research	NONCONVULSIVE STATUS EPILEPTICUS; INTENSIVE-CARE-UNIT; THERAPEUTIC HYPOTHERMIA; ELECTROGRAPHIC SEIZURES; CONSENSUS STATEMENT; COMATOSE CHILDREN; CARDIAC-ARREST; ELECTROENCEPHALOGRAPHY; PREVALENCE; PROGNOSIS	The objective of the study was to estimate the proportion of patients who receive an electroencephalogram (EEG) among five common indications for EEG monitoring in the intensive care unit: traumatic brain injury (TBI), extracorporeal membrane oxygenation (ECMO), cardiac arrest, cardiac surgery and hypoxic-ischemic encephalopathy (HIE). We performed a retrospective cross-sectional descriptive study utilizing the Kids' Inpatient Database (KID) for the years 2010-2012. The KID is the largest pediatric inpatient database in the USA and it is based on discharge reports created by hospitals for billing purposes. We evaluated the use of electroencephalogram (EEG) or video-electroencephalogram in critically ill children who were mechanically ventilated. The KID database had a population of approximately 6,000,000 pediatric admissions. Among 22,127 admissions of critically ill children who had mechanical ventilation, 1504 (6.8%) admissions had ECMO, 9201 (41.6%) TBI, 4068 (18.4%) HIE, 2774 (12.5%) cardiac arrest, and 4580 (20.7%) cardiac surgery. All five conditions had a higher proportion of males, with the highest (69.8%) in the TBI group. The mortality rates ranged from 7.02 to 39.9% (lowest in cardiac surgery and highest in ECMO). The estimated use of EEG was 1.6% in cardiac surgery, 4.1% in TBI, 7.2% in ECMO, 8.2% in cardiac arrest, and 12.1% in HIE, with an overall use of 5.8%. Among common indications for EEG monitoring in critically ill children and neonates, the estimated proportion of patients actually having an EEG is low.	[Gainza-Lein, Marina; Sanchez Fernandez, Ivan; Loddenkemper, Tobias] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Div Epilepsy & Clin Neurophysiol, Boston, MA 02115 USA; [Gainza-Lein, Marina] Univ Austral Chile, Fac Med, Valdivia, Chile; [Sanchez Fernandez, Ivan] Univ Barcelona, Hosp St Joan Deu, Dept Child Neurol, Barcelona, Spain		Loddenkemper, T (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Div Epilepsy & Clin Neurophysiol, Boston, MA 02115 USA.	tobias.loddenkemper@childrens.harvard.edu		Loddenkemper, Tobias/0000-0003-2074-0674	Epilepsy Research Fund; Fundacion Alfonso Martin Escudero; HHV6 Foundation; American Epilepsy Society; Epilepsy Foundation of America; Epilepsy Therapy Project; PCORIPatient-Centered Outcomes Research Institute - PCORI; Pediatric Epilepsy Research Foundation; CURE; HHV-6 Foundation; LundbeckLundbeck Corporation; EisaiEisai Co Ltd; Upsher-Smith; Acorda; PfizerPfizer	Marina Gainza-Lein is supported by the Epilepsy Research Fund. Ivan Sanchez Fernan dez is funded by Fundacion Alfonso Martin Escudero and the HHV6 Foundation. Tobias Loddenkemper serves on the Laboratory Accreditation Board for Long Term (Epilepsy and Intensive Care Unit) Monitoring, on the Council (and as Vice President) of the American Clinical Neurophysiology Society, on the American Board of Clinical Neurophysiology, as an Associate Editor for Seizure, as Contributing Editor for Epilepsy Currents, and as an Associate Editor for Wyllie's Treatment of Epilepsy 6th edition. He is part of pending patent applications to detect and predict seizures and to diagnose epilepsy. He receives research support from the Epilepsy Research Fund, the American Epilepsy Society, the Epilepsy Foundation of America, the Epilepsy Therapy Project, PCORI, the Pediatric Epilepsy Research Foundation, CURE, HHV-6 Foundation, and received Research Grants from Lundbeck, Eisai, Upsher-Smith, Acorda, and Pfizer. He serves as a consultant for Zogenix, Upsher Smith, Lundbeck, and Sunovion. He performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies at Boston Children's Hospital and affiliated hospitals and bills for these procedures and he evaluates pediatric neurology patients and bills for clinical care. He has received speaker honorariums from national societies including the AAN, AES and ACNS, and for grand rounds at various academic centers. His wife, Dr. Karen Stannard, is a pediatric neurologist and she performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies and bills for these procedures and she evaluates pediatric neurology patients and bills for clinical care.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2007, PEDIATR NEUROL, V37, P165, DOI 10.1016/j.pediatrneurol.2007.05.012; Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P257, DOI 10.1097/WNP.0000000000000170; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0330-3; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Alehan FK, 2001, J CHILD NEUROL, V16, P484, DOI 10.2310/7010.2001.17060; Berman MF, 2002, AM J NEURORADIOL, V23, P700; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; DeShazo JP, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1025-7; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kessler SK, 2011, NEUROCRIT CARE, V14, P37, DOI 10.1007/s12028-010-9450-2; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Ney JP, 2013, NEUROLOGY, V81, P2002, DOI 10.1212/01.wnl.0000436948.93399.2a; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Shellhaas RA, 2011, J CLIN NEUROPHYSIOL, V28, P611, DOI 10.1097/WNP.0b013e31823e96d7; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Virnig BA, 2001, ANNU REV PUBL HEALTH, V22, P213, DOI 10.1146/annurev.publhealth.22.1.213; Westhall E, 2017, SEMIN NEUROL, V37, P48, DOI 10.1055/s-0036-1595815; Westhall E, 2016, NEUROLOGY, V86, P1482, DOI 10.1212/WNL.0000000000002462; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x	37	7	7	1	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUN	2017	264	6					1165	1173		10.1007/s00415-017-8510-3			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX2TX	WOS:000403081100016	28503704				2022-02-06	
J	Tang, SY; Xu, S; Fourney, WL; Leiste, UH; Proctor, JL; Fiskum, G; Gullapalli, RP				Tang, Shiyu; Xu, Su; Fourney, William L.; Leiste, Ulrich H.; Proctor, Julie L.; Fiskum, Gary; Gullapalli, Rao P.			Central Nervous System Changes Induced by Underbody Blast-Induced Hyperacceleration: An in Vivo Diffusion Tensor Imaging and Magnetic Resonance Spectroscopy Study	JOURNAL OF NEUROTRAUMA			English	Article						DTI; hyperacceleration; MRS; underbody blast	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; AXONAL INJURY; INDUCED NEUROTRAUMA; HIPPOCAMPAL VOLUME; HEAD-INJURY; RAT-BRAIN; MODEL; MR; MECHANISMS	Blast-related traumatic brain injury (bTBI) resulting from improvised explosive devices is the hallmark injury of recent wars, and affects many returning veterans who experienced either direct or indirect exposure. Many of these veterans have long-term neurocognitive symptoms. However, there is very little evidence to show whether blast-induced acceleration alone, in the absence of secondary impacts, can cause mild TBI. In this study, we examine the effect of under-vehicle blast-induced hyperacceleration (uBIH) of similar to 1700 g on the biochemical and microstrucutral changes in the brain using diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (MRS). Two groups of adult male Sprague-Dawley (SD) rats were subjected to a sham procedure and uBIH, respectively. Axonal and neurochemical alterations were assessed using in vivo DTI and MRS at 2 h, 24 h, and 7 days after uBIH. Significant reduction in mean diffusivity, axial diffusivity, and radial diffusivity were observed in the hippocampus, thalamus, internal capsule, and corpus callosum as early as 2 h, and sustained up to 7 days post-uBIH. Total creatine (Cr) and glutamine (Gln) were reduced in the internal capsule at 24 h post-uBIH. The reductions in DTI parameters, Cr and Gln in vivo suggest potential activation of astrocytes and diffuse axonal injury following a single underbody blast, confirming previous histology reports.	[Tang, Shiyu; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Tang, Shiyu; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Core Translat Res Imaging Maryland, Baltimore, MD 21201 USA; [Proctor, Julie L.; Fiskum, Gary] Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA; [Proctor, Julie L.; Fiskum, Gary] Univ Maryland, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA; [Fourney, William L.; Leiste, Ulrich H.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Fourney, William L.; Leiste, Ulrich H.] Univ Maryland, Ctr Energet Concepts Dev, College Pk, MD 20742 USA		Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 S Greene St, Baltimore, MD 21201 USA.	rgullapalli@umm.edu			United States ArmyUnited States Department of Defense [W81XWH-13-1-0016]; United States Air ForceUnited States Department of Defense [711HPW/XPT, FA8650-11-2-6142, FA8650-11-2-6D04]	This material is based on research sponsored by the United States Army grant W81XWH-13-1-0016 and by the United States Air Force grant 711HPW/XPT under Cooperative Agreement numbers FA8650-11-2-6142 and FA8650-11-2-6D04. The United States government is authorized to reproduce and distribute reprints for governmental purposes notwithstanding any copyright notation thereon. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Air Force, the Department of Defense, or the United States government.	Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bremner J.D., 2005, ANN NY ACAD SCI, V1032, P154; Bremner JD, 2004, J CLIN PSYCHIAT, V65, P1559, DOI 10.4088/JCP.v65n1120; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; CHABAI AJ, 1965, J GEOPHYS RES, V70, P5075, DOI 10.1029/JZ070i020p05075; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FRAHM J, 1986, MAGNET RESON MED, V3, P321, DOI 10.1002/mrm.1910030217; Frounfelker P., 2015, US ARM RES DEV ENG C; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haase A, 2011, J Magn Reson, V213, P533, DOI 10.1016/j.jmr.2011.09.021; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Proctor JL, 2014, J TRAUMA ACUTE CARE, V77, pS83, DOI 10.1097/TA.0000000000000340; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Rodriguez O, 2016, J NEUROTRAUM, V33, P662, DOI 10.1089/neu.2015.4002; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Savic J, 1991, Vojnosanit Pregl, V48, P489; Shah Ms Alok S, 2012, Biomed Sci Instrum, V48, P393; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xu S, 2013, MAGN RESON MED, V69, P937, DOI 10.1002/mrm.24321; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhuo JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136151	67	7	7	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2017	34	11					1972	1980		10.1089/neu.2016.4650			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EV4KD	WOS:000401727500007	28322622				2022-02-06	
J	Zatzick, DF; Rowhani-Rahbar, A; Wang, J; Russo, J; Darnell, D; Ingraham, L; Whiteside, LK; Guiney, R; Hedrick, MK; Rivara, FP				Zatzick, Douglas F.; Rowhani-Rahbar, Ali; Wang, Jin; Russo, Joan; Darnell, Doyanne; Ingraham, Leah; Whiteside, Lauren K.; Guiney, Roxanne; Hedrick, Margot Kelly; Rivara, Frederick P.			The Cumulative Burden of Mental, Substance Use, and General Medical Disorders and Rehospitalization and Mortality After an Injury	PSYCHIATRIC SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POLYTRAUMA-CLINICAL-TRIAD; TRAUMATIC INJURY; HOSPITALIZATION; COMORBIDITY; VETERANS; COHORT; CARE; INTERVENTION; READMISSION	Objective: Each year in the United States, 1.5-2.5 million individuals require hospitalization for an injury. Multiple mental, substance use, and chronic general medical disorders are endemic among injury survivors with and without traumatic brain injury (TBI), yet few studies have assessed the association between the cumulative burden of these conditions and health care outcomes. This study of patients hospitalized for an injury assessed associations between comorbid mental, substance use, and general medical disorders, TBI, and violent events or suicide attempts and the postinjury outcomes of recurrent hospitalization and death. Methods: Recurrent hospitalization and all-cause mortality were examined in this population-based retrospective cohort study. A total of 76,942 patients hospitalized for an injury in Washington State during 2006-2007 were followed for five years. ICD-9-CM codes identified conditions prior to or at the index injury admission. Index admissions related to injuries from firearms, assaultive violence, suicide attempts, and overdoses were identified through E-codes. Results: Adjusted regression analyses demonstrated a significant, dose-response relationship between an increasing cumulative burden of disorders and an increasing risk of recurrent hospitalization (four or more conditions, relative risk= 3.89, 95% confidence interval [CI]= 3.66- 4.14). Adjusted Cox proportional hazard regression demonstrated a similar relationship between increasing cumulative burden of disorders and all-cause mortality (four or more conditions, hazard ratio= 5.33, CI= 4.71-6.04). Conclusions: Increasing cumulative burden of disorders was associated with greater postinjury risk of recurrent hospitalization and death. Orchestrated investigative and policy efforts could introduce screening and intervention procedures that target this spectrum of comorbidity.	[Zatzick, Douglas F.; Russo, Joan; Darnell, Doyanne; Ingraham, Leah; Guiney, Roxanne; Hedrick, Margot Kelly] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA; [Whiteside, Lauren K.] Univ Washington, Sch Med, Dept Emergency Med, Seattle, WA USA; [Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Zatzick, Douglas F.; Rowhani-Rahbar, Ali; Wang, Jin; Whiteside, Lauren K.; Guiney, Roxanne; Rivara, Frederick P.] Univ Washington, Sch Med, Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Zatzick, DF (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	dzatzick@uw.edu		Kelly-Hedrick, Margot/0000-0002-2188-1244; Rowhani-Rahbar, Ali/0000-0002-2705-4485; Whiteside, Lauren/0000-0002-0284-5336	City of Seattle [124195]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K24 MH086814, U54 AT007748, UH2/U3 MH106338]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54AT007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [UH3MH106338, UH2MH106338, K24MH086814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K23DA039974] Funding Source: NIH RePORTER	This work was supported by contract 124195 awarded by the City of Seattle and grants K24 MH086814 and U54 AT007748 and UH2/U3 MH106338 from the National Institutes of Health.	American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; [Anonymous], 2012, CDC 2012; [Anonymous], 2007, REP PRES COMM CAR AM; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Cunningham RM, 2009, ACAD EMERG MED, V16, P1078, DOI 10.1111/j.1553-2712.2009.00552.x; D'Onofrio G, 2010, ANN EMERG MED, V56, P551, DOI 10.1016/j.annemergmed.2010.06.562; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Goodman RA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120239; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Merkow RP, 2015, JAMA-J AM MED ASSOC, V313, P483, DOI 10.1001/jama.2014.18614; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rowhani-Rahbar A, 2015, ANN INTERN MED, V162, P492, DOI 10.7326/M14-2362; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Sims DW, 1989, J TRAUMA, V29, P946; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Sugarman J, 2014, JAMA-J AM MED ASSOC, V311, P2381, DOI 10.1001/jama.2014.4164; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; U. S. Department of Health and Human Services, 2010, MULT CHRON COND A ST; WEISBESKI D, 1989, J TRAUMA, V29, P940, DOI 10.1097/00005373-198907000-00006; World Health Organization, 2012, DIS INJ COUNTR EST; Worrell SS, 2006, J TRAUMA, V60, P379, DOI 10.1097/01.ta.0000203549.15373.7b; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zatzick D, 2015, J TRAUMA STRESS, V28, P391, DOI 10.1002/jts.22041; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	31	7	7	0	5	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JUN 1	2017	68	6					596	602		10.1176/appi.ps.201600311			7	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	EW4SH	WOS:000402490700012	28142384	Bronze, Green Accepted			2022-02-06	
J	Ledbetter, C; Moore, AL; Mitchell, T				Ledbetter, Christina; Moore, Amy Lawson; Mitchell, Tanya			Cognitive Effects of ThinkRx Cognitive Rehabilitation Training for Eleven Soldiers with Brain Injury: A Retrospective Chart Review	FRONTIERS IN PSYCHOLOGY			English	Article						cognitive training; cognitive rehabilitation; traumatic brain injury (TBI); neuroplasticity; Memory; processing speed; IQ	CLINICAL-SIGNIFICANCE; ATTENTION; TRIAL; IMPAIRMENT; PLASTICITY; MATTER	Cognitive rehabilitation training is a promising technique for remediating the cognitive deficits associated with brain injury. Extant research is dominated by computer-based interventions with varied results. Results from clinician-delivered cognitive rehabilitation are notably lacking in the literature. The current study examined the cognitive outcomes following ThinkRx, a clinician-delivered cognitive rehabilitation training program for soldiers recovering from traumatic brain injury and acquired brain injury. In a retrospective chart review, we examined cognitive outcomes of 11 cases who had completed an average of 80 h of ThinkRx cognitive rehabilitation training delivered by clinicians and supplemented with digital training exercises. Outcome measures included scores from six cognitive skill batteries on the Woodcock Johnson III Tests of Cognitive Abilities. Participants achieved gains in all cognitive skills tested and achieved statistically significant changes in long-term memory, processing speed, auditory processing, and fluid reasoning with very large effect sizes. Clinically significant changes in multiple cognitive skills were also noted across cases. Results of the study suggest that ThinkRx clinician-delivered cognitive training supplemented with digital exercises may be a viable method for targeting the cognitive deficits associated with brain injury.	[Ledbetter, Christina] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA; [Moore, Amy Lawson] Gibson Inst Cognit Res, Colorado Springs, CO 80919 USA; [Mitchell, Tanya] LearningRx, Res & Dev, Colorado Springs, CO USA		Moore, AL (corresponding author), Gibson Inst Cognit Res, Colorado Springs, CO 80919 USA.	amoore@gibsonresearch.org	Moore, Amy Lawson/H-9591-2014	Moore, Amy Lawson/0000-0002-2514-8701	Gibson Institute of Cognitive Research internal RD funding	Funding for the current study was provided by Gibson Institute of Cognitive Research internal R&D funding.	Atkins DC, 2005, J CONSULT CLIN PSYCH, V73, P982, DOI 10.1037/0022-006X.73.5.982; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carpenter DM, 2016, APPL COGNITIVE PSYCH, V30, P815, DOI 10.1002/acp.3257; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cohen J, 1969, STAT POWER ANAL BEHA; Defense and Veteran's Brain Injury Center [DVBIC], 2017, DOD WORLDW NUMB TRAU; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury [DCOE] and Defense and Veterans' Brain Injury Center, 2009, COGN REH MILD TRAUM; Department of the Army, 2009, WARR TRANS UN CONS G; Faul M, 2010, TRAUMATIC BRAIN INJU; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Gearing RE, 2006, J CAN ACAD CHILD ADO, V15, P126; Gibson K., 2015, VISION DEV REHABILIT, V1, P119; Gibson K, 2003, THINKRX COGNITIVE TR; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Haskins E.C., 2012, COGNITIVE REHABILITA; Huang J. C., 2009, J BEHAV OPTOM, V20, P95; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Ledbetter C., 2016, SOC NEUR SAN DIEG CA; Moore A. L., 2016, SOC NEUR 2016 SAN DI; Schwartz J. M., 2003, MIND BRAIN NEUROPLAS; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Sinotte MP, 2007, NEUROREHABILITATION, V22, P303; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Sumowski JF, 2010, J INT NEUROPSYCH SOC, V16, P1147, DOI 10.1017/S1355617710001128; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Wainer H, 2016, LEARNINGRX CLIENT OU; Wilkins A. J., 2005, ADV CLIN NEUROSCIENC, V4, P22; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Woodcock RW, 2001, WOODCOCKJOHNSON 3; Worster A, 2004, ACAD EMERG MED, V11, P187, DOI 10.1197/j.aem.2003.03.002	36	7	7	1	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 22	2017	8								825	10.3389/fpsyg.2017.00825			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EV9KG	WOS:000402104300002	28588534	Green Published, gold			2022-02-06	
J	Wang, C; Costanzo, ME; Rapp, PE; Darmon, D; Bashirelahi, K; Nathan, DE; Cellucci, CJ; Roy, MJ; Keyser, DO				Wang, Chao; Costanzo, Michelle E.; Rapp, Paul E.; Darmon, David; Bashirelahi, Kylee; Nathan, Dominic E.; Cellucci, Christopher J.; Roy, Michael J.; Keyser, David O.			Identifying Electrophysiological Prodromes of Post-traumatic Stress Disorder: Results from a Pilot Study	FRONTIERS IN PSYCHIATRY			English	Article						post-traumatic stress disorder; prodromes; event-related potentials; delayed onset; traumatic brain injury; P300	EVENT-RELATED POTENTIALS; ANTERIOR CINGULATE CORTEX; COMORBIDITY SURVEY REPLICATION; DIAGNOSTIC-ODDS RATIO; DSM-IV DISORDERS; MILD TBI EXHIBIT; COMBAT VETERANS; CONFIDENCE-INTERVALS; PTSD; P300	The objective of this research project is the identification of a physiological prodrome of post-traumatic stress disorder (PTSD) that has a reliability that could justify preemptive treatment in the sub-syndromal state. Because abnormalities in event-related potentials (ERPs) have been observed in fully expressed PTSD, the possible utility of abnormal ERPs in predicting delayed-onset PTSD was investigated. ERPs were recorded from military service members recently returned from Iraq or Afghanistan who did not meet PTSD diagnostic criteria at the time of ERP acquisition. Participants (n = 65) were followed for up to 1 year, and 7.7% of the cohorts (n = 5) were PTSD-positive at follow-up. The initial analysis of the receiver operating characteristic (ROC) curve constructed using ERP metrics was encouraging. The average amplitude to target stimuli gave an area under the ROC curve of greater than 0.8. Classification based on the Youden index, which is determined from the ROC, gave positive results. Using average target amplitude at electrode Cz yielded Sensitivity = 0.80 and Specificity = 0.87. A more systematic statistical analysis of the ERP data indicated that the ROC results may simply represent a fortuitous consequence of small sample size. Predicted error rates based on the distribution of target ERP amplitudes approached those of random classification. A leave-one-out cross validation using a Gaussian likelihood classifier with Bayesian priors gave lower values of sensitivity and specificity. In contrast with the ROC results, the leave-one-out classification at Cz gave Sensitivity = 0.65 and Specificity = 0.60. A bootstrap calculation, again using the Gaussian likelihood classifier at Cz, gave Sensitivity = 0.59 and Specificity = 0.68. Two provisional conclusions can be offered. First, the results can only be considered preliminary due to the small sample size, and a much larger study will be required to assess definitively the utility of ERP prodromes of PTSD. Second, it may be necessary to combine ERPs with other biomarkers in a multivariate metric to produce a prodrome that can justify preemptive treatment.	[Wang, Chao; Rapp, Paul E.; Darmon, David; Bashirelahi, Kylee; Nathan, Dominic E.; Keyser, David O.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, Bethesda, MD 20814 USA; [Wang, Chao; Costanzo, Michelle E.; Darmon, David; Bashirelahi, Kylee; Nathan, Dominic E.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Costanzo, Michelle E.; Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA; [Costanzo, Michelle E.; Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Nathan, Dominic E.] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Bethesda, MD 20814 USA; [Cellucci, Christopher J.] Aquinas LLC, Berwyn, PA USA		Rapp, PE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, Bethesda, MD 20814 USA.	paul.rapp@usuhs.edu	Wang, Chao/M-3165-2016	Wang, Chao/0000-0002-1313-2569	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [351030]; Defense Medical Research and Development Program [D10_ 1_ AR_ J5_ 605]	Funding was provided by the Center for Neuroscience and Regenerative Medicine Project 351030 and by the Defense Medical Research and Development Program Project D10_ 1_ AR_ J5_ 605.	Addington J, 2012, SCHIZOPHR RES, V142, P77, DOI 10.1016/j.schres.2012.09.012; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Araki T, 2005, NEUROIMAGE, V25, P43, DOI 10.1016/j.neuroimage.2004.11.039; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Blomhoff S, 1998, BIOL PSYCHIAT, V44, P1045, DOI 10.1016/S0006-3223(98)00058-4; Bohning D, 2011, STAT METHODS MED RES, V20, P541, DOI 10.1177/0962280210374532; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CHARLES G, 1995, NEUROPSYCHOBIOLOGY, V32, P72, DOI 10.1159/000119216; Clark S, 2015, J NEURAL TRANSM, V122, P155, DOI 10.1007/s00702-014-1325-9; Cohen J, 1997, INT J PSYCHOPHYSIOL, V25, P249, DOI 10.1016/S0167-8760(96)00743-X; Costello EJ, 2010, J CHILD PSYCHOL PSYC, V51, P526, DOI 10.1111/j.1469-7610.2010.02221.x; Croft RJ, 1998, ELECTROEN CLIN NEURO, V107, P387, DOI 10.1016/S0013-4694(98)00086-8; Darmon D, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18050190; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Efron B., 1993, INTRO BOOTSTRAP; Efron B., 1986, STAT SCI, V1, P54, DOI 10.1214/ss/1177013815; Felmingham KL, 2002, PSYCHIAT RES, V109, P171, DOI 10.1016/S0165-1781(02)00003-3; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Ghisolfi ES, 2004, INT J PSYCHOPHYSIOL, V51, P209, DOI 10.1016/j.ijpsycho.2003.09.002; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hansenne M, 2006, PSYCHOL BELG, V46, P5, DOI 10.5334/pb-46-1-2-5; HOEFFDING W, 1963, J AM STAT ASSOC, V58, P13, DOI 10.2307/2282952; Insel TR, 2007, EARLY INTERV PSYCHIA, V1, P5, DOI 10.1111/j.1751-7893.2007.00017.x; Insel TR, 2008, PSYCHIAT TIMES, V25, P13; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Javanbakht A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-5; Jiang WY, 2008, STAT APPL GENET MOL, V7; Joa I, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0470-5; Johnson JD, 2013, CLIN EEG NEUROSCI, V44, P112, DOI 10.1177/1550059412469742; Jovanovic Tanja, 2011, Front Behav Neurosci, V5, P44, DOI 10.3389/fnbeh.2011.00044; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; Karstoft KI, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0399-8; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kimble M, 2004, J NEUROPSYCH CLIN N, V16, P102, DOI 10.1176/appi.neuropsych.16.1.102; Kimble M, 2000, BIOL PSYCHIAT, V47, P880, DOI 10.1016/S0006-3223(99)00258-9; Kovacs M, 2010, J CHILD PSYCHOL PSYC, V51, P472, DOI 10.1111/j.1469-7610.2010.02230.x; KRAMER AF, 1985, J EXP PSYCHOL HUMAN, V11, P393, DOI 10.1037/0096-1523.11.4.393; Krazanowski W.J., 2009, ROC CURVES CONTINUOU; Lachenbruch P. A., 1975, DISCRIMINANT ANAL; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; MCFARLANE AC, 1993, BIOL PSYCHIAT, V34, P311, DOI 10.1016/0006-3223(93)90088-U; Metzger LJ, 2002, PSYCHOPHYSIOLOGY, V39, P49, DOI 10.1017/S0048577201020029; Metzger LJ, 1997, BIOL PSYCHIAT, V42, P1006, DOI 10.1016/S0006-3223(97)00138-8; Metzger LJ, 1997, INTEGR PHYS BEH SCI, V32, P43, DOI 10.1007/BF02688612; Mulert C, 2004, EUR ARCH PSY CLIN N, V254, P190, DOI 10.1007/s00406-004-0469-2; Murphy JR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-45; Neylan TC, 2003, BIOL PSYCHIAT, V53, P216, DOI 10.1016/S0006-3223(02)01450-6; Neylan TC, 1999, BIOL PSYCHIAT, V46, P1656, DOI 10.1016/S0006-3223(99)00047-5; Orr SP, 2000, J AFFECT DISORDERS, V61, P225, DOI 10.1016/S0165-0327(00)00340-2; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Pepe M S, 2003, STAT EVALUATION MED; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petit G, 2014, NEUROPSYCH DIS TREAT, V10, P1025, DOI 10.2147/NDT.S61475; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rapp PE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00177; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Riley KP, 2005, NEUROBIOL AGING, V26, P341, DOI 10.1016/j.neurobiolaging.2004.06.019; Rothbaum BO, 2012, BIOL PSYCHIAT, V72, P957, DOI 10.1016/j.biopsych.2012.06.002; SHEDLER J, 1993, AM PSYCHOL, V48, P1117, DOI 10.1037/0003-066X.48.11.1117; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Smid GE, 2011, THESIS; Smid GE, 2012, PSYCHOL TRAUMA-US, V4, P312, DOI 10.1037/a0023868; Smid GE, 2009, J CLIN PSYCHIAT, V70, P1572, DOI 10.4088/JCP.08r04484; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Wasserman L., 2010, ALL STAT CONCISE COU; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zou KH, 1997, STAT MED, V16, P2143	80	7	7	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	MAY 15	2017	8								71	10.3389/fpsyt.2017.00071			14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EV3JN	WOS:000401655200001	28555113	gold, Green Published			2022-02-06	
J	Edsberg, LE; Crowgey, EL; Osborn, PM; Wyffels, JT				Edsberg, Laura E.; Crowgey, Erin L.; Osborn, Patrick M.; Wyffels, Jennifer T.			A survey of proteomic biomarkers for heterotopic ossification in blood serum	JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH			English	Article						Heterotopic ossification; SRM-MS; Osteocalcin; Osteomodulin; Collagen alpha-1(v)	TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; RISK-FACTORS; BONE; OSTEOBLASTS; PREVALENCE; NETWORK; MARKERS; MUSCLE; WOUNDS	Background: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarkers for HO using proteomic techniques and blood serum. Methods: Isobaric tags for relative and absolute quantitation (iTRAQ) was used to generate a semi-quantitative global proteomics survey of serum from patients with and without heterotopic ossification. Leveraging the iTRAQ data, a targeted selection reaction monitoring mass spectrometry (SRM-MS) assay was developed for 10 protein candidates: alkaline phosphatase, osteocalcin, alpha-2 type I collagen, collagen alpha-1(V) chain isoform 2 preprotein, bone sialoprotein 2, phosphatidate phosphatase LPIN2, osteomodulin, protein phosphatase 1J, and RRP12-like protein. Results: The proteomic survey of serum from both healthy and disease patients includes 1220 proteins and was enriched for proteins involved in the response to elevated platelet Ca+2, wound healing, and extracellular matrix organization. Proteolytic peptides from three of the ten SRM-MS proteins, osteocalcin preprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein from serum, are potential clinical biomarkers for HO. Conclusions: This study is the first reported SRM-MS analysis of serum from individuals with and without heterotopic ossification, and differences in the serum proteomic profile between healthy and diseased subjects were identified. Furthermore, our results indicate that normal wound healing signals can impact the ability to identify biomarkers, and a multi-protein panel assay, including osteocalcin preproprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein, may provide a solution for HO detection and monitoring.	[Edsberg, Laura E.] Daemen Coll, Nat Sci, Ctr Wound Healing Res, Amherst, NY 14226 USA; [Crowgey, Erin L.] Nemours Alfred I duPont Hosp Children, Bioinformat, Nemours Biomed Res, Wilmington, DE 19803 USA; [Osborn, Patrick M.] San Antonio Mil Med Ctr, San Antonio, TX USA; [Wyffels, Jennifer T.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE 19711 USA		Edsberg, LE (corresponding author), Daemen Coll, Nat Sci, Ctr Wound Healing Res, Amherst, NY 14226 USA.	Ledsberg@daemen.edu	Wyffels, Jennifer/AAS-7919-2020	Wyffels, Jennifer/0000-0002-0884-8634; Crowgey, Erin/0000-0002-2037-0389	Department of DefenseUnited States Department of Defense [W81-WXH-10-2-0139]; Nemours Biomedical Research department; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54-GM104941]	The research was funded by the Department of Defense, grant W81-WXH-10-2-0139, LEE Co-PI. ELC was supported by the Nemours Biomedical Research department and the National Institute of General Medical Sciences of the National Institutes of Health, grant U54-GM104941 (DE-CTR).	Alfieri KA, 2012, BONE JOINT RES, V1, P174, DOI 10.1302/2046-3758.18.2000102; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Chauveau C, 2004, EXP MOL PATHOL, V76, P37, DOI 10.1016/j.yexmp.2003.10.001; Davis TA, 2011, J BONE JOINT SURG AM, V93A, P1122, DOI [10.2106/JBJS.J.01417, 10.2106/JBJSJ.01417]; Edsberg LE, 2012, WOUND REPAIR REGEN, V20, P378, DOI 10.1111/j.1524-475X.2012.00791.x; Evans KN, 2014, CLIN ORTHOP RELAT R, V472, P396, DOI 10.1007/s11999-013-3325-8; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Foruria AM, 2014, BONE JOINT J, V96B, P1681, DOI 10.1302/0301-620X.96B12.34091; Gundberg CM, 2012, ADV NUTR, V3, P149, DOI 10.3945/an.112.001834; Handschin AE, 2006, LANGENBECK ARCH SURG, V391, P376, DOI 10.1007/s00423-005-0021-5; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Lee JH, 2014, BMB REP, V47, P141, DOI 10.5483/BMBRep.2014.47.3.270; Li XJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007013; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Nauth A, 2012, J ORTHOP TRAUMA, V26, P684, DOI 10.1097/BOT.0b013e3182724624; Ninomiya K, 2007, BIOCHEM BIOPH RES CO, V362, P460, DOI 10.1016/j.bbrc.2007.07.193; Patti A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/846480; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Potter BK, 2010, J BONE JOINT SURG AM, V92A, P74, DOI 10.2106/JBJS.J.00776; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tashima T, 2015, BIOCHEM BIOPH RES CO, V463, P292, DOI 10.1016/j.bbrc.2015.05.053; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Wilkinson JM, 2003, J ORTHOPAED RES, V21, P529, DOI 10.1016/S0736-0266(02)00236-X; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53	31	7	8	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-799X			J ORTHOP SURG RES	J. Orthop. Surg. Res.	MAY 4	2017	12								69	10.1186/s13018-017-0567-2			13	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	EV3FA	WOS:000401642000001	28472996	Green Published, gold			2022-02-06	
J	Block, C; Santos, OA; Flores-Medina, Y; Camacho, DFR; Arango-Lasprilla, JC				Block, Cady; Santos, Octavio A.; Flores-Medina, Yvonne; Rivera Camacho, Diego Fernando; Carlos Arango-Lasprilla, Juan			Neuropsychology and Rehabilitation Services in the United States: Brief Report from a Survey of Clinical Neuropsychologists	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Rehabilitation; Professional issues	SURVEY PROFESSIONAL PRACTICES; SALARY SURVEY; U.S. NEUROPSYCHOLOGISTS; BELIEFS; INCOMES	Objective: To provide a brief presentation of preliminary data on rehabilitation services provided by clinical neuropsychologists within the United States. Method: This survey utilized data extracted from a larger international research study conducted in 39 countries including N = 173 professionals who reported to engage in neuropsychological rehabilitative services within the past year (63.6% female, 44.36 +/- 11.83 years of age) took part in the study. Results: Neuropsychologists providing rehabilitation services in the United States in the past year were more likely to provide individual versus group therapy, likely to employ technology (e.g., personal computers, mobile phones/smartphones) as part of treatment services, see a range of diagnostic groups most prominently traumatic brain injury and stroke/vascular conditions, and work to address a range of both cognitive (e.g., memory, attention/concentration, and executive functioning) and psychological (e.g., emotional/behavioral adjustment and well-being, awareness of disability/disease) issues. Conclusions: Prior published surveys suggest that clinical neuropsychologists have a growing involvement in rehabilitation services within the United States but with little clarity as to the actual characteristics of actual professional activities and practices. The present study aimed to provide such information and hopefully will be helpful in promoting additional systematic studies in this area.	[Block, Cady] Ohio State Univ, Wexner Med Ctr, Dept Psychiat & Behav Hlth, Sect Neurobehav Hlth, Columbus, OH 43210 USA; [Santos, Octavio A.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53211 USA; [Flores-Medina, Yvonne] Natl Inst Psychiat Ramon de la Fuente Muniz, Dept Psychol, Mexico City, DF, Mexico; [Rivera Camacho, Diego Fernando] Univ Deusto, Fac Psychol & Educ, Bilbao 48007, Spain; [Carlos Arango-Lasprilla, Juan] BioCruces Hlth Res Inst, Bizkaia 48903, Spain		Block, C (corresponding author), Ohio State Univ, Dept Psychiat & Behav Hlth, Sect Neurobehav Hlth, 1670 Upham Dr, Columbus, OH 43210 USA.	cady.block@osumc.edu	Arango-Lasprilla, Juan Carlos/AAB-5407-2019	Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Flores-Medina, Yvonne/0000-0002-4508-8734			Arango-Lasprilla J. C. O., 2015, NEUROPSICOLOGIA COLO, P21; CAPLAN B, 1982, ARCH PHYS MED REHAB, V63, P362; Arango-Lasprilla JC, 2017, APPL NEUROPSYCH-ADUL, V24, P318, DOI 10.1080/23279095.2016.1185423; Egeland J, 2016, CLIN NEUROPSYCHOL, V30, P1479, DOI 10.1080/13854046.2016.1237675; Fonseca-Aguilar Paola, 2015, Psicol. caribe, V32, P344, DOI 10.14482/psdc.32.3.7896; Guilmette T. J., 2009, ARCH CLIN NEUROPSYCH, V5, P373; Hartlage L. C., 1985, PSYCHOTHERAPY PRIVAT, V3, P61; Fernandez AL, 2016, CLIN NEUROPSYCHOL, V30, P1154, DOI 10.1080/13854046.2016.1197313; Olabarrieta-Landa L, 2016, CLIN NEUROPSYCHOL, V30, P1335, DOI 10.1080/13854046.2016.1183049; Seretny M L, 1986, Arch Clin Neuropsychol, V1, P5, DOI 10.1016/0887-6177(86)90021-1; Sweet J. J., 2010, CLIN NEUROPSYCHOL, V16, P109; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; The Society for Clinical Neuropsychology Division 40 of the American Psychological Association, 2003, PAR DEF PROF PRACT C, P149; Truter S., APPL NEUROP IN PRESS; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212	18	7	7	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2017	32	3					369	374		10.1093/arclin/acx002			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EU2WN	WOS:000400890700011	28431032	Bronze			2022-02-06	
J	Hanson, A; Jolly, NA; Peterson, J				Hanson, Andrew; Jolly, Nicholas A.; Peterson, Jeremy			Safety regulation in professional football: Empirical evidence of intended and unintended consequences	JOURNAL OF HEALTH ECONOMICS			English	Article						Safety regulation; Health outcomes; Unintended consequences	HELMET LAWS; YOUTH	In response to increasing public awareness and negative long-term health effects of concussions, the National Football League implemented the "Crown-of-the-Helmet Rule" (CHR). The CHR imposes penalties on players who initiate contact using the top of the helmet. This paper examines the intended effect of this policy and its potential for unintended consequences. We find evidence supporting the intended effect of the policy-a reduction in weekly concussion reports among defensive players by as much as 32% (34% for all head and neck injuries), but also evidence of an increase in weekly lower extremity injury reports for offensive players by as much as 34%. (C) 2017 Elsevier B.V. All rights reserved.	[Hanson, Andrew; Jolly, Nicholas A.; Peterson, Jeremy] Marquette Univ, Dept Econ, POB 1881, Milwaukee, WI 53211 USA		Hanson, A (corresponding author), Marquette Univ, Dept Econ, POB 1881, Milwaukee, WI 53211 USA.	andrew.r.hanson@marquette.edu; nicholas.jolly@marquette.edu; jeremy.peterson@marquette.edu					Battista Judy, 2013, NY TIMES; Belson K, 2016, NY TIMES; Carpenter CS, 2011, J LAW ECON, V54, P305, DOI 10.1086/652902; Conlin M, 2009, REV ECON STAT, V91, P178, DOI 10.1162/rest.91.1.178; Dickert-Conlin S, 2011, J LAW ECON, V54, P907, DOI 10.1086/661256; DiNardo J, 2001, J HEALTH ECON, V20, P991, DOI 10.1016/S0167-6296(01)00102-3; Edwards JC, 2014, J LAW MED ETHICS, V42, P128, DOI 10.1111/jlme.12126; Fainaru S., 2013, ESPN; NFL, 2013, PLAY HLTH SAF REP; NFL Football Operations, THES OFF REALL GOOD; NFL Football Operations, HLTH SAF RUL CHANG; Niemeier Janet P, 2015, N C Med J, V76, P105; PELTZMAN S, 1975, J POLIT ECON, V83, P677, DOI 10.1086/260352; Public Broadcasting System, CONC WATCH; Public Broadcasting System-Frontline, 2013, LEAG DEN NFLS CONC C; Starkey J. P., 2013, NFL RULE CHANGES ILL; Strauss Chris, 2013, HARSH REALITY NFL CO; Trottenberg Polly, 2013, TREATMENT VALUE PREV	18	7	7	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6296	1879-1646		J HEALTH ECON	J. Health Econ.	MAY	2017	53						87	99		10.1016/j.jhealeco.2017.01.004			13	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	EU9XX	WOS:000401394100006	28319792	Green Published			2022-02-06	
J	Leonard, AV; Menendez, JY; Pat, BM; Hadley, MN; Floyd, CL				Leonard, Anna Victoria; Menendez, Joshua York; Pat, Betty Maki; Hadley, Mark N.; Floyd, Candace Lorraine			Localization of the corticospinal tract within the porcine spinal cord: Implications for experimental modeling of traumatic spinal cord injury	NEUROSCIENCE LETTERS			English	Article						Porcine model; Spinal cord injury; Corticospinal tract; Localization; Tract tracing; Image guided surgery	RED NUCLEUS; FUNCTIONAL-ORGANIZATION; RUBROSPINAL TRACT; MOTOR SYSTEM; LESIONS; RAT; RECOVERY; PROJECTIONS; PIG; LOCOMOTION	Spinal cord injury (SCI) researchers have predominately utilized rodents for SCI modeling and experimentation. Unfortunately, a large number of novel therapies developed in rodent models have failed to demonstrate efficacy in human clinical trials which suggests that improved animal models are an important translational tool. Recently, porcine models of SCI have been identified as a valuable intermediary model for preclinical evaluation of promising therapies to aid clinical translation. However, the localization of the major spinal tracts in pigs has not yet been described. Given that significant differences exist in the location of the corticospinal tract (CST) between rodents and humans, determining its location in pigs will provide important information related to the translational potential of the porcine pre-clinical model of SCI. Thus, the goal of this study is to investigate the localization of the CST within the porcine spinal cord. Mature female domestic pigs (n = 4, 60 kg) received microinjections of fluorescent dextran tracers (Alexa Fluor, 10,000 MW) into the primary motor cortex, using image-guided navigation (StealthStation (R)), to label the CST. At 5 weeks post-tracer injection animals were euthanized, the entire neuroaxis harvested and processed for histological examination. Serial sections of the brain and spinal cord were prepared and imaged using confocal microscopy to observe the location of the CST in pigs. Results demonstrate that the CST of pigs is located in the lateral white matter, signifying greater similarity to human anatomical structure compared to that of rodents. We conclude that the corticospinal tract in pigs demonstrates anatomical similarity to human, suggesting that the porcine model has importance as a translational intermediary pre-clinical model. Published by Elsevier Ireland Ltd.	[Leonard, Anna Victoria; Pat, Betty Maki; Floyd, Candace Lorraine] Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Spain Rehabil Ctr, Birmingham, AL USA; [Menendez, Joshua York; Hadley, Mark N.] Univ Alabama Birmingham, Sch Med, Dept Neurosurg, Birmingham, AL USA; [Leonard, Anna Victoria] Univ Adelaide, Sch Med, Discipline Anat & Pathol, Adelaide, SA, Australia		Floyd, CL (corresponding author), Univ Alabama Birmingham, Dept Phys Med & Rehabil, Spain Rehabil Ctr 529C, 1717 6th Ave South, Birmingham, AL 35249 USA.	anna.leonard@adelaide.edu.au; menendjy@uab.edu; bettypat@uabmc.edu; spinal@uab.edu; candacefloyd@uabmc.edu			University of Alabama through the School of Medicine, Department of Physical Medicine and Rehabilitation; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I21RX002200]; Veterans AffairsUS Department of Veterans Affairs [I21RX002200] Funding Source: NIH RePORTER	This work was supported by the University of Alabama at Birmingham Functional Neurorecovery Resident Physician Collaborative Research Award administered through the School of Medicine, Department of Physical Medicine and Rehabilitation. This work was also conducted through the Birmingham Veteran's Administration Medical Center and is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (I21RX002200).	Aflalo TN, 2006, J NEUROSCI, V26, P6288, DOI 10.1523/JNEUROSCI.0768-06.2006; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; BROWN LT, 1971, EXP BRAIN RES, V13, P432; Brustein E, 1998, J NEUROPHYSIOL, V80, P1245, DOI 10.1152/jn.1998.80.3.1245; Crossman A., 2005, GRAYS ANATOMY ANATOM, V1, P307; Hagan C. E., 2012, COMP ANATOMY HISTOLO; Hendriks WTJ, 2006, J NEUROTRAUM, V23, P18, DOI 10.1089/neu.2006.23.18; Hughes GC, 2003, J APPL PHYSIOL, V94, P1689, DOI 10.1152/japplphysiol.00465.2002; Hukuda S, 1973, Surg Neurol, V1, P107; Jones CF, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025100; KENNEDY PR, 1990, TRENDS NEUROSCI, V13, P474, DOI 10.1016/0166-2236(90)90079-P; Kuchler M, 2002, J COMP NEUROL, V448, P349, DOI 10.1002/cne.10259; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; Liu Y, 1999, J NEUROSCI, V19, P4370; Luehr M, 2014, INNOVATIONS, V9, P60, DOI 10.1097/IMI.0000000000000038; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Morris R, 2011, J NEUROTRAUM, V28, P2439, DOI 10.1089/neu.2010.1708; Muir GD, 2000, EUR J NEUROSCI, V12, P1113, DOI 10.1046/j.1460-9568.2000.00987.x; N. S. C. I. S. Center, 2015, 2015 ANN STAT REP CO; Nieuwenhuys R, 1998, CENTRAL NERVOUS SYST; NSCIS Center, 2016, SPIN CORD INJ SCI FA; Pleticha J, 2013, J NEUROSCI METH, V216, P10, DOI 10.1016/j.jneumeth.2013.03.006; Raineteau O, 2002, EUR J NEUROSCI, V16, P1761, DOI 10.1046/j.1460-9568.2002.02243.x; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Schieber Marc H, 2007, Handb Clin Neurol, V82, P15, DOI 10.1016/S0072-9752(07)80005-4; Skinner SA, 2009, J NEUROSURG-SPINE, V11, P369, DOI 10.3171/2009.3.SPINE08881; Steeves JD, 2011, SPINAL CORD, V49, P257, DOI 10.1038/sc.2010.99; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Wewetzer K, 2011, EXP NEUROL, V229, P80, DOI 10.1016/j.expneurol.2010.08.029; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; WHO, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P1; Yang HS, 2011, NEUROSCI LETT, V504, P45, DOI 10.1016/j.neulet.2011.08.054; Yilgor C, 2013, SPINE, V38, P2156, DOI 10.1097/BRS.0000000000000026; Zhou XH, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01365	39	7	7	1	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 1	2017	648						1	7		10.1016/j.neulet.2017.03.020			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV3RO	WOS:000401677000001	28323088	hybrid			2022-02-06	
J	Whitaker-Lea, WA				Whitaker-Lea, Wittstatt Alexandra			Acute Management of Moderate-Severe Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Intracranial pressure; Management; Outcome; Traumatic brain injury	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; CLINICAL-TRIALS; PREVENTION; HYPOTHERMIA; INDUCTION; COMA	Traumatic brain injury (TBI) continues to be a major public health problem. Proposed treatments have not withstood testing in clinical trials because of failure to account for different types of TBI and other weaknesses in trial design. Management goals continue to be prevention and prompt treatment of secondary insults (hypotension, hypoxia, and other physiologic derangements). This goal is best accomplished by careful attention to airway, breathing, circulation, and basic principles of intensive care unit management. Attempts to intervene prophylactically to prevent intracranial hypertension or other complications have not been beneficial and may even have deleterious effects.	[Whitaker-Lea, Wittstatt Alexandra] Virginia Commonwealth Univ, Dept Neurosurg, 417 North 11th St,6th Floor,POB 980631, Richmond, VA 23298 USA		Whitaker-Lea, WA (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, 417 North 11th St,6th Floor,POB 980631, Richmond, VA 23298 USA.	avaladka@gmail.com					American College of Surgeons Trauma Quality Improvement Program, ACS TQIP BEST PRACT; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; [Anonymous], 2015, C TRAUM BRAIN INJ US; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Faul M, 2010, TRAUMATIC BRAIN INJU; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Neurocritical Care Society, NEUR CAR SOC 2014 AN; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383	41	7	9	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					227	+		10.1016/j.pmr.2016.12.002			18	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	EU5AJ	WOS:000401043700004	28390510				2022-02-06	
J	Gao, M; Dong, Q; Yao, H; Lu, YZ; Ji, XC; Zou, MM; Yang, ZJ; Xu, MH; Xu, RX				Gao, Mou; Dong, Qin; Yao, Hui; Lu, Yingzhou; Ji, Xinchao; Zou, Mingming; Yang, Zhijun; Xu, Minhui; Xu, Ruxiang			Systemic Administration of Induced Neural Stem Cells Regulates Complement Activation in Mouse Closed Head Injury Models	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION; EXPRESSION; IMMUNE; DISEASE; PROTEIN; CRRY; TRANSPLANTATION; INHIBITION	Complement activation plays important roles in the pathogenesis of central nervous system (CNS) diseases. Patients face neurological disorders due to the development of complement activation, which contributes to cell apoptosis, brain edema, blood-brain barrier dysfunction and inflammatory infiltration. We previously reported that induced neural stem cells (iNSCs) can promote neurological functional recovery in closed head injury (CHI) animals. Remarkably, we discovered that local iNSC grafts have the potential to modulate CNS inflammation post-CHI. In this study, we aimed to explore the role of systemically delivered iNSCs in complement activation following CNS injury. Our data showed that iNSC grafts decreased the levels of sera C3a and C5a and down-regulated the expression of C3d, C9, active Caspase-3 and Bax in the brain, kidney and lung tissues of CHI mice. Furthermore, iNSC grafts decreased the levels of C3d(+)/ NeuN(+), C5b-9(+)/ NeuN(+), C3d(+)/Map2(+) and C5b-9(+)/Map2(+) neurons in the injured cortices of CHI mice. Subsequently, we explored the mechanisms underlying these effects. With flow cytometry analysis, we observed a dramatic increase in complement receptor type 1-related protein y (Crry) expression in iNSCs after CHI mouse serum treatment. Moreover, both in vitro and in vivo loss-of-function studies revealed that iNSCs could modulate complement activation via Crry expression.	[Gao, Mou; Xu, Minhui] Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China; [Gao, Mou; Yao, Hui; Ji, Xinchao; Zou, Mingming; Yang, Zhijun; Xu, Ruxiang] PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Dong, Qin] Capital Med Univ, Fu Xing Hosp, Dept Neurol, Beijing 100038, Peoples R China; [Lu, Yingzhou] Capital Med Univ, Fu Xing Hosp, Dept Obstet, Beijing 100038, Peoples R China		Xu, MH (corresponding author), Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China.; Xu, RX (corresponding author), PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.	dpmhxu@126.com; jzprofxu@126.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81671189]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2013M532138]	We thank Dr. Jianwei Zhu, Dr. Cuiying Wu, Dr. Yang Yang, Ms. Chen Chen, Dr. Weiqiang Jia, Dr. Xiaohu Nie, Ms. Ning Liu and Ms. Qinqin Wang for technical support. This work was supported by grants from the National Natural Science Foundation of China (NSFC) (No. 81671189), and the China Postdoctoral Science Foundation (2013M532138).	Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Canova C, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-22; Caragine TA, 2002, BLOOD, V100, P3304, DOI 10.1182/blood.V100.9.3304; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao M, 2017, BRAIN BEHAV IMMUN, V59, P288, DOI 10.1016/j.bbi.2016.09.020; Gao M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29955; Garrett MC, 2009, BRAIN RES, V1298, P171, DOI 10.1016/j.brainres.2009.04.047; Govoni M, 2016, J AUTOIMMUN, V74, P41, DOI 10.1016/j.jaut.2016.06.013; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Jacob A, 2014, MOL IMMUNOL, V61, P149, DOI 10.1016/j.molimm.2014.06.039; Kim H, 2014, CYTOTHERAPY, V16, P357, DOI 10.1016/j.jcyt.2013.10.011; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Lee JD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-119; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lyzogubov V, 2014, AM J PATHOL, V184, P2537, DOI 10.1016/j.ajpath.2014.06.001; Miwa T, 2002, BLOOD, V99, P3707, DOI 10.1182/blood.V99.10.3707; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Payne NL, 2013, CELL TRANSPLANT, V22, P1409, DOI 10.3727/096368912X657620; Pedersen ED, 2009, SCAND J IMMUNOL, V69, P555, DOI 10.1111/j.1365-3083.2009.02253.x; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Yao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137211; Zeng SM, 2016, J PATHOL, V238, P446, DOI 10.1002/path.4669	32	7	7	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 6	2017	7								45989	10.1038/srep45989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER1JN	WOS:000398546500001	28383046	Green Published, gold			2022-02-06	
J	Chan, CWL; Miller, WC; Queree, M; Noonan, VK; Wolfe, DL				Chan, Christie W. L.; Miller, William C.; Queree, Matthew; Noonan, Vanessa K.; Wolfe, Dalton L.		SCIRE Res Team	The development of an outcome measures toolkit for spinal cord injury rehabilitation	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Assessment tools; Consensus; Delphi technique; Outcome assessment; Psychometrics	QUALITY-OF-LIFE; HEALTH CONDITIONS; TRAUMATIC BRAIN; SCALE; RELIABILITY; INDEX; VALIDATION; DISABILITY; VALIDITY; QUESTIONNAIRE	Background. Spinal cord injury (SCI) is a complex medical condition that can be difficult to monitor. Purpose. This study aimed to establish a common set of validated outcome measures specifically for SCI clinical practice. Method. In a three-round online Delphi process, experts in SCI care across Canada suggested and ranked outcome measures for clinical practice. The facilitators provided feedback between rounds and determined if consensus (at least 75% agreement) was reached on a single outcome measure per clinical area. Findings. One hundred and forty-eight outcome measures were initially considered for inclusion. After three rounds, consensus was reached for 23 out of 30 clinical areas. In the remaining seven, more than one outcome measure was recommended. The final toolkit comprises 33 outcome measures with sufficient measurement properties for use with a SCI population. Implications. An outcome measures toolkit validated specifically for SCI should lead to improved identification of best practice and enable clinicians to monitor client progress effectively.	[Chan, Christie W. L.; Miller, William C.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, T325 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada; [Miller, William C.] Univ British Columbia, Fac Med, Profess Educ, Vancouver, BC, Canada; [Queree, Matthew] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Noonan, Vanessa K.] Rick Hansen Inst, Practice Implementat, Vancouver, BC, Canada		Miller, WC (corresponding author), Univ British Columbia, Dept Occupat Sci & Occupat Therapy, T325 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.		Miller, William/S-7407-2019		SCI Solutions Network (SCISN) Grant from the Rick Hansen Institute [2010-57]	SCI Solutions Network (SCISN) Grant (2010-57) from the Rick Hansen Institute. Principal Investigator: Janice Eng, PhD.	Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; Alexander MS, 2009, SPINAL CORD, V47, P582, DOI 10.1038/sc.2009.18; American Spinal Injury Association, 2002, INT STAND NEUR CLASS; Andresen EM, 1999, ARCH PHYS MED REHAB, V80, P877, DOI 10.1016/S0003-9993(99)90077-1; Andrews AW, 1996, PHYS THER, V76, P248, DOI 10.1093/ptj/76.3.248; [Anonymous], 2007, PRACT ASSESS RES EVA, DOI DOI 10.1576/T0AG.7.2.120.27071; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Bates-Jensen B M, 1992, Decubitus, V5, P20; BERG K, 1989, Physiotherapy Canada, V41, P304; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; BIERI D, 1990, PAIN, V41, P139, DOI 10.1016/0304-3959(90)90018-9; Biering-Sorensen F, 2006, SPINAL CORD, V44, P530, DOI 10.1038/sj.sc.3101930; Black Joyce, 2007, Dermatol Nurs, V19, P343; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Cardenas DA, 2002, ARCH PHYS MED REHAB, V83, P1708, DOI 10.1053/apmr.2002.35651; Catz A, 1997, SPINAL CORD, V35, P850, DOI 10.1038/sj.sc.3100504; Charlton J. R. H., 2004, SAGE ENCY SOCIAL SCI, P245, DOI DOI 10.4135/9781412950589.N219; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Craven C, 2012, J SPINAL CORD MED, V35, P361, DOI 10.1179/2045772312Y.0000000046; Demers L., 2002, TECHNOL DISABIL, V14, P101, DOI [10.3233/TAD-2002-14304, 10.13072/midss.298, DOI 10.3233/TAD-2002-14304]; Ditunno JF, 2000, SPINAL CORD, V38, P234, DOI 10.1038/sj.sc.3100993; Dobkin BH, 2009, CURR OPIN NEUROL, V22, P563, DOI 10.1097/WCO.0b013e3283314b11; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Eng J. J., 2014, SPINAL CORD INJURY R; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Hammel J., 2013, MODULE 2 USING OUTCO; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harvey LA, 1998, SPINAL CORD, V36, P427, DOI 10.1038/sj.sc.3100636; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hermann RC, 2004, MED CARE, V42, P1246, DOI 10.1097/00005650-200412000-00012; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Jette AM, 2002, MILBANK Q, V80, P325, DOI 10.1111/1468-0009.t01-1-00006; Johnston MV, 2008, J SPINAL CORD MED, V31, P13, DOI 10.1080/10790268.2008.11753976; Jutai J., 2002, TECHNOLOGY DISABILIT, V14, P107, DOI DOI 10.3233/TAD-2002-14305; Kalsi-Ryan S, 2009, TOP SPINAL CORD INJ, V14, P34, DOI DOI 10.1310/sci1404-34; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Law M., 1987, CAN J OCCUP THER, V54, P133, DOI [DOI 10.1177/000841748705400308, 10.1177/000841748705400308]; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Ludwig B, 1997, J EXTENSION, V35, P5; Marino RJ, 1998, ARCH PHYS MED REHAB, V79, P1512, DOI 10.1016/S0003-9993(98)90412-9; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; May LA, 2002, SPINAL CORD, V40, P341, DOI 10.1038/sj.sc.3101311; Mulcahey MJ, 2007, J REHABIL RES DEV, V44, P91, DOI 10.1682/JRRD.2005.10.0167; National Institute of Neurological Disorders and Stroke, COMM DAT EL PROJ; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Pullman SL, 2000, NEUROLOGY, V55, P171, DOI 10.1212/WNL.55.2.171; Raichle KA, 2006, J PAIN, V7, P179, DOI 10.1016/j.jpain.2005.10.007; Rehabilitation Institute of Chicago, 2010, REH MEAS DAT; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Salzberg CA, 1996, AM J PHYS MED REHAB, V75, P96, DOI 10.1097/00002060-199603000-00004; Scherer MJ, 2001, DISABIL REHABIL, V23, P387; Skinner A, 2006, CLIN REHABIL, V20, P609, DOI 10.1191/0269215506cr981oa; Smith AW, 2000, ARCH PHYS MED REHAB, V81, P1428, DOI 10.1053/apmr.2000.9399; SMITH HB, 1973, AM J OCCUP THER, V27, P244; SOLLERMAN C, 1995, SCAND J PLAST RECONS, V29, P167, DOI 10.3109/02844319509034334; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Taleporos G, 2002, SEX DISABIL, V20, P159, DOI 10.1023/A:1021441631385; Taylor WJ, 2008, ANN RHEUM DIS, V67, P1652, DOI 10.1136/ard.2007.079970.corr1; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; Wade DT, 2004, CLIN REHABIL, V18, P233, DOI 10.1191/0269215504cr183ed; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weigl M, 2004, J REHABIL MED, V36, P12, DOI 10.1080/16501960410015443; West GTA Stroke Network, 2009, IMPL REG STROK REH A; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wong JYP, 2007, J HAND THER, V20, P49, DOI 10.1197/j.jht.2006.10.004	75	7	7	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2017	84	2					119	129		10.1177/0008417417690170			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU0PA	WOS:000400712500008	28378605				2022-02-06	
J	Chaudhry, R; Batra, S; Mancillas, OL; Wegner, R; Grewal, N; Williams, GW				Chaudhry, Rabail; Batra, Sachin; Mancillas, Omar L.; Wegner, Robert; Grewal, Navneet; Williams, George W.			In-Hospital Mortality with Use of Percutaneous Endoscopic Gastrostomy in Traumatic Brain Injury Patients: Results of a Nationwide Population-Based Study	NEUROCRITICAL CARE			English	Article						Percutaneous endoscopic gastrostomy; PEG; Traumatic brain injury; In-hospital mortality; Nutrition; Patient outcomes	RISK-FACTORS; COMORBIDITY; INDEX	Percutaneous endoscopic gastrostomy (PEG) is a frequently performed invasive procedure that has been associated with high short-term mortality. Its use of special interest in traumatic brain injury (TBI) patients as nutrition support constitutes important issues in intensive care of this group. We used a national database to determine the incidence of, and factors associated with, in-hospital mortality among TBI patients undergoing PEG. We conducted a retrospective study using the US nationwide inpatient sample to analyze data from all hospitalizations in 2008 with International Classification of Diseases, Ninth Revision, diagnostic and procedure codes identifying patients with TBI and hemorrhagic stroke who received PEG. Bivariate and multivariate logistic regression analyses were performed using demographic and clinical variables to identify predictors of in-hospital mortality in this patient population. Patients who did not undergo PEG were used as control. In-hospital mortality after PEG was 6% (95% CI, 0.05-0.76%) among the TBI population with 0.2% occurring in the first 7 days and 2% occurring in the first 14 days. These patients had a higher incidence of other trauma-related comorbidities and were classified as high-risk stratification based on SRRi score compared to the non-PEG group. Factors strongly predictive of in-hospital mortality were age > 51 years, not receiving a PEG, and having a high comorbidity burden of > 2. Understanding the rate of mortality associated with PEG in this patient population and identifying factors that increase and decrease the risk of death will improve patient selection for those most likely to benefit from this procedure.	[Chaudhry, Rabail; Mancillas, Omar L.; Wegner, Robert; Grewal, Navneet] Univ Texas Houston, McGovern Med Sch, Dept Anesthesiol, 6431 Fannin,MSB 5-020, Houston, TX 77030 USA; [Batra, Sachin] Harvard Med Sch, Dept Surg, Boston, MA USA; [Williams, George W.] Univ Texas Houston, McGovern Med Sch, Dept Anesthesiol & Neurosurg, 6431 Fannin,MSB 5-020, Houston, TX 77030 USA		Williams, GW (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Anesthesiol & Neurosurg, 6431 Fannin,MSB 5-020, Houston, TX 77030 USA.	George.W.Williams@uth.tmc.edu		Chaudhry, Rabail/0000-0002-8827-0579			Arora G, 2013, CLIN GASTROENTEROL H, V11, P1437, DOI 10.1016/j.cgh.2013.04.011; Clark D, 2011, ICDPIC; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Grant MD, 1998, JAMA-J AM MED ASSOC, V279, P1973, DOI 10.1001/jama.279.24.1973; Gullo A, 2012, IMPACT NUTR ROUTE IN, P411; Johnston SD, 2008, GASTROINTEST ENDOSC, V68, P223, DOI 10.1016/j.gie.2007.10.019; Lang A, 2004, ENDOSCOPY, V36, P522, DOI 10.1055/s-2004-814400; Macario A, 1997, ANESTHESIOLOGY, V86, P92, DOI 10.1097/00000542-199701000-00013; Marimuthu K, 2012, ANN SURG, V255, P1060, DOI 10.1097/SLA.0b013e318252edf8; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Rabeneck L, 1996, J GEN INTERN MED, V11, P287, DOI 10.1007/BF02598270; Richter-Schrag HJ, 2011, CAN J GASTROENTEROL, V25, P201, DOI 10.1155/2011/609601; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387	16	7	8	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					232	238		10.1007/s12028-016-0330-2			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300011	27905046				2022-02-06	
J	Doig, E; Fleming, J; Ownsworth, T; Fletcher, S				Doig, Emmah; Fleming, Jenny; Ownsworth, Tamara; Fletcher, Stephanie			An occupation-based, metacognitive approach to assessing error performance and online awareness	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						awareness; brain injury; executive function; patient outcome assessment; rehabilitation	TRAUMATIC BRAIN-INJURY; SELF-AWARENESS; NORMATIVE DATA; DEFICITS; INTERVENTIONS; RELIABILITY; DYSFUNCTION; EXECUTION; EDUCATION; FLUENCY	Background/aim: Online awareness is the ability to self-monitor, identify and self-correct errors while engaged in an activity. Current assessments of online awareness involve observing and classifying error behaviour during structured, uniform tasks. However, during rehabilitation, practitioners typically work towards improving performance in individually meaningful tasks unique to the client. This article presents a metacognitive, task analytic approach to assessing online awareness involving observation and classification of errors during meaningful occupations determined after client-centred goal setting with two male clients with severe traumatic brain injury (aged 22 and 23). Study aims were to describe the approach, evaluate its feasibility and determine inter-rater agreement for error detection and error categorisation by two experienced occupational therapists. Furthermore, the error profiles and cognitive impairments of the participants on standardised neuropsychological assessment were examined to explore the validity of the assessment. Methods: Individualised assessment tasks included snack preparation, budgeting, timetabling, hot-drink preparation and use of a computer program, which were administered repeatedly over two to three months and audio-visual recordings taken. Independent ratings of two trained occupational therapists were compared using exact percent agreement. Results: Overall agreement about errors was 76%, for which there was 65% agreement about error categorisation and 100% agreement about error correction. Conclusions: There was fair inter-rater agreement between two trained occupational therapists of error behaviour and error correction when using the described occupation-based approach to assessing online awareness. This approach has promise, particularly when combined with standardised, neuropsychological assessments, for providing an in-depth understanding of error behaviour and awareness of errors during meaningful occupations.	[Doig, Emmah; Fleming, Jenny; Fletcher, Stephanie] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia Campus, Brisbane, Qld 4072, Australia; [Fleming, Jenny] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Fleming, Jenny] Queensland Hlth, Metro South Hlth Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Griffith Hlth Inst, Griffith Sch Appl Psychol, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Griffith Hlth Inst, Behav Basis Hlth Program, Brisbane, Qld, Australia		Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia Campus, Brisbane, Qld 4072, Australia.	e.doig@uq.edu.au	Doig, Emmah/AAG-6674-2021; Ownsworth, Tamara/ABB-6961-2021	Doig, Emmah/0000-0002-7020-053X; Ownsworth, Tamara/0000-0003-1835-7094	University of QueenslandUniversity of Queensland [2012003082]	This research was conducted with the assistance of the University of Queensland New Staff Research Start-Up grant (grant number 2012003082).	Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Burgess P, 1996, BEHAV ASSESSMENT DYS; Buxbaum LJ, 1997, COGNITIVE NEUROPSYCH, V14, P219, DOI 10.1080/026432997381565; Chapparo C, 1997, OCCUPATIONAL PERFORM, P189; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Cicerone K., 2014, HDB NEUROPSYCHOLOGY, P191, DOI [10.1007/978-1-4939-0784-7_10, DOI 10.1007/978-1-4939-0784-7_10]; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Creek J., 2010, CORE CONCEPTS OCCUPA; Doig E, 2014, AM J OCCUP THER, V68, P578, DOI 10.5014/ajot.2014.010785; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V1; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V2; Fleming J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI [https://doi.org/10.1177/030802269505800204, DOI 10.1177/030802269505800204]; Fleming JM, 1996, BRAIN INJURY, V10, P1; Franzen M. D., 1998, ECOLOGICAL VALIDITY, P91; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Law M, 1991, CANADIAN OCCUPATIONA; Lee GP, 1997, CLIN NEUROPSYCHOL, V11, P59, DOI 10.1080/13854049708407030; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McNaughton S., 1987, PAUSE PROMPT PRAISE; Nott MT, 2009, AUST OCCUP THER J, V56, P307, DOI 10.1111/j.1440-1630.2008.00763.x; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Schmidt J, 2012, AUST OCCUP THER J, V59, P138, DOI 10.1111/j.1440-1630.2012.00998.x; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherer M., 2014, HDB NEUROPSYCHOLOGY, P233, DOI [10.1007/978-1-4939-0784-7_12, DOI 10.1007/978-1-4939-0784-7_12]; Simmond M., 2003, OCCUP THER J RES, V66, P447, DOI [10.1177/030802260306601003, DOI 10.1177/030802260306601003]; Tate RL, 2012, BRAIN IMPAIR, V13, P347, DOI 10.1017/BrImp.2012.32; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8	37	7	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	APR	2017	64	2					137	148		10.1111/1440-1630.12322			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	ET9BZ	WOS:000400602000006	27619079				2022-02-06	
J	Fujita, M; Oda, Y; Yamashita, S; Kaneda, K; Kaneko, T; Suehiro, E; Dohi, K; Kuroda, Y; Kobata, H; Tsuruta, R; Maekawa, T				Fujita, Motoki; Oda, Yasutaka; Yamashita, Susumu; Kaneda, Kotaro; Kaneko, Tadashi; Suehiro, Eiichi; Dohi, Kenji; Kuroda, Yasuhiro; Kobata, Hitoshi; Tsuruta, Ryosuke; Maekawa, Tsuyoshi		Brain Hypothermia B-Hypo Study	Early-Stage Hyperoxia Is Associated with Favorable Neurological Outcomes and Survival after Severe Traumatic Brain Injury: A Post-Hoc Analysis of the Brain Hypothermia Study	JOURNAL OF NEUROTRAUMA			English	Article						hyperoxia; PaO2; P/F ratio; TBI	NEUROGENIC PULMONARY-EDEMA; IN-HOSPITAL MORTALITY; CEREBRAL-BLOOD-FLOW; ARTERIAL HYPEROXIA; CARDIAC-ARREST; RESUSCITATION; METAANALYSIS; COHORT	The effects of hyperoxia on the neurological outcomes of patients with severe traumatic brain injury (TBI) are still controversial. We examined whether the partial pressure of arterial oxygen (PaO2) and hyperoxia were associated with neurological outcomes and survival by conducting post-hoc analyses of the Brain Hypothermia (B-HYPO) study, a multicenter randomized controlled trial of mild therapeutic hypothermia for severe TBI. The differences in PaO2 and PaO2/fraction of inspiratory oxygen (P/F) ratio on the 1st day of admission were compared between patients with favorable (n = 64) and unfavorable (n = 65) neurological outcomes and between survivors (n = 90) and deceased patients (n = 39). PaO2 and the P/F ratio were significantly greater in patients with favorable outcomes than in patients with unfavorable neurological outcomes (PaO2: 252 +/- 122 vs. 202 +/- 87mm Hg, respectively, p = 0.008; P/F ratio: 455 +/- 171 vs. 389 +/- 155, respectively, p = 0.022) and in survivors than in deceased patients (PaO2: 242 +/- 117 vs. 193 +/- 75mm Hg, respectively, p = 0.005; P/F ratio: 445 +/- 171 vs. 370 +/- 141, respectively, p = 0.018). Similar tendencies were observed in subgroup analyses in patients with fever control and therapeutic hypothermia, and in patients with an evacuated mass or other lesions (unevacuated lesions). PaO2 was independently associated with survival (odds ratio 1.008, p = 0.037). These results suggested that early-stage hyperoxia might be associated with favorable neurological outcomes and survival following severe TBI.	[Fujita, Motoki; Oda, Yasutaka; Kaneda, Kotaro; Suehiro, Eiichi; Tsuruta, Ryosuke] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Dept Emergency Med, Yamaguchi, Japan; [Kaneko, Tadashi] Kumamoto Univ Hosp, Emergency & Gen Med, Kumamoto, Japan; [Suehiro, Eiichi] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi, Japan; [Dohi, Kenji] Showa Univ Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Kuroda, Yasuhiro] Kagawa Univ, Fac Med, Dept Emergency Disaster & Crit Care Med, Takamatsu, Kagawa, Japan; [Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Osaka, Japan; [Maekawa, Tsuyoshi] Yamaguchi Prefectural Grand Med Ctr, Yamaguchi, Japan		Fujita, M (corresponding author), Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	motoki-ygc@umin.ac.jp	Suehiro, Eiichi/I-5852-2019; Kaneko, Tadashi/AAD-1516-2022	Kaneko, Tadashi/0000-0002-7171-7231; dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001) and by the Japanese Human Science Association, 2002-2004.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; Fujita M, 2010, SHOCK, V34, P299, DOI 10.1097/SHK.0b013e3181ceeeec; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Ihle JF, 2013, CRIT CARE RESUSC, V15, P186; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kobata H, 2017, J NEUROTRAUM, V34, P987, DOI 10.1089/neu.2016.4662; KURODA Y, 1992, NEUROSURGERY, V30, P687; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; SCHELL RM, 1993, ANESTH ANALG, V76, P849; Suehiro E., 2015, J NEUROTRAUM, V32, P1; The Japan Society of Neurotraumatology, 2001, GUID MAN SEV HEAD IN	28	7	7	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1565	1570		10.1089/neu.2016.4753			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500008	27958774				2022-02-06	
J	Meyer, RM; Larkin, MB; Szuflita, NS; Neal, CJ; Tomlin, JM; Armonda, RA; Bailey, JA; Bell, RS				Meyer, R. Michael; Larkin, M. Benjamin; Szuflita, Nicholas S.; Neal, Chris J.; Tomlin, Jeffrey M.; Armonda, Rocco A.; Bailey, Jeffrey A.; Bell, Randy S.			Early venous thromboembolism chemoprophylaxis in combat-related penetrating brain injury	JOURNAL OF NEUROSURGERY			English	Article						penetrating brain injury; venous thromboembolism chemoprophylaxis; military neurosurgery; trauma; traumatic brain injury	TRAUMATIC BRAIN; ANTICOAGULATION; EFFICACY; SAFETY	OBJECTIVE Traumatic brain injury (TB!) is independently associated with deep vein thrombosis (DVT) and pulmonary embolism (PE). Given the numerous studies of civilian closed-head injury, the Brain Trauma Foundation recommends venous thromboembolism chemoprophylaxis (VTC) after severe TBI. No studies have specifically examined this practice in penetrating brain injury (FBI). Therefore, the authors examined the safety and effectiveness of early VTC after FBI with respect to worsening intracranial hemorrhage and DVT or PE. METHODS The Kandahar Airfield neurosurgery service managed 908 consults between January 2010 and March 2013. Eighty of these were US active duty members with FBI, 13 of whom were excluded from analysis because they presented with frankly nonsurvivable CNS injury or they died during initial resuscitation. This is a retrospective analysis of the remaining 67 patients. RESULTS Thirty-two patients received early VTC and 35 did not. Mean time to the first dose was 24 hours. Fifty-two patients had blast-related PBI and 15 had gunshot wounds (GSWs) to the head. The incidence of worsened intracranial hemorrhage was 16% after early VTC and 17% when it was not given, with the relative risk approaching 1 (RR = 0.91). The incidence of DVT or PE was 12% after early VTC and 17% when it was not given (RR = 0.73), though this difference was not statistically significant. CONCLUSIONS Early VTC was safe with regard to the progression of intracranial hemorrhage in this cohort of combat related PBI patients. Data in this study suggest that this intervention may have been effective for the prevention of DVT or PE but not statistically significantly so. More research is needed to clarify the safety and efficacy of this practice.	[Meyer, R. Michael; Larkin, M. Benjamin; Szuflita, Nicholas S.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Neal, Chris J.; Tomlin, Jeffrey M.; Armonda, Rocco A.; Bell, Randy S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Walter Reed Natl Mil Med Ctr, Div Neurosurg, 8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Tomlin, Jeffrey M.] Naval Med Ctr San Diego, Dept Neurosurg, San Diego, CA USA; [Armonda, Rocco A.] Georgetown Univ, Dept Neurosurg, Washington, DC USA; [Bailey, Jeffrey A.] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Dept Surg, 8901 Wisconsin Ave, Bethesda, MD 20889 USA		Bell, RS (corresponding author), Uniformed Serv Univ Hlth Sci, Div Neurosurg, Dept Surg, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.; Bell, RS (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	randy.s.bell.mil@mail.mil					Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Ingalls N, 2014, JAMA SURG, V149, P807, DOI 10.1001/jamasurg.2014.621; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179	17	7	8	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2017	126	4					1047	1055		10.3171/2016.4.JNS16101			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EQ1NX	WOS:000397837900004	27315028	Bronze			2022-02-06	
J	Plourde, V; Brooks, BL				Plourde, Vickie; Brooks, Brian L.			Is Computerized Cognitive Testing Useful in Children and Adolescents with Moderate-to-Severe Traumatic Brain Injury?	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Pediatric; Head injury; Neuropsychology; Validity; Assessment; Computer test	FALSE DISCOVERY RATE; QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL ASSESSMENT; EMERGENCY-DEPARTMENT; YOUNG-CHILDREN; POST-TBI; RECOVERY; OUTCOMES; ATTENTION; CHILDHOOD	Objectives: Children and adolescents with moderate-to-severe traumatic brain injury (TBI) present with short and long-term neuropsychological deficits following their injury. The aim of this study was to investigate the utility of a brief computerized test battery for evaluating cognitive functioning sub-acutely following a TBI. Methods: Participants (n = 33) sustained a moderate-to-severe TBI, were between 8 and 18 years old, and were assessed using CNS Vital Signs (CNSVS) within 6 months post-injury (median = 0.6 month). Participants with TBI were matched to 33 healthy controls based on age, sex, and handedness to compare their cognitive functioning on the CNSVS battery. Results: Children and adolescents with moderate-to-severe TBI had significantly lower scores and large effect sizes on Reaction Time, Complex Attention, and Cognitive Flexibility domains, as well as medium effect sizes on two Visual Memory test scores and one Psychomotor Speed test score. A significantly higher percentage of participants with TBI had cognitive impairment on Reaction Time domain score compared to the control group. Finally, CNSVS domain scores correctly categorized 76% of participants as either group with TBI or control group. Conclusions: CNSVS may be a useful tool for screening cognitive abilities in children and adolescents who are early in their recovery from a moderate-to-severe TBI, particularly when a rapid screening evaluation can help guide management, interventions, and track recovery.	[Plourde, Vickie; Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Plourde, Vickie; Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Brain Injury & Rehabil Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Arts, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca		Plourde, Vickie/0000-0002-0098-5431	Alberta Children's Hospital Research Institute (ACHRI); Cumming School of Medicine; Integrated Concussion Research Program (ICRP) at the University of Calgary; Neurosciences Program at the Alberta Children's Hospital and a Canadian Institutes for Health Research (CIHR); Alberta Innovates [201610079] Funding Source: researchfish	Special thanks to the families who participated in this research. The authors thank Helen Carlson PhD for her time and expertise with data management, as well as (alphabetically) Hussain Daya, Christianne Lalibert Durish, Lisa Goodman, Courtney Habina, Michelle Huie, Andrea Jubinville, Lonna Mitchell, Victoria Purcell, Jasmine Santos, Kalina Slepicka, Emily Tam, and Julie Wershler for help with data entry into the larger BrainChild database program. Vickie Plourde PhD is supported by the Alberta Children's Hospital Research Institute (ACHRI), the Cumming School of Medicine, and the Integrated Concussion Research Program (ICRP) at the University of Calgary. Brian Brooks PhD receives salary support from the Neurosciences Program at the Alberta Children's Hospital and a Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary award. Disclosure: Collection of computer-assisted cognitive data was supported by in-kind funding (i.e., test credits) to Brian Brooks from the publisher of the CNS Vital Signs test. Brian Brooks receives royalties from Psychological Assessment Resources Inc. for pediatric neuropsychological tests [Child and Adolescent Memory Profile (ChAMP), Sherman& Brooks, 2015; Memory Validity Profile (MVP), Sherman & Brooks, 2015; Multidimensional Everyday Memory Ratings for Youth (MEMRY), Sherman & Brooks, 2017], and from Oxford University Press (Sherman & Brooks, 2012; Pediatric Forensic Neuropsychology). Neither of the authors nor their families have a financial interest in the CNS Vital Signs. Vickie Plourde has no conflict of interest to declare.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braun M, 2011, COGN BEHAV NEUROL, V24, P107, DOI 10.1097/WNN.0b013e3182351289; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; IBM Corp, 2013, IBM SPSS STAT MAC; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Sawilowsky S., 2002, J MOD APPL STAT METH, V1, P461; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates K. O., TXB CLIN NE IN PRESS; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	44	7	7	1	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2017	23	4					304	313		10.1017/S1355617717000066			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	ES2YO	WOS:000399394000002	28215191				2022-02-06	
J	Rallis, D; Poulos, P; Kazantzi, M; Chalkias, A; Kalampalikis, P				Rallis, Dimitrios; Poulos, Panagiotis; Kazantzi, Maria; Chalkias, Athanasios; Kalampalikis, Panagiotis			Effectiveness of 7.5% hypertonic saline in children with severe traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Intracranial pressure; Hypertonic saline; Pediatric	ELEVATED INTRACRANIAL-PRESSURE; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; SODIUM-CHLORIDE; MANNITOL; HYPERTENSION; MANAGEMENT; THERAPY; VOLUME; TRIAL	Purpose: Hyperosmolar therapies aim at controlling increased intracranial pressure (ICP) in patients with traumatic brain injury (TBI). The aim of this study was to evaluate the effect of 7.5% hypertonic saline (HTS) on ICP and cerebral perfusion pressure (CPP) in children with severe TBI. Materials and methods: Medical records of patients 14 years or younger with severe TBI, admitted in the pediatric intensive care unit of "Aghia Sophia" Children's Hospital, Athens, Greece, during 2009 to 2015, and received HTS apart from mannitol were retrospectively reviewed. The ICP and CPP pre-HTS and 30, 60, and 120 minutes post-HTS infusion were evaluated. Furthermore, the presence of adverse effects, the long-term neurological outcome, and survival were recorded. Results: Twenty-nine patients requiring in total 136 HTS infusions were analyzed. The ICP was significantly reduced and CPP elevated at 30, 60, and 120 minutes postinfusion; and furthermore, postadministration ICP and CPP were predominantly within acceptable limits. No significant adverse effects were recorded and most of the patients survived, however, one third had severe neurological impairment at 6 months postinjury. Conclusions: In our study, 7.5% HTS infusion as a second-tier osmotic therapy was associated with significant reduction of ICP and increase of CPP in children with severe TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Rallis, Dimitrios; Poulos, Panagiotis; Kazantzi, Maria; Kalampalikis, Panagiotis] Aghia Sophia Childrens Hosp, Pediat Intens Care Unit, Athens 11527, Greece; [Chalkias, Athanasios] Univ Athens, Med Sch, Cardiopulm Resuscitat, Athens, Greece		Rallis, D (corresponding author), Aghia Sophia Childrens Hosp, Pediat Intens Care Unit, Athens 11527, Greece.	dimitrisrallis@hotmail.com	RhoAlphaLambdaLambdaEtaSigma, DeltaEtaMuEtaTauRhoIotaOmicronSigma/AAH-7198-2021; Rallis, D/ABD-9018-2021	RhoAlphaLambdaLambdaEtaSigma, DeltaEtaMuEtaTauRhoIotaOmicronSigma/0000-0002-5156-0345; Chalkias, Athanasios/0000-0002-7634-4665			Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Chen HW, 2014, TOXICOL APPL PHARM, V280, P1, DOI 10.1016/j.taap.2014.07.024; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Dominguez TE, 2004, CRIT CARE MED, V32, P1438, DOI 10.1097/01.CCM.0000124860.91886.C2; Dominguez TE, 2004, CRIT CARE MED, V32, P9; Ferreros I, 2012, REV NEUROLOGIA, V54, P719, DOI 10.33588/rn.5412.2011701; Fink EL, 2012, PEDIATR CRIT CARE ME, V13, P80, DOI 10.1097/PCC.0b013e3181fe27c7; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P166, DOI 10.5505/tjtes.2011.22800; JENNETT B, 1975, LANCET, V1, P480; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Li M, 2015, MEDICINE, V94; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Nakagawa K, 2012, J CLIN ANESTH, V24, P318, DOI 10.1016/j.jclinane.2011.10.011; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Piper BJ, 2015, ANAESTH INTENS CARE, V43, P204, DOI 10.1177/0310057X1504300210; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Webster DL, 2015, J CRIT CARE, V30, P1267, DOI 10.1016/j.jcrc.2015.07.022; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	40	7	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2017	38						52	56		10.1016/j.jcrc.2016.10.014			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU5UU	WOS:000401100300010	27838440				2022-02-06	
J	Taylor, P; Dehbozorgi, S; Tabasum, A; Scholz, A; Bhatt, H; Stewart, P; Kumar, P; Draman, MS; Watt, A; Rees, A; Hayhurst, C; Davies, S				Taylor, Peter; Dehbozorgi, Sasan; Tabasum, Arshiya; Scholz, Anna; Bhatt, Harsh; Stewart, Philippa; Kumar, Pranav; Draman, Mohd S.; Watt, Alastair; Rees, Aled; Hayhurst, Caroline; Davies, Stephen			Cerebral salt wasting following traumatic brain injury	ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS			English	Article							SUBARACHNOID HEMORRHAGE; NATRIURETIC PEPTIDE; DIAGNOSIS	Hyponatraemia is the most commonly encountered electrolyte disturbance in neurological high dependency and intensive care units. Cerebral salt wasting (CSW) is the most elusive and challenging of the causes of hyponatraemia, and it is vital to distinguish it from the more familiar syndrome of inappropriate antidiuretic hormone (SIADH). Managing CSW requires correction of the intravascular volume depletion and hyponatraemia, as well as mitigation of on-going substantial sodium losses. Herein we describe a challenging case of CSW requiring large doses of hypertonic saline and the subsequent substantial benefit with the addition of fludrocortisone.	[Taylor, Peter; Tabasum, Arshiya; Scholz, Anna; Kumar, Pranav; Draman, Mohd S.; Rees, Aled; Davies, Stephen] Univ Wales Hosp, Dept Diabet & Endocrinol, Heath Pk, Cardiff, S Glam, Wales; [Taylor, Peter; Draman, Mohd S.] Cardiff Univ, Sch Med, Div Infect & Immun, Thyroid Res Grp, Heath Pk, Cardiff, S Glam, Wales; [Dehbozorgi, Sasan; Bhatt, Harsh; Stewart, Philippa; Hayhurst, Caroline] Univ Wales Hosp, Dept Neurosurg, Heath Pk, Cardiff, S Glam, Wales; [Watt, Alastair] North Devon Dist Hosp, Dept Diabet & Endocrinol, Barnstaple, England; [Rees, Aled] Cardiff Univ, Sch Med, Inst Neurosci, Cardiff, S Glam, Wales; [Rees, Aled] Cardiff Univ, Sch Med, Mental Hlth Res Inst, Cardiff, S Glam, Wales		Taylor, P (corresponding author), Univ Wales Hosp, Dept Diabet & Endocrinol, Heath Pk, Cardiff, S Glam, Wales.; Taylor, P (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Thyroid Res Grp, Heath Pk, Cardiff, S Glam, Wales.	taylorpn@cardiff.ac.uk	Bhatt, Harsh/AAB-3000-2019	Bhatt, Harsh/0000-0003-3437-2534			Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Betjes Michiel G.H., 2002, Eur J Intern Med, V13, P9, DOI 10.1016/S0953-6205(01)00192-3; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Tomida M, 1998, STROKE, V29, P1584, DOI 10.1161/01.STR.29.8.1584; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011	6	7	7	0	2	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND		2052-0573		ENDOCRINOL DIAB META	Endocrinol. Diabetes Metab. Case Rep.	APR	2017									0142	10.1530/EDM-16-0142			4	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	GM2YP	WOS:000437961700003	28458890	Green Published, Green Submitted, gold, Green Accepted			2022-02-06	
J	Wang, JW; Zou, QY; Han, RF; Li, YP; Wang, YL				Wang, Jingwei; Zou, Qiuyan; Han, Renfeng; Li, Yupeng; Wang, Yulin			Serum levels of Glial fibrillary acidic protein in Chinese children with autism spectrum disorders	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Autism spectrum disorders; Glial fibrillary acidic protein; Chinese	DORSOLATERAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; INTRACEREBRAL HEMORRHAGE; MICROGLIAL ACTIVATION; ACUTE STROKE; GFAP; AUTOANTIBODIES; DISEASES	Objective: Glial fibrillary acidic protein (GFAP) has been studied in many neurological diseases. The purpose of this study is to investigate the potential role of GFAP in Chinese children with autism spectrum disorders (ASD) by measuring serum circulating levels of GFAP and comparing them with age and gender-matched typical development children. Methods: A total of one hundred and fifty 2-6 years old Chinese children (75 confirmed autism cases and 75 their age-gender matched typical development children) participated in this study. Serum levels of GFAP were assayed with enzyme-linked immunosorbent assay methods, and severity of ASD was evaluated with the Childhood Autism Rating Scale (CARS) Score. Results: The results indicated that the mean serum GFAP level was significantly (P < 0.001) higher in autistic children as compared to controls (1.71 +/- 0.53 ng/ml vs. 0.99 +/- 0.25 ng/ml). There was a significant positive association between serum GFAP levels and CARS scores (r [Pearson] = 0.390, P=0.001). Based on the Receiver operating characteristic (ROC) curve, the optimal cut-off value of serum GFAP levels as an indicator for auxiliary diagnosis of autism was projected to be 1.28 ng/ml which yielded a sensitivity of 77.3% and a specificity of 88.4%, the area under the curve was 0.895(95%Cl 0.844-0.947). Further, an increased risk of ASD was associated with GFAP levels >1.28 ng/ml (adjusted OR 9.88, 95% CI: 3.32-17.82) in the multivariate logistic analysis model. Conclusion: The data indicates that serum GFAP levels may be associated with severity of ASD among Chinese children, suggesting the hypothesis that increased serum levels of GFAP could be implicated in the pathophjrsiology of autism in Chinese children. (C) 2017 ISDN. Published by Elsevier Ltd. All rights reserved.	[Wang, Jingwei; Wang, Yulin] Shandong Univ, Shandong Prov Hosp, Dept Pediat, 324 Jingwu Rd, Jinan 250021, Peoples R China; [Wang, Jingwei; Han, Renfeng] Yantaishan Hosp, Dept Pediat, Yantai 264001, Peoples R China; [Zou, Qiuyan] Zhangjiagang Women & Children Hlth Ctr, Dept Childrens Hlth Prevent, Zhangjiagang 215600, Peoples R China; [Li, Yupeng] Peoples Hosp Rizhao, Dept Pediat, Rizhao 276500, Peoples R China		Wang, YL (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Pediat, 324 Jingwu Rd, Jinan 250021, Peoples R China.	wangyulin1224@163.com					AHLSEN G, 1993, BIOL PSYCHIAT, V33, P734, DOI 10.1016/0006-3223(93)90124-V; Baxter AJ, 2015, PSYCHOL MED, V45, P601, DOI 10.1017/S003329171400172X; Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197; Cetin I., 2016, BIOMARKERS, P1; Crawford JD, 2015, AUTISM RES, V8, P649, DOI 10.1002/aur.1480; Edmonson C, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-3; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Feneberg E, 2013, SLEEP MED, V14, P692, DOI 10.1016/j.sleep.2013.04.013; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Husain H, 2012, J NEURO-ONCOL, V109, P123, DOI 10.1007/s11060-012-0874-8; Kirkman NJ, 2008, J AUTISM DEV DISORD, V38, P333, DOI 10.1007/s10803-007-0398-9; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Singh VK, 1997, PEDIATR NEUROL, V17, P88, DOI 10.1016/S0887-8994(97)00045-3; Su W, 2012, CLIN NEUROL NEUROSUR, V114, P372, DOI 10.1016/j.clineuro.2011.11.002; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Tetreault NA, 2012, J AUTISM DEV DISORD, V42, P2569, DOI 10.1007/s10803-012-1513-0; Theoharides TC, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.77; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Uzawa A, 2013, CLIN CHIM ACTA, V421, P181, DOI 10.1016/j.cca.2013.03.020; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wang LX, 2016, INT J DEV NEUROSCI, V51, P12, DOI 10.1016/j.ijdevneu.2016.04.004; Zhang QB, 2014, INT J DEV NEUROSCI, V37, P65, DOI 10.1016/j.ijdevneu.2014.06.013	30	7	7	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	APR	2017	57						41	45		10.1016/j.ijdevneu.2017.01.004			5	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Developmental Biology; Neurosciences & Neurology	EP4UC	WOS:000397374400006	28088366				2022-02-06	
J	Wolahan, SM; Prins, ML; McArthur, DL; Real, CR; Hovda, DA; Martin, NA; Vespa, PM; Glenn, TC				Wolahan, Stephanie M.; Prins, Mayumi L.; McArthur, David L.; Real, Courtney R.; Hovda, David A.; Martin, Neil A.; Vespa, Paul M.; Glenn, Thomas C.			Influence of Glycemic Control on Endogenous Circulating Ketone Concentrations in Adults Following Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Glycemic control; Ketone bodies; Glucose; Insulin	INTENSIVE INSULIN THERAPY; CRITICALLY-ILL; BETA-HYDROXYBUTYRATE; CEREBRAL GLUCOSE; METABOLISM; LACTATE; MICRODIALYSIS; HYPERGLYCEMIA; TRANSPORT; IMPACT	The objective was to investigate the impact of targeting tight glycemic control (4.4-6.1 mM) on endogenous ketogenesis in severely head-injured adults. The data were prospectively collected during a randomized, within-patient crossover study comparing tight to loose glycemic control, defined as 6.7-8.3 mM. Blood was collected periodically during both tight and loose glycemic control epochs. Post hoc analysis of insulin dose and total nutritional provision was performed. Fifteen patients completed the crossover study. Total ketones were increased 81 mu M ([38 135], p < 0.001) when blood glucose was targeted to tight (4.4-6.1 mM) compared with loose glycemic control (6.7-8.3 mM), corresponding to a 60 % increase. There was a significant decrease in total nutritional provisions (p = 0.006) and a significant increase in insulin dose (p = 0.008). Permissive underfeeding was tolerated when targeting tight glycemic control, but total nutritional support is an important factor when treating hyperglycemia.	[Wolahan, Stephanie M.; Prins, Mayumi L.; McArthur, David L.; Real, Courtney R.; Hovda, David A.; Martin, Neil A.; Vespa, Paul M.; Glenn, Thomas C.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA		Wolahan, SM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA.	swolahan@mednet.ucla.edu		Glenn, Thomas/0000-0003-4273-3408	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01NS058489, R21NS093136-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS093136, P01NS058489] Funding Source: NIH RePORTER	NIH P01NS058489; grant recipient David Hovda, Ph.D and NIH R21NS093136-01; grant recipient Thomas Glenn, Ph.D.	Anderson D.R., 2002, MODEL SELECTION MULT, Vsecond, DOI 10.1007/b97636; Badjatia N, 2014, NEUROCRIT CARE, V21, P159, DOI 10.1007/s12028-014-0036-2; Barton, 2013, MUMIN MULTIMODEL INF; BEYLOT M, 1989, AM J PHYSIOL, V257, pE665, DOI 10.1152/ajpendo.1989.257.5.E665; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Dalsgaard MK, 2006, J CEREBR BLOOD F MET, V26, P731, DOI 10.1038/sj.jcbfm.9600256; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Gowda GAN, 2010, ANAL CHEM, V82, P8983, DOI 10.1021/ac101938w; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Herzog RI, 2013, J CLIN INVEST, V123, P1988, DOI 10.1172/JCI65105; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; MOORE TJ, 1976, AM J PHYSIOL, V230, P619, DOI 10.1152/ajplegacy.1976.230.3.619; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pan JW, 2001, J NEUROCHEM, V79, P539, DOI 10.1046/j.1471-4159.2001.00575.x; Pinheiro J. C., 2000, MIXED EFFECTS MODELS; Pinheiro JC, 2020, nlme: Linear and Nonlinear Mixed Effects Models_. R package version 31-151; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasmussen P, 2010, J CEREBR BLOOD F MET, V30, P1240, DOI 10.1038/jcbfm.2010.25; Revelle W., 2015, PACKAGE PSYCH 2015 R; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wilcox R., 1997, INTRO ROBUST ESTIMAT; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001	44	7	8	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					239	246		10.1007/s12028-016-0313-3			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300012	27761730	Green Accepted			2022-02-06	
J	Womack, KB; Paliotta, C; Strain, JF; Ho, JS; Skolnick, Y; Lytton, WW; Turtzo, LC; McColl, R; Diaz-Arrastia, R; Bergold, PJ				Womack, Kyle B.; Paliotta, Christopher; Strain, Jeremy F.; Ho, Johnson S.; Skolnick, Yosef; Lytton, William W.; Turtzo, L. Christine; McColl, Roderick; Diaz-Arrastia, Ramon; Bergold, Peter J.			Measurement of Peripheral Vision Reaction Time Identifies White Matter Disruption in Patients with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diagnosis; mTBI; reaction time; peripheral vision; reaction time; neuropsychiatric tests	POSTERIOR CORPUS-CALLOSUM; TENSOR IMAGING DETECTS; INTERHEMISPHERIC-TRANSFER; AXONAL DAMAGE; INFORMATION; DYSFUNCTION	This study examined whether peripheral vision reaction time (PVRT) in patients with mild traumatic brain injury (mTBI) correlated with white matter abnormalities in centroaxial structures and impairments in neuropsychological testing. Within 24 h after mTBI, crossed reaction times (CRT), uncrossed reaction times (URT), and crossed-uncrossed difference (CUD) were measured in 23 patients using a laptop computer that displayed visual stimuli predominantly to either the left or the right visual field of the retina. The CUD is a surrogate marker of the interhemispheric transfer time (ITT). Within 7 days after the injury, patients received a diffusion tensor-MRI (DTI) scan and a battery of neuropsychological tests. Nine uninjured control subjects received similar testing. Patients 18-50 years of age were included if they had a postresuscitation Glasgow Coma Scale > 13 and an injury mechanism compatible with mTBI. Healthy controls were either age-and gender-matched family members of the TBI patients or healthy volunteers. CUD deficits > 2 standard deviations (SD) were seen in 40.9% of patients. The CUD of injured patients correlated with mean diffusivity (MD) (p < 0.001, q = -0.811) in the posterior corpus callosum. Patients could be stratified on the basis of CUD on the Stroop 1, Controlled Oral Word Association Test (COWAT), and the obsessive-compulsive component of the Basic Symptom Inventory tests. These studies suggest that the PVRT indirectly measures white matter integrity in the posterior corpus callosum, a brain region frequently damaged by mTBI.	[Womack, Kyle B.; Paliotta, Christopher] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Womack, Kyle B.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [McColl, Roderick] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA; [Womack, Kyle B.; Strain, Jeremy F.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Berman Lab Learning & Memory, Dallas, TX USA; [Strain, Jeremy F.] Washington Univ, Dept Neurol, St Louis, MO USA; [Ho, Johnson S.; Skolnick, Yosef; Lytton, William W.; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11203 USA; [Turtzo, L. Christine; Diaz-Arrastia, Ramon] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11203 USA.	pbergold@downstate.edu	Womack, Kyle/O-5422-2018	Womack, Kyle/0000-0002-6060-9075; Lytton, William/0000-0002-3727-2849; Diaz-Arrastia, Ramon/0000-0001-6051-3594; McColl, Roderick/0000-0001-7022-100X	United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH1011061]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This work was funded an award from the United States Army Medical Research and Materiel Command W81XWH1011061. L.C.T. and R.D.-A. were also supported by the Center for Neuroscience and Regenerative Medicine. The United States Army Medical Research and Materiel Command had no input into the design and conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Bendon RW, 1996, PEDIATR PATHOL LAB M, V16, P299, DOI 10.1080/107710496175787; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERLUCCH.G, 1971, BRAIN, V94, P419, DOI 10.1093/brain/94.3.419; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Huang H, 2012, NEUROBIOL AGING, V33, P2029, DOI 10.1016/j.neurobiolaging.2011.06.027; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Westerhausen R, 2006, NEUROSCI LETT, V409, P140, DOI 10.1016/j.neulet.2006.09.028; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491	36	7	7	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1539	1545		10.1089/neu.2016.4670			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500005	27927083	Green Published			2022-02-06	
J	Ahmad, S; Siddiqi, MI				Ahmad, Sabahuddin; Siddiqi, Mohammad Imran			Insights from molecular modeling into the selective inhibition of cathepsin S by its inhibitor	JOURNAL OF MOLECULAR MODELING			English	Article						Cysteinyl cathepsins; Atherosclerosis; Elastin; RO5444101; Selective inhibition	TRAUMATIC BRAIN-INJURY; CHRONIC RENAL-DISEASE; CYSTEINE CATHEPSINS; ALZHEIMERS-DISEASE; NEUROPATHIC PAIN; BONE LOSS; ATHEROSCLEROSIS; DISCOVERY; DEFICIENCY; SEARCH	Cathepsin S has been demonstrated to play a crucial role in the remodeling of extracellular matrix proteins such as elastin and collagen, which in turn contribute to the structural integrity of the cardiovascular wall. Atherosclerotic lesions, aneurysm formation, plaque rupture, thrombosis, and calcification are some of the cardiovascular disorders related to cathepsin S. A highly selective inhibitor of human as well as animal cathepsin S, RO5444101, was recently reported to attenuate the progression of atherosclerotic lesions. Here, we attempted to gain insight into the molecular mechanism of action of RO5444101 on cathepsin S by performing molecular docking and molecular dynamics (MD) simulation studies. The results of our studies correlate well with relevant reported experimental data and potentially explain the selectivity of this inhibitor for cathepsin S rather than cathepsin L1/L, cathepsin L2/V, and cathepsin K, which share conserved catalytic sites and have sequence similarities of 49%, 50%, and 55%, respectively, with respect to cathepsin S. In contrast to those closely related cathepsins, 20 ns MD simulation data reveal that the overall interaction of cathepsin S with RO5444101 is more stable and involves more protein-molecule interactions than the interactions of the inhibitor with the other cathepsins. This study therefore considerably improves our understanding of the molecular mechanism responsible for cathepsin S inhibition and facilitates the identification of potential novel selective inhibitors of cathepsin S.	[Ahmad, Sabahuddin] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Siddiqi, Mohammad Imran] CSIR, Cent Drug Res Inst, Acad Sci & Innovat Res AcSIR, Lucknow 226031, Uttar Pradesh, India		Siddiqi, MI (corresponding author), CSIR, Cent Drug Res Inst, Acad Sci & Innovat Res AcSIR, Lucknow 226031, Uttar Pradesh, India.	mi_siddiqi@cdri.res.in		Ahmad, Sabahuddin/0000-0002-8762-4670	CSIR network projects GENESIS [BSC0121]; THUNDER [BSC0102]	The work reported in this project was supported by grants from the CSIR network projects GENESIS (BSC0121) and THUNDER (BSC0102). This manuscript has CSIR-CDRI communication number 9431.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aggarwal N, 2014, PROTEOM CLIN APPL, V8, P427, DOI 10.1002/prca.201300105; Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Basalyga DM, 2004, CIRCULATION, V110, P3480, DOI 10.1161/01.CIR.0000148367.08413.E9; Cai JQ, 2010, BIOORG MED CHEM LETT, V20, P6890, DOI 10.1016/j.bmcl.2010.10.012; Cheng XW, 2011, HYPERTENSION, V58, P978, DOI 10.1161/HYPERTENSIONAHA.111.180935; Dossetter AG, 2012, J MED CHEM, V55, P6363, DOI 10.1021/jm3007257; Figueiredo JL, 2015, AM J PATHOL, V185, P1156, DOI 10.1016/j.ajpath.2014.11.026; Gomperts R., 2016, GAUSSIAN 09 REVISION; Hao L, 2015, J PERIODONTOL, V86, P972, DOI 10.1902/jop.2015.140643; Hewitt E, 2016, J PHARMACOL EXP THER, V358, P387, DOI 10.1124/jpet.116.232926; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/neu.2013.2944, 10.1089/NEU.2013.2944]; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Irie O, 2008, J MED CHEM, V51, P5502, DOI 10.1021/jm800839j; Jadhav PK, 2014, ACS MED CHEM LETT, V5, P1138, DOI 10.1021/ml500283g; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Kuhn B, 2016, J MED CHEM, V59, P4087, DOI 10.1021/acs.jmedchem.5b01875; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Markt P, 2008, J CHEM INF MODEL, V48, P1693, DOI 10.1021/ci800101j; Moriya S, 2016, J CELL PHYSIOL, V231, P1163, DOI 10.1002/jcp.25214; Mukherjee K, 2016, BIOCHEM PHARMACOL, V117, P10, DOI 10.1016/j.bcp.2016.04.010; Panwar P, 2016, BRIT J PHARMACOL, V173, P396, DOI 10.1111/bph.13383; Pauly TA, 2003, BIOCHEMISTRY-US, V42, P3203, DOI 10.1021/bi027308i; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossi A, 2004, BIOL CHEM, V385, P363, DOI 10.1515/BC.2004.040; Ruan Hang, 2015, Horiz Cancer Res, V56, P23; Schiener M, 2014, TRENDS MOL MED, V20, P271, DOI 10.1016/j.molmed.2013.12.001; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tumminello FM, 2008, BIOMED PHARMACOTHER, V62, P130, DOI 10.1016/j.biopha.2007.07.001; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002	41	7	7	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1610-2940	0948-5023		J MOL MODEL	J. Mol. Model.	MAR	2017	23	3							92	10.1007/s00894-017-3255-6			17	Biochemistry & Molecular Biology; Biophysics; Chemistry, Multidisciplinary; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Chemistry; Computer Science	EM0CD	WOS:000394985500025	28236030				2022-02-06	
J	Becker, S; Frohlich, M; Kelm, J; Ludwig, O				Becker, Stephan; Froehlich, Michael; Kelm, Jens; Ludwig, Oliver			Change of Muscle Activity as Well as Kinematic and Kinetic Parameters during Headers after Core Muscle Fatigue	SPORTS			English	Article						soccer; heading; fatigue; kinematics; kinetics; electromyography; concussion	SOCCER; FOOTBALL	In soccer, headers are a tactical measure and influenced by numerous factors. The goal of this study was to identify whether changes in kinematics and muscular activity, especially of the head-stabilizing muscles, occur during headers when the core musculature is fatigued. In two subgroups, muscular activity (12 amateur players, age 23.6 +/- 4.2 years) and kinematics and dynamics (29 amateur players, age 23.7 +/- 2.8 years) were examined during straight headers on a pendulum header. Data were collected before and after the core muscles were fatigued by an exercise program. Telemetric surface EMG, 3D acceleration sensor, force plate, and video recordings were used. Under fatigue, the activity of M. erector spinae and M. rectus abdominis was significantly reduced in the preparation phase of the header. The activity of M. sternocleidomastoideus was significantly increased during the jump phase, and the hip extension angle during maximum arched body tension was significantly reduced under fatigue. Jumping height, acceleration force impulse, and linear head acceleration were also significantly reduced. We conclude that fatigue of the core muscles affects the motion technique of the header and the activity of the muscle groups stabilizing the head. Therefore, the necessity of specific training in soccer should be emphasized from a medical-preventive point of view.	[Becker, Stephan; Froehlich, Michael] Univ Kaiserslautern, Dept Sport Sci, D-67663 Kaiserslautern, Germany; [Kelm, Jens] Chirurgisch Orthopad Zentrum, D-66557 Illingen, Germany; [Ludwig, Oliver] Univ Saarland, Inst Sports Sci, D-66123 Saarbrucken, Germany		Becker, S (corresponding author), Univ Kaiserslautern, Dept Sport Sci, D-67663 Kaiserslautern, Germany.	stephan.becker@sowi.uni-kl.de; michael.froehlich@sowi.uni-kl.de; jens.kelm@chirurgie-illingen.de; oliver.ludwig1@uni-saarland.de	Ludwig, Oliver/AAG-3410-2019	Becker, Stephan/0000-0002-0115-7064			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Augustsson J, 2006, SCAND J MED SCI SPOR, V16, P111, DOI 10.1111/j.1600-0838.2005.00446.x; Cohen J., 2013, STAT POWER ANAL BEHA; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Hermens HJ., 1999, EUROPEAN RECOMMENDAT; Kartal A, 2004, EUR SPINE J, V13, P76, DOI 10.1007/s00586-003-0623-y; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Lynch J. M., 1996, HEADING US SOCCER SP, P81; Mawdsley H. P., 1978, BIOMECHANICAL ANAL H, V3, P16; Mehnert Michael J, 2005, Pain Physician, V8, P391; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Smodlaka VN, 1984, PHYSICIAN SPORTSMED, V12, P127, DOI DOI 10.1080/00913847.1984.11701777; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stolen T, 2005, SPORTS MED, V35, P501; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	20	7	7	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4663		SPORTS	Sports	MAR	2017	5	1							10	10.3390/sports5010010			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	ER3VQ	WOS:000398728200009	29910369	Green Published, Green Submitted, gold			2022-02-06	
J	Blackwell, LS; Robinson, AF; Proctor, MR; Taylor, AM				Blackwell, Laura S.; Robinson, Anna F.; Proctor, Mark R.; Taylor, Alex M.			Same Care, Different Populations: Return-to-Learn Practices Following Concussion in Primary and Secondary Schools	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; mild traumatic brain injury; return to learn; return to play; head injury	SPORT-RELATED CONCUSSION; CHILDREN; REST; ADOLESCENTS; STATEMENT; KNOWLEDGE; DURATION; SYMPTOMS; STUDENT	The authors conducted a cross-sectional survey of Massachusetts school nurses examining return-to-learn practices for children recovering from concussion in prekindergarten through high school. Regardless of school setting, all students received academic accommodations to support learning during recovery. School nurses perceived less benefit to prolonged cognitive rest (>4 days) for high school students relative to students in elementary school, but provided academic accommodations to them for comparatively longer periods of time (10-14 days vs 6-10 days). In all settings, respondents indicated a need for improved communication among treating physicians, parents, and school personnel, as well as improved education and standardized management tools for younger children and those who sustain non-sport-related injuries. Despite serving children at different developmental stages, school return-to-learn practices are essentially the same in primary and secondary schools, highlighting the need for standardized, developmentally appropriate return-to-learn plans and additional education for the providers and school personnel who implement them.	[Blackwell, Laura S.; Robinson, Anna F.; Taylor, Alex M.] Childrens Hosp, Dept Psychiat, 300 Longwood Ave, Boston, MA 02115 USA; [Robinson, Anna F.] Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA; [Taylor, Alex M.] Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA		Taylor, AM (corresponding author), Childrens Hosp, Dept Neurol, BCH 3124, 300 Longwood Ave, Boston, MA 02115 USA.	alex.taylor@childrens.harvard.edu			Kettering Family Foundation	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported in part by a grant from the Kettering Family Foundation. The sponsor had no role in the study design; collection, analysis, or interpretation of data; manuscript preparation; or decision to submit for publication.	Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Centers for Disease Control and Prevention, HEADS UP; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod Tamara C Valovich, 2014, NASN Sch Nurse, V29, P232; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; National Association of School Nurses, CONC ROL SCH NURS; National Center for Injury Prevention and Control, IMPL RET PLAY LEARN; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Ommaya AK, 2009, BRIT J NEUROSURG, V16, P220; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady M, 2011, PHYS MED REHABIL, V22, P1; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; United States Census Bureau, **NON-TRADITIONAL**; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	31	7	7	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAR	2017	32	3					327	333		10.1177/0883073816681351			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	EP2ZF	WOS:000397251500008	27920269				2022-02-06	
J	Fratantoni, JM; DeLaRosa, BL; Didehbani, N; Hart, J; Kraut, MA				Fratantoni, Julie M.; DeLaRosa, Bambi L.; Didehbani, Nyaz; Hart, John, Jr.; Kraut, Michael A.			Electrophysiological Correlates of Word Retrieval in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						EEG; ERP; sports concussion; traumatic brain injury; word retrieval	EVENT-RELATED POTENTIALS; MILD COGNITIVE IMPAIRMENT; OBJECT MEMORY RETRIEVAL; CONCUSSION; DYSFUNCTION; PLAYERS; ABNORMALITIES; SEPARATION; ARTIFACTS; INTEGRITY	Persons who have had a traumatic brain injury (TBI) often have word retrieval deficits; however, the underlying neural mechanisms of such deficits are yet to be clarified. Previous studies in normal subjects have shown that during a word retrieval task, there is a 750msec event-related potential (ERP) divergence detected at the left fronto-temporal region when subjects evaluate word pairs that facilitate retrieval compared with responses elicited by word pairs that do not facilitate retrieval. In this study, we investigated the neurophysiological correlates of word retrieval networks in 19 retired professional athletes with TBI and 19 healthy control (HC) subjects. We recorded electroencephalography (EEG) in the participants during a semantic object retrieval task. In this task, participants indicated whether presented word pairs did (retrieval) or did not (non-retrieval) facilitate the retrieval of an object name. There were no significant differences in accuracy or reaction time between the two groups. The EEG showed a significant group by condition interaction over the left fronto-temporal region. The HC group mean amplitudes were significantly different between conditions, but the TBI group data did not show this difference, suggesting neurophysiological effects of injury. These findings provide evidence that ERP amplitudes may be used as a marker of disrupted semantic retrieval circuits in persons with TBI even when those persons perform normally.	[Fratantoni, Julie M.; DeLaRosa, Bambi L.; Didehbani, Nyaz; Hart, John, Jr.] Univ Texas Dallas, Ctr BrainHlth, 2200 West Mockingbird Lane, Dallas, TX 75235 USA; [Didehbani, Nyaz] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Hart, John, Jr.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Kraut, Michael A.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA		Fratantoni, JM (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 West Mockingbird Lane, Dallas, TX 75235 USA.	Julie.Fratantoni@utdallas.edu		Didehbani, Nyaz/0000-0001-6121-5759			Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brier MR, 2008, J INT NEUROPSYCH SOC, V14, P815, DOI 10.1017/S135561770808096X; Broca P., 1861, B MEM SOC ANAT PARIS, V6, P330; Calley CS, 2010, BRAIN IMAGING BEHAV, V4, P248, DOI 10.1007/s11682-010-9103-2; Chiang HS, 2015, J ALZHEIMERS DIS, V46, P703, DOI 10.3233/JAD-142781; Chiang HS, 2014, BIOL PSYCHOL, V100, P106, DOI 10.1016/j.biopsycho.2014.05.010; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Crosson B, 1999, BRAIN COGNITION, V40, P414, DOI 10.1006/brcg.1999.1088; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Hart J, 2013, BRAIN LANG, V126, P89, DOI 10.1016/j.bandl.2012.08.002; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hart Jr J, 2015, NEUROBIOLOGY COGNITI; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1017/S0048577200980624; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kraut MA, 2002, J COGNITIVE NEUROSCI, V14, P24, DOI 10.1162/089892902317205294; Kraut MA, 2007, COGN BEHAV NEUROL, V20, P62, DOI 10.1097/WNN.0b013e3180335f7d; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Whitney C, 2012, J COGNITIVE NEUROSCI, V24, P133, DOI 10.1162/jocn_a_00123; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48	34	7	7	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1017	1021		10.1089/neu.2016.4651			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200006	27596052	Green Published, hybrid, Green Submitted			2022-02-06	
J	Kontos, AP; Van Cott, AC; Roberts, J; Pan, JW; Kelly, MB; McAllister-Deitrick, J; Hetherington, HP				Kontos, Anthony P.; Van Cott, Anne C.; Roberts, Jodilyn; Pan, Jullie W.; Kelly, Monique B.; McAllister-Deitrick, Jamie; Hetherington, Hoby P.			Clinical and Magnetic Resonance Spectroscopic Imaging Findings in Veterans With Blast Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder	MILITARY MEDICINE			English	Article; Proceedings Paper	5th Military Health System Research Symposium	AUG 17-21, 2015	Fort Lauderdale, FL				EXPLOSIVE BLAST; 7 T; AFGHANISTAN; HISTORY; ARRAYS; IRAQ; CARE	Objectives: To compare magnetic resonance spectroscopic imaging (MRSI) findings from the hippocampal regions of military veterans with blast-related mild traumatic brain injury (blast mTBI) and post-traumatic stress disorder (PTSD) to those with PTSD only; and to examine the relationship of MRSI findings to cognitive and neuromotor impairment. Methods: 35 military veterans-23 with blast mTBI and PTSD (blast mTBI/PTSD) and 12 with PTSD only participated in the study. Whole plane MRSI data including N-acetyl aspartate (NAA) and choline (Ch) were acquired at 7T for the hippocampus. Concurrent cognitive and neuromotor data were collected using established assessments. General linear models (GLMs) with Bonferroni correction were used to compare the two groups on NAA/Ch ratios across regions of the hippocampus. Spearman's correlations were used to examine correlations between NAA/Ch and cognitive and neuromotor impairment. Results: The NAA/Ch results for the left hippocampus were lower in the blast mTBI/PTSD group than the PTSD-only group. The blast mTBI/PTSD group also scored worse on the WAIS-IV-vocabulary. Significant correlations between NAA/Ch and neuromotor outcomes-including vestibular impairment-were supported. Conclusions: Combined MRSI and cognitive and neuromotor data may help inform more objective and accurate diagnoses and effective treatments for patients with blast mTBI and PTSD.	[Kontos, Anthony P.; McAllister-Deitrick, Jamie] Univ Pittsburgh, Dept Orthopaed Surg, 3471 Fifth Ave,1010, Pittsburgh, PA 15213 USA; [Van Cott, Anne C.; Roberts, Jodilyn; Kelly, Monique B.] VA Pittsburgh Healthcare Syst, Univ Dr C, Pittsburgh, PA 15240 USA; [Van Cott, Anne C.; Pan, Jullie W.] Univ Pittsburgh, Dept Neurol, 811 Kaufmann Med Bldg,3471 Fifth Ave 810, Pittsburgh, PA 15213 USA; [Hetherington, Hoby P.] Univ Pittsburgh, Magnet Resonance Res Ctr, 200 Lothrop St, Pittsburgh, PA 15213 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 3471 Fifth Ave,1010, Pittsburgh, PA 15213 USA.			Kontos, Anthony/0000-0002-3749-4310	National Institutes of Health/National Institute of Neurological DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [Stroke-NIH-R01NS081772]; National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering NIH [R01EB011639]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB011639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by a grant to the University of Pittsburgh to Dr. Hetherington and Dr. VanCott from the National Institutes of Health/National Institute of Neurological Disorders and Stroke-NIH-R01NS081772; and by a grant to the University of Pittsburgh to Dr. Kontos from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1); and a grant to Dr Jullie W. Pan from the National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering NIH R01EB011639.	[Anonymous], DOD WORLDW NUMB TBI; Arnold DL, 1998, J NEUROL NEUROSUR PS, V64, pS94; Avdievich NI, 2009, MAGN RESON MED, V62, P17, DOI 10.1002/mrm.21970; Avdievich NI, 2011, APPL MAGN RESON, V41, P483, DOI 10.1007/s00723-011-0280-y; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; Eibner C., 2008, INVISIBLE WOUNDS WAR; Foa EB, 2009, EFFECTIVE TREATMENTS, V2nd; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Hetherington HP, 2007, NEUROLOGY, V69, P2256, DOI 10.1212/01.wnl.0000286945.21270.6d; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hugg JW, 1996, ANN NEUROL, V40, P236, DOI 10.1002/ana.410400215; Kansagara D., 2013, COMPLICATIONS MILD T; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pan JW, 2012, MAGN RESON MED, V68, P1007, DOI 10.1002/mrm.24122; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Yang ZY, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140693	27	7	7	0	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			99	104		10.7205/MILMED-D-16-00177			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	ER6VN	WOS:000398947100017	28291459	Bronze, Green Accepted			2022-02-06	
J	Lehman, PJ; Carl, RL				Lehman, Patrick J.; Carl, Rebecca L.			The Preparticipation Physical Evaluation	PEDIATRIC ANNALS			English	Article							AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; CONSENSUS STATEMENT; SUDDEN-DEATH; YOUNG; PARTICIPATION; CHILDREN; ADOLESCENTS; CONCUSSION; CARDIOLOGY	With rising rates of sports participation among children and adolescents, pediatricians are increasingly being called upon to perform preparticipation physical evaluations (PPEs) for young athletes. The purpose of this review article is to discuss the general structure of a comprehensive PPE and how the PPE differs from a typical health maintenance visit. The PPE focuses attention on screening for cardiac conditions that predispose athletes to sudden cardiac death with exercise. This review also addresses the debate over whether electrocardiogram screening should be a routine required part of the PPE. In addition to cardiac screening, evaluation and management of musculoskeletal injury, concussion, and the female athlete triad will be discussed in greater detail.	[Lehman, Patrick J.; Carl, Rebecca L.] Ann & Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 86, Chicago, IL 60611 USA		Lehman, PJ (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 86, Chicago, IL 60611 USA.	plehman@luriechildrens.org					[Anonymous], 1983, PEDIATRICS, V72, P884; Bernhardt D, 2010, PREPARTICIPATION PHY; Caswell SV, 2015, PEDIATRICS, V135, P26, DOI 10.1542/peds.2014-1451; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Souza MJ, 2014, CLIN J SPORT MED, V24, P96, DOI 10.1097/JSM.0000000000000085; Demorest RA, 2010, PEDIATRICS, V125, P1287, DOI 10.1542/peds.2010-0658; Drezner JA, 2012, J AM BOARD FAM MED, V25, P408, DOI 10.3122/jabfm.2012.04.110225; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harmon KG, 2011, CIRCULATION, V123, P1594, DOI 10.1161/CIRCULATIONAHA.110.004622; Kelly AKW, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0922; Maron BJ, 2014, CIRCULATION, V130, P1303, DOI 10.1161/CIR.0000000000000025; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Roberts WO, 2014, CURR SPORT MED REP, V13, P395, DOI 10.1249/JSR.0000000000000100; SMITH DM, 1991, PRIMARY CARE, V18, P777; Smith J, 1998, MAYO CLIN PROC, V73, P419	19	7	7	1	6	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	MAR	2017	46	3					E85	E92		10.3928/19382359-20170222-01			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EQ5FQ	WOS:000398108200004	28287681				2022-02-06	
J	Maruta, J; Jaw, E; Modera, P; Rajashekar, U; Spielman, LA; Ghajar, J				Maruta, Jun; Jaw, Eugene; Modera, Peter; Rajashekar, Umesh; Spielman, Lisa A.; Ghajar, Jamshid			Frequency Responses to Visual Tracking Stimuli May Be Affected by Concussion	MILITARY MEDICINE			English	Article							PURSUIT EYE-MOVEMENTS; SMOOTH; SYNCHRONIZATION	Human visual tracking performance is known to be reduced with an increase of the target's speed and oscillation frequency, but changes in brain states following a concussion may alter these frequency responses. The goal of this study was to characterize and compare frequency-dependent smooth pursuit velocity degradation in normal subjects and patients who had chronic postconcussion symptoms, and also examine cases of acutely concussed patients. Eye movements were recorded while subjects tracked a target that moved along a circular trajectory of 10 degrees radius at 0.33, 0.40, or 0.67 Hz. Performance was characterized by the gain of smooth pursuit velocity, with reduced gain indicating reduced performance. The difference between normal and chronic patient groups in the pattern of decrease in the gain of horizontal smooth pursuit velocity as a function of the stimulus frequency reflected patients performing more poorly than normal subjects at 0.4Hz while both groups performing similarly at 0.33 or 0.67 Hz. The performance of acute patients may represent yet another type of frequency response. The findings suggest that there may be ranges of stimulus frequencies that differentiate the effects of concussion from normal individuals.	[Maruta, Jun; Jaw, Eugene; Modera, Peter; Rajashekar, Umesh; Spielman, Lisa A.; Ghajar, Jamshid] Brain Trauma Fdn, 1999 South Bascom Ave,Suite 1040, Campbell, CA 95008 USA; [Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, 300 Pasteur Dr,R200, Stanford, CA 94305 USA		Maruta, J (corresponding author), Brain Trauma Fdn, 1999 South Bascom Ave,Suite 1040, Campbell, CA 95008 USA.		Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	CDMRPUnited States Department of Defense [W81XWH-08-1-0646]; James S. McDonnell Foundation	The authors thank Brain Trauma Foundation's clinical research staff for assistance with data collection and maintenance. Funding was provided by CDMRP W81XWH-08-1-0646, and James S. McDonnell Foundation.	Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; Lekwuwa GU, 1996, BRAIN, V119, P473, DOI 10.1093/brain/119.2.473; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2012, PROC SPIE, V8371, DOI 10.1117/12.927790; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Rottach KG, 1996, VISION RES, V36, P2189, DOI 10.1016/0042-6989(95)00302-9	8	7	7	0	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			120	123		10.7205/MILMED-D-16-00093			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6VN	WOS:000398947100020	28291462	Bronze			2022-02-06	
J	Nishijima, DK; Gaona, S; Waechter, T; Maloney, R; Bair, T; Blitz, A; Elms, AR; Farrales, RD; Howard, C; Montoya, J; Bell, JM; Coronado, VC; Sugerman, DE; Ballard, DW; Mackey, KE; Vinson, DR; Holmes, JF				Nishijima, Daniel K.; Gaona, Samuel; Waechter, Trent; Maloney, Ric; Bair, Troy; Blitz, Adam; Elms, Andrew R.; Farrales, Roel D.; Howard, Calvin; Montoya, James; Bell, Jeneita M.; Coronado, Victor C.; Sugerman, David E.; Ballard, Dustin W.; Mackey, Kevin E.; Vinson, David R.; Holmes, James F.			Do EMS Providers Accurately Ascertain Anticoagulant and Antiplatelet Use in Older Adults with Head Trauma?	PREHOSPITAL EMERGENCY CARE			English	Article						Emergency Medical Services; anticoagulants; platelet aggregation inhibitors; medication reconciliation; head injuries; closed	BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; INTEROBSERVER AGREEMENT; WARFARIN; PATIENT; MANAGEMENT; STROKE; KAPPA; RISK	Objective: Prehospital provider assessment of the use of anticoagulant or antiplatelet medications in older adults with head trauma is important. These patients are at increased risk for traumatic intracranial hemorrhage and therefore field triage guidelines recommend transporting these patients to centers capable of rapid evaluation and treatment. Our objective was to evaluate EMS ascertainment of anticoagulant and antiplatelet medication use in older adults with head trauma. Methods: A retrospective study of older adults with head trauma was conducted throughout Sacramento County. All 5 transporting EMS agencies and all 11 hospitals in the county were included in the study, which ran from January 2012 to December 2012. Patients 55years who were transported to a hospital by EMS after head trauma were included. We excluded patients transferred between two facilities, patients with penetrating head trauma, prisoners, and patients with unmatched hospital data. Anticoagulant and antiplatelet use were categorized as: warfarin, direct oral anticoagulants (DOAC; dabigatran, rivaroxaban, and apixaban), aspirin, and other antiplatelet agents (e.g., clopidogrel and ticagrelor). We calculated the percent agreement and kappa statistic for binary variables between EMS and emergency department (ED)/hospital providers. A kappa statistic 0.60 was considered acceptable agreement. Results: After excluding 174 (7.6%) patients, 2,110 patients were included for analysis; median age was 73years (interquartile range 62-85years) and 1,259 (60%) were male. Per ED/hospital providers, the use of any anticoagulant or antiplatelet agent was identified in 595 (28.2%) patients. Kappa statistics between EMS and ED/hospital providers for the specific agents were: 0.76 (95% CI 0.71-0.82) for warfarin, 0.45 (95% CI 0.19-0.71) for DOAC agents, 0.33 (95% CI 0.28-0.39) for aspirin, and 0.51 (95% CI 0.42-0.60) for other antiplatelet agents. Conclusions: The use of antiplatelet or anticoagulant medications in older adults who are transported by EMS for head trauma is common. EMS and ED/hospital providers have acceptable agreement with preinjury warfarin use but not with DOAC, aspirin, and other antiplatelet use.	[Nishijima, Daniel K.; Gaona, Samuel; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA; [Waechter, Trent] City Sacramento Fire Dept, Sacramento, CA USA; [Maloney, Ric] Sacramento Metropolitan Fire Dept, Sacramento, CA USA; [Bair, Troy] Cosumnes Community Serv Dist Fire Dept, Elk Grove, CA USA; [Blitz, Adam] Amer Med Response, Sacramento, CA USA; [Elms, Andrew R.; Mackey, Kevin E.] Kaiser Permanente South Sacramento, Med Ctr, Sacramento, CA USA; [Farrales, Roel D.] Mercy Gen Hosp, Sacramento, CA USA; [Howard, Calvin] City Folsom Fire Dept, Folsom, CA USA; [Montoya, James] Sutter Community Hosp, Sacramento, CA USA; [Bell, Jeneita M.; Coronado, Victor C.; Sugerman, David E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Ballard, Dustin W.] Kaiser Permanente San Rafael Med Ctr, San Rafael, CA USA; [Vinson, David R.] Kaiser Permanente Sacramento Med Ctr, Sacramento, CA USA		Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St,PSSB 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu	Vinson, David R/AAK-3227-2020	Vinson, David R/0000-0001-6559-1858	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177]; Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000134, UL1TR000002] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177] Funding Source: NIH RePORTER	This work was funded by the Centers for Disease Control and Prevention (CDC), grant number U01CE002177. Dr. Nishijima was supported through Mentored Clinical Research Training Program Award (Grant Number UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	[Anonymous], HEAD INJ TRIAG ASS I; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Damlien L, 2015, EUR J EMERG IN PRESS; Evans D, 2015, AM J EMERG MED, V33, P1635, DOI 10.1016/j.ajem.2015.07.044; Faul M, 2016, PREHOSP EMERG CARE, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Lurio J, 2010, J AM MED INFORM ASSN, V17, P217, DOI 10.1136/jamia.2009.000539; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Miller SL, 2008, ANN EMERG MED, V52, P483, DOI 10.1016/j.annemergmed.2008.03.021; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Palacio AM, 2015, PATIENT PREFER ADHER, V9, P133, DOI 10.2147/PPA.S64295; Patel PA, 2015, CIRC-CARDIOVASC QUAL, V8, P383, DOI 10.1161/CIRCOUTCOMES.114.000907; Quinn JV, 2004, ANN EMERG MED, V43, P224, DOI 10.1016/S0196-0644(03)00823-0; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; STIELL IG, 1992, AM J EMERG MED, V10, P14, DOI 10.1016/0735-6757(92)90117-G; THOMPSON WD, 1988, J CLIN EPIDEMIOL, V41, P949, DOI 10.1016/0895-4356(88)90031-5; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Yasuda CL, 2003, ARQ NEURO-PSIQUIAT, V61, P1011, DOI 10.1590/S0004-282X2003000600023	39	7	7	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	MAR-APR	2017	21	2					209	215		10.1080/10903127.2016.1218985			7	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	EN1CM	WOS:000395748100009	27636529	Green Accepted			2022-02-06	
J	Palmer, L				Palmer, Lee			Fluid Management in Patients with Trauma: Restrictive Versus Liberal Approach	VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE			English	Article						Damage controlled resuscitation; Permissive hypotension; Lethal triad; Hemostatic resuscitation; Trauma; Hemorrhagic shock	UNCONTROLLED HEMORRHAGIC-SHOCK; DAMAGE CONTROL RESUSCITATION; MULTIPLE TRAUMA; BRAIN-INJURY; STRATEGIES; MODEL; COAGULOPATHY; TRIALS; DOGS; CARE	Massive hemorrhage remains a major cause of traumatic deaths. The ideal fluid resuscitative strategy is much debated. Research has provided inconsistent results regarding which fluid strategy is ideal; the optimum fluid type, timing, and volume remains elusive. Aggressive large-volume resuscitation has been the mainstay based on controlled hemorrhage animal models. For uncontrolled hemorrhagic shock, liberal fluid resuscitative strategies exacerbate the lethal triad, invoke resuscitative injury, and increase mortality while more restrictive fluid strategies tend to ameliorate trauma-induced coagulopathy and favor a greater chance of survival. This article discusses the current evidence regarding liberal and restrictive fluid strategies for trauma.	[Palmer, Lee] Auburn Univ, Wilford & Kate Bailey Small Anim Teaching Hosp, 1220 Wire Rd, Auburn, AL 36849 USA		Palmer, L (corresponding author), Auburn Univ, Wilford & Kate Bailey Small Anim Teaching Hosp, 1220 Wire Rd, Auburn, AL 36849 USA.	lpalmer2508@gmail.com					Abelson AL, 2013, J VET EMERG CRIT CAR, V23, P395, DOI 10.1111/vec.12073; Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Alam HB, 2005, WORLD J SURG, V29, pS7, DOI 10.1007/s00268-004-2052-4; Anand LK, 2013, ANAESTH PAIN INTENSI, V17, P65; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Barbee RW, 2010, SHOCK, V33, P113, DOI 10.1097/SHK.0b013e3181b8569d; Beuran M, 2012, CHIRURGIA-BUCHAREST, V107, P564; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Boldt J, 2010, INTENS CARE MED, V36, P1299, DOI 10.1007/s00134-010-1912-7; Bougle A, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-1; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Cannon WB, 1918, J AMER MED ASSOC, V70, P618; Capone A, 1996, J TRAUMA, V40, P388, DOI 10.1097/00005373-199603000-00011; CARRICO CJ, 1976, CRIT CARE MED, V4, P46, DOI 10.1097/00003246-197603000-00002; Chatrath Veena, 2015, J Anaesthesiol Clin Pharmacol, V31, P308, DOI 10.4103/0970-9185.161664; Cherkas David, 2011, Emerg Med Pract, V13, P1; Cortes DO, 2014, BRIT J ANAESTH, V112, P968, DOI 10.1093/bja/aeu047; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Datta R, 2010, Med J Armed Forces India, V66, P312, DOI 10.1016/S0377-1237(10)80006-1; Duchesne JC, 2011, AM SURGEON, V77, P201; Ertmer C, 2011, CURR OPIN ANESTHESIO, V24, P202, DOI 10.1097/ACO.0b013e3283445326; Field Management Guidelines, 2005, FIELD MAN GUID; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Hirshberg A, 2006, J TRAUMA, V60, P1221, DOI 10.1097/01.ta.0000220392.36865.fa; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2010, BIOLOGICALS, V38, P72, DOI 10.1016/j.biologicals.2009.10.007; Holowaychuk MK, 2014, J VET EMERG CRIT CAR, V24, P93, DOI 10.1111/vec.12141; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; Kwan I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002245.pub2; Legrand M, 2010, ANESTHESIOLOGY, V112, P119, DOI 10.1097/ALN.0b013e3181c4a5e2; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Mapstone J, 2003, J TRAUMA, V55, P571, DOI 10.1097/01.TA.0000062968.69867.6F; Midwinter M J, 2009, J R Army Med Corps, V155, P323; Millham FH, 2010, SURGERY, V148, P1026, DOI 10.1016/j.surg.2010.02.014; Noritomi DT, 2011, CLINICS, V66, P1969, DOI 10.1590/S1807-59322011001100019; Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022; Palmer L, 2014, J VET EMERG CRIT CAR, V24, P75, DOI 10.1111/vec.12138; Palmer L, 2014, J VET EMERG CRIT CAR, V24, P63, DOI 10.1111/vec.12130; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SCALEA TM, 1994, CRIT CARE MED, V22, P1610; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Smail N, 1998, J TRAUMA, V44, P701, DOI 10.1097/00005373-199804000-00026; Stahel PF, 2009, INJURY, V40, pS27, DOI 10.1016/j.injury.2009.10.034; Stein Deborah M, 2012, Adv Surg, V46, P237; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Tisherman SA, 2004, J TRAUMA, V57, P898, DOI 10.1097/01.TA.0000133577.25793.E5; Tremblay LN, 2001, CAN J SURG, V44, P172; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Yagmur Y, 2008, EUR SURG, V40, P130, DOI 10.1007/s10353-008-0409-x	53	7	11	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0195-5616	1878-1306		VET CLIN N AM-SMALL	Vet. Clin. N. Am.-Small Anim. Pract.	MAR	2017	47	2					397	+		10.1016/j.cvsm.2016.10.014			15	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	EM3QR	WOS:000395230200028	27914759				2022-02-06	
J	Piccenna, L; Lannin, NA; Scott, K; Bragge, P; Gruen, R				Piccenna, Loretta; Lannin, Natasha A.; Scott, Katherine; Bragge, Peter; Gruen, Russell			Guidance for community-based caregivers in assisting people with moderate to severe traumatic brain injury with transfers and manual handling: evidence and key stakeholder perspectives	HEALTH & SOCIAL CARE IN THE COMMUNITY			English	Article						caregivers; community; home; manual handling; transfers; traumatic brain injury		Adults with moderate to severe traumatic brain injury (TBI) rely on assistance from paid and unpaid caregivers upon return to the community. An inability to move independently makes these adults highly dependent on caregivers for transfers and manual handling tasks. Evidence-based guidelines are therefore important to ensure that caregivers and people in the community are protected and that practices are standard and consistent. This study commenced with a rapid review of evidence-based recommendations between 2000 and 2015 pertaining to transfers and manual handling in people with TBI; and ended with a structured stakeholder dialogue that reflected upon this evidence and gathered perspectives on how to address key issues in community-based manual handling following TBI. Three relevant guidelines were identified, providing nine recommendations encompassing assessment of the person's ability to assist caregivers, manual handling and appropriate equipment use. Due to the low number of recommendations and low level of supporting evidence, these recommendations alone could not provide comprehensive guidance. Three systematic reviews and two primary studies were also identified, and these suggest that comprehensive training programmes in transfers and manual handling tasks are effective. Further to this, a structured stakeholder dialogue was conducted, which revealed six major themes - (i) comprehensive risk assessment, (ii) presence of two caregivers, (iii) provision of training, (iv) home environment modification, (v) equipment, and (vi) policy implementation context. Recommendations for health professionals include providing information packs to caregivers, risk assessment and mitigation for those at high risk, and strategies to prevent and minimise injury in caregivers. Development of comprehensive guidance for caregivers in transfers and manual handling in people with moderate to severe TBI living in the community is a hidden but important priority.	[Piccenna, Loretta; Scott, Katherine; Bragge, Peter; Gruen, Russell] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Piccenna, Loretta; Scott, Katherine; Bragge, Peter; Gruen, Russell] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Piccenna, Loretta; Lannin, Natasha A.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Lannin, Natasha A.] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic, Australia; [Lannin, Natasha A.] Univ Sydney, Sydney Med Sch Northern, Kolling Inst, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [Bragge, Peter] Monash Univ, Monash Sustainabil Inst, BehaviourWorks Australia, Melbourne, Vic, Australia; [Gruen, Russell] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore		Piccenna, L (corresponding author), La Trobe Univ, Sch Allied Hlth, Living Disabil Ctr, Bundoora, Vic 3086, Australia.	l.piccenna@latrobe.edu.au	piccenna, Loretta/I-2533-2014; Lannin, Natasha A/A-4195-2013	piccenna, Loretta/0000-0003-3895-8145; Lannin, Natasha A/0000-0002-2066-8345; Scott, Kate/0000-0001-7342-5470; Bragge, Peter/0000-0003-0745-5131			ABIKUS Guideline Development Group, 2007, ABIKUS EV BAS REC RE; [Anonymous], 2006, TRAUM BRAIN INJ DIAG; Australian Nursing and Midwifery Federation V. B, 2013, SAF PAT HANDL FORM N; Baptiste A., 2004, ONLINE J ISSUES NURS, V9; Field Marilyn J., 1990, CLIN PRACT GUID DIR, P38; Hignett S, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e6; Jung Y, 2009, EVIDENCE BASED RES E; Kayess R., 2013, RES NEED 2 CARE WORK; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Moat KA, 2014, B WORLD HEALTH ORGAN, V92, P20, DOI 10.2471/BLT.12.116806; Nelson Audrey L, 2007, Nurs Manage, V38, P26, DOI 10.1097/01.NUMA.0000262923.39562.0e; NTRI, 2012, NTRI FOR IMPR CAR IN; Reinhard S. C., 2008, PATIENT SAFETY QUALI; Turner-Stokes L., 2003, REH FOLL ACQ GRAIN I, P1	14	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0410	1365-2524		HEALTH SOC CARE COMM	Health Soc. Care Community	MAR	2017	25	2					458	465		10.1111/hsc.12327			8	Public, Environmental & Occupational Health; Social Work	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Work	EL9YS	WOS:000394976600016	26790858	Green Published			2022-02-06	
J	Pullens, P; Bladt, P; Sijbers, J; Maas, AIR; Parizel, PM				Pullens, Pim; Bladt, Piet; Sijbers, Jan; Maas, Andrew I. R.; Parizel, Paul M.			Technical Note: A safe, cheap, and easy-to-use isotropic diffusion MRI phantom for clinical and multicenter studies	MEDICAL PHYSICS			English	Article						diffusion tensor imaging; imaging; multicenter study; phantoms; quality control	TRAUMATIC BRAIN-INJURY; QUANTIFICATION; IMPLEMENTATION; ANISOTROPY	Purpose: Since Diffusion Weighted Imaging (DWI) data acquisition and processing are not standardized, substantial differences in DWI derived measures such as Apparent Diffusion Coefficient (ADC) may arise which are related to the acquisition or MRI processing method, but not to the sample under study. Quality assurance using a standardized test object, or phantom, is a key factor in standardizing DWI across scanners. Methods: Current diffusion phantoms are either complex to use, not available in larger quantities, contain substances unwanted in a clinical environment, or are expensive. A diffusion phantom based on a polyvinylpyrrolidone (PVP) solution, together with a phantom holder, is presented and compared to existing diffusion phantoms for use in clinical DWI scans. An ADC vs. temperature calibration curve was obtained. Results: ADC of the phantom (808 to 857 +/- 0.2 mm(2)/s) is in the same range as ADC values found in brain tissue. ADC measurements are highly reproducible across time with an intra-class correlation coefficient of > 0.8. ADC as function of temperature (in Kelvin) can be estimated as ADC(m)(T) = [expd(-7.09).exp (-2903.8 (1/T - 1/293.55))] with a total uncertainty (95% confidence limit) of +/- 1.7%. Conclusion: We present an isotropic diffusion MRI phantom, together with its temperature calibration curve, that is easy-to-use in a clinical environment, cost-effective, reproducible to produce, and that contains no harmful substances. (C) 2017 American Association of Physicists in Medicine	[Pullens, Pim; Parizel, Paul M.] Univ Antwerp Hosp, Dept Radiol, B-2650 Edegem, Belgium; [Pullens, Pim; Maas, Andrew I. R.; Parizel, Paul M.] Univ Antwerp, B-2650 Edegem, Belgium; [Bladt, Piet; Sijbers, Jan] Univ Antwerp, Dept Phys, iMinds Vis Lab, B-2610 Antwerp, Belgium; [Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium		Pullens, P (corresponding author), Univ Antwerp Hosp, Dept Radiol, B-2650 Edegem, Belgium.; Pullens, P (corresponding author), Univ Antwerp, B-2650 Edegem, Belgium.	w.l.p.m.pullens@gmail.com	Sijbers, Jan/C-4214-2011; Sijbers, Jan/H-4324-2015	Sijbers, Jan/0000-0003-4225-2487; Sijbers, Jan/0000-0003-4225-2487; Parizel, Paul M./0000-0002-0221-2854; Pullens, Pim/0000-0003-2014-7248	Framework 7 program of the European Union [602150-2]	This work was performed in the context of CENTER-TBI (Comparative European Neurotrauma Effectiveness Research in Traumatic Brain Injury), supported by the Framework 7 program of the European Union (Grant number: 602150-2). The authors wish to thank Dr. Carlo Pierpaoli ( NICHD/NIH) for helpful discussions.	Boss M, 2014, P ISMRM, V22, P4505; De Santis S, 2013, MAGN RESON MED, V70, P490, DOI 10.1002/mrm.24465; Emsell L., 2016, DIFFUSION TENSOR IMA; Horkay F, 2012, US Patent, Patent No. [US2012/0068699 A1, 20120068699]; Ivancevic M, 2009, P 17 SCI M INT SOC M, P4166; Jones D.K., 2010, DIFFUSION MRI THEORY; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kim SJ, 2015, KOREAN J RADIOL, V16, P297, DOI 10.3348/kjr.2015.16.2.297; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P123, DOI 10.1002/cmr.a.20049; Laubach HJ, 1998, J MAGN RESON IMAGING, V8, P1349, DOI 10.1002/jmri.1880080627; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Malyarenko DI, 2016, MAGN RESON MED, V75, P1312, DOI 10.1002/mrm.25754; Obuchowski NA, 2015, STAT METHODS MED RES, V24, P68, DOI 10.1177/0962280214537390; Pierpaoli C, 2009, P INT SOC MAG RES IM, P87371; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Schmidt H, 2015, INVEST RADIOL, V50, P46, DOI 10.1097/RLI.0000000000000095; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stocker T., 2016, P INT SOC MAG RESON, V24; Tofts PS, 2000, MAGN RESON MED, V43, P368, DOI 10.1002/(SICI)1522-2594(200003)43:3<368::AID-MRM8>3.0.CO;2-B; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	20	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	MAR	2017	44	3					1063	1070		10.1002/mp.12101			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	EQ2AN	WOS:000397870800024	28079257				2022-02-06	
J	Rhine, T; Quatman-Yates, C; Clark, RA				Rhine, Tara; Quatman-Yates, Catherine; Clark, Ross A.			A Longitudinal Examination of Postural Impairments in Children With Mild Traumatic Brain Injury: Implications for Acute Testing	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild traumatic brain injury; pediatrics; postural equilibrium; posturography; standing balance; wavelet analysis	CONCUSSION; BALANCE; DYNAMICS; STABILITY; FREQUENCY; RECOVERY; INSIGHTS; STANCE; TASK	Objective: To examine how postural control changes following pediatric mild traumatic brain injury. Setting: Urban pediatric emergency department. Participants: Children 11 to 16 years old who presented within 6 hours of sustaining mild traumatic brain injury. Design: Prospective observational cohort followed for 1 month. Main Measures: Total center of pressure path velocity and path velocity within distinct frequency bands, ranging from moderate to ultralow, were recorded by the Nintendo Wii Balance Board during a 2-legged stance. Measurements were recorded in 2 separate tests with eyes open and closed. The scores of the 2 tests were compared, and a Romberg quotient was computed. Results: Eleven children were followed for 1 month postinjury. The ultralow frequency, which reflects slow postural movements associated with exploring stability boundaries, was lower (p = .02) during the eyes closed stance acutely following injury. The Romberg quotient for this frequency was also significantly lower acutely following injury (p = .007) than at 1 month. Conclusion: Following mild traumatic brain injury, children acutely demonstrate significantly more rigid sway patterns with eyes closed than with eyes open, which were highlighted by the Romberg quotient. The Romberg quotient could allow for accurate identification and tracking of postural instability without requiring knowledge of preinjury balance ability.	[Rhine, Tara] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Emergency Med, 3333 Burnet Ave,ML2008, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Sports Med, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA; [Clark, Ross A.] Australian Catholic Univ, Fac Hlth Sci, Melbourne, Vic, Australia		Rhine, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Emergency Med, 3333 Burnet Ave,ML2008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org	Quatman-Yates, Catherine/U-9580-2019; Quatman-Yates, Catherine/AAK-4507-2021; Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553	Cincinnati Children's Medical Center; KL2 Mentored Career Award from the Center for Clinical and Translational Science and Training; Cincinnati Children's Medical Center Division of Emergency Medicine, Divisional Internal Grant (Rhine); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	This study was partially supported through a parent study funded by Cincinnati Children's Medical Center, KL2 Mentored Career Award from the Center for Clinical and Translational Science and Training (PI: Lynn Babcock, MD, MS, Cincinnati Children's Hospital Medical Center) and by Cincinnati Children's Medical Center Division of Emergency Medicine, Divisional Internal Grant (Rhine).	Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Doyle RJ, 2007, GAIT POSTURE, V25, P166, DOI 10.1016/j.gaitpost.2006.03.004; Faul M, 2010, TRAUMATIC BRAIN INJU; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Grissom R.J., 2012, EFFECT SIZES RES UNI, V2; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Liang ZQ, 2014, GAIT POSTURE, V39, P397, DOI 10.1016/j.gaitpost.2013.08.007; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Murnaghan CD, 2011, NEUROSCIENCE, V195, P54, DOI 10.1016/j.neuroscience.2011.08.020; Murnaghan CD, 2013, GAIT POSTURE, V38, P734, DOI 10.1016/j.gaitpost.2013.03.012; Quek J, 2014, GAIT POSTURE, V39, P1069, DOI 10.1016/j.gaitpost.2014.01.009; RICHARDSON PK, 1992, AM J OCCUP THER, V46, P793, DOI 10.5014/ajot.46.9.793; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Tsai CL, 2008, HUM MOVEMENT SCI, V27, P142, DOI 10.1016/j.humov.2007.08.002; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	24	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E18	E23		10.1097/HTR.0000000000000192			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700002	26580689				2022-02-06	
J	Rupprecht, H; Heppner, HJ; Wohlfart, K; Turkoglu, A				Rupprecht, Holger; Heppner, Hans Juergen; Wohlfart, Kristina; Tuerkoglu, Alp			The geriatric polytrauma: Risk profile and prognostic factors	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Geriatric polytrauma; Glasgow Coma Scale; Hannover Polytrauma Score; polytrauma	MULTIPLE TRAUMA; INJURY PATTERNS; MAJOR TRAUMA; PELVIC FRACTURE; MORTALITY; OUTCOMES; MANAGEMENT; CARE; CLASSIFICATION; SURVIVAL	BACKGROUND: In the German population, the percentage of elderly patients is increasing, and consequently there are more elderly patients among trauma cases, and particularly cases of polytrauma. The aim of this study was to present clinical results and a risk profile for geriatric polytrauma patients. METHODS: Review of 140 geriatric (over 65 years of age) polytrauma patients who received prehospital treatment was performed. Severity of trauma was retrospectively assessed with Hannover Polytrauma Score (HPTS). Age, hemoglobin (Hb) level, systolic blood pressure (BP), Glasgow Coma Scale (GCS) score, timing of and necessity for intubation were analyzed in relation to mortality and in comparison with younger patients. RESULTS: Geriatric polytrauma patients (n= 140) had overall mortality rate of 65%, whereas younger patients (n= 1468) had mortality rate of 15.9%. Despite equivalent severity of injury (HPTS less age points) in geriatric and non-geriatric groups, mortality rate was 4 times higher in geriatric group. Major blood loss with Hb < 8 g/dL was revealed to be 3 times more fatal than moderate or minor blood loss (Hb >= 8 g/dL). GCS score < 12 corresponded to double mortality rate (39% vs 83%). CONCLUSION: Age by itself is significant risk factor and predictor of increased mortality in polytrauma patients. Additional risk factors include very low GCS score and systolic BP < 80 mm Hg, for instance, as potential clinical indicators of massive bleeding and traumatic brain injury. Such parameters demand early and rapid treatment at prehospital stage and on admission.	[Rupprecht, Holger; Wohlfart, Kristina; Tuerkoglu, Alp] Klinikum Furth, Dept Gen & Visceral Surg, Furth, Germany; [Heppner, Hans Juergen] Univ Witten Herdecke, Dept Geriatr, Schwelm, Germany		Rupprecht, H (corresponding author), Klinikum Furth, Chirurg Klin 1, Jakob Henle Str 1, D-90766 Furth, Germany.	holger.rupprecht@klinikum-fuerth.de					Aldrian S, 2005, WIEN KLIN WOCHENSCHR, V117, P145, DOI 10.1007/s00508-004-0290-y; Aucar John A., 1998, P427; Aufmkolk M, 1997, UNFALLCHIRURG, V100, P477, DOI 10.1007/s001130050145; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; Boldt J, 1998, INTENSIVMED, V35, P667; BROOS PLO, 1993, INJURY, V24, P365, DOI 10.1016/0020-1383(93)90096-O; BROOS PLO, 1988, INT SURG, V73, P119; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; Chong K H, 1997, Iowa Orthop J, V17, P110; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Cordts Filho Roberto de Moraes, 2011, Rev Col Bras Cir, V38, P310; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; DAY RJ, 1994, MED J AUSTRALIA, V160, P675, DOI 10.5694/j.1326-5377.1994.tb125903.x; DEMARIA EJ, 1987, J TRAUMA, V27, P1200; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Ferrera PC, 2000, AM J EMERG MED, V18, P575, DOI 10.1053/ajem.2000.9266; Gowing R, 2007, CAN J SURG, V50, P437; Henry SM, 2002, J TRAUMA, V53, P15, DOI 10.1097/00005373-200207000-00004; Huber-Wagner S, 2007, VOX SANG, V92, P69, DOI 10.1111/j.1423-0410.2006.00858.x; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; KLEIN SR, 1992, J CARDIOVASC SURG, V33, P349; KNUDSON MM, 1994, ARCH SURG-CHICAGO, V129, P448; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; Muller-Werdan U, 2011, MED KLIN, V106, P10, DOI [10.1007/s00063-011-00242-5, 10.1007/s00063-011-0042-5]; Nirula R, 2004, J TRAUMA, V57, P37, DOI 10.1097/01.TA.0000128236.45043.6A; O'Brien DP, 2002, SURGERY, V132, P710, DOI 10.1067/msy.2002.127690; OESTERN HJ, 1985, UNFALLCHIRURG, V88, P465; Oestern HJ, 1997, CHIRURG, V68, P1059, DOI 10.1007/s001040050323; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; OSLER T, 1988, AM J SURG, V156, P537, DOI 10.1016/S0002-9610(88)80548-8; Patel VI, 2004, J NATL MED ASSOC, V96, P1553; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; PLEWA M C, 1990, Emergency Medicine Clinics of North America, V8, P193; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; ROBINSON A, 1995, CAN MED ASSOC J, V152, P1453; SANTORA TA, 1994, SURG CLIN N AM, V74, P163; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; Scarborough K, 2008, ARCH SURG-CHICAGO, V143, P22, DOI 10.1001/archsurg.2007.2-b; SHORR RM, 1989, J TRAUMA, V29, P234, DOI 10.1097/00005373-198902000-00016; SMITH DP, 1990, SOUTHERN MED J, V83, P171, DOI 10.1097/00007611-199002000-00010; Soffer D, 2006, ISRAEL MED ASSOC J, V8, P635; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; TEASDALE G, 1974, LANCET, V2, P81; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; Trunkey DD, 2000, ARCH SURG-CHICAGO, V135, P34, DOI 10.1001/archsurg.135.1.34; Tscherne H, 1996, J BONE JOINT SURG BR, V78B, P840, DOI 10.1302/0301-620X.78B5.0780840; VANAALST JA, 1991, J TRAUMA, V31, P1096; vanderSluis CK, 1996, J TRAUMA, V40, P78, DOI 10.1097/00005373-199601000-00015; Wutzler S, 2008, UNFALLCHIRURG, V111, P592, DOI 10.1007/s00113-008-1448-2; Yee WY, 2006, EMERG MED J, V23, P42, DOI 10.1136/emj.2005.023754; ZIETLOW SP, 1994, J TRAUMA, V37, P985, DOI 10.1097/00005373-199412000-00020	55	7	7	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAR	2017	23	2					156	162		10.5505/tjtes.2016.77177			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EQ1EM	WOS:000397812400013	28467584	Bronze			2022-02-06	
J	Schmitt, SE				Schmitt, Sarah E.			Utility of Clinical Features for the Diagnosis of Seizures in the Intensive Care Unit	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Seizures; Continuous EEG; ICU; Nonepileptic movements	TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; STATUS EPILEPTICUS; ICU	Purpose:Seizures in the intensive care unit are often subtle, and may have little or no clinical correlate. This study attempts to determine what clinical features are most strongly associated with the presence of electrographic seizures on continuous EEG (cEEG) monitoring.Methods:A retrospective review for all patients who underwent cEEG monitoring between January 2003 and March 2009 for either characterization of clinical events or altered mental status was performed. Clinical events were categorized as (1) limb myoclonus/tremor, (2) extremity weakness, (3) eye movement abnormalities, (4) facial/periorbital twitching, and (5) other abnormal movements. The presence of associated dyscognitive event features was also recorded.Results:Records from 626 patients who underwent cEEG were reviewed154 for event characterization and 472 for altered mental status. Seizures were captured in 48 patients (31.2%) undergoing cEEG monitoring for characterization of clinical events. This was not significantly different from the incidence of seizures in patients undergoing cEEG for altered mental status (N = 133, 28.2%). Patients undergoing cEEG monitoring for facial/periorbital twitching were significantly more likely to have electrographic seizures (78.9%, P < 0.005) than patients undergoing cEEG for altered mental status or characterization of other types of events.Conclusions:The incidence of seizures in patients in the intensive care unit with clinical events is generally not significantly higher than the incidence of seizures in patients in the intensive care unit with altered mental status. However, the presence of facial/periorbital twitching was associated a higher incidence of electrographic seizures.	[Schmitt, Sarah E.] Hosp Univ Penn, Dept Neurol, PENN Epilepsy Ctr, 3400 Spruce St, Philadelphia, PA 19104 USA; [Schmitt, Sarah E.] Med Univ South Carolina, Dept Neurol, 96 Jonathan Lucas St,CSB 301, Charleston, SC 29425 USA		Schmitt, SE (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,CSB 301, Charleston, SC 29425 USA.	schmitts@musc.edu		Schmitt, Sarah/0000-0003-1384-9794			Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Benbadis SR, 2010, EPILEPSIA, V51, P2338, DOI 10.1111/j.1528-1167.2010.02683.x; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Huang CW, 2014, NEUROLOGY, V82, P768, DOI 10.1212/WNL.0000000000000166; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Narayanan JT, 2007, EPILEPSIA, V48, P900, DOI 10.1111/j.1528-1167.2007.01099.x; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; Peterson JF, 2006, J AM GERIATR SOC, V54, P479, DOI 10.1111/j.1532-5415.2005.00621.x; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Young GB, 1996, NEUROLOGY, V47, P83	17	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	MAR	2017	34	2					158	161		10.1097/WNP.0000000000000335			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EM8XD	WOS:000395593500011	27571047				2022-02-06	
J	Sharpe, JP; Magnotti, LJ; Gobbell, WC; Huang, X; Perez, EA; Fabian, TC; Croce, MA				Sharpe, John P.; Magnotti, Louis J.; Gobbell, Wade C.; Huang, Xin; Perez, Edward A.; Fabian, Timothy C.; Croce, Martin A.			Impact of early operative pelvic fixation on long-term self-reported outcome following severe pelvic fracture	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Functional outcomes; pelvic fracture; trauma	INTERNAL-FIXATION; RING FRACTURES; OPEN REDUCTION; INPATIENT REHABILITATION; AFTER-DISCHARGE; MANAGEMENT; MORTALITY; INJURIES; EPIDEMIOLOGY; PREDICTORS	Background Traumatic disruption of the pelvic ring is a significant cause of life-threatening hemorrhage. For those patients who survive the initial injury, these fractures are associated with long periods of immobilization and intense rehabilitation. There is little published information available regarding long-term functional outcomes in these patients. This study evaluated the impact of severe pelvic fractures on those long-term outcomes. Methods All patients with severe pelvic fractures over an 18-year period were identified. Severe pelvic fractures were defined as those with vascular disruption, open-book component with symphysis diastasis, or sacroiliac disruption with vertical shear. Functional outcome was measured using the Boston University Activity Measure for Post-Acute Care to assess mobility (normal, >84) and daily activity (normal, >84). Multiple linear regression analysis was used to identify predictors of functional outcome after severe pelvic fracture. Results From January 1996 to September 2014, 401 patients were identified: 240 (60%) men and 161 (40%) women. Overall mortality was 29%. Of the 285 survivors, follow-up was obtained in 145 patients (51%). Mean follow-up was 8.3 years, with a maximum of 20 years. Mean age and Injury Severity Score were 53 years and 27, respectively. Mean Activity Measure for Post-Acute Care scores for mobility and daily activity were 55 and 63, respectively; both signifying significant impairment when compared with normal. Multiple linear regression analysis using age, traumatic brain injury, transfusions, Injury Severity Score, ventilator days, presence of associated lower-extremity fractures, and time to operative pelvic fixation identified time to pelvic fixation as the only predictor of decreased mobility ( = -0.74, p = 0.04) and activity ( = -0.21, p = 0.03) following severe pelvic fracture. Conclusions Prolonged time to operative pelvic fixation led to worse long-term functional outcomes in patients with severe pelvic ring disruption. Early fixation of the pelvic ring is the only potentially modifiable risk factor for decreased functional outcomes in patients with severe pelvic fractures. Level of Evidence Therapeutic study, level IV.	[Sharpe, John P.; Magnotti, Louis J.; Gobbell, Wade C.; Huang, Xin; Perez, Edward A.; Fabian, Timothy C.; Croce, Martin A.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA		Sharpe, JP (corresponding author), Dept Surg, 910 Madison Ave 210, Memphis, TN 38163 USA.	jsharpe6@uthsc.edu					Balogh Z, 2005, J TRAUMA, V58, P778, DOI 10.1097/01.TA.0000158251.40760.B2; Biffl WL, 2001, ANN SURG, V233, P843, DOI 10.1097/00000658-200106000-00015; Borg T, 2010, INJURY, V41, P400, DOI 10.1016/j.injury.2009.11.006; Britt LD, 2011, J AM COLL SURGEONS, V212, P635; Burlew CC, 2011, J AM COLL SURGEONS, V212, P628, DOI 10.1016/j.jamcollsurg.2010.12.020; Coster WJ, 2006, J REHABIL MED, V38, P237, DOI 10.1080/16501970600609774; Cothren CC, 2007, J TRAUMA, V62, P834, DOI 10.1097/TA.0b013e31803c7632; Croce MA, 2007, J AM COLL SURGEONS, V204, P935, DOI 10.1016/j.jamcollsurg.2007.01.059; Demetriades D, 2002, J AM COLL SURGEONS, V195, P1, DOI 10.1016/S1072-7515(02)01197-3; Dienstknecht T, 2013, BONE JOINT J, V95B, P548, DOI 10.1302/0301-620X.95B4.30804; Durkin A, 2006, AM J SURG, V192, P211, DOI 10.1016/j.amjsurg.2006.05.001; Eckroth-Bernard K, 2010, CURR OPIN CRIT CARE, V16, P582, DOI 10.1097/MCC.0b013e3283402869; Enninghorst N, 2010, J TRAUMA, V68, P935, DOI 10.1097/TA.0b013e3181d27b48; Ertel W, 2001, J ORTHOP TRAUMA, V15, P468, DOI 10.1097/00005131-200109000-00002; FLINT L, 1990, ANN SURG, V211, P703, DOI 10.1097/00000658-199006000-00008; Flint LM, 2007, J AM COLL SURGEONS, V204, P940; Gabbe BJ, 2015, ANZ J SURG, V85, P749, DOI 10.1111/ans.12700; Gansslen A, 1996, INJURY, V27, P13, DOI 10.1016/S0020-1383(96)90106-0; Gettys FK, 2011, ORTHOP CLIN N AM, V42, P69, DOI 10.1016/j.ocl.2010.08.006; GILLILAND MD, 1982, J TRAUMA, V22, P691, DOI 10.1097/00005373-198208000-00007; GRUEN GS, 1995, J TRAUMA, V39, P838, DOI 10.1097/00005373-199511000-00006; Haley SM, 2006, ARCH PHYS MED REHAB, V87, P1033, DOI 10.1016/j.apmr.2006.04.020; Kabak S, 2003, J ORTHOP TRAUMA, V17, P555, DOI 10.1097/00005131-200309000-00003; Katsoulis E, 2006, INJURY, V37, P1133, DOI 10.1016/j.injury.2006.07.017; Korovessis P, 2000, ORTHOPEDICS, V23, P1165; Madhu TS, 2007, INJURY, V38, P598, DOI 10.1016/j.injury.2006.11.005; Papakostidis C, 2009, INT ORTHOP, V33, P329, DOI 10.1007/s00264-008-0555-6; Smith W, 2007, J ORTHOP TRAUMA, V21, P31, DOI 10.1097/BOT.0b013e31802ea951; Stephen DJG, 1999, J TRAUMA, V47, P638, DOI 10.1097/00005373-199910000-00006; Suzuki T, 2007, J TRAUMA, V63, P884, DOI 10.1097/01.ta.0000235888.90489.fc; Tran TLN, 2016, J TRAUMA ACUTE CARE, V81, P1171, DOI 10.1097/TA.0000000000001230; Vallier HA, 2012, J ORTHOP TRAUMA, V26, P296, DOI 10.1097/BOT.0b013e318221e94e; Van den Bosch EW, 1999, J TRAUMA, V47, P365, DOI 10.1097/00005373-199908000-00026; Velmahos G, 2007, J TRAUMA, V62, P839; Yan LH, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00207	35	7	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2017	82	3					444	450		10.1097/TA.0000000000001346			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EM8XV	WOS:000395595300002	28030509				2022-02-06	
J	Toedebusch, CM; Bachrach, MD; Garcia, VB; Johnson, GC; Katz, ML; Shaw, G; Coates, JR; Garcia, ML				Toedebusch, C. M.; Bachrach, M. D.; Garcia, V. B.; Johnson, G. C.; Katz, M. L.; Shaw, G.; Coates, J. R.; Garcia, M. L.			Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						Amyotrophic lateral sclerosis; Biomarker; Dog; Neurodegenerative disease	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; SUBUNIT PNF-H; NF-H; PROGNOSTIC BIOMARKER; MISSENSE MUTATION; SOD1 MUTATION; AXONAL INJURY; SERUM; PROTEIN	Background: No definitive, antemortem diagnostic test for canine degenerative myelopathy (DM) is available. Phosphorylated neurofilament heavy (pNF-H) is a promising biomarker for nervous system diseases. Hypothesis/Objective: Cerebrospinal fluid (CSF) and serum pNF-H is a detectable biological marker for diagnosis of canine DM. Animals: Fifty-three DM-affected, 27 neurologically normal, 7 asymptomatic at-risk, and 12 DM mimic dogs. Methods: Archived CSF and serum pNF-H concentrations were determined by a commercially available ELISA. A receiver- operating characteristic (ROC) curve was generated with CSF values. Results: Compared with old control dogs, median CSF pNF-H concentration was increased in all stages of DM; old dogs 5.1 ng/mL (interquartile range [IQR] 1.4-9.3) versus DM stage 1 23.9 ng/mL (IQR 20.8-29.6; P <.05) versus DM stage 2 36.8 ng/mL (IQR 22.9-51.2; P <.0001) versus DM stage 3 25.2 ng/mL (IQR 20.2-61.8; P <.001) versus DM stage 4 38.0 ng/mL (IQR 11.6-59.9; P <.01). Degenerative myelopathy stage 1 dogs had increased median CSF pNF-H concentrations compared with asymptomatic, at-risk dogs (3.4 ng/mL [IQR 1.5-10.9; P <.01]) and DM mimics (6.6 ng/mL [ IQR 3.012.3; P <.01]). CSF pNF-H concentration > 20.25 ng/mL was 80.4% sensitive (confidence interval [CI] 66.09-90.64%) and 93.6% specific (CI 78.58-99.21%) for DM. Area under the ROC curve was 0.9467 (CI 0.92-0.9974). No differences in serum pNF-H concentration were found between control and DM-affected dogs. Conclusions and Clinical Importance: pNF-H concentration in CSF is a sensitive biomarker for diagnosis of DM. Although there was high specificity for DM in this cohort, further study should focus on a larger cohort of DM mimics, particularly other central and peripheral axonopathies.	[Toedebusch, C. M.; Coates, J. R.] Coll Vet Med, Dept Vet Med & Surg, Columbia, MO USA; [Bachrach, M. D.; Garcia, V. B.; Garcia, M. L.] Bond Life Sci Ctr, Div Biol Sci, Columbia, MO USA; [Johnson, G. C.] Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA; [Katz, M. L.] Univ Missouri, Sch Med, Mason Eye Inst, 1201 E Rollins St, Columbia, MO 65211 USA; [Shaw, G.] EnCor Biotechnol Inc, Gainesville, FL USA		Garcia, ML (corresponding author), Univ Missouri, Bond Life Sci Ctr, Div Biol Sci, CS Bond Life Sci Ctr 340C, 1201 E Rollins St, Columbia, MO 65211 USA.; Coates, JR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, 1201 E Rollins St, Columbia, MO 65211 USA.	coatesj@missouri.edu; garciaml@missouri.edu	Fiumefreddo, Andrea/T-2977-2019	Toedebusch, Christine/0000-0002-3216-3344	AKC Canine Health Foundation [2165]; American Boxer Charitable Foundation	This work was supported by the AKC Canine Health Foundation Grant #2165, American Boxer Charitable Foundation.	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; AVERILL DR, 1973, J AM VET MED ASSOC, V162, P1045; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; BRAUND KG, 1978, AM J VET RES, V39, P1309; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Coates JR, 2007, J VET INTERN MED, V21, P1323, DOI 10.1892/07-059.1; Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; Gresle MM, 2014, J NEUROL NEUROSUR PS, V85, P1209, DOI 10.1136/jnnp-2013-306789; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; Julien JP, 2000, J NEUROL SCI, V180, P7, DOI 10.1016/S0022-510X(00)00422-6; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; Mashita T, 2015, J VET MED SCI, V77, P433, DOI 10.1292/jvms.14-0582; Morgan BR, 2014, J NEUROSCI RES, V92, P531, DOI 10.1002/jnr.23332; Morgan BR, 2013, J NEUROSCI RES, V91, P1639, DOI 10.1002/jnr.23287; Nishida H, 2014, VET SURG, V43, P289, DOI 10.1111/j.1532-950X.2014.12144.x; Oji T, 2007, VET CLIN PATH, V36, P281, DOI 10.1111/j.1939-165X.2007.tb00225.x; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2007, J IMMUNOL METHODS, V319, P34, DOI 10.1016/j.jim.2006.09.021; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Shafie INF, 2014, CELL STRESS CHAPERON, V19, P311, DOI 10.1007/s12192-013-0457-4; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; SHAW G, 1986, EUR J CELL BIOL, V42, P1; SHEA TB, 1993, J NEUROSCI RES, V35, P507, DOI 10.1002/jnr.490350507; Shelton GD, 2012, J NEUROL SCI, V318, P55, DOI 10.1016/j.jns.2012.04.003; Steinacker P, 2016, J NEUROL NEUROSUR PS, V87, P12, DOI 10.1136/jnnp-2015-311387; Wininger FA, 2011, J VET INTERN MED, V25, P1166, DOI [10.1111/j.1939-1676.2011.0760.x, 10.1111/j.1939-1676.2011.00760.x]; Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317	37	7	7	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-1676			J VET INTERN MED	J. Vet. Intern. Med.	MAR-APR	2017	31	2					513	520		10.1111/jvim.14659			8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	EQ3TN	WOS:000397995900030	28186658	gold, Green Published			2022-02-06	
J	Vidak, HK; Ivkovic, TC; Vidak, Z; Kapitanovic, S				Vidak, Helena Kapitanovic; Ivkovic, Tina Catela; Vidak, Zoran; Kapitanovic, Sanja			COX-1 and COX-2 polymorphisms in susceptibility to cerebral palsy in very preterm infants	MOLECULAR NEUROBIOLOGY			English	Article						Cerebral palsy; Very premature infants; Gene polymorphisms; COX-1; COX-2	NECROSIS-FACTOR-ALPHA; WHITE-MATTER LESIONS; INFLAMMATORY RESPONSE; FUNCTIONAL POLYMORPHISMS; NERVOUS-SYSTEM; BRAIN; CYCLOOXYGENASE-2; ASSOCIATION; GENE; MICROGLIA	Cerebral palsy (CP) is a nonprogressive motor disorder caused by white matter damage in the developing brain. Recent epidemiological and clinical data suggest intrauterine infection/inflammation as the most common cause of preterm delivery and neonatal complications, including CP. Cyclooxygenases are key enzymes in the conversion of arachidonic acid to prostaglandins. The COX family consists of two isoforms, COX-1 and COX-2. In the brain, COX-2 is constitutively expressed at high levels on pyramidal neurons, while COX-1 is predominantly expressed by microglia and can be upregulated in pathological conditions, such as infection, ischemia and traumatic brain injury. Single nucleotide polymorphisms in the COX-1 and COX-2 gene could have profound effects on COX-1 and COX-2 expression and, directly or indirectly, influence the pathogenesis, development and severity of CP. In this study we investigated the association between single nucleotide polymorphisms of the COX-1 and COX-2 gene and susceptibility to cerebral palsy in very preterm infants. The results of our study showed the association between COX-1 high expression genotype (-842 AA) and COX-1 high expression allele -842A and risk of CP in infants with cystic periventricular leucomalacia (cPVL). Our results support an important role of COX-1 enzyme on microglial activation during neuroinflammation resulting in huge neuroinflammatory response and the proinflammatory mediator overproduction, with the serious white matter damage and CP development as a consequence.	[Vidak, Helena Kapitanovic] Special Hosp Children Neurodev & Motor Difficulti, Goljak 2, Zagreb, Croatia; [Ivkovic, Tina Catela; Kapitanovic, Sanja] Rudjer Boskovic Inst, Div Mol Med, Lab Personalized Med, Bijenicka C 54, Zagreb, Croatia; [Vidak, Zoran] Clin Hosp Merkur, Dept Obstet & Gynecol, Div Neonatol, Ivana Zajca 19, Zagreb, Croatia		Vidak, HK (corresponding author), Special Hosp Children Neurodev & Motor Difficulti, Goljak 2, Zagreb, Croatia.	hkvidak@irb.hr	Ivkovic, Tina Catela/AAL-1324-2020	Ivkovic, Tina Catela/0000-0003-3909-6858; Kapitanovic, Sanja/0000-0001-8788-3085	Ministry of Education, Science and Sports of Croatia [098-0982464-2508]	This study was funded by Ministry of Education, Science and Sports of Croatia (grant number 098-0982464-2508).	Aid S, 2010, J CEREBR BLOOD F MET, V30, P370, DOI 10.1038/jcbfm.2009.223; Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Akkiz H, 2011, MOL CELL BIOCHEM, V347, P201, DOI 10.1007/s11010-010-0629-9; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Arpino Carla, 2005, Ann Ist Super Sanita, V41, P229; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Calvello R, 2012, PHARMACOL RES, V65, P137, DOI 10.1016/j.phrs.2011.09.009; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Choi SH, 2010, PHARMACOGENOMICS J, V10, P448, DOI 10.1038/tpj.2009.68; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2006, J NEUROCHEM, V98, P801, DOI 10.1111/j.1471-4159.2006.03926.x; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Favrais G, 2007, NEUROBIOL DIS, V25, P496, DOI 10.1016/j.nbd.2006.10.012; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Halushka MK, 2003, CLIN PHARMACOL THER, V73, P122, DOI 10.1067/mcp.2003.1; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; Li M, 2009, J DERMATOL SCI, V53, P176, DOI 10.1016/j.jdermsci.2008.09.010; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Milatovic D, 2011, NEUROTOXICOLOGY, V32, P312, DOI 10.1016/j.neuro.2011.02.004; Morteau Olivier, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P473; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Sanak M, 2005, J ALLERGY CLIN IMMUN, V116, P221, DOI 10.1016/j.jaci.2005.03.010; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shi J, 2005, EUR RESPIR J, V26, P249, DOI 10.1183/09031936.05.00140104; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Ulrich Cornelia M, 2002, Hum Mutat, V20, P409, DOI 10.1002/humu.9080; Vidak HK, 2012, CYTOKINE, V58, P57, DOI 10.1016/j.cyto.2011.12.018; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Xu XM, 1997, J BIOL CHEM, V272, P6943, DOI 10.1074/jbc.272.11.6943; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P19, DOI 10.1016/S0002-9378(97)70432-0; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	42	7	7	2	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2017	54	2					930	938		10.1007/s12035-016-9713-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9TX	WOS:000394964100011	26781425				2022-02-06	
J	Wong, A; Erdman, M; Hammond, DA; Holt, T; Holzhausen, JM; Horng, M; Huang, LL; Jarvis, J; Kram, B; Kram, S; Leech, C; Mercer, J; Rech, MA; Rivosecchi, R; Stump, B; Teevan, C; Day, S				Wong, Adrian; Erdman, Michael; Hammond, Drayton A.; Holt, Tara; Holzhausen, Jenna M.; Horng, Michelle; Huang, Lori Lynn; Jarvis, Jennifer; Kram, Bridgette; Kram, Shawn; Leech, Christine; Mercer, Jessica; Rech, Megan A.; Rivosecchi, Ryan; Stump, Brian; Teevan, Colleen; Day, Sarah			Major publications in the critical care pharmacotherapy literature in 2015	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article						cardiology; critical care; drug therapy; neurology; nutrition therapy; review	HOSPITAL CARDIAC-ARREST; HEART-ASSOCIATION GUIDELINES; RENAL REPLACEMENT THERAPY; TRAUMATIC BRAIN-INJURY; REGIONAL CITRATE ANTICOAGULATION; INAPPROPRIATE SINUS TACHYCARDIA; COMPLICATED INTRAABDOMINAL INFECTIONS; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; CONTINUOUS VENOVENOUS HEMODIALYSIS; PROTHROMBIN COMPLEX CONCENTRATE	Purpose. Recently published practice guidelines and research reports on pharmacotherapy in critical care patient populations are summarized. Summary. The Critical Care Pharmacotherapy Literature Update (CCPLU) Group is composed of over 50 experienced critical care pharmacists who evaluate 31 peer-reviewed journals monthly to identify literature pertaining to pharmacotherapy in critical care populations. Articles are chosen for summarization in a monthly CCPLU Group publication on the basis of applicability and relevance to clinical practice and strength of study design. From January to December 2015, a total of 121 articles were summarized; of these, 3 articles presenting clinical practice guidelines and 12 articles presenting original research findings were objectively selected for inclusion in this review based on their potential to change or reinforce current evidence-based practice. The reviewed guidelines address the management of intracranial hemorrhage (ICH), adult advanced cardiac life support (ACLS) and post cardiac arrest care, and the management of supraventricular tachycardia (SVT). The reviewed research reports address topics such as nutrition in critically ill adults, administration of beta-lactams for severe sepsis, anticoagulant selection in the context of continuous renal replacement therapy, early goal-directed therapy in septic shock, magnesium use for neuroprotection in acute stroke, and progesterone use in patients with traumatic brain injury. Conclusion. Important recent additions to the critical care pharmacy literature include updated joint clinical practice guidelines on the management of spontaneous ICH, ACLS, and SVT.	[Wong, Adrian] MCPHS Univ, Brigham & Womens Hosp, Boston, MA USA; [Erdman, Michael] Univ Florida Hlth Jacksonville, Jacksonville, FL USA; [Hammond, Drayton A.] Univ Arkansas Med Sci, Little Rock, AR USA; [Holt, Tara] IU Hlth Methodist, Indianapolis, IN USA; [Holzhausen, Jenna M.] Beaumont Hosp Royal Oak, Royal Oak, MI USA; [Horng, Michelle] Henry Ford Hosp, Detroit, MI USA; [Huang, Lori Lynn] VA Med Ctr, Ann Arbor, MI USA; [Jarvis, Jennifer] St Marys Michigan, Saginaw, MI USA; [Kram, Bridgette] Duke Univ Hosp, Durham, NC USA; [Kram, Shawn] Duke Univ Med Ctr, Med & Cardiothorac ICU, Durham, NC USA; [Leech, Christine] Columbia Univ Med Ctr, NewYork Presbyterian Hosp, NeurolCU, New York, NY USA; [Mercer, Jessica] Roper St Francis Hlth Care, Charleston, SC USA; [Rech, Megan A.] Loyola Univ Med Ctr, Maywood, IL USA; [Rivosecchi, Ryan] UPMC Presbyterian, Pittsburgh, PA USA; [Stump, Brian] Frederick Mem Hosp, Frederick, MD USA; [Teevan, Colleen] Hosp Cent Connecticut, New Britain, CT USA; [Day, Sarah] Doctors Hosp OhioHealth, Columbus, OH USA		Wong, A (corresponding author), MCPHS Univ, Brigham & Womens Hosp, Boston, MA USA.	awong22@partners.org	Jarvis, Jennifer/ABE-1557-2021; Horng, Michelle/AAV-6755-2020; Hammond, Drayton Adam/U-8508-2019; Jarvis, Jennifer/R-9957-2019; Erdman, Michael/H-5771-2019	Horng, Michelle/0000-0001-6735-0687; Hammond, Drayton Adam/0000-0002-9056-5560; Erdman, Michael/0000-0003-2990-0259			Abdul-Aziz MH, 2016, INTENS CARE MED, V42, P1535, DOI 10.1007/s00134-015-4188-0; Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Aglio L S, 1991, J Cardiothorac Vasc Anesth, V5, P201, DOI 10.1016/1053-0770(91)90274-W; Al-Khatib SM, 2016, HEART RHYTHM, V13, pE222, DOI [10.1161/CIR.0000000000000309, 10.1016/j.hrthm.2015.09.017]; Amgen inc, 2015, CORL IV PACK INS; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Angus DC, 2015, INTENS CARE MED, V41, P1549, DOI 10.1007/s00134-015-3822-1; Arabi YM, 2015, NEW ENGL J MED, V372, P2398, DOI 10.1056/NEJMoa1502826; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Arima H, 2012, STROKE, V43, P2236, DOI 10.1161/STROKEAHA.112.651422; Bai M, 2015, INTENS CARE MED, V41, P2098, DOI 10.1007/s00134-015-4099-0; Basoli A, 2008, J GASTROINTEST SURG, V12, P592, DOI 10.1007/s11605-007-0277-x; Benezet-Mazuecos J, 2013, PACE, V36, P830, DOI 10.1111/pace.12118; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Braunschweig CA, 2015, JPEN-PARENTER ENTER, V39, P13, DOI 10.1177/0148607114528541; Callaway CW, 2006, AM J CARDIOL, V98, P1316, DOI 10.1016/j.amjcard.2006.06.022; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cappato R, 2012, J AM COLL CARDIOL, V60, P1323, DOI 10.1016/j.jacc.2012.06.031; Charles EJ, 2014, AM J CLIN NUTR, V100, P1337, DOI 10.3945/ajcn.114.088609; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Crosara ICR, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0079-3; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Donnino Michael W, 2014, BMJ, V348, pg3028, DOI 10.1136/bmj.g3028; Ducros L, 2011, J EMERG MED, V41, P453, DOI 10.1016/j.jemermed.2010.02.030; Dulhunty JM, 2015, AM J RESP CRIT CARE, V192, P1298, DOI 10.1164/rccm.201505-0857OC; Dulhunty JM, 2013, CLIN INFECT DIS, V56, P236, DOI 10.1093/cid/cis856; Erickson SE, 2009, CRIT CARE MED, V37, P1, DOI 10.1097/CCM.0b013e31819292ea; Ferguson Katrina N, 2004, J Stroke Cerebrovasc Dis, V13, P109, DOI 10.1016/j.jstrokecerebrovasdis.2004.04.001; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Gattas DJ, 2015, CRIT CARE MED, V43, P1622, DOI 10.1097/CCM.0000000000001004; Goto Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12872; Gu WJ, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-41; Gueugniaud PY, 2008, NEW ENGL J MED, V359, P21, DOI 10.1056/NEJMoa0706873; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hafner S, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0102-7; Hazelrigg SR, 2004, ANN THORAC SURG, V77, P824, DOI 10.1016/j.athoracsur.2003.08.027; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jerath A, 2015, CRIT CARE MED, V43, P1062, DOI 10.1097/CCM.0000000000000938; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Klinger RY, 2015, ANESTH ANALG, V121, P861, DOI 10.1213/ANE.0000000000000873; Koscik C, 2013, RESUSCITATION, V84, P915, DOI 10.1016/j.resuscitation.2013.03.023; Leissinger CA, 2008, AM J HEMATOL, V83, P137, DOI 10.1002/ajh.21046; Lindner KH, 1997, LANCET, V349, P535, DOI 10.1016/S0140-6736(97)80087-6; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majeed A, 2010, STROKE, V41, P2860, DOI 10.1161/STROKEAHA.110.593087; Marik PE, 2016, INTENS CARE MED, V42, P316, DOI 10.1007/s00134-015-4131-4; Mathew JP, 2013, STROKE, V44, P3407, DOI 10.1161/STROKEAHA.113.002703; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mentzelopoulos SD, 2013, JAMA-J AM MED ASSOC, V310, P270, DOI 10.1001/jama.2013.7832; Mentzelopoulos SD, 2009, ARCH INTERN MED, V169, P15, DOI 10.1001/archinternmed.2008.509; Miller S, 2005, HEART, V91, P618, DOI 10.1136/hrt.2004.033811; Milling TJ, 2016, ANN EMERG MED, V67, P96, DOI 10.1016/j.annemergmed.2015.04.036; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Morrison LJ, 2015, CIRCULATION, V132, pS368, DOI 10.1161/CIR.0000000000000253; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Mouton JW, 2007, CURR OPIN CRIT CARE, V13, P598, DOI 10.1097/MCC.0b013e3282e2a98f; Mukoyama T, 2009, RESUSCITATION, V80, P755, DOI 10.1016/j.resuscitation.2009.04.005; Nakahara S, 2012, ACAD EMERG MED, V19, P782, DOI 10.1111/j.1553-2712.2012.01387.x; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Noto MJ, 2015, JAMA-J AM MED ASSOC, V313, P369, DOI 10.1001/jama.2014.18400; Ong MEH, 2012, RESUSCITATION, V83, P953, DOI 10.1016/j.resuscitation.2012.02.005; Page RL, 2016, CIRCULATION, V133, pE506, DOI 10.1161/CIR.0000000000000311; PARIS PM, 1984, ANN EMERG MED, V13, P1008, DOI 10.1016/S0196-0644(84)80059-1; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pieracci FM, 2007, CURR OPIN CRIT CARE, V13, P440, DOI 10.1097/MCC.0b013e32825a6720; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI DOI 10.1056/NEJMOA1502000; POUNGVARIN N, 1987, NEW ENGL J MED, V316, P1229, DOI 10.1056/NEJM198705143162001; Ptaszynski P, 2013, EUROPACE, V15, P116, DOI 10.1093/europace/eus204; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roberts JA, 2007, J ANTIMICROB CHEMOTH, V59, P285, DOI [10.1093/jac/dkl478, 10.1093/jac/dk1478]; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sartelli M, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-36; Sartelli M, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-1; Saver JL, 2015, NEW ENGL J MED, V372, P528, DOI 10.1056/NEJMoa1408827; Sawyer RG, 2015, NEW ENGL J MED, V372, P1996, DOI 10.1056/NEJMoa1411162; SCHEIN M, 1994, BRIT J SURG, V81, P989, DOI 10.1002/bjs.1800810720; Schultheiss C, 2012, CRIT CARE, V16, DOI 10.1186/cc11485; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Singh S, 2000, CIRCULATION, V102, P2385, DOI 10.1161/01.CIR.102.19.2385; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Slowinski T, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1066-7; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Soukup J, 2009, J CRIT CARE, V24, P535, DOI 10.1016/j.jcrc.2009.01.003; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stucker F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0822-z; Surviving Sepsis Campaign, 2015, UPD BUNDL RESP NEW E; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Tendera M, 2001, AM HEART J, V142, P93, DOI 10.1067/mhj.2001.115439; Tsai MS, 2007, AM J EMERG MED, V25, P318, DOI 10.1016/j.ajem.2006.12.007; Turnidge JD, 2013, COMMUN DIS INTELL, V37, pE219; Viswanathan A, 2006, NEUROLOGY, V66, P206, DOI 10.1212/01.wnl.0000194267.09060.77; Wang Z, 2016, MOL NEUROBIOL, V53, P7070, DOI 10.1007/s12035-015-9614-3; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; White CL, 2013, AM J HYPERTENS, V26, P1114, DOI 10.1093/ajh/hpt076; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yang Y, 2000, NEUROSCI LETT, V285, P119, DOI 10.1016/S0304-3940(00)01048-X; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zeng YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140624	119	7	7	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	MAR 1	2017	74	5					295	311		10.2146/ajhp160144			17	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EN4HZ	WOS:000395969900010	28122702				2022-02-06	
J	Livingston, WS; Gill, JM; Cota, MR; Olivera, A; O'Keefe, JL; Martin, C; Latour, LL				Livingston, Whitney S.; Gill, Jessica M.; Cota, Martin R.; Olivera, Anlys; O'Keefe, Jessica L.; Martin, Christiana; Latour, Lawrence L.			Differential Gene Expression Associated with Meningeal Injury in Acute Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; concussion; gene expression; MRI	GLASGOW COMA SCALE; BARRIER DISRUPTION; APACHE-II; INFLAMMATION; STROKE; MENINGITIS; PREDICTION; OUTCOMES; HUMANS; SCORES	Injury to the meninges is not uncommon after traumatic brain injury (TBI), yet minimal research has been directed toward understanding the relevant biology. After a concussive event, the meninges are observed to abnormally enhance on post-contrast magnetic resonance imaging (MRI) in some patients, but not all. The aim of this work is to identify genes differentially expressed in patients with meningeal injury. Patients presenting to the emergency room with suspected TBI received a standard research MRI and blood draw within 48 h of injury. Two groups of patients were included: those with and without abnormal enhancement of the meninges on post-contrast MRI, both without other imaging findings. Groups were compared on microarray gene expression in peripheral blood samples using Affymetrix (Santa Clara, CA) and Partek Genomics Suite (Partek, Inc., St. Louis, MO) software (false discovery rate, <0.05). Forty patients were enrolled with a time from injury to MRI/blood draw of 16.8 h (interquartile range, 7.5-24.1). We observed 76 genes to be differentially expressed in patients with meningeal injury compared to those without, such as receptor for Fc fragment of IgA, multiple C2 domains, transmembrane 2, and G-protein-coupled receptor 27, which have been previously associated with initiating inflammatory mediators, phagocytosis, and other regulatory mechanisms. Post-contrast MRI is able to detect meningeal injury and has a unique biological signature observed through gene expression. These findings suggest that an acute inflammatory response occurs in response to injury to the meninges following a concussion.	[Livingston, Whitney S.; Gill, Jessica M.; Olivera, Anlys; Martin, Christiana] NINR, NIH, Bethesda, MD 20892 USA; [Gill, Jessica M.; Latour, Lawrence L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Cota, Martin R.; O'Keefe, Jessica L.; Latour, Lawrence L.] NINDS, NIH, 10 Ctr Dr,Bldg 10,B1D733, Bethesda, MD 20892 USA		Latour, LL (corresponding author), NINDS, NIH, 10 Ctr Dr,Bldg 10,B1D733, Bethesda, MD 20892 USA.	latourl@ninds.nih.gov	Gill, Gill M/Q-2020-2017; Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263; Martin, Christiana/0000-0002-4484-6134; Cota, Martin/0000-0003-4638-3978	Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Nursing Research (NINR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120, ZICNS003044] Funding Source: NIH RePORTER	The authors are grateful to the patients and their families, for without them this research would not be possible. The authors acknowledge the staff at Johns Hopkins Suburban Hospital, MedStar Washington Hospital Center, and the National Institute of Neurological Disorders and Stroke (NINDS) Acute Stroke Team for their assistance during this study. Support for this work included Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM), the NINDS, and the National Institute of Nursing Research (NINR).	Barichello T, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/371465; Ben Mkaddem S, 2013, AUTOIMMUN REV, V12, P666, DOI 10.1016/j.autrev.2012.10.011; Borlongan CV, 2012, CURR PHARM DESIGN, V18, P3670; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Deng GM, 2001, J IMMUNOL, V167, P4616, DOI 10.4049/jimmunol.167.8.4616; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Grmec S, 2001, CRIT CARE, V5, P19; Grond-Ginsbach C, 2008, J NEUROL, V255, P723, DOI 10.1007/s00415-008-0784-z; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Henning EC, 2008, J CEREBR BLOOD F MET, V28, P882, DOI 10.1038/sj.jcbfm.9600598; Kim KS, 2003, EXPERT OPIN THER TAR, V7, P141; Kim SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102229; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; Merrill JE, 1997, BRAIN BEHAV IMMUN, V11, P245, DOI 10.1006/brbi.1997.0496; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Monteiro RC, 2010, J CLIN IMMUNOL, V30, pS61, DOI 10.1007/s10875-010-9397-2; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SHEN L, 1994, J IMMUNOL, V152, P4080; Tsai CL, 2012, NEUROL INDIA, V60, P608, DOI 10.4103/0028-3886.105195; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	28	7	7	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					853	860		10.1089/neu.2016.4479			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200012	27430610	Green Published			2022-02-06	
J	Arriaza, R; Cierna, D; Regueiro, P; Inman, D; Roman, F; Abarca, B; Barrientos, M; Saavedra, MA				Arriaza, Rafael; Cierna, Dusana; Regueiro, Patricia; Inman, David; Roman, Franco; Abarca, Benjamin; Barrientos, Merce; Saavedra, Miguel A.			Low risk of concussions in top-level karate competition	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SOCCER PLAYERS; INTERNATIONAL-CONFERENCE; SPORT; STATEMENT; IMPAIRMENT; MANAGEMENT	Background Although it is well known that injuries occur in combat sports, the true incidence of concussions is not clearly defined in the literature for karate competition. Aim To determine the incidence of concussions in top-level (World Karate Federation World Championships) karate competition. Methods Injuries that took place in 4 consecutive World Karate Championships (from 2008 to 2014) were prospectively registered. A total of 4625 fights (2916 in the male category and 1709 in the female category) were scrutinised, and concussions were identified and analysed separately for frequency (rate per fight) and injury risk. Results A total of 4 concussions were diagnosed by the attending physicians after carrying out athlete examinations. Globally, there was 1 concussion in every 1156 fights, or 0.43/1000 athlete-exposures (AE). In male athletes, the rate of concussion was 1/5832 min of fighting, and in female athletes, it was 1/6836 min. OR for concussion in women is 0.57 (95% CI 0.06 to 5.47; z=0.489; p=0.6249) and risk ratio for concussions in men is RR 1.478 (95% CI 0.271 to 8.072), p=0.528, representing a higher risk of definite concussions in men than in women, but not statistically significant. There is not a significantly higher risk of concussions in team competition (no weight limit) when compared with individual competition (held with strict weight limits for each category). Conclusion The risk of concussions in top-level karate competition is low, with a tendency for an increased risk for men and for competition without weight limits, but not statistically significant with respect to women or individual competition.	[Arriaza, Rafael] Univ A Coruna, Inst Med Arriaza & Asociados, Catedra HM Traumatol Deporte, Calle Enrique Marinas 32, La Coruna 15008, Spain; [Cierna, Dusana] Comenius Univ, Phys Educ & Sports Sch, Bratislava, Slovakia; [Regueiro, Patricia; Barrientos, Merce; Saavedra, Miguel A.] Univ A Coruna, Phys Educ & Sports Sch, La Coruna, Spain; [Inman, David] Oldfield Osteopath Clin, Bath, Avon, England; [Roman, Franco] Commiss Med Natl, Federat Francaise Karate & Disciplines Associees, Paris, France; [Abarca, Benjamin] Comis Med Nacl, Federac Chilena Karate, Puerto Montt, Chile		Arriaza, R (corresponding author), Univ A Coruna, Inst Med Arriaza & Asociados, Catedra HM Traumatol Deporte, Calle Enrique Marinas 32, La Coruna 15008, Spain.	rafael@arriaza.es	Saavedra-Garcia, Miguel/B-4573-2015	Saavedra-Garcia, Miguel/0000-0001-6248-9188; Cierna, Dusana/0000-0003-0206-6815; Arriaza, Rafael/0000-0003-1743-3809			Arriaza R, 2016, AM J SPORT MED, V44, P305, DOI 10.1177/0363546515615577; Arriaza R, 2009, KNEE SURG SPORT TR A, V17, P1437, DOI 10.1007/s00167-009-0856-3; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lystad RP, 2014, J INT ASS TAEKWONDO, V1, P1; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2014, J SPORT HEALTH SCI, V3, P307, DOI 10.1016/j.jshs.2014.07.005; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Ryan AJ, 1998, CLIN SPORT MED, V17, P155, DOI 10.1016/S0278-5919(05)70070-3; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004	23	7	7	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2017	51	4					226	230		10.1136/bjsports-2016-096574			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EL3ST	WOS:000394540300003	27986764				2022-02-06	
J	Lin, YP; Luo, LL; Sun, J; Gao, WW; Tian, Y; Park, E; Baker, A; Chen, JL; Jiang, RC; Zhang, JN				Lin, Yunpeng; Luo, Lan Lan; Sun, Jian; Gao, Weiwei; Tian, Ye; Park, Eugene; Baker, Andrew; Chen, Jieli; Jiang, Rongcai; Zhang, Jianning			Relationship of Circulating CXCR4(+) EPC with Prognosis of Mild Traumatic Brain Injury Patients	AGING AND DISEASE			English	Article						traumatic brain injury; endothelial progenitor cells; C-X-C chemokine receptor type 4 (CXCR-4); stromal derived factor-1 (SDF-1)	ENDOTHELIAL PROGENITOR CELLS; TRANSPLANTATION; FACTOR-1-ALPHA; COMMUNICATION; ANGIOGENESIS; LOCALIZATION; MODULATION	To investigate the changes of circulating endothelial progenitor cells (EPCs) and stromal cell-derived factor-1 alpha (SDF-1 alpha)/CXCR4 expression in patients with mild traumatic brain injury (TBI) and the correlation between EPC level and the prognosis of mild TBI. 72 TBI patients (57 mild TBI, 15 moderate TBI patients) and 25 healthy subjects (control) were included. The number of circulating EPCs, CD34(+), and CD133(+) cells and the percentage of CXCR4(+) cells in each cell population at 1,4,7,14,21 days after TBI were counted by flow cytometer. SDF-1 alpha levels in serum were detected by ELISA assay. The patients were divided into poor and good prognosis groups based on Extended Glasgow Outcome Scale and Activity of Daily Living Scale at 3 months after TBI. Correlation analysis between each detected index and prognosis of mild TBI was performed. Moderate TBI patients have higher levels of SDF-1 alpha and CXCR4 expression than mild TBI patients (P < 0.05). The percentage of CXCR4(+) EPCs at day 7 post-TBI was significantly higher in mild TBI patients with poor prognosis than the ones with good prognosis (P < 0.05). HAMA and HAMD scores in mild TBI patients were significantly lower than moderate TBI patients (P < 0.05) in early term. The percentage of CXCR4(+) EPCs at day 7 after TBI was significantly correlated with the prognosis outcome at 3 months. The mobilization of circulating EPCs can be induced in mild TBI. The expression of CXCR4(+) in EPCs at 7 days after TBI reflects the short-term prognosis of brain injury, and could be a potential biological marker for prognosis prediction of mild TBI.	[Lin, Yunpeng; Sun, Jian; Gao, Weiwei; Tian, Ye; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Lin, Yunpeng; Sun, Jian; Gao, Weiwei; Tian, Ye; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Lin, Yunpeng; Sun, Jian; Gao, Weiwei; Tian, Ye; Jiang, Rongcai; Zhang, Jianning] Minist Educ & Tianjin City, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin 300052, Peoples R China; [Luo, Lan Lan] Tianjin Med Univ, Gen Hosp, Dept Psychol Sci, Tianjin 300052, Peoples R China; [Park, Eugene; Baker, Andrew] St Michaels Hosp, Dept Traumat Crit Care Unit, Toronto, ON, Canada; [Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chen, Jieli] Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Tianjin, Peoples R China		Jiang, RC; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	jianghope@gmail.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100920, 81271359]; Ontario-China Research and Innovation Fund (OCRIF) [2011DFG33430]; Tianjin Research Program of Application Foundation and Advanced Technology [11JCZDJC18100]	We acknowledge Guangchao Cao, Xiaolong Wen and Ye Tian for their assistance with the technical aspects of experiments. This work was supported by the National Natural Science Foundation of China (grant 81100920), the National Natural Science Foundation of China (grant 81271359), the Ontario-China Research and Innovation Fund (OCRIF, 2011DFG33430), and the Tianjin Research Program of Application Foundation and Advanced Technology (grant 11JCZDJC18100).	Bachstetter AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149451; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Banisadr Ghazal, 2005, Current Drug Targets - Inflammation and Allergy, V4, P387, DOI 10.2174/1568010054022097; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen HL, 2016, EXP THER MED, V11, P1865, DOI 10.3892/etm.2016.3141; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Falk AC, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-20; Fierro FA, 2009, LEUKEMIA, V23, P393, DOI 10.1038/leu.2008.182; Friedrich EB, 2009, BASIC RES CARDIOL, V104, P613, DOI 10.1007/s00395-009-0022-6; Gonzalez FJ, 1997, INT ARCH ALLERGY IMM, V113, P345, DOI 10.1159/000237597; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Guyon A, 2006, J NEUROCHEM, V96, P1540, DOI 10.1111/j.1471-4159.2006.03659.x; Guyon A, 2014, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2014.00115; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Li Li-Ping, 2008, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V33, P461; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Pearson WS, 2012, W J EMERG MED, V13, P289; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Proudfoot AEI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00183; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Trop S, 2008, TRENDS CARDIOVAS MED, V18, P180, DOI 10.1016/j.tcm.2008.07.001; WANG Y, 2013, PLOS ONE, V2013; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	38	7	9	0	0	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	FEB	2017	8	1					115	127		10.14336/AD.2016.0610			13	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	EQ5MM	WOS:000398126900010	28203485	Green Submitted, Green Published, gold			2022-02-06	
J	Moghaddam, OM; Lahiji, MN; Hassani, V; Mozari, S				Moghaddam, Omid Moradi; Lahiji, Mohammad Niakan; Hassani, Valiollah; Mozari, Shakiba			Early Administration of Selenium in Patients with Acute Traumatic Brain Injury: A Randomized Double-blinded Controlled Trial	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Acute traumatic brain injury; extended glasgow outcome scale; selenium	OXIDATIVE STRESS; N-ACETYLCYSTEINE; PATHOPHYSIOLOGY	Aim: The present study was carried out to examine this hypothesis that administration of selenium can prevent the development of injuries by brain trauma and thus can modulate patients' functional recovery and also improve posttraumatic outcome. Materials and Methods: This double-blinded controlled trial was carried out on 113 patients who were hospitalized following traumatic brain injury (TBI) with Glasgow Coma Scale score of 4-12 that were randomly assigned to receive selenium within 8 h after injury plus standard treatment group or routine standard treatment alone as the control. The primary endpoint was to assess patients' functional recovery at 2 months after the injury based on extended Glasgow Outcome Scale score (GOS-E). Secondary outcomes included the changes in Full Outline of Unresponsiveness score (FOUR) score, Sequential Organ Failure Assessment (SOFA) score, and acute physiology and chronic health evaluation (APACHE) III score, side effects of selenium, length of Intensive Care Unit (ICU) stay, and length of hospital stay. Results: There was no difference in the length of ICU and hospital stay, the trend of the change in FOUR and SOFA scores within 15 days of first interventions, and the mean APACHE III score on the 1st and 15th days between the two groups. Mortality was 15.8% in selenium group and 19.6% in control group with no between-group difference. No difference was revealed between the two groups in appropriate outcome according to GOS-E score at 60 +/- 10 days and also 30 +/- 5 days according to the severity of TBI. Conclusion: This human trial study could not demonstrate beneficial effects of intravenous infusion of selenium in the improvement of outcomes in patients with acute TBI.	[Moghaddam, Omid Moradi; Lahiji, Mohammad Niakan; Hassani, Valiollah] Iran Univ Med Sci, Rasool E Akram Hosp, Dept Anesthesiol, Tehran, Iran; [Moghaddam, Omid Moradi; Lahiji, Mohammad Niakan; Hassani, Valiollah] Iran Univ Med Sci, Rasool E Akram Hosp, Dept Crit Care, Tehran, Iran; [Mozari, Shakiba] Sabzevar Univ Med Sci, Fac Med, Sabzevar, Iran		Mozari, S (corresponding author), Iran Univ Med Sci, Rasool E Akram Hosp, Dept Anesthesiol & Crit Care, Tehran, Iran.	sh.mozari@gmail.com	moghaddam, omid moradi/AAF-3672-2021; Moghaddam, Omid Moradi/M-7561-2018	Hassani, Valiollah/0000-0003-1964-6779			Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Pearn ML, 2016, CELL MOL NEUROBIOL; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004	13	7	7	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	FEB	2017	21	2					75	79		10.4103/ijccm.IJCCM_391_16			5	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EN1YR	WOS:000395807000002	28250601	Green Published, Bronze			2022-02-06	
J	Owens, JA; Spitz, G; Ponsford, JL; Dymowski, AR; Ferris, N; Willmott, C				Owens, Jacqueline A.; Spitz, Gershon; Ponsford, Jennie L.; Dymowski, Alicia R.; Ferris, Nicholas; Willmott, Catherine			White matter integrity of the medial forebrain bundle and attention and working memory deficits following traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						attention; medial forebrain bundle; traumatic brain injury	AXONAL INJURY; DOPAMINE; METHYLPHENIDATE; CATECHOLAMINES; SPEED; DTI; DYSFUNCTION; ASSOCIATION; PERFORMANCE; PATHWAYS	Background and Objective: The medial forebrain bundle (MFB) contains ascending catecholamine fibers that project to the prefrontal cortex (PFC). Damage to these fibers following traumatic brain injury (TBI) may alter extracellular catecholamine levels in the PFC and impede attention and working memory ability. This study investigated white matter microstructure of the medial MFB, specifically the supero-lateral branch (slMFB), following TBI, and its association with performance on attention and working memory tasks. Method: Neuropsychological measures of attention and working memory were administered to 20 moderate-severe participants with TBI (posttraumatic amnesia M=40.0537.10days, median time since injury 10.48months, range 3.72-87.49) and 20 healthy controls. Probabilistic tractography was used to obtain fractional anisotropy (FA) and mean diffusivity (MD) values for 17 participants with TBI and 20 healthy controls. Results: When compared to controls, participants with TBI were found to have significantly lower FA (p<.001) and higher MD (p<.001) slMFB values, and they were slower to complete tasks including Trail Making Task-A, Hayling, selective attention task, n-back, and Symbol Digit Modalities Test. Conclusion: This study was the first to demonstrate microstructural white matter damage within the slMFB following TBI. However, no evidence was found for an association of alterations to this tract and performance on attentional tasks.	[Owens, Jacqueline A.; Spitz, Gershon; Ponsford, Jennie L.; Dymowski, Alicia R.; Willmott, Catherine] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Owens, Jacqueline A.; Spitz, Gershon; Ponsford, Jennie L.; Dymowski, Alicia R.; Willmott, Catherine] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Owens, Jacqueline A.; Spitz, Gershon; Ponsford, Jennie L.; Dymowski, Alicia R.; Willmott, Catherine] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Ferris, Nicholas] Monash Univ, Monash Biomed Imaging, Melbourne, Vic, Australia		Owens, JA (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia.	Jacqueline.Owens@monash.edu	Willmott, Catherine/AAA-5105-2019; Spitz, Gershon/H-7755-2014	Willmott, Catherine/0000-0001-8517-9035; Spitz, Gershon/0000-0002-7810-1480	Monash Biomedical Imaging Centre, Monash University; Faculty of Medicine, Nursing and Health Sciences, Monash UniversityMonash University	Monash Biomedical Imaging Centre, Monash University; Faculty of Medicine, Nursing and Health Sciences, Monash University	Alcaro A, 2011, NEUROSCI BIOBEHAV R, V35, P1805, DOI 10.1016/j.neubiorev.2011.03.002; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Anthofer JM, 2015, ACTA NEUROCHIR, V157, P469, DOI 10.1007/s00701-014-2335-y; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN, P59; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bracht T, 2015, PSYCHOL MED, V45, P865, DOI 10.1017/S0033291714001949; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P341, DOI 10.1016/S0149-7634(87)80006-4; CLARK CR, 1989, NEUROPSYCHOLOGIA, V27, P131, DOI 10.1016/0028-3932(89)90166-8; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P353, DOI 10.1016/S0149-7634(87)80007-6; CLARK CR, 1986, PSYCHOPHARMACOLOGY, V90, P28; Clark KL, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00033; Coenen VA, 2012, J NEUROPSYCH CLIN N, V24, P223, DOI 10.1176/appi.neuropsych.11080180; Coenen VA, 2011, NEUROSCI BIOBEHAV R, V35, P1971, DOI 10.1016/j.neubiorev.2010.12.009; Coenen VA, 2009, NEUROSURGERY, V64, P1106, DOI 10.1227/01.NEU.0000345631.54446.06; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fujinaka T, 2003, NEUROL RES, V25, P35, DOI 10.1179/016164103101201094; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kharas N., 2016, NEUROPATHOLOGY DRUG, V3, P699; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MONTARON MF, 1982, BEHAV BRAIN RES, V6, P129, DOI 10.1016/0166-4328(82)90010-9; MOORE RY, 1978, ANNU REV NEUROSCI, V1, P129, DOI 10.1146/annurev.ne.01.030178.001021; Nelson H.E., 1982, NATL ADULT READING T; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J, 2004, COGNITIVE BEHAV REHA; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Reitan R, 1985, HALSTEAD REITAN NEUR; Ruff RM., 1995, RUFF 2 7 SELECTIVE A; SALAMONE JD, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P599; Schweren LJS, 2016, EUR NEUROPSYCHOPHARM, V26, P674, DOI 10.1016/j.euroneuro.2016.02.007; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1991, SYMBOL DIGIT MODALIT; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wise RA, 2005, J COMP NEUROL, V493, P115, DOI 10.1002/cne.20689; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	72	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	FEB	2017	7	2							e00608	10.1002/brb3.608			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	EM9KR	WOS:000395630900005	28239519	Green Published, gold			2022-02-06	
J	Thibault-Halman, G; Rivers, CS; Bailey, CS; Tsai, EC; Drew, B; Noonan, VK; Fehlings, MG; Dvorak, MF; Kuerban, D; Kwon, BK; Christie, SD				Thibault-Halman, Ginette; Rivers, Carly S.; Bailey, Christopher S.; Tsai, Eve C.; Drew, Brian; Noonan, Vanessa K.; Fehlings, Michael G.; Dvorak, Marcel F.; Kuerban, Dilinuer; Kwon, Brian K.; Christie, Sean D.		RHSCIR Network	Predicting Recruitment Feasibility for Acute Spinal Cord Injury Clinical Trials in Canada Using National Registry Data	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; feasibility studies; registries; research methodology; spinal cord injury	TRAUMATIC BRAIN-INJURY; ICCP PANEL; GUIDELINES; CONDUCT	Traumatic spinal cord injury (SCI) represents a significant burden of illness, but it is relatively uncommon and heterogeneous, making it challenging to achieve sufficient subject enrollment in clinical trials of therapeutic interventions for acute SCI. The Rick Hansen Spinal Cord Injury Registry (RHSCIR) is a national SCI Registry that enters patients with SCI from acute-care centers across Canada. To predict the feasibility of conducting clinical trials of acute SCI within Canada, we have applied the inclusion/exclusion criteria of six previously conducted SCI trials to the RHSCIR data set and generated estimates of how many Canadian persons would have been eligible theoretically for enrollment in these studies. Data for SCI cases were prospectively collected for RHSCIR at 18 acute and 13 rehabilitation sites across Canada. RHSCIR patients enrolled between 2009-2013 who met the following key criteria were included: non-penetrating traumatic SCI; received acute care at a RHSCIR site; age more than 18, less than 75 years, and had complete admission single neurological level of injury data. Inclusion and exclusion criteria for the Minocycline in Acute Spinal Cord injury (Minocycline), Riluzole, Surgical Timing in Acute Spinal Cord Injury Study (STASCIS), Cethrin, Nogo antibody study (NOGO), and Sygen studies were applied retrospectively to this data set. The numbers of patients eligible for each clinical trial were determined. There were 2166 of the initial 2714 patients (79.8%) who met the key criteria and were included in the data set. Projected annual numbers of eligible patients for each trial were: Minocycline, 117; Riluzole, 62; STASCIS, 109; Cethrin, 101; NOGO, 82; and Sygen, 70. An additional 8.0% of the sample had a major head injury (Glasgow Coma Scale [GCS] score <= 12) and would have been excluded from the trials. RHSCIR provides a comprehensive national data set that may serve as a useful tool in the planning of multicenter clinical SCI trials.	[Thibault-Halman, Ginette; Christie, Sean D.] Dalhousie Univ, Div Neurosurg, Halifax, NS, Canada; [Rivers, Carly S.; Noonan, Vanessa K.; Kuerban, Dilinuer] Rick Hansen Inst, Vancouver, BC, Canada; [Bailey, Christopher S.] Western Univ, London, ON, Canada; [Tsai, Eve C.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Drew, Brian] McMaster Univ, Hamilton Gen, Hamilton, ON, Canada; [Noonan, Vanessa K.] Univ British Columbia, Vancouver, BC, Canada; [Fehlings, Michael G.] Univ Toronto, Div Neurosurg & Spinal Program, Toronto, ON, Canada; [Dvorak, Marcel F.; Kwon, Brian K.] Blusson Spinal Cord Ctr, Vancouver, BC, Canada		Christie, SD (corresponding author), Dalhousie Univ, Dept Surg Neurosurg, 1796 Summer St,Room 3814, Halifax, NS B3H 3A7, Canada.	sean.christie@dal.ca	Tsai, Eve/ABE-6056-2021; Bailey, Chris S/L-7522-2015; Tsai, Eve/D-7007-2014	Bailey, Chris S/0000-0001-5508-8415; Tsai, Eve/0000-0002-8152-349X; Christie, Sean/0000-0002-3540-6022; Fehlings, Michael/0000-0002-5722-6364; Dvorak, Marcel/0000-0002-9404-8448			AOSpine North America Research, 2015, RIL SPIN CORD INJ ST; Campbell M K, 2007, Health Technol Assess, V11, pix; Casha S., 2015, MINOCYCLINE ACUTE SP; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Geisler F, 2001, SPINE S, V26, P87; Geisler FH, 2001, SPINE, V26, pS58, DOI 10.1097/00007632-200112151-00013; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kwon BK, 2012, J NEUROTRAUM, V29, P2727, DOI 10.1089/neu.2012.2550; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Lee RS, 2012, J CLIN NEUROSCI, V19, P1338, DOI 10.1016/j.jocn.2012.02.015; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Noonan VK, 2012, SPINAL CORD, V50, P22, DOI 10.1038/sc.2011.109; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Sipski ML, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.08.0001; Smith CT, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-32; Sumi E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-426; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Tuszynski MH, 2007, SPINAL CORD, V45, P222, DOI 10.1038/sj.sc.3102009; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712	24	7	9	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2017	34	3					599	606		10.1089/neu.2016.4568			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EI9GJ	WOS:000392815600007	27627704				2022-02-06	
J	Yu, BS; Wang, SL; Yang, T; Fan, YJ				Yu Binshan; Wang Sheliang; Yang Tao; Fan Yujiang			BP Neural Netwok Constitutive Model Based on Optimization with Genetic Algorithm for SMA	ACTA METALLURGICA SINICA			Chinese	Article						SMA; genetic algorithm; BP neural network; dynamic constitutive model	SHAPE-MEMORY ALLOYS	Systematic study was conducted on the variation regularity of stress-strain curve, feature point stress, dissipated energy and equivalent damping ratio of shape memory alloy (SMA) wires changed with wire diameter, strain amplitude, loading rate and loading cyclic number. By nonlinearly modeling experimental results for SMA using the neural network intelligent algorithm (a neural network algorithm with back-propagation training) and optimizing the initial weight and threshold value of neurons using genetic algorithm, a new BP neural network constitutive model for SMA optimized with genetic algorithm is established. This model successfully overcomes the shortcomings of other mathematical models such as the phenomenological Brinson, by which the various influence factors to mechanical properties in an experiment for SMA are hardly simulated exactly. In fact, the average error between experimental and simulated results is only 1.13% by using this model, much better than conventional BP neural network models. The results show that the BP neural networks constitutive model optimized with genetic algorithm can not only predict accurately the superelastic performance of SMA under cyclic loading, but also avoid the no convergence problem caused by concussion of BP network due to the improper initial weight and threshold value set up. Furthermore, this model would be a better model than others because of fully considering the dynamic influence of loading/unloading rate on SMA experiments.	[Yu Binshan; Wang Sheliang; Yang Tao] Xian Univ Architecture & Technol, Sch Civil Engn, Xian 710055, Peoples R China; [Fan Yujiang] Changan Univ, Sch Architecture, Xian 710061, Peoples R China		Wang, SL (corresponding author), Xian Univ Architecture & Technol, Sch Civil Engn, Xian 710055, Peoples R China.	wangshel@aliyun.com			Nation Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51678480]; Co-ordinator Innovation Projects Foundation of Shaanxi Province [2013SZS01-S02]; Industry-Foundation Research Project of Shaanxi Province [2014K06-34]	Supported by Nation Natural Science Foundation of China (No.51678480), Co-ordinator Innovation Projects Foundation of Shaanxi Province (No.2013SZS01-S02), and Industry-Foundation Research Project of Shaanxi Province (No.2014K06-34)	Bani-Hani K, 1998, EARTHQUAKE ENG STRUC, V27, P1225, DOI 10.1002/(SICI)1096-9845(1998110)27:11<1225::AID-EQE780>3.0.CO;2-T; Brinson, 1993, J INTELLIGENT MATERI, V4, P229, DOI [10.1177/1045389X9300400213, DOI 10.1177/1045389X9300400213]; Brocca M, 2002, J MECH PHYS SOLIDS, V50, P1051, DOI 10.1016/S0022-5096(01)00112-0; Chen M, 2013, MATLAB NEURAL NETWOR, P52; Cong S, 2010, NEURAL NETWORK THEOR, P151; [崔迪 Cui Di], 2006, [振动工程学报, Journal of Vibration Engineering], V19, P109; Lei YJ, 2005, MATLAB GENETIC ALGOR, P78; Li S, 2007, IDENTIFIED DEFORMATI; Li Song, 2011, Control and Decision, V26, P1581; Liang C., 1990, CONSTITUTIVE MODELIN; Meng H, 2010, RES SEISMIC MONITORI; MULLER I, 1979, ARCH RATION MECH AN, V70, P61; Peng X, 2001, INT J SOLIDS STRUCT, V38, P6925, DOI 10.1016/S0020-7683(00)00402-9; Qu D, 2010, PREDICTION SHAPE MEM; Ren W J, 2006, J DALIAN U TECHNOL, V46, pS157; Ren W. J, 2008, SEISMIC RESPONSE CON; Ren WJ, 2012, RARE METAL MAT ENG, V41, P243; Tanaka K, 1987, T JPN SOC MECH ENG, V53, P1368; Wang W, 2012, CONSTITUTIVE MODEL E; Wang ZQ, 2007, ACTA METALL SIN, V43, P1211; Wu Y Z, 2012, MECH PROPERTIES CONS; Xue M Y, 2010, APPL NEURAL NETWORK; Yun CB, 2001, ENG STRUCT, V23, P425, DOI 10.1016/S0141-0296(00)00067-5; Zhou B, 2006, ACTA METALL SIN, V42, P919; [周星德 ZHOU Xingde], 2005, [计算力学学报, Chinese journal of computational Mechanics], V22, P780	25	7	12	3	31	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	0412-1961			ACTA METALL SIN	Acta Metall. Sin.	FEB	2017	53	2					248	256		10.11900/0412.1961.2016.00218			9	Metallurgy & Metallurgical Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Metallurgy & Metallurgical Engineering	EN4GU	WOS:000395966800014					2022-02-06	
J	Singh, S; Pelegri, AA; Shreiber, DI				Singh, Sagar; Pelegri, Assimina A.; Shreiber, David I.			Estimating axonal strain and failure following white matter stretch using contactin-associated protein as a fiduciary marker	JOURNAL OF BIOMECHANICS			English	Article						Axon; Injury; Strain; Multi-scale; Kinematics; Traumatic brain injury; Spinal cord injury	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; MYELINATION; BEHAVIOR; FIBERS; GROWTH; DAMAGE; MODEL; CNS	Axonal injury occurs during trauma when tissue-scale loads are transferred to individual axons. Computational models are used to understand this transfer and predict the circumstances that cause injury. However, these findings are limited by a lack of validating experimental work examining the mechanics of axons in their in situ state. As a first step towards validation for dynamic stretch, we use contactin-associated protein (Caspr), expressed at the nodes of Ranvier, as a fiduciary marker of quasistatic axonal stretch. We measured changes in the distance between immunolabled Caspr pairs along axons as a function of tissue-level stretch in chick embryo spinal cords harvested from different developmental periods. We then identified and characterized broken axons and adapted a kinematic model published previously by our group (Singh et al., 2015) to estimate average strain thresholds for axon mechanical failure. The distance between Caspr pairs increased with stretch, though not as much as predicted by simple continuum mechanics. For equivalent tissue stretch, greater numbers of broken axons were found at later stages of development. In adapting our kinematic model to predict a breaking threshold strain, we found that breaking thresholds decrease with development stage. When thresholds were split and classified based on kinematic behavior, non-affine, uncoupled axons had higher strain thresholds than affine, coupled axons, corroborating thresholds predicted from in vitro and in vivo preparations. These results provide a valuable launching point for generating more accurate multi-scale models in primary central nervous system injury. (C) 2016 Elsevier Ltd. All rights reserved.	[Singh, Sagar; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA; [Pelegri, Assimina A.] Rutgers State Univ, Dept Mech & Aerosp Engn, 98 Brett Rd, Piscataway, NJ 08854 USA		Shreiber, DI (corresponding author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.	shreiber@rci.rutgers.edu	Shreiber, David/ABE-8254-2021	Pelegri, Assimina/0000-0003-1145-8175; Singh, Sagar/0000-0001-7936-5827	NSF CMMI Grant [1436743]	This work was funded by the NSF CMMI Grant #1436743.	Anderson ES, 2000, J NEUROCYTOL, V29, P755, DOI 10.1023/A:1010994505741; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; CHUNG K, 1983, J COMP NEUROL, V214, P72, DOI 10.1002/cne.902140107; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Dabbing J., 1957, J EMBRYO EXP MORPHOL, V5, P428; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; ELEISHI HI, 1967, J NEUROCHEM, V14, P405, DOI 10.1111/j.1471-4159.1967.tb09538.x; Hao H, 2007, J BIOMECH ENG-T ASME, V129, P511, DOI 10.1115/1.2746372; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Nilsson M, 2012, NMR BIOMED, V25, P795, DOI 10.1002/nbm.1795; Ouyang H, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-21; Pan Y, 2013, FRONT BIOENG BIOTECH, V1, P1, DOI DOI 10.3389/FBIOE.2013.00019; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; Singh S, 2015, BIOMECH MODEL MECHAN, V14, P1303, DOI 10.1007/s10237-015-0675-z; Skold MK, 2005, J NEUROTRAUMA, V22, P353; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Spedden E, 2013, INT J MOL SCI, V14, P16124, DOI 10.3390/ijms140816124; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844	27	7	7	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JAN 25	2017	51						32	41		10.1016/j.jbiomech.2016.11.055			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	EK4WE	WOS:000393927500005	27939751				2022-02-06	
J	Banks, SJ; Miller, JB; Rissman, RA; Bernick, CB				Banks, Sarah J.; Miller, Justin B.; Rissman, Robert A.; Bernick, Charles B.			Lack of Influence of Apolipoprotein E Status on Cognition or Brain Structure in Professional Fighters	JOURNAL OF NEUROTRAUMA			English	Article						apolipoprotein E; cognition; hippocampus; thalamus; trauma	CEREBRAL-BLOOD-FLOW; ALZHEIMER-DISEASE; APOE GENOTYPE; INJURY; HEALTH	The role of the apolipoprotein e4 allele in moderating cognitive and neuroanatomical degeneration following repeated traumatic brain injury is controversial. Here we sought to establish the presence or absence of such a moderating relationship in a prospective study of active and retired boxers and mixed martial arts fighters. Fighters (n = 193) underwent cognitive evaluations, interviews regarding fight history, MRI of the brain, and genetic testing. We used a series of moderator analyses to test for any relationship of apolipoprotein genotype on structural volumes of brain regions previously established to be smaller in those with the most fight exposure, and on cognitive abilities also established to be sensitive to fight exposure. No moderating relationship was detected in any of the analyses. The results of this study suggest that there is no impact of apolipoprotein genotype on the apparent negative association between exposure to professional fighting and brain structure volume or aspects of cognition.	[Banks, Sarah J.; Miller, Justin B.; Bernick, Charles B.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 West Bonneville Ave, Las Vegas, NV 89135 USA; [Rissman, Robert A.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Rissman, Robert A.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA		Banks, SJ (corresponding author), Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 West Bonneville Ave, Las Vegas, NV 89135 USA.	bankss2@ccf.org		Banks, Sarah/0000-0001-7536-2370; Miller, Justin B./0000-0002-4439-6604	Top Rank; Ultimate Fighting Championship; Haymon; Belator/Spike TV; Lincy Foundation; UCLA Dream Fund; Golden Boy	The study was funded by philanthropic donations from Top Rank, Ultimate Fighting Championship, Haymon, Belator/Spike TV, the Lincy Foundation, the UCLA Dream Fund, and Golden Boy. Dr. Banks completed initial analyses and wrote the majority of the manuscript. Dr. Miller completed aspects of the analyses and wrote much of the methods and results sections. Dr. Rissman and Dr. Bernick collaborated on the original idea to include genetics in this study. Dr. Rissman completed the genetics analysis, and contributed to the manuscript. Dr. Bernick is the Principle Investigator on the Professional Fighters' Brain Health Study, which was initially his idea. He oversaw this idea in development, was central to the formulation of the current analysis, and edited every version of the manuscript. All authors read and approved the manuscript.	Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Katsnelson A, 2011, NAT MED, V17, P638, DOI 10.1038/nm0611-638; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035; Wierenga CE, 2013, J ALZHEIMERS DIS, V34, P921, DOI 10.3233/JAD-121897; Wierenga CE, 2012, J CEREBR BLOOD F MET, V32, P1589, DOI 10.1038/jcbfm.2012.58	11	7	7	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					380	384		10.1089/neu.2016.4453			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800013	27245878	Green Published			2022-02-06	
J	Dona, O; Noseworthy, MD; DeMatteo, C; Connolly, JF				Dona, Olga; Noseworthy, Michael D.; DeMatteo, Carol; Connolly, John F.			Fractal Analysis of Brain Blood Oxygenation Level Dependent (BOLD) Signals from Children with Mild Traumatic Brain Injury (mTBI)	PLOS ONE			English	Article							SPONTANEOUS FLUCTUATIONS; ACTIVATION; COMPLEXITY; DIMENSION; SYMPTOMS; NETWORK; MOTIONS; SYSTEMS; NOISES; FMRI	Background Conventional imaging techniques are unable to detect abnormalities in the brain following mild traumatic brain injury (mTBI). Yet patients with mTBI typically show delayed response on neuropsychological evaluation. Because fractal geometry represents complexity, we explored its utility in measuring temporal fluctuations of brain resting state blood oxygen level dependent (rs-BOLD) signal. We hypothesized that there could be a detectable difference in rs-BOLD signal complexity between healthy subjects and mTBI patients based on previous studies that associated reduction in signal complexity with disease. Methods Fifteen subjects (13.4 +/- 2.3 y/o) and 56 age-matched (13.5 +/- 2.34 y/o) healthy controls were scanned using a GE Discovery MR750 3T MRI and 32-channel RF-coil. Axial FSPGR-3D images were used to prescribe rs-BOLD (TE/TR = 35/2000ms), acquired over 6 minutes. Motion correction was performed and anatomical and functional images were aligned and spatially warped to the N27 standard atlas. Fractal analysis, performed on grey matter, was done by estimating the Hurst exponent using de-trended fluctuation analysis and signal summation conversion methods. Results and Conclusions Voxel-wise fractal dimension (FD) was calculated for every subject in the control group to generate mean and standard deviation maps for regional Z-score analysis. Voxel-wise validation of FD normality across controls was confirmed, and non-Gaussian voxels (3.05% over the brain) were eliminated from subsequent analysis. For each mTBI patient, regions where Z-score values were at least 2 standard deviations away from the mean (i.e. where vertical bar Z vertical bar > 2.0) were identified. In individual patients the frequently affected regions were amygdala (p = 0.02), vermis(p = 0.03), caudate head (p = 0.04), hippocampus(p = 0.03), and hypothalamus(p = 0.04), all previously reported as dysfunctional after mTBI, but based on group analysis. It is well known that the brain is best modeled as a complex system. Therefore a measure of complexity using rs-BOLD signal FD could provide an additional method to grade and monitor mTBI. Furthermore, this approach can be personalized thus providing unique patient specific assessment.	[Dona, Olga; Noseworthy, Michael D.; Connolly, John F.] McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada; [Dona, Olga; Noseworthy, Michael D.] St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Med, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Dept Linguist, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Engn Technol Bldg,ETB-406,1280 Main St, Hamilton, ON L8S 4K1, Canada		Noseworthy, MD (corresponding author), McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Radiol, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Elect & Comp Engn, Engn Technol Bldg,ETB-406,1280 Main St, Hamilton, ON L8S 4K1, Canada.	nosewor@mcmaster.ca	Noseworthy, Michael/B-2957-2011	Noseworthy, Michael/0000-0003-1464-159X; Connolly, John/0000-0001-8869-5369	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This work was supported by the Canadian Institutes of Health Research (CIHR), http://www.cihr-irsc.gc.ca/.	Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bullmore ET, 2009, NEUROIMAGE, V47, P1125, DOI 10.1016/j.neuroimage.2009.05.032; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Eickhoff, 2005, NEUROIMAGE, V25; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; El Boustani S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000519; Faul M, 2010, TRAUMATIC BRAIN INJU; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Felger JC, 2016, MOL PSYCHIATR, V21, P1358, DOI 10.1038/mp.2015.168; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Herman P, 2011, NEUROIMAGE, V58, P1060, DOI 10.1016/j.neuroimage.2011.06.082; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kannathal N, 2004, P ANN INT IEEE EMBS, V26, P604; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lu Liyan, 2015, IRON DEPOSITION POSI, V2015; Malenka RC, MOL NEUROPHARMACOLOG, p[147, 367, 376]; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; MANDELBROT BB, 1985, PHYS SCRIPTA, V32, P257, DOI 10.1088/0031-8949/32/4/001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Munivenkatappa A, 2015, J NEUROSURG SCI; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Simpson PE, 1993, BRAIN RES, V607, P9, DOI 10.1016/0006-8993(93)91483-9; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Smits FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149587; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Vallez Garcia D, 2016, J NEUROTRAUMA; Warsi MA, 2013, VISUALIZATION IMAGE, V2; Warsi MA, 2012, MAGN RESON MATER PHY, V25, P335, DOI 10.1007/s10334-012-0312-0; Weber AM, 2014, MAGN RESON MATER PHY, V27, P291, DOI 10.1007/s10334-013-0420-5; Wenzel JM, 2015, ACS CHEM NEUROSCI, V6, P16, DOI 10.1021/cn500255p; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	45	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169647	10.1371/journal.pone.0169647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	WOS:000391844200035	28072842	gold, Green Published, Green Submitted			2022-02-06	
J	Saleem, S; Tzeng, YC; Kleijn, WB; Teal, PD				Saleem, Saqib; Tzeng, Yu-Chieh; Kleijn, W. Bastiaan; Teal, Paul D.			Detection of Impaired Sympathetic Cerebrovascular Control Using Functional Biomarkers Based on Principal Dynamic Mode Analysis	FRONTIERS IN PHYSIOLOGY			English	Article						biomarkers; blood flow; blood pressure; kernels; principal dynamic modes	NONLINEAR PHYSIOLOGICAL SYSTEMS; CEREBRAL-BLOOD-FLOW; SLOW DYNAMICS; AUTOREGULATION; HEMODYNAMICS; MECHANISMS; IDENTIFICATION; PRESSURE	This study sought to determine whether models of cerebrovascular function based on Laguerre-Volterra kernels that account for nonlinear cerebral blood flow (CBF) dynamics can detect the effects of functional cerebral sympathetic blockade. We retrospectively analyzed continuous beat-to-beat blood pressure, middle cerebral blood velocity, and partial-pressure of end-tidal CO2 (PETCO2) recordings from eighteen healthy individuals who were treated with either an oral dose of the alpha(1)-adrenergic receptor blocker Prazosin or a placebo treatment. The global principal dynamic modes (PDMs) were analyzed using Laguerre-Volterra kernels to examine the nonlinear system dynamics. Our principal findings were: (1) very low frequency (<0.03 Hz) linear components of first-order kernels for BP and PETCO2 are mutually coupled to CBF dynamics with the ability to separate individuals between control and blockade conditions, and (2) the gains of the nonlinear functions associated with low-pass and approximate to 0.03 Hz global PDMs for the BP are sensitive to sympathetic blockade. Collectively these results suggest that very low frequency global PDMs for BP may have potential utility as functional biomarkers of sympathetic neurovascular dysfunction which can occur in conditions like autonomic failure, stroke and traumatic brain injury.	[Saleem, Saqib] COMSATS Inst Informat Technol, Dept Elect Engn, Sahiwal, Pakistan; [Tzeng, Yu-Chieh] Univ Otago, Ctr Translat Physiol, Wellington Med Technol Grp, Wellington, New Zealand; [Kleijn, W. Bastiaan; Teal, Paul D.] Victoria Univ Wellington, Sch Engn & Comp Sci, Wellington, New Zealand		Teal, PD (corresponding author), Victoria Univ Wellington, Sch Engn & Comp Sci, Wellington, New Zealand.	paul.teal@vuw.ac.nz	Saleem, Saqib/M-4377-2016	Kleijn, W./0000-0002-1973-3920	New Zealand Research Health Council [11/125]	This research was supported in part by funding from the New Zealand Research Health Council (Ref: 11/125; to YT).	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Angarita-Jaimes N, 2014, MED ENG PHYS, V36, P607, DOI 10.1016/j.medengphy.2013.12.012; CHON KH, 1994, AM J PHYSIOL, V267, pF160, DOI 10.1152/ajprenal.1994.267.1.F160; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; JAILLON P, 1980, CLIN PHARMACOKINET, V5, P365, DOI 10.2165/00003088-198005040-00004; Kang Y, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2401005; Korpelainen JT, 1999, CLIN AUTON RES, V9, P325, DOI 10.1007/BF02318379; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Marmarelis VZ, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0180; Marmarelis VZ, 2014, MED ENG PHYS, V36, P628, DOI 10.1016/j.medengphy.2014.02.025; Marmarelis VZ, 2013, ANN BIOMED ENG, V41, P1029, DOI 10.1007/s10439-012-0736-8; Marmarelis VZ, 2013, J COMPUT NEUROSCI, V34, P73, DOI 10.1007/s10827-012-0407-7; Marmarelis Vz, 2012, Open Biomed Eng J, V6, P42, DOI 10.2174/1874230001206010042; MARMARELIS VZ, 1993, ANN BIOMED ENG, V21, P591, DOI 10.1007/BF02368640; Marmarelis VZ, 1997, ANN BIOMED ENG, V25, P239, DOI 10.1007/BF02648038; Marmarelis VZ., 2004, NONLINEAR DYNAMIC MO, V10; Mitsis G. D., 2005, POSTGENOMIC PERSPECT, P259; Mitsis GD, 2004, IEEE T BIO-MED ENG, V51, P1932, DOI 10.1109/TBME.2004.834272; Mitsis GD, 2002, ANN BIOMED ENG, V30, P272, DOI 10.1114/1.1458591; Mitsis GD, 2002, ANN BIOMED ENG, V30, P555, DOI 10.1114/1.1477448; Mitsis GD, 2006, J APPL PHYSIOL, V101, P354, DOI 10.1152/japplphysiol.00548.2005; Mitsis GD, 2009, IEEE ENG MED BIOL, V28, P54, DOI 10.1109/MEMB.2009.934908; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Peebles KC, 2012, J APPL PHYSIOL, V113, P700, DOI 10.1152/japplphysiol.00614.2012; Peng TY, 2008, ANN BIOMED ENG, V36, P308, DOI 10.1007/s10439-007-9412-9; Saleem S, 2016, AM J PHYSIOL-HEART C, V311, pH837, DOI 10.1152/ajpheart.00254.2016; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Takahashi Courtney, 2015, Handb Clin Neurol, V128, P539, DOI 10.1016/B978-0-444-63521-1.00034-0; Ursino M, 2004, ANN BIOMED ENG, V32, P1286, DOI 10.1114/B:ABME.0000039362.26850.17; Zanos TP, 2008, IEEE T NEUR SYS REH, V16, P336, DOI 10.1109/TNSRE.2008.926716; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302	33	7	7	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	JAN 9	2017	7								685	10.3389/fphys.2016.00685			13	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	EG9CT	WOS:000391356300002	28119628	gold, Green Published, Green Submitted			2022-02-06	
J	Feng, JL; Wang, W				Feng, Jinli; Wang, Wei			Hypoxia pretreatment and EPO-modification enhance the protective effects of MSC on neuron-like PC12 cells in a similar way	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Mesenchymal stem cells (MSC); PC12; Erythropoietin (EPO); Hypoxia injuries	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; TRANSPLANTATION; APOPTOSIS; MODEL; RATS; EXPRESSION; ISCHEMIA; SURVIVAL	Mesenchymal stem cells (MSC) based cell transplantation therapy is proved to be an attractive strategy with great potential for improvement of hypoxia induced neural damage. In the present study, MSCs were co-culture with PC12 to investigate its protective effects against hypoxia pretreatment, and the Lactate dehydrogenase (LDH) release assay, MTT and Anexin V staining were performed to analysis the cellular damage or apoptotic. RT-PCR and Western blotting were further used to investigate the underlying mechanism. The results indicate that hypoxia treatment results in the decrease of PC12 cell viability, yet co-culture with MSC could protect the PC12 from hypoxia induced damage. Hypoxia pre activated or EPO transduced MSC with up-regulated erythropoietin (EPO) expression could further enhance MSC's protective effect against hypoxia induced cell damage, which was associated with high level of anti-apoptotic p-Akt and ration Bcl-2/Bax, and decreased Caspase 3 in PC12. Taken together, these data suggests high levels of MSC-mediated cyto-protection is closely tied to high gene expression levels of EPO. The up-regulation of EPO for enhanced MSC-mediated cyto-protection may has great potential for the MSC cellular therapy of neural or neuronal injuries induced by hypoxia. (C) 2016 Elsevier Inc. All rights reserved.	[Feng, Jinli; Wang, Wei] 309th Hosp PIA, Dept Neurol, 17 Heishanhu Rd, Beijing, Peoples R China			fengjinli886@tom.com; 13910581521@163.com					CHEN Q, 2014, CELL DEATH DIS, V5; Ferroni L, 2013, ADV BIOCHEM ENG BIOT, V129, P89, DOI 10.1007/10_2012_152; Giusi G, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-39; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Heo JS, 2013, NEUROSCIENCE, V238, P305, DOI 10.1016/j.neuroscience.2013.02.011; Jung JY, 2007, LIFE SCI, V80, P1355, DOI 10.1016/j.lfs.2006.11.033; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Lee Jae-Hong, 2012, Korean J Audiol, V16, P47, DOI 10.7874/kja.2012.16.2.47; Minano A, 2008, J NEUROSCI RES, V86, P1734, DOI 10.1002/jnr.21633; Mo SJ, 2012, NEUROSCI LETT, V522, P92, DOI 10.1016/j.neulet.2012.06.002; Mortazavi MM, 2015, CLIN ANAT, V28, P37, DOI 10.1002/ca.22443; Oh JS, 2010, NEUROSCI LETT, V472, P215, DOI 10.1016/j.neulet.2010.02.008; Pyko IV, 2008, EUR J NEUROL, V15, P216; Torun YA, 2014, BRAIN DEV-JPN, V36, P864, DOI 10.1016/j.braindev.2014.01.005; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Xiao L, 2013, HUM CELL, V26, P91, DOI 10.1007/s13577-013-0069-4; Yamada M, 2011, J PATHOL, V224, P101, DOI 10.1002/path.2862; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387	20	7	8	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 8	2017	482	2					232	238		10.1016/j.bbrc.2016.11.046			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	EI7PJ	WOS:000392690100007	27845038				2022-02-06	
J	Kim, HJ; Han, SJ				Kim, Ho Jeong; Han, Soo Jeong			A simple rat model of mild traumatic brain injury: a device to reproduce anatomical and neurological changes of mild traumatic brain injury	PEERJ			English	Article						Concussion; Rat; Device; Methodology	CONCUSSION; RECOVERY; MANAGEMENT; MOUSE	Mild traumatic brain injury typically involves temporary impairment of neurological function. Previous studies used water pressure or rotational injury for designing the device to make a rat a mild traumatic brain injury model. The objective of this study was to make a simple model of causing mild traumatic brain injury in rats. The device consisted of a free-fall impactor that was targeted onto the rat skull. The weight (175 g) was freely dropped 30 cm to rat's skull bregma. We installed a safety device made of acrylic panel. To confirm a mild traumatic brain injury in 36 Sprague-Dawley rats, we performed magnetic resonance imaging (MRI) of the brain within 24 h after injury. We evaluated behavior and chemical changes in rats before and after mild traumatic brain injury. The brain MRI did not show high or low signal intensity in 34 rats. The mobility on grid floor was decreased after mild traumatic brain injury. The absolute number of foot-fault and foot-fault ratio were decreased after mild traumatic brain injury. However, the difference of the ratio was a less than absolute number of foot-fault. These results show that the device is capable of reproducing mild traumatic brain injury in rats. Our device can reduce the potential to cause brain hemorrhage and reflect the mechanism of real mild traumatic brain injury compared with existing methods and behaviors. This model can be useful in exploring physiology and management of mild traumatic brain injury.	[Kim, Ho Jeong] Ewha Womans Univ, Med Ctr, Seonam Hosp, Dept Rehabil Med, Seoul, South Korea; [Han, Soo Jeong] Ewha Womans Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea		Han, SJ (corresponding author), Ewha Womans Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea.	ocrystal@ewha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2059711]; Research Grant of Alumni Chapters of Medical College of Ewha Womans University	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2059711) and Research Grant of Alumni Chapters of Medical College of Ewha Womans University in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa EH, 2016, J MOTOR BEHAV, V48, P5, DOI 10.1080/00222895.2015.1024824; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Chao OY, 2012, NEUROSCIENCE, V202, P318, DOI 10.1016/j.neuroscience.2011.11.016; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dominguez DC, 2014, SEMIN SPEECH LANG, V35, P159, DOI 10.1055/s-0034-1384677; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tiwari HS, 2015, NEUROSCI LETT, V589, P121, DOI 10.1016/j.neulet.2015.01.038; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	25	7	7	0	7	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	JAN 3	2017	5								e2818	10.7717/peerj.2818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5XE	WOS:000394694000003	28070456	Green Submitted, Green Published, gold			2022-02-06	
J	Alaeddini, A; Jaramillo, CA; Faruqui, SHA; Pugh, MJ				Alaeddini, Adel; Jaramillo, Carlos A.; Faruqui, Syed H. A.; Pugh, Mary J.			Mining Major Transitions of Chronic Conditions in Patients with Multiple Chronic Conditions	METHODS OF INFORMATION IN MEDICINE			English	Article						Multiple chronic conditions; Markov clustering; latent regression model; Markov mixture model	TRAUMATIC BRAIN-INJURY; CARDIOVASCULAR-DISEASE; DEPRESSION INCREASES; RISK; MODELS; VETERANS; TRAJECTORIES; HYPERTENSION; ASSOCIATIONS; PREVALENCE	Objectives: Evolution of multiple chronic conditions (MCC) follows a complex stochastic process, influenced by several factors including the inter-relationship of existing conditions, and patient-level risk factors. Nearly 20% of citizens aged 18 years and older are burdened with two or more (multiple) chronic conditions (MCC). Treatment for people living with MCC currently accounts for an estimated 66% of the Nation's health-care costs. However, it is still not known precisely how MCC emerge and accumulate among individuals or in the general population. This study investigates major patterns of MCC transitions in a diverse population of patients and identifies the risk factors affecting the transition process. Methods: A Latent regression Markov clustering (LRMCL) algorithm is proposed to identify major transitions of four MCC that include hypertension (HTN), depression, Post Traumatic Stress Disorder (PTSD), and back pain. A cohort of 601,805 individuals randomly selected from the population of Iraq and Afghanistan war Veterans (IAVs) who received VA care during three or more years between 2002-2015, is used for training the proposed LRMCL-algorithm. Results: Two major clusters of MCC transition patterns with 78% and 22% probability of membership respectively were identified. The primary cluster demonstrated the possibility of improvement when the number of MCC is small and an increase in probability of MCC accumulation as the number of co-morbidities increased. The second cluster showed stability (no change) of MCC overtime as the major pattern. Age was the most significant risk factor associated with the most probable cluster for each IAV. Conclusions: These findings suggest that our proposed LRMCL algorithm can be used to describe and understand MCC transitions, which may ultimately allow healthcare systems to support optimal clinical decision making. This method will be used to describe a broader range of MCC transitions in this and non-VA populations, and will add treatment information to see if models including treatments and MCC emergence can be used to support clinical decision-making in patient care.	[Alaeddini, Adel; Faruqui, Syed H. A.] Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA; [Jaramillo, Carlos A.; Pugh, Mary J.] South Texas Vet Healthcare Syst, San Antonio, TX USA		Alaeddini, A (corresponding author), Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA.	adel.alaeddini@utsa.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763; Faruqui, Syed Hasib Akhter/0000-0002-5073-8690	National Institute of General Medical Sciences (NIGMS) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1SC2GM118266-01]; VA Health Services Research and DevelopmentUS Department of Veterans Affairs [DHI-09-237-2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [SC2GM118266] Funding Source: NIH RePORTER	Supported by National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under award number 1SC2GM118266-01, and VA Health Services Research and Development under award number VA HSR & D; DHI-09-237-2.	Acuna E, 2004, ST CLASS DAT ANAL, P639; Agresti A., 2011, CATEGORICAL DATA ANA; Alagoz O, 2007, MANAGE SCI, V53, P1702, DOI 10.1287/mnsc.1070.0726; Alterovitz R, 2008, SPRINGER TRAC ADV RO, V47, P319; Boshuizen HC, 2012, DEMOGRAPHY, V49, P1259, DOI 10.1007/s13524-012-0122-z; Centers for Medicare and Medicaid Services, 2012, CHRON COND MED BEN C; Chung H, 2004, AM STAT, V58; Copeland LA FE, 2016, MED CARE IN PRESS; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Denton BT, 2009, MED DECIS MAKING, V29, P351, DOI 10.1177/0272989X08329462; Dobra A, 2011, ANN APPL STAT, V5, P969, DOI 10.1214/10-AOAS397; Dumont J, 2008, ENG MED BIOL SOC 200; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elsayed E. A., 2012, RELIABILITY ENG; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fahrmeir L., 2013, MULTIVARIATE STAT MO; Faissol DM, 2007, INFORMS INT M; Rubio-Guerra AF, 2013, EXP CLIN CARDIOL, V18, P10; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Hauskrecht M, 2000, ARTIF INTELL MED, V18, P221, DOI 10.1016/S0933-3657(99)00042-1; Health UDo Services H., 2010, MULT CHRON COND STRA; Hempstead K, 2014, MED CARE, V52, pS67, DOI 10.1097/MLR.0000000000000049; Hospedales T, 2009, COMP VIS 2009 IEEE 1; Hu CP, 1996, OPER RES, V44, P696, DOI 10.1287/opre.44.5.696; Jaffe A, 2007, EXP CLIN PSYCHOPHARM, V15, P301, DOI 10.1037/1064-1297.15.3.301; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Kemere C, 2008, J NEUROPHYSIOL, V100, P2441, DOI 10.1152/jn.00924.2007; Kenter W., 2015, THESIS; Kharoufeh JP, 2005, IIE TRANS, V37, P533, DOI 10.1080/07408170590929009; Kibler JL, 2014, WORLD J CARDIOL, V6, P455, DOI 10.4330/wjc.v6.i6.455; Kreke J. E., 2007, THESIS; Kreke JE, 2008, IIE TRANS, V40, P853, DOI 10.1080/07408170802165872; KURT M, WHAT LIPID RATIOS SH; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Leino-Arjas P, 2006, SCAND J WORK ENV HEA, V32, P12, DOI 10.5271/sjweh.971; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Lighthall NR, 2013, PSYCHOL AGING, V28, P35, DOI 10.1037/a0029823; Linn KA, 2015, J STAT SOFTW, V64; Maillart LM, 2008, OPER RES, V56, P1411, DOI 10.1287/opre.1080.0614; Meng L, 2012, J HYPERTENS, V30, P842, DOI 10.1097/HJH.0b013e32835080b7; Neumann M, 2011, SUPPORT CARE CANCER, V19, P1197, DOI 10.1007/s00520-010-0939-1; PAULLI M, 1995, J CLIN ONCOL, V13, P1343, DOI 10.1200/JCO.1995.13.6.1343; Piette JD, 2004, AM J MANAG CARE, V10, P152; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Pugh MJ FE, BRAIN INJUR IN PRESS; Pujades-Rodriguez M, 2015, INT J EPIDEMIOL, V44, P129, DOI 10.1093/ije/dyu218; Rajarshi M.B, 2013, MARKOV CHAINS THEIR, P19; Schaefer AJ, 2004, INT SER OPER RES MAN, V70, P593; Shechter SM, 2008, OPER RES, V56, P20, DOI 10.1287/opre.1070.0480; Strine TW, 2007, ARTHRIT RHEUM-ARTHR, V57, P656, DOI 10.1002/art.22684; Sugiyama T, 1998, HYPERTENS RES-CLIN E, V21, P103, DOI 10.1291/hypres.21.103; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Vlasblom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-99; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Waltz JA, 2007, BIOL PSYCHIAT, V62, P756, DOI 10.1016/j.biopsych.2006.09.042; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Wolfe F, 2000, ARTHRITIS RHEUM-US, V43, P2751, DOI 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6; World Health Organization, 1990, DIET NUTR PREV CHRON; Wu M-F, 2012, PERV COMP TECHN HEAL; Xun L, 2012, COMP SCI EL ENG ICCS; Zhang BH, 2008, AM J GERIAT PSYCHIAT, V16, P145, DOI 10.1097/JGP.0b013e318157caec; Zhao YF, 2011, BIOMETRICS, V67, P1422, DOI 10.1111/j.1541-0420.2011.01572.x	65	7	7	1	6	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0026-1270	2511-705X		METHOD INFORM MED	Methods Inf. Med.		2017	56	5					391	400		10.3414/ME16-01-0135			10	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Health Care Sciences & Services; Medical Informatics	FN3QI	WOS:000415913500006	29582934	Green Accepted			2022-02-06	
J	Alfwaress, FSD; Bibars, AR; Hamasha, A; Al Maaitah, E				Alfwaress, Firas S. D.; Bibars, Abdel Rahim; Hamasha, Abedelhadi; Al Maaitah, Emad			Outcomes of Palatal Lift Prosthesis on Dysarthric Speech	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Dysarthria; hypernasality; palatal lift prosthesis	AMYOTROPHIC-LATERAL-SCLEROSIS; VELOPHARYNGEAL INCOMPETENCE; NASALANCE SCORES; MANAGEMENT; PALATOPLASTY	Purpose: This study was designed to investigate the effect of palatal lift prosthesis (PLP) on the speech of individuals with different types of dysarthria. Participants: Thirty (19 males and 11 females) native speakers of Jordanian Arabic with dysarthria participated in the study. The age of the participants ranged from 8 to 67 years with an average of 34.1 years. Traumatic brain injury was the most common etiology of dysarthria among 12 participants, stroke among 11, multiple sclerosis among 3, and pseudobulbar palsy among 2; 1 participant had Parkinson disease, and another participant had amyotrophic lateral sclerosis. Methods: Five acoustic and aerodynamic measures were evaluated to determine the speech outcomes including nasalance scores, sequential motion rate, speech rate, vital capacity, and sound pressure level. The acoustic measures were obtained from the participants in PLP-out and PLP-in conditions. Results: Results showed statistically significant decrease in the nasalance scores of the syllable repetition, vowel prolongation, and sentence repetition tasks in the PLP-in condition below the 28% cutoff score. Furthermore, results revealed statistically significant increase in sequential motion rate, speech rate, vital capacity, and sound pressure level (P = 0.000). Conclusion: The use of PLP is an effective treatment option of dysarthric speech. Besides nasalance scores, the sequential motion rate, speech rate, vital capacity, and sound pressure level are considered reliable speech measures that may be used to evaluate the effect of PLP on dysarthria.	[Alfwaress, Firas S. D.] Jordan Univ Sci & Technol, Dept Rehabil Sci, Fac Appl Med Sci, POB 3030, Irbid 22110, Jordan; [Bibars, Abdel Rahim] Jordan Univ Sci & Technol, Fac Appl Med Sci, Dept Appl Dent Technol, Irbid, Jordan; [Hamasha, Abedelhadi; Al Maaitah, Emad] Jordan Univ Sci & Technol, Dept Prevent Dent, Fac Dent, Irbid, Jordan			fsalfwaress@just.edu.jo	Hamasha, Abed Al-Hadi/ABE-4693-2020; Alfwaress, Firas/AAV-3452-2020; Bibars, Abdel Rahim/S-6866-2016	Hamasha, Abed Al-Hadi/0000-0001-9597-4104; Alfwaress, Firas/0000-0002-6817-0570; Bibars, Abdel Rahim/0000-0002-1810-8402; Al Maaitah, Emad/0000-0002-2144-4167	Scientific Research Support Fund at the Ministry of Higher Education & Scientific Research, Jordan [Mph/1/5/2012]	This work had been funded by the Scientific Research Support Fund at the Ministry of Higher Education & Scientific Research, Jordan, no. Mph/1/5/2012.	Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); Bressmann T, 2012, CAN J SPEECH-LANG PA, V36, P50; DALSTON RM, 1993, CLEFT PALATE-CRAN J, V30, P285, DOI 10.1597/1545-1569(1993)030<0285:NSASAC>2.3.CO;2; Esposito SJ, 2000, J PROSTHET DENT, V83, P90, DOI 10.1016/S0022-3913(00)70093-X; Karnell MP, 2004, J MED SPEECH-LANG PA, V12, P21; Krause JC, 2009, J ACOUST SOC AM, V125, P3346, DOI 10.1121/1.3097491; Kummer AW, 2001, CLEFT PALATE CRANIOF; Leeper H, 1986, HUM COMM CAN, V10, P5; Leeper H, 1989, J SPEECH LANG PATHOL, V13, P57; Lima-Gregio AM, 2011, J APPL ORAL SCI, V19, P616, DOI 10.1590/S1678-77572011000600012; Lithovius RH, 2014, OR SURG OR MED OR PA, V118, P632, DOI 10.1016/j.oooo.2014.07.002; MacKay IR., 1994, MACKAY KUMMER SNAP T; Natour Y, 2007, DIRASAT HUM SOC SCI, V34, P181; Ninomiya T, 2009, P 19 INT C OR MAX SU, V38, P397; Nishio M, 2000, CLIN LINGUIST PHONET, V14, P485; Ogata Y, 2009, ORAL SCI INT, V6, P73, DOI 10.1016/S1348-8643(09)80002-5; PORTNOY RA, 1982, J SPEECH HEAR DISORD, V47, P324, DOI 10.1044/jshd.4703.324; Raju H, 2009, INT J PROSTHODONT, V22, P579; Ramya R, 2011, J DENT SCI RES, V2, P1; Sell D, 1996, BRIT J ORAL MAX SURG, V34, P357, DOI 10.1016/S0266-4356(96)90087-X; Shifman A, 2000, J PROSTHET DENT, V83, P99, DOI 10.1016/S0022-3913(00)70094-1; Tachimura T, 2004, CLEFT PALATE-CRAN J, V41, P315, DOI 10.1597/02-107.1; Watanabe S, 2012, J ORAL MAX SURG MED, V24, P119, DOI 10.1016/j.ajoms.2011.11.006; Watterson T, 2005, CLEFT PALATE-CRAN J, V42, P574, DOI 10.1597/04-017.1; Witt PD, 1998, PLAST RECONSTR SURG, V102, P1375, DOI 10.1097/00006534-199810000-00009; WITT PD, 1993, CLIN PLAST SURG, V20, P707; WITT PD, 1995, CLEFT PALATE-CRAN J, V32, P469, DOI 10.1597/1545-1569(1995)032<0469:DPLPSV>2.3.CO;2; WOLFAARDT JF, 1993, J PROSTHET DENT, V69, P186, DOI 10.1016/0022-3913(93)90139-F	28	7	9	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2017	28	1					30	35		10.1097/SCS.0000000000003167			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EI2EJ	WOS:000392299200009	27831974				2022-02-06	
J	Avramovic, P; Kenny, B; Power, E; McDonald, S; Tate, R; Hunt, L; MacDonald, S; Heard, R; Togher, L				Avramovic, Petra; Kenny, Belinda; Power, Emma; McDonald, Skye; Tate, Robyn; Hunt, Louise; MacDonald, Sheila; Heard, Rob; Togher, Leanne			Exploring the relationship between cognition and functional verbal reasoning in adults with severe traumatic brain injury at six months post injury	BRAIN INJURY			English	Article						Traumatic brain injury; assessment; cognitive communication; cognition; executive functions; ICF	CLOSED HEAD-INJURY; SPEECH-LANGUAGE PATHOLOGISTS; INCOG RECOMMENDATIONS; WORKING-MEMORY; COMMUNICATION; HEALTH; IMPAIRMENT; DISABILITY; MANAGEMENT; DISORDERS	Objective(s): This study aims to determine the association between cognitive impairment and functional verbal reasoning in adults with severe traumatic brain injury (TBI), at six months post-injury. Method(s): 38 participants with severe TBI were assessed using the four tasks on the Functional Assessment of Verbal Reasoning and Executive Strategies (FAVRES) [1] and a battery of neuropsychological tests at 6 months post injury in a cross-sectional observational study. Results: Overall performance on the FAVRES [1] was strongly associated with overall performance on the neuropsychological battery (rho = 0.60). FAVRES Task 2 and FAVRES Task 4 had the most significant positive associations with the cognitive indices of Attention and speed of processing, Memory and Executive functions. There was one weak significant association between the Task 1 Accuracy score and the Total Cognitive index (rho = 0.46). Conclusions: Performance on the FAVRES [1] is positively associated with cognitive processes. Participants with stronger verbal reasoning skills which may be required for activities in work, home and social contexts also had higher scores on tests of cognitive functioning. These findings may inform clinical practices for speech pathologists and other health professionals, in the assessment and treatment of cognitive communication disorders during early stages of recovery in people with severe TBI.	[Avramovic, Petra; Kenny, Belinda; Power, Emma; Hunt, Louise; Heard, Rob; Togher, Leanne] Univ Sydney, Discipline Speech Pathol, Sydney, NSW, Australia; [Kenny, Belinda; Power, Emma; Togher, Leanne] NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [McDonald, Skye] Univ NSW, Sch Psychol, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Sydney Med Sch, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [MacDonald, Sheila] Sheila MacDonald & Associates, Toronto, ON, Canada		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Speech Pathol, S155 S Block,Cumberland Campus C42,75 East St, Lidcombe, NSW 2141, Australia.	Leanne.togher@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia	Author number seven, is the author of the FAVRES and has financial interest in CCD Publishing, publisher of the FAVRES. The authors alone are responsible for the content and writing of the paper. The data collected will form part of a larger project investigating longitudinal communication recovery following TBI. This larger project is funded by the National Health and Medical Research Council (NHMRC). The second author is a Senior Research Fellow of the NHMRC. The relationship between the research team and the funding provider constitutes no ethical issue.	American Speech-Language-Hearing Association, 2005, KNOWL SKILLS NEED SP; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RH, 1997, NEUROPSYCHOL REV, V23, P169; Biggs J., 1982, EVALUATING QUALITY L; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Body R., 2006, BRAIN IMPAIR, V7, P212, DOI DOI 10.1375/BRIM.7.3.212; CASLPO, 2002, PREF PRACT GUID COGN; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Christie J., 1986, MOUNT WILGA HI UNPUB; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C, 2005, NONSTANDARDIZED ASSE; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Douglas J, 2000, TROBE COMMUNICATION; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Ellmo W., 1995, MCLA MEASURE COGNITI; Enderby P., 2012, FDA 2 FRENCHAY DYSAR; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Ghayoumi Z, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.21473; Gong JJ, 2000, CONTROL CLIN TRIALS, V21, P313, DOI 10.1016/S0197-2456(00)00049-0; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Hughes J, 2007, REV CANAD ORTHOPHON, V31, P135; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IBM C, 2013, IBM SPSS STAT WIND V, V22nd; Isaki E, 2000, BRAIN INJURY, V14, P441; Katz R, 2002, J MED SPEECH-LANG PA, V10, pix; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kertesz A., 2007, WAB R W APHASIA BATT; Larkins Brigette, 2007, Seminars in Speech and Language, V28, P334, DOI 10.1055/s-2007-986530; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meulenbroek P., 2015, DISABIL REHABIL, V38, P1; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Penn C, 1997, APHASIOLOGY, V11, P601, DOI 10.1080/02687039708248492; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Smith A., 2002, SYMBOL DIGIT MODALIT; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turkstra LS, 2005, USE STANDARDIZED TES; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wechsler D., 2008, WECHSLER ADULT INTEL; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; World Health Organization, 2007, INT CLASS FUNCT DIS; Yap BW, 2011, J STAT COMPUT SIM, V81, P2141, DOI 10.1080/00949655.2010.520163; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M., 1998, COLLABORATIVE BRAIN	72	7	7	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	4					502	516		10.1080/02699052.2017.1280854			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES9TD	WOS:000399902900009	28340321				2022-02-06	
J	Bacciardi, S; Maremmani, AGI; Nikoo, N; Cambioli, L; Schutz, C; Jang, K; Krausz, M				Bacciardi, Silvia; Maremmani, Angelo G. I.; Nikoo, Nooshin; Cambioli, Luca; Schutz, Christian; Jang, Kerry; Krausz, Michael			Is bipolar disorder associated with tramautic brain injury in the homeless?	RIVISTA DI PSICHIATRIA			English	Article						bipolar disorder; traumatic brain injury; homelessness; schizophrenia; alcohol dependence; substance dependence	PSYCHIATRIC-DISORDERS; SUBSTANCE-ABUSE; HEAD-INJURY; MEDICAL COMORBIDITY; RISK-FACTOR; AFFECTIVE TEMPERAMENTS; AXIS-I; IMPULSIVITY; POPULATION; SPECTRUM	Links between Bipolar Disorder (BD) and medical conditions are increasingly reported. Traumatic Brain Injury (TBI) is a prevalent medical condition found in homeless populations. Aim. This paper examines the correlation between the presence of BD and TBI, comparing homeless affected by Bipolar Disorder, Unipolar Depression (UD) and Schizophrenia Spectrum Disorder (SSD), controlled for other TBI risk factors such as age, gender, comorbid alcohol and substance use disorders as the confounding variables. Methods. From 489 participants of Vancouver arm of the At Home/Chez Soi Study, 416 homeless had psychiatric diagnoses, alcohol and substance dependence, and TBI determined by the MINI Questionnaire and the Comorbid Conditions List. 147 patients with BD were compared with 175 UD and 94 SSD for age, gender, the presence, number and severity of TBI and the presence of alcohol and substance use diagnosis, at a univariate and multivariate level. Results. The homeless with BD had higher percentage of TBI compared to the homeless with SSD. However, the reported severity and frequency of TBI by patients with BD, UD, and SSD were not statistically different. BD diagnosis was associated with TBI at multivariate level. Conclusions. TBI could be considered one of the physical burdens associated with BD in the homeless population.	[Bacciardi, Silvia; Maremmani, Angelo G. I.] Univ Pisa, Dept Clin & Expt Med, Vincent P Dole Dual Diag Unit, Pisa, Italy; [Maremmani, Angelo G. I.] Assoc Applicat Neurosci Knowledge Social Aims AU, Pietrasanta, Lucca, Italy; [Nikoo, Nooshin; Krausz, Michael] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Nikoo, Nooshin; Schutz, Christian; Krausz, Michael] Univ British Columbia, Inst Mental Hlth, Dept Psychiat, Vancouver, BC, Canada; [Cambioli, Luca] Med Univ Vienna, Dept Psychiat & Psychotherapy, Neuroimaging Labs NIL, PET & MRI & EEG & Chem Lab, Vienna, Austria; [Schutz, Christian; Jang, Kerry; Krausz, Michael] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Krausz, Michael] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada		Bacciardi, S (corresponding author), Univ Pisa, Dept Clin & Expt Med, Vincent P Dole Dual Diag Unit, Pisa, Italy.	s.baciard@gmail.com		Maremmani, Angelo Giovanni Icro/0000-0001-7728-3705	Mental Health Commission of Canada (MHCC) - a Health Canada mandate	The Mental Health Commission of Canada (MHCC) - a Health Canada mandate, had funded the database-source of the At Home/Chez Soi Vancouver. The Mental Health Commission of Canada (MHCC) played neither a role in this study design; data collection, analysis and interpretation of data; nor in the writing of the report; or the decision to submit this paper for publication. Professor Krausz is the Co-Primary Investigator of At Home/Chez Soi Vancouver, funded by MHCC. Other Authors declare no conflict of interest.	AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; Akiskal HS, 2007, PSYCHOPHARMACOL BULL, V40, P99; American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bacciardi S, 2013, HEROIN ADDICT REL CL, V15, P29; Beyer J, 2005, NEUROPSYCHOPHARMACOL, V30, P401, DOI 10.1038/sj.npp.1300608; Bianchini V, 2015, RIV PSICHIATR, V50, P168, DOI 10.1708/2002.21644; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney CP, 2006, PSYCHOSOM MED, V68, P684, DOI 10.1097/01.psy.0000237316.09601.88; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DAVISON K, 1969, CURRENT PROBLEMS NEU; Deb S, 1999, AM J PSYCHIAT, V156, P374; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Faul M, 2010, TRAUMATIC BRAIN INJU; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fichter MM, 2001, ACTA PSYCHIAT SCAND, V103, P94, DOI 10.1034/j.1600-0447.2001.00217.x; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Goering P., 2004, MAKING DIFFERENCE ON; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Jallo J, 2009, NEUROTRAUMA CRITICAL, V3; Jelalian E, 2000, J ADOLESCENT HEALTH, V27, P84, DOI 10.1016/S1054-139X(00)00098-7; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kemp DE, 2014, ACTA PSYCHIAT SCAND, V129, P24, DOI 10.1111/acps.12101; Kilbourne AM, 2004, BIPOLAR DISORD, V6, P368, DOI 10.1111/j.1399-5618.2004.00138.x; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Krausz RM, 2013, SOC PSYCH PSYCH EPID, V48, P1235, DOI 10.1007/s00127-012-0649-8; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; Maremmani I., 2004, ADDICT, V3, P156, DOI [10.1097/01.adt.0000134613.28760.2f, DOI 10.1097/01.ADT.0000134613.28760.2F]; Maremmani I, 2006, J AFFECT DISORDERS, V93, P1, DOI 10.1016/j.jad.2006.02.022; Maremmani I, 2009, J AFFECT DISORDERS, V117, P186, DOI 10.1016/j.jad.2009.01.007; Mares AS, 2007, HUD HHS VA COLLABORA; Martens W H, 2001, Public Health Rev, V29, P13; McIntyre RS, 2007, CURR OPIN PSYCHIATR, V20, P406, DOI 10.1097/YCO.0b013e3281938102; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Mortensen PB, 2003, J AFFECT DISORDERS, V76, P79, DOI 10.1016/S0165-0327(02)00073-3; Najt P, 2007, EUR NEUROPSYCHOPHARM, V17, P313, DOI 10.1016/j.euroneuro.2006.10.002; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; North CS, 2004, AM J PUBLIC HEALTH, V94, P103, DOI 10.2105/AJPH.94.1.103; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Pacini M, 2009, ALCOHOL, V43, P397, DOI 10.1016/j.alcohol.2009.05.002; Pani PP, 2010, J AFFECT DISORDERS, V122, P185, DOI 10.1016/j.jad.2009.06.012; Peluso MAM, 2007, J AFFECT DISORDERS, V100, P227, DOI 10.1016/j.jad.2006.09.037; Perugi G, 2002, PSYCHIAT CLIN N AM, V25, P713, DOI 10.1016/S0193-953X(02)00023-0; Pini S, 2011, RIV PSICHIATR, V46, P233, DOI 10.1708/931.10204; Post RM, 2014, J NERV MENT DIS, V202, P265, DOI 10.1097/NMD.0000000000000116; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Somers JM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-365; Strehlau V, 2014, SEX HEALTH, V11, P91, DOI 10.1071/SH14019; Strehlau V, 2012, J PSYCHIATR PRACT, V18, P349, DOI 10.1097/01.pra.0000419819.60505.dc; SUSSER E, 1993, EPIDEMIOL REV, V15, P546, DOI 10.1093/oxfordjournals.epirev.a036133; Swann AC, 2004, BIPOLAR DISORD, V6, P204, DOI 10.1111/j.1399-5618.2004.00110.x; Swann AC, 2003, J AFFECT DISORDERS, V73, P105, DOI 10.1016/S0165-0327(02)00328-2; Swann AC, 2001, PSYCHIAT RES, V101, P195, DOI 10.1016/S0165-1781(00)00249-3; Swann AC, 2011, BIPOLAR DISORD, V13, P173, DOI 10.1111/j.1399-5618.2011.00900.x; Swann AC, 2010, ANN NY ACAD SCI, V1187, P276, DOI 10.1111/j.1749-6632.2009.05146.x; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Taylor V, 2006, J CLIN PSYCHIAT, V67, P1034, DOI 10.4088/JCP.v67n0704; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vannucchi G, 2014, J AFFECT DISORDERS, V155, P118, DOI 10.1016/j.jad.2013.10.035; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; World Health Organization, 1992, ICD 10 CLASSIFICATIO	80	7	7	0	2	PENSIERO SCIENTIFICO EDITOR	ROME	VIA BRADANO 3/C, 00199 ROME, ITALY	0035-6484	2038-2502		RIV PSICHIATR	Riv. Psichiatr.	JAN-FEB	2017	52	1					40	46					7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EO3VL	WOS:000396622400006	28287196				2022-02-06	
B	Bonert, VS; Melmed, S		Melmed, S		Bonert, Vivien S.; Melmed, Shlomo			Growth Hormone	PITUITARY, 4TH EDITION			English	Article; Book Chapter							GH-RELEASING HORMONE; FACTOR-BINDING-PROTEIN; QUALITY-OF-LIFE; BONE-MINERAL DENSITY; IGF-I ASSAYS; SOMATOSTATIN RECEPTOR SUBTYPES; CARDIOVASCULAR RISK MARKERS; ANTERIOR-PITUITARY-CELLS; TRAUMATIC BRAIN-INJURY; CHRONIC HEART-FAILURE		[Bonert, Vivien S.; Melmed, Shlomo] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA		Bonert, VS (corresponding author), Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.						Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Alatzoglou KS, 2014, ENDOCR REV, V35, P376, DOI 10.1210/er.2013-1067; Alatzoglou KS, 2010, NAT REV ENDOCRINOL, V6, P562, DOI 10.1038/nrendo.2010.147; Alatzoglou KS, 2009, J CLIN ENDOCR METAB, V94, P3191, DOI 10.1210/jc.2008-2783; ALBAROTH J, 1988, J CLIN ENDOCR METAB, V67, P1186, DOI 10.1210/jcem-67-6-1186; Algeciras-Schimnich A, 2013, CLIN CHEM, V59, P1187, DOI 10.1373/clinchem.2013.205070; Alvarez-Castro P, 2004, CLIN ENDOCRINOL, V61, P250, DOI 10.1111/j.1365-2265.2004.02092.x; AMATO G, 1993, J CLIN ENDOCR METAB, V77, P1671, DOI 10.1210/jc.77.6.1671; Arsene CG, 2014, BIOANALYSIS, V6, P2391, DOI 10.4155/bio.14.196; Arvat E, 2001, J CLIN ENDOCR METAB, V86, P1169, DOI 10.1210/jc.86.3.1169; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Auriemma RS, 2010, EUR J ENDOCRINOL, V162, P1035, DOI 10.1530/EJE-10-0007; Backeljauw PF, 2001, J CLIN ENDOCR METAB, V86, P1504, DOI 10.1210/jc.86.4.1504; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Baker JS, 2006, EUR J INTERN MED, V17, P479, DOI 10.1016/j.ejim.2006.04.010; BALA RM, 1981, J CLIN ENDOCR METAB, V52, P508, DOI 10.1210/jcem-52-3-508; BARINAGA M, 1985, NATURE, V314, P279, DOI 10.1038/314279a0; BARKAN AL, 1988, J CLIN ENDOCR METAB, V67, P69, DOI 10.1210/jcem-67-1-69; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Barzilai N, 2009, J GERONTOL A-BIOL, V64, P187, DOI 10.1093/gerona/gln061; BAUMANN G, 1990, J CLIN ENDOCR METAB, V71, P1339, DOI 10.1210/jcem-71-5-1339; BAUMANN G, 1983, J CLIN ENDOCR METAB, V56, P946, DOI 10.1210/jcem-56-5-946; Baumann GP, 2012, ENDOCR REV, V33, P155, DOI 10.1210/er.2011-1035; BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6898, DOI 10.1073/pnas.86.18.6898; BAXTER RC, 1986, J CLIN INVEST, V78, P1504, DOI 10.1172/JCI112742; Bayes-Genis A, 2000, CIRC RES, V86, P125, DOI 10.1161/01.RES.86.2.125; Beauregard C, 2008, J CLIN ENDOCR METAB, V93, P2063, DOI 10.1210/jc.2007-2371; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; Bell J, 2010, J CLIN ENDOCR METAB, V95, P167, DOI 10.1210/jc.2009-0178; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; BERELOWITZ M, 1981, SCIENCE, V212, P1279, DOI 10.1126/science.6262917; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; Bidlingmaier M, 2010, GROWTH HORM IGF RES, V20, P19, DOI 10.1016/j.ghir.2009.09.005; BILEZIKJIAN LM, 1983, ENDOCRINOLOGY, V113, P1726, DOI 10.1210/endo-113-5-1726; BILEZIKJIAN LM, 1986, ENDOCRINOLOGY, V118, P2045, DOI 10.1210/endo-118-5-2045; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Birzniece V, 2011, TRENDS ENDOCRIN MET, V22, P171, DOI 10.1016/j.tem.2011.02.005; Blanco M, 2003, HISTOCHEM CELL BIOL, V120, P259, DOI 10.1007/s00418-003-0562-z; Blum WF, 2013, J CLIN ENDOCR METAB, V98, pE1383, DOI 10.1210/jc.2013-1222; Bogazzi F, 2007, J CLIN ENDOCR METAB, V92, P4271, DOI 10.1210/jc.2007-1213; Boger RH, 1996, J CLIN INVEST, V98, P2706, DOI 10.1172/JCI119095; Boguszewski CL, 1998, J CLIN ENDOCR METAB, V83, P2878, DOI 10.1210/jc.83.8.2878; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; Borson-Chazot F, 1999, J CLIN ENDOCR METAB, V84, P1329, DOI 10.1210/jc.84.4.1329; Bouillon R, 2004, J CLIN ENDOCR METAB, V89, P4993, DOI 10.1210/jc.2004-0054; Bouillon R, 2000, J PEDIATR ENDOCR MET, V13, P1327; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Brod M, 2014, J CLIN ENDOCR METAB, V99, P1204, DOI 10.1210/jc.2013-3438; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Bruel A, 2002, GROWTH HORM IGF RES, V12, P106, DOI 10.1054/ghir.2002.0269; BRUEL A, 1995, EUR J ENDOCRINOL, V132, P195, DOI 10.1530/eje.0.1320195; Burns C, 2009, GROWTH HORM IGF RES, V19, P457, DOI 10.1016/j.ghir.2009.02.002; BUSBY WH, 1988, J CLIN ENDOCR METAB, V67, P1225, DOI 10.1210/jcem-67-6-1225; Bystrom C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043457; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2005, NEW ENGL J MED, V352, P2014, DOI 10.1056/NEJMe058080; Carani C, 1999, EUR J ENDOCRINOL, V140, P224, DOI 10.1530/eje.0.1400224; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Carter-Su C, 2016, GROWTH HORM IGF RES, V28, P11, DOI 10.1016/j.ghir.2015.09.002; Casanueva FF, 2008, P NATL ACAD SCI USA, V105, P20452, DOI 10.1073/pnas.0811680106; CASANUEVA FF, 1990, J CLIN ENDOCR METAB, V70, P234, DOI 10.1210/jcem-70-1-234; CASANUEVA FF, 1984, J CLIN ENDOCR METAB, V59, P526, DOI 10.1210/jcem-59-3-526; CASANUEVA FF, 1987, J CLIN ENDOCR METAB, V65, P634, DOI 10.1210/jcem-65-4-634; Casanueva FF, 1999, TRENDS ENDOCRIN MET, V10, P30, DOI 10.1016/S1043-2760(98)00116-7; Chan JL, 2008, J CLIN ENDOCR METAB, V93, P2819, DOI 10.1210/jc.2008-0056; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chanson P, 2010, J CLIN ENDOCR METAB, V95, P3684, DOI 10.1210/jc.2010-0295; CHAPMAN IM, 1994, J CLIN ENDOCR METAB, V78, P1312, DOI 10.1210/jc.78.6.1312; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; CHEN XZ, 1992, MOL ENDOCRINOL, V6, P598, DOI 10.1210/me.6.4.598; Chesnokova V, 2016, P NATL ACAD SCI USA, V113, pE3250, DOI 10.1073/pnas.1600561113; Chia DJ, 2006, J BIOL CHEM, V281, P3190, DOI 10.1074/jbc.M510204200; Chihara K, 2007, EUR J ENDOCRINOL, V157, P19, DOI 10.1530/EJE-07-0066; Child CJ, 2015, EUR J ENDOCRINOL, V172, P779, DOI 10.1530/EJE-14-1123; Choi HK, 2000, ENDOCRINOLOGY, V141, P3245, DOI 10.1210/en.141.9.3245; CITTADINI A, 1994, AM J PHYSIOL, V267, pE219, DOI 10.1152/ajpendo.1994.267.2.E219; Cittadini A, 2009, J CLIN ENDOCR METAB, V94, P3329, DOI 10.1210/jc.2009-0533; Clasey JL, 2001, J CLIN ENDOCR METAB, V86, P3845, DOI 10.1210/jc.86.8.3845; Clemmons DR, 2007, PITUITARY, V10, P121, DOI 10.1007/s11102-007-0032-z; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Clemmons DR, 2007, ENDOCRIN METAB CLIN, V36, P109, DOI 10.1016/j.ecl.2006.11.008; Clemmons DR, 2006, NAT CLIN PRACT ENDOC, V2, P436, DOI 10.1038/ncpendmet0244; Clemmons DR, 2016, TRENDS ENDOCRIN MET, V27, P375, DOI 10.1016/j.tem.2016.03.019; Clemmons DR, 2014, J CLIN ENDOCR METAB, V99, P409, DOI 10.1210/jc.2013-4187; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; CLEMMONS DR, 1979, NEW ENGL J MED, V301, P1138, DOI 10.1056/NEJM197911223012102; CLEMMONS DR, 1983, J CELL PHYSIOL, V115, P137, DOI 10.1002/jcp.1041150206; Colao A, 2004, J CLIN ENDOCR METAB, V89, P5998, DOI 10.1210/jc.2004-1042; Colao A, 2001, CLIN ENDOCRINOL, V54, P137, DOI 10.1046/j.1365-2265.2001.01218.x; Colao A, 2006, GROWTH HORM IGF RES, V16, pS41, DOI 10.1016/j.ghir.2006.03.006; Collett-Solberg PF, 2008, J CLIN ENDOCR METAB, V93, P10, DOI 10.1210/jc.2007-1534; Cook DM, 1999, J CLIN ENDOCR METAB, V84, P3956, DOI 10.1210/jc.84.11.3956; Cook DM, 2009, ENDOCR PRACT S2, P1, DOI DOI 10.4158/EP.15.S2.1; Cordoba-Chacon J, 2011, AM J PHYSIOL-ENDOC M, V300, pE46, DOI 10.1152/ajpendo.00514.2010; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Cox HD, 2014, CLIN CHEM, V60, P541, DOI 10.1373/clinchem.2013.208538; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; Davey HW, 1999, J BIOL CHEM, V274, P35331, DOI 10.1074/jbc.274.50.35331; David A, 2011, ENDOCR REV, V32, P472, DOI 10.1210/er.2010-0023; DAVIS JRE, 1986, CLIN ENDOCRINOL, V24, P135, DOI 10.1111/j.1365-2265.1986.tb00755.x; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Zegher F, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1934; DEAN HJ, 1982, J CLIN ENDOCR METAB, V55, P1167, DOI 10.1210/jcem-55-6-1167; DEGERBLAD M, 1989, ACTA ENDOCRINOL-COP, V120, P195, DOI 10.1530/acta.0.1200195; Di Vito L, 2002, CLIN ENDOCRINOL, V56, P643, DOI 10.1046/j.1365-2265.2002.01530.x; DiGirolamo DJ, 2007, J BIOL CHEM, V282, P31666, DOI 10.1074/jbc.M705219200; DONATH MY, 1994, P NATL ACAD SCI USA, V91, P1686, DOI 10.1073/pnas.91.5.1686; Drake WM, 2001, CLIN ENDOCRINOL, V54, P525, DOI 10.1046/j.1365-2265.2001.01246.x; DROP SLS, 1984, J CLIN ENDOCR METAB, V59, P908, DOI 10.1210/jcem-59-5-908; Duffy JMN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000099.pub3; Erfurth EM, 2013, J CLIN ENDOCR METAB, V98, P4219, DOI 10.1210/jc.2013-2415; Erotokritou-Mulligan I, 2012, GROWTH HORM IGF RES, V22, P53, DOI 10.1016/j.ghir.2011.12.005; Erotokritou-Mulligan I, 2009, CLIN ENDOCRINOL, V70, P161, DOI 10.1111/j.1365-2265.2008.03319.x; EZZAT S, 1991, J CLIN ENDOCR METAB, V73, P441, DOI 10.1210/jcem-73-2-441; Fleetwood MR, 2012, J BIOL CHEM, V287, P25454, DOI 10.1074/jbc.M112.365825; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Frajese G, 2001, J CLIN ENDOCR METAB, V86, P5172, DOI 10.1210/jc.86.11.5172; FRANKENNE F, 1988, J CLIN ENDOCR METAB, V66, P1171, DOI 10.1210/jcem-66-6-1171; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Garcia JM, 2013, J CLIN ENDOCR METAB, V98, P2422, DOI 10.1210/jc.2013-1157; Gardner CJ, 2015, EUR J ENDOCRINOL, V172, P371, DOI 10.1530/EJE-14-0654; Gazzaruso C, 2014, J CLIN ENDOCR METAB, V99, P18, DOI 10.1210/jc.2013-2394; GELATO MC, 1983, J CLIN ENDOCR METAB, V57, P674, DOI 10.1210/jcem-57-3-674; Gevers EF, 2002, ENDOCRINOLOGY, V143, P4065, DOI 10.1210/en.2002-220428; GHIGO E, 1990, CLIN ENDOCRINOL, V32, P763, DOI 10.1111/j.1365-2265.1990.tb00923.x; Giampietro A, 2009, FERTIL STERIL, V91, DOI 10.1016/j.fertnstert.2008.09.065; Giavoli C, 2012, J CLIN ENDOCR METAB, V97, P3983, DOI 10.1210/jc.2012-2477; Gibney J, 2005, AM J PHYSIOL-ENDOC M, V289, pE266, DOI 10.1152/ajpendo.00483.2004; Gibney J, 2003, J CLIN ENDOCR METAB, V88, P1792, DOI 10.1210/jc.2002-020540; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gola M, 2005, J CLIN ENDOCR METAB, V90, P1864, DOI 10.1210/jc.2004-0545; Goldenberg N, 2007, ENDOCRIN METAB CLIN, V36, P37, DOI 10.1016/j.ecl.2006.11.003; GOLSTEIN J, 1983, J CLIN ENDOCR METAB, V56, P433, DOI 10.1210/jcem-56-3-433; Graham MR, 2008, HORM RES, V69, P343, DOI 10.1159/000117390; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; GREENMAN Y, 1994, J CLIN ENDOCR METAB, V78, P398, DOI 10.1210/jc.78.2.398; GREENMAN Y, 1994, J CLIN ENDOCR METAB, V79, P724, DOI 10.1210/jc.79.3.724; GUBLER U, 1983, P NATL ACAD SCI-BIOL, V80, P4311, DOI 10.1073/pnas.80.14.4311; GUILLEMIN R, 1982, SCIENCE, V218, P585, DOI 10.1126/science.6812220; GULER HP, 1989, P NATL ACAD SCI USA, V86, P2868, DOI 10.1073/pnas.86.8.2868; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hallengren E, 2014, J AM COLL CARDIOL, V64, P1452, DOI 10.1016/j.jacc.2014.03.063; Hamrahian AH, 2016, PITUITARY, V19, P332, DOI 10.1007/s11102-016-0712-7; HAN VKM, 1987, SCIENCE, V236, P193, DOI 10.1126/science.3563497; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hartman ML, 2013, J CLIN ENDOCR METAB, V98, P980, DOI 10.1210/jc.2012-2684; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552; HAZEL SJ, 1994, KIDNEY INT, V46, P58, DOI 10.1038/ki.1994.244; Healy ML, 2003, J CLIN ENDOCR METAB, V88, P5221, DOI 10.1210/jc.2002-021872; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Ho KKY, 2000, LANCET, V356, P1125, DOI 10.1016/S0140-6736(00)02748-3; HODGKINSON SC, 1989, J ENDOCRINOL, V123, P461, DOI 10.1677/joe.0.1230461; Hodson EM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003264.pub3; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; Holly J, 2006, NEUROENDOCRINOLOGY, V83, P154, DOI 10.1159/000095523; HOLLY JMP, 1988, CLIN ENDOCRINOL, V29, P667, DOI 10.1111/j.1365-2265.1988.tb03715.x; Holmer H, 2013, PSYCHONEUROENDOCRINO, V38, P842, DOI 10.1016/j.psyneuen.2012.09.008; Holt RIG, 2009, GROWTH HORM IGF RES, V19, P320, DOI 10.1016/j.ghir.2009.04.009; Holt RIG, 2001, J CLIN ENDOCR METAB, V86, P5715, DOI 10.1210/jc.86.12.5715; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hubina E, 2004, CALCIFIED TISSUE INT, V74, P55, DOI 10.1007/s00223-002-2149-4; Hull KL, 2000, ENDOCRINE, V13, P243, DOI 10.1385/ENDO:13:3:243; Hull KL, 2001, J ENDOCRINOL, V168, P1, DOI 10.1677/joe.0.1680001; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Irving BA, 2004, J CLIN ENDOCR METAB, V89, P4298, DOI 10.1210/jc.2004-0067; ISAKSSON OGP, 1982, SCIENCE, V216, P1237, DOI 10.1126/science.7079756; Isgaard J, 2015, ENDOCRINE, V48, P25, DOI 10.1007/s12020-014-0327-6; ISLEY WL, 1983, J CLIN INVEST, V71, P175, DOI 10.1172/JCI110757; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Jasim S, 2016, ENDOCRINE; Jessup SK, 2003, J CLIN ENDOCR METAB, V88, P4776, DOI 10.1210/jc.2003-030246; Johannsson G, 2004, CLIN ENDOCRINOL, V60, P550, DOI 10.1111/j.1365-2265.2004.02018.x; Jostel A, 2005, CLIN ENDOCRINOL, V62, P698, DOI 10.1111/j.1365-2265.2005.02282.x; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P3335, DOI 10.1210/jc.80.11.3335; Kamegai J, 2004, ENDOCRINOLOGY, V145, P3731, DOI 10.1210/en.2003-1424; Kamenicky P, 2008, ENDOCRINOLOGY, V149, P3294, DOI 10.1210/en.2008-0143; Kamenicky P, 2014, ENDOCR REV, V35, P234, DOI 10.1210/er.2013-1071; Kamenicky P, 2012, J CLIN ENDOCR METAB, V97, P2124, DOI 10.1210/jc.2011-3188; Karasik D, 2002, CALCIFIED TISSUE INT, V71, P323, DOI 10.1007/s00223-002-1002-0; Karavitaki N, 2006, CLIN ENDOCRINOL, V64, P556, DOI 10.1111/j.1365-2265.2006.02508.x; Kargi AY, 2013, NAT REV ENDOCRINOL, V9, P335, DOI 10.1038/nrendo.2013.77; Katz LEL, 2002, J CLIN ENDOCR METAB, V87, P2978, DOI 10.1210/jc.87.6.2978; Kawai M, 2007, J MOL ENDOCRINOL, V38, P19, DOI 10.1677/jme.1.02154; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; KELLY PA, 1991, ENDOCR REV, V12, P235, DOI 10.1210/edrv-12-3-235; KOERKER DJ, 1974, SCIENCE, V184, P482, DOI 10.1126/science.184.4135.482; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kontoleon PE, 2003, INT J CARDIOL, V87, P179, DOI 10.1016/S0167-5273(02)00212-7; Koutkia P, 2004, AM J PHYSIOL-ENDOC M, V287, pE506, DOI 10.1152/ajpendo.00548.2003; Krantz E, 2015, J CLIN ENDOCR METAB, V100, P3251, DOI 10.1210/jc.2015-1757; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Ku CR, 2014, EUR J ENDOCRINOL, V171, P379, DOI 10.1530/EJE-14-0304; Laron Z, 2000, ACTA PAEDIATR, V89, P38, DOI 10.1080/080352500750029031; Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033; Laron Z, 2016, GROWTH HORM IGF RES, V28, P53, DOI 10.1016/j.ghir.2015.08.004; Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967; Le Corvoisier P, 2007, J CLIN ENDOCR METAB, V92, P180, DOI 10.1210/jc.2006-1313; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; Leung KC, 1997, P NATL ACAD SCI USA, V94, P11381, DOI 10.1073/pnas.94.21.11381; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; LOSA M, 1986, J CLIN ENDOCR METAB, V63, P88, DOI 10.1210/jcem-63-1-88; Losa M, 2008, THYROID, V18, P1249, DOI 10.1089/thy.2008.0266; Lui JC, 2015, CURR OPIN PEDIATR, V27, P502, DOI 10.1097/MOP.0000000000000235; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; MAEDA K, 1976, ACTA ENDOCRINOL-COP, V81, P1; Magalhaes DM, 2011, THERIOGENOLOGY, V75, P182, DOI 10.1016/j.theriogenology.2010.08.004; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; MARTIN JB, 1973, NEW ENGL J MED, V288, P1384, DOI 10.1056/NEJM197306282882606; Massart C, 2006, CLIN CHIM ACTA, V373, P176, DOI 10.1016/j.cca.2006.05.027; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MAYO KE, 1983, NATURE, V306, P86, DOI 10.1038/306086a0; Mazziotti G, 2013, J CLIN ENDOCR METAB, V98, P3402, DOI 10.1210/jc.2013-1460; Mazziotti G, 2015, TRENDS ENDOCRIN MET, V26, P11, DOI 10.1016/j.tem.2014.10.005; Mazziotti G, 2013, NAT REV ENDOCRINOL, V9, P265, DOI 10.1038/nrendo.2013.5; McIntyre HD, 2000, J CLIN ENDOCR METAB, V85, P1143, DOI 10.1210/jc.85.3.1143; Meinhardt U, 2010, ANN INTERN MED, V152, P568, DOI 10.7326/0003-4819-152-9-201005040-00007; Melmed S, 1996, RECENT PROG HORM RES, V51, P189; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Melmed S, 2003, WILLIAMS TXB ENDOCRI, P177; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Melmed S, 2016, NAT REV ENDOCRINOL, V12, P90, DOI 10.1038/nrendo.2015.196; Melmed S, 2013, J CLIN ENDOCR METAB, V98, P2187, DOI 10.1210/jc.2012-4012; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; MERIMEE TJ, 1971, J CLIN INVEST, V50, P574, DOI 10.1172/JCI106527; MILLER GM, 1995, J CLIN ENDOCR METAB, V80, P1386, DOI 10.1210/jc.80.4.1386; MILLER WL, 1983, ENDOCR REV, V4, P97, DOI 10.1210/edrv-4-2-97; Mitchell CJ, 2009, J CLIN ENDOCR METAB, V94, P4703, DOI 10.1210/jc.2009-1038; Mo DJ, 2015, LANCET DIABETES ENDO, V3, P331, DOI 10.1016/S2213-8587(15)00098-4; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Monaghan PJ, 2013, REV ENDOCR METAB DIS, V14, P143, DOI 10.1007/s11154-013-9240-1; Mosca S, 2013, INT J CARDIOL, V167, P1712, DOI 10.1016/j.ijcard.2012.11.109; Mullis PE, 2002, HORM RES, V58, P53, DOI 10.1159/000064663; Murray PG, 2015, J ENDOCRINOL, V226, pT123, DOI 10.1530/JOE-15-0120; Murray RD, 2006, J CLIN ENDOCR METAB, V91, P432, DOI 10.1210/jc.2005-0897; NAKAGAWA K, 1985, J CLIN ENDOCR METAB, V60, P306, DOI 10.1210/jcem-60-2-306; Nass R, 2008, ANN INTERN MED, V149, P601, DOI 10.7326/0003-4819-149-9-200811040-00003; Nelson AE, 2006, J CLIN ENDOCR METAB, V91, P4424, DOI 10.1210/jc.2006-0612; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Pandya N, 1998, J CLIN ENDOCR METAB, V83, P1186, DOI 10.1210/jc.83.4.1186; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Pappachan JM, 2015, J CLIN ENDOCR METAB, V100, P1405, DOI 10.1210/jc.2014-3787; Pasarica M, 2007, J CLIN ENDOCR METAB, V92, P4265, DOI 10.1210/jc.2007-0786; PETERFREUND RA, 1984, NEUROENDOCRINOLOGY, V39, P397, DOI 10.1159/000124011; Pfaffle R, 2015, BEST PRACT RES CL EN, V29, P339, DOI 10.1016/j.beem.2015.04.009; Pilecka I, 2007, TRENDS ENDOCRIN MET, V18, P12, DOI 10.1016/j.tem.2006.11.004; Pokrajac A, 2007, CLIN ENDOCRINOL, V67, P65, DOI 10.1111/j.1365-2265.2007.02836.x; Popovic V, 2003, J CLIN ENDOCR METAB, V88, P3450, DOI 10.1210/jc.2003-030211; Powrie JK, 2007, GROWTH HORM IGF RES, V17, P220, DOI 10.1016/j.ghir.2007.01.011; Pritzlaff-Roy CJ, 2002, J APPL PHYSIOL, V92, P2053, DOI 10.1152/japplphysiol.01018.2001; Pulichino AM, 2004, M S-MED SCI, V20, P1009, DOI 10.1051/medsci/200420111009; Quigley CA, 2007, ENDOCRIN METAB CLIN, V36, P131, DOI 10.1016/j.ecl.2006.11.006; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; Reddy GR, 2007, ENDOCRINOLOGY, V148, P2045, DOI 10.1210/en.2006-1285; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; RIVIER J, 1982, NATURE, V300, P276, DOI 10.1038/300276a0; Romero C, 2009, MOL BASIS HYPOPITUIT; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; ROSENTHAL SM, 1986, J CLIN INVEST, V77, P176, DOI 10.1172/JCI112273; ROSS RJM, 1987, CLIN ENDOCRINOL, V26, P117, DOI 10.1111/j.1365-2265.1987.tb03645.x; ROTH J, 1963, SCIENCE, V140, P987, DOI 10.1126/science.140.3570.987; Rotwein P, 2012, TRENDS ENDOCRIN MET, V23, P186, DOI 10.1016/j.tem.2012.01.001; RUBIN KR, 1986, AM J DIS CHILD, V140, P555, DOI 10.1001/archpedi.1986.02140200065029; RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164; Russell-Aulet M, 1999, J CLIN ENDOCR METAB, V84, P3490, DOI 10.1210/jc.84.10.3490; Russell-Aulet M, 2001, J GERONTOL A-BIOL, V56, pM124, DOI 10.1093/gerona/56.2.M124; Ryther RCC, 2004, ENDOCRINOLOGY, V145, P2988, DOI 10.1210/en.2003-1724; Sacca L, 2003, CLIN ENDOCRINOL, V59, P660, DOI 10.1046/j.1365-2265.2003.01780.x; SACCA L, 1994, ENDOCR REV, V15, P555, DOI 10.1210/er.15.5.555; Salevic P, 2014, J NEPHROL, V27, P537, DOI 10.1007/s40620-014-0094-8; Sattler FR, 2009, J CLIN ENDOCR METAB, V94, P1991, DOI 10.1210/jc.2008-2338; Schilbach K, 2015, BEST PRACT RES CL EN, V29, P671, DOI 10.1016/j.beem.2015.06.004; SCHIMPFF RM, 1980, ACTA ENDOCRINOL-COP, V93, P155, DOI 10.1530/acta.0.0930155; Schnabel P, 2000, BIOCHEM BIOPH RES CO, V275, P1, DOI 10.1006/bbrc.2000.3255; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; SHEN LP, 1982, P NATL ACAD SCI-BIOL, V79, P4575, DOI 10.1073/pnas.79.15.4575; SHEPPARD MC, 1978, CLIN ENDOCRINOL, V9, P583, DOI 10.1111/j.1365-2265.1978.tb01518.x; Shimon I, 1997, J CLIN INVEST, V100, P2386, DOI 10.1172/JCI119779; Shimon I, 1998, J CLIN ENDOCR METAB, V83, P174, DOI 10.1210/jc.83.1.174; Shuto Y, 2002, J CLIN INVEST, V109, P1429, DOI [10.1172/JCI0213300, 10.1172/JCI200213300]; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sirotkin AV, 2005, VET J, V170, P307, DOI 10.1016/j.tvjl.2004.05.014; SLOOTWEG MC, 1995, ENDOCRINOLOGY, V136, P4210, DOI 10.1210/en.136.10.4210; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Stephure DK, 2005, J CLIN ENDOCR METAB, V90, P3360, DOI 10.1210/jc.2004-2187; SUDA T, 1980, J CLIN ENDOCR METAB, V51, P1048, DOI 10.1210/jcem-51-5-1048; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Svensson J, 2003, J CLIN ENDOCR METAB, V88, P2061, DOI 10.1210/jc.2002-020901; Svensson J, 2002, J CLIN ENDOCR METAB, V87, P2121, DOI 10.1210/jc.87.5.2121; TAI PKK, 1990, J BIOL CHEM, V265, P21828; Tanaka H, 1996, MECH AGEING DEV, V92, P1, DOI 10.1016/S0047-6374(96)01793-9; TANNENBAUM GS, 1989, ENDOCRINOLOGY, V124, P1380, DOI 10.1210/endo-124-3-1380; Tannenbaum GS, 2003, ENDOCRINOLOGY, V144, P967, DOI 10.1210/en.2002-220852; TANNENBAUM GS, 1984, ENDOCRINOLOGY, V115, P1952, DOI 10.1210/endo-115-5-1952; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; TATEMOTO K, 1981, P NATL ACAD SCI-BIOL, V78, P6603, DOI 10.1073/pnas.78.11.6603; Tauber M, 1997, J CLIN ENDOCR METAB, V82, P352, DOI 10.1210/jc.82.2.352; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Thomas JDJ, 2009, EUR J ENDOCRINOL, V161, pS97, DOI 10.1530/EJE-09-0258; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Tritos NA, 2014, J CLIN ENDOCR METAB, V99, P2018, DOI 10.1210/jc.2014-1013; TYRRELL JB, 1977, J CLIN ENDOCR METAB, V44, P218, DOI 10.1210/jcem-44-1-218; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; van Varsseveld NC, 2015, J CLIN ENDOCR METAB, V100, P3132, DOI 10.1210/jc.2015-1764; Vance ML, 1999, NEW ENGL J MED, V341, P1206, DOI 10.1056/NEJM199910143411607; VANCE ML, 1989, J CLIN ENDOCR METAB, V68, P22, DOI 10.1210/jcem-68-1-22; Varco-Merth B, 2014, AM J PHYSIOL-ENDOC M, V307, pE847, DOI 10.1152/ajpendo.00324.2014; Vasan RS, 2003, ANN INTERN MED, V139, P642, DOI 10.7326/0003-4819-139-8-200310210-00007; Veldhuis JD, 2006, ENDOCR REV, V27, P101, DOI 10.1210/er.2005-0006; Veldhuis JD, 2003, NEUROBIOL AGING, V24, pS93, DOI 10.1016/S0197-4580(03)00058-7; Veldhuis JD, 1998, GROWTH HORM IGF RES, V8, P49, DOI 10.1016/S1096-6374(98)80024-5; Veldhuis JD, 2015, METABOLISM, V64, P1022, DOI 10.1016/j.metabol.2015.05.008; Verhelst J, 2013, EUR J ENDOCRINOL, V168, P177, DOI 10.1530/EJE-12-0753; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Vila G, 2015, FERTIL STERIL, V104, P1210, DOI 10.1016/j.fertnstert.2015.07.1132; Vimalachandra D, 2001, COCHRANE DB SYST REV; Vogeser M, 2010, CLIN CHEM, V56, P1234, DOI 10.1373/clinchem.2009.138602; Wallace JD, 2001, J CLIN ENDOCR METAB, V86, P1731, DOI 10.1210/jc.86.4.1731; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Watanabe S, 2010, EUR J HEART FAIL, V12, P1214, DOI 10.1093/eurjhf/hfq166; WATANABE YG, 1979, DEV BIOL, V68, P557, DOI 10.1016/0012-1606(79)90226-4; Webb SM, 2009, J CLIN ENDOCR METAB, V94, P392, DOI 10.1210/jc.2008-0713; Widdowson WM, 2008, J CLIN ENDOCR METAB, V93, P4413, DOI 10.1210/jc.2008-1239; Woodhouse LJ, 2006, ENDOCR REV, V27, P287, DOI 10.1210/er.2004-0022; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Xing WR, 2012, J BONE MINER RES, V27, P1067, DOI 10.1002/jbmr.1551; Xu BXC, 1996, J BIOL CHEM, V271, P19768, DOI 10.1074/jbc.271.33.19768; YAMASHITA S, 1986, ENDOCRINOLOGY, V118, P176, DOI 10.1210/endo-118-1-176; Yang SM, 2004, OBES RES, V12, P330, DOI 10.1038/oby.2004.41; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Yuan MJ, 2014, ONCOL LETT, V8, P969, DOI 10.3892/ol.2014.2245; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299; ZADIK Z, 1985, J CLIN ENDOCR METAB, V60, P513, DOI 10.1210/jcem-60-3-513; ZAPF J, 1989, P NATL ACAD SCI USA, V86, P3813, DOI 10.1073/pnas.86.10.3813; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhu XY, 2005, CURR OPIN GENET DEV, V15, P332, DOI 10.1016/j.gde.2005.04.011; Zizzari P, 2005, ENDOCRINOLOGY, V146, P3836, DOI 10.1210/en.2005-0212	370	7	8	0	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-813421-4; 978-0-12-804169-7				2017							85	127		10.1016/B978-0-12-804169-7.00004-0			43	Endocrinology & Metabolism	Book Citation Index – Science (BKCI-S)	Endocrinology & Metabolism	BJ3WP	WOS:000424462900005					2022-02-06	
J	Brunsden, C; Kiemle, G; Mullin, S				Brunsden, Cara; Kiemle, Gundi; Mullin, Stephen			Male partner experiences of females with an acquired brain injury: An interpretative phenomenological analysis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired brain injury; Male partners; Qualitative research; Relationships; Intimacy	HEAD-INJURY; SEXUALITY; DISTRESS; ISSUES; STROKE; IMPACT; MEN	Acquired brain injury (ABI) not only has an impact on the survivor, but also on the partner and personal relationships as a whole. The present study aimed to investigate the male partner experience of living with a female with an ABI; exploring role change, intimacy and future expectations. Semi-structured interviews were conducted with six male partners of five females with a subarachnoid haemorrhage and one female with a traumatic brain injury. Interviews were transcribed verbatim and analysed in depth using Interpretative Phenomenological Analysis (IPA). Four main themes captured the male partner's lived experience; Entering the unknown world of ABI, Imprisoned by the ABI, Compassion without self-compassion, and Holding on to hope. The accounts uncovered the male partner's journey following ABI; the unpredictability, sorrow, frustration, and finally acceptance and commitment to their partner. They identified the limited support available for partners following ABI; the sense of feeling forgotten by services and the need for information and support in the acute stages. Rehabilitation needs to take a systemic and longer-term focus, supporting both the survivor and their partner through the journey of ABI.	[Brunsden, Cara; Kiemle, Gundi] Univ Liverpool, Dept Clin Psychol, Whelan Bldg, Liverpool L69 3GB, Merseyside, England; [Mullin, Stephen] 5 Boroughs Partnership NHS Fdn Trust, Acquired Brain Injury Serv, Specialist Psychol Therapy Serv, Hazelmere Unit,Leigh Infirm, Leigh, England; [Brunsden, Cara] Mersey Care NHS Trust, Brain Injury Rehabil Ctr, Sid Watkins Bldg,Lower Lane, Fazakerley L9 7LJ, England		Brunsden, C (corresponding author), Univ Liverpool, Dept Clin Psychol, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.; Brunsden, C (corresponding author), Mersey Care NHS Trust, Brain Injury Rehabil Ctr, Sid Watkins Bldg,Lower Lane, Fazakerley L9 7LJ, England.	cara_brunsden@hotmail.com		Pelser, Cara/0000-0002-1022-4214			Bowen C, 2011, PSYCHOL HEALTH, V26, P113, DOI 10.1080/08870440903287934; Bowen C., 2010, RELATIONAL APPROACH; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Calabro RS, 2011, INT J NEUROSCI, V121, P598, DOI 10.3109/00207454.2011.600647; Chwalisz K, 1996, Appl Neuropsychol, V3, P28, DOI 10.1207/s15324826an0301_5; Clifton, 2006, QUALITATIVE RES PSYC, V3, P102, DOI [DOI 10.1191/1478088706QP0620A, 10.1191/1478088706qp062oa, DOI 10.1191/1478088706QP062OA]; Doka K.J., 1989, DISENFRANCHISED GRIE; Endler NS, 1994, PSYCHOL ASSESSMENT, V6, P50, DOI [DOI 10.1037/1040-3590.6.1.50, 10.1037/1040-3590.6.1.50]; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; Gribble JN, 1999, J SEX RES, V36, P16, DOI 10.1080/00224499909551963; HARRIS PB, 1993, GERONTOLOGIST, V33, P551, DOI 10.1093/geront/33.4.551; Kieffer-Kristensen R, 2013, BRAIN INJURY, V27, P1562, DOI 10.3109/02699052.2013.841995; Kingerlee R, 2012, PSYCHOL PSYCHOTHER-T, V85, P83, DOI 10.1111/j.2044-8341.2011.02017.x; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Lemieux L, 2001, SEX DISABIL, V19, P253, DOI 10.1023/A:1017953308761; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Nvivo, 2012, NVIVO QUAL DAT AN SO; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Rees R., 2012, RESILIENCE PEOPLE TR; Russell R, 2001, J AGING STUD, V15, P351, DOI 10.1016/S0890-4065(01)00028-7; Schmitz MA, 2010, TOP STROKE REHABIL, V17, P204, DOI 10.1310/tsr1703-204; Smith J.A., 2009, INTERPRETATIVE PHENO; Smith J.A., 2008, QUALITATIVE PSYCHOL, P51; Smith JA, 2011, HEALTH PSYCHOL REV, V5, P9, DOI 10.1080/17437199.2010.510659; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; Thompson S., 2011, WEBMEDCENTRAL PHYS M, V2; Wood RL, 2005, PSYCHOLOGIST, V18, P138; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Yeates G, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P138, DOI 10.1017/CBO9780511581083.012	35	7	7	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	6					937	958		10.1080/09602011.2015.1109525			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EY1FQ	WOS:000403711600004	26610187				2022-02-06	
S	Cheong, SH; Lee, DS		Lee, DH; Schaffer, SW; Park, E; Kim, HW		Cheong, Sun Hee; Lee, Dong-Sung			Taurine Chloramine Prevents Neuronal HT22 Cell Damage Through Nrf2-Related Heme Oxygenase-1	TAURINE 10	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	20th International Taurine Meeting	MAY 23-27, 2016	Seoul, SOUTH KOREA			Taurine chloramine; Oxidative stress; Heme oxygenase-1; Nuclear factor E2-related factor 2; Mouse hippocampal HT22 cells	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; OXIDATIVE STRESS; GLUTAMATE RECEPTORS; HYDROGEN-PEROXIDE; HO-1 EXPRESSION; GENE-EXPRESSION; NO PRODUCTION; MACROPHAGES; NRF2	Oxidative cell damages are able to contribute to neuronal degeneration in several diseases of the central nervous system (CNS) including stroke as well as ischemia. Heme oxygenase (HO)-1 plays a major role in the pathogenesis of neuronal disorder. Taurine chloramine (TauCl) has been shown to possess strong neuronal activities; however, the direct effects of TauCl on neuronal cell death remain to be determined. Therefore, this study was designed to assess the neuroprotective effect of TauCl using oxidative stress-stimulated mouse hippocampal HT22 cells. TauCl showed protective effects against oxidative stress-induced neurotoxicity and inhibited the reactive oxygen species (ROS) production by inducing the heme oxygenase (HO)-1 expression in HT22 cells. TauCl upregulated HO-1 expression and it also increased the nuclear factor E2-related factor 2 (Nrf2) translocation to nuclear. Using an inhibitor of HO-1 activity, we verified that the oxidative stress-related HT22 cell death was significantly suppressed by TauCl. In addition, we found reduced TauCl-induced HO-1 expression and cytoprotection following treatment of the cells with an extracellular signal-regulated kinase (ERK) inhibitor (PD98059) or a p38 inhibitor (SB203580), but not following treatment with a SP600125 as a c-Jun NH2-terminal kinase (JNK) inhibitor. These findings suggest that TauCl improves cellular damage induced by glutamate or H2O2 through ERK and p38, Nrf2, and HO-1 pathways in HT22 cells.	[Cheong, Sun Hee] Chonnam Natl Univ, Dept Marine Bio Food Sci, Coll Fisheries & Ocean Sci, Yeosu 550749, South Korea; [Lee, Dong-Sung] Chosun Univ, Coll Pharm, Gwangju 61452, South Korea		Cheong, SH (corresponding author), Chonnam Natl Univ, Dept Marine Bio Food Sci, Coll Fisheries & Ocean Sci, Yeosu 550749, South Korea.; Lee, DS (corresponding author), Chosun Univ, Coll Pharm, Gwangju 61452, South Korea.	sunny3843@jnu.ac.kr; dslee2771@chosun.ac.kr			Chonnam National University	This study was financially supported by Chonnam National University, 2016.	Barua M, 2001, J IMMUNOL, V167, P2275, DOI 10.4049/jimmunol.167.4.2275; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DIFAZIO MC, 1992, NEUROLOGY, V42, P402, DOI 10.1212/WNL.42.2.402; Elbirt KK, 1998, J BIOL CHEM, V273, P8922, DOI 10.1074/jbc.273.15.8922; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; Halliwell B, 1993, FREE RADICALS BIOL M; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jang JS, 2009, J CLIN BIOCHEM NUTR, V45, P37, DOI 10.3164/jcbn.08-262; Kang IS, 2013, ADV EXP MED BIOL, V775, P259, DOI 10.1007/978-1-4614-6130-2_22; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; Kim C, 2014, AMINO ACIDS, V46, P89, DOI 10.1007/s00726-013-1545-6; Kim C, 2010, INT IMMUNOPHARMACOL, V10, P440, DOI 10.1016/j.intimp.2009.12.018; Kim JW, 2005, BIOCHEM PHARMACOL, V70, P1352, DOI 10.1016/j.bcp.2005.08.006; LEARN DB, 1990, J LEUKOCYTE BIOL, V48, P174, DOI 10.1002/jlb.48.2.174; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Maher P, 1996, J NEUROSCI, V16, P6394; MAVELLI I, 1982, BIOCHEM J, V204, P535, DOI 10.1042/bj2040535; Midwinter RG, 2004, J BIOL CHEM, V279, P32205, DOI 10.1074/jbc.M402070200; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Piao S, 2011, J CLIN BIOCHEM NUTR, V49, P50, DOI 10.3164/jcbn.10-120; Qiang W, 2004, J VIROL, V78, P11926, DOI 10.1128/JVI.78.21.11926-11938.2004; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Srisook K, 2006, BIOCHEM PHARMACOL, V71, P307, DOI 10.1016/j.bcp.2005.10.042; Thomas E L, 1986, Methods Enzymol, V132, P569	28	7	7	2	5	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0065-2598	2214-8019	978-94-024-1079-2; 978-94-024-1077-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2017	975						145	157		10.1007/978-94-024-1079-2_13			13	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine	BJ8IB	WOS:000428231500013	28849451				2022-02-06	
J	Chin, TY; Kiat, SS; Faizul, HG; Wu, WT; Abdullah, JM				Chin, Tan Yew; Kiat, Sim Sze; Faizul, Hizal Ghazali; Wu, Wutian; Abdullah, Jafri Malin			The Effects of Minocycline on Spinal Root Avulsion Injury in Rat Model	MALAYSIAN JOURNAL OF MEDICAL SCIENCE			English	Article						minocycline; avulsion injury; histological study; microglia	NEURONAL SURVIVAL; NITRIC-OXIDE; CORD-INJURY; BRAIN; MICROGLIA; PROTECTS; DEATH	Background: The neuroprotective role of minocycline in the treatment of brachial plexus injury is controversial. Objective: To study the neuroprotective effect of minocycline via different routes in adult Sprague Dawley rats with brachial plexus injury. Methods: The C7 nerve roots of the animals were avulsed via an anterior extravertebral approach. Traction force was used to transect the ventral motor nerve roots at the preganglionic level. Intraperitoneal and intrathecal minocycline (50 mg/kg for the first week and 25 mg/kg for the second week) were administered to promote motor healing. The spinal cord was harvested six weeks after the injury, and structural changes following the avulsion injury and pharmacological intervention were analysed. Results: Motor neuron death and microglial proliferation were observed after the administration of minocycline via two different routes (intraperitoneal and intrathecal) following traumatic avulsion injury of the ventral nerve root. The administration of intraperitoneal minocycline reduced the microglia count but increased the motor neuron count. Intrathecal minocycline also reduced the microglial count, with a greater reduction than in the intraperitoneal group, but it decreased the motor neuron count. Conclusions: Intraperitoneal minocycline increased motor neuron survival by inhibiting microglial proliferation following traumatic avulsion injury of the nerve root. The inhibitory effect was augmented by the use of intrathecal minocycline, in which the targeted drug delivery method increased the bioavailability of the therapeutic agent. However, motor neuron survival was impaired at a higher concentration of minocycline via the intrathecal route due to the more efficient method of drug delivery. Microglial suppression via minocycline can have both beneficial and damaging effects, with a moderate dose being beneficial as regards motor neuron survival but a higher dose proving neurotoxic due to impairment of the glial response and Wallerian degeneration, which is a pre-requisite for regeneration.	[Chin, Tan Yew; Kiat, Sim Sze; Faizul, Hizal Ghazali; Abdullah, Jafri Malin] Univ Sains Malaysia, Dept Neurosci, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia; [Wu, Wutian] Univ Hong Kong, Dept Anat, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China; [Chin, Tan Yew; Abdullah, Jafri Malin] Univ Sains Malaysia, Ctr Neurosci Serv & Res, Kubang Kerian 16150, Kelantan, Malaysia; [Kiat, Sim Sze] Univ Malaysia Sarawak, Dept Surg, Fac Med & Hlth Sci, Kota Samarahan 94300, Sarawak, Malaysia		Chin, TY (corresponding author), Univ Sains Malaysia, Dept Neurosci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	tanyewchin@gmail.com	Abdullah, J/C-2828-2011	Abdullah, J/0000-0002-0258-7410			Aldskogius H, 2001, MICROSC RES TECHNIQ, V54, P40, DOI 10.1002/jemt.1119; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Barbizan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063260; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Bowes AL, 2014, J NEUROTRAUM, V31, P1753, DOI 10.1089/neu.2014.3429; Cui W, 2001, GLIA, V34, P272, DOI 10.1002/glia.1061; Faizul HG, 2016, SAINS MALAYS, V45, P1641; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; Hoang TX, 2008, EXP BRAIN RES, V189, P71, DOI 10.1007/s00221-008-1398-5; Juan MG, 2015, SPINE J, V15, P365; Kaiser R, 2014, INJURY, V45, P223, DOI 10.1016/j.injury.2012.05.013; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Pinkernelle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073422; Potter EG, 2009, J NEUROSCI RES, V87, P1356, DOI 10.1002/jnr.21963; Sim SK, 2015, TURK NEUROSURG, V25, P617, DOI 10.5137/1019-5149.JTN.14035-15.1; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Tanaka T, 2013, J NEUROCHEM, V127, P259, DOI 10.1111/jnc.12289; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	20	7	8	0	2	UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES	KELANTAN	HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.	JAN-FEB	2017	24	1					31	39		10.21315/mjms2017.24.1.4			9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	EP4ZI	WOS:000397388200004	28381927	Green Published, gold, Green Accepted			2022-02-06	
J	Darkazalli, A; Vied, C; Badger, CD; Levenson, CW				Darkazalli, Ali; Vied, Cynthia; Badger, Crystal-Dawn; Levenson, Cathy W.			Human Mesenchymal Stem Cell Treatment Normalizes Cortical Gene Expression after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; genomics; stem cells; traumatic brain injury	ALZHEIMERS-DISEASE; HEAD-INJURY; BIOCONDUCTOR PACKAGE; FUNCTIONAL RECOVERY; RATS; MECHANISMS; RECEPTORS; RISK; DIFFERENTIATION; TRANSPLANTATION	Traumatic brain injury (TBI) results in a progressive disease state with many adverse and long-term neurological consequences. Mesenchymal stem cells (MSCs) have emerged as a promising cytotherapy and have been previously shown to reduce secondary apoptosis and cognitive deficits associated with TBI. Consistent with the established literature, we observed that systemically administered human MSCs (hMSCs) accumulate with high specificity at the TBI lesion boundary zone known as the penumbra. Substantial work has been done to illuminate the mechanisms by which MSCs, and the bioactive molecules they secrete, exert their therapeutic effect. However, no such work has been published to examine the effect of MSC treatment on gene expression in the brain post-TBI. In the present study, we use high-throughput RNA sequencing (RNAseq) of cortical tissue from the TBI penumbra to assess the molecular effects of both TBI and subsequent treatment with intravenously delivered hMSCs. RNAseq revealed that expression of almost 7000 cortical genes in the penumbra were differentially regulated by TBI. Pathway analysis using the KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway database revealed that TBI regulated a large number of genes belonging to pathways involved in metabolism, receptor-mediated cell signaling, neuronal plasticity, immune cell recruitment and infiltration, and neurodegenerative disease. Remarkably, hMSC treatment was found to normalize 49% of all genes disrupted by TBI, with notably robust normalization of specific pathways within the categories mentioned above, including neuroactive receptor-ligand interactions (57%), glycolysis and gluconeogenesis (81%), and Parkinson's disease (100%). These data provide evidence in support of the multi-mechanistic nature of stem cell therapy and suggest that hMSC treatment is capable of simultaneously normalizing a wide variety of important molecular pathways that are disrupted by brain injury.	[Darkazalli, Ali; Vied, Cynthia; Badger, Crystal-Dawn; Levenson, Cathy W.] Florida State Univ, Coll Med, Dept Biomed Sci, Coll Med Res Bldg,MSR 2350-E,1115 West Call St, Tallahassee, FL 32306 USA; [Darkazalli, Ali; Levenson, Cathy W.] Florida State Univ, Coll Med, Program Neurosci, Coll Med Res Bldg,MSR 2350-E,1115 West Call St, Tallahassee, FL 32306 USA		Levenson, CW (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Coll Med Res Bldg,MSR 2350-E,1115 West Call St, Tallahassee, FL 32306 USA.; Levenson, CW (corresponding author), Florida State Univ, Coll Med, Program Neurosci, Coll Med Res Bldg,MSR 2350-E,1115 West Call St, Tallahassee, FL 32306 USA.	cathy.levenson@med.fsu.edu		Levenson, Cathy W/0000-0003-4463-3136; Vied, Cynthia/0000-0003-3941-3614			Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biervert C, 2001, NEUROSCI LETT, V315, P25, DOI 10.1016/S0304-3940(01)02312-6; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Delhomme N, 2012, BIOINFORMATICS, V28, P2532, DOI 10.1093/bioinformatics/bts477; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Lanza C, 2009, J NEUROCHEM, V110, P1674, DOI 10.1111/j.1471-4159.2009.06268.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Moreno-Flores MT, 1999, NEUROSCIENCE, V91, P193, DOI 10.1016/S0306-4522(98)00568-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muroski ME, 2014, J AM CHEM SOC, V136, P14763, DOI 10.1021/ja505190q; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; NAUTA AJ, 2008, LIBRARY, V110, P3499, DOI DOI 10.1182/BL00D-2007-02-069716; Nguyen TP, 2015, J LEUKOCYTE BIOL, V97, P1139, DOI 10.1189/jlb.4A0714-345RR; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Peterson TC, 2015, J NEUROTRAUM, V32, P765, DOI 10.1089/neu.2014.3530; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Urban ETR, 2012, MOL CELL BIOCHEM, V369, P267, DOI 10.1007/s11010-012-1390-z; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang XY, 2014, GENET MOL RES, V13, P9220, DOI 10.4238/2014.November.7.9; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	62	7	7	2	24	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					204	212		10.1089/neu.2015.4322			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100022	27161121				2022-02-06	
J	Donders, J; Darland, K				Donders, Jacobus; Darland, Kara			Psychometric properties and correlates of the PHQ-2 and PHQ-9 after traumatic brain injury	BRAIN INJURY			English	Article						Screening; classification; depression	MAJOR DEPRESSIVE DISORDER; PATIENT HEALTH QUESTIONNAIRE; SPINAL-CORD-INJURY; PRIMARY-CARE; RISK-FACTORS; VALIDITY; 2-ITEM; PREVALENCE; VALIDATION; DIAGNOSIS	Primary objective: To determine the predictive accuracy of the Patient Health Questionnaire (PHQ)-2 in predicting PHQ-9 findings and to examine demographic, historical, and injury correlates of PHQ-9 ratings.& para;& para;Research design: Retrospective analysis of data collected as part of routine clinical outpatient care over a period of 30 months on 168 persons with mild to severe traumatic brain injury, who were referred for neuropsychological evaluation within 1-12 months after injury.& para;& para;Main outcomes and results: PHQ-2 scores >= 2 had a sensitivity of 0.90 in predicting PHQ-9 scores >= 10, and a sensitivity of 0.95 in predicting endorsement of any passive or active suicidal thoughts on the PHQ-9. Premorbid history of having experienced personal abuse was the strongest predictor of post-injury PHQ-9 ratings.& para;& para;Conclusions: The PHQ-2 has adequate sensitivity in predicting PHQ-9 findings and can be used as a screener in clinical practice in persons with traumatic brain injury, as long as formal psychometric assessment is supplemented with a comprehensive review of premorbid history.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Darland, Kara] Calvin Coll, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Banos J, 2010, PRINCIPLES PRACTICE, P329; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boyle LL, 2011, INT J GERIATR PSYCH, V26, P952, DOI 10.1002/gps.2632; Carey M, 2016, AUST J PRIM HEALTH, V22, P262, DOI 10.1071/PY14149; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Corson K, 2004, AM J MANAG CARE, V10, P839; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; de Man-van Ginkel JM, 2012, STROKE, V43, P854, DOI 10.1161/STROKEAHA.111.640276; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Fuchs CH, 2015, FAM SYST HEALTH, V33, P18, DOI 10.1037/fsh0000089; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; Murphy KR, 2004, STAT POWER ANAL SIMP, P51; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Piepenburg SM, 2015, CIRC-HEART FAIL, V8, P464, DOI 10.1161/CIRCHEARTFAILURE.114.001488; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Sakakibara BM, 2009, SPINAL CORD, V47, P841, DOI 10.1038/sc.2009.93; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stucky KJ, 2014, NEUROPSYCHOLOGY STUD, P432; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Williams RT, 2016, ARCH PHYS MED REHAB, V97, P929, DOI 10.1016/j.apmr.2016.01.017	37	7	7	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1871	1875		10.1080/02699052.2017.1334962			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500020	28686062				2022-02-06	
J	Erdodi, LA; Lichtenstein, JD				Erdodi, Laszlo A.; Lichtenstein, Jonathan D.			Invalid before impaired: an emerging paradox of embedded validity indicators	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity assessment; embedded validity indicators; near-pass; soft fail; alpha and beta bias	VERBAL-LEARNING TEST; FORCED-CHOICE RECOGNITION; TRAUMATIC BRAIN-INJURY; COMPLEX IDEATIONAL MATERIAL; RELIABLE DIGIT SPAN; PERFORMANCE TEST-II; SYMPTOM VALIDITY; CLASSIFICATION ACCURACY; WAIS-IV; OFFICIAL POSITION	Objective: Embedded validity indicators (EVIs) are cost-effective psychometric tools to identify non-credible response sets during neuropsychological testing. As research on EVIs expands, assessors are faced with an emerging contradiction: the range of credible impairment disappears between the 'normal' and 'invalid' range of performance. We labeled this phenomenon as the invalid-before-impaired paradox. This study was designed to explore the origin of this psychometric anomaly, subject it to empirical investigation, and generate potential solutions. Method: Archival data were analyzed from a mixed clinical sample of 312 (M-Age = 45.2; M-Education = 13.6) patients medically referred for neuropsychological assessment. The distribution of scores on eight subtests of the third and fourth editions of Wechsler Adult Intelligence Scale (WAIS) were examined in relation to the standard normal curve and two performance validity tests (PVTs). Results: Although WAIS subtests varied in their sensitivity to non-credible responding, they were all significant predictors of performance validity. While subtests previously identified as EVIs (Digit Span, Coding, and Symbol Search) were comparably effective at differentiating credible and non-credible response sets, their classification accuracy was driven by their base rate of low scores, requiring different cutoffs to achieve comparable specificity. Conclusions: Invalid performance had a global effect on WAIS scores. Genuine impairment and non-credible performance can co-exist, are often intertwined, and may be psychometrically indistinguishable. A compromise between the alpha and beta bias on PVTs based on a balanced, objective evaluation of the evidence that requires concessions from both sides is needed to maintain/restore the credibility of performance validity assessment.	[Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Neuropsychol Track, Windsor, ON, Canada; [Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Serv, Lebanon, NH USA		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Neuropsychol Track, Windsor, ON, Canada.	lerdodi@gmail.com					An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2013, J CLIN EXP NEUROPSYC, V35, P413, DOI 10.1080/13803395.2013.781134; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; Erdodi L. A., 2016, ADV ONLINE PUBLICATI, DOI [10.1080/23279095.2016.1232262, DOI 10.1080/23279095.2016.1232262]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Erdodi LA, 2009, J PSYCHOEDUC ASSESS, V27, P374, DOI 10.1177/0734282909332913; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G. J., 2012, FORENSIC NEUROPSYCHO, P117; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Lichtenstein J. D., 2016, ADV ONLINE PUBLICATI, DOI [10.1080/09297049.2016.1259402, DOI 10.1080/09297049.2016.1259402]; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Michelsen H, 1996, OCCUP ENVIRON MED, V53, P478, DOI 10.1136/oem.53.7.478; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pearson, 2009, ADV CLIN SOLUTIONS W; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross TP, 2016, ARCH CLIN NEUROPSYCH, V31, P97, DOI 10.1093/arclin/acv062; RYAN JJ, 1983, J CONSULT CLIN PSYCH, V51, P149, DOI 10.1037/0022-006X.51.1.149; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Seke K., 2017, 45 ANN CONV INT NEUR; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; SLATE JR, 1990, J PSYCHOL, V124, P343, DOI 10.1080/00223980.1990.10543229; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wald NJ, 2014, J MED SCREEN, V21, P51, DOI 10.1177/0969141313517497; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	81	7	7	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	6-7			SI		1029	1046		10.1080/13854046.2017.1323119			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FF9DW	WOS:000409318000005	28552028				2022-02-06	
J	Farzaneh, E; Fattahzadeh-Ardalani, G; Abbasi, V; Kahnamouei-aghdam, F; Molaei, B; Iziy, E; Ojaghi, H				Farzaneh, Esmaeil; Fattahzadeh-Ardalani, Ghasem; Abbasi, Vahid; Kahnamouei-aghdam, Fariba; Molaei, Behnam; Iziy, Elham; Ojaghi, Habib			The Epidemiology of Hospital-Referred Head Injury in Ardabil City	EMERGENCY MEDICINE INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY	Background and Purpose. Trauma is the leading cause of death for youth in developing countries. Given the prevalence of head trauma (HT) in society and its complication and burden, the epidemiologic study of head trauma is necessary and is the main aim of this study. Materials and Methods. This retrospective population-based survey describes the epidemiology of head injury in a defined population in Ardabil city. It includes all 204 patients with head injury referred to the University Hospital of Ardabil, Iran, during 2013-2014. Data were collected by a checklist and analyzed by statistical methods in SPSS.19. Significance level P < 0.05 was considered. Results. Of all registered cases, 146 (71.6%) were male and the rest of them were female. Most of HT patients lived in Ardabil city (60.8%). The mean age of patients was 22.6 +/- 25.9 and most of victims were young. 24.5% of traumatic patients have injuries in severe to critical level (grade 3-4). The most cause of trauma was accidents (41.7%). Most of injuries occurred in night (55.9%) and in summer season (42.2%). Causes were traffic accident in 41.7%. Conclusion. Results showed that the leading cause of head trauma especially in the warm seasons is accidents and so, designing programs to reduce road accidents can dramatically reduce the rate of trauma in the future in Ardabil province.	[Farzaneh, Esmaeil; Fattahzadeh-Ardalani, Ghasem; Abbasi, Vahid; Kahnamouei-aghdam, Fariba; Molaei, Behnam; Ojaghi, Habib] Ardabil Univ Med Sci, Fac Med, Ardebil, Iran; [Iziy, Elham] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Fac Sci, Tehran, Iran; [Iziy, Elham] Sabzevar Univ Med Sci, Tradit & Complementary Med Res Ctr, Sabzevar, Iran		Fattahzadeh-Ardalani, G (corresponding author), Ardabil Univ Med Sci, Fac Med, Ardebil, Iran.	g.fattahzadeh2015@gmail.com	farzaneh, Esmaeil/R-9220-2017; abbasi, vahid/U-6916-2017; ojaghi, habib/N-2657-2017	farzaneh, Esmaeil/0000-0001-6825-171X; ojaghi, habib/0000-0002-8372-2185; fattahzadeh, ghasem/0000-0001-5101-876X; abbasi, vahid/0000-0003-4588-9432			Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; Beigzadeh A., 2015, J EMERGENCY PRACTICE, V1, P33, DOI DOI 10.15171/JEPT.2015.16; Centers for Disease Control and Prevention, 2006, TRAUMATIC BRAIN INJU; Dosios TJ, 2000, J TRAUMA, V49, P696, DOI 10.1097/00005373-200010000-00018; Dziadzko M. A., 2016, APPROACHING PSYCHOL, P4744; Ebrahimi FH, 2010, ARAK U MED SCI J, V12, P1; Ebrahimipour H., 2015, SAFETY PROMOTION INJ, V2, P155; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gururaj J., 2013, NEUROL RES, V24, P24; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Jeddi F. Rangraz, 2002, FEYZ, V6, P88; Kasmaei VM, 2015, EMERGENCY, V3, P141; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Masel B., 2014, UNDERSTANDING TRAUMA, P28; Mohammadfam E., 2000, SCI J FORENSIC MED, V20, P5; Mostafazadeh B, 2008, TURK NEUROSURG, V18, P228; Paun S., 1990, CHIRURGIA, V106, P439; Ratan Simmi K., 2002, Indian Journal of Pediatrics, V69, P573, DOI 10.1007/BF02722680; Salari A., 2002, J S SADOUGHI U MED S, V10, P19; Salimi J., 2008, PAYESH, V7, P115; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Yousef zade Chabok S, 2008, J GUILAN U MED SCI, V16, P112; Zargar M., 2002, HAKIM, V5, P77	29	7	7	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.		2017	2017								1439486	10.1155/2017/1439486			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EK4TV	WOS:000393920600001	28255457	Green Published, gold, Green Submitted			2022-02-06	
B	Goldman, SM; Musgrove, RE; Jewell, SA; Di Monte, DA		Aschner, M; Costa, LG		Goldman, Samuel M.; Musgrove, Ruth E.; Jewell, Sarah A.; Di Monte, Donato A.			Pesticides and Parkinson's Disease: Current Experimental and Epidemiological Evidence	ENVIRONMENTAL FACTORS IN NEURODEGENERATIVE DISEASES	Advances in Neurotoxicology		English	Article; Book Chapter							ENVIRONMENTAL RISK-FACTORS; TRAUMATIC BRAIN-INJURY; NIGROSTRIATAL DOPAMINE SYSTEM; AGE-RELATED NEURODEGENERATION; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; DEVELOPMENTAL EXPOSURE; HERBICIDE PARAQUAT; ORGANOCHLORINE INSECTICIDES; AGRICULTURAL HEALTH		[Goldman, Samuel M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goldman, Samuel M.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA USA; [Musgrove, Ruth E.; Jewell, Sarah A.; Di Monte, Donato A.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany		Di Monte, DA (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	donato.dimonte@dzne.de	Goldman, Samuel/A-2225-2014	Goldman, Samuel/0000-0002-3039-9927			Agency for Toxic Substances and Disease Registry, 2002, TOX PROF ALDR DIELDR; Agency for Toxic Substances and Disease Registry, 2010, TOX PROF TAX; Agency for Toxic Substances and Disease Registry, 1999, TOX PROF CHLOR; Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211; Anderson DW, 1998, MOVEMENT DISORD, V13, P626, DOI 10.1002/mds.870130403; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Baldereschi M, 2003, ACTA NEUROL SCAND, V108, P239, DOI 10.1034/j.1600-0404.2003.00128.x; Baldi I, 2003, NEUROEPIDEMIOLOGY, V22, P305, DOI 10.1159/000071194; Baldi I, 2003, AM J EPIDEMIOL, V157, P409, DOI 10.1093/aje/kwf216; BARBEAU A, 1987, CAN J NEUROL SCI, V14, P36; Benito-Leon J, 2004, NEUROLOGY, V62, P734, DOI 10.1212/01.WNL.0000113727.73153.68; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blair A, 2002, EPIDEMIOLOGY, V13, P94, DOI 10.1097/00001648-200201000-00015; Bonneh-Barkay D, 2005, ANTIOXID REDOX SIGN, V7, P649, DOI 10.1089/ars.2005.7.649; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; Bourque M, 2012, FRONT NEUROENDOCRIN, V33, P169, DOI 10.1016/j.yfrne.2012.02.003; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brouwer M, 2015, OCCUP ENVIRON MED, V72, P448, DOI 10.1136/oemed-2014-102209; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Bureau of Labor Statistics, 2003, OCC EMPL WAG; Cabras P, 2002, J AGR FOOD CHEM, V50, P2576, DOI 10.1021/jf011430r; Casarejos MJ, 2006, J NEUROCHEM, V97, P934, DOI 10.1111/j.1471-4159.2006.03777.x; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Corrigan FM, 1998, EXP NEUROL, V150, P339, DOI 10.1006/exnr.1998.6776; Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907; Cory-Slechta DA, 2005, ENVIRON HEALTH PERSP, V113, P1263, DOI 10.1289/ehp.7570; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Cristovao AC, 2012, J NEUROSCI, V32, P14465, DOI 10.1523/JNEUROSCI.2246-12.2012; Deng YF, 2004, ANN NEUROL, V55, P897, DOI 10.1002/ana.20143; Desplats P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-49; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Di Monte DA, 2003, LANCET NEUROL, V2, P531; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Dick S, 2007, OCCUP MED-OXFORD, V57, P50, DOI 10.1093/occmed/kql109; DIMONTE D, 1986, BIOCHEM BIOPH RES CO, V137, P303, DOI 10.1016/0006-291X(86)91210-6; Dutheil F, 2010, ARCH NEUROL-CHICAGO, V67, P739, DOI 10.1001/archneurol.2010.101; Elbaz A, 2004, ANN NEUROL, V55, P430, DOI 10.1002/ana.20051; Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Fitzmaurice AG, 2014, NEUROLOGY, V82, P419, DOI 10.1212/WNL.0000000000000083; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; FLEMING L, 1994, ANN NEUROL, V36, P100, DOI 10.1002/ana.410360119; Fong CS, 2007, CLIN CHIM ACTA, V378, P136, DOI 10.1016/j.cca.2006.11.006; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Furlong M, 2015, ENVIRON INT, V75, P144, DOI 10.1016/j.envint.2014.11.002; Gatto NM, 2009, ENVIRON HEALTH PERSP, V117, P1912, DOI 10.1289/ehp.0900852; Goers J, 2003, BIOCHEMISTRY-US, V42, P8465, DOI 10.1021/bi0341152; Goldman SM, 2016, MOVEMENT DISORD, V31, pS148; Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216; Goldman SM, 2005, NEUROLOGY, V65, P1430, DOI 10.1212/01.wnl.0000180361.74060.70; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; Hatcher JM, 2007, EXP NEUROL, V204, P619, DOI 10.1016/j.expneurol.2006.12.020; Helwig M, 2016, BRAIN, V139, P856, DOI 10.1093/brain/awv376; HERTZMAN C, 1994, MOVEMENT DISORD, V9, P69, DOI 10.1002/mds.870090111; HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Institute of Medicine, 2016, VET AG OR UPD 2014; Isenring R, 2017, ADVERSE HLTH EFFECTS; Kachroo A, 2014, BRAIN RES, V1563, P103, DOI 10.1016/j.brainres.2014.03.031; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Li XJ, 2009, INT ARCH OCC ENV HEA, V82, P235, DOI 10.1007/s00420-008-0327-z; Liew Z, 2014, ARCH ENVIRON OCCUP H, V69, P241, DOI 10.1080/19338244.2013.778808; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Manthripragada AD, 2010, EPIDEMIOLOGY, V21, P87, DOI 10.1097/EDE.0b013e3181c15ec6; MARTTILA RJ, 1976, ACTA NEUROL SCAND, V53, P81; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McCormack AL, 2008, J NEUROPATH EXP NEUR, V67, P793, DOI 10.1097/NEN.0b013e318180f0bd; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Moisan F, 2015, ENVIRON HEALTH PERSP, V123, P1123, DOI 10.1289/ehp.1307970; MUTCH WJ, 1986, BRIT MED J, V292, P534, DOI 10.1136/bmj.292.6519.534; Muthukumaran K, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-21; Narayan S, 2015, ENVIRON RES, V143, P98, DOI 10.1016/j.envres.2015.08.022; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178; Peng J, 2007, J NEUROSCI, V27, P6914, DOI 10.1523/JNEUROSCI.1569-07.2007; Peng J, 2010, J NEUROCHEM, V115, P1363, DOI 10.1111/j.1471-4159.2010.07036.x; Petrovitch H, 2002, ARCH NEUROL-CHICAGO, V59, P1787, DOI 10.1001/archneur.59.11.1787; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prasad K, 2007, ENVIRON HEALTH PERSP, V115, P1448, DOI 10.1289/ehp.9932; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Purisai MG, 2007, NEUROBIOL DIS, V25, P392, DOI 10.1016/j.nbd.2006.10.008; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Richardson JR, 2008, NEUROTOXICOLOGY, V29, P855, DOI 10.1016/j.neuro.2008.05.007; Richardson JR, 2006, FASEB J, V20, P1695, DOI 10.1096/fj.06-5864fje; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Richardson JR, 2011, NEUROTOXICOLOGY, V32, P640, DOI 10.1016/j.neuro.2011.04.002; Ross GW, 2012, MOVEMENT DISORD, V27, P1418, DOI 10.1002/mds.25144; Ross GW, 2006, MOVEMENT DISORD, V21, pS2; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275; SEMCHUK KM, 1992, NEUROLOGY, V42, P1328, DOI 10.1212/WNL.42.7.1328; SEMCHUK KM, 1993, NEUROLOGY, V43, P1173, DOI 10.1212/WNL.43.6.1173; Slotkin TA, 2011, BRAIN RES BULL, V86, P340, DOI 10.1016/j.brainresbull.2011.09.017; Smeyne RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164094; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; SVENSON LW, 1993, CAN J NEUROL SCI, V20, P307; Svensson E, 2015, ANN NEUROL, V78, P522, DOI 10.1002/ana.24448; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Taylor KSM, 2006, MOVEMENT DISORD, V21, P976, DOI 10.1002/mds.20866; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Tuchsen F, 2000, SCAND J WORK ENV HEA, V26, P359; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Ulusoy A, 2013, EMBO MOL MED, V5, P1119, DOI 10.1002/emmm.201302475; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; van der Mark M, 2014, OCCUP ENVIRON MED, V71, P757, DOI 10.1136/oemed-2014-102170; van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Wan N, 2016, J RURAL HEALTH, V32, P303, DOI 10.1111/jrh.12154; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93; Wilk JB, 2006, NEUROLOGY, V67, P2206, DOI 10.1212/01.wnl.0000249149.22407.d1; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Wilson WW, 2014, NEUROTOXICOLOGY, V44, P279, DOI 10.1016/j.neuro.2014.07.008; Zharikov AD, 2015, J CLIN INVEST, V125, P2721, DOI 10.1172/JCI64502; Zorzon M, 2002, ACTA NEUROL SCAND, V105, P77, DOI 10.1034/j.1600-0404.2002.1o040.x; Zschiedrich K, 2009, J NEUROL, V256, P115, DOI 10.1007/s00415-009-0089-x	139	7	7	0	4	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-812765-0; 978-0-12-812764-3	ADV NEUROTOXICOL			2017							83	117		10.1016/bs.ant.2017.07.004			35	Neurosciences; Toxicology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Toxicology	BJ4EZ	WOS:000424949900004					2022-02-06	
J	Guo, AH; Hao, FL; Liu, LF; Wang, BJ; Jiang, XF				Guo, A. H.; Hao, F. L.; Liu, L. F.; Wang, B. J.; Jiang, X. F.			An assessment of the correlation between early postinfarction pyramidal tract Wallerian degeneration and nerve function recovery using diffusion tensor imaging	GENETICS AND MOLECULAR RESEARCH			English	Article						Cerebral infarction; Pyramidal tract; Neurological recovery; Diffusion tensor imaging	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; STROKE; DTI; TRACTOGRAPHY; SPECTROSCOPY; DISEASE	This study aimed to evaluate the clinical significance of diffusion tensor imaging (DTI) in the early diagnosis of pyramidal tract Wallerian degeneration (WD) and assessment of neurological recovery following cerebral infarction. This study included 23 patients with acute cerebral infarction and 10 healthy adult controls. All participants underwent both magnetic resonance imaging (MRI) and DTI scans. DTI images were analyzed using the Functional MRI of the Brain Software Library to determine the regions of interest (ROI) and obtain the mean diffusivity (MD) and fractional anisotropy (FA) value for each ROI. The correlation between FA or MD and postinfarction functionalrecovery of the nervous system was further analyzed to assess the feasibility of using a DTI scan in the evaluation of functional recovery of the nervous system in patients with cerebral infarction. DTI may be useful in detecting signals of early postinfarction pyramidal tract WD and is useful for the evaluation of postinfarction neurological recovery. Cerebral lesions were detected using MRI in all patients. It was found that in some patients, the FA value of the ipsilateral pyramidal tract on DTI was decreased as early as day 3 after the onset of infarction and in all patients by day 7. Subsequent correlation studies showed that the FA value of the ipsilateral pyramidal tract on day 13 was negatively correlated with the National Institutes of Health Stroke Scale score, but positively correlated with the Barthel Index, motricity index, and modified Rankin Scale scores.	[Guo, A. H.; Hao, F. L.; Wang, B. J.] Yanan Univ, Xianyang Hosp, Dept Neurol, Xianyang, Peoples R China; [Liu, L. F.; Jiang, X. F.] Yanan Univ, Xianyang Hosp, Dept Med Imaging, Xianyang, Peoples R China		Liu, LF (corresponding author), Yanan Univ, Xianyang Hosp, Dept Med Imaging, Xianyang, Peoples R China.	liulianfenghgf@126.com					Carota A, 2012, ACTA NEUROL BELG, V112, P115, DOI 10.1007/s13760-012-0033-1; Chen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082697; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Fan QY, 2014, BRAIN CONNECT, V4, P718, DOI 10.1089/brain.2014.0305; Fayazi Maryam, 2012, Med J Islam Repub Iran, V26, P27; Freeman MR, 2014, CURR OPIN NEUROBIOL, V27, P224, DOI 10.1016/j.conb.2014.05.001; George E, 2014, CHILD NERV SYST, V30, P1135, DOI 10.1007/s00381-013-2351-x; Hageman NS, 2009, IEEE T MED IMAGING, V28, P348, DOI 10.1109/TMI.2008.2004403; Hsu M, 2015, MUSCLE NERVE, V51, P268, DOI 10.1002/mus.24306; Huang LA, 2014, GENET MOL RES, V13, P2683, DOI 10.4238/2014.April.8.11; Jeyaseelan RD, 2015, PM&R, V7, P593, DOI 10.1016/j.pmrj.2014.12.007; Jones KC, 2013, DEV MED CHILD NEUROL, V55, P173, DOI 10.1111/dmcn.12010; Knorr Z, 2013, J NEURORADIOLOGY, V40, P68, DOI 10.1016/j.neurad.2011.12.002; Liu X, 2012, J NEUROIMAGING, V22, P255, DOI 10.1111/j.1552-6569.2011.00617.x; Maeshima S, 2013, NEUROL SCI, V34, P1765, DOI 10.1007/s10072-013-1330-z; Mascalchi M, 2015, AM J NEURORADIOL, V36, P1096, DOI 10.3174/ajnr.A4343; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; McArthur K, 2013, INT J STROKE, V8, P403, DOI 10.1111/j.1747-4949.2011.00759.x; Miyai I, 2001, J Stroke Cerebrovasc Dis, V10, P210, DOI 10.1053/jscd.2001.30731; Pires P, 2015, AM J NEURORADIOL, V36, P1043, DOI 10.3174/ajnr.A4322; Pujol S, 2015, J NEUROIMAGING, V25, P875, DOI 10.1111/jon.12283; Samartzis L, 2014, J NEUROIMAGING, V24, P101, DOI 10.1111/j.1552-6569.2012.00779.x; Taraschenko OD, 2015, PEDIATR NEUROL, V52, P252, DOI 10.1016/j.pediatrneurol.2014.10.025; Walker L, 2016, NEUROIMAGE, V124, P1125, DOI 10.1016/j.neuroimage.2015.05.083; Waller, 1850, PHILOS T R SOC LOND, VI, P423, DOI [10.1098/rspl.1843.0224, DOI 10.1098/RSTL.1850.0021]; Yeo SS, 2013, NEURAL REGEN RES, V8, P90, DOI 10.3969/j.issn.1673-5374.2013.01.012	26	7	7	0	1	FUNPEC-EDITORA	RIBEIRAO PRETO	RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL	1676-5680			GENET MOL RES	Genet. Mol. Res.		2017	16	1							16019035	10.4238/gmr16019035			9	Biochemistry & Molecular Biology; Genetics & Heredity	Emerging Sources Citation Index (ESCI)	Biochemistry & Molecular Biology; Genetics & Heredity	EO1KA	WOS:000396456100006	28128402	Bronze			2022-02-06	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Aggravation of excessive daytime sleepiness concurrent with aggravation of an injured ascending reticular activating system in a patient with mild traumatic brain injury A case report	MEDICINE			English	Article						ascending reticular activating system; diffusion tensor tractography; hypersomnia; mild traumatic brain injury		Background: We report on a patient who developed aggravation of excessive daytime sleepiness (EDS) concurrent with aggravation of an injured ascending reticular activating system (ARAS) following mild traumatic brain injury (TBI), demonstrated by follow-up diffusion tensor tractographies (DTTs). Methods: A 42-year-old male patient experienced head trauma resulting from flexion-hyperextension injury after collision with another vehicle from behind while stopped at an intersection. The patient lost consciousness for approximately 10seconds and experienced no post-traumatic amnesia following the accident. The patient's Glasgow Coma Scale score was 15. No specific lesion was observed on the conventional brain MRI performed at 10 weeks after onset. The patient complained of EDS after the head trauma and aggravation of EDS with passage of time. The Epworth Sleepiness Scale indicated abnormality with a score of 12 at 10 weeks after onset (cut-off: 10 points full mark: 24 score) and it was aggravated with a score of 18 at 16 months. Results: On 10-week DTT, decreased neural connectivity of the intralaminar thalamic nucleus to the prefrontal cortex and basal forebrain was observed in both hemispheres. However, no significant abnormality was observed in the dorsal and ventral lower ARAS. On 16-month DTT, the upper portion of the left dorsal lower ARAS showed partial tearing and the ventral lower ARAS showed thinning (both sides) and partial tearing (right side). Conclusions: Aggravation of EDS concurrent with aggravation of an injured ARAS was demonstrated in a patient with mild TBI using DTT.	[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1,Daemyungdong, Daegu 705717, South Korea		Kwon, HG (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1,Daemyungdong, Daegu 705717, South Korea.	khg0715@hanmail.net			National Research Foundation of Korea(NRF) grant - Korea government(MSIP) [NRF-2015R1A2A2A01004073]	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (NRF-2015R1A2A2A01004073).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002628; Jang SH, 2016, SLEEP MED, V17, P124, DOI 10.1016/j.sleep.2015.09.020; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002484; Jang SH, 2016, INT J STROKE, V11, pNP5, DOI 10.1177/1747493015607502; Jang SH, 2015, NEUROSCI LETT, V590, P58, DOI 10.1016/j.neulet.2015.01.071; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416	14	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2017	96	4							e5958	10.1097/MD.0000000000005958			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EK1WT	WOS:000393717200033	28121943	Green Published, gold			2022-02-06	
J	Karimi, A; Rahmati, SM; Razaghi, R				Karimi, Alireza; Rahmati, Seyed Mohammadali; Razaghi, Reza			A combination of experimental measurement, constitutive damage model, and diffusion tensor imaging to characterize the mechanical properties of the human brain	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Brain; mechanical properties; constitutive damage model; diffusion tensor imaging; axon fibers	BASILAR ARTERY; TISSUE; BEHAVIOR; SEGMENTATION; BIOMECHANICS; COMPRESSION; FALLS; WALL	Understanding the mechanical properties of the human brain is deemed important as it may subject to various types of complex loadings during the Traumatic Brain Injury (TBI). Although many studies so far have been conducted to quantify the mechanical properties of the brain, there is a paucity of knowledge on the mechanical properties of the human brain tissue and the damage of its axon fibers under the various types of complex loadings during the Traumatic Brain Injury (TBI). Although many studies so far have been conducted to quantify the mechanical properties of the brain, there is a paucity of knowledge on the mechanical properties of the human brain tissue and the damage of its axon fibers under the frontal lobe of the human brain. The constrained nonlinear minimization method was employed to identify the brain coefficients according to the axial and transversal compressive data. The pseudo-elastic damage model data was also well compared with that of the experimental data and it not only up to the primary loading but also the discontinuous softening could well address the mechanical behavior of the brain tissue.	[Karimi, Alireza] Kyushu Univ, Dept Mech Engn, Fukuoka, Japan; [Rahmati, Seyed Mohammadali] Amirkabir Univ Technol, Fac Biomed Engn, Biomech Grp, Tehran, Iran; [Razaghi, Reza] Basir Eye Hlth Res Ctr, Tehran, Iran		Karimi, A (corresponding author), Kyushu Univ, Dept Mech Engn, Fukuoka, Japan.	karimi@kyudai.jp	Razaghi, Reza/S-7173-2019	Razaghi, Reza/0000-0002-9563-7535			Alves RS, 2015, COMPUTATIONAL EXPT B, P173, DOI DOI 10.1007/978-3-319-15799-3_13; ASPDEN RM, 1987, J ANAT, V155, P141; Baek S, 2007, COMPUT METHOD APPL M, V196, P3070, DOI 10.1016/j.cma.2006.06.018; Balakrishnan A., 2007, DEV NOVEL DYNAMIC IN; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Canham PB, 1997, CARDIOVASC RES, V34, P557, DOI 10.1016/S0008-6363(97)00056-4; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020; ESTES MS, 1970, MECH ENG, V92, P58; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Ferruzzi J, 2011, J R SOC INTERFACE, V8, P435, DOI 10.1098/rsif.2010.0299; Fung Y. C., 1972, BIOMECHANICS ITS FDN, P181; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Ghazanfari S, 2012, BIOCHEM BIOPH RES CO, V426, P54, DOI 10.1016/j.bbrc.2012.08.031; Ghazanfari S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127847; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Holzapfel GA, 1998, COMPUT BIOL MED, V28, P377, DOI 10.1016/S0010-4825(98)00022-5; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Hu JJ, 2007, ANN BIOMED ENG, V35, P19, DOI 10.1007/s10439-006-9186-5; Jarrahi A, 2016, MATER TECHNOL, V31, P247, DOI 10.1179/1753555715Y.0000000049; Jodas DS, 2016, EXPERT SYST APPL, V46, P1, DOI 10.1016/j.eswa.2015.10.016; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Karimi A, 2017, ARTIF ORGANS, V41, pE103, DOI 10.1111/aor.12855; Karimi A, 2017, J CHEM NEUROANAT, V86, P15, DOI 10.1016/j.jchemneu.2017.07.004; Karimi A, 2015, BIOMED ENG-APP BAS C, V27, DOI 10.4015/S1016237215500398; Karimi A, 2015, TISSUE CELL, V47, P152, DOI 10.1016/j.tice.2015.01.004; Karimi A, 2014, J MATER SCI-MATER M, V25, P1623, DOI 10.1007/s10856-014-5198-0; Karimi A, 2013, P I MECH ENG H, V227, P609, DOI 10.1177/0954411913476779; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LANIR Y, 1979, J BIOMECH, V12, P423, DOI 10.1016/0021-9290(79)90027-7; Lee WH, 2012, INT J RADIAT ONCOL, V82, P1559, DOI 10.1016/j.ijrobp.2010.12.032; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Ma Z, 2010, COMPUT METHOD BIOMEC, V13, P235, DOI 10.1080/10255840903131878; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Oliveira RB, 2016, COMPUT METH PROG BIO, V131, P127, DOI 10.1016/j.cmpb.2016.03.032; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pierce DM, 2015, J MECH BEHAV BIOMED, V41, P92, DOI 10.1016/j.jmbbm.2014.10.003; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; SCHEFFE H, 1953, BIOMETRIKA, V40, P87, DOI 10.1093/biomet/40.1-2.87; Seppanen A, 2007, BRAIN RES, V1158, P50, DOI 10.1016/j.brainres.2007.04.073; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tavares JMRS, 2014, LECT NOTES COMPUT SC, V8887, P21, DOI 10.1007/978-3-319-14249-4_3; Tower TT, 2001, BIOPHYS J, V81, P2964, DOI 10.1016/S0006-3495(01)75936-X; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; Wicker BK, 2008, COMPUT METHOD BIOMEC, V11, P539, DOI 10.1080/10255840801949793; Zeinali-Davarani S, 2009, J BIOMECH, V42, P524, DOI 10.1016/j.jbiomech.2008.11.022	58	7	7	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2017	20	12					1350	1363		10.1080/10255842.2017.1362694			14	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	FH0GM	WOS:000410817600008	28812366				2022-02-06	
J	Khokhar, B; Simoni-Wastila, L; Albrecht, JS				Khokhar, Bilal; Simoni-Wastila, Linda; Albrecht, Jennifer S.			Risk of Stroke Among Older Medicare Antidepressant Users With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Medicare; older adults; SSRI; stroke; traumatic brain injury	SEROTONIN REUPTAKE INHIBITORS; UNITED-STATES; ADULTS; DEPRESSION; EPIDEMIOLOGY; ASSOCIATION; OUTCOMES; DISEASE; SURVEILLANCE; POPULATION	Objective: To estimate the risk of stroke associated with new antidepressant use among older adults with traumatic brain injury (TBI). Participants: A total of 64 214 Medicare beneficiaries aged 65 years or older meeting inclusion criteria and hospitalized with a TBI during 2006 to 2010. Design: New user design. Generalized estimating equations were used to estimate the relative risks (RRs) of stroke. Main Measures: Primary exposure was new antidepressant use following TBI identified through Medicare part D claims. The primary outcome was stroke following TBI. Ischemic and hemorrhagic strokes were secondary outcomes. Results: A total of 20 859 (32%) beneficiaries used an antidepressant at least once following TBI. Selective serotonin reuptake inhibitors accounted for the majority of antidepressant use. Selective serotonin reuptake inhibitor use was associated with an increased risk of hemorrhagic stroke (RR, 1.26; 95% confidence interval [CI], 1.06-1.50) but not ischemic stroke (RR, 1.04; 95% CI, 0.94-1.15). The selective serotonin reuptake inhibitors escitalopram (RR, 1.33; 95% CI, 1.02-1.74) and sertraline (RR, 1.46; 95% CI, 1.10-1.94) were associated with an increase in the risk of hemorrhagic stroke. Conclusion: Findings from this study will aid prescribers in choosing appropriate antidepressants to treat depression in older adults with TBI.	[Khokhar, Bilal; Simoni-Wastila, Linda] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, 220 Arch St,12th Floor, Baltimore, MD 21201 USA; [Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA		Khokhar, B (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, 220 Arch St,12th Floor, Baltimore, MD 21201 USA.	bkhokh1@umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG000262-14, K12HD43489-13]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000262] Funding Source: NIH RePORTER	Mr Khokhar was supported by National Institutes of Health grant T32AG000262-14 (Magaziner, PI). Dr Albrecht was supported by National Institutes of Health grant K12HD43489-13. (Tracey, PI).	Albrecht JS, 2015, J NEUROTRAUM, V32, P1223, DOI 10.1089/neu.2014.3651; Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Allison PaulD., 1982, SOCIOLOGICAL METHODO, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Bak S, 2002, STROKE, V33, P1465, DOI 10.1161/01.STR.0000018589.56991.BA; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Medicare and Medicaid Services Chronic Conditions Warehouse, COND CAT; Centers for Medicare & Medicaid Services Chronic Condition Data Warehouse, 2014, MED ADM DAT US GUID; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; de Abajo FJ, 2011, DRUG AGING, V28, P345, DOI 10.2165/11589340-000000000-00000; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Gartlehner G, DRUG CLASS REV 2 GEN; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; Henderson KM, 2013, STROKE, V44, P367, DOI 10.1161/STROKEAHA.112.679159; Hung CC, 2013, AM J GERIAT PSYCHIAT, V21, P811, DOI 10.1016/j.jagp.2013.01.018; Kharofa J, 2007, STROKE, V38, P3049, DOI 10.1161/STROKEAHA.107.491472; Marr A., 2004, CENTRAL NERVOUS SYST; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sauer WH, 2003, CIRCULATION, V108, P32, DOI 10.1161/01.CIR.0000079172.43229.CD; Sayal K, 2000, ACTA PSYCHIAT SCAND, V102, P250, DOI 10.1034/j.1600-0447.2000.102004250.x; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Teles JS, 2012, EINSTEIN-SAO PAULO, V10, P110, DOI 10.1590/S1679-45082012000100024; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Trifiro G, 2010, J CLIN PSYCHOPHARM, V30, P252, DOI 10.1097/JCP.0b013e3181dca10a; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Zagaria MAE, 2013, US PHARM, V38, P20; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	41	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					E42	E49		10.1097/HTR.0000000000000231			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400012	27022963	Green Accepted			2022-02-06	
J	Kudo, D; Kushimoto, S; Shiraishi, A; Ogura, H; Hagiwara, A; Saitoh, D				Kudo, Daisuke; Kushimoto, Shigeki; Shiraishi, Atsushi; Ogura, Hiroshi; Hagiwara, Akiyoshi; Saitoh, Daizoh			The impact of preinjury antithrombotic medication on hemostatic interventions in trauma patients	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	29th Annual Meeting of the Japanese-Association-for-the-Surgery-of-Trauma	JUN 11-12, 2015	Sapporo, JAPAN	Japanese Assoc Surg Trauma			BRAIN-INJURY PATIENTS; PROTHROMBIN COMPLEX CONCENTRATE; RED-BLOOD-CELL; MORTALITY; PLASMA; ANTICOAGULATION; COMPLICATIONS; ANTIPLATELET; TRANSFUSION; PLATELET	Purpose: The purpose of this study was to determine whether preinjury medication with antithrombotic agents was related to an increase in hemostatic interventions in patients with severe trauma without traumatic brain injury. Methods: Consecutive trauma patients who were admitted to the emergency departments of the study hospitals with an injury severity score >= 16 were enrolled in this retrospective, observational, multicenter study of coagulation in the acute phase of severe trauma. Patients without a traumatic brain injury with an abbreviated injury scale >= 3 were evaluated. Patients were divided into those with and those without preinjury medication with antithrombotic agents. The impact of preinjury antithrombotic medication on the composite primary outcome, defined as administration of fresh frozen plasma >= 10 U and/or hemostatic treatment (surgery and/or interventional radiology) within 24 hours, was analyzed. Results: The preinjury medication group consisted of 20 (6.4%) of the total 312 patients. Preinjury medication was one of the independent risk factors for the composite outcome (odds ratio, 3.16; 95% confidence interval, 1.089.10; P <.05) adjusting for age, sex, and injury severity score on multivariate analysis. Preinjury antithrombotic therapy was also associated with hemostatic treatments within 24 hours (odds ratio, 3.40; 95% confidence interval, 1.16-9.85; P =.026). Survival time was not different between the 2 groups on Cox regression analysis. Conclusions: Preinjury antithrombotic medication in severe trauma patients without traumatic brain injury may be associated with a higher risk of hemostatic interventions. (C) 2016 Elsevier Inc. All rights reserved.	[Kudo, Daisuke; Kushimoto, Shigeki] Tohoku Univ, Sch Med, Div Emergency & Crit Care Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9800871, Japan; [Shiraishi, Atsushi] Tokyo Med & Dent Univ Hosp Med, Trauma & Acute Crit Care Med Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1130034, Japan; [Shiraishi, Atsushi] Kameda Med Ctr, Emergency Dept, 929 Higashimachi, Kamogawa 2968602, Japan; [Ogura, Hiroshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan; [Hagiwara, Akiyoshi] Natl Ctr Global Hlth & Med, Dept Emergency Med & Crit Care, 21-1 Toyama, Tokyo 1620052, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Div Traumatol Res Inst, 3-2 Namiki, Tokorozawa, Saitama 3590042, Japan		Kudo, D (corresponding author), Tohoku Univ, Sch Med, Div Emergency & Crit Care Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9800871, Japan.	kudodaisuke@med.tohoku.ac.jp; kussie@emergency-medicine.med.tohoku.ac.jp; siris.accm@tmd.ac.jp; ogura@hp-emerg.med.osaka-u.ac.jp; kudodaisuke@med.tohoku.ac.jp; ds0711@ndmc.ac.jp	Kudo, Daisuke/AAE-4019-2020	Kudo, Daisuke/0000-0001-8213-5176; Shiraishi, Atsushi/0000-0002-9192-625X	Japan Society for the Promotion of Science KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462810]; General Insurance Association of Japan	The current study has been supported, in part, by the Japan Society for the Promotion of Science KAKENHI (grant 25462810) and the General Insurance Association of Japan.	Abraham Neena S, 2015, Gastrointest Endosc Clin N Am, V25, P449, DOI 10.1016/j.giec.2015.02.002; Ahmed S, 2008, JAMA-J AM MED ASSOC, V300, P1784, DOI 10.1001/jama.300.15.1784; Barnes GD, 2015, VASC MED, V20, P143, DOI 10.1177/1358863X14566429; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brilakis ES, 2013, JAMA-J AM MED ASSOC, V310, P189, DOI 10.1001/jama.2013.7086; Cotton BA, 2011, NEW ENGL J MED, V365, P2039, DOI 10.1056/NEJMc1111095; Eikelboom JW, 2012, NEW ENGL J MED, V366, P863, DOI 10.1056/NEJMc1114806; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Gershon AS, 2014, JAMA-J AM MED ASSOC, V312, P1114, DOI 10.1001/jama.2014.11432; Goldstein JN, 2015, LANCET, V385, P2077, DOI 10.1016/S0140-6736(14)61685-8; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P417, DOI 10.1097/TA.0000000000000372; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2014, J SURG RES, V186, P287, DOI 10.1016/j.jss.2013.08.009; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; *MIN ED C SPORTS S, 2015, ETH GUID MED HLTH RE; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193	25	7	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2017	35	1					62	65		10.1016/j.ajem.2016.10.002			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	EP5KE	WOS:000397416600012	27745921				2022-02-06	
J	LaMotte, AD; Taft, CT; Weatherill, RP; Casement, MD; Creech, SK; Milberg, WP; Fortier, CB; McGlinchey, RE				LaMotte, Adam D.; Taft, Casey T.; Weatherill, Robin P.; Casement, Melynda D.; Creech, Suzannah K.; Milberg, William P.; Fortier, Catherine B.; McGlinchey, Regina E.			Sleep Problems and Physical Pain as Moderators of the Relationship Between PTSD Symptoms and Aggression in Returning Veterans	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						posttraumatic stress disorder; violence; sleep; pain; veteran		Objective: This study investigated sleep problems and physical pain as moderators of the relationship between PTSD symptoms and aggression among returning veterans. Prior research has demonstrated associations between PTSD symptoms and aggression, but little work has sought to identify moderators of this relationship. Sleep problems and physical pain are both common clinical problems among veterans and have theoretical links to aggression. Method: Participants were 103 returning service members and veterans recruited from the greater Boston area and enrolled in the VA Translational Research Center for Traumatic Brain Injury (TBI) and Stress Disorders (TRACTS). Aggression outcomes included physical and psychological intimate partner aggression (IPA), as well as physical and psychological general aggression (GA). Variables were measured via self-report questionnaires, with the exception of PTSD symptoms, which were assessed via clinician interview. Results: Bivariate correlations revealed significant associations between PTSD symptoms, sleep problems, physical pain, and aggression outcomes. Both sleep problems and physical pain significantly moderated the relationship between PTSD symptoms and physical GA, such that this relationship became stronger at higher levels of these moderator variables. However, moderation was not found for the other aggression outcomes. Conclusions: Findings suggest that sleep problems and physical pain strengthen the relationship between veterans' PTSD symptoms and physical aggression toward others. Although further replication and elucidation is needed, these factors may disinhibit aggression among those at higher risk due to their PTSD symptoms.	[LaMotte, Adam D.; Taft, Casey T.; Weatherill, Robin P.] VA Boston Healthcare Syst, Natl Ctr PTSD, 116B 4,150 South Huntington Ave, Boston, MA 02130 USA; [Taft, Casey T.; Weatherill, Robin P.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Casement, Melynda D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Creech, Suzannah K.] Cent Texas Vet Healthcare Syst, VHA VISN Ctr Excellence Res Returning War Vet 17, Waco, TX USA; [Creech, Suzannah K.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat, Providence, RI 02912 USA; [Milberg, William P.; Fortier, Catherine B.; McGlinchey, Regina E.] Harvard Med Sch, Translat Res Ctr Traumat Brain Injury & Stress Di, Natl Network Res Ctr, Boston, MA USA; [Milberg, William P.; Fortier, Catherine B.; McGlinchey, Regina E.] Harvard Med Sch, GRECC, Boston, MA USA; [Milberg, William P.; Fortier, Catherine B.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Taft, CT (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, 116B 4,150 South Huntington Ave, Boston, MA 02130 USA.	casey.taft@va.gov	Casement, Melynda/AAT-2870-2020; Fortier, Catherine/AAS-2163-2021	Casement, Melynda/0000-0002-5906-0994; Fortier, Catherine/0000-0002-8953-9904; Creech, Suzannah/0000-0002-6582-1673	TRACTS, a VA Rehabilitation Research and Development Service Traumatic Brain Injury National Network Research Center [B9254-C]	This research was supported by TRACTS, a VA Rehabilitation Research and Development Service Traumatic Brain Injury National Network Research Center (B9254-C). The contents of this article do not represent the views of the United States Department of Veterans Affairs or the United States Government.	Anderson C, 2011, BEHAV BRAIN RES, V217, P463, DOI 10.1016/j.bbr.2010.09.020; Berryman C, 2014, CLIN PSYCHOL REV, V34, P563, DOI 10.1016/j.cpr.2014.08.003; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bruns D, 2000, PAIN MED, V1, P131, DOI 10.1046/j.1526-4637.2000.00017.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Elbogen EB, 2014, PSYCHOL SERV, V11, P220, DOI 10.1037/a0035088; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Holtzworth-Munroe A, 2000, J CONSULT CLIN PSYCH, V68, P1000, DOI 10.1037/0022-006X.68.6.1000; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Nes LS, 2009, ANN BEHAV MED, V37, P173, DOI 10.1007/s12160-009-9096-5; Ohayon MM, 2005, J PSYCHIAT RES, V39, P151, DOI 10.1016/j.jpsychires.2004.07.001; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Taft CT, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P195, DOI 10.1007/978-1-4419-7064-0_10; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	16	7	7	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	JAN	2017	9	1					113	116		10.1037/tra0000178			4	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	EK1HL	WOS:000393676300016	27732020				2022-02-06	
J	Lamprecht, MR; Elkin, BS; Kesavabhotla, K; Crary, JF; Hammers, JL; Huh, JW; Raghupathi, R; Morrison, B				Lamprecht, Michael R.; Elkin, Benjamin S.; Kesavabhotla, Kartik; Crary, John F.; Hammers, Jennifer L.; Huh, Jimmy W.; Raghupathi, Ramesh; Morrison, Barclay, III			Strong Correlation of Genome-Wide Expression after Traumatic Brain Injury In Vitro and In Vivo Implicates a Role for SORLA	JOURNAL OF NEUROTRAUMA			English	Article						genomics; in vitro studies; in vivo studies; traumatic brain injury	DIFFERENTIAL GENE-EXPRESSION; CLOSED-HEAD INJURY; AXONAL INJURY; AMYLOID-BETA; CELL-DEATH; MICROARRAY ANALYSIS; ORGANOTYPIC CULTURES; ALZHEIMERS-DISEASE; IMMATURE RAT; C-JUN	The utility of in vitro models of traumatic brain injury (TBI) depends on their ability to recapitulate the in vivo TBI cascade. In this study, we used a genome-wide approach to compare changes in gene expression at several time points post-injury in both an in vitro model and an in vivo model of TBI. We found a total of 2073 differentially expressed genes in our in vitro model and 877 differentially expressed genes in our in vivo model when compared to noninjured controls. We found a strong correlation in gene expression changes between the two models (r = 0.69), providing confidence that the in vitro model represented at least part of the in vivo injury cascade. From these data, we searched for genes with significant changes in expression over time (analysis of covariance) and identified sorting protein-related receptor with A-type repeats (SORLA). SORLA directs amyloid precursor protein to the recycling pathway by direct binding and away from amyloid-beta producing enzymes. Mutations of SORLA have been linked to Alzheimer's disease (AD). We confirmed downregulation of SORLA expression in organotypic hippocampal slice cultures by immunohistochemistry and Western blotting and present preliminary data from human tissue that is consistent with these experimental results. Together, these data suggest that the in vitro model of TBI used in this study strongly recapitulates the in vivo TBI pathobiology and is well suited for future mechanistic or therapeutic studies. The data also suggest the possible involvement of SORLA in the post-traumatic cascade linking TBI to AD.	[Lamprecht, Michael R.; Elkin, Benjamin S.; Kesavabhotla, Kartik; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA; [Elkin, Benjamin S.] MEA Forens Engineers & Scientists, Mississauga, ON, Canada; [Crary, John F.] Icahn Sch Med Mt Sinai, Dept Pathol, Fishberg Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA; [Crary, John F.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Hammers, Jennifer L.] CUNY, Off Chief Med Examiner, New York, NY 10021 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; [Raghupathi, Ramesh] Drexel Univ, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19104 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008; Raghupathi, Ramesh/AAX-5538-2021	Morrison, Barclay/0000-0001-7676-0864; 	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03 NS054256]; National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD 069163]; National Science FoundationNational Science Foundation (NSF); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	This work was supported, in part, by NIH NINDS R03 NS054256 (BMIII), National Institute of Child Health and Development R01 HD 069163 (RR), a National Science Foundation Graduate Research Fellowship (to M.R.L.), and a Natural Sciences and Engineering Research Council of Canada postgraduate scholarship (to B.S.E.).	Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Barr TL, 2011, BIOL RES NURS, V13, P140, DOI 10.1177/1099800410385671; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Buggia-Prevot V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008562; Caglayan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007747; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XK, 2006, NEUROSCIENTIST, V12, P375, DOI 10.1177/1073858406291588; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Ding J, 2009, IMAGE SIGNAL PROCESS, V2009, P1; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Engelhardt G, 1996, BRIT J RHEUMATOL, V35, P4; Fernandes KA, 2012, NEUROBIOL DIS, V46, P393, DOI 10.1016/j.nbd.2012.02.003; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Kang WH, 2011, J NEUROTRAUM, V28, P1219, DOI 10.1089/neu.2011.1879; Kelley RE, 2012, NEUROL CLIN, V30, P187, DOI 10.1016/j.ncl.2011.09.014; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Motoi Y, 1999, BRAIN RES, V833, P209, DOI 10.1016/S0006-8993(99)01542-5; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Ries V, 2008, J NEUROCHEM, V107, P1578, DOI 10.1111/j.1471-4159.2008.05713.x; ROBERTSON HA, 1992, BIOCHEM CELL BIOL, V70, P729, DOI 10.1139/o92-112; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Taussky P, 2011, WORLD NEUROSURG, V76, pS9, DOI 10.1016/j.wneu.2011.05.048; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Willis C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003986.PUB2; Yang J, 2008, HISTOL HISTOPATHOL, V23, P877, DOI 10.14670/HH-23.877; Yu Zhe, 2006, Conf Proc IEEE Eng Med Biol Soc, VSuppl, P6732	75	7	7	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					97	108		10.1089/neu.2015.4306			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100012	26919808	Green Published			2022-02-06	
J	Liston, DB; Wong, LR; Stone, LS				Liston, Dorion B.; Wong, Lily R.; Stone, Leland S.			Oculometric Assessment of Sensorimotor Impairment Associated with TBI	OPTOMETRY AND VISION SCIENCE			English	Article						sensorimotor; traumatic brain injury; diagnostic tool; pursuit eye movement; neurological impairment	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; PURSUIT EYE-MOVEMENTS; SMOOTH-PURSUIT; VISUAL TRACKING; NERVE PALSIES; DEFICITS; CONCUSSION; PERCEPTION; VELOCITY	Purpose. Diffuse tissue damage from impact or blast traumatic brain injury (TBI) degrades information processing throughout the brain, often resulting in impairments in sensorimotor function. We have developed an eye-movement assessment test, consisting of a simple, appropriately randomized, radial tracking task together with a broad set of oculometric measures that can be combined to yield a sensitive overall indicator of sensorimotor functional status. We show here that this multidimensional method can be used to detect and characterize sensorimotor deficits associated with TBI. Methods. To compare dynamic visuomotor processing of TBI subjects (n = 34) with a separate control population (n = 41), we used the Comprehensive Oculometric Behavioral Response Assessment (COBRA) method (Liston & Stone, J Vision. 14: 12, 2014) to quantify 10 performance metrics for each subject. Each TBI subject's set of oculometrics was then combined to compute a single TBI impairment vector whose magnitude we refer to as the impairment index. Results. In our TBI population, several individual oculometrics were significantly degraded, including pursuit latency, initial pursuit acceleration, pursuit gain, catch-up saccade amplitude, proportion smooth tracking, and speed responsiveness. Furthermore, the TBI impairment index discriminated TBI subjects from controls with an 81% probability that increased with self-reported TBI severity; although the 9 subjects self-reporting "little-to-no'' residual impairment were statistically indistinguishable from controls (58% probability), the remaining 25 subjects were easily detectable (91% probability). Given the demonstrated link between higher-order visual perception/cognition and eye movements, we interpret the observed TBI-related impairments as degradations in the speed, accuracy, and precision of information processing within cortical circuits supporting higher-order visual processing and sensorimotor control, not just low-level brainstem motor deficits. Conclusions. We conclude that multidimensional oculometric testing could be used as a sensitive screen for subtle neurological signs of subclinical neurological insults, to quantify functional impairment, to monitor deterioration or recovery, and to evaluate treatment efficacy.	[Liston, Dorion B.; Wong, Lily R.; Stone, Leland S.] NASA, Ames Res Ctr, Mountain View, CA USA; [Liston, Dorion B.; Wong, Lily R.] San Jose State Univ, San Jose, CA 95192 USA		Liston, DB (corresponding author), San Jose State Univ, Bldg 262,Room 222,POB 1,MS 262-2, Moffett Field, CA 94035 USA.	dorion.liston@gmail.com			Office of Naval Research Force Health Protection program [N0001415IP00028/30]	This work has been supported by the Office of Naval Research Force Health Protection program (N0001415IP00028/30). The authors thank Laura Jamison from Santa Clara Valley Medical Center for invaluable assistance in recruiting subjects. DL and LS share a non-provisional patent application (application #61994673), which is a subject of this publication, not yet licensed or otherwise commercialized.	Ali FR, 2006, EXP BRAIN RES, V169, P237, DOI 10.1007/s00221-005-0143-6; ASCHAN G, 1958, Acta Otolaryngol Suppl, V140, P69; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Barker F, 2013, DEV TRAUMATIC BRAIN; Beutter BR, 2000, VISUAL NEUROSCI, V17, P139, DOI 10.1017/S0952523800171147; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; Boff K. R., 1988, ENG DATA COMPENDIUM; Bradley, 2004, NEUROLOGY CLIN PRACT; Cazzoli D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087146; Citek Karl, 2003, Optometry, V74, P695; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Daved SZ, 2012, BIOCYBERN BIOMED ENG, V32, P65; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Diefendorf AR, 1908, BRAIN, V31, P451, DOI 10.1093/brain/31.3.451; Green D.M., 1966, SOCIETY; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hutton S, 1998, NEUROLOGY, V50, P604, DOI 10.1212/WNL.50.3.604; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; LEVIN S, 1988, J PSYCHIAT RES, V22, P195, DOI 10.1016/0022-3956(88)90005-2; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; Liston DB, 2014, J VISION, V14, DOI 10.1167/14.14.12; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Masson GS, 2002, J NEUROPHYSIOL, V88, P2869, DOI 10.1152/jn.00987.2001; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pelak VS, 2005, NEURO-OPHTHALMOLOGY, V29, P137, DOI 10.1080/01658100500218046; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Samadani U, 2015, J NEUROSURG, V122, P707, DOI 10.3171/2014.10.JNS14762; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Stone LS, 2009, ENCY NEUROSCIENCE, P503; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307	40	7	7	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					51	59		10.1097/OPX.0000000000000918			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EM5ZZ	WOS:000395393900008	27391532	Green Published			2022-02-06	
J	Liu, YT; Hung, TY; Lee, YK; Huang, MY; Hsu, CY; Su, YC				Liu, Yin-Tzu; Hung, Tzu-Yao; Lee, Yi-Kung; Huang, Ming-Yuan; Hsu, Chen-Yang; Su, Yung-Cheng			Association between Chronic Kidney Disease and Risk of Cataract: A Nationwide Retrospective Cohort Study	AMERICAN JOURNAL OF NEPHROLOGY			English	Article						Cataract; Chronic kidney disease; End-stage renal disease	TRAUMATIC BRAIN-INJURY; STAGE RENAL-DISEASE; INCIDENT CATARACT; EYE DISEASES; CLASSIFICATION; ABNORMALITIES; HEMODIALYSIS; IMPAIRMENT; FAILURE; SURGERY	Background: Previous studies have established a relationship between chronic kidney disease (CKD) and cataract, but the relationship between the severity of renal impairment and risk of cataract is uncertain. This study investigates the relationship between the severity of renal disease and cataract in a nationwide sample from Taiwan. Methods: The cohort from 1-million National Health Insurance beneficiaries from Taiwan was retrospectively analyzed. All adult beneficiaries were followed from January 1, 2005 until December 31, 2013, to identify patients who underwent cataract surgeries. On the basis of the ambulatory care records, those diagnosed with CKD (ICD-9-CM code: 585) during the follow-up period were enrolled as CKD patients after careful evaluation. Each patient with CKD was age-and gender-matched with 4 individuals who did not have CKD. Cox regression models were applied to compare the hazard of cataract surgery in individuals with and without CKD. Subgroup analysis was used to compare patients with end-stage renal disease (ESRD) with age-and gender-matched non-CKD individuals. ESRD was defined by CKD patients who need regular renal replacement therapy. The same method was applied to evaluate hazard ratios (HRs). Results: After age and gender matching, there were 11,881 patients in the CKD group and 47,524 in the non-CKD group. After control for possible confounding, the adjusted HR (aHR) of cataract was 1.84 (95% CI 1.73-1.95) for the CKD group. Subgroup analysis of patients with ESRD (n = 3,209) and non-CKD individuals (n = 12,836), with matching done on the basis of age and gender, indicated an aHR of cataract was 2.33 (95% CI 2.10-2.59) for the ESRD group. Conclusions: This study indicates a relationship between CKD and cataract, and suggests that the risk for cataract increases with the severity of renal impairment. (C) 2017 S. Karger AG, Basel	[Liu, Yin-Tzu] Natl Chiao Tung Univ, Hsinchu Branch, Taipei Vet Gen Hosp, Dept Ophthalmol, Hsinchu, Taiwan; [Hung, Tzu-Yao] Natl Chiao Tung Univ, Dept Biomed Sci & Engn, Hsinchu, Taiwan; [Lee, Yi-Kung; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Yi-Kung; Su, Yung-Cheng] Buddhist Tzu Chi Med Fdn, Dept Emergency, Dalin Tzu Chi Hosp, 2 Minsheng Rd, Dalin Township 622, Chiayi, Taiwan; [Hung, Tzu-Yao] Taipei City Hosp, Zhongxing Branch, Dept Emergency, Taipei, Taiwan; [Huang, Ming-Yuan] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Hsu, Chen-Yang] Daichung Hosp, Miaoli, Taiwan		Su, YC (corresponding author), Buddhist Tzu Chi Med Fdn, Dept Emergency, Dalin Tzu Chi Hosp, 2 Minsheng Rd, Dalin Township 622, Chiayi, Taiwan.	drsu119@gmail.com		Su, Yung-Cheng/0000-0002-8201-1592			Brown CJ, 2015, CLIN OPHTHALMOL, V9, P1093, DOI 10.2147/OPTH.S84790; Chen JJ, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0187-y; Chen PC, 2013, DIABETES CARE, V36, P376, DOI 10.2337/dc12-0473; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; COSTAGLIOLA C, 1990, EXP EYE RES, V51, P631, DOI 10.1016/0014-4835(90)90046-W; Demirci FYK, 2006, MOL VIS, V12, P324; Deva R, 2011, CLIN J AM SOC NEPHRO, V6, P1866, DOI 10.2215/CJN.10321110; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Hou SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071801; Huynh SC, 2005, OPHTHALMOLOGY, V112, P293, DOI 10.1016/j.ophtha.2004.09.014; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; KAZI GQ, 1984, POSTGRAD MED J, V60, P166, DOI 10.1136/pgmj.60.700.166; Klein BEK, 2008, ARCH OPHTHALMOL-CHIC, V126, P1724, DOI 10.1001/archophthalmol.2008.502; Klein BEK, 1998, CURR EYE RES, V17, P720, DOI 10.1080/02713689808951248; KOCH HR, 1976, KLIN MONATSBL AUGENH, V168, P346; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Ng KJ, 2015, J THROMB HAEMOST, V13, P206, DOI 10.1111/jth.12805; Ortwerth BJ, 2003, INVEST OPHTH VIS SCI, V44, P3094, DOI 10.1167/iovs.02-0857; OSMAN EM, 1992, NEPHROL DIAL TRANSPL, V7, P1162; Panday M, 2016, CLIN EXP OPHTHALMOL, V44, P114, DOI 10.1111/ceo.12636; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Rim TH, 2016, INVEST OPHTH VIS SCI, V57, P1112, DOI 10.1167/iovs.15-18276; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; VANHEYNINGEN R, 1986, LANCET, V1, P1111; Wang TJ, 2012, OPHTHAL EPIDEMIOL, V19, P137, DOI 10.3109/09286586.2012.680531; Wong CW, 2016, EBIOMEDICINE, V5, P193, DOI 10.1016/j.ebiom.2016.01.023; Wong CW, 2014, KIDNEY INT, V85, P1290, DOI 10.1038/ki.2013.491; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	31	7	7	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0250-8095	1421-9670		AM J NEPHROL	Am. J. Nephrol.		2017	45	6					524	531		10.1159/000475555			8	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	EZ0AW	WOS:000404361700009	28528337				2022-02-06	
J	Mahmood, S; El-Menyar, A; Shabana, A; Mahmood, I; Asim, M; Abdelrahman, H; Al-Thani, H				Mahmood, Saeed; El-Menyar, Ayman; Shabana, Amr; Mahmood, Ismail; Asim, Mohammad; Abdelrahman, Husham; Al-Thani, Hassan			Bispectral index as a predictor of unsalvageable traumatic brain injury	BRAIN INJURY			English	Article						Bispectral index; traumatic brain injury; severe coma; brain death; outcome	DEATH; ANESTHESIA; COMA; BIS	Primary Objective: We aimed to assess the utility of bispectral index (BIS) monitoring to diagnose brain death (BD) in patients with severe traumatic brain injury (TBI).Research Design and methods: A prospective observational study was conducted for patients with severe TBI between 2012 and 2014.Main outcomes And results: This study included 62 patients with a mean age of 32.5 10.5 years. Nine patients had BD on admission with a sustainable BIS value of 0. Fifty-three patients were not initially diagnosed with BD with BIS values of 2-56. Forty-four patients deteriorated to BD, and their respective BIS values progressively decreased to 0. Nine patients with mean BIS of 39.2 +/- 9.0 recovered and were transferred to a specialized high dependency unit. BIS values showed positive correlation with the Glasgow Coma Score (GCS) on admission (r = 0.43, p = 0.001). Survivors had higher BIS values than those who were initially declared BD or those who died during the hospitalization course (p = 0.001).Conclusion: BIS values have a significant correlation with initial GCS and can assist in the early detection of BD in patients with severe acute TBI. Further larger studies are needed to support our findings.	[Mahmood, Saeed; Shabana, Amr; Mahmood, Ismail; Abdelrahman, Husham; Al-Thani, Hassan] HGH, Trauma Surg Sect, Dept Surg, Doha, Qatar; [El-Menyar, Ayman; Asim, Mohammad] HGH, Dept Surg, Clin Res, Trauma Surg Sect, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Sch, Med Clin, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp, Weill Cornell Med Coll, Consultant Clin Res, Trauma Surg, POB 3050, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741018; Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; Barnard JP, 2007, BRIT J ANAESTH, V99, P532, DOI 10.1093/bja/aem198; Dou L, 2014, WORLD J EMERG MED, V5, P53, DOI [10.5847/wjem.j.issn.1920-8642.2014.01.009, 10.5847/wjem.j.1920-8642.2014.01.009]; Ebtehaj M, 2012, IRISH J MED SCI, V181, P77, DOI 10.1007/s11845-011-0768-3; Escudero D, 2005, TRANSPL P, V37, P3661, DOI 10.1016/j.transproceed.2005.08.054; Fabregas N, 2004, ANESTHESIOLOGY, V101, P43, DOI 10.1097/00000542-200407000-00009; Flowers WM, 2000, SOUTHERN MED J, V93, P364, DOI 10.1097/00007611-200004000-00003; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heller H, 2005, ANESTH ANALG, V101, P235, DOI 10.1213/01.ANE.0000155957.48503.93; Jung JY, 2013, KOREAN J ANESTHESIOL, V64, P246, DOI 10.4097/kjae.2013.64.3.246; Li Hai-ling, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P352; Mahmood Saeed, 2014, Surg Neurol Int, V5, P141, DOI 10.4103/2152-7806.141890; Misis M, 2008, TRANSPL P, V40, P1279, DOI 10.1016/j.transproceed.2008.03.145; Myles Paul S, 2009, J Extra Corpor Technol, V41, pP15; Myles PS, 2009, ANESTHESIOLOGY, V110, P1106, DOI 10.1097/ALN.0b013e31819daef6; Paul Danie B, 2006, J Clin Monit Comput, V20, P399, DOI 10.1007/s10877-006-9045-9; POWER BM, 1995, ANAESTH INTENS CARE, V23, P26, DOI 10.1177/0310057X9502300107; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Vivien B, 2002, INTENS CARE MED, V28, P419, DOI 10.1007/s00134-002-1219-4; Wang XF, 2013, TURK J MED SCI, V43, P718, DOI 10.3906/sag-1209-76; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	22	7	8	2	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1382	1386		10.1080/02699052.2017.1330966			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800017	28657350				2022-02-06	
J	Markovic, G; Schult, ML; Bartfai, A				Markovic, Gabriela; Schult, Marie-Louise; Bartfai, Aniko			The effect of sampling bias on generalizability in intervention trials after brain injury	BRAIN INJURY			English	Article						Sampling bias; brain injuries; treatment outcome; cognitive training	COGNITIVE REHABILITATION; CLINICAL-TRIALS; STATEMENT; ATTENTION; RECOMMENDATIONS; DESIGN	Objective and design: The first objective of this descriptive study was to explore the effect of strict inclusion and exclusion criteria on patient recruitment in cognitive rehabilitation; the second was to analyse the representativeness of study patients for all eligible stroke and traumatic brain injury patients referred to the department from September 2011 to November 2014. Methods: The setting was multi-professional in- and outpatient brain injury rehabilitation in a university hospital. Participants were enrolled consecutively in acute (< 4 months) or subacute (4-12 months) phases of rehabilitation after injury. Results: Nine-hundred-and-forty-four patients were screened. Many failed to meet the inclusion and exclusion criteria (acute phase = 90.5%; sub-acute phase = 85.3% excluded). The most frequent exclusion criteria were age and multiple co-morbidity. The most striking differences between eligible participants and non-participants were the latter's lower educational and occupational levels. Conclusion: Results indicate the need for a closer connection between selection criteria and study aims. Strict inclusion and exclusion criteria render the study population less represen, tative and, thus, reduces generalizability. Data collection is prolonged. This study, instead, advocates the use of broad inclusion criteria and common data elements and the need to report data from the total patient population. Increased awareness of the participants' socioeconomic backgrounds is also needed when recruiting to research studies.	[Markovic, Gabriela; Schult, Marie-Louise; Bartfai, Aniko] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Rehabil, Stockholm, Sweden		Bartfai, A (corresponding author), Danderyd Hosp, Dept Rehabil Med, S-18288 Stockholm, Sweden.	aniko.bartfai@ki.se					Baddeley A, 1980, Int Rehabil Med, V2, P138; Bartfai A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-102; Blaha RZ, 2015, J HEAD TRAUMA REHAB, V30, pE33, DOI 10.1097/HTR.0000000000000059; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Gialanella B, 2009, EUR J PHYS REHAB MED, V45, P363; Helm-Estabrooks N, 2002, J COMMUN DISORD, V35, P171, DOI 10.1016/S0021-9924(02)00063-1; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MAHONEY F I, 1965, Md State Med J, V14, P61; Mayer JF, 2012, J COMMUN DISORD, V45, P325, DOI 10.1016/j.jcomdis.2012.06.002; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murray LL, 2006, J COMMUN DISORD, V39, P37, DOI 10.1016/j.jcomdis.2005.06.001; Neuhauser D, 2011, BMJ QUAL SAF, V20, pI36, DOI 10.1136/bmjqs.2010.046334; Ojha RP, 2013, PEDIATR BLOOD CANCER, V60, P856, DOI 10.1002/pbc.24348; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Schulz KF, 2011, INT J SURG, V9, P672, DOI [10.7326/0003-4819-152-11-201006010-00232, 10.1016/j.ijsu.2011.09.004]; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Spencer-Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119522; Theill N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-103; Wilson B, 1991, RIVERMEAD BEHAV MEMO; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	7	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					9	15		10.1080/02699052.2016.1206213			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600002	27819515				2022-02-06	
J	Moore, M; Kiatchai, T; Ayyagari, RC; Vavilala, MS				Moore, Megan; Kiatchai, Taniga; Ayyagari, Rajiv C.; Vavilala, Monica S.			Targeted areas for improving health literacy after traumatic brain injury	BRAIN INJURY			English	Article						family-centred care; qualitative research; physician-patient communication; health literacy; Health communication	CENTERED CARE; BURDEN; FAMILIES; OUTCOMES; CHILDREN; STRESS; IMPACT	Objective: To develop a framework to identify targeted areas for improving health literacy for caregivers after traumatic brain injury (TBI).& para;& para;Method: Qualitative study using inductive and deductive qualitative content analysis was conducted in a large, urban, level I trauma centre. Interviews were conducted with 23 caregivers of persons with TBI. Participants' perspectives on communication and preparation for discharge were explored and understanding of commonly used words and discharge instructions were assessed.& para;& para;Results: Four types of communication patterns were identified: formal, informal, indirect and caregiver-initiated. Informal and caregiver-initiated communication were the most common. All caregivers reported confusion about their family member's condition, care plan or discharge plan. Caregivers were not able to define commonly used terms in discharge instructions, and were confused by formatting and medical language. Caregivers were not aware of expected caregiving roles upon discharge. Conceptualizing findings within a family-centred care model, we offer specific strategies to improve health communication and caregiver capacity building to enhance health literacy.& para;& para;Conclusions: Health literacy and caregiver capacity to care for loved ones with TBI after hospital discharge is low. We offer specific target areas for improvement in verbal and written communication and capacity building that take into account provider, patient and family characteristics.	[Moore, Megan] Univ Washington, Sch Social Work, Box 354900,4101 15th Ave NE, Seattle, WA 98105 USA; [Moore, Megan; Kiatchai, Taniga; Ayyagari, Rajiv C.; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98105 USA; [Kiatchai, Taniga; Vavilala, Monica S.] Univ Washington, Anesthesiol & Pain Med, Seattle, WA 98105 USA; [Ayyagari, Rajiv C.] Johns Hopkins Univ, Baltimore, MD USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, Box 354900,4101 15th Ave NE, Seattle, WA 98105 USA.	mm99@uw.edu			National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421, KL2TR002317] Funding Source: NIH RePORTER	This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000421 to Dr. Moore). Authors declare no conflicts of interest.	Adams D, 2016, NEUROREHABILITATION, V39, P223, DOI 10.3233/NRE-161353; Alper J., 2015, HLTH LIT PRES FUT WO; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Choudhry AJ, 2016, AM J SURG, V211, P631, DOI 10.1016/j.amjsurg.2015.12.005; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Eltorai AEM, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.20141; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hermans E, 2012, NEUROREHABILITATION, V30, P213, DOI 10.3233/NRE-2012-0747; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kadakia RJ, 2013, J ORTHOP TRAUMA, V27, P467, DOI 10.1097/BOT.0b013e3182793338; Kutner M, 2006, HLTH LITERACY AM ADU, P1; Lewin S. A., 2001, COCHRANE DB SYST REV, V4, P3267, DOI DOI 10.1002/14651858.CD003267; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Moore M, 2015, PEDIATR CRIT CARE ME, V16, P758, DOI 10.1097/PCC.0000000000000494; Paasche-Orlow MK, 2010, J HEALTH COMMUN, V15, P5, DOI 10.1080/10810730.2010.499995; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pollack MM, 2003, CRIT CARE MED, V31, P1620, DOI 10.1097/01.CCM.0000063302.76602.86; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Sanghvi S, 2012, LARYNGOSCOPE, V122, P1943, DOI 10.1002/lary.23424; Shahan CP, 2016, J TRAUMA ACUTE CARE, V81, P1167, DOI 10.1097/TA.0000000000001140; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Stewart M, 2000, J FAM PRACTICE, V49, P796; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	27	7	7	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1876	1881		10.1080/02699052.2017.1346291			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500021	28816517	Green Accepted			2022-02-06	
J	Moser, RS; Schatz, P				Moser, Rosemarie Scolaro; Schatz, Philip			Increased Symptom Reporting in Young Athletes Based on History of Previous Concussions	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							SPORT-RELATED CONCUSSION; HIGH-SCHOOL; BRAIN-INJURY; RECOVERY; OUTCOMES; LINE	Research documents increased symptoms in adolescents with a history of two or more concussions. This study examined baseline evaluations of 2,526 younger athletes, ages 10 to 14. Between-groups analyses examined Post Concussion Symptom Scale symptoms by concussion history group (None, One, Two+) and clusters of Physical, Cognitive, Emotional, and Sleep symptoms. Healthy younger athletes with a concussion history reported greater physical, emotional, and sleep-related symptoms than those with no history of concussion, with a greater endorsement in physical/sleep symptom clusters. Findings suggest younger athletes with a history of multiple concussions may experience residual symptoms.	[Moser, Rosemarie Scolaro] Sports Concuss Ctr New Jersey, 281 Witherspoon St,Suite 230, Princeton, NJ 08540 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Moser, RS (corresponding author), Sports Concuss Ctr New Jersey, 281 Witherspoon St,Suite 230, Princeton, NJ 08540 USA.	rmoser@sportsconcussionNJ.com					Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; [Anonymous], 2015, CONC; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Guskiewicz K. M., 2003, JAMA-J AM MED ASSOC, V26, P1217; IBM, 2015, STAT PACK SOC SCI IB; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Lovell M. R., 2013, IMPACT TECHNICAL MAN, V2013; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Montopoli B., 2013, CBS NEWS; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; National Center for Injury Prevention and Control (NCIPC), 2016, REP PED MILD TRAUM B; Piaget J., 1969, PSYCHOL CHILD; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Simon LM, 2016, CURR SPORT MED REP, V15, P161, DOI 10.1249/JSR.0000000000000268; Von Elm E., BRIT J MED, V335, P806; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	33	7	7	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2017	42	4					276	283		10.1080/87565641.2017.1334785			8	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FD6AK	WOS:000407610800003	28678608				2022-02-06	
J	Parks, AC; Gfeller, J; Emmert, N; Lammert, H				Parks, Adam C.; Gfeller, Jeffrey; Emmert, Natalie; Lammert, Hannah			Detecting feigned postconcussional and posttraumatic stress symptoms with the structured inventory of malingered symptomatology (SIMS)	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Assessment; diagnosis; measurement; statistics; symptom validity testing	TRAUMATIC BRAIN-INJURY; PERFORMANCE VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; DIAGNOSTIC UTILITY; MENTAL-DISORDERS; VETERANS; PTSD; TESTS; PSYCHOPATHOLOGY; METAANALYSIS	The Structured Inventory of Malingered Symptomatology (SIMS) is a standalone symptom validity test (SVT) designed as a screening measure to detect a variety of exaggerated psychological symptoms. A number of studies have explored the accuracy of the SIMS in litigious and clinical populations, yet few have examined the validity of the SIMS in detecting feigned symptoms of postconcussional disorder (PCD) and posttraumatic stress disorder (PTSD). The present study examined the sensitivity of the SIMS in detecting undergraduate simulators (N=78) feigning symptoms of PCD, PTSD, and the comorbid presentation of both PCD and PTSD symptomatologies. Overall, the SIMS Total score produced the highest sensitivities for the PCD symptoms and PCD+PTSD symptoms groups (.89 and .85, respectively), and to a lesser extent, the PTSD symptoms group (.69). The Affective Disorders (AF) subscale was most sensitive to the PTSD symptoms group compared to the PCD and PCD+PTSD symptoms groups. Additional sensitivity values are presented and examined at multiple scale cutoff scores. These findings support the use of the SIMS as a SVT screening measure for PCD and PTSD symptom exaggeration in neuropsychological assessment.	[Parks, Adam C.] Mayo Clin Florida, Dept Psychiat & Psychol, Jacksonville, FL USA; [Gfeller, Jeffrey; Emmert, Natalie] St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA; [Lammert, Hannah] Univ Minnesota, Dept Psychol, Duluth, MN 55812 USA		Parks, AC (corresponding author), Mayo Clin, Dept Psychiat & Psychol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	parks.adam@mayo.edu					Alwes YR, 2008, J CLIN EXP NEUROPSYC, V30, P133, DOI 10.1080/13803390701260363; American Association Psychiatric, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Babikian T., 2009, ASSESSMENT FEIGNED C, P103; Benge JF, 2012, EPILEPSY BEHAV, V24, P439, DOI 10.1016/j.yebeh.2012.05.007; Berry D. T. R., 2007, ASSESSMENT MALINGERE, P226; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Capilla Ramirez P., 2008, INVENTARIO ESTRUCTOR, P72; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Clegg C, 2009, J FORENSIC PSYCHI PS, V20, P239, DOI 10.1080/14789940802267760; Edens JF, 1999, J AM ACAD PSYCHIATRY, V27, P387; Egeland J, 2015, APPL NEUROPSYCH-ADUL, V22, P215, DOI 10.1080/23279095.2014.910212; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Guriel Jennifer, 2003, Clin Psychol Rev, V23, P881; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinze MC., 2001, J FORENSIC PSYCHOL P, V1, P23, DOI [10.1300/J158v01n04_02, DOI 10.1300/J158V01N04_02]; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; Jelicic M, 2006, J PSYCHOPATHOL BEHAV, V28, P19, DOI 10.1007/s10862-006-4535-0; Jelicic M, 2007, INT J NEUROSCI, V117, P1185, DOI 10.1080/00207450600934697; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Kunst MJJ, 2011, J INTERPERS VIOLENCE, V26, P3561, DOI 10.1177/0886260511403753; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCrea M., 2008, MILD TRAUMATIC BRAIN; Merckelbach H, 2003, ARCH CLIN NEUROPSYCH, V18, P145, DOI 10.1016/S0887-6177(01)00191-3; Merten T, 2008, AKTUEL NEUROL, V35, P8, DOI 10.1055/s-2007-986232; Merten T., 2010, GERMAN J PSYCHIAT, V13, P140; Meyers J. E., 2007, ASSESSMENT FEIGNED C, P239; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Morey L.C., 2007, PERSONALITY ASSESSME; Murdoch M, 2005, MED CARE, V43, P112, DOI 10.1097/00005650-200502000-00004; Nelson N.W., 2013, MILD TRAUMATIC BRAIN, P119; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R, 2014, BEHAV SCI LAW, V32, P455, DOI 10.1002/bsl.2131; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Smith G. P., 2008, CLIN ASSESSMENT MALI, P323; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van Beilen M, 2009, EUR J NEUROL, V16, P1118, DOI 10.1111/j.1468-1331.2009.02655.x; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Widows M. R., 2005, STRUCTURED INVENTORY; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Wisdom NM, 2010, ARCH CLIN NEUROPSYCH, V25, P118, DOI 10.1093/arclin/acp110; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; * Zimmermann P., 2013, GERMAN J PSYCHIAT, V16, P54	69	7	7	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	5					429	438		10.1080/23279095.2016.1189426			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FC9MU	WOS:000407166400005	27284810				2022-02-06	
J	Pearce, AJ; Young, JA; Parrington, L; Aimers, N				Pearce, Alan J.; Young, Janet A.; Parrington, Lucy; Aimers, Nicole			Do as I say: contradicting beliefs and attitudes towards sports concussion in Australia	JOURNAL OF SPORTS SCIENCES			English	Article						Concussion; sports; exercise science; attitudes	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; FOOTBALL PLAYERS; NEUROCOGNITIVE PERFORMANCE; PLANNED BEHAVIOR; SEX-DIFFERENCES; HOCKEY PLAYERS; KNOWLEDGE; PREVENTION; MANAGEMENT	The objective of this study was to explore beliefs and attitudes of students studying exercise science in Australia towards sports concussion. A secondary objective explored differences between gender and previous experience of concussion. A total of 312 participants (m=217; f=95) responded to a series of statements ranging across a number of areas including personal attitudes and beliefs towards concussion: if they would risk playing with a concussion; their views on elite/professional athletes who continue to play after a concussion; and attitudes towards rehabilitation. Overall, attitudes revealed that it was not safe to play with a concussion, and it was believed that those who have had repeated concussions would be likely to suffer problems later in life. However, responses also indicated that they would risk playing with a concussion, and admired elite athletes who continued to play. When controlling for gender and previous concussions, males and those who sustained a previous concussion/s were more likely to continue playing. Conversely, females were more likely to complete rehabilitation prior to returning to sport. This study demonstrates in an Australian student cohort studying for a career in exercise and sports science, disparity between beliefs and attitudes regarding sports concussion.	[Pearce, Alan J.; Aimers, Nicole] Swinburne Univ Technol, Fac Hlth Arts & Design, Melbourne, Vic, Australia; [Pearce, Alan J.] Univ Melbourne, Melbourne Sch Hlth Sci, Melbourne, Vic, Australia; [Young, Janet A.] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic, Australia; [Parrington, Lucy] Swinburne Univ Technol, Dept Biomed & Hlth Sci, Melbourne, Vic, Australia		Pearce, AJ (corresponding author), Swinburne Univ Technol, POB 218 Hawthorn, Melbourne, Vic 3122, Australia.	alanpearce@swin.edu.au	Pearce, Alan J/W-1195-2018	Pearce, Alan J/0000-0002-9264-9880; YOUNG, JANET/0000-0002-0040-0691; Parrington, Lucy/0000-0001-8507-9974	Australian Football League and Smart Head Play; Samsung CorporationSamsung	No funding was provided specifically for this study. AJP is funded by grants by the Australian Football League and Smart Head Play, and has previously been supported by the Samsung Corporation. Other authors declare no sources of research funding.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Australian Bureau of Statistics, 2013, HIT BOOKS CHAR HIGH; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Braham RA, 2004, BRIT J SPORT MED, V38, P426, DOI 10.1136/bjsm.2002.004051; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Cady E. H., 1978, COLL SPORTS AM LIFE; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Department of Employment Government of Australia, 2016, JOB OUTL AUSTR GOV I; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Elkington L., 2016, AUSTR I SPORT AUSTR; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grant D, 2009, SOCIOL PERSPECT, V52, P59, DOI 10.1525/sop.2009.52.1.59; Hetherington S., 2015, 2015 WORKFORCE SURVE; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Light RL, 2010, J SPORT SOC ISSUES, V34, P379, DOI 10.1177/0193723510383848; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Malinauskas R, 2008, J SPORT MED PHYS FIT, V48, P107; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; MITTEN MJ, 1993, U PITT LAW REV, V55, P129; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; Ozolins B, 2016, BRAIN INJURY, V30, P937, DOI 10.3109/02699052.2016.1147080; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Raftery M, 2014, BRIT J SPORT MED, V48, P79, DOI 10.1136/bjsports-2013-093051; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Rosenbaum A. M., 2007, EXAMINATION KNOWLEDG; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Shields DLL, 1997, J PSYCHOL, V131, P196, DOI 10.1080/00223989709601964; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	54	7	7	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2017	35	19					1911	1919		10.1080/02640414.2016.1241420			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EZ7VV	WOS:000404934700007	27754774	Green Accepted			2022-02-06	
J	Siqueira, EMP; Diccini, S				Pires Siqueira, Ellen Maria; Diccini, Solange			Postoperative complications in elective and non-elective neurosurgery	ACTA PAULISTA DE ENFERMAGEM			English	Article						Neurosurgical procedures; Postoperative complications; Perioperative nursing	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; CRANIAL NEUROSURGERY; SURGICAL-MANAGEMENT; SUBDURAL-HEMATOMA; CRANIOTOMY; RESECTION; OUTCOMES; COHORT	Objective: To evaluate the incidence of postoperative complications and mortality among patients submitted to elective or non-elective neurosurgery. Methods: Prospective cohort study in adult patients, followed from preoperative period until hospital discharge or death. Results: One hundred and twenty seven patients were included in elective surgery group and 75 patients in non-elective surgery group. The elective group had more vomiting (p= 0.010) and pain (p< 0.001) and the non-elective group presented more intracranial hypertension (p= 0.001), anisocoria (p= 0.002), cerebral vasospasm (p= 0.043), light-unresponsive pupil (p= 0.006) and reoperation (p= 0.046). The mortality rate was 5.5% in the elective surgery group and 26.7% in the non-elective surgery group (p< 0.001). Conclusion: Elective procedures in neurosurgery are related to higher frequencies of systemic complications while non-elective surgeries had significantly higher rates of neurological complications and mortality.	[Pires Siqueira, Ellen Maria; Diccini, Solange] Univ Fed Sao Paulo, Escola Paulista Enfermagem, Sao Paulo, SP, Brazil		Siqueira, EMP (corresponding author), Napoleao de Barros St 754, BR-04024002 Sao Paulo, SP, Brazil.	emc.pires@yahoo.com.br					Aboukais R, 2015, CLIN NEUROL NEUROSUR, V138, P137, DOI 10.1016/j.clineuro.2015.08.017; Badin J, 2011, CRIT CARE, V15, DOI 10.1186/cc10253; Bui JQH, 2011, J NEUROSURG, V115, P1236, DOI 10.3171/2011.8.JNS11105; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Englot DJ, 2012, NEUROSURGERY, V71, P572, DOI 10.1227/NEU.0b013e31825ea3ba; Fatigba HO, 2013, WORLD NEUROSURG, V80, P246, DOI 10.1016/j.wneu.2011.09.016; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Inoue T, 2015, CLIN NEUROL NEUROSUR, V139, P302, DOI 10.1016/j.clineuro.2015.10.029; Javadi A, 2011, WORLD NEUROSURG, V75, P731, DOI 10.1016/j.wneu.2010.11.042; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Ibanez FAL, 2011, WORLD NEUROSURG, V75, P709, DOI 10.1016/j.wneu.2010.11.010; Latz B, 2011, J NEUROSURG, V114, P491, DOI 10.3171/2010.9.JNS10151; Lepanluoma M, 2014, SCAND J SURG, V103, P66, DOI 10.1177/1457496913482255; Lonjaret L, 2016, ANAESTH CRIT CARE PA; Park J, 2016, J NEUROSURG, V124, P310, DOI 10.3171/2015.1.JNS14309; Qi J, 2015, WORLD NEUROSURG, V84, P1686, DOI 10.1016/j.wneu.2015.07.016; Reponen E, 2015, WORLD NEUROSURG, V84, P1845, DOI 10.1016/j.wneu.2015.08.007; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Stark AM, 2011, J CLIN NEUROSCI, V18, P34, DOI 10.1016/j.jocn.2010.03.046; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Tsitsopoulos PP, 2012, ACTA NEUROCHIR, V154, P1189, DOI 10.1007/s00701-012-1372-7; Walcott BP, 2014, J NEUROSURG, V120, P278, DOI 10.3171/2013.8.JNS13703; Zacharia BE, 2014, NEUROSURGERY, V74, P638, DOI 10.1227/NEU.0000000000000342; Zeng LC, 2015, NEUROSURG REV, V38, P481, DOI 10.1007/s10143-015-0619-1	25	7	9	0	0	UNIV FED SAO PAULO, DEPT ENFERMAGEN	SAO PAULO	RUA NAPOLEAO DE BARROS, 754 VILA CLEMENTINO, SAO PAULO, CEP04024-002, BRAZIL	0103-2100	1982-0194		ACTA PAUL ENFERM	Acta Paul. Enferm.	JAN-FEB	2017	30	1					101	108		10.1590/1982-0194201700015			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	EW4HI	WOS:000402462200015		Green Published, gold			2022-02-06	
J	Popescu, M; Hughes, JD; Popescu, EA; Mikola, J; Merrifield, W; DeGraba, M; Riedy, G; DeGraba, TJ				Popescu, Mihai; Hughes, John D.; Popescu, Elena-Anda; Mikola, Judy; Merrifield, Warren; DeGraba, Maria; Riedy, Gerard; DeGraba, Thomas J.			Activation of dominant hemisphere association cortex during naming as a function of cognitive performance in mild traumatic brain injury: Insights into mechanisms of lexical access	NEUROIMAGE-CLINICAL			English	Article						Magnetoencephalography; Traumatic brain injury; Picture naming; Lexical retrieval; Attractor dynamics	POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR CINGULATE CORTEX; TONGUE; TIP; DYNAMICS; RETRIEVAL; NETWORK; SYSTEM; MEG; INVOLVEMENT	Patients with a history of mild traumatic brain injury (mTBI) and objective cognitive deficits frequently experience word finding difficulties in normal conversation. We sought to improve our understanding of this phenomenon by determining if the scores on standardized cognitive testing are correlated with measures of brain activity evoked in a word retrieval task (confrontational picture naming). The study participants (n = 57) were military service members with a history of mTBI. The General Memory Index (GMI) determined after administration of the Rivermead Behavioral Memory Test, Third Edition, was used to assign subjects to three groups: low cognitive performance (Group 1: GMI = 87, n = 18), intermediate cognitive performance (Group 2: 88 = GMI = 99, n = 18), and high cognitive performance (Group 3: GMI = 100, n = 21). Magnetoencephalography data were recorded while participants named eighty pictures of common objects. Group differences in evoked cortical activity were observed relatively early (within 200 ms from picture onset) over a distributed network of left hemisphere cortical regions including the fusiform gyrus, the entorhinal and parahippocampal cortex, the supramarginal gyrus and posterior part of the superior temporal gyrus, and the inferior frontal and rostral middle frontal gyri. Differences were also present in bilateral cingulate cortex and paracentral lobule, and in the right fusiform gyrus. All differences reflected a lower amplitude of the evoked responses for Group 1 relative to Groups 2 and 3. These findings may indicate weak afferent inputs to and within an extended cortical network including association cortex of the dominant hemisphere in patients with low cognitive performance. The association between word finding difficulties and low cognitive performance may therefore be the result of a diffuse pathophysiological process affecting distributed neuronal networks serving a wide range of cognitive processes. These findings also provide support for a parallel processing model of lexical access.	[Popescu, Mihai; Hughes, John D.; Popescu, Elena-Anda; Mikola, Judy; Merrifield, Warren; DeGraba, Maria; Riedy, Gerard; DeGraba, Thomas J.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Hughes, John D.] Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Hughes, JD (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	john.d.hughes4.ctr@mail.mil					Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Barrow IM, 2006, J TRAUMA, V61, P1142, DOI 10.1097/01.ta.0000241238.70269.c1; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berthier ML, 2011, NEUROPSYCHOL REV, V21, P302, DOI 10.1007/s11065-011-9177-7; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bonilha L, 2016, NEUROREHAB NEURAL RE, V30, P266, DOI 10.1177/1545968315593808; Breier JI, 2008, J CLIN NEUROPHYSIOL, V25, P7, DOI 10.1097/WNP.0b013e318163ccd5; Brennen T, 1996, COGNITIVE NEUROPSYCH, V13, P93, DOI 10.1080/026432996382079; Brown AS, 1996, AM J PSYCHOL, V109, P79, DOI 10.2307/1422928; BROWN AS, 1991, PSYCHOL BULL, V109, P204, DOI 10.1037/0033-2909.109.2.204; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Butz M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00115; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dell GS, 1999, COGNITIVE SCI, V23, P517; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; EECKMAN FH, 1991, BRAIN RES, V557, P13, DOI 10.1016/0006-8993(91)90110-H; Einarsson EO, 2012, LEARN MEMORY, V19, P449, DOI 10.1101/lm.027227.112; FINLEY GE, 1989, EDUC GERONTOL, V15, P259, DOI 10.1080/0380127890150305; FOSTER TC, 1992, BRAIN RES, V587, P95, DOI 10.1016/0006-8993(92)91432-E; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freeman WJ, 2002, J NEUROPHYSIOL, V87, P937, DOI 10.1152/jn.00254.2001; Freeman WJ, 2004, CLIN NEUROPHYSIOL, V115, P2077, DOI 10.1016/j.clinph.2004.02.029; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Goudar V, 2014, NAT NEUROSCI, V17, P487, DOI 10.1038/nn.3679; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hughes JD, 2000, BRAIN LANG, V71, P96, DOI 10.1006/brln.1999.2223; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kanamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053854; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim JH, 2007, J CLIN NEUROL, V3, P62, DOI 10.3988/jcn.2007.3.1.62; Knott V, 2014, HUM PSYCHOPHARM CLIN, V29, P446, DOI 10.1002/hup.2418; Lee JH, 2015, J NEUROSCI, V35, P15000, DOI 10.1523/JNEUROSCI.0629-15.2015; Levelt W.J.M., 1989, SPEAKING INTENTION A; Levelt WJM, 1998, J COGNITIVE NEUROSCI, V10, P553, DOI 10.1162/089892998562960; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Liljestrom M, 2009, HUM BRAIN MAPP, V30, P1845, DOI 10.1002/hbm.20785; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; MCKENNA TM, 1994, NEUROSCIENCE, V60, P587, DOI 10.1016/0306-4522(94)90489-8; Mikuni N, 2006, EPILEPSIA, V47, P1347, DOI 10.1111/j.1528-1167.2006.00610.x; Miozzo M, 2015, CEREB CORTEX, V25, P3343, DOI 10.1093/cercor/bhu137; Moller J, 2007, CEREB CORTEX, V17, P1173, DOI 10.1093/cercor/bhl028; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Popescu M, 2016, CLIN NEUROPHYSIOL, V127, P3075, DOI 10.1016/j.clinph.2016.06.004; Rapp B, 2000, PSYCHOL REV, V107, P460, DOI 10.1037/0033-295X.107.3.460; Rastle KG, 1996, J MEM LANG, V35, P586, DOI 10.1006/jmla.1996.0031; Rohrer JD, 2008, BRAIN, V131, P8, DOI 10.1093/brain/awm251; Roopun AK, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00008; Roth HL, 2006, NEUROCASE, V12, P61, DOI 10.1080/13554790500502892; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Schwartz BL, 1999, PSYCHON B REV, V6, P379, DOI 10.3758/BF03210827; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; SHUREN J, 1993, NEUROLOGY, V43, P1900, DOI 10.1212/WNL.43.10.1900; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tadel F., 2011, BRAINSTORM USER FRIE; Tanaka Y, 1997, LANCET, V350, P116, DOI 10.1016/S0140-6736(05)61820-X; Wang YP, 1999, NEUROSCIENCE, V89, P423, DOI 10.1016/S0306-4522(98)00299-1; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Wennekers T, 2006, J PHYSIOL-PARIS, V100, P16, DOI 10.1016/j.jphysparis.2006.09.007; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; Yasuda Y, 1997, CLIN NEUROL NEUROSUR, V99, P102, DOI 10.1016/S0303-8467(97)00605-7	78	7	7	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	15						741	752		10.1016/j.nicl.2017.06.029			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG3MN	WOS:000410067200077	28702351	gold, Green Published			2022-02-06	
J	Reddy, RP; Rajeswaran, J; Devi, BI; Kandavel, T				Reddy, Rajakumari Pampa; Rajeswaran, Jamuna; Devi, B. Indira; Kandavel, Thennarasu			Cascade of Traumatic Brain Injury: A Correlational Study of Cognition, Postconcussion Symptoms, and Quality of Life	INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE			English	Article									[Reddy, Rajakumari Pampa; Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bengaluru, Karnataka, India; [Devi, B. Indira] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru, Karnataka, India; [Kandavel, Thennarasu] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bengaluru, Karnataka, India		Reddy, RP (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bengaluru, Karnataka, India.	rajkumari.pampa@gmail.com					Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; Diamond A, 2002, PRINCIPLES FRONTAL L, P483; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; KasondeNgandou S, 1999, S KONZ VORST BEH VER, P114; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rahman RO, 2004, INT J PSYCHOSOC REHA, V9, P153; Rao S. L., 2004, NIMHANS NEUROPSYCHOL; Reddy RP, 2013, J NEUROTHER, V17, P213, DOI DOI 10.1080/10874208.2013.847139; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; TARTER RE, 1988, GASTROENTEROL CLIN N, V17, P207; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Viguier D, 2001, BRAIN INJURY, V15, P263; von Wild KRH, 2008, ACT NEUR S, V101, P55; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WHO Group, 1994, INT J MENT HEALTH, V2, P2456	37	7	7	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0253-7176	0975-1564		INDIAN J PSYCHOL MED	Indian J. Psychol. Med.	JAN	2017	39	1					32	39		10.4103/0253-7176.198940			8	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	QA9WS	WOS:000613795800006	28250556	Green Published			2022-02-06	
J	Reznik, JE; Biros, E; Lamont, AC; Sacher, Y; Kibrik, O; Milanese, S; Gordon, S; Galea, MP				Reznik, J. E.; Biros, E.; Lamont, A. C.; Sacher, Y.; Kibrik, O.; Milanese, S.; Gordon, S.; Galea, M. P.			A preliminary investigation on the effect of extracorporeal shock wave therapy as a treatment for neurogenic heterotopic ossification following traumatic brain injury. Part I: Effects on pain	BRAIN INJURY			English	Article							SPINAL-CORD-INJURY; NEUROPATHIC PAIN; RISK-FACTORS; MANAGEMENT; SCALE	Introduction: Neurogenic heterotopic ossification (NHO) is a complication of a neurological injury following traumatic brain injury (TBI) and may be present around major synovial joints. It is often accompanied by severe pain, which may lead to limitation in activities of daily living. Currently, a common intervention for NHO is surgery, which has been reported to carry many additional risks. This study was designed to assess the effect of extracorporeal shock wave therapy (ESWT) on pain in patients with TBI with chronic NHO. Methods: A series of single-case studies (n = 11) was undertaken with patients who had TBI and chronic NHO at the hip or knee. Each patient received four applications of high-energy EWST delivered to the affected joint over 8 weeks. Two-weekly follow-up assessments were carried out, and final assessments were made 3 and 6 months post-intervention. Pain was measured using the Faces Rating Scale, and X-rays were taken at baseline and 6-months post-intervention to physiologically measure the size of the NHO. Results: The application of high-energy ESWT was associated with significant overall reduction of pain in patients with TBI and NHO (Tau-0.412, 95% confidence interval -0.672 to -0.159, p = 0.002). Conclusions: ESWT is a novel non-invasive intervention for reducing pain resulting from NHO in patients with TBI.	[Reznik, J. E.] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia; [Reznik, J. E.] James Cook Univ, Div Trop Hlth & Med, Townsville, Qld 4811, Australia; [Biros, E.] James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld, Australia; [Lamont, A. C.] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Lamont, A. C.] Townsville Hosp, Dept Radiol, Townsville, Qld, Australia; [Sacher, Y.] Tel Aviv Univ, Sackler Fac Med, Brain Injury Unit, Raanana, Israel; [Kibrik, O.] Tel Aviv Univ, Sackler Fac Med, Loewenstein Rehabil Ctr, Raanana, Israel; [Milanese, S.] Univ South Australia, Discipline Physiotherapy, Adelaide, SA, Australia; [Gordon, S.] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia; [Gordon, S.] Flinders Univ S Australia, Sch Hlth Sci, Bedford Pk, SA, Australia; [Galea, M. P.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic, Australia; [Galea, M. P.] James Cook Univ, Townsville, Qld, Australia		Reznik, JE (corresponding author), James Cook Univ, Div Trop Hlth & Med, Townsville, Qld 4811, Australia.	jackie.reznik@jcu.edu.au	Milanese, Steve/F-3898-2013; Galea, Mary/F-4242-2010	Milanese, Steve/0000-0002-6470-3296; Galea, Mary/0000-0003-0045-7978; Gordon, Susan/0000-0002-4760-1212			Akbar M, 2007, PHYS MED REHAB KUROR, V17, P156, DOI 10.1055/s-2007-956519; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Banovac K, 1997, SPINAL CORD, V35, P158, DOI 10.1038/sj.sc.3100380; Brissot R., 2005, Annales de Readaptation et de Medecine Physique, V48, P581, DOI 10.1016/j.annrmp.2005.04.014; Burtis CA., 2012, TIETZ TXB CLIN CHEM, V5th; Buselli P, 2010, ULTRASOUND MED BIOL, V36, P397, DOI 10.1016/j.ultrasmedbio.2009.11.007; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Chao YH, 2008, ULTRASOUND MED BIOL, V34, P841, DOI 10.1016/j.ultrasmedbio.2007.11.002; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Clark AK, 2013, J PAIN RES, V6, P803, DOI 10.2147/JPR.S53660; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Goldman J, 1980, Physiotherapy, V66, P219; Haran MJ, 2010, COCHRANE DB SYST REV; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; KJAERSGAARDANDERSEN P, 1988, CLIN ORTHOP RELAT R, P102; Kratochwill TR, 2010, PSYCHOL METHODS, V15, P124, DOI 10.1037/a0017736; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Merskey H, 1994, CLASSIFICATION CHRON; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Pfeil U, 1997, ORTHOPADE, V26, P528; Portney LG., 2008, FDN CLIN RES APPL PR, V3rd ed; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Reznik JE, 2013, BRAIN INJURY, V27, P242, DOI 10.3109/02699052.2012.729293; Siebert Werner, 2003, MMW Fortschr Med, V145, P18; Silver JR, 2011, SPINAL CORD, V49, P482, DOI 10.1038/sc.2010.133; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Topolovec-Vranic J, 2010, AM J CRIT CARE, V19, P345, DOI 10.4037/ajcc2010247; Torrance David Allen, 2011, J Can Chiropr Assoc, V55, P240; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	37	7	8	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	4					526	532		10.1080/02699052.2017.1283059			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES9TD	WOS:000399902900011	28340308	Green Accepted			2022-02-06	
J	Rigoglio, NN; Barreto, RSN; Favaron, PO; Jacob, JCF; Smith, LC; Gastal, MO; Gastal, EL; Miglino, MA				Rigoglio, Nathia N.; Barreto, Rodrigo S. N.; Favaron, Phelipe O.; Jacob, Julio C. F.; Smith, Lawrence C.; Gastal, Melba O.; Gastal, Eduardo L.; Miglino, Maria Angelica			Central Nervous System and Vertebrae Development in Horses: a Chronological Study with Differential Temporal Expression of Nestin and GFAP	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Neurodevelopment; Equine; Fetal brain development; Spinal cord; Nerves; Ganglia; Head trauma	FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; ADULT MAMMALIAN BRAIN; MILD HEAD-INJURY; SUBVENTRICULAR ZONE; RADIAL GLIA; TRANSCRIPTION FACTOR; PROGENITOR CELLS; PRECURSOR CELLS	The neural system is one of the earliest systems to develop and the last to be fully developed after birth. This study presents a detailed description of organogenesis of the central nervous system (CNS) at equine embryonic/fetal development between 19 and 115 days of pregnancy. The expression of two important biomarkers in the main structure of the nervous system responsible for neurogenesis in the adult individual, and in the choroid plexus, was demonstrated by Nestin and glial fibrillary acid protein (GFAP) co-labeling. In the 29th day of pregnancy in the undifferentiated lateral ventricle wall, the presence of many cells expressing Nestin and few expressing GFAP was observed. After the differentiation of the lateral ventricle wall zones at 60 days of pregnancy, the subventricular zone, which initially had greater number of Nestin(+) cells, began to show higher numbers of GFAP(+) cells at 90 days of pregnancy. A similar pattern was observed for Nestin(+) and GFAP(+) cells during development of the choroid plexus. This study demonstrates, for the first time, detailed chronological aspects of the equine central nervous system organogenesis associated with downregulation of Nestin and upregulation of GFAP expression.	[Rigoglio, Nathia N.; Barreto, Rodrigo S. N.; Favaron, Phelipe O.; Miglino, Maria Angelica] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil; [Jacob, Julio C. F.] Univ Fed Rural Rio de Janeiro, Dept Reprod & Anim Evaluat, Rio De Janeiro, Brazil; [Smith, Lawrence C.] Univ Montreal, Dept Vet Biomed, Ctr Rech Reprod Anim, Fac Vet Med, St Hyacinthe, PQ, Canada; [Gastal, Melba O.; Gastal, Eduardo L.] Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL USA		Miglino, MA (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil.	miglino@usp.br	Smith, Lawrence/AAP-4321-2021; Barreto, Rodrigo/E-4634-2015; Miglino, Maria Angelica/B-9519-2012; Smith, Lawrence C/K-4658-2012; Gastal, Eduardo Leite/O-8359-2019; Gastal, Eduardo L/Q-9854-2017	Smith, Lawrence/0000-0001-8766-0148; Barreto, Rodrigo/0000-0001-5240-6959; Miglino, Maria Angelica/0000-0003-4979-115X; Gastal, Eduardo Leite/0000-0002-8855-6980; Gastal, Eduardo L/0000-0002-8855-6980; Favaron, Phelipe/0000-0002-6431-6886			Acker DA, 2001, AM J VET RES, V62, P1358, DOI 10.2460/ajvr.2001.62.1358; Almqvist PM, 2002, J HISTOCHEM CYTOCHEM, V50, P147, DOI 10.1177/002215540205000203; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Anderson R, 2005, HEAD INJURY PATHOPHY, P26; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Andressen C, 2001, STEM CELLS, V19, P419, DOI 10.1634/stemcells.19-5-419; ANTANITUS DS, 1976, BRAIN RES, V103, P613, DOI 10.1016/0006-8993(76)90464-9; Aquino DA, 1996, DEV BRAIN RES, V91, P1, DOI 10.1016/0165-3806(95)00146-8; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Biagiotti T, 2006, STEM CELLS, V24, P443, DOI 10.1634/stemcells.2004-0264; Bifari F, 2009, J CELL MOL MED, V13, P3195, DOI 10.1111/j.1582-4934.2009.00706.x; BIRSE SC, 1980, J COMP NEUROL, V194, P291, DOI 10.1002/cne.901940202; Blumbergs P. C., 2005, HEAD INJURY PATHOPHY, P41; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; Coumbe C, 1996, GUIDE MANAGEMENT EME, P71; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; DEGIORGIO LA, 1994, J NEUROL SCI, V124, P141, DOI 10.1016/0022-510X(94)90319-0; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dyson S, 1996, GUIDE MANAGEMENT EME, P89; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Eurell J. A., 2007, DELLMANNS TXB VET HI; EVANS H E, 1973, Zentralblatt fuer Veterinaermedizin Reihe C, V2, P11; Feary DJ, 2007, JAVMA-J AM VET MED A, V231, P259, DOI 10.2460/javma.231.2.259; Feige K, 2000, EQUINE VET EDUC, V12, P220, DOI 10.1111/j.2042-3292.2000.tb00044.x; Fiedorowicz A, 2008, GLIA, V56, P209, DOI 10.1002/glia.20605; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Halfter W, 2002, J NEUROSCI, V22, P6029; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Holmin S, 2001, NEUROSCI LETT, V314, P151, DOI 10.1016/S0304-3940(01)02292-3; Honig LS, 1996, CEREB CORTEX, V6, P794, DOI 10.1093/cercor/6.6.794; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Itokazu Y, 2006, GLIA, V53, P32, DOI 10.1002/glia.20255; Jacobs A, 1996, J NUCL MED, V37, P1605; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; LOPEZGARCIA C, 1992, HISTOL HISTOPATHOL, V7, P725; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lothian C, 1999, EXP CELL RES, V248, P509, DOI 10.1006/excr.1999.4417; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MacKay RJ, 2004, VET CLIN N AM-EQUINE, V20, P199, DOI 10.1016/j.cveq.2003.11.006; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MOKUNO K, 1989, J NEUROSCI RES, V23, P396, DOI 10.1002/jnr.490230405; Moore Rush B, 1997, CURRENT THERAPY EQUI, P301; Nakagawa T, 2004, CAN J NEUROL SCI, V31, P514, DOI 10.1017/S0317167100003747; Nakamura T, 2003, BRAIN RES, V981, P108, DOI 10.1016/S0006-8993(03)02991-3; NEUBERGER TJ, 1989, J NEUROCYTOL, V18, P695, DOI 10.1007/BF01187088; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Parker K, 2005, ANTICANCER RES, V25, P3855; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pimentel LA, 2009, PESQUI VET BRASIL, V29, P589, DOI 10.1590/S0100-736X2009000700015; RAGLE CA, 1988, VET RADIOLOGY, V29, P206, DOI 10.1111/j.1740-8261.1988.tb01500.x; RAGLE CA, 1993, VET CLIN N AM-EQUINE, V9, P171, DOI 10.1016/S0749-0739(17)30422-4; RAYMOND PA, 1983, J NEUROSCI, V3, P1077; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SARNAT HB, 1992, J NEUROPATH EXP NEUR, V51, P58, DOI 10.1097/00005072-199201000-00008; SASAKI S, 1994, ACTA NEUROPATHOL, V87, P578; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Simonati A, 1997, NEUROPATH APPL NEURO, V23, P203, DOI 10.1111/j.1365-2990.1997.tb01203.x; SORIANO E, 1989, J COMP NEUROL, V281, P586, DOI 10.1002/cne.902810408; STAGAARD M, 1989, ANAT EMBRYOL, V180, P17, DOI 10.1007/BF00321896; SUMMERS BA, 1995, VET NEUROPATHOLOGY, P189; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tardy M, 1990, Adv Exp Med Biol, V265, P41; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; TYLER CM, 1993, AUST VET J, V70, P445, DOI 10.1111/j.1751-0813.1993.tb00846.x; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yeom YI, 1996, DEVELOPMENT, V122, P881; You H, 2005, J NEURO-ONCOL, V74, P1, DOI 10.1007/s11060-004-2354-2; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100; Zhu H, 2003, BRAIN RES, V977, P180, DOI 10.1016/S0006-8993(03)02627-1; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1; Zupanc GKH, 1999, J EXP BIOL, V202, P1435; [No title captured]	124	7	7	0	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JAN	2017	61	1					61	78		10.1007/s12031-016-0805-9			18	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EH9ZL	WOS:000392130800008	27525635				2022-02-06	
J	Riley, JP; Boucher, AB; Kim, DS; Barrow, DL; Reynolds, MR				Riley, Jonathan P.; Boucher, Andrew B.; Kim, Denise S.; Barrow, Daniel L.; Reynolds, Matthew R.			The Role of Intraoperative Cerebral Angiography in Transorbital Intracranial Penetrating Trauma: A Case Report and Literature Review	WORLD NEUROSURGERY			English	Article						Cerebral angiography; Foreign body; Injury; Intracranial; Penetrating; Transorbital; Trauma	DIGITAL-SUBTRACTION-ANGIOGRAPHY; HELICAL CT ANGIOGRAPHY; INJURY; COMPLICATIONS; MANAGEMENT; DIAGNOSIS; ANEURYSMS; BRAIN	BACKGROUND: Transorbital intracranial penetrating trauma with a retained intracranial foreign body is a rare event lacking a widely accepted diagnostic and therapeutic algorithm. Intraoperative catheter angiography (IOA) has been advocated by some authorities to rule out cerebrovascular injury before and/or after removal of the object, but no standard of care currently exists. CASE DESCRIPTION: A 19-year-old man was involved in a construction site accident whereby a framing nail penetrated the left globe, traversed the lateral bony orbit, and terminated in the midtemporal lobe. No hematoma or injury to the middle cerebral arteries (MCAs) was apparent on noncontrast head computed tomography (CT) or CT angiography, respectively. The foreign body was removed in the operating room under direct visualization after a frontotemporal craniotomy without incident. No significant venous or arterial bleeding was encountered. All visualized MCA branches appeared intact. Indocyanine green videoangiography performed immediately after object removal showed adequate filling of the MCA branches. Given these uneventful clinical and radiographic findings, IOA was not performed. Postoperative head CT and CT angiography showed no obvious neurovascular injury. On postoperative day 2, the patient was noted to have an expressive aphasia. Cerebral angiography showed absent antegrade filling of the angular artery with some retrograde perfusion. Magnetic resonance imaging confirmed an ischemic infarction in the midtemporal lobe. The patient's expressive aphasia improved to near baseline during his hospitalization and he made an excellent clinical recovery. CONCLUSIONS: In transorbital intracranial penetrating trauma with a retained intracranial object, we advocate microsurgical removal of the object under direct visualization followed immediately by IOA. IOA should be strongly considered even in the setting of minimal intraoperative bleeding and normal findings on videoangiography (a course of action that was not followed in the present case). Given that CT angiography and intraoperative videoangiography may miss a potentially treatable traumatic arterial injury, IOA can help determine whether cerebral revascularization may be necessary.	[Riley, Jonathan P.; Reynolds, Matthew R.] Thomas Jefferson Univ, Jefferson Hosp Neurosci, Dept Neurosurg, Philadelphia, PA 19107 USA; [Boucher, Andrew B.; Barrow, Daniel L.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Kim, Denise S.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA USA		Reynolds, MR (corresponding author), Thomas Jefferson Univ, Jefferson Hosp Neurosci, Dept Neurosurg, Philadelphia, PA 19107 USA.	Matthew.Reynolds@jefferson.edu		Barrow, Daniel/0000-0003-0413-7883			Agrawal A, 2007, PEDIATR NEUROSURG, V43, P498, DOI 10.1159/000108794; Anderson GB, 1999, NEUROSURGERY, V45, P1315, DOI 10.1097/00006123-199912000-00008; Arat YO, 2015, ULUS TRAVMA ACIL CER, V21, P271, DOI 10.5505/tjtes.2015.48839; BARROW DL, 1992, NEUROSURGERY, V30, P153, DOI 10.1227/00006123-199202000-00001; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; DERDEYN CP, 1995, AM J NEURORADIOL, V16, P307; Doss VT, 2014, INTERV NEUROL, V3, P129, DOI 10.1159/000381148; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GREENE KA, 1993, SURG NEUROL, V40, P499, DOI 10.1016/0090-3019(93)90054-5; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; Kim MS, 2014, J KOREAN NEUROSURG S, V55, P222, DOI 10.3340/jkns.2014.55.4.222; Lasky JB, 1997, J TRAUMA, V42, P555, DOI 10.1097/00005373-199703000-00030; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; MARTIN NA, 1990, J NEUROSURG, V73, P526, DOI 10.3171/jns.1990.73.4.0526; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Munera F, 2000, RADIOLOGY, V216, P356, DOI 10.1148/radiology.216.2.r00jl25356; Paiva WS, 2010, CLIN OPHTHALMOL, V4, P1103, DOI 10.2147/OPTH.S9638; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Skoch J, 2013, J NEUROL SURG REP, V74, P23, DOI 10.1055/s-0033-1346976; TEASDALE G, 1974, LANCET, V2, P81; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; VANDER JF, 1988, OPHTHALMIC SURG LAS, V19, P328; Vieco PT, 1996, AM J NEURORADIOL, V17, P455; Wellwood J, 2002, NEUROL RES, V24, pS13	26	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97								76100000	10.1016/j.wneu.2016.09.083			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400150	27693768				2022-02-06	
J	Rodriguez, M; Boyce, P; Hodges, J				Rodriguez, Marcelo; Boyce, Philip; Hodges, John			A neuropsychological study of older adult first-time sex offenders	NEUROCASE			English	Article						Neuropsychological assessment; sex offenders; pedophiles; executive function; Iowa Gambling Task; frontotemporal dementia	COMPLEX FIGURE TEST; VARIANT FRONTOTEMPORAL DEMENTIA; TRAUMATIC BRAIN-INJURY; COGNITIVE TEST BATTERY; EXECUTIVE FUNCTIONS; PROCESSING SPEED; TEST-PERFORMANCE; EPISODIC MEMORY; FRONTAL-LOBE; FUNCTIONAL-ANATOMY	Background/Aims: The issue of whether sex offenders have cognitive deficits remains controversial. The objective of this study was to compare the neuropsychological function of older adult first time sex-offenders (FTSO), who had not previously been charged with a sexual offence prior to the age of 50, to historical long-term sex offenders (HSO) and non-sex offenders (NSO). The hypotheses were (a) that FTSO would demonstrate greater deficits in executive function, decision-making, and memory compared to non-sex offenders; and (b) the HSOs would present similar neuropsychological deficits to non-sex offenders. Method: A battery of neuropsychological measures was administered to 100 participants comprising 32 FTSOs, 36 HSOs, and 32 NSOs. Results: Both FTSOs and HSOs showed significant impairment on tests of executive function (including verbal fluency, trail-making, and the Hayling test of response inhibition) as well as on tests of verbal and verbal memory compared to NSOs; however, there was no difference between the two sex offender groups. Conclusions: Older adult sex offenders, overall, demonstrated poorer neuropsychological performance than older adult non-sex offenders did, although there was no difference between older first-time and historical offenders. Cognitive deficits may increase the risk of sexual offending due to impaired capacity in self-regulation, planning, judgment, and inhibition. A proportion of older adult sex offenders may be harboring acquired frontal lobe pathology.	[Rodriguez, Marcelo] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Boyce, Philip; Hodges, John] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia		Rodriguez, M (corresponding author), Justice Hlth & Forens Mental Hlth Network, Matraville, NSW, Australia.	mrodriguez@ozemail.com.au	Rodriguez, Marcelo/AAJ-5297-2021; , Philip/N-8430-2019	, Philip/0000-0002-9816-7356	National Health and Medical Research Council of Australia ProgramNational Health and Medical Research Council of Australia [1037746]; Australian Research Council Centre of Excellence in Cognition and its Disorders Memory NodeAustralian Research Council [CE110001021]	JRH is supported by Forefront, a collaborative research group dedicated to the study of frontotemporal dementia and motor neurone disease, from the National Health and Medical Research Council of Australia Program [Grant 1037746]; the Australian Research Council Centre of Excellence in Cognition and its Disorders Memory Node [CE110001021].	Abracen J., 1991, J FORENSIC PSYCHIATR, V2, P167, DOI [10.1080/09585189108407646, DOI 10.1080/09585189108407646]; Abwender DA, 2001, ASSESSMENT, V8, P323, DOI 10.1177/107319110100800308; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 1989, SEXUAL MARITAL THERA, V4, P59, DOI DOI 10.1080/02674658908407874; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A., 2007, IOWA GAMBLING TASK P; Bielak AAM, 2011, PSYCHOL AGING, V26, P576, DOI 10.1037/a0023313; Bondi MW, 2002, NEUROPSYCHOLOGY, V16, P335, DOI 10.1037//0894-4105.16.3.335; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burns JM, 2003, ARCH NEUROL-CHICAGO, V60, P437, DOI 10.1001/archneur.60.3.437; Cantor JM, 2005, PSYCHOL BULL, V131, P555, DOI 10.1037/0033-2909.131.4.555; Collette F, 2001, NEUROIMAGE, V14, P258, DOI 10.1006/nimg.2001.0846; Cornell DG, 1997, ARCH CLIN NEUROPSYCH, V12, P47; Cotrena C, 2016, J AFFECT DISORDERS, V190, P744, DOI 10.1016/j.jad.2015.11.007; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Dolan M, 2002, MED SCI LAW, V42, P34, DOI 10.1177/002580240204200107; Douglas KM, 2009, AUST NZ J PSYCHIAT, V43, P1105, DOI 10.3109/00048670903279887; Eastvold A, 2011, J INT NEUROPSYCH SOC, V17, P295, DOI 10.1017/S1355617710001669; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; Fossati P, 1999, PSYCHIAT RES, V89, P171, DOI 10.1016/S0165-1781(99)00110-9; Gillespie N. K., 2000, J SEX AGGRESS, V5, P21, DOI [10.1080/13552600008413293, DOI 10.1080/13552600008413293]; Hamsher K., 1989, MULTILINGUAL APHASIA; Hartley DE, 2004, PHARMACOL BIOCHEM BE, V78, P611, DOI 10.1016/j.pbb.2004.04.027; Harvey PO, 2004, J PSYCHIATR RES, V38, P567, DOI 10.1016/j.jpsychires.2004.03.003; HOOSHMAND H, 1969, NEUROLOGY, V19, P1119, DOI 10.1212/WNL.19.11.1119; Hornberger M, 2010, NEUROLOGY, V74, P472, DOI 10.1212/WNL.0b013e3181cef85d; Hornberger M, 2008, NEUROLOGY, V71, P1481, DOI 10.1212/01.wnl.0000334299.72023.c8; Hornberger M, 2012, BRAIN, V135, P678, DOI 10.1093/brain/aws011; Huey ED, 2009, NEUROLOGY, V72, P453, DOI 10.1212/01.wnl.0000341781.39164.26; Irish M, 2013, NEUROIMAGE-CLIN, V2, P836, DOI 10.1016/j.nicl.2013.06.005; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Johns EK, 2009, NEUROPSYCHOLOGY, V23, P765, DOI 10.1037/a0016792; Fernandez-Serrano MJ, 2010, J PSYCHOPHARMACOL, V24, P1317, DOI 10.1177/0269881109349841; Joyal CC, 2007, SEX ABUSE-J RES TR, V19, P155, DOI 10.1177/107906320701900206; Joyal CC, 2014, SEX ABUSE-J RES TR, V26, P149, DOI 10.1177/1079063213482842; Kafka Martin P, 2002, Sex Abuse, V14, P349, DOI 10.1023/A:1020007004436; Kerbs John J, 2009, Crim Justice Rev, V34, P119, DOI 10.1177/0734016808324245; KOLARSKY A, 1967, ARCH GEN PSYCHIAT, V17, P735; Langevin R, 2008, J FORENSIC PSYCHOL P, V8, P150, DOI 10.1080/15228930801963960; Levenson JS, 2011, SEX ABUSE-J RES TR, V23, P346, DOI 10.1177/1079063210382048; Levenson JS, 2004, SEX ABUSE-J RES TR, V16, P49, DOI 10.1023/B:SEBU.0000006284.33837.d7; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Luiselli JK, 2000, INT J OFFENDER THER, V44, P647, DOI 10.1177/0306624X00446002; Manes FF, 2010, NAT REV NEUROL, V6, P347, DOI 10.1038/nrneurol.2010.34; Maschi T, 2012, GERONTOLOGIST, V52, P441, DOI 10.1093/geront/gnr131; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mendez M, 2011, J SEX MED, V8, P1092, DOI 10.1111/j.1743-6109.2010.02172.x; Mendez MF, 2000, J NEUROPSYCH CLIN N, V12, P71, DOI 10.1176/jnp.12.1.71; Mendez MF, 2005, DEMENT GERIATR COGN, V20, P99, DOI 10.1159/000086474; Meyers J. E., 1995, CLIN NEUROPSYCHOL, V9, P63, DOI [10.1080/13854049508402059, DOI 10.1080/13854049508402059]; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; NathanielJames DA, 1997, NEUROPSYCHOLOGIA, V35, P559, DOI 10.1016/S0028-3932(96)00104-2; Nordlund A, 2007, NEUROPSYCHOLOGY, V21, P706, DOI 10.1037/0894-4105.21.6.706; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Perry RJ, 2000, NEUROLOGY, V54, P2277, DOI 10.1212/WNL.54.12.2277; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; Ratti MT, 2002, ACTA NEUROL SCAND, V105, P276, DOI 10.1034/j.1600-0404.2002.0o315.x; Raz N, 2003, BEHAV NEUROSCI, V117, P1169, DOI 10.1037/0735-7044.117.6.1169; REGESTEIN QR, 1978, J NERV MENT DIS, V166, P794, DOI 10.1097/00005053-197811000-00007; Ricci M, 2012, CLIN NEUROPSYCHOL, V26, P926, DOI 10.1080/13854046.2012.704073; Schiffer B, 2011, J SEX MED, V8, P1975, DOI 10.1111/j.1743-6109.2010.02140.x; Schmidt M., 2004, REY AUDITORY VERBAL; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Seto M. C., 2004, ARCH SEX BEHAV, V3, P55; Seux ML, 1998, J HYPERTENS, V16, P963, DOI 10.1097/00004872-199816070-00009; Shenal BV, 2003, NEUROPSYCHOL REV, V13, P33, DOI 10.1023/A:1022300622902; Silva HCA, 1999, ARQ NEURO-PSIQUIAT, V57, P798; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Stojkovic S, 2007, J ELDER ABUSE NEGL, V19, P97, DOI 10.1300/J084v19n03_06; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Suchy Y, 2014, J ABNORM PSYCHOL, V123, P273, DOI 10.1037/a0035812; Tabachnick B.G., 2013, USING MULTIVARIATE S; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Tsourtos G, 2002, PSYCHOL MED, V32, P259, DOI 10.1017/S0033291701005001; Veneziano C, 2004, PERCEPT MOTOR SKILL, V98, P661; Westervelt H, 2000, ARCH CLIN NEUROPSYCH, V15, P684, DOI 10.1016/S0887-6177(00)80060-8; Wiederkehr S, 2009, J GERIATR PSYCH NEUR, V22, P196, DOI 10.1177/0891988709335797; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zhou SS, 2011, BRAIN COGNITION, V75, P205, DOI 10.1016/j.bandc.2010.12.003	87	7	7	0	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2017	23	2					154	161		10.1080/13554794.2017.1334802			8	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	EZ3VX	WOS:000404639700009	28613138				2022-02-06	
J	Sanyang, E; Peek-Asa, C; Bass, P; Young, TL; Daffeh, B; Fuortes, LJ				Sanyang, Edrisa; Peek-Asa, Corinne; Bass, Paul; Young, Tracy L.; Daffeh, Babanding; Fuortes, Laurence J.			Risk Factors for Road Traffic Injuries among Different Road Users in the Gambia	JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH			English	Article							EPIDEMIOLOGY; EMERGENCY; TRANSPORT; TRADE	We identified risk factors for road traffic injuries among road users who received treatment at two major trauma hospitals in urban Gambia. The study includes pedestrians, bicyclists, motorcyclists, and drivers/passengers of cars and trucks. We examined distributions of injury by age, gender, collision vehicle types and vehicle category, and driver and environment factors. Two hundred and fifty-four patients were included in the study. Two-thirds were male and one-third female. Two-thirds (67%) of road traffic injuries involved pedestrians, bicyclists, and motorcyclists; and these were more common during weekdays (74%) than weekends. Nearly half (47%) of road traffic injuries involved pedestrians. One-third (34%) of injured patients were students (mean age of students was less than 14 years), more than half (51%) of whomwere injured on the roadway as pedestrians. Head/skull injuries were common. Concussion/brain injuries were 3.5 times higher among pedestrians, bicyclists, and motorcyclists than vehicle occupants. Crashes involving pedestrians were more likely to involve young people(< 25 years; aOR 6.36, 95% CI: 3.32-12.17) and involve being struck by a motor car (aOR 3.95, 95% CI: 2.09-7.47). Pedestrians contribute the largest proportion of hospitalizations in the Gambia. Young pedestrians are at particularly high risk. Prevention efforts should focus on not only vehicle and driver factors, but also protecting pedestrians, bicyclists, and motorcyclists.	[Sanyang, Edrisa; Bass, Paul] Univ Gambia, Sch Med & Allied Hlth Sci, Dept Publ & Environm Hlth, Brikama, Gambia; [Sanyang, Edrisa; Peek-Asa, Corinne; Young, Tracy L.] Univ Iowa, Coll Publ Hlth, Injury Prevent & Res Ctr, Iowa City, IA USA; [Daffeh, Babanding] Serrekunda Gen Hosp, Emergency Dept, Kanifing, Gambia; [Fuortes, Laurence J.] Univ Iowa, Coll Publ Hlth, Ctr Int Rural & Environm Hlth, Iowa City, IA USA		Sanyang, E (corresponding author), Univ Gambia, Sch Med & Allied Hlth Sci, Dept Publ & Environm Hlth, Brikama, Gambia.	esanyang@utg.edu.gm		Bass, Paul/0000-0001-7032-9758	NIOSH CDC HHS [T42 OH008491] Funding Source: Medline; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [T42OH008491] Funding Source: NIH RePORTER		Akpan U, 2014, AFR DEV REV, V26, P64, DOI 10.1111/1467-8268.12093; [Anonymous], 2015, GAMB 2013 POP HOUS C; Bakhtiyari M, 2015, TRAFFIC INJ PREV, V16, P36, DOI 10.1080/15389588.2014.898182; Buys P, 2010, J AFR ECON, V19, P399, DOI 10.1093/jae/ejq006; El-Gendy SD, 2015, E MEDITERR HEALTH J, V21, P120, DOI 10.26719/2015.21.2.120; European Transport Council, 2010, SPEED FACT SHEET SET; Government of the Gambia, 2011, ACC GROWTH EMPL DEV; Government of the Gambia, 2011, PROGR ACC GROWTH EMP; Hamann C., 2014, INJURY PREVENTION; Hyder AA, 2014, B WORLD HEALTH ORGAN, V92, P423, DOI 10.2471/BLT.13.132613; Iddriss A, 2011, B WORLD HEALTH ORGAN, V89, P565, DOI 10.2471/BLT.11.086892; Karau P. B., 2015, ANN AFRICAN SURG, V12, P4; Ma DR, 2015, TRAFFIC INJ PREV, V16, P835, DOI 10.1080/15389588.2015.1030501; Majdan M, 2015, TRAFFIC INJ PREV, V16, P450, DOI 10.1080/15389588.2014.962133; Mitchell RJ, 2015, INJURY, V46, P874, DOI 10.1016/j.injury.2015.02.006; Olumide AO, 2015, TRAFFIC INJ PREV, V16, P691, DOI 10.1080/15389588.2014.1001842; Organization for Economic Conference and Development, 2006, SPEED MAN; Pattinson W, 2014, PROCD SOC BEHV, V125, P251, DOI 10.1016/j.sbspro.2014.01.1471; Sietchiping R, 2012, CITIES, V29, P183, DOI 10.1016/j.cities.2011.11.005; Solagberu BA, 2015, TRAFFIC INJ PREV, V16, P184, DOI 10.1080/15389588.2014.921817; Turner S, 2011, TRANSPORT RES REC, P66, DOI 10.3141/2236-08; Wood JM, 2009, ACCIDENT ANAL PREV, V41, P772, DOI 10.1016/j.aap.2009.03.014; World Economic Forum, 2013, TRAV TOUR COMP REP 2; World Health Organization, GLOB STAT REP ROAD S; World Health Organization, 2015, GLOB STAT REP ROAD S	25	7	7	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9805	1687-9813		J ENVIRON PUBLIC HEA	J. Environ. Public Health		2017	2017								8612953	10.1155/2017/8612953			9	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	ES7WM	WOS:000399762100001	28512475	Green Submitted, Green Published, gold			2022-02-06	
J	Saykally, JN; Hatic, H; Keeley, KL; Jain, SC; Ravindranath, V; Citron, BA				Saykally, Jessica N.; Hatic, Haris; Keeley, Kristen L.; Jain, Subhash C.; Ravindranath, Vijayalakshmi; Citron, Bruce A.			Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury	CELL TRANSPLANTATION			English	Article						Ayurveda; Withania somnifera; neuroprotection; neurites; SH-SY5Y; traumatic brain injury	BRAIN-INJURY; OXIDATIVE STRESS; DISEASE; CELLS; ASHWAGANDHA; APOPTOSIS; MEDICINE; STRETCH; STROKE; MEMORY	Withania somnifera has been used in traditional medicine for a variety of neural disorders. Recently, chronic neurodegenerative conditions have been shown to benefit from treatment with this extract. To evaluate the action of this extract on traumatically injured neurons, the efficacy of W. somnifera root extract as a neuroprotective agent was examined in cultured model neurons exposed to an in vitro injury system designed to mimic mild traumatic brain injury (TBI). Neuronal health was evaluated by staining with annexin V (an early, apoptotic feature) and monitoring released lactate dehydrogenase activity (a terminal cell loss parameter). Potential mechanisms underlying the observed neuroprotection were examined. Additionally, morphological changes were monitored following injury and treatment. Although no differences were found in the expression of the antioxidant transcription factor nuclear factor erythroid 2-like 2 (Nrf2) or other Nrf2-related downstream components, significant changes were seen in apoptotic signaling. Treatment with the extract resulted in an increased length of neurites projecting from the neuronal cell body after injury. W. somnifera extract treatment also resulted in reduced cell death in the model neuron TBI system. The cell death factor Bax was involved (its expression was reduced 2-fold by the treatment) and injury-induced reduction in neurite lengths and numbers was reversed by the treatment. This all indicates that W. somnifera root extract was neuroprotective and could have therapeutic potential to target factors involved in secondary injury and long-term sequelae of mild TBI.	[Saykally, Jessica N.; Hatic, Haris; Keeley, Kristen L.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Res & Dev, Lab Mol Biol, Bay Pines, FL USA; [Saykally, Jessica N.; Citron, Bruce A.] USF Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [Jain, Subhash C.] Univ Delhi, Dept Chem, Delhi, India; [Ravindranath, Vijayalakshmi] Indian Inst Sci, Ctr Neurosci, Bangalore, Karnataka, India		Citron, BA (corresponding author), Bay Pines VA Healthcare Syst, Res & Dev 151, Lab Mol Biol, Bldg 22,Room 123,POB 4125, Bay Pines, FL 33744 USA.	bcitron@health.usf.edu			Department of Veterans AffairsUS Department of Veterans Affairs [I01RX001520]; Bay Pines Foundation; Florida Department of Health James and Esther King Biomedical Research Program [4KB14]; Veterans AffairsUS Department of Veterans Affairs [I01RX001520] Funding Source: NIH RePORTER	We appreciate the support provided by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development #I01RX001520), The Bay Pines Foundation, and the Florida Department of Health James and Esther King Biomedical Research Program (#4KB14).	Adams JD, 2002, ALTERN THER HEALTH M, V8, P18; Alam N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-175; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Baitharu I, 2013, J ETHNOPHARMACOL, V145, P431, DOI 10.1016/j.jep.2012.10.063; Brooks AR, 2002, PHYSIOL GENOMICS, V9, P27, DOI 10.1152/physiolgenomics.00075.2001; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Chaudhary G, 2003, CLIN EXP PHARMACOL P, V30, P399, DOI 10.1046/j.1440-1681.2003.03849.x; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Chopra A, 2004, JCR-J CLIN RHEUMATOL, V10, P236, DOI 10.1097/01.rhu.0000138087.47382.6d; Cooley K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006628; Du Y, 2008, ENVIRON HEALTH PERSP, V116, P1154, DOI 10.1289/ehp.11464; Durg S, 2015, J PHARM PHARMACOL, V67, P879, DOI 10.1111/jphp.12398; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Friedemann T, 2014, J ETHNOPHARMACOL, V155, P607, DOI 10.1016/j.jep.2014.06.004; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gupta G. L., 2007, Pharmacognosy Reviews, V1, P129; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Hu SQ, 2011, J ETHNOPHARMACOL, V135, P34, DOI 10.1016/j.jep.2011.02.017; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Kane MJ, 2011, BRAIN RES, V1425, P123, DOI 10.1016/j.brainres.2011.09.047; Kuboyama T, 2006, EUR J NEUROSCI, V23, P1417, DOI 10.1111/j.1460-9568.2006.04664.x; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kuboyama T, 2014, BIOL PHARM BULL, V37, P892, DOI 10.1248/bpb.b14-00022; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; Pingali U, 2014, PHARMACOGN RES, V6, P12, DOI 10.4103/0974-8490.122912; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Prabhakaran Y, 2012, PAK J PHARM SCI, V25, P595; RajaSankar S, 2009, J ETHNOPHARMACOL, V125, P369, DOI 10.1016/j.jep.2009.08.003; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Singh R, 2008, BIOGERONTOLOGY, V9, P369, DOI 10.1007/s10522-008-9185-z; Singh Ram Harsh, 2010, Int J Ayurveda Res, V1, P65, DOI 10.4103/0974-7788.64394; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Vareed SK, 2014, PHYTOTHER RES, V28, P1260, DOI 10.1002/ptr.5118; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Zhang Y, 2007, CELL RES, V17, P363, DOI 10.1038/cr.2007.11	44	7	7	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1193	1201		10.1177/0963689717714320			9	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800008	28933215	Green Published, gold			2022-02-06	
J	Schober, P; Bossers, SM; Schwarte, LA				Schober, Patrick; Bossers, Sebastiaan M.; Schwarte, Lothar A.			Intracranial Hematoma Detection by Near Infrared Spectroscopy in a Helicopter Emergency Medical Service: Practical Experience	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; INFRASCANNER; TECHNOLOGY; CHILDREN; DEVICE	In (helicopter) emergency medical services, (H) EMS, the prehospital detection of intracranial hematomas should improve patient care and the triage to specialized neurosurgical hospitals. Recently, noninvasive detection of intracranial hematomas became possible by applying transcranial near infrared spectroscopy (NIRS). Herein, second-generation devices are currently available, for example, the Infrascanner 2000 (Infrascan), that appear suited also for prehospital (H) EMS applications. Since (H) EMS operations are time-critical, we studied the Infrascanner 2000 as a "first-time-right" monitor in healthy volunteers (n = 17, hospital employees, no neurologic history). Further, we studied the implementation of the Infrascanner 2000 in a European HEMS organization (Lifeliner 1, Amsterdam, The Netherlands). The principal results of our study were as follows: The screening for intracranial hematomas in healthy volunteers with first-time-right intention resulted in a marked rate of virtual hematomas (false positive results, i.e., 12/ 17), rendering more time consuming repeat measurements advisable. The results of the implementation of the Infrascanner in HEMS suggest that NIRS-based intracranial hematoma detection is feasible in the HEMS setting. However, some drawbacks exist and their possible solutions are discussed. Future studies will have to demonstrate how NIRS-based intracranial hematoma detection will improve prehospital decision making in (H) EMS and ultimately patient outcome.	[Schober, Patrick; Bossers, Sebastiaan M.; Schwarte, Lothar A.] Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands; [Schober, Patrick; Schwarte, Lothar A.] Vrije Univ Amsterdam, Med Ctr, Trauma Ctr, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands; [Schober, Patrick; Schwarte, Lothar A.] Vrije Univ Amsterdam, Med Ctr, Helicopter Emergency Med Serv HEMS Lifeliner 1, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands		Schwarte, LA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands.; Schwarte, LA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Trauma Ctr, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands.; Schwarte, LA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Helicopter Emergency Med Serv HEMS Lifeliner 1, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands.	l.schwarte@vumc.nl	Bossers, Sebastiaan/AAE-1085-2020; Schober, Patrick/G-7400-2012	Bossers, Sebastiaan/0000-0002-2396-2777; Schober, Patrick/0000-0003-0814-081X			Braun T, 2015, UNFALLCHIRURG, V118, P693, DOI 10.1007/s00113-013-2549-0; Bressan S, 2014, CHILD NERV SYST, V30, P477, DOI [10.1007/s00381-014-2368-9, 10.1007/s00381-013-2314-2]; Francis SV, 2005, J CLIN NEUROSCI, V12, P291, DOI 10.1016/j.jocn.2004.06.009; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Ghalenoui H, 2008, PREHOSP DISASTER MED, V23, P558, DOI 10.1017/S1049023X00006415; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kim AL, 2015, MIL MED, V180, P597, DOI 10.7205/MILMED-D-14-00670; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Schober P., 2016, AIR MED J, V35; Schweigkofler U, 2015, UNFALLCHIRURG, V118, P240, DOI 10.1007/s00113-014-2566-7; Semenova ZB, 2016, BRAIN INJURY, V30, P18, DOI 10.3109/02699052.2014.989401; Sen AN, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031409; Wilson MH, 2016, RESUSCITATION, V105, P52, DOI 10.1016/j.resuscitation.2016.05.007; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988	17	7	7	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2017	2017								1846830	10.1155/2017/1846830			6	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	EY4HD	WOS:000403937300001	28717647	Green Published, Green Submitted, gold			2022-02-06	
J	Stanley, RM; Johnson, MD; Vance, C; Bajaj, L; Babcock, L; Atabaki, S; Thomas, D; Simon, HK; Cohen, DM; Rubacalva, D; Adelson, PD; Bulloch, B; Rogers, AJ; Mahajan, P; Baren, J; Lee, L; Hoyle, J; Quayle, K; Casper, TC; Dean, JM; Kuppermann, N				Stanley, Rachel M.; Johnson, Michael D.; Vance, Cheryl; Bajaj, Lalit; Babcock, Lynn; Atabaki, Shireen; Thomas, Danny; Simon, Harold K.; Cohen, Daniel M.; Rubacalva, Daniel; Adelson, P. David; Bulloch, Blake; Rogers, Alexander J.; Mahajan, Prashant; Baren, Jill; Lee, Lois; Hoyle, John; Quayle, Kimberly; Casper, T. Charles; Dean, J. Michael; Kuppermann, Nathan		PECARN	Challenges Enrolling Children Into Traumatic Brain Injury Trials: An Observational Study	ACADEMIC EMERGENCY MEDICINE			English	Article							CLINICAL-TRIALS; TRANEXAMIC ACID; UNIQUE CHALLENGES; PROGESTERONE; MULTICENTER; HYPOTHERMIA	ObjectivesIn preparation for a clinical trial of therapeutic agents for children with moderate-to-severe blunt traumatic brain injuries (TBIs) in emergency departments (EDs), we conducted this feasibility study to (1) determine the number and clinical characteristics of eligible children, (2) determine the timing of patient andguardian arrival to the ED, and (3) describe the heterogeneity of TBIs on computed tomography (CT) scans. MethodsWe conducted a prospective observational study at 16 EDs of children 18years of age presenting with blunt head trauma and Glasgow Coma Scale scores of 3-12. We documented the number of potentially eligible patients, timing of patient and guardian arrival, patient demographics and clinical characteristics, severity of injuries, and cranial CT findings. ResultsWe enrolled 295 eligible children at the 16 sites over 6 consecutive months. Cardiac arrest and nonsurvivable injuries were the most common characteristics that would exclude patients from a future trial. Most children arrived within 2hours of injury, but most guardians did not arrive until 2-3hours after the injury. There was a substantial range in types of TBIs, with subdural hemorrhages being the most common. ConclusionEnrolling children with moderate-to-severe TBI into time-sensitive clinical trials will require large numbers of sites and meticulous preparation and coordination and will prove challenging to obtain informed consent given the timing of patient and guardian arrival. The Federal Exception from Informed Consent for Emergency Research will be an important consideration for enrolling these children.	[Stanley, Rachel M.; Rogers, Alexander J.] Univ Michigan, Dept Emergency Med & Pediat, Ann Arbor, MI 48109 USA; [Stanley, Rachel M.; Cohen, Daniel M.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Johnson, Michael D.] Univ Utah, Div Pediat Emergency Med, Salt Lake City, UT USA; [Vance, Cheryl; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Vance, Cheryl; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Bajaj, Lalit] Childrens Hosp Colorado, Dept Pediat, Denver, CO USA; [Babcock, Lynn] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Atabaki, Shireen] Childrens Natl Med Ctr, Dept Emergency Med, Washington, DC 20010 USA; [Thomas, Danny] Med Coll Wisconsin, Childrens Hosp Wisconsin, Sect Pediat Emergency Med, Milwaukee, WI 53226 USA; [Simon, Harold K.] Emory Univ, Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA 30322 USA; [Simon, Harold K.] Emory Univ, Childrens Healthcare Atlanta, Dept Emergency Med, Atlanta, GA 30322 USA; [Rubacalva, Daniel] Texas Childrens Hosp, Baylor Coll Med, Emergency Med, Dept Pediat Med, Houston, TX 77030 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Div Neurosurg, Phoenix, AZ USA; [Bulloch, Blake] Phoenix Childrens Hosp, Div Emergency Med, Phoenix, AZ USA; [Mahajan, Prashant] Wayne State Univ, Childrens Hosp Michigan, Div Pediat Emergency Med, Detroit, MI USA; [Baren, Jill] Univ Penn, Childrens Hosp Philadelphia, Dept Emergency Med, Philadelphia, PA 19104 USA; [Lee, Lois] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Hoyle, John] Helen DeVos Childrens Hosp, Emergency Med, Div Pediat Emergency Med, Grand Rapids, MI USA; [Hoyle, John] Michigan State Univ, Dept Emergency Med, Grand Rapids, MI USA; [Hoyle, John] Western Michigan Univ, Sch Med, Dept Emergency Med, Kalamazoo, MI 49008 USA; [Hoyle, John] Western Michigan Univ, Sch Med, Dept Pediat Adolescent Med, Kalamazoo, MI 49008 USA; [Quayle, Kimberly] Washington Univ, Sch Med, Div Pediat Emergency Med, St Louis, MO USA; [Casper, T. Charles; Dean, J. Michael] Univ Utah, PECARN Data Coordinating Ctr, Div Pediat Crit Care, Salt Lake City, UT USA		Stanley, RM (corresponding author), Univ Michigan, Dept Emergency Med & Pediat, Ann Arbor, MI 48109 USA.; Stanley, RM (corresponding author), Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA.	Rachel.Stanley@nationwidechildrens.org	Adelson, David/W-2083-2019	Babcock, Lynn/0000-0002-2658-6893; Johnson, Michael/0000-0001-5483-5933; Thomas, Danny/0000-0002-7470-9835	Health Resources and Services Administration (HRSA)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); Maternal and Child Health Bureau (MCHB); Emergency Medical Services for Children (EMSC) Targeted Issues Grant (TIG) [H34MC10353]; HRSA, MCHB, EMSC Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	This project was supported by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Targeted Issues Grant (TIG) H34MC10353 and the HRSA, MCHB, EMSC Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Badaki-Makun O, 2014, PEDIATR BLOOD CANCER, V61, P1049, DOI 10.1002/pbc.24925; Beno S, 2014, CRIT CARE, V18, DOI 10.1186/cc13965; Center for Disease Control and Prevention, RAT TBI REL DEATHS A; Centers for Disease Control and Prevention, GET STATS TRAUM BRAI; Chamberlain JM, 2014, JAMA-J AM MED ASSOC, V311, P1652, DOI 10.1001/jama.2014.2625; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Faul M, 2010, TRAUMATIC BRAIN INJU; Food and Drug Administration, 2011, GUID I REV BOARDS CL; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Holmes JF, 2009, ACAD EMERG MED, V16, P15, DOI 10.1111/j.1553-2712.2008.00293.x; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Moler FW, 2011, CRIT CARE MED, V39, P141, DOI 10.1097/CCM.0b013e3181fa3c17; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Nishijima DK, 2016, J EMERG MED, V50, P868, DOI 10.1016/j.jemermed.2016.02.004; Pusateri AE, 2013, SHOCK, V39, P121, DOI 10.1097/SHK.0b013e318280409a; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stanley R., EMSC TARG ISS GRANT; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Tzimenatos L, 2015, PEDIATR EMERG CARE, V31, P70, DOI 10.1097/PEC.0000000000000303; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	34	7	7	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JAN	2017	24	1					31	39		10.1111/acem.13085			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EK4DD	WOS:000393876400004	27618167	Bronze, Green Published			2022-02-06	
J	Studerus-Germann, AM; Engel, DC; Stienen, MN; von Ow, D; Hildebrandt, G; Gautschi, OP				Studerus-Germann, Aline M.; Engel, Doortje C.; Stienen, Martin N.; von Ow, Dieter; Hildebrandt, Gerhard; Gautschi, Oliver P.			Three versus seven days to return-to-work after mild traumatic brain injury: a randomized parallel-group trial with neuropsychological assessment	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Mild traumatic brain injury; return-to-work; post-concussion syndrome; neuropsychological assessment; temporary work disability	CONCUSSION; SYMPTOMS; ASSOCIATION; PREDICTION; MANAGEMENT; FOOTBALL; RECOVERY; OUTCOMES	Although most patients with a mild traumatic brain injury (mTBI) recover within days to weeks, some experience persistent physical, cognitive and emotional symptoms, often described as post-concussion syndrome (PCS). The optimal recovery time including return-to-work (RTW) after mTBI is unclear. In this single-centre parallel-group trial, patients assigned three days (3D-group) or seven days (7D-group) sick leave were compared with a comprehensive neuropsychological test battery including the Post-Concussion Symptom Scale (PCSS) within one week, after three and 12 months post-injury. The influence of the effective time until RTW on post-concussional symptoms and cognitive performance was analysed. The 3D-group rated significantly higher mean scores in some PCSS symptoms, tended to fulfil diagnosis criteria of PCS more often and showed better cognitive performance in several neuropsychological test scores than the 7D-group at all three time-points of follow-up. Overall, patients returned to work 11.35 d post-injury, thus distinctly above both recommended sick leaves. There was a trend for longer sick leave in patients randomized into the 3D-group. Further analyses revealed that the group with an absolute RTW within one week showed lower symptom severity in fatigue at 3 and 12 months, less PCS and faster performance in fine motor speed at 12 months than the group with an absolute RTW after one week. Our data underline the heterogeneity of mTBI and show that acute and sub-acute symptoms are not prognostic factors for neuropsychological outcome at one year. Later, ability to work seems to be prognostic for long-term occurrence of PCS.	[Studerus-Germann, Aline M.] State Hosp St Gallen, Div Neuropsychol, Dept Neurol, St Gallen, Switzerland; [Studerus-Germann, Aline M.] Univ Zurich, Dept Psychopathol & Clin Intervent, Zurich, Switzerland; [Engel, Doortje C.; Stienen, Martin N.; Hildebrandt, Gerhard; Gautschi, Oliver P.] Cantonal Hosp St Gallen, Dept Neurosurg, St Gallen, Switzerland; [Engel, Doortje C.] Univ Hosp Tubingen, Dept Neurosurg, Tubingen, Germany; [Stienen, Martin N.] Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; [Stienen, Martin N.] Univ Hosp Geneva, Fac Med, Geneva, Switzerland; [von Ow, Dieter; Gautschi, Oliver P.] Cantonal Hosp St Galllen, Emergency Dept, St Gallen, Switzerland		Gautschi, OP (corresponding author), Cantonal Hosp St Gallen, Dept Neurosurg, St Gallen, Switzerland.; Gautschi, OP (corresponding author), Cantonal Hosp St Galllen, Emergency Dept, St Gallen, Switzerland.	ogautschi@gmail.com	Stienen, Martin Nikolaus/I-2547-2019	Stienen, Martin Nikolaus/0000-0002-6417-1787	clinical trial unit (CTU) commission; Olga Mayenfisch Foundation; Hans und Wilma Stutz Foundation; Alfred und Bertha Zangger-Weber Foundation; Wilma Stutz foundation; Commission of the Clinical Trials Unit of the Cantonal Hospital St. Gallen; Department of Neurosurgery, Cantonal Hospital St. Gallen	The authors thank Mrs Patzl and Mrs Filipin of the Clinical Trial Unit of the Cantonal Hospital St. Gallen for their important contribution in the collection of data. The authors also thank the clinical trial unit (CTU) commission, the Olga Mayenfisch Foundation, the Hans und Wilma Stutz Foundation and the Alfred und Bertha Zangger-Weber Foundation for their financial support.; The study was funded by three independent private foundations (Olga Mayenfisch, Wilma Stutz and Alfred und Bertha Zangger-Weber), the Commission of the Clinical Trials Unit of the Cantonal Hospital St. Gallen and the Department of Neurosurgery, Cantonal Hospital St. Gallen.	Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Balzer C, 2011, MAT NORMWERTE NEUROP; Bullinger M., 1995, J PUBLIC HEALTH-UK, V3, P21, DOI [10.1007/BF02959944, DOI 10.1007/BF02959944]; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Kruijk JR, 2001, BRAIN INJURY, V15, P117, DOI 10.1080/026990501458353; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Green P, 2004, GREENS MED SYMPTOM V; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hautzinger M, 2006, BECK DEPRESSION INVE; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Janke W, 2008, 4 UBERARBEITETE ERWE; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Maercker A, 2007, PSYCHOPATHOLOGY, V40, P135, DOI 10.1159/000099290; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Margraf, 2007, BECK ANGST INVENTAR; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Reitan RM, 1992, TRAIL MAKING TEST MA; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schellig D., 2001, VISUELLER VERBALER M; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Trites R., 1989, GROOVED PEGBOARD TES; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Velikonja D, 2013, BRAIN INJURY, V27, P158, DOI 10.3109/02699052.2012.729289; von Aster M., 2006, WECHSLER INTELLIGENZ; von Wild KRH, 2008, ACT NEUR S, V101, P55; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Zazzo R., 1969, MANUEL EXAMEN PSYCHO, V2, P469; Zimmermann P, 2002, TESTBATTERIE AUFMERK	39	7	7	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2017	127	10					900	908		10.1080/00207454.2017.1278589			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FC9NS	WOS:000407169000010	28042930				2022-02-06	
J	Veliu, B; Leathem, J				Veliu, Bahrie; Leathem, Janet			Neuropsychological assessment of refugees: Methodological and cross-cultural barriers	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Assessment; cross culture; neuropsychology	AFRICAN-AMERICAN ACCULTURATION; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; TEST-PERFORMANCE; TESTS; ABILITIES; EDUCATION; LANGUAGE; MEMORY; HEALTH	Cross-cultural research in neuropsychological assessment has primarily focused on Hispanic and African American populations. Less is known about the impact of language, culture, education, socioeconomic factors, and life experiences on assessment for other cultural groups. We highlight the methodological and cross-cultural barriers encountered at each stage of the neuropsychological assessment of Arabic- and Burmese-speaking refugees, who were culturally and linguistically diverse (CALD). A total of 18 refugees (13 men/five women; in their 20-50s) who were victims of torture in their countries of origin, some with post-traumatic stress disorder (PTSD) and now residents in New Zealand, were seen for neuropsychological assessment. Measures were officially translated, back translated, and administered with the assistance of professional interpreters. Multiple challenges arose in terms of administration (e.g., use of interpreters, interactions with the tester, assessment environment, assessment experience, and motivation), scoring, and interpretation (e.g., age appropriate scoring, estimation of prior function, estimation of brain injury severity, obtaining collateral information), the tests themselves, and ecological validity. There are more challenges in the neuropsychological assessment of people who are CALD than can be managed by adhering to current guidelines. The best approach is to find a balance between maintaining assessment integrity and working creatively and sensitively with this group.	[Veliu, Bahrie; Leathem, Janet] Massey Univ, Sch Psychol, POB 756, Wellington, New Zealand		Leathem, J (corresponding author), Massey Univ, Sch Psychol, POB 756, Wellington, New Zealand.	J.M.Leathem@massey.ac.nz					Acevedo A, 2000, J INT NEUROPSYCH SOC, V6, P760, DOI 10.1017/S1355617700677032; ADAM BARBARA, 1990, TIME SOCIAL THEORY; Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; [Anonymous], 2002, Am Psychol, V57, P1060; ARDILA A, 1995, J CLIN EXP NEUROPSYC, V17, P143, DOI 10.1080/13803399508406589; Ardila A, 2005, NEUROPSYCHOL REV, V15, P185, DOI 10.1007/s11065-005-9180-y; ARDILA A, 1989, BRAIN COGNITION, V11, P147, DOI 10.1016/0278-2626(89)90015-8; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P495, DOI 10.1016/S0887-6177(99)00040-2; Ardila A, 2001, J INT NEUROPSYCH SOC, V7, P510, DOI 10.1017/S1355617701004076; Ardila A., 2013, NEUROPSYCHOLOGY NEW, P59; Ardila A, 2010, ARCH CLIN NEUROPSYCH, V25, P689, DOI 10.1093/arclin/acq079; Arnold B. R., 1994, ASSESSMENT, V1, P239, DOI DOI 10.1177/107319119400100303; Blake TM, 2009, CLIN NEUROPSYCHOL, V23, P373, DOI 10.1080/13854040802279691; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Cagigas X.E., 2014, CLIN NEUROPSYCHOLOGY, P132; Carstairs JR, 2006, AUST PSYCHOL, V41, P48, DOI 10.1080/00050060500391878; Cattell RB, 1940, J EDUC PSYCHOL, V31, P161, DOI 10.1037/h0059043; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; CHEN TH, 1994, PERCEPT MOTOR SKILL, V79, P1683, DOI 10.2466/pms.1994.79.3f.1683; Cockburn J., 2003, RIVERMEAD BEHAV MEMO; Crosby SS, 2013, JAMA-J AM MED ASSOC, V310, P519, DOI 10.1001/jama.2013.8788; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dilks L., 2006, AM J PSYCHOL RES, V2, P8; Gangsei David, 2007, Torture, V17, P79; Greenfield PM, 1997, AM PSYCHOL, V52, P1115, DOI 10.1037/0003-066X.52.10.1115; Hambleton R. K., 2005, ADAPTING ED PSYCHOL; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Hughes Diane O, 1995, TIME HIST ETHNOLOGIE; IRVINE SH, 1988, HUMAN ABILITIES CULT; KAUFMAN AS, 1988, J CLIN PSYCHOL, V44, P231, DOI 10.1002/1097-4679(198803)44:2<231::AID-JCLP2270440224>3.0.CO;2-J; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Keatley E, 2013, J HEAD TRAUMA REHAB, V28, pE8, DOI 10.1097/HTR.0b013e3182776a70; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Khaleefa O. H., 1995, J ISLAMIC STUDIES, V6, P222, DOI [10.1093/jis/6.2.222, DOI 10.1093/JIS/6.2.222]; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Long C.J., 1995, ADV MED PSYCHOTHERAP, V8, P59; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Luria A.R., 1976, COGNITIVE DEV ITS CU; Luria AR, 1932, PEDAGOG SEMIN J GEN, V40, P241; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Makatura TJ, 1999, BRAIN INJURY, V13, P355; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Murray K., 2008, PSYCHOL WELLBEING RE; Nell V, 2004, COMPREHENSIVE HDB PS, V1, P333; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ogden JA, 1997, NEW ZEAL J PSYCHOL, V26, P2; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PUENTE A, 2004, COMPREHENSIVE HDB PS, V1, P321; Puente A. E., 2013, HDB MULTICULTURAL ME, VSecond, P225; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; Reis A, 1997, J INT NEUROPSYCH SOC, V3, P444, DOI 10.1017/S135561779700444X; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; REYNOLDS CR, 1987, J SCHOOL PSYCHOL, V25, P323, DOI 10.1016/0022-4405(87)90035-5; Romero HR, 2009, CLIN NEUROPSYCHOL, V23, P761, DOI 10.1080/13854040902881958; ROSSELLI M, 1990, BRAIN COGNITION, V12, P281, DOI 10.1016/0278-2626(90)90020-O; Rosselli M, 2001, DEV NEUROPSYCHOL, V20, P355, DOI 10.1207/S15326942DN2001_3; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; SALMON DP, 1995, CLIN NEUROPSYCHOL, V9, P159, DOI 10.1080/13854049508401598; Shannon PJ, 2015, QUAL HEALTH RES, V25, P443, DOI 10.1177/1049732314549475; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Stanczak DE, 2001, ARCH CLIN NEUROPSYCH, V16, P141, DOI 10.1016/S0887-6177(99)00060-8; Tombaugh T. N., 1997, TEST MEMORY MALINGER; Walker AJ, 2010, AUST PSYCHOL, V45, P112, DOI 10.1080/00050060903428210; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitfield KE, 1999, INT J AGING HUM DEV, V48, P73, DOI 10.2190/YGAQ-0D95-M0V4-820M; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Worrell F. C., 2016, PSYCHOEDUCATIONAL AS	78	7	7	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	6					481	492		10.1080/23279095.2016.1201483			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FQ8ME	WOS:000418616100001					2022-02-06	
J	Xiao, H; Jacobsen, A; Chen, ZQ; Wang, Y				Xiao, Hui; Jacobsen, Andre; Chen, Ziqian; Wang, Yang			Detecting social-cognitive deficits after traumatic brain injury: An ALE meta-analysis of fMRI studies	BRAIN INJURY			English	Article						Traumatic brain injury; social function; social-cognitive ability; functional MRI; ALE meta-analysis	DIFFUSE AXONAL INJURY; EMOTION RECOGNITION; ATTENTIONAL SKILLS; PREFRONTAL CORTEX; FUNCTIONAL MRI; HEAD-INJURY; CHILDREN; MIND; ACTIVATION; LANGUAGE	Purpose: Traumatic brain injury (TBI) can result in significant social dysfunction, which is represented by impairment to social-cognitive abilities (i.e. social cognition, social attention/executive function and communication). This study is aimed to explore brain networks mediating the social dysfunction after TBI and its underlying mechanisms. Methods: We performed a quantitative meta-analysis using the activation likelihood estimation (ALE) approach on functional magnetic resonance imaging (fMRI) studies of social-cognitive abilities following TBI. Sixteen studies fulfilled the inclusion criteria resulting in a total of 190 patients with TBI and 206 controls enrolled in the ALE meta-analysis. Results: The temporoparietal junction (TPJ) and the medial prefrontal cortex (mPFC) were the specific regions that social cognition predominantly engaged. The cingulate gyrus, frontal gyrus and inferior parietal lobule were the main regions related to social attention/executive functions. Communication dysfunction, especially related to language deficits, was found to show greater activation of the temporal gyrus and fusiform gyrus in TBI. Conclusion: The current ALE meta-analytic findings provide evidence that patients have significant social-cognitive disabilities following TBI. The relatively limited pool of literature and the varied fMRI results from published studies indicate that social-cognitive abilities following TBI is an area that would greatly benefit from further investigation.	[Xiao, Hui; Chen, Ziqian] PLA, Dept Med Imaging, Fuzhou Gen Hosp Nanjing Mil Command, Fuzhou, Fujian, Peoples R China; [Jacobsen, Andre; Wang, Yang] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA		Wang, Y (corresponding author), Med Coll Wisconsin, Ctr Imaging Res, Dept Radiol, MACC Fund Res Ctr, G2412,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	yangwang@mcw.edu			GE-NFL Head Health Challenge I; Indiana Spinal Cord and Brain Injury Research Fund (ISCBIRF)	This work was partially supported by the GE-NFL Head Health Challenge I and Indiana Spinal Cord and Brain Injury Research Fund (ISCBIRF) (to Y.W.). The authors report no conflicts of interest.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; BRETT M, 1999, MNI BRAIN TALAIRACH; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kochunov P, 2002, NEUROIMAGE, V17, P922, DOI 10.1006/nimg.2002.1084; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Kramer ME, 2009, J PEDIATR REHAB MED, V2, P255, DOI 10.3233/PRM-2009-0091; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617713000428; Muller RA, 1998, ARCH NEUROL-CHICAGO, V55, P1113, DOI 10.1001/archneur.55.8.1113; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schroeter ML, 2010, NEUROPSYCHOLOGIA, V48, P185, DOI 10.1016/j.neuropsychologia.2009.09.004; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Staudt M, 2001, NEUROLOGY, V57, P122, DOI 10.1212/WNL.57.1.122; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Szaflarski JP, 2006, ANN NEUROL, V59, P796, DOI 10.1002/ana.20817; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531	65	7	7	3	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1331	1339		10.1080/02699052.2017.1319576			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800010	28627941				2022-02-06	
J	Xie, F; Cai, HW; Peng, FY				Xie, Fang; Cai, Huawei; Peng, Fangyu			(CuCl2)-Cu-64 PET/CT imaging of mouse muscular injury induced by electroporation	AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Muscle injury; electroporation; positron emission tomography; copper metabolism; copper-64 chloride	COPPER-METABOLISM; SKELETAL-MUSCLE; MODEL; ZINC	Skeletal muscle injury is common in body injuries suffered in sports and car accidents. Development of new tracers is significant for assessing muscular injury with positron emission tomography/computed tomography (PET/CT) and monitoring repair of muscle injury in response to treatment. Copper is required for wound healing and increased copper ions were detected in the soft tissue of wound in rodents and human. Based on the recent finding of increased Cu-64 uptake in the traumatic brain injury, this study aimed to explore use of (CuCl2)-Cu-64 as a radiotracer for molecular imaging of muscular injury using PET/CT. Focally increased Cu-64 uptake by the injured muscular tissue (5.4 +/- 1.2% ID/g) was detected in the C57BL/6 mice with electroporation-induced skeletal muscle injury by PET/CT after intravenous injection of (CuCl2)-Cu-64 as a tracer, compared to low Cu-64 uptake associated with muscular inflammation induced by intramuscular injection of lipopolysaccharides (0.82 +/- 0.26% ID/g, P < 0.01) or physiological Cu-64 uptake of the non-injured muscular tissues (0.78 +/- 0.20% ID/g, P < 0.01). The findings support further investigation of (CuCl2)-Cu-64 as a new radiotracer for molecular imaging of skeletal muscle injury using PET/CT.	[Xie, Fang; Cai, Huawei; Peng, Fangyu] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Peng, Fangyu] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Cai, Huawei] Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China		Peng, FY (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Fangyu.Peng@UTSouthwes-tern.edu	Peng, Fangyu/D-1079-2015	Peng, Fangyu/0000-0002-3142-3845	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [7R21EB005331-03, 1R21NS074394-01A1]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24CA086307] Funding Source: NIH RePORTER	We acknowledge assistance from Rachel Sparks in mouse tissue histological analysis. This pilot study was partially supported by NIH (7R21EB005331-03 and 1R21NS074394-01A1 to FP). The production of <SUP>64</SUP>CuCl<INF>2</INF> at Washington University School of Medicine was supported by NIH/NCI (R24 CA86307).	Carter EA, 1997, LIFE SCI, V61, P39, DOI 10.1016/S0024-3205(97)00355-X; Connell DA, 2004, AM J ROENTGENOL, V183, P975, DOI 10.2214/ajr.183.4.1830975; Ekstrand J, 2012, BRIT J SPORT MED, V46, P112, DOI 10.1136/bjsports-2011-090155; Heiderscheit BC, 2010, J ORTHOP SPORT PHYS, V40, P67, DOI 10.2519/jospt.2010.3047; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Jones PW, 2000, J INORG BIOCHEM, V81, P1, DOI 10.1016/S0162-0134(00)00119-7; Koulouris G, 2005, RADIOGRAPHICS, V25, P571, DOI 10.1148/rg.253045711; Koulouris G, 2007, AM J SPORT MED, V35, P1500, DOI 10.1177/0363546507301258; Lansdown ABG, 1999, J ANAT, V195, P375, DOI 10.1046/j.1469-7580.1999.19530375.x; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Maffulli N., 2014, TRANSL MED UNISA, V12, P14; May DA, 2000, RADIOGRAPHICS, V20, pS295, DOI 10.1148/radiographics.20.suppl_1.g00oc18s295; MILANINO R, 1993, AGENTS ACTIONS, V39, P195, DOI 10.1007/BF01998974; Olivares M, 1996, AM J CLIN NUTR, V63, P791, DOI 10.1093/ajcn/63.5.791; Peng FY, 2015, J NUCL MED, V56, P1252, DOI 10.2967/jnumed.115.154575; Peng FY, 2012, MOL IMAGING BIOL, V14, P600, DOI 10.1007/s11307-011-0532-0; Peng FY, 2012, MOL IMAGING BIOL, V14, P70, DOI 10.1007/s11307-011-0476-4; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Slavotinek JP, 2010, SEMIN MUSCULOSKEL R, V14, P194, DOI 10.1055/s-0030-1253160; SPEER KP, 1993, AM J SPORT MED, V21, P89, DOI 10.1177/036354659302100116; Uauy R, 1998, AM J CLIN NUTR, V67, p952S, DOI 10.1093/ajcn/67.5.952S; WHITEHOUSE MW, 1978, AGENTS ACTIONS, V8, P85, DOI 10.1007/BF01972407	23	7	7	0	5	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-8407			AM J NUCL MED MOLEC	Am. J. Nucl. Med. Molec. Imaging		2017	7	1					33	39					7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	EQ5KX	WOS:000398122700004	28123866				2022-02-06	
J	Xu, XL; Zhao, SJ; Liu, H; Sun, ZP; Wang, JW; Zhang, WG				Xu, Xiangliang; Zhao, Shijie; Liu, Hui; Sun, Zhipeng; Wang, Jianwei; Zhang, Weiguang			An Anatomical Study of Maxillary-Zygomatic Complex Using Three-Dimensional Computerized Tomography-Based Zygomatic Implantation	BIOMED RESEARCH INTERNATIONAL			English	Article							BONE; PLACEMENT; SINUS; COMPLICATIONS; INSERTION; SURVIVAL; PROTOCOL; GUIDES; FLOOR	Objective. To obtain anatomical data of maxillary-zygomatic complex based on simulating the zygomatic implantation using cadaver heads and three-dimensional computerized tomography (3D-CT). Methods. Simulating zygomatic implantation was performed using seven cadaver heads and 3D-CT images from forty-eight adults. After measuring the maxillary-zygomatic complex, we analyzed the position between the implantation path and the maxillary sinus cavity as well as the distance between the implantation path and the zygomatic nerve. Results. The distance from the starting point to the endpoint of the implant was 56.85 +/- 5.35 mm in cadaver heads and 58.15 +/- 7.37 mm in 3D-CT images. For the most common implantation path (80.20%), the implant went through the maxillary sinus cavity completely. The projecting points of the implant axis (IA) on the surface of zygoma were mainly located in the region of frontal process of zygomatic bone close to the lateral orbital wall. The distances between IA and zygomatic nerve in 53 sides were shorter than 2 mm. Conclusion. The simulating zygomatic implantation on cadaver skulls and 3D-CT imaging provided useful anatomical data of the maxillary-zygomatic complex. It is necessary to take care to avoid the zygomatic nerve injury during implantation, because it frequently appears on the route of implantation.	[Xu, Xiangliang; Zhao, Shijie] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100081, Peoples R China; [Liu, Hui] Peking Univ, Dept Radiol, Shougang Hosp, Beijing 100041, Peoples R China; [Sun, Zhipeng] Peking Univ, Dept Med Radiol, Sch & Hosp Stomatol, Beijing 100081, Peoples R China; [Wang, Jianwei; Zhang, Weiguang] Peking Univ, Dept Anat & Histol & Embryol, Hlth Sci Ctr, Beijing 100191, Peoples R China		Zhang, WG (corresponding author), Peking Univ, Dept Anat & Histol & Embryol, Hlth Sci Ctr, Beijing 100191, Peoples R China.	zhangwg@bjmu.edu.cn		Zhang, Wei-Guang/0000-0001-5055-4907			Boyes-Varley JG, 2003, INT J ORAL MAX IMPL, V18, P232; BRANEMARK PI, 1984, J ORAL MAXIL SURG, V42, P497, DOI 10.1016/0278-2391(84)90008-9; Chow J, 2006, J ORAL MAXIL SURG, V64, P804, DOI 10.1016/j.joms.2006.01.021; Chrcanovic BR, 2016, J ORAL MAXIL SURG, V74, P1949, DOI 10.1016/j.joms.2016.06.166; Chrcanovic BR, 2013, ORAL MAXILLOFAC SURG, V17, P1, DOI 10.1007/s10006-012-0316-y; Corvello PC, 2011, J CRANIO MAXILL SURG, V39, P119, DOI 10.1016/j.jcms.2010.03.021; Esposito M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004151.pub3; Gasparini G, 2017, J CRANIOFAC SURG, V28, P250, DOI 10.1097/SCS.0000000000003261; Kahnberg KE, 2001, CLIN ORAL IMPLAN RES, V12, P479, DOI 10.1034/j.1600-0501.2001.120508.x; Malevez C, 2004, CLIN ORAL IMPLAN RES, V15, P18, DOI 10.1046/j.1600-0501.2003.00985.x; Malevez C, 2003, PERIODONTOL 2000, V33, P82, DOI 10.1046/j.0906-6713.2002.03307.x; Molinero-Mourelle P, 2016, MED ORAL PATOL ORAL, V21, pE751, DOI 10.4317/medoral.21357; Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P72, DOI 10.1034/j.1600-0501.2003.140110.x; Parel SM, 2001, J PROSTHET DENT, V86, P377, DOI 10.1067/mpr.2001.118874; Raghoebar GM, 1997, BRIT J ORAL MAX SURG, V35, P119, DOI 10.1016/S0266-4356(97)90687-2; Rigolizzo MB, 2005, INT J ORAL MAX IMPL, V20, P441; Rossi M, 2008, CLIN IMPLANT DENT R, V10, P271, DOI 10.1111/j.1708-8208.2008.00091.x; Takamaru N, 2016, INT J ORAL MAX SURG, V45, P104, DOI 10.1016/j.ijom.2015.07.015; ten Bruggenkate CM, 1998, PERIODONTOL 2000, V17, P176; Uchida Y, 2001, J ORAL MAXIL SURG, V59, P1193, DOI 10.1053/joms.2001.26725; van Steenberghe D, 2003, CLIN ORAL IMPLAN RES, V14, P131, DOI 10.1034/j.1600-0501.2003.140118.x; Vrielinck L, 2003, INT J ORAL MAX SURG, V32, P7, DOI 10.1054/ijom.2002.0337; Zwahlen RA, 2006, INT J ORAL MAX IMPL, V21, P413	23	7	7	1	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2017	2017								8027307	10.1155/2017/8027307			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	FP6QN	WOS:000417750700001	29376077	Green Published, Green Submitted, gold			2022-02-06	
J	Bjork, JM; Burroughs, TK; Franke, LM; Pickett, TC; Johns, SE; Moeller, FG; Walker, WC				Bjork, James M.; Burroughs, Thomas K.; Franke, Laura M.; Pickett, Treven C.; Johns, Sade E.; Moeller, F. Gerard; Walker, William C.			Laboratory impulsivity and depression in blast-exposed military personnel with post-concussion syndrome	PSYCHIATRY RESEARCH			English	Article						Impulsivity; Military; Veteran; Depression; Suicide; Commission errors; Concussion; Traumatic brain injury; Blast exposure; Substance abuse	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SUICIDAL-BEHAVIOR; POSTCONCUSSIVE SYMPTOMS; EXECUTIVE DYSFUNCTION; RESPONSE-INHIBITION; MILD; VETERANS; RISK; PTSD	In military populations, traumatic brain injury (TBI) also holds potential to increase impulsivity and impair mood regulation due to blast injury effects on ventral frontal cortex to put military personnel at risk for suicide or substance abuse. We assessed a linkage between depression and impaired behavioral inhibition in 117 blast exposed service members (SM) and veterans with post-concussion syndrome (PCS), where PCS was defined using a Rivermead Postconcussive Symptom Questionnaire (RPQ) modified to clarify whether each symptom worsened compared to pre-blast. Center for Epidemiological Studies-Depression Scale (CES-D) scores, PTSD Checldist 5 (PCL-5) scores, and RPQ raw subscale scores correlated positively with commission and perseverative errors on the continuous performance test II (CPT-II). In contrast, the number of RPQ symptoms ostensibly tuorsened post-blast did not correlate with impulsive errors on the CPT-II. These data replicate earlier findings that link increased affective symptomatology to impaired behavior inhibition in military TBI populations, but where additional effects on impulsivity from the blast itself remain equivocal.	[Bjork, James M.; Burroughs, Thomas K.; Pickett, Treven C.; Walker, William C.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Franke, Laura M.; Walker, William C.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Bjork, James M.; Pickett, Treven C.; Johns, Sade E.; Moeller, F. Gerard] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Franke, Laura M.; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Bjork, JM (corresponding author), Hunter Holmes McGuire VA Med Ctr, Mental Hlth Serv, Room 2M-245,1201 Broad Rock Blvd, Richmond, VA 23249 USA.	james.bjork@va.gov	Bjork, James/Q-5108-2019; Franke, Lude/P-7036-2016	Bjork, James/0000-0003-0593-3291; Franke, Lude/0000-0002-5159-8802	Congressionally Directed Medical Research Projects (CDMRP) [W91ZSQ8118N620]; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs [W91YTZ-11-C-0033]; National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01DA041120, P50DA033935, U54DA038999, R01DA034131]; Veterans Health AdministrationUS Department of Veterans Affairs; Office of Research and Development; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P50DA033935, U54DA038999, R01DA034131] Funding Source: NIH RePORTER	This work was funded primarily by the Congressionally Directed Medical Research Projects (CDMRP) Award # W91ZSQ8118N620 with some support from the Defense and Veterans Brain Injury Center (DVBIC) (# W91YTZ-11-C-0033). JMB is currently supported by National Institutes of Health, USA grants 1U01DA041120 and P50DA033935, and FGM by National Institutes of Health, USA grants U54DA038999 and R01DA034131. The authors report no other conflicts of interest. This material is in part based upon work supported in part by the Veterans Health Administration, and Office of Research and Development.	Admon R, 2009, P NATL ACAD SCI USA, V106, P14120, DOI 10.1073/pnas.0903183106; Armistead-Jehle P., 2015, APPL NEUROPSYCH-ADUL, P1; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P343, DOI 10.1080/13854046.2013.774438; Bjork JM, 2004, ALCOHOL, V34, P133, DOI 10.1016/j.alcohol.2004.06.012; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Conners C. K., 2000, CONNERS CPT 2 WINDOW; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Dougherty DM, 2004, SUICIDE LIFE-THREAT, V34, P374, DOI 10.1521/suli.34.4.374.53738; Dougherty DM, 2009, PSYCHIAT RES, V169, P22, DOI 10.1016/j.psychres.2008.06.011; Ersner-Hershfield H, 2009, SOC COGN AFFECT NEUR, V4, P85, DOI 10.1093/scan/nsn042; Franke L. M., 2016, PREVALENCE COG UNPUB; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Holbourn AHS, 1943, LANCET, V2, P438; Horesh N, 2001, Crisis, V22, P27, DOI 10.1027//0227-5910.22.1.27; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jentsch JD, 2014, ANN NY ACAD SCI, V1327, P1, DOI 10.1111/nyas.12388; Keilp JG, 2013, PSYCHOL MED, V43, P539, DOI 10.1017/S0033291712001419; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Moeller SJ, 2014, TRENDS COGN SCI, V18, P635, DOI 10.1016/j.tics.2014.09.003; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; O'Connor RC, 2014, LANCET PSYCHIAT, V1, P73, DOI 10.1016/S2215-0366(14)70222-6; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Sladky R, 2015, CEREB CORTEX, V25, P895, DOI 10.1093/cercor/bht279; Smith JL, 2014, DRUG ALCOHOL DEPEN, V145, P1, DOI 10.1016/j.drugalcdep.2014.08.009; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; WechslerD, 2001, WECHSLER TEST ADULT; White SF, 2016, AM J PSYCHIAT, V173, P282, DOI 10.1176/appi.ajp.2015.15020250; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wu CS, 2009, COMPR PSYCHIAT, V50, P315, DOI 10.1016/j.comppsych.2008.09.006; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	50	7	7	0	15	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	DEC 30	2016	246						321	325		10.1016/j.psychres.2016.10.008			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EG3TT	WOS:000390968300048	27750113				2022-02-06	
J	Haber, YO; Chandler, HK; Serrador, JM				Haber, Yaa O.; Chandler, Helena K.; Serrador, Jorge M.			Symptoms Associated with Vestibular Impairment in Veterans with Posttraumatic Stress Disorder	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ANXIETY DISORDERS; PTSD CHECKLIST; PRIMARY-CARE; HEAD-INJURY; PSYCHOMETRIC PROPERTIES; MOBILITY INVENTORY; CIVILIAN VERSION; BALANCE CONTROL; DIZZY PATIENTS	Posttraumatic stress disorder (PTSD) is a chronic and disabling, anxiety disorder resulting from exposure to life threatening events such as a serious accident, abuse or combat (DSM IV definition). Among veterans with PTSD, a common complaint is dizziness, disorientation and/or postural imbalance in environments such as grocery stores and shopping malls. The etiology of these symptoms in PTSD is poorly understood and some attribute them to anxiety or traumatic brain injury. There is a possibility that an impaired vestibular system may contribute to these symptoms since, symptoms of an impaired vestibular system include dizziness, disorientation and postural imbalance. To our knowledge, this is the first report to describe the nature of vestibular related symptoms in veterans with and without PTSD. We measured PTSD symptoms using the Posttraumatic Stress Disorder Checklist (PCL-C) and compared it to responses on vestibular function scales including the Dizziness Handicap Inventory (DHI), the Vertigo Symptom Scale Short Form (VSS-SF), the Chambless Mobility Inventory (CMI), and the Neurobehavioral Scale Inventory (NSI) in order to identify vestibular-related symptoms. Our findings indicate that veterans with worse PTSD symptoms report increased vestibular related symptoms. Additionally veterans with PTSD reported 3 times more dizziness related handicap than veterans without PTSD. Veterans with increased avoidance reported more vertigo and dizziness related handicap than those with PTSD and reduced avoidance. We describe possible contributing factors to increased reports of vestibular symptoms in PTSD, namely, anxiety, a vestibular component as well as an interactive effect of anxiety and vestibular impairment. We also present some preliminary analyses regarding the contribution of TBI. This data suggests possible evidence for vestibular symptom reporting in veterans with PTSD, which may be explained by possible underlying vestibular impairment, worthy of further exploration.	[Haber, Yaa O.; Serrador, Jorge M.] Rutgers Biomed Hlth Sci, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Haber, Yaa O.; Chandler, Helena K.; Serrador, Jorge M.] Vet Affairs New Jersey Healthcare Syst, War Related Illness & Injury Study Ctr, E Orange, NJ USA; [Serrador, Jorge M.] Natl Univ Ireland Galway, Cardiovasc Elect, Galway, Ireland		Chandler, HK (corresponding author), Vet Affairs New Jersey Healthcare Syst, War Related Illness & Injury Study Ctr, E Orange, NJ USA.	Helena.chandler@va.gov		Serrador, Jorge Manuel/0000-0003-1830-4398	War Related Illness and Injury Study Center (WRIISC); Office of Public Health within the Department of Veteran Affairs	This work was supported by the War Related Illness and Injury Study Center (WRIISC) and the Office of Public Health within the Department of Veteran Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Andersson G, 2000, SCAND J PSYCHOL, V41, P49, DOI 10.1111/1467-9450.00170; AZZENA GB, 1993, ARCH ITAL BIOL, V131, P127; Baker DG, 1997, ARCH INTERN MED, V157, P2076, DOI 10.1001/archinte.157.18.2076; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Balaban CD, 2001, J ANXIETY DISORD, V15, P27, DOI 10.1016/S0887-6185(00)00041-4; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; CHAMBLESS DL, 1985, BEHAV RES THER, V23, P35, DOI 10.1016/0005-7967(85)90140-8; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Cominski TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00273; COX BJ, 1993, BEHAV RES THER, V31, P427, DOI 10.1016/0005-7967(93)90102-Z; Dobie DJ, 2006, J GEN INTERN MED, V21, pS58, DOI 10.1111/j.1525-1497.2006.00376.x; Dutia MB, 2010, CURR OPIN OTOLARYNGO, V18, P420, DOI 10.1097/MOO.0b013e32833de71f; Furman JM, 2006, J VESTIBUL RES-EQUIL, V16, P209; Gore KL, 2008, GEN HOSP PSYCHIAT, V30, P391, DOI 10.1016/j.genhosppsych.2008.05.002; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; Jacob RG, 1996, AM J PSYCHIAT, V153, P503; JOHANSSON R, 1991, ACTA OTO-LARYNGOL, P585; Karstoft KI, 2014, PSYCHOL ASSESSMENT, V26, P321, DOI 10.1037/a0034889; Karstoft KI, 2013, PSYCHOL ASSESSMENT, DOI [10.1186/1472-6815-8-2, DOI 10.1186/1472-6815-8-2]; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Ma FR, 2007, CHINESE MED J-PEKING, V120, P120, DOI 10.1097/00029330-200701020-00009; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Murray K, 2001, Physiother Res Int, V6, P251, DOI 10.1002/pri.232; Pogoda TK, 2012, MULTISENSORY IMPAIRM, P971; Radziej K, 2015, J PSYCHOSOM RES, V79, P123, DOI 10.1016/j.jpsychores.2015.05.005; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Rogers C, 2011, S AFR J COMMUN DISOR, V58, P6; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Saman Yougan, 2012, Front Neurol, V3, P116, DOI 10.3389/fneur.2012.00116; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schlund MW, 2010, NEUROIMAGE, V53, P769, DOI 10.1016/j.neuroimage.2010.06.058; Schubert MC, 2004, PHYS THER, V84, P373, DOI 10.1093/ptj/84.4.373; Serrador JM BM, ASS RES OTOLARYNGOLO; Surget A, 2008, EUR J PHARMACOL, V583, P340, DOI 10.1016/j.ejphar.2007.11.065; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; Teggi R, 2010, J LARYNGOL OTOL, V124, P285, DOI 10.1017/S0022215109991976; WALL C, 1983, ACTA OTO-LARYNGOL, V95, P235, DOI 10.3109/00016488309130940; Wilhelmsen K, 2008, BMC EAR NOSE THROAT, V8, DOI 10.1186/1472-6815-8-2; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; YARDLEY L, 1994, SOC SCI MED, V39, P573, DOI 10.1016/0277-9536(94)90100-7; YARDLEY L, 1995, BEHAV RES THER, V33, P435, DOI 10.1016/0005-7967(94)00060-W; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; Yeh JR, 2014, GAIT POSTURE, V40, P581, DOI 10.1016/j.gaitpost.2014.06.016	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2016	11	12							e0168803	10.1371/journal.pone.0168803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7KQ	WOS:000391226900049	28033352	gold, Green Published, Green Submitted			2022-02-06	
J	Falk, SSI; Mittlmeier, T; Gradl, G				Falk, Steffi S. I.; Mittlmeier, Thomas; Gradl, Georg			Results of geriatric distal radius fractures treated by intramedullary fixation	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						intramedullary interlocking; radius fractures; osteoporotic fractures; Colles' fractures; functional assessment; geriatric fracture; geriatric patients	VOLAR PLATE FIXATION; LOCKING-PLATE; UNSTABLE FRACTURES; SURGICAL-TREATMENT; INTERNAL-FIXATION; PIN FIXATION; RISK-FACTORS; PALMAR; COMPLICATIONS; EPIDEMIOLOGY	Introduction: Distal radius fracture are common injuries but no gold standard for their therapy exists. The aim of this study was to evaluate the quality of fracture care in distal radius fractures using an intramedullary implant (Targon DR interlocking nail). The nail had been developed to minimize the surgical exposure, increase fixation strength, to prevent tendon irritations and to allow for a fast return to activity. Patients and Methods: This prospective study reports the result of 43 patients with an age over 70 years (range 7091 years) treated by closed reduction and intramedullary fixation. Inclusion criteria were displaced unilateral isolated AOA or C type fractures. The Targon DR interlocking nailwas used for all patients. The minimum follow up was 12 months. Results: All fractures united within 2 months. At one-year follow-up the patients had a mean extension of 96.1 +/- 1.5%, flexion of 91.6 +/- 3.3%, pronation of 99.4 +/- 0.7%, supination of 94.0 +/- 2.0%, radial abduction of 98.1 +/- 1.3%, ulnar deviation of 91.4 +/- 3.0% and a grip strength of 91.5 +/- 4.3% compared to the contralateral wrist. Pain score measured by a Visual Analogue Scale scored 0.0 +/- 0.0 at rest and in activity 0.3 +/- 0.3. The mean Castaing Score was good (1.06 +/- 0.30) and the Gartland & Werley Scorewas excellent (1.50 +/- 0.57). The mean radial shortening was 0.2 +/- 0.1 mm and radial inclination was 3.1 +/- 1.1 degrees (range +15 degrees to 0 degrees). No deep soft-tissue or chronic osseous infections were observed. One patient developed a carpal tunnel syndrome. Paraesthesia or dysaesthesia of the superficial radial nerve was registered in seven patients and fully recovered in four patients. There were two cases of single screw loosening. We also found two cases of screw overlength and consecutive contact with the ulnar head, one patient underwent implant removal. Another patient developed CRPS (2.3%). We did not observe any case of hardware failure, tendon irritation or tendon rupture. Conclusion: In geriatric patients intramedullary interlocking nailing of displaced extraarticular or intraarticular distal radius fracture with the Targon DR nail represents a viable treatment option and alternative to the use of volar interlocking plating in terms of fracture reduction, maintenance of reduction and functional outcome. (C) 2016 Elsevier Ltd. All rights reserved.	[Falk, Steffi S. I.; Mittlmeier, Thomas] Rostock Univ Med Ctr, Dept Trauma Hand & Reconstruct Surg, Rostock, Germany; [Gradl, Georg] Munich Municipal Hosp Grp, Dept Trauma Orthoped & Reconstruct Surg, Harlaching Clin, Munich, Germany		Falk, SSI (corresponding author), Rostock Univ Med Ctr, Dept Trauma Hand & Reconstruct Surg, Rostock, Germany.	steffi.falk@uni-rostock.de	Falk, Steffi/AAT-5402-2021; Mittlmeier, Thomas/R-5741-2019	Mittlmeier, Thomas/0000-0002-0536-8045	B. Braun Aesculap	The study was funded by B. Braun Aesculap. The funding organisation had no role in the design and conduct of the study; collection, management and analysis of the data; or preparation, review and approval of the manuscript.	Arealis G, 2014, INJURY, V45, P1579, DOI 10.1016/j.injury.2014.06.017; Arora R, 2007, J ORTHOP TRAUMA, V21, P316, DOI 10.1097/BOT.0b013e318059b993; Ateschrang A, 2010, Z ORTHOP UNFALLCHIR, V148, P319, DOI 10.1055/s-0029-1241027; Brogren E, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-48; Brooks KR, 2006, CLIN ORTHOP RELAT R, P42, DOI 10.1097/01.blo.0000205892.96575.d4; Burkhart KJ, 2010, CLIN BIOMECH, V25, P771, DOI 10.1016/j.clinbiomech.2010.06.004; CASTAING J, 1964, Rev Chir Orthop Reparatrice Appar Mot, V50, P581; Chen NC, 2007, J BONE JOINT SURG AM, V89A, P2051, DOI 10.2106/JBJS.G.00020; Chung KC, 2001, J HAND SURG-AM, V26A, P908, DOI 10.1053/jhsu.2001.26322; Costa ML, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4807; Endres HG, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-87; Espen D, 2009, OPER ORTHOPADE TRAUM, V21, P459, DOI 10.1007/s00064-009-1912-3; Farias Cisneros Efrain, 2010, Acta Ortop Mex, V24, P220; GARTLAND JJ, 1951, J BONE JOINT SURG AM, V33-A, P895, DOI 10.2106/00004623-195133040-00009; Geerts RWPM, 2011, ACTA ORTHOP TRAUMATO, V45, P85, DOI 10.3944/AOTT.2011.2333; Gruber G, 2006, ARCH ORTHOP TRAUM SU, V126, P680, DOI 10.1007/s00402-006-0191-9; Handoll HHG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006522.pub2; Handoll HHG, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003209.pub2, 10.1002/14651858.CD000434.pub4]; Harreld K, 2010, HAND CLIN, V26, P363, DOI 10.1016/j.hcl.2010.04.009; Horst TA, 2016, INJURY, V47, P313, DOI 10.1016/j.injury.2015.09.030; Ilyas AM, 2008, J HAND SURG-AM, V33A, P1706, DOI 10.1016/j.jhsa.2008.07.004; Jupiter, 1997, J Am Acad Orthop Surg, V5, P119; Jupiter JB, 2009, BONE JOINT SURG AM, V91, P55; Kreder HJ, 1996, J HAND SURG-AM, V21A, P31, DOI 10.1016/S0363-5023(96)80151-1; Lee YS, 2012, INT ORTHOP, V36, P789, DOI 10.1007/s00264-011-1424-2; Letsch R, 2003, ARCH ORTHOP TRAUM SU, V123, P333, DOI 10.1007/s00402-003-0538-4; Leung F, 2008, J BONE JOINT SURG AM, V90A, P16, DOI 10.2106/JBJS.F.01581; Lindemann-Sperfeld L, 2003, CHIRURG, V74, P1000, DOI 10.1007/s00104-003-0763-y; Loveridge J, 2013, J HAND SURG-ASIAN-PA, V18, P159, DOI 10.1142/S0218810413500184; MCQUEEN M, 1988, J BONE JOINT SURG BR, V70, P649, DOI 10.1302/0301-620X.70B4.3403617; McQueen MM, 1999, J ORTHOP TRAUMA, V13, P501, DOI 10.1097/00005131-199909000-00007; McQueen MM, 1998, J BONE JOINT SURG BR, V80B, P665, DOI 10.1302/0301-620X.80B4.8150; Muller M., 1990, COMPREHENSIVE CLASSI; Musgrave DS, 2005, J HAND SURG-AM, V30A, P743, DOI 10.1016/j.jhsa.2005.03.006; Nazar M A, 2009, Open Orthop J, V3, P96, DOI 10.2174/1874325000903010096; Nishiwaki M, 2011, J BONE JOINT SURG AM, V93A, P1436, DOI 10.2106/JBJS.J.01159; Perugia D, 2015, INJURY, V46, P1423, DOI [10.1016/j.injury.2014.10.018, 10.1016/j.injury.2015.04.028]; Reichl M, 2011, UNFALLCHIRURG, V114, P1099, DOI 10.1007/s00113-010-1859-8; Richard MJ, 2011, J HAND SURG-AM, V36A, P1614, DOI 10.1016/j.jhsa.2011.06.030; Rizzo Marco, 2008, Hand (N Y), V3, P111, DOI 10.1007/s11552-007-9080-0; Rozental TD, 2006, J HAND SURG-AM, V31A, P359, DOI 10.1016/j.jhsa.2005.10.010; Selvan DR, 2014, INJURY, V45, P1885, DOI 10.1016/j.injury.2014.05.035; Sieber CC, 2007, INTERNIST, V48, P1190, DOI 10.1007/s00108-007-1945-3; Simic Paul M, 2003, Instr Course Lect, V52, P185; Soong M, 2011, J BONE JOINT SURG AM, V93A, P328, DOI 10.2106/JBJS.J.00193; Soong M, 2011, J HAND SURG-AM, V36A, P3, DOI 10.1016/j.jhsa.2010.09.033; Sugun TS, 2011, J HAND SURG-EUR VOL, V36E, P320, DOI 10.1177/1753193410392869; Tan Virak, 2005, Tech Hand Up Extrem Surg, V9, P195, DOI 10.1097/01.bth.0000190818.66285.b6; Thompson PW, 2004, INJURY, V35, P462, DOI 10.1016/S0020-1383(03)00117-7; Van Staa TP, 2001, BONE, V29, P517, DOI 10.1016/S8756-3282(01)00614-7; Vanhaecke J, 2015, INJURY, V46, pS33, DOI 10.1016/j.injury.2015.08.010; Wick M, 2010, Z ORTHOP UNFALLCHIR, V148, P66, DOI 10.1055/s-0029-1186203; Wijffels MME, 2014, INJURY, V45, P1889, DOI 10.1016/j.injury.2014.08.007	53	7	7	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2016	47			7			S31	S35		10.1016/S0020-1383(16)30851-8			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EM3CW	WOS:000395193100008	28040075				2022-02-06	
J	Guay, JL; Lebretore, BM; Main, JM; DeFrangesco, KE; Taylor, JL; Amedoro, SM				Guay, Julie L.; Lebretore, Brittany M.; Main, Jesse M.; DeFrangesco, Katelyn E.; Taylor, Jessica L.; Amedoro, Sarah M.			The Era of Sport Concussion: Evolution of Knowledge, Practice, and the Role of Psychology	AMERICAN PSYCHOLOGIST			English	Article						sport concussion; psychology; neuropsychology; school psychology; multicultural	CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; HIGH-SCHOOL; BRAIN-INJURY; POSITION STATEMENT; UNITED-STATES; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; POSTCONCUSSIVE SYMPTOMS	The topic of sport concussion has gained significant prominence over the last 20 years, resulting in dramatic growth in research funding, widespread media coverage, and increased public awareness. Although the knowledge base has greatly expanded, there is still much that is unknown or controversial about the long-term effects of sports-related head injury. Because of the high stakes of mismanaging these injuries, professional sports organizations, federal/state government, and various health-related disciplines have responded with efforts to educate the public and improve treatment and management of this injury. This has resulted in changes to laws, game rules and policies, and recovery management protocols. The field of psychology has also made significant contributions to research on sports concussions, resulting in the development of new assessment and treatment protocols. This article summarizes the latest research findings on sport concussion, highlights areas that require more research before consensus can be reached, and discusses the ways that multiple disciplines within psychology (clinical, neuropsychology, school) can continue to play a critical role in enhancing patient care.	[Guay, Julie L.; Lebretore, Brittany M.; Main, Jesse M.; DeFrangesco, Katelyn E.; Taylor, Jessica L.; Amedoro, Sarah M.] Immaculata Univ, Malvern, PA USA; [Guay, Julie L.] Bryn Mawr Rehab Psychol Associates, Malvern, PA 19355 USA		Guay, JL (corresponding author), Bryn Mawr Rehab Psychol Associates, Malvern, PA 19355 USA.	julieguay1@yahoo.com					Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bey T, 2009, WEST J EMERG MED, V10, P6; Brody JE, 2015, NY TIMES; Brown S. R., 2012, NEW YORK DAILY NEWS; Bruce JM, 2004, NEUROLOGY, V63, P1516; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, 2014, RAT TBI REL EM DEP V; ChildStats. gov, 2013, FOR CHILD FAM STAT; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, VIn: Vol 12, P386; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Duff M., 2009, ASHA LEADER, V11, P10; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Fecke J., 2013, 9 FOOTBALL PLAYERS K; Ferguson RJ, 1996, SOURCEBOOK PSYCHOL T, P615; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kirk JW, 2012, MILD TRAUMATIC BRAIN, P321; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lewandowski LJ, 2009, J APPL SCH PSYCHOL, V25, P95, DOI 10.1080/15377900802484547; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Salinas CM, 2012, J CLIN SPORT PSYCHOL, V6, P363, DOI 10.1123/jcsp.6.4.363; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Tormenti M, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12282; Wallerson Ryan, 2014, WALL STREET J; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	82	7	7	3	26	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0003-066X	1935-990X		AM PSYCHOL	Am. Psychol.	DEC	2016	71	9					875	887		10.1037/a0040430			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EI1CK	WOS:000392213100003	28032779				2022-02-06	
J	Haley, KL; Shafer, JN; Harmon, TG; Jacks, A				Haley, Katarina L.; Shafer, Jennifer N.; Harmon, Tyson G.; Jacks, Adam			Recovering With Acquired Apraxia of Speech: The First 2 Years	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							APHASIA; STROKE; DYSARTHRIA	Purpose: This study was intended to document speech recovery for 1 person with acquired apraxia of speech quantitatively and on the basis of her lived experience. Method: The second author sustained a traumatic brain injury that resulted in acquired apraxia of speech. Over a 2-year period, she documented her recovery through 22 video-recorded monologues. We analyzed these monologues using a combination of auditory perceptual, acoustic, and qualitative methods. Results: Recovery was evident for all quantitative variables examined. For speech sound production, the recovery was most prominent during the first 3 months, but slower improvement was evident for many months. Measures of speaking rate, fluency, and prosody changed more gradually throughout the entire period. A qualitative analysis of topics addressed in the monologues was consistent with the quantitative speech recovery and indicated a subjective dynamic relationship between accuracy and rate, an observation that several factors made speech sound production variable, and a persisting need for cognitive effort while speaking. Conclusions: Speech features improved over an extended time, but the recovery trajectories differed, indicating dynamic reorganization of the underlying speech production system. The relationship among speech dimensions should be examined in other cases and in population samples. The combination of quantitative and qualitative analysis methods offers advantages for understanding clinically relevant aspects of recovery.	[Haley, Katarina L.; Shafer, Jennifer N.; Harmon, Tyson G.; Jacks, Adam] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC 27514 USA		Haley, KL (corresponding author), Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC 27514 USA.	Katarina_Haley@med.unc.edu	Jacks, Adam/AAD-8704-2020; Harmon, Tyson/AAB-6528-2020	Jacks, Adam/0000-0001-6358-2878; Harmon, Tyson/0000-0003-1936-8668; Haley, Katarina/0000-0002-1158-2160; Shafer, Jennifer/0000-0002-2154-0511			ACKERMANN H, 1993, CLIN LINGUIST PHONET, V7, P75, DOI 10.3109/02699209308985545; Boersma P, 2014, PRAAT DOING PHONETIC; Brady MC, 2011, CLIN REHABIL, V25, P935, DOI 10.1177/0269215511405079; Brendel B, 2008, APHASIOLOGY, V22, P77, DOI 10.1080/02687030600965464; Cunningham KT, 2016, APHASIOLOGY, V30, P396, DOI 10.1080/02687038.2015.1065470; Duffy JR., 2013, MOTOR SPEECH DISORDE; Geranmayeh F, 2014, BRAIN, V137, P2632, DOI 10.1093/brain/awu163; Goldberg S, 2012, AM J SPEECH-LANG PAT, V21, P222, DOI 10.1044/1058-0360(2012/11-0056); Grabe E, 2002, PHONOL PHONET, V4-1, P515; Haley K. L., 2015, ANN CONV AM SPEECH L; Haley K. L., 2013, CLIN APH C TUCS AZ; Haley KL, 2012, J SPEECH LANG HEAR R, V55, pS1502, DOI 10.1044/1092-4388(2012/11-0318); Haley KL, 2011, APHASIOLOGY, V25, P1600, DOI 10.1080/02687038.2011.628379; Haley KL, 2001, APHASIOLOGY, V15, P1125, DOI 10.1080/02687040143000537; Harris K., 1966, CORTEX, V2, P277; Jacks A., 2015, ANN CONV AM SPEECH L; Jacks A, 2015, J SPEECH LANG HEAR R, V58, P1670, DOI 10.1044/2015_JSLHR-S-14-0277; Kertesz A., 2007, WAB R W APHASIA BATT; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Low E., 2000, LANG SPEECH, V43, P377, DOI DOI 10.1177/00238309000430040301; Mauszycki SC., 2014, INT J PHYS MED REHAB, V2, P188, DOI [10.4172/2329-9096.1000188, DOI 10.4172/2329-9096.1000188]; Mauszycki SC, 2008, APHASIOLOGY, V22, P906, DOI 10.1080/02687030701800818; McNeil M.R., 2009, CLIN MANAGEMENT SENS, P249; MCNEIL MR, 1990, BRAIN LANG, V38, P135, DOI 10.1016/0093-934X(90)90106-Q; Pedersen PM, 2004, CEREBROVASC DIS, V17, P35, DOI 10.1159/000073896; Quene Hugo, 2010, PRAAT SCRIPT SYLLABL; Rorden C., 2014, MRICRON COMPUTER SOF; Rosenbek, 1984, APRAXIA SPEECH ADULT; SANDS ES, 1978, BRAIN LANG, V6, P97, DOI 10.1016/0093-934X(78)90047-0; Shafer J., 2015, ANN CONV AM SPEECH L; Shafer J., VOICE HALTED WEB LOG; Shriberg L.D., 2013, CLIN PHONETICS; Shriberg LD, 2003, CLIN LINGUIST PHONET, V17, P575, DOI 10.1080/0269920031000138141; SKENES LL, 1987, J COMMUN DISORD, V20, P61, DOI 10.1016/0021-9924(87)90044-X; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Wambaugh JL, 1998, J SPEECH LANG HEAR R, V41, P725, DOI 10.1044/jslhr.4104.725; Youmans G, 2011, AM J SPEECH-LANG PAT, V20, P23, DOI 10.1044/1058-0360(2010/09-0085)	37	7	7	0	10	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	DEC	2016	25	4		S			S687	S696		10.1044/2016_AJSLP-15-0143			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EI1WC	WOS:000392276100002	27997946				2022-02-06	
J	Hanson, KL; Schiehser, DM; Clark, AL; Sorg, SF; Kim, RT; Jacobson, MW; Werhane, ML; Jak, AJ; Twamley, EW; Delano-Wood, L				Hanson, Karen L.; Schiehser, Dawn M.; Clark, Alexandra L.; Sorg, Scott F.; Kim, Russell T.; Jacobson, Mark W.; Werhane, Madeleine L.; Jak, Amy J.; Twamley, Elizabeth W.; Delano-Wood, Lisa			Problem alcohol use in veterans with mild traumatic brain injury: Associations with cognitive performance and psychiatric symptoms	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Alcohol; Cognition; Posttraumatic stress disorder; Traumatic brain injury; Veterans	POSTTRAUMATIC-STRESS-DISORDER; DUTY MILITARY PERSONNEL; SUBSTANCE USE DISORDERS; NEUROPSYCHOLOGICAL OUTCOMES; ABSTINENT ALCOHOLICS; AUDIT QUESTIONNAIRE; COMBAT DEPLOYMENT; SERVICE MEMBERS; BINGE DRINKING; ABUSE	Introduction: Given that little is known about the associations between alcohol use, cognition, and psychiatric symptoms among veterans with a history of mild traumatic brain injury (mTBI), we aimed to (a) characterize how they differ from veteran controls on a measure of problem drinking; (b) investigate whether problem drinking is associated with demographic or mTBI characteristics; and (c) examine the associations between alcohol use, mTBI history, psychiatric functioning, and cognition. Method: We assessed 59 veterans (n = 32 with mTBI history; n = 27 military controls) for problem alcohol use (Alcohol Use Disorders Identification Test: AUDIT), psychiatric symptoms, and neuropsychological functioning. Results: Compared to controls, veterans with mTBI history were more likely to score above the AUDIT cutoff score of 8 (p = .016), suggesting a higher rate of problem drinking. Participants with mTBI history also showed elevated psychiatric symptoms (ps < .001) and lower cognitive scores (ps < .05 to < .001). Veterans with higher AUDIT scores were younger (p = .05) and had less education (p < .01) and more psychiatric symptoms (ps < .01), but mTBI characteristics did not differ. After controlling for combat and mTBI history (R-2 = .04, ns) and posttraumatic stress disorder (PTSD) symptoms (R-2 = .08, p = .05), we found that higher AUDIT scores were associated with poorer attention/processing speed, F(9, 37) = 2.55, p = .022; R-2 = .26, p = .03. Conclusions: This preliminary study suggested that veterans with mTBI history may be at increased risk for problem drinking. Problem alcohol use was primarily associated with more severe PTSD symptoms and poorer attention/processing speed, though not with combat or mTBI characteristics per se. Importantly, findings emphasize the importance of assessing for and treating problematic alcohol use and comorbid psychiatric symptoms among veterans, including those with a history of neurotrauma.	[Hanson, Karen L.; Schiehser, Dawn M.; Clark, Alexandra L.; Sorg, Scott F.; Kim, Russell T.; Jacobson, Mark W.; Werhane, Madeleine L.; Jak, Amy J.; Twamley, Elizabeth W.; Delano-Wood, Lisa] VA San Diego Healthcare Syst VASDHS, San Diego, CA USA; [Schiehser, Dawn M.; Jak, Amy J.; Twamley, Elizabeth W.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Hanson, Karen L.; Kim, Russell T.; Jacobson, Mark W.; Jak, Amy J.; Delano-Wood, Lisa] Vet Med Res Fdn, San Diego, CA USA; [Hanson, Karen L.; Schiehser, Dawn M.; Jacobson, Mark W.; Jak, Amy J.; Twamley, Elizabeth W.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Clark, Alexandra L.; Werhane, Madeleine L.] Univ Calif San Diego, San Diego State Univ Joint Doctoral Program Clin, San Diego, CA 92103 USA		Hanson, KL (corresponding author), 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA.	klhanson@ucsd.edu			Veterans Affairs (Merit and Career Development Awards) grant [CDA-2-034-07F, CX000842-01A2, CDA-2-065-10S]; Department of Defense (Investigator-Initiated Research Grant, IIRG) [W81XWH-10-2-0169]; VA San Diego Healthcare System (VA Center of Excellence for Stress and Mental Health)	This project was the result of research conducted at the VA San Diego Healthcare System (VASDHS) and the Veterans Medical Research Foundation, San Diego. This research was supported by grants from the Veterans Affairs (Merit and Career Development Awards) awarded to L. Delano-Wood [grant number CDA-2-034-07F], [grant number CX000842-01A2] and D. M. Schiehser [grant number CDA-2-065-10S]; and the Department of Defense (Investigator-Initiated Research Grant, IIRG) to L. Delano-Wood [grant number W81XWH-10-2-0169]. This material is the result of work supported with resources of the VA San Diego Healthcare System (VA Center of Excellence for Stress and Mental Health).	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Allen DN, 2009, APPL NEUROPSYCHOL, V16, P186, DOI 10.1080/09084280903098687; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Bates ME, 2005, ALCOHOL CLIN EXP RES, V29, P367, DOI 10.1097/01.ALC.0000156131.88125.2A; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1111/j.1360-0443.1995.tb03552.x; CONIGRAVE KM, 1995, ADDICTION, V90, P1479, DOI 10.1111/j.1360-0443.1995.tb02810.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2003, J INT NEUROPSYCH SOC, V9, P936, DOI 10.1017/S1355617703960139; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; FEIN G, 1990, WESTERN J MED, V152, P531; Fein G, 2006, ALCOHOL CLIN EXP RES, V30, P1538, DOI 10.1111/j.1530-0277.2006.00185.x; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Green KT, 2014, ADDICT BEHAV, V39, P406, DOI 10.1016/j.addbeh.2013.08.024; Hanson KL, 2011, J CHILD ADOLES SUBST, V20, P135, DOI 10.1080/1067828X.2011.555272; Hanson KL, 2010, J CLIN EXP NEUROPSYC, V32, P337, DOI 10.1080/13803390903042361; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kaplan E, 1983, BOSTON NAMING TEST; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Lafayette Instruments, 1989, INSTR MAN 32025 GROO; Lange RT, 2008, CLIN NEUROPSYCHOL, V22, P209, DOI 10.1080/13854040701290062; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; REED RJ, 1992, ALCOHOL CLIN EXP RES, V16, P677, DOI 10.1111/j.1530-0277.1992.tb00660.x; Rourke SB, 1999, J INT NEUROPSYCH SOC, V5, P234, DOI 10.1017/S1355617799533067; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schumm JA, 2012, ALCOHOL RES-CURR REV, V34, P401; Sher KJ, 1997, EXP CLIN PSYCHOPHARM, V5, P304, DOI 10.1037/1064-1297.5.3.304; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Sozda CN, 2014, NEUROPSYCHOLOGY, V28, P347, DOI 10.1037/neu0000043; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Steer, 1990, MANUAL BECK ANXIETY; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sullivan EV, 2000, ALCOHOL CLIN EXP RES, V24, P611, DOI 10.1111/j.1530-0277.2000.tb02032.x; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Traumatic Brain Injury Task Force, 2008, REP SURG GEN TRAUM B; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Yee MK, 2016, J HEAD TRAUMA REHAB, V31, P320, DOI 10.1097/HTR.0000000000000173	75	7	7	0	25	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	2016	38	10					1115	1130		10.1080/13803395.2016.1198468			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DZ0WI	WOS:000385560000006	27430280				2022-02-06	
J	Hatefi, M; Dastjerdi, MM; Ghiasi, B; Rahmani, A				Hatefi, Masoud; Dastjerdi, Masoud Moghadas; Ghiasi, Bahareh; Rahmani, Asghar			Association of Serum Uric Acid Level with the Severity of Brain Injury and Patient's Outcome in Severe Traumatic Brain Injury	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Computed tomography scan; Glasgow coma scale; Outcome; Prognosis	PARKINSONS-DISEASE; ISCHEMIC-STROKE; ANTIOXIDANT; URATE; PEROXYNITRITE; RISK; DYSFUNCTION; ACTIVATION; DAMAGE; RAT	Introduction: The prognostic value of serum Uric Acid (UA) levels in Traumatic Brain Injury (TBI) is unclear. Aim: To investigate the relationship between serum UA levels and prognosis of patients with TBI when in hospital and at six months after discharge. Materials and Methods: All patients attended our emergency department during July 2014 and December 2015 and were consecutively entered into the study and among 890 evaluated candidates based on inclusion criteria we finally investigated the serum UA levels of 725 TBI patients. Computed Tomography (CT) images of the brain were obtained within the first 24 hours of hospitalization. Outcome was assessed using the Glasgow Outcome Scale (GOS) score at discharge and at six months after discharge. Results: Data of 725 patients (42.89% men; mean age: 54.69+/-12.37 years) were analyzed. Mean+/-Standard Deviation (SD) of Glasgow Coma Scale (GCS) scores was 4.65+/-1.76. Serum levels of UA, when in hospital and at six months after discharge, among those who died were lower than those who survived (in hospital: 0.126+/-0.026 vs. 0.243+/-0.942 mmol/l, p = 0.000; 6 months post-discharge: 0.130+/-0.044 vs. 0.286+/-0.069 mmol/l, p<0.001). The mean UA plasma was significantly different between deceased and alive patients according to GOS scores (p<0.001 and p=0.030, respectively). The UA levels showed a significant relationship with GCS scores and severity of brain injury assessed using the Marshall Classification Score (p=0.005). Conclusion: Our results showed a strong relationship between UA levels and patients' outcomes either in hospital or at six months after discharge. Serum UA level could be considered as a valuable marker for evaluating the severity of brain injury and outcomes of TBI.	[Hatefi, Masoud] Ilam Univ Med Sci, Fac Med, Dept Neurosurg, Ilam, Iran; [Dastjerdi, Masoud Moghadas] Isfahan Univ Med Sci, Sch Med, Dept Emergency Med, Esfahan, Iran; [Ghiasi, Bahareh] Ilam Univ Med Sci, Fac Med, Dept Nephrol, Ilam, Iran; [Rahmani, Asghar] Ilam Univ Med Sci, Students Res Comm, Ilam, Iran		Rahmani, A (corresponding author), Ilam Univ Med Sci, Students Res Comm, Ilam, Iran.	asrahmani1991@yahoo.com	asadollahi, khairollah/A-8011-2011	asadollahi, khairollah/0000-0001-7701-1558; Hatafi, Masoud/0000-0002-1529-2419	Faculty of Medicine, Ilam University of Medical Sciences	This study was supported by Faculty of Medicine, Ilam University of Medical Sciences.	Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Bowman GL, 2010, J ALZHEIMERS DIS, V19, P1331, DOI 10.3233/JAD-2010-1330; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Davis JW, 1996, AM J EPIDEMIOL, V144, P480, DOI 10.1093/oxfordjournals.aje.a008954; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Gao X, 2008, AM J EPIDEMIOL, V167, P831, DOI 10.1093/aje/kwm385; Gao XA, 2007, HYPERTENSION, V50, P306, DOI 10.1161/HYPERTENSIONAHA.107.091041; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Keller JN, 1998, J NEUROSCI, V18, P687; Langemann H, 2001, J NEUROL NEUROSUR PS, V71, P169, DOI 10.1136/jnnp.71.2.169; Langemann H, 1999, 8 INT C IN VIV METH, P349; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miele M, 1996, J NEUROSCI METH, V70, P15, DOI 10.1016/S0165-0270(96)00094-5; Miller AA, 2006, ANTIOXID REDOX SIGN, V8, P1113, DOI 10.1089/ars.2006.8.1113; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Selim MH, 2004, AGEING RES REV, V3, P345, DOI 10.1016/j.arr.2004.04.001; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129, DOI 10.1093/ajcn/54.6.1129s; Shen CH, 2013, CAN J NEUROL SCI, V40, P73, DOI 10.1017/S0317167100012981; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tayag EC, 1996, BRAIN RES, V733, P287, DOI 10.1016/0006-8993(96)00669-5; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; Waring WS, 2001, J CARDIOVASC PHARM, V38, P365, DOI 10.1097/00005344-200109000-00005	31	7	8	0	2	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	DEC	2016	10	12					OC20	OC24		10.7860/JCDR/2016/21918.8993			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ3KG	WOS:000397970300073	28208906	Green Published, gold			2022-02-06	
J	Hercher, LS; Caudle, M; Griffin, J; Herzog, M; Matviychuk, D; Tidwell, J				Hercher, Laura S.; Caudle, Michelle; Griffin, Julie; Herzog, Matthew; Matviychuk, Diana; Tidwell, Jenna			Student-Athletes' Views on APOE Genotyping for Increased Risk of Poor Recovery after a Traumatic Brain Injury	JOURNAL OF GENETIC COUNSELING			English	Article						Genetic testing; Apolipoprotein genotyping; APOE; Traumatic brain injury; Alzheimer's disease; Genetic discrimination; NCAA	APOLIPOPROTEIN-E; ALZHEIMER-DISEASE; TYPE-4 ALLELE; SEX; AGE	Use of apolipoprotein E genotyping to personalize the risk of a poor recovery after traumatic brain injury is complicated by the potential for genetic discrimination and the potential to reveal an increased risk for late onset Alzheimer's disease. We developed a survey to gauge interest in testing among athletes participating in National Collegiate Athletic Association programs. Eight hundred and forty seven student-athletes were surveyed to determine their interest in genetic testing, their willingness to share the results of testing with parents, coaches and physicians, their concerns about privacy and/or discrimination, and their interest in genetic counseling. Nearly three quarters of respondents expressed some level of interest in testing, with the largest number describing themselves as 'possibly interested' (54.9 %, n = 463) and a smaller number describing themselves as 'very interested' (18.9 %, n = 159). Most student-athletes said that receiving secondary information about their risk for late-onset Alzheimer's disease made them more likely to test (50.6 %, n = 426) rather than less likely to test (12.4 %, n = 104). Student-athletes were open to apolipoprotein E genotyping and willing to share test results with their parents, coaches and physicians. They did not anticipate that test results would impact their behavior or ability to play. Testing programs may be welcome but should provide clear information as to risks and benefits.	[Hercher, Laura S.; Caudle, Michelle] Sarah Lawrence Coll, Joan H Marks Grad Programin Human Genet, 1 Mead Way, Bronxville, NY 10708 USA; [Griffin, Julie] Univ Louisville, Sch Med, Dept Pediat, Weisskopf Child Evaluat Ctr, Louisville, KY 40292 USA; [Herzog, Matthew] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Matviychuk, Diana] Kingston Gen Hosp, Med Genet Unit, Kingston, ON, Canada; [Tidwell, Jenna] MemorialCare Hlth Syst, MemorialCare Canc Inst, Canc Risk & Prevent Program, Laguna Hills, CA USA		Hercher, LS (corresponding author), Sarah Lawrence Coll, Joan H Marks Grad Programin Human Genet, 1 Mead Way, Bronxville, NY 10708 USA.	lhercher@sarahlawrence.edu			Sarah Lawrence College Joan H. Marks Graduate Program in Human Genetics	We would like the thank Mike Smith for his valuable assistance with data analysis and Jehannine Austin for her excellent advice. We gratefully acknowledge the Sarah Lawrence College Joan H. Marks Graduate Program in Human Genetics for providing services and funding in support of our participant recruitment process.	American Society of Hematology, 2012, STAT SCREEN SICKL CE; [Anonymous], 1995, JAMA, V274, P1627; [Anonymous], 2015, US NEWS WORLD REPORT; [Anonymous], 2015, US TODAY; [Anonymous], 2014, NY TIMES; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIAZARRISTIA R, 2006, THE JOURNAL OF HEAD, V21, P361; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Evans JP, 2001, BMJ-BRIT MED J, V322, P1052, DOI 10.1136/bmj.322.7293.1052; EVANS RB, 2009, NC JL TECH, V11, P205; Fainaru S, 2013, ESPN            1114; Farrari R., 2015, J GENETIC COUNSELING, V24, P873; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Goldman JS, 2011, GENET MED, V13, P749, DOI 10.1097/GIM.0b013e31822dd062; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; NCAA, 2014, SELF REP CONC NCAA A; NCAA, 2015, MED COND SICKL CELL; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Secretary's Advisory Committee on Heritable Disorders in Newborns and Children, 2010, SCREEN US COLL ATHL; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tarini BA, 2012, HEALTH SERV RES, V47, P446, DOI 10.1111/j.1475-6773.2011.01357.x; TEASDALE GM, 1997, LANCET, V11, P1069; The Sickle Cell Disease Association of America, 2015, SICKL CELL TRAIT ATH; Thompson AA, 2013, HEMATOL-AM SOC HEMAT, P632, DOI 10.1182/asheducation-2013.1.632	27	7	7	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-7700	1573-3599		J GENET COUNS	J. Genet. Couns.	DEC	2016	25	6					1267	1275		10.1007/s10897-016-9965-6			9	Genetics & Heredity; Health Policy & Services; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Health Care Sciences & Services; Biomedical Social Sciences	EC5LP	WOS:000388177100015	27207686	Bronze			2022-02-06	
J	Kersten, L; Pratzlich, M; Mannstadt, S; Ackermann, K; Kohls, G; Oldenhof, H; Saure, D; Krieger, K; Herpertz-Dahlmann, B; Popma, A; Freitag, CM; Trestman, RL; Stadler, C				Kersten, Linda; Pratzlich, Martin; Mannstadt, Sandra; Ackermann, Katharina; Kohls, Gregor; Oldenhof, Helena; Saure, Daniel; Krieger, Katrin; Herpertz-Dahlmann, Beate; Popma, Arne; Freitag, Christine M.; Trestman, Robert L.; Stadler, Christina			START NOW - a comprehensive skills training programme for female adolescents with oppositional defiant and conduct disorders: study protocol for a cluster-randomised controlled trial	TRIALS			English	Article						Randomised controlled trial; Treatment; Adolescents; Females; Residential care; Conduct disorder; Oppositional defiant disorder; Skills training; Emotion regulation	DISRUPTIVE BEHAVIOR DISORDERS; CALLOUS-UNEMOTIONAL TRAITS; TRAUMATIC BRAIN-INJURY; TREATMENT ENGAGEMENT; EMOTION REGULATION; ANTISOCIAL-BEHAVIOR; VIOLENT OFFENDERS; SUBSTANCE-ABUSE; MENTAL-HEALTH; HEART-RATE	Background: In Europe, the number of females exhibiting oppositional defiant disorder (ODD) and conduct disorder (CD) is growing. Many of these females live in youth welfare institutions. Consequently, there is a great need for evidence-based interventions within youth welfare settings. A recently developed approach targeting the specific needs of girls with ODD and CD in residential care is START NOW. The aim of this group-based behavioural skills training programme is to specifically enhance emotional regulation capacities to enable females with CD or ODD to appropriately deal with daily-life demands. It is intended to enhance psychosocial adjustment and well-being as well as reduce oppositional and aggressive behaviour. We present the study protocol (version 4.1; 10 February 2016) of the FemNAT-CD intervention trial titled 'Group-Based Treatment of Adolescent Female Conduct Disorders: The Central Role of Emotion Regulation'. Methods/design: The study is a prospective, confirmatory, cluster-randomised, parallel-group, multi-centre, randomised controlled trial with 128 institutionalised female adolescents who fulfil the diagnostic criteria of ODD and/or CD. Institutions/wards will be randomised either to provide the 12-week skills training as an add-on intervention or to provide treatment as usual. Once the first cycle is completed, each institution will run a second cycle with the opposite condition. Primary endpoints are the pre-post change in number of CD/ODD symptoms as assessed by a standardised, semi-structured psychiatric interview (Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime, CD/ODD section) between baseline and the end of intervention, as well as between baseline and a 3-month follow-up point. Secondary objectives include pre-post change in CD/ODD-related outcome measures, most notably emotional regulation on a behavioural and neurobiological level after completion of START NOW compared with treatment as usual. Discussion: To our knowledge, this study is the first to date to systematically investigate the effectiveness of an adapted integrative psychosocial intervention designed for female adolescents with ODD and CD in youth welfare settings.	[Kersten, Linda; Pratzlich, Martin; Mannstadt, Sandra; Stadler, Christina] Univ Basel, Univ Psychiat Clin Basel, Dept Psychol, Dept Child & Adolescent Psychiat, Basel, Switzerland; [Ackermann, Katharina; Freitag, Christine M.] Goethe Univ, Univ Hosp Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Kohls, Gregor; Herpertz-Dahlmann, Beate] Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Aachen, Germany; [Oldenhof, Helena; Popma, Arne] Univ Amsterdam, VUmc, Dept Child & Adolescent Psychiat, Amsterdam, Netherlands; [Saure, Daniel] Heidelberg Univ, Dept Med Biometry, Inst Med Biometry & Informat, Heidelberg, Germany; [Krieger, Katrin] Univ Heidelberg Hosp, Coordinat Ctr Clin Trials, Heidelberg, Germany; [Trestman, Robert L.] UConn Hlth, Correct Managed Hlth Care, Farmington, CT USA		Kersten, L (corresponding author), Univ Basel, Univ Psychiat Clin Basel, Dept Psychol, Dept Child & Adolescent Psychiat, Basel, Switzerland.	linda.kersten@upkbs.ch	Kohls, Gregor/AAH-6429-2020; Trestman, Robert/R-5688-2019; Stadler, Christina/H-3971-2014	Freitag, Christine Margarete/0000-0001-9676-4782; Stadler, Christina/0000-0003-2178-0635	FemNAT-CD consortium (Group-Based Treatment of Adolescent Female Conduct Disorders: The Central Role of Emotion Regulation); European Union under the 7th Framework Programme [602407]	This study is part of the FemNAT-CD consortium (Group-Based Treatment of Adolescent Female Conduct Disorders: The Central Role of Emotion Regulation). FemNAT-CD is a Collaboration Project funded by the European Union under the 7th Framework Programme (grant agreement no. 602407).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Baer RA, 2014, PRACT RESOUR MENT, P3, DOI 10.1016/B978-0-12-416031-6.00001-3; Bagner DM, 2012, BEHAV THER, V43, P652, DOI 10.1016/j.beth.2011.12.002; Beauchaine TP, 2000, AGGRESSIVE BEHAV, V26, P425, DOI 10.1002/1098-2337(200011)26:6<425::AID-AB2>3.0.CO;2-I; Berg-Smith SM, 1999, HEALTH EDUC RES, V14, P399, DOI 10.1093/her/14.3.399; Berkout OV, 2011, AGGRESS VIOLENT BEH, V16, P503, DOI 10.1016/j.avb.2011.06.001; Berzins L. G., 2004, INT J FORENSIC MENTA, V3, P93, DOI DOI 10.1080/14999013.2004.10471199; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Bogels S, 2008, BEHAV COGN PSYCHOTH, V36, P193, DOI 10.1017/S1352465808004190; Botvin G.J., 2004, J PRIM PREV, V25, P211, DOI [DOI 10.1023/B:J0PP.0000042391.58573.5B, 10.1023/B:JOPP.0000042391.58573.5b, DOI 10.1023/B:JOPP.0000042391.58573.5B]; Carroll KM, 2006, DRUG ALCOHOL DEPEN, V81, P301, DOI 10.1016/j.drugalcdep.2005.08.002; Chambers JC, 2008, AGGRESS VIOLENT BEH, V13, P276, DOI 10.1016/j.avb.2008.04.003; Channon SJ, 2007, DIABETES CARE, V30, P1390, DOI 10.2337/dc06-2260; Cislo AM, 2016, PSYCHIAT SERV, V67, P143, DOI 10.1176/appi.ps.201500456; Cohen M, 2009, J QUANT CRIMINOL, V25, P25, DOI 10.1007/s10940-008-9057-3; Colby SM, 1998, J CONSULT CLIN PSYCH, V66, P574, DOI 10.1037/0022-006X.66.3.574; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; Davis TM, 2003, DRUG ALCOHOL DEPEN, V69, P197, DOI 10.1016/S0376-8716(02)00317-4; De Swart JJW, 2012, CHILD YOUTH SERV REV, V34, P1818, DOI 10.1016/j.childyouth.2012.05.015; de Wied M, 2012, J ABNORM CHILD PSYCH, V40, P211, DOI 10.1007/s10802-011-9557-8; Delmo C, 2000, KIDDIE SADS PRESENT; Dennis M, 2004, J SUBST ABUSE TREAT, V27, P197, DOI 10.1016/j.jsat.2003.09.005; Diamond G, 2002, ADDICTION, V97, P70, DOI 10.1046/j.1360-0443.97.s01.3.x; Dopfner M, 1998, FRAG JUG; Essau CA, 2006, ASSESSMENT, V13, P454, DOI 10.1177/1073191106287354; Feindler E. L., 1986, ADOLESCENT ANGER CON; Fengler J, 2011, AUSGEBRANNTE TEAMS B; Fengler J, 2011, AUSGEBRANNTE TEAMS B, V235; Fernandez-Rivas A, 2013, EUR CHILD ADOLES PSY, V22, P583, DOI 10.1007/s00787-013-0465-z; Fishbein D, 2009, LAW HUMAN BEHAV, V33, P419, DOI 10.1007/s10979-008-9163-7; Fontaine N, 2009, J CHILD PSYCHOL PSYC, V50, P363, DOI 10.1111/j.1469-7610.2008.01949.x; Ford J. D., 2006, TRAUMA AFFECT REGULA; Ford T, 2007, BRIT J PSYCHIAT, V190, P319, DOI 10.1192/bjp.bp.106.025023; Foster EM, 2005, AM J PUBLIC HEALTH, V95, P1767, DOI 10.2105/AJPH.2004.061424; Gelhorn HL, 2007, COMPR PSYCHIAT, V48, P529, DOI 10.1016/j.comppsych.2007.04.009; Glick B., 2010, AGGRESSION REPLACEME; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Grawe K, 2000, PRAXIS PSYCHOTHERAPI, P314; Grisso T., 2006, MASSACHUSETTS YOUTH; Hagemann W., 2009, BURNOUT SCREENING SK; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; HEDEKER D, 1994, J CONSULT CLIN PSYCH, V62, P757, DOI 10.1037/0022-006X.62.4.757; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Howells K, 2006, INT J OFFENDER THER, V50, P174, DOI 10.1177/0306624X05281336; Huebner ES, 2000, SCHOOL PSYCHOL INT, V21, P281, DOI 10.1177/0143034300213005; Javdani S, 2011, CLIN PSYCHOL REV, V31, P1324, DOI 10.1016/j.cpr.2011.09.002; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Keenan K, 1999, Clin Child Fam Psychol Rev, V2, P3, DOI 10.1023/A:1021811307364; Kersten L, 2016, PSYCHIAT SERV, V67, P37, DOI 10.1176/appi.ps.201400471; Lancaster GA, 2010, STAT METHODS MED RES, V19, P349, DOI 10.1177/0962280209359883; Linehan MM., 1993, COGNITIVE BEHAV TREA; Lochman JE, 2003, BEHAV THER, V34, P493, DOI 10.1016/S0005-7894(03)80032-1; Lynch TR, 2006, J CLIN PSYCHOL, V62, P459, DOI 10.1002/jclp.20243; Mansson KNT, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.22; Maughan B, 2004, J CHILD PSYCHOL PSYC, V45, P609, DOI 10.1111/j.1469-7610.2004.00250.x; McCambridge J, 2004, ADDICTION, V99, P39, DOI 10.1111/j.1360-0443.2004.00564.x; McCann RA, 2000, COGN BEHAV PRACT, V7, P447, DOI 10.1016/S1077-7229(00)80056-5; McDougall J., 2007, GOAL ATTAINMENT SCAL, V2nd; Mcrae K, 2012, SOC COGN AFFECT NEUR, V7, P11, DOI 10.1093/scan/nsr093; Miller W.R., 2002, MOTIVATIONAL INTERVI; Mohr DC, 2009, PSYCHOTHER PSYCHOSOM, V78, P275, DOI 10.1159/000228248; Monti P, 2002, TREATING ALCOHOL DEP; Morgan RD, 2002, GROUP DYN-THEOR RES, V6, P203, DOI 10.1037//1089-2699.6.3.203; Morgenstern J, 2001, PSYCHOL ADDICT BEHAV, V15, P83, DOI 10.1037/0893-164X.15.2.83; Napoli M, 2005, J APPL SCH PSYCHOL, V21, P99, DOI 10.1300/J370v21n01_05; National Collaborating Centre for Mental Health, 2013, ANT BEH COND DIS CHI; Nelson-Gray RO, 2006, BEHAV RES THER, V44, P1811, DOI 10.1016/j.brat.2006.01.004; Neumark-Sztainer DR, 2010, AM J PREV MED, V39, P421, DOI 10.1016/j.amepre.2010.07.017; Newman JP, 1998, J ABNORM PSYCHOL, V107, P527, DOI 10.1037/0021-843X.107.3.527; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Petermann U., 2011, WECHSLER INTELLIGENC; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Quinn A, 2009, INT J LAW PSYCHIAT, V32, P288, DOI 10.1016/j.ijlp.2009.06.002; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P148, DOI 10.1007/s00787-008-1016-x; Rusby J., 2009, PERPETRATION VICTIMI; Sampl S, 2010, START NOW WORKBOOK F; Sampl S, 2015, START NOW FACILITATO; Scarpa A, 2010, BIOL PSYCHOL, V84, P488, DOI 10.1016/j.biopsycho.2009.11.006; Schmid Marc, 2008, Child Adolesc Psychiatry Ment Health, V2, P2, DOI 10.1186/1753-2000-2-2; Schwab-Stone M, 1999, J AM ACAD CHILD PSY, V38, P359, DOI 10.1097/00004583-199904000-00007; Schwarzer R., 1999, SKALEN ERFASSUNG LEH, P60; Shelton Deborah, 2011, J Am Psychiatr Nurses Assoc, V17, P148, DOI 10.1177/1078390311401023; Shelton D, 2011, J CHILD ADOL PS NURS, V24, P105, DOI 10.1111/j.1744-6171.2011.00275.x; Sheridan, 2002, PSYCHOPATHS CURRENT, P131; Singh NN, 2007, J EMOT BEHAV DISORD, V15, P56, DOI 10.1177/10634266070150010601; Stadler C, 2015, PSYCH UP2DATE, V9, P225; Stadler C, 2008, CHILD PSYCHIAT HUM D, V39, P299, DOI 10.1007/s10578-007-0089-y; Stadler C, 2016, Z KINDER JUG-PSYCH, V44, P443, DOI 10.1024/1422-4917/a000478; Stadler C, 2012, KINDH ENTWICKL, V21, P103, DOI 10.1026/0942-5403/a000076; Stein L A R, 2006, Psychol Serv, V3, P25, DOI 10.1037/1541-1559.3.1.0; Stringaris A, 2012, J CHILD PSYCHOL PSYC, V53, P1109, DOI 10.1111/j.1469-7610.2012.02561.x; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; Tottenham N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00039; Trupin E. W., 2002, CHILD ADOLESCENT MEN, V7, P121, DOI DOI 10.1111/1475-3588.00022; van de Weijer-Bergsma E, 2012, J CHILD FAM STUD, V21, P775, DOI 10.1007/s10826-011-9531-7; van Vugt E, 2014, CHILD ABUSE NEGLECT, V38, P114, DOI 10.1016/j.chiabu.2013.10.015; Wang DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039501; Weisz J.R., 2010, EVIDENCE BASED PSYCH; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; Zanarini M. C., 1996, DIAGNOSTIC INTERVIEW, P340	106	7	7	2	32	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	DEC 1	2016	17								568	10.1186/s13063-016-1705-6			16	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	ED5OK	WOS:000388901400001	27903282	Green Published, Green Submitted, gold			2022-02-06	
J	Knies, AK; Hwang, DY				Knies, Andrea K.; Hwang, David Y.			Palliative Care Practice in Neurocritical Care	SEMINARS IN NEUROLOGY			English	Article						critical care; palliative care; shared decision making; end-of-life care	SURROGATE DECISION-MAKERS; OF-LIFE CARE; PROLONGED MECHANICAL VENTILATION; TRAUMATIC BRAIN-INJURY; CRITICAL ILLNESS; INTRACEREBRAL HEMORRHAGE; POLICY STATEMENT; FAMILY-MEMBERS; ILL PATIENTS; SUBSTITUTED JUDGMENT	Many neurocritically ill patients and their families have high amounts of palliative care needs. Multiple professional societies relevant to neurocritical care have released consensus statements on meeting palliative care needs in neuroscience intensive care units. In this review, the authors discuss the ongoing debate regarding what model of palliative care delivery is optimal, focus on the process of shared decision making during goals-of-care discussions, and briefly comment on transitions from intensive care to comfort care. Regardless of an institution's model of palliative care practice, every neurocritical care clinician should possess core competencies necessary to provide basic, integrative palliative care for neurocritically ill patients. Given the high proportion of neurocritically ill patients who lack decision-making capacity, communication skills that enable clinicians to facilitate shared decision making with patients' surrogates are of particular relevance, especially when the limitation of life support is in the discussion. High-quality decision aids to assist neurocritical care teams and surrogate decision makers during common goals-of-care discussions may have the potential for further promotion of best palliative care practices.	[Knies, Andrea K.] Yale Sch Nursing, Div Primary Care, West Haven, CT USA; [Hwang, David Y.] Yale Sch Med, Dept Neurol, Div Neurocrit Care & Emergency Neurol, New Haven, CT 06520 USA		Hwang, DY (corresponding author), Yale Sch Med, Dept Neurol, Div Neurocrit Care & Emergency Neurol, New Haven, CT 06520 USA.	david.hwang@yale.edu	Hwang, David/ABG-6957-2020	Hwang, David/0000-0002-2150-4289			Akgun KM, 2015, SEMIN RESP CRIT CARE, V36, P921, DOI 10.1055/s-0035-1565254; American Bar Association, 2008, GUARD CAR LIAB; American Bar Association, MYTHS FACTS HLTH CAR; American Bar Association, 2014, DEF SURR CONS STAT; Anderson WG, 2009, J CRIT CARE, V24, P249, DOI 10.1016/j.jcrc.2007.12.010; Apatira L, 2008, ANN INTERN MED, V149, P861, DOI 10.7326/0003-4819-149-12-200812160-00005; Aslakson R, 2014, J PALLIAT MED, V17, P219, DOI 10.1089/jpm.2013.0409; Aslakson RA, 2014, CRIT CARE MED, V42, P2418, DOI 10.1097/CCM.0000000000000573; Back Anthony L, 2003, Ann Intern Med, V138, P439; Bandy RJ, 2010, J GEN INTERN MED, V25, P1003, DOI 10.1007/s11606-010-1351-8; Benejam B, 2009, J NEUROL, V256, P1126, DOI 10.1007/s00415-009-5083-9; Bernat JL, 2015, NEUROCRIT CARE, V23, P1, DOI 10.1007/s12028-015-0142-9; Billings JA, 2011, J PALLIAT MED, V14, P1058, DOI 10.1089/jpm.2011.0038-c; Blinderman CD, 2015, NEW ENGL J MED, V373, P2549, DOI 10.1056/NEJMra1411746; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Bradley CT, 2009, CRIT CARE MED, V37, P946, DOI 10.1097/CCM.0b013e3181968f68; Brush DR, 2012, AM J RESP CRIT CARE, V186, P633, DOI 10.1164/rccm.201202-0354OC; Cai XM, 2015, NEUROCRIT CARE, V23, P131, DOI 10.1007/s12028-015-0149-2; Chiarchiaro J, 2015, CRIT CARE MED, V43, P542, DOI 10.1097/CCM.0000000000000719; Cook D, 2014, NEW ENGL J MED, V370, P2506, DOI 10.1056/NEJMra1208795; Cox CE, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0045-0; Cox CE, 2014, AM J RESP CRIT CARE, V190, P366, DOI 10.1164/rccm.201404-0728CP; Cox CE, 2012, CRIT CARE MED, V40, P2327, DOI 10.1097/CCM.0b013e3182536a63; Creutzfeldt CJ, 2015, STROKE, V46, P2714, DOI 10.1161/STROKEAHA.115.008224; Creutzfeldt CJ, 2015, CRIT CARE MED, V43, P1677, DOI 10.1097/CCM.0000000000001018; Creutzfeldt CJ, 2012, STROKE, V43, P3405, DOI 10.1161/STROKEAHA.112.673376; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Curtis JR, 2015, PALLIATIVE MED, V29, P291, DOI 10.1177/0269216315573901; Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; Flint AC, 2013, STROKE, V44, P3365, DOI 10.1161/STROKEAHA.113.002794; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Glavan BJ, 2008, CRIT CARE MED, V36, P1138, DOI 10.1097/CCM.0b013e318168f301; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Holloway RG, 2013, NEUROLOGY, V80, P764, DOI 10.1212/WNL.0b013e318282509c; Hua M, 2014, CURR OPIN CRIT CARE, V20, P673, DOI 10.1097/MCC.0000000000000149; Hwang DY, 2016, NEUROLOGY, V86, P126, DOI 10.1212/WNL.0000000000002266; Hwang DY, 2014, J CRIT CARE, V29, P278, DOI 10.1016/j.jcrc.2013.11.022; Hwang DY, 2014, J NEUROSCI NURS, V46, P106, DOI 10.1097/JNN.0000000000000038; Hwang DY, NEUROCRITIC IN PRESS; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Kaufer M, 2008, AM J HOSP PALLIAT ME, V25, P318, DOI 10.1177/1049909108319262; Kelley AS, 2015, NEW ENGL J MED, V373, P747, DOI 10.1056/NEJMra1404684; Kelly AG, 2014, CURR OPIN NEUROL, V27, P61, DOI 10.1097/WCO.0000000000000048; Kompanje EJO, 2008, INTENS CARE MED, V34, P1593, DOI 10.1007/s00134-008-1172-y; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Lewis-Newby M, 2015, AM J RESP CRIT CARE, V191, P219, DOI 10.1164/rccm.201410-1916ST; Majesko A, 2012, CRIT CARE MED, V40, P2281, DOI 10.1097/CCM.0b013e3182533317; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; Murthy SB, 2016, CRIT CARE MED, V44, P575, DOI 10.1097/CCM.0000000000001391; Nelson JE, 2013, CRIT CARE MED, V41, P2318, DOI 10.1097/CCM.0b013e31828cf12c; Nelson JE, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.02.007; Nelson JE, 2010, CRIT CARE MED, V38, P1765, DOI 10.1097/CCM.0b013e3181e8ad23; Patak L, 2006, APPL NURS RES, V19, P182, DOI 10.1016/j.apnr.2005.09.006; Payne S, 2010, PALLIATIVE MED, V24, P146, DOI 10.1177/0269216309350252; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Quill TE, 2011, JAMA-J AM MED ASSOC, V306, P1483, DOI 10.1001/jama.2011.1413; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Rusinova K, 2009, CRIT CARE MED, V37, pS140, DOI [10.1097/CCM.0b013e31819207e7, 10.1097/CCM.0b013e3181b6e145]; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Schaefer KG, 2009, CURR OPIN CRIT CARE, V15, P569, DOI 10.1097/MCC.0b013e328332f524; Searight HR, 2005, AM FAM PHYSICIAN, V71, P515; Siegel MD, 2008, CRIT CARE MED, V36, P1722, DOI 10.1097/CCM.0b013e318174da72; Simmons BB, 2008, J PALLIAT MED, V11, P1336, DOI 10.1089/jpm.2008.0169; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Stein J, 2006, TOP STROKE REHABIL, V13, P42, DOI 10.1310/tsr1304-42; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; SUHL J, 1994, ARCH INTERN MED, V154, P90, DOI 10.1001/archinte.154.1.90; Treece PD, 2004, CRIT CARE MED, V32, P1141, DOI 10.1097/01.CCM.0000125509.34805.0C; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Vig EK, 2006, J AM GERIATR SOC, V54, P1688, DOI 10.1111/j.1532-5415.2006.00911.x; Weil AG, 2011, CAN J NEUROL SCI, V38, P434, DOI 10.1017/S0317167100011835; Weissman DE, 2010, J PALLIAT MED, V13, P328, DOI 10.1089/jpm.2010.9862; Weissman DE, 2010, J PALLIAT MED, V13, P203, DOI 10.1089/jpm.2010.9879; Weissman DE, 2010, J PALLIAT MED, V13, P204, DOI 10.1089/jpm.2010.9878; White DB, 2010, CRIT CARE MED, V38, P743, DOI 10.1097/CCM.0b013e3181c58842; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012; White DB, 2009, AM J RESP CRIT CARE, V180, P320, DOI 10.1164/rccm.200811-1776OC; White DB, 2006, CRIT CARE MED, V34, P2053, DOI 10.1097/01.CCM.0000227654.38708.C1; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008	89	7	8	0	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	DEC	2016	36	6					631	641		10.1055/s-0036-1592358			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE0PT	WOS:000389282100019	27907968				2022-02-06	
J	Lachance, CC; Feldman, F; Laing, AC; Leung, PM; Robinovitch, SN; Mackey, DC				Lachance, Chantelle C.; Feldman, Fabio; Laing, Andrew C.; Leung, Pet Ming; Robinovitch, Stephen N.; Mackey, Dawn C.			Study protocol for the Flooring for Injury Prevention (FLIP) Study: a randomised controlled trial in long-term care	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN-INJURY; RESIDENT ASSESSMENT INSTRUMENT; BODY-MASS INDEX; HIP FRACTURE; OLDER-ADULTS; IMPACT ATTENUATION; ELDERLY-WOMEN; RISK-FACTORS; FALLS; FORCE	Background A promising strategy for reducing the incidence and severity of fall-related injuries in long-term care (LTC) is to decrease the ground surface stiffness, and the subsequent forces applied to the body parts at impact, through installation of compliant flooring that does not substantially affect balance or mobility. Definitive evidence of the effects of compliant flooring on fall-related injuries in LTC is lacking. The Flooring for Injury Prevention (FLIP) Study is designed to address this gap. Methods The FLIP Study is a 4-year, parallel-group, 2-arm, randomised controlled superiority trial of flooring in 150 resident rooms at a LTC site. The primary objective is to determine whether compliant flooring reduces serious fall-related injuries relative to control flooring. Intervention (2.54cm SmartCells compliant; 74 rooms) and control (2.54cm plywood; 76 rooms) floorings were installed over the top of existing concrete floors and covered with identical 2.00mm vinyl. The primary outcome is serious fall-related injury, defined as any impact-related injury due to a fall in a study room that results in Emergency Department visit or hospital admission. Secondary outcomes include minor fall-related injury, any fall-related injury, falls, number of fallers, fractures, and healthcare utilisation and costs for serious fall-related injuries. Randomisation of study rooms, and residents in rooms, was stratified by residential unit, and flooring assignments were concealed. Outcome ascertainment began September 2013. Discussion Results from the FLIP Study will provide evidence about the effects of compliant flooring on fall-related injuries in LTC and will guide development of safer environments for vulnerable older adults. Trial registration number NCT01618786.	[Lachance, Chantelle C.; Feldman, Fabio; Robinovitch, Stephen N.; Mackey, Dawn C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Lachance, Chantelle C.; Feldman, Fabio; Robinovitch, Stephen N.; Mackey, Dawn C.] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Feldman, Fabio; Leung, Pet Ming] Fraser Hlth Author, Surrey, BC, Canada; [Laing, Andrew C.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada		Lachance, CC (corresponding author), Simon Fraser Univ, Aging & Populat Hlth Lab, Dept Biomed Physiol & Kinesiol, Shrum Sci Ctr K9625, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	dmackey@sfu.ca	Lachance, Chantelle C/J-6641-2019	Lachance, Chantelle C/0000-0001-5755-5160; Robinovitch, Stephen/0000-0003-3881-6227	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103945]; AGE-WELL, Inc.; Canadian National Centre for Excellence; Fraser Health Authority; Centre for Hip Health and Mobility; New Vista Society Care Home; Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR); AGE-WELL Graduate Student and Postdoctoral Award in Technology and Aging; Michael Smith Foundation for Health Research Scholar AwardMichael Smith Foundation for Health Research	The study has received funding from the Canadian Institutes of Health Research (grant TIR-103945 to SNR); AGE-WELL, Inc., a Canadian National Centre for Excellence; Fraser Health Authority; Centre for Hip Health and Mobility; and New Vista Society Care Home. In addition, SATech provided SmartCells flooring, flooring installation materials (eg, adhesive, tape and transitions), and labour for flooring installation. CCL is supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship and an AGE-WELL Graduate Student and Postdoctoral Award in Technology and Aging. DCM is supported by a Michael Smith Foundation for Health Research Scholar Award.	Bhan S, 2014, J BIOMECH, V47, P2391, DOI 10.1016/j.jbiomech.2014.04.026; Bhan S, 2013, J APPL BIOMECH, V29, P731, DOI 10.1123/jab.29.6.731; Butler M, 1996, AGE AGEING, V25, P381, DOI 10.1093/ageing/25.5.381; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; CHESNUT RM, 1999, REHABILITATION TRAUM; Choi WJ, 2010, CLIN BIOMECH, V25, P63, DOI 10.1016/j.clinbiomech.2009.08.009; Drahota AK, 2013, AGE AGEING, V42, P633, DOI 10.1093/ageing/aft067; Empana JP, 2004, J AM GERIATR SOC, V52, P685, DOI 10.1111/j.1532-5415.2004.52203.x; Glinka MN, 2013, J APPL BIOMECH, V29, P563, DOI 10.1123/jab.29.5.563; Glinka MN, 2013, MED ENG PHYS, V35, P108, DOI 10.1016/j.medengphy.2012.04.006; GRISSO JA, 1990, J AM GERIATR SOC, V38, P1326, DOI 10.1111/j.1532-5415.1990.tb03456.x; Gustavsson J, 2015, INJURY PREV, V21, P320, DOI 10.1136/injuryprev-2014-041468; Hanger HC, 6 AUSTR NZ FALLS PRE; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hawes C, 1997, AGE AGEING, V26, P19, DOI 10.1093/ageing/26.suppl_2.19; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Knoefel F, 2013, J AM MED DIR ASSOC, V14, P303, DOI 10.1016/j.jamda.2012.12.077; Korall AMB, 2015, J AM MED DIR ASSOC, V16, P185, DOI 10.1016/j.jamda.2014.12.004; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Laing AC, 2006, J ORTHOP RES, V24, P1405, DOI 10.1002/jor.20172; Laing AC, 2009, ACCIDENT ANAL PREV, V41, P642, DOI 10.1016/j.aap.2009.03.001; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; MAKI BE, 1990, APPL ERGON, V21, P107, DOI 10.1016/0003-6870(90)90132-H; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Norton R, 2000, DISABIL REHABIL, V22, P345; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Palvanen M, 2000, OSTEOPOROSIS INT, V11, P822, DOI 10.1007/s001980070040; Papaioannou A, 2015, CAN MED ASSOC J, V187, P1135, DOI 10.1503/cmaj.141331; Parachute, 2015, COST INJ CAN, P26; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Rapp K, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.011; Ray WA, 2005, ARCH INTERN MED, V165, P2293, DOI 10.1001/archinte.165.19.2293; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Santesso N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub5; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Schwenk M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-50; Simpson AHRW, 2004, AGE AGEING, V33, P242, DOI 10.1093/ageing/afh071; SPAITE DW, 1990, ANN EMERG MED, V19, P1418, DOI 10.1016/S0196-0644(05)82611-3; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vlaeyen E, 2015, J AM GERIATR SOC, V63, P211, DOI 10.1111/jgs.13254; Vu Man Quang, 2006, J Am Med Dir Assoc, V7, pS53, DOI 10.1016/j.jamda.2005.12.016; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Wolinsky FD, 1997, AM J PUBLIC HEALTH, V87, P398, DOI 10.2105/AJPH.87.3.398; Wright AD, 2014, GAIT POSTURE, V40, P160, DOI 10.1016/j.gaitpost.2014.03.015; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Wright AD, 2011, ACCIDENT ANAL PREV, V43, P1480, DOI 10.1016/j.aap.2011.02.028	48	7	7	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2016	22	6					453	460		10.1136/injuryprev-2016-042008			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EF8PL	WOS:000390591200014	27044272				2022-02-06	
J	Missori, P; Morselli, C; Domenicucci, M; Paolini, S; Peschillo, S; Scapeccia, M; Rastelli, E; Martini, S; Caporlingua, F; Di Stasio, E				Missori, Paolo; Morselli, Carlotta; Domenicucci, Maurizio; Paolini, Sergio; Peschillo, Simone; Scapeccia, Marco; Rastelli, Emanuela; Martini, Stefano; Caporlingua, Federico; Di Stasio, Enrico			Measurement of Bone Flap Surface Area and Midline Shift to Predict Overall Survival After Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Brain; Bone; Computed tomography; Craniectomy; Flap; Shift; Ventricular system	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; MIDDLE CEREBRAL-ARTERY; MANAGEMENT; HEMICRANIECTOMY; INFARCTION; COMA	BACKGROUND: There is uncertainty about the optimal method for measuring the decompressive craniectomy (DC) surface area and how large the DC should be. METHODS: A radiological technique for measuring the surface area of removed bone flaps in a series of 73 DCs was developed. Preoperative and early postoperative computed tomography scans of each patient were evaluated. Midline shift (MLS) was considered the key factor for successful DC and was assigned to either normal (0-4 mm) or pathological (>= 5 mm) ranges. The association between postoperative MLS and patient survival at 12 months was assessed. RESULTS: Measurements of all removed bone flaps yielded a mean surface area of 7759 mm(2). The surface area of the removed bone flap did not influence survival (surviving 7643 mm(2) vs. deceased 7372 mm(2)). The only factor associated with survival was reduced postoperative MLS (P < 0.034). Risk of death was 14.4 (3.0-70.1)- fold greater in patients with postoperative shift >= 5 mm (P < 0.001). CONCLUSION: The ideal surface area for "large" square bone flaps should result in an MLS of < 5 mm. Enlargement of the craniectomy edges should be considered for patients in whom MLS >= 5 mm persists according to early postoperative computed tomography scans.	[Missori, Paolo; Morselli, Carlotta; Domenicucci, Maurizio; Caporlingua, Federico] Policlin Umberto 1, Dept Neurol & Psychiat, Neurosurg, Rome, Italy; [Paolini, Sergio] IRCCS Neuromed Pozzilli, Rome, Italy; [Peschillo, Simone] Sapienza Univ Rome, Policlin Umberto 1, Dept Neurol & Psychiat, Endovasc Neurosurg Intervent Neuroradiol, Rome, Italy; [Scapeccia, Marco; Rastelli, Emanuela; Martini, Stefano] Sapienza Univ Rome, Policlin Umberto 1, Dept Radiol, Neuroradiol, Rome, Italy; [Di Stasio, Enrico] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Univ Hosp A Gemelli Rome, Rome, Italy		Missori, P (corresponding author), Policlin Umberto 1, Dept Neurol & Psychiat, Neurosurg, Rome, Italy.	missorp@yahoo.com	di stasio, enrico/AAL-3082-2020; Peschillo, Simone/H-4717-2019	Peschillo, Simone/0000-0002-3920-8517; Morselli, Carlotta/0000-0003-1031-4874; DOMENICUCCI, Maurizio/0000-0002-9745-6439			Amorim RL, 2014, STROKE, V45, P1375, DOI 10.1161/STROKEAHA.113.003670; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fletcher TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110408; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 2006, NEUROSURGERY, V58, P655; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pullicino PM, 1997, NEUROLOGY, V49, P1090, DOI 10.1212/WNL.49.4.1090; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Zhang YD, 2012, CHIN J TRAUMATOL, V15, P228, DOI 10.3760/cma.j.issn.1008-1275.2012.04.006	23	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2016	96						11	14		10.1016/j.wneu.2016.05.043			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO1EZ	WOS:000396442500003	27241094				2022-02-06	
J	Spencer, RJ; Reckow, J; Drag, LL; Bieliauskas, LA				Spencer, Robert J.; Reckow, Jaclyn; Drag, Lauren L.; Bieliauskas, Linas A.			Incidental Learning: A Brief, Valid Measure of Memory Based on the WAIS-IV Vocabulary and Similarities Subtests	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						military; incidental learning; memory; neuropsychological assessment; traumatic brain injury	PERFORMANCE	Objective: We assessed the validity of a brief incidental learning measure based on the Similarities and Vocabulary subtests of the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV). Background: Most neuropsychological assessments for memory require intentional learning, but incidental learning occurs without explicit instruction. Incidental memory tests such as the WAIS-III Symbol Digit Coding subtest have existed for many years, but few memory studies have used a semantically processed incidental learning model. Methods: We conducted a retrospective analysis of 37 veterans with traumatic brain injury, referred for outpatient neuropsychological testing at a Veterans Affairs hospital. As part of their evaluation, the participants completed the incidental learning tasks. We compared their incidental learning performance to their performance on traditional memory measures. Results: Incidental learning scores correlated strongly with scores on the California Verbal Learning Test-Second Edition (CVLT-II) and Brief Visuospatial Memory Test-Revised (BVMT-R). After we conducted a partial correlation that controlled for the effects of age, incidental learning correlated significantly with the CVLT-II Immediate Free Recall, CVLT-II Short-Delay Recall, CVLT-II Long-Delay Recall, and CVLT-II Yes/No Recognition Hits, and with the BVMT-R Delayed Recall and BVMT-R Recognition Discrimination Index. Conclusions: Our incidental learning procedures derived from subtests of the WAIS-IV Edition are an efficient and valid way of measuring memory. These tasks add minimally to testing time and capitalize on the semantic encoding that is inherent in completing the Similarities and Vocabulary subtests.	[Spencer, Robert J.; Reckow, Jaclyn; Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Mental Hlth Serv, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Reckow, Jaclyn] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA; [Drag, Lauren L.; Bieliauskas, Linas A.] Stanford Hosp & Clin, Stanford, CA USA		Spencer, RJ (corresponding author), VA Ann Arbor Healthcare, Mental Hlth 116C,2215 Fuller Rd, Ann Arbor, MI 48105 USA.	rspencer33@gmail.com					Asa-Makitaipale S, 2009, ENVIRON HEALTH INSIG, V3, P13; Ashendorf L, 2012, APPL NEUROPSYCH-ADUL, V19, P272, DOI 10.1080/09084282.2012.670151; Benedict R., 1997, BRIEF VISUOSPATIAL M; Challis BH, 1996, CONSCIOUS COGN, V5, P142, DOI 10.1006/ccog.1996.0009; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denney DR, 2015, ARCH CLIN NEUROPSYCH, V30, P322, DOI 10.1093/arclin/acv019; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Joy S, 2000, J INT NEUROPSYCH SOC, V6, P770, DOI 10.1017/S1355617700677044; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; Karrasch M, 2010, CLIN NEUROPSYCHOL, V24, P1355, DOI 10.1080/13854046.2010.521982; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Meyers JE., 1995, REY COMPLEX FIGURE T; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ryan JJ, 2015, N AM J PSYCHOL, V17, P197; Sharon T, 2011, P NATL ACAD SCI USA, V108, P1146, DOI 10.1073/pnas.1005238108; Smith CN, 2014, P NATL ACAD SCI USA, V111, P475, DOI 10.1073/pnas.1322263111; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Tombaugh T.N., 1996, TEST MEMORY MALINGER; VILKKI J, 1989, NEUROSURGERY, V25, P166, DOI 10.1227/00006123-198908000-00003; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL	27	7	7	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2016	29	4					206	211		10.1097/WNN.0000000000000108			6	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	EH4CS	WOS:000391719200005	27984258				2022-02-06	
J	Wang, X; Wang, Y; Zhang, C; Liu, C; Yang, HF; Hu, WH; Zhang, JG; Zhang, K				Wang, Xiu; Wang, Yao; Zhang, Chao; Liu, Chang; Yang, Hai-Feng; Hu, Wen-Han; Zhang, Jian-Guo; Zhang, Kai			Endogenous cannabinoid system alterations and their role in epileptogenesis after brain injury in rat	EPILEPSY RESEARCH			English	Article						Cannabinoid; CB1 receptor; Post-traumatic epilepsy; Epileptogenesis	CLOSED-HEAD-INJURY; ENDOCANNABINOID SYSTEM; HIPPOCAMPAL-NEURONS; EPILEPSY; RECEPTOR; SEIZURE; ANTAGONIST; MODEL; HYPEREXCITABILITY; EXCITOTOXICITY	Post-traumatic epilepsy (PTE) is one of the most common complications resulting from brain injury, however, antiepileptic drugs usually fail to prevent it. Several lines of evidence have demonstrated that the endogenous cannabinoid system (ECS) plays a pivotal role during epileptogenesis in several animal models. A recent study has shown that a cannabinoid type 1 (CB1) receptor antagonist could suppress long-term neuron hyperexcitability after brain injury, but the underlying mechanisms remain largely unknown. In this study, we first analyzed the dynamic expression of different components of the ECS at various time points after brain injury in rats. Then, we conducted a 12-month-long session of behavioral monitoring after the brain injury, and based on the results, the rats were divided into a PTE group and a non-PTE group. Finally, the changes in the ECS between the two groups were compared. We found that the ECS exhibited a biphasic alteration after brain injury; the expression of the CB1 receptor and 2-arachidonoylglycerol (2-AG) in the PTE group was significantly higher than that of the non-PTE group 12 months after traumatic brain injury. Our preliminary results indicated that the ECS might be involved in post-traumatic epileptogenesis. (C) 2016 Elsevier B.V. All rights reserved.	[Wang, Xiu; Wang, Yao; Zhang, Chao; Zhang, Jian-Guo; Zhang, Kai] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 6 Tian Tan Xi Li, Beijing 100050, Peoples R China; [Wang, Xiu; Wang, Yao; Zhang, Chao; Liu, Chang; Hu, Wen-Han; Zhang, Jian-Guo; Zhang, Kai] Beijing Key Lab Neurostimulat, Beijing 100050, Peoples R China; [Yang, Hai-Feng] Beijing Jingmei Grp Gen Hosp, Beijing 102300, Peoples R China; [Hu, Wen-Han; Zhang, Jian-Guo] Capital Med Univ, Beijing Neurosurg Inst, Stereotact & Funct Neurosurg Lab, Beijing 100050, Peoples R China; [Hu, Wen-Han; Zhang, Jian-Guo; Zhang, Kai] Peking Univ, Hosp Fengtai Hosp 1, Med Alliance Beijing Tian Tan Hosp, Epilepsy Ctr, Beijing 100050, Peoples R China		Zhang, K (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 6 Tian Tan Xi Li, Beijing 100050, Peoples R China.	zhangkai62035@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171218]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding [XMLX201304, ZYLX201305]	This work was supported by grants from the National Natural Science Foundation of China (No. 81171218), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding (code: XMLX201304; code: ZYLX201305).	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blair RE, 2006, J PHARMACOL EXP THER, V317, P1072, DOI 10.1124/jpet.105.100354; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Gholizadeh S, 2007, NEUROPHARMACOLOGY, V53, P763, DOI 10.1016/j.neuropharm.2007.08.005; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kozan R, 2009, EPILEPSIA, V50, P1760, DOI 10.1111/j.1528-1167.2009.02098.x; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Serrano A, 2012, ALCOHOL CLIN EXP RES, V36, P984, DOI 10.1111/j.1530-0277.2011.01686.x; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Straiker A, 2007, J PHYSIOL-LONDON, V578, P773, DOI 10.1113/jphysiol.2006.117499; Temkin N R, 1995, New Horiz, V3, P518; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Vinogradova LV, 2011, EPILEPSY RES, V96, P250, DOI 10.1016/j.eplepsyres.2011.06.007; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Xapelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063529	37	7	7	1	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	DEC	2016	128						35	42		10.1016/j.eplepsyres.2016.10.002			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EG0SM	WOS:000390742500006	27810514				2022-02-06	
J	Flaherty, MR; Raybould, T; Jamal-Allial, A; Kaafarani, HMA; Lee, J; Gervasini, A; Ginsburg, R; Mandell, M; Donelan, K; Masiakos, PT				Flaherty, Michael R.; Raybould, Toby; Jamal-Allial, Aziza; Kaafarani, Haytham M. A.; Lee, Jarone; Gervasini, Alice; Ginsburg, Richard; Mandell, Mark; Donelan, Karen; Masiakos, Peter T.			Impact of a State Law on Physician Practice in Sports-Related Concussions	JOURNAL OF PEDIATRICS			English	Article							PRIMARY-CARE; KNOWLEDGE; MEDICINE; CHILDREN; REST; PROVIDERS; SYMPTOMS; INJURIES; HEADS	Objective To determine physician-reported adherence to and support of the 2010 Massachusetts youth concussion law, as well as barriers to care and clinical practice in the context of legislation. Study design Primary care physicians (n = 272) in a large pediatric network were eligible for a cross-sectional survey in 2014. Survey questions addressed key policy and practice provisions: concussion knowledge, state regulations and training, practice patterns, referrals, patient characteristics, and barriers to care. Analyses explored relationships between practice and policy, adjusting for physician demographic and practice characteristics. Results The survey response rate was 64% among all responders (173 of 272). A total of 146 respondents who had evaluated, treated, or referred patients with a suspected sports-related concussion in the previous year were eligible for analysis. The vast majority (90%) of providers agreed that the current Massachusetts laws regarding sports concussions are necessary and support the major provisions. Three-quarters (74%) had taken a required clinician training course on concussions. Those who took training courses were significantly more likely to develop individualized treatment plans (OR, 3.6; 95% CI, 1.1-11.0). Physician training did not improve screening of youth with concussion for depression or substance use. Most physicians (77%) advised patients to refrain from computer, telephone, or television for various time periods. Physicians reported limited communication with schools. Conclusions Primary care physicians report being comfortable with the diagnosis and management of concussions, and support statewide regulations; however, adherence to mandated training and specific legal requirements varied. Broader and more frequent training may be necessary to align current best evidence with clinical care and state-mandated practice.	[Flaherty, Michael R.; Mandell, Mark] Massachusetts Gen Hosp, Dept Pediat Crit Care, Boston, MA 02114 USA; [Flaherty, Michael R.; Kaafarani, Haytham M. A.; Lee, Jarone; Gervasini, Alice; Ginsburg, Richard; Mandell, Mark; Donelan, Karen; Masiakos, Peter T.] Harvard Med Sch, Boston, MA USA; [Raybould, Toby; Jamal-Allial, Aziza; Kaafarani, Haytham M. A.; Lee, Jarone; Gervasini, Alice] Massachusetts Gen Hosp, Dept Surg, Div Trauma Emergency Serv & Surg Crit Care, Boston, MA 02114 USA; [Ginsburg, Richard] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Donelan, Karen] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Masiakos, Peter T.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA		Flaherty, MR (corresponding author), Massachusetts Gen Hosp, Dept Pediat Crit Care Med, 175 Cambridge St, Boston, MA 02114 USA.	mrflaherty@partners.org	Donelan, Karen/R-6162-2019				American Association for Public Opinion Research, STAND ETH AAPOR C3D; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fendrich Howard, 2015, AP ANAL YOUTH CONCUS; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stevens PK, 2010, J TRAUMA NURS, V17, P183; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Winston FK, 2013, CLIN PEDIATR, V52, P960, DOI 10.1177/0009922813495956; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	25	7	7	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	NOV	2016	178						268	274		10.1016/j.jpeds.2016.08.025			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EF0ON	WOS:000390025400047	27597735				2022-02-06	
J	Gomez, C; Poza, J; Gutierrez, MT; Prada, E; Mendoza, N; Hornero, R				Gomez, Carlos; Poza, Jesus; Gutierrez, Maria T.; Prada, Esther; Mendoza, Nuria; Hornero, Roberto			Characterization of EEG patterns in brain-injured subjects and controls after a Snoezelen intervention	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Brain-injury; Electroencephalography (EEG); Biomedical signal processing; Snoezelen (R); Non-pharmacological therapies	MULTISENSORY STIMULATION; RELAXATION RESPONSE; APPROXIMATE ENTROPY; SPECTRAL-ANALYSIS; COMPLEXITY; PERFORMANCE; CHILDREN; BEHAVIOR; PEOPLE; ROOM	Background and objective: The aim of this study was to assess the changes induced in electroencephalographic (EEG) activity by a Snoezelen intervention on individuals with brain injury and control subjects. Methods: EEG activity was recorded preceding and following a Snoezelen session in 18 people with cerebral palsy (CP), 18 subjects who have sustained traumatic brain-injury (TBI) and 18 controls. EEG data were analyzed by means of spectral and nonlinear measures: median frequency (MF), individual alpha frequency (IAF), sample entropy (SampEn) and Lempel-Ziv complexity (LZC). Results: Our results showed decreased values for MF, IAF, SampEn and LZC as a consequence of the therapy. The main changes between pre-stimulation and post-stimulation conditions were found in occipital and parietal brain areas. Additionally, these changes are more widespread in controls than in brain-injured subjects, which can be due to cognitive deficits in TBI and CP groups. Conclusions: Our findings support the notion that Snoezelen therapy affects central nervous system, inducing a slowing of oscillatory activity, as well as a decrease of EEG complexity and irregularity. These alterations seem to be related with higher levels of relaxation of the participants. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Gomez, Carlos; Poza, Jesus; Hornero, Roberto] Univ Valladolid, Biomed Engn Grp, Valladolid, Spain; [Poza, Jesus; Hornero, Roberto] Univ Valladolid, Inst Invest Matemat, IMUVA, Valladolid, Spain; [Gutierrez, Maria T.; Prada, Esther] Ctr Referencia Estatal CRE Atenc Personas Grave D, Leon, Spain; [Mendoza, Nuria] Univ Castilla La Mancha, Dept Actividad Fis & Ciencias Deporte, Toledo, Spain		Gomez, C (corresponding author), Univ Valladolid, Biomed Engn Grp, ETS Ingenieros Telecomunicac, Campus Miguel Delibes,Paseo Belen 15, E-47011 Valladolid, Spain.	carlos.gomez@tel.uva.es	Hornero, Roberto/M-5313-2019; Poza, Jesus/B-4509-2008; Gomez, Carlos/B-4659-2008	Hornero, Roberto/0000-0001-9915-2570; Poza, Jesus/0000-0001-8577-9559; Gomez, Carlos/0000-0002-9488-0605; Prada Esteban, Esther/0000-0001-9186-8638	"CRE para la Atencion a Personas con Grave Discapacidad y Dependencia" (Project "Evaluacion de la terapia multi-sensorial en una sala Snoezelen mediante el analisis de electroencefalogramas en pacientes con dano cerebral"),; FEDEREuropean Commission [TEC2014-53196-R]; Consejeria de Educacion de la Junta de Castilla y Leon [VA059U13]; Consejeria de Sanidad de la Junta de Castilla y Leon [BIO/VA08/15]	This research was supported in part by "CRE para la Atencion a Personas con Grave Discapacidad y Dependencia" (Project "Evaluacion de la terapia multi-sensorial en una sala Snoezelen mediante el analisis de electroencefalogramas en pacientes con dano cerebral"), "Ministerio de Economia y Competitividad" and FEDER (TEC2014-53196-R), "Consejeria de Educacion de la Junta de Castilla y Leon" (VA059U13) and "Consejeria de Sanidad de la Junta de Castilla y Leon" (BIO/VA08/15). The authors would like to thank the brain-injured subjects and the staff at "CRE para la Atencion a Personas con Grave Discapacidad y Dependencia" for participating in this study.	Aftanas LI, 2002, NEUROSCI LETT, V330, P143, DOI 10.1016/S0304-3940(02)00745-0; BURG JS, 1995, BRAIN INJURY, V9, P395, DOI 10.3109/02699059509005779; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Cuvo AJ, 2001, RES DEV DISABIL, V22, P183, DOI 10.1016/S0891-4222(01)00067-1; Fava L, 2010, RES DEV DISABIL, V31, P160, DOI 10.1016/j.ridd.2009.08.006; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Hauck YL, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-20; Hogg J, 2001, RES DEV DISABIL, V22, P353, DOI 10.1016/S0891-4222(01)00077-4; Hotz GA, 2006, BRAIN INJURY, V20, P879, DOI 10.1080/02699050600832635; Houghton S, 1998, J INTELLECT DEV DIS, V23, P267, DOI 10.1080/13668259800033761; Huang H. -Y., 2009, Journal of Medical Engineering & Technology, V33, P314, DOI 10.1080/03091900802602677; Jacobs GD, 2004, APPL PSYCHOPHYS BIOF, V29, P245, DOI 10.1007/s10484-004-0385-2; JACOBS GD, 1989, BEHAV MED, V15, P125, DOI 10.1080/08964289.1989.9934575; Jap BT, 2009, EXPERT SYST APPL, V36, P2352, DOI 10.1016/j.eswa.2007.12.043; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knott V, 1997, J ANXIETY DISORD, V11, P365, DOI 10.1016/S0887-6185(97)00016-9; Lagopoulos J, 2009, J ALTERN COMPLEM MED, V15, P1187, DOI 10.1089/acm.2009.0113; Lancioni GE, 2002, DISABIL REHABIL, V24, P175, DOI 10.1080/09638280110074911; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Liu JP, 2010, BIOMED SIGNAL PROCES, V5, P124, DOI 10.1016/j.bspc.2010.01.001; Lotan M, 2005, BRAIN DEV-JPN, V27, pS88, DOI 10.1016/j.braindev.2005.03.021; Maseda A, 2014, AM J ALZHEIMERS DIS, V29, P463, DOI 10.1177/1533317514522540; Matson JL, 2004, RES DEV DISABIL, V25, P89, DOI 10.1016/j.ridd.2003.10.001; McAdams RM, 2011, NEO REV, V12, pe564; McKee SA, 2007, RES DEV DISABIL, V28, P304, DOI 10.1016/j.ridd.2006.04.001; Moffat N., 1993, SNOEZELEN EXPERIENCE; Nagarajan R, 2002, IEEE T BIO-MED ENG, V49, P1371, DOI 10.1109/TBME.2002.804582; Natarajan K, 2004, BIOMED ENG ONLINE, V3; Niedermayer E., 1999, ELECTROENCEPHALOGRAP; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Poza J, 2007, MED ENG PHYS, V29, P1073, DOI 10.1016/j.medengphy.2006.11.006; Poza J, 2013, MED ENG PHYS, V35, P365, DOI 10.1016/j.medengphy.2012.06.001; Rasekhi J, 2013, J NEUROSCI METH, V217, P9, DOI 10.1016/j.jneumeth.2013.03.019; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; SALINSKY MC, 1994, ELECTROEN CLIN NEURO, V90, P186, DOI 10.1016/0013-4694(94)90090-6; Schofield Pat, 2002, Br J Nurs, V11, P812; Schofield Patricia, 2003, Int J Palliat Nurs, V9, P124; Singh NN, 2004, RES DEV DISABIL, V25, P285, DOI 10.1016/j.ridd.2003.08.003; Staal JA, 2007, INT J PSYCHIAT MED, V37, P357, DOI 10.2190/PM.37.4.a; Stewart J, 2014, LIVER TRANSPLANT, V20, P1256, DOI 10.1002/lt.23944; Teplan M, 2014, MEAS SCI REV, V14, P237, DOI 10.2478/msr-2014-0032; THOMPSON SBN, 1994, BRIT J OCCUPATIONAL, V57, P341; van Weert JCM, 2005, J AM GERIATR SOC, V53, P24, DOI 10.1111/j.1532-5415.2005.53006.x; Vyata O, 2014, J BIOMEDICAL SCI ENG, V7, P731, DOI [10.4236/jbise.2014.79072, DOI 10.4236/JBISE.2014.79072]; WACKERMANN J, 1993, ELECTROEN CLIN NEURO, V86, P193, DOI 10.1016/0013-4694(93)90007-I; Withers P.S., 1995, BRIT J LEARN DISABIL, V23, P164; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	51	7	7	1	31	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	NOV	2016	136						1	9		10.1016/j.cmpb.2016.08.008			9	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	DY7SU	WOS:000385330400002	27686698	Green Submitted			2022-02-06	
J	Lin, DS; Liu, ZB; Huang, D				Lin Dingsheng; Liu Zengbing; Huang Dong			Favorable effects of progesterone on skin random flap survival in rats	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Angiogenesis; Malondialdehyde; Progesterone; Random skin flap; Superoxide dismutase; Vascular endothelial - growth factor	TRAUMATIC BRAIN-INJURY; DIABETIC-RATS; COMBINATION; PROTECT; MODEL	Objective(s): The aim of this study is to determine the effects of progesterone treatment on the survival of random skin flaps. Materials and Methods: McFarlane flaps were established and 40 male rats were randomly assigned to the progesterone-treated as the test group or normal saline-treated as the control group. Progesterone or normal saline (10 mg/kg) was administered intraperitoneally once daily. On postoperative day 2, malondialdehyde (MDA) and superoxide dismutase (SOD) were detected using test kits. Flap survival rates were evaluated with transparent graph paper under direct visualization, the levels of inflammation were examined by haematoxylin and eosin (H&E) staining, and the expression of vascular endothelial growth factor (VEGF) was immunohistochemically evaluated on day 7. Results: Compared to that in the control group, the mean survival area was significantly larger in the progesterone group. SOD activity was increased significantly, but the MDA levels in the test group were decreased. H&E-stained slices revealed that inflammation was inhibited in the test group. VEGF expression markedly increased in the progesterone group. Conclusion: This study showed that progesterone administered intraperitoneally significantly improved random skin flap survival in rats.	[Lin Dingsheng; Liu Zengbing; Huang Dong] Southern Med Univ, Dept Orthopaed, Guangdong Prov Peoples Hosp 2, Guangzhou, Guangdong, Peoples R China; [Lin Dingsheng] Wenzhou Med Univ, Affiliated Hosp 2, Dept Hand Surg, Wenzhou, Peoples R China; [Liu Zengbing] 4 Peoples Hosp Hengshui, Dept Hand Surg, Hengshui, Peoples R China		Huang, D (corresponding author), Southern Med Univ, Dept Orthopaed, Guangdong Prov Peoples Hosp 2, Guangzhou, Guangdong, Peoples R China.	huangdong_177@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81503397]; Zhejiang Province Chinese medicine scientific research fund [2014ZB074]; Zhejiang provincial medical and health science and technology program [2016KYB195]	This study was supported by the National Natural Science Foundation of China (No. 81503397), Zhejiang Province Chinese medicine scientific research fund (No. 2014ZB074), Zhejiang provincial medical and health science and technology program (2016KYB195).	Bagdas D, 2014, BIOL PHARM BULL, V37, P361, DOI 10.1248/bpb.b13-00635; Brown DL, 2007, J PLAST RECONSTR AES, V60, P294, DOI 10.1016/j.bjps.2005.10.028; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Cao B, 2015, DERMATOL SURG, V41, P53, DOI 10.1097/DSS.0000000000000241; Ciloglu NS, 2014, J PLAST SURG HAND SU, V48, P234, DOI 10.3109/2000656X.2013.863777; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; De Nicola AF, 2013, CNS NEUROL DISORD-DR, V12, P1205; de Sa JZ, 2012, ACTA CIR BRAS, V27, P905, DOI 10.1590/S0102-86502012001200013; Dolen UC, 2015, ARCH PLAST SURG-APS, V42, P695, DOI 10.5999/aps.2015.42.6.695; Evsen MS, 2013, EUR REV MED PHARMACO, V17, P1869; Fang TL, 2014, J RECONSTR MICROSURG, V30, P1, DOI 10.1055/s-0033-1345429; Gurlek A, 2004, J PINEAL RES, V36, P58, DOI 10.1046/j.1600-079X.2003.00099.x; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hyder SM, 1999, MOL ENDOCRINOL, V13, P806, DOI 10.1210/me.13.6.806; Jiang C., 2016, MARIT POLICY MANAG, P1; Kelly CP, 2010, J PLAST RECONSTR AES, V63, P1553, DOI 10.1016/j.bjps.2009.08.011; Lin YT, 2015, J RECONSTR MICROSURG, V31, P464, DOI 10.1055/s-0035-1549444; Ozkan F, 2012, J SURG RES, V176, P601, DOI 10.1016/j.jss.2011.10.032; Ozkan O, 2006, PLAST RECONSTR SURG, V117, P1671, DOI 10.1097/01.prs.0000208874.61037.2b; Reichenberger MA, 2011, PLAST RECONSTR SURG, V127, P1830, DOI 10.1097/PRS.0b013e31820cf1fb; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Sirota T. V., 2014, Biomeditsinskaya Khimiya, V60, P63; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Zhang T, 2007, UNDERSEA HYPERBAR M, V34, P335; Zhu Wei-Hua, 2006, Hepatobiliary Pancreat Dis Int, V5, P205	26	7	7	1	4	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	NOV	2016	19	11					1166	1170					5	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	EG5NB	WOS:000391089600003	27917271				2022-02-06	
J	Ma, Q; Cai, M; Shang, JW; Yang, J; Gu, XY; Liu, WB; Yang, Q				Ma, Q.; Cai, M.; Shang, J. -W.; Yang, J.; Gu, X. -Y.; Liu, W. -B.; Yang, Q.			In vitro neural differentiation of bone marrow stromal cells induced by hepatocyte growth factor and glial cell derived neurotrophic factor	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Bone marrow stromal cells; Cell therapy; Hepatocyte growth factor; Glial cell derived neurotrophic factor; Neural differentiation	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; NEURONAL DIFFERENTIATION; GDNF; TRANSPLANTATION; INDUCTION; VIVO; PERSPECTIVE; THERAPY; RAT	OBJECTIVE: Bone marrow stromal cells (BMSCs) have great potential for cell-based transplantation therapy in treating neurological disease. However, the best combination of various trophic factors to produce full neural differentiation of BMSCs was still unclear. In our study, we aimed to investigate the neural differentiation capacity of rat BMSCs induced by growth factors including hepatocyte growth factor (HGF) and glial cell-derived neurotrophic factor (GDNF). MATERIALS AND METHODS: Cell counting kit-8 (CCK-8) assay, BrdU cell proliferation assay and flow cytometry were implemented to evaluate whether GDNF and HGF had positive effects on the proliferation of BMSCs. Moreover, the expression of neural specific markers in BMSCs was identified using immunofluorescence and quantitative real-time polymerase chain reaction (RT-PCR) at various time points (1, 7, 14 and 21-day post-induction). RESULTS: CCK-8 and BrdU proliferation analyses demonstrated that only HGF treatment had positive effects on the proliferation of BMSCs on the day 14 and 21 after incubation. RT-PCR and immunofluorescence analyses showed that GDNF and HGF elevated the expression of nestin and NCAM, and the combined application of GDNF and HGF has the most significant effect on day 7 after induction. However, at the day of 14 and 21 post-induction, the expression level of nestin and NCAM in GDNF-treatment group was significantly higher than the other three groups. CONCLUSIONS: HGF, not GDNF plays a positive role in BMSCs proliferation, whereas GDNF and HGF are capable of promoting BMSCs to differentiate into neuron-like cells.	[Ma, Q.; Yang, J.; Yang, Q.] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning Provin, Peoples R China; [Ma, Q.; Cai, M.; Shang, J. -W.; Gu, X. -Y.; Liu, W. -B.] Dalian Univ, Affiliated Zhongshan Hosp, Dept Neurol, Dalian, Liaoning Provin, Peoples R China		Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning Provin, Peoples R China.	yangqingdalian@163.com	Yang, Jun/D-6353-2011	Yang, Jun/0000-0002-4409-3099			ANCHI N, 2003, BRAIN RES, V991, P46; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Chen Y, 2006, CELL MOL LIFE SCI, V63, P1649, DOI 10.1007/s00018-006-6019-5; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Cohen AD, 2011, BRAIN RES, V1370, P80, DOI 10.1016/j.brainres.2010.11.006; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; Gao HY, 2012, J HUAZHONG U SCI-MED, V32, P87, DOI 10.1007/s11596-012-0015-9; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Ha Xiaoqin, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P613; Hamanoue M, 1996, J NEUROSCI RES, V43, P554, DOI 10.1002/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO;2-H; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee SH, 2007, NEUROSCIENCE, V146, P1020, DOI 10.1016/j.neuroscience.2007.02.058; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sango K, 2011, J NEUROSCI RES, V89, P898, DOI 10.1002/jnr.22605; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Van Belle E, 1998, CIRCULATION, V97, P381; Wang HT, 2010, J NEUROSCI, V30, P1523, DOI 10.1523/JNEUROSCI.3861-09.2010; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu HS, 2014, EUR REV MED PHARMACO, V18, P520; Yang JD, 2014, CYTOTECHNOLOGY, V66, P1007, DOI 10.1007/s10616-013-9654-3; Yang YJ, 2016, EUR REV MED PHARMACO, V20, P2899; ZALLONE AZ, 1996, P NATL ACAD SCI USA, V93, P7644; ZAWA T, 1989, NATURE, V342, P440; Zhang XY, 2012, TOXICOL RES-UK, V1, P201, DOI 10.1039/c2tx20035j; Zhang XY, 2011, J NANOPART RES, V13, P6941, DOI 10.1007/s11051-011-0603-9; Zhu TQ, 2015, CELL MOL NEUROBIOL, V35, P255, DOI 10.1007/s10571-014-0120-3	38	7	7	0	8	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	NOV	2016	20	22					4654	4663					10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EF1YC	WOS:000390120100006	27906439				2022-02-06	
J	Middleton, A; Graham, JE; Krishnan, S; Ottenbacher, KJ				Middleton, Addie; Graham, James E.; Krishnan, Shilpa; Ottenbacher, Kenneth J.			Program Interruptions and Short-Stay Transfers Represent Potential Targets for Inpatient Rehabilitation Care-Improvement Efforts	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Rehabilitation; Medicare; Health Care Reform; Quality Improvement	UNIFORM DATA SYSTEM; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; LENGTH-OF-STAY; HOSPITAL READMISSION; OLDER-ADULTS; MORTALITY; MEDICARE	Objective The objective of this work was to present comprehensive descriptive summaries of program interruptions and short-stay transfers among Medicare fee-for-service beneficiaries receiving inpatient rehabilitation after stroke, traumatic brain injury (TBI), and traumatic spinal cord injury (SCI). Design Retrospective cohort study of Medicare beneficiaries with any of the 3 conditions of interest who were admitted to inpatient rehabilitation directly from an acute hospital between July 1, 2012, and November 15, 2013. Results In the final sample (stroke, n = 71 769; TBI, n = 7109; SCI, n = 659), program interruption rates were 0.9% (stroke), 0.8% (TBI), and 1.4% (SCI). Short-stay transfer rates were 22.3% (stroke), 21.8% (TBI), and 31.6% (SCI); 14.7% of short-stay transfers and 12.3% of interruptions resulting in a return to acute care were identified as potentially preventable among those with stroke; 10.2% of transfers and 11.7% of interruptions among those with TBI, and 3.8% of transfers and 11.1% of interruptions among those with SCI. Conclusions Broad health care policies aimed at improving quality and reducing costs are currently being implemented. Reducing program interruptions and short-stay transfers during inpatient rehabilitative care represents a potential target for care-improvement efforts. Future research focused on identifying modifiable risk factors for potentially undesirable outcomes will allow for targeted preventative interventions.	[Middleton, Addie; Graham, James E.; Krishnan, Shilpa; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA		Middleton, A (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.		Shilpa Krishnan, PT/H-9628-2019	Shilpa Krishnan, PT/0000-0002-9419-0495; Ottenbacher, Kenneth/0000-0001-5990-3982; Middleton, Addie/0000-0001-8970-3703	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24-HD065702, R01-HD069443, 5K12HD055929-09]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133G140127]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702, P2CHD065702, K12HD055929, R01HD069443] Funding Source: NIH RePORTER	This work was partially funded by the National Institutes of Health (R24-HD065702, R01-HD069443, and 5K12HD055929-09 PI, K. Ottenbacher) and the National Institute on Disability, Independent Living, and Rehabilitation Research (H133G140127, PI, K. Ottenbacher).	Acumen LLC, 2016, SPEC MED SP IN PRESS; [Anonymous], 2014, FED REG, V79; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Carney ML, 2006, AM J PHYS MED REHAB, V85, P453, DOI 10.1097/01.phm.0000214279.04759.45; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Department of Health and Human Services. Centers for Medicare & Medicaid Services, 2014, INP REH FAC PROSP PA; Department of Health and Human Services. Centers for Medicare & Medicaid Services. Medicare Program, MED PROGR INP REH FA; Deutsch A, 2008, ARCH PHYS MED REHAB, V89, P2274, DOI 10.1016/j.apmr.2008.06.014; Downey L. V. A., 2014, Annals of Physical and Rehabilitation Medicine, V57, P193, DOI 10.1016/j.rehab.2014.01.004; Dunne TJ, 2014, J EVAL CLIN PRACT, V20, P396, DOI 10.1111/jep.12144; Engbers MJ, 2014, J THROMB HAEMOST, V12, P290, DOI 10.1111/jth.12480; FDA, 2015, FED REG; Gardiner JC, 2016, INT WOUND J, V13, P809, DOI 10.1111/iwj.12386; Granger CV, 2012, AM J PHYS MED REHAB, V91, P289, DOI 10.1097/PHM.0b013e31824ad2fd; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS293, DOI 10.1016/j.apmr.2014.08.026; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS98, DOI 10.1016/j.apmr.2012.11.051; Kaye KS, 2014, J AM GERIATR SOC, V62, P306, DOI 10.1111/jgs.12634; Lewin Group, 2015, CMS BUNDL PAYM CAR I; Lum HD, 2012, J GEN INTERN MED, V27, P1467, DOI 10.1007/s11606-012-2116-3; Medicare Payment Advisory Committee, 2016, REP C MED PAYM POL; MedPAC, 2015, REP C MED PAYM POL; Meikle B, 2002, ARCH PHYS MED REHAB, V83, P1222, DOI 10.1053/apmr.2002.33657; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Press MJ, 2016, JAMA-J AM MED ASSOC, V315, P131, DOI 10.1001/jama.2015.18161; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; UB Foundation Activities, 2012, INP REH FAC PAT ASS; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Werner R, 2010, HEALTH AFFAIR, V29, P1706, DOI 10.1377/hlthaff.2009.0556	30	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	NOV	2016	95	11					850	861		10.1097/PHM.0000000000000629			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EA6TK	WOS:000386761700014	27631389	Green Accepted			2022-02-06	
J	Abdolmaleki, A; Moghimi, A; Ghayour, MB; Rassouli, MB				Abdolmaleki, Arash; Moghimi, Ali; Ghayour, Mohammad B.; Rassouli, Morteza B.			Evaluation of neuroprotective, anticonvulsant, sedative and anxiolytic activity of citicoline in rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Seizure; Epilepsy; Traumatic brain injury; Pentylentetrazole; Citicoline	5'-DIPHOSPHOCHOLINE CDP-CHOLINE; TRANSIENT CEREBRAL-ISCHEMIA; EPILEPSY; SEIZURE; STIMULATION; PREVENTION; MECHANISMS; TRANSPORT; NETWORK; STROKE	Citicoline (cytidine-5'-diphosphocholine) is a neuroprotective agent that is administered following ischemic and traumatic brain injuries. There is little information about the antiseizure and anxiolytic effects of citicoline, which are therefore addressed in the present study. For evaluating the anticonvulsant effect of citicoline in the pentylentetrazole seizure model, a single intraperitoneal dose of citicoline was administered at 50, 100 or 150 mg/kg. Sedative and anxiolytic effects of citicoline were examined via elevated plus maze and pentobarbital induced sleep tests. Results show that citicoline at the doses of 100 and 150 mg/kg significantly delayed the latent period compared with the control (P < 0.05). Citicoline at the doses of 100 and 150 mg/kg significantly decreased total locomotion compared with the control (P < 0.05). Additionally, citicoline at the doses of 100 and 150 mg/kg significantly increased both percentage of entry and time spent in the open arms in the elevated plus maze test (P < 0.05). The pentobarbital induced sleep test showed that citicoline significantly reduced the latency to sleep (P < 0.05). Our results suggest that acute administration of citicoline has anticonvulsant activity and sedative effect. (C) 2016 Elsevier B.V. All rights reserved.	[Abdolmaleki, Arash; Moghimi, Ali; Ghayour, Mohammad B.; Rassouli, Morteza B.] Ferdowsi Univ Mashhad, Dept Biol, Fac Sci, Mashhad, Iran		Ghayour, MB (corresponding author), Ferdowsi Univ Mashhad, Dept Biol, Fac Sci, Mashhad, Iran.	mohammad.ghayour@stu.um.ac.ir	Moghimi, Ali/AAB-7028-2020; Behnam-Rassouli, Morteza/AAH-2407-2019	Behnam-Rassouli, Morteza/0000-0003-4734-9886			Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Adibhatla RM, 2003, J NEUROSCI RES, V73, P308, DOI 10.1002/jnr.10672; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; BIAGINI G, 1993, BIOL PSYCHIAT, V33, P712, DOI 10.1016/0006-3223(93)90121-S; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; DANDIYA PC, 1959, J PHARMACOL EXP THER, V125, P353; Davalos A, 2002, STROKE, V33, P2850, DOI 10.1161/01.STR.0000038691.03334.71; Dudek FE, 1997, J CLIN NEUROPHYSIOL, V14, P90, DOI 10.1097/00004691-199703000-00002; Ekhlas H., 2010, QJM-INT J MED, V10, P81; GALLETTI P, 1991, J NEUROL SCI, V103, pS19; GALLETTI P, 1985, BIOCHEM PHARMACOL, V34, P4121, DOI 10.1016/0006-2952(85)90204-7; Graham D. I., 2006, NEUROLOGY AND TRAUMA, P45; Grieb P, 2014, CNS DRUGS, V28, P185, DOI 10.1007/s40263-014-0144-8; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hurtado O, 2008, NEUROBIOL DIS, V29, P123, DOI 10.1016/j.nbd.2007.08.004; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Karpova MN, 2015, B EXP BIOL MED+, V158, P315, DOI 10.1007/s10517-015-2750-y; Kim JH, 2015, BRAIN RES, V1595, P156, DOI 10.1016/j.brainres.2014.11.011; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Plataras C, 2000, CLIN BIOCHEM, V33, P351, DOI 10.1016/S0009-9120(00)00084-9; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Saver Jeffrey L, 2008, Rev Neurol Dis, V5, P167; SECADES JJ, 1995, METHOD FIND EXP CLIN, V17, P1; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Vazquez B, 2003, EPILEPSY BEHAV, V4, pS20, DOI 10.1016/j.yebeh.2003.10.005; Ziburkus J, 2013, J NEUROPHYSIOL, V109, P1296, DOI 10.1152/jn.00232.2012; Zweifler M., 2002, CURR MED RES OPIN, V18, P14	32	7	8	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	OCT 15	2016	789						275	279		10.1016/j.ejphar.2016.07.048			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DY7RR	WOS:000385327500031	27475676				2022-02-06	
J	Ghoshal, S; Bondada, V; Saatman, KE; Guttmann, RP; Geddes, JW				Ghoshal, Sarbani; Bondada, Vimala; Saatman, Kathryn E.; Guttmann, Rodney P.; Geddes, James W.			Phage display for identification of serum biomarkers of traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Biomarkers; Rodents; Animal models; Concussion; Blood	FIBRILLARY ACIDIC PROTEIN; CLINICAL-APPLICATIONS; BREAKDOWN PRODUCTS; EARLY INTERVENTION; FILAMENTOUS PHAGE; CORTICAL IMPACT; HEAD-INJURY; MILD; DIAGNOSIS; DAMAGE	Background: The extent and severity of traumatic brain injuries (TBIs) can be difficult to determine with current diagnostic methods. To address this, there has been increased interest in developing biomarkers to assist in the diagnosis, determination of injury severity, evaluation of recovery and therapeutic efficacy, and prediction of outcomes. Several promising serum TBI biomarkers have been identified using hypothesis-driven approaches, largely examining proteins that are abundant in neurons and non-neural cells in the CNS. New method: An unbiased approach, phage display, was used to identify serum TBI biomarkers. In this proof-of-concept study, mice received a TBI using the controlled cortical impact model of TBI (1 mm injury depth, 3.5 m/s velocity) and phage display was utilized to identify putative serum biomarkers at 6 h postinjury. Results: An engineered phage which preferentially bound to injured serum was sequenced to identify the 12-mer 'recognizer' peptide expressed on the coat protein. Following synthesis of the recognizer peptide, pull down, and mass spectrometry analysis, the target protein was identified as glial fibrillary acidic protein (GFAP). Comparison with existing methods and conclusions: GFAP has previously been identified as a promising TBI biomarker. The results provide proof of concept regarding the ability of phage display to identify TBI serum biomarkers. This methodology is currently being applied to serum biomarkers of mild TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Ghoshal, Sarbani; Bondada, Vimala; Saatman, Kathryn E.; Geddes, James W.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B483 Biomed & Biol Sci Res Bldg BBSRB, Lexington, KY 40536 USA; [Guttmann, Rodney P.] Univ Kentucky, Dept Gerontol, Lexington, KY USA; [Ghoshal, Sarbani] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA; [Guttmann, Rodney P.] Univ West Florida, Ctr Aging, Pensacola, FL USA		Geddes, JW (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B483 Biomed & Biol Sci Res Bldg BBSRB, Lexington, KY 40536 USA.	jgeddes@uky.edu	guttmann, rodney/AAN-8880-2021	guttmann, rodney/0000-0001-5553-3099; Geddes, James/0000-0003-0369-3642	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS084088, P30 NS051220]; Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS084088, P30NS051220] Funding Source: NIH RePORTER	This research was supported by NIH grants R21 NS084088 and P30 NS051220 and by the Kentucky Spinal Cord and Head Injury Research Trust. We thank Kathleen Schoch, Ph.D. for the TBI surgeries.	Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Araujo GR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0685-3; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Bonnycastle LLC, 1996, J MOL BIOL, V258, P747, DOI 10.1006/jmbi.1996.0284; Bradbury A.R., 2010, CURR PROTOC NEUROSCI; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Butler I.J., 2013, JAMA NEUROL, P1; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Diamandis EP, 2004, J NATL CANCER I, V96, P353, DOI 10.1093/jnci/djh056; Ding J, 2015, ARQ NEURO-PSIQUIAT, V73, P342, DOI 10.1590/0004-282X20150006; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Coelho EAF, 2015, REV SOC BRAS MED TRO, V48, P370, DOI 10.1590/0037-8682-0096-2015; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Guttmann RP, 2005, BIOCHEM BIOPH RES CO, V333, P1087, DOI 10.1016/j.bbrc.2005.06.036; Hof D, 2006, MOL CELL PROTEOMICS, V5, P245, DOI 10.1074/mcp.M500239-MCP200; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Mackness B, 1998, GEN PHARMACOL-VASC S, V31, P329, DOI 10.1016/S0306-3623(98)00028-7; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Maroon JC, 2012, PHYSICIAN SPORTSMED, V40, P73, DOI 10.3810/psm.2012.11.1990; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Park JP, 2010, BIOTECHNOL BIOENG, V105, P678, DOI 10.1002/bit.22597; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Reiter Y, 2002, CURRENT PROTOCOLS IM, V10, p9B, DOI [10.1002/0471142735.im1019bs48, DOI 10.1002/0471142735.IM1019BS48]; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Schirrmann T, 2011, MOLECULES, V16, P412, DOI 10.3390/molecules16010412; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wang K.K., 2015, J NEUROTRAU IN PRESS; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang M, 2011, RHEUMATOL INT, V31, P1009, DOI 10.1007/s00296-010-1403-8; Weng XJ, 2012, CLIN BIOCHEM, V45, P303, DOI 10.1016/j.clinbiochem.2011.12.018; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZJ, 2011, J CLIN LAB ANAL, V25, P402, DOI 10.1002/jcla.20491; Zurbig P, 2012, ELECTROPHORESIS, V33, P3617, DOI 10.1002/elps.201200360	64	7	7	1	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2016	272				SI		33	37		10.1016/j.jneumeth.2016.04.026			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA6LF	WOS:000386740000004	27168498	Green Accepted			2022-02-06	
J	Vonder Haar, C; Winstanley, CA				Vonder Haar, Cole; Winstanley, Catharine A.			Minor Functional Deficits in Basic Response Patterns for Reinforcement after Frontal Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						behavior; cognition; controlled cortical impact; operant; schedules of reinforcement	CONTROLLED CORTICAL IMPACT; GAMBLING TASK-PERFORMANCE; LONG-TERM; DOPAMINERGIC MODULATION; DECISION-MAKING; UNITED-STATES; MODEL; DISCRIMINATION; RECOVERY; DYSFUNCTION	Traumatic brain injury (TBI) is a major contributor to numerous psychiatric conditions and chronic behavioral dysfunction. Recent studies in experimental brain injury have begun to adopt operant methodologies to assess these deficits, all of which rely on the process of reinforcement. No studies have directly examined how reinforced behaviors are affected by TBI, however. The current study assessed performance under the four most common schedules of reinforcement (fixed ratio, variable ratio, fixed interval, variable interval) and one higher order schedule assessing motivation (progressive ratio) after bilateral, pre-frontal controlled cortical impact injury. TBI-induced differences on the basic schedules were minor, with the exception of the variable ratio, where increased efficacy (more reinforcers, higher response rates, lower interresponse times) at higher requirements was observed as a result of brain injury. Performance on the progressive ratio schedule showed some gross differences between the groups, in that sham rats became more efficient under this schedule while injured rats perseverated in lever pressing. Further, injured rats were specifically impaired at lower response requirements on the progressive ratio. Taken together, these findings indicate that simple reinforced behaviors are mostly unaffected after TBI, except in the case of variable ratio schedules, but the altered performance on the higher-order progressive ratio schedule suggests changes involving motivation or potentially perseveration. These findings validate operant measures of more complex behaviors for brain injury, all of which rely on reinforcement and can be taken into consideration when adapting and developing novel functional assessments.	[Vonder Haar, Cole; Winstanley, Catharine A.] Univ British Columbia, Dept Psychol, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada		Vonder Haar, C; Winstanley, CA (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	cole.vonderhaar@psych.ubc.ca; cwinstanley@psych.ubc.ca		Vonder Haar, Cole/0000-0001-7949-2068			Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Ferrara A, 2009, BEHAV BRAIN RES, V205, P525, DOI 10.1016/j.bbr.2009.08.011; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Killeen PR, 2009, J EXP PSYCHOL ANIM B, V35, P35, DOI 10.1037/a0012497; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Linden J, 2015, BEHAV BRAIN RES, V279, P82, DOI 10.1016/j.bbr.2014.10.042; Linden J, 2014, BEHAV BRAIN RES, V258, P127, DOI 10.1016/j.bbr.2013.10.028; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Maruichi K, 2009, NEUROPATHOLOGY, V29, P422, DOI 10.1111/j.1440-1789.2008.00995.x; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Pope DA, 2015, J EXP ANAL BEHAV, V103, P450, DOI 10.1002/jeab.148; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Simon NW, 2009, NEUROPSYCHOPHARMACOL, V34, P2208, DOI 10.1038/npp.2009.48; Skinner B. F., 1957, SCHEDULES REINFORCEM; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Stein JS, 2012, J EXP ANAL BEHAV, V97, P305, DOI 10.1901/jeab.2012.97-305; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Vonder Haar C, 2014, BRAIN INJURY, V28, P235, DOI 10.3109/02699052.2013.860473; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62	46	7	7	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1892	1900		10.1089/neu.2015.4276			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300009	26756392				2022-02-06	
J	Slomic, M; Christiansen, B; Soberg, HL; Sveen, U				Slomic, Mirela; Christiansen, Bjorg; Soberg, Helene L.; Sveen, Unni			User involvement and experiential knowledge in interprofessional rehabilitation: a grounded theory study	BMC HEALTH SERVICES RESEARCH			English	Article						User involvement; Patient involvement; Experiential knowledge; Traumatic brain injury; Multiple trauma; Interdisciplinary rehabilitation	TRAUMATIC BRAIN-INJURY; PATIENT INVOLVEMENT; HEALTH-POLICY; MENTAL-HEALTH; CARE; MEDICINE	Background: User involvement is increasingly important in developing relevant health care services. The aim of this study was to contribute to a deeper understanding of user involvement and patients' experiential knowledge as recognized and incorporated into clinical practice by rehabilitation professionals. Methods: A qualitative design using a grounded theory approach was applied. Data were collected by observations of the interprofessional meetings at two rehabilitation units treating patients with traumatic brain injury and multiple trauma and by individual semi-structured interviews with rehabilitation professionals. Results: The professionals recognized and incorporated user involvement into clinical practice as formal or authentic. Formal user involvement was sometimes considered pro forma. Incorporating patient' experiential knowledge was considered a part of authentic user involvement. Possible gaps between the patients' experiential knowledge and professional expertise were recognized. Challenges included dealing with 'artifacts', sources of information external to the patients' own experiences, and addressing the patients' possibly reduced insight due to trauma. Conclusion: Patients' experiential knowledge was recognized as an essential component of the professionals' knowledge base. The professionals considered user involvement and patients' experiential knowledge as part of their clinical practice. Implementation of user involvement and contribution of patients' experiential knowledge could be improved by understanding the issues raised in practice, such as possible negative consequences of user involvement in form of burdening or disempowering the patients. A better understanding of the characteristics and measures of user involvement is necessary in order to be able to offer its full benefits for both the patients and the professionals.	[Slomic, Mirela; Christiansen, Bjorg; Soberg, Helene L.; Sveen, Unni] Oslo & Akershus Univ Coll, Fac Hlth Sci, Oslo, Norway; [Soberg, Helene L.; Sveen, Unni] Oslo Univ Hosp, Oslo, Norway		Slomic, M (corresponding author), Oslo & Akershus Univ Coll, Fac Hlth Sci, Oslo, Norway.	mirela.slomic@hioa.no			Research Council of NorwayResearch Council of Norway	This study was financed by the Research Council of Norway. The funding source had no role in the design, execution, or interpretation of the findings in this study.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andreassen TA, 2009, PUBLIC MONEY MANAGE, V29, P117, DOI 10.1080/09540960902768012; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bee P, 2015, INT J NURS STUD, V52, P1834, DOI 10.1016/j.ijnurstu.2015.07.008; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Brinkmann S., 2009, INTERVIEWS LEARNING; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Dent M, 2015, J HEALTH ORGAN MANAG, V29, P546, DOI 10.1108/JHOM-05-2015-0078; Djulbegovic B, 2015, USERS GUIDES MED LIT; Fudge N, 2008, BMJ-BRIT MED J, V336, P313, DOI 10.1136/bmj.39456.552257.BE; Greenhalgh T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0437-x; Greenhalgh T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b49; Howe Amanda, 2006, J Interprof Care, V20, P527, DOI 10.1080/13561820600936244; Karlsson K, 2007, DISABIL REHABIL, V29, P245, DOI 10.1080/09638280600756414; Kitson A, 2013, J ADV NURS, V69, P4, DOI 10.1111/j.1365-2648.2012.06064.x; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Lequerica AH, 2009, DISABIL REHABIL, V31, P753, DOI 10.1080/09638280802309095; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Nair KPS, 2003, CLIN REHABIL, V17, P192, DOI 10.1191/0269215503cr599oa; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Patton M., 2015, QUALITATIVE RES EVAL, V4; Rise MB, 2013, HEALTH EXPECT, V16, P266, DOI 10.1111/j.1369-7625.2011.00713.x; Soberg HL, 2008, J REHABIL MED, V40, P340, DOI 10.2340/16501977-0174; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Soberg HL, 2011, J TRAUMA, V71, P425, DOI 10.1097/TA.0b013e3181eff54f; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Taylor D, 2007, SOCIOL HEALTH ILL, V29, P27, DOI 10.1111/j.1467-9566.2007.00516.x; Vrangbaek K, 2015, J HEALTH ORGAN MANAG, V29, P611, DOI 10.1108/JHOM-01-2015-0002	30	7	7	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	OCT 4	2016	16								547	10.1186/s12913-016-1808-5			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DX9FB	WOS:000384697900006	27716269	Green Published, gold			2022-02-06	
J	Ashkenazi, I; Schecter, WP; Peleg, K; Givon, A; Olsha, O; Turegano-Fuentes, F; Alfici, R				Ashkenazi, Itamar; Schecter, William P.; Peleg, Kobi; Givon, Adi; Olsha, Oded; Turegano-Fuentes, Fernando; Alfici, Ricardo		Israeli Trauma Grp	Glasgow Coma Scale Score in Survivors of Explosion With Possible Traumatic Brain Injury in Need of Neurosurgical Intervention	JAMA SURGERY			English	Article							TERRORIST BOMBINGS; EMERGENCY-DEPARTMENT; OUTCOMES; PREDICTION; CITY	IMPORTANCE Head injury following explosions is common. Rapid identification of patients with severe traumatic brain injury (TBI) in need of neurosurgical intervention is complicated in a situation where multiple casualties are admitted following an explosion. OBJECTIVE To evaluate whether Glasgow Coma Scale (GCS) score or the Simplified Motor Score at presentation would identify patients with severe TBI in need of neurosurgical intervention. DESIGN, SETTING, AND PARTICIPANTS Analysis of clinical data recorded in the Israel National Trauma Registry of 1081 patients treated following terrorist bombings in the civilian setting between 1998 and 2005. Primary analysis of the data was conducted in 2009, and analysis was completed in 2015. MAIN OUTCOMES AND MEASURES Proportion of patients with TBI in need of neurosurgical intervention per GCS score or Simplified Motor Score. RESULTS Of 1081 patients (median age, 29 years [range, 0-90 years]; 38.9% women), 198 (18.3%) were diagnosed as having TBI (48 mild and 150 severe). Severe TBI was diagnosed in 48 of 877 patients (5%) with a GCS score of 15 and in 99 of 171 patients (58%) with GCS scores of 3 to 14 (P < .001). In 65 patients with abnormal GCS (38%), no head injury was recorded. Nine of 877 patients (1%) with a GCS score of 15 were in need of a neurosurgical operation, and fewer than 51 of the 171 patients (30%) with GCS scores of 3 to 14 had a neurosurgical operation (P < .001). No difference was found between the proportion of patients in need of neurosurgery with GCS scores of 3 to 8 and those with GCS scores of 9 to 14 (30% vs 27%; P = .83). When the Simplified Motor Score and GCS were compared with respect to their ability to identify patients in need of neurosurgical interventions, no difference was found between the 2 scores. CONCLUSIONS AND RELEVANCE Following an explosion in the civilian setting, 65 patients (38%) with GCS scores of 3 to 14 did not experience severe TBI. The proportion of patients with severe TBI and severe TBI in need of a neurosurgical intervention were similar in patients presenting with GCS scores of 3 to 8 and GCS scores of 9 to 14. In this study, GCS and Simplified Motor Score did not help identify patients with severe TBI in need of a neurosurgical intervention.	[Ashkenazi, Itamar; Alfici, Ricardo] Hillel Yaffe Med Ctr, Dept Surg, Hadera, Israel; [Schecter, William P.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Peleg, Kobi; Givon, Adi] Gertner Inst, Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel; [Peleg, Kobi] Tel Aviv Univ, Fac Med, Disaster Med Dept, Tel Aviv, Israel; [Olsha, Oded] Shaare Zedek Med Ctr, Dept Surg, Jerusalem, Israel; [Turegano-Fuentes, Fernando] Hosp Gen Univ Gregorio Maranon, Emergency Surg Dept, Madrid, Spain		Ashkenazi, I (corresponding author), Hillel Yaffe Med Ctr, Dept Surg B, POB 169, IL-38100 Hadera, Israel.	i_ashkenazi@yahoo.com	, ita/AAG-5879-2020	, ita/0000-0002-6305-4159			Aharonson-Daniel L, 2003, INJURY PREV, V9, P156, DOI 10.1136/ip.9.2.156; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Cushman JG, 2003, J TRAUMA, V54, P147, DOI 10.1097/00005373-200301000-00018; Einav S, 2004, ANN SURG, V239, P304, DOI 10.1097/01.sla.0000114013.19114.57; Etemadifar M, STUDY SEIZURES 153 H; Fain WB, 2015, MIL MED, V180, P201, DOI 10.7205/MILMED-D-14-00431; Fischer H., GUIDE MILITARY CASUA; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Hogan DE, 1999, ANN EMERG MED, V34, P160, DOI 10.1016/S0196-0644(99)70224-6; Institute of Medicine, 2009, GULF WAR AND HLTH, V7; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Singh AK, 2015, EMERG RADIOL, V22, P527, DOI 10.1007/s10140-015-1322-9; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Turegano-Fuentes F, 2008, WORLD J SURG, V32, P1168, DOI 10.1007/s00268-008-9557-1; Wang EW, 2013, NEUROL RES, V35, P285, DOI 10.1179/1743132812Y.0000000138; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277	21	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	OCT	2016	151	10					954	958		10.1001/jamasurg.2016.1742			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EA5WS	WOS:000386696200016	27409973				2022-02-06	
J	Chong, ZZ				Chong, Zhao Zhong			S100B raises the alert in subarachnoid hemorrhage	REVIEWS IN THE NEUROSCIENCES			English	Article						neuroinflammation; nuclear factor-kappa B; oxidative stress; phosphoinositide 3 kinase; receptor of advanced glycation end products (RAGE); stroke	NEURON-SPECIFIC ENOLASE; GLYCATION END-PRODUCTS; TRAUMATIC BRAIN-INJURY; BINDING-PROTEIN S100B; OXIDATIVE STRESS; CEREBRAL VASOSPASM; SERUM S100B; S-100 PROTEIN; MYOBLAST PROLIFERATION; MONOCLONAL-ANTIBODY	Subarachnoid hemorrhage (SAH) is a devastating disease with high mortality and mobility, the novel therapeutic strategies of which are essentially required. The calcium binding protein S100B has emerged as a brain injury biomarker that is implicated in pathogenic process of SAH. S100B is mainly expressed in astrocytes of the central nervous system and functions through initiating intracellular signaling or via interacting with cell surface receptor, such as the receptor of advanced glycation end products. The biological roles of S100B in neurons have been closely associated with its concentrations, resulting in either neuroprotection or neurotoxicity. The levels of S100B in the blood have been suggested as a biomarker to predict the progress or the prognosis of SAH. The role of S100B in the development of cerebral vasospasm and brain damage may result from the induction of oxidative stress and neuroinflammation after SAH. To get further insight into mechanisms underlying the role of S100B in SAH based on this review might help us to find novel therapeutic targets for SAH.	[Chong, Zhao Zhong] Univ Illinois, Dept Anesthesiol, 835 S Wolcott St, Chicago, IL 60612 USA		Chong, ZZ (corresponding author), Univ Illinois, Dept Anesthesiol, 835 S Wolcott St, Chicago, IL 60612 USA.	zzchong@uic.edu					Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Alexanian AR, 1999, FASEB J, V13, P1611, DOI 10.1096/fasebj.13.12.1611; Amiri M, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00065; Arcuri C, 2005, J BIOL CHEM, V280, P4402, DOI 10.1074/jbc.M406440200; Arfvidsson B, 2015, CLIN CHEM LAB MED, V53, P111, DOI 10.1515/cclm-2014-0283; Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; BAUDIER J, 1982, FEBS LETT, V148, P231, DOI 10.1016/0014-5793(82)80813-2; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bluhm B, 2015, CEREBELLUM, V14, P119, DOI 10.1007/s12311-014-0606-z; Bowman G, 2006, NEUROCRIT CARE, V5, P222, DOI 10.1385/NCC:5:3:222; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Castagnola Massimo, 2013, Methods Mol Biol, V963, P357, DOI 10.1007/978-1-62703-230-8_22; Changyaleket B, 2016, BRAIN RES, V1634, P171, DOI 10.1016/j.brainres.2015.12.061; Chong ZZ, 2008, CURR NEUROVASC RES, V5, P159, DOI 10.2174/156720208785425666; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Chong ZZ, 2016, CURR MED CHEM, V23, P1571, DOI 10.2174/0929867323666160406121117; Chong ZZ, 2015, CURR DRUG TARGETS, V16, P1107, DOI 10.2174/1389450116666150408103448; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; CHYATTE D, 1984, J NEUROSURG, V60, P923, DOI 10.3171/jns.1984.60.5.0923; Clatterbuck RE, 2003, J NEUROSURG, V99, P376, DOI 10.3171/jns.2003.99.2.0376; COCCHIA D, 1981, NATURE, V294, P85, DOI 10.1038/294085a0; Corvino V, 2003, NEUROCHEM RES, V28, P341, DOI 10.1023/A:1022345720852; Dang XB, 2014, INT J CLIN EXP PATHO, V7, P3818; Darlot F, 2008, AM J PHYSIOL-RENAL, V295, pF1142, DOI 10.1152/ajprenal.00599.2007; Di Legge S, 2003, NEUROL SCI, V24, P351, DOI 10.1007/s10072-003-0188-x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Druse MJ, 2007, BRAIN RES, V1150, P46, DOI 10.1016/j.brainres.2007.02.092; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Falcone T, 2015, J PSYCHIATR RES, V62, P14, DOI 10.1016/j.jpsychires.2014.12.002; Faye RS, 2008, MELANOMA RES, V18, P134, DOI 10.1097/CMR.0b013e3282f623d9; Foerch C, 2004, STROKE, V35, P2160, DOI 10.1161/01.STR.0000138730.03264.ac; Friedrich V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-103; Gaetani P, 1992, J Neurosurg Sci, V36, P1; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Goncalves CF, 2010, J ORAL MAXIL SURG, V68, P2341, DOI 10.1016/j.joms.2009.03.059; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Heizmann Claus W, 2002, Methods Mol Biol, V172, P69; Hoozemans JJM, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-27; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jiang Y, 2012, J CLIN NEUROSCI, V19, P866, DOI 10.1016/j.jocn.2011.08.038; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kaneda K, 2010, BRAIN RES BULL, V81, P173, DOI 10.1016/j.brainresbull.2009.10.020; Katayama Y, 2007, STROKE, V38, P2373, DOI 10.1161/STROKEAHA.106.480038; Kim DE, 2002, STROKE, V33, P2687, DOI 10.1161/01.STR.0000033071.99143.9E; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Koppal T, 2001, NEUROCHEM INT, V39, P401, DOI 10.1016/S0197-0186(01)00047-X; Laaksamo E, 2013, NEUROSURGERY, V72, P109, DOI 10.1227/NEU.0b013e3182770e8c; Lai PMR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151853; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lin CL, 2005, SURG NEUROL, V64, P201, DOI 10.1016/j.surneu.2005.04.038; Lin J, 2010, J BIOL CHEM, V285, P27487, DOI 10.1074/jbc.M110.155382; Liu Y, 2008, MOL PHARMACOL, V74, P371, DOI 10.1124/mol.108.044925; Maiese K, 2012, INT J MOL SCI, V13, P13830, DOI 10.3390/ijms131113830; MARSHAK DR, 1981, P NATL ACAD SCI-BIOL, V78, P6793, DOI 10.1073/pnas.78.11.6793; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Miller BA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/384342; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Montaner J, 2012, J PROTEOMICS, V75, P4758, DOI 10.1016/j.jprot.2012.01.033; Mori T, 2001, STROKE, V32, P636, DOI 10.1161/01.STR.32.3.636; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Moutsatsou P, 2014, CLIN CHEM LAB MED, V52, P999, DOI 10.1515/cclm-2013-0978; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nishino A, 2010, NEUROL RES, V32, P873, DOI 10.1179/016164109X12608733393791; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; Niven J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132688; Pentimalli L, 2004, J NEUROSURG, V101, P1018, DOI 10.3171/jns.2004.101.6.1018; Pereira AR, 2007, NEUROCRIT CARE, V7, P18, DOI 10.1007/s12028-007-0053-5; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Pozdnyakov N, 1997, BIOCHEMISTRY-US, V36, P14159, DOI 10.1021/bi971792l; Provencio JJ, 2010, NEUROCRIT CARE, V12, P244, DOI 10.1007/s12028-009-9308-7; Provencio JJ, 2016, BRAIN BEHAV IMMUN, V54, P233, DOI 10.1016/j.bbi.2016.02.007; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Pyne-Geithman GJ, 2009, NEUROL RES, V31, P195, DOI 10.1179/174313209X393906; Rambotti MG, 1999, NEUROSCIENCE, V92, P1089, DOI 10.1016/S0306-4522(99)00074-3; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Sanchez-Pena P, 2008, CRIT CARE MED, V36, P2267, DOI 10.1097/CCM.0b013e3181809750; Sanchez-Pena P, 2012, CRIT CARE MED, V40, P594, DOI 10.1097/CCM.0b013e31822f05e7; Scotto C, 1998, J BIOL CHEM, V273, P3901, DOI 10.1074/jbc.273.7.3901; Serbinek D, 2010, CARDIOVASC PSYCHIAT, V2010; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; Sorci G, 2004, J CELL PHYSIOL, V199, P274, DOI 10.1002/jcp.10462; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; SPRECA A, 1989, J HISTOCHEM CYTOCHEM, V37, P441, DOI 10.1177/37.4.2926122; Steinacker P, 2013, ACTA NEUROL SCAND, V128, P249, DOI 10.1111/ane.12113; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Stroth N, 2015, EUR NEUROPSYCHOPHARM, V25, P2372, DOI 10.1016/j.euroneuro.2015.10.003; Sviatoha V, 2010, MELANOMA RES, V20, P118, DOI 10.1097/CMR.0b013e3283350554; Tanaka Y, 2008, BRAIN RES, V1227, P248, DOI 10.1016/j.brainres.2008.06.076; Tanaka Y, 2008, NEUROSCI LETT, V436, P40, DOI 10.1016/j.neulet.2008.02.056; Tanaka Y, 2007, BRAIN RES, V1154, P194, DOI 10.1016/j.brainres.2007.03.085; Thelin EP, 2016, EUR J TRAUMA EMERG S, V42, P617, DOI 10.1007/s00068-015-0583-z; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO; Tsoporis JN, 2009, AM J HYPERTENS, V22, P1048, DOI 10.1038/ajh.2009.145; Tsoporis JN, 2005, CIRCULATION, V111, P598, DOI 10.1161/01.CIR.0000154554.65287.F5; Tubaro C, 2011, BBA-MOL CELL RES, V1813, P1092, DOI 10.1016/j.bbamcr.2010.11.015; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Villarreal A, 2014, J NEUROCHEM, V131, P190, DOI 10.1111/jnc.12790; Villarreal A, 2011, J NEUROCHEM, V117, P321, DOI 10.1111/j.1471-4159.2011.07207.x; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008; Whitlow JL, 2009, J MOL GRAPH MODEL, V27, P969, DOI 10.1016/j.jmgm.2009.02.006; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Xiong ZG, 2000, EXP CELL RES, V257, P281, DOI 10.1006/excr.2000.4902; Xu HL, 2014, BRAIN RES, V1586, P83, DOI 10.1016/j.brainres.2014.08.036; Xu HL, 2015, BRAIN RES, V1603, P141, DOI 10.1016/j.brainres.2015.01.047; Yang Q, 1999, EXP CELL RES, V246, P501, DOI 10.1006/excr.1998.4314; Yoneko M, 2010, METHOD FIND EXP CLIN, V32, P727, DOI 10.1358/mf.2010.32.10.1561078; Zhan Y, 2012, CRIT CARE MED, V40, P1291, DOI 10.1097/CCM.0b013e31823da96d; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002	153	7	7	0	4	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	OCT	2016	27	7					745	759		10.1515/revneuro-2016-0021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY8GU	WOS:000385368100006	27442365				2022-02-06	
J	Damestani, Y; De Howitt, N; Halaney, DL; Garay, JE; Aguilar, G				Damestani, Yasaman; De Howitt, Natalie; Halaney, David L.; Garay, Javier E.; Aguilar, Guillermo			Evaluation of Laser Bacterial Anti-Fouling of Transparent Nanocrystalline Yttria-Stabilized-Zirconia Cranial Implant	LASERS IN SURGERY AND MEDICINE			English	Article						windows to the brain; transparent cranial implant; biofilm laser therapy; bioluminescent bacteria; fouling control	PRESSURE-ASSISTED DENSIFICATION; IN-VITRO GROWTH; ESCHERICHIA-COLI; 810 NM; CRANIOPLASTY; INFECTIONS; SURFACES; LIGHT; IRRADIATION; MECHANISM	Background and Objective: The development and feasibility of a novel nanocrystalline yttria-stabilized-zirconia (nc-YSZ) cranial implant has been recently established. The purpose of what we now call "window to the brain (WttB)" implant (or platform), is to improve patient care by providing a technique for delivery and/or collection of light into/from the brain, on demand, over large areas, and on a chronically recurring basis without the need for repeated craniotomies. WttB holds the transformative potential for enhancing light-based diagnosis and treatment of a wide variety of brain pathologies including cerebral edema, traumatic brain injury, stroke, glioma, and neurodegenerative diseases. However, bacterial adhesion to the cranial implant is the leading factor for biofilm formation (fouling), infection, and treatment failure. Escherichia coli (E. coli), in particular, is the most common isolate in gram-negative bacillary meningitis after cranial surgery or trauma. The transparency of our WttB implant may provide a unique opportunity for non-invasive treatment of bacterial infection under the implant using medical lasers. Study Design/Materials and Methods: A drop of a diluted overnight culture of BL21-293 E. coli expressing luciferase was seeded between the nc-YSZ implant and the agar plate. This was followed by immediate irradiation with selected laser. After each laser treatment the nc-YSZ was removed, and cultures were incubated for 24 hours at 37 degrees C. The study examined continuous wave (CW) and pulsed wave (PW) modes of near-infrared (NIR) 810 nm laser wavelength with a power output ranging from 1 to 3 W. During irradiation, the temperature distribution of nc-YSZ surface was monitored using an infrared thermal camera. Relative luminescence unit (RLU) was used to evaluate the viability of bacteria after the NIR laser treatment. Results: Analysis of RLU suggests that the viability of E. coli biofilm formation was reduced with NIR laser treatment when compared to the control group (P<0.01) and loss of viability depends on both laser fluence and operation mode (CW or PW). The results demonstrate that while CW laser reduces the biofilm formation more than PW laser with the same power, the higher surface temperature of the implant generated by CW laser limits its medical efficacy. In contrast, with the right parameters, PW laser produces a more moderate photothermal effect which can be equally effective at controlling bacterial growth. Conclusions: Our results show that E. coli biofilm formation across the thickness of the nc-YSZ implant can be disrupted using NIR laser treatment. The results of this in vitro study suggest that using nc-YSZ as a cranial implant in vivo may also allow for locally selective, non-invasive, chronic treatment of bacterial layers (fouling) that might form under cranial implants, without causing adverse thermal damage to the underlying host tissue when appropriate laser parameters are used. (C) 2016 Wiley Periodicals, Inc.	[Damestani, Yasaman; De Howitt, Natalie; Aguilar, Guillermo] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Halaney, David L.; Aguilar, Guillermo] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Garay, Javier E.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA		Aguilar, G (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	gaguilar@engr.ucr.edu	Aguilar, Guillermo/M-8353-2017	Aguilar, Guillermo/0000-0001-7326-1162; Halaney, David/0000-0003-4437-0516			Alaniz JE, 2009, OPT MATER, V32, P62, DOI 10.1016/j.optmat.2009.06.004; Amaya C, 2012, MATER CHEM PHYS, V136, P917, DOI 10.1016/j.matchemphys.2012.08.019; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Block C M, 1992, Int J Oral Maxillofac Implants, V7, P441; Briggs S, 2004, SCAND J INFECT DIS, V36, P165, DOI 10.1080/00365540410027193; Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Damestani Y, 2014, LASER SURG MED, V46, P488, DOI 10.1002/lsm.22258; Damestani Y, 2013, NANOMED-NANOTECHNOL, V9, P1135, DOI 10.1016/j.nano.2013.08.002; Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842; Dashti SR, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E10; Dinjaski N, 2014, ACTA BIOMATER, V10, P2935, DOI 10.1016/j.actbio.2014.03.005; DUMOULIN GC, 1985, BRAIN RES, V340, P261, DOI 10.1016/0006-8993(85)90922-9; ERIKSSON AR, 1983, J PROSTHET DENT, V50, P101, DOI 10.1016/0022-3913(83)90174-9; Fournier M, 2011, AM J PHYS ANTHROPOL, V144, P137; Garay JE, 2010, ANNU REV MATER RES, V40, P445, DOI [10.1146/annurev-matsci-070909-104433, 10.1146/annurev-matsci-070909-10443]; Geminiani A, 2011, IMPLANT DENT, V20, P379, DOI 10.1097/ID.0b013e3182310d57; Ghosh S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3264613; Goh RCW, 2010, J PLAST RECONSTR AES, V63, P1479, DOI 10.1016/j.bjps.2009.08.010; Gordon CR, 2014, OPER NEUROSURG, V10, P179, DOI 10.1227/NEU.0000000000000296; Haas R, 1997, CLIN ORAL IMPLAN RES, V8, P249, DOI 10.1034/j.1600-0501.1997.080401.x; Hamblin MR, 2002, PHOTOCHEM PHOTOBIOL, V75, P51, DOI 10.1562/0031-8655(2002)075<0051:RCOWIB>2.0.CO;2; Hauser-Gerspach I, 2010, CLIN ORAL IMPLAN RES, V21, P277, DOI 10.1111/j.1600-0501.2009.01835.x; He Xiaoming, 2011, Open Biomed Eng J, V5, P47, DOI 10.2174/1874120701105010047; Hibst R, 2010, J BIOPHOTONICS, V3, P296, DOI 10.1002/jbio.201000007; Kato T, 1998, LASER SURG MED, V23, P299, DOI 10.1002/(SICI)1096-9101(1998)23:5<299::AID-LSM10>3.0.CO;2-K; Kim S, 2013, PHOTOMED LASER SURG, V31, P554, DOI 10.1089/pho.2012.3343; Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012; Kodera Y, 2013, SCRIPTA MATER, V69, P149, DOI 10.1016/j.scriptamat.2013.02.013; Kreisler M, 2002, INT J PROSTHODONT, V15, P582; Lee J, 2002, APPL ENVIRON MICROB, V68, P5379, DOI 10.1128/AEM.68.11.5379-5386.2002; Lubart R., 2011, Laser Therapy, V20, P17; Majaron B, 2002, PHYS MED BIOL, V47, P3275, DOI 10.1088/0031-9155/47/18/301; Mason M L, 1992, Dent Today, V11, P74; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Nandakumar K, 2003, BIOFOULING, V19, P109, DOI 10.1080/0892701021000028488; Nussbaum EL, 2003, J CLIN LASER MED SUR, V21, P283, DOI 10.1089/104454703322564497; Nussbaum EL, 2002, LASER SURG MED, V31, P343, DOI 10.1002/lsm.10121; Sennhenn-Kirchner S, 2007, CLIN ORAL IMPLAN RES, V18, P126, DOI 10.1111/j.1600-0501.2006.01298.x; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Stuebinger S, 2008, LASER SURG MED, V40, P223, DOI 10.1002/lsm.20614; Wang KW, 2005, J CLIN NEUROSCI, V12, P647, DOI 10.1016/j.jocn.2004.09.017; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470	43	7	7	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	OCT	2016	48	8					782	789		10.1002/lsm.22558			8	Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology; Surgery	EB0EH	WOS:000387015700008	27389389	Green Submitted			2022-02-06	
J	Geurten, M; Vincent, E; Van der Linden, M; Coyette, F; Meulemans, T				Geurten, Marie; Vincent, Eric; Van der Linden, Martial; Coyette, Francoise; Meulemans, Thierry			Working Memory Assessment: Construct Validity of the Brown-Peterson Test	CANADIAN JOURNAL OF BEHAVIOURAL SCIENCE-REVUE CANADIENNE DES SCIENCES DU COMPORTEMENT			English	Article						Brown-Peterson task; working memory; construct validity; normative data	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; NORMATIVE DATA; STRATEGY USE; TASK; PARADIGM; AGE; IMPAIRMENTS; PERFORMANCE; DYSFUNCTION	The classical Brown-Peterson task is generally supposed to assess working memory capacities. To date, however, the construct validity of the task remains mostly unexamined. In this context, the aim of the present study was to demonstrate the convergent and the divergent validity as well as the clinical and the developmental sensitivity of a computerized version of the Brown-Peterson test. A group of 726 French-speaking participants, ages 18 to 86 years, and 47 patients who had sustained a traumatic brain injury (TBI) were administered the Brown-Peterson task and various other cognitive tasks assessing executive functioning, verbal and visual memory, or processing speed. The correlation analyses revealed the good convergence of the task, which was shown to be able to distinguish between participants with TBI and control participants. We found an effect of age and education level on the different scores recorded for the Brown-Peterson test. Normative data taking into account the influence of the latter variables were thus provided. On the whole, these findings seem to confirm the validity of the Brown-Peterson task as a tool for assessing working memory abilities.	[Geurten, Marie; Meulemans, Thierry] Univ Liege, Psychol & Neurosci Cognit Unit, B33 Trifacultaire Quartier Agora,Pl Orateurs 1, B-4000 Liege, Belgium; [Vincent, Eric] Univ Liege, Liege, Belgium; [Van der Linden, Martial] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Coyette, Francoise] St Luc Hosp, Neuropsychol Rehabil Unit, Brussels, Belgium; [Vincent, Eric] Univ Hosp Liege, Neuropsychol Rehabil Unit, Liege, Belgium		Geurten, M (corresponding author), Univ Liege, Psychol & Neurosci Cognit Unit, B33 Trifacultaire Quartier Agora,Pl Orateurs 1, B-4000 Liege, Belgium.	mgeurten@ulg.ac.be		Geurten, Marie/0000-0003-3743-5246			Anil AE, 2003, CLIN NEUROPSYCHOL, V17, P159, DOI 10.1076/clin.17.2.159.16510; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Belleville S., 2002, MEMORIA BATTERIE INF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bherer L, 2001, DEV NEUROPSYCHOL, V19, P237, DOI 10.1207/S15326942DN1903_1; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOONE KB, 1999, SCI PRACT NEUROPSYCH, P247; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Callahan BL, 2014, CLIN NEUROPSYCHOL, V28, P317, DOI 10.1080/13854046.2013.873082; Cohen J., 2013, STAT POWER ANAL BEHA; Coyette F., 2003, EVALUATION PRISE CHA, P293; Della Sala S., 1997, VISUAL PATTERN TEST; Dunlosky J, 2007, Q J EXP PSYCHOL, V60, P1227, DOI 10.1080/17470210600926075; FLEMING K, 1995, PSYCHIAT RES, V56, P155, DOI 10.1016/0165-1781(95)02589-3; Floden D, 2000, AGING NEUROPSYCHOL C, V7, P245, DOI 10.1076/anec.7.4.245.795; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Geurten M, 2016, CHILD NEUROPSYCHOL, V22, P443, DOI 10.1080/09297049.2014.998642; Geurten M, 2015, APPL COGNITIVE PSYCH, V29, P244, DOI 10.1002/acp.3102; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hill T., 2007, STAT METHODS APPL; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Kapur N., 1988, MEMORY DISORDERS CLI; LENG NRC, 1989, CORTEX, V25, P251, DOI 10.1016/S0010-9452(89)80041-3; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McNamara DS, 2001, MEM COGNITION, V29, P10, DOI 10.3758/BF03195736; Mertens VB, 2006, ARCH CLIN NEUROPSYCH, V21, P733, DOI 10.1016/j.acn.2006.08.005; Meulemans T, 2008, FONCTIONS EXECUTIVES, P217; MORRIS RG, 1986, COGNITIVE NEUROPSYCH, V3, P77, DOI 10.1080/02643298608252670; Morrow LA, 2002, CLIN NEUROPSYCHOL, V16, P373, DOI 10.1076/clin.16.3.373.13850; Neath I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00035; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Portney L. G., 2000, FDN CLIN RES APPL PR, V2; Rai MK, 2013, J GENET PSYCHOL, V174, P153, DOI 10.1080/00221325.2011.653839; Regard M., 1981, STROOP TEST VICTORIA; RYAN C, 1980, ALCOHOL CLIN EXP RES, V4, P288, DOI 10.1111/j.1530-0277.1980.tb04816.x; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; TEASDALE G, 1974, LANCET, V2, P81; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Van der Linden M.A., 2004, EVALUATION TROUBLES; Wang TF, 2015, INTELLIGENCE, V49, P84, DOI 10.1016/j.intell.2015.01.002; Wechsler D., 1997, WMS 3 WECHSLER MEMOR, V3rd edn	47	7	7	1	18	CANADIAN PSYCHOLOGICAL  ASSOC	OTTAWA	141 LAURIER AVE WEST, STE 702, OTTAWA, ONTARIO K1P 5J3, CANADA	0008-400X	1879-2669		CAN J BEHAV SCI	Can. J. Behav. Sci.-Rev. Can. Sci. Comport.	OCT	2016	48	4					328	336		10.1037/cbs0000057			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	DZ7QK	WOS:000386060700008		Green Submitted			2022-02-06	
J	Kofler, M; Schiefecker, A; Beer, R; Sohm, F; Broessner, G; Rhomberg, P; Lackner, P; Pfausler, B; Thome, C; Schmutzhard, E; Helbok, R				Kofler, Mario; Schiefecker, Alois; Beer, Ronny; Sohm, Florian; Broessner, Gregor; Rhomberg, Paul; Lackner, Peter; Pfausler, Bettina; Thome, Claudius; Schmutzhard, Erich; Helbok, Raimund			Neuroglucopenia and Metabolic Distress in Two Patients with Viral Meningoencephalitis: A Microdialysis Study	NEUROCRITICAL CARE			English	Article						Cerebral microdialysis; Encephalitis; Multimodal neuromonitoring; Brain tissue glucose; Neuroglucopenia	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; SUBARACHNOID HEMORRHAGE; CONSENSUS STATEMENT; BEDSIDE DIAGNOSIS; NEURONAL INJURY; ENCEPHALITIS; CRISIS; PRESSURE	Viral encephalitis is an emerging disease requiring intensive care management in severe cases. Underlying pathophysiologic mechanisms are incompletely understood and may be elucidated using invasive multimodal neuromonitoring techniques in humans. Two otherwise healthy patients were admitted to our neurological intensive care unit with altered level of consciousness necessitating mechanical ventilation. Brain imaging and laboratory workup suggested viral encephalitis in both patients. Invasive neuromonitoring was initiated when head computed tomography revealed generalized brain edema, including monitoring of intracranial pressure, brain metabolism (cerebral microdialysis; CMD), brain tissue oxygen tension (in one patient), and cerebral blood flow (in one patient). Brain metabolism revealed episodes of severe neuroglucopenia (brain glucose < 0.7 mM/l) in both patients, which were not attributable to decreased cerebral perfusion or hypoglycemia. CMD-glucose levels changed depending on variations in insulin therapy, nutrition, and systemic glucose administration. The metabolic profile, moreover, showed a pattern of non-ischemic metabolic distress suggestive for mitochondrial dysfunction. Both patients had a prolonged but favorable clinical course and improved to a modified Rankin Scale Score of 1 and 0 three months later. Invasive multimodal neuromonitoring is feasible in poor-grade patients with viral meningoencephalitis and may help understand pathophysiologic mechanisms associated with secondary brain injury. The detection of neuroglucopenia and mitochondrial dysfunction may serve as treatment targets in the future.	[Kofler, Mario; Schiefecker, Alois; Beer, Ronny; Broessner, Gregor; Lackner, Peter; Pfausler, Bettina; Schmutzhard, Erich; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria; [Sohm, Florian; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria; [Rhomberg, Paul] Med Univ Innsbruck, Dept Radiol, Anichstr 35, A-6020 Innsbruck, Austria		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@uki.at	Helbok, Raimund/AAA-8361-2021	Schmutzhard, Erich/0000-0003-3295-7491	University of Innsbruck; Medical University of Innsbruck	Open access funding provided by University of Innsbruck and Medical University of Innsbruck.	Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Canal CE, 2005, PHYSIOL BEHAV, V84, P245, DOI 10.1016/j.physbeh.2004.11.009; da Costa LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033871; El-Bacha T, 2013, INT J BIOCHEM CELL B, V45, P41, DOI 10.1016/j.biocel.2012.09.021; Glaser CA, 2008, NEUROCRIT CARE, V9, P74, DOI 10.1007/s12028-007-9042-y; Gliemroth J, 2002, CLIN NEUROL NEUROSUR, V105, P27, DOI 10.1016/S0303-8467(02)00088-4; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Helbok R, 2014, NEUROCRIT CARE S2, pS85; Helbok R, 2011, STROKE, V42, P1534, DOI 10.1161/STROKEAHA.110.604488; Helbok R, 2011, J NEUROL NEUROSUR PS, V82, P378, DOI 10.1136/jnnp.2009.198754; Hu W, 2014, NEUROCHEM INT, V79, P57, DOI 10.1016/j.neuint.2014.10.005; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Ko SB, 2012, ANN NEUROL, V72, P344, DOI 10.1002/ana.23619; Kramer AH, 2013, CRIT CARE CLIN, V29, P621, DOI 10.1016/j.ccc.2013.03.011; Kumar G, 2009, CLIN NEUROL NEUROSUR, V111, P399, DOI 10.1016/j.clineuro.2009.03.004; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Poulsen FR, 2015, NEUROCRIT CARE, V22, P221, DOI 10.1007/s12028-014-0057-x; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; Schiefecker AJ, 2015, THER HYPOTHERMIA TEM, V5, P126, DOI 10.1089/ther.2014.0028; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Schmidt JM, 2012, CRITICAL CARE, V16, pR15; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Tanguy M, 2012, J NEUROTRAUM, V29, P1105, DOI 10.1089/neu.2011.1817; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Yang WJ, 2015, NEUROCHEM INT, V80, P33, DOI 10.1016/j.neuint.2014.11.003	31	7	7	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2016	25	2					273	281		10.1007/s12028-016-0272-8			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DY5YN	WOS:000385181000016	27112148	Green Published, hybrid			2022-02-06	
J	Li, GC; Zhu, XB; Gu, XH; Sun, Y; Gao, XF; Zhang, Y; Hou, K				Li, Guichen; Zhu, Xiaobo; Gu, Xiuhong; Sun, Yang; Gao, Xianfeng; Zhang, Yang; Hou, Kun			Ocular Movement Nerve Palsy After Mild Head Trauma	WORLD NEUROSURGERY			English	Article						Abducens nerve; Cranial nerve palsy; Mild head trauma; Ocular movement nerve; Oculomotor nerve; Trochlear nerve	ABDUCENS NERVE; OCULOMOTOR PALSY; INJURY; RESOLUTION; PARALYSIS; RECOVERY; AVULSION; SIGN	BACKGROUND: Ocular movement nerve (cranial nerve III, IV and VI) palsy (OMNP) is rarely encountered after mild head trauma. Asa result of the inconsistent definition of this specific entity in published studies, it is difficult to offer an accurate management strategy and prognosis assessment to affected patients. METHODS: A retrospective review of the medical records of the patients at the First Hospital of Jilin University combined with a systematic review of published studies was conducted. RESULTS: Thirty-one patients (17 females. 55%), including 6 cases in our institution, were identified in this systematic review. Cranial nerves III, IV, and VI were involved in 54.8%, 3.2%, and 45.2% of the patients, respectively. Although all the patients in our case series experienced complete resolution, only 54.6% experienced complete resolution in a time course of 10 days to 13 months. Additional intracranial findings other than traumatic brain injury on imaging modalities that might predispose to OMNP after mild head trauma were identified in 25.8% of the patients. CONCLUSIONS: OMNP after mild head trauma is a rare entity in neurosurgical practice. In patients with no positive intracranial finding, observation and follow-up are the mainstay of management. If any underlying intracranial lesions are identified, the management should be focused on the underlying lesions. From the data available, mild trauma does not mean Mild injury or favorable recovery in OMNP after mild head trauma.	[Li, Guichen] Jilin Univ, Hosp 1, Dept Neurol, Changchun, Peoples R China; [Zhu, Xiaobo; Sun, Yang; Gao, Xianfeng; Zhang, Yang; Hou, Kun] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Peoples R China; [Gu, Xiuhong] Tonghua Iron & Steel Grp, Middle Sch Hosp, Dept Internal Med, Tonghua, Jilin, Peoples R China		Zhang, Y; Hou, K (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Peoples R China.	zhangyang_930@126.com; hkyyayz@yeah.net		Li, Guichen/0000-0003-2128-9969; Hou, Kun/0000-0001-7112-7883			Advani RM, 2003, ANN EMERG MED, V41, P27, DOI 10.1067/mem.2003.46; Asproudis Ioannis, 2015, Oman J Ophthalmol, V8, P179, DOI 10.4103/0974-620X.169905; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; Czyz CN, 2011, ORBIT, V30, P239, DOI 10.3109/01676830.2011.579683; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Ditta LC, 2015, J AAPOS, V19, P385, DOI 10.1016/j.jaapos.2015.03.021; Erenler Ali Kemal, 2015, Asian J Neurosurg, V10, P265, DOI 10.4103/1793-5482.161169; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Hanson RA, 2004, NEUROLOGY, V62, P33, DOI 10.1212/WNL.62.1.33; Hollis GJ, 1997, J ACCID EMERG MED, V14, P172; JACOBSON DM, 1988, J CLIN NEURO-OPHTHAL, V8, P263; Janssen K, 2008, PEDIATR EMERG CARE, V24, P621, DOI 10.1097/PEC.0b013e3181850c5c; Kim E, 2013, J KOREAN NEUROSURG S, V54, P434, DOI 10.3340/jkns.2013.54.5.434; LESSER RL, 1980, ARCH OPHTHALMOL-CHIC, V98, P1993; Levy RL, 2005, NEUROLOGY, V65, P169, DOI 10.1212/01.wnl.0000167288.10702.03; Lin C, 2013, J NEUROSURG, V118, P364, DOI 10.3171/2012.9.JNS12702; Lopes BSC, 2011, ARQ NEURO-PSIQUIAT, V69, P721, DOI 10.1590/S0004-282X2011000500030; Mishra Avinash, 2015, Med J Armed Forces India, V71, pS620, DOI 10.1016/j.mjafi.2015.01.015; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Najafi MR, 2012, ARCH IRAN MED, V15, P583, DOI 012159/AIM.0015; Park-Matsumoto Yong Choo, 1997, Neurologia Medico-Chirurgica, V37, P181, DOI 10.2176/nmc.37.181; Patwardhan Maneesha Anil, 2015, Asian J Neurosurg, V10, P56, DOI 10.4103/1793-5482.151523; Salunke P, 2012, INDIAN J OPHTHALMOL, V60, P149, DOI 10.4103/0301-4738.90491; Suzuki H, 2000, NEUROSURGERY, V47, P977, DOI 10.1097/00006123-200010000-00038; Taskin U, 2009, J CRANIOFAC SURG, V20, P2178, DOI 10.1097/SCS.0b013e3181c017fc; WAKAI S, 1987, NEUROSURGERY, V20, P794, DOI 10.1227/00006123-198705000-00022; WALTER KA, 1994, NEUROLOGY, V44, P148, DOI 10.1212/WNL.44.1.148; Yanamadala V, 2012, J CLIN NEUROSCI, V19, P585, DOI 10.1016/j.jocn.2011.09.007	29	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2016	94						296	302		10.1016/j.wneu.2016.06.133			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5EJ	WOS:000390353200039	27422684				2022-02-06	
J	Novais, EN; Heare, TC; Hill, MK; Mayer, SW				Novais, Eduardo N.; Heare, Travis C.; Hill, Mary K.; Mayer, Stephanie W.			Surgical Hip Dislocation for the Treatment of Intra-Articular Injuries and Hip Instability Following Traumatic Posterior Dislocation in Children and Adolescents	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						surgical hip dislocation; posterior hip dislocation; hip instability; femoroacetabular impingement	FEMOROACETABULAR IMPINGEMENT; ACETABULAR LABRUM; WALL FRACTURE; FEMORAL-HEAD; REDUCTION; INTERPOSITION; ARTHROPLASTY; CHILDHOOD; JOINT	Background:Traumatic posterior hip dislocation in children is a rare injury that typically is treated with closed reduction. Surgical treatment is typically recommended for nonconcentric reduction with joint space asymmetry with entrapped labrum or an osteochondral fragment. The surgical hip dislocation (SHD) approach allows for full assessment of the acetabulum and femoral head and has been our preferred surgical strategy. The purpose of this study was to (1) describe the intra-articular pathologic findings seen at the time of SHD; and (2) to investigate hip pain, function, and activity level of a cohort of children and adolescents after open treatment of a posterior hip dislocation using the SHD approach.Methods:Following IRB approval, 23 patients who sustained a traumatic posterior hip dislocation between January 2009 and December 2013 were identified. In 8/23 (34.8%) patients there was evidence of nonconcentric reduction after closed treatment and surgical treatment was performed using the SHD approach. Seven male and 1 female (mean age, 11.2 y; range, 6 to 14.6 y) were followed for an average of 28 months (range, 13 to 67 mo). The modified Harris Hip Score (mHHS) and the University of California Los Angeles activity score assessed clinical hip outcome and activity level at minimum of 1 year after surgery.Results:Six patients were treated after an acute trauma, whereas 2 were treated after recurrent dislocations. Five patients were involved in motor vehicle accidents and 3 in sports-related injuries. Intraoperative findings include posterior labral avulsion in all patients, fracture of the cartilaginous posterior wall (n=3), and femoral head chondral injuries (n=5) and fracture (n=1). The labral root was repaired using suture anchor technique in 7/8 patients and resected in 1. In 2 patients, labral repair was complemented by screw fixation of the posterior wall. All but one patient (mHHS=94) reported maximum mHHS. The University of California Los Angeles activity score was 10 for 5/8 patients and 7 in 3 patients. No case of femoral head osteonecrosis was noted. One patient developed an asymptomatic heterotopic ossification.Conclusions:When open reduction is recommended for the treatment of intra-articular pathologies and hip instability following traumatic dislocation of the hip in children and adolescents, the SHD is an excellent approach that allows surgical correction of the damaged bony and soft-tissue structures including repair of the capsule-labral complex, and reduction and internal fixation of the cartilaginous posterior wall and femoral head fractures.Level of Evidence:Level IV.	[Novais, Eduardo N.; Heare, Travis C.; Hill, Mary K.; Mayer, Stephanie W.] Childrens Hosp Colorado, 13123 East 16th Ave,POB 060, Aurora, CO 80045 USA		Novais, EN (corresponding author), Childrens Hosp Colorado, 13123 East 16th Ave,POB 060, Aurora, CO 80045 USA.	eduardo.novais@childrenscolorado.org					AMSTUTZ HC, 1984, J BONE JOINT SURG AM, V66A, P228, DOI 10.2106/00004623-198466020-00010; BURGOS J, 1995, J PEDIATR ORTHOP B, V4, P216, DOI 10.1097/01202412-199504020-00017; CANALE ST, 1979, J BONE JOINT SURG AM, V61, P7, DOI 10.2106/00004623-197961010-00003; Chun KA, 2004, SKELETAL RADIOL, V33, P728, DOI 10.1007/s00256-004-0800-z; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Fabricant PD, 2013, J BONE JOINT SURG AM, V95A, P230, DOI [10.2106/JBJS.L.00592, 10.2106/JBJS.L.00772]; Ferguson SJ, 2000, J BIOMECH, V33, P953, DOI 10.1016/S0021-9290(00)00042-7; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Hamilton PR, 1998, J PEDIATR ORTHOPED, V18, P691; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Hearty T, 2011, J ORTHOP TRAUMA, V25, pE68, DOI 10.1097/BOT.0b013e3181f9a7ba; HEEG M, 1989, J BONE JOINT SURG BR, V71, P418, DOI 10.1302/0301-620X.71B3.2722933; Kim Yoon Taek, 2003, J Orthop Sci, V8, P232, DOI 10.1007/s007760300039; Larson CM, 2012, AM J SPORT MED, V40, P1015, DOI 10.1177/0363546511434578; Manner HM, 2012, J PEDIATR ORTHOP B, V21, P574, DOI 10.1097/BPB.0b013e328357bf04; Masse A, 2012, HIP INT, V22, P137, DOI 10.5301/HIP.2012.9208; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; Moed BR, 2002, J BONE JOINT SURG AM, V84A, P752, DOI 10.2106/00004623-200205000-00008; Nepple Jeffrey J, 2011, Iowa Orthop J, V31, P187; Hung NN, 2012, J PEDIATR ORTHOP B, V21, P542, DOI 10.1097/BPB.0b013e328356371b; Novais EN, 2014, J PEDIATR ORTHOPED, V34, P287, DOI 10.1097/BPO.0000000000000093; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; OLSSON O, 1994, ACTA ORTHOP SCAND, V65, P476, DOI 10.3109/17453679408995496; Podeszwa DA, 2014, J PEDIAT ORTHOP; Rubel IF, 2002, PEDIATR RADIOL, V32, P435, DOI 10.1007/s00247-001-0634-y; SCHLONSKY J, 1973, J BONE JOINT SURG AM, VA 55, P1057, DOI 10.2106/00004623-197355050-00015; Steppacher SD, 2013, CLIN ORTHOP RELAT R, V471, P1937, DOI 10.1007/s11999-013-2863-4; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; Yoo JH, 2015, INJURY, V46, P344, DOI 10.1016/j.injury.2014.07.020	30	7	7	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	OCT-NOV	2016	36	7					673	679		10.1097/BPO.0000000000000527			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	DX7RC	WOS:000384585400004	25985375				2022-02-06	
J	Rebollo-Soria, MC; Arregui-Dalmases, C; Sanchez-Molina, D; Velazquez-Ameijide, J; Galtes, I				Rebollo-Soria, M. Carmen; Arregui-Dalmases, Carlos; Sanchez-Molina, David; Velazquez-Ameijide, Juan; Galtes, Ignasi			Injury pattern in lethal motorbikes-pedestrian collisions, in the area of Barcelona, Spain	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Pedestrian collision; Injury pattern; Motorcycles; Motorbikes; Autopsy; Traumatic brain injury		Introduction: There are several studies about M1 type vehicle-pedestrian collision injury pattern, and based on them, there has been several changes in automobiles for pedestrian protection. However, the lack of sufficient studies about injury pattern in motorbikes-pedestrian collisions leads to a lack of optimization design of these vehicles. The objective of this research is to study the injury pattern of pedestrians involved in collisions with motorized two-wheeled vehicles. Methods: A retrospective descriptive study of pedestrian's deaths after collisions with motorcycles in an urban area, like Barcelona was performed. The cases were collected from the Forensic Pathology Service database of the Institute of Legal Medicine of Catalonia. The selected cases were categorized as pedestrian-motorcycle collision, between January 1st, 2005 and December 31st, 2014. Data were collected from the autopsy, medical, and police report. The collected information was then analyzed using Microsoft Excel statistical functions. Results: Traumatic Brain Injury is the main cause of death in pedestrian hit by motorized two-wheeled vehicles (62.85%). The most frequent injury was the subarachnoid hemorrhage, in 71.4% of cases, followed by cerebral contusions and skull base fractures (65.7%). By contrast, pelvic fractures and tibia fractures only appeared in 28.6%. Conclusions: The study characterizes the injury pattern of pedestrians involved in a collision with motorized two-wheeled vehicles in an urban area, like Barcelona, which has been found to be different from other vehicle-pedestrian collisions, with a higher incidence of brain injuries and minor frequency of lower extremities fractures in pelvis, tibia and fibula. (C) 2016 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Rebollo-Soria, M. Carmen; Galtes, Ignasi] Inst Legal Med Catalonia, Forens Pathol Serv, Barcelona, Spain; [Arregui-Dalmases, Carlos] Univ Politecn Cataluna, Dept Mech Engn, Barcelona Tech, Barcelona, Spain; [Arregui-Dalmases, Carlos] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22903 USA; [Sanchez-Molina, David; Velazquez-Ameijide, Juan] Univ Politecn Cataluna, Barcelona Tech, Dept Mat & Struct Engn, Barcelona, Spain		Arregui-Dalmases, C (corresponding author), Univ Politecn Cataluna, Dept Mech Engn, Carrer Comte dUrgell 187, Barcelona 08036, Spain.	carlos.arregui@upc.edu	Sanchez-Molina, David/I-2149-2014; Galtes, Ignasi/K-3053-2014	Sanchez-Molina, David/0000-0002-0671-4106; Galtes, Ignasi/0000-0002-5758-2668; arregui-dalmases, carlos/0000-0003-0688-3599; Velazquez-Ameijide, Juan/0000-0001-6872-3609			Arregui-Dalmases C, PEDESTRIAN PROTECTIO, P3049; Arregui-Dalmases C, 2011, ETRASA, P315; Arregui-Dalmases C, 2010, ACCIDENT ANAL PREV, V42, P1164, DOI 10.1016/j.aap.2010.01.005; Chalya Phillipo L, 2012, J Trauma Manag Outcomes, V6, P1, DOI 10.1186/1752-2897-6-1; Damsere-Derry J, 2010, ACCIDENT ANAL PREV, V42, P1080, DOI 10.1016/j.aap.2009.12.016; Dandona R, 2006, INJURY PREV, V12, P183, DOI 10.1136/ip.2005.010728; Ehrlich E, 2009, LEG MED, V11, P324; Gisbert JA, 1998, REIMPR MASSON A, V5a, P336; Peng RY, 1999, J AM COLL SURGEONS, V189, P343, DOI 10.1016/S1072-7515(99)00166-0; Siram SM, 2011, J SURG RES, V167, P14, DOI 10.1016/j.jss.2010.10.007; Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221; Starnes MJ, 2011, J EMERG MED, V40, P617, DOI 10.1016/j.jemermed.2008.03.012; Uli Schmucker, 2010, J TRAUMA MANAG OUTCO, V4, P1; WHO, 2009, GLOB STAT REP ROAD S, P287; World health Organization (WHO), 2013, PED SAF ROAD SAF MAN, P132	15	7	7	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	OCT	2016	43						80	84		10.1016/j.jflm.2016.07.009			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	EE3SB	WOS:000389516900013	27494040	Green Published			2022-02-06	
J	Wan, Y; Shi, L; Wang, ZM; Sun, G; Pan, TH; Zhang, SG; Zeng, YJ				Wan, Yi; Shi, Lei; Wang, Zhimin; Sun, Guan; Pan, Tianhong; Zhang, Shuguang; Zeng, Yanjun			Effective treatment via early cranioplasty for intractable contralateral subdural effusion after standard decompressive craniectomy in patients with severe traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Intractable contralateral subdural effusion; Standard decompressive craniectomy; Cranioplasty; GOS score; Severe traumatic brain injury	INTRACRANIAL-PRESSURE; HEMICRANIECTOMY; MANAGEMENT; HEMATOMA; HYGROMA	Objective: This study aimed to introduce an effective treatment for intractable contralateral subdural effusion after standard decompressive craniectomy in patients with severe traumatic brain injury (TBI) and to analyze the underlying mechanism. Methods: A retrospective analysis was performed in 13 patients with severe traumatic craniocerebral injury showing complicated intractable contralateral subdural effusion after standard decompressive craniectomy, in whom satisfactory results were not obtained from treatments, including compression bandaging, head-down bed rest (HDBR), continuing lumbar drainage, and Ommaya catheter drainage. Among these patients, 6 underwent temporal muscle sticking, while 7 underwent early cranioplasty. The postoperative changes in the subdural effusion were observed. Results: In the 6 patients who underwent temporal muscle sticking and the 7 who underwent early cranioplasty, the subdural effusion completely resolved or was significantly reduced within one month, and no recurrence was observed in the 6-month follow-up period. However, secondary bilateral cranioplasty was still necessary in the postoperative 3-6 months for the patients who underwent temporal muscle sticking. In the early cranioplasty group, there were three total operations, and the average length of stay (ALOS) was 76 days. In the temporal muscle sticking group, there were four total operations, and the ALOS was 56.1 days. A retrospective analysis of surgical pain showed that 100% of the patients in the first group experienced unacceptable suffering, while 14.3% of the patients in the second group experienced pain. Conclusion: Early cranioplasty is an effective, economical, and less painful treatment for intractable contralateral subdural effusion after standard decompressive craniectomy. (C) 2016 Elsevier B.V. All rights reserved.	[Wan, Yi; Wang, Zhimin] Shanghai Jiao Tong Univ, Sch Med, Suzhou Kowloon Hosp, Dept Neurosurg, Suzhou 215021, Peoples R China; [Shi, Lei; Pan, Tianhong; Zhang, Shuguang] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou 215300, Peoples R China; [Sun, Guan] Nantong Univ, Affiliated Yancheng Hosp 4, Dept Neurosurg, Yancheng 224000, Peoples R China; [Zeng, Yanjun] Beijing Univ Technol, Biomech & Med Informat Inst, Beijing 100022, Peoples R China		Wang, ZM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Suzhou Kowloon Hosp, Dept Neurosurg, Suzhou 215021, Peoples R China.; Shi, L (corresponding author), Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou 215300, Peoples R China.; Zeng, YJ (corresponding author), Beijing Univ Technol, Biomech & Med Informat Inst, Beijing 100022, Peoples R China.	s11012002322@126.com; wanyiwzm@126.com; yjzeng@bjut.edu.cn			China Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81000963, 81370062, 81201976]; Jiangsu Province's 333 Talent Program [BRA2011046]; Jiangsu Province "six personnel peak" [2013-WSN-145/028]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK2012670]; Medical Research Foundation by Jiangsu Province Health Department [YG201301, Z201318]; Clinical Technology Development of Jiangsu University [JLY20120053]; Yancheng Medical Science Development Foundation [YK2013003, YK2013019]; Kunshan Social Development Foundation [KS1006, KS1009]; Suzhou Social Development Foundation [SYS201063]	This work was supported by the China Natural Science Foundation (81000963, 81370062, and 81201976), Jiangsu Province's 333 Talent Program (BRA2011046), Jiangsu Province "six personnel peak" funded projects (2013-WSN-145/028), Jiangsu Province's Natural Science Foundation (BK2012670), Medical Research Foundation by Jiangsu Province Health Department (YG201301 and Z201318), the Clinical Technology Development of Jiangsu University (JLY20120053), Yancheng Medical Science Development Foundation (YK2013003, YK2013019), the Kunshan Social Development Foundation (KS1006, KS1009), and the Suzhou Social Development Foundation (SYS201063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Dong L, 2016, CLIN NEUROL NEUROSUR, V148, P42, DOI 10.1016/j.clineuro.2016.06.004; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Eide PK, 2007, NEUROL RES, V29, P798, DOI 10.1179/016164107X224132; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; Krishnan P, 2015, BRIT J NEUROSURG, V29, P730, DOI 10.3109/02688697.2015.1039485; Kwon Young Sub, 2016, Korean J Neurotrauma, V12, P22, DOI 10.13004/kjnt.2016.12.1.22; Lee KS, 1998, BRAIN INJURY, V12, P901; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; Paredes Igor, 2011, Surg Neurol Int, V2, P88, DOI 10.4103/2152-7806.82370; PARK CK, 1994, ACTA NEUROCHIR, V127, P41, DOI 10.1007/BF01808545; Regan JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115085; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; Sun HL, 2014, NEUROSCIENCES, V19, P229; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; TAKAHASHI Y, 1981, Neurologia Medico-Chirurgica, V21, P485; Wang HK, 2012, INJURY, V43, P594, DOI 10.1016/j.injury.2010.06.004; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]; Yamada H, 1979, No To Shinkei, V31, P115; Yamada H., 2007, NO TO SHINKEI, V31, P115; Yamaura A, 1977, No Shinkei Geka, V5, P345	26	7	10	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2016	149						87	93		10.1016/j.clineuro.2016.08.004			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DW7JH	WOS:000383826500016	27500656				2022-02-06	
J	Agarwal, S; Stamatakis, EA; Geva, S; Warburton, EA				Agarwal, Smriti; Stamatakis, Emmanuel A.; Geva, Sharon; Warburton, Elizabeth A.			Dominant hemisphere functional networks compensate for structural connectivity loss to preserve phonological retrieval with aging	BRAIN AND BEHAVIOR			English	Article						Aging; DTI; functional connectivity; language; phonology; PPI; word retrieval	PERISYLVIAN LANGUAGE NETWORKS; AGE-RELATED DIFFERENCES; TRAUMATIC BRAIN-INJURY; ADULT LIFE-SPAN; OF-THE-TONGUE; OLDER-ADULTS; WORD RETRIEVAL; CALLOSAL STRUCTURE; COGNITIVE DECLINE; DIFFUSION TENSOR	Introduction: Loss of hemispheric asymmetry during cognitive tasks has been previously demonstrated in the literature. In the context of language, increased right hemisphere activation is observed with aging. Whether this relates to compensation to preserve cognitive function or dedifferentiation implying loss of hemispheric specificity without functional consequence, remains unclear. Methods: With a multifaceted approach, integrating structural and functional imaging data during a word retrieval task, in a group of younger and older adults with equivalent cognitive performance, we aimed to establish whether interactions between hemispheres or reorganization of dominant hemisphere networks preserve function. We examined functional and structural connectivity on data from our previously published functional activation study. Functional connectivity was measured using psychophysiological interactions analysis from the left inferior frontal gyrus (LIFG) and the left insula (LINS), based on published literature, and the right inferior frontal gyrus (RIFG) based on our previous study. Results: Although RIFG showed increased activation, its connectivity decreased with age. Meanwhile, LIFG and LINS connected more bilaterally in the older adults. White matter integrity, measured by fractional anisotropy (FA) from diffusion tensor imaging, decreased significantly in the older group. Importantly, LINS functional connectivity to LIFG correlated inversely with FA. Conclusions: We demonstrate that left hemispheric language areas show higher functional connectivity in older adults with intact behavioral performance, and thus, may have a role in preserving function. The inverse correlation of functional and structural connectivity with age is in keeping with emerging literature and merits further investigation with tractography studies and in other cognitive domains.	[Agarwal, Smriti; Warburton, Elizabeth A.] Univ Cambridge, Stroke Res Grp, Addenbrookes Hosp, R3,Box 83,Hills Rd, Cambridge CB2 2QQ, England; [Stamatakis, Emmanuel A.] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Box 93,Hills Rd, Cambridge CB2 2QQ, England; [Geva, Sharon] UCL Inst Child Hlth, Dev Cognit Neurosci Unit, 30 Guilford St, London WC1N 1EH, England		Agarwal, S (corresponding author), Univ Cambridge, Stroke Res Grp, Addenbrookes Hosp, R3,Box 83,Hills Rd, Cambridge CB2 2QQ, England.	smriti.agarwal@cantab.net		Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500874]; National Institute for Health Research, UKNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0500874] Funding Source: UKRI	Medical Research Council (Grant/Award Number: G0500874) and the National Institute for Health Research, UK.	Aboitiz F, 1992, Biol Res, V25, P51; Antonenko D, 2014, GERONTOLOGY, V60, P3, DOI 10.1159/000354376; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Basso A, 1987, Funct Neurol, V2, P189; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Christensen H, 1999, PSYCHOL AGING, V14, P365, DOI 10.1037/0882-7974.14.3.365; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; Correia MM, 2009, MAGN RESON IMAGING, V27, P163, DOI 10.1016/j.mri.2008.06.011; Daselaar SM, 2015, CEREB CORTEX, V25, P983, DOI 10.1093/cercor/bht289; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; Fling BW, 2012, CEREB CORTEX, V22, P2643, DOI 10.1093/cercor/bhr349; Fling BW, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00038; Fling BW, 2011, J COGNITIVE NEUROSCI, V23, P2171, DOI 10.1162/jocn.2010.21600; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Friederici AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020726; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Galdo-Alvarez S, 2009, BIOL PSYCHOL, V81, P14, DOI 10.1016/j.biopsycho.2009.01.002; Geerligs L, 2014, HUM BRAIN MAPP, V35, P319, DOI 10.1002/hbm.22175; Geva S, 2012, J COGNITIVE NEUROSCI, V24, P2135, DOI 10.1162/jocn_a_00278; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Geva S, 2011, APHASIOLOGY, V25, P323, DOI 10.1080/02687038.2010.511236; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Goh JOS, 2011, AGING DIS, V2, P30; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; Grady CL, 2003, HIPPOCAMPUS, V13, P572, DOI 10.1002/hipo.10114; Hagoort P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00416; Hartwigsen G, 2013, P NATL ACAD SCI USA, V110, P16402, DOI 10.1073/pnas.1310190110; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Meinzer M, 2009, J COGNITIVE NEUROSCI, V21, P2007, DOI 10.1162/jocn.2009.21219; Nusbaum AO, 2001, AM J NEURORADIOL, V22, P136; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papoutsi M, 2011, NEUROIMAGE, V58, P656, DOI 10.1016/j.neuroimage.2011.06.036; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rijntjes Michel, 2012, Front Evol Neurosci, V4, P9, DOI 10.3389/fnevo.2012.00009; Rowe JB, 2006, NEUROIMAGE, V32, P747, DOI 10.1016/j.neuroimage.2006.03.061; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Shafto MA, 2014, SCIENCE, V346, P583, DOI 10.1126/science.1254404; Shafto MA, 2010, J COGNITIVE NEUROSCI, V22, P1530, DOI 10.1162/jocn.2009.21321; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Stern Y, 2012, BRAIN RES, V1435, P130, DOI 10.1016/j.brainres.2011.11.061; Tyler LK, 2010, BRAIN, V133, P3396, DOI 10.1093/brain/awq262; Tyler LK, 2010, CEREB CORTEX, V20, P352, DOI 10.1093/cercor/bhp105; Upton C., 2004, OXFORD RHYMING DICT; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119	62	7	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	SEP	2016	6	9							e00495	10.1002/brb3.495			14	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	DZ8OB	WOS:000386128600002	27688934	Green Published, gold, Green Submitted			2022-02-06	
J	Alves, JL; Santiago, JG; Costa, G; Pinto, AM				Alves, Jose Luis; Santiago, Joao Goncalo; Costa, Guerreiro; Pinto, Anabela Mota			A Standardized Classification for Subdural Hematomas- I	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						subdural hematoma; traumatic brain injury; classification; trauma	RISK-FACTORS; EXUDATION; FEATURES; RUPTURE	Subdural hematomas are a frequent and highly heterogeneous traumatic disorder, with significant clinical and socioeconomic consequences. In clinical and medicolegal practice, subdural hematomas are classified according to its apparent age, which significantly influences its intrinsic pathogenic behavior, forensic implications, clinical management, and outcome. Although practical, this empirical classification is somewhat arbitrary and scarcely informative, considering the remarkable heterogeneity of this entity. The current research project aims at implementing a comprehensive multifactorial classification of subdural hematomas, allowing a more standardized and coherent assessment and management of this condition. This new method of classification of subdural hematomas takes into account its intrinsic and extrinsic features, using imaging data and histopathological elements, to provide an easily apprehensible and intuitive nomenclature. The proposed classification unifies and organizes all relevant details concerning subdural hematomas, hopefully improving surgical care and forensic systematization.	[Alves, Jose Luis; Santiago, Joao Goncalo; Costa, Guerreiro; Pinto, Anabela Mota] Ctr Hosp & Univ Coimbra, Dept Neurosurg, Rua Fonseca Pinto, P-3000075 Coimbra, Portugal		Alves, JL (corresponding author), Ctr Hosp & Univ Coimbra, Dept Neurosurg, Rua Fonseca Pinto, P-3000075 Coimbra, Portugal.	jlmonteiroalves@gmail.com	Mota-Pinto, Anabela/M-1523-2013	Mota-Pinto, Anabela/0000-0002-0820-9568; Alves, Jose Luis/0000-0003-4030-2874			Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Aran-Echabe E, 2014, REV NEUROLOGIA, V58, P420, DOI 10.33588/rn.5809.2014007; Barrios L, 2014, J FORENSIC LEG MED, V22, P145, DOI 10.1016/j.jflm.2013.12.003; Biesbroek JM, 2013, J NEUROL NEUROSUR PS, V84, P254, DOI 10.1136/jnnp-2011-302139; Breisch E, 2010, FORENSIC SCI MED PAT, V6, P249, DOI 10.1007/s12024-009-9136-2; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; Echlin E, 1949, J NEUROSURG, V6; Fujisawa H, 1998, ACTA NEUROCHIR, V140, P161, DOI 10.1007/s007010050077; Fujisawa H, 2006, NEUROL MED-CHIR, V46, P333, DOI 10.2176/nmc.46.333; Gabaeff SC, 2013, LEG MED TOKYO, V15; Gandhoke GS, 2013, J CLIN NEUROSCI, V20, P1398, DOI 10.1016/j.jocn.2013.01.010; Louhab N, 2014, INT J GEN MED, V7, P71, DOI 10.2147/IJGM.S48656; Lynch MJ, 2014, J LAW MED, V21, P774; Marion DW, 2006, NEUROSURGERY, V58, P655; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; Nakaguchi H, 2003, NEUROL SURG TOKYO, V31, P639; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; NOMURA S, 1994, J NEUROSURG, V81, P910, DOI 10.3171/jns.1994.81.6.0910; Pappamikail Lia, 2013, Surg Neurol Int, V4, P21, DOI 10.4103/2152-7806.107548; Postema FAM, 2014, EMERG RADIOL, V21, P349, DOI 10.1007/s10140-014-1196-2; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; Sano R, 2013, LEGAL MED-TOKYO, V15, P32, DOI 10.1016/j.legalmed.2012.05.005; Sieswerda-Hoogendoorn T, 2014, EUR J RADIOL, V83, P1257, DOI 10.1016/j.ejrad.2014.03.015; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; SY WM, 1974, J NUCL MED, V15, P693; Tokmak M, 2007, J NEUROSURG, V107, P290, DOI 10.3171/JNS-07/08/0290; Tosaka M, 2013, NEUROL MED-CHIR, V53, P273, DOI 10.2176/nmc.53.273; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Walter Till, 2009, Leg Med (Tokyo), V11 Suppl 1, pS56, DOI 10.1016/j.legalmed.2009.01.112; Wang Y, 2014, TURK NEUROSURG, V24, P44, DOI 10.5137/1019-5149.JTN.8017-13.1; WINTZEN AR, 1980, BRAIN, V103, P855, DOI 10.1093/brain/103.4.855; Wittschieber D, 2015, AM J NEURORADIOL, V36, P432, DOI 10.3174/ajnr.A3989; YAMASHIMA T, 1985, Zentralblatt fuer Neurochirurgie, V46, P304	33	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2016	37	3					174	178		10.1097/PAF.0000000000000255			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	DU4KR	WOS:000382182000009	27428027	Green Published			2022-02-06	
J	Behmanesh, B; Setzer, M; Noack, A; Bartels, M; Quick-Weller, J; Seifert, V; Freiman, TM				Behmanesh, Bedjan; Setzer, Matthias; Noack, Anika; Bartels, Marco; Quick-Weller, Johanna; Seifert, Volker; Freiman, Thomas M.			Noninvasive epicutaneous transfontanelle intracranial pressure monitoring in children under the age of 1 year: a novel technique	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						noninvasive ICP monitoring; craniosynostosis; children; technique	TRAUMATIC BRAIN-INJURY; INFECTIONS; COMPLICATIONS	Monitoring of intracranial pressure (ICP) may be indicated in children with traumatic brain injury, premature intraventricular hemorrhage, or hydrocephalus. The standard technique is either a direct measurement with invasive intracranial insertion of ICP probes or indirect noninvasive assessment using transfontanelle ultrasonography to measure blood flow. The authors have developed a new technique that allows noninvasive epicutaneous transfontanelle ICP measurement with standard ICP probes. They compared the ICP measurements obtained using the same type of standard probe used in 2 different ways in 5 infants (age < 1 year) undergoing surgery for craniosynostosis. The first ICP probe was implanted epidurally (providing control measurements) and the second probe was fixed epicutaneously on the skin over the reopened frontal fontanelle. ICP values were measured hourly for the first 24 hours after surgery and the values obtained with the 2 methods were compared using Bland-Altman 2-methods analysis. A total of 110 pairs of measurements were assessed. There was no significant difference between the ICP5 measured using the epicutaneous transfontanelle method (mean 13.10 mm Hg, SEM 6.68 mm Hg) and the epidural measurements (mean 12.46 mm Hg, SEM 6.45 mm Hg; p = 0.4643). The results of this analysis indicate that epicutaneous transfontanelle measurement of ICP is a reliable method that allows noninvasive ICP monitoring in children under the age of 1 year. Such noninvasive ICP monitoring could be implemented in the therapy of children with traumatic brain injury or intraventricular hemorrhage or for screening children with elevated ICP without invasive intracranial implantation of ICP probes.	[Behmanesh, Bedjan; Setzer, Matthias; Noack, Anika; Quick-Weller, Johanna; Seifert, Volker; Freiman, Thomas M.] Goethe Univ Frankfurt, Dept Neurosurg, Frankfurt, Germany; [Bartels, Marco] Goethe Univ Frankfurt, Dept Neuropaediat, Frankfurt, Germany		Behmanesh, B (corresponding author), Goethe Univ Frankfurt, Dept Neurosurg, Frankfurt, Germany.; Behmanesh, B (corresponding author), Univ Hosp, Dept Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	bedjan.behmanesh@kgu.de	Freiman, Thomas/AAV-8494-2021	Freiman, Thomas/0000-0002-2591-2829			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Citerio G, 2004, INTENS CARE MED, V30, P1882, DOI 10.1007/s00134-004-2377-3; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lang JM, 2003, NEUROSURGERY, V52, P1455, DOI 10.1227/01.NEU.0000065136.70455.6F; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; Raksin Patricia B, 2003, Neurosurg Focus, V14, pe4; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Wall SA, 2014, J NEUROSURG-PEDIATR, V14, P674, DOI 10.3171/2014.8.PEDS1425	18	7	7	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2016	18	3					372	376		10.3171/2016.3.PEDS15701			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DT8YJ	WOS:000381781300016	27231824	Bronze			2022-02-06	
J	Bhatnagar, T; Liu, J; Yung, A; Cripton, P; Kozlowski, P; Tetzlaff, W; Oxland, T				Bhatnagar, Tim; Liu, Jie; Yung, Andrew; Cripton, Peter; Kozlowski, Piotr; Tetzlaff, Wolfram; Oxland, Thomas			Relating Histopathology and Mechanical Strain in Experimental Contusion Spinal Cord Injury in a Rat Model	JOURNAL OF NEUROTRAUMA			English	Article						biomechanics; contusion; histology; image registration; in vivo; MRI; spinal cord injury	WHITE-MATTER; CERVICAL-SPINE; DEFORMATION; DISLOCATION; ELONGATION; RECOVERY; STRETCH; DEVICE; DAMAGE; BRAIN	During traumatic spinal cord injury (SCI), the spinal cord is subject to external displacements that result in damage of neural tissues. These displacements produce complex internal deformations, or strains, of the spinal cord parenchyma. The aim of this study is to determine a relationship between these internal strains during SCI and primary damage to spinal cord gray matter (GM) in an in vivo rat contusion model. Using magnetic resonance imaging and novel image registration methods, we measured three-dimensional (3D) mechanical strain in in vivo rat cervical spinal cord (n = 12) during an imposed contusion injury. We then assessed expression of the neuronal transcription factor, neuronal nuclei (NeuN), in ventral horns of GM (at the epicenter of injury as well as at intervals cranially and caudally), immediately post-injury. We found that minimum principal strain was most strongly correlated with loss of NeuN stain across all animals (R-2 = 0.19), but varied in strength between individual animals (R-2 = 0.06-0.52). Craniocaudal distribution of anatomical damage was similar to measured strain distribution. A Monte Carlo simulation was used to assess strain field error, and minimum principal strain (which ranged from 8% to 36% in GM ventral horns) exhibited a standard deviation of 2.6% attributed to the simulated error. This study is the first to measure 3D deformation of the spinal cord and relate it to patterns of ensuing tissue damage in an in vivo model. It provides a platform on which to build future studies addressing the tolerance of spinal cord tissue to mechanical deformation.	[Bhatnagar, Tim; Liu, Jie; Yung, Andrew; Cripton, Peter; Kozlowski, Piotr; Tetzlaff, Wolfram; Oxland, Thomas] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, 818 West 10th Ave,Room 5000, Vancouver, BC V5Z 1M9, Canada; [Bhatnagar, Tim; Cripton, Peter; Oxland, Thomas] Univ British Columbia, Dept Mech Engn, Vancouver, BC, Canada; [Yung, Andrew; Kozlowski, Piotr] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC, Canada; [Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Oxland, Thomas] Univ British Columbia, Dept Orthoped, Vancouver, BC, Canada		Bhatnagar, T (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries ICORD, 818 West 10th Ave,Room 5000, Vancouver, BC V5Z 1M9, Canada.	tim.bhatnagar@gmail.com	Tetzlaff, Wolfram/AAY-4430-2020; Kozlowski, Piotr/A-5266-2018; Cripton, Peter Alec/AAC-8268-2020	Kozlowski, Piotr/0000-0002-6462-2891; Cripton, Peter Alec/0000-0002-5067-0833			Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bhatnagar T, 2016, ANN BIOMED ENG, V44, P1285, DOI 10.1007/s10439-015-1412-6; Bhatnagar T, 2016, COMPUT METHOD BIOMEC, V19, P386, DOI 10.1080/10255842.2015.1032944; Bhatnagar T, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027670; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carlson GD, 1997, J NEUROTRAUM, V14, P951, DOI 10.1089/neu.1997.14.951; CHANG GL, 1981, J TRAUMA, V21, P807, DOI 10.1097/00005373-198109000-00011; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; Hall E., 1989, J CEREB BLOOD FLO S1, V19, pS561; HUNG TK, 1981, SURG NEUROL, V15, P471, DOI 10.1016/S0090-3019(81)80043-2; Ichihara K, 2001, J NEUROTRAUM, V18, P361, DOI 10.1089/08977150151071053; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Maikos JT, 2008, J NEUROTRAUM, V25, P795, DOI 10.1089/neu.2007.0423; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221; Russell CM, 2012, J NEUROTRAUM, V29, P1574, DOI 10.1089/neu.2011.2225; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Sjovold SG, 2013, J NEUROTRAUM, V30, P1374, DOI 10.1089/neu.2013.2906; Soblosky JS, 2001, BEHAV BRAIN RES, V119, P1, DOI 10.1016/S0166-4328(00)00328-4; Sparrey CJ, 2009, J NEUROTRAUM, V26, P585, DOI 10.1089/neu.2008.0654; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Yeo SJ, 2004, J KOREAN MED SCI, V19, P574, DOI 10.3346/jkms.2004.19.4.574	32	7	9	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2016	33	18					1685	1695		10.1089/neu.2015.4200			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DX1DG	WOS:000384105200004	26729511	Green Published, hybrid			2022-02-06	
J	Blanchard, C; Kushare, I; Boyles, A; Mundy, A; Beebe, AC; Klingele, KE				Blanchard, Christopher; Kushare, Indranil; Boyles, Aaron; Mundy, Andrew; Beebe, Allan C.; Klingele, Kevin E.			Traumatic, Posterior Pediatric Hip Dislocations With Associated Posterior Labrum Osteochondral Avulsion: Recognizing the Acetabular "Fleck" Sign	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						hip trauma; concentric reduction; open reduction; fleck sign	FINITE-ELEMENT MODEL; CHILDREN; JOINT; CHILDHOOD; FRACTURES; REPAIR; TEAR; SEAL; RECONSTRUCTION; STABILITY	Background: Traumatic dislocation of the hip is uncommon in the pediatric population. Concentric reduction is usually achieved by closed means. Open reduction may be needed if there is femoral head fracture, incarcerated fragment, or incomplete reduction due to soft tissue entrapment. We present a series of 10 patients who sustained a posterior hip dislocation or subluxation with associated osteochondral avulsion of the posterior labrum. During surgery they were noted to have a labral injury pattern not previously recognized. Such treatment was dictated by postreduction advanced imaging, which revealed a consistent acetabular "fleck" sign indicative of this labral injury, which has not been previously described in literature. Methods: We performed a retrospective case review of patients with traumatic posterior hip dislocation/subluxation, treated operatively for a suspected associated labral tear and fractures. Results: Ten patients (2 girls and 8 boys) were identified. Average age was 12.7 years. Eight patients had postreduction computed tomography scans, which revealed a posterior acetabular wall "fleck" sign, suggestive of osteochondral injury. The small bony fragment was consistently displaced at least 2 to 3mm in all patients with majority of the posterior wall remaining intact. Closed reduction was felt to be congruent in 7 of the 10 patients. All patients were treated operatively for exploration and stabilization of the suspected posterior labrum pathology and associated injuries using a surgical hip dislocation. A consistent pattern of labral pathology was seen in all patients, with disruption of the posterior labrum from the superior 12 o'clock attachment to detachment at the inferior 6 o'clock location. Reattachment of the osteochondral labral avulsion was performed with suture anchors along the posterior rim, and the associated femoral head fractures were also addressed with internal fixation. Two patients had inadequate follow-up and were excluded, the average follow-up for the remaining 8 patients was 9.8 months (range, 6 to 26 mo). There were no findings of avascular necrosis in any of the 8 patients. Conclusions: Posterior hip dislocation in children may produce an acetabular "fleck" sign on advanced imaging, which in a stable, concentrically reduced hip has been treated without surgery in the past. Acetabular fleck sign may represent a near-complete avulsion of the posterior labrum as seen in our series. We recommend a high suspicion for this type of labral pathology and surgical repair when acetabular "fleck" sign is identified with hip subluxation or dislocation. Traumatic, posterior hip dislocations in young patients may be associated with significant labral pathology. Acetabular "fleck" sign on advanced imaging may predict such pathology.	[Blanchard, Christopher; Kushare, Indranil; Boyles, Aaron; Mundy, Andrew; Beebe, Allan C.; Klingele, Kevin E.] Ohio State Univ, Nationwide Childrens Hosp, Dept Orthopaed Surg, Columbus, OH 43210 USA; [Beebe, Allan C.; Klingele, Kevin E.] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA		Klingele, KE (corresponding author), Nationwide Childrens Hosp, Dept Orthopaed Surg, 700 Childrens Dr Suite A2630, Columbus, OH 43205 USA.	kevin.klingele@nationwidechildrens.org	KUSHARE, INDRANIL/AAE-4339-2020	KUSHARE, INDRANIL/0000-0002-3303-5221			Dwyer MK, 2014, AM J SPORT MED, V42, P812, DOI 10.1177/0363546514522395; Ferguson SJ, 2000, J BIOMECH, V33, P953, DOI 10.1016/S0021-9290(00)00042-7; Ferguson SJ, 2000, CLIN BIOMECH, V15, P463, DOI 10.1016/S0268-0033(99)00099-6; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Hamilton PR, 1998, J PEDIATR ORTHOPED, V18, P691; Kelly BT, 2005, ARTHROSCOPY, V21, P3, DOI 10.1016/j.arthro.2004.09.016; Khanna V, 2014, ARTHROSCOPY, V30, P299, DOI 10.1016/j.arthro.2013.11.027; KIM YT, 1995, CLIN ORTHOP RELAT R, P176; Leunig M, 2003, ARCH ORTHOP TRAUM SU, V123, P392, DOI 10.1007/s00402-003-0575-z; MACFARLANE I, 1976, AUST NZ J SURG, V46, P227, DOI 10.1111/j.1445-2197.1976.tb03320.x; Macnicol MF, 2000, J PEDIATR ORTHOP B, V9, P122, DOI 10.1097/01202412-200004000-00009; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; MYERSON MS, 1986, FOOT ANKLE, V6, P225, DOI 10.1177/107110078600600504; Nepple JJ, 2014, KNEE SURG SPORT TR A, V22, P730, DOI 10.1007/s00167-014-2875-y; Hung NN, 2012, J PEDIATR ORTHOP B, V21, P542, DOI 10.1097/BPB.0b013e328356371b; Philippon MJ, 2007, ARTHROSCOPY, V23, P376, DOI 10.1016/j.arthro.2007.01.017; Philippon MJ, 2014, KNEE SURG SPORT TR A, V22, P722, DOI 10.1007/s00167-014-2874-z; Philippon MJ, 2009, ARTHROSCOPY, V25, P169, DOI 10.1016/j.arthro.2008.09.013; RIEGER H, 1991, ARCH ORTHOP TRAUM SU, V110, P114, DOI 10.1007/BF00393886; Rubel IF, 2002, PEDIATR RADIOL, V32, P435, DOI 10.1007/s00247-001-0634-y; Safran MR, 2011, AM J SPORT MED, V39, p92S, DOI 10.1177/0363546511414017; Smith MV, 2011, AM J SPORT MED, V39, p103S, DOI 10.1177/0363546511400981; Song Y, 2012, J BIOMECH, V45, P524, DOI 10.1016/j.jbiomech.2011.11.044; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; WATTS HG, 1976, ORTHOP CLIN N AM, V7, P615; Yoo JH, 2014, ORTHOP TRAUMATOL-SUR, V100, P187, DOI 10.1016/j.otsr.2013.12.016	26	7	7	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	SEP	2016	36	6					602	607		10.1097/BPO.0000000000000507			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	DT2OK	WOS:000381319800011	25929774				2022-02-06	
J	Fanous, AA; Jowdy, PK; Lipinski, LJ; Balos, LL; Li, V				Fanous, Andrew A.; Jowdy, Patrick K.; Lipinski, Lindsay J.; Balos, Lucia L.; Li, Veetai			Association between trauma and acute hemorrhage of cavernous malformations in children: report of 3 cases	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						acute hemorrhage; cavernous malformation; developmental venous anomaly; traumatic brain injury; trauma; vascular disorders	CENTRAL-NERVOUS-SYSTEM; NATURAL-HISTORY; HEMANGIOMAS; EPILEPSY; GROWTH	OBJECTIVE Cavernous hemangiomas are benign congenital vascular abnormalities. Intracerebral cavernous hemangiomas have an appreciable risk of spontaneous hemorrhage. Little is known as to whether head trauma increases the risk of bleeding for these lesions. In this study, the authors present a case series of 3 patients with posttraumatic non-spontaneous hemorrhage of intracerebral cavernous malformations (CMs). For the first time, to the authors' knowledge, they propose that trauma might constitute a risk factor for acute hemorrhage in intracerebral cavernomas. METHODS The authors reviewed the charts of all patients with a new diagnosis of intracerebral cavernoma at their pediatric hospital between 2010 and 2014. Patients with a history of head trauma prior to presentation were subsequently studied to identify features common to these posttraumatic, hemorrhage-prone lesions. RESULTS A history of head trauma was identified in 3 of 19 cases. These 3 patients presented with seizures and/or headaches and were found to have acute hemorrhage within a cavernous hemangioma. None of these patients had any history of abnormal neurological symptoms. All 3 abnormal vascular lesions had associated developmental venous anomalies (DVAs). The 3 patients underwent resection of their respective vascular abnormalities, and the diagnosis of cavernous hemangioma was confirmed with postsurgical tissue pathology. All 3 patients had complete resolution of symptoms following complete excision of their lesions. CONCLUSIONS Trauma may represent a risk factor for acute hemorrhage in patients with CMs. The presence of associated DVAs may represent a risk factor for posttraumatic hemorrhage of cavernomas. Excision should be considered in such cases, if feasible.	[Fanous, Andrew A.; Jowdy, Patrick K.; Lipinski, Lindsay J.; Li, Veetai] SUNY Buffalo, Dept Neurosurg, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Fanous, Andrew A.; Jowdy, Patrick K.; Lipinski, Lindsay J.; Li, Veetai] Buffalo Kaleida Hlth, Dept Neurosurg, Women & Childrens Hosp, Buffalo, NY USA; [Balos, Lucia L.] Kaleida Hlth Syst, Dept Pathol & Anat Sci, Buffalo, NY USA		Li, V (corresponding author), Women & Childrens Hosp Buffalo, Dept Neurosurg, 219 Bryant St, Buffalo, NY 14222 USA.	vli@ubns.com					Abdul Aziz DA, 2011, BMJ CASE REP, V2011; Abdulrauf SI, 1999, NEUROSURGERY, V44, P41, DOI 10.1097/00006123-199901000-00020; AIBA T, 1995, J NEUROSURG, V83, P56, DOI 10.3171/jns.1995.83.1.0056; Batra S, 2009, NAT REV NEUROL, V5, P659, DOI 10.1038/nrneurol.2009.177; Beuth W, 1999, Neurol Neurochir Pol, V33, P603; Cartwright G, 2010, BMJ CASE REP, V2010, pbcr0720103167; Coban A, 2008, NEUROLOGIST, V14, P46, DOI 10.1097/NRL.0b013e31813e343f; Vela JJC, 2012, RADIOLOGIA-MADRID, V54, P401, DOI 10.1016/j.rx.2011.09.016; Davis G, 2009, BRIT J SPORT MED, V43, P866, DOI 10.1136/bjsm.2008.048223; Gallati Christopher P, 2012, Surg Neurol Int, V3, P166, DOI 10.4103/2152-7806.105278; Hotokezaka M, 1996, J CLIN GASTROENTEROL, V23, P69, DOI 10.1097/00004836-199607000-00020; Kanazawa S, 1990, Rinsho Hoshasen, V35, P979; Kocakusak Ahmet, 2002, Ulus Travma Derg, V8, P176; KONDZIOLKA D, 1995, J NEUROSURG, V83, P820, DOI 10.3171/jns.1995.83.5.0820; Moran NF, 1999, J NEUROL NEUROSUR PS, V66, P561, DOI 10.1136/jnnp.66.5.561; Mottolese C, 2001, NEUROSURG REV, V24, P55, DOI 10.1007/PL00014581; OSTERTUN B, 1993, NEURORADIOLOGY, V35, P97, DOI 10.1007/BF00593962; Petersen TA, 2010, AM J NEURORADIOL, V31, P377, DOI 10.3174/ajnr.A1822; Porter PJ, 1997, J NEUROSURG, V87, P190, DOI 10.3171/jns.1997.87.2.0190; POZZATI E, 1989, NEUROSURGERY, V25, P92, DOI 10.1227/00006123-198907000-00017; Pozzati E, 1996, NEUROSURGERY, V38, P662, DOI 10.1227/00006123-199604000-00006; REQUENA I, 1991, J NEUROL NEUROSUR PS, V54, P590, DOI 10.1136/jnnp.54.7.590; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; Smith ER, 2010, NEUROSURG CLIN N AM, V21, P483, DOI 10.1016/j.nec.2010.03.003; Stefan H, 2004, ACTA NEUROL SCAND, V110, P393, DOI 10.1111/j.1600-0404.2004.00333.x; Ventura AJR, 2007, NEUROLOGIA, V22, P839; ZABRAMSKI JM, 1994, J NEUROSURG, V80, P422, DOI 10.3171/jns.1994.80.3.0422	27	7	7	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2016	18	3					263	268		10.3171/2016.3.PEDS15517			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DT8YJ	WOS:000381781300002	27153379	Bronze			2022-02-06	
J	Henry, MK; Zonfrillo, MR; French, B; Song, LH; Feudtner, C; Wood, JN				Henry, M. Katherine; Zonfrillo, Mark R.; French, Benjamin; Song, Lihai; Feudtner, Chris; Wood, Joanne N.			Hospital Variation in Cervical Spine Imaging of Young Children With Traumatic Brain Injury	ACADEMIC PEDIATRICS			English	Article						accidental falls; child abuse; spinal injuries; traumatic brain injury	ABUSIVE HEAD TRAUMA; PEDIATRIC INJURY; OUTCOMES; ASSOCIATION; ACCURACY; CODES	OBJECTIVE: Cervical imaging practices are poorly understood in young children with traumatic brain injury (TBI). We therefore sought to identify child-level and hospital-level factors associated with performance of cervical imaging of children with TBI from falls and abusive head trauma (AHT) and to describe across-hospital variation in cervical imaging performance. We hypothesized that imaging decisions would be influenced by hospital volume of young injured children. METHODS: We performed a retrospective study of children younger than 2 years of age with TBI from 2009 to 2013 in the Premier Perspective Database. After adjustment for observed patient characteristics, we evaluated variation in advanced cervical imaging (computed tomography or magnetic resonance imaging) in children with AHT and TBI from falls. RESULTS: Of 2347 children with TBI, 18.7% were from abuse and 57.1% were from falls. Fifteen percent of children with TBI underwent advanced cervical imaging. Moderate or severe head injuries were associated with increased odds of cervical imaging in AHT (odds ratio 7.10; 95% confidence interval 2.75, 18.35) and falls (odds ratio 2.25; 95% confidence interval 1.19, 4.27). There was no association between annual hospital volume of injured children and cervical imaging performance. The adjusted probability of imaging across hospitals ranged from 4.3% to 84.3% in AHT and 3.1 to 39.0% in TBI from falls (P < .001). CONCLUSIONS: These results highlight variation across hospitals in adjusted probability of cervical imaging in AHT (nearly 20-fold) and TBI from falls (over 10-fold) not explained by observed patient characteristics. This variation suggests opportunities for further research to inform imaging practices.	[Henry, M. Katherine; Feudtner, Chris; Wood, Joanne N.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Henry, M. Katherine; Song, Lihai; Feudtner, Chris; Wood, Joanne N.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Song, Lihai; Wood, Joanne N.] Childrens Hosp Philadelphia, PolicyLab, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Injury Prevent Ctr, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA; [French, Benjamin] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Feudtner, Chris; Wood, Joanne N.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA		Henry, MK (corresponding author), Childrens Hosp Philadelphia, 3535 Market St,Room 1494, Philadelphia, PA 19104 USA.	henrym2@email.chop.edu	Feudtner, Chris/AAI-1126-2019; Zonfrillo, Mark R./H-9403-2017	Feudtner, Chris/0000-0002-5879-0434; Zonfrillo, Mark R./0000-0002-0610-9563	National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32H060550-05]; NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD071967-04, K08HD073241]; Children's Hospital of Philadelphia; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [F32HS024194]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [F32HS024194] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241, K23HD071967, T32HD060550] Funding Source: NIH RePORTER	We thank Kristina B. Metzger, PhD, MPH, for her assistance in calculating head injury severity scores for our analyses. Salary support was provided by the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) institutional training grant 5T32H060550-05 (Dr Henry) and NIH/NICHD Career Development awards 1K23HD071967-04 (Dr Wood) and K08HD073241 (Dr Zonfrillo). The Children's Hospital of Philadelphia has received payment for Dr Wood's expert testimony after subpoenas in cases for suspected child abuse. This project was supported by grant F32HS024194 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The above grants did not play a role in study design, data collection, writing of the report, or the decision to submit the article for publication.	American College of Radiology, 2014, ACR SPR PRACT PAR SK; [Anonymous], 2008, ABBR INJ SCAL AIS 20; Bennett TD, 2015, PEDIATR EMERG CARE, V31, P243, DOI 10.1097/PEC.0000000000000395; Berger RP, 2015, INJURY PREV, V21, pE133, DOI 10.1136/injuryprev-2013-040924; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Centers for Disease Control and Prevention; National Center for Injury Prevention and Control; Division of Unintentional Injury Prevention, 2014, PERC DISTR TBI REL H; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Densmore JC, 2006, J PEDIATR SURG, V41, P92, DOI 10.1016/j.jpedsurg.2005.10.013; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; FESMIRE F M, 1989, Journal of Emergency Medicine, V7, P133, DOI 10.1016/0736-4679(89)90258-8; Fisher BT, 2012, PHARMACOEPIDEM DR S, P244, DOI DOI 10.1002/9781119959946.CH16; French B, 2012, STAT MED, V31, P366, DOI 10.1002/sim.4410; Givens TG, 1996, J TRAUMA, V41, P310, DOI 10.1097/00005373-199608000-00019; Hooft AM, 2015, ACAD PEDIATR, V15, P444, DOI 10.1016/j.acap.2015.01.008; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Marin JR, 2015, J PEDIATR-US, V167, P897, DOI 10.1016/j.jpeds.2015.06.052; Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096; Oderda Gary M, 2013, J Pain Palliat Care Pharmacother, V27, P62, DOI 10.3109/15360288.2012.751956; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Pieretti-Vanmarcke R, 2009, J TRAUMA, V67, P543, DOI 10.1097/TA.0b013e3181b57aa1; Robinson Scott B, 2014, Infect Dis Clin Pract (Baltim Md), V22, P320; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731	30	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1876-2859	1876-2867		ACAD PEDIATR	Acad. Pediatr.	SEP-OCT	2016	16	7					684	691		10.1016/j.acap.2016.01.017			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DU7RO	WOS:000382412500012	26854208	Green Accepted			2022-02-06	
J	Jang, SH; Yi, JH; Kwon, HG				Jang, Sung Ho; Yi, Ji Hyun; Kwon, Hyeok Gyu			Injury of the dorsolateral prefronto-thalamic tract in a patient with depression following mild traumatic brain injury: A case report	MEDICINE			English	Article						depression; diffusion tensor tractography; dorsolateral prefrontal cortex; mild traumatic brain injury; prefronto-thalamic tract	LATE-LIFE DEPRESSION; GRAY-MATTER; MICROSTRUCTURAL ABNORMALITIES; WHITE-MATTER; CORTEX; TRACTOGRAPHY; DISORDER; METAANALYSIS; CONNECTIONS; VOLUME	Background:Depression, a prevalent psychiatric disorder, is associated with abnormality in the prefrontal cortex, particularly the left dorsolateral prefrontal cortex. In this study, we report on a patient with severe depression who showed injury of the dorsolateral prefronto-thalamic tract following mild traumatic brain injury, which was demonstrated by diffusion tensor tractography (DTT).Methods and results:A 63-year-old female patient suffered an in-car accident. The patient lost consciousness for approximately 10 minutes and experienced posttraumatic amnesia approximately 30 minutes from the time of the accident. Her Glasgow Coma Scale score was 15. No specific lesion was observed on the conventional brain magnetic resonance imaging. Since the onset of head trauma, she had shown continuous depression and on 32 month evaluation, she exhibited severe depression (Beck Depression Inventory-II: 42 [full score: 63 score] and Patient Health Questionnaire-9: 24 [full score: 27 score]).Results:On 32-month DTT, partical tearing of the dorsolateral prefronto-thalamic tract was observed in the right hemisphere and thinning in the left hemisphere.Conclusion:Injury of the dorsolateral prefronto-thalamic tract was demonstrated in a patient with depression following mild traumatic brain injury, using DTT. We believe that injury of the dorsolateral prefronto-thalamic tract might be a pathogenetic mechanism of depression in patients with brain injury.	[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea; [Yi, Ji Hyun] Yeungnam Univ, Coll Med, Dept Diagnost Radiol, Daegu, South Korea		Kwon, HG (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea.	khg0715@hanmail.net			Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BENCH CJ, 1992, PSYCHOL MED, V22, P607, DOI 10.1017/S003329170003806X; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Chang CC, 2011, PSYCHIAT RES-NEUROIM, V193, P1, DOI 10.1016/j.pscychresns.2011.01.003; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; DOLAN RJ, 1993, J NEUROL NEUROSUR PS, V56, P1290, DOI 10.1136/jnnp.56.12.1290; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Jang SH, 2015, BRAIN INJURY, V29, P1725, DOI 10.3109/02699052.2015.1075170; Jang SH, 2014, YONSEI MED J, V55, P709, DOI 10.3349/ymj.2014.55.3.709; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee HD, 2015, BRAIN INJURY, V29, P1219, DOI 10.3109/02699052.2015.1045028; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Lim HK, 2012, NEUROPSYCHOPHARMACOL, V37, P838, DOI 10.1038/npp.2011.264; Mayberg HS, 2003, NEUROIMAG CLIN N AM, V13, P805, DOI 10.1016/S1052-5149(03)00104-7; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Wechsler D, 1981, WECHSLER ADULT INTEL; Williams JM., 1991, MAS MEMORY ASSESSMEN; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yang Q, 2007, INT PSYCHOGERIATR, V19, P757, DOI 10.1017/S1041610207004875	27	7	7	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP	2016	95	39							e5009	10.1097/MD.0000000000005009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0PE	WOS:000385541400075	27684865	Green Published, gold			2022-02-06	
J	Jordy, SS; Starzewski, A; Macedo, FAB; Manica, GR; Tilbery, CP; Carabetta, EG				Jordy, Sergio Semeraro; Starzewski Junior, Alberto; Basso Macedo, Felipe Andre; Manica, Gabriela Reginatto; Tilbery, Charles Peter; Carabetta, Eduardo Gregorin			Olfactory alterations in patients with multiple sclerosis	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						multiple sclerosis; smell	DYSFUNCTION	This cross-sectional study involves 100 multiple sclerosis (MS) and 100 non-MS patients, under the age of 60 years old, with nasal obstruction, traumatic brain injury, previous rhinoplasty or neurosurgery, and so forth. Objective:To assess olfactory function using the Connecticut test and verify correlations between olfactory alteration, disease duration and the Expanded Disability Status Scale (EDSS). Methods: One hundred MS patients and 100 healthy control patients responded to a questionnaire. Those with olfactory alteration underwent a facial CT to exclude other causes. Results: Thirty-two percent of patients showed alterations, compared with 3% in the healthy control group. Patients having EDSS above 4, showed a 5.2-times increased risk of dysfunction. Patients over 38 years of age have a 2.2-times increased risk over younger patients. Conclusions: Because MS patients are likely to experience olfactory alterations, this study is a useful tool in follow-up care, although more studies are necessary to evaluate the correlations in MS evolution.	[Jordy, Sergio Semeraro; Tilbery, Charles Peter; Carabetta, Eduardo Gregorin] Santa Casa de Misericordia Sao Paulo, CATEM, Sao Paulo, SP, Brazil; [Starzewski Junior, Alberto; Basso Macedo, Felipe Andre; Manica, Gabriela Reginatto] Univ Anhembi Morumbi, Fac Med, Sao Paulo, SP, Brazil		Tilbery, CP (corresponding author), Irmandade Santa Casa de Misericordia Sao Paulo, CATEM, Rua Cesario Mote Jr 112-3 Andar, BR-01221020 Sao Paulo, SP, Brazil.	charlespt@einstein.br					Altmann EBC, 1997, FISSURAS LABIOPALATI, P325; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Caminiti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103151; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doty RL, 1998, ANN NY ACAD SCI, V855, P781, DOI 10.1111/j.1749-6632.1998.tb10658.x; Gold R, 2011, ACTA NEUROL SCAND, V124, P75, DOI 10.1111/j.1600-0404.2010.01444.x; Hawkes CH, 1998, ANN NY ACAD SCI, V855, P608, DOI 10.1111/j.1749-6632.1998.tb10631.x; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Lutterotti A, 2011, MULT SCLER J, V17, P964, DOI 10.1177/1352458511399798; Neto FXP, 2011, INT ARCH OTORHINOLAR, V15, P350, DOI 10.1590/S1809-48722011000300014; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Silva AM, 2012, MULT SCLER J, V18, P616, DOI 10.1177/1352458511427156; Starzewski Junior A, 2008, REV BRAS MED, V3, P78; Toledano A, 2005, ACTA OTORRINOLAR ESP, V56, P116, DOI 10.1016/S0001-6519(05)78585-X; Zivadinov R, 1999, J NEUROL SCI, V168, P127, DOI 10.1016/S0022-510X(99)00189-6; Zorzon M, 2000, MULT SCLER, V6, P386, DOI 10.1177/135245850000600605	17	7	7	0	4	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2016	74	9					697	700		10.1590/0004-282X20160128			4	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DY2ZV	WOS:000384961500003	27706416	gold, Green Submitted			2022-02-06	
J	Kaufmann, D; Bates, EA; Yagen, B; Bialer, M; Saunders, GH; Wilcox, K; White, HS; Brennan, KC				Kaufmann, Dan; Bates, Emily A.; Yagen, Boris; Bialer, Meir; Saunders, Gerald H.; Wilcox, Karen; White, H. Steve; Brennan, K. C.			sec-Butylpropylacetamide (SPD) has antimigraine properties	CEPHALALGIA			English	Article						sec-butylpropylacetamide (SPD); migraine; cortical spreading depression; nitroglycerine test; mechanical allodynia	CORTICAL SPREADING DEPRESSION; TRIGEMINAL NUCLEUS CAUDALIS; TRAUMATIC BRAIN-INJURY; MIGRAINE PROPHYLAXIS; CUTANEOUS ALLODYNIA; CELLULAR MECHANISMS; STATUS EPILEPTICUS; LABORATORY MICE; UNIQUE ACTIVITY; VALPROIC ACID	Background Though migraine is disabling and affects 12%-15% of the population, there are few drugs that have been developed specifically for migraine prevention. Valproic acid (VPA) is a broad-spectrum antiepileptic drug (AED) that is also used for migraine prophylaxis, but its clinical use is limited by its side effect profile. sec-Butylpropylacetamide (SPD) is a novel VPA derivative, designed to be more potent and tolerable than VPA, that has shown efficacy in animal seizure and pain models. Methods We evaluated SPD's antimigraine potential in the cortical spreading depression (CSD) and nitroglycerin (NTG) models of migraine. To evaluate SPD's mechanism of action, we performed whole-cell recordings on cultured cortical neurons and neuroblastoma cells. Results In the CSD model, the SPD-treated group showed a significantly lower median number of CSDs compared to controls. In the NTG-induced mechanical allodynia model, SPD dose-dependently reduced mechanical sensitivity compared to controls. SPD showed both a significant potentiation of GABA-mediated currents and a smaller but significant decrease in NMDA currents in cultured cortical neurons. Kainic acid-evoked currents and voltage-dependent sodium channel currents were not changed by SPD. Conclusions These results demonstrate SPD's potential as a promising novel antimigraine compound, and suggest a GABAergic mechanism of action.	[Kaufmann, Dan; Saunders, Gerald H.; Wilcox, Karen; White, H. Steve] Univ Utah, Dept Pharmacol & Toxicol, Anticonvulsant Drug Dev Program, 112 Skaggs Hall, Salt Lake City, UT 84112 USA; [Kaufmann, Dan; Brennan, K. C.] Univ Utah, Dept Neurol, 383 Colorow Dr,Room 364, Salt Lake City, UT 84108 USA; [Bates, Emily A.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; [Yagen, Boris; Bialer, Meir] Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, IL-91905 Jerusalem, Israel; [Yagen, Boris; Bialer, Meir] Hebrew Univ Jerusalem, Fac Med, David R Bloom Ctr Pharm, IL-91905 Jerusalem, Israel		Brennan, KC (corresponding author), Univ Utah, Dept Neurol, 383 Colorow Dr,Room 364, Salt Lake City, UT 84108 USA.	K.C.Brennan@hsc.utah.edu	Saunders, Gabrielle/V-2288-2019	Saunders, Gabrielle/0000-0002-9997-0845; Brennan, K.C./0000-0003-4193-5841; White, H. Steve/0000-0003-4550-4408	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 059072, NS 083010]; Department of Defense CDMRPUnited States Department of Defense [PR100060, PR130373]; Migraine Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS083010, R01NS085413, K08NS059072] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (NIH) (NS 059072, NS 083010; KCB), Department of Defense CDMRP (PR100060 and PR130373), and the Migraine Research Foundation (DK, KCB).	Alex AB, 2006, J NEUROPHYSIOL, V96, P1084, DOI 10.1152/jn.01325.2005; Andreou AP, 2010, NEUROBIOL DIS, V37, P314, DOI 10.1016/j.nbd.2009.10.007; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Bartsch T, 2005, PAIN, V117, P30, DOI 10.1016/j.pain.2005.05.015; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Bernstein C, 2012, J CLIN NEUROL, V8, P89, DOI 10.3988/jcn.2012.8.2.89; Bigal ME, 2003, EPILEPSY BEHAV, V4, pS13, DOI 10.1016/j.yebeh.2003.07.003; Brandes JL, 2004, JAMA-J AM MED ASSOC, V291, P965, DOI 10.1001/jama.291.8.965; Brennan KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005784; Brennan KC, 2010, CURR OPIN NEUROL, V23, P266, DOI 10.1097/WCO.0b013e32833821c1; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Brennan KC, 2007, ANN NEUROL, V61, P603, DOI 10.1002/ana.21138; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Calabresi P, 2007, TRENDS PHARMACOL SCI, V28, P188, DOI 10.1016/j.tips.2007.02.005; Cesarovic N, 2010, LAB ANIM-UK, V44, P329, DOI 10.1258/la.2010.009085; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Charles A, 2010, HDB CLIN NEUROLOGY, P99; Christiansen I, 2000, EUR J NEUROL, V7, P405, DOI 10.1046/j.1468-1331.2000.00094.x; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Greco R, 2013, CEPHALALGIA, V34, P594; Greco R, 2013, HEADACHE, V53, P288, DOI 10.1111/j.1526-4610.2012.02249.x; Greco R, 2011, J HEADACHE PAIN, V12, P177, DOI 10.1007/s10194-010-0274-4; Guy N, 2010, CEPHALALGIA, V30, P881, DOI 10.1111/j.1468-2982.2009.02008.x; Hen N, 2013, J MED CHEM, V56, P6467, DOI 10.1021/jm4007565; HERING R, 1992, CEPHALALGIA, V12, P81, DOI 10.1046/j.1468-2982.1992.1202081.x; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/NMETH.1500, 10.1038/nmeth.1500]; IVERSEN HK, 1995, CEPHALALGIA, V15, P281, DOI 10.1046/j.1468-2982.1995.1504281.x; Kaufmann D, SEC BUTYLPROPY UNPUB; Kaufmann D, 2009, J MED CHEM, V52, P7236, DOI 10.1021/jm901229s; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; LANGMOEN IA, 1995, EUR J ANAESTH, V12, P51; Li FP, 2011, J HEADACHE PAIN, V12, P47, DOI 10.1007/s10194-011-0300-1; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Martinez HR, 2003, HEADACHE, V43, P1080, DOI 10.1046/j.1526-4610.2003.03209.x; Michot B, 2014, NEUROPHARMACOLOGY, V79, P432, DOI 10.1016/j.neuropharm.2013.12.011; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; Oshinsky ML, 2012, HEADACHE, V52, P1336, DOI 10.1111/j.1526-4610.2012.02247.x; Otto JF, 2002, MOL PHARMACOL, V61, P921, DOI 10.1124/mol.61.4.921; Pradhan AA, 2014, PAIN, V155, P269, DOI 10.1016/j.pain.2013.10.004; Ramachandran R, 2012, CEPHALALGIA, V32, P73, DOI 10.1177/0333102411430855; Storer RJ, 2004, BRAIN RES, V1013, P188, DOI 10.1016/j.brainres.2004.03.068; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tassorelli C, 1999, PROG NEUROBIOL, V57, P607, DOI 10.1016/S0301-0082(98)00071-9; Tong CK, 2000, J NEUROPHYSIOL, V84, P2449, DOI 10.1152/jn.2000.84.5.2449; White HS, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2011.03338.x; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329; Zhu XF, 2011, NEUROL SCI, V32, P589, DOI 10.1007/s10072-011-0486-7	52	7	9	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	SEP	2016	36	10					924	935		10.1177/0333102415612773			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DV3XR	WOS:000382859300003	26568161	Green Accepted			2022-02-06	
J	Khanna, R; Ferrara, L				Khanna, Rohit; Ferrara, Lisa			Dynamic telescopic craniotomy: a cadaveric study of a novel device and technique	JOURNAL OF NEUROSURGERY			English	Article						cerebral swelling; traumatic brain injury; malignant stroke; decompressive craniectomy; intracranial hypertension; edema; hemorrhage; cranial fixation; surgical technique	TRAUMATIC BRAIN-INJURY; MIDDLE-CEREBRAL-ARTERY; ASSOCIATION/AMERICAN STROKE ASSOCIATION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; HEALTH-CARE PROFESSIONALS; INTRA-CRANICAL PRESSURE; SEVERE HEAD-INJURY; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; EARLY DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE	OBJECTIVE The authors assessed the feasibility of the dynamic decompressive craniotomy technique using a novel cranial fixation plate with a telescopic component. Following a craniotomy in human cadaver skulls, the telescopic plates were placed to cover the bur holes. The plates allow constrained outward movement of the bone flap upon an increase in intracranial pressure (ICP) and also prevent the bone flap from sinking once the ICP normalizes. The authors compared the extent of postcraniotomy ICP control after an abrupt increase in intracranial volume using the dynamic craniotomy technique versus the standard craniotomy or hinge craniotomy techniques. METHODS Fixation of the bone flap after craniotomy was performed in 5 cadaver skulls using 3 techniques: 1) dynamic telescopic craniotomy, 2) hinge craniotomy, and 3) standard craniotomy with fixed plates. The ability of each technique to allow for expansion during intracranial hypertension was evaluated by progressively increasing intracranial volume. Biomechanical evaluation of the telescopic plates with load-bearing tests was also undertaken. RESULTS Both the dynamic craniotomy and the hinge craniotomy techniques provided significant control of ICP during increases in intracranial volume as compared with the standard craniotomy technique. With the standard craniotomy, ICP increased from a mean of 11.4 to 100.1 mm Hg with the addition of 120 ml of intracranial volume. However, with the dynamic craniotomy, the addition of 120 ml of intracranial volume increased the ICP from a mean of 2.8 to 13.4 mm Hg, maintaining ICP within the normal range as compared with the standard craniotomy (p = 0.04). The dynamic craniotomy was also superior in controlling ICP as compared with the hinge craniotomy, providing expansion for an additional 40 ml of intracranial volume while maintaining ICP within a normal range (p = 0.008). Biomechanical load-bearing tests for the dynamic telescopic plates revealed rigid restriction of bone-flap sinking as compared with standard fixation plates and clamps. CONCLUSIONS The dynamic telescopic craniotomy technique with the novel cranial fixation plate provides superior control of ICP after an abrupt increase in intracranial volume as compared with the standard craniotomy and hinge craniotomy techniques.	[Khanna, Rohit] Halifax Hlth, Neurosurg Serv, Port Orange, FL USA; [Khanna, Rohit] Florida State Univ, Coll Med, Daytona Beach, FL USA; [Ferrara, Lisa] OrthoKinet Technol LLC, Southport, NC USA		Khanna, R (corresponding author), 311 N Clyde Morris Blvd,Ste 580, Daytona Beach, FL 32114 USA.	khanna.md@aol.com			OrthoKinetic Technologies	Dr. Khanna holds patents with NeuroVention LLC and CoolSpine LLC. Dr. Ferrara received research support from OrthoKinetic Technologies for the study described.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aaron S, 2013, J NEUROL NEUROSUR PS, V84, P995, DOI 10.1136/jnnp-2012-303356; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chibbaro S, 2009, J NEUROSURG, V111, P884; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Ebraheim NA, 2007, SPINE J, V7, P689, DOI 10.1016/j.spinee.2006.09.007; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V115, P191, DOI 10.3171/2011.4.JNS101116a; Fernandes HM, 2000, ACT NEUR S, V76, P463; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Gelb AW, 2008, ANESTH ANALG, V106, P585, DOI 10.1213/01.ane.0000295804.41688.8a; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hayes SB, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12422; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Heuts SG, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1326; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; JANNY P, 1982, ACTA NEUROCHIR, V61, P181, DOI 10.1007/BF01740083; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; KAYE AH, 1981, J NEUROSURG, V54, P726, DOI 10.3171/jns.1981.54.6.0726; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Lerch KD, 1999, NEUROSURGERY, V44, P902, DOI 10.1097/00006123-199904000-00137; LEROUX PD, 1995, J NEUROSURG, V83, P394, DOI 10.3171/jns.1995.83.3.0394; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Neugebauer H, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12363; NORNES H, 1972, J NEUROSURG, V36, P537, DOI 10.3171/jns.1972.36.5.0537; Otani Naoki, 2013, Acta Neurochir Suppl, V118, P269, DOI 10.1007/978-3-7091-1434-6_51; PAPO I, 1979, NEUROSURGERY, V4, P504, DOI 10.1227/00006123-197906000-00002; Rasmussen M, 2004, J NEUROSURG, V101, P621, DOI 10.3171/jns.2004.101.4.0621; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P725, DOI 10.1001/archneur.1984.04050180047016; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Stapleton CJ, 2015, NEUROSURGERY, V76, P258, DOI 10.1227/NEU.0000000000000596; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; TAKEUCHI S, 1989, NEUROSURGERY, V24, P878, DOI 10.1227/00006123-198906000-00014; Takeuchi S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12424; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Traxler H, 2002, CLIN ANAT, V15, P173, DOI 10.1002/ca.10022; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vivakaran TTR, 2012, J NEUROSURG, V117, P738, DOI 10.3171/2012.6.JNS11102; VOLDBY B, 1982, J NEUROSURG, V56, P186, DOI 10.3171/jns.1982.56.2.0186; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; WOODCOCK J, 1982, STROKE, V13, P785, DOI 10.1161/01.STR.13.6.785; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Ziai WC, 2009, CEREBROVASC DIS, V27, P403, DOI 10.1159/000209241	81	7	7	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2016	125	3					674	682		10.3171/2015.6.JNS15706			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DT8YS	WOS:000381782300019	26654180	Bronze			2022-02-06	
J	Lynch, C; LaGasse, AB				Lynch, Colleen; LaGasse, A. Blythe			Training Endogenous Task Shifting Using Music Therapy: A Feasibility Study	JOURNAL OF MUSIC THERAPY			English	Article						acquired brain injury; endogenous attention; executive function; music therapy; feasibility; intervention fidelity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; INTERVENTION RESEARCH; DAILY-LIFE; RECOVERY; REHABILITATION; FIDELITY; TRAIL; SET	Background: People with acquired brain injury (ABI) are highly susceptible to disturbances in executive functioning (EF), and these effects are pervasive. Research studies using music therapy for cognitive improvement in this population are limited. Objective: The purpose of this study was to determine the feasibility of a Musical Executive Function Training (MEFT) intervention to address task-shifting skills in adults with ABI and to obtain preliminary evidence of intervention effect on task shifting. Methods: Fourteen participants were randomly assigned to one of three groups: a music therapy intervention group (MTG), a singing group (SG), or the no-intervention control group (CG). The SG and MTG met for one hour a day for five days. Feasibility measures included participant completion rates and intervention fidelity. Potential benefits were measured using the Trail Making Test and the Paced Auditory Serial Addition Task as a pre- and posttest measure. Results: Participant completion rates and interventionist fidelity to the protocol supported feasibility. One-way ANOVA of the pre- and posttest group differences revealed a trend toward improvement in the MTG over the SG. Conclusions: Feasibility and effect size data support a larger trial of the MEFT protocol.	[Lynch, Colleen] Ostalb Klinikum Aalen, Psychosomat Clin, Aalen, Germany; [LaGasse, A. Blythe] Colorado State Univ, Mus Therapy, 1778 Campus Delivery, Ft Collins, CO 80523 USA		LaGasse, AB (corresponding author), Colorado State Univ, Mus Therapy, 1778 Campus Delivery, Ft Collins, CO 80523 USA.	blagasse@colostate.edu	LaGasse, Blythe/AAB-9517-2021	LaGasse, A. Blythe/0000-0002-1631-3605			Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 2005, EFFECTIVENESS REHABI, P211, DOI DOI 10.1093/ACPROF:OSO/9780198526544.001.0001; Burns D. S., 2009, CANC NURSING, V32, P8; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010; Cristofori I, 2015, NEUROLOGY, V84, P1394, DOI 10.1212/WNL.0000000000001446; Doherty TA, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00022; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gardiner JC, 2015, MUSIC THER PERSPECT, V33, P193, DOI 10.1093/mtp/miu045; Gearing RE, 2011, CLIN PSYCHOL REV, V31, P79, DOI 10.1016/j.cpr.2010.09.007; Gerrits NJHM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0181-3; Gordon EE, 1989, ADV MEASURES MUSIC A; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Koelsch S, 2009, ANN NY ACAD SCI, V1169, P374, DOI 10.1111/j.1749-6632.2009.04592.x; LaGasse AB, 2013, J MUSIC THER, V50, P304, DOI 10.1093/jmt/50.4.304; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Mukai I, 2011, J VISION, V11, DOI 10.1167/11.1.25; Parham LD, 2007, AM J OCCUP THER, V61, P216, DOI 10.5014/ajot.61.2.216; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Robb S.L., 2011, MUSIC MED, V3, P271, DOI [10.1177/1943862111420539, DOI 10.1177/1943862111420539]; Rubin A., 2008, PRACTITIONERS GUIDE; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Schutz LE, 2009, AM J PHYS MED REHAB, V88, P419, DOI 10.1097/PHM.0b013e3181a0e2d3; Schuurs A, 2013, PSYCHO-ONCOLOGY, V22, P1043, DOI 10.1002/pon.3102; Silverman MJ, 2014, J MUSIC THER, V51, P228, DOI 10.1093/jmt/thu011; Slagter HA, 2006, COGN AFFECT BEHAV NE, V6, P175, DOI 10.3758/CABN.6.3.175; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Stegemoller EL, 2014, J MUSIC THER, V51, P211, DOI 10.1093/jmt/thu023; Stuss D. T., 2009, REHABILITATION EXECU, P3; Thaut M.H., 2014, OXFORD HDB NEUROLOGI; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Tickle-Degnen L, 2013, AM J OCCUP THER, V67, P171, DOI 10.5014/ajot.2013.006270; Vaughan L, 2010, PSYCHOL AGING, V25, P343, DOI 10.1037/a0017729; Werner J., 2015, AGING MENTAL HLTH; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	44	7	7	0	13	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	FAL	2016	53	3					279	+		10.1093/jmt/thw008			29	Music; Rehabilitation	Social Science Citation Index (SSCI)	Music; Rehabilitation	DW5TA	WOS:000383708600001	27235114				2022-02-06	
J	Mullah, SH; Abutarboush, R; Moon-Massat, PF; Saha, BK; Haque, A; Walker, PB; Auker, CR; Arnaud, FG; McCarron, RM; Scultetus, AH				Mullah, Saad H.; Abutarboush, Rania; Moon-Massat, Paula F.; Saha, Biswajit K.; Haque, Ashraful; Walker, Peter B.; Auker, Charles R.; Arnaud, Francoise G.; McCarron, Richard M.; Scultetus, Anke H.			Sanguinate's effect on pial arterioles in healthy rats and cerebral oxygen tension after controlled cortical impact	MICROVASCULAR RESEARCH			English	Article						Cerebral oxygenation; Hemoglobin-based oxygen carrier; Intravital microscopy; Microcirculation; Oxygen therapeutic; Phosphorescence quenching method; Polyethylene glycol-conjugated carboxyhemoglobin; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CELL-FREE HEMOGLOBIN; NITRIC-OXIDE CONCENTRATION; SEVERE HEAD-INJURY; BOVINE HEMOGLOBIN; CARBON-MONOXIDE; TISSUE OXYGENATION; BLOOD SUBSTITUTES; ISCHEMIA/REPERFUSION INJURY; PERFLUOROCARBON EMULSION	Sanguinate, a polyethylene glycol-conjugated carboxyhemoglobin, was investigated for cerebral vasoactivity in healthy male Sprague-Dawley rats (Study 1) and for its ability to increase brain tissue oxygen pressure (PbtO(2)) after controlled cortical impact (CCI) - traumatic brain injury (TBI) (Study 2). In both studies ketamine-acepromazine anesthetized rats were ventilated with 40% O-2. In Study 1, a cranial window was used to measure the diameters of medium (50-100 mu m) and small-sized (<50 mu m) pial arterioles before and after four serial infusions of Sanguinate (8 mL/kg/h, cumulative 16 mL/kg IV), volume-matched Hextend, or normal saline. In Study 2, PbtO(2) was measured using a phosphorescence quenching method before TBI, 15 min after TBI (T15) and then every 10 min thereafter for 155 min. At T15, rats received either 8 mL/kg IV Sanguinate (40 mL/kg/h) or no treatment (saline, 4 mL/kg/h). Results showed: 1) in healthy rats, percentage changes in pial arteriole diameter were the same among the groups, 2) in TBI rats, PbtO(2) decreased from 36.5 +/- 3.9 mm Hg to 19.8 +/- 3.0 mm Hg at T15 in both groups after TBI and did not recover in either group for the rest of the study, and 3) MAP increased 16 +/- 4 mm Hg and 36 +/- 5 mm Hg after Sanguinate in healthy and TBI rats, respectively, while MAP was unchanged in control groups. In conclusion, Sanguinate did not cause vasoconstriction in the cerebral pial arterioles of healthy rats but it also did not acutely increase PbtO(2) when administered after TBI. Sanguinate was associated with an increase in MAP in both studies. (C) 2016 Elsevier Inc. All rights reserved.	[Mullah, Saad H.; Abutarboush, Rania; Moon-Massat, Paula F.; Saha, Biswajit K.; Haque, Ashraful; Walker, Peter B.; Auker, Charles R.; Arnaud, Francoise G.; McCarron, Richard M.; Scultetus, Anke H.] Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Arnaud, Francoise G.; McCarron, Richard M.; Scultetus, Anke H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Mullah, SH (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	saad.h.mullah.ctr@mail.mil; rania.abutarboush.ctr@mail.mil; paula.f.moon-massat.ctr@mail.mil; biswajit.k.saha.ctr@mail.mil; ashraful.haque.ctr@mail.mil; peter.b.walker.mil@mail.mil; charles.r.auker.ctr@mail.mil; francoise.amaud.ctr@mail.mil; richard.m.mccarron.civ@mail.mil; anke.h.scultetus2.ctr@mail.mil			Defense Health Program (DHP) [603115HP.3730.001A1247]	The work was supported by Defense Health Program (DHP) work unit number 603115HP.3730.001A1247.	Abutarboush Rania, 2013, Curr Drug Discov Technol, V10, P315; Acharya SA, 2005, ARTIF CELL BLOOD SUB, V33, P239, DOI 10.1081/BIO-200066365; Alayash AI, 2007, EXPERT OPIN BIOL TH, V7, P665, DOI 10.1517/14712598.7.5.665; Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Ananthakrishnan R, 2013, ARTIF CELL NANOMED B, V41, P428, DOI 10.3109/21691401.2012.762370; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chowdhury T, 2014, SAUDI J ANAESTH, V8, P114, DOI 10.4103/1658-354X.125971; Conover CD, 1997, ARTIF ORGANS, V21, P369; Conover CD, 1996, J INVEST MED, V44, P238; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; Defazio R, 2015, TOXICOL PATHOL, V43, P249, DOI 10.1177/0192623314538345; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Drabkin DL, 1935, J BIOL CHEM, V112, P51; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Evelyn KA, 1938, J BIOL CHEM, V126, P655; Hare GMT, 2004, ANESTH ANALG, V99, P528, DOI 10.1213/01.ANE.0000136769.65960.D1; Klaus JA, 2010, ARTIF CELL BLOOD SUB, V38, P223, DOI 10.3109/10731199.2010.488635; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mendez DR, 2004, J TRAUMA, V57, P244, DOI 10.1097/01.TA.0000103983.22362.67; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Misra H, 2014, ARTIF ORGANS, V38, P702, DOI 10.1111/aor.12341; Moon-Massat P., 2015, J NEUROTRAUMA; Mullah S, 2014, BRAIN INJURY, V28, P744; Mullah SH, 2016, BRAIN RES, V1634, P132, DOI 10.1016/j.brainres.2016.01.012; Mullah Saad Habib-E-Rasul, 2013, Acta Neurochir Suppl, V118, P89, DOI 10.1007/978-3-7091-1434-6_15; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; NHO K, 1992, BIOMAT ARTIF CELL IM, V20, P511, DOI 10.3109/10731199209119677; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Ozaki KS, 2012, TRANSPLANT REV-ORLAN, V26, P125, DOI 10.1016/j.trre.2011.01.004; Rebel A, 2006, AM J PHYSIOL-HEART C, V290, pH1027, DOI 10.1152/ajpheart.00500.2005; Rebel A, 2003, AM J PHYSIOL-HEART C, V285, pH1600, DOI 10.1152/ajpheart.00077.2003; ROSENBLUM WI, 1976, STROKE, V7, P283, DOI 10.1161/01.STR.7.3.283; ROSENBLUM WI, 1963, ARCH NEUROL-CHICAGO, V9, P414, DOI 10.1001/archneur.1963.00460100102012; Schroeder JL, 2008, J NEUROSURG-SPINE, V9, P213, DOI 10.3171/SPI/2008/9/8/213; Song BK, 2013, MIL MED, V178, P570, DOI 10.7205/MILMED-D-12-00408; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Tsai AG, 2005, AM J PHYSIOL-HEART C, V288, pH1730, DOI 10.1152/ajpheart.00998.2004; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; URBAITIS BK, 1991, J LAB CLIN MED, V117, P115; Vandegriff KD, 2008, BRIT J PHARMACOL, V154, P1649, DOI 10.1038/bjp.2008.219; Varelas P., 2014, USE SANGUINATE ENCEP; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; WEINER M, 1994, ARTIF CELL BLOOD SUB, V22, P763, DOI 10.3109/10731199409117909; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; Wilson DF, 2006, J APPL PHYSIOL, V101, P1648, DOI 10.1152/japplphysiol.00394.2006; Yu J, 2013, ANAESTHESIA, V68, P723, DOI 10.1111/anae.12227; Zhang J., 1985, J APPL PHYSL BETHESD, V113, P1709	54	7	7	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0026-2862	1095-9319		MICROVASC RES	Microvasc. Res.	SEP	2016	107						83	90		10.1016/j.mvr.2016.06.001			8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	DR4QW	WOS:000379888300011	27287870				2022-02-06	
J	Shahrokhi, N; Soltani, Z; Khaksari, M; Karamouzian, S; Mofid, B; Asadikaram, G				Shahrokhi, Nader; Soltani, Zahra; Khaksari, Mohammad; Karamouzian, Saeid; Mofid, Behshad; Asadikaram, Gholamreza			The Serum Changes of Neuron-Specific Enolase and Intercellular Adhesion Molecule-1 in Patients With Diffuse Axonal Injury Following Progesterone Administration: A Randomized Clinical Trial	ARCHIVES OF TRAUMA RESEARCH			English	Article						Intercellular Adhesion Molecule-1; Neuron-Specific Enolase; Progesterone; Serum; Diffuse Axonal Injury	TRAUMATIC BRAIN-INJURY; SEX STEROID-HORMONES; OXIDATIVE STRESS; INFLAMMATION; MARKERS; DAMAGE; NEUROINFLAMMATION; NEUROPROTECTION; EXPRESSION; OUTCOMES	Background: Improvement of neurologic outcome in progesterone-administered patients with diffuse axonal injury ( DAI) has been found in a recent study. Also, there has been interest in the importance of serum parameters as predictors of outcome in traumatic brain injury. Objectives: The aim of this study was to examine the effect of progesterone administration on serum levels of neuron-specific enolase ( NSE), and intercellular adhesion molecule-1 ( ICAM-1) in clinical DAI. Patients and Methods: In this study, the serum levels of ICAM-1 and NSE of 32 male DAI patients ( 18 -60 years of age, a Glasgow coma scale of 12 or less, and admitted within 4 hours after injury) who were randomized for a controlled phase II trial of progesterone were analyzed. The analysis was performed between the control and progesterone groups at admission time, and 24 hours and six days after DAI, respectively. Results: A reduction in the serum level of ICAM-1 was noticed in the progesterone group 24 hours after the injury ( P < 0.05). There was no significant difference in the serum level of NSE between the study groups during evaluation. At 24 hours after the injury, the level of ICAM-1 in the control group was higher than that at admission time ( P < 0.05). The lowest level of NSE in the two groups was seen six days after DAI ( P < 0.01). Conclusions: In summary, progesterone administration reduced serum ICAM-1, and whereby may attenuate blood brain barrier disruption, the latter needs further investigation for confirmation.	[Shahrokhi, Nader] Kerman Univ Med Sci, Afzalipour Sch Med, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Soltani, Zahra] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Karamouzian, Saeid; Mofid, Behshad] Kerman Univ Med Sci, Dept Neurosurg, Kerman, Iran; [Asadikaram, Gholamreza] Kerman Univ Med Sci, Dept Biochem, Kerman, Iran		Soltani, Z (corresponding author), Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran.	soltaniy@yahoo.com	Soltani, Zahra/AAC-1350-2019; Haddad, Mohammad Khaksari/AAB-9025-2019; Shahrokhi, Nader/AAV-3747-2020; Asadikaram, Gholamreza/AAG-4437-2021	Soltani, Zahra/0000-0002-8423-6189; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Shahrokhi, Nader/0000-0002-0149-7819; Asadikaram, Gholamreza/0000-0002-9100-0756; Karamouzian, Saeid/0000-0001-6256-0941	physiology and neuroscience research centers of Kerman University of Medical Sciences	We would like to thank the managers of physiology and neuroscience research centers of Kerman University of Medical Sciences, Prof. Najafipour and Prof. Sheibani, for their financial support.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Cooper E. H., 1994, International Journal of Biological Markers, V9, P205; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Robertson CL, 2015, PEDIATR CRIT CARE ME, V16, P236, DOI 10.1097/PCC.0000000000000323; SCHAARSCHMIDT H, 1994, STROKE, V25, P558, DOI 10.1161/01.STR.25.3.558; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Wang JP, 2011, MOL MED REP, V4, P319, DOI 10.3892/mmr.2011.418; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	34	7	7	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	SEP	2016	5	3							e37005	10.5812/atr.37005			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	DY6KI	WOS:000385218100012	27800469	Green Published, Green Submitted, Bronze			2022-02-06	
J	Wander, PL; Enquobahrie, DA; Pritchard, CC; McKnight, B; Rice, K; Christiansen, M; Lemaitre, RN; Rea, T; Siscovick, D; Sotoodehnia, N				Wander, P. L.; Enquobahrie, D. A.; Pritchard, C. C.; McKnight, B.; Rice, K.; Christiansen, M.; Lemaitre, R. N.; Rea, T.; Siscovick, D.; Sotoodehnia, N.			Circulating microRNAs and sudden cardiac arrest outcomes	RESUSCITATION			English	Article						Cardiac arrest; Outcomes; Epigenetics; microRNAs; Epidemiology	ACUTE MYOCARDIAL-INFARCTION; TRAUMATIC BRAIN-INJURY; PLASMA; BIOMARKER; DISEASE; MIR-124	Aim: MicroRNAs (miRNAs) have regulatory functions in organs critical in resuscitation from sudden cardiac arrest due to ventricular fibrillation (VF-SCA); therefore, circulating miRNAs may be markers of VF-SCA outcome. Methods: We measured candidate miRNAs (N=45) in plasma using qRT-PCR among participants of a population-based VF-SCA study. Participants were randomly selected cases who died in the field (DF, n=15), died in hospital (DH, n=15), or survived to discharge (DC, n=15), and, age-, sex-, and race-matched controls (n=15). MiRNA levels were compared using ANOVA, t-tests, and fold-changes. Results: Mean age of groups ranged from 66.9 to 69.7. Most participants were male (53-67%) and white (67%). Comparing cases to controls, plasma levels of 17 miRNAs expressed in heart, brain, liver, and other tissues (including miR-29c,-34a,-122,-145,-200a,-210,-499-5p, and-663b) were higher and three nonspecific miRNAs lower (miR-221,-330-3p, and-9-5p). Among DH or DC compared with DF cases, levels of two miRNAs (liver-specific miR-122 and non-specific miR-205) were higher and two heart-specific miRNAs (miR-208b and-499-5p) lower. Among DC vs. DF cases, levels of three miRNAs (miR-122, and non-specific miR-200a and-205) were higher and four heart-specific miRNAs (miR-133a,-133b,-208b, and-499-5p) lower. Among DC vs. DH cases, levels of two non-specific miRNAs (miR-135a and-9-3p) were lower. Conclusions: Circulating miRNAs expressed in heart, brain, and other tissues differ between VF-SCA cases and controls and are related to resuscitation outcomes. Measurement of miRNAs may clarify mechanisms underlying resuscitation, improve prognostication, and guide development of therapies. Results require replication. Published by Elsevier Ireland Ltd.	[Wander, P. L.; Christiansen, M.; Lemaitre, R. N.; Rea, T.; Sotoodehnia, N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Enquobahrie, D. A.; Sotoodehnia, N.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Pritchard, C. C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McKnight, B.; Rice, K.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wander, P. L.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Rea, T.] Publ Hlth Seattle & King Cty, Emergency Med Serv Div, Seattle, WA USA; [Siscovick, D.] New York Acad Med, New York, NY USA; [Sotoodehnia, N.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA		Wander, PL (corresponding author), Univ Washington, Dept Med, Div Gen Internal Med, 325 Ninth Ave,Box 359780, Seattle, WA 98104 USA.	lwander@u.washington.edu		Wander, Pandora/0000-0003-3671-1464; Enquobahrie, Daniel/0000-0001-9844-0597	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K08DK103945]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01-HL091244, R01-HL092111, R01-HL088456, R01-HL111089]; University of Washington Nutrition and Obesity Research Center [P30 DK035816]; Locke Charitable Foundation; Medic One Foundation; Alpha Phi Foundation; Laughlin Family; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL111089, R01HL092111, R01HL091244, R01HL088456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K08DK103945, P30DK035816] Funding Source: NIH RePORTER	Our gratitude to Hye Son Yi, who performed the laboratory assays for this report. Research reported in this manuscript was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number K08DK103945 and grants from the National Heart, Lung, and Blood Institute (R01-HL091244, R01-HL092111, R01-HL088456, R01-HL111089), the University of Washington Nutrition and Obesity Research Center (P30 DK035816), and the Locke Charitable Foundation, the Medic One Foundation, the Alpha Phi Foundation, and the Laughlin Family. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; EISENBERG MS, 1980, NEW ENGL J MED, V302, P1379, DOI 10.1056/NEJM198006193022502; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Gilje P, 2014, CRIT CARE, V18, DOI 10.1186/cc13753; Good P., 2000, PERMUTATION TESTS PR; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Kim F, 2005, CIRCULATION, V112, P715, DOI 10.1161/CIRCULATIONAHA.105.544528; Kriegel AJ, 2014, MIR 29 FAMILY GENOMI; Li CW, 2012, CLIN BIOCHEM, V45, P727, DOI 10.1016/j.clinbiochem.2012.04.013; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Ludwig Christian Hinske GSF, 2014, MIRIAD INTEGRATING M; Michels K. B., 2012, EPIGENETIC EPIDEMIOL, P1; Miyachi M, 2010, BIOCHEM BIOPH RES CO, V400, P89, DOI 10.1016/j.bbrc.2010.08.015; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Peng L, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-89; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Stammet P, 2012, CRIT CARE MED, V40, P3209, DOI 10.1097/CCM.0b013e31825fdd5e; Tisherman SA, 2012, CRIT CARE MED, V40, P3321, DOI 10.1097/CCM.0b013e31826536c9; Weng HC, 2011, BIOMED RES-TOKYO, V32, P135, DOI 10.2220/biomedres.32.135	28	7	8	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	SEP	2016	106						96	101		10.1016/j.resuscitation.2016.06.038			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	DT7DT	WOS:000381648000031	27423422	Green Accepted			2022-02-06	
J	Seyer, B; Pham, V; Albiston, AL; Chai, SY				Seyer, Benjamin; Vi Pham; Albiston, Anthony L.; Chai, Siew Yeen			Cannula implantation into the lateral ventricle does not adversely affect recognition or spatial working memory	NEUROSCIENCE LETTERS			English	Article						Memory; Spontaneous alternation; Novel object recognition; Astrocyte; Glial; Cannulation	TRAUMATIC BRAIN-INJURY; SPONTANEOUS-ALTERNATION; GENERAL-ANESTHESIA; AGED RATS; DEFICITS; HIPPOCAMPUS; PERFORMANCE; MENINGITIS; INHIBITION; EXPRESSION	Indwelling cannulas are often used to deliver pharmacological agents into the lateral ventricles of the brain to study their effects on memory and learning, yet little is known about the possible adverse effects of the cannulation itself. In this study, the effect of implanting an indwelling cannula into the right lateral ventricle was examined with respect to cognitive function and tissue damage in rats. Specifically, the cannula passed through sections of the primary motor (M1) and somatosensory hind limb (S1HL) cortices. One week following implantation, rats were impaired on the rotarod task, implying a deficit in fine motor control, likely caused by the passage of the cannula through the aforementioned cortical regions. Importantly, neither spatial working nor recognition memory was adversely affected. Histological examination showed immune cell activation only in the area immediately surrounding the cannulation site and not spreading to other brain regions. Both GFAP and CD-11 b mRNA expression was elevated in the area immediately surrounding the cannulation site, but not in the contralateral hemisphere or the hipp ocampus. Neither of the inflammatory cytokines, TNF-alpha or IL-6, were upregulated in any region. These results show that cannulation into the lateral ventricle does not impair cognition and indicates that nootropic agents delivered via this method are enhancing normal memory rather than rescuing deficits caused by the surgery procedure. (C) 2016 The Authors. Published by Elsevier Ireland Ltd.	[Seyer, Benjamin; Vi Pham; Chai, Siew Yeen] Monash Univ, Biomed Discovery Inst, Fac Biomed & Psychol Sci, Dept Physiol, Clayton, Vic 3800, Australia; [Albiston, Anthony L.] Victoria Univ, Coll Hlth & Biomed, St Albans Campus, Melbourne, Vic 8001, Australia		Chai, SY (corresponding author), Monash Univ, Biomed Discovery Inst, Fac Biomed & Psychol Sci, Dept Physiol, Clayton, Vic 3800, Australia.	siew.chai@monash.edu		Chai, Siew Yeen/0000-0001-7209-4112	National Health and Medical Research Council (NHMRC) AustraliaNational Health and Medical Research Council of Australia; Alzheimer's Australia	The National Health and Medical Research Council (NHMRC) Australia and Alzheimer's Australia funded this work; no conflict of interest was present. S.Y. Chai is an NHMRC Senior Research Fellow.	Albiston AL, 2008, FASEB J, V22, P4209, DOI 10.1096/fj.08-112227; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Bild W., 2013, PROG NEUROPSYCHOPHAR, V43; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Coutellier L, 2011, GENES BRAIN BEHAV, V10, P90, DOI 10.1111/j.1601-183X.2010.00643.x; Crosby C, 2005, ANESTH ANALG, V101, P1389, DOI 10.1213/01.ANE.0000180835.72669.AD; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; de Lima MN, 2006, NEUROSCI LETT, V405, P142, DOI 10.1016/j.neulet.2006.06.044; Frumberg DB, 2007, BRAIN RES, V1144, P209, DOI 10.1016/j.brainres.2007.01.134; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Kelsey A. P., 2012, J NEURAL ENG, V9; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; PARSONS MW, 1992, BEHAV NEURAL BIOL, V57, P90, DOI 10.1016/0163-1047(92)90801-A; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Ren WJ, 2011, NEUROPSYCHOPHARMACOL, V36, P979, DOI 10.1038/npp.2010.236; Shetty AK, 1999, EXP NEUROL, V158, P491, DOI 10.1006/exnr.1999.7107; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Wellmer A, 2000, NEUROSCI LETT, V296, P137, DOI 10.1016/S0304-3940(00)01645-1; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	27	7	7	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 15	2016	628						171	178		10.1016/j.neulet.2016.06.034			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT6JP	WOS:000381590800029	27345383	hybrid			2022-02-06	
J	Broglio, SP; Rettmann, A; Greer, J; Brimacombe, S; Moore, B; Narisetty, N; He, X; Eckner, J				Broglio, S. P.; Rettmann, A.; Greer, J.; Brimacombe, S.; Moore, B.; Narisetty, N.; He, X.; Eckner, J.			Investigating a Novel Measure of Brain Networking Following Sports Concussion	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						concussion; brain network activation (BNA); electrophysiology	TEST-RETEST RELIABILITY; HIGH-SCHOOL FOOTBALL; RECOVERY-TIME; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PROLONGED RECOVERY; NORMATIVE DATA; YOUNG-ADULTS; SYMPTOMS; MANAGEMENT	Clinicians managing sports-related concussions are left to their clinical judgment in making diagnoses and return-to-play decisions. This study was designed to evaluate the utility of a novel measure of functional brain networking for concussion management. 24 athletes with acutely diagnosed concussion and 21 control participants were evaluated in a research laboratory. At each of the 4 post-injury time points, participants completed the Axon assessment of neurocognitive function, a self-report symptom inventory, and the auditory oddball and go/no-go tasks while electroencephalogram (EEG) readings were recorded. Brain Network Activation (BNA) scores were calculated from EEG data related to the auditory oddball and go/no-go tasks. BNA scores were unable to differentiate between the concussed and control groups or by self-report symptom severity. These findings conflict with previous work implementing electrophysiological assessments in concussed athletes, suggesting that BNA requires additional investigation and refinement before clinical implementation.	[Broglio, S. P.] Univ Michigan, Neurotrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Rettmann, A.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Greer, J.; Brimacombe, S.; Moore, B.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Narisetty, N.; He, X.] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Eckner, J.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Broglio, SP (corresponding author), Univ Michigan, Neurotrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	broglio@umich.edu			ElMindA, Ltd.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502] Funding Source: NIH RePORTER	The authors would like to thank Max Zeiger, Samantha Zetlin, Susan Brimbcombe, Richelle Williams MS, ATC and Jeffery Kutcher MD for their assistance with this investigation. The study was funded by ElMindA, Ltd.	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kiefer AW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00243; Kontos AP, BRAIN IMAGI IN PRESS; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leahy S., 2011, US TODAY; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Sefton J. M., 2004, J ATHL TRAINING, V39, pS52; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	61	7	8	0	28	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2016	37	9					714	722		10.1055/s-0042-107250			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DS4UP	WOS:000380777400007	27286176	Green Accepted			2022-02-06	
J	Khajeh, L; Ribbers, GM; Heijenbrok-Kal, MH; Blijdorp, K; Dippel, DWJ; Sneekes, EM; van den Berg-Emons, HJG; van der Lely, AJ; Neggers, SJCMM; van Kooten, F				Khajeh, L.; Ribbers, G. M.; Heijenbrok-Kal, M. H.; Blijdorp, K.; Dippel, D. W. J.; Sneekes, E. M.; van den Berg-Emons, H. J. G.; van der Lely, A. J.; Neggers, S. J. C. M. M.; van Kooten, F.			The effect of hypopituitarism on fatigue after subarachnoid hemorrhage	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						fatigue; growth hormone deficiency; hypopituitarism; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; PITUITARY DYSFUNCTION; SEVERITY SCALE; DEFICIENCY; PREDICTORS; OUTCOMES	Background and purposeAneurysmal subarachnoid hemorrhage (SAH) survivors often complain of fatigue, which is disabling. Fatigue is also a common symptom of pituitary dysfunction (PD), in particular in patients with growth hormone deficiency (GHD). A possible association between fatigue after SAH and long-term pituitary deficiency in SAH survivors has not yet been established. MethodsA single center observational study was conducted amongst 84 aneurysmal SAH survivors to study the relationship between PD and fatigue over time after SAH, using mixed model analysis. Fatigue was measured with the Fatigue Severity Scale and its relationships with other clinical variables were studied. ResultsThree-quarters of respondents (76%) have pathological fatigue directly after SAH and almost two-thirds (60%) of patients still have pathological levels of fatigue after 14 months. The severity of SAH measured with a World Federation of Neurosurgical Societies (WFNS) score higher than 1 (P = 0.008) was associated with long-term fatigue. There is no statistically significant effect of PD (P = 0.8) or GHD (P = 0.23) on fatigue in SAH survivors over time. ConclusionsFatigue is a common symptom amongst SAH survivors. WFNS is a usable clinical determinant of fatigue in SAH survivors. Neither PD nor GHD has a significant effect on long-term fatigue after SAH.	[Khajeh, L.; Dippel, D. W. J.; van Kooten, F.] Erasmus Univ, Endocrinol Sect, Dept Neurol, Med Ctr Rotterdam, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands; [Ribbers, G. M.; Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.] Erasmus Univ, Dept Rehabil, Med Ctr, Rotterdam, Netherlands; [Ribbers, G. M.; Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.] Rijndam Rehabil Ctr Rotterdam, Rotterdam, Netherlands; [Blijdorp, K.; van der Lely, A. J.; Neggers, S. J. C. M. M.] Erasmus Univ, Dept Med, Sect Endocrinol, Med Ctr Rotterdam, Rotterdam, Netherlands		Khajeh, L (corresponding author), Erasmus Univ, Endocrinol Sect, Dept Neurol, Med Ctr Rotterdam, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	l.khajeh@erasmusmc.nl	Dippel, Diederik/AAJ-2192-2020; Ribbers, Gerard M/C-1454-2014; Ribbers, Gerard/N-3623-2019	Dippel, Diederik/0000-0002-9234-3515; Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	Dutch Brain Foundation; PfizerPfizer	Dutch Brain Foundation; Pfizer.	Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Blijdorp K, 2013, EUR J ENDOCRINOL, V169, P497, DOI 10.1530/EJE-13-0436; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Krupp L, 2006, MULT SCLER J, V12, P367, DOI 10.1191/135248506ms1373ed; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; Passier PECA, 2011, J NEUROL, V258, P1091, DOI 10.1007/s00415-010-5891-y; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P772, DOI 10.1136/jnnp.72.6.772; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277	21	7	9	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	AUG	2016	23	8					1269	1274		10.1111/ene.13014			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR7TJ	WOS:000380102300012	27128968				2022-02-06	
J	Liou, DZ; Singer, MB; Barmparas, G; Harada, MY; Mirocha, J; Bukur, M; Salim, A; Ley, EJ				Liou, D. Z.; Singer, M. B.; Barmparas, G.; Harada, M. Y.; Mirocha, J.; Bukur, M.; Salim, A.; Ley, E. J.			Insulin-dependent diabetes and serious trauma	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Diabetes mellitus; Insulin dependent; Trauma; Mortality	CRITICALLY-ILL PATIENTS; BRAIN-INJURY; MONONUCLEAR-CELLS; GLUCOSE CONTROL; DATA-BANK; MORTALITY; HYPERGLYCEMIA; THERAPY; IMPACT	Trauma patients with diabetes mellitus (DM) represent a unique population as the acute injury and the underlying disease may both cause hyperglycemia that leads to poor outcomes. We investigated how insulin-dependent DM (IDDM) and noninsulin-dependent DM (NIDDM) impact mortality after serious trauma without brain injury. The National Trauma Data Bank (NTDB) version 7.0 was queried for all patients with moderate to severe traumatic injury [injury severity score (ISS) > 9]. Patients were excluded if missing data, age < 10 years, severe brain injury [head abbreviated injury scale (AIS) > 3], dead on arrival or any AIS = 6. Logistic regression modeled the association between DM and mortality as well as IDDM, NIDDM and mortality. Overall 166,103 trauma patients without brain injury were analyzed. Mortality was 7.6 and 4.4 % in patients with and without DM, respectively (p < 0.01). Mortality was 9.9 % for patients with IDDM and 6.7 % for NIDDM (p < 0.01). The increased mortality associated with DM was only significantly higher for DM patients in their forties (5.6 vs. 3.3 %, p < 0.01). Regression analyses demonstrated that DM (AOR 1.14, p = 0.04) and IDDM (AOR 1.46, p < 0.01) were predictors of mortality compared to no DM, but NIDDM was not (AOR 1.02, p = 0.83). While DM was a predictor for higher mortality after serious trauma, this increase was only observed in IDDM and not NIDDM. Our findings suggest IDDM patients who present after serious trauma are unique and attention to their hyperglycemia and related insulin therapy may play a critical role in recovery.	[Liou, D. Z.; Singer, M. B.; Barmparas, G.; Harada, M. Y.; Mirocha, J.; Ley, E. J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Bukur, M.] Delray Med Ctr, Dept Trauma & Crit Care, Delray Beach, FL USA; [Bukur, M.] Broward Gen Med Ctr, Ft Lauderdale, FL USA; [Salim, A.] Brigham & Womens Hosp, Dept Surg, Div Trauma Burn & Surg Crit Care, 75 Francis St, Boston, MA 02115 USA		Barmparas, G (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA.	Galinos.Barmparas@cshs.org	Barmparas, Galinos/L-6530-2019				Aljada A, 2002, J CLIN ENDOCR METAB, V87, P1419, DOI 10.1210/jc.87.3.1419; [Anonymous], 2011, INJ CTR OV; [Anonymous], 2011, NTDB ANN REP 2011; [Anonymous], 2011, STAT DIAB; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Eardley DD, 1950, J IMMUNOL BALTIM MD, V1986, P3994; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Salim A, 2009, AM SURGEON, V75, P25; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72	20	7	8	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2016	42	4					491	496		10.1007/s00068-015-0561-5			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DS3WD	WOS:000380712500015	26253885				2022-02-06	
J	Slomine, BS; Grasmick, PH; Suskauer, SJ; Salorio, CF				Slomine, Beth S.; Grasmick, Paige H.; Suskauer, Stacy J.; Salorio, Cynthia F.			Psychometric Properties of the Cognitive and Linguistic Scale: A Follow-Up Study	REHABILITATION PSYCHOLOGY			English	Article						assessment; brain injury; children and adolescents; cognition; rehabilitation	TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; YOUNG-ADULTS; CHILDREN; WEEFIM; STATE	Objective: In a pediatric rehabilitation setting, monitoring recovery of cognitive skills is challenging due to diversity in age and brain injury severity. The Cognitive and Linguistic Scale (CALS) is a measure with promising psychometric properties that was designed for inpatient pediatric rehabilitation care. This study re-examines the reliability and validity of the CALS in a larger, independent sample. Method: Two hundred fifty-eight children (2-21 years) who were consecutively admitted to an inpatient brain injury facility between 2008 and 2014 for a first inpatient rehabilitation admission following a traumatic or acquired brain injury were included. Both CALS and Functional Independence Measure for Children (WeeFIM) were examined at admission and discharge. CALS scores by age groups (preschool-aged, school-aged, adolescents, or young adults), gender, and etiology (acquired vs. traumatic brain injury) and in two subgroups. Results: The internal consistency of the CALS was high. Total CALS score and individual item scores improved significantly between admission and discharge for children of all age groups, both genders, both traumatic and acquired etiologies, and in subgroups with limited responsiveness and no change on the WeeFIM cognitive domain. No age group had a floor or ceiling effect. Correlations with the WeeFIM were high. Factor analysis revealed 2 factors (basic responding and higher-level cognitive skills). Conclusions: The CALS has strong psychometric properties across a wide range of ages, brain injury etiologies, and cognitive severity. The CALS can be used to track cognitive and linguistic recovery in children, adolescents, and young adults with brain injury during inpatient rehabilitation. Impact and Implications A preliminary study found that the Cognitive and Linguistic Scale (CALS) had adequate psychometric properties. This follow up study explores the psychometric properties of the CALS in a larger, independent sample. This study confirms that the psychometric properties of the CALS are strong even with preschool-aged children and those with a range of cognitive severity following traumatic or acquired brain injury. Psychologists working in an inpatient pediatric rehabilitation facility should consider using the CALS as a tool to assess and track cognitive recovery over time.	[Slomine, Beth S.; Salorio, Cynthia F.] Kennedy Krieger Inst, Dept Neuropsychol, 707 North Broadway, Baltimore, MD 21205 USA; [Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21218 USA; [Grasmick, Paige H.] Sinai Hosp Baltimore, Baltimore, MD USA; [Suskauer, Stacy J.] Kennedy Krieger Inst, Dept Pediat Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.; Salorio, Cynthia F.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA		Slomine, BS (corresponding author), Kennedy Krieger Inst, Dept Neuropsychol, 707 North Broadway, Baltimore, MD 21205 USA.	slomine@kennedykrieger.org					ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Cohen J., 2013, STAT POWER ANAL BEHA; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; Donders J, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P91; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Haley SM, 2010, PEDIATR PHYS THER, V22, P69, DOI 10.1097/PEP.0b013e3181cbfbf6; Hotz G., 2010, PEDIAT TEST BRAIN IN; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Randolph C., 2012, RBANS UPDATE REPEATA; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Uniform Data System for Medical Rehabilitation, 2006, WEEFIM 2 CLIN GUID V; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	18	7	7	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2016	61	3					328	335		10.1037/rep0000096			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	DV9HR	WOS:000383251900012	27196853				2022-02-06	
J	Stead, TS; Rastogi, V; Hedna, VS; Ganti, L				Stead, Thor S.; Rastogi, Vaibhav; Hedna, Vishnumurthy S.; Ganti, Latha			Awareness of the CDC "Heads Up!" to Youth Sports Campaign among Pediatric Sports Coaches: A Pilot Survey Study	CUREUS			English	Article						concussion awareness; concussion; sports medicine; centers for disease control	CONCUSSION; MANAGEMENT	Objectives: This study sought to: 1) estimate the penetrance (in terms of youth coaches being aware of them) of the CDC "Heads Up!" guidelines, 2) determine whether these guidelines changed the coaches' practice, and 3) understand whether these guidelines resulted in a perceived decrease in the number of concussions. Methods: This was a cross-sectional survey of pediatric sports coaches in the United States designed to assess the impact of the CDC "Heads Up!" guidelines. "Heads Up!" Concussion in Youth Sports is a free, online course available to coaches, parents, and others helping to keep athletes safe from concussions. The "Heads Up!" fact sheet provides important information on preventing, recognizing, and responding to a concussion. Results: Half the cohort had heard of the CDC "Heads Up!" campaign. Fifty-five percent of the cohort thought that pediatric concussions in youth sports was a "big deal" (rated on a Likert scale from 1-10). Coaches who were also parents (58%) were significantly more likely to have heard of the campaign (P=0.0032, 95% CI=0.1153-0.5513). Having heard of the " Heads Up!" campaign was significantly associated with how important coaches thought pediatric concussions are (P=0.0133, 95% CI=0.0590-0.4960), as was higher income of the coaches (P=0.0100), and this was significantly correlated with the coach being more likely to call the athlete's parent at injury (P=0.0030, 95% CI=0.1160-0.5471). Coaches of football/soccer were significantly more likely to think pediatric concussions were a " big deal" (P=0.0021,95% CI=0.1374-0.5947). More than a third of coaches 35% reported that the " Heads Up!" campaign decreased the number of concussions on their team.	[Stead, Thor S.] Univ Cent Florida, Coll Math, Orlando, FL 32816 USA; [Rastogi, Vaibhav] UCF, Dept Med, Orlando, FL USA; [Hedna, Vishnumurthy S.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Ganti, Latha] UCF Coll Med, Clin Sci, Orlando, FL USA		Ganti, L (corresponding author), UCF Coll Med, Clin Sci, Orlando, FL USA.	latha.ganti@ucf.edu	Ganti, Latha/AAF-6268-2020	Ganti, Latha/0000-0001-7717-3864			[Anonymous], 1996, BRIT MED J, V313, P1448; Bressan S, 2016, J PAEDIATR CHILD H, V52, P151, DOI 10.1111/jpc.12967; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Provance AJ, 2016, ORTHOPEDICS, V39, P24, DOI 10.3928/01477447-20151218-13; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	16	7	7	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	AUG	2016	8	8							e755	10.7759/cureus.755			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VH6EK	WOS:000453614700039	27733960	gold, Green Published			2022-02-06	
J	Tenyi, D; Gyimesi, C; Horvath, R; Kovacs, N; Abraham, H; Darnai, G; Fogarasi, A; Buki, A; Janszky, J				Tenyi, Dalma; Gyimesi, Csilla; Horvath, Reka; Kovacs, Norbert; Abraham, Hajnalka; Darnai, Gergely; Fogarasi, Andras; Buki, Andras; Janszky, Jozsef			Concussive convulsions: A YouTube video analysis	EPILEPSIA			English	Article						Concussive convulsion; Nonepileptic seizure; Brain trauma; Seizure semiology	EPILEPTIC SEIZURES; BRAIN-INJURY; MOTOR; MANIFESTATIONS; SYNCOPE; TOOL	Objective: To analyze seizure-like motor phenomena immediately occurring after concussion (concussive convulsions). Methods: Twenty-five videos of concussive convulsions were obtained from YouTube as a result of numerous sports-related search terms. The videos were analyzed by four independent observers, documenting observations of the casualty, the head injury, motor symptoms of the concussive convulsions, the postictal period, and the outcome. Results: Immediate responses included the fencing response, bear hug position, and bilateral leg extension. Fencing response was the most common. The side of the hit (p = 0.039) and the head turning (p = 0.0002) was ipsilateral to the extended arm. There was a tendency that if the blow had only a vertical component, the bear hug position appeared more frequently (p = 0.12). The motor symptom that appeared with latency of 6 +/- 3 s was clonus, sometimes superimposed with tonic motor phenomena. Clonus was focal, focally evolving bilateral or bilateral, with a duration of 27 +/- 19 s (5-72 s). Where lateralization of clonus could be determined, the side of clonus and the side of hit were contralateral (p = 0.039). Significance: Concussive convulsions consist of two phases. The short-latency first phase encompasses motor phenomena resembling neonatal reflexes and may be of brainstem origin. The long-latency second phase consists of clonus. We hypothesize that the motor symptoms of the long-latency phase are attributed to cortical structures; however, they are probably not epileptic in origin but rather a result of a transient cortical neuronal disturbance induced by mechanical forces.	[Tenyi, Dalma; Gyimesi, Csilla; Horvath, Reka; Kovacs, Norbert; Darnai, Gergely; Janszky, Jozsef] Univ Pecs, Dept Neurol, Ret U 2, H-7632 Pecs, Hungary; [Kovacs, Norbert; Janszky, Jozsef] PTE MTA Clin Neurosci MR Res Grp, Pecs, Hungary; [Abraham, Hajnalka] Univ Pecs, Dept Med Biol, Pecs, Hungary; [Fogarasi, Andras] Bethesda Childrens Hosp, Epilepsy Ctr, Budapest, Hungary; [Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary		Janszky, J (corresponding author), Univ Pecs, Dept Neurol, Ret U 2, H-7632 Pecs, Hungary.	jozsef.janszky@aok.pte.hu	Kovacs, Norbert/A-8775-2011	Kovacs, Norbert/0000-0002-7332-9240	Hungarian Brain Research Program [KTIA_13_NAP-A-II/9,11]; Bolyai Fellowship of the Hungarian Academy of Science	Jozsef Janszky and Hajnalka Abraham were supported by the Hungarian Brain Research Program, Grant No. KTIA_13_NAP-A-II/9,11. Norbert Kovacs was supported by the Bolyai Fellowship of the Hungarian Academy of Science.	Brna PM, 2013, EPILEPSY BEHAV, V29, P305, DOI 10.1016/j.yebeh.2013.08.003; Conradsen I, 2011, EPILEPSIA, V52, P2125, DOI 10.1111/j.1528-1167.2011.03286.x; Fat MJL, 2011, J CHILD NEUROL, V26, P804, DOI 10.1177/0883073811402345; Fogarasi A, 2006, NEUROLOGY, V66, P271, DOI 10.1212/01.wnl.0000194220.06251.53; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; GASTAUT H, 1957, LANCET, V2, P1018; Hamer HM, 2002, EPILEPSY RES, V51, P155, DOI 10.1016/S0920-1211(02)00104-3; Horvath R, 2008, IDEGGYOGY SZEMLE, V61, P231; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Janszky J, 2004, J NEUROL NEUROSUR PS, V75, P773, DOI 10.1136/jnnp.2003.020941; Janszky J, 2001, EPILEPSY RES, V43, P125, DOI 10.1016/S0920-1211(00)00186-8; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; LIN JTY, 1982, ANN NEUROL, V11, P525, DOI 10.1002/ana.410110513; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; Muhammed L, 2014, EPILEPSY BEHAV, V37, P221, DOI 10.1016/j.yebeh.2014.06.003; Nass RD, 2011, FORTSCHR NEUROL PSYC, V79, P655, DOI 10.1055/s-0031-1281688; Sander JWAS, 1997, BRIT MED J, V314, P158, DOI 10.1136/bmj.314.7075.158; THEODORE WH, 1994, NEUROLOGY, V44, P1403, DOI 10.1212/WNL.44.8.1403; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; WYLLIE E, 1986, NEUROLOGY, V36, P606, DOI 10.1212/WNL.36.5.606	22	7	7	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	AUG	2016	57	8					1310	1316		10.1111/epi.13432			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS4KP	WOS:000380750300021	27334642				2022-02-06	
J	Vatsyayan, A; Adhyapok, AK; Debnath, SC; Malik, K				Vatsyayan, Ashutosh; Adhyapok, Apurba Kumar; Debnath, Subhas Chandra; Malik, Kapil			Reconstruction and rehabilitation of short-range gunshot injury to lower part of face: A systematic approach of three cases	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Maxillofacial injuries; Wounds; Gunshot; Firearms		Gunshot injuries are always known to cause severe morbidity and mortality when head and neck are involved. They vary in morbidity, which can occur in civilian surroundings. The wound largely depends on the type of weapon, mass and velocity of the bullet, and the distance from where it has been shot. Close-range gunshot wounds in the head and neck region can result in devastating aesthetic and functional impairment. The complexity in facial skeletal anatomy cause multiple medical and surgical challenges to an operating surgeon, demanding elaborate soft and hard tissue reconstruction. Here we presented the successful management of three patients shot by short-range pistol with basic life support measures, wound management, reconstruction and rehabilitation. (C) 2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V.	[Vatsyayan, Ashutosh; Adhyapok, Apurba Kumar; Debnath, Subhas Chandra; Malik, Kapil] Reg Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Gauhati 781032, Assam, India		Vatsyayan, A (corresponding author), Reg Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Gauhati 781032, Assam, India.	dental@live.in					Baig Moghees A, 2002, Ann R Australas Coll Dent Surg, V16, P123; Bartlett C S, 2000, J Am Acad Orthop Surg, V8, P21; Clark N, 1996, PLAST RECONSTR SURG, V98, P583, DOI 10.1097/00006534-199609001-00001; DEMUTH WE, 1971, J TRAUM, V11, P219, DOI 10.1097/00005373-197103000-00003; Futran ND, 2005, OTOLARYNG HEAD NECK, V132, P75, DOI 10.1016/j.otohns.2004.08.013; GRUSS JS, 1991, PLAST RECONSTR SURG, V87, P436, DOI 10.1097/00006534-199103000-00008; Hollier L, 2001, J ORAL MAXIL SURG, V59, P277, DOI 10.1053/joms.2001.20989; KIHTIR T, 1993, J TRAUMA, V35, P569, DOI 10.1097/00005373-199310000-00012; LINDSEY D, 1980, J TRAUMA, V20, P1068, DOI 10.1097/00005373-198012000-00012; Mohan R, 2009, J CRANIOFAC SURG, V20, P21, DOI 10.1097/SCS.0b013e318190327a; Motamedi MHK, 2007, J ORAL MAXIL SURG, V65, P1215, DOI 10.1016/j.joms.2007.03.001; Newgard K., 1992, WOUND BALLISTICS REV, V1, P12; OLDING M, 1993, ANN PLAS SURG, V31, P82; ORDOG GJ, 1994, J TRAUMA, V36, P106, DOI 10.1097/00005373-199401000-00017; Osborne TE, 1991, ORAL MAXILLOFACIAL T, V2, P672; Shelton DW, 1992, PETERSONS PRINCIPLES, V2, P596; Suominen E, 2001, CLIN PLAST SURG, V28, P323; THORNE CH, 1992, CLIN PLAST SURG, V19, P233; Vayvada H, 2005, J CRANIOFAC SURG, V16, P794, DOI 10.1097/01.scs.0000180014.06352.65; VITKUS K, 1990, J RECONSTR MICROSURG, V6, P279, DOI 10.1055/s-2007-1006831	20	7	7	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2016	19	4					239	243		10.1016/j.cjtee.2016.01.016			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1PQ	WOS:000442109000013	27578384	gold, Green Published			2022-02-06	
J	Washington, PM; Burns, MP				Washington, Patricia M.; Burns, Mark P.			The Effect of the APOE4 Gene on Accumulation of A beta(40) After Brain Injury Cannot Be Reversed by Increasing apoE4 Protein	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						beta-Amyloid; Apolipoprotein E (apoE); Traumatic brain injury (TBI)	AMYLOID BETA-PROTEIN; TRAUMA-INDUCED INCREASES; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; TERM SURVIVORS; DEPOSITION; PEPTIDE; CLEARANCE; IMPACT; PATHOLOGY	The apolipoprotein E (apoE) protein is involved in clearance of beta-amyloid (A beta) from the brain; and the APOE4 gene is associated with A beta plaque formation in humans following traumatic brain injury (TBI). Here, we examined the association between apoE and A beta(40) after experimental TBI and the effects of APOE alleles on this relationship. We report a biphasic response of soluble apoE protein after TBI with an acute reduction at 1 day postinjury followed by an increase at 7 days postinjury. TBI-induced A beta(40) levels decreased as soluble apoE levels increased. In APOE4 mice there was a diminished apoE response to TBI that corresponded to prolonged accumulation of TBI-induced A beta(40) versus that in APOE3 mice. Amyloid precursor protein processing was similar in APOE3 and APOE4 mice suggesting that impaired clearance was responsible for the abnormal accumulation of A beta(40) in the latter. Treatment of APOE4 mice with bexarotene for 7 days increased apoE4 protein levels but was not sufficient to reduce TBI-induced A beta(40). Thus, rapid clearance of TBI-induced A beta(40) occurs in mice but these pathways are impaired in APOE4 carriers. These data may help explain the deposition of Ab in APOE4 carriers and the increased incidence of brain Ab plaques following TBI.	[Washington, Patricia M.; Burns, Mark P.] Georgetown Univ, Med Ctr, Lab Brain Injury & Dementia, Dept Neurosci, Washington, DC 20007 USA		Burns, MP (corresponding author), Georgetown Univ, Dept Neurosci, Med Ctr, New Res Bldg WP22a,3970 Reservoir Rd NW, Washington, DC 20007 USA.	mpb37@georgetown.edu		Burns, Mark P/0000-0003-4750-2000	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081068, T32NS041218] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS081068, T32 NS041218] Funding Source: Medline		Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bennett RE, 2013, J NEUROPATH EXP NEUR, V72, P396, DOI 10.1097/NEN.0b013e31828e24ab; Beraud D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00080; Cartagena CM, 2008, J NEUROTRAUM, V25, P1087, DOI 10.1089/neu.2007.0444; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corona AW, 2016, J NEUROIMMUNE PHARM, V11, P61, DOI 10.1007/s11481-015-9627-8; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Hartman RE, 2002, J NEUROSCI, V22, P10083; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; REBECK GW, 1993, NEURON, V11, P575; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tai LM, 2014, J BIOL CHEM, V289, P30538, DOI 10.1074/jbc.M114.600833; Tamboli IY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093120; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456	46	7	7	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	AUG	2016	75	8					770	778		10.1093/jnen/nlw049			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	DV9KT	WOS:000383260100006	27297672	Green Published, hybrid			2022-02-06	
J	Lin, YN; Hwang, HF; Chen, YJ; Cheng, CH; Liang, WM; Lin, MR				Lin, Yen-Nung; Hwang, Hei-Fen; Chen, Yi-Ju; Cheng, Chui-Hsuan; Liang, Wen-Miin; Lin, Mau-Roung			Suitability of the Quality of Life after Brain Injury Instrument for Older People with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						psychometrics; quality of life; Taiwan; traumatic brain injury	MINI-MENTAL-STATE; QOLIBRI; HEALTH; SCALE; VALIDATION; MORTALITY; AGE	We prospectively investigated the psychometric properties of the Quality of Life after Brain Injury (QOLIBRI) instrument among older patients with traumatic brain injury (TBI). The 37-item QOLIBRI comprises six domains (cognition, self, daily life and autonomy, social relationships, emotions, and physical problems). We recruited 333 patients >= 60 years of age with TBI from the neurosurgery clinics and emergency departments of three hospitals in Taipei, Taiwan. The ceiling and floor values for most QOLIBRI domains were <5%, and the internal consistency and test-retest reliability ranged from 0.84 to 0.97 and 0.83 to 0.96, respectively. For the known-groups validity, patients with TBI attained lower scores for all QOLIBRI domains, except physical problems, compared with those with soft-tissue injuries. Patients with intact cognition who had higher levels on the Glasgow Outcome Scale Extended (GOSE) and the Glasgow Coma Scale, fewer limitations in activities of daily living, and fewer chronic conditions obtained higher scores for almost all the QOLIBRI domains, compared with their counterparts. For convergent validity, the correlation coefficients for the QOLIBRI domains and the selected functional measures conceptually related to that domain were all >= 0.4. A confirmatory factor analysis revealed that the original six-domain structure fit the data with a comparative fit index of >= 0.9. Effect sizes for changes in the GOSE over a 6-month follow-up period were clinically meaningful (>= 0.2) for all the QOLIBRI domains except emotions. For older people with TBI, the use of the QOLIBRI is generally appropriate, and adding the domain of environment to the scale would be beneficial.	[Lin, Yen-Nung; Lin, Mau-Roung] Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 11031, Taiwan; [Lin, Yen-Nung] Wan Fang Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hwang, Hei-Fen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Chen, Yi-Ju] Cathay Gen Hosp, Dept Nursing, Taipei, Taiwan; [Cheng, Chui-Hsuan] Buddhist Tzu Chi Gen Hosp, Dept Emergency Med, Taichung Branch, Taichung, Taiwan; [Liang, Wen-Miin] China Med Univ, Ctr Biostat, Taichung, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 11031, Taiwan.	mrlin@tmu.edu.tw	Lin, Yen-Nung/J-5278-2019; Cheng, Chui-Hsuan/AAY-4057-2020	Lin, Yen-Nung/0000-0002-7350-503X; 			BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bogner J, 2010, ARCH PHYS MED REHAB, V91, pS66, DOI 10.1016/j.apmr.2009.11.032; CASSILETH BR, 1984, NEW ENGL J MED, V311, P506, DOI 10.1056/NEJM198408233110805; Chang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038079; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hwang HF, 2003, AGE AGEING, V32, P593, DOI 10.1093/ageing/afg102; Kessel B, 2001, AGE AGEING, V30, P121, DOI 10.1093/ageing/30.2.121; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAWTON MP, 1983, GERONTOLOGIST, V23, P349, DOI 10.1093/geront/23.4.349; Lin M-R, 1999, CHINESE J PUBLIC HLT, V18, P262; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ormel J, 1997, PSYCHOL MED, V27, P1065, DOI 10.1017/S0033291797005321; Sedikides C, 2007, FRONT SOC PSYCHOL, P163; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Stewart A.L., 1996, QUALITY LIFE PHARMAC, P819; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yu DSF, 2004, RES NURS HEALTH, V27, P135, DOI 10.1002/nur.20008	39	7	7	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1363	1370		10.1089/neu.2015.4094			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100008	26482926				2022-02-06	
J	Budisin, B; Bradbury, CCLB; Sharma, B; Hitzig, SL; Mikulis, D; Craven, C; McGilivray, C; Corbie, J; Green, RE				Budisin, Bojana; Bradbury, Cheryl C. L. B.; Sharma, Bhanu; Hitzig, Sander L.; Mikulis, David; Craven, Cathy; McGilivray, Colleen; Corbie, Jasmine; Green, Robin E.			Traumatic Brain Injury in Spinal Cord Injury: Frequency and Risk Factors	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computed tomography; dual diagnosis; magnetic resonance imaging; neuroimaging; neurological indices; neuropsychology; traumatic spinal cord injury; traumatic brain injury	CLOSED HEAD-INJURY; REORGANIZATION; TBI; CONSCIOUSNESS; INTEGRITY; ATROPHY	Background: The frequency of traumatic brain injury (TBI) co-occurring with traumatic spinal cord injury (tSCI) is unclear despite a number of past studies; as well, limited research has examined predictors of co-morbid TBI in tSCI patients. Objectives: (1a) To summarize past literature on comorbid diagnosis of TBI in tSCI in order to reexamine the frequency of dual diagnosis in a study designed to obviate past methodological limitations; (1b) to compare dual-diagnosis frequency with vs without the inclusion of diagnostically ambiguous cases; and (2) to measure risk factors for tSCI and comorbid TBI. Methods: Ninety-one of 135 eligible adults with tSCI, 3 to 6 months postinjury, were prospectively recruited from a tertiary inpatient tSCI rehabilitation program. TBI diagnosis was based on comprehensive, validated clinical neurological and neuroimaging measures. Results: Objective 1: 39.6% of the tSCI patients sustained a concomitant TBI, but when ambiguous cases were removed from analysis, frequency rose to 58.1%. Objective 2: Motor vehicle collisions were most likely to yield a comorbid TBI diagnosis, but 31.6% of falls also resulted in TBI. Patients with cervical and thoracic injuries showed a very similar frequency of comorbid TBI. Conclusions: Varied methodological approaches, particularly the decision to include/exclude ambiguous cases, likely explain disparate past estimates of TBI in tSCI. However, even this study's lower frequency estimate, at nearly 40%, is clinically important. The prevailing assumption that dual diagnosis is less common in thoracic than cervical spine injuries was not supported. Finally, while comorbid TBI most frequently occurred in motor vehicle collisions, nearly a third of tSCIs sustained in falls resulted in comorbid TBI in our sample.	[Budisin, Bojana; Bradbury, Cheryl C. L. B.; Sharma, Bhanu; Craven, Cathy; McGilivray, Colleen; Corbie, Jasmine; Green, Robin E.] Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Hitzig, Sander L.] Fac Med, Inst Life Course & Aging, Toronto, ON, Canada; [Mikulis, David] Toronto Western Hosp, Univ Hlth Network, Toronto, ON, Canada		Green, RE (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	robin.green@uhn.ca	Mikulis, David J/H-5167-2019; Hitzig, Sander/AAN-2287-2020; Craven, Beverley/D-5001-2015	Green, Robin/0000-0001-9451-3963; Craven, Beverley/0000-0001-8234-6803; Mikulis, David/0000-0003-3956-0892	Ontario Neurotrauma Foundation [2005-ABI-392]; Canada Research Chairs ProgramCanada Research Chairs	This work was supported by the Ontario Neurotrauma Foundation (grant no. 2005-ABI-392) and by the Canada Research Chairs Program.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Elovic E, 1999, TOP SPINAL CORD INJ, V5, P1, DOI DOI 10.1310/V75J-RE76-20GH-X7BY; Faul M, 2010, TRAUMATIC BRAIN INJU; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Ghobrial GM, 2014, CLIN NEUROL NEUROSUR, V123, P174, DOI 10.1016/j.clineuro.2014.05.013; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Harris P, 1968, Paraplegia, V5, P215; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MAYNARD FM, 1979, J NEUROSURG, V50, P611, DOI 10.3171/jns.1979.50.5.0611; PAGNI CA, 1991, ACTA NEUROCHIR, V111, P1, DOI 10.1007/BF01402506; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Scheuneman A, 1982, SPINAL CORD INJURY D, V4, P35; SCI MSDo, 2012, NAT SPIN CORD INJ DA; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; TEASDALE G, 1974, LANCET, V2, P81; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; WAGNER PD, 1983, BIOCHEMISTRY-US, V22, P1334, DOI 10.1021/bi00275a003; Watanabe T, 1999, TOP SPINAL CORD INJ, V5, P83; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0	45	7	7	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					E33	E42		10.1097/HTR.0000000000000153			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000004	26394288				2022-02-06	
J	Czuba, KJ; Kersten, P; Kayes, NM; Smith, GA; Barker-Collo, S; Taylor, WJ; McPherson, KM				Czuba, Karol J.; Kersten, Paula; Kayes, Nicola M.; Smith, Greta A.; Barker-Collo, Suzanne; Taylor, William J.; McPherson, Kathryn M.			Measuring Neurobehavioral Functioning in People With Traumatic Brain Injury: Rasch Analysis of Neurobehavioral Functioning Inventory	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; measurement; neurobehavioral functioning; Rasch analysis; traumatic brain injury	OUTCOME MEASURES; ACUTE PREDICTORS; POPULATION; DISABILITY; RECOMMENDATIONS; PERSPECTIVES; RETURN; MODEL; SCALE	Objective: To examine internal construct validity of the Neurobehavioral Functioning Inventory (NFI) by applying Rasch analysis. Setting: An outpatient rehabilitation program trial in New Zealand employing a goal-setting intervention in people with traumatic brain injury (TBI). Participants: One hundred eight people (mean age = 46 years; 73% male) between 6 months and 5 years post-TBI. Design: Rasch analysis of the NFI (Partial Credit Model). Results: Three NFI subscales were not unidimensional and at least 4 items in each subscale had disordered response categories. Two items showed differential item functioning by age, 1 item by educational attainment, and 2 items were found to misfit the overall construct. These items were excluded from the total score calculation. The revised scale fit the Rasch model and supported the internal construct validity of the NFI. Conclusions: Current scoring of the NFI subscales for people with TBI in New Zealand does not meet the requirements of the Rasch model. The revised version of NFI can improve the interpretation of scores but should be further tested with people with TBI in other settings.	[Czuba, Karol J.; Kersten, Paula; Kayes, Nicola M.; Smith, Greta A.; McPherson, Kathryn M.] Auckland Univ Technol, Person Ctr Res Ctr, 90 Akoranga Dr, Auckland 0627, North Island, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Ctr Brain Res, Auckland, New Zealand; [Taylor, William J.] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand		Czuba, KJ (corresponding author), Auckland Univ Technol, Person Ctr Res Ctr, 90 Akoranga Dr, Auckland 0627, North Island, New Zealand.	kczuba@aut.ac.nz		McPherson, Kathryn/0000-0003-1240-8882; McPherson, Kath/0000-0003-0487-8497	Research Council of New Zealand; AUT University Strategic Research Investment Fund; Laura Fergusson Trust Auckland	The Health Research Council of New Zealand funded the primary study, AUT University Strategic Research Investment Fund funded Karol Czuba's time on the analysis described in this paper. Kathryn M McPherson's position is part funded by the Laura Fergusson Trust Auckland.	ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Andrich D., 2010, RUMM2030 COMPUTER SO; Andrich D, 1988, RASCH MODELS MEASURE, V68; Bond T, 2001, APPL RASCH MODEL FUN; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Corty Eric, 2007, USING INTERPRETING S; Cusimano MD, 2014, J HEAD TRAUMA REHAB, V29, P172, DOI 10.1097/HTR.0b013e31827c7d15; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Friedly J, 2014, ARCH PHYS MED REHAB, V95, P1419, DOI 10.1016/j.apmr.2014.03.022; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GOODWIN LD, 1991, RES NURS HEALTH, V14, P235, DOI 10.1002/nur.4770140311; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Happell B, 2012, INT J MENT HEALTH NU, V21, P131, DOI 10.1111/j.1447-0349.2011.00777.x; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jepson RG, 2007, SOC SCI MED, V65, P890, DOI 10.1016/j.socscimed.2007.04.009; KERSTEN P, 2011, NZ J PHYSIOTHERAPY, V39, P92; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Linacre, 1992, RASCH MEASUREMENT T, V6, P233; Marais Ida, 2008, J Appl Meas, V9, P105; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rasch G., 1960, PROBABILISTIC MODELS; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Stevens AM, 2005, SUPPORT CARE CANCER, V13, P1027, DOI 10.1007/s00520-005-0815-6; Streiner DL., 2008, HLTH MEASUREMENT SCA; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tennant A., 2006, RASCH MEAS T, V20, P1048; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; WAINER H, 1987, J EDUC MEAS, V24, P185, DOI 10.1111/j.1745-3984.1987.tb00274.x; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Woltmann EM, 2010, PSYCHIATR REHABIL J, V34, P29, DOI 10.2975/34.1.2010.29.36; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; [No title captured]; [No title captured]	42	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					E59	E68		10.1097/HTR.0000000000000170			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000007	26394297	Green Published			2022-02-06	
J	Dowling, KA; Goodrich, JT				Dowling, Kamilah A.; Goodrich, James Tait			Two cases of 16th century head injuries managed in royal European families	NEUROSURGICAL FOCUS			English	Article						Ambroise Pare; Andreas Vesalius; Berengario da Carpi; Henry II; Lorenzo de Medici; head injury; traumatic injury; history of neurosurgery	HENRY-II; FRANCE; DEATH	In Europe, during the 16th century, there were a number of prominent general surgeons adventurous enough to consider operating on the brain for head injuries. From the time of Hippocrates, operating on the skull and brain was considered both treacherous and too dangerous to be undertaken except on rare occasions. Operating on a member of a royal court was considered even more exceptional because if the outcome was poor, the surgeon could lose a hand or limb, or, even worse, be beheaded. The authors present two interesting cases of royal family members who underwent surgery for head injuries that were quite severe. The surgeons involved, Ambroise Pare, Andreas Vesalius, and Berengario da Carpi, were among the most prominent surgeons in Europe. Despite very challenging political situations, all were willing to undertake a complex surgical intervention on the member of a prominent royal family. The individuals involved, both royal and medical, plus the neurosurgical injuries are discussed.	[Dowling, Kamilah A.] Childrens Hosp Montefiore, Albert Einstein Coll Med, Div Pediat Neurol Surg, Bronx, NY USA; [Dowling, Kamilah A.; Goodrich, James Tait] Childrens Hosp Montefiore, Albert Einstein Coll Med, Leo Davidoff Dept Neurol Surg, Bronx, NY USA		Dowling, KA (corresponding author), Childrens Hosp Montefiore, Div Pediat Neurosurg, 111 East 210th St, Bronx, NY 10467 USA.	kdowling@montefiore.org					Berengario da Carpi J, 1522, ISAGOGE BREVES PERLU; Berengario da Carpi J., 1514, ANOTHOMIA MUNDINI NO; Berengario da Carpi J., 1521, COMMENTARIA CUM AMPL; Cavalcanti DD, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.7.FOCUS09127; Da Carpi JB., 1518, TRACTATUS FRACTURA C; DEVIGO G, 1514, PRACTICA ARTE CHIRUR; Di Ieva A, 2011, J NEUROSURG, V114, P1461, DOI 10.3171/2010.10.JNS101331; FARIA MA, 1992, J NEUROSURG, V77, P964, DOI 10.3171/jns.1992.77.6.0964; Goodrich J T, 1985, Med Herit, V1, P280; Lind LR, 1990, BERENGARIO CARPI F 4, V80; NOSTRADAMUS M, 1980, PROPHESIES; O'Malley CD, 1973, DICT SCI BIOGRAPHY, V1, P617; OMalley CD, 1964, A VESALIUS BRUSSELS; Pare A., 1633, WORKS AMBROISE PAR; Pare A., 1545, METHODE TRAICTER PLA; Pare Ambrose, 1634, WORKS FAMOUS CHIRURG; Park R, 1901, TREATISE SURG AM AUT; Putti Vittoro, 1937, BERENGARIO CARPI SAG; RYFF WH, 1541, ALLER FURTREFFLICHST; Vesalius A., 1543, HUMANI CORPORIFABR; Zanello M, 2015, ACTA NEUROCHIR, V157, P145, DOI 10.1007/s00701-014-2280-9; Zetzei JEG, 1995, DE RE PUBLICA	22	7	7	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUL	2016	41	1							E2	10.3171/2016.4.FOCUS15119			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DS4MM	WOS:000380755200002	27364255	gold			2022-02-06	
J	Hertle, DN; Heer, M; Santos, E; Scholl, M; Kowoll, CM; Dohmen, C; Diedler, J; Veltkamp, R; Graf, R; Unterberg, AW; Sakowitz, OW				Hertle, Daniel N.; Heer, Marina; Santos, Edgar; Schoell, Michael; Kowoll, Christina M.; Dohmen, Christian; Diedler, Jennifer; Veltkamp, Roland; Graf, Rudolf; Unterberg, Andreas W.; Sakowitz, Oliver W.			Changes in electrocorticographic beta frequency components precede spreading depolarization in patients with acute brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Spreading depolarization; Ketamine; Beta frequency; EEG	SUBARACHNOID HEMORRHAGE; ISCHEMIC-STROKE; DEPRESSION; ELECTROENCEPHALOGRAPHY; KETAMINE; TRAUMA; PREDICTION; CLUSTERS	Objective: Spreading depolarization (SD) occurs after traumatic brain injury, subarachnoid hemorrhage, malignant hemispheric stroke and intracranial hemorrhage. SD has been associated with secondary brain injury, which can be reduced by ketamine. In this present study frequency bands of electrocorticographic (ECoG) recordings were investigated with regards to SDs. Methods: A total of 43 patients after acute brain injury were included in this retrospective and explorative study. Relative delta 0.5-4 Hz, theta 4-8 Hz, alpha 8-13 Hz and beta 13-40 Hz bands were analyzed with regards to SD occurrence and analgesic and sedative administration. Higher frequencies, including gamma 40-70 Hz, fast gamma 70-100 Hz and high frequency oscillations 100-200 Hz were analyzed in a subset of patients with a sampling rate of up to 400 Hz. Results: A close association of relative beta frequency and SD was found. Relative beta frequency was suppressed up to two hours prior to SD when compared to hours with no SD. This finding was partially explained by administration of ketamine. Even after removal of all patient data during administration of ketamine, SDs occurred predominantly during times with low relative beta frequency in a patientin-dependent analysis. Conclusion: Suppression of beta frequency by ketamine or without ketamine is associated with low SD counts. Significance: Alteration of beta frequency might help to predict occurrence of SDs in acutely brain injured patients. (C) 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Hertle, Daniel N.; Heer, Marina; Santos, Edgar; Schoell, Michael; Unterberg, Andreas W.; Sakowitz, Oliver W.] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Kowoll, Christina M.; Dohmen, Christian] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Dohmen, Christian; Graf, Rudolf] Max Planck Inst Metab Res, Cologne, Germany; [Diedler, Jennifer; Veltkamp, Roland] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Diedler, Jennifer] Univ Tubingen, Dept Neurol & Neurosurg, Tubingen, Germany; [Veltkamp, Roland] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London, England; [Sakowitz, Oliver W.] Klinikum Ludwigsburg, Dept Neurosurg, Ludwigsburg, Germany		Hertle, DN (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, INF 400, D-69120 Heidelberg, Germany.	daniel.hertle@med.uni-heidelberg.de	Santos, Edgar/AAV-2506-2021	Santos, Edgar/0000-0002-8976-5549; Sakowitz, Oliver/0000-0003-3248-6335			Bojak I, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00022; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Burghaus L, 2007, CLIN NEUROL NEUROSUR, V109, P45, DOI 10.1016/j.clineuro.2006.06.003; CILLESSEN JPM, 1994, STROKE, V25, P1968, DOI 10.1161/01.STR.25.10.1968; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diedler J, 2009, NEUROCRIT CARE, V11, P210, DOI 10.1007/s12028-009-9236-6; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Gotman J, 2010, EPILEPSIA, V51, P63, DOI 10.1111/j.1528-1167.2009.02449.x; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jeffcote T, 2014, NEUROCRIT CARE, V20, P21, DOI 10.1007/s12028-013-9938-7; Kolenda H, 1997, ACTA NEUROCHIR, V139, P1193, DOI 10.1007/BF01410987; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Maksimow A, 2006, CLIN NEUROPHYSIOL, V117, P1660, DOI 10.1016/j.clinph.2006.05.011; Moeller JJ, 2011, ARCH NEUROL-CHICAGO, V68, P1595, DOI 10.1001/archneurol.2011.1080; MOGHADDAM B, 1987, CAN J PHYSIOL PHARM, V65, P1105, DOI 10.1139/y87-173; MUIR KW, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001244; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P671, DOI 10.1097/00000542-199809000-00017; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; SALETU B, 1975, Neuropsychobiology, V1, P218, DOI 10.1159/000117497; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tackla R, 2015, NEUROCRIT CARE, V23, P339, DOI 10.1007/s12028-015-0146-5	32	7	7	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	JUL	2016	127	7					2661	2667		10.1016/j.clinph.2016.04.026			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO7UQ	WOS:000377988900014	27291885				2022-02-06	
J	Maa, T; Yeates, KO; Moore-Clingenpeel, M; O'Brien, NF				Maa, Tensing; Yeates, Keith Owen; Moore-Clingenpeel, Melissa; O'Brien, Nicole F.			Age-related carbon dioxide reactivity in children after moderate and severe traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric traumatic brain injury; carbon dioxide reactivity; transcranial Doppler ultrasound; cerebrovascular reactivity; trauma	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; CEREBROVASCULAR RESPONSE; CO2 REACTIVITY; VASOREACTIVITY; AUTOREGULATION; HYPEREMIA; OXYGEN	OBJECTIVE The objective of this study is to assess carbon dioxide reactivity (CO2R) in children following traumatic brain injury (TBI). METHODS This prospective observational study enrolled children younger than 18 years old following moderate and severe TBI. Thirty-eight mechanically ventilated children had daily CO2R testing performed by measuring changes in their bilateral middle cerebral artery flow velocities using transcranial Doppler ultrasonography (TCD) after a transient increase in minute ventilation. The cohort was divided into 3 age groups: younger than 2 years (n = 12); 2 to 5 years old (n = 9); and older than 5 years (n = 17). RESULTS Children younger than 2 years old had a lower mean CO2R over time. The 2-5-year-old age group had higher mean CO2R than younger patients (p = 0.01), and the highest CO2R values compared with either of the other age groups (vs > 5 years old, p = 0.046; vs < 2 years old, p = 0.002). Having a lower minimum CO2R had a statistically significant negative effect on outcome at discharge (p = 0.0413). Impaired CO2R beyond Postinjury Day 4 trended toward having an effect on outcome at discharge (p = 0.0855). CONCLUSIONS Abnormal CO2R is prevalent in children following TBI, and the degree of impairment varies by age. No clinical or laboratory parameters were identified as risk factors for impaired CO2R. Lower minimum CO2R values are associated with worse outcome at discharge.	[Maa, Tensing; O'Brien, Nicole F.] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Moore-Clingenpeel, Melissa] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Yeates, Keith Owen] Univ Calgary, Calgary, AB T2N 1N4, Canada		Maa, T (corresponding author), Nationwide Childrens Hosp, Div Crit Care, 700 Childrens Dr,ED 357, Columbus, OH 43205 USA.	tensing.maa@nationwidechildrens.org	Maa, Tensing/J-9791-2012; Moore-Clingenpeel, Melissa/K-7232-2019; Yeates, Keith/AAJ-4223-2020	Maa, Tensing/0000-0001-6104-8401; Yeates, Keith/0000-0001-7680-2892	Research Institute at Nationwide Children's Hospital, Columbus, Ohio; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001070]	This work was supported by an intramural funding grant from the Research Institute at Nationwide Children's Hospital, Columbus, Ohio. The project described was supported by a grant (no. UL1TR001070) from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; Faul M, 2010, TRAUMATIC BRAIN INJU; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Haenggi M, 2012, J NEUROTRAUM, V29, P1779, DOI 10.1089/neu.2011.1809; Ide Kojiro, 2003, Journal of Applied Physiology, V95, P129; Karsli C, 2003, PAEDIATR ANAESTH, V13, P26, DOI 10.1046/j.1460-9592.2003.01017.x; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; LEON JE, 1991, CAN J ANAESTH, V38, P817, DOI 10.1007/BF03036954; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Poon WS, 2005, ACT NEUR S, V93, P207; Puppo C, 2008, ACTA NEUROCHIR SUPPL, V102, P171, DOI 10.1007/978-3-211-85578-2_34; QUINT SR, 1980, STROKE, V11, P286, DOI 10.1161/01.STR.11.3.286; Reinstrup P, 2014, NEUROCRIT CARE, V20, P54, DOI 10.1007/s12028-012-9727-8; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowney DA, 2002, BRIT J ANAESTH, V88, P357, DOI 10.1093/bja/88.3.357; Scaife ER, 2010, CURR OPIN PEDIATR, V22, P339, DOI 10.1097/MOP.0b013e3283395f2b; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SETTERGREN G, 1980, ACTA PAEDIATR SCAND, V69, P457, DOI 10.1111/j.1651-2227.1980.tb07114.x; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; WASSERMAN A, 1961, J CLIN INVEST, V40, P1297, DOI 10.1172/JCI104359; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	33	7	9	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2016	18	1					73	78		10.3171/2016.1.PEDS15564			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DQ1SC	WOS:000378979700011	27035550	Bronze			2022-02-06	
J	Olufajo, OA; Yorkgitis, BK; Cooper, Z; Rios-Diaz, A; Metcalfe, D; Havens, JM; Kelly, E; Haider, AH; Gates, JD; Salim, A				Olufajo, Olubode A.; Yorkgitis, Brian K.; Cooper, Zara; Rios-Diaz, Arturo; Metcalfe, David; Havens, Joaquim M.; Kelly, Edward; Haider, Adil H.; Gates, Jonathan D.; Salim, Ali			How long should we fear? Long-term risk of venous thromboembolism in patients with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	29th Annual Scientific Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 09-16, 2016	San Antonio, TX	Eastern Assoc Surg Trauma		Incidence; long term; trauma; traumatic brain injury; venous thromboembolism	DEEP-VEIN THROMBOSIS; SEVERITY SCORE ISS; DATA-BANK; COMORBIDITY INDEX; UNITED-STATES; MORTALITY; PROPHYLAXIS; CARE; VALIDATION; PREDICTORS	BACKGROUND: Although patients with traumatic brain injury (TBI) are known to be at high risk for venous thromboembolism(VTE), it is not clear how long this risk persists after injury. We aimed to determine the risk of VTE in patients with TBI during one year after injury and to identify associated factors. METHODS: Patients 18 years and older with International Classification of Diseases, Ninth Revision, Clinical Modification diagnoses of isolated TBI (head Abbreviated Injury Scale [AIS] >= 3 and AIS < 3 for all other body regions) were identified in the California State Inpatient Database (2007-2011). Patient and admission (injury severity score, length of stay, and discharge disposition) characteristics were assessed. Hospital factors (teaching status, trauma center verification, and bed size) were extracted from the American Hospital Association database. Patients who developed VTE during the index admission and at different time points after discharge were determined. Multivariate logistic regression models were used to assess the associated risk factors for VTE after discharge. RESULTS: There were 38,984 patients with isolated TBI identified. The incidence of VTE was 1.31% during the index admission and the cumulative incidence of VTE involving hospitalization within one year of injury was 2.83%. The major risk factors for VTE one year after injury (not including the index admission) were discharge to extended care facilities versus home [adjusted odds ratio, 2.69 (95% confidence interval, 2.14-3.37)], age older than 64 years versus 18 to 44 years [2.62 (1.80-3.81)], having an operation during the index admission [1.65 (1.36-2.01)], and hospital length of stay of more than 7 days versus 3 days or less [1.64 (1.27-2.11)]. CONCLUSION: The risk of VTE persists long after discharge in a significant proportion of patients with TBI. Demographic and admission characteristics of patients play significant roles in the risk of VTE after discharge. These results highlight the need for sustained surveillance and preventive measures among patients with TBI at increased risk for long-term VTE. (J Trauma Acute Care Surg. 2016; 81: 71-78. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Olufajo, Olubode A.; Yorkgitis, Brian K.; Cooper, Zara; Havens, Joaquim M.; Kelly, Edward; Haider, Adil H.; Gates, Jonathan D.; Salim, Ali] Brigham & Womens Hosp, Dept Surg, Div Trauma Burn & Surg Crit Care, 75 Francis St, Boston, MA 02115 USA; [Olufajo, Olubode A.; Cooper, Zara; Rios-Diaz, Arturo; Metcalfe, David; Havens, Joaquim M.; Haider, Adil H.; Salim, Ali] Harvard Med Sch, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA USA; Harvard TH Chan Sch Publ Hlth, Boston, MA USA		Olufajo, OA (corresponding author), Brigham & Womens Hosp, Div Trauma Burn & Surg Crit Care, 75 Francis St, Boston, MA 02115 USA.	oao777@mail.harvard.edu	Metcalfe, David/D-9699-2012	Metcalfe, David/0000-0003-1008-3105			Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Barrera LM, 2013, COCHRANE DB SYST REV, V283; Bennett KM, 2010, J SURG RES, V163, P127, DOI 10.1016/j.jss.2010.04.031; Centers for Disease Control and Prevention, 2015, VEN THROMB BLOOD CLO; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark DE, 2010, STAT SOFTWARE COMPON; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Dean Steven M, 2010, Congest Heart Fail, V16, P164, DOI 10.1111/j.1751-7133.2010.00148.x; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dobesh PP, 2009, PHARMACOTHERAPY, V29, P943, DOI 10.1592/phco.29.8.943; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Godat LN, 2015, J TRAUMA ACUTE CARE, V78, P475, DOI 10.1097/TA.0000000000000556; Haider AH, 2012, ARCH SURG-CHICAGO, V147, P63, DOI 10.1001/archsurg.2011.254; Hashmi ZG, 2014, J TRAUMA ACUTE CARE, V76, P1184, DOI 10.1097/TA.0000000000000215; Haut ER, 2009, J TRAUMA, V66, P994, DOI 10.1097/TA.0b013e3181991adc; Havens JM, 2015, JAMA SURG, V11, P1; Healthcare Cost and Utilization Project, 2016, US GUID HCUP SUPPL V; Healthcare Cost Utilization Project, 2014, SID DOC 2014; Healthcare Cost Utilization Project, 2015, OV HEALTHC COST UT P; Jeyaraj JA, 2013, BRAIN INJURY, V27, P1338, DOI 10.3109/02699052.2013.823650; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Keller JM, 2012, J ORTHOP TRAUMA, V26, pE161, DOI 10.1097/BOT.0b013e3182324460; Kim DY, 2012, J TRAUMA ACUTE CARE, V72, P1286, DOI 10.1097/TA.0b013e31824ef9ec; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Olufajo OA, 2016, AM J SURG, V211, P649, DOI 10.1016/j.amjsurg.2015.09.018; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pierce CA, 2008, J TRAUMA, V64, P932, DOI 10.1097/TA.0b013e318166b808; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Singer MB, 2013, J TRAUMA ACUTE CARE, V74, P312, DOI 10.1097/TA.0b013e31826fc899; Stagg V, 2006, STAT SOFTWARE COMPON; US Medicare Payment Advisory Commission, 2014, REP C MED PAYM POL; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; White RH, 2010, THROMB RES, V126, P61, DOI 10.1016/j.thromres.2010.03.009; Yusuf Hussain R., 2012, Morbidity and Mortality Weekly Report, V61, P401	43	7	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2016	81	1					71	78		10.1097/TA.0000000000001046			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	DS5BV	WOS:000380796400012	27015575	Green Submitted			2022-02-06	
J	Setkowicz, Z; Kosonowska, E; Kaczynska, M; Gzielo-Jurek, K; Janeczko, K				Setkowicz, Zuzanna; Kosonowska, Emilia; Kaczynska, Malgorzata; Gzielo-Jurek, Kinga; Janeczko, Krzysztof			Physical training decreases susceptibility to pilocarpine-induced seizures in the injured rat brain	BRAIN RESEARCH			English	Article						Exercise; Treadmill; Immunostaining; GFAP; Parvalbumin; Calretinin; NPY; Cell counting	TEMPORAL-LOBE EPILEPSY; NEUROPEPTIDE-Y; NEUROTROPHIC FACTOR; CELL-PROLIFERATION; PARVALBUMIN IMMUNOREACTIVITY; NEOCORTICAL INJURIES; CEREBRAL-ISCHEMIA; CYCLOSPORINE-A; ANIMAL-MODEL; EXERCISE	There is growing evidence that physical activity ameliorates the course of epilepsy in animal models as well as in clinical conditions. Since traumatic brain injury is one of the strongest determinants of epileptogenesis, the present study focuses on the question whether a moderate long-term physical training can decrease susceptibility to seizures evoked following brain damage. Wistar rats received a mechanical brain injury and were subjected to daily running sessions on a treadmill for 21 days. Thereafter, seizures were induced by pilocarpine injections in trained and non-trained, control groups. During the acute period of status epilepticus, the intensity of seizures was assessed within the six hour observation period. The trained rats showed considerable amelioration of pilocarpine-induced motor symptoms when compared with their non-trained counterparts. Histological investigations of effects of the brain injury and of physical training detected significant quantitative changes in parvalbumin-, calretinin- and NPY-immunopositive neuronal populations. Some of the injury-induced changes, especially those shoved by parvalbumin-immunopositive neurons, were abolished by the subsequent physical training procedure and could, therefore, be considered as neuronal correlates of the observed functional amelioration of the injured brain. (C) 2016 Elsevier B.V. All rights reserved.	[Setkowicz, Zuzanna; Kosonowska, Emilia; Kaczynska, Malgorzata; Gzielo-Jurek, Kinga; Janeczko, Krzysztof] Jagiellonian Univ, Inst Zool, Dept Neuroanat, 9 Gronostajowa St, PL-30387 Krakow, Poland		Janeczko, K (corresponding author), Jagiellonian Univ, Inst Zool, Dept Neuroanat, 9 Gronostajowa St, PL-30387 Krakow, Poland.	k.janeczko@uj.edu.pl	Gzielo, Kinga/AAJ-9079-2021	Gzielo, Kinga/0000-0003-2774-3982; Setkowicz, Zuzanna/0000-0002-7213-8194; Janeczko, Krzysztof/0000-0002-9544-918X; Kosonowska, Emilia/0000-0002-5792-0321; Kaczynska, Malgorzata/0000-0002-3926-296X	Ministry of Science and Higher EducationMinistry of Science and Higher Education, PolandEuropean Commission [N303 052 31/1636]; Institute of Zoology, Jagiellonian University [K/ZDS/004196]	The present study was supported by the Ministry of Science and Higher Education, Grant no. N303 052 31/1636, and a grant for statutory research of the Institute of Zoology, Jagiellonian University, No. K/ZDS/004196.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; Arida RM, 1998, EPILEPSY RES, V30, P127, DOI 10.1016/S0920-1211(97)00102-2; Arida RM, 1999, EPILEPSY RES, V37, P45, DOI 10.1016/S0920-1211(99)00032-7; Bardi M, 2012, STRESS, V15, P306, DOI 10.3109/10253890.2011.623739; Bartynski WS, 2001, AM J NEURORADIOL, V22, P1901; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bjornebekk A, 2006, NEUROPSYCHOPHARMACOL, V31, P256, DOI 10.1038/sj.npp.1300820; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Corvino V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088294; Corvino V, 2012, J NEUROCHEM, V122, P415, DOI 10.1111/j.1471-4159.2012.07770.x; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; da Silva SG, 2012, HIPPOCAMPUS, V22, P347, DOI 10.1002/hipo.20903; da Silva SG, 2010, BRAIN DEV-JPN, V32, P137, DOI 10.1016/j.braindev.2008.12.012; de Almeida AA, 2013, NEUROSCI LETT, V553, P1, DOI 10.1016/j.neulet.2013.08.015; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Ding YH, 2006, CURR NEUROVASC RES, V3, P263, DOI 10.2174/156720206778792911; Ding YH, 2006, CURR NEUROVASC RES, V3, P15, DOI 10.2174/156720206775541787; DISHMAN RK, 1988, PHYSIOL BEHAV, V43, P541, DOI 10.1016/0031-9384(88)90206-5; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Furuichi Y, 2003, BRAIN RES, V965, P137, DOI 10.1016/S0006-8993(02)04151-3; Heck TG, 2011, CELL BIOCHEM FUNCT, V29, P215, DOI 10.1002/cbf.1739; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Janeczko K, 1997, BRAIN RES, V770, P237, DOI 10.1016/S0006-8993(97)00873-1; Jiang P, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/729827; Katchanov J, 2003, BRAIN PATHOL, V13, P452; Lahteinen S, 2004, EUR J NEUROSCI, V19, P3245, DOI 10.1111/j.1460-9568.2004.03440.x; Laubender RP, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.4_suppl.635; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Levenson CW, 1998, NEUROSCI LETT, V242, P177, DOI 10.1016/S0304-3940(98)00064-0; Li H, 2005, NEUROSCI LETT, V386, P160, DOI 10.1016/j.neulet.2005.06.009; Liu X, 2010, NEUROSCI LETT, V476, P99, DOI 10.1016/j.neulet.2010.04.011; LOSCHER W, 1995, BRAIN RES, V697, P197, DOI 10.1016/0006-8993(95)00843-F; Nguyen JCD, 2013, BEHAV BRAIN RES, V256, P598, DOI 10.1016/j.bbr.2013.09.004; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Phillips C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00170; Piacentini R, 2008, J NEUROCHEM, V105, P2109, DOI 10.1111/j.1471-4159.2008.05297.x; Popovic M, 2008, NEUROSCIENCE, V155, P182, DOI 10.1016/j.neuroscience.2008.05.023; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Saganova K, 2012, LIFE SCI, V91, P77, DOI 10.1016/j.lfs.2012.06.022; Schwartz M, 2003, J CEREBR BLOOD F MET, V23, P385, DOI 10.1097/01.WCB.0000061881.75234.5E; Setkowicz Z, 2006, NEUROL RES, V28, P453, DOI 10.1179/016164106X115062; Setkowicz Z, 2006, EPILEPSY RES, V68, P255, DOI 10.1016/j.eplepsyres.2005.11.012; Setkowicz Z, 2004, EPILEPSY RES, V61, P63, DOI 10.1016/j.eplepsyres.2004.06.001; Setkowicz Z, 2003, EPILEPSY RES, V53, P216, DOI 10.1016/S0920-1211(03)00029-9; Setkowicz Z., 2007, EPILEPSY RES, V71, P142; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Uysal N, 2015, BIOTECH HISTOCHEM, V90, P55, DOI 10.3109/10520295.2014.946968; Vezzani A, 1999, NEUROSCIENCE, V90, P1445, DOI 10.1016/S0306-4522(98)00553-3; Warren KE, 2001, J NATL CANCER I, V93, P1401, DOI 10.1093/jnci/93.18.1401; Weisman D, 2006, VITAM HORM, V74, P505, DOI 10.1016/S0083-6729(06)74020-1; Whalley HC, 2001, NEURORADIOLOGY, V43, P263, DOI 10.1007/s002340000437; Wirth MJ, 2005, P NATL ACAD SCI USA, V102, P3064, DOI 10.1073/pnas.0404712102; Xapelli S, 2008, EUR J NEUROSCI, V27, P2089, DOI 10.1111/j.1460-9568.2008.06172.x; Yau SY, 2012, NEUROSCIENCE, V222, P289, DOI 10.1016/j.neuroscience.2012.07.019; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	66	7	7	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 1	2016	1642						20	32		10.1016/j.brainres.2016.03.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP7EI	WOS:000378661600003	26972533				2022-02-06	
J	Valier, AR; Bacon, CEW; Bay, RC; Houston, MN; McLeod, TCV				Valier, Alison R.; Bacon, Cailee E. Welch; Bay, R. Curtis; Houston, Megan N.; McLeod, Tamara C. Valovich			Validity of Single-Item Patient-Rated Outcomes in Adolescent Football Athletes With Concussion	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Athletic injuries; Patient-centered care; Patient outcome assessment; Quality of life; Rehabilitation	RELIABILITY	Objective: To determine the longitudinal and concurrent validity of single-item patient-rated outcomes (PROs) in adolescent football athletes with concussion. Design: Longitudinal. Setting: Athletic training facilities. Participants: Convenience sample of male adolescent interscholastic athletes (n=94; mean age, 15.7 +/- 1.1y; mean grade, 10.1 +/- 1.1) from a larger investigation who suffered a sport-related concussion during football and had at least 3 follow-up assessments at 3, 10, and 30 days postinjury (N=249). Interventions: Not applicable. Main Outcome Measures: Participants were administered 3 global rating questions (1 generic, 1 for daily activities, and 1 for athletic activities) along with the Pediatric Quality of Life Inventory (PedsQL), Multidimensional Fatigue Scale (MFS), and Headache Impact Test-6 (HIT-6) at 3, 10, and 30 days postconcussion. Longitudinal validity was determined through a mixed linear model with random effects for subjects, with pairwise differences assessed using Bonferroni correction (P<.05). Concurrent validity was determined by examining Spearman rho correlations between the single-item PROs and multi-item PROs. Results: All 3 single-item PROs improved over time, demonstrating longitudinal validity (P<.001), except day 10 versus day 30 for global change (P = .072). Fair to moderate correlations were identified between the single-item PROs and the PedsQL, MFS, and HIT-6. Conclusions: The improvement of single-item PRO scores over a postinjury time period of 30 days suggests that these PROs respond as expected to patient recovery. The correlations identified between the single-item PROs and common multi-item PROs used in athletes with concussion demonstrate concurrent validity. Therefore, single-item PROs appear to measure patient progress in adolescent football athletes postconcussion. (C) 2016 by the American Congress of Rehabilitation Medicine	[Valier, Alison R.; Bacon, Cailee E. Welch; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [Valier, Alison R.; Bacon, Cailee E. Welch; Bay, R. Curtis; Houston, Megan N.; McLeod, Tamara C. Valovich] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ 85206 USA; [Valier, Alison R.; Bacon, Cailee E. Welch; McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA; [Valier, Alison R.] AT Still Univ, Res Support, Mesa, AZ 85206 USA		Valier, AR (corresponding author), AT Still Univ, Athlet Training Programs, Sch Osteopath Med Arizona, Arizona Sch Hlth Sci, 5850 E Still Circle, Mesa, AZ 85206 USA.	arsnyder@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722	National Operating Committee on Standards for Athletic Equipment [01-10]	Supported by the National Operating Committee on Standards for Athletic Equipment (grant no. 01-10).	Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bayliss M., 2002, HIT 6 USERS GUIDE; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jette DU, 2009, PHYS THER, V89, P125, DOI 10.2522/ptj.20080234; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Valier ARS, 2014, J ATHL TRAINING, V49, P674, DOI 10.4085/1062-6050-49.3.15; Valovich McLeod TC, 2008, J ATHL TRAINING, V43, P437, DOI DOI 10.404/1062-6050-43.4.437; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Washington A Eugene, 2011, N Engl J Med, V365, pe31, DOI 10.1056/NEJMp1109407; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572	13	7	7	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2016	97	7					1202	1205		10.1016/j.apmr.2015.11.015			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DQ1RZ	WOS:000378979400019	26707408				2022-02-06	
J	Zhang, DF; Teng, JF				Zhang, Dongfeng; Teng, Junfang			Nrf2 knockout: The effect on neurological dysfunction and the activation of glial cells of mice after brain injury	PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Craniocerebral trauma; nerve dysfunction; glia activation; Nrf2 gene	MICROGLIA; INFLAMMATION	To investigate the protective role and possible mechanisms of Nrf2 gene in cerebral trauma in mice. The types Nrf2(-/-) and Nrf2(+/+) mice were confirmed by PCR, and the model of closed head injury was established. The severity of injury and the effect of the injury on neurological status were assessed by Neurological Severity Score (NSS) and fatality rate, and the activated conditions of microglia and astrocyte around the injured area were observed by immunohistochemical method. Compared with Nrf2(+/+) mice, the nerve dysfunction of the Nrf2(-/-) mice was obviously more severe (P<0.01). On the first day after injury, the activation of microglia around the injured area increased significantly in Nrf2 (-/-) mice, the difference was more significant on the third day, and there was still statistical difference until the 7th day (P<0.05). Moreover, On the days 1, 3, 7 after injury, the activation of astrocyte around the injured area also increased in Nrf2(-/-) mice, however, there was statistical difference only on the 3rd day (P<0.05). Nrf2 gene knockout can aggravate the nerve dysfunction after cerebral trauma, and this effect is achieved, at least partly, possibly via the effect of Nrf2 on glial activation.	[Zhang, Dongfeng; Teng, Junfang] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Jianshe East Rd, Zhengzhou, Henan, Peoples R China		Teng, JF (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Jianshe East Rd, Zhengzhou, Henan, Peoples R China.	zmby519@163.com			Henan Research Program of Application Foundation and Advanced Technology [22300410259]; Zhengzhou Research Programs for Science and Technology Development [121PPTGG494-1]	Henan Research Program of Application Foundation and Advanced Technology - "Research on the relationship between ATP7B mutation and hepatolenticular degeneration diseases" (project number: 22300410259). Zhengzhou Research Programs for Science and Technology Development - "Clinical research on the treatment for hepatolenticular degeneration hepatic fibrosis by mesenchymal stem cells" (Project No. 121PPTGG494-1).	Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kraft AD, 2006, J NEUROCHEM, V98, P1852, DOI 10.1111/j.1471-4159.2006.04019.x; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7	18	7	7	0	0	UNIV KARACHI	KARACHI	UNIV CAMPUS, FAC PHARMACY, KARACHI, 75270, PAKISTAN	1011-601X			PAK J PHARM SCI	Pak. J. Pharm. Sci.	JUL	2016	29	4		S			1365	1369					5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DU6VH	WOS:000382352200005	27592473				2022-02-06	
J	Feng, Z; Du, Q				Feng, Zhen; Du, Qing			Mechanisms responsible for the effect of median nerve electrical stimulation on traumatic brain injury-induced coma: orexin-A-mediated N-methyl-D-aspartate receptor subunit NR1 upregulation	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; NR1; median nerve electrical stimulation; traumatic brain injury; coma; wakefulness; orexin-A; prefrontal cortex; neural regeneration	RAT PREFRONTAL CORTEX; NMDA RECEPTORS; PYRAMIDAL NEURONS; CELL-DEATH; GLUTAMATE; BLOCKADE; ANTAGONISTS; EXPRESSION; DISEASE; ACID	Electrical stimulation of the median nerve is a noninvasive technique that facilitates awakening from coma. In rats with traumatic brain injury-induced coma, median nerve stimulation markedly enhances prefrontal cortex expression of orexin-A and its receptor, orexin receptor 1. To further understand the mechanism underlying wakefulness mediated by electrical stimulation of the median nerve, we evaluated its effects on the expression of the N-methyl-D-aspartate receptor subunit NR1 in the prefrontal cortex in rat models of traumatic brain injury-induced coma, using immunohistochemistry and western blot assays. In rats with traumatic brain injury, NR1 expression increased with time after injury. Rats that underwent electrical stimulation of the median nerve (30 Hz, 0.5 ms, 1.0 mA for 15 minutes) showed elevated NR1 expression and greater recovery of consciousness than those without stimulation. These effects were reduced by intracerebroventricular injection of the orexin receptor 1 antagonist SB334867. Our results indicate that electrical stimulation of the median nerve promotes recovery from traumatic brain injury-induced coma by increasing prefrontal cortex NR1 expression via an orexin-A-mediated pathway.	[Feng, Zhen; Du, Qing] Nanchang Univ, Affiliated Hosp 1, Dept Rehabil, Nanchang, Jiangxi, Peoples R China		Feng, Z (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Rehabil, Nanchang, Jiangxi, Peoples R China.	fengzhenly@sina.com		Feng, Zhen/0000-0002-6268-2516	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260295]; Natural Science Foundation of Jiangxi Province of ChinaNatural Science Foundation of Jiangxi Province [20132BAB205063]	This study was supported by the National Natural Science Foundation of China, No. 81260295; the Natural Science Foundation of Jiangxi Province of China, No. 20132BAB205063.	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Aluisio L, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00107; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cooper EB, 2003, ACT NEUR S, V87, P7; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dhawan J, 2010, NEUROIMAGE, V51, P599, DOI 10.1016/j.neuroimage.2010.02.073; Dingledine R, 1999, PHARMACOL REV, V51, P7; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; JUHASZ G, 1990, NEUROSCI LETT, V114, P333, DOI 10.1016/0304-3940(90)90586-X; Kabadi SV, 2014, NEURAL REGEN RES, V9, P1578, DOI 10.4103/1673-5374.141779; Lei J, 2015, J NEUROTRAUM, V32, P1584, DOI 10.1089/neu.2014.3768; Monti B, 2000, EUR J NEUROSCI, V12, P3117, DOI 10.1046/j.1460-9568.2000.00189.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Okazaki Y, 2008, NEUROSCI RES, V61, P129, DOI 10.1016/j.neures.2008.01.016; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Shi Yu-Feng, 2013, Zhejiang Da Xue Xue Bao Yi Xue Ban, V42, P583; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Song CH, 2006, NEUROSCI LETT, V399, P101, DOI 10.1016/j.neulet.2006.01.065; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; STEPHENS JR, 1994, EPILEPSIA, V35, P164, DOI 10.1111/j.1528-1157.1994.tb02928.x; Sun HL, 2013, BEHAV BRAIN RES, V257, P1, DOI 10.1016/j.bbr.2013.08.044; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tose R, 2009, BRAIN RES, V1250, P81, DOI 10.1016/j.brainres.2008.10.041; Yan J, 2012, NEUROSCI LETT, V520, P92, DOI 10.1016/j.neulet.2012.05.038; [张春青 ZHANG Chunqing], 2007, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V29, P922; Zhong YJ, 2015, MOL MED REP, V12, P4441, DOI 10.3892/mmr.2015.3898	34	7	10	3	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2016	11	6					951	956		10.4103/1673-5374.184494			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DS9QU	WOS:000381119200028	27482224	Green Published, gold			2022-02-06	
J	Fujimoto, K; Miura, M; Otsuka, T; Kuratsu, J				Fujimoto, Kenji; Miura, Masaki; Otsuka, Tadahiro; Kuratsu, Jun-ichi			Sequential changes in Rotterdam CT scores related to outcomes for patients with traumatic brain injury who undergo decompressive craniectomy	JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; Glasgow Outcome Scale; mortality; Rotterdam CT score; traumatic brain injury	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; INTRACRANIAL HYPERTENSION; CLINICAL ARTICLE; PROGNOSTIC VALUE; HEMICRANIECTOMY; IMPACT; OXYGEN; ICP	OBJECTIVE Rotterdam CT scoring is a CT classification system for grouping patients with traumatic brain injury (TBI) based on multiple CT characteristics. This retrospective study aimed to determine the relationship between initial or preoperative Rotterdam CT scores and TBI prognosis after decompressive craniectomy (DC). METHODS The authors retrospectively reviewed the medical records of all consecutive patients who underwent DC for nonpenetrating TBI in 2 hospitals from January 2006 through December 2013. Univariate and multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were used to determine the relationship between initial or pre-operative Rotterdam CT scores and mortality at 30 days or Glasgow Outcome Scale (GOS) scores at least 3 months after the time of injury. Unfavorable outcomes were GOS Scores 1-3 and favorable outcomes were GOS Scores 4 and 5. RESULTS A total of 48 cases involving patients who underwent DC for TBI were included in this study. Univariate analyses showed that initial Rotterdam CT scores were significantly associated with mortality and both initial and preoperative Rotterdam CT scores were significantly associated with unfavorable outcomes. Multivariable logistic regression analysis adjusted for established predictors of TBI outcomes showed that initial Rotterdam CT scores were significantly associated with mortality (OR 4.98, 95% CI 1.40-17.78, p = 0.01) and unfavorable outcomes (OR 3.66, 95% CI 1.29-10.39, p = 0.02) and preoperative Rotterdam CT scores were significantly associated with unfavorable outcomes (OR 15.29, 95% CI 2.50-93.53, p = 0.003). ROC curve analyses showed cutoff values for the initial Rotterdam CT score of 5.5 (area under the curve [AUC] 0.74, 95% CI 0.59-0.90, p = 0.009, sensitivity 50.0%, and specificity 88.2%) for mortality and 4.5 (AUC 0.71, 95% CI 0.56-0.86, p = 0.02, sensitivity 62.5%, and specificity 75.0%) for an unfavorable outcome and a cutoff value for the preoperative Rotterdam CT score of 4.5 (AUC 0.81, 95% CI 0.69-0.94, p < 0.001, sensitivity 90.6%, and specificity 56.2%) for an unfavorable outcome. CONCLUSIONS Assessment of changes in Rotterdam CT scores over time may serve as a prognostic indicator in TBI and can help determine which patients require DC.	[Fujimoto, Kenji; Miura, Masaki] Japanese Red Cross Kumamoto Hosp, Dept Neurosurg, Higashi Ku, Kumamoto, Japan; [Otsuka, Tadahiro] Natl Hosp Org, Kumamoto Med Ctr, Dept Neurosurg, Chuo Ku, Kumamoto, Japan; [Fujimoto, Kenji; Kuratsu, Jun-ichi] Kumamoto Univ, Sch Med, Dept Neurosurg, Fac Life Sci,Chuo Ku, 1-1-1 Honjo, Kumamoto 8618556, Japan		Fujimoto, K (corresponding author), Kumamoto Univ, Sch Med, Dept Neurosurg, Fac Life Sci,Chuo Ku, 1-1-1 Honjo, Kumamoto 8618556, Japan.	schwarz_k1216@yahoo.co.jp					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marshall LF, 1991, J NEUROSURG S, V75, P14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131	29	7	8	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2016	124	6					1640	1645		10.3171/2015.4.JNS142760			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DM6PZ	WOS:000376476200014	26495949	Bronze			2022-02-06	
J	Honeybul, S				Honeybul, Stephen			Management of the temporal muscle during cranioplasty: technical note	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						decompressive craniectomy; cranioplasty; temporal muscle; craniofacial	ADHESION PREVENTIVE MATERIAL; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DURAL SUBSTITUTE; PRESERVATION; RECONSTRUCTION; COMPLICATIONS; DURAPLASTY; INFECTION; SECONDARY	Over the past 2 decades there has been a resurgence of interest in the use of decompressive craniectomy in the management of neurological emergencies. While technically straightforward, the procedure is associated with a number of complications relating to the initial decompression and subsequent cranioplasty. One complication that has received relatively little attention relates to the management of the temporal muscle. Here, through an illustrative case, the author describes a novel method of minimizing dissection of the temporal muscle during a cranioplasty procedure. Rather than placing a synthetic' material over the dura mater to prevent adhesions or dissecting the muscle off the dura, the dura was opened and reflected laterally, pedicled to the temporal muscle. The dural defect was closed with a dural substitute, and the bone flap was secured in a routine fashion. The temporal muscle was then secured in its anatomical position. At the 6-month follow-up, radiological and clinical examination confirmed the restoration of muscle volume with excellent cosmetic and functional results. Opening the dura on a temporal muscle pedicle does not represent a routine form of surgical reconstruction; however, the use of this technique may have some advantages especially in young patients who have made a good recovery and for whom facial aesthetics may be particularly important.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; [Honeybul, Stephen] Royal Perth Hosp, 5th Fl,North Block,Wellington St, Perth, WA 6000, Australia		Honeybul, S (corresponding author), Royal Perth Hosp, Dept Neurosurg, 5th Fl,North Block,Wellington St, Perth, WA 6000, Australia.	stephen.honeybul@health.wa.gov.au					Adeleye A Olufemi, 2011, Surg Neurol Int, V2, P150, DOI 10.4103/2152-7806.86227; Bulters D, 2010, BRIT J NEUROSURG, V24, P75, DOI 10.3109/02688690903506135; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Di Rienzo A, 2013, NEUROL MED-CHIR, V53, P590; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Gordon CR, 2014, OPER NEUROSURG, V10, P179, DOI 10.1227/NEU.0000000000000296; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Huang YH, 2011, J TRAUMA, V71, P533, DOI 10.1097/TA.0b013e318203208a; Kawaguchi T, 2003, NEUROL MED-CHIR, V43, P320, DOI 10.2176/nmc.43.320; Lee CH, 2007, CLIN NEUROL NEUROSUR, V109, P667, DOI 10.1016/j.clineuro.2007.05.015; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Missori P, 2008, SURG NEUROL, V70, P437, DOI 10.1016/j.surneu.2007.03.029; Missori P, 2013, ACTA NEUROCHIR, V155, P1335, DOI 10.1007/s00701-013-1695-z; Miyake S, 2006, NEUROL MED-CHIR, V46, P104, DOI 10.2176/nmc.46.104; Mumert ML, 2012, J CLIN NEUROSCI, V19, P455, DOI 10.1016/j.jocn.2011.09.004; Nakagawa S, 2003, NEUROL MED-CHIR, V43, P120, DOI 10.2176/nmc.43.120; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Sharma SD, 2012, BRIT J ORAL MAX SURG, V50, pE36, DOI 10.1016/j.bjoms.2011.07.025; Vakis A, 2006, CLIN NEUROL NEUROSUR, V108, P798, DOI 10.1016/j.clineuro.2005.11.026; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zhang GL, 2010, CHIN J TRAUMATOL, V13, P259, DOI 10.3760/cma.j.issn.1008-1275.2010.05.001	22	7	7	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2016	17	6					701	704		10.3171/2015.11.PEDS15556			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DM6PX	WOS:000376476000012	26894519	Bronze			2022-02-06	
J	Jin, W; Xu, W; Chen, J; Zhang, XX; Shi, L; Ren, CC				Jin, Wei; Xu, Wei; Chen, Jing; Zhang, Xiaoxiao; Shi, Lei; Ren, Chuancheng			Adenosine kinase facilitated astrogliosis-induced cortical neuronal death in traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Adenosine kinase; Astrogliosis; Lipopolysaccharide; Neuron; Traumatic brain injury	FIBROBLAST GROWTH-FACTOR; ASTROCYTE ACTIVATION; RECEPTORS; INHIBITION; EPILEPTOGENESIS; OVEREXPRESSION; ELEVATION; TARGET; MICE	Adenosine kinase (ADK) plays a pivotal role in regulating brain function by regulating adenosine level, and ADK inhibition protects against neuronal damage in cerebral ischemia and epilepsy; however, the effects of ADK in traumatic brain injury (TBI) have not been investigated. For exploring its effects, we generated a blade-induced rat focal brain injury model. Western blot analysis, immunohistochemistry and immunofluorescent staining suggested that ADK was up-regulated after TBI, and it was temporally and spatially associated with astrogliosis. Terminal deoxynucleotidyl transferase-mediated biotinylated-dUTP nick-end labeling showed that neuronal apoptosis was paralleled with TBI-induced ADK up-regulation and astrogliosis. For further investigating the role of ADK in astrogliosis-induced neuronal death, primary cultured astrocytes and neurons were utilized, lipopolysaccharide (LPS) was employed to mediate astrogliosis, and condition medium (CM) of reactive astrocytes was used to treat neurons. The results showed that astrocytes increased iNOS expression and secreted pro-inflammatory cytokines after LPS treatment, and CM of reactive astrocytes resulted neuronal death. Additionally, ADK knock-down didn't ameliorate LPS-induced astrocyte proliferation, but it protected against neuronal death by reducing iNOS expression, tumor necrosis factor alpha and interleukin 1 beta secretion of reactive astrocytes. Taken together, ADK was associated with astrogliosis after TBI, its inhibition in reactive astrocytes ameliorated astrogliosis-induced neuronal death. Our findings extended the current knowledge on the role of ADK in astrogliosis, and also provided new evidence for the TBI treatment.	[Jin, Wei; Xu, Wei; Chen, Jing; Zhang, Xiaoxiao; Shi, Lei; Ren, Chuancheng] Fudan Univ, Dept Neurol, Shanghai Hosp 5, 801 Heqing Rd, Shanghai 200240, Peoples R China		Ren, CC (corresponding author), Fudan Univ, Dept Neurol, Shanghai Hosp 5, 801 Heqing Rd, Shanghai 200240, Peoples R China.	renchuancheng@outlook.com			National Natural Science Foundations of China (NSFC)National Natural Science Foundation of China (NSFC) [81071061, 81571277]; Natural Science Foundation of Minhang District [2010MHZ019]	The present study was supported by National Natural Science Foundations of China (NSFC; No. 81071061, No. 81571277), and also supported by Natural Science Foundation of Minhang District (No. 2010MHZ019).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002; Brambilla R, 2003, GLIA, V43, P190, DOI 10.1002/glia.10243; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Cui M, 2011, GLIA, V59, P641, DOI 10.1002/glia.21134; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Fedele DE, 2005, BRAIN, V128, P2383, DOI 10.1093/brain/awh555; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Lavrnja I, 2015, ACTA HISTOCHEM, V117, P155, DOI 10.1016/j.acthis.2014.12.004; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914; Li TF, 2008, J CLIN INVEST, V118, P571, DOI 10.1172/JCI33737; LOGAN A, 1992, J NEUROSCI, V12, P3828; Lynch JJ, 1998, NEUROSCI LETT, V252, P207, DOI 10.1016/S0304-3940(98)00376-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; PAK MA, 1994, NEUROPHARMACOLOGY, V33, P1049, DOI 10.1016/0028-3908(94)90142-2; Parpura V, 2012, ASN NEURO, V4, P201, DOI 10.1042/AN20120019; Pearson T, 2006, J NEUROCHEM, V97, P1357, DOI 10.1111/j.1471-4159.2006.03823.x; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Robinson KA, 1999, J NEUROSCI RES, V55, P724, DOI 10.1002/(SICI)1097-4547(19990315)55:6<724::AID-JNR7>3.0.CO;2-9; Rooker S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/90123; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003	36	7	10	2	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2016	47	3					259	271		10.1007/s10735-016-9670-7			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN2FF	WOS:000376878800004	26983602				2022-02-06	
J	Raffard, S; Bortolon, C; Burca, M; Gely-Nargeot, MC; Capdevielle, D				Raffard, Stephane; Bortolon, Catherine; Burca, Marianna; Gely-Nargeot, Marie-Christine; Capdevielle, Delphine			Multidimensional model of apathy in older adults using partial least squares-path modeling	AGE			English	Article						Apathy; Older adults; Anticipatory pleasure; Physical ability; Partial least squares; Path modeling	REWARD QUESTIONNAIRE SPSRQ; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; EVALUATION SCALE; NEUROPSYCHIATRIC SYMPTOMS; PSYCHOMETRIC PROPERTIES; DIAGNOSTIC-CRITERIA; SENSITIVITY	Apathy defined as a mental state characterized by a lack of goal-directed behavior is prevalent and associated with poor functioning in older adults. The main objective of this study was to identify factors contributing to the distinct dimensions of apathy (cognitive, emotional, and behavioral) in older adults without dementia. One hundred and fifty participants (mean age, 80.42) completed self-rated questionnaires assessing apathy, emotional distress, anticipatory pleasure, motivational systems, physical functioning, quality of life, and cognitive functioning. Data were analyzed using partial least squares variance-based structural equation modeling in order to examine factors contributing to the three different dimensions of apathy in our sample. Overall, the different facets of apathy were associated with cognitive functioning, anticipatory pleasure, sensitivity to reward, and physical functioning, but the contribution of these different factors to the three dimensions of apathy differed significantly. More specifically, the impact of anticipatory pleasure and physical functioning was stronger for the cognitive than for emotional apathy. Conversely, the impact of sensibility to reward, although small, was slightly stronger on emotional apathy. Regarding behavioral apathy, again we found similar latent variables except for the cognitive functioning whose impact was not statistically significant. Our results highlight the need to take into account various mechanisms involved in the different facets of apathy in older adults without dementia, including not only cognitive factors but also motivational variables and aspects related to physical disability. Clinical implications are discussed.	[Raffard, Stephane; Bortolon, Catherine; Gely-Nargeot, Marie-Christine] Univ Montpellier 3, Epsylon Lab Dynam Human Abil & Hlth Behav, Montpellier, France; [Raffard, Stephane; Bortolon, Catherine; Burca, Marianna; Capdevielle, Delphine] Univ Montpellier I, CHRU Montpellier, Hop Colombiere, Univ Dept Adult Psychiat, Montpellier, France; [Raffard, Stephane] Univ Montpellier 3, Univ Dept Adult Psychiat 1, Lab Epsylon, EA 4556, 39 Ave Charles Flahault, F-34295 Montpellier 5, France; [Capdevielle, Delphine] INSERM, U1061, Montpellier, France		Raffard, S (corresponding author), Univ Montpellier 3, Univ Dept Adult Psychiat 1, Lab Epsylon, EA 4556, 39 Ave Charles Flahault, F-34295 Montpellier 5, France.	stephraffard@hotmail.com	Raffard, Stephane/M-3926-2019	Raffard, Stephane/0000-0001-5563-0323; Capdevielle, Delphine/0000-0002-7146-8554			Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Bagozzi RP., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327; Barnhart W Jason, 2004, J Psychiatr Pract, V10, P196, DOI 10.1097/00131746-200405000-00010; Brodaty H, 2010, INT PSYCHOGERIATR, V22, P426, DOI 10.1017/S1041610209991335; Burgess P.W., 1997, HAYLING BRIXTON TEST; Caeiro L, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346076; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Chin WW, 2010, HDB PARTIAL LEAST; Clarke DE, 2007, J NEUROPSYCH CLIN N, V19, P57, DOI 10.1176/appi.neuropsych.19.1.57; Delis DC., 2001, DELIS KAPLAN EXECUTI; den Brok MGHE, 2015, MOVEMENT DISORD, V30, P759, DOI 10.1002/mds.26208; Donovan NJ, 2015, J ALZHEIMERS DIS, V46, P63, DOI 10.3233/JAD-142940; Drijgers RL, 2009, DEMENT GERIATR COGN, V28, P13, DOI 10.1159/000228840; Fava M, 2006, J CLIN PSYCHIAT, V67, P1754, DOI 10.4088/JCP.v67n1113; Favrod J, 2009, ENCEPHALE, V35, P241, DOI 10.1016/j.encep.2008.02.013; Favrod J, 2010, PERSPECT PSYCHIATR C, V46, P171, DOI 10.1111/j.1744-6163.2010.00255.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Freitas AL, 2002, PERS SOC PSYCHOL B, V28, P121, DOI 10.1177/0146167202281011; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gray JA., 2000, NEUROPSYCHOLOGY ANXI; Groeneweg-Koolhoven I, 2014, AM J GERIAT PSYCHIAT, V22, P186, DOI 10.1016/j.jagp.2012.10.024; Grool AM, 2014, NEUROLOGY, V82, P1628, DOI 10.1212/WNL.0000000000000378; Guercio BJ, 2015, J ALZHEIMERS DIS, V47, P421, DOI 10.3233/JAD-150146; Haenlein M., 2004, Understanding Statistics, V3, P283, DOI 10.1207/s15328031us0304_4; Hair J. F, 2014, PRIMER PARTIAL LEAST; Ishii S, 2009, J AM MED DIR ASSOC, V10, P381, DOI 10.1016/j.jamda.2009.03.007; Jordan LL, 2013, MOVEMENT DISORD, V28, P1301, DOI 10.1002/mds.25496; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Konstantakopoulos G, 2011, SCHIZOPHR RES, V133, P193, DOI 10.1016/j.schres.2011.07.003; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lardi C, 2008, PERS INDIV DIFFER, V45, P722, DOI 10.1016/j.paid.2008.07.019; Levenson RW, 2014, ANNU REV CLIN PSYCHO, V10, P581, DOI 10.1146/annurev-clinpsy-032813-153653; Ligthart SA, 2012, ARCH GEN PSYCHIAT, V69, P636, DOI 10.1001/archgenpsychiatry.2011.1858; Lou Q, 2015, J CLIN NURS, V24, P2668, DOI 10.1111/jocn.12870; Mackinnon A, 2005, ENCEPHALE, V31, P31; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Moonen JEF, 2015, J AM GERIATR SOC, V63, P112, DOI 10.1111/jgs.13199; Mossaheb N, 2012, J CLIN PSYCHIAT, V73, P1009, DOI 10.4088/JCP.11m06962; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Njomboro P, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00073; O'Connor RM, 2004, PERS INDIV DIFFER, V37, P985, DOI 10.1016/j.paid.2003.11.008; Okura T, 2010, J AM GERIATR SOC, V58, P330, DOI 10.1111/j.1532-5415.2009.02680.x; Onyike CU, 2007, AM J GERIAT PSYCHIAT, V15, P365, DOI 10.1097/01.JGP.0000235689.42910.0d; Pagonabarraga J, 2015, LANCET NEUROL, V14, P518, DOI 10.1016/S1474-4422(15)00019-8; Rea R, 2014, SCI WORLD J, DOI 10.1155/2014/421385; Ringle CM, 2005, SMARTPLS VERSION 0 0; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Rochat L, 2013, NEUROLOGY, V81, P1674, DOI 10.1212/01.wnl.0000435290.49598.1d; Rog LA, 2014, CLIN NEUROPSYCHOL, V28, P215, DOI 10.1080/13854046.2013.876101; Shelton JT, 2009, INTELLIGENCE, V37, P283, DOI 10.1016/j.intell.2008.11.005; Squares WW Chin, 2010, SPRINGER HDB COMPUTA, P655; Tang WK, 2013, CEREBROVASC DIS, V35, P566, DOI 10.1159/000351152; Telenius EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126102; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Yao H, 2015, J STROKE CEREBROVASC, V24, P2625, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.018	61	7	7	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0161-9152	1574-4647		AGE	Age	JUN	2016	38	3							55	10.1007/s11357-016-9916-z			12	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DX9RZ	WOS:000384734100008	27153818	Green Published			2022-02-06	
J	Tjonndal, A				Tjonndal, Anne			NHL Heavyweights: Narratives of Violence and Masculinity in Ice Hockey	PHYSICAL CULTURE AND SPORT STUDIES AND RESEARCH			English	Article						player violence; hockey; sports; masculinity; NHL	AGGRESSION; CONCUSSIONS; AMERICAN; RISK	Sport is often considered a masculine area of social life, and few sports are more commonly associated with traditional norms of masculinity than ice hockey. Ice hockey is played with a great level of intensity and body contact. This is true for both men and women's hockey. However, men's ice hockey in particular has been subjected to criticism for its excessive violence. Sport has also been analyzed as an arena where boys and men learn masculine values, relations, and rituals, and is often linked to orthodox masculinity in particular. Tolerance for gender diversity and diverse forms of masculinity has generally increased during the last 30 years. However, orthodox masculinity seems to maintain a dominate position in sports, particularly in hyper-masculine sports such as ice hockey. In this article, narratives of masculinity and violence in professional ice hockey are a central focus. Through a narrative analysis of the biographies of two former National Hockey League (NHL) players, Bob Probert and Derek Boogaard, this article explores how narratives of masculinity and violence among hockey players have been described and how these narratives tell stories of the interplay between masculinity and violence in modern sport. The analysis illustrates how the narratives of the lives and careers of these athletes provide insight into the many personal risks and implications athletes in highly masculine sporting environments face. The analysis also illustrates how the common acceptance (and sometimes encouragement) of player violence and 'violence against the self' in ice hockey has led to many broken bodies, lives, and careers among professional male athletes.	[Tjonndal, Anne] Nord Univ, Bodo, Norway		Tjonndal, A (corresponding author), Nord Univ, Fac Social Sci, Postboks 1490, N-8049 Bodo, Norway.	anne.b.tjonndal@nord.no		Tjonndal, Anne/0000-0002-8579-1539			Anderson E, 2005, SOCIOL PERSPECT, V48, P337, DOI 10.1525/sop.2005.48.3.337; Anderson E, 2009, ROUTL RES GEND SOC, P1; Anderson E, 2002, GENDER SOC, V16, P860, DOI 10.1177/089124302237892; Anderson E, 2011, GENDER EDUC, V23, P729, DOI 10.1080/09540253.2010.528377; Andrews M., 2007, SHAPING HIST; Andrews M., 2002, GENERATIONAL CONSCIO; Andrews Molly., 2014, NARRATIVE IMAGINATIO; Apter Michael J., 1989, REVERSAL THEORY MOTI; Atkinson M., 2008, DEVIANCE SOCIAL CONT; Atkinson M., 2001, N AM SOC SOC SPORT S; Atyeo D, 1979, VIOLENCE IN SPORTS; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Branch J, 2014, BOY ICE LIFE DEATH D; Bratberg O., 2014, TEKSTANALYSE SAMFUNN; Cashmore E., 2005, TYSON NURTURE BEAST; Cashmore Ellis., 2000, SPORTS CULTURE A Z G; Coakley J., 2004, SPORTS SOC ISSUES CO; Coakley J.J., 2009, SPORTS SOC ISSUES CO, V10th ed.; Coates D., 2012, SPORTS EC MANAGEMENT, V9, P47; Connell R.W., 1995, MASCULINITIES; Courson S., 1991, FALSE GLORY; Dahlen P., 2003, BECKHAM MANNEN MYTEN; Douglas K, 2009, J APPL SPORT PSYCHOL, V21, P213, DOI 10.1080/10413200902795109; Elias N., 1986, QUEST EXCITEMENT SPO; Elias N, 1939, CIVILIZING PROCESS; Eng H., 2002, IDRETTENS BEVEGELSER; Engebretsen E., 2012, MAKT PA NYE MATER; Freeman M., 2003, REWRITING SELF HIST; Gee CJ, 2007, PSYCHOL SPORT EXERC, V8, P567, DOI 10.1016/j.psychsport.2006.06.006; Gibney A., 2011, THE LAST GLADIATORS; Gruneau, 2006, ARTIFICIAL ICE HOCKE; Guttmann A., 2004, RITUAL RECORD NATURE; Hjelseth A., 2016, SOSIOLOGISK TIDSSKRI, V24, P79; Hjelseth A., 2006, THESIS; Hjelseth A, 2005, SOCIOLOGI DAG, V35, P69; Horrow R., 1980, SPORTS VIOLENCE INTE; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kerr J.H., 2004, RETHINKING VIOLENCE; Kerr JH, 2002, AGGRESSIVE BEHAV, V28, P1, DOI 10.1002/ab.90001; Lieblich A., 1998, NARRATIVE RES READIN; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Marsh P., 1978, RULES DISORDER; McEwen K, 2011, QUAL RES SPORT EXERC, V3, P152, DOI 10.1080/2159676X.2011.572181; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; NHL, 2014, OFF RUL 2014 2015; Probert B., 2010, TOUGH GUY MY LIFE ED; Pronger B, 1990, ARENA MASCULINITY; Riessman C, 1993, NARRATIVE ANAL QUALI; Riessman K. C., 2008, NARRATIVE METHODS HU; RUSSELL GW, 1976, HUM RELAT, V29, P723, DOI 10.1177/001872677602900802; Rustin M., 2000, TURN BIOGRAPHICAL ME; Smith M. D., 1983, VIOLENCE AND SPORT; Smith S, 2010, READING AUTOBIOGRAPHY: A GUIDE FOR INTERPRETING LIFE NARRATIVES, SECOND EDITION, P1; Squire C., 2008, DOING NARRATIVE RES; Squire C., 2014, WHAT IS NARRATIVE RE; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Theberge N, 2003, YOUTH SOC, V34, P497, DOI 10.1177/0044118X03034004005; Tjonndal A., 2016, QUALITATIVE SO UNPUB, V12; Tjonndal A., 2016, KJONN SOM S IN PRESS; Weinstein MD, 1995, SEX ROLES, V33, P831, DOI 10.1007/BF01544782; Widmeyer WN, 1997, INT J SPORT PSYCHOL, V28, P57; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; YOUNG K, 1993, SOCIOL SPORT J, V10, P373, DOI 10.1123/ssj.10.4.373; Young K., 2012, SPORT VIOLENCE SOC; [No title captured]	65	7	7	1	11	SCIENDO	WARSAW	BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND	2081-2221	1899-4849		PHYS CULT SPORT STUD	Phys. Cult. Sport Stud. Res.	JUN	2016	70	1					55	68		10.1515/pcssr-2016-0013			14	Hospitality, Leisure, Sport & Tourism	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	FK6SG	WOS:000413634900005		Green Submitted, gold			2022-02-06	
J	Wang, J; Ding, D; Teodorski, EE; Mahajan, HP; Cooper, RA				Wang, Jing; Ding, Dan; Teodorski, Emily E.; Mahajan, Harshal P.; Cooper, Rory A.			Use of Assistive Technology for Cognition Among People With Traumatic Brain Injury: A Survey Study	MILITARY MEDICINE			English	Article							PORTABLE ELECTRONIC DEVICES; CLOSED-HEAD-INJURY; MEMORY; REHABILITATION; AIDS; RECOMMENDATIONS; INDIVIDUALS; AFGHANISTAN; THERAPY; IMPACT	A survey was designed and administered in this study to assess the use of assistive technology for cognition (ATC), especially portable electronic ATC, among veterans with traumatic brain injury (TBI). The aim of the survey was to obtain information on current ATC devices and applications use, users' experience with different features of ATC, and relevant training/support for their ATC. Twenty-nine veterans with TBI participated in this study. Results showed that portable electronic ATC, especially smartphones and a variety of apps, were widely used by the participants to compensate for cognitive limitations. Portable electronic devices such as smartphones and smart pads received higher usability ratings than paper-based tools. More than 75% of participants did not go through a service delivery process for these electronic ATC. The information collected in the study provided a more updated picture of ATC use, especially portable electronic ATC use, among people with TBI. It also potentially informs the future development of ATC and supports the need for training and an appropriate acquisition process of portable electronic ATC devices.	[Wang, Jing] Univ Pittsburgh, Dept Rehabil Sci & Technol, Sch Hlth & Rehabil Sci, 6425 Penn Ave,Suite 401, Pittsburgh, PA 15206 USA; [Ding, Dan; Teodorski, Emily E.; Mahajan, Harshal P.; Cooper, Rory A.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Sch Hlth & Rehabil Sci, 6425 Penn Ave,Suite 400, Pittsburgh, PA 15206 USA		Wang, J (corresponding author), Univ Pittsburgh, Dept Rehabil Sci & Technol, Sch Hlth & Rehabil Sci, 6425 Penn Ave,Suite 401, Pittsburgh, PA 15206 USA.				Department of Veterans AffairsUS Department of Veterans Affairs	This research was funded through the Department of Veterans Affairs.	Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Constantinidou F., 2004, TRAUMA BRAIN INJ REH, V2, P338; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Day H, 2002, DISABIL REHABIL, V24, P31, DOI 10.1080/09638280110066343; Day H., 1996, CAN J REHABIL, V9, P159; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; DePompei R, 2004, LEARNING COGNITIVE C; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Goldenberg G, 2001, NEUROPSYCHOL REHABIL, V11, P147, DOI 10.1080/09602010042000204; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PARENTE R, 1991, COGNITIVE REHABILITA, P147; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Phillips B, 1993, Assist Technol, V5, P36; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Scherer MJ, 2005, REHABIL PSYCHOL, V50, P132, DOI 10.1037/0090-5550.50.2.132; Scherer MJ, 2001, DISABIL REHABIL, V23, P387; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; United States, 2010, HOSP DEATH 2002 2006; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; YLVISAKER M, 1998, TRAUMATIC BRAIN INJU, P181	35	7	7	0	7	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JUN	2016	181	6					560	566		10.7205/MILMED-D-14-00704			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5LO	WOS:000383686900015	27244066	Bronze			2022-02-06	
J	Womble, MN; Reynolds, E; Schatz, P; Shah, KM; Kontos, AP				Womble, Melissa N.; Reynolds, Erin; Schatz, Philip; Shah, Kishan M.; Kontos, Anthony P.			Test-Retest Reliability of Computerized Neurocognitive Testing in Youth Ice Hockey Players	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Practice effects; reliable change; Statistical methods	SPORT-RELATED CONCUSSION; WHITE-MATTER; TEST BATTERY; IMPACT; MANAGEMENT; RECOVERY	Computerized neurocognitive tests are frequently used to assess pediatric sport-related concussions; however, only 1 study has focused on the test-retest reliability of the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) in high school athletes and age influences have largely been ignored. Therefore, the purpose was to investigate the test-retest reliability of ImPACT and underlying age influences in a pediatric population. Two hundred (169 men and 31 women) youth ice hockey players completed ImPACT before/after a 6-month season. Reliability was assessed using Pearson correlation coefficients, intraclass correlation coefficients (ICCs), and regression-based methods (RBz). ICCs for the sample ranged from .48 to .75 (single)/.65 to .86 (average). In general, the older athletes (15-18: Single/Average ICCs = .35-.75/.52-.86) demonstrated greater reliability across composites than the younger athletes (11-14: Single/Average ICCs = .54-.63/.70-.77). Although there was variation in athletes' performance across two test administrations, RBz revealed that only a small percentage of athletes performed beyond 80%, 90%, and 95% confidence intervals. Statistical metrics demonstrated reliability coefficients for ImPACT composites in a pediatric sample similar to previous studies, and also revealed important age-related influences.	[Womble, Melissa N.; Reynolds, Erin; Shah, Kishan M.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Dept Orthopaed Surg, 3200 South Water St, Pittsburgh, PA 15203 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Pittsburgh, PA USA; [Shah, Kishan M.] Indiana Univ Sch Med, Dept Orthoped Surg, Indianapolis, IN 46202 USA		Womble, MN (corresponding author), Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Dept Orthopaed Surg, 3200 South Water St, Pittsburgh, PA 15203 USA.	womblemn@upmc.edu	Meijer, Anna/K-5118-2016	Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; University of PittsburghUniversity of Pittsburgh; Bauer Hockey, Inc.	This research was supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to APK, and through a research contract between the University of Pittsburgh and Bauer Hockey, Inc. to APK.	Baumgartner T., 2001, MEASUREMENT PHYS ED, P179; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Slick DJ, 2006, COMPENDIUM NEUROPSYC, P3; Stevens MC, 2009, NEUROIMAGE, V48, P738, DOI 10.1016/j.neuroimage.2009.06.065	23	7	8	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2016	31	4					305	312		10.1093/arclin/acw011			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DN9RG	WOS:000377417200003	27084734	Green Published, Bronze			2022-02-06	
J	Zhao, YL; Song, JN; Ma, XD; Zhang, BF; Li, DD; Pang, HG				Zhao, Yong-lin; Song, Jin-ning; Ma, Xu-dong; Zhang, Bin-fei; Li, Dan-dong; Pang, Hong-gang			Rosiglitazone ameliorates diffuse axonal injury by reducing loss of tau and up-regulating caveolin-1 expression	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; diffuse axonal injury; rosiglitazone; hyperphosphorylated tau; total tau; caveolin-1; rats; amyloid precursor protein; ser404; cortex; immunocytochemistry; western blot assay; neural regeneration	TRAUMATIC BRAIN-INJURY; NEURODEGENERATIVE DISEASES; MEMORY IMPAIRMENT; AMYLOID-BETA; CELLS; HYPERPHOSPHORYLATION; INHIBITION; MECHANISMS; RATS; PHOSPHORYLATION	Rosiglitazone up-regulates caveolin-1 levels and has neuroprotective effects in both chronic and acute brain injury. Therefore, we postulated that rosiglitazone may ameliorate diffuse axonal injury via its ability to up-regulate caveolin-1, inhibit expression of amyloid-beta precursor protein, and reduce the loss and abnormal phosphorylation of tau. In the present study, intraperitoneal injection of rosiglitazone significantly reduced the levels of amyloid-beta precursor protein and hyperphosphorylated tau (phosphorylated at Ser (404) (p-tau (S (404) )), and it increased the expression of total tau and caveolin-1 in the rat cortex. Our results show that rosiglitazone inhibits the expression of amyloid-beta precursor protein and lowers p-tau (S (404) ) levels, and it reduces the loss of total tau, possibly by up-regulating caveolin-1. These actions of rosiglitazone may underlie its neuroprotective effects in the treatment of diffuse axonal injury.	[Zhao, Yong-lin; Song, Jin-ning; Ma, Xu-dong; Zhang, Bin-fei; Li, Dan-dong; Pang, Hong-gang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China.	jinningsong@126.com		Song, Jin-Ning/0000-0002-0620-8983	New Century Supporting Programs to Excellent Talents in China [NCET-05-0831]	This study was funded by the New Century Supporting Programs to Excellent Talents in China, No. NCET-05-0831.	Bernal C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00078; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Cheng MF, 2014, ACTA NEUROCHIR, V156, P2103, DOI 10.1007/s00701-014-2196-4; Chintharlapalli S, 2004, CANCER RES, V64, P5994, DOI 10.1158/0008-5472.CAN-04-0399; Dong DW, 2014, BRAIN RES, V1543, P280, DOI 10.1016/j.brainres.2013.11.004; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Liu J, 2015, DRUG AGING, V32, P57, DOI 10.1007/s40266-014-0228-7; Llaverias G, 2004, J LIPID RES, V45, P2015, DOI 10.1194/jlr.M400049-JLR200; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Madeira JM, 2015, NEURAL REGEN RES, V10, P391, DOI 10.4103/1673-5374.153686; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Mu J, 2015, INT J CLIN EXP PATHO, V8, P4388; Seda O, 2008, PHARMACOGENOMICS, V9, P141, DOI 10.2217/14622416.9.2.141; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Song Jin-zhi, 2014, Yaoxue Xuebao, V49, P807; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Tencer L, 2008, ANTICANCER RES, V28, P895; Tokutake T, 2012, J BIOL CHEM, V287, P35222, DOI 10.1074/jbc.M112.348300; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xu SJ, 2014, NEUROSCI LETT, V578, P7, DOI 10.1016/j.neulet.2014.06.010; Yao J, 2015, MOL MED REP, V12, P7693, DOI 10.3892/mmr.2015.4401; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yonutas HM, 2013, CURR DRUG TARGETS, V14, P733, DOI 10.2174/1389450111314070003; Yoon SY, 2010, NEUROBIOL DIS, V40, P449, DOI 10.1016/j.nbd.2010.07.005; Yu Y, 2015, J NEURAL TRANSM, V122, P593, DOI 10.1007/s00702-014-1294-z	31	7	7	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2016	11	6					944	950		10.4103/1673-5374.184493			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DS9QU	WOS:000381119200027	27482223	Green Published, gold			2022-02-06	
J	Altmeyer, W; Steven, A; Gutierrez, J				Altmeyer, Wilson; Steven, Andrew; Gutierrez, Juan			Use of Magnetic Resonance in the Evaluation of Cranial Trauma	MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA			English	Article						Cranial trauma; Diffuse axonal injury; Contusion; Hematoma; MR imaging	DIFFUSE AXONAL INJURY; MRI UTILIZATION TRENDS; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; INTRACRANIAL HYPOTENSION; SUBDURAL HYGROMA; CT ANGIOGRAPHY; CHILDREN; LESIONS; DIAGNOSIS	Magnetic resonance (MR) imaging is an extremely useful tool in the evaluation of traumatic brain injury in the emergency department. Although Computed tomography (CT) still plays the dominant role in urgent patient triage, MR imaging's impact on traumatic brain injury imaging continues to expand. MR imaging has shown superiority to CT for certain traumatic processes, such as diffuse axonal injury, cerebral contusion, and infarction. Magnetic resonance angiography and magnetic resonance venography allow emergent vascular imaging for patients that should avoid ionizing radiation or intravenous contrast.	[Altmeyer, Wilson] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Steven, Andrew] Univ Maryland Med Syst, Dept Radiol, 22 Sout Green St, Baltimore, MD 21201 USA; [Gutierrez, Juan] Ctr Avanzado Diagnost Med CEDIMED, Calle 18 AA 29 C 340, Medellin, Colombia		Altmeyer, W (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	altmeyer@uthscsa.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Agarwal R, 2010, J AM COLL RADIOL, V7, P949, DOI 10.1016/j.jacr.2010.08.015; Ahn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112650; Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Chen CCC, 2005, AM J NEURORADIOL, V26, P2349; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Choudhary AK, 2015, PEDIATR RADIOL, V45, P1803, DOI 10.1007/s00247-015-3399-4; da Rocha AJ, 2006, J COMPUT ASSIST TOMO, V30, P295, DOI 10.1097/00004728-200603000-00025; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; de Souza JM, 2008, AM J NEURORADIOL, V29, P154, DOI 10.3174/ajnr.A0748; Evans R., 2006, NEUROLOGY AND TRAUMA; Farb RI, 2007, AM J NEURORADIOL, V28, P1489, DOI 10.3174/ajnr.A0621; Faul M, 2010, CENT DIS CONTROL PRE; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Grandin CB, 2000, AM J NEURORADIOL, V21, P1611; Huisman TAGM, 2009, J NEURORADIOLOGY, V36, P93, DOI 10.1016/j.neurad.2008.06.003; Ito J, 1996, J NEUROSURG, V841, P97; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; Kabir SMR, 2004, BRIT J NEUROSURG, V18, P297, DOI 10.1080/02688690410001732797; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; MCCLUNEY KW, 1992, AM J NEURORADIOL, V13, P1335; Mitchell P, 2001, J NEUROL NEUROSUR PS, V70, P205, DOI 10.1136/jnnp.70.2.205; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Osborn AG, 2013, OSBORNS BRAIN IMAGIN; PANNULLO SC, 1993, NEUROLOGY, V43, P919, DOI 10.1212/WNL.43.5.919; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Quaday KA, 2014, AM J EMERG MED, V32, P524, DOI 10.1016/j.ajem.2014.01.054; Rankey D, 2008, ACAD RADIOL, V15, P438, DOI 10.1016/j.acra.2008.01.003; Rodallec MH, 2008, RADIOGRAPHICS, V28, P1711, DOI 10.1148/rg.286085512; Shah LM, 2013, AM J ROENTGENOL, V200, P400, DOI 10.2214/AJR.12.8611; Shams S, 2015, AM J NEURORADIOL, V36, P1089, DOI 10.3174/ajnr.A4248; Siddiqui FM, 2011, NEUROTHERAPEUTICS, V8, P28, DOI 10.1007/s13311-010-0009-x; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Srinivasan A, 2006, RADIOGRAPHICS, V26, pS75, DOI 10.1148/rg.26si065501; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verma RK, 2013, EUR J RADIOL, V82, P1539, DOI 10.1016/j.ejrad.2013.03.021; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189; Wasay M, 2005, J NEUROIMAGING, V15, P118, DOI 10.1177/1051228404272883; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; Yousem DM, 2010, NEURORADIOLOGY REQUI; Yuan Mei-Kang, 2005, J Chin Med Assoc, V68, P131; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc; Zhang ZQ, 2000, CHINESE MED J-PEKING, V113, P1043; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	51	7	8	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-9689	1557-9786		MAGN RESON IMAGING C	Magn. Reson. Imaging Clin. N. Am.	MAY	2016	24	2					305	+		10.1016/j.mric.2015.11.011			20	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DN5YV	WOS:000377148500004	27150321				2022-02-06	
J	Phang, I; Mada, M; Kolias, AG; Newcombe, VFJ; Trivedi, RA; Carpenter, A; Hawkes, RC; Papadopoulos, MC				Phang, Isaac; Mada, Marius; Kolias, Angelos G.; Newcombe, Virginia F. J.; Trivedi, Rikin A.; Carpenter, Adrian; Hawkes, Rob C.; Papadopoulos, Marios C.			Magnetic Resonance Imaging of the Codman Microsensor Transducer Used for Intraspinal Pressure Monitoring	SPINE			English	Article						heating; human; ISP; magnetic; MRI; paralysis; radiofrequency; safety; spinal cord injury; spinal cord perfusion pressure; transducer	CORD PERFUSION-PRESSURE; INJURY	Study Design. Laboratory and human study. Objective. To test the Codman Microsensor Transducer (CMT) in a cervical gel phantom. To test the CMT inserted to monitor intraspinal pressure in a patient with spinal cord injury. Summary of Background Data. We recently introduced the technique of intraspinal pressure monitoring using the CMT to guide management of traumatic spinal cord injury [Werndle et al. Crit Care Med 2014; 42: 646]. This is analogous to intracranial pressure monitoring to guide management of patients with traumatic brain injury. It is unclear whether magnetic resonance imaging (MRI) of patients with spinal cord injury is safe with the intraspinal pressure CMT in situ. Methods. We measured the heating produced by the CMT placed in a gel phantom in various configurations. A 3-T MRI system was used with the body transmit coil and the spine array receive coil. A CMT was then inserted subdurally at the injury site in a patient who had traumatic spinal cord injury and MRI was performed at 1.5 T. Results. In the gel phantom, heating of up to 5 degrees C occurred with the transducer wire placed straight through the magnet bore. The heating was abolished when the CMT wire was coiled and passed away from the bore. We then tested the CMT in a patient with an American Spinal Injuries Association grade C cervical cord injury. The CMT wire was placed in the configuration that abolished heating in the gel phantom. Good-quality T1 and T2 images of the cord were obtained without neurological deterioration. The transducer remained functional after the MRI. Conclusion. Our data suggest that the CMT is MR conditional when used in the spinal configuration in humans. Data from a large patient group are required to confirm these findings.	[Phang, Isaac; Papadopoulos, Marios C.] St Georges Univ London, Acad Neurosurg Unit, London SW17 0RE, England; [Mada, Marius; Newcombe, Virginia F. J.; Carpenter, Adrian; Hawkes, Rob C.] Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge, England; [Kolias, Angelos G.; Trivedi, Rikin A.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England		Papadopoulos, MC (corresponding author), St Georges Univ London, Rm 0-136 Jenner, London SW17 0RE, England.	mpapadop@sgul.ac.uk		Newcombe, Virginia/0000-0001-6044-9035; Kolias, Angelos/0000-0003-3992-0587; Papadopoulos, Marios/0000-0001-9174-4176	Fletcher Fund; Neurosciences Research Foundation; London Deanery; Wings for Life funds; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-CSF4-Newcombe] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2009-14-007] Funding Source: researchfish	The Fletcher Fund, the Neurosciences Research Foundation, London Deanery, and Wings for Life funds were received in support of this work.	Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Matthes R, 2004, HEALTH PHYS, V87, P197; Newcombe VFJ, 2008, J NEUROSURG, V109, P159, DOI 10.3171/JNS/2008/109/7/0159; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Tanaka R, 2012, J NEUROSURG, V117, P1100, DOI 10.3171/2012.9.JNS12738; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Williams EJ, 1999, J NEUROSURG, V91, P706, DOI 10.3171/jns.1999.91.4.0706	9	7	7	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY	2016	41	10					E605	E610		10.1097/BRS.0000000000001334			6	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	DL4RZ	WOS:000375626200005	26641852	Green Accepted			2022-02-06	
J	Phillips, MM; Reddy, CC				Phillips, Mary Miller; Reddy, Cara Camiolo			Managing Patients with Prolonged Recovery Following Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Postconcussion syndrome; Pharmacologic interventions; Non-pharmacologic management	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; APOLIPOPROTEIN-E POLYMORPHISM; COLLEGIATE FOOTBALL PLAYERS; PLACEBO-CONTROLLED TRIAL; MINOR HEAD-INJURY; OF-THE-LITERATURE; POSTCONCUSSION SYNDROME; RISK-FACTORS; COGNITIVE REHABILITATION	Persistent symptoms following concussion can be debilitating for patients and challenging for clinicians; however, evidence-based approaches to symptom management are emerging. The presentation of postconcussion syndrome can be variable among patients. Given this variability, a thorough history and physical examination are necessary to tailor an individualized treatment approach. Pharmacologic interventions can be considered when prolonged symptoms are negatively affecting quality of life. This article reviews evidence available to guide such treatment decisions.	[Phillips, Mary Miller; Reddy, Cara Camiolo] Univ Pittsburgh, Med Ctr, Brain Injury Program, Dept Phys Med & Rehabil,UPMC Rehabil Inst, 1400 Locust St,D-G103, Pittsburgh, PA 15219 USA		Reddy, CC (corresponding author), Univ Pittsburgh, Med Ctr, Brain Injury Program, Dept Phys Med & Rehabil,UPMC Rehabil Inst, 1400 Locust St,D-G103, Pittsburgh, PA 15219 USA.	camice@upmc.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Balaban CD, 2012, BRAIN RES, V1482, P101, DOI 10.1016/j.brainres.2012.08.040; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bell KR, 1999, J HEAD TRAUMA REHAB, V14, P34, DOI 10.1097/00001199-199902000-00006; Bendtsen L, 2005, HEADACHES, P735; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bonk AD, 2000, J MUSCULOSKELET PAIN, V8, P123, DOI 10.1300/J094v08n01_10; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Collie A, 2006, BRIT J SPORT MED, V40, P805; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dick RW, 2009, BRIT J SPORT MED, V43, P146; DiFazio M, 2015, CLIN PEDIAT PHILA; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Farace E, 2000, Neurosurg Focus, V8, pe6; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Freund BJ, 2000, HEADACHE, V40, P231, DOI 10.1046/j.1526-4610.2000.00033.x; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hickling EJ, 1992, HEADACHE Q-CURR TREA, V3, P285; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JENSEN OK, 1990, CEPHALALGIA, V10, P241, DOI 10.1046/j.1468-2982.1990.1005241.x; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lampl C, 2006, CEPHALALGIA, V26, P1203, DOI 10.1111/j.1468-2982.2006.01193.x; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lercher K, 2014, PROG NEUROL SURG, V28, P139, DOI 10.1159/000358771; Lerman B, 2011, J NEUROTRAUM, V28, pA16; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lucas S., 2015, BRAIN NEUROTRAUMA MO, P93; LUCOTTE G, 1994, AM J MED GENET, V54, P286, DOI 10.1002/ajmg.1320540319; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Magis D, 2007, HEADACHE, V47, P52, DOI 10.1111/j.1526-4610.2006.00626.x; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maroon JC, 2012, PHYSICIAN SPORTSMED, V40, P73, DOI 10.3810/psm.2012.11.1990; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, BRIT J SPORT MED, V43, pi76; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Muller U, 1999, BRAIN INJURY, V13, P805, DOI 10.1080/026990599121197; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Peikert A, 1996, CEPHALALGIA, V16, P257, DOI 10.1046/j.1468-2982.1996.1604257.x; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Ramadan N, 1999, NEUROLOGY, V55, P754; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Reiter RJ, 2008, SAUDI MED J, V29, P1537; Rogers NL, 2003, SLEEP, V26, P1058; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Samantaray S, 2009, J PINEAL RES, V47, P134, DOI 10.1111/j.1600-079X.2009.00703.x; Sandor PS, 2005, NEUROLOGY, V64, P713, DOI 10.1212/01.WNL.0000151975.03598.ED; Schneider RC., 1973, HEAD NECK INJURIES F; Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tatrow K, 2003, APPL PSYCHOPHYS BIOF, V28, P267, DOI 10.1023/A:1027326808356; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Theriault M, 2010, J CLIN EXP NEUROPSYC, V17, P1; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	153	7	7	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					455	+		10.1016/j.pmr.2015.12.005			21	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DN4RU	WOS:000377055700008	27154856				2022-02-06	
J	Pratt, B; Cheesman, J; Breslin, C; Do, MT				Pratt, B.; Cheesman, J.; Breslin, C.; Do, M. T.			Occupational injuries in Canadian youth: an analysis of 22 years of surveillance data collected from the Canadian Hospitals Injury Reporting and Prevention Program	HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION IN CANADA-RESEARCH POLICY AND PRACTICE			English	Article						adolescent; injury surveillance; occupational injuries; young workers; youth injuries	TRAUMATIC BRAIN-INJURY; YOUNG WORKERS; EMERGENCY-DEPARTMENTS; QUALITY	Introduction: Inexperience, inadequate training and differential hazard exposure may contribute to a higher risk of injury in young workers. This study describes features of work-related injuries in young Canadians to identify areas for potential occupational injury prevention strategies. Methods: We analyzed records for youth aged 10-17 presenting to Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP) emergency departments (EDs) from 1991-2012. We classified work-related injuries into job groups corresponding to National Occupational Classification for Statistics 2006 codes and conducted descriptive analyses to assess injury profiles by job group. Age-and sex-adjusted proportionate injury ratios (PIRs) and 95% confidence intervals (CIs) were calculated to compare the nature of injuries between occupational and non-occupational events overall and by job group. Results: Of the 6046 injuries (0.72% of events in this age group) that occurred during work, 63.9% were among males. Youth in food and beverage occupations (54.6% males) made up 35.4% of work-related ED visits and 10.2% of work-related hospital admissions, while primary industry workers (76.4% males) made up 4.8% of work-related ED visits and 24.6% of work-related hospital admissions. PIRs were significantly elevated for burns (9.77, 95% CI: 8.94-10.67), crushing/amputations (6.72, 95% CI: 5.79-7.80), electrical injuries (6.04, 95% CI: 3.64-10.00), bites (5.09, 95% CI: 4.47-5.79), open wounds (2.68, 95% CI: 2.59-2.78) and eye injuries (2.50, 95% CI: 2.20-2.83) in occupational versus non-occupational events. These were largely driven by high proportional incidence of injury types unique to job groups. Conclusion: Our findings provide occupation group-specific information on common injury types that can be used to support targeted approaches to reduce incidence of youth injury in the workplace.	[Pratt, B.; Cheesman, J.; Do, M. T.] Publ Hlth Agcy Canada, Surveillance & Epidemiol Div, 785 Carling Ave, Ottawa, ON K1A 0K9, Canada; [Pratt, B.; Do, M. T.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Breslin, C.] Inst Work & Hlth, Toronto, ON, Canada		Do, MT (corresponding author), Publ Hlth Agcy Canada, Surveillance & Epidemiol Div, 785 Carling Ave, Ottawa, ON K1A 0K9, Canada.	Minh.T.Do@phac-aspc.gc.ca					Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Association of Workers' Compensation Boards of Canada, 2013, NAT WORK INJ DIS STA; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barnetson Bob, 2013, CAN J WORK SOC, V20, P14; Bhattacharya A, 2014, INT J IND ERGONOM, V44, P448, DOI 10.1016/j.ergon.2014.01.008; Boyle P, 1991, CANC REGISTRATION PR, V95; Breslin C, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e10; Breslin FC, 2007, ANN EPIDEMIOL, V17, P814, DOI 10.1016/j.annepidem.2007.04.004; Breslin FC, 2007, SOC SCI MED, V64, P782, DOI 10.1016/j.socscimed.2006.10.024; Breslin FC, 2013, AM J IND MED, V56, P1180, DOI 10.1002/ajim.22195; Breslow NE, 1987, STAT METHODS CANC RE, VI; Canadian Institute for Health Information, 2015, INJ TRAUM EM DEP STA; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; DO MT, 2013, INT J CIRCUMPOL HEAL, V72, P1; GALARNEAU D, 2005, PERSP LABOUR INCOME, V17, P40; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kang J, 2013, INT J INJ CONTROL SA, V20, P19, DOI 10.1080/17457300.2012.656315; Knowles SB, 2010, J ATHL TRAINING, V45, P475, DOI 10.4085/1062-6050-45.5.475; Koehoorn M, 2008, J ADOLESCENT HEALTH, V43, P466, DOI 10.1016/j.jadohealth.2008.04.012; Lewko J, 2011, CURRENT HLTH SAFETY; Lipscomb H J, 2001, Inj Prev, V7, P205, DOI 10.1136/ip.7.3.205; Lipskie Tammy, 2005, Chronic Dis Can, V26, P107; Lombardi DA, 2009, ACCIDENT ANAL PREV, V41, P755, DOI 10.1016/j.aap.2009.03.017; Loughlin C, 2001, J OCCUP ORGAN PSYCH, V74, P543, DOI 10.1348/096317901167514; Macarthur C, 1999, AM J EPIDEMIOL, V149, P586; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; Reichard AA, 2015, AM J IND MED, V58, P290, DOI 10.1002/ajim.22407; Runyan CW, 2008, AM J IND MED, V51, P735, DOI 10.1002/ajim.20624; SAS Institute Inc. Cary NC USA, 2012, SAS SOFTW SAS SYST W; Statistics Canada, 2015, LAB FORC SURV LFS; Statistics Canada, 2015, LAB FORC SURV EST LF; Statistics Canada. Minister of Industry, 2006, NAT OCC CLASS STAT N; Tucker S, 2014, J SAFETY RES, V50, P67, DOI 10.1016/j.jsr.2014.04.001; Welch L S, 2001, Appl Occup Environ Hyg, V16, P755, DOI 10.1080/10473220152403691; Wray-Lake L, 2011, YOUTH SOC, V43, P1110, DOI 10.1177/0044118X10381367; Zierold KM, 2004, OCCUP ENVIRON MED, V61, P518, DOI 10.1136/oem.2003.010546	36	7	8	0	3	PUBLIC HEALTH AGENCY CANADA	OTTAWA	130 COLONNADE RD, ADDRESS LOCATOR 6501G, OTTAWA, ONTARIO K1A 0K9, CANADA	2368-738X			HEALTH PROMOT CHRON	Health Promot. Chronic Dis. Prev. Can.-Res. Policy Pract.	MAY	2016	36	5								10.24095/hpcdp.36.5.01			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	DM8GM	WOS:000376599400001	27172126	gold, Green Published			2022-02-06	
J	Prodan, CI; Vincent, AS; Dale, GL				Prodan, Calin I.; Vincent, Andrea S.; Dale, George L.			Coated-Platelet Levels Increase with Number of Injuries in Patients with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mild traumatic brain injury; platelets; stroke; thrombosis	STROKE; RISK; INFARCTION; SEROTONIN; LACUNAR; SURFACE	Coated-platelets are procoagulant platelets that are elevated in stroke and are associated with stroke recurrence. In a previous study, prompted by data showing an increased risk for stroke following traumatic brain injury (TBI), we found that coated-platelet levels are elevated in patients with combat-related mild TBI (mTBI) several years after the injury, compared with controls. We now investigate in an expanded patient population whether parameters commonly recorded in mTBI are related to increased coated-platelet potential. Coated-platelet levels were assayed in 120 mTBI patients at intervals ranging from 6 months to 10 years from the last injury. Correlations were calculated between coated-platelet levels and age, gender, race/ethnicity, loss of consciousness, alteration in consciousness, post-traumatic amnesia, number of injuries, mechanism of injury, time since first and last injury, smoking, medications that may influence coated-platelet levels, and pertinent comorbid conditions. Significant correlations were detected between coated-platelet levels and number of injuries (p = 0.026), gender (p = 0.01), and time since last injury (p = 0.04). A multi-variable linear model analysis, including these three parameters and an additional three parameters (race/ethnicity, smoking, and mechanism of injury) that reached a p value of <0.2, showed that the number of injuries were predictive of coated-platelet levels (p = 0.004). These results support a mechanistic link between increased coated-platelet levels and repeated injuries in mTBI. Long-term studies will be required to determine the impact of increased prothrombotic potential in mTBI patients.	[Prodan, Calin I.] Univ Oklahoma, Hlth Sci Ctr, Vet Adm Med Ctr, Oklahoma City, OK USA; [Prodan, Calin I.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK USA; [Dale, George L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Vincent, Andrea S.] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73019 USA		Prodan, CI (corresponding author), 920 SL Young Blvd,Suite 2040, Oklahoma City, OK 73104 USA.	calin-prodan@ouhsc.edu					Brooks MB, 2007, J THROMB HAEMOST, V5, P1972, DOI 10.1111/j.1538-7836.2007.02683.x; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Daskalakis M, 2014, CYTOM PART B-CLIN CY, V86, P397, DOI [10.1002/cyto.b.21157, 10.1002/cytob.21157]; *DEF VET BRAIN INJ, 2006, CLIN PRACT GUID REC; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Faul M, 2010, TRAUMATIC BRAIN INJU; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jenkins Alicia J, 2008, Diabetes Res Clin Pract, V81, pe8, DOI 10.1016/j.diabres.2008.04.004; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Meschia JF, 2014, MAYO CLIN PROC, V89, P142, DOI 10.1016/j.mayocp.2013.12.006; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Norgard NB, 2008, J CARDIOVASC PHARM, V52, P536, DOI 10.1097/FJC.0b013e3181907390; Prodan CI, 2008, J THROMB HAEMOST, V6, P609, DOI 10.1111/j.1538-7836.2008.02890.x; Prodan CI, 2007, J THROMB HAEMOST, V5, P2149, DOI 10.1111/j.1538-7836.2007.02691.x; Prodan CI, 2010, J THROMB HAEMOST, V8, P1185, DOI 10.1111/j.1538-7836.2010.03851.x; Prodan CI, 2014, J HEAD TRAUMA REHAB, V29, P522, DOI 10.1097/HTR.0000000000000010; Prodan CI, 2013, PLATELETS, V24, P316, DOI 10.3109/09537104.2012.696747; Prodan CI, 2013, J CEREBR BLOOD F MET, V33, P287, DOI 10.1038/jcbfm.2012.168; Prodan CI, 2010, STROKE, V41, P1301, DOI 10.1161/STROKEAHA.110.581447; Prodan CI, 2009, STROKE, V40, P2578, DOI 10.1161/STROKEAHA.109.549014; Prodan CI, 2006, PLATELETS, V17, P56, DOI 10.1080/09537100500181913; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tanielian T., 2008, INVISIBLE WOUNDS WAR; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Valaydon ZS, 2009, NEPHROLOGY, V14, P148, DOI 10.1111/j.1440-1797.2008.01026.x; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757	34	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					818	824		10.1089/neu.2014.3846			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800003	26414016				2022-02-06	
J	Rhine, TD; Byczkowski, TL; Clark, RA; Babcock, L				Rhine, Tara D.; Byczkowski, Terri L.; Clark, Ross A.; Babcock, Lynn			Investigating the Feasibility and Utility of Bedside Balance Technology Acutely After Pediatric Concussion: A Pilot Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; postural control; assessment; children; path length	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; PRESSURE MEASURES; CHILDREN; BOARD; RECOVERY; YOUTH	Objective: To examine postural instability in children acutely after concussion, using the Wii Balance Board (WBB). We hypothesized that children with traumatic brain injury would have significantly worse balance relative to children without brain injury. Design: Prospective case-control pilot study. Setting: Emergency department of a tertiary urban pediatric hospital. Participants: Cases were a convenience sample 11-16 years old who presented within 6 hours of sustaining concussion. Two controls, matched on gender, height, and age, were enrolled for each case that completed study procedures. Controls were children who presented for a minor complaint that was unlikely to affect balance. Interventions: Not applicable. Main Outcome Measures: The participant's postural sway expressed as the displacement in centimeters of the center of pressure during a timed balance task. Balance testing was performed using 4 stances (single or double limb, eyes open or closed). Results: Three of the 17 (17.6%) cases were too dizzy to complete testing. One stance, double limbs eyes open, was significantly higher in cases versus controls (85.6 vs 64.3 cm, P = 0.04). Conclusions: A simple test on the WBB consisting of a 2-legged standing balance task with eyes open discriminated children with concussion from non-head-injured controls. The low cost and feasibility of this device make it a potentially viable tool for assessing postural stability in children with concussion for both longitudinal research studies and clinical care. Clinical Relevance: These pilot data suggest that the WBB is an inexpensive tool that can be used on the sideline or in the outpatient setting to objectively identify and quantify postural instability.	[Rhine, Tara D.; Byczkowski, Terri L.; Babcock, Lynn] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave ML 2008, Cincinnati, OH 45229 USA; [Clark, Ross A.] Australian Catholic Univ, Div Hlth Sci, Melbourne, Vic, Australia		Rhine, TD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave ML 2008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Babcock, Lynn/0000-0002-2658-6893	Cincinnati Children's Medical Center Division of Emergency Medicine, Divisional Internal Grant; Cincinnati Children's Medical Center, KL2 Mentored Career Award from the Center for Clinical and Translational Science and Training; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, KL2TR000078, UL1TR000077] Funding Source: NIH RePORTER	Supported by Cincinnati Children's Medical Center Division of Emergency Medicine, Divisional Internal Grant to T. D. Rhine and by Cincinnati Children's Medical Center, KL2 Mentored Career Award from the Center for Clinical and Translational Science and Training to L. Babcock.	Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Doyle RJ, 2007, GAIT POSTURE, V25, P166, DOI 10.1016/j.gaitpost.2006.03.004; Faul M, 2010, TRAUMATIC BRAIN INJU; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gil-Gomez JA, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-30; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Levac D, 2012, PHYS OCCUP THER PEDI, V32, P180, DOI 10.3109/01942638.2011.616266; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Lorefice LE, 2015, DEV MED CHILD NEUROL, V57, P175, DOI 10.1111/dmcn.12550; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Peterka R J, 1990, J Vestib Res, V1, P73; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Wright MJ, 2005, PHYS THER, V85, P782, DOI 10.1093/ptj/85.8.782; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	23	7	7	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2016	26	3					221	225		10.1097/JSM.0000000000000234			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DL4KX	WOS:000375605800011	26331470	Green Accepted			2022-02-06	
J	Liu, JS; Li, Z; Shen, HX; Qin, FX; Jiang, SD; Du, ZX; Phan, MH; Sun, JF				Liu, Jingshun; Li, Ze; Shen, Hongxian; Qin, Faxiang; Jiang, Sida; Du, Zhaoxin; Phan, Manh-Huong; Sun, Jianfei			Composite electroplating to enhance the GMI output stability of melt-extracted wires	MATERIALS & DESIGN			English	Article						Amorphous wires; Wire-terminal-connection; Ni/Cu composite electroplating; Impedance output stability	GIANT MAGNETOIMPEDANCE; AMORPHOUS WIRES; MAGNETIC WIRES; MICROWIRES; SENSORS; SOLDER; RICH	Impedance output stability of Co-rich amorphous wires depends largely on the wire-terminal-connection, which can be accomplished by composite electroplating towards a robust sensor application. The present experimental results indicated that Ni/Cu composite layer composed of Ni, Cu plating and passivating treatment show a homogeneous microstructure, and excellent surface wettability, weldability and thermal expansion coefficient matching under variable temperature of wire-terminal-connecting. The properties of composite electroplated layer are mainly influenced by cathode current density, electroplating time and electrolyte temperature. The inhomogeneous distributed clustering-regions, disproportionated reaction, tendency of hydrogen brittleness and crack have been reduced by optimized coactions of intermolecular Van der Waals force, inner diffusion and mechanical bonding of electroplated layer. Therefore, the wire-terminal-connection is able to effectively improve impedance output stability by minimizing the disturbance of stray capacity, decreasing radio-frequency wave emission and electromagnetic signal attenuation, and suppressing the destabilization or concussion. (C) 2016 Published by Elsevier Ltd.	[Liu, Jingshun; Li, Ze; Du, Zhaoxin] Inner Mongolia Univ Technol, Sch Mat Sci & Engn, Hohhot 010051, Peoples R China; [Shen, Hongxian; Jiang, Sida; Sun, Jianfei] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China; [Qin, Faxiang] Zhejiang Univ, Sch Mat Sci & Engn, Inst Composites Sci Innovat InCSI, Hangzhou 310027, Peoples R China; [Phan, Manh-Huong] Univ S Florida, Dept Phys, Tampa, FL 33620 USA		Liu, JS (corresponding author), Inner Mongolia Univ Technol, Sch Mat Sci & Engn, Hohhot 010051, Peoples R China.	jingshun_liu@163.com	Phan, Manh-Huong/A-6709-2014; Liu, Jingshun/J-2482-2012	Liu, Jingshun/0000-0003-1969-3639	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [51401111, 51561026]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2014BS0503]; NSFCNational Natural Science Foundation of China (NSFC) [51501162]	This work was financially supported by the National Natural Science Foundation of China (NSFC) under grant Nos. 51401111 and 51561026, Natural Science Foundation of Inner Mongolia Autonomous Region of China under grant No. 2014BS0503. FXQ would like to thank the support from NSFC under grant No. 51501162.	Chiriac H, 2011, J MAGN MAGN MATER, V323, P2929, DOI 10.1016/j.jmmm.2011.06.072; Chiriac H, 1996, PROG MATER SCI, V40, P333, DOI 10.1016/S0079-6425(97)00001-7; Hauser H, 2001, IEEE INSTRU MEAS MAG, V4, P28, DOI 10.1109/5289.930983; Honkura Y, 2002, J MAGN MAGN MATER, V249, P375, DOI 10.1016/S0304-8853(02)00561-9; Knobel M, 2002, J MAGN MAGN MATER, V242, P33, DOI 10.1016/S0304-8853(01)01180-5; Liu JS, 2012, J ALLOY COMPD, V541, P215, DOI 10.1016/j.jallcom.2012.05.126; Liu J-T, 2014, J APPL PHYS, P115; Liu JS, 2013, IEEE T MAGN, V49, P5639, DOI 10.1109/TMAG.2012.2212023; Liu JS, 2011, PHYS STATUS SOLIDI A, V208, P530, DOI 10.1002/pssa.201026351; M. Yamamoto Y. Honkura K. Mouri, 2001, US Patent, Patent No. [006273322 B1, 006273322]; Ning Z, 2008, SURF COAT TECH, V202, P2139, DOI 10.1016/j.surfcoat.2007.08.062; Phan MH, 2008, PROG MATER SCI, V53, P323, DOI 10.1016/j.pmatsci.2007.05.003; Qin FX, 2013, PROG MATER SCI, V58, P183, DOI 10.1016/j.pmatsci.2012.06.001; Roozmeh SE, 2009, J NON-CRYST SOLIDS, V355, P2653, DOI 10.1016/j.jnoncrysol.2009.09.002; Sinnecker JP, 1997, J APPL PHYS, V82, P5871, DOI 10.1063/1.366456; Sun G. F., 2008, MAGNETIC FUNCTIONAL; Tee TY, 2003, MICROELECTRON RELIAB, V43, P1117, DOI 10.1016/S0026-2714(03)00127-6; Vazquez M, 2001, PHYSICA B, V299, P302, DOI 10.1016/S0921-4526(01)00482-3; Yao Shoushan, 2005, SURFACE SCI TECHNOLO; Zeng KJ, 2002, IEEE T ELECTRON PACK, V25, P162, DOI 10.1109/TEPM.2002.801648; Zhuang Y.Q., 1996, RELIABILITY TECHNOLO; Zhukov A, 2006, ADV FUNCT MATER, V16, P675, DOI 10.1002/adfm.200500248; Zhukov A, 2014, J ALLOY COMPD, V586, pS279, DOI 10.1016/j.jallcom.2012.10.082	23	7	7	1	48	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0261-3069	1873-4197		MATER DESIGN	Mater. Des.	APR 15	2016	96						251	256		10.1016/j.matdes.2016.01.090			6	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	DF4CX	WOS:000371296000030					2022-02-06	
J	Kemp, JL; Newton, JD; White, PE; Finch, CF				Kemp, Joanne L.; Newton, Joshua D.; White, Peta E.; Finch, Caroline F.			Implementation of concussion guidelines in community Australian Football and Rugby League-The experiences and challenges faced by coaches and sports trainers	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Football; Implementation; Community participation; Concussion guidelines	KNOWLEDGE; TRANSLATION; PREVENTION; STATEMENT; CONSENSUS; INTENTION; INJURY; POLICY	Objectives: While guidelines outlining the appropriate management of sport-related concussion have been developed and adapted for use within community sport, it remains unknown how they are experienced by those responsible for implementing them. Design: Longitudinal study. Methods: 111 coaches and sports trainers from community-level Australian Football and Rugby League teams completed pre- and post-season surveys assessing their attitudes towards using concussion guidelines. Participants also provided post-season feedback regarding their experiences in using the guidelines. Results: 71% of participants reported using the guidelines in the preceding season. Post-season attitude was related to pre-season attitude (p = 0.002), football code (p = 0.015), and team role (p = 0.045). An interaction between team role and guideline use (p = 0.012) was also found, with coaches who had used the guidelines, and sports trainers who had not, reporting more positive post-season attitudes towards using the concussion guidelines. Implementation challenges included disputing of decisions about return-to-play by players, parents, and coaches, and a perceived lack of time. Recommendations for improved guideline materials included using larger fonts and providing for witnessing of advice given to players. Conclusions: This is the first study to examine the implementation of concussion guidelines in community sport. Training of coaches/sports trainers needs enhancement. In addition, new education should be developed for parents/players about the importance of the return-to-play advice given to them by those who follow these guidelines. Information provided by those who attempted to use the guidelines will assist the refinement of implementation and dissemination processes around concussion guidelines across sports. (C) 2015 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Kemp, Joanne L.; White, Peta E.; Finch, Caroline F.] Federat Univ Australia, ACRISP, Melbourne, Vic, Australia; [Newton, Joshua D.] Deakin Univ, Fac Business & Law, Off Pro Vice Chancellor, Burwood Campus, Geelong, Vic 3217, Australia		Kemp, JL (corresponding author), Federat Univ Australia, ACRISP, Melbourne, Vic, Australia.	j.kemp@federation.edu.au		Kemp, Joanne/0000-0002-9234-1923	Victorian Sports Injury Prevention Research Grant through the Department of Planning and Community Development Sport and Recreation Victoria; NHMRC Principal Research FellowshipNational Health and Medical Research Council of Australia [1058737]; International Olympic Committee (IOC); Department of Planning and Community Development, Victoria, Australia	This study was funded by a Victorian Sports Injury Prevention Research Grant through the Department of Planning and Community Development Sport and Recreation Victoria. CFF was supported by an NHMRC Principal Research Fellowship (ID: 1058737). The Australian Centre for Research into Injury in Sport and its Prevention (ACRISP) is one of the International Research Centres for the Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee (IOC).; The research presented in this paper was part of the work undertaken for a Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria, Australia. That project's larger chief investigator team included all co-authors of this paper as well as Paul McCrory, Michael Makdissi, Gavin Davis, Michael Ewing, Alex Donaldson, Angela Clapperton, John Sullivan, Willem Meeuwisse and Carolyn Emery.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Donaldson A, 2012, BRIT J SPORT MED, V46, P306, DOI 10.1136/bjsports-2011-090461; Donaldson A, 2015, AM J LIFEST IN PRESS; Donaldson A, 2014, BRIT J SPORT MED, V46, P759; Donaldson A, 2014, BRIT J SPORT MED, V48, P151, DOI 10.1136/bjsports-2012-091551; Finch CF, 2010, BRIT J SPORT MED, V44, P973, DOI 10.1136/bjsm.2008.056069; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Finch CF, 2011, BRIT J SPORT MED, V45, P1253, DOI 10.1136/bjsports-2011-090230; Fremont P, 2015, BRIT J SPORT MED, V49, P88, DOI 10.1136/bjsports-2014-093961; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Newton JD, 2014, J SCI MED SPORT, V17, P469, DOI 10.1016/j.jsams.2013.10.240; Newton JD, 2013, PSYCHOL HEALTH, V28, P495, DOI 10.1080/08870446.2012.745936; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pearce AJ, J SCI MED SPORT; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Savage J, 2013, J SPORTS MED, V2013, P7; White PE, 2014, BRIT J SPORT MED, V48, P130, DOI 10.1136/bjsports-2013-092720; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785	27	7	7	0	31	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	APR	2016	19	4					305	310		10.1016/j.jsams.2015.03.010			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DJ1ND	WOS:000373968600007	25981181	Green Published, Bronze			2022-02-06	
J	Nemunaitis, G; Roach, MJ; Claridge, J; Mejia, M				Nemunaitis, Gregory; Roach, Mary Joan; Claridge, Jeffrey; Mejia, Melvin			Early Predictors of Functional Outcome After Trauma	PM&R			English	Article							INJURY SEVERITY SCORE; GLASGOW COMA SCALE; ADVANCED LIFE-SUPPORT; LONG-TERM OUTCOMES; BRAIN-INJURY; MAJOR TRAUMA; INDEPENDENCE MEASURE; INSURANCE STATUS; IMPACT; MORTALITY	Background: Despite the availability of routinely collected trauma data, researchers who investigate rehabilitation outcomes, functional evaluation, and comparative effectiveness have not incorporated this potentially clinically meaningful information in their modeling as predictors or adjustors. Objective: The purpose of this study was to identify variables from the scene of a traumatic accident and from the emergency department that can be used in assessing functional outcomes of persons who survive trauma. Design: Prospective study. Setting: Level I academic trauma center. Patients: Persons who sustained and survived a spinal cord injury, a traumatic brain injury, or polytrauma. Methods: Trauma and rehabilitation registries were merged by matching the 2 data files for each patient by medical record number, and the files were verified by gender and date of birth. Analysis consisted of standard descriptive statistics (frequencies and averages). A 2-staged linear regression was used to investigate the relationship between the demographic, scene, and ED data elements and discharge functional outcome. Main Outcome Measure: Discharge Functional Independence Measure (FIM). Results: Older patients with government insurance had poorer discharge FIM scores compared with patients who had commercial insurance. The Injury Severity Score (ISS) and Glasgow Coma Scale score from the scene of the accident were significantly associated with the discharge FIM. Persons with a lower ISS had significantly higher discharge FIM scores than did persons with a higher ISS (P < .001). For every unit change in Glasgow Coma Scale score, FIM scores increased by 0.488 points (P = .030). Conclusion: The use of routinely collected trauma data elements can be useful in assessing the continuum of patient care. Incorporating trauma data into research has the potential to improve our models of functional outcomes and provide meaningful risk adjustors when comparing and evaluating rehabilitation care systems and treatments.	[Nemunaitis, Gregory; Roach, Mary Joan; Mejia, Melvin] MetroHlth Rehabil Inst Ohio, Cleveland, OH USA; [Nemunaitis, Gregory; Roach, Mary Joan; Claridge, Jeffrey; Mejia, Melvin] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Roach, Mary Joan] Metrohlth Med Ctr, Ctr Hlth Res & Policy, Cleveland, OH USA; [Roach, Mary Joan] Metrohlth Med Ctr, Dept PM&R, Rammelkamp R222A,2500 MetroHealth Dr, Cleveland, OH 44109 USA; [Claridge, Jeffrey] Metrohlth Med Ctr, Trauma Div, Cleveland, OH USA		Roach, MJ (corresponding author), MetroHlth Rehabil Inst Ohio, Cleveland, OH USA.; Roach, MJ (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH USA.; Roach, MJ (corresponding author), Metrohlth Med Ctr, Ctr Hlth Res & Policy, Cleveland, OH USA.; Roach, MJ (corresponding author), Metrohlth Med Ctr, Dept PM&R, Rammelkamp R222A,2500 MetroHealth Dr, Cleveland, OH 44109 USA.	mroach@metrohealth.org					Al-Jarrah MD, 2009, NEUROSCIENCES, V14, P41; Alban RF, 2010, AM SURGEON, V76, P1108; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beaulieu RA, 2014, J SURG RES, V190, P264, DOI 10.1016/j.jss.2014.02.032; Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa; Bilello J, 2009, J TRAUMA, V20, P1; BRENNEMAN FD, 1995, J TRAUMA, V39, P320, DOI 10.1097/00005373-199508000-00021; Cameron PA, 2014, BRIT J ANAESTH, V113, P226, DOI 10.1093/bja/aeu231; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cowperthwaite M, 2010, J TRAUMA MANAG OUTCO, V5, P1; Data Management Service of the Uniform Data System for Medical Rehabilitation and the Center for Functional Assessment Research, 1990, GUID US UN DAT SET M; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Edwards M, 2010, AM SURGEON, V76, P1035; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabbe BJ, 2015, ANN SURG, V261, P565, DOI 10.1097/SLA.0000000000000522; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; George RL, 2003, J TRAUMA, V54, P464, DOI 10.1097/01.TA.0000051939.95039.E6; Granger CV, 1984, FUNCTIONAL ASSESSMEN; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Hamilton B, 1991, ARCH PHYS MED REHAB, V72, P572; Inaba K, 2003, J TRAUMA, V54, P486, DOI 10.1097/01.TA.0000051588.05542.D6; Jacoby SF, 2006, J NURS SCHOLARSHIP, V38, P133, DOI 10.1111/j.1547-5069.2006.00090.x; Jurkovich GJ, 1999, J TRAUMA, V47, pS46, DOI 10.1097/00005373-199909001-00011; Kelley-Quon L, 2010, AM SURGEON, V76, P1055; Lansink KWW, 2007, CURR OPIN CRIT CARE, V13, P686, DOI 10.1097/MCC.0b013e3282f1e7a4; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Lim HJ, 2007, J TRAUMA, V63, P902, DOI 10.1097/01.ta.0000240110.14909.71; MACKENZIE EJ, 1986, MED CARE, V24, P377, DOI 10.1097/00005650-198605000-00001; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; National Trauma Data Bank, 2014, NAT TRAUM DAT BANK 2; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; RUTLEDGE R, 1995, SURG CLIN N AM, V75, P305, DOI 10.1016/S0039-6109(16)46590-4; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; SPAITE DW, 1991, ANN EMERG MED, V20, P1299, DOI 10.1016/S0196-0644(05)81070-4; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Toschlog EA, 2003, AM SURGEON, V69, P491; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; US Department of Health and Human Services, 2006, MOD TRAUM SYST PLANN	53	7	7	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	APR	2016	8	4					314	320		10.1016/j.pmrj.2015.08.007			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DJ4LE	WOS:000374176100003	26314232				2022-02-06	
J	Wharewera-Mika, J; Cooper, E; Kool, B; Pereira, S; Kelly, P				Wharewera-Mika, Julie; Cooper, Erana; Kool, Bridget; Pereira, Susana; Kelly, Patrick			Caregivers' voices: The experiences of caregivers of children who sustained serious accidental and non-accidental head injury in early childhood	CLINICAL CHILD PSYCHOLOGY AND PSYCHIATRY			English	Article						Caregivers; children; head injury; non-accidental head injury; thematic analysis; whnau; families	TRAUMATIC BRAIN-INJURY; SHAKEN BABY SYNDROME; FAMILY BURDEN; NEW-ZEALAND; PREDICTORS; OUTCOMES; EPIDEMIOLOGY; INFANTS; CARE; PARTICIPATION	Head injury is a leading cause of mortality and acquired neurological impairment in children. Head-injured children may have neurobehavioural deficits that persist for years following injury. Head injury can result in significant and persistent caregiver burden, including mental health issues, family stress and disorganisation, and unmet social and healthcare service needs. Few studies have examined the healthcare and social service needs of children and their families following head injury sustained at an early age. This qualitative study aims to describe the experiences of caregivers of children who sustained a serious head injury (particularly non-accidental head injury) before the age of 2years. Caregivers were interviewed up to 15years following the initial injury. Semi-structured interviews with 21 caregivers of 15 children (aged 3-15years at the time of interview) were completed. Thematic analysis of interview data generated three key themes: impact, support and information. The study's findings reveal the broad impact of serious childhood head injury on caregivers, specifically the significant distress and burden brought about through lack of information, challenges in accessing support and inconsistent care. Recommendations for developing a quality model of care' and improving ease of access to supports for caregivers are provided.	[Wharewera-Mika, Julie; Cooper, Erana] Flying Doctors Nga Manu Arahi, Auckland, New Zealand; [Kool, Bridget] Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Private Bag 92019, Auckland 1142, New Zealand; [Pereira, Susana; Kelly, Patrick] Starship Childrens Hosp, Te Puaruruhau Child Protect Team, Auckland, New Zealand; [Kelly, Patrick] Univ Auckland, Fac Med & Hlth Sci, Dept Paediat, Auckland 1142, New Zealand		Kool, B (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Private Bag 92019, Auckland 1142, New Zealand.	b.kool@auckland.ac.nz		Kelly, Patrick/0000-0002-8813-8877	Auckland Medical Research Foundation; University of Auckland; Starship Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Bridget Kool's time on this project was supported by an Auckland Medical Research Foundation Post-Doctoral Fellowship. Research expenses for this study were covered by a Performance-Based Research Fund grant awarded to Bridget Kool by the University of Auckland. Dr Pereira's time as Child Protection Fellow and the supermarket vouchers were funded by the Starship Foundation.	Aho KLT, 2010, INT J CONFL VIOLENCE, V4, P124; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arlidge B, 2009, ETHNIC HEALTH, V14, P169, DOI 10.1080/13557850802307791; Ashton R, 2010, J CHILD PSYCHOL PSYC, V51, P967, DOI 10.1111/j.1469-7610.2010.02272.x; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bronfenbrenner U., 1999, MEASURING ENV LIFE S, P3, DOI [DOI 10.1037/10317-001, 10.1037/10317-001]; Bull M J, 1990, West J Nurs Res, V12, P758, DOI 10.1177/019394599001200605; Byard Katie, 2011, Clin Child Psychol Psychiatry, V16, P165, DOI 10.1177/1359104511403582; CARNWATH TCM, 1987, BRIT MED J, V294, P409, DOI 10.1136/bmj.294.6569.409; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Couch CM, 2011, ARCH CLIN NEUROPSYCH, V26, P349, DOI 10.1093/arclin/acr028; Durie M., 2001, MAURI ORA DYNAMICS M; Durie M, 1998, TE MANA TE KAWANATAN; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Friedman J, 2012, CHILD ABUSE NEGLECT, V36, P760, DOI 10.1016/j.chiabu.2012.07.008; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gergen KJ., 1999, INVITATION SOCIAL CO; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Jackson M., 1988, MAORI CRIMINAL JUS 2 MAORI CRIMINAL JUS 2; Jayawant S, 2007, ARCH DIS CHILD, V92, P343, DOI 10.1136/adc.2005.084988; Jones M., 2010, NZ J OCCUPATIONAL TH, V57, P4; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; KIRO C, 2000, SOCIAL WORK REV, V12, P26; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Ormond A, 2006, ALTERNATIVE, V2, P174, DOI 10.1177/117718010600200108; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Robson B., 2007, HAUORA MAORI STANDAR, P1; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062	55	7	7	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1359-1045	1461-7021		CLIN CHILD PSYCHOL P	Clin. Child Psychol. Psychiatry	APR	2016	21	2					268	286		10.1177/1359104515589636			19	Psychology, Clinical; Psychology, Developmental; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DJ2QE	WOS:000374049200008	26088208				2022-02-06	
J	Kirmani, BF; Robinson, DM; Fonkem, E; Graf, K; Huang, JH				Kirmani, Batool F.; Robinson, Diana Mungall; Fonkem, Ekokobe; Graf, Kevin; Huang, Jason H.			Role of Anticonvulsants in the Management of Posttraumatic epilepsy	FRONTIERS IN NEUROLOGY			English	Article						posttraumatic seizures; traumatic brain injury; epilepsy; anticonvulsants; management	TRAUMATIC BRAIN-INJURY; PROPHYLACTICALLY ADMINISTERED PHENYTOIN; HEAD-INJURY; SEIZURE PROPHYLAXIS; INTRAVENOUS LEVETIRACETAM; ANTIEPILEPTIC DRUGS; PROGESTERONE; HYPOTHERMIA; PREVENTION; VALPROATE	Posttraumatic seizures (PTS) have been recognized as a major complication of traumatic brain injury (TBI). The annual incidence of TBI in the United States is 1.7 million. The role of anticonvulsants in the treatment of posttraumatic epilepsy (PTE) remains uncertain. Based on current studies, however, anticonvulsants have been shown to reduce early PTS occurring within the first 7 days, but little to no benefits have been shown in late PTS occurring after 7 days. In this paper, we provide a mini review of the role of anticonvulsants and current advances in the management of PTE.	[Kirmani, Batool F.] Baylor Scott & White Hlth Neurosci Inst, Texas A&M Hlth Sci Ctr, Coll Med, Epilepsy Ctr,Dept Neurol, Temple, TX USA; [Robinson, Diana Mungall] Univ Virginia, Med Ctr, Dept Psychiat, Charlottesville, VA USA; [Fonkem, Ekokobe; Graf, Kevin] Baylor Scott & White Hlth Neurosci Inst, Texas A&M Hlth Sci Ctr, Coll Med, Div Neurooncol,Dept Neurosurg, Temple, TX USA; [Huang, Jason H.] Baylor Scott & White Hlth Neurosci Inst, Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosurg, Temple, TX USA		Kirmani, BF (corresponding author), Baylor Scott & White Hlth Neurosci Inst, Texas A&M Hlth Sci Ctr, Coll Med, Epilepsy Ctr,Dept Neurol, Temple, TX USA.	Batool.kirmani@BSWHealth.org	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Eastman CL, 2010, EXP NEUROL, V224, P369, DOI 10.1016/j.expneurol.2010.04.013; Eftekhar B, 2009, J NEUROSURG, V110, P319, DOI 10.3171/2008.4.17519; Faul M, 2010, TRAUMATIC BRAIN INJU; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Fox JL, 2010, CAN J EMERG MED, V12, P355; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kirmani BF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00170; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Krisztian KS, 2014, J NEUROL DISORD STRO, V2, P1071; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; LaRoche SM, 2007, NEUROLOGIST, V13, P133, DOI 10.1097/01.nrl.0000256353.14257.7c; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Steinmetz S, 2013, EPILEPSIA, V54, P580, DOI 10.1111/epi.12071; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TASKER RC, 1992, J NEUROSCI, V12, P4298; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vartanian MG, 1996, DEV BRAIN RES, V95, P169, DOI 10.1016/0165-3806(96)00073-9; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Watson NF, 2004, EPILEPSIA, V45, P690, DOI 10.1111/j.0013-9580.2004.59403.x; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; WROBLEWSKI BA, 1992, CLIN NEUROPHARMACOL, V15, P44, DOI 10.1097/00002826-199202000-00006; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	53	7	7	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 22	2016	7								32	10.3389/fneur.2016.00032			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH1HC	WOS:000372534000001	27047441	Green Published, gold			2022-02-06	
J	Najafi, E; Stoodley, MA; Bilston, LE; Hemley, SJ				Najafi, E.; Stoodley, M. A.; Bilston, L. E.; Hemley, S. J.			INWARDLY RECTIFYING POTASSIUM CHANNEL 4.1 EXPRESSION IN POST-TRAUMATIC SYRINGOMYELIA	NEUROSCIENCE			English	Article						Kir4.1; astrocyte; syrinx; post-traumatic syringomyelia	SPINAL-CORD-BARRIER; CEREBROSPINAL-FLUID FLOW; CENTRAL-NERVOUS-SYSTEM; SUBARACHNOID SPACE; KIR4.1 CHANNELS; ANIMAL-MODEL; AQUAPORIN-4 EXPRESSION; PATHOPHYSIOLOGY; INJURY; BRAIN	Post-traumatic syringomyelia (PTS) is a serious neurological disorder characterized by fluid filled cavities that develop in the spinal cord. PTS is thought to be caused by an imbalance between fluid inflow and outflow in the spinal cord, but the underlying mechanisms are unknown. The ion channel Kir4.1 plays an important role in the uptake of K+ ions from the extracellular space and release of K+ ions into the microvasculature, generating an osmotic gradient that drives water movement. Changes in Kir4.1 expression may contribute to disturbances in K+ homeostasis and subsequently fluid imbalance. Here we investigated whether changes in Kir4.1 protein expression occur in PTS. Western blotting and immunohistochemistry were used to evaluate Kir4.1 and glial fibrillary acidic protein (GFAP) expression in a rodent model of PTS at 3 days, 1, 6 or 12 weeks post-surgery. In Western blotting experiments, Kir4.1 expression increased 1 week post-surgery at the level of the cavity. Immunohistochemical analysis examined changes in the spinal parenchyma directly in contact with the syrinx cavity. In these experiments, there was a significant decrease in Kir4.1 expression in PTS animals compared to controls at 3 days and 6 weeks post-surgery, while an up-regulation of GFAP in PTS animals was observed at 1 and 12 weeks. This suggests that while overall Kir4.1 expression is unchanged at these time-points, there are many astrocytes surrounding the syrinx cavity that are not expressing Kir4.1. The results demonstrate a disturbance in the removal of K+ ions in tissue surrounding a post-traumatic syrinx cavity. It is possible this contributes to water accumulation in the injured spinal cord leading to syrinx formation or exacerbation of the underlying pathology. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Najafi, E.; Stoodley, M. A.; Hemley, S. J.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia; [Bilston, L. E.] Neurosci Res Australia, Sydney, NSW, Australia; [Bilston, L. E.] Univ New S Wales, Prince Wales Clin Sch, Randwick, NSW, Australia; [Stoodley, M. A.] Macquarie Univ, Fac Med & Hlth Sci, Macquarie Neurosurg, 2 Technol Pl, Sydney, NSW 2109, Australia; [Bilston, L. E.] Neurosci Res Australia, Margarete Ainsworth Bldg,Barker St, Randwick, NSW 2031, Australia		Hemley, SJ (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia.	atieh.najafi@students.mq.edu.au; marcus.stoodley@mq.edu.au; l.bilston@neura.edu.au; sarah.hemley@mq.edu.au	Bilston, Lynne/C-9665-2011	Bilston, Lynne/0000-0001-8250-9019; Stoodley, Marcus/0000-0002-4207-8493; hemley, sarah/0000-0003-3064-861X	Column of Hope Research Grant; National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia [604008]; Brain Foundation of Australia; Australian School of Advanced Medicine and Macquarie University; NHMRC senior research fellowshipNational Health and Medical Research Council of Australia	This work was funded by a Column of Hope Research Grant; the National Health and Medical Research Council (NHMRC) of Australia (Project No. 604008); and the Brain Foundation of Australia.; Dr. Najafi was supported by a scholarship from the Australian School of Advanced Medicine and Macquarie University. Professor Bilston is supported by an NHMRC senior research fellowship.	Bataveljic D, 2012, GLIA, V60, P1991, DOI 10.1002/glia.22414; Bilgen M, 2002, MAGN RESON IMAGING, V20, P337, DOI 10.1016/S0730-725X(02)00504-0; Bilston LE, 2010, J NEUROSURG, V112, P808, DOI 10.3171/2009.5.JNS08945; Bogdanov EI, 2002, CLIN NEUROL NEUROSUR, V104, P90, DOI 10.1016/S0303-8467(01)00189-5; Bonfield CM, 2010, SPINE, V35, pS245, DOI 10.1097/BRS.0b013e3181f32e9c; Bordey A, 2001, J NEUROPHYSIOL, V85, P1719, DOI 10.1152/jn.2001.85.4.1719; Brodbelt AR, 2003, SPINE, V28, pE413, DOI 10.1097/01.BRS.0000092346.83686.B9; Brodbelt AR, 2003, EUR SPINE J, V12, P300, DOI 10.1007/s00586-002-0492-9; Brodbelt AR, 2003, J CLIN NEUROSCI, V10, P401, DOI 10.1016/S0967-5868(02)00326-0; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Carroll AM, 2005, SPINE, V30, P1206, DOI 10.1097/01.brs.0000162277.76012.0b; Cheng S, 2012, J BIOMECH, V45, P1186, DOI 10.1016/j.jbiomech.2012.01.050; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Dibaj P, 2007, J NEUROCHEM, V103, P2620, DOI 10.1111/j.1471-4159.2007.04979.x; Ferreira T, 2010, IMAGEJ USER GUIDE IJ; FOO D, 1989, PARAPLEGIA, V27, P63, DOI 10.1038/sc.1989.10; HALL P, 1980, J NEUROSURG, V52, P812, DOI 10.3171/jns.1980.52.6.0812; Harada Y, 2013, BRAIN RES, V1517, P141, DOI 10.1016/j.brainres.2013.04.009; Heiss JD, 1999, J NEUROSURG, V91, P553, DOI 10.3171/jns.1999.91.4.0553; Hemley SJ, 2013, J NEUROTRAUM, V30, P1457, DOI 10.1089/neu.2012.2614; Hemley SJ, 2012, J NEUROSURG-SPINE, V17, P602, DOI 10.3171/2012.9.SPINE1265; Hemley SJ, 2009, J NEUROSURG-SPINE, V11, P696, DOI 10.3171/2009.6.SPINE08564; Karam Y, 2014, CLIN NEUROL NEUROSUR, V124, P44, DOI 10.1016/j.clineuro.2014.06.007; Klekamp J, 2001, NEUROSURGERY, V48, P174, DOI 10.1097/00006123-200101000-00031; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; MILHORAT TH, 1995, J NEUROSURG, V82, P802, DOI 10.3171/jns.1995.82.5.0802; Min KJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-100; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; OLDFIELD EH, 1994, J NEUROSURG, V80, P3, DOI 10.3171/jns.1994.80.1.0003; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Runge VM, 1997, INVEST RADIOL, V32, P105, DOI 10.1097/00004424-199702000-00006; Schaller B, 1999, J SPINAL DISORD, V12, P485; Vella J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00108; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wong J, 2015, J NEUROSURG IN PRESS; Wong J, 2012, NEUROSURGERY, V71, P474, DOI 10.1227/NEU.0b013e31825927d6	44	7	9	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAR 11	2016	317						23	35		10.1016/j.neuroscience.2016.01.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC0LW	WOS:000368909800003	26768400				2022-02-06	
J	Barton, DJ; Tift, FW; Cournoyer, LE; Vieth, JT; Hudson, KB				Barton, David J.; Tift, Frank W.; Cournoyer, Lauren E.; Vieth, Julie T.; Hudson, Korin B.			Acute Alcohol Use and Injury Patterns in Young Adult Prehospital Patients	PREHOSPITAL EMERGENCY CARE			English	Article							TRAUMATIC BRAIN-INJURY; MEDICAL-SERVICES USE; EMERGENCY-DEPARTMENT; CARE SURVEY; CONSUMPTION; COLLEGE; RISK; INTOXICATION; MORTALITY; DRINKING	The objective was to determine if acute alcohol consumption is associated with differences in injury pattern among young adult patients with traumatic injuries presenting to emergency medical services (EMS). A cross-sectional, retrospective review of prehospital patient care reports (PCRs) was conducted evaluating injured patients who presented to a collegiate EMS agency from January 1, 2011 to December 31, 2012. Included patients were age 18-24 y and sustained an injury within the previous 24h. PCRs were reviewed independently by two abstractors to determine if the patient was documented to have acutely consumed alcohol proximate to his/her injury. Primary and secondary sites of regional body injury were recorded. Injury severity was recorded using the Revised Trauma Score (RTS). The association between primary injury site and acute alcohol use was assessed using a chi-square test. Multiple logistic regression was used to control for sex in predicting injury type. Of 440 injured patients, 135 (30.6%) had documented alcohol use prior to injury. Acute alcohol consumption altered the overall pattern of regional injury (p < 0.001). Alcohol users were more likely to present with injury secondary to assault, fall/trip, and unknown mechanism of injury (p < 0.001, all comparisons). RTS scores were statistically lower in the alcohol group (p < 0.001), although the clinical significance of this is unclear. Controlling for sex, acute alcohol consumption predicted increased risk of head/neck injury 5.59-fold (p < 0.001). Acute alcohol use in collegiate EMS patients appears to alter injury patterns in young adults and increases risk of head/neck injury. EMS providers in similar agencies should consider these trends when assessing and treating injured college-aged patients. Key words: alcohol; college; trauma; injury; prehospital; emergency medical services	[Barton, David J.; Tift, Frank W.; Cournoyer, Lauren E.; Vieth, Julie T.; Hudson, Korin B.] Georgetown Univ, Georgetown Emergency Response Med Serv, Washington, DC USA; [Barton, David J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Tift, Frank W.; Vieth, Julie T.; Hudson, Korin B.] MedStar Georgetown Univ Hosp, Dept Emergency Med, Washington, DC USA; [Tift, Frank W.; Vieth, Julie T.; Hudson, Korin B.] MedStar Washington Hosp Ctr, Washington, DC USA; [Cournoyer, Lauren E.] Univ Vermont, Burlington, VT USA; [Vieth, Julie T.] Canton Potsdam Hosp, Emergency Dept, Potsdam, NY USA		Hudson, KB (corresponding author), Georgetown Univ Hosp, Dept Emergency Med, 3800 Reservoir Dr NW, Washington, DC 20007 USA.	kbh25@georgetown.edu	Tift, Frank/AAN-1986-2020; Barton, David J/C-9282-2011	Barton, David J/0000-0003-0976-0383			Carey KB, 2009, J PUBLIC HEALTH MAN, V15, P524, DOI 10.1097/PHH.0b013e3181a5d279; Carter AC, 2010, J STUD ALCOHOL DRUGS, V71, P742, DOI 10.15288/jsad.2010.71.742; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Chen SC, 1999, J TRAUMA, V47, P881, DOI 10.1097/00005373-199911000-00011; Cherpitel CJ, 2003, ADDICTION, V98, P1277, DOI 10.1046/j.1360-0443.2003.00459.x; Choi Y, 2009, AM J EMERG MED, V27, P956, DOI 10.1016/j.ajem.2008.07.035; do Canto-Pereira LHM, 2007, HUM EXP TOXICOL, V26, P311, DOI 10.1177/0960327106070490; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gustavsen I, 2011, J CLIN PSYCHOPHARM, V31, P481, DOI 10.1097/JCP.0b013e3182214be6; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Hsieh CH, 2013, AM SURGEON, V79, P1289; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Knight S, 2003, ANN EMERG MED, V42, P689, DOI 10.1016/S0196-0644(03)00524-9; Kuendig H, 2008, J TRAUMA, V65, P203, DOI 10.1097/TA.0b013e318068fc64; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maehlum S, 1984, Br J Sports Med, V18, P181; McLaughlin MP, 2010, PREHOSP EMERG CARE, V14, P485, DOI 10.3109/10903127.2010.497897; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Shah MN, 2008, PREHOSP EMERG CARE, V12, P269, DOI 10.1080/10903120802100167; Shah MN, 2007, ACAD EMERG MED, V14, P441, DOI [10.1197/j.aem.2007.01.019, 10.1111/j.1553-2712.2007.tb01804.x]; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Socie E, 2012, J STUD ALCOHOL DRUGS, V73, P260, DOI 10.15288/jsad.2012.73.260; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; Trinks A, 2012, J ADDICT NURS, V23, P152, DOI 10.1097/JAN.0b013e31826f4bbd; Vardy J, 2009, EMERG MED J, V26, P164, DOI 10.1136/emj.2007.056259; Watt K, 2006, J STUD ALCOHOL, V67, P14, DOI 10.15288/jsa.2006.67.14; Watt K, 2005, ALCOHOL ALCOHOLISM, V40, P263, DOI 10.1093/alcalc/agh164; Watt K, 2004, ADDICTION, V99, P1262, DOI 10.1111/j.1360-0443.2004.00823.x	30	7	7	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	MAR 3	2016	20	2					206	211		10.3109/10903127.2015.1076101			6	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	DH5PX	WOS:000372845300005	27002348				2022-02-06	
J	Botwinick, I; Johnson, JH; Safadjou, S; Cohen-Levy, W; Reddy, SH; McNelis, J; Teperman, SH; Stone, ME				Botwinick, Isadora; Johnson, Joshua H.; Safadjou, Saman; Cohen-Levy, Wayne; Reddy, Srinivas H.; McNelis, John; Teperman, Sheldon H.; Stone, Melvin E., Jr.			Geriatric nursing home falls: A single institution cross-sectional study	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Fall; Nursing home; In-hospital mortality	OLDER-ADULTS; HEALTH-CARE; MORTALITY; TRAUMA; IMPACT; POPULATION; PEOPLE; ANEMIA	Background: Falls are the leading cause of fatal injury in geriatric patients. Nursing home falls occur at twice the rate of community falls, yet few studies have compared these groups. We hypothesized that nursing home residents admitted for fall would be sicker than their community counterparts on presentation and have worse outcomes. Methods: Records of 1708 patients, age 65 years and older with a documented nursing home status, admitted to our center between 2008 and 2012 were reviewed. Clinical data including injury severity score (ISS), admission Glasgow coma scale (GCS), in-hospital complications, length of stay (LOS), and in-hospital mortality were collected. Continuous data were analyzed using Mann-Whitney tests and categorical data using Fisher exact tests. Variables in the univariate tests were analyzed in a multivariate logistic regression. Results: Nursing home patients were older than community patients, presented with lower GCS, lower hemoglobin, higher international normalized ratio (INR) and a higher percentage of patients with body mass index (BMI) < 18.5. LOS for nursing home patients was longer, and they suffered higher rates of in-hospital complications. ISS, rates of traumatic brain injury, operative intervention and mortality were not significantly different. In a multivariate logistic regression, ISS, GCS and age, but not nursing home status, were significant predictors of in-hospital mortality. Conclusions: In comparison to their community counterparts, nursing home patients presenting after fall are more debilitated and have increased morbidity as evidenced by more in-house complications and increased LOS. However, nursing home residency was not a significant predictor of mortality. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Botwinick, Isadora] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Botwinick, Isadora] Jacobi Med Ctr, Dept Surg, Bronx, NY 10467 USA; [Johnson, Joshua H.; Safadjou, Saman; Cohen-Levy, Wayne; Reddy, Srinivas H.; McNelis, John; Teperman, Sheldon H.; Stone, Melvin E., Jr.] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Safadjou, Saman; Reddy, Srinivas H.; McNelis, John; Teperman, Sheldon H.; Stone, Melvin E., Jr.] Jacobi Med Ctr, Dept Surg, Bronx, NY 10461 USA		Botwinick, I (corresponding author), Montefiore Med Ctr, 182 E 210th St, Bronx, NY 10467 USA.	Isadora.Botwinick@gmail.com; Joshua.Johnson@med.einstein.yu.edu; Saman.Safadjou@NBHN.net; Wayne.Cohen-Levy@med.einstein.yu.edu; Srinivas.H.Reddy@NBHN.net; John.McNelis@NBHN.net; Sheldon.Teperman@NBHN.net; Melvin.Stone@NBHN.net					al Tehewy MM, 2015, J PATIENT SAF, V11, P210, DOI 10.1097/PTS.0000000000000117; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beghe C, 2004, AM J MED, V116, P3, DOI 10.1016/j.amjmed.2003.12.009; Bergeron E, 2006, J TRAUMA, V60, P268, DOI 10.1097/01.ta.0000197651.00482.c5; Bouillon K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-64; Close JCT, 2012, EMERG MED J, V29, P742, DOI 10.1136/emermed-2011-200380; HANNAN EL, 1995, J TRAUMA, V38, P697, DOI 10.1097/00005373-199505000-00004; Hughes CM, 2009, DRUG AGING, V26, P505, DOI 10.2165/00002512-200926060-00007; Jones A. L., 2009, VITAL HLTH STAT, V13, DOI 10.1037/e565222009-001; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Monaghan SF, 2011, J TRAUMA, V71, P1569, DOI 10.1097/TA.0b013e31821e2b8f; PANISSET M, 1995, ARCH NEUROL-CHICAGO, V52, P127, DOI 10.1001/archneur.1995.00540260029010; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Siracuse JJ, 2012, AM J SURG, V203, P335, DOI 10.1016/j.amjsurg.2011.09.018; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sporer KA, 2013, EMERG MED J, V30, P243, DOI 10.1136/emermed-2011-200452; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stone ME, 2007, J TRAUMA, V63, P1348, DOI 10.1097/TA.0b013e31815b838c; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Winter JE, 2014, AM J CLIN NUTR, V99, P875, DOI 10.3945/ajcn.113.068122; Woodman R, 2005, CURR OPIN HEMATOL, V12, P123	21	7	7	0	18	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	MAR-APR	2016	63						43	48		10.1016/j.archger.2015.12.002			6	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	DA7WA	WOS:000368014500006	26791170				2022-02-06	
J	Changyaleket, B; Xu, HL; Vetri, F; Valyi-Nagy, T; Paisansathan, C; Chong, ZZ; Pelligrino, DA; Testai, FD				Changyaleket, Benjarat; Xu, Haoliang; Vetri, Francesco; Valyi-Nagy, Tibor; Paisansathan, Chanannait; Chong, Zhao Zhong; Pelligrino, Dale A.; Testai, Fernando D.			Intracerebroventricular application of S100B selectively impairs pial arteriolar dilating function in rats	BRAIN RESEARCH			English	Article						S100B; Pial arteriole; Vasodilation; The receptor of advanced glycation endproducts; Subarachnoid hemorrhage	GLYCATION END-PRODUCTS; TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION INJURY; SUBARACHNOID HEMORRHAGE; ARUNDIC ACID; IN-VIVO; HIPPOCAMPAL NEUROGENESIS; CEREBROSPINAL-FLUID; COGNITIVE RECOVERY; PROGNOSTIC VALUE	S100B is an astrocyte-derived protein that can act through the receptor for advanced glycation endproducts (RAGE) to mediate either "trophic" or "toxic" responses. Its levels increase in many neurological conditions with associated microvascular dysregulation, such as subarachnoid hemorrhage (SAH) and traumatic brain injury. The role of S100B in the pathogenesis of microvasculopathy has not been addressed. This study was designed to examine whether S100B alters pial arteriolar vasodilating function. Rats were randomized to receive (1) artificial cerebrospinal fluid (aCSF), (2) exogenous S100B, and (3) exogenous S100B+the decoy soluble RAGE (sRAGE). S100B was infused intracerebroven-tricularly (icy) using an osmotic pump and its levels in the CSF were adjusted to achieve a concentration similar to what we observed in SAH. After 48 h of continuous icy infusion, a cranial window/intravital microscopy was applied to animals for evaluation of pial arteriolar dilating responses to sciatic nerve stimulation (SNS), hypercapnia, and topical suffusion of vasodilators including acetylcholine (ACh), s-nitroso-N-acetyl penicillamine (SNAP), or adenosine (ADO). Pial arteriolar dilating responses were calculated as the percentage change of arteriolar diameter in relation to baseline. The continuous S100B infusion for 48 h was associated with reduced responses to the neuronal-dependent vasodilator SNS (p <0.05) and the endothelial -dependent vasodilator ACh (p <0.05), compared to controls. The inhibitory effects of S100B were prevented by sRAGE. On the other hand, S100B did not alter the responses elicited by vascular smooth muscle cell-dependent vasodilators, namely hypercapnia, SNAP, or ADO. These findings indicate that S100B regulates neuronal and endothelial dependent cerebral arteriolar dilation and suggest that this phenomenon is mediated through RAGE-associated pathways. (C) 2016 Elsevier B.V. All rights reserved.	[Changyaleket, Benjarat; Xu, Haoliang; Vetri, Francesco; Paisansathan, Chanannait; Chong, Zhao Zhong; Pelligrino, Dale A.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60612 USA; [Xu, Haoliang; Valyi-Nagy, Tibor] Univ Illinois, Dept Pathol, 840 S Wolcott St,Room 130 CSN,M-C 847, Chicago, IL 60612 USA; [Testai, Fernando D.] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60612 USA		Xu, HL (corresponding author), Univ Illinois, Dept Pathol, 840 S Wolcott St,Room 130 CSN,M-C 847, Chicago, IL 60612 USA.	hlxu@uic.edu					Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Britz GW, 2007, STROKE, V38, P1329, DOI 10.1161/01.STR.0000259853.43084.03; Chen C, 2014, NEUROSCIENCE, V257, P1, DOI 10.1016/j.neuroscience.2013.10.056; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Fazeli M S, 1990, Adv Exp Med Biol, V268, P369; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Hanada M, 2014, J NEUROL SCI, V337, P186, DOI 10.1016/j.jns.2013.12.008; Hein TW, 1999, CIRC RES, V85, P634, DOI 10.1161/01.RES.85.7.634; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hu JR, 1999, BRAIN RES, V842, P46, DOI 10.1016/S0006-8993(99)01804-1; Hu JR, 1997, J NEUROCHEM, V69, P2294; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kay A, 2003, STROKE, V34, pE240, DOI 10.1161/01.STR.0000100157.88508.2F; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P1351, DOI 10.1007/s00701-013-1720-2; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Li H, 2014, BRAIN RES, V1543, P315, DOI 10.1016/j.brainres.2013.11.023; Li YK, 1998, J NEUROCHEM, V71, P1421; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; ODowd BS, 1997, NEUROBIOL LEARN MEM, V67, P197, DOI 10.1006/nlme.1997.3766; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Ohtani R, 2007, BRAIN RES, V1135, P195, DOI 10.1016/j.brainres.2006.11.084; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; RICKMANN M, 1995, BRAIN RES, V688, P8, DOI 10.1016/0006-8993(95)00495-C; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sanchez-Pena P, 2008, CRIT CARE MED, V36, P2267, DOI 10.1097/CCM.0b013e3181809750; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Shapiro L.A, 2010, CARDIOVASC PSYCHIAT, V2010, P1; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; Souza TME, 2000, PHYSIOL BEHAV, V71, P29, DOI 10.1016/S0031-9384(00)00299-7; Villarreal A, 2011, J NEUROCHEM, V117, P321, DOI 10.1111/j.1471-4159.2011.07207.x; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Wilder PT, 1998, PROTEIN SCI, V7, P794, DOI 10.1002/pro.5560070330; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Xu H. L., 2012, FASEB J, V685, P34; Xu HL, 2008, AM J PHYSIOL-HEART C, V294, pH622, DOI 10.1152/ajpheart.00530.2007; Xu HL, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0234-7; Xu HL, 2014, BRAIN RES, V1586, P83, DOI 10.1016/j.brainres.2014.08.036; Xu HL, 2015, BRAIN RES, V1603, P141, DOI 10.1016/j.brainres.2015.01.047; Xu HL, 2004, STROKE, V35, P1974, DOI 10.1161/01.STR.0000135016.24349.9F; Xu HL, 2002, AM J PHYSIOL-HEART C, V282, pH237, DOI 10.1152/ajpheart.2002.282.1.H237; Xu HL, 2014, NEUROVASCULAR COUPLI, P179	57	7	7	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 1	2016	1634						171	178		10.1016/j.brainres.2015.12.061			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH3LK	WOS:000372688300017	26773687				2022-02-06	
J	Dennis, M; Cirino, PT; Simic, N; Juranek, J; Taylor, WP; Fletcher, JM				Dennis, Maureen; Cirino, Paul T.; Simic, Nevena; Juranek, Jenifer; Taylor, W. Pat; Fletcher, Jack M.			White and grey matter relations to simple, choice, and cognitive reaction time in spina bifida	BRAIN IMAGING AND BEHAVIOR			English	Article						Spina bifida; Hydrocephalus; Reaction time; Magnetic resonance imaging; FreeSurfer	TRAUMATIC BRAIN-INJURY; PROCESSING SPEED; CORTICAL THICKNESS; CRANIAL RADIATION; WORKING-MEMORY; INSULAR CORTEX; CHILDREN; HYDROCEPHALUS; IQ; MYELOMENINGOCELE	Elevated reaction time (RT) is common in brain disorders. We studied three forms of RT in a neurodevelopmental disorder, spina bifida myelomeningocele (SBM), characterized by regional alterations of both white and grey matter, and typically developing individuals aged 8 to 48 years, in order to establish the nature of the lifespan-relations of RT and brain variables. Cognitive accuracy and RT speed and variability were all impaired in SBM relative to the typically developing group, but the most important effects of SBM on RT are seen on tasks that require a cognitive decision rule. Individuals with SBM are impaired not only in speeded performance, but also in the consistency of their performance on tasks that extend over time, which may contribute to poor performance on a range of cognitive tasks. The group with SBM showed smaller corrected corpus callosum proportions, larger corrected cerebellar white matter proportions, and larger corrected proportions for grey matter in the Central Executive and Salience networks. There were clear negative relations between RT measures and corpus callosum, Central Executive, and Default Mode networks in the group with SBM; relations were not observed in typically developing age peers. Statistical mediation analyses indicated that corpus callosum and Central Executive Network were important mediators. While RT is known to rely heavily on white matter under conditions of typical development and in individuals with adult-onset brain injury, we add the new information that additional involvement of grey matter may be important for a key neuropsychological function in a common neurodevelopmental disorder.	[Dennis, Maureen; Simic, Nevena] Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada; [Dennis, Maureen] Univ Toronto, Fac Mus, Mus & Hlth Res Collaboratory, Toronto, ON, Canada; [Cirino, Paul T.; Taylor, W. Pat; Fletcher, Jack M.] Univ Houston, Dept Psychol, Houston, TX USA; [Cirino, Paul T.; Taylor, W. Pat; Fletcher, Jack M.] Univ Houston, TIMES, Houston, TX USA; [Juranek, Jenifer] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA		Simic, N (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	simicn@hhsc.ca	Fletcher, Jack/AAX-2931-2020; fletcher, jack/Q-5975-2019	Cirino, Paul T./0000-0002-9587-0388	Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [P01 HD35946-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD035946] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant (P01 HD35946-06, "Spina Bifida: Cognitive and Neurobiological Variability"). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. We thank Caroline Roncadin for assistance with the adapting her RT paradigms for the study.	Achiron A, 2007, EUR J NEUROL, V14, P1102, DOI 10.1111/j.1468-1331.2007.01909.x; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anstey KJ, 2007, NEUROPSYCHOLOGIA, V45, P1911, DOI 10.1016/j.neuropsychologia.2006.11.020; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brewer VR, 2001, NEUROPSYCHOLOGY, V15, P185, DOI 10.1037//0894-4105.15.2.185; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Dennis M, 2006, J INT NEUROPSYCH SOC, V12, P285, DOI 10.1017/S1355617706060371; Dennis M, 2005, NEUROPSYCHOLOGY, V19, P456, DOI 10.1037/0894-4105.19.4.456; Dennis M, 2005, NEUROPSYCHOLOGIA, V43, P976, DOI 10.1016/j.neuropsychologia.2004.08.012; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Gorus E, 2006, AGING CLIN EXP RES, V18, P407, DOI 10.1007/BF03324837; Gu XS, 2013, CEREB CORTEX, V23, P20, DOI 10.1093/cercor/bhr367; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hasan KM, 2008, J MAGN RESON IMAGING, V27, P700, DOI 10.1002/jmri.21297; Heath M, 2007, J INTELL DISABIL RES, V51, P972, DOI 10.1111/j.1365-2788.2007.01009.x; Hultsch D. F., 2002, J GERONTOL B-PSYCHOL, V57, P101, DOI DOI 10.1093/GER0NB/57.2.P101; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Juranek J, 2008, NEUROIMAGE, V40, P1516, DOI 10.1016/j.neuroimage.2008.01.043; Juranek J, 2010, DEV DISABIL RES REV, V16, P23, DOI 10.1002/ddrr.88; KAIL R, 1993, J EXP CHILD PSYCHOL, V56, P254, DOI 10.1006/jecp.1993.1034; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P398, DOI 10.1097/WNP.0b013e318150694b; Luks TL, 2010, NEUROPSYCHOLOGIA, V48, P165, DOI 10.1016/j.neuropsychologia.2009.09.001; Mabbott DJ, 2006, NEURO-ONCOLOGY, V8, P244, DOI 10.1215/15228517-2006-002; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Palmer SL, 2013, J CLIN ONCOL, V31, P3494, DOI 10.1200/JCO.2012.47.4775; Perneczky R, 2011, NEUROBIOL DIS, V43, P79, DOI 10.1016/j.nbd.2011.01.032; PRIGATANO GP, 1983, CHILD BRAIN, V10, P112; Ratcliff R, 2001, PSYCHOL AGING, V16, P323, DOI 10.1037//0882-7974.16.2.323; Schatz J, 2000, NEUROPSYCHOLOGY, V14, P189, DOI 10.1037//0894-4105.14.2.189; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; TEW B, 1980, Z KINDERCHIR, V31, P381; Treble A, 2013, CEREB CORTEX, V23, P2357, DOI 10.1093/cercor/bhs226; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Walhovd KB, 2007, NEUROPSYCHOLOGIA, V45, P2277, DOI 10.1016/j.neuropsychologia.2007.02.022; Ware AL, 2014, NEUROIMAGE-CLIN, V5, P120, DOI 10.1016/j.nicl.2014.05.012; Wiedenbauer G, 2007, DEV NEUROPSYCHOL, V32, P809, DOI 10.1080/87565640701539626	48	7	7	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	MAR	2016	10	1					238	251		10.1007/s11682-015-9388-2			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO5NJ	WOS:000377829500025	26040977				2022-02-06	
J	Erdman, EA; Pierce, SR				Erdman, Ellen A.; Pierce, Samuel R.			Use of Hippotherapy With a Boy After Traumatic Brain Injury: A Case Study	PEDIATRIC PHYSICAL THERAPY			English	Article						activities of daily living; adolescent; ambulation; community participation; hippotherapy; human; male; postural balance; traumatic brain injury	MINIMUM DETECTABLE CHANGE; BERG BALANCE SCALE; DYNAMIC GAIT INDEX; CEREBRAL-PALSY; CHILDREN; DISORDERS	Purpose: The purpose of this case report was to describe the use of hippotherapy with a boy who sustained a brain injury. Key Points: A 13-year-old boy, 6 months after traumatic brain injury received 12 physical therapy sessions, which included hippotherapy. Improvements were noted in balance, strength, grossmotor skills, gait speed, functional mobility, and reported participation. Summary: Hippotherapy used with a 13-year-old boy after traumatic brain injury may have had a positive effect in the body structure, activity, and participation domains.	[Erdman, Ellen A.; Pierce, Samuel R.] Widener Univ, Inst Phys Therapy Educ, 121 Cottee Hall,One Univ Pl, Chester, PA 19013 USA; [Erdman, Ellen A.] Quest Therapeut Serv Inc, W Chester, PA USA		Erdman, EA (corresponding author), Widener Univ, Inst Phys Therapy Educ, 121 Cottee Hall,One Univ Pl, Chester, PA 19013 USA.; Erdman, EA (corresponding author), Quest Therapeut Serv Inc, W Chester, PA USA.	eaerdman@widener.edu					American Hippotherapy Association, LIST REG THER; American Hippotherapy Association, PRES US EQ MOV PT OT; Benda W, 2003, J ALTERN COMPLEM MED, V9, P817, DOI 10.1089/107555303771952163; Bizub AL, 2003, PSYCHIATR REHABIL J, V26, P377, DOI 10.2975/26.2003.377.384; Bronson C, 2010, EUR J PHYS REHAB MED, V46, P347; Casady Renee L, 2004, Pediatr Phys Ther, V16, P165, DOI 10.1097/01.PEP.0000136003.15233.0C; Champagne Danielle, 2010, Physiotherapy Theory and Practice, V26, P564, DOI 10.3109/09593981003623659; Chasseny O, 2004, PSYCHOL WELL BEING I; Granados AC, 2011, J ALTERN COMPLEM MED, V17, P191, DOI 10.1089/acm.2009.0229; Debuse D., 2009, Physiotherapy Theory and Practice, V25, P174, DOI 10.1080/09593980902776662; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; Franjoine Mary Rose, 2003, Pediatr Phys Ther, V15, P114, DOI 10.1097/01.PEP.0000068117.48023.18; Frank A, 2011, PEDIATR PHYS THER, V23, P301, DOI 10.1097/PEP.0b013e318227caac; Garner BA, 2015, HUM MOVEMENT SCI, V39, P121, DOI 10.1016/j.humov.2014.06.011; Granacher U, 2013, SPORTS MED, V43, P627, DOI 10.1007/s40279-013-0041-1; Granacher U, 2013, GERONTOLOGY, V59, P105, DOI 10.1159/000343152; Haehl V., 1999, PEDIATR PHYS THER, V11, P89, DOI DOI 10.1097/00001577-199901120-00006; Hagen C, 1979, REHABILITATION HEAD, P88; Hammer Ann, 2005, Physiotherapy Theory and Practice, V21, P51, DOI 10.1080/09593980590911525; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Lechner HE, 2007, ARCH PHYS MED REHAB, V88, P1241, DOI 10.1016/j.apmr.2007.07.015; Lentini JA, 2009, OEPN COMPLEMENT MED, V1, P51, DOI DOI 10.2174/1876391X00901010051; Lubetzky-Vilnai A, 2011, PEDIATR PHYS THER, V23, P268, DOI 10.1097/PEP.0b013e318227cd82; Marchetti GF, 2006, PHYS THER, V86, P1651, DOI 10.2522/ptj.20050402; Oeffinger D, 2008, DEV MED CHILD NEUROL, V50, P918, DOI 10.1111/j.1469-8749.2008.03150.x; Riede D, 1988, PHYSIOTHERAPY HORSE, P41; Riede D, 1988, ACCELERATION VIBRATI, P71; Romero S, 2011, J GERIATR PHYS THER, V34, P131, DOI 10.1519/JPT.0b013e3182048006; Russell, 1993, GROSS MOTOR FUNCTION; Schirm A, 1998, 3 EUR C THER RID MUN; Shurtleff TL, 2009, ARCH PHYS MED REHAB, V90, P1185, DOI 10.1016/j.apmr.2009.01.026; Silkwood-Sherer DJ, 2012, PHYS THER, V92, P707, DOI 10.2522/ptj.20110081; Stmwoo H, 2012, ANN REHABIL MED-ARM, V36, P756, DOI 10.5535/arm.2012.36.6.756; van Brussel M, 2009, PEDIATR PHYS THER, V21, P244, DOI 10.1097/01.pep.0000359326.12040.0b	34	7	8	0	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	SPR	2016	28	1					109	116		10.1097/PEP.0000000000000204			8	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Rehabilitation	DO1MZ	WOS:000377543900028	27088700				2022-02-06	
J	Fines, P; Garner, R; Bancej, C; Bernier, J; Manuel, DG				Fines, Philippe; Garner, Rochelle; Bancej, Christina; Bernier, Julie; Manuel, Douglas G.			Development and implementation of microsimulation models of neurological conditions	HEALTH REPORTS			English	Article						Alzheimer's disease and other dementias; cerebral palsy; epilepsy; health costs; microsimulation; multiple sclerosis; Parkinson's disease; traumatic brain injury; traumatic spinal cord injury	PREVALENCE; HEALTH; VALIDATION; REMISSION	Background: As part of a program of the first National Population Health Study of Neurological Conditions launched in 2009, a series of microsimulation models of neurological conditions (called POHEM-Neurological meta-model) was developed to project health and economic impacts of seven neurological conditions (NCs)-Alzheimer's disease and other dementias, cerebral palsy, epilepsy, multiple sclerosis, Parkinson's disease, traumatic brain injury, and traumatic spinal cord injury-over a 20-year horizon. Data and methods: The common framework of the seven models allows for dynamic, continuous-time, discrete-event simulation of synthetic large populations in which persons are subject to the risk of developing the NC under study and are assigned a value of functional health and a probability of receiving a caregiver and of entering long-term care. Calculations for transitions are done every year over the life course, and costs are accumulated throughout the life of the synthetic person. The need to reconcile empirical estimates of incidence and mortality with prevalence required implementation of "cure" parameters for two of the NCs. Results: The POHEM-Neurological meta-model integrates the latest Canadian microdata on neurological conditions and satisfies most criteria for validation of microsimulation models, including conceptualization, computer implementation, assessment of output plausibility, and comparison with external data. Limitations include an absence of risk factors and the lack of uncertainty measures. Interpretation: The POHEM-Neurological meta-model has been useful for projections of health and economic impacts of NCs on persons affected and their caregivers, and allows for comparison of specific scenarios to the base case.	[Fines, Philippe; Garner, Rochelle; Bernier, Julie; Manuel, Douglas G.] STAT Canada, Hlth Anal Div, Ottawa, ON, Canada; [Manuel, Douglas G.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Manuel, Douglas G.] Bruyere Res Inst, Ottawa, ON, Canada; [Manuel, Douglas G.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Bancej, Christina] Publ Hlth Agcy Canada, Ottawa, ON, Canada		Fines, P (corresponding author), STAT Canada, Hlth Anal Div, Ottawa, ON, Canada.	philippe.fines@canada.ca	Manuel, Doug/D-7100-2014	Manuel, Doug/0000-0003-0912-0845			Berg AT, 2011, ANN NEUROL, V70, P566, DOI 10.1002/ana.22461; Butt DA, 2014, NEUROEPIDEMIOLOGY, V43, P28, DOI 10.1159/000365590; Caesar-Chavannes CR, 2013, CHRON DIS INJ CAN, V33, P188; Camfield P, 2007, EPILEPSIA, V48, P1128, DOI 10.1111/j.1528-1167.2007.01072.x; Canadian Institute for Health Information, 2007, BURD NEUR DIS DIS IN; Evans WK, 2013, INT J TECHNOL ASSESS, V29, P131, DOI 10.1017/S0266462313000044; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Health Canada and the Public Health Agency of Canada, 2015, EV NAT POP HLTH STUD; Kopec JA, 2010, OSTEOARTHR CARTILAGE, V18, P303, DOI 10.1016/j.joca.2009.10.010; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Manuel Douglas G, 2014, CMAJ Open, V2, pE94, DOI 10.9778/cmajo.2012-0015; Modgen, MOD GEN; Norton S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1; Pringsheim T, 2014, NEUROLOGY, V83, P1661, DOI 10.1212/WNL.0000000000000929; Public Health Agency of Canada National Population Health Study of Neurological Conditions (Canada)., 2014, MAPP CONN UND NEUR C; Statistics Canada, NAT POP HLTH SURV HO; Statistics Canada, GEN SOC SURV HLTH GS; Statistics Canada, 2012, SURV LIV NEUR COND C; Statistics Canada, PART ACT LIM SURV PA; Statistics Canada, CAN COMM HLTH SURV A; TAUDORF K, 1986, NEUROPEDIATRICS, V17, P19, DOI 10.1055/s-2008-1052493; Tu K, 2014, EPILEPSIA, V55, P335, DOI 10.1111/epi.12506; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wodchis WP, 2013, WORKING PAPER SERIES; Wolf DA, 2001, PAPERS MICROSIMULATI; Zucchelli E, 2010, 1003 HEDG U YORK	27	7	7	1	3	STATISTICS CANADA	OTTAWA	100 TUNNEYS PASTURE DRIVEWAY, OTTAWA, ONTARIO K1A 0T6, CANADA	0840-6529	1209-1367		HEALTH REP	Health Rep.	MAR	2016	27	3					3	9					7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EF0CW	WOS:000389994200001	26983006				2022-02-06	
J	Gonzalez, CA; Elliott, M				Gonzalez, Carlene A.; Elliott, Marta			Faculty Attitudes and Behaviors Towards Student Veterans	JOURNAL OF POSTSECONDARY EDUCATION AND DISABILITY			English	Article						veterans; faculty attitudes; and postsecondary education	COMMUNITY-COLLEGE	According to the U.S. Department of Education (2013), approximately 11% of undergraduate students reported having a disability in the 2007-2008 academic year. Of these students, veterans reported having disabilities more than their non-veteran counterparts (5% vs. 3%)(1). This study investigates faculty members' attitudes and behaviors toward student veterans pursuing postsecondary education. Over half a million U.S. troops have returned from the wars in die Middle East and opted to use their GI-bill benefits to enroll in college. Many of diese students face common post-war experiences such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Previous research has shown that mental health issues led student veterans to perceive faculty as judging them unfairly, but little is known about w hat faculty actually think of student veterans. Using survey data collected from 160 instructors at a community college and four-wear university, we estimate structural equation models to explain the associations among faculty members' prior contact with the military, their attitudes toward student veterans and willingness to help them, and their treatment of military-related issues in the classroom. The results reveal that faculty who have greater contact with the military in their own lives discuss the military more often in class and are more willing to help student veterans because they know more of them. Policy recommendations in line with Universal Design (UD) are offered for training faculty who do not have contact with the military and need to be aware of special issues related to student veterans in their classrooms, such as helping students who arc dealing with visible and invisible injuries related to their military service.	[Gonzalez, Carlene A.] Natl Council Juvenile & Family Court Judges, Reno, NV 89507 USA; [Elliott, Marta] Univ Nevada, Sociol, Reno, NV 89557 USA		Gonzalez, CA (corresponding author), Natl Council Juvenile & Family Court Judges, Reno, NV 89507 USA.	CAgonzalez55@yahoo.com					Ackerman R., 2009, NEW DIRECTIONS STUDE, V126, P5, DOI [https://doi.org/10.1002/ss.311, DOI 10.1002/SS.311]; American Council on Education, ACC STUD VET TRAUM B; Association on Higher Education and Disability, UN DES; Astin, 1993, WHAT MATTERS COLL 4; Barnard-Brak L, 2011, J VOCAT REHABIL, V35, P29, DOI 10.3233/JVR-2011-0551; BAUER PF, 1994, COLL UNIV, V69, P116; Branker C, 2009, J POSTSECOND EDUC DI, V22, P59; BRITT LW, 1999, NASPA J, V36, P305, DOI DOI 10.2202/0027-6014.1086; Burgstahler S, 2012, UNIVERSAL DESIGN WEB; Burgstahler S., 2012, UNIVERSAL DESIGN ED; Cate C. A., 2013, STUDENT VETERANS AM, V1; Cate C.A., 2014, MILLION RECORDS PROJ; Center for Universal Design, 1997, PRINC UN DES VERS 2; Church TE., 2009, J POSTSECOND ED DISA, V22, P224; Dillman D., 2008, INTERNET MAIL MIXED; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Durdella NR., 2012, J STUD ED, V2, P109; Elliott M., 2012, STATE STUDENT VETERA; Elliott M, 2015, ANAL SOC ISS PUB POL, V15, P105, DOI 10.1111/asap.12066; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; GONZALEZ C. A., 2012, THESIS; Grossman PD, 2009, J POSTSECOND EDUC DI, V22, P4; HAMILTON RF, 1993, SOC FORCES, V71, P603, DOI 10.2307/2579887; Kline R. B., 2016, PRINCIPLES PRACTICE, VFourth; Lighthall A., 2012, NEA HIGHER ED J THOU, V28, P81; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Meyers L. S., 2006, APPL MULTIVARIATE RE; Monroe S. J., 2008, DEAR COLLEAGUE LETT; Muthen L. K., 1998, MPLUS USERS GUIDE, V7th; National Survey of Student Engagement, 2010, MAJOR DIFFERENCES EX; Osborne NJ, 2014, INNOV HIGH EDUC, V39, P247, DOI 10.1007/s10755-013-9274-z; Persky KR, 2010, COMMUNITY COLL J RES, V35, P111, DOI 10.1080/10668926.2011.525184; Queen B., 2014, 2014017 NCES US DEP; Raue K, 2011, STUDENTS DISABILITIE; Runmann C, 2011, NEW DIRECTIONS STUDE, V155, P51; Sander L., 2012, CHRONICLE HIGHER ED; Scott S. S, 2001, PRINCIPLES UNIVERSAL; Steele JL., 2010, SERVICE MEMBERS SCH; Synder T. D, 2010, 2010013 NCES US DEP; TOWNSEND BK, 1995, REV HIGH EDUC, V18, P175, DOI 10.1353/rhe.1995.0022; U. S. Department of Education, 2008, SO YOU WANT GO BACK; Umbach PD, 2005, RES HIGH EDUC, V46, P153, DOI 10.1007/s11162-004-1598-1; US Department of Education National Center for Education Statistics, 2013, 2014015 NCES US DEP; Vaala L. D., 1991, NASPA J, V28, P198; Vance ML, 2009, J POSTSECOND EDUC DI, V22, P18; Wheaton B., 1977, SOCIOLOGICAL METHODO, V8, P84	46	7	7	0	0	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD	COLUMBUS	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD, COLUMBUS, OH 00000 USA	2379-7762	2328-3343		J POSTSECOND EDUC DI	J. Postsecond. Educ. Disabil.	SPR	2016	29	1					35	46					12	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VE7HK	WOS:000440162000004					2022-02-06	
J	Hou, QX; Yu, L; Tian, SQ; Jiang, CJ; Yang, WJ; Wang, ZJ				Hou, Qing-Xian; Yu, Li; Tian, Shao-Qi; Jiang, Cui-Jun; Yang, Wen-Jiu; Wang, Zhi-Jie			Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Antioxidant; Atomoxetine; Neurology; Spinal cord injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; LIPID-PEROXIDATION; BRAIN-INJURY; ADULT RATS; METHYLPREDNISOLONE; NOREPINEPHRINE; MECHANISMS; DOPAMINE; RECOVERY; EXPRESSION	Objective(s): Spinal cord injury (SCI) often causes serious and irreversible neurological deficit leading to disability or impairment of normal physical activity. Atomoxetine, a selective norepinephrine transporter (NET) inhibitor has gained much attention in the field of the neurodevelopmental disorder, but its effect on SCI has not been evaluated. The present study has been undertaken to investigate the neuroprotective effects of atomoxetine. Materials and Methods: Administration of atomoxetine 20 mg/kg IP was compared with methylprednisolone (MP) 30 mg/kg IP in traumatic spinal cord injured Wistar rats. Tissue samples were evaluated for apoptosis, inflammation, and oxidative stress, along with histopathological examination and neurological evaluation. Results: There was no significant difference in the caspase-3 activity between the control and the sham groups or between the MP and the atomoxetine groups (P=0.811). The administration of atomoxetine significantly reduced tissue tumour necrosis factor alpha (TNF-alpha), and nitric oxide (NO) levels compared to the trauma group (P<0.001). Treatment with atomoxetine also decreased the tissue myeloperoxidase (MPO) activity (P=0.026) and increased the tissue superoxide dismutase (SOD) activity compared to the trauma group (P=0.001 and P=0.004, respectively). Histopathological examination showed less degenerated neurons in the atomoxetine group compared to trauma group. Conclusion: This is the first experimental evidence showing meaningful neuroprotective effects of atomoxetine over SCI through anti-apoptotic, anti-inflammatory, and antioxidant effects by reducing lipid peroxidation, which was confirmed by biochemical, histopathological and the functional evaluation.	[Hou, Qing-Xian; Tian, Shao-Qi; Jiang, Cui-Jun; Yang, Wen-Jiu; Wang, Zhi-Jie] Hosp Qingdao Univ, Dept Orthoped, 16 Jiangsu Rd, Qingdao 266000, Shandong, Peoples R China; [Yu, Li] Shandong Univ, Dept Pharm, Qilu Hosp, Qingdao 266000, Shandong, Peoples R China		Wang, ZJ (corresponding author), Hosp Qingdao Univ, Dept Orthoped, 16 Jiangsu Rd, Qingdao 266000, Shandong, Peoples R China.	wangzj6922@gmail.com			Qingdao University, Qingdao, China	The study was financially supported by the Qingdao University, Qingdao, China.	BALENTINE JD, 1978, LAB INVEST, V39, P236; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BORGENS RB, 1986, J COMP NEUROL, V250, P157, DOI 10.1002/cne.902500203; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; DAWSON TM, 1994, ANN NY ACAD SCI, V738, P76; Dinc C, 2013, SPINE, V38, pE1649, DOI 10.1097/BRS.0000000000000055; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-81; GEHLERT DR, 1993, NEUROSCI LETT, V157, P203, DOI 10.1016/0304-3940(93)90737-6; Gould TJ, 2005, NEUROSCI LETT, V377, P85, DOI 10.1016/j.neulet.2004.11.073; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kertmen H, 2013, EUR J PHARMACOL, V714, P148, DOI 10.1016/j.ejphar.2013.05.012; Kratochvil CJ, 2003, EXPERT OPIN PHARMACO, V4, P1165, DOI 10.1517/14656566.4.7.1165; Kurt G, 2009, SURG NEUROL, V71, P332, DOI 10.1016/j.surneu.2008.01.038; Liu XZ, 1997, J NEUROSCI, V17, P5395; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan WH, 2003, J NEUROIMMUNOL, V134, P111, DOI 10.1016/S0165-5728(02)00426-5; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Pataki Caroly S, 2004, Expert Opin Emerg Drugs, V9, P293, DOI 10.1517/14728214.9.2.293; Ripley DL, 2006, J HEAD TRAUMA REHAB, V21, P85, DOI 10.1097/00001199-200601000-00010; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Sauer JM, 2005, CLIN PHARMACOKINET, V44, P571, DOI 10.2165/00003088-200544060-00002; Schroter A, 2009, NEUROSCIENCE, V161, P753, DOI 10.1016/j.neuroscience.2009.04.016; Somkuwar SS, 2013, NEUROPSYCHOPHARMACOL, V38, P2588, DOI 10.1038/npp.2013.163; SUN Y, 1988, CLIN CHEM, V34, P497; Swanson CJ, 2006, NEUROPHARMACOLOGY, V50, P755, DOI 10.1016/j.neuropharm.2005.11.022; Torres S, 2010, NEUROPATHOLOGY, V30, P36, DOI 10.1111/j.1440-1789.2009.01037.x; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744	40	7	8	0	1	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	MAR	2016	19	3					272	280					9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	DG8IS	WOS:000372327800008	27114797				2022-02-06	
J	Rabner, J; Gottlieb, S; Lazdowsky, L; LeBel, A				Rabner, Jonathan; Gottlieb, Sarah; Lazdowsky, Lori; LeBel, Alyssa			Psychosis following traumatic brain injury and cannabis use in late adolescence	AMERICAN JOURNAL ON ADDICTIONS			English	Article								BackgroundBoth cannabis and traumatic brain injury (TBI) pose risks on the developing brain, including a potential increased vulnerability for developing psychosis. Recent reports detail an upward trend in both adolescent cannabis use and the concentration of THC, the most potent psychoactive component in cannabis. Similarly, it is estimated that 1.7 million Americans incur a TBI each year. Previously trivialized as a minor nuisance, attitudes towards TBIs are changing as researchers and the public recognize TBIs' possible long-lasting sequelae. Case ReportTwo cases are presented of adolescent patients with histories of TBI and self-reported heavy, recreational cannabis use who developed symptoms of psychosis. DiscussionSimilar neuronal signaling pathways involved in cannabis ingestion and TBI recovery, specifically CB1 receptors of the endocannabinoid system, as well as the allostatic load model provide context for the two presented cases. Given the cases and theories presented, we believe that cannabis use may act as a neurological stressor and risk factor for psychosis outweighing its possible benefits as a therapeutic solution for pain in late adolescent and young adult populations. SignificanceThe presented cases provide further support for the compounded risk of developing psychosis following TBI and cannabis use. (Am J Addict 2016;25:91-93)	[Rabner, Jonathan; Gottlieb, Sarah; Lazdowsky, Lori; LeBel, Alyssa] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Pediat Headache Program, Waltham, MA USA		Rabner, J; LeBel, A (corresponding author), Boston Childrens Hosp Waltham, 9 Hope Ave, Waltham, MA 02453 USA.	jonathan.rabner@childrens.harvard.edu; alyssa.lebel@childrens.harvard.edu	Rabner, Jonathan/AAM-1100-2021	Rabner, Jonathan/0000-0001-8345-4769			Bahr BA, 2006, EXPERT OPIN INV DRUG, V15, P351, DOI 10.1517/13543784.15.4.351; Benbadis SR, 2014, EXPERT REV NEUROTHER, V14, P1453, DOI 10.1586/14737175.2014.985209; Biegon A, 2004, CURR PHARM DESIGN, V10, P2177, DOI 10.2174/1381612043384196; Freeman D, 2015, SCHIZOPHRENIA BULL, V41, P391, DOI 10.1093/schbul/sbu098; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Hilt RJ, 2014, PEDIATR ANN, V43, P89, DOI 10.3928/00904481-20140221-02; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nugent KL, 2015, PSYCHONEUROENDOCRINO, V60, P120, DOI 10.1016/j.psyneuen.2015.06.009; Stone MH, 2015, J CHILD ADOLESC BEHA, V3, P188; United Nations Office on Drugs and Crime, WORLD DRUG REP 2015; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74	12	7	7	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1055-0496	1521-0391		AM J ADDICTION	Am. J. Addict.	MAR	2016	25	2					91	93		10.1111/ajad.12338			3	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	DF3IV	WOS:000371238400002	26849855				2022-02-06	
J	Roberts, CM; Spitz, G; Ponsford, JL				Roberts, Caroline M.; Spitz, Gershon; Ponsford, Jennie L.			Comparing Prospectively Recorded Posttraumatic Amnesia Duration With Retrospective Accounts	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury; Westmead PTA Scale; retrospective; posttraumatic amnesia	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; PRACTICAL SCALE; SEVERITY; REHABILITATION; COGNITION; RECOVERY; MODERATE; COMA	Objective: Limited research has been conducted comparing different methods for determining the duration of posttraumatic amnesia (PTA). This study compared prospectively recorded PTA duration (P-PTA) with retrospective reports of the return of continuous memory (R-PTA). Participants: Fifty-nine individuals admitted to a head injury rehabilitation unit with a traumatic brain injury who had their PTA duration recorded using the Westmead Post-Traumatic Amnesia Scale. Participants were between 6 months and 6 years postinjury at the time of study. Measures: P-PTA was determined on the basis of Westmead Post-Traumatic Amnesia Scale responses. R-PTA was ascertained using a semistructured telephone interview. Results: Although the PTA measures were significantly positively correlated (r = 0.76), mean R-PTA was significantly longer than mean P-PTA. In 34 cases (57.6%), R-PTA was longer than P-PTA (13 participants moved to a higher injury severity band), and in 22 cases (37.3%), R-PTA was shorter than P-PTA (8 participants moved to a lower injury severity band). The difference between P-PTA and R-PTA was not significantly associated with age, Glasgow Coma Scale score, overall PTA duration, or the number of days postinjury of the retrospective interview. Conclusions: Prospective and retrospective estimates of PTA duration were not comparable within the present sample. Further research comparing the two methods is needed.	[Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia; Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480; Roberts, Caroline/0000-0003-1200-4415			Ahmed S, 2000, BRAIN INJURY, V14, P765; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Ashla PM, 2009, J NEUROPSYCH CLIN N, V21, P467, DOI 10.1176/appi.neuropsych.21.4.467; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Jennett B, 1981, MANAGEMENT HEAD INJU; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M, 2015, ARCH PHYS MED REHAB, V96, P652, DOI 10.1016/j.apmr.2014.10.024; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Symonds CP, 1943, LANCET, V1, P7; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; TEASDALE G, 1974, LANCET, V2, P81; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	41	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E71	E77		10.1097/HTR.0000000000000154			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300007	26098260				2022-02-06	
J	Teel, EF; Gay, MR; Arnett, PA; Slobounov, SM				Teel, Elizabeth F.; Gay, Michael R.; Arnett, Peter A.; Slobounov, Semyon M.			Differential Sensitivity Between a Virtual Reality Balance Module and Clinically Used Concussion Balance Modalities	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						injury; trauma; sensitivity and specificity; brain concussion; virtual reality; postural balance	SENSORY ORGANIZATION TEST; POSTURAL STABILITY; RECOVERY; ADULTS; MANAGEMENT; RESPONSES; SUPPORT; INJURY; SPORTS	Objective: Balance assessments are part of the recommended clinical concussion evaluation, along with computerized neuropsychological testing and self-reported symptoms checklists. New technology has allowed for the creation of virtual reality (VR) balance assessments to be used in concussion care, but there is little information on the sensitivity and specificity of these evaluations. The purpose of this study is to establish the sensitivity and specificity of a VR balance module for detecting lingering balance deficits clinical concussion care. Design: Retrospective case-control study. Setting: Institutional research laboratory. Participants: Normal controls (n = 94) and concussed participants (n = 27). Interventions: All participants completed a VR balance assessment paradigm. Concussed participants were diagnosed by a Certified Athletic Trainer or physician (with 48 hours postinjury) and tested in the laboratory between 7 and 10 days postinjury. Receiver operating characteristic curves were performed to establish the VR module's sensitivity and specificity for detecting lingering balance deficits. Main Outcome Measures: Final balance score. Results: For the VR balance module, a cutoff score of 8.25 was established to maximize sensitivity at 85.7% and specificity at 87.8%. Conclusions: The VR balance module has high sensitivity and specificity for detecting subacute balance deficits after concussive injury. Clinical Relevance: The VR balance has a high subacute sensitivity and specificity as a stand-alone balance assessment tool and may detect ongoing balance deficits not readily detectable by the Balance Error Scoring System or Sensory Organization Test. Virtual reality balance modules may be a beneficial addition to the current clinical concussion diagnostic battery.	[Teel, Elizabeth F.; Gay, Michael R.; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Teel, Elizabeth F.; Gay, Michael R.; Slobounov, Semyon M.] Penn State Ctr Sport Concuss Res & Serv, University Pk, PA USA; [Teel, Elizabeth F.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Teel, EF (corresponding author), 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	eteel@live.unc.edu		Teel, Elizabeth/0000-0002-2846-5884	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R01 NS056227-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056227] Funding Source: NIH RePORTER	Supported by the National Institute of Health Grant No. 2R01 NS056227-06, "The effects of mild traumatic brain injury on neuropsychological test scores, postural stability, and general brain function."	Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Dickin DC, 2010, CLIN J SPORT MED, V20, P278, DOI 10.1097/JSM.0b013e3181e8f8b1; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haibach PS, 2008, GAIT POSTURE, V27, P303, DOI 10.1016/j.gaitpost.2007.04.004; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sebastianelli W., 2014, CONCUSSION ATHLETICS; Slaboda JC, 2013, IEEE T NEUR SYS REH, V21, P218, DOI 10.1109/TNSRE.2013.2246583; Slaboda JC, 2012, J NEUROL, V259, P2664, DOI 10.1007/s00415-012-6566-7; Slobounov S, 2011, C P IEEE ENG MED BIO, V6; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109	22	7	7	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2016	26	2					162	166		10.1097/JSM.0000000000000210			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DF4DM	WOS:000371297600012	26505696	Green Accepted, Green Submitted			2022-02-06	
J	Zeng, EQ; Zeng, BQ; Tian, JL; Du, B; Tian, XB; Chen, H				Zeng, En Quan; Zeng, Ben Qiang; Tian, Jing Lun; Du, Bing; Tian, Xiao Bing; Chen, Hong			Perceived Social Support and Its Impact on Mental Fatigue in Patients with Mild Traumatic Brain Injury	BALKAN MEDICAL JOURNAL			English	Article						Mental fatigue; social support; traumatic brain injury	MULTIDIMENSIONAL SCALE; COMMUNITY INTEGRATION; LIFE SATISFACTION; SYMPTOMS; PERFORMANCE; DEPRESSION	Background: Although mental fatigue was well-recognized as one of the long-term consequences following mild traumatic brain injury (MTBI) that required ongoing support, evidences for the optimal management remained inadequate. Aims: To investigate the temporal profile of mental fatigue during the first year after MTBI and examine the impact of perceived social support on the recovery from post-MTBI fatigue. Study Design: Observational case-control study. Methods: This study was conducted among post-MTBI patients admitted to the emergency department in a tertiary-care hospital in Sichuan, China. During four waves of assessments at 1 week, 3, 6 and 12 months, mental fatigue was assessed through Mental Fatigue Scale (MFS) whereas social support was assessed by the Multidimensional Scale of Perceived Social Support (MSPSS). Results: There were 65.1%, 37.1%, 34.8% and 32.5% individuals being identified as those with mental fatigue at 1 week, 3, 6 and 12 months, respectively. The scores of MFS didn't change substantially since 3 months post-injury. Compared to non-fatigued MTBI patients, those with long-lasting post-MTBI fatigue reported extremely lower level of perceived social support. Moreover, improved social support at 1 week was negatively associated with the occurrence of long-lasting fatigue. Conclusion: Sufficient social support could significantly decrease the occurrence of long-lasting mental fatigue among MTBI cases. It seemed of great importance to modify the emphasis of rehabilitation to include assessment and improvement of perceived social support at earlier stages after injury.	[Zeng, En Quan; Du, Bing; Tian, Xiao Bing] North Shichuan Med Coll, Nanchong, Sichuan, Peoples R China; [Zeng, Ben Qiang; Tian, Jing Lun] Peoples Hosp Wenjiang, Chengdu, Peoples R China; [Chen, Hong] North Sichuan Med Coll, Affiliated Hosp, Nanchong, Sichuan, Peoples R China		Chen, H (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Nanchong, Sichuan, Peoples R China.	nsmcchengh@163.com					Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Chou KL, 2000, PERS INDIV DIFFER, V28, P299, DOI 10.1016/S0191-8869(99)00098-7; Cook GA, 2014, MIL MED, V179, P1083, DOI 10.7205/MILMED-D-13-00435; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Izaute M, 2008, BRAIN INJURY, V22, P758, DOI 10.1080/02699050802366002; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Matsuda T, 2014, PSYCHOLOGY, P2014; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Schillinger A, 2015, TIDSSKR NORSKE LAEGE, V135, P331, DOI 10.4045/tidsskr.14.0271; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13, DOI 10.1097/00001199-199309000-00004; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242; Zhou KN, 2015, COMPR PSYCHIAT, V60, P182, DOI 10.1016/j.comppsych.2015.03.007; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	29	7	9	0	11	GALENOS YAYINCILIK	FINDIKZADE	ERKAN MOR, MOLLA GURANI CAD 21-1, FINDIKZADE, ISTANBUL 34093, TURKEY	2146-3123	2146-3131		BALK MED J	Balk. Med. J.	MAR	2016	33	2					152	157		10.5152/balkanmedj.2016.15701			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SX	WOS:000375056600005	27403383	Green Published, Green Submitted, gold			2022-02-06	
J	Maruta, J; Spielman, LA; Yarusi, BB; Wang, YS; Silver, JM; Ghajar, J				Maruta, Jun; Spielman, Lisa A.; Yarusi, Brett B.; Wang, Yushi; Silver, Jonathan M.; Ghajar, Jamshid			Chronic Post-Concussion Neurocognitive Deficits. II. Relationship with Persistent Symptoms	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						attention networks; mild traumatic brain injury; neuropsychology; post-concussion syndrome; predictive visual tracking	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ATTENTIONAL NETWORKS; SLEEP-DEPRIVATION; SPECIFICITY; SYNCHRONIZATION; SOLDIERS; HISTORY; IRAQ	Individuals who sustain a concussion may continue to experience problems long after their injury. However, it has been postulated in the literature that the relationship between a concussive injury and persistent complaints attributed to it is mediated largely by the development of symptoms associated with posttraumatic stress disorder (PTSD) and depression. We sought to characterize cognitive deficits of adult patients who had persistent symptoms after a concussion and determine whether the original injury retains associations with these deficits after accounting for the developed symptoms that overlap with PTSD and depression. We compared the results of neurocognitive testing from 33 patients of both genders aged 18-55 at 3 months to 5 years post-injury with those from 140 control subjects. Statistical comparisons revealed that patients generally produced accurate responses on reaction time-based tests, but with reduced efficiency. On visual tracking, patients increased gaze position error variability following an attention demanding task, an effect that may reflect greater fatigability. When neurocognitive performance was examined in the context of demographic- and symptom-related variables, the original injury retained associations with reduced performance at a statistically significant level. For some patients, reduced cognitive efficiency and fatigability may represent key elements of interference when interacting with the environment, leading to varied paths of recovery after a concussion. Poor recovery may be better understood when these deficits are taken into consideration.	[Maruta, Jun; Spielman, Lisa A.; Yarusi, Brett B.; Wang, Yushi; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Silver, Jonathan M.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Ghajar, Jamshid] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Maruta, J (corresponding author), Brain Trauma Fdn, New York, NY USA.	jmaruta@braintrauma.org	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	U.S. Department of Defense Congressionally Directed Medical Research Programs through an Advanced Technology Award [W81XWH-08-1-0646]	We thank the staff of the Brain Trauma Foundation for assistance with data collection. This work was supported by U.S. Department of Defense Congressionally Directed Medical Research Programs through an Advanced Technology Award (W81XWH-08-1-0646) to JG.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carpenter R. H. S., 1981, EYE MOVEMENTS COGNIT, P237; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Conners C.K., 1999, CAARS ADULT ADHD RAT; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Diemer MA, 2013, ANAL SOC ISS PUB POL, V13, P77, DOI 10.1111/asap.12001; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Maruta J, 2017, J ATTEN DISORD, V21, P1169, DOI 10.1177/1087054714538659; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; PsychCorp, 2001, WECHSLER TEST ADULT; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Temme L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00041; Tong JL, 2014, EXP BRAIN RES, V232, P121, DOI 10.1007/s00221-013-3725-8; Topolovec-Vranic J., 2014, BRAIN INJURY, V28, P517, DOI [10.3109/02699052.2014.892379, DOI 10.3109/02699052.2014.892379]; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; World Health Organization, 1992, ICD 10 CLASSIFICATIO	39	7	7	0	29	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 15	2016	10								45	10.3389/fnhum.2016.00045			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DD7RC	WOS:000370120800001	26912999	Green Published, gold			2022-02-06	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			Real-time, whole-brain, temporally resolved pressure responses in translational head impact	INTERFACE FOCUS			English	Article						traumatic brain injury; translational head impact; linear acceleration; Head Injury Criterion; Dartmouth head injury model	FINITE-ELEMENT-ANALYSIS; DYNAMIC-RESPONSE; CONTACT SPORTS; INJURY; ACCELERATION; CONCUSSION; STRAIN; DEFORMATION; PREDICTORS; FOOTBALL	Theoretical debate still exists on the role of linear acceleration (a(lin)) on the risk of brain injury. Recent injury metrics only consider head rotational acceleration (a(rot)) but not a(lin), despite that real-world on-field head impacts suggesting alin significantly improves a concussion risk function. These controversial findings suggest a practical challenge in integrating theory and real-world experiment. Focusing on tissue-level mechanical responses estimated from finite-element (FE) models of the human head, rather than impact kinematics alone, may help address this debate. However, the substantial computational cost incurred (runtime and hardware) poses a significant barrier for their practical use. In this study, we established a real-time technique to estimate whole-brain a(lin)-induced pressures. Three hydrostatic atlas pressures corresponding to translational impacts (referred to as 'brain print') along the three major axes were pre-computed. For an arbitrary a(lin) profile at any instance in time, the atlas pressures were linearly scaled and then superimposed to estimate whole-brain responses. Using 12 publically available, independently measured or reconstructed real-world a(lin) profiles representative of a range of impact/injury scenarios, the technique was successfully validated (except for one case with an extremely short impulse of approx. 1 ms). The computational cost to estimate whole-brain pressure responses for an entire a(lin) profile was less than 0.1 s on a laptop versus typically hours on a high-end multicore computer. These findings suggest the potential of the simple, yet effective technique to enable future studies to focus on tissue-level brain responses, rather than solely relying on global head impact kinematics that have plagued early and contemporary brain injury research to date.	[Zhao, Wei; Ji, Songbai] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Ji, Songbai] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA		Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.; Ji, SB (corresponding author), Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA.	songbai.ji@dartmouth.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781, R21 NS078607]; Dartmouth Hitchcock Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R21NS078607, R01NS092853] Funding Source: NIH RePORTER	This work was sponsored by the NIH via grant nos. R01 NS092853, R21 NS088781 and R21 NS078607, and the Dartmouth Hitchcock Foundation.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; de Lange Ronald, 2005, Stapp Car Crash J, V49, P457; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Franklyn Melanie, 2005, Stapp Car Crash J, V49, P1; FUJIWARA S, 1989, FORENSIC SCI INT, V43, P159, DOI 10.1016/0379-0738(89)90132-1; Gadd C. W., 1966, 660793 SAE, DOI [10.4271/660793, DOI 10.4271/660793]; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Graff K. F., 1975, WAVE MOTION ELASTIC; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki B., 2013, J NEUROL NEUROPHYSIO, V5, P1, DOI DOI 10.4172/2155-9562.1000181; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Melvin J, 1993, ACCIDENTAL INJURY, P269; Mertz H., 1997, 973318 SAE, DOI [10.4271/973318, DOI 10.4271/973318]; Morfey, 2001, P 17 INT TECHN C ENH; Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Newman JA, 1980, 801317 SAE, DOI [10.4271/801317, DOI 10.4271/801317]; NUSHOLTZ GS, 1995, AVIAT SPACE ENVIR MD, V66, P661; Patrick L, 1963, 7 STAPP CAR CRASH C; Pearce CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114292; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ruan J, 2001, Stapp Car Crash J, V45, P395; Ruan JS, 2006, J BIOMECH, V39, P383, DOI 10.1016/j.jbiomech.2005.03.004; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; The CDC NI H DoD and VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Thibault L, 1985, 856002 SAE; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Ward C., 1980, 801304 SAE, DOI [10.4271/801304, DOI 10.4271/801304]; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2015, IRCOBI C LYON FRANC, P227; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0	58	7	7	0	4	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2042-8898	2042-8901		INTERFACE FOCUS	Interface Focus	FEB 6	2016	6	1							20150091	10.1098/rsfs.2015.0091			11	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	DG4TM	WOS:000372065600017	26855762	Bronze, Green Published			2022-02-06	
J	Azad, TD; Li, A; Pendharkar, AV; Veeravagu, A; Grant, GA				Azad, Tej D.; Li, Amy; Pendharkar, Arjun V.; Veeravagu, Anand; Grant, Gerald A.			Junior Seau: An Illustrative Case of Chronic Traumatic Encephalopathy and Update on Chronic Sports-Related Head Injury	WORLD NEUROSURGERY			English	Article						American football; Chronic traumatic injury; Sports-related injury; Traumatic brain injury	COLLEGIATE FOOTBALL PLAYERS; IMPACT EXPOSURE; BRAIN-INJURY; NEUROPATHOLOGY; CONCUSSION; SPECTRUM	BACKGROUND: Few neurologic diseases have captured the nation's attention more completely than chronic traumatic encephalopathy (CTE), which has been discovered in the autopsies of professional athletes, most notably professional football players. The tragic case of Junior Seau, a Hall of Fame, National Football League linebacker, has been the most high-profile confirmed case of CTE. Here we describe Seau's case, which concludes an autopsy conducted at the National Institutes of Health that confirmed the diagnosis. CASE DESCRIPTION: Since 1990, Junior Seau had a highly distinguished 20-year career playing for the National Football League as a linebacker, from which he sustained multiple concussions. He committed suicide on May 2, 2012, at age 43, after which an autopsy confirmed a diagnosis of CTE. His clinical history was significant for a series of behavioral disturbances. Seau's history and neuropathologic findings were used to better understand the pathophysiology, diagnosis, and possible risk factors for CTE. CONCLUSIONS: This high-profile case reflects an increasing awareness of CTE as a long-term consequence of multiple traumatic brain injuries. The previously unforeseen neurologic risks of American football have begun to cast doubt on the safety of the sport.	[Azad, Tej D.; Li, Amy; Pendharkar, Arjun V.; Veeravagu, Anand; Grant, Gerald A.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA		Grant, GA (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	ggrant2@stanford.edu		Azad, Tej/0000-0001-7823-4294			[Anonymous], 2014, ASS PRESS; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blankenstein A., 2010, JUNIOR SEAU FORMER F; Breech J., 2015, JUNIOR SEAUS FAMILY; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; Duke A, 2012, JUNIOR SEAUS DEATH C; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kounang N., 2012, BRAIN BANK EXAMINES; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; National Football League National Football League Head Neck and Spine Committee's Protocols Regarding Return to Participation Following Concussion, 2014, NAT FOOTB LEAG HEAD; National Institues of Health, 2012, AUT PATH REP JUN SEA; National Institutes of Health, 2013, NIH STAT JUN SEAU AU; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Saigal Rajiv, 2014, Neurosurgery, V75 Suppl 4, pS149, DOI 10.1227/NEU.0000000000000497; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Wagner GN, 2012, JUNIOR SEAU AUTOPSY; Wang YS, 1998, J PHARMACOL EXP THER, V285, P105; Zlokovic BV, 2001, NEUROSURGERY, V48, P1196, DOI 10.1097/00006123-200105000-00066	45	7	7	0	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2016	86								515.e11	10.1016/j.wneu.2015.10.032			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD0QU	WOS:000369625300104	26493714				2022-02-06	
J	Nguyen, H; Ivers, R; Jan, S; Martiniuk, A; Segal, L; Pham, C				Ha Nguyen; Ivers, Rebecca; Jan, Stephen; Martiniuk, Alexandra; Segal, Leonie; Cuong Pham			Cost and impoverishment 1 year after hospitalisation due to injuries: a cohort study in Thai Binh, Vietnam	INJURY PREVENTION			English	Article							LOW-INCOME COUNTRY; HEALTH-INSURANCE; UNITED-STATES; PRODUCTIVITY LOSSES; LIFETIME COSTS; CARE; PAYMENTS; IMPACT	Background Evidence on the economic impact on individuals and their families following an injury in Vietnam is limited. This study examines the costs and the risk of impoverishment due to hospitalised injuries at 12 months following hospital discharge and associated factors. Method Employing a prospective cohort design, 892 people hospitalised for injury were recruited from Thai Binh General Hospital in Vietnam in 2010 and followed up for 12 months. All out-of-pocket costs incurred and income lost by injured persons and their caregivers associated with care and treatment of their injuries were reported. To examine associated factors, we used generalised estimating equation models for costs and modified Poisson regression for the risk of impoverishment. Results The mean total costs by 12 months postdischarge were US$804, nearly 1.2 times the annual average income. Injuries that incurred highest costs were falls (US$950) and road traffic injuries (RTIs) (US$794). At 12-month follow-up, 181 persons (26.9%) became impoverished, with those injured in RTIs and falls at highest risk (26.1% and 35.4%, respectively). Factors associated with higher costs were also those associated with higher risk of impoverishment. These include those injured in RTIs or falls; having higher severity level; principal injured region as upper extremities, lower extremities or head; physical nature of injuries as fracture or concussion injuries; and longer hospitalisation. Conclusions Injuries impose significant economic burden on injured persons and their families during and beyond hospitalisation. In addition to prevention, there is a need to reform health financing system to protect injured persons from significant out-of-pocket expense for healthcare services.	[Ha Nguyen; Segal, Leonie] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5000, Australia; [Ivers, Rebecca; Jan, Stephen; Martiniuk, Alexandra] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Cuong Pham] Hanoi Sch Publ Hlth, Ctr Injury Policy & Prevent Res, Hanoi, Vietnam		Nguyen, H (corresponding author), Univ S Australia, Sch Populat Hlth, SAHMRI, N Terrace, Adelaide, SA 5000, Australia.	ha.nguyen2@unisa.edu.au	Jan, Stephen/AAG-3333-2021; Martiniuk, Alexandra/K-2600-2019; Nguyen, Ha/O-1586-2019; Pham, Cuong/AAU-5721-2020	Martiniuk, Alexandra/0000-0003-1368-8206; Nguyen, Ha/0000-0001-8327-5488; Pham, Cuong/0000-0002-2309-8253; Jan, Stephen/0000-0003-2839-1405; Ivers, Rebecca/0000-0003-3448-662X	Atlantic Philanthropies in project [AP1533]	The study received funding from The Atlantic Philanthropies in a project to build capacity on injury prevention research for the Hanoi School of Public Health, Vietnam (grant number AP1533). The funder has no involvement in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication.	Administration of Preventive Medicine-Ministry of Health, 2012, NAT MORT STAT 2010; Akobundu E, 2006, PHARMACOECONOMICS, V24, P869, DOI 10.2165/00019053-200624090-00005; Association for the Advancement of Automotive Medicine, ABBR INJ SCAL AIS 20; Australian Institute of Health and Welfare, 2010, HLTH WELF EXP SER, V36; Bohl AA, 2010, J AM GERIATR SOC, V58, P853, DOI 10.1111/j.1532-5415.2010.02816.x; Carter MW, 2011, J AM GERIATR SOC, V59, P406, DOI 10.1111/j.1532-5415.2010.03283.x; Center for Injury Policy and Prevention Resesarch, 2012, VIETN NAT INJ SURV 2; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Corso PS, 2007, AM J PREV MED, V32, P474, DOI 10.1016/j.amepre.2007.02.010; Nguyen CV, 2012, HEALTH ECON, V21, P946, DOI 10.1002/hec.1768; Drummond M., 2005, METHODS EC EVALUATIO; General Statistics Office of Vietnam, 2011, RES SURV HOUS LIV ST; Nguyen H, 2013, INJURY, V44, P684, DOI 10.1016/j.injury.2012.05.006; Hallenbeck James L, 2004, J Palliat Med, V7, P477, DOI 10.1089/1096621041349446; Hardin James W., 2003, GEN ESTIMATING EQUAT, DOI [10.1201/b13880, DOI 10.1201/B13880]; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Minh VH, 2013, SOC SCI MED, V96, P258, DOI 10.1016/j.socscimed.2012.11.028; Nguyen KT, 2012, AM J PUBLIC HEALTH, V102, P1450, DOI 10.2105/AJPH.2011.300618; Lim SJ, 2011, INJURY PREV, V17, P291, DOI 10.1136/ip.2010.028118; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Lord SR, 2006, AGE AGEING, V35, P55, DOI 10.1093/ageing/afl088; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Ministry of Health and Health Partnership Group, 2011, JOINT ANN HLTH REV 2, P29; Ministry of Health Health Strategy and Policy Institute and Bank W, 2011, LESS HOSP AUT IMPL V; Naumann RB, 2010, TRAFFIC INJ PREV, V11, P353, DOI 10.1080/15389588.2010.486429; Rice D P, 2000, Inj Prev, V6, P177, DOI 10.1136/ip.6.3.177; Rice DP, 1989, COST INJURY US REPOR; Rowell D, 2011, J TRAUMA, V70, P1086, DOI 10.1097/TA.0b013e3181ed4d29; Sepehri A, 2014, INT J HEALTH SERV, V44, P73, DOI 10.2190/HS.44.1.e; Sepehri A, 2009, HEALTH POLICY, V92, P250, DOI 10.1016/j.healthpol.2009.05.005; Thai Binh Department of Health, 2011, REP STAT INJ 12 MONT; Thanh NX, 2006, HEALTH POLICY, V78, P249, DOI 10.1016/j.healthpol.2005.10.003; Vian T, 2012, PUBLIC ADMIN DEVELOP, V32, P49, DOI 10.1002/pad.1607; Vietnam Academy of Social Sciences, 2011, POV RED VIETN ACH CH; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; World Health Organization, 2011, VIOL INJ FACTS 2010; World Health Organization, 2010, VIOL INJ DIS BIENN R; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	FEB	2016	22	1					33	39		10.1136/injuryprev-2014-041493			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DB4VY	WOS:000368512900005	26070866	Green Accepted			2022-02-06	
J	Jayakumar, AR; Bak, LK; Rao, KVR; Waagepetersen, HS; Schousboe, A; Norenberg, MD				Jayakumar, A. R.; Bak, L. K.; Rao, K. V. Rama; Waagepetersen, H. S.; Schousboe, A.; Norenberg, M. D.			Neuronal Cell Death Induced by Mechanical Percussion Trauma in Cultured Neurons is not Preceded by Alterations in Glucose, Lactate and Glutamine Metabolism	NEUROCHEMICAL RESEARCH			English	Article						Cell death; GC-MS; Oxidative metabolism; Neuron; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; CONCUSSIVE BRAIN-INJURY; EXCITATORY AMINO-ACIDS; D-ASPARTATE RECEPTORS; NF-KAPPA-B; IMMATURE RATS; IN-VITRO; GLUTAMATERGIC NEURONS; GABAERGIC NEURONS; HEAD-INJURY	Traumatic brain injury (TBI) is a devastating neurological disorder that usually presents in acute and chronic forms. Brain edema and associated increased intracranial pressure in the early phase following TBI are major consequences of acute trauma. On the other hand, neuronal injury, leading to neurobehavioral and cognitive impairments, that usually develop months to years after single or repetitive episodes of head trauma, are major consequences of chronic TBI. The molecular mechanisms responsible for TBI-induced injury, however, are unclear. Recent studies have suggested that early mitochondrial dysfunction and subsequent energy failure play a role in the pathogenesis of TBI. We therefore examined whether oxidative metabolism of C-13-labeled glucose, lactate or glutamine is altered early following in vitro mechanical percussion-induced trauma (5 atm) to neurons (4-24 h), and whether such events contribute to the development of neuronal injury. Cell viability was assayed using the release of the cytoplasmic enzyme lactate dehydrogenase (LDH), together with fluorescence-based cell staining (calcein and ethidium homodimer-1 for live and dead cells, respectively). Trauma had no effect on the LDH release in neurons from 1 to 18 h. However, a significant increase in LDH release was detected at 24 h after trauma. Similar findings were identified when traumatized neurons were stained with fluorescent markers. Additionally C-13-labeling of glutamate showed a small, but statistically significant decrease at 14 h after trauma. However, trauma had no effect on the cycling ratio of the TCA cycle at any time-period examined. These findings indicate that trauma does not cause a disturbance in oxidative metabolism of any of the substrates used for neurons. Accordingly, such metabolic disturbance does not appear to contribute to the neuronal death in the early stages following trauma.	[Jayakumar, A. R.; Rao, K. V. Rama; Norenberg, M. D.] Vet Affairs Med Ctr, Neuropathol Lab, Miami, FL 33125 USA; [Bak, L. K.; Waagepetersen, H. S.; Schousboe, A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Norenberg, M. D.] Univ Miami, Sch Med, Dept Pathol D 33, POB 016960, Miami, FL 33101 USA; [Norenberg, M. D.] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA		Norenberg, MD (corresponding author), Vet Affairs Med Ctr, Neuropathol Lab, Miami, FL 33125 USA.; Norenberg, MD (corresponding author), Univ Miami, Sch Med, Dept Pathol D 33, POB 016960, Miami, FL 33101 USA.; Norenberg, MD (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA.	mnorenbe@med.miami.edu		Schousboe, Arne/0000-0001-9600-402X; Waagepetersen, Helle/0000-0003-4583-8379; Bak, Lasse K./0000-0003-0784-7864	US Department of Veterans AffairsUS Department of Veterans Affairs; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK063311]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK063311] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000416] Funding Source: NIH RePORTER	This work was supported by a Merit Review from the US Department of Veterans Affairs and by a National Institutes of Health grant DK063311. The authors thank Alina Fernandez-Revuelta for the preparation of cell cultures and Ms. Anna Hansen for expert technical assistance performing the GC-MS analyses.	Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bak LK, 2006, J CEREBR BLOOD F MET, V26, P1285, DOI 10.1038/sj.jcbfm.9600281; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Biemann K, 1962, ORGANIC CHEM APPL, P223; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; BRADFORD HF, 1978, J NEUROCHEM, V30, P1453, DOI 10.1111/j.1471-4159.1978.tb10477.x; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRANDSEN A, 1987, NEUROCHEM INT, V10, P583, DOI 10.1016/0197-0186(87)90088-X; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Hazell AS, 1997, NEUROCHEM RES, V22, P1443, DOI 10.1023/A:1021994126329; HERTZ L, 1988, NEUROCHEM RES, V13, P605, DOI 10.1007/BF00973275; Hertz L, 1989, DISSECTION TISSUE CU, P105; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morrison RS, 2002, ADV EXP MED BIOL, V513, P41; National Hospital Discharge Survey [NHDS], 2010, NAT HOSP AMB MED CAR; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Nilsson P, 1990, J CEREB BLOOD FLOW M, V10, P331; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sabati M, 2014, J MAGN RESON IMAGING, V39, P224, DOI 10.1002/jmri.24130; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Voss CM, 2015, NEUROCHEM RES, V40, P2431, DOI 10.1007/s11064-015-1558-5; Waagepetersen HS, 2003, NEUROSCIENTIST, V9, P398, DOI 10.1177/1073858403254006; Walls AB, 2014, NEUROMETHODS, V90, P73, DOI 10.1007/978-1-4939-1059-5_4; WESTERGAARD N, 1995, NEUROSCI LETT, V185, P24, DOI 10.1016/0304-3940(94)11216-6; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; Zhang JR, 1996, J NEUROCHEM, V66, P355	64	7	7	0	14	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	FEB	2016	41	1-2			SI		307	315		10.1007/s11064-015-1801-0			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DF5SO	WOS:000371412800030	26729365	Green Accepted			2022-02-06	
J	Lin, JY; Zhang, MW; Wang, JG; Li, H; Wei, HY; Liu, R; Dai, G; Liao, XX				Lin, Ji-Yan; Zhang, Min-Wei; Wang, Jin-Gao; Li, Hui; Wei, Hong-Yan; Liu, Rong; Dai, Gang; Liao, Xiao-Xing			Hydrogen sulfide improves neural function in rats following cardiopulmonary resuscitation	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						cardiopulmonary resuscitation; apoptosis; brain injury; neurological behavior; hydrogen sulfide	PEDIATRIC CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; MOTOR CORTEX; CELL INJURY; RECOVERY; NEURONS	The alleviation of brain injury is a key issue following cardiopulmonary resuscitation (CPR). Hydrogen sulfide (H2S) is hypothesized to be involved in the pathophysiological process of ischemia-reperfusion injury, and exerts a protective effect on neurons. The aim of the present study was to investigate the effects of H2S on neural functions following cardiac arrest (CA) in rats. A total of 60 rats were allocated at random into three groups. CA was induced to establish the model and CPR was performed after 6 min. Subsequently, sodium hydrosulfide (NaHS), hydroxylamine or saline was administered to the rats. Serum levels of H2S, neuron-specific enolase (NSE) and S100 beta were determined following CPR. In addition, neurological deficit scoring (NDS), the beam walking test (BWT), prehensile traction test and Morris water maze experiment were conducted. Neuronal apoptosis rates were detected in the hippocampal region following sacrifice. After CPR, as the H2S levels increased or decreased, the serum NSE and S100 beta concentrations decreased or increased, respectively (P<0.0w. The NDS results of the NaHS group were improved compared with those of the hydroxylamine group at 24 h after CPR (P<0.05). In the Morris water maze experiment, BWT and prehensile traction test the animals in the NaHS group performed best and rats in the hydroxylamine group performed worst. At day 7, the apoptotic index and the expression of caspase-3 were reduced in the hippocampal CA1 region, while the expression of Bcl-2 increased in the NaHS group; and results of the hydroxylamine group were in contrast. Therefore, the results of the present study indicate that H2S is able to improve neural function in rats following CPR.	[Lin, Ji-Yan; Zhang, Min-Wei; Wang, Jin-Gao] Xiamen Univ, Affiliated Hosp 1, Dept Emergency & Crit Care Med, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China; [Li, Hui; Wei, Hong-Yan; Liu, Rong; Liao, Xiao-Xing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Emergency, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Dai, Gang] Sun Yat Sen Univ, Minist Hlth, Key Lab Assisted Circulat, Guangzhou 510080, Guangdong, Peoples R China		Lin, JY (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Emergency & Crit Care Med, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China.; Liao, XX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Emergency, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	ljcndoc@163.com; liaowens@163.com			Medical innovation project of Fujian Province, China [2011-CXB-31]; social development research project of Xiamen, China [3502Z20114006, 3502Z20124042, 3502Z20134003]	The present study was supported by grants from Medical innovation project of Fujian Province, China (no. 2011-CXB-31) and the social development research project of Xiamen, China (no. 3502Z20114006, 3502Z20124042 and 3502Z20134003). The funding source had no role in the study design, the collection and interpretation of the data, writing of the report, or decision to submit the paper for publication. The authors would like to thank the staff of the Emergency Department of the First Affiliated Hospital of Xiamen University and the Key Laboratory on Assisted Circulation of Ministry of Health of Sun Yat-Sen University for their excellent technical assistance and constructive criticism. The authors also thank Professor Wen Jie and Dr Lin Gui-ping for their valuable help.	CHAO CC, 1992, J IMMUNOL, V149, P2736; Cronberg T, 2009, RESUSCITATION, V80, P1119, DOI 10.1016/j.resuscitation.2009.06.021; DEMASTER EG, 1989, BIOCHEM BIOPH RES CO, V163, P527, DOI 10.1016/0006-291X(89)92169-4; Derwall M, 2010, SHOCK, V34, P190, DOI 10.1097/SHK.0b013e3181d0ee3d; Drabek T, 2007, CRIT CARE MED, V35, P532, DOI 10.1097/01.CCM.0000253398.61666.0D; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Han Y, 2005, NEUROSCI RES, V53, P216, DOI 10.1016/j.neures.2005.07.002; Han Ying, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P141; Idris AH, 1996, CIRCULATION, V94, P2324, DOI 10.1161/01.CIR.94.9.2324; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Kida K, 2012, RESUSCITATION, V83, P1292, DOI 10.1016/j.resuscitation.2012.02.020; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Knapp J, 2011, RESUSCITATION, V82, P1076, DOI 10.1016/j.resuscitation.2011.03.038; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Li J, 2010, BRAIN RES, V1356, P11, DOI 10.1016/j.brainres.2010.08.012; Lin Ji-yan, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P363; Lin JY, 2010, RESUSCITATION, V81, P1197, DOI 10.1016/j.resuscitation.2010.05.019; Luo YG, 2013, NEUROCHEM INT, V63, P826, DOI 10.1016/j.neuint.2013.06.004; Markova J, 2014, PFLUG ARCH EUR J PHY, V466, P1329, DOI 10.1007/s00424-013-1366-1; McCook O, 2014, NITRIC OXIDE-BIOL CH, V41, P48, DOI 10.1016/j.niox.2014.03.163; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Plaisier F, 2008, BRAIN RES, V1208, P240, DOI 10.1016/j.brainres.2008.02.007; Popp Erik, 2004, Crit Care Med, V32, pS359, DOI 10.1097/01.CCM.0000134223.09056.FC; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Schreckinger M, 2007, RESUSCITATION, V75, P105, DOI 10.1016/j.resuscitation.2007.02.017; Stammet P, 2013, J AM COLL CARDIOL, V62, P851, DOI 10.1016/j.jacc.2013.04.039; Sulaj M, 2009, CELL MOL NEUROBIOL, V29, P807, DOI 10.1007/s10571-009-9361-y; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tahamtan M, 2013, ARCH IRAN MED, V16, P697, DOI 0131612/AIM.004; Tamakoshi K, 2014, BEHAV BRAIN RES, V260, P34, DOI 10.1016/j.bbr.2013.11.034; Thal SC, 2008, J NEUROL SCI, V268, P150, DOI 10.1016/j.jns.2007.12.002; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang YL, 2014, J NEUROCHEM, V129, P827, DOI 10.1111/jnc.12695; Zhang H, 2014, NEUROCHEM RES, V39, P276, DOI 10.1007/s11064-013-1219-5; Zhang LM, 2009, NEUROCHEM RES, V34, P1984, DOI 10.1007/s11064-009-0006-9; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4	44	7	10	0	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	FEB	2016	11	2					577	587		10.3892/etm.2015.2950			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DC9PU	WOS:000369554300033	26893650	Green Published, gold			2022-02-06	
J	Soble, JR; Osborn, KE; Mattingly, ML; Vale, FL; Benbadis, SR; Rodgers-Neame, NT; Schoenberg, MR				Soble, Jason R.; Osborn, Katie E.; Mattingly, Michelle L.; Vale, Fernando L.; Benbadis, Selim R.; Rodgers-Neame, Nancy T.; Schoenberg, Mike R.			Utility of Green's Word Memory Test Free Recall Subtest as a Measure of Verbal Memory: Initial Evidence from a Temporal Lobe Epilepsy Clinical Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Epilepsy; Assessment; Learning and memory; Lateralization	SYMPTOM VALIDITY TEST; TRAUMATIC BRAIN-INJURY; TEST-PERFORMANCE; RELIABILITY; SENSITIVITY	This study investigated the Word Memory Test (WMT) Free Recall (FR) subtest as a conventional memory measure. Nineteen participants with pharmacoresistant left temporal lobe epilepsy (LTLE) and 16 with right temporal lobe epilepsy (RTLE) completed the WMT, Rey Auditory Verbal Learning Test (RAVLT), and Wechsler Memory Scale-Fourth Edition Logical Memory (LM) subtest during presurgical evaluation. LTLE participants performed significantly worse on FR subtest (p < .05, eta(2)(p) = 0.17) and RAVLT Trial 7 (p < .01, eta(2)(p) = 0.25), but not on LM subtest. Age was a significant covariate for FR (p < .01, eta(2)(p) = 0.22). Logistic regression revealed FR plus age and RAVLT age-adjusted T-scores both yielded 77.1% classification accuracy and respective diagnostic odds ratios of 11.36 and 11.84. Receiver operating characteristic curves to classify seizure laterality found that RAVLT and FR were significant (area under the curve [AUC] = 0.82 and 0.74), whereas LM was nonsignificant (AUC = 0.67). Cut scores and positive/negative predictive values were established for improved clinical classification.	[Soble, Jason R.] South Texas Vet Hlth Care Syst, Psychol Serv, San Antonio, TX USA; [Osborn, Katie E.; Mattingly, Michelle L.; Schoenberg, Mike R.] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsani Coll Med, Tampa, FL USA; [Vale, Fernando L.; Schoenberg, Mike R.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Benbadis, Selim R.; Schoenberg, Mike R.] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL 33620 USA; [Rodgers-Neame, Nancy T.] Florida Comprehens Epilepsy & Seizure Disorders C, Tampa, FL USA		Schoenberg, MR (corresponding author), 3515 E Fletcher Ave,MDC Box 14, Tampa, FL 33613 USA.	mschoenb@health.usf.edu					Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Allen MD, 2011, PSYCHOL INJ LAW, V4, P140, DOI 10.1007/s12207-011-9105-4; ARMISTEADJEHLE P, 2015, APPL NEUROPSYCHOL, V15, P1; Barr WB, 1997, PSYCHOL ASSESSMENT, V9, P171; Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; Benbadis SR, 2009, NEUROLOGY, V73, P843, DOI 10.1212/WNL.0b013e3181b78425; Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Buchtel HA, 2002, EPILEPSIA, V43, P1056, DOI 10.1046/j.1528-1157.2002.00902.x; Carone DA, 2014, APPL NEUROPSYCH-ADUL, V21, P155, DOI 10.1080/09084282.2012.755533; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Davis JJ, 2014, ARCH CLIN NEUROPSYCH, V29, P747, DOI 10.1093/arclin/acu030; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Eichstaedt KE, 2014, CLIN NEUROPSYCHOL, V28, P941, DOI 10.1080/13854046.2014.942374; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2005, MANUAL WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Helmstaedter C, 2009, EPILEPSY RES, V87, P203, DOI 10.1016/j.eplepsyres.2009.09.002; Hermann BP, 1996, EPILEPSIA, V37, P942, DOI 10.1111/j.1528-1157.1996.tb00531.x; Jones-Gotman M, 2010, EPILEPSY BEHAV, V18, P3, DOI 10.1016/j.yebeh.2010.02.019; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; Loring DW, 2008, J INT NEUROPSYCH SOC, V14, P394, DOI 10.1017/S1355617708080582; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rienstra A, 2009, ARCH CLIN NEUROPSYCH, V24, P255, DOI 10.1093/arclin/acp035; Rienstra A, 2013, ARCH CLIN NEUROPSYCH, V28, P463, DOI 10.1093/arclin/act026; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Sanchez-Alvarez JC, 2002, REV NEUROLOGIA, V35, P931, DOI 10.33588/rn.3510.2002142; Schmidt M., 1996, REY AUDITORY VERBAL; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Soble JR, 2014, EPILEPSY BEHAV, V41, P232, DOI 10.1016/j.yebeh.2014.10.014; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thompson PJ, 2005, EPILEPSIA, V46, P1780, DOI 10.1111/j.1528-1167.2005.00279.x; Trenerry M R, 1995, Neuroimaging Clin N Am, V5, P721; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2009, ADM SCORING MANUAL W; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde N, 2001, J INT NEUROPSYCH SOC, V7, P881, DOI 10.1017/S1355617701777120	54	7	7	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2016	31	1					79	87		10.1093/arclin/acv084			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DD8QQ	WOS:000370192400011	26663824	Bronze			2022-02-06	
J	Mohammed, M; Syed, MF; Aslan, K				Mohammed, Muzaffer; Syed, Maleeha F.; Aslan, Kadir			Microwave-accelerated bioassay technique for rapid and quantitative detection of biological and environmental samples	BIOSENSORS & BIOELECTRONICS			English	Article						Glial Fibrillary Acidic Protein; Shiga like toxin; ELISA; Microwave-accelerated bioassays; Silver island films; Circular bioassay platform; Metal-enhanced fluorescence	METAL-ENHANCED FLUORESCENCE; TRAUMATIC BRAIN-INJURY; ULTRA-FAST; GFAP; ELISA; SERUM; CHEMILUMINESCENCE; BIOMARKERS; DISEASE; ASSAY	Quantitative detection of molecules of interest from biological and environmental samples in a rapid manner, particularly with a relevant concentration range, is imperative to the timely assessment of human diseases and environmental issues. In this work, we employed the microwave-accelerated bioassay (MAB) technique, which is based on the combined use of circular bioassay platforms and microwave heating, for rapid and quantitative detection of Glial Fibrillary Acidic Protein (GFAP) and Shiga like toxin (STX 1). The proof-of-principle use of the MAB technique with the circular bioassay platforms for the rapid detection of GFAP in buffer based on colorimetric and fluorescence readouts was demonstrated with a 900 W kitchen microwave. We also employed the MAB technique with a new microwave system (called the iCrystal system) for the detection of GFAP from mice with brain injuries and SIX 1 from a city water stream. Control bioassays included the commercially available gold standard bioassay kits run at room temperature. Our results show that the lower limit of detection (LLOD) of the calorimetric and fluorescence based bioassays for GFAP was decreased by similar to 1000 times using the MAB technique and our circular bioassay platforms as compared to the commercially available bioassay kits. The overall bioassay time for GFAP and SIX 1 was reduced from 4 h using commercially available bioassay kits to 10 min using the MAB technique. (C) 2015 Elsevier B.V. All rights reserved.	[Mohammed, Muzaffer; Syed, Maleeha F.; Aslan, Kadir] Morgan State Univ, Dept Chem, Baltimore, MD 21251 USA		Aslan, K (corresponding author), Morgan State Univ, Dept Chem, 1700 East Cold Spring Lane, Baltimore, MD 21251 USA.	Kadir.Aslan@morgan.edu	ASLAN, KADIR/AAH-1238-2019	ASLAN, KADIR/0000-0002-7617-0175	National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [5-K25EB007565-05]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K25EB007565] Funding Source: NIH RePORTER	This work was supported by National Institute of Biomedical Imaging and Bioengineering, Award number 5-K25EB007565-05. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Biomedical Imaging and Bioengineering or NIH. We thank Dr. Michael Koban and Lalith S. Naidu for their help with mice samples.	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Andrievskaia O, 2014, J FOOD PROTECT, V77, P2088, DOI 10.4315/0362-028X.JFP-14-223; Aslan K, 2005, ANAL CHEM, V77, P8057, DOI 10.1021/ac0516077; Aslan K, 2005, CURR OPIN BIOTECH, V16, P55, DOI 10.1016/j.copbio.2005.01.001; Aslan K, 2006, J FLUORESC, V16, P3, DOI 10.1007/s10895-005-0026-z; Aslan K, 2005, J FLUORESC, V15, P99, DOI 10.1007/s10895-005-2515-5; Aslan K, 2008, ANALYST, V133, P1469, DOI 10.1039/b808292h; Aslan Kadir, 2010, Nano Biomed Eng, V2, P1; Aslan K, 2006, J IMMUNOL METHODS, V312, P137, DOI 10.1016/j.jim.2006.03.009; Carballo-Quintas M, 2011, NEUROTOXICOLOGY, V32, P478, DOI 10.1016/j.neuro.2011.04.003; Chowdhury MH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2195776; Chowdhury MH, 2007, J OPT SOC AM B, V24, P2259, DOI 10.1364/JOSAB.24.002259; Chowdhury MH, 2007, CHEM PHYS LETT, V435, P114, DOI 10.1016/j.cplett.2006.12.063; Chowdhury MH, 2006, J FLUORESC, V16, P295, DOI 10.1007/s10895-006-0082-z; Dixit CK, 2010, ANAL CHEM, V82, P7049, DOI 10.1021/ac101339q; FRANKE S, 1995, J CLIN MICROBIOL, V33, P3174, DOI 10.1128/JCM.33.12.3174-3178.1995; Geginat G, 2012, EUR J CLIN MICROBIOL, V31, P733, DOI 10.1007/s10096-011-1366-z; Grell TAJ, 2013, LANGMUIR, V29, P13209, DOI 10.1021/la402455x; Gui Chen, 2011, NANO BIOMED ENG, V3, P260, DOI DOI 10.5101/NBE.V3I4.P260-273; Ilhan-Mutlu A, 2013, J NEURO-ONCOL, V113, P359, DOI 10.1007/s11060-013-1134-2; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; Jiang Shu-Hong, 2014, Zhongguo Dang Dai Er Ke Za Zhi, V16, P1193; Jones DA, 2002, RESOUR CONSERV RECY, V34, P75, DOI 10.1016/S0921-3449(01)00088-X; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kiilerich-Pedersen K, 2011, POLYM BASED BIOSENSO, P193; Liu Y, 2009, ANAL CHIM ACTA, V650, P77, DOI 10.1016/j.aca.2009.06.048; Lotosh NG, 2013, B EXP BIOL MED+, V155, P48, DOI 10.1007/s10517-013-2077-5; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lumor SE, 2012, J FOOD PROTECT, V75, P1036, DOI 10.4315/0362-028X.JFP-11-372; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Messing A., 2011, P INT JOINT C BIOM I, P1; Mohammed M., 2013, NANO BIOMED ENG, V5, P20; Mohammed Muzaffer, 2014, Nano Biomed Eng, V6, P76; Mohammed Muzaffer, 2013, Nano Biomed Eng, V5, P10; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nyholm O, 2015, ZOONOSES PUBLIC HLTH; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Serrano-Pozo A, 2013, AM J PATHOL, V182, P2332, DOI 10.1016/j.ajpath.2013.02.031; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Storoni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023489; Wada Y, 2013, J NEUROL SCI, V331, P161, DOI 10.1016/j.jns.2013.05.019; Wei P, 2013, TUMOR BIOL, V34, P2283, DOI 10.1007/s13277-013-0770-7; Xia L, 2013, BEHAV BRAIN RES, V256, P472, DOI 10.1016/j.bbr.2013.08.048; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	44	7	7	0	66	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	JAN 15	2016	75						420	426		10.1016/j.bios.2015.08.061			7	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	CT5PI	WOS:000362862000055	26356762	Green Accepted			2022-02-06	
J	Piponnier, JC; Forget, R; Gagnon, I; McKerral, M; Giguere, JF; Faubert, J				Piponnier, Jean-Claude; Forget, Robert; Gagnon, Isabelle; McKerral, Michelle; Giguere, Jean-Francois; Faubert, Jocelyn			First- and Second-Order Stimuli Reaction Time Measures Are Highly Sensitive to Mild Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						first-order; motion; mTBI; reaction time; second-order	VISUAL-EVOKED-POTENTIALS; EMERGENCY-DEPARTMENT ASSESSMENT; POST CONCUSSION SYNDROME; DIFFUSE AXONAL INJURY; POSTCONCUSSIVE SYMPTOMS; PROCESSING 1ST-ORDER; MOTION; ATTENTION; LUMINANCE; PERCEPTION	Mild traumatic brain injury (mTBI) has subtle effects on several brain functions that can be difficult to assess and follow up. We investigated the impact of mTBI on the perception of sine-wave gratings defined by first- and second-order characteristics. Fifteen adults diagnosed with mTBI were assessed at 15 days, 3 months, and 12 months postinjury. Fifteen matched controls followed the same testing schedule. Reaction times (RTs) for flicker detection and motion direction discrimination were measured. Stimulus contrast of first- and second-order patterns was equated to control for visibility, and correct-response RT means, standard deviations (SDs), medians, and interquartile ranges (IQRs) were calculated. The level of symptoms was also evaluated to compare it to RT data. In general in mTBI, RTs were longer, and SDs as well as IQRs larger, than those of controls. In addition, mTBI participants' RTs to first-order stimuli were shorter than those to second-order stimuli, and SDs as well as IQRs larger for first- than for second-order stimuli in the motion condition. All these observations were made over the three sessions. The level of symptoms observed in mTBI was higher than that of control participants, and this difference did also persist up to 1 year after the brain injury, despite an improvement. The combination of RT measures with particular stimulus properties is a highly sensitive method for measuring mTBI-induced visuomotor anomalies and provides a fine probe of the underlying mechanisms when the brain is exposed to mild trauma.	[Piponnier, Jean-Claude; Faubert, Jocelyn] Univ Montreal, Ecole Optometrie, Visual Psychophys & Percept Lab, Montreal, PQ H3T 1P1, Canada; [Forget, Robert] Univ Montreal, Ecole Readaptat, Montreal, PQ H3T 1P1, Canada; [Forget, Robert] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [McKerral, Michelle] Univ Montreal, Ctr Readaptat Lucie Bruneau, Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ H3T 1P1, Canada; [McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H3T 1P1, Canada; [Giguere, Jean-Francois] Univ Montreal, Hop Sacre Coeur, Dept Surg, Montreal, PQ H3T 1P1, Canada		Faubert, J (corresponding author), Univ Montreal, Ecole Optometrie, Visual Psychophys & Percept Lab, 3744 Jean Brillant,Bur 210-40, Montreal, PQ H3T 1P1, Canada.	jocelyn.faubert@umontreal.ca	Faubert, Jocelyn/E-2207-2011	Piponnier, Jean-Claude/0000-0003-4868-8759; Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-18004]	This study was funded by the Canadian Institutes of Health Research (MOP-18004). The authors thank David Nguyen-Tri for programming and English proofreading; Isabelle Roy and Ariane Demers (HSCM) and Lisa Grilli (MUHC) for recruitment of participants; Thomas Romeas (School of Optometry, Universite de Montreal; project coordinator); Remy Allard and Frederic Poirier for comments on the manuscript; Claudine Habak for English proofreading and comments on the manuscript; and all the participants that participated in this study.	Allard R, 2006, J VISION, V6, P322, DOI 10.1167/6.4.3; Allard R, 2013, J VISION, V13, DOI 10.1167/13.11.2; Allard R, 2013, J VISION, V13, DOI 10.1167/13.5.4; Allen HA, 2003, VISION RES, V43, P2927, DOI 10.1016/j.visres.2003.07.005; Armstrong V, 2009, VISION RES, V49, P2774, DOI 10.1016/j.visres.2009.08.016; Ashida H, 2007, J NEUROPHYSIOL, V97, P1319, DOI 10.1152/jn.00723.2006; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Bertone A, 2008, NEUROREPORT, V19, P225, DOI 10.1097/WNR.0b013e3282f48401; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Billino J, 2011, NEUROPSYCHOLOGIA, V49, P3151, DOI 10.1016/j.neuropsychologia.2011.07.009; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Brown L., 1997, TEST NONVERBAL INTEL, V3rd; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Chakor H, 2005, DOC OPHTHALMOL, V110, P163, DOI 10.1007/s10633-005-3694-8; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Conners CK, 1997, CONNERS RATING SCALE; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Delorme A, 2006, ENCY MEDICAL DEVICE, V6, P240, DOI DOI 10.1002/0471732877.EMD318; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dumoulin SO, 2003, CEREB CORTEX, V13, P1375, DOI 10.1093/cercor/bhg085; Dupont P, 2003, EUR J NEUROSCI, V17, P1509, DOI 10.1046/j.1460-9568.2003.02571.x; Ellemberg D, 2003, VISION RES, V43, P651, DOI 10.1016/S0042-6989(03)00006-3; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Farivar R, 2009, BRAIN RES REV, V61, P144, DOI 10.1016/j.brainresrev.2009.05.006; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gegenfurtner KR, 1996, VISION RES, V36, P1281, DOI 10.1016/0042-6989(95)00198-0; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Habak C, 2000, VISION RES, V40, P943, DOI 10.1016/S0042-6989(99)00235-7; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hutchinson CV, 2006, VISION RES, V46, P324, DOI 10.1016/j.visres.2005.03.002; Ivarsson J, 2002, J BIOMECH ENG-T ASME, V124, P422, DOI 10.1115/1.1485752; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kalaycioglu C, 2009, BRAIN RES, V1296, P85, DOI 10.1016/j.brainres.2009.08.018; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Korth M, 2000, VISUAL NEUROSCI, V17, P631, DOI 10.1017/S0952523800174127; KUBA M, 1992, DOC OPHTHALMOL, V80, P83, DOI 10.1007/BF00161234; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Ledgeway T, 2005, VISION RES, V45, P2081, DOI 10.1016/j.visres.2005.02.005; Ledgeway T, 2008, VISION RES, V48, P208, DOI 10.1016/j.visres.2007.11.008; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McKerral M, 2001, VISION RES, V41, P1085, DOI 10.1016/S0042-6989(01)00037-2; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Noguchi Y, 2005, CEREB CORTEX, V15, P1592, DOI 10.1093/cercor/bhi037; Prieto EA, 2007, NEUROIMAGE, V37, P1384, DOI 10.1016/j.neuroimage.2007.03.080; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schofield AJ, 2000, VISION RES, V40, P2475, DOI 10.1016/S0042-6989(00)00111-5; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Sukurnar S, 2007, VISION RES, V47, P581, DOI 10.1016/j.visres.2006.10.004; Sunaert S, 2000, NEUROIMAGE, V11, P612, DOI 10.1006/nimg.2000.0587; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; ULRICH R, 1994, J EXP PSYCHOL GEN, V123, P34, DOI 10.1037/0096-3445.123.1.34; Vaina LM, 2003, PROG BRAIN RES, V144, P197, DOI 10.1016/S0079-6123(03)14401-4; Vakalopoulos C, 2005, MED HYPOTHESES, V65, P922, DOI 10.1016/j.mehy.2005.05.016; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wadood AC, 2002, AM J OPHTHALMOL, V133, P327, DOI 10.1016/S0002-9394(01)01424-6; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	90	7	7	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					242	253		10.1089/neu.2014.3832			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800010	25950948				2022-02-06	
J	Rudolph, JL; Fonda, JR; Hunt, PR; McGlinchey, RE; Milberg, WP; Reynolds, MW; Yonan, C				Rudolph, James L.; Fonda, Jennifer R.; Hunt, Phillip R.; McGlinchey, Regina E.; Milberg, William P.; Reynolds, Matthew W.; Yonan, Charles			Association of Pseudobulbar Affect symptoms with quality of life and healthcare costs in Veterans with traumatic brain injury	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Pseudobulbar Affect; Health-related quality of life; Traumatic brain injury; Post-traumatic stress disorder; Emotional lability; Health care cost	POSTTRAUMATIC-STRESS-DISORDER; IRAQ; PATHOPHYSIOLOGY; COMORBIDITY; AFGHANISTAN; PREVALENCE; DIAGNOSES; COMBAT; SCALE; PAIN		[Rudolph, James L.; Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, GRECC, Boston, MA 02130 USA; [Rudolph, James L.; Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA 02130 USA; [Rudolph, James L.] Providence VA Med Ctr, Ctr Innovat Geriatr Serv, Providence, RI USA; [Fonda, Jennifer R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hunt, Phillip R.; Reynolds, Matthew W.] Evidera, Hlth Econ & Epidemiol, Lexington, MA USA; [McGlinchey, Regina E.; Milberg, William P.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Yonan, Charles] Avanir Pharmaceut Inc, Hlth Econ & Outcomes Res, Aliso Viejo, CA USA		Rudolph, JL (corresponding author), VA Boston Healthcare Syst, GRECC TRACTS JP 182, 150 South Huntington Ave, Boston, MA 02130 USA.	James.Rudolph@va.gov	Fonda, Jennifer R./ABG-2890-2021; McGlinchey, Regina E/R-1971-2016	Fonda, Jennifer R./0000-0001-9482-2918; 	Avanir Pharmaceuticals, Inc.	Funding and editorial support were provided by Avanir Pharmaceuticals, Inc. Evidera provided support for the protocol and manuscript preparation, in collaboration with VA investigators. VA Boston Healthcare System and the Translational Research Center for TBI and Stress Disorders (TRACTS), which is a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), are acknowledged for providing overall and infrastructural support.	Agresti A, 2002, ANAL CATEGORICAL DAT; Arciniegas DB, 2005, CNS SPECTRUMS, V10, P1, DOI 10.1017/S1092852900026602; Boyd MA, 2013, ARCH PSYCHIAT NURS, V27, P10, DOI 10.1016/j.apnu.2012.10.005; Brooks BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072232; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Eber S, 2013, MIL MED, V178, P966, DOI 10.7205/MILMED-D-13-00175; Engelman W, 2014, NEUROPSYCH DIS TREAT, V10, P1903, DOI 10.2147/NDT.S63304; Fonda J., 2015, J REHABIL R IN PRESS, V52; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lauterbach EC, 2013, NEUROSCI BIOBEHAV R, V37, P1893, DOI 10.1016/j.neubiorev.2013.03.002; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Phuong L, 2009, PARKINSONISM RELAT D, V15, P511, DOI 10.1016/j.parkreldis.2009.01.001; Rabin R, 2011, USER GUIDE BASIC INF; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Smith RA, 2004, MULT SCLER J, V10, P679, DOI 10.1191/1352458504ms1106oa; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001	27	7	7	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JAN 15	2016	190						150	155		10.1016/j.jad.2015.10.003			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CY5QT	WOS:000366463000024	26519634	hybrid			2022-02-06	
J	MacAllister, WS; Vasserman, M; Coulehan, K; Hall, AF; Bender, HA				MacAllister, William S.; Vasserman, Marsha; Coulehan, Kelly; Hall, Ari F.; Bender, H. Allison			Cognitive estimations as a measure of executive dysfunction in childhood epilepsy	CHILD NEUROPSYCHOLOGY			English	Article						Epilepsy; Executive function; Estimation	TEMPORAL-LOBE EPILEPSY; DEFICIT HYPERACTIVITY DISORDER; BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; FRONTAL-LOBE; ABSENCE EPILEPSY; CHILDREN; ATTENTION; ADHD	Children and adolescents with epilepsy are known to demonstrate executive function deficits. Despite prior work that has shown that cognitive estimation tasks are sensitive to executive dysfunction in children, such tasks have not been studied in children with epilepsy. This is particularly important given the fact that executive tasks have heretofore shown poor ecological validity, and it has been speculated that estimation tasks may show stronger ecological validity than other executive tests. One hundred and thirteen clinically referred children and adolescents with epilepsy were included. The Biber Cognitive Estimations Test was sensitive to cognitive dysfunction, with about half showing impairments on this task in comparison to age-matched normative data; the most frequently impaired subscales were quantity estimation and time estimation. Moreover, the Biber Cognitive Estimation Test showed moderate correlations with not only overall intellectual functions and academic achievement but also other commonly administered tests of executive functions, including digit span, Trailmaking, and the Tower of London but not with the contingency naming test. Cognitive estimations were also modestly correlated with age of epilepsy onset but not other epilepsy-severity variables such as number of antiepilepsy drugs (AEDs) or seizure frequency. Unfortunately, the hypothesis that the Biber Cognitive Estimation Test would show strong ecological validity was not supported, as it showed weak relations with parent-reported executive function deficits. The significance and limitations of this investigation are discussed.	[MacAllister, William S.] NYU, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Vasserman, Marsha] NYU, Ctr Child Study, Dept Child & Adolescent Psychiat, New York, NY 10016 USA; [Coulehan, Kelly] Fordham Univ, Dept Psychol, New York, NY 10023 USA; [Hall, Ari F.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Bender, H. Allison] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Bender, H. Allison] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA		MacAllister, WS (corresponding author), NYU, Dept Neurol, Comprehens Epilepsy Ctr, ABPP CN 223 East 34th St, New York, NY 10016 USA.	William.macallister@nyumc.org		Vasserman, Marsha/0000-0003-4221-8983			Adjutant General's Office, 1944, ARM IND TEST BATT MA; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Barabassy A, 2007, J NEURAL TRANSM, V114, P1479, DOI 10.1007/s00702-007-0752-2; Barkley RA, 2001, NEUROPSYCHOLOGY, V15, P351, DOI 10.1037//0894-4105.15.3.351; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Billino J, 2008, INT J GERIATR PSYCH, V23, P982, DOI 10.1002/gps.1985; BOURGEOIS BFD, 1983, ANN NEUROL, V14, P438, DOI 10.1002/ana.410140407; Bullard SE, 2004, ARCH CLIN NEUROPSYCH, V19, P835, DOI 10.1016/j.acn.2003.12.002; Conant LL, 2010, EPILEPSY BEHAV, V18, P414, DOI 10.1016/j.yebeh.2010.05.010; Culbertson W. C., 2000, TOWER OF LONDON DX; Culhane-Shelburne K, 2002, J INT NEUROPSYCH SOC, V8, P623, DOI 10.1017/S1355617702801308; D'Agati E, 2012, BRAIN DEV-JPN, V34, P812, DOI 10.1016/j.braindev.2012.03.001; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; Gioia GA IP, 2000, BEHAV RATING INVENTO; Guimaraes CA, 2007, J CHILD NEUROL, V22, P836, DOI 10.1177/0883073807304701; Harel BT, 2007, CHILD NEUROPSYCHOL, V13, P309, DOI 10.1080/09297040600837354; Heaton R., 1993, WISCONSIN CART SORTI; Hermann B, 2007, BRAIN, V130, P3135, DOI 10.1093/brain/awm227; Levinoff EJ, 2006, NEUROPSYCHOLOGY, V20, P123, DOI 10.1037/0894-4105.20.1.123; Longo CA, 2013, EPILEPSY BEHAV, V26, P102, DOI 10.1016/j.yebeh.2012.11.003; Lopes AFD, 2010, REV NEUROLOGIA, V50, P265, DOI 10.33588/rn.5005.2009452; Loring DW, 2004, NEUROLOGY, V62, P872, DOI 10.1212/01.WNL.0000115653.82763.07; Luton LM, 2010, ARCH CLIN NEUROPSYCH, V25, P762, DOI 10.1093/arclin/acq066; MacAllister WS, 2007, NEUROPSYCHOL REV, V17, P427, DOI 10.1007/s11065-007-9048-4; MacAllister WS, 2014, APPL NEUROPSYCH-CHIL, V3, P215, DOI 10.1080/21622965.2013.839605; MacAllister WS, 2012, APPL NEUROPSYCH-CHIL, V1, P121, DOI 10.1080/21622965.2012.709421; MacAllister WS, 2012, CHILD NEUROPSYCHOL, V18, P404, DOI 10.1080/09297049.2011.613812; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Neri ML, 2012, EPILEPSY BEHAV, V24, P403, DOI 10.1016/j.yebeh.2012.04.131; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Raiford S.E, 2005, TECHNICAL REPORT; Rathouz PJ, 2014, DEV MED CHILD NEUROL, V56, P635, DOI 10.1111/dmcn.12432; Rzezak P, 2007, PEDIATR NEUROL, V37, P176, DOI 10.1016/j.pediatrneurol.2007.05.009; Rzezak P, 2009, EPILEPSY BEHAV, V15, P376, DOI 10.1016/j.yebeh.2009.04.014; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; Sherman EMS, 2006, EPILEPSIA, V47, P1936, DOI 10.1111/j.1528-1167.2006.00816.x; Sherman EMS, 2012, EPILEPSIA, V53, P1060, DOI 10.1111/j.1528-1167.2012.03493.x; Sikora DA, 2002, DEV NEUROPSYCHOL, V21, P243, DOI 10.1207/S15326942DN2103_2; Silverberg ND, 2007, J INT NEUROPSYCH SOC, V13, P898, DOI 10.1017/S1355617707071135; Slick DJ, 2006, CHILD NEUROPSYCHOL, V12, P181, DOI 10.1080/09297040600611320; TAYLOR HG, 1987, J PEDIATR PSYCHOL, V12, P395, DOI 10.1093/jpepsy/12.3.395; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Vuilleumier P, 2000, EPILEPSIA, V41, P687, DOI 10.1111/j.1528-1157.2000.tb00229.x; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2009, WECHSLER INDIVIDUAL; Wechsler D, 2011, WASI 2 WECHSLER ABBR	48	7	7	0	30	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JAN 2	2016	22	1					65	80		10.1080/09297049.2014.967670			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CV3VV	WOS:000364195400003	25387349				2022-02-06	
J	Tennant, F				Tennant, Forest			Why oral opioids may not be effective in a subset of chronic pain patients	POSTGRADUATE MEDICINE			English	Article						Malabsorption; Dysautonomia; Ineffective; Cytochrome P450; Oral; Gastrointestinal; Opioid	INFLAMMATORY-BOWEL-DISEASE; HYPOPITUITARISM; PREVALENCE; EXPRESSION	Objective: To identify possible underlying causes of poor oral opioid effectiveness. Methods: Ninety-five (95) adults who were referred for evaluation and medical management of their intractable pain were screened to determine if oral opioids provided enough pain relief to physically and mentally function and carry out activities of daily living. A clinical evaluation included history, physical examination, cytochrome P450 enzyme testing and a hydromorphone injection to help confirm lack of oral opioid effectiveness. Results: Twenty (20; 21.1%) of the 95 patients reported that three or more oral opioids had not provided enough pain relief to allow them to mentally and physically function and carry out activities of daily living. Patients all reported some typical symptoms of malabsorption including nausea and steatorrhea, and 14 (70.0%) reported that they had observed undigested medication in their stools. Fifteen (15; 75.0%) had experienced pain relief with an injectable opioid. Two major causes for lack of oral opioid effectiveness were apparent: (1) gastrointestinal disorder (11; 55.0%) and (2) cytochrome P450 enzymatic defects (9; 45.0%). In addition to these basic causes, a number of other possible contributing factors were identified which included abdominal, pelvic and spine surgeries, traumatic brain and neck injury, and autoimmune disorders. Conclusions: There is a group of intractable pain patients who do not effectively metabolize oral opioids. Although gastrointestinal disease and cytochrome P450 enzymatic defects appeared to be dominant causes of oral opioid ineffectiveness, there were other possible contributing factors such as abdominal, pelvic and spine surgeries, head and neck trauma, and autoimmune disease. Pain patients who report poor oral opioid effectiveness should be evaluated for the presence of underlying pathologic conditions which may interfere with oral opioid metabolism and, if found, be considered for nonoral opioid treatment.	[Tennant, Forest] Veract Intractable Pain Clin, Res Dept, 338 S Glendora Ave, West Covina, CA 91790 USA		Tennant, F (corresponding author), Veract Intractable Pain Clin, Res Dept, 338 S Glendora Ave, West Covina, CA 91790 USA.	veractinc@msn.com			Tennant Foundation	This study was funded by the Tennant Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Agha A, 2006, AM J MED, V1818, P1416; Aimaretti G, 2005, THESCIENTIFICWORLDJO, V5, P777, DOI 10.1100/tsw.2005.100; Argoff CI, 2010, CLIN J PAIN S10, V26, P516; DiMagno MJ, 2013, CURR OPIN GASTROEN, V29, P531, DOI 10.1097/MOG.0b013e3283639370; Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; HUSEBYE E, 1995, J INTERN MED, V237, P419, DOI 10.1111/j.1365-2796.1995.tb01196.x; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kaminsky LS, 2003, DRUG METAB DISPOS, V31, P1520, DOI 10.1124/dmd.31.12.1520; Karras P J, 1997, Curr Ther Endocrinol Metab, V6, P462; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lai Ping So A, 1997, Semin Gastrointest Dis, V8, P22; Mayer EA, 2011, ANNU REV MED, V62, P381, DOI 10.1146/annurev-med-012309-103958; McQuaid KR, 2015, LANGE 2015 CURRENT M, P617; Obach RS, 2001, DRUG METAB DISPOS, V29, P347; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; Paine MF, 1999, DRUG METAB DISPOS, V27, P360; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Schiller LR, 2015, CONNS CURRENT THERAP, P581; Srinath AI, 2012, THER ADV GASTROENTER, V5, P339, DOI 10.1177/1756283X12446158; Tennant F., 2013, PRACT PAIN MGT, V13, P31; Tennant F, 2012, PRAC PAIN MGMT, V7, P43; Tennant F, 2007, J PALLIAT MED, V10, P1253, DOI 10.1089/jpm.2007.0066; Tennant Forest, 2015, J Opioid Manag, V11, P237, DOI 10.5055/jom.2015.0272; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Virally-Monod M, 1998, DIABETES METAB, V24, P530; Washington K, 1996, AM J SURG PATHOL, V20, P1240, DOI 10.1097/00000478-199610000-00010; Webster LR, 2008, CLIN LAB MED, V38, P581; Wilkinson CW, 2012, FRONT NEUROL, V3, P1; Yang JS, 2004, CLIN PHARMACOL THER, V76, P391, DOI 10.1016/j.clpt.2004.07.001; Zhang QY, 1999, DRUG METAB DISPOS, V27, P804	31	7	8	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0032-5481	1941-9260		POSTGRAD MED	Postgrad. Med.	JAN 2	2016	128	1					18	22		10.1080/00325481.2016.1128306			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF3OO	WOS:000371254400003	26635137				2022-02-06	
J	Williams, J; Crowe, LM; Dooley, J; Collie, A; Davis, G; McCrory, P; Clausen, H; Maddocks, D; Anderson, V				Williams, Jacqueline; Crowe, Louise M.; Dooley, Julian; Collie, Alex; Davis, Gavin; McCrory, Paul; Clausen, Helen; Maddocks, David; Anderson, Vicki			Developmental Trajectory of Information-Processing Skills in Children: Computer-Based Assessment	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						adolescent; attention; child; CogState; development; processing speed	COGNITIVE IMPAIRMENT; CONCUSSION; PERFORMANCE; CHILDHOOD; BATTERY; MILD; RELIABILITY; MATURATION; HEALTHY; TESTS	There are significant merits to a comprehensive cognitive assessment, but they are also time-consuming, costly, and susceptible to practice effects and may not detect change in the context of medical interventions or minor brain disruptions. Brief computer-based assessments focused on fluid cognitive domains (e.g., information-processing skills), which are vulnerable to disruption as a result of a brain injury, may provide an alternative assessment option. This study sought to: (a) examine the utility of a well-established, adult-based computerized tool, CogSport for Kids (CogState), for evaluating information-processing skills in children and adolescents; and (b) to report normative data for healthy children and adolescents. The study was a cross-sectional, community-based observational study of typically developing children aged 9 to 17 years old (N = 832). Participants completed the CogSport for Kids test battery, which includes six brief computerized tasks that assess cognitive functions including processing speed, attention, and working memory. Results showed an improvement with age for response speed and accuracy. The greatest change occurred between 9 and 12 years with performance stabilizing at 15 years. This brief screening tool is appropriate for clinical and research use in children aged 9 years and older and may be used to track cognitive development from childhood into adulthood and to identify children who deviate from normal expectations.	[Williams, Jacqueline; Dooley, Julian; Davis, Gavin] Murdoch Childrens Res Inst, Child Neuropsychol, Melbourne, Vic, Australia; [Crowe, Louise M.] Univ Melbourne, Child Neuropsychol, Clin Sci, Murdoch Children, Melbourne, Vic, Australia; [Crowe, Louise M.; Anderson, Vicki] Univ Melbourne, Psychol Sci, Melbourne, Vic, Australia; [Collie, Alex] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Davis, Gavin] Austin Hosp, Dept Neurosurg, Melbourne, Vic 3084, Australia; [Davis, Gavin] Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [McCrory, Paul] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Clausen, Helen] Melbourne Neuropsychol Serv, Melbourne, Vic, Australia; [Maddocks, David] Perry Maddocks Trellope, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Child Neuropsychol, Murdoch Childrens Res Inst, Melbourne, Vic, Australia		Crowe, LM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Child Neuropsychol, Clin Sci, Flemington Rd, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au	Williams, Jacqueline/C-5947-2009; McCrory, Paul/Q-8688-2019; Williams, Jacqueline/AAC-3645-2019	Williams, Jacqueline/0000-0003-1235-5186; Williams, Jacqueline/0000-0003-1235-5186; Collie, Alex/0000-0003-2617-9339; McCrory, Paul/0000-0003-4850-0568; Crowe, Louise/0000-0003-4619-9708	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [334337]; Victorian Government's Operational Infrastructure Support Program	This project was funded by the National Health and Medical Research Council of Australia (#334337) and by the Victorian Government's Operational Infrastructure Support Program.	Anderson V., 2002, DEV NEUROPSYCHOLOGY; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Crowe L., 2009, EMERG MED AUSTRALAS, V22, P56; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Darby DG, 2012, ALZHEIMERS DEMENT, V8, P95, DOI 10.1016/j.jalz.2010.12.009; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; Lim YY, 2013, ARCH CLIN NEUROPSYCH, V28, P320, DOI 10.1093/arclin/act021; Luciana M, 2003, J CHILD PSYCHOL PSYC, V44, P649, DOI 10.1111/1469-7610.00152; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; Mollica CM, 2005, CHILD NEUROPSYCHOL, V11, P303, DOI 10.1080/092970490911306; Mollica CM, 2004, HUM PSYCHOPHARM CLIN, V19, P445, DOI 10.1002/hup.624; Newman JB, 2013, CLIN NEUROPSYCHOL, V27, P779, DOI 10.1080/13854046.2013.789552; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500	31	7	7	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JAN 2	2016	5	1					35	43		10.1080/21622965.2014.939271			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DB7TH	WOS:000368718500005	25551176				2022-02-06	
J	Ahlawat, A; Carandang, R; Heard, SO; Muehlschlegel, S				Ahlawat, Aditi; Carandang, Raphael; Heard, Stephen O.; Muehlschlegel, Susanne			The Modified Apnea Test During Brain Death Determination: An Alternative in Patients With Hypoxia	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						brain death; apnea testing; neurocritical care	DIAGNOSIS; INJURY	Introduction: Conventional apnea testing in patients with severe hypoxemia or hemodynamic instability with removal from the ventilator support is unsafe. We describe an alternative approach to apnea testing, which may be used in patients with hypoxia unable to undergo conventional apnea testing. Methods: Case Report. A 42-year-old man had a severe traumatic brain injury resulting in diffuse cerebral edema and subarachnoid hemorrhage with herniation. His presentation was complicated by hypoxic respiratory failure from pulmonary contusions and hemorrhagic shock. On hospital day 2, the patient lost brain stem reflexes. Brain death testing with conventional apnea testing was attempted but aborted due to hypoxia. Results: A modified apnea test was applied, which had been approved by appropriate hospital committees including critical care operations, ethics, and the brain death protocol council. Minute ventilation was gradually decreased by 50% to attain a PaCo2 level 20 mm Hg above baseline. The ventilation mode was then switched from volume control to continuous positive airway pressure while observing the patient for signs of respiration for a duration of 60 seconds. Conclusion: The modified apnea test does not require circuit disconnection and can be successfully applied to determine brain death without compromising safety in high-risk patients having severe hypoxia.	[Ahlawat, Aditi; Carandang, Raphael; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Neurol Neurocrit Care, Worcester, MA 01655 USA; [Carandang, Raphael; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA 01655 USA; [Heard, Stephen O.; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Anesthesia Crit Care, Worcester, MA 01655 USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol Neurocrit Care, 55 Lake Ave North, Worcester, MA 01655 USA.	susanne.muehlschlegel@umassmemorial.org			National Institutes of Health NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD080971]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. Muehlschlegel is funded by the National Institutes of Health NIH/NICHD 1K23HD080971.	ANDREWS RJ, 1994, NEUROSURGERY, V34, P466, DOI 10.1227/00006123-199403000-00012; BENZEL EC, 1992, J NEUROSURG, V76, P1029, DOI 10.3171/jns.1992.76.6.1029; BERGER AJ, 1977, NEW ENGL J MED, V297, P92, DOI 10.1056/NEJM197707142970206; Calixto M, 2009, ANN INDIAN ACAD NEUR, V12, P197; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Goudreau JL, 2000, NEUROLOGY, V55, P1045, DOI 10.1212/WNL.55.7.1045; GUTMANN DH, 1991, ANN NEUROL, V30, P852, DOI 10.1002/ana.410300620; Hocker S, 2014, NEUROCRIT CARE, V20, P298, DOI 10.1007/s12028-013-9932-0; LANG CJG, 1995, NEUROLOGY, V45, P966, DOI 10.1212/WNL.45.5.966; Lang CJG, 2005, ACTA NEUROL SCAND, V112, P358, DOI 10.1111/j.1600-0404.2005.00527.x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; ROPPER AH, 1981, J NEUROSURG, V55, P942, DOI 10.3171/jns.1981.55.6.0942; SCHAFER JA, 1978, NEUROLOGY, V28, P661, DOI 10.1212/WNL.28.7.661	13	7	8	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	JAN	2016	31	1					66	69		10.1177/0885066615599086			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY7RP	WOS:000366606900008	26574562	Green Accepted			2022-02-06	
J	Ali, ZS; Johnson, VE; Stewart, W; Zager, EL; Xiao, R; Heuer, GG; Weber, MT; Mallela, AN; Smith, DH				Ali, Zarina S.; Johnson, Victoria E.; Stewart, William; Zager, Eric L.; Xiao, Rui; Heuer, Gregory G.; Weber, Maura T.; Mallela, Arka N.; Smith, Douglas H.			Neuropathological Characteristics of Brachial Plexus Avulsion Injury With and Without Concomitant Spinal Cord Injury	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Axonal pathology; Brachial plexus avulsion; Inflammation; Motor neuron loss; Neonatal; Spinal cord injury; Upper trunk injury	NITRIC-OXIDE SYNTHASE; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; VENTRAL ROOT AVULSION; NEUROTROPHIC FACTOR; PERIPHERAL-NERVES; TRACTION INJURIES; MOTONEURON DEATH; NERVOUS-SYSTEM; MOTOR-NEURONS	Neonatal brachial plexus avulsion injury (BPAI) commonly occurs as a consequence of birth trauma and can result in lifetime morbidity; however, little is known regarding the evolving neuropathological processes it induces. In particular, mechanical forces during BPAI can concomittantly damage the spinal cord and may contribute to outcome. Here, we describe the functional and neuropathological outcome following BPAI, with or without spinal cord injury, in a novel pediatric animal model. Twenty-eight-day-old piglets underwent unilateral C5-C7 BPAI with and without limited myelotomy. Following avulsion, all animals demonstrated right forelimb monoparesis. Injury extending into the spinal cord conferred greater motor deficit, including long tract signs. Consistent with clinical observations, avulsion with myelotomy resulted in more severe neuropathological changes with greater motor neuron death, progressive axonopathy, and persistent glial activation. These data demonstrate neuropathological features of BPAI associated with poor functional outcome. Interestingly, in contrast to adult small animal models of BPAI, a degree of motor neuron survival was observed, even following severe injury in this neonatal model. If this is also the case in human neonatal BPAI, repair may permit functional restoration. This model also provides a clinically relevant platform for exploring the complex postavulsion neuropathological responses that may inform therapeutic strategies.	[Ali, Zarina S.; Johnson, Victoria E.; Stewart, William; Zager, Eric L.; Weber, Maura T.; Mallela, Arka N.; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Ali, Zarina S.; Johnson, Victoria E.; Stewart, William; Weber, Maura T.; Mallela, Arka N.; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Xiao, Rui] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Heuer, Gregory G.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA		Smith, DH (corresponding author), Univ Penn, Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.; Smith, DH (corresponding author), Univ Penn, Res & Educ, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.; Smith, DH (corresponding author), Univ Penn, Penn Ctr Brain Injury & Repair, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu		Stewart, William/0000-0003-2199-2582	National Institutes of Health grantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS056202, NS038104, NS092389]; American Association of Neurological Surgeons David Kline Award; Neurosurgical Research and Education Foundation Fellowship Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092398, P01NS056202, R01NS038104] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health grants NS056202, NS038104, NS092389, The American Association of Neurological Surgeons David Kline Award (ZA), and The Neurosurgical Research and Education Foundation Fellowship Grant (ZA). NHS Research Scotland Career Research Fellowship (WS).	Allison DJ, 2015, SPINAL CORD, V53, P14, DOI 10.1038/sc.2014.184; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; BERTELLI JA, 1994, J NEUROSURG, V81, P107, DOI 10.3171/jns.1994.81.1.0107; BERTELLI JA, 1994, BRAIN RES, V644, P150, DOI 10.1016/0006-8993(94)90358-1; Birch R., 1998, SURG DISORDERS PERIP; Cao XC, 2003, J RECONSTR MICROSURG, V19, P265; CARLSTEDT TP, 1993, J NEUROL NEUROSUR PS, V56, P649, DOI 10.1136/jnnp.56.6.649; CARLSTEDT TP, 1995, MICROSURG, V16, P13, DOI 10.1002/micr.1920160106; Chen LJ, 2010, J CLIN NEUROSCI, V17, P87, DOI 10.1016/j.jocn.2009.03.042; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen ZM, 2005, NEUROSCI LETT, V376, P166, DOI 10.1016/j.neulet.2004.11.051; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Del Fabbro L, 2012, BRAIN RES, V1475, P31, DOI 10.1016/j.brainres.2012.08.008; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI; Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484; Faden A. I., 2015, BR J PHARM; Foad SL, 2008, J BONE JOINT SURG AM, V90A, P1258, DOI 10.2106/JBJS.G.00853; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GREENWALD AG, 1984, J PEDIATR ORTHOPED, V4, P689, DOI 10.1097/01241398-198411000-00006; GRIFFITHS IR, 1974, J SMALL ANIM PRACT, V15, P165, DOI 10.1111/j.1748-5827.1974.tb05674.x; GU YD, 1991, J RECONSTR MICROSURG, V7, P15, DOI 10.1055/s-2007-1006759; Gu YM, 1997, DEV NEUROSCI-BASEL, V19, P255, DOI 10.1159/000111214; GUTH L, 1970, EXP NEUROL, V28, P365, DOI 10.1016/0014-4886(70)90244-X; Haninec P, 2004, EXP BRAIN RES, V159, P425, DOI 10.1007/s00221-004-1969-z; Hems TEJ, 1999, J HAND SURG-BRIT EUR, V24B, P550, DOI 10.1054/jhsb.1999.0234; HOFFMANN CFE, 1993, CLIN NEUROL NEUROSUR, V95, pS39; HOFFMANN CFE, 1993, CLIN NEUROL NEUROSUR, V95, pS112; Inciong JGB, 2000, PLAST RECONSTR SURG, V105, P2059, DOI 10.1097/00006534-200005000-00021; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karlsson AH, 1999, LIVEST PROD SCI, V60, P255, DOI 10.1016/S0301-6226(99)00098-6; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Lagerkvist AL, 2010, DEV MED CHILD NEUROL, V52, P529, DOI 10.1111/j.1469-8749.2009.03479.x; LEVINE MG, 1984, OBSTET GYNECOL, V63, P792; Li K, 2015, J MOL NEUROSCI, V56, P917, DOI 10.1007/s12031-015-0543-4; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Liu L J, 1999, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V13, P295; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Moissonnier P, 1998, SPINAL CORD, V36, P391, DOI 10.1038/sj.sc.3100591; Muñetón-Gómez Vilma, 2004, Biomed., V24, P183; NARAKAS AO, 1987, ORTHOPADE, V16, P81; Nordin L, 2009, J BONE JOINT SURG BR, V91B, P88, DOI 10.1302/0301-620X.91B1.21668; Ochiai H, 2002, J NEUROSCI METH, V119, P51, DOI 10.1016/S0165-0270(02)00167-X; Oo TF, 2002, EXP NEUROL, V175, P1, DOI 10.1006/exnr.2002.7881; Penas C, 2009, J NEUROTRAUM, V26, P763, DOI [10.1089/neu.2008.0661, 10.1089/neu.2008-0661]; Piehl F, 1998, EXP BRAIN RES, V119, P191, DOI 10.1007/s002210050333; PIEHL F, 1993, EUR J NEUROSCI, V5, P1321, DOI 10.1111/j.1460-9568.1993.tb00918.x; Pondaag W, 2004, DEV MED CHILD NEUROL, V46, P138; Rhee PC, 2011, J BONE JOINT SURG AM, V93A, P2271, DOI [10.2106/JBJS.J.00922, 10.2106/JBJSJ.00922]; Rodrigues-Filho R, 2004, BRAIN RES, V1018, P159, DOI 10.1016/j.brainres.2004.05.058; Roldan P, 1982, Arch Neurobiol (Madr), V45, P225; Ryu YC, 2008, MEAT SCI, V80, P363, DOI 10.1016/j.meatsci.2007.12.020; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Skorjanc D, 2007, CZECH J ANIM SCI, V52, P103, DOI 10.17221/2270-CJAS; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Somashekar D, 2014, AM J NEURORADIOL, V35, P1209, DOI 10.3174/ajnr.A3820; Spinner RJ, 2000, MICROSURG, V20, P94, DOI 10.1002/(SICI)1098-2752(2000)20:2<94::AID-MICR8>3.0.CO;2-L; TADA K, 1979, EXP NEUROL, V65, P301, DOI 10.1016/0014-4886(79)90100-6; Tavakkolizadeh A, 2001, J HAND SURG-BRIT EUR, V26, P183, DOI 10.1054/jhsb.2000.0555; Tian F, 2015, NEUROSCI LETT, V584, P50, DOI 10.1016/j.neulet.2014.09.049; van Dijk JG, 2001, MUSCLE NERVE, V24, P1451, DOI 10.1002/mus.1168; VOLLE E, 1992, NEURORADIOLOGY, V34, P235, DOI 10.1007/BF00596345; Wang BQ, 2012, NEURAL REGEN RES, V7, P1786, DOI 10.3969/j.issn.1673-5374.2012.23.004; Wang L, 2009, NEUROPATHOLOGY, V29, P230, DOI 10.1111/j.1440-1789.2008.00969.x; Weil ZM, 2008, PROG NEUROBIOL, V86, P48, DOI 10.1016/j.pneurobio.2008.06.001; Wrathall JR, 1998, J NEUROSCI, V18, P8780; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; WU WT, 1993, EXP NEUROL, V120, P153, DOI 10.1006/exnr.1993.1050; WU YG, 1995, NEUROSCI LETT, V194, P109, DOI 10.1016/0304-3940(95)11741-E; Yoshikawa T, 2006, RADIOGRAPHICS, V26, pS133, DOI 10.1148/rg.26si065511; Zhang CG, 2005, BRIT J PLAST SURG, V58, P765, DOI 10.1016/j.bjps.2005.04.012; Zhao XC, 2012, J NEUROCHEM, V121, P362, DOI 10.1111/j.1471-4159.2012.07696.x	79	7	7	2	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JAN	2016	75	1					69	85		10.1093/jnen/nlv002			17	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	DK9DJ	WOS:000375230400008	26671984	Bronze, Green Published			2022-02-06	
J	Balanc, B; Bapteste, L; Lieutaud, T; Ressnikoff, D; Guy, R; Bezin, L; Marinesco, S				Balanc, Baptiste; Bapteste, Lionel; Lieutaud, Thomas; Ressnikoff, Denis; Guy, Rainui; Bezin, Laurent; Marinesco, Stephane			Neuronal Loss as Evidenced by Automated Quantification of Neuronal Density Following Moderate and Severe Traumatic Brain Injury in Rats	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						immunohistochemistry; NeuN; lateral fluid percussion; hippocampus; cortex; AB_11210778; AB_141367	LIMITS MICROGLIAL ACTIVATION; CELL-DEATH; COGNITIVE DYSFUNCTION; FLUORO-JADE; NEUROINFLAMMATION; OPPORTUNITIES; HIPPOCAMPUS; MODELS	Traumatic brain injury causes widespread neurological lesions that can be reproduced in animals with the lateral fluid percussion (LFP) model. The characterization of the pattern of neuronal death generated in this model remains unclear, involving both cortical and subcortical brain regions. Here, 7 days after moderate (3 atmospheres absolute [ATA]) or severe (3.8 ATA) LFP, we estimated neuronal loss by using immunohistochemistry together with a computer-assisted automated method for quantifying neuronal density in brain sections. Neuronal counts were performed ipsilateral to the impact, in the parietal cortex ventral to the site of percussion, in the temporal cortex, in the dorsal thalamus, and in the hippocampus. These results were compared with the counts observed at similar areas in sham animals. We found that neuronal density was severely decreased in the temporal cortex (60%), in the dorsal thalamus (-63%), and in area CA3 of the hippocampus (-36%) of injured animals compared with controls but was not significantly modified in the cortices located immediately ventral to the impact. Total cellular density increased in brain structures displaying neuronal death, suggesting the presence of gliosis. The increase in the severity of LFP did not change the pattern of neuronal injury. This automated method simplified the study of neuronal loss following traumatic brain injury and allowed the identification of a pattern of neuronal loss that spreads from the dorsal thalamus to the temporal cortex, with the most severe lesions being in brain structures remote from the site of impact. (C) 2015 Wiley Periodicals, Inc.	[Balanc, Baptiste; Guy, Rainui; Marinesco, Stephane] Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, Team WAKING, F-69373 Lyon 08, France; [Balanc, Baptiste; Bapteste, Lionel] Hosp Civils Lyon, P Wertheimer Neurol Hosp, Dept Anesthesiol & Intens Care, Lyon, France; [Balanc, Baptiste; Bapteste, Lionel; Lieutaud, Thomas; Ressnikoff, Denis; Guy, Rainui; Bezin, Laurent; Marinesco, Stephane] Univ Lyon 1, F-69365 Lyon, France; [Lieutaud, Thomas; Bezin, Laurent] Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, Team TIGER, F-69373 Lyon 08, France; [Ressnikoff, Denis] Ctr Imagerie Quantitat Lyon Est, Lyon, France; [Marinesco, Stephane] Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, AniRA Neurochem Technol Platform, F-69373 Lyon 08, France		Marinesco, S (corresponding author), Lyon Neurosci Res Ctr, Team WAKING, 8 Ave Rockefeller, F-69373 Lyon 08, France.	stephane.marinesco@univ-lyon1.fr	Marinesco, Stephane/M-6694-2017; balanca, baptiste/W-2261-2018; balanca, baptiste/ABG-2847-2020	Marinesco, Stephane/0000-0003-2712-6263; balanca, baptiste/0000-0001-7917-9645; balanca, baptiste/0000-0001-7917-9645	Lyon Neuroscience Research Center; Fondation Les Gueules Cassees [FGC-11-2013]; Ecole de l'Inserm Liliane Bettencour; HCL;  [INSERM U1028];  [CNRS UMR 5292]	Contract grant sponsor: Lyon Neuroscience Research Center; Contract grant sponsor: INSERM U1028; Contract grant sponsor: CNRS UMR 5292; Contract grant sponsor: Fondation Les Gueules Cassees; Contract grant number: FGC-11-2013; Contract grant sponsor: Ecole de l'Inserm Liliane Bettencour (to B.B.); Contract grant sponsor: HCL (to L.Ba. and B.B.).	Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; Enomoto T, 2005, J NEUROTRAUM, V22, P783, DOI 10.1089/neu.2005.22.783; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Maxeiner S, 2014, HISTOCHEM CELL BIOL, V141, P43, DOI 10.1007/s00418-013-1159-9; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Woeffler-Maucler C, 2014, J NEUROSCI METH, V225, P32, DOI 10.1016/j.jneumeth.2014.01.009; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	32	7	7	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2016	94	1					39	49		10.1002/jnr.23676			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU7VH	WOS:000363749400004	26451689				2022-02-06	
J	Biester, RC; Krych, D; Schmidt, MJ; Parrott, D; Katz, DI; Abate, M; Hirshson, CI				Biester, Rosette C.; Krych, Dave; Schmidt, M. J.; Parrott, Devan; Katz, Douglas I.; Abate, Melissa; Hirshson, Chari I.			Individuals With Traumatic Brain Injury and Their Significant Others' Perceptions of Information Given About the Nature and Possible Consequences of Brain Injury Analysis of a National Survey	PROFESSIONAL CASE MANAGEMENT			English	Article						family education; knowledge translation; patient education; prognosis; satisfaction; traumatic brain injury	FAMILY NEEDS; PSYCHOLOGICAL DISTRESS; CARE; CHILDREN; REHABILITATION; SATISFACTION; CAREGIVERS; OUTCOMES	Purpose of the Study: An online survey was developed to assess how well individuals with brain injuries and family/friends of those with traumatic brain injury (TBI) (significant others) felt they were informed about the nature and consequences of brain injury. Participants: A total of 117 significant others completed the survey. They were primarily female (84.6%), white (94.9%), and well educated (81.2%). A total of 149 individuals with brain injuries completed the survey and again were primarily female (63.8%), white (88.2%), and well educated (82.9%). Results: More than half of the significant other respondents indicated that they were not provided enough information about TBI (53.5%). Up to 53.8% of the respondents with TBI felt that they were not provided enough information, with 43% reporting dissatisfaction with services. Female survivors and those with mild brain injuries were significantly more likely to feel that they were not provided sufficient rehabilitation or information. Increased satisfaction with services was correlated with decreased time since injury (r = - 0.165, p =.049). Qualitative analysis revealed key themes about prognostic information and the adequacy of discharge planning and resources. Implications for Case Management Practice: Given that more than half of all surveyed indicated that they were not well-informed about brain injury and its possible effects, it is evident that case managers and their teams need to be aware of and invested in their efforts to educate both individuals with brain injuries and their significant others (family and friends) about both the nature and consequences of brain injury. Specific recommendations for practice are included.	[Biester, Rosette C.] Univ Penn, Sch Med, Phys Med & Rehabil, Philadelphia, PA 19104 USA; [Biester, Rosette C.] Michael Crescentz Vet Affairs Med Ctr, Philadelphia, PA USA; [Krych, Dave] ReMed Recovery Care Ctr, Paoli, PA USA; [Parrott, Devan] Rehabil Hosp Indiana, Indianapolis, IN USA; [Parrott, Devan] Indiana Univ Purdue Univ, Math Dept, Indianapolis, IN 46202 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Neurol, Boston, MA 02215 USA; [Katz, Douglas I.] Boston Med Ctr, Boston, MA USA; [Katz, Douglas I.] Braintree Rehabil Hosp Massachusetts, Brain Injury Program, Braintree, MA USA; [Katz, Douglas I.] Amer Congress Rehabil Med, Reston, VA USA; [Abate, Melissa] Mt Sinai Med Ctr, New York, NY 10029 USA; [Abate, Melissa] Brain Injury Alliance Colorados Publ Policy Colla, Denver, CO USA; [Abate, Melissa] Colorado Hlth Care Policy & Finance, Denver, CO USA; [Hirshson, Chari I.] Mt Sinai Sch Med, New York, NY USA		Schmidt, MJ (corresponding author), ReMed, 16 Ind Blvd,Ste 203, Paoli, PA 19301 USA.	mschmidt@remed.com					Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Breed S, 2008, J HEAD TRAUMA REHAB, V23, P149, DOI 10.1097/01.HTR.0000319931.76966.ff; Coco K., 2013, J NURSING ED PRACTIC, V3, P112; deWit S., 2012, J PERINATOLOGY, V3, P1; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Engli M, 1993, J Neurosci Nurs, V25, P78; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Guerin M. R., 2012, J NURSING ED PRACTIC, V2, P1, DOI DOI 10.5430/JNEP.V2N3P1; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hermans E, 2012, NEUROREHABILITATION, V30, P213, DOI 10.3233/NRE-2012-0747; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Larson CO, 1996, INT J QUAL HEALTH C, V8, P447, DOI 10.1093/intqhc/8.5.447; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lezak M. D., 1986, REHABIL PSYCHOL, V31, P257; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mayring P., 2000, FORUM QUALITATIVE SO, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-1.2.1089]; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; Meade MA, 2004, REHABIL PSYCHOL, V49, P150, DOI 10.1037/0090-5550.49.2.150; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MERRITT KL, 1990, PSYCHOL REP, V67, P129, DOI 10.2466/PR0.67.5.129-130; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; Weiser EB, 2000, CYBERPSYCHOL BEHAV, V3, P167, DOI 10.1089/109493100316012; Wijdicks EFM, 2007, NEUROLOGY, V68, P1092, DOI 10.1212/01.wnl.0000259401.36220.1a; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Zhang Y., 2009, P308, DOI DOI 10.1002/HBM.20661; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008	37	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1932-8087	1932-8095		PROF CASE MANAG	Prof. Case Manag.	JAN-FEB	2016	21	1					22	33		10.1097/NCM.0000000000000121			12	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	EW6PM	WOS:000402632700003	26618266				2022-02-06	
J	Bratu, LM; Rogobete, AF; Papurica, M; Sandesc, D; Cradigati, CA; Sarandan, M; Dumache, R; Popovici, SE; Crisan, DC; Stanca, H; Tanasescu, S; Bedreag, OH				Bratu, Lavinia M.; Rogobete, Alexandru F.; Papurica, Marius; Sandesc, Dorel; Cradigati, Carmen A.; Sarandan, Mirela; Dumache, Raluca; Popovici, Sonia E.; Crisan, Dan C.; Stanca, Horia; Tanasescu, Sonia; Bedreag, Ovidiu H.			Literature Research Regarding miRNAs' Expression in the Assessment and Evaluation of the Critically Ill Polytrauma Patient with Traumatic Brain and Spinal Cord Injury	CLINICAL LABORATORY			English	Article						miRNAs; biomarkers; traumatic brain injury; spinal cord injury; polytrauma	OXIDATIVE STRESS; MICRORNAS; BIOMARKERS; MICROGLIA	Background: One of the most severe conditions specific to the critically ill polytrauma patient is traumatic brain injury and traumatic spinal cord injury. The mortality rate is high in the case of these patients, both because of the direct traumatic lesions, and because of the pathophysiological imbalances associated with trauma. Amongst the most common pathologies associated with the critically ill polytrauma patients responsible for a lower survival rate, are redox imbalance, systemic inflammatory response, infections, and multiple organ dysfunction syndrome. Methods: For this study, was analysed the literature available on PubMed. The key words used in the search were "traumatic brain injury", "spinal cord injury", "microRNAs expression", "polytrauma patients", and "biomarkers". Results: For the study were selected 34 science articles. The oxidative attack on lipids is responsible for the biosynthesis of an increased quantity of free radicals, which further intensifies and aggravates the redox status in these patients. Conclusions: A new era for biomarkers is represented by the expression of miRNAs. In the case of the critically ill polytrauma patient, using miRNAs' expression as biomarkers for the evaluation and monitoring of the molecular and pathophysiological dysfunctions can bring a range of valuable answers that could contribute to an increased survival rate.	[Bratu, Lavinia M.] Victor Babes Univ Med & Pharm, Fac Pharm, Timisoara, Romania; [Rogobete, Alexandru F.; Papurica, Marius; Sandesc, Dorel; Popovici, Sonia E.; Crisan, Dan C.; Tanasescu, Sonia; Bedreag, Ovidiu H.] Victor Babes Univ Med & Pharm, Fac Med, Timisoara, Romania; [Rogobete, Alexandru F.; Papurica, Marius; Sandesc, Dorel; Bedreag, Ovidiu H.] Emergency Cty Hosp Pius Brinzeu, Clin Anesthesia & Intens Care, Bd Iosif Bulbuca 10, Timisoara 300736, Romania; [Cradigati, Carmen A.; Sarandan, Mirela; Dumache, Raluca] Emergency Cty Hosp Pius Brinzeu, Clin Anesthesia & Intens Care Casa Austria, Timisoara, Romania; [Stanca, Horia] Carol Davila Univ Med & Pharm, Fac Med, Bucharest, Romania		Rogobete, AF (corresponding author), Emergency Cty Hosp Pius Brinzeu, Clin Anesthesia & Intens Care, Bd Iosif Bulbuca 10, Timisoara 300736, Romania.	alexandru.rogobete@umft.ro	Tanasescu, Sonia/AAP-9971-2021; Balica, Nicolae/Y-8102-2019; Stanca, Horia T/H-2744-2014; Rogobete, Alexandru Florin/F-4334-2014; Dumache, Raluca/N-5615-2015	Balica, Nicolae/0000-0001-7755-4608; Stanca, Horia T/0000-0003-2595-6319; Rogobete, Alexandru Florin/0000-0003-1286-4431; Dumache, Raluca/0000-0003-1790-8130; Bratu, Tiberiu/0000-0002-2844-6771; Popovici, Sonia Elena/0000-0001-5195-3993	"Aurel Mogosanu" Association for Intensive Therapy and Anaesthesia; "Pius Brinzeu" Emergency County Hospital Timisoara	The authors thank Mr. Mihai Alexandru Chira for his support. This article was published with the support of the "Aurel Mogosanu" Association for Intensive Therapy and Anaesthesia and the "Pius Brinzeu" Emergency County Hospital Timisoara.	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/782424; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Badescu A, 2014, REV ROMANA MED LAB, V22, P209, DOI 10.2478/rrlm-2014-0025; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Burkhardt M, 2012, CRIT CARE, V16, DOI 10.1186/cc11487; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Ciriello V, 2013, INJURY, V44, P1680, DOI 10.1016/j.injury.2013.09.024; Croitoru MD, 2015, REV ROMANA MED LAB, V23, P127, DOI 10.1515/rrlm-2015-0001; Dumache R, 2015, ANAL CELL PATHOL, V2015, P1, DOI 10.1155/2015/186716; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hu JZ, 2015, BRAIN RES, V1608, P191, DOI 10.1016/j.brainres.2015.02.036; Jiang SC, 2008, PURINERG SIGNAL, V4, P61, DOI 10.1007/s11302-007-9093-8; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Lu Q, 2016, CLIN LAB, V62, P73, DOI 10.7754/Clin.Lab.2015.150524; Magenta A, 2013, INT J MOL SCI, V14, P17319, DOI 10.3390/ijms140917319; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; Nian X, 2016, CLIN LAB, V62, P781, DOI 10.7754/Clin.Lab.2015.150729; Psarros C, 2015, J CRIT CARE MED, V1, P43, DOI 10.1515/jccm-2015-0007; Puskarichl MA, 2015, J ACUTE DIS, V4, P101, DOI 10.1016/S2221-6189(15)30017-2; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Tarassishin L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-187; Tranca Sebastian Daniel, 2014, Rom J Anaesth Intensive Care, V21, P118; von Brandenstein M, 2012, LIFE SCI, V91, P475, DOI 10.1016/j.lfs.2012.06.025; Xu SJ, 2012, INT J MOL SCI, V13, P16945, DOI 10.3390/ijms131216945; Zhang L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-211; Zhang R., 2016, CLIN LAB, P1	34	7	8	0	12	CLIN LAB PUBL	HEIDELBERG	IM BREITSPIEL 15, HEIDELBERG, D-69126, GERMANY	1433-6510			CLIN LAB	Clin. Lab.		2016	62	10					2019	2024		10.7754/Clin.Lab.2016.160327			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	DY7UZ	WOS:000385336100023	28164531				2022-02-06	
J	Corporaal, SHA; Swinnen, SP; Duysens, J; Bruijn, SM				Corporaal, Sharissa H. A.; Swinnen, Stephan P.; Duysens, Jacques; Bruijn, Sjoerd M.			Slow maturation of planning in obstacle avoidance in humans	JOURNAL OF NEUROPHYSIOLOGY			English	Article						children; development; obstacle avoidance; locomotion; limb control	TRAUMATIC BRAIN-INJURY; TYPICALLY-DEVELOPED CONTROLS; VISUALLY GUIDED LOCOMOTION; AGE-RELATED-CHANGES; FOOT PLACEMENT; MOTOR IMAGERY; ACUITY TEST; GAIT; CHILDREN; STRATEGIES	Complex gait (e.g., obstacle avoidance) requires a higher cognitive load than simple steady-state gait, which is a more automated movement. The higher levels of the central nervous system, responsible for adjusting motor plans to complex gait, develop throughout childhood into adulthood. Therefore, we hypothesize that gait strategies in complex gait are likely to mature until adulthood as well. However, little is known about the maturation of complex gait from childhood into adolescence and adulthood. To address this issue, we investigated obstacle avoidance in forty-four 8- to 18-yr-old participants who walked at preferred speed along a 6-m walkway on which a planar obstacle (150% of step length, 1 m wide) was projected. Participants avoided the obstacle by stepping over this projection, while lower body kinematics were recorded. Results showed that step length and speed adjustments during successful obstacle avoidance were similar across all ages, even though younger children modified step width to a greater extent. Additionally, the younger children used larger maximal toe elevations and take-off distances than older children. Moreover, during unsuccessful trials, younger children deployed exaggerated take-off distances, which resulted in obstacle contact upon the consecutive heel strike. These results indicate that obstacle avoidance is not fully matured in younger children, and that the inability to plan precise foot placements is an important factor contributing to failures in obstacle avoidance.	[Corporaal, Sharissa H. A.; Swinnen, Stephan P.; Duysens, Jacques; Bruijn, Sjoerd M.] Katholieke Univ Leuven, Dept Kinesiol, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Duysens, Jacques] Univ Sao Paulo, Escola Politecn, Mechatron Dept, Biomechatron Lab, Sao Paulo, Brazil; [Bruijn, Sjoerd M.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Bruijn, Sjoerd M.] Fujian Med Univ, Dept Orthoped Surg, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China		Swinnen, SP (corresponding author), Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Dept Kinesiol, Tervuursevest 101,Box 1501, B-3001 Leuven, Belgium.	stephan.swinnen@faber.kuleuven.be	Bruijn, Sjoerd/H-9021-2013	Bruijn, Sjoerd/0000-0003-0290-2131; Duysens, Jacques/0000-0002-0043-8817	KU Leuven Research Fund Grant [OT/11/071]; Flanders Fund for Scientific Research (FWO) Grants [G.A114.11, G0721.12, G0708.14]; Interuniversity Attraction Poles Program - Belgian Science Policy Office [P7/11]; National Council for Scientific and Technological Development visiting professorship; Research Foundation-Flanders (FWO)FWO; VENI grant (NWO) from the Netherlands Organization for Scientific Research (NWO) [451-12-041]	This work was supported by KU Leuven Research Fund Grant (OT/11/071), Flanders Fund for Scientific Research (FWO) Grants (G.A114.11, G0721.12, G0708.14), and the Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office (P7/11), awarded to S. P. Swinnen. Furthermore, J. Duysens is the recipient of a National Council for Scientific and Technological Development visiting professorship, and S.H.A. Corporaal is supported by an aspirant fellowship of the Research Foundation-Flanders (FWO). S. M. Bruijn is supported by a VENI grant (NWO no. 451-12-041) from the Netherlands Organization for Scientific Research (NWO).	Armstrong DM, 1996, CAN J PHYSIOL PHARM, V74, P443, DOI 10.1139/cjpp-74-4-443; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P1; Berard JR, 2006, EXP BRAIN RES, V175, P21, DOI 10.1007/s00221-006-0529-0; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; CHEN HC, 1991, J GERONTOL, V46, pM196, DOI 10.1093/geronj/46.6.M196; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chou LS, 1998, J BIOMECH, V31, P685, DOI 10.1016/S0021-9290(98)00081-5; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Dusing SC, 2007, GAIT POSTURE, V25, P135, DOI 10.1016/j.gaitpost.2006.06.003; Friel KM, 2007, J NEUROPHYSIOL, V97, P3396, DOI 10.1152/jn.00750.2006; Froehle AW, 2013, GAIT POSTURE, V38, P14, DOI 10.1016/j.gaitpost.2012.10.005; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Heijnen MJH, 2012, EXP BRAIN RES, V223, P219, DOI 10.1007/s00221-012-3253-y; Herting MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119774; Hof A.L., 1996, GAIT POSTURE, V4, P222; Katz-Leurer M, 2011, NEUROREHABILITATION, V29, P45, DOI 10.3233/NRE-2011-0676; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; Lajoie K, 2007, J NEUROPHYSIOL, V97, P2339, DOI 10.1152/jn.01196.2006; LEE DN, 1982, J EXP PSYCHOL HUMAN, V8, P448; Lowrey CR, 2007, EXP BRAIN RES, V182, P289, DOI 10.1007/s00221-007-0986-0; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; McFadyen BJ, 2001, GAIT POSTURE, V13, P7, DOI 10.1016/S0966-6362(00)00090-4; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Michel J, 2010, GAIT POSTURE, V31, P341, DOI 10.1016/j.gaitpost.2009.12.001; Moosabhoy MA, 2006, GAIT POSTURE, V24, P493, DOI 10.1016/j.gaitpost.2005.12.004; Moraes R, 2006, EXP BRAIN RES, V171, P497, DOI 10.1007/s00221-005-0297-2; Nordin E, 2010, GAIT POSTURE, V32, P92, DOI 10.1016/j.gaitpost.2010.03.012; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; Pijnappels M, 2001, GAIT POSTURE, V14, P11, DOI 10.1016/S0966-6362(01)00110-2; Pryde KM, 1997, HUM MOVEMENT SCI, V16, P507, DOI 10.1016/S0167-9457(96)00064-4; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Raznahan A, 2014, P NATL ACAD SCI USA, V111, P1592, DOI 10.1073/pnas.1316911111; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Sheehan RC, 2014, J BIOMECH, V47, P2611, DOI 10.1016/j.jbiomech.2014.05.022; Smid KA, 2013, GAIT POSTURE, V38, P242, DOI 10.1016/j.gaitpost.2012.11.019; Vallis LA, 2005, EXP BRAIN RES, V167, P119, DOI 10.1007/s00221-005-0054-6; van Roon D, 2008, CHILD DEV, V79, P852, DOI 10.1111/j.1467-8624.2008.01163.x; Vaughan CL, 2003, EXP BRAIN RES, V153, P123, DOI 10.1007/s00221-003-1635-x; Weerdesteyn V, 2008, HUM MOVEMENT SCI, V27, P738, DOI 10.1016/j.humov.2008.03.003	43	7	7	3	15	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JAN 1	2016	115	1					404	412		10.1152/jn.00701.2015			9	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Physiology	DC2QR	WOS:000369061900034	26561604	Green Published, Bronze			2022-02-06	
J	Davenport, ND; Lamberty, GJ; Nelson, NW; Lim, KO; Armstrong, MT; Sponheim, SR				Davenport, Nicholas D.; Lamberty, Greg J.; Nelson, Nathaniel W.; Lim, Kelvin O.; Armstrong, Michael T.; Sponheim, Scott R.			PTSD confounds detection of compromised cerebral white matter integrity in military veterans reporting a history of mild traumatic brain injury	BRAIN INJURY			English	Article						PTSD; mTBI; white matter; concussion; military; DTI	POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL CONNECTIVITY; ENDURING FREEDOM; BLAST EXPOSURE; MENTAL-HEALTH; DIFFUSION; ABNORMALITIES; SYMPTOMS; CONCUSSION; TIME	Primary objective: Based on high comorbidity between mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) among deployed military service members, this study tested the hypothesis that the presence of PTSD disrupts the association between mTBI and lower white matter integrity identified in non-military samples.Research design/Methods and procedures: In a sample of 124 recent veterans with a range of mTBI and PTSD history, diffusion tensor imaging (DTI) metrics of white matter integrity in 20 regions were compared using multiple mTBI and PTSD contrasts.Main outcomes and results: Civilian mTBI was associated with lower global anisotropy, higher global diffusivity and higher diffusivity in 17 of 20 regions. No main effects of deployment mTBI were observed, but an interaction between deployment mTBI and lifetime PTSD on FA was observed globally and in 10 regions. Impact and blast mTBI demonstrated similar but weaker effects to those of civilian and deployment mTBI, respectively, demonstrating the context of mTBI is more relevant to white matter integrity than mechanism of injury.Conclusions: Overall, a main effect of civilian mTBI indicates long-term disruptions to white matter are likely present, while the interaction between deployment mTBI and PTSD indicates that a history of PTSD alters this relationship.	[Davenport, Nicholas D.; Lamberty, Greg J.; Nelson, Nathaniel W.; Lim, Kelvin O.; Armstrong, Michael T.; Sponheim, Scott R.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Davenport, Nicholas D.; Lim, Kelvin O.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, Minneapolis, MN USA; [Lim, Kelvin O.; Sponheim, Scott R.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA		Davenport, ND (corresponding author), VA Med Ctr B68 2, 1 Vet Dr, Minneapolis, MN 55417 USA.	nicholas.davenport@va.gov	Davenport, Nicholas/AAY-8057-2020; Sponheim, Scott/J-3857-2017; Lim, Kelvin/AAF-6833-2020	Davenport, Nicholas/0000-0002-3441-7256; Sponheim, Scott/0000-0002-2782-0856; Lim, Kelvin/0000-0002-2390-7268	VA Rehabilitation R&D Merit Review Award [I01RX000622]; VA Rehabilitation R&D Career Development Award [IK2RX000709]; Chronic Effects of Neurotrauma Consortium Award [I01RX002171]; Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095]; Veterans AffairsUS Department of Veterans Affairs [I01RX000622] Funding Source: NIH RePORTER	This research was supported by a VA Rehabilitation R&D Merit Review Award (I01RX000622) to Dr. Sponheim, a VA Rehabilitation R&D Career Development Award (IK2RX000709) to Dr. Davenport and a Chronic Effects of Neurotrauma Consortium Award to Dr. Davenport funded by VA Rehabilitation R&D (I01RX002171) and the Department of Defense (W81XWH-13-2-0095).	Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Assemlal H-E, 2007, 2007 IEEE INT C IM P, V3; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Cohen J., 2013, STAT POWER ANAL BEHA; Davenport ND, 2015, BRAIN IMAGING BEHAV, V9, P472, DOI 10.1007/s11682-015-9371-y; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; David AC, 2010, J TRAUMA STRESS, V23, P599, DOI 10.1002/jts.20566; Engelhard IM, 2008, MEMORY, V16, P3, DOI 10.1080/09658210701334022; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Miles J., 2001, APPL REGRESSION CORR; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, NEW ENGL J MED, V353, P633; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784	65	7	7	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1491	1500		10.1080/02699052.2016.1219057			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100011	27834537				2022-02-06	
J	Finch, E; French, A; Ou, RJ; Fleming, J				Finch, Emma; French, Anna; Ou, Rachel J.; Fleming, Jennifer			Participation in communication activities following traumatic brain injury: A time use diary study	BRAIN INJURY			English	Article						Traumatic brain injury; participation; communication activities; time-use diary	QUALITY-OF-LIFE; SOCIAL INTEGRATION; HEAD-INJURY; RETURN; WORK; REHABILITATION; INDIVIDUALS; CONVERSATION; ADOLESCENTS; IMPAIRMENT	Background: Communication impairments following traumatic brain injury (TBI) can represent a significant barrier to successful community reintegration. Previous research has typically focused on linguistic competence to identify communication difficulties experienced by people with TBI living in the community, rather than participation in everyday communication activities. Objective: To describe communication activities and communication partners of people with traumatic brain injury (TBI) over a 24-hour period compared to matched controls. Research design: A cross-sectional study using a customized, mixed-methods survey with time-use data collected from people with TBI and a demographically matched control group. Methods: Twenty people with TBI living within the community and 20 matched non-injured controls were interviewed about their involvement in communication activities over the previous 24 hours using a time-use diary. Activities were compared between the groups using Mann-Whitney U-tests and Chi-squared tests. Results: The TBI group spent significantly less time engaged in communication activities and less time engaged in conversation and reported significantly fewer numbers of communication partners compared to the control group. Conclusion The results highlight discrepancies in participation in communication activities between people with TBI and people without TBI, suggesting the need for intervention studies to enhance communication participation in daily life following TBI.	[Finch, Emma; French, Anna; Ou, Rachel J.; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; [Finch, Emma] Princess Alexandra Hosp, Speech Pathol Dept, Woolloongabba, Qld 4102, Australia; [Finch, Emma; Fleming, Jennifer] Metro South Hosp, Ctr Functioning & Hlth Res, Eight Mile Plains, Qld, Australia; [Finch, Emma; Fleming, Jennifer] Queensland Hlth, Hlth Serv, Eight Mile Plains, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld 4102, Australia		Finch, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	e.finch@uq.edu.au	Fleming, Jennifer/AAH-5108-2020; Finch, Emma/B-3067-2011	Finch, Emma/0000-0002-9690-8165			Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Aubert S., 2004, Annales de Readaptation et de Medecine Physique, V47, P135, DOI 10.1016/j.annrmp.2004.02.001; Bird J, 2014, NEUROREHABILITATION, V34, P39, DOI 10.3233/NRE-131006; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Coronado V. G., 2013, TRAUMATIC BRAIN INJU; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Dombovy Mary L, 2011, Continuum (Minneap Minn), V17, P584, DOI 10.1212/01.CON.0000399074.07686.76; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Erlandsson L.-K., 2001, SCAND J OCCUP THER, V8, P31, DOI [DOI 10.1080/11038120120035, 10.1080/110381201300078483]; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Johnson K, 1998, BEHAV MODIF, V22, P502, DOI 10.1177/01454455980224004; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Krupa T, 2003, AM J OCCUP THER, V57, P558, DOI 10.5014/ajot.57.5.558; Leufstadius Christel, 2006, Occup Ther Int, V13, P123, DOI 10.1002/oti.207; Levine JM, 2010, PSYCHIAT CLIN N AM, V33, P877, DOI 10.1016/j.psc.2010.09.001; Lew HL, 2012, J REHABIL RES DEV, V49, pVII, DOI 10.1682/JRRD.2012.07.0126; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; Nichols JL, 2014, J REHABIL, V80, P21; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Sacco K, 2008, J COGN SCI, V9, P111; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; SAMOVAR LA, 1969, J COMMUN, V19, P301, DOI 10.1111/j.1460-2466.1969.tb00852.x; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sommer JB, 2013, J REHABIL MED, V45, P778, DOI 10.2340/16501977-1208; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Valente SM, 2011, JNP-J NURSE PRACT, V7, P863, DOI DOI 10.1016/J.NURPRA.2011.09.016; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; WHO, 2001, INT CLASS FUNCT DIS; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303	41	7	7	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					883	890		10.3109/02699052.2016.1146959			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400007	27029816				2022-02-06	
J	Hellstrom, T; Westlye, LT; Server, A; Lovstad, M; Brunborg, C; Lund, MJ; Nordhoy, W; Andreassen, OA; Andelic, N				Hellstrom, T.; Westlye, L. T.; Server, A.; Lovstad, M.; Brunborg, C.; Lund, M. J.; Nordhoy, W.; Andreassen, O. A.; Andelic, N.			Volumetric and morphometric MRI findings in patients with mild traumatic brain injury	BRAIN INJURY			English	Article						Mild brain injury; concussion; radiology; neuroimaging; intracranial injury; cortical thickness	MAJOR DEPRESSIVE DISORDER; HUMAN CEREBRAL-CORTEX; MINOR HEAD-INJURY; RISK-FACTORS; MODERATE; ATROPHY; SYMPTOMS; NEUROPATHOLOGY; PERFORMANCE; TASK	Objective: This study compared cortical and sub-cortical volumes between patients with complicated (i.e. presence of intracranial abnormality on the day-of-injury CT) and uncomplicated (i.e. absence of intracranial abnormality) mild traumatic brain injury (MTBI) 4 weeks post-injury. The study hypothesized regionally decreased brain volumes and reduced cortical thickness in patients with complicated MTBIs compared with uncomplicated MTBI. Methods: This study was part of a larger 2 years cohort study on MTBI. Baseline clinical and magnetic resonance imaging (MRI) data were compared for those with complicated and uncomplicated MTBI. It identified 168 patients with MTBI (90 uncomplicated and 78 complicated), aged 16-65 years. 3T MRI-system (Signa HDxt, GE Medical Systems, Milwaukee, WI) and cortical reconstruction and volumetric segmentation by FreeSurfer software have been used. Results: No significant differences between uncomplicated and complicated MTBIs were found in neuroanatomic volumes and cortical thickness after controlling for age, gender and education. The complicated MTBI group showed larger ventricles compared with the uncomplicated group, but this effect diluted when adjusting for potential confounders. Conclusion: The study findings suggest that the classification of complicated and uncomplicated MTBI may be too broad to differentiate volumetric and morphometric effects of injury in the early post-injury phase.	[Hellstrom, T.; Andelic, N.] Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950, N-0407 Oslo, Norway; [Westlye, L. T.; Lund, M. J.; Andreassen, O. A.] Oslo Univ Hosp, Norwegian Ctr Mental Disorder Res NORMENT, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Westlye, L. T.; Lovstad, M.] Univ Oslo, Dept Psychol, Oslo, Norway; [Server, A.] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Lovstad, M.] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Brunborg, C.] Oslo Univ Hosp, Res Support Serv, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Nordhoy, W.] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Andelic, N.] Univ Oslo, Inst Hlth & Soc, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Oslo, Norway		Hellstrom, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950, N-0407 Oslo, Norway.	torgeir.hellstrom@ous-hf.no	Hellstrom, Torgeir/AAY-6043-2021; Hellstrom, Torgeir/AAW-4301-2021	Hellstrom, Torgeir/0000-0003-0831-3274; Westlye, Lars T./0000-0001-8644-956X; Andelic, Nada/0000-0002-3719-4406	Department of Physical Medicine and Rehabilitation, Oslo University Hospital	The authors thank all of the patients who took time to participate in the study. We also thank radiograph Anne-Hilde Farstad for practical MRI assistance and the Department of Physical Medicine and Rehabilitation, Oslo University Hospital for institutional and financial support.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2000, BRAIN INJURY, V14, P1057; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kronenberg G, 2009, J PSYCHIATR RES, V43, P1112, DOI 10.1016/j.jpsychires.2009.03.007; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mak AKY, 2009, PROG NEURO-PSYCHOPH, V33, P1184, DOI 10.1016/j.pnpbp.2009.06.025; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rando K, 2011, AM J PSYCHIAT, V168, P183, DOI 10.1176/appi.ajp.2010.10020233; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tellier A, 1999, BRAIN INJURY, V13, P463; Theberge Jean, 2008, Top Magn Reson Imaging, V19, P111, DOI 10.1097/RMR.0b013e3181808140; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	69	7	7	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1683	1691		10.1080/02699052.2016.1199905			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800023	27996331				2022-02-06	
S	Jaber, Z; Aouad, P; Al Medawar, M; Bahmad, H; Abou-Abbass, H; Kobeissy, F		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Jaber, Zaynab; Aouad, Patrick; Al Medawar, Mohamad; Bahmad, Hisham; Abou-Abbass, Hussein; Kobeissy, Firas			Application of Systems Biology to Neuroproteomics: The Path to Enhanced Theranostics in Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Systems biology; Functional group categorization; Pathway analysis; Neurotrauma; Protein-protein interaction network; TBI	UNITED-STATES; NETWORK; DISCOVERY; BIOINFORMATICS; REPRESENTATION; EPIDEMIOLOGY; BIOMARKERS; MODELS	The application of systems biology tools in analyzing heterogeneous data from multiple sources has become a necessity, especially in biomarker discovery. Such tools were developed with several approaches to address different types of research questions and hypotheses. In the field of neurotrauma and traumatic brain injury (TBI), three distinct approaches have been used so far as systems biology tools, namely functional group categorization, pathway analysis, and protein-protein interaction (PPI) networks. The databases allow for query of the system to identify candidate targets which can be further studied to elucidate potential downstream biomarkers indicative of disease progression, severity, and improvement. The various systems biology tools, databases, and strategies that can be implemented on available TBI data in neuroproteomic studies are discussed in this chapter.	[Jaber, Zaynab] CUNY, Grad Sch, Dept Biochem, New York, NY 10021 USA; [Jaber, Zaynab] CUNY, Univ Ctr, New York, NY 10021 USA; [Jaber, Zaynab; Abou-Abbass, Hussein; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Aouad, Patrick] Amer Univ Beirut, Dept Biol, Fac Arts & Sci, Beirut, Lebanon; [Al Medawar, Mohamad] Tech Univ Dresden, Div Vasc Endothelium & Microcirculat, Dept Med 3, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Bahmad, Hisham] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Bahmad, Hisham; Abou-Abbass, Hussein] Beirut Arab Univ, Fac Med, Beirut, Lebanon; [Kobeissy, Firas] Banyan Biomarkers Inc, Alachua, FL USA; [Kobeissy, Firas] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA		Jaber, Z (corresponding author), CUNY, Grad Sch, Dept Biochem, New York, NY 10021 USA.; Jaber, Z (corresponding author), CUNY, Univ Ctr, New York, NY 10021 USA.; Jaber, Z (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon.		Kobeissy, Firas/E-7042-2017; Almedawar, Mohamad Musbah/O-7910-2019; Bahmad, Hisham/A-5369-2019; Almedawar, Mohamad/AAN-1482-2021	Kobeissy, Firas/0000-0002-5008-6944; Almedawar, Mohamad Musbah/0000-0002-3595-4715; Bahmad, Hisham/0000-0003-3799-2595; 			Ali A, 2014, BIOMARKERS BRAIN INJ, P3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assmus HE, 2006, EXPERT REV MOL DIAGN, V6, P891, DOI 10.1586/14737159.6.6.891; Bard J, 2007, MAMM GENOME, V18, P402, DOI 10.1007/s00335-007-9027-3; Barrett CL, 2006, CURR OPIN BIOTECH, V17, P488, DOI 10.1016/j.copbio.2006.08.001; Baumgartner Christian, 2011, J Clin Bioinforma, V1, P2, DOI 10.1186/2043-9113-1-2; Beltrao P, 2007, CURR OPIN STRUC BIOL, V17, P378, DOI 10.1016/j.sbi.2007.05.005; Boettler T, 2007, DEUT MED WOCHENSCHR, V132, P2702, DOI 10.1055/s-2007-993122; Boutte A, 2015, BIOMARKERS OF BRAIN INJURY AND NEUROLOGICAL DISORDERS, P42; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Chen SS, 2007, SPRINGER SER OPTIM A, V7, P363; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Croft David, 2013, Methods Mol Biol, V1021, P273, DOI 10.1007/978-1-62703-450-0_14; D'Eustachio P, 2013, CHEM BIOL, V20, P629, DOI 10.1016/j.chembiol.2013.03.018; Davidov EJ, 2003, DRUG DISCOV TODAY, V8, P175, DOI 10.1016/S1359-6446(03)02600-X; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Fang ZY, 2012, CELL RES, V22, P565, DOI 10.1038/cr.2011.149; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guo Z, 2007, BIOINFORMATICS, V23, P2121, DOI 10.1093/bioinformatics/btm294; Haynes WA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002967; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Judeh T, 2013, NUCLEIC ACIDS RES, V41, P1425, DOI 10.1093/nar/gks1299; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mieczkowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041541; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI [10.1093/nar/gkt263, 10.1093/nar/gkt1223]; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Sohler F, 2004, BIOINFORMATICS, V20, P1517, DOI 10.1093/bioinformatics/bth112; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yu C, 2015, BRAIN NEUROTRAUMA MO; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	50	7	7	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						139	155		10.1007/978-1-4939-3816-2_9	10.1007/978-1-4939-3816-2		17	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500011	27604717				2022-02-06	
S	Jaber, Z; Aouad, P; Al Medawar, M; Bahmad, H; Abou-Abbass, H; Ghandour, H; Mondello, S; Kobeissy, F		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Jaber, Zaynab; Aouad, Patrick; Al Medawar, Mohamad; Bahmad, Hisham; Abou-Abbass, Hussein; Ghandour, Hiba; Mondello, Stefania; Kobeissy, Firas			Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Neurotrauma; Traumatic brain injury TBI; Biomarkers; Systems biology tools; UCHL1; SBDPs; NSE; GFAP; S100 beta	NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; SERUM S100B LEVELS; ALPHA-II-SPECTRIN; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN; CEREBROSPINAL-FLUID; CEREBRAL-CORTEX	Years of research in the field of neurotrauma have led to the concept of applying systems biology as a tool for biomarker discovery in traumatic brain injury (TBI). Biomarkers may lead to understanding mechanisms of injury and recovery in TBI and can be potential targets for wound healing, recovery, and increased survival with enhanced quality of life. The literature available on neurotrauma studies from both animal and clinical studies has provided rich insight on the molecular pathways and complex networks of TBI, elucidating the proteomics of this disease for the discovery of biomarkers. With such a plethora of information available, the data from the studies require databases with tools to analyze and infer new patterns and associations. The role of different systems biology tools and their use in biomarker discovery in TBI are discussed in this chapter.	[Jaber, Zaynab] CUNY, Grad Sch, Dept Biochem, New York, NY 10021 USA; [Jaber, Zaynab] CUNY, Univ Ctr, New York, NY 10021 USA; [Jaber, Zaynab; Abou-Abbass, Hussein; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Aouad, Patrick] Amer Univ Beirut, Dept Biol, Fac Arts & Sci, Beirut, Lebanon; [Al Medawar, Mohamad] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, Div Vasc Endothelium & Microcirculat, Dresden, Germany; [Bahmad, Hisham] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon; [Bahmad, Hisham; Abou-Abbass, Hussein] Beirut Arab Univ, Fac Med, Beirut, Lebanon; [Ghandour, Hiba] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon; [Mondello, Stefania; Kobeissy, Firas] Banyan Biomarkers Inc, Alachua, FL USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Kobeissy, Firas] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA		Jaber, Z (corresponding author), CUNY, Grad Sch, Dept Biochem, New York, NY 10021 USA.; Jaber, Z (corresponding author), CUNY, Univ Ctr, New York, NY 10021 USA.; Jaber, Z (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon.		Almedawar, Mohamad/AAN-1482-2021; Ghandour, Hiba/AAH-2399-2021; Bahmad, Hisham/A-5369-2019; Kobeissy, Firas/E-7042-2017; Almedawar, Mohamad Musbah/O-7910-2019; Mondello, Stefania/A-1813-2012	Ghandour, Hiba/0000-0002-3375-6600; Bahmad, Hisham/0000-0003-3799-2595; Kobeissy, Firas/0000-0002-5008-6944; Almedawar, Mohamad Musbah/0000-0002-3595-4715; Mondello, Stefania/0000-0002-8587-3614			Alawieh A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00187; Ali A, 2014, BIOMARKERS BRAIN INJ, P3; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Boutte A, 2015, BIOMARKERS OF BRAIN INJURY AND NEUROLOGICAL DISORDERS, P42; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; Cardali S, 2006, J Neurosurg Sci, V50, P25; Cook GA, 2014, MIL MED, V179, P1083, DOI 10.7205/MILMED-D-13-00435; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Denslow N, 2003, J NEUROTRAUM, V20, P401, DOI 10.1089/089771503765355487; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DONATO R, 1986, J NEUROCHEM, V46, P1333, DOI 10.1111/j.1471-4159.1986.tb01743.x; Dumont D, 2004, PROTEOMICS, V4, P2117, DOI 10.1002/pmic.200300715; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Fridriksson T, 2000, ACAD EMERG MED, V7, P816, DOI 10.1111/j.1553-2712.2000.tb02276.x; GALEA E, 1995, J NEUROSCI RES, V41, P452, DOI 10.1002/jnr.490410404; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Hammack BN, 2004, MULT SCLER, V10, P245, DOI 10.1191/1352458504ms1023oa; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Martinez D, 2014, ARCH PHYS MED REHAB, V95, pe54; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mundy L, 2013, TECHNOLOGY BRIEF HLT; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nielson JL, 2014, J NEUROTRAUM, V31, P1789, DOI 10.1089/neu.2014.3399; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Ottens AK, 2010, J NEUROTRAUM, V27, P1837, DOI 10.1089/neu.2010.1374; Ou S, 2014, EUR REV MED PHARMACO, V18, P101; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Phan N., 2012, TRAUMATIC BRAIN INJU, P21; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Rothoerl RD, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00054; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Selakovic V, 2005, J CLIN NEUROSCI, V12, P542, DOI 10.1016/j.jocn.2004.07.019; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sullivan SM, 2012, NEUROCHEM RES, V37, P2364, DOI 10.1007/s11064-012-0774-5; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2007, NEUROCRIT CARE, V6, P94, DOI 10.1007/s12028-007-0005-0; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang KK, 2015, J NEUROTRAUMA; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yu C, 2015, BRAIN NEUROTRAUMA MO; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZQ, 2011, TRANSL STROKE RES, V2, P455, DOI 10.1007/s12975-011-0137-6; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	115	7	9	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						157	174		10.1007/978-1-4939-3816-2_10	10.1007/978-1-4939-3816-2		18	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500012	27604718				2022-02-06	
J	Kemp, S; Duff, A; Hampson, N				Kemp, Steven; Duff, Alistair; Hampson, Natalie			The neurological, neuroimaging and neuropsychological effects of playing professional football: Results of the UK five-year follow-up study	BRAIN INJURY			English	Article						Heading; concussion; football; neuropsychology; neurology	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; RECURRENT CONCUSSION; HEAD TRAUMA; PLAYERS; ENCEPHALOPATHY; RECOVERY; ASSOCIATION; SOCCER	Background: Whilst the scientific understanding of mild traumatic brain injury sequelae has advanced, the consequences of neurological insults sustained during football play in the form of multiple concussions and heading remains unclear.Method: To the authors' knowledge, this is the first longitudinal prospective study to follow-up a group of footballers and controls over time. Thirty-two elite young professional footballers were recruited and 24 were identified at follow-up. Thirty-three controls were recruited and 17 identified at follow-up. Medical examination, MRI (brain) imaging and detailed neuropsychological data were collected on the footballers at baseline and 5-year follow-up. Medical examination and detailed neuropsychological data were collected on the controls at baseline and 5-year follow-up.Results: All participants had normal neurological examination at both time points. At baseline, 37% of the footballers had sustained minor neurological insults. Between baseline and 5 years, 66% of the footballers had sustained minor neurological insults. No MRI (brain) abnormalities were identified among the footballers at either time point. Regarding the neuropsychology, there was a 6-point IQ difference between footballers and controls, with the footballers being low. Test-re-test analysis on a range of carefully selected neurocognitive tests revealed a picture of good stability in cognitive functioning over this 5-year period.Conclusions: These longitudinal prospective data indicate no significant neurological, structural brain imaging or neuropsychological change among a sample of young elite professional footballers over the first 5 years of their professional career.	[Kemp, Steven; Duff, Alistair] St James Hosp, Dept Clin & Hlth Psychol, Beckett St, Leeds LS9 7TF, W Yorkshire, England; [Hampson, Natalie] Salford Royal Hosp, Manchester, Lancs, England		Kemp, S (corresponding author), St James Hosp, Dept Clin & Hlth Psychol, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	stevenkemp@nhs.net		Duff, Alistair/0000-0003-2158-9347	Football Association (FA)	The authors would like to thank Dr. Andrew Rutherford, Keele University for his guidance on the preparation of this manuscript. They would also like to thank Dr. Tufail Patankar, Consultant Neuroradiologist, for reviewing the MRI (brain) scans in conference with the research team post peer review. The work was initiated by an award from the Football Association (FA).	Baddeley A., 1992, SPEED CAPACITY LANGU; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Casson IR, 2014, SPORTS HEALTH, P6384; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Hamsher K., 1989, MULTILINGUAL APHASIA; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heaton RK, 1991, COMPREHENSIVE NORMS; Hollows S. E., 1985, ADULT MEMORY INFORM; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Nelson H.E., 1982, TEST MANUAL; Robertson IH, 1996, TEST EVERYDAY ATTENT; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC	34	7	7	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	9					1068	1074		10.3109/02699052.2016.1148776			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DV5BN	WOS:000382940600004	27184946				2022-02-06	
J	Linsenmaier, U; Wirth, S; Kanz, KG; Geyer, LL				Linsenmaier, Ulrich; Wirth, Stefan; Kanz, Karl-Georg; Geyer, Lucas L.			Imaging minor head injury (MHI) in emergency radiology: MRI highlights additional intracranial findings after measurement of trauma biomarker S-100B in patients with normal CCT	BRITISH JOURNAL OF RADIOLOGY			English	Article							BRAIN-INJURY; COMPUTED-TOMOGRAPHY; CRANIAL CT; PROTEIN; SERUM; S100B; MILD; MARKER; ADULTS; LESIONS	Objective: To investigate whether MRI in emergency radiology can detect (a) additional trauma-related findings after minor head injury (MHI) or (b) structural, non-trauma-related intracranial lesions when trauma biomarker S-100B concentration is raised, or clinical symptoms are unexplained, or both. Methods: 41 patients with MHI were included. Concentrations of S-100B in serum were measured and categorized using an established cut-off at 0.1 mu gl(-1). Intracerebral trauma-related as well as non-trauma-related chronic structural findings (atrophy, microangiopathy and chronic parenchymal defects) were assessed by cranial CT (CCT) and MRI by two independent radiologists (UL and LLG). All CCT and MRI results were compared with biomarker S-100B. Results: Compared with CCT, MRI detected 10 additional lesions. 5 patients had abnormal MRI with a total of 15 trauma-related lesions and showed elevated S-100B concentrations. Although sensitivity of S-100B was 100%, specificity was only 25%. Patients with structural brain lesions showed significantly higher S-100B serum levels (0.50 and 0.14 mu g l(-1), p=0.01). Conclusion: Biomarker S-100B has proven its high negative-predictive value to rule out intracranial bleeding in patients after MHI even if MRI is used as imaging modality. Regarding the low specificity of S-100B, structural lesions of the brain parenchyma not related to the acute trauma may be associated with increased serum concentrations of protein S-100B. Advances in knowledge: Biomarker S-100B has a high negative-predictive value to rule out intracranial bleeding after MHI. Biomarker S-100B's low specificity may be associated with non-traumatic brain parenchyma lesions. MRI is superior to CCT in detecting subtle findings in neuroimaging after MHI. Biomarker S-100B can potentially reduce the large number of normal CCT studies after MHI.	[Linsenmaier, Ulrich] HELIOS Kliniken Munchen WEST & Munchen Perlach, Inst Diagnost & Intervent Radiol, Munich, Germany; [Linsenmaier, Ulrich] Klinikum Augustinum Munchen, Munich, Germany; [Linsenmaier, Ulrich] European Soc Emergency Radiol, Vienna, Austria; [Wirth, Stefan; Geyer, Lucas L.] LMU Univ Munich, Dept Clin Radiol, Munich, Germany; [Kanz, Karl-Georg] Tech Univ Munich, Dept Trauma Surg, D-80290 Munich, Germany		Linsenmaier, U (corresponding author), HELIOS Kliniken Munchen WEST & Munchen Perlach, Inst Diagnost & Intervent Radiol, Munich, Germany.; Linsenmaier, U (corresponding author), Klinikum Augustinum Munchen, Munich, Germany.; Linsenmaier, U (corresponding author), European Soc Emergency Radiol, Vienna, Austria.	Ulrich.Linsenmaier@helios-kliniken.de	Wirth, Stefan/I-7150-2016				Ahlhelm F, 2007, RADIOLOGE, V47, P863, DOI 10.1007/s00117-007-1546-0; Ahmad O, 2012, CEREBROVASC DIS, V33, P47, DOI 10.1159/000332810; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Chang MS, 2005, BRAIN RES, V1031, P1, DOI 10.1016/j.brainres.2004.07.043; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JENKINS A, 1986, LANCET, V2, P445; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Korfias S, 2006, BRAIN INJURY, V20, P867, DOI 10.1080/02699050600832395; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leidel BA, 2012, UNFALLCHIRURG, V115, P903, DOI 10.1007/s00113-010-1946-x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Muller B, 2011, EMERG MED J, V28, P938, DOI 10.1136/emj.2010.095372; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Neurochirurgie DGf, 2015, LEITL SCHAD HIRN TRA; Neurologie DGf, 2012, LEITL DIAGN THER NEU; NOGUCHI K, 1994, AM J NEURORADIOL, V15, P1940; Oh EJ, 2007, J CLIN LAB ANAL, V21, P387, DOI 10.1002/jcla.20201; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Petzold A, 2003, NEUROSCI LETT, V336, P167, DOI 10.1016/S0304-3940(02)01257-0; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Springborg Jtiaocnob Bertram, 2009, Ugeskr Laeger, V171, P978; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V358, P105, DOI 10.1016/S0140-6736(01)05328-4; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wiesmann M, 1998, RADIOLOGE, V38, P645, DOI 10.1007/s001170050405; Wiesmann M, 1998, CLIN CHEM, V44, P1056; Yardan T, 2011, J PAK MED ASSOC, V61, P276; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	44	7	7	0	7	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.		2016	89	1061							20150827	10.1259/bjr.20150827			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DM6UQ	WOS:000376488500018	26607648	Green Published			2022-02-06	
J	Mirow, S; Wilson, SH; Weaver, LK; Churchill, S; Deru, K; Lindblad, AS				Mirow, Susan; Wilson, Steffanie H.; Weaver, Lindell K.; Churchill, Susan; Deru, Kayla; Lindblad, Anne S.			Linear analysis of heart rate variability in post-concussive syndrome	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						mild traumatic brain injury; heart rate variability; autonomic nervous system; post-concussive syndrome	TRAUMATIC BRAIN-INJURY; AUTONOMIC NERVOUS-SYSTEM; POSTTRAUMATIC-STRESS-DISORDER; HYPERBARIC-OXYGEN; PANIC DISORDER; POINCARE PLOT; SLEEP; DISTURBANCES; DYSFUNCTION; AGE	Heart rate variability (HRV) represents measurable output of coordinated structural and functional systems within the body and brain. Both mild traumatic brain injury (mTBI) and HRV are modulated by changes in autonomic nervous system function. We present baseline HRV results from an ongoing mTBI clinical trial. HRV was assessed via 24-hour ambulatory electrocardiography; recordings were segmented by physiological state (sleep, wakefulness, exercise, standing still). Time, frequency, and spatial domain measures were summarized and compared with symptoms, sleep quality, and neurological examination. Median low frequency/high frequency (LF/HF) ratio exceeded 1.0 across segments, indicating prevalence of sympathetic modulation. Abnormal Sharpened Romberg Test was associated with 29% LF/HF decrease (95% CI [2.1, 47.7], p=0.04); pathological nystagmus associated with decreased standard deviation of electrocardiogram R-R interval (SDNN) index (25% decrease, 95% CI [0.8, 43.4], p=0.04). Increased sympathetic modulation was associated with increased anger scores (19% LF/HF increase with 5-point State Trait Anger Expression Inventory-2 trait anger increase (95% CI [1.2, 39.1], p=0.04)). A 13% HF increase (95% CI [2.1, 25.7], p=0.02) was observed with increased Pittsburgh Sleep Quality Index scores. These results support autonomic nervous system dysfunction in service members after mTBI.	[Mirow, Susan] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Wilson, Steffanie H.; Lindblad, Anne S.] Emmes Corp, Rockville, MD USA; [Weaver, Lindell K.; Churchill, Susan; Deru, Kayla] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Weaver, Lindell K.; Churchill, Susan; Deru, Kayla] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA		Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA.	lindell.weaver@imail.org		Khan, Tapan/0000-0002-0737-3884	U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the U.S. Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication has not yet been locked and is therefore subject to change.	Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Berntson, 2000, HDB PSYCHOPHYSIOLOGY, P533; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blechert J, 2007, PSYCHOSOM MED, V69, P935, DOI 10.1097/PSY.0b013e31815a8f6b; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Buysse D J, 1989, Psychiatry Res, V28, P193; Camm AJ, 1996, EUR HEART J, V17, P354; Chang HA, 2013, ASIA-PAC PSYCHIAT, V5, P80, DOI 10.1111/appy.12032; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Crasset V, 2001, CIRCULATION, V103, P84; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Figueroa A, 2008, CLIN PHYSIOL FUNCT I, V28, P49, DOI 10.1111/j.1475-097X.2007.00776.x; Fitzgerald B, 1996, SPUMS J, V26, P142; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gorman Jack M., 2000, American Heart Journal, V140, pS77; Haley RN, 2004, AM J MED, V117, P469, DOI 10.1016/j.amjmed.2004.03.041; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hauschildt M, 2011, BIOL PSYCHOL, V88, P215, DOI 10.1016/j.biopsycho.2011.08.004; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Israel B, 2012, SLEEP, V35, P1285, DOI 10.5665/sleep.2088; Jindal RD, 2008, AM J GERIAT PSYCHIAT, V16, P861, DOI 10.1097/JGP.0b013e318180053d; Khandoker AH, 2013, HEART RATE ASYMMETRY, P69; King ML, 1997, BRAIN INJURY, V11, P445; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kobayashi H, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-9; Korpelainen JT, 1996, STROKE, V27, P2059, DOI 10.1161/01.STR.27.11.2059; Kumagai H, 2012, HYPERTENS RES, V35, P132, DOI 10.1038/hr.2011.208; Lee C T, 1998, SPUMS J, V28, P125; Leslie K, 1996, DREAMING, V6, P1; loachimescu AG, 2014, PITUITARY; Longin E, 2005, EARLY HUM DEV, V81, P663, DOI 10.1016/j.earlhumdev.2005.03.015; Lund V, 2000, ACTA PHYSIOL SCAND, V170, P39; Lund V, 2003, UNDERSEA HYPERBAR M, V30, P29; Lund VE, 1999, ACTA PHYSIOL SCAND, V167, P29; Lund VE, 2005, UNDERSEA HYPERBAR M, V32, P111; Mancia G, 2014, CIRC RES, V114, P1804, DOI 10.1161/CIRCRESAHA.114.302524; Mani AR, 2009, AM J PHYSIOL-GASTR L, V296, pG330, DOI 10.1152/ajpgi.90488.2008; Massetani R, 1997, EPILEPSIA, V38, P363, DOI 10.1111/j.1528-1157.1997.tb01129.x; Mastrocola C, 1999, ACTA NEUROL SCAND, V99, P245, DOI 10.1111/j.1600-0404.1999.tb07355.x; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Minassian A, 2014, PSYCHOSOM MED, V76, P292, DOI 10.1097/PSY.0000000000000056; Mirow S., 2012, United States patent US, Patent No. [8,306,610, 8306610]; Park SK, 2005, ENVIRON HEALTH PERSP, V113, P304, DOI 10.1289/ehp.7447; Perkiomaki J, 2014, J CARDIOVASC ELECTR, V25, P719, DOI 10.1111/jce.12402; Piskorski J, 2007, PHYSIOL MEAS, V28, P287, DOI 10.1088/0967-3334/28/3/005; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Porges S., 2011, NORTON SERIES INTERP; Prasko J, 2011, NEUROENDOCRINOL LETT, V32, P641; Savi M. A., 2005, J. Braz. Soc. Mech. Sci. & Eng., V27, P157, DOI 10.1590/S1678-58782005000200008; Sharma Rajiv Kumar, 2011, J Cardiovasc Dis Res, V2, P115, DOI 10.4103/0975-3583.83040; Sloan EP, 1999, BIOL PSYCHIAT, V45, P1313, DOI 10.1016/S0006-3223(98)00158-9; Spielberger CD, 2000, STATE TRAIT ANGER EX; Stabile JR, 2015, UNDERSEA HYPERBAR M, V42, P307; Stefanovska A, 2007, IEEE ENG MED BIOL, V26, P25, DOI [10.1109/EMB.2007.907088, 10.1109/MEMB.2007.907088]; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Taggart P, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00067; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; van der Meijden WP, 2015, J SLEEP RES, V24, P206, DOI 10.1111/jsr.12253; Voss A, 2009, PHILOS T R SOC A, V367, P277, DOI 10.1098/rsta.2008.0232; Walker JM, 2016, UNDERSEA HYPERBAR M, V43, P549; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wichniak A, 2012, CURR PHARM DESIGN, V18, P5802, DOI 10.2174/138161212803523608; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P521; Wohlgemuth WK, 2015, SLEEP MED, V16, P336, DOI 10.1016/j.sleep.2014.08.013; Worthington D, 2008, UNDERSEA HYPERBAR M, V35, P283; Zucker TL, 2009, APPL PSYCHOPHYS BIOF, V34, P135, DOI 10.1007/s10484-009-9085-2	84	7	7	1	7	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		531	547					17	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300005	28768072				2022-02-06	
J	Munivenkatappa, A; Devi, BI; Shukla, DP; Rajeswaran, J				Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Shukla, Dhaval P.; Rajeswaran, Jamuna			Role of the thalamus in natural recovery of cognitive impairment in patients with mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; volume changes; tensor changes; cognitive scores; natural recovery; attention; memory	NEUROFEEDBACK	Introduction: Patients with mild traumatic brain injury (mTBI) may have normal neuroimaging but manifest with a broad-spectrum of cognitive-deficits, which may resolve eventually. The function of the thalamus in the process of natural-recovery remains elusive. The current study investigates the role of the thalamus in natural-recovery of cognitive-deficits in patients with mTBI. Methods: Twenty-one patients with mTBI were evaluated with an initial MRI scan, within 36 hours of injury and assessed with neuropsychological tests(NPT) at 3-4 weeks after injury. First and second follow-up MRI and NPT were performed at 3-4 months and 6-7 months, respectively. The volume and tensor measures of the thalamus and cognitive-scores were analysed at each assessment using repeated-measures of variance. The association of cognitive-scores with corresponding period imaging measures was analysed using bivariate-correlation. Results: Serial evaluation showed that all the cognitive-domains improved significantly. During this period there was a significant increase in mean thalamic volume (p = 0.049, effect-size = 0.18). After 3-4 months there was emergence of anisotropic thalamo-cortical connections. At 2-3 weeks and 6-7 months after injury, the alterations in diffusivity values were positively associated with improvement in memory-scores. Improvement in attention-scores correlated significantly with changes in tensor values at the 6-7 months after-injury. Conclusion: The correlation between improvement in cognitive-scores and changes in thalamic tensor and volume measures reflect the role of the thalamus in natural-recovery after mTBI.	[Munivenkatappa, Ashok] Natl Inst Mental Hlth & Neurosci, Dept Clin Neurosci, Bangalore 560069, Karnataka, India; [Devi, Bhagavatula Indira; Shukla, Dhaval P.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560069, Karnataka, India; [Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore 560069, Karnataka, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560069, Karnataka, India.	drindiradb@gmail.com	Munivenkatappa, Ashok/ABA-5952-2021		Department of Science and Technology (DST)Department of Science & Technology (India)	We thank the Department of Science and Technology (DST) for encouraging this work through financial support.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kujala T, 2010, PROG NEUROBIOL, V91, P55, DOI 10.1016/j.pneurobio.2010.01.006; Levesque J, 2011, NEUROFEEDBACK AND NEUROMODULATION TECHNIQUES AND APPLICATIONS, P353, DOI 10.1016/B978-0-12-382235-2.00013-5; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lubar JF, 1997, APPL PSYCHOPHYS BIOF, V22, P111, DOI 10.1023/A:1026276228832; Miles L, 2010, ARCH NEUROL-CHICAGO, V67, P1336; Munivenkatappa A, 2014, NEUROREHABILITATION, V35, P481, DOI 10.3233/NRE-141140; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Tinius T. P., 2000, J NEUROTHER, V4, P27, DOI [DOI 10.1300/J184v04n02_05, 10.1300/J184v04n02_05]; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2	16	7	7	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					388	392		10.3109/02699052.2015.1089599			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200003	26619364				2022-02-06	
J	Mwita, CC; Muthoka, J; Maina, S; Mulingwa, P; Gwer, S				Mwita, Clifford Chacha; Muthoka, Johnstone; Maina, Stephen; Mulingwa, Phillip; Gwer, Samson			Early management of traumatic brain injury in a Tertiary hospital in Central Kenya: A clinical audit	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Clinical audit; head injury; traumatic brain injury	TEMPORAL BONE-FRACTURES; CRITERIA; RULE; PERSPECTIVE; SPINE	Background: Traumatic brain injury (TBI) is a major cause of death and disability worldwide and is mostly attributed to road traffic accidents in resource-poor areas. However, access to neurosurgical care is poor in these settings and patients in need of neurosurgical procedures are often managed by general practitioners or surgeons. Materials and Methods: A retrospective clinical audit of the initial management of patients with TBI in Thika Level 5 Hospital (TL5H), a Tertiary Hospital in Central Kenya. Seventeen audit criteria divided into five clinical domains were identified and patient case notes reviewed for compliance with each criterion. Data were analyzed separately for those below 13 years owing to differences in response to brain trauma in those below this age. Results: Overall, there was poor compliance with audit criteria in both groups. Among those below 13 years of age, only 3 out of 17 criteria achieved compliance and 4 out of 17 criteria achieved compliance for those above 13 years of age. Assessment for the need for a cervical radiograph (7.1% and 8.8% compliance) and administration of oxygen (21.4% and 20.6% compliance) had the worst performance in both groups. Conclusion: Poor compliance to audit criteria indicates the low quality of care for patients with TBI in TL5H. Quality improvement strategies with follow-up audits are needed to improve care. There is a need to develop and enforce evidence-based protocols and guidelines for use in the management of patients with TBI in sub-Saharan Africa.	[Mwita, Clifford Chacha; Muthoka, Johnstone; Maina, Stephen; Mulingwa, Phillip] Thika Level 5 Hosp, Dept Surg, POB 227, Thika, Kenya; [Mwita, Clifford Chacha] Afya Res Africa, Evidence & Translat Unit, Nairobi, Kenya; [Gwer, Samson] Kenyatta Univ, Dept Human Physiol, Nairobi, Kenya; [Mwita, Clifford Chacha] Moi Univ, Dept Surg, Eldoret, Kenya; [Muthoka, Johnstone] Kenya Methodist Univ, Dept Human Anat, Meru, Kenya		Mwita, CC (corresponding author), Thika Level 5 Hosp, Dept Surg, POB 227, Thika, Kenya.	cliffmwita@gmail.com	Mwita, Clifford/ABA-5560-2020	Mwita, Clifford/0000-0002-2332-6519			Alexander T, 2009, S AFR J SURG, V47, P120; Brodie HA, 1997, AM J OTOL, V18, P188; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; ELJAMEL M S, 1990, British Journal of Neurosurgery, V4, P381, DOI 10.3109/02688699008992759; ELJAMEL MS, 1993, BRIT J NEUROSURG, V7, P501, DOI 10.3109/02688699308995072; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Howlett W, 2012, NEUROLOGY IN AFRICA, P413; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kaye AH, 2005, ESSENTIAL NEUROSURGE, P40; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P873, DOI 10.1007/s10995-008-0408-3; Masiira-Mukasa N, 2002, East Afr Med J, V79, P373; New Zealand Guidelines Group, 2007, TRAUM BRAIN INJ DIAG; Nosan DK, 1997, OTOLARYNG HEAD NECK, V117, P67, DOI 10.1016/S0194-5998(97)70209-2; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Thomson R, 1994, Qual Health Care, V3, P86, DOI 10.1136/qshc.3.2.86; von Deimling A, 1994, Recent Results Cancer Res, V135, P33; Williams N, 2008, BAILEY LOVES SHORT P; Wiltshire RN, 2004, J MOL DIAGN, V6, P166, DOI 10.1016/S1525-1578(10)60507-7; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3; Zulu BMW, 2007, INJURY, V38, P576, DOI 10.1016/j.injury.2007.01.002	24	7	8	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-MAR	2016	7	1					97	101		10.4103/0976-3147.165390			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DJ2TV	WOS:000374058900021	26933354	Green Submitted, gold, Green Published			2022-02-06	
J	Naghibi, T; Madani, S; Mazloomzadeh, S; Dobakhti, F				Naghibi, Taraneh; Madani, Sara; Mazloomzadeh, Saideh; Dobakhti, Faramarz			Simvastatin's effects on survival and outcome in traumatic brain injury patients: a comparative study	TURKISH JOURNAL OF MEDICAL SCIENCES			English	Article						Simvastatin; traumatic brain injury; outcome; survival	INFLAMMATORY RESPONSE; STATIN THERAPY; CYTOKINES; PATHOPHYSIOLOGY	Background/aim: Mortality and morbidity still remain high in patients with traumatic brain injuries. Understanding the role of new treatments in these patients is critical. The aim of this study was to determine the effect of simvastatin on survival and outcome in traumatic brain injury patients. Materials and methods: Forty-four patients were assigned to receive either simvastatin or a placebo. The serum interleukin-6 and C-reactive protein levels were measured at the first 24 h and 48 h after trauma. All data, including the Glasgow Coma Scale score, survival at discharge, length of intensive care unit stay, and duration of mechanical ventilation, were collected. The effect of simvastatin on the collected data was then investigated. Results: The Glasgow Coma Scale level at discharge was significantly higher in the simvastatin group. The overall mortality rate, duration of mechanical ventilation, and length of intensive care unit stay were similar between the 2 groups. The C-reactive protein concentration 48 h after trauma was significantly lower in the simvastatin group, but there was no significant difference according to the interleukin-6 level 48 h after trauma between the 2 groups. Conclusion: Simvastatin could be suggested as an adjunctive therapy in traumatic brain injury patients.	[Naghibi, Taraneh; Madani, Sara] Zanjan Univ Med Sci, Sch Med, Dept Anesthesiol & Crit Care Med, Zanjan, Iran; [Mazloomzadeh, Saideh] Zanjan Univ Med Sci, Sch Med, Dept Epidemiol, Zanjan, Iran; [Dobakhti, Faramarz] Zanjan Univ Med Sci, Sch Pharm, Zanjan, Iran		Naghibi, T (corresponding author), Zanjan Univ Med Sci, Sch Med, Dept Anesthesiol & Crit Care Med, Zanjan, Iran.	tnaghibi@zums.ac.ir	Naghibi, Taraneh/M-5900-2016; Dobakhti, Faramarz/N-8666-2016; Mazloomzadeh, Saeideh/H-4062-2016	Naghibi, Taraneh/0000-0001-6882-7598; Dobakhti, Faramarz/0000-0002-7822-6013; Mazloomzadeh, Saeideh/0000-0001-6325-0662			Al Harbi Shmeylan A, 2011, BMC Clin Pharmacol, V11, P12, DOI 10.1186/1472-6904-11-12; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Christensen S, 2010, CRIT CARE, V14, DOI 10.1186/cc8902; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; HOCH RC, 1993, CRIT CARE MED, V21, P839, DOI 10.1097/00003246-199306000-00010; Jansen JO, 2013, CRIT CARE, V17, DOI 10.1186/cc12499; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Morandi A, 2011, CHEST, V140, P580, DOI 10.1378/chest.10-3065; Novack V, 2009, INTENS CARE MED, V35, P1255, DOI 10.1007/s00134-009-1429-0; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Tapia-Perez JH, 2013, NEUROSURG REV, V36, P279, DOI 10.1007/s10143-012-0431-0; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Wang KW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/910260; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	21	7	7	0	7	TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY	ANKARA	ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY	1300-0144	1303-6165		TURK J MED SCI	Turk. J. Med. Sci.		2016	46	1					1	5		10.3906/sag-1404-125			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5MP	WOS:000368558600009	27511325	Green Submitted			2022-02-06	
J	Ozkul, E; Gem, M; Alemdar, C; Arslan, H; Bogatekin, F; Kisin, B				Ozkul, Emin; Gem, Mehmet; Alemdar, Celil; Arslan, Huseyin; Bogatekin, Ferit; Kisin, Bulent			Results of two different surgical techniques in the treatment of advanced-stage Freiberg's disease	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						Metatarsal; dorsal closing-wedge osteotomy; Freiberg's disease; metatarsal; osteochondrosis; resection	WEDGE OSTEOTOMY; INFRACTION	Background: Freiberg's disease is an osteochondrosis most commonly seen in adolescent women and characterized by pain, swelling and motion restriction in the second metatarsal. The early stages of this disease can be managed with semirigid orthoses, metatarsal bars and short leg walking cast. Number of operative methods are suggested which can be used depending on the pathophysiology of the disease, including abnormal biomechanics, joint congruence and degenerative process. We evaluated the outcomes of the patients with Freiberg's disease who were treated with dorsal closing-wedge osteotomy and resection of the metatarsal head. Patients and Methods: 16 patients (11 female, 5 male) with a mean age of 24.5 (range 13u49 years) years who underwent dorsal closing wedge osteotomy or resection of the metatarsal head were included in this retrospective study. Second metatarsal was affected in 13 and third metatarsal in three patients. According to the Smillie's classification system, ten patients had type IV osteonecrosis and six patients had type V. The results of the patients were evaluated using the lesser metatarsophalangeal-interphalangeal (LMPI) scale. Results: According to the LMPI scale, the postoperative scores for the osteotomy and excision groups were 86 (range 64u100) and 72.6 (range 60u85), respectively. In the osteotomy group, mean passive flexion restriction was 18 degrees (range 0 degrees u35 degrees) and mean passive extension restriction was 12 degrees (range 0 degrees u25 degrees). Mean metatarsal shortening was 2.2 mm (range 2u4 mm) in the osteotomy group as opposed to 9.8 mm (range 7u14 mm) in the excision group. Significant pain relief was obtained in both groups following the surgery. Conclusions: The decision of performing osteotomy or resection arthroplasty in the patients with advanced-stage Freiberg's disease should be based on the joint injury and the patients should be informed about the cosmetic problems like shortening which may arise from resection.	[Ozkul, Emin; Gem, Mehmet; Alemdar, Celil; Arslan, Huseyin] Dicle Univ, Fac Med, Dept Orthopaed & Traumatol, Diyarbakir, Turkey; [Bogatekin, Ferit; Kisin, Bulent] Diyarbakir Training & Educ Hosp, Diyarbakir, Turkey		Ozkul, E (corresponding author), Dicle Univ, Fac Med, Dept Orthopaed & Traumatol, Diyarbakir, Turkey.	eminozkul21@hotmail.com		OZKUL, EMIN/0000-0003-2149-8154			Chao KH, 1999, ACTA ORTHOP SCAND, V70, P483, DOI 10.3109/17453679909000985; Farrar MJ, 1997, FOOT, V7, P52; FREIBERG J A, 1957, Instr Course Lect, V14, P238; GAUTHIER G, 1979, CLIN ORTHOP RELAT R, P93; Hayashi K, 2002, ARTHROSCOPY, V18, P660, DOI 10.1053/jars.2002.32865; Hofstaetter SG, 2005, J BONE JOINT SURG BR, V87B, P1507, DOI 10.1302/0301-620X.87B11.16590; Ihedioha U, 2003, FOOT EDINB, V13, P143; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P349, DOI 10.1177/107110079401500701; Lee SK, 2007, FOOT ANKLE INT, V28, P43, DOI 10.3113/FAI.2007.0008; McGlamry E D, 1976, J Am Podiatry Assoc, V66, P155; Miyamoto W, 2008, FOOT ANKLE INT, V29, P950, DOI 10.3113/FAI.2008.0950; Murphy AG, 2008, CAMPBELLS OPERATIVE, V2, P1252; Ozkan Y, 2008, FOOT ANKLE INT, V29, P488, DOI 10.3113/FAI.2008.0488; Sansone V, 2010, J BONE JOINT SURG BR, V92B, P807, DOI 10.1302/0301-620X.92B6.23171; Shih AT, 2004, J AM PODIAT MED ASSN, V94, P590, DOI 10.7547/0940590; SMILLIE IS, 1957, J BONE JOINT SURG BR, V39, P580	16	7	8	0	6	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	JAN-FEB	2016	50	1					70	73		10.4103/0019-5413.173514			4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	DH3VG	WOS:000372714300012	26955180	Green Published			2022-02-06	
J	Paddack, M; DeWolf, R; Covassin, T; Kontos, A				Paddack, Michael; DeWolf, Ryan; Covassin, Tracey; Kontos, Anthony			Policies, Procedures, and Practices Regarding Sport-Related Concussion in Community College Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						academic accommodations; return to play; athletic trainers; continuing education	ASSOCIATION POSITION STATEMENT; INTERNATIONAL-CONFERENCE; FOOTBALL; RETURN; EPIDEMIOLOGY; MANAGEMENT; INJURY; SCHOOL	Context: College sport organizations and associations endorse concussion-management protocols and policies. To date, little information is available on concussion policies and practices at community college institutions. Objective: To assess and describe current practices and policies regarding the assessment, management, and return-to-play criteria for sport-related concussion (SRC) among member institutions of the California Community College Athletic Association (CCCAA). Design: Cross-sectional study. Setting: Web-based survey. Patients or Other Participants: A total of 55 head athletic trainers (ATs) at CCCAA institutions. Main Outcome Measure(s): Data about policies, procedures, and practices regarding SRC were collected over a 3-week period in March 2012 and analyzed using descriptive statistics, the Fisher exact test, and the Spearman test. Results: Almost half (47%) of ATs stated they had a policy for SRC assessment, management, and return to play at their institution. They reported being in compliance with baseline testing guidelines (25%), management guidelines (34.5%), and return-to-play guidelines (30%). Nearly 31% of ATs described having an SRC policy in place for academic accommodations. Conference attendance was positively correlated with institutional use of academic accommodations after SRC (r = 0.44, P = .01). The number of meetings ATs attended and their use of baseline testing were also positively correlated (r = 0.38, P = .01). Conclusions: At the time of this study, nearly half of CCCAA institutions had concussion policies and 31% had academic-accommodation policies. However, only 18% of ATs at CCCAA institutions were in compliance with all of their concussion policies. Our findings demonstrate improvements in the management of SRCs by ATs at California community colleges compared with previous research but a need for better compliance with SRC policies.	[Paddack, Michael] Calif State Univ Monterey Bay, Seaside, CA 93955 USA; [DeWolf, Ryan] Univ Delaware, 541 South Coll Ave, Newark, DE 19716 USA; [Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA; [Kontos, Anthony] Univ Pittsburgh, Pittsburgh, PA 15260 USA		DeWolf, R (corresponding author), Univ Delaware, 541 South Coll Ave, Newark, DE 19716 USA.	rdewolf@udel.edu		Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Dr Kontos.	[Anonymous], CONC MILD TRAUM BRAI; [Anonymous], 2014, AB 2127 INT SPORTS F; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chinn NR, 2010, THESIS U CALIFORNIA; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Ferrara Michael S., 2001, J Athl Train, V36, P145; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Miller JJ, 2011, J APPL SPORT MANAG, V3, P91; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81	23	7	7	1	12	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2016	51	1					82	88		10.4085/1062-6050-51.2.01			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DK2OT	WOS:000374755000011	26765512	Green Published, Bronze			2022-02-06	
J	Pati, S; Muthuraju, S; Hadi, RA; Huat, TJ; Singh, S; Maletic-Savatic, M; Abdullah, JM; Jaafar, H				Pati, Soumya; Muthuraju, Sangu; Hadi, Raisah Ab.; Huat, Tee Jong; Singh, Shailja; Maletic-Savatic, Mirjana; Abdullah, Jafri Malin; Jaafar, Hasnan			Neurogenic Plasticity of Mesenchymal Stem Cell, an Alluring Cellular Replacement for Traumatic Brain Injury	CURRENT STEM CELL RESEARCH & THERAPY			English	Article						Immunomodulation and therapeutic; mesenchymal stem cells; neuro-transdifferentiation; traumatic brain injury	MARROW STROMAL CELLS; BONE-MARROW; IN-VITRO; COLLAGEN SCAFFOLDS; NEURAL CELLS; NITRIC-OXIDE; RAT MODEL; MIGRATION; BLOOD; MECHANISMS	Traumatic brain injury (TBI) imposes horrendous neurophysiological alterations leading to most devastating forms of neuro-disability. Which includes impaired cognition, distorted locomotors activity and psychosomatic disability in both youths and adults. Emerging evidence from recent studies has identified mesenchymal stem cells (MSCs) as one of the promising category of stem cells having excellent neuroregenerative capability in TBI victims. Some of the clinical and animal studies reported that MSCs transplantation could cure neuronal damage as well as improve cognitive and locomotors behaviors in TBI. However, mechanism behind their broad spectrum neuroregenerative potential in TBI has not been reviewed yet. Therefore, in the present article, we present a comprehensive data on the important attributes of MSCs, such as neuro-transdifferentiation, neuroprotection, axonal repair and plasticity, maintenance of blood-brain integrity, reduction of reactive oxygen species (ROS) and immunomodulation. We have reviewed in detail the crucial neurogenic capabilities of MSCs in vivo and provided consolidated knowledge regarding their cellular remodeling in TBI for future therapeutic implications.	[Pati, Soumya; Huat, Tee Jong; Singh, Shailja] Shiv Nadar Univ, Sch Nat Sci, Dept Life Sci, Greater Noida 201314, UP, India; [Muthuraju, Sangu; Hadi, Raisah Ab.; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Jalan Hosp Univ Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia; [Huat, Tee Jong; Jaafar, Hasnan] Univ Sains Malaysia, Sch Med Sci, Dept Pathol, Jalan Hosp Univ Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia; [Maletic-Savatic, Mirjana] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Program Struct & Computat Biol & Mol Biophys, Dept Pediat Neurol & Neurosci,Baylor Coll Med, 1250 Moursund St,Room 1250, Houston, TX 77030 USA; [Muthuraju, Sangu; Abdullah, Jafri Malin] Univ Sains Malaysia Hosp, Ctr Neurosci Serv & Res, Jalan Hosp Univ Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia		Jaafar, H (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Pathol, Jalan Hosp Univ Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.; Abdullah, JM (corresponding author), Univ Sains Malaysia Hosp, Ctr Neurosci Serv & Res, Jalan Hosp Univ Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.	brainsciences@gmail.com; hasnan@usm.my	MUTHURAJU, SANGU/B-2742-2018; HUAT, TEE JONG/AAK-4820-2020; SANGU, MUTHURAJU/AAY-8060-2020; Abdullah, J/C-2828-2011; SANGU, MUTHURAJU/C-3200-2011	MUTHURAJU, SANGU/0000-0002-7949-2110; HUAT, TEE JONG/0000-0003-3436-8148; Abdullah, J/0000-0002-0258-7410; SANGU, MUTHURAJU/0000-0002-7949-2110			Ahmad M, 2010, TRANSL STROKE RES, V1, P74, DOI 10.1007/s12975-010-0023-7; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chen, 2013, J NEUROINFLAMM, V10, P106; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Fu XM, 2007, GLIA, V55, P935, DOI 10.1002/glia.20515; Giordano R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-14; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Han C, 2014, CELL BIOL INT, V38, P768, DOI 10.1002/cbin.10256; Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279; Heo JS, 2013, NEUROSCIENCE, V238, P305, DOI 10.1016/j.neuroscience.2013.02.011; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jose S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0149-8; Kang YJ, 2005, J CELL BIOCHEM, V95, P1135, DOI 10.1002/jcb.20499; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Le Blon D, IMMUNOLOGY CELL BIOL, V92, P650; Le Blon D, 2014, IMMUNOL CELL BIOL, V92, P650, DOI 10.1038/icb.2014.49; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Liu NM, 2013, J CELL BIOCHEM, V114, P2677, DOI 10.1002/jcb.24615; Liu Y. H., 2014, PLOS ONE, V9, P9; Liu Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-135; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Mahmood A, 2014, J NEUROSURG, V120, P1147, DOI 10.3171/2013.12.JNS131362; Mahmood A, 2014, BRAIN RES, V1542, P41, DOI 10.1016/j.brainres.2013.10.045; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Nielsen S, 1997, J NEUROSCI, V17, P171; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; Oppenheim Joost J., 1996, P187; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Pati S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/503162; Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416; Redondo J, 2015, J NEUROSCI RES, V93, P882, DOI 10.1002/jnr.23556; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Tajiri N, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00116; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074857; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Taran R, 2014, J BIOSCIENCES, V39, P157, DOI 10.1007/s12038-013-9409-5; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Tsai HL, 2014, TISSUE ENG PT A, V20, P1908, DOI [10.1089/ten.tea.2013.0188, 10.1089/ten.TEA.2013.0188]; Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Youssif, 2014, BIOMEDICINE BIOTECHN, V2, P66; Yu Q, 2015, CELL J, V16, P440	74	7	9	1	10	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1574-888X	2212-3946		CURR STEM CELL RES T	Curr. Stem Cell Res. Ther.		2016	11	2					149	157		10.2174/1574888X10666151019120050			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG8KO	WOS:000372332900006	26763886				2022-02-06	
J	Pirota, V; Monzani, E; Dell'Acqua, S; Casella, L				Pirota, V.; Monzani, E.; Dell'Acqua, S.; Casella, L.			Interactions between heme and tau-derived R1 peptides: binding and oxidative reactivity	DALTON TRANSACTIONS			English	Article							AMYLOID-BETA PEPTIDE; PAIRED HELICAL FILAMENTS; TRAUMATIC BRAIN-INJURY; IRON PORPHYRIN MODELS; ALZHEIMERS-DISEASE; SPECTROSCOPIC CHARACTERIZATION; NEURODEGENERATIVE DISEASES; ENDOGENOUS TAU; PROTEIN; PEROXIDASE	The interaction of hemin with the first 18-amino acid repeat in tau protein has been investigated at both the N-terminal free-amine (R1 tau) and N-acetylated (AcR1 tau) forms for its potential relevance in traumatic brain injury and possibly other neurodegenerative diseases. The binding properties of hemin-R1 tau and hemin-AcR1 tau were compared with those of the hemin complex with amyloid-beta peptide fragment 1-16 (A beta 16) and synthetic hemins. AcR1 tau and R1 tau bind with moderate affinity to both monomeric and dimeric hemin to form 1 : 1 complexes, but for the acetylated peptide, the affinity is one order of magnitude larger (K-1 = 3.3 x 10(6) M-1). The binding constants were similar to that of A beta 16 for hemin, but unlike the latter, neither of the two R1 tau peptides forms a 2 : 1 complex with hemin. This is mostly due to electrostatic repulsion between R1 tau chains, and in particular the C-terminal proline-15 kink, while structural features of the hemin-R1 tau complexes do not seem to play a role. In fact, the same features are observed for the interaction between ferric heme and peptide R1 tau*, where the P15 residue is replaced by an alanine. Imidazole neither binds to [hemin(R1 tau)] nor [hemin(AcR1 tau)], whereas small ligands such as CN and CO easily bind to the ferric and ferrous forms of the complexes, respectively. A detailed comparative study of the peroxidase activity of [hemin(R1 tau)] and [hemin(AcR1 tau)] shows that such activity is very low. Thus, the association between heme and unfolded neuronal peptides does not, per se, involve a significant gain of toxic pseudo-enzymatic activity. However, under conditions of heavy heme release occurring on traumatic brain injury or when this activity is prolonged for long time, it can contribute to neuronal oxidative stress. In addition, the presence of hemin increases the aggregation propensity of R1 tau.	[Pirota, V.; Monzani, E.; Dell'Acqua, S.; Casella, L.] Univ Pavia, Dipartimento Chim, Via Taramelli 12, I-27100 Pavia, Italy		Casella, L (corresponding author), Univ Pavia, Dipartimento Chim, Via Taramelli 12, I-27100 Pavia, Italy.	bioinorg@unipv.it	Pirota, Valentina/H-2169-2013; Pirota, Valentina/AAA-5553-2020	Pirota, Valentina/0000-0002-6683-1726; Pirota, Valentina/0000-0002-6683-1726; MONZANI, ENRICO/0000-0002-8791-6446; Dell'Acqua, Simone/0000-0002-1231-4045	Italian MIURMinistry of Education, Universities and Research (MIUR) [2010M2JAR]	The authors thank the Italian MIUR for support through the PRIN project 2010M2JAR, and also CIRCMSB and COST CM1003.	ADAMS PA, 1990, J CHEM SOC PERK T 2, P1407, DOI 10.1039/p29900001407; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atamna H, 2009, ARCH BIOCHEM BIOPHYS, V487, P59, DOI 10.1016/j.abb.2009.05.003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Baruch-Suchodolsky R, 2009, BIOCHEMISTRY-US, V48, P4354, DOI 10.1021/bi802361k; Bush AI, 2012, J ALZHEIMERS DIS, V30, P1; Casella L, 1996, INORG CHEM, V35, P439, DOI 10.1021/ic950148x; Ciregna D, 2013, CHEM COMMUN, V49, P4027, DOI 10.1039/c3cc41297k; Collins D. P., 2013, COMPREHENSIVE INORGA, V3, P65; da Silva GFZ, 2005, ANGEW CHEM INT EDIT, V44, P5501, DOI 10.1002/anie.200501013; da Silva GFZ, 2007, ANGEW CHEM INT EDIT, V46, P3337, DOI 10.1002/anie.200604421; Dallacosta C, 2004, CHEMBIOCHEM, V5, P1692, DOI 10.1002/cbic.200400175; Dallacosta C, 2003, J BIOL INORG CHEM, V8, P770, DOI 10.1007/s00775-003-0478-z; Dallacosta C, 2007, DALTON T, P2197, DOI 10.1039/b703240d; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Montellano PRO, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P79, DOI 10.1007/978-3-642-12627-7_5; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dunford H. B., 1991, PEROXIDASES CHEM BIO, VII, P1; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Frey PA, 2012, ACS CHEM BIOL, V7, P1477, DOI 10.1021/cb300323q; Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3; Ghosh C, 2015, ACCOUNTS CHEM RES, V48, P2556, DOI 10.1021/acs.accounts.5b00102; Gullotti M, 2007, INORG CHEM, V46, P8971, DOI 10.1021/ic700852c; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hooda J, 2014, NUTRIENTS, V6, P1080, DOI 10.3390/nu6031080; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Johnstone D, 2010, J NEUROCHEM, V113, P1387, DOI 10.1111/j.1471-4159.2010.06697.x; JONES P, 1982, J INORG BIOCHEM, V17, P293, DOI 10.1016/S0162-0134(00)80090-2; Jones P., 1978, BIOCHEM J, V135, P361; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kruer M. C., 2012, INT REV NEUROBIOL, V110, P163; Kuhl T, 2014, CHEMBIOCHEM, V15, P2024, DOI 10.1002/cbic.201402218; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Ma OF, 2005, BIOPOLYMERS, V79, P74, DOI 10.1002/bip.20335; Ma QF, 2006, PEPTIDES, V27, P841, DOI 10.1016/j.peptides.2005.09.002; Meining W, 2012, BIOCHEM J, V445, P175, DOI 10.1042/BJ20120448; Meyer Y. P., 1978, METHOD ENZYMOL, V54, P249; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Minoura K, 2004, EUR J BIOCHEM, V271, P545, DOI 10.1046/j.1432-1033.2003.03956.x; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukherjee S, 2013, INORG CHEM, V52, P5226, DOI 10.1021/ic4001413; Nicolis S, 2007, CR CHIM, V10, P380, DOI 10.1016/j.crci.2006.09.013; Pirota V, 2014, NEW J CHEM, V38, P518, DOI 10.1039/c3nj01279d; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Pramanik D, 2013, COORDIN CHEM REV, V257, P81, DOI 10.1016/j.ccr.2012.02.025; Pramanik D, 2011, J AM CHEM SOC, V133, P15545, DOI 10.1021/ja204628b; Pramanik D, 2011, J AM CHEM SOC, V133, P81, DOI 10.1021/ja1084578; Reynolds MR, 2006, BIOCHEMISTRY-US, V45, P4314, DOI 10.1021/bi052142h; Roberts BR, 2012, J NEUROCHEM, V120, P149, DOI 10.1111/j.1471-4159.2011.07500.x; RODRIGUEZ RE, 1989, INORG CHEM, V28, P589, DOI 10.1021/ic00302a039; RODRIGUEZ RE, 1990, INORG CHEM, V29, P1434, DOI 10.1021/ic00332a030; Roncone R, 2005, J BIOL INORG CHEM, V10, P11, DOI 10.1007/s00775-004-0606-4; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Ryabova ES, 2004, J BIOL INORG CHEM, V9, P385, DOI 10.1007/s00775-004-0532-5; Schneider A, 1999, J NEUROCHEM, V73, pS26; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shin BK, 2011, J PHYS CHEM B, V115, P15067, DOI 10.1021/jp204410h; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Smith AG, 2011, METALLOMICS, V3, P955, DOI 10.1039/c1mt00085c; Soragni A, 2008, BIOCHEMISTRY-US, V47, P10841, DOI 10.1021/bi8008856; Thiabaud G, 2013, ANGEW CHEM INT EDIT, V52, P8041, DOI 10.1002/anie.201302989; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhou LX, 2007, PEPTIDES, V28, P2229, DOI 10.1016/j.peptides.2007.08.022; Zhou LX, 2006, BIOCHEM BIOPH RES CO, V348, P637, DOI 10.1016/j.bbrc.2006.07.099; Zhou YL, 2013, ACS CHEM NEUROSCI, V4, P535, DOI 10.1021/cn300231q	74	7	7	0	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2016	45	36					14343	14351		10.1039/c6dt02183b			9	Chemistry, Inorganic & Nuclear	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	DX2XR	WOS:000384237300040	27539650				2022-02-06	
J	Ponsford, J				Ponsford, Jennie			The practice of clinical neuropsychology in Australia	CLINICAL NEUROPSYCHOLOGIST			English	Article						Clinical neuropsychology; Australia; training; practice	TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; INDIGENOUS AUSTRALIANS; POSTTRAUMATIC AMNESIA; ALZHEIMERS-DISEASE; NORMATIVE DATA; CHILDREN; VALIDATION; SCALE; ADOLESCENTS	Objective: This paper describes the development and practice of clinical neuropsychology in Australia. Method: Clinical Neuropsychology has shown rapid growth in Australia over the past three decades. Comprehensive and specialized training programs are producing high quality graduates who are employed in a broad range of settings or private practice. Results: Australia now has a substantial number of clinical neuropsychologists with specialist training. Whilst the majority of Australian clinical neuropsychologists still undertake assessment predominantly, there are growing opportunities for clinical neuropsychologists in rehabilitation and in a broad range of research contexts. Cultural issues relating to the assessment of Indigenous Australians and immigrants from many countries present significant challenges. Some major contributions have been made in the realms of test development and validation across various age groups. Australian clinical neuropsychologists are also contributing significantly to research in the fields of traumatic brain injury, aging and dementias, epilepsy, memory assessment, rehabilitation, substance abuse, and other psychiatric disorders. Conclusion: Expansion of roles of clinical neuropsychologists, in domains such as rehabilitation and research is seen as essential to underpin continuing growth of employment opportunities for the profession.	[Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia.	jennie.ponsford@monash.edu					Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Anderson V., 1995, NEUROPSYCHOLOGICAL A; Anderson V A, 1996, Appl Neuropsychol, V3, P128, DOI 10.1207/s15324826an0303&4_5; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; BOWDEN SC, 1994, AUST PSYCHOL, V29, P34, DOI 10.1080/00050069408257317; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Dingwall KM, 2011, DRUG ALCOHOL REV, V30, P33, DOI 10.1111/j.1465-3362.2010.00194.x; Dingwall KM, 2012, DRUG ALCOHOL REV, V31, P40, DOI 10.1111/j.1465-3362.2010.00279.x; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P631, DOI 10.3109/00048671003627405; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Gonzalez LM, 2008, J INT NEUROPSYCH SOC, V14, P337, DOI 10.1017/S135561770808020X; Grove RA, 2014, CURR ALZHEIMER RES, V11, P47, DOI 10.2174/1567205010666131212110148; Honan CA, 2016, CLIN NEUROPSYCHOL, V30, P243, DOI 10.1080/13854046.2015.1136691; Kearney G. E, 1973, PSYCHOL ABORIGINAL A; Lewis MS, 2010, AUST PSYCHOL, V45, P123, DOI 10.1080/00050060903352998; Lim YY, 2014, ALZHEIMERS DEMENT, V10, P743, DOI 10.1016/j.jalz.2013.11.005; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1999, TEST EVERYDAY ATTENT; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2015, BRAIN IMPAIR, V16, P3, DOI 10.1017/BrImp.2015.7; McKay A, 2012, BRAIN IMPAIR, V13, P339, DOI 10.1017/BrImp.2012.27; Muscara F, 2010, BRAIN IMPAIR, V11, P162, DOI 10.1375/brim.11.2.162; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Porteus S. D., 1965, MANKIND Q, V5, P123; Rocca A, 2008, BRAIN IMPAIR, V9, P14, DOI 10.1375/brim.9.1.14; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; SEAGRIM G, 1980, FURNISHING MIND COMP; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Silbert BS, 2004, BRIT J ANAESTH, V92, P814, DOI 10.1093/bja/aeh157; Stolwyk RJ, 2013, BRAIN IMPAIR, V14, P243, DOI 10.1017/BrImp.2013.23; Tate RL, 2010, COMPENDIUM TESTS SCA; Thomas A, 2010, AUST NZ J PSYCHIAT, V44, P40, DOI 10.3109/00048670903393589; Walsh K. W., 1977, NEUROPSYCHOLOGY CLIN	40	7	8	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	8					1179	1192		10.1080/13854046.2016.1195015			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EA8NR	WOS:000386893100003	27684501				2022-02-06	
J	Powell, RI; Copping, AG				Powell, Ronald I.; Copping, Alex G.			Measuring fatigue-related impairment in the workplace	JOURNAL OF ENGINEERING DESIGN AND TECHNOLOGY			English	Article						Fatigue; Safety; Sleep; Accidents; Impairment; Cognitive tests	COGNITIVE IMPAIRMENT; SLEEP-DEPRIVATION; CLINICAL-TRIALS; MEMORY DECLINE; BATTERY; SCHIZOPHRENIA; PERFORMANCE; CONCUSSION; INJURY; TESTS	Purpose - This research was founded on the premise that more can be done to help improve safety in the global construction industry. Worker fatigue-impairment may be an underlying cause or major contributor to accidents. Fatigue-impairment is believed to be pervasive in construction, and research has shown it can be as concerning as alcohol-impairment. When fatigue-impairment is acknowledged as existing, there is poor understanding of its severity or how it contributes to performance and accidents. The purpose of this research was to attempt to measure fatigue-impairment in real time. Design/methodology/approach - This research expanded on actual measurements of fatiguerelated impairment from workers on a large construction project displaying significant fatigue-related impairment. The research identified and tested possible techniques for real-time measurement solutions to assist with this safety-related issue. 100 participants had their sleep/wake cycles monitored for a month with an actigraph to derive their on-going mental effectiveness levels by the minute. The same participants took cognitive tests over the month to compare mental performance results to the modelled mental effectiveness levels. Findings - Performance results from cognitive tests were compared with modelled mental effectiveness from actigraph-monitored sleep of 100 participants for a month each and showed significant correlation for all cognitive tests used. Practical implications - This research showed that real-time surrogate measurements for fatigue-impairment in the workplace exist to assist organizations manage an important workplace hazard. Originality/value - Derived from operational settings, this research developed predictive models based on simple, quick and inexpensive cognitive tests as screening techniques for workplace impairment and confirmed the need for and found a solution for fatigue monitoring in the workplace.	[Powell, Ronald I.; Copping, Alex G.] Univ Bath, Dept Architecture & Civil Engn, Bath, Avon, England		Powell, RI (corresponding author), Univ Bath, Dept Architecture & Civil Engn, Bath, Avon, England.	ronald.powell@snclavalin.com			WorkSafeBC	The authors would like to gratefully acknowledge the contributions of: Dr Gavin Shaddick, a Reader in Statistics within the department of Mathematical Sciences at the University of Bath, as well as Holly Tovey, a student of Dr Shaddick's. Their insight and knowledge of statistics was most instrumental in ensuring proper treatment of the collected data to draw valid final conclusions. Dr David Darby, Associate Professor at the University of Melbourne, for his on-going support over several years that this research spanned. His insight, knowledge, patience and prompt responses were immensely helpful in guiding the work associated with the cognitive screens. WorkSafeBC for their funding and financial contribution without which this research would not have completed in this time frame or scale.	Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2007, CONTEMP CLIN TRIALS, V28, P391, DOI 10.1016/j.cct.2006.10.010; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Darby DG, 2011, J ALZHEIMERS DIS, V27, P627, DOI 10.3233/JAD-2011-110818; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Dinges D.F., 2003, SLEEP BIOL RHYTHMS, V1, P5, DOI [10.1046/j.1446-9235.2003.00006.x, DOI 10.1046/J.1446-9235.2003.00006.X]; Dinges DF, 1997, SLEEP, V20, P267; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Faraway J, 2006, EXTENDING LINEAR MOD; Fletcher A., 2003, SLEEP RES ONLINE, V5, P67; Fredrickson J, 2010, NEUROEPIDEMIOLOGY, V34, P65, DOI 10.1159/000264823; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Lamond N, 1999, J SLEEP RES, V8, P255, DOI 10.1046/j.1365-2869.1999.00167.x; LEVINE B, 1988, SLEEP, V11, P39; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; Maruff P, 2004, DEMENT GERIATR COGN, V18, P342, DOI 10.1159/000080229; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; MORGENTHALER T, 2007, SLEEP, V0030; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Pietrzak RH, 2009, HUM PSYCHOPHARM CLIN, V24, P113, DOI 10.1002/hup.998; Powell R, 2010, J CONSTR ENG M ASCE, V136, P1086, DOI 10.1061/(ASCE)CO.1943-7862.0000211; R Development Core Team, 2010, R LANG ENV STAT COMP; Reason J., 2008, HUMAN CONTRIBUTION U; Snyder Peter J, 2005, Alzheimers Dement, V1, P126, DOI 10.1016/j.jalz.2005.09.004; Snyder PJ, 2005, HUM PSYCHOPHARM CLIN, V20, P263, DOI 10.1002/hup.692; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Van Dongen HPA, 2004, AVIAT SPACE ENVIR MD, V75, pA15; WEHR TA, 1993, AM J PHYSIOL, V265, pR846, DOI 10.1152/ajpregu.1993.265.4.R846; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	48	7	7	0	7	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1726-0531			J ENG DES TECHNOL	J. Eng. Des. Technol.		2016	14	3					507	525		10.1108/JEDT-09-2014-0063			19	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	FA5NP	WOS:000405490400006					2022-02-06	
J	Preece, MHW; Horswill, MS; Ownsworth, T				Preece, Megan H. W.; Horswill, Mark S.; Ownsworth, Tamara			Do self-reported concussions have cumulative or enduring effects on drivers' anticipation of traffic hazards?	BRAIN INJURY			English	Article						Brain concussion; mild head injury; fitness-to-drive; automobile driving; motor vehicles; hazard perception skill	TRAUMATIC BRAIN-INJURY; FUNCTIONING UNIVERSITY-STUDENTS; COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; NEUROCOGNITIVE PERFORMANCE; MULTIPLE CONCUSSIONS; SOCCER PLAYERS; HISTORY; PERCEPTION; METAANALYSIS	Aim: To investigate the cumulative effect of multiple self-reported concussions and the enduring effect of concussion on drivers' hazard perception ability. It was hypothesized: (1) that individuals reporting multiple previous concussions would be slower to anticipate traffic hazards than individuals reporting either one previous concussion or none; and (2) that individuals reporting a concussion within the past 3 months would be slower to anticipate traffic hazards than individuals reporting either an earlier concussion or no prior concussion.Method: Two hundred and eighty-two predominantly young drivers (n(concussed) = 68, M-age = 21.57 years, SDage = 6.99 years, 66% female) completed a validated hazard perception test (HPT) and measures of emotional, cognitive, health and driving status.Results: A one-way analysis of variance showed that there was no significant effect of concussion number on HPT response times. Similarly, pairwise comparisons showed no significant differences between the HPT response times of individuals reporting a concussion within the previous 3 months, individuals reporting an earlier concussion and the never concussed group.Conclusion: The findings suggest that previous concussions do not adversely affect young drivers' ability to anticipate traffic hazards; however, due to reliance on self-reports of concussion history, further prospective longitudinal research is needed.	[Preece, Megan H. W.; Ownsworth, Tamara] Griffith Univ, Brisbane, Qld, Australia; [Preece, Megan H. W.] Childrens Hlth Queensland Hosp & Hlth Serv, Brisbane, Qld, Australia; [Horswill, Mark S.] Univ Queensland, Brisbane, Qld, Australia		Preece, MHW (corresponding author), Child & Youth Mental Hlth Serv, POB 5492, Brisbane, Qld 4101, Australia.	megan.preece@griffithuni.edu.au	Ownsworth, Tamara/ABB-6961-2021; Horswill, Mark/J-9029-2019	Ownsworth, Tamara/0000-0003-1835-7094; Horswill, Mark/0000-0002-0286-6292			Babor T.F., 2001, AUDIT THE ALCOHOL US; Baddeley A., 1992, SPEED CAPACITY LANGU; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bottari C, 2012, REHABIL RES PRACT, V2012; Boufous S, 2011, TRAFFIC INJ PREV, V12, P475, DOI 10.1080/15389588.2011.591856; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Congdon P., 1999, VICROADS HAZARD PERC; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Darby P, 2009, SAFETY SCI, V47, P436, DOI 10.1016/j.ssci.2008.05.004; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Devilly G.J., 2007, CLINTOOLS SOFTWARE W; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; HOLM S, 1979, SCAND J STAT, V6, P65; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lawton R, 1997, J APPL SOC PSYCHOL, V27, P1258, DOI 10.1111/j.1559-1816.1997.tb01805.x; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Marrington SA, 2008, OPTOMETRY VISION SCI, V85, P1121, DOI 10.1097/OPX.0b013e31818e8d00; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McKenna F.P., 1999, J INT ASS TRAFFIC SA, V23, P26; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; PARKER D, 1995, ERGONOMICS, V38, P1036, DOI 10.1080/00140139508925170; Pelz D.C., 1974, ACCIDENT ANAL PREV, V6, P45, DOI [10.1016/0001-4575(74)90015-3., DOI 10.1016/0001-4575(74)90015-3]; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Sosin DM, 1996, BRAIN INJURY, V10, P47; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wechsler D, 1981, WESCHLER ADULT INTEL; Wells P, 2008, COHORT 2 STUDY LEARN; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	59	7	7	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	9					1096	1102		10.3109/02699052.2016.1165868			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DV5BN	WOS:000382940600007	27260616				2022-02-06	
J	Qian, ZY; Li, QY; Huang, SM; Ma, H				Qian Zhiyuan; Li Qingyong; Huang Shengming; Ma Hui			Protective effect of rhEPO on tight junctions of cerebral microvascular endothelial cells early following traumatic brain injury in rats	BRAIN INJURY			English	Article						Traumatic brain injury; cerebral endothelial cell; blood-brain barrier; tight junction; rhEPO	RECOMBINANT-HUMAN-ERYTHROPOIETIN; SPINAL-CORD; BARRIER; EXPRESSION; MODEL; PERMEABILITY; MECHANISM; ISCHEMIA; KINASE	Objective: The goal of this study was to investigate the protective effect of recombinant human EPO(rhEPO) on cerebral microvascular endothelial cells and the mechanisms by which rhEPO interacts with TJs proteins, claudin-5, Occludin and ZO-1 during the early period following traumatic brain injury. Research design: Rats (n = 81) were randomly divided into sham-operated group, TBI group and rhEPO+TBI group. Traumatic brain injury was induced by the Marmarou method. Methods and procedures: Rats were killed at 3, 24, 72 and 168 hours after TBI. The integrity of the blood-brain barrier was investigated by using a spectrophotometer to assess extravasation of Evans blue dye. The expression of Claudin-5, Occludin and ZO-1 were determined by immunohistochemistry and real-time fluorescence quantitative PCR. Results: From 3 hours to 3 days, rats in the TBI group demonstrated a remarkable increase in Evans blue content in the brain, relative to rats in the sham-operated group (p < 0.05). The expression of Claudin-5 and Occludin was significantly lower than those in the sham-operated group (p < 0.05). In contrast, rats in the TBI+rhEPO group demonstrated a significant decrease in brain levels. Conclusion: It was found that administration of rhEPO protected cerebral microvascular endothelial cells and reduced permeability of BBB and the mechanisms may be due to increasing the expression of TJs proteins.	[Qian Zhiyuan; Li Qingyong] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Peoples R China; [Huang Shengming] Cent Hosp Xianning, Xianning, Peoples R China; [Ma Hui] First Peoples Hosp Jining, Jining, Peoples R China		Li, QY (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Peoples R China.	liqingyong_0728@hotmail.com			Suzhou Science and Technology Development Foundation [SYSD2010122]	This work was supported by Suzhou Science and Technology Development Foundation (NO. SYSD2010122). The authors report no conflicts of interest.	Bahcekapili N, 2007, LIFE SCI, V80, P1245, DOI 10.1016/j.lfs.2006.12.014; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Chatagner A, 2010, ARCH PEDIATRIE, V17, pS78, DOI 10.1016/S0929-693X(10)70905-2; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Cruzalegui FH, 2000, CELL MOL LIFE SCI, V57, P402, DOI 10.1007/PL00000702; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grotta JC, 2002, STROKE PROGR REV GRO; Hoffman WH, 2009, BRAIN RES, V1254, P138, DOI 10.1016/j.brainres.2008.11.100; Jelkmann W, 1996, ANN ANAT, V178, P391, DOI 10.1016/S0940-9602(96)80124-5; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; Knabe W, 2005, ANAT EMBRYOL, V210, P209, DOI 10.1007/s00429-005-0019-3; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; KOURY MJ, 1992, EUR J BIOCHEM, V210, P649, DOI 10.1111/j.1432-1033.1992.tb17466.x; Krueger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056419; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Liu K, 2013, J MOL NEUROSCI, V49, P369, DOI 10.1007/s12031-012-9883-5; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Norsted E, 2008, J CHEM NEUROANAT, V36, P107, DOI 10.1016/j.jchemneu.2008.06.002; Okutan O, 2007, J CLIN NEUROSCI, V14, P364, DOI 10.1016/j.jocn.2006.01.022; Okutan O, 2008, SURG NEUROL, V70, P498, DOI 10.1016/j.surneu.2007.07.061; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com	30	7	9	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					462	467		10.3109/02699052.2015.1080386			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200011	26934476				2022-02-06	
J	Root, AE; Wimsatt, M; Rubin, KH; Bigler, ED; Dennis, M; Gerhardt, CA; Stancin, T; Taylor, HG; Vannatta, K; Yeates, KO				Root, Amy E.; Wimsatt, Maureen; Rubin, Kenneth H.; Bigler, Erin D.; Dennis, Maureen; Gerhardt, Cynthia A.; Stancin, Terry; Taylor, H. Gerry; Vannatta, Kathryn; Yeates, Keith O.			Children with traumatic brain injury: Associations between parenting and social adjustment	JOURNAL OF APPLIED DEVELOPMENTAL PSYCHOLOGY			English	Article						Traumatic brain injury; Parenting; Social adjustment; Peer rejection	BEHAVIOR PROBLEMS; PEER REJECTION; EXECUTIVE DYSFUNCTION; ADOLESCENTS; COMPETENCE; OUTCOMES; FRIENDSHIP; STRESS; TERM; RESPONSIVENESS	Similarities and differences in parenting practices of children (M-age = 10; range, 8-13 years) with traumatic brain injury (TBI) and socially-typical controls were examined. In addition, parenting practices were examined as moderators between injury group status (TBI or socially typical) and social adjustment in the peer group. Mothers completed assessments of parenting practices; children's peers reported about children's social adjustment. The mothers of children with TBI reported significantly lower levels of nurturance and significantly higher levels of restrictiveness than mothers of socially-typical children. In addition, mothers' nurturance moderated the relation between injury group and peer rejection, such that children with TBI were more rejected by classmates compared to their socially-typical peers at low levels of maternal nurturance. The findings are interpreted as supporting the important role parents play in the development of children with a history of TBI, as well as the implications for family level interventions. (C) 2015 Elsevier Inc. All rights reserved.	[Root, Amy E.] W Virginia Univ, Dept Learning Sci & Human Dev, 504J Allen Hall,Box 6122, Morgantown, WV 26506 USA; [Wimsatt, Maureen; Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, 3304 Benjamin Bldg, College Pk, MD 20742 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA; [Dennis, Maureen] Univ Toronto, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Gerhardt, Cynthia A.] Nationwide Childrens Hosp, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA; [Stancin, Terry] Med Ctr, 2500 Metrohlth Dr, Cleveland, OH 44109 USA; [Taylor, H. Gerry] Rainbow Child Dev Ctr, WO Walker Bldg,Suite 3150,10524 Euclid Ave, Cleveland, OH 44106 USA; [Yeates, Keith O.] Univ Calgary, AD 254,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada		Root, AE (corresponding author), W Virginia Univ, Dept Learning Sci & Human Dev, 504J Allen Hall,Box 6122, Morgantown, WV 26506 USA.	Amy.Kennedy@mail.wvu.edu; wimsattm@umd.edu; krubin@umd.edu; erin_bigler@byu.edu; maureen.dennis@sickkids.ca; Cynthia.Gerhardt@nationwidechildrens.org; stancin@metrohealth.org; hgt2@case.edu; Kathryn.Vannatta@nationwidechildrens.org; kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019; Rubin, Kenneth H/M-5276-2018	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R01HD048946]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH58116]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH058116] Funding Source: NIH RePORTER	This research was supported by the National Institute of Child Health and Human Development (Grant # 5R01HD048946) and the National Institute of Mental Health (Grant # MH58116).	Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.1111/j.1467-8624.1984.tb00275.x; Booth-LaForce C, 2006, ATTACH HUM DEV, V8, P309, DOI 10.1080/14616730601048209; Booth-LaForce C, 2012, J CLIN CHILD ADOLESC, V41, P138, DOI 10.1080/15374416.2012.651995; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; BOWLBY J, 1969, ATTACHMENT; Brand AE, 2010, NEW DIR CHILD ADOLES, V128, P85, DOI 10.1002/cd.270; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Brophy-Herb HE, 2011, SOC DEV, V20, P73, DOI 10.1111/j.1467-9507.2009.00570.x; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Bumpus MF, 2001, DEV PSYCHOL, V37, P163, DOI 10.1037/0012-1649.37.2.163; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Collins WA, 2006, CAMB ST SOC, P23, DOI 10.1017/CBO9780511499760.003; Cook EC, 2012, SOC DEV, V21, P461, DOI 10.1111/j.1467-9507.2011.00642.x; Fearon RP, 2010, CHILD DEV, V81, P435, DOI 10.1111/j.1467-8624.2009.01405.x; GELFAND DM, 1992, J CLIN CHILD PSYCHOL, V21, P262, DOI 10.1207/s15374424jccp2103_8; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grusec Hastings, 2007, HDB SOCIALIZATION TH, P284, DOI DOI 10.1111/J.1467-8624.2010.01426.X; Grusec J. E., 2013, HDB PSYCHOL DEV PSYC, V6, P243; Guhn M, 2013, J HAPPINESS STUD, V14, P1529, DOI 10.1007/s10902-012-9393-8; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hoglund WLG, 2008, SOC DEV, V17, P528, DOI 10.1111/j.1467-9507.2007.00449.x; Hullmann SE, 2010, J CLIN PSYCHOL MED S, V17, P357, DOI 10.1007/s10880-010-9213-4; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kochanska G, 2007, DEV PSYCHOL, V43, P222, DOI 10.1037/0012-1649.43.1.222; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Ladd GW, 2006, CHILD DEV, V77, P822, DOI 10.1111/j.1467-8624.2006.00905.x; Ladd GW, 1998, DEV PSYCHOL, V34, P1450, DOI 10.1037/0012-1649.34.6.1450; Lewis-Morrarty E, 2012, J ABNORM CHILD PSYCH, V40, P1363, DOI 10.1007/s10802-012-9663-2; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McShane KE, 2009, INT J BEHAV DEV, V33, P481, DOI 10.1177/0165025409103874; Park J., 2005, EARLY EDUC DEV, V16, P233, DOI [DOI 10.1080/10409289.2005.10472869, 10.1080/10409289.2005.10472869]; PARKER JG, 1989, PEER RELATIONSHIPS C, P00095; Pedersen S, 2007, CHILD DEV, V78, P1037, DOI 10.1111/j.1467-8624.2007.01051.x; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; RICKEL AU, 1982, J CLIN PSYCHOL, V38, P129, DOI 10.1002/1097-4679(198201)38:1<129::AID-JCLP2270380120>3.0.CO;2-3; Rodriguez EM, 2012, J PEDIATR PSYCHOL, V37, P185, DOI 10.1093/jpepsy/jsr054; Rubin K. H., 2015, HDB CHILD PSYCHOL DE, V4, P175, DOI [10.1002/9781118963418.childpsy405, DOI 10.1002/9781118963418.CHILDPSY405]; Rubin K.H., 2013, SOCIAL PERSONALITY D, P317; Rubin KH, 2003, DEV PSYCHOL, V39, P164, DOI 10.1037//0012-1649.39.1.164; Schuster RM, 2013, J YOUTH ADOLESCENCE, V42, P1194, DOI 10.1007/s10964-012-9809-0; Sentse M, 2010, J ABNORM CHILD PSYCH, V38, P119, DOI 10.1007/s10802-009-9351-z; Steinberg LD., 2002, HDB PARENTING, V2, P103; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Swanson J, 2011, J EARLY ADOLESCENCE, V31, P548, DOI 10.1177/0272431610366249; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Uslu MM, 2008, ARCH ORTHOP TRAUM SU, V128, P417, DOI 10.1007/s00402-007-0393-9; van der Voort A, 2013, CHILD YOUTH SERV REV, V35, P439, DOI 10.1016/j.childyouth.2012.12.008; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zeller M, 2003, DEV PSYCHOL, V39, P129, DOI 10.1037//0012-1649.39.1.129	59	7	8	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0193-3973	1873-7900		J APPL DEV PSYCHOL	J. Appl. Dev. Psychol.	JAN-FEB	2016	42						1	7		10.1016/j.appdev.2015.10.002			7	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	DD7NF	WOS:000370110700001	26726276	Green Accepted			2022-02-06	
J	Sharpe, JP; Magnotti, LJ; Weinberg, JA; Schroeppel, TJ; Fabian, TC; Croce, MA				Sharpe, John P.; Magnotti, Louis J.; Weinberg, Jordan A.; Schroeppel, Thomas J.; Fabian, Timothy C.; Croce, Martin A.			The old man and the C-spine fracture: Impact of halo vest stabilization in patients with blunt cervical spine fractures	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Age; halo vest; cervical spine fracture; trauma	ODONTOID FRACTURES; FIXATION; IMMOBILIZATION; MANAGEMENT; STABILITY	BACKGROUND Placement of a halo vest for cervical spine fractures is presumed to be less morbid than operative fixation. However, restrictions imposed by the halo vest can be detrimental, especially in older patients. The purpose of this study was to evaluate the impact of halo vest placement on outcomes by age in patients with cervical spine fractures without spinal cord injury. METHODS All patients with blunt cervical spine fractures managed over an 18-year period were identified. Those with spinal cord injury and severe traumatic brain injury were excluded. Patients were stratified by age, sex, halo vest, injury severity, and severity of shock. Outcomes included intensive care unit length of stay, ventilator days, ventilator-associated pneumonia, functional status, and mortality. Multivariable logistic regression was performed to determine whether halo vest was an independent predictor of mortality in older patients. RESULTS A total of 3,457 patients were identified: 69% were male, with a mean Injury Severity Score (ISS) and Glasgow Coma Scale (GCS) score of 19 and 13, respectively. Overall mortality was 5.3%. One hundred seventy-nine patients were managed with a halo vest, 133 of those 54 years and older and 46 of those younger than 54 years. Both mortality (13% vs. 0%, p < 0.001) and intensive care unit length of stay (4 days vs. 2 days, p = 0.02) were significantly increased in older patients despite less severe injury (admission GCS score of 15 vs. 14 and ISS of 14 vs. 17, p = 0.03). Multivariable logistic regression identified halo vest as an independent predictor of mortality after adjusting for injury severity and severity of shock (odds ratio, 2.629; 95% confidence interval, 1.056-6.543) in older patients. CONCLUSION The potential risk of operative stabilization must be weighed against that of halo vest placement for older patients with cervical spine fractures following blunt trauma. Patient age should be strongly considered before placement of a halo vest for cervical spine stabilization.	[Sharpe, John P.; Magnotti, Louis J.; Weinberg, Jordan A.; Schroeppel, Thomas J.; Fabian, Timothy C.; Croce, Martin A.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA		Sharpe, JP (corresponding author), Dept Surg, 910 Madison Ave,210, Memphis, TN 38163 USA.	jsharpe6@uthsc.edu		Schroeppel, Thomas/0000-0001-9164-5004			AEBI M, 1986, CLIN ORTHOP RELAT R, P244; BEDNAR DA, 1995, J SPINAL DISORD, V8, P166; Berlemann U, 1997, ACTA ORTHOP SCAND, V68, P319, DOI 10.3109/17453679708996169; BONI M, 1980, Italian Journal of Orthopaedics and Traumatology, V6, P305; Boni M, 1983, Ital J Orthop Traumatol, V9 Suppl, P107; Borm W, 2003, NEUROSURGERY, V52, P1089, DOI 10.1227/01.NEU.0000057697.62046.16; Botte, 1996, J Am Acad Orthop Surg, V4, P44; Campanelli M, 1999, SURG NEUROL, V51, P596, DOI 10.1016/S0090-3019(98)00136-0; Croce MA, 2001, ANN SURG, V233, P851, DOI 10.1097/00000658-200106000-00016; Denaro L, 2010, PITFALLS IN CERVICAL SPINE SURGERY: AVOIDANCE AND MANAGEMENT OF COMPLICATIONS, P175, DOI 10.1007/978-3-540-85019-9_12; Denaro L, 2010, PITFALLS IN CERVICAL SPINE SURGERY: AVOIDANCE AND MANAGEMENT OF COMPLICATIONS, P291, DOI 10.1007/978-3-540-85019-9_19; DORR LD, 1982, SPINE, V7, P545, DOI 10.1097/00007632-198211000-00006; Fagin AM, 2010, J TRAUMA, V68, P583, DOI 10.1097/TA.0b013e3181b23608; Garrido MM, 2014, HEALTH SERV RES, V49, P1701, DOI 10.1111/1475-6773.12182; HANIGAN WC, 1993, J NEUROSURG, V78, P32, DOI 10.3171/jns.1993.78.1.0032; Irwin ZN, 2004, SPINE, V29, P796, DOI 10.1097/01.BRS.0000119400.92204.B5; Kerwin AJ, 2008, J TRAUMA, V65, P824, DOI 10.1097/TA.0b013e318182af7b; KRAG MH, 1988, SPINE, V13, P228, DOI 10.1097/00007632-198803000-00002; Le CT, 2006, STAT METHODS MED RES, V15, P571, DOI 10.1177/0962280206070637; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lindsey RW, 2003, SKELETAL TRAUMA, P746; Longo UG, 2010, PITFALLS IN CERVICAL SPINE SURGERY: AVOIDANCE AND MANAGEMENT OF COMPLICATIONS, P239, DOI 10.1007/978-3-540-85019-9_17; Majercik S, 2005, J TRAUMA, V59, P350, DOI 10.1097/01.ta.0000174671.07664.7c; PEPIN JW, 1985, CLIN ORTHOP RELAT R, P178; PERRY J, 1959, J BONE JOINT SURG AM, V41, P37, DOI 10.2106/00004623-195941010-00006; Rao G, 2004, CERVICAL SPINE, P614; Richardson JK, 2000, ARCH PHYS MED REHAB, V81, P255, DOI 10.1053/apmr.2000.0810255; Strohm PC, 2007, ZBL CHIR, V132, P54, DOI 10.1055/s-2006-960479; Tashjian RZ, 2006, J TRAUMA, V60, P199, DOI 10.1097/01.ta.0000197426.72261.17; Tinubu J, 2015, SURG CLIN N AM, V95, P115, DOI 10.1016/j.suc.2014.09.017; TRIGGS KJ, 1989, SPINE, V14, P781, DOI 10.1097/00007632-198908000-00001; *US CENS BUR, AG DAT; Weller SJ, 1997, SURG NEUROL, V47, P274, DOI 10.1016/S0090-3019(96)00362-X	33	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2016	80	1					76	80		10.1097/TA.0000000000000894			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DA1GN	WOS:000367544400011	26491800				2022-02-06	
J	Sheng, T; Fairchild, JK; Kong, JY; Kinoshita, LM; Cheng, JJ; Yesavage, JA; Helmer, DA; Reinhard, MJ; Ashford, JW; Adamson, MM				Sheng, Tong; Fairchild, J. Kaci; Kong, Jennifer Y.; Kinoshita, Lisa M.; Cheng, Jauhtai J.; Yesavage, Jerome A.; Helmer, Drew A.; Reinhard, Matthew J.; Ashford, J. Wesson; Adamson, Maheen M.			The influence of physical and mental health symptoms on Veterans' functional health status	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						chronic multisymptom illness; daily functioning; functional health; mental health; posttraumatic stress; quality of life; symptoms; traumatic brain injury; Veterans; war-related illness	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; CHRONIC MULTISYMPTOM ILLNESS; OPERATIONS ENDURING FREEDOM; POPULATION-BASED SURVEY; GULF-WAR VETERANS; PSYCHOMETRIC PROPERTIES; PTSD CHECKLIST; CARE; MILITARY	Veterans who have been deployed to combat often have complex medical histories, including some combination of traumatic brain injury (TBI); mental health problems; and other chronic, medically unexplained symptoms (i.e., chronic multisymptom illness [CMI] clusters). How these multiple pathologies relate to functional health is unclear. In the current study, 120 Veterans (across multiple combat cohorts) underwent comprehensive clinical evaluations and completed self-report assessments of mental health symptoms (Patient Health Questionnaire-2 [PHQ-2], Posttraumatic Stress Disorder Checklist-Civilian Version [PCL-C]) and functional health (Veterans Rand 36-Item Health Survey). Canonical correlation and regression modeling using split-sample permutation tests revealed that the PHQ-2/PCL-C composite variable (among TBI severity and number of problematic CMI clusters) was the primary predictor of multiple functional health domains. Two subscales, Bodily Pain and General Health, were associated with multiple predictors (TBI, PHQ-2/PCL-C, and CMI; and PHQ-2/PCL-C and CMI, respectively), demonstrating the multifaceted nature of how distinct medical problems might uniquely and collectively impair aspects of functional health. Apart from these findings, however, TBI and CMI were not predictors of any other aspects of functional health. Taken together, our findings suggest that mental health problems might exert ubiquitous influence over multiple domains of functional health. Thus, screening of mental health problems and education and promotion of mental health resources can be important to the treatment and care of Veterans.	[Sheng, Tong; Fairchild, J. Kaci; Kinoshita, Lisa M.; Cheng, Jauhtai J.; Yesavage, Jerome A.; Ashford, J. Wesson; Adamson, Maheen M.] Dept Vet Affairs VA Palo Alto Hlth Care Syst, War Related Illness & Injury Study Ctr, Palo Alto, CA USA; [Sheng, Tong; Fairchild, J. Kaci; Cheng, Jauhtai J.; Yesavage, Jerome A.; Ashford, J. Wesson; Adamson, Maheen M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA USA; [Kong, Jennifer Y.] Boston Univ, Sch Social Work, Boston, MA 02215 USA; [Helmer, Drew A.] VA New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ USA; [Reinhard, Matthew J.] VA Med Ctr, War Related Illness & Injury Study Ctr, Washington, DC USA; [Adamson, Maheen M.] VA Palo Alto Hlth Care Syst, Def & Vet Brain Injury Ctr, Palo Alto, CA USA		Sheng, T (corresponding author), 3801 Miranda Ave, Palo Alto, CA 94303 USA.	Tong.Sheng@va.gov	Ashford, J. Wesson/D-3929-2009; Sheng, Tong/C-6306-2019	Sheng, Tong/0000-0003-1067-7608; Adamson, Maheen/0000-0002-1534-4063	WRIISC at the VA Palo Alto Health Care System	This material was based on work supported by the WRIISC at the VA Palo Alto Health Care System.	Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Baker DG, 1997, ARCH INTERN MED, V157, P2076, DOI 10.1001/archinte.157.18.2076; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blanchard MS, 2006, AM J EPIDEMIOL, V163, P66, DOI 10.1093/aje/kwj008; BOUSQUET J, 1994, AM J RESP CRIT CARE, V149, P371, DOI 10.1164/ajrccm.149.2.8306032; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cohen H, 2002, SEMIN ARTHRITIS RHEU, V32, P38, DOI 10.1053/sarh.2002.33719; Committee on Gulf War and Health: Treatment for Chronic Multisymptom Illness; Board on the Health of Select Populations; Institute of Medicine, 2013, GULF WAR HLTH TREATM; Corson K, 2004, AM J MANAG CARE, V10, P839; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gerrity MS, 2007, J GEN INTERN MED, V22, P1321, DOI 10.1007/s11606-007-0290-5; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hawkley LC, 2003, BRAIN BEHAV IMMUN, V17, pS98; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Karstoft KI, 2014, PSYCHOL ASSESSMENT, V26, P321, DOI 10.1037/a0034889; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lange G, 2013, MIL MED, V178, P705, DOI 10.7205/MILMED-D-13-00053; LEEDHAM CS, 1993, MIL MED, V158, P508, DOI 10.1093/milmed/158.8.508; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Miller CS, 1999, JAMA-J AM MED ASSOC, V282, P328; Nisenbaum R, 2000, J NERV MENT DIS, V188, P259, DOI 10.1097/00005053-200005000-00002; Orsillo S.M., 2001, PRACTITIONERS GUIDE, P255, DOI DOI 10.1007/0-306-47628-2_20; Petrie KJ, 2004, BRIT J HEALTH PSYCH, V9, P101, DOI 10.1348/135910704322778759; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Schnurr PP, 1999, J NERV MENT DIS, V187, P353, DOI 10.1097/00005053-199906000-00004; Smith TC, 2014, AM J EPIDEMIOL, V180, P1176, DOI 10.1093/aje/kwu240; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; U.S. Veterans Health Administration Office of Performance and Quality Center for Health Quality Outcomes & Economic Research, 1998, HLTH STAT OUTC VET P; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wolfe J, 1999, PSYCHOSOM MED, V61, P532, DOI 10.1097/00006842-199907000-00018; Wolfe J, 2002, J OCCUP ENVIRON MED, V44, P271, DOI 10.1097/00043764-200203000-00015	61	7	7	2	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	6					781	795		10.1682/JRRD.2015.07.0146			15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EK5SC	WOS:000393985100012	28273324	gold			2022-02-06	
J	Sun, D				Sun, Dong			The potential of neural transplantation for brain repair and regeneration following traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						traumatic brain injury; stem cells; neural transplantation; regeneration; functional recovery	NEURONAL PROGENITOR CELLS; ADULT HUMAN BRAIN; LATENT NEUROGENIC PROGRAM; SUBCORTICAL WHITE-MATTER; STEM-CELLS; FUNCTIONAL RECOVERY; HIPPOCAMPAL NEUROGENESIS; STEM/PROGENITOR CELLS; COLLAGEN SCAFFOLDS; COGNITIVE FUNCTION	Traumatic brain injury is a major health problem worldwide. Currently, there is no effective treatment to improve neural structural repair and functional recovery of patients in the clinic. Cell transplantation is a potential strategy to repair and regenerate the injured brain. This review article summarized recent development in cell transplantation studies for post-traumatic brain injury brain repair with varying types of cell sources. It also discussed the potential of neural transplantation to repair/promote recovery of the injured brain following traumatic brain injury.	[Sun, Dong] Virginia Commonwealth Univ, Dept Neurosurg, Sch Med, Richmond, VA USA		Sun, D (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, Sch Med, Richmond, VA USA.	dsun@vcu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS078710]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS078710] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Health Grant No. NS078710.	Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Brunet JF, 2005, EXP NEUROL, V196, P195, DOI 10.1016/j.expneurol.2005.04.005; Brunet JF, 2003, CRYOBIOLOGY, V47, P179, DOI 10.1016/j.cryobiol.2003.08.005; Brunet JF, 2002, LAB INVEST, V82, P809, DOI 10.1097/01.LAB.0000017166.26718.BB; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Klassen H, 2003, VISION RES, V43, P947, DOI 10.1016/S0042-6989(03)00094-4; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lie DC, 2002, J NEUROSCI, V22, P6639; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Olstorn H, 2007, NEUROSURGERY, V60, P1089, DOI 10.1227/01.NEU.0000255461.91892.0D; Palmer TD, 1999, J NEUROSCI, V19, P8487; Richardson RM, 2006, ACTA NEUROCHIR, V148, P773, DOI 10.1007/s00701-006-0778-5; Richardson RM, 2005, MOL CELL NEUROSCI, V28, P674, DOI 10.1016/j.mcn.2004.11.013; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Skardelly M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00318; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Sun D, 2011, J NEUROTRAUMA; Sun T, 2013, MOL NEUROBIOL, V47, P938, DOI 10.1007/s12035-012-8388-0; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Weiss S, 1996, J NEUROSCI, V16, P7599; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Zhang RL, 2003, NEUROSCIENCE, V116, P373, DOI 10.1016/S0306-4522(02)00696-6; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106	55	7	8	0	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2016	11	1					18	22		10.4103/1673-5374.169605			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DD7ZF	WOS:000370142800004	26981070	Green Published, gold			2022-02-06	
S	Tortella, FC		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Tortella, Frank C.			Challenging the Paradigms of Experimental TBI Models: From Preclinical to Clinical Practice	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Animal models; Neuroprotection; Clinical trials; Experimental TBI; Animal modeling	TRAUMATIC BRAIN-INJURY; COMMON DATA ELEMENTS; ANIMAL-MODELS; NEUROTRAUMA; BIOMARKERS	Despite prodigious advances in TBI neurobiology research and a broad arsenal of animal models mimicking different aspects of human brain injury, this field has repeatedly experienced collective failures to translate from animals to humans, particularly in the area of therapeutics. This lack of success stems from variability and inconsistent standardization across models and laboratories, as well as insufficient objective and quantifiable diagnostic measures (biomarkers, high-resolution imaging), understanding of the vast clinical heterogeneity, and clinically centered conception of the TBI animal models. Significant progress has been made by establishing well-defined standards for reporting animal studies with " preclinical common data elements" (CDE), and for the reliability and reproducibility in preclinical TBI therapeutic research with the Operation Brain Trauma Therapy (OBTT) consortium. However, to break the chain of failures and achieve a therapeutic breakthrough in TBI will probably require the use of higher species models, specific mechanism-based injury models by which to theranostically targeted treatment portfolios are tested, more creative concepts of therapy intervention including combination therapy and regeneration neurobiology strategies, and the adoption of dosing regimens based upon pharmacokinetic-pharmacodynamic (PK-PD) studies and guided by the injury severity and TBI recovery process.	[Tortella, Frank C.] Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Tortella, FC (corresponding author), Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.						Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Briones TL, 2015, ANNU REV NURS RES-SE, V33, P31, DOI 10.1891/0739-6686.33.31; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Tortella FC, 2015, SHOCK, V44, P17, DOI 10.1097/SHK.0000000000000380; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	15	7	7	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						735	740		10.1007/978-1-4939-3816-2_40	10.1007/978-1-4939-3816-2		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500042	27604748				2022-02-06	
J	Wilson, SH; Weaver, LK; Lindblad, AS				Wilson, Steffanie H.; Weaver, Lindell K.; Lindblad, Anne S.			Neuropsychological assessments in a hyperbaric trial of post-concussive symptoms	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						brain concussion; neuropsychology; post-concussion syndrome; methodology	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; ALCOHOL-CONSUMPTION QUESTIONS; MCGILL-PAIN-QUESTIONNAIRE; TBI IDENTIFICATION METHOD; OIF/OEF VETERANS; HEAD-INJURY; MILD TBI; CES-D	Results of studies addressing the effect of mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) on symptoms and neuropsychological assessments are mixed regarding cognitive deficits in these populations. Neuropsychological assessments were compared between U.S. military service members with mTBI only (n=36) vs. those with mTBI+PTSD (n=35) from a randomized interventional study of mTBI participants with persistent post-concussive symptoms (PCS). The mTBI group endorsed worse symptoms than published norms on PCS, PTSD and pain scales (>50% abnormal on Neurobehavioral Symptom Inventory (NSI), PTSD Checklist-Civilian, McGill Pain Questionnaire-Short Form) and some quality of life domains. Worse symptom reporting was found in the mTBI+PTSD group compared to mTBI (e.g., mean NSI total score in mTBI 27.5 (SD=12.7), mTBI+PTSD 39.9 (SD=13.6), p<0.001). The mTBI+PTSD group performed worse than mTBI on the Weschler Adult Intelligence Scale digit span (mean difference-1.5, 95% Cl[-2.9,-0.1], p=0.04) and symbol search (mean difference-1.5, 95% Cl[-2.7,-0.2], p=0.03) and Grooved Pegboard (dominant hand mean difference-7.0, 95% Cl[-11.5,-2.4], p=0.003; non-dominant mean difference-9.8, 95% Cl[-14.9,-4.7], p<0.001). Differences were detected in ANAM simple reaction time (p=0.04) and mathematical processing (p=0.03) but not verbal fluency or visuospatial memory assessments. Results indicate increased symptom severity and some cognitive deficits in mTBI+PTSD compared to mTBI alone.	[Wilson, Steffanie H.; Lindblad, Anne S.] Emmes Corp, Rockville, MD USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA		Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA.	lindell.weaver@imail.org			U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication has not yet been locked and is therefore subject to change.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bahraini NH, 2015, VA TRAUM BRAIN INJ S; Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1097/00000374-199811000-00034; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC) the National Institutes of Health (NIH) the Department of Defense (DoD) and the Department of Veterans Affairs (VA), 2013, REP C TRAUM INJ US U; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Gillis MM, 1995, PSYCHOL ASSESSMENT, V7, P450, DOI 10.1037/1040-3590.7.4.450; Golden C.J., 1978, MANUAL STROOP COLOR; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Ibarra S., 2011, ENCY CLIN NEUROPSYCH, P325; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Meier B, 2015, NY TIMES; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Strand LI, 2008, EUR J PAIN, V12, P917, DOI 10.1016/j.ejpain.2007.12.013; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The WHOQOL group, 1998, PSYCHO MED, V28, P551; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF 36 HLTH SURVEY MA; Weaver LK, 2014, UNDERSEA HYPERBAR M, V41, P431; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137	61	7	7	0	6	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		585	599					15	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300008	28768075				2022-02-06	
J	Wu, CH; Tsai, TH; Su, YF; Zhang, ZH; Liu, W; Wu, MK; Chang, CH; Kuo, KL; Lu, YY; Lin, CL				Wu, Chieh-Hsin; Tsai, Tai-Hsin; Su, Yu-Feng; Zhang, Zi-Hao; Liu, Wei; Wu, Ming-Kung; Chang, Chih-Hui; Kuo, Keng-Liang; Lu, Ying-Yi; Lin, Chih-Lung			Traumatic Brain Injury and Substance Related Disorder: A 10-Year Nationwide Cohort Study in Taiwan	NEURAL PLASTICITY			English	Article							ORBITOFRONTAL CORTEX; RISK; ALCOHOL; HISTORY	Whether traumatic brain injury (TBI) is causally related to substance related disorder (SRD) is still debatable, especially in persons with no history of mental disorders at the time of injury. This study analyzed data in the Taiwan National Health Insurance Research Database for 19,109 patients aged >= 18 years who had been diagnosed with TBI during 2000-2010. An additional 19,109 randomly selected age and gender matched patients without TBI (1 : 1 ratio) were enrolled in the control group. The relationship between TBI and SRD was estimated with Cox proportional hazard regression models. During the follow-up period, SRD developed in 340 patients in the TBI group and in 118 patients in the control group. After controlling for covariates, the overall incidence of SRD was 3.62-fold higher in the TBI group compared to the control group. Additionally, patients in the severe TBI subgroup were 9.01 times more likely to have SRD compared to controls. Notably, patients in the TBI group were prone to alcohol related disorders. The data in this study indicate that TBI is significantly associated with the subsequent risk of SRD. Physicians treating patients with TBI should be alert to this association to prevent the occurrence of adverse events.	[Wu, Chieh-Hsin; Lu, Ying-Yi; Lin, Chih-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan; [Wu, Chieh-Hsin; Tsai, Tai-Hsin; Su, Yu-Feng; Chang, Chih-Hui; Kuo, Keng-Liang; Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 807, Taiwan; [Zhang, Zi-Hao] 7 Peoples Hosp Hebei Prov, Dept Neurosurg, Dingzhou 073000, Hebei, Peoples R China; [Liu, Wei] Yucheng Peoples Hosp, Dept Neurosurg, Yucheng 251200, Shandong, Peoples R China; [Wu, Ming-Kung] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung 807, Taiwan; [Wu, Ming-Kung] Chang Gung Univ, Coll Med, Kaohsiung 807, Taiwan; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung 807, Taiwan; [Lu, Ying-Yi] Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung 807, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Fac Med, Coll Med, Dept Neurosurg, Kaohsiung 807, Taiwan		Lu, YY; Lin, CL (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 807, Taiwan.; Lu, YY (corresponding author), Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung 807, Taiwan.; Lu, YY (corresponding author), Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung 807, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Fac Med, Coll Med, Dept Neurosurg, Kaohsiung 807, Taiwan.	u103800011@cc.kmu.edu.tw; chihlung1@yahoo.com		Su, Yu-feng/0000-0003-0355-3981; Lin, Chih-Lung/0000-0002-6716-2771; Kuo, Keng-Liang/0000-0001-7353-0967			Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Chung KH, 2015, J CLIN SLEEP MED, V11, P542, DOI 10.5664/jcsm.4700; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DiRusso SM, 2000, J TRAUMA, V49, P212, DOI 10.1097/00005373-200008000-00006; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Franulic A, 2000, BRAIN INJURY, V14, P431; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hu LY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002800; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Johnson L. A., 2014, MIL MED, V180, P208; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kuan AS, 2014, J CHIN MED ASSOC, V77, P457, DOI 10.1016/j.jcma.2014.06.005; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Mortensen EM, 2010, AM J MED, V123, P66, DOI 10.1016/j.amjmed.2009.08.009; Nakagawa TA, 2011, CRIT CARE MED, V39, P2139, DOI 10.1097/CCM.0b013e31821f0d4f; Nanchal R, 2014, RESP CARE, V59, P644, DOI 10.4187/respcare.02505; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Tung YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129043; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001	36	7	7	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2016	2016								8030676	10.1155/2016/8030676			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY4PZ	WOS:000385082600001		Green Published, Green Submitted, gold			2022-02-06	
J	Yang, LZ; Yan, XP; Xu, ZY; Tan, W; Chen, Z; Wu, B				Yang, Liuzhu; Yan, Xinping; Xu, Zunying; Tan, Wei; Chen, Zhong; Wu, Bo			Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Erythropoietin; delayed treatment; spinal cord injury; myelin; functional recovery; rats	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION; GENE-EXPRESSION; METHYLPREDNISOLONE; NEUROPROTECTION; RECEPTOR; CELLS; MODEL; PATHOLOGY; CULTURE	Purpose: A previous study showed that a 1-h delay in treatment of thoracic spinal cord injury (SCI) with recombinant human erythropoietin (rhEPO) lacked neuroprotective efficacy. The aim of the present study was to reassess delayed administration of different doses of rhEPO on acute spinal cord compressive injury in rats. Methods: The experiment was divided into first and second stages, which SCI rats were observed for 4 and 28 days, respectively. All rats were randomly divided into four groups at both stages: control group, and rhEPO-3,000U (Unit), rhEPO4,000U and rhEPO-5,000U groups. SCI rats received rhEPO treatment at different time points. The primary indicators were locomotor recovery, histopathology, apoptotic index, inflammatory index, ultrastructural scoring system and volume of areas of demyelination. Results: The most significant locomotor functional and histopathological improvements and the best myelin protection were observed after administration of 5,000 U/kg rhEPO. rhEPO at 3,000, 4,000 and 5,000 U/kg showed similar ultrastructural neuroprotection, as well as similar inhibition of apoptosis and regulation of inflammation. Conclusion: Delayed administration of rhEPO can reduce apoptosis and inflammation, and promote myelin repair and functional recovery following spinal cord compressive injury in rats.	[Yang, Liuzhu; Yan, Xinping; Xu, Zunying; Tan, Wei; Chen, Zhong; Wu, Bo] Southern Med Univ, Zhujiang Hosp, Dept Orthoped, 253 Ind Rd, Guangzhou 510280, Guangdong, Peoples R China; [Yang, Liuzhu] Hezhou City Pepoles Hosp, Dept Orthoped, Hezhou, Guangxi, Peoples R China		Chen, Z (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Orthoped, 253 Ind Rd, Guangzhou 510280, Guangdong, Peoples R China.	czjzkd2013@sina.com		Tan, Wei/0000-0002-5739-2258; Chen, Zhong/0000-0002-6743-1601	Science and Technology Planning Project of Guangdong Province [2011B031300005]; Guangzhou Haizhu District [2011-YL-01]	This work was supported by Science and Technology Planning Project of Guangdong Province (2011B031300005) and Guangzhou Haizhu District(2011-YL-01). We thank Dr. Jia-Gen Chen and Dr. Yan-Yang Jia for the technical assistance.	Arishima Y, 2006, SPINE, V31, P2432, DOI 10.1097/01.brs.0000239124.41410.7a; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; Boran BO, 2005, RESTOR NEUROL NEUROS, V23, P341; BUNGE RP, 1993, ADV NEUROL, V59, P75; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cerri G, 2012, NEUROSCIENCE, V219, P290, DOI 10.1016/j.neuroscience.2012.05.041; Cervellini I, 2013, MOL MED, V19, P223, DOI 10.2119/molmed.2013.00013; Cetin A, 2006, EUR SPINE J, V15, P1539, DOI 10.1007/s00586-006-0091-2; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cho YK, 2012, BIOCHEM BIOPH RES CO, V417, P753, DOI 10.1016/j.bbrc.2011.12.029; Deller T, 2006, ADV EXP MED BIOL, V557, P101; ECKARDT KU, 1993, KIDNEY INT, V43, P815, DOI 10.1038/ki.1993.115; Fumagalli F, 2008, EUR J PHARMACOL, V578, P19, DOI 10.1016/j.ejphar.2007.09.021; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grigoriadis N, 2004, CLIN NEUROL NEUROSUR, V106, P211, DOI 10.1016/j.clineuro.2004.02.017; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; Hong ZH, 2011, EXP THER MED, V2, P837, DOI 10.3892/etm.2011.285; Jin W, 2014, J TRAUMA ACUTE CARE, V76, P1228, DOI 10.1097/TA.0000000000000211; Kaptanoglu E, 2002, J NEUROSURG, V97, P49, DOI 10.3171/spi.2002.97.1.0049; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Kasper C., 2003, CYTOKINE HDB, VI, P149; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; Mann C, 2008, EXP NEUROL, V211, P34, DOI 10.1016/j.expneurol.2007.12.013; Min K, 2013, RESTOR NEUROL NEUROS, V31, P397, DOI 10.3233/RNN-120289; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Priestley John V, 2012, Handb Clin Neurol, V109, P463, DOI 10.1016/B978-0-444-52137-8.00029-2; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Sekiguchi Y, 2003, SPINE, V28, P2577, DOI 10.1097/01.BRS.0000096674.12519.12; Solaroglu I, 2003, CHILD NERV SYST, V19, P19, DOI 10.1007/s00381-002-0680-2; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Xiong M, 2011, J HUAZHONG U SCI-MED, V31, P652, DOI 10.1007/s11596-011-0576-z; Yazihan N, 2008, INJURY, V39, P1408, DOI 10.1016/j.injury.2008.03.010; Yin Y, 2013, NEUROCHEM INT, V62, P903, DOI 10.1016/j.neuint.2013.03.005; Yu PP, 2008, NEUROBIOL DIS, V32, P535, DOI 10.1016/j.nbd.2008.09.012; Zhang Y., 2015, RESTOR NEUROL NEUROS	43	7	8	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	4					647	663		10.3233/RNN-150498			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DV8MC	WOS:000383190100014	26444376				2022-02-06	
J	Yuen, KM; Tsai, YH; Lin, WC; Yang, CC; Huang, SJ				Yuen, Kit-Man; Tsai, Yi-Hsin; Lin, Wei-Chi; Yang, Chi-Cheng; Huang, Sheng-Jean			Retrospectively evaluated preinjury personality traits influence postconcussion symptoms	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Personality traits; postconcussion symptoms; preinjury	TRAUMATIC BRAIN-INJURY; GOOD-OLD-DAYS; EMOTIONAL RISK-FACTORS; CLOSED-HEAD INJURY; DAYS BIAS; MISERABLE MINORITY; CLASSIFICATION; POPULATION; PREDICTORS; DISORDERS	Postconcussion symptoms (PCS) are not uncommon following mild traumatic brain injury (mTBI). Personality traits have always been viewed as one of the most important explanations for persistent postconcussion symptoms (PPCS). Unfortunately, studies on the association between preinjury personality traits and the PPCS are still limited. This study thus aimed to examine the relationship between the preinjury personality and PCS in patients with mTBI. A total of 106 participants including 53 healthy participants were recruited. All participants complete the modified Checklist of Postconcussion Symptoms and the Health, Personality, & Habit Scale. Participants were evaluated within 4 weeks and at 4 months, respectively, after injury. The results showed patients reported significantly more PCS than healthy participants did within 4 weeks postinjury. A significant positive association between PCS and retrospectively evaluated preinjury personality was found. Specifically, patients who reported that their preinjury personality was depressive or anxious-related presented more PCS. This study might be the first to directly demonstrate that preinjury personality traits are closely linked to PCS reporting in patients with mTBI. Importantly, PCS reporting might be associated with different personality traits at different periods after injuries, and thus, a careful evaluation for personality characteristics is merited after mTBI.	[Yuen, Kit-Man; Lin, Wei-Chi; Yang, Chi-Cheng] Chang Gung Univ, Div Clin Psychol, Coll Med, Behav Sci, Taoyuan, Taiwan; [Huang, Sheng-Jean] Taipei City Hosp, Taipei, Taiwan; [Tsai, Yi-Hsin] Far Eastern Mem Hosp, Dept Neurosurg, New Taipei, Taiwan		Yang, CC (corresponding author), Chang Gung Univ, Coll Med, Dept Occupat Therapy, Div Clin Psychol, 259 Wen Hwa 1st Rd, Taoyuan, Taiwan.	ccyang@mail.cgu.edu.tw		YANG, CHI CHENG/0000-0002-4544-3978	Ministry of Science and Technology in TaiwanMinistry of Science and Technology, Taiwan [MOST 101-2410-H-182-009-MY2]	This study was supported by the Ministry of Science and Technology in Taiwan (MOST 101-2410-H-182-009-MY2).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cherpitel CJ, 1999, ALCOHOL CLIN EXP RES, V23, P121, DOI 10.1111/j.1530-0277.1999.tb04032.x; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hall CM, 1998, THEORIES PERSONALITY, P1; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hua M-S, 1986, WORD SEQUENCE LEARNI; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JENNETT B, 1975, LANCET, V1, P480; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Ko Y. H, 1999, HLTH PERSONALITY HAB; Ko Y. H, 2003, HLTH PERSONALITY HAB; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Levin H. S., 1983, PACED AUDITORY UNPUB; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Marin RS, 1997, PSYCHIAT ANN, V27, P18, DOI 10.3928/0048-5713-19970101-06; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Millon T., 2006, MILLON CLIN MULTIAXI, VThird; Pervin L. A., 1993, PERSONALITY THEORY R, P1; Peterson T, 1999, ANN EMERG MED, V33, P192, DOI 10.1016/S0196-0644(99)70393-8; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruocco AC, 2007, BRAIN INJURY, V21, P1233, DOI 10.1080/02699050701716919; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Stella Julian, 2002, Emerg Med (Fremantle), V14, P58, DOI 10.1046/j.1442-2026.2002.00287.x; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; Yuen K. M., 2012, PREDICTORS PER UNPUB	55	7	7	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	5					322	332		10.1080/23279095.2015.1057638			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DR8DX	WOS:000380129700002	26786604				2022-02-06	
J	Zhai, XF; Ding, Y; Wang, Q; Zhang, H; Li, FY				Zhai, Xiaofu; Ding, Ying; Wang, Qi; Zhang, Hao; Li, Fayin			Rutin Acid Ameliorates Neural Apoptosis Induced by Traumatic Brain Injury via Mitochondrial Pathways in Mice	NEUROIMMUNOMODULATION			English	Article						Rutin; Traumatic brain injury; Neurologic scores; Mitochondria	MODEL; NEUROPROTECTION; ASSOCIATION; EXPRESSION; SYMPTOMS; PROTECTS; STRESS; DAMAGE; RATS	Rutin reportedly conveys many beneficial effects, including neuroprotection in brain injury. However, the mechanisms underlying these effects are still not well understood. This study investigates the effect of rutin on potential mechanisms for neuroprotective effects, using the weight-drop model of traumatic brain injury (TBI) in male mice treated either with rutin or a vehicle via intraperitoneal injection 30 min after TBI. After euthanasia and 24 h after TBI, all mice were examined by tests, including neurologic scores, blood-brain barrier permeability, brain water content and neuronal cell death in the cerebral cortex. Results indicate that the levels of cytochrome c, malondialdehyde (MDA) and superoxide dismutase (SOD) were restored by rutin treatment. Rutin treatment resulted in the downregulation of caspase-3 expression in a reduced number of positive cells under terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay, and also the improved survival of neurons. Furthermore, pretreatment levels of MDA were restored, while Bcl-2-associated X protein translocation to mitochondria and cytochrome c release into cytosol were reduced by rutin treatment. Our results demonstrate that rutin improves neurological outcome by protecting neural cells against apoptosis via mechanisms that involve the mitochondria following TBI. (C) 2016 S. Karger AG, Basel	[Zhai, Xiaofu] Nanjing Med Univ, Dept Neurosurg, Huaian Peoples Hosp 2, Xuzhou Med Coll, Huaian, Peoples R China; [Wang, Qi] Nanjing Med Univ, Dept Radiol, Huaian Peoples Hosp 4, Huaian, Peoples R China; [Li, Fayin] Nanjing Med Univ, Dept Anesthesia, Huaian Peoples Hosp 1, Huaian 223300, Jiangsu, Peoples R China; [Ding, Ying; Zhang, Hao] Nanjing Med Univ, Dept Anesthesia, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China		Li, FY (corresponding author), Nanjing Med Univ, Dept Anesthesia, Huaian Peoples Hosp 1, Huaian 223300, Jiangsu, Peoples R China.	lifayin712025@163.com					Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Antonius D, 2014, J NEUROPSYCH CLIN N, V26, P313, DOI 10.1176/appi.neuropsych.13090201; Bizzozero OA, 2006, J NEUROSCI RES, V83, P656, DOI 10.1002/jnr.20771; Chen JY, 2014, J PINEAL RES, V56, P12, DOI 10.1111/jpi.12086; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Hindy N, 2014, EUR J TRAUMA EMERG S, V40, P481, DOI 10.1007/s00068-013-0337-8; Ferri P, 2015, FOOD FUNCT, V6, P394, DOI [10.1039/c4fo00817k, 10.1039/C4FO00817K]; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao ZH, 2002, BIOL TRACE ELEM RES, V88, P271, DOI 10.1385/BTER:88:3:271; Ghadiri T, 2014, J NEUROSCI METH, V233, P18, DOI 10.1016/j.jneumeth.2014.05.035; Go KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183469; Greene-Schloesser D, 2013, CLIN CANCER RES, V19, P2294, DOI 10.1158/1078-0432.CCR-11-2903; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hur SJ, 2011, J AGR FOOD CHEM, V59, P10699, DOI 10.1021/jf202279r; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Li YY, 2001, CIRCULATION, V104, P2492, DOI 10.1161/hc4501.098944; Man YG, 2015, INT J CLIN EXP MED, V8, P14397; Mele M, 2015, J MOL NEUROSCI, V55, P374, DOI 10.1007/s12031-014-0342-3; Qu J, 2014, BRIT J PHARMACOL, V171, P3702, DOI 10.1111/bph.12725; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Roquilly A, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.11.021; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; Shafi S, 2014, J AM COLL SURGEONS, V219, P189, DOI 10.1016/j.jamcollsurg.2014.04.005; Stratton KJ, 2014, J PAIN, V15, P1023, DOI 10.1016/j.jpain.2014.07.002; Tang V, 2007, J HEAD TRAUMA REHAB, V22, P409, DOI 10.1097/01.HTR.0000300236.21114.bc; Tyurin VA, 2008, METHOD ENZYMOL, V442, P375, DOI [10.1017/S0076-6879(08)01419-5, 10.1016/S0076-6879(08)01419-5]; Vervliet T., 2016, ONCOGENE; Wagner C, 2010, ARCH TOXICOL, V84, P89, DOI 10.1007/s00204-009-0482-3; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651	36	7	8	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2016	23	3					179	187		10.1159/000448716			9	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	ED0ZU	WOS:000388574000006	27644033				2022-02-06	
J	Bhatti, JA; Stevens, K; Mir, MU; Hyder, AA; Razzak, JA				Bhatti, Junaid Ahmad; Stevens, Kent; Mir, Muhammad Umer; Hyder, Adnan A.; Razzak, Junaid Abdul			Emergency care of traumatic brain injuries in Pakistan: a multicenter study	BMC EMERGENCY MEDICINE			English	Article							LATIN-AMERICA; CENTERS; COSTS	Background: This study assessed factors associated with emergency care outcomes and out-of-pocket treatment costs in traumatic brain injury (TBI) patients in Pakistan. Methods: Data on TBI patients were extracted from a four-month surveillance study conducted in the emergency departments (ED) of seven large teaching hospitals. Emergency care access to physicians and imaging facilities were compared with respect to ED outcomes (discharged, admitted or dead). Out-of-pocket treatment costs (in United States dollars [USD]) were compared among different patient strata. Results: ED outcomes were available for 1,787 TBI patients. Of them, most were males (79%), aged <25 years (46%) and arrived by ambulances (32%). Nurses or paramedical staff saw almost all patients (95%). Physicians with practice privileges (medical officers, residents or consultants) saw about half (55%) of them. Computerized tomography (CT) scans were performed in two of five patients (40%). Of all, 26% (n = 460) were admitted and 3% died (n = 52). Emergency care factors significantly associated with being admitted or died were arriving by ambulance (adjusted odds ratio [aOR] = 2.37, 95% confidence interval (CI) [95% CI] = 1.78-3.16); seen by medical officer/residents (aOR = 2.11; 95% CI = 1.49-2.99); and had CT scan (aOR = 2.93; 95% CI = 2.25-3.83). Out-of-pocket treatment costs at the ED were reported in 803 patients. Average costs were USD 8, (standard deviation [SD] = 23). Costs were twice as high in those arriving in ambulances (USD 20, SD = 49) or who underwent CT scans (USD 16, SD = 37). Conclusion: TBI patients' access to ambulance transport, experienced physicians, and imaging facilities during emergency care needs to be improved in Pakistan.	[Bhatti, Junaid Ahmad; Razzak, Junaid Abdul] Aga Khan Univ, Dept Emergency Med, Karachi, Pakistan; [Bhatti, Junaid Ahmad] Sunnybrook Hlth Sci Ctr, Res Inst, Toronto, ON, Canada; [Bhatti, Junaid Ahmad] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bhatti, Junaid Ahmad] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Stevens, Kent] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD USA; [Stevens, Kent; Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Johns Hopkins Int Injury Res Unit, Baltimore, MD USA; [Mir, Muhammad Umer] Tulane Univ, Sch Publ Hlth, Global Hlth Syst & Dev, Orleans, LA USA; [Razzak, Junaid Abdul] Johns Hopkins Sch Med, Dept Emergency Med, Baltimore, MD USA		Bhatti, JA (corresponding author), Aga Khan Univ, Dept Emergency Med, Karachi, Pakistan.	junaid.bhatti@ices.on.ca	Hyder, Adnan/AAT-9503-2021; Razzak, Junaid/ABE-3549-2020	Razzak, Junaid/0000-0003-0735-9094; Hyder, Adnan/0000-0002-7292-577X	NIH-Fogarty JHU-AKU grant through International Collaborative Trauma and Injury Research and Training (ICTIRT) program (NIH) [D43TW007292]; Johns Hopkins School of Public Health; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007292] Funding Source: NIH RePORTER	We are grateful to the data collectors and ED administration staff in all participating sites who have participated in this study. We are also thankful to Ms. Bobbi Nicotera for language editing of the paper. This work was funded by NIH-Fogarty JHU-AKU grant through International Collaborative Trauma and Injury Research and Training (ICTIRT) program (NIH grant #D43TW007292). The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.r This article has been published as part of BMC Emergency Medicine Volume 15 Supplement 2, 2015: Articles from the Pakistan National Emergency Departments Surveillance Study (Pak-NEDS). The full contents of the supplement are available online at http://www.biomedcentral.com/bmcemergmed/supplements/15/S2. Publication of this supplement was funded by the Johns Hopkins School of Public Health.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Akmal M, 2003, SPINE, V28, P180, DOI 10.1097/00007632-200301150-00016; Ali M, 2013, J POSTGRADUATE MED I, V27, P445; Anderson PD, 2012, ANN EMERG MED; Arreola-Risa C, 2000, J TRAUMA, V48, P119, DOI 10.1097/00005373-200001000-00020; ARREOLARISA C, 1995, J TRAUMA, V39, P457; Bhatti Junaid A, 2013, Ann Adv Automot Med, V57, P257; Biros MH, 2010, ROSENS EMERGENCY MED; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Curtis K, 2014, AUST HEALTH REV, V38, P30, DOI 10.1071/AH13061; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Faul M, 2010, TRAUMATIC BRAIN INJU; Haque A, 2009, CRIT CARE MED, V37, pA321; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Holcomb JB, 2005, MIL MED, V170, P7, DOI 10.7205/MILMED.170.1.7; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kobusingye OC, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1261; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Raja IA, 2001, WORLD J SURG, V25, P1230; Razzak J A, 2001, Prehosp Emerg Care, V5, P312, DOI 10.1080/10903120190939896; Razzak JA, 2013, EMERGENCY MED J EMJ; Razzak JA, 2015, BURDEN EMERGENCY MED; Razzak JA, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-8; Razzak JA, 2011, INT J INJ CONTROL SA, V18, P199, DOI 10.1080/17457300.2011.551942; Razzak JA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-357; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; Swadron SP, 2012, NEUROCRIT CARE, V17, P112, DOI 10.1007/s12028-012-9760-7; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zammit Christopher, 2013, Emerg Med Pract, V15, P1	35	7	7	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	DEC 11	2015	15			2					S12	10.1186/1471-227X-15-S2-S12			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V55GR	WOS:000210481600012	26691277	Green Published, gold			2022-02-06	
J	Operskalski, JT; Paul, EJ; Colom, R; Barbey, AK; Grafman, J				Operskalski, Joachim T.; Paul, Erick J.; Colom, Roberto; Barbey, Aron K.; Grafman, Jordan			Lesion Mapping the Four-Factor Structure of Emotional Intelligence	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						emotional intelligence; MSCEIT; social cognition; voxel-based lesion-symptom mapping; traumatic brain injury	VENTROMEDIAL PREFRONTAL CORTEX; FUSIFORM FACE AREA; ORBITOFRONTAL CONTRIBUTIONS; TRADITIONAL STANDARDS; DECISION-MAKING; PARIETAL CORTEX; NEURAL SYSTEMS; ARCHITECTURE; DAMAGE	Emotional intelligence (El) refers to an individual's ability to process and respond to emotions, including recognizing the expression of emotions in others, using emotions to enhance thought and decision making, and regulating emotions to drive effective behaviors. Despite their importance for goal-directed social behavior, little is known about the neural mechanisms underlying specific facets of El. Here, we report findings from a study investigating the neural bases of these specific components for El in a sample of 130 combat veterans with penetrating traumatic brain injury. We examined the neural mechanisms underlying experiential (perceiving and using emotional information) and strategic (understanding and managing emotions) facets of El. Factor scores were submitted to voxel-based lesion symptom mapping to elucidate their neural substrates. The results indicate that two facets of El (perceiving and managing emotions) engage common and distinctive neural systems, with shared dependence on the social knowledge network, and selective engagement of the orbitofrontal and parietal cortex for strategic aspects of emotional information processing. The observed pattern of findings suggests that sub-facets of experiential and strategic El can be characterized as separable but related processes that depend upon a core network of brain structures within frontal, temporal and parietal cortex.	[Operskalski, Joachim T.; Paul, Erick J.; Barbey, Aron K.] Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA; [Operskalski, Joachim T.; Paul, Erick J.; Barbey, Aron K.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Operskalski, Joachim T.; Barbey, Aron K.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Colom, Roberto] Univ Autonoma Madrid, Dept Biol & Hlth Psychol, Madrid, Spain; [Barbey, Aron K.] Univ Illinois, Dept Internal Med, Urbana, IL 61801 USA; [Barbey, Aron K.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, Chicago, IL 60611 USA		Barbey, AK (corresponding author), Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA.	barbey@illinois.edu	Colom, Roberto/F-8779-2010; Barbey, Aron/L-7312-2015	Colom, Roberto/0000-0001-5865-163X; Barbey, Aron/0000-0002-6092-0912	US National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0675]; Ministerio de Ciencia e Innovacron [Ministry of Science and Innovation, Spain] [PSI2010-20364]; Universidad Autonoma de Madrid [CEMU-2012-004]	This work was supported by funding from the US National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the US Army Medical Research and Materiel Command administered by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase a 30 year post injury follow-up study, grant number DAMD17-01-1-0675). R. Colom was supported by grant PSI2010-20364 from Ministerio de Ciencia e Innovacron [Ministry of Science and Innovation, Spain] and CEMU-2012-004 [Universidad Autonoma de Madrid].	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Barbey AK, 2011, OXFORD HDB SOCIAL NE, P349; Barbey AK, 2014, BRAIN, V137, P2823, DOI 10.1093/brain/awu207; Barbey AK, 2014, BRAIN STRUCT FUNCT, V219, P485, DOI 10.1007/s00429-013-0512-z; Barbey AK, 2014, SOC COGN AFFECT NEUR, V9, P265, DOI 10.1093/scan/nss124; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barbey AK, 2013, NEUROPSYCHOLOGIA, V51, P1361, DOI 10.1016/j.neuropsychologia.2012.05.017; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1999, J NEUROSCI, V19, P5473; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Caruso D.R., 2002, MAYER SALOVEY CARUSO; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Dehaene S, 1998, NAT NEUROSCI, V1, P549, DOI 10.1038/2785; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Glascher J, 2012, P NATL ACAD SCI USA, V109, P14681, DOI 10.1073/pnas.1206608109; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gu XS, 2012, BRAIN, V135, P2726, DOI 10.1093/brain/aws199; Harry B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00692; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koenigs M, 2011, NEUROPSYCHOLOGIA, V49, P3612, DOI 10.1016/j.neuropsychologia.2011.09.013; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Matthews SC, 2004, NEUROIMAGE, V22, P1151, DOI 10.1016/j.neuroimage.2004.03.005; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; Mayer JD, 2004, PSYCHOL INQ, V15, P197, DOI 10.1207/s15327965pli1503_02; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; Mayer JD, 2001, EMOTION, V1, P232, DOI 10.1037//1528-3542.1.3.232; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Perry D, 2011, NEUROIMAGE, V54, P1669, DOI 10.1016/j.neuroimage.2010.08.057; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Reis DL, 2007, NEUROIMAGE, V35, P1385, DOI 10.1016/j.neuroimage.2006.12.045; Roberts RD, 2001, EMOTION, V1, P196, DOI 10.1037//1528-3542.1.3.196; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Smith DV, 2013, P NATL ACAD SCI USA, V110, P1518, DOI 10.1073/pnas.1210126110; Takeuchi H, 2013, NEUROIMAGE, V83, P318, DOI 10.1016/j.neuroimage.2013.06.044; Takeuchi H, 2013, HUM BRAIN MAPP, V34, P1025, DOI 10.1002/hbm.21492; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Tan YF, 2014, BRAIN COGNITION, V91, P100, DOI 10.1016/j.bandc.2014.08.007; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	62	7	7	1	37	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 10	2015	9								649	10.3389/fnhum.2015.00649			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CZ0NP	WOS:000366802300001	26858627	gold, Green Published			2022-02-06	
J	Kissane, AL; Eldridge, BJ; Kelly, S; Vidmar, S; Galea, MP; Williams, GP				Kissane, Anne L.; Eldridge, Beverley J.; Kelly, Stacy; Vidmar, Suzanna; Galea, Mary P.; Williams, Gavin P.			High-level mobility skills in children and adolescents with traumatic brain injury	BRAIN INJURY			English	Article							MOTOR FUNCTION MEASURE; ASSESSMENT-TOOL HIMAT; HIGH-FUNCTIONING CHILDREN; INPATIENT REHABILITATION; DISABILITY INVENTORY; PEDIATRIC EVALUATION; CEREBRAL-PALSY; CHALLENGE-MODULE; RECOVERY; PARTICIPATION		[Kissane, Anne L.; Vidmar, Suzanna] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Eldridge, Beverley J.; Kelly, Stacy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Galea, Mary P.; Williams, Gavin P.] Univ Melbourne, Melbourne, Vic, Australia; [Williams, Gavin P.] Epworth Med Fdn, Melbourne, Vic, Australia		Williams, GP (corresponding author), Epworth Med Fdn, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Galea, Mary/F-4242-2010	Galea, Mary/0000-0003-0045-7978; Williams, Gavin/0000-0003-2758-7473	Traffic Accident Commission (TAC) Victoria, Australia; Murdoch Children's Research Institute, Melbourne, Australia	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was supported by the Traffic Accident Commission (TAC) Victoria, Australia and Murdoch Children's Research Institute, Melbourne, Australia.	Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Beretta E, 2009, BRAIN INJURY, V23, P751, DOI 10.1080/02699050903133988; Deitz Jean C, 2007, Phys Occup Ther Pediatr, V27, P87, DOI 10.1300/J006v27n04_06; Dumas HM, 2004, PHYS THER, V84, P232, DOI 10.1093/ptj/84.3.232; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Glazebrook CM, 2014, PEDIATR PHYS THER, V26, P201, DOI 10.1097/PEP.0000000000000035; Haley SM, 2003, DEV MED CHILD NEUROL, V45, P671, DOI 10.1017/S0012162203001257; Haley SM, 2011, DEV MED CHILD NEUROL, V53, P1100, DOI 10.1111/j.1469-8749.2011.04107.x; Ibey RJ, 2010, PEDIATR PHYS THER, V22, P268, DOI 10.1097/PEP.0b013e3181ea8ff6; Iyer LV, 2003, PHYS THER, V83, P888, DOI 10.1093/ptj/83.10.888; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Nordmark E, 2000, DEV MED CHILD NEUROL, V42, P245, DOI 10.1017/S0012162200000426; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Thomas-Stonell N, 2006, Pediatr Rehabil, V9, P14, DOI 10.1080/13638490500050097; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, HIGH LEVEL MOBILITY; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson A, 2011, PHYS OCCUP THER PEDI, V31, P135, DOI 10.3109/01942638.2010.489543; Wright FV, 2010, BRAIN INJURY, V24, P1585, DOI 10.3109/02699052.2010.523045	27	7	7	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1711	1716		10.3109/02699052.2015.1075174			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800024	26479336				2022-02-06	
J	Adornetti, I				Adornetti, Ines			The Phylogenetic Foundations of Discourse Coherence: A Pragmatic Account of the Evolution of Language	BIOSEMIOTICS			English	Article						Ape language; Cognitive pragmatics; Coherence; Discourse processing; Executive functions; Language evolution; Neurolinguistics; Tool making	TRAUMATIC BRAIN INJURY; EXECUTIVE FUNCTIONS; NARRATIVE LANGUAGE; PREFRONTAL CORTEX; STORY NARRATIVES; FRONTAL LOBES; STONE TOOLS; PAN; SKILLS; COMMUNICATION	In this paper we propose a pragmatic approach to the evolution of language based on analysis of a particular element of human communication: discourse coherence. We show that coherence is essential for effective communication. Through analysis of a collection of neuropsychological and neurolinguistic studies, we maintain that the proper functioning of executive processes responsible for planning and executing actions plays a key role in the construction of coherent discourses. Studies that tested the discursive and conversational abilities of bonobos have showed that apes are unable to construct a flow of discourse governed by coherence, and therefore, apes' conversational interactions are quite different from those of humans. We then propose that the emergence of coherence in communication occurred after the split between great apes' and humans' lines of descendants and that this emergence might have been the result of a specific gradual development in the course of hominin evolution of the executive functions.	[Adornetti, Ines] Roma Tre Univ, Dept Philosophy Commun & Visual Arts, I-00146 Rome, Italy; [Adornetti, Ines] Univ Aquila, Dept Human Sci, I-67100 Laquila, Italy		Adornetti, I (corresponding author), Roma Tre Univ, Dept Philosophy Commun & Visual Arts, Via Ostiense 234, I-00146 Rome, Italy.	ines.adornetti@uniroma3.it		ADORNETTI, Ines/0000-0002-5277-3238			ADORNETTI I., 2014, WAYS PROTOLANGUAGE, V3, P9; Adornetti I., 2013, FARSI DISFARSI DISCO; AGAR M, 1982, DISCOURSE PROCESS, V5, P1, DOI 10.1080/01638538209544529; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Bara Bruno, 2010, COGNITIVE PRAGMATICS; Barkley RA., 2012, EXECUTIVE FUNCTIONS; Berzlanovich I., 2008, LEXICAL COHESION ORG; Bickerton D., 1990, LANGUAGE SPECIES; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bolhuis JJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001934; Brakke KE, 1996, LANG COMMUN, V16, P361, DOI 10.1016/S0271-5309(96)00018-3; BRAKKE KE, 1995, LANG COMMUN, V15, P121, DOI 10.1016/0271-5309(95)00001-7; Bublitz W., 2011, DISCURSIVE PRAGMATIC, P37; Carpenter M., 2013, AGENCY JOINT ATTENTI, P49, DOI [10.1093/acprof:oso/9780199988341.003.0003, DOI 10.1093/ACPROF:OSO/9780199988341.003.0003]; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chomsky Noam, 2005, LANGUAGE MIND; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho C, 2012, NEUROPSYCHOLOGIA, V50, P3564, DOI 10.1016/j.neuropsychologia.2012.09.005; Coolidge F., 2009, COGNITIVE ARCHAEOLOG; Darwin C., 1871, P423; Davis G. Albyn, 2007, Seminars in Speech and Language, V28, P111, DOI 10.1055/s-2007-970569; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Davis GA, 1997, BRAIN LANG, V56, P183; Deacon T., 1997, SYMBOLIC SPECIES; DEACON T, 2012, OXFORD HDB LANGUAGE, P393; Deacon T.W., 2003, LANGUAGE EVOLUTION, P111; Donald M., 2012, OXFORD HDB LANGUAGE, P180; Donald M, 2007, J PHYSIOL-PARIS, V101, P214, DOI 10.1016/j.jphysparis.2007.11.006; Donald Merlin, 2001, MIND SO RARE EVOLUTI; Donald Merlin, 1991, ORIGINS MODERN MIND; Enqvist N. L., 1978, COHESION SEMANTICS, P109; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; FERRETTI F, 2012, DALLA COMUNICAZIONE; Ferretti F, 2014, LANG COMMUN, V37, P29, DOI 10.1016/j.langcom.2014.04.003; Ferretti F, 2013, J NEUROLINGUIST, V26, P327, DOI 10.1016/j.jneuroling.2012.11.001; FERRETTI Francesco, 2007, PERCHE NON SIAMO SPE; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; FOUTS R, 1997, NEXT KIN WHAT CHIMPA; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; GARDNER RA, 1969, SCIENCE, V165, P664, DOI 10.1126/science.165.3894.664; Gibson KR, 2012, OXFORD HDB LANGUAGE, P46; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; GIORA R, 1985, POETICS TODAY, V6, P699, DOI 10.2307/1771962; Giora R., 2014, HDB LANGUAGE SOCIAL, P141; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; Greaves W., 2002, FUNCTIONAL DIMENSION; Greenfield P.M., 1990, P540, DOI 10.1017/CBO9780511665486.022; Halliday M. K., 1976, COHESION ENGLISH; Hauser MD, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00401; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Humphreys GW, 1998, COGN NEUROPSYCHOL, V15, P771; Hurford James R., 2007, ORIGINS MEANING LANG; Hurford JR, 2003, LANGUAGE EVOLUTION, V3, P38, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0003; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Leitten L, 2012, INTERACT STUD, V13, P147, DOI 10.1075/is.13.2.01lei; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Linell P., 1998, APPROACHING DIALOGUE; Louwerse M. M., 2005, ENCY LINGUISTICS, P216; Lyn H, 2000, LANG COMMUN, V20, P255, DOI 10.1016/S0271-5309(99)00026-9; Lyn HD, 2011, FIRST LANG, V31, P300, DOI 10.1177/0142723710391872; Lyn H, 2011, LANG COMMUN, V31, P63, DOI 10.1016/j.langcom.2010.11.001; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MCDONALD S, 1999, COMMUNICATION DISORD; McDonald S, 2008, HDB NEUROLINGUISTICS, P485; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Pedersen J, 2009, INTEGR PSYCHOL BEHAV, V43, P22, DOI 10.1007/s12124-008-9067-6; Peirce C.S., 1955, PHILOS WRITINGS PEIR, P98; Perkins M. R., 1995, CASE STUDIES CLIN LI, P293; Perkins Michael R., 2007, PRAGMATIC IMPAIRMENT; PREMACK D, 1977, INTELLIGENCE APE MAN; REINHART T, 1980, POETICS TODAY, V1, P161, DOI 10.2307/1771893; Roberts M. B., 1999, BOXGROVE MIDDLE PLEI; Rumbaugh DM., 1977, LANGUAGE LEARNING CH; Saussure F, 1983, COURS LINGUISTIQUE G; Savage-Rumbaugh S., 1998, APES LANGUAGE HUMAN; SAVAGERUMBAUGH S, 1986, J EXP PSYCHOL GEN, V115, P211, DOI 10.1037/0096-3445.115.3.211; SAVAGERUMBAUGH S, 1994, KANZI APE BRINK HUMA; Schenker NM, 2005, J HUM EVOL, V49, P547, DOI 10.1016/j.jhevol.2005.06.004; Sebeok T., 1994, SIGNS INTRO SEMIOTIC; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Smaers JB, 2013, P NATL ACAD SCI USA, V110, pE3682, DOI 10.1073/pnas.1308850110; Smaers JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009123; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Stout D, 2010, TOP COGN SCI, V2, P614, DOI 10.1111/j.1756-8765.2009.01078.x; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Tanskanen S. K, 2006, COLLABORATING COHERE; TERRACE HS, 1979, SCIENCE, V206, P891, DOI 10.1126/science.504995; TERRACE HS, 1979, NIM; Tomasello M, 2008, JEAN NICOD LECT, P1; Uomini NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072693; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Zalla T, 2003, NEUROPSYCHOLOGIA, V41, P1619, DOI 10.1016/S0028-3932(03)00098-8; Zalla T, 2001, NEUROPSYCHOLOGIA, V39, P759, DOI 10.1016/S0028-3932(01)00019-7; Zasler N., 2012, BRAIN INJURY MED ACC; Zlatev J, 2008, J PHYSIOL-PARIS, V102, P137, DOI 10.1016/j.jphysparis.2008.03.016; Zlatev J, 2014, INTERDISC EVOL RES, V1, P165, DOI 10.1007/978-3-319-02669-5_9	115	7	7	0	14	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1875-1342	1875-1350		BIOSEMIOTICS-NETH	Biosemiotics	DEC	2015	8	3					421	441		10.1007/s12304-015-9230-7			21	Humanities, Multidisciplinary; History & Philosophy Of Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Arts & Humanities - Other Topics; History & Philosophy of Science	CX4RC	WOS:000365687000005					2022-02-06	
J	Gillis, MM; Hampstead, BM				Gillis, M. Meredith; Hampstead, Benjamin M.			A two-part preliminary investigation of encoding-related activation changes after moderate to severe traumatic brain injury: hyperactivation, repetition suppression, and the role of the prefrontal cortex	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Encoding; Memory; Functional neuroimaging; Working memory; Repetition suppression	NEUROPSYCHOLOGICAL STATUS RBANS; WORKING-MEMORY DYSFUNCTION; MILD COGNITIVE IMPAIRMENT; REPEATABLE BATTERY; EPISODIC MEMORY; DEFAULT NETWORK; FUNCTIONAL MRI; FMRI; MECHANISMS; FATIGUE	Traumatic brain injury (TBI) survivors typically exhibit significant learning and memory deficits and also frequently demonstrate hyperactivation during functional magnetic resonance imaging (fMRI) tasks involving working memory encoding and maintenance. However, it remains unclear whether the hyperactivation observed during such working memory tasks is also present during long-term memory encoding. The preliminary experiments presented here were designed to examine this question. In Experiment 1, 7 healthy controls (HC) and 7 patients with moderate to severe TBI encoded ecologically relevant object location associations (OLA) while undergoing fMRI and then completed a memory test outside of the fMRI environment. fMRI data analysis included only the correctly encoded trials and revealed hyperactivation in the TBI relative to HC group in regions critical for OLA encoding, including bilateral dorsal and ventral visual processing areas, bilateral frontoparietal working memory network regions, and the left medial temporal lobe. There was also an incidental finding that this hyperactivation persisted after multiple exposures to the same stimulus, which may indicate an attenuated repetition suppression effect that could ultimately contribute to cognitive fatigue and inefficient memory encoding after TBI. Experiment 2 directly assessed repetition suppression in some of the same HC and TBI participants. During early encoding trials, the TBI group showed large areas of hyperactivation in the right prefrontal cortex and bilateral posterior parietal cortices relative to the HC. Following additional exposure to these stimuli, the TBI group showed repetition suppression in visual and spatial processing regions, but continued to show hyperactivation in the right dorsolateral prefrontal cortex. Findings from these preliminary studies may reflect that increased reliance on cognitive control mechanisms following TBI extends to memory encoding.	[Hampstead, Benjamin M.] Atlanta VAMC, Rehabil R&D Ctr Excellence, Atlanta, GA 30033 USA; [Gillis, M. Meredith; Hampstead, Benjamin M.] Emory Univ, Sch Medicine, Ctr Rehabil Med, Dept Rehabil Med, Atlanta, GA 30322 USA		Hampstead, BM (corresponding author), Univ Michigan, Dept Psychiat, Neuropsychol Sect, 2101 Commonwealth Blvd Suite C, Ann Arbor, MI 48105 USA.	bhampste@med.umich.edu			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B6366W]	We would like to thank Dr. Felicia Goldstein and Dr. Suzanne Penna for their assistance with participant recruitment. Authors M. Meredith Gillis and Benjamin M. Hampstead have no conflict of interest. This research was supported by funding from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and Rehabilitation Research and Development Service (grant B6366W to BMH). The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the United States Government.	Araujo HF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00548; Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Babor TF, 2001, AUDIT ALCOHOL USE DI; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2011, J COGNITIVE NEUROSCI, V23, P3855, DOI 10.1162/jocn_a_00066; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1990, BECK ANXIETY INVENTO; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Cerasa A, 2008, BRAIN RES, V1201, P114, DOI 10.1016/j.brainres.2008.01.048; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Faul M, 2010, TRAUMATIC BRAIN INJU; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hampstead BM, 2011, NEUROPSYCHOLOGIA, V49, P2349, DOI 10.1016/j.neuropsychologia.2011.04.008; Hampstead BM, 2011, NEUROREHAB NEURAL RE, V25, P210, DOI 10.1177/1545968310382424; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00024; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kim H, 2012, NEUROIMAGE, V61, P966, DOI 10.1016/j.neuroimage.2012.03.025; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Mani TM, 2007, BRAIN INJURY, V21, P1155, DOI 10.1080/02699050701687367; Martinelli P, 2013, HUM BRAIN MAPP, V34, P1515, DOI 10.1002/hbm.22008; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Miotto EC, 2006, HUM BRAIN MAPP, V27, P288, DOI 10.1002/hbm.20184; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Muehlhan M, 2011, INT J PSYCHOPHYSIOL, V79, P118, DOI 10.1016/j.ijpsycho.2010.09.009; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rice NJ, 2007, NEUROIMAGE, V36, pT87, DOI 10.1016/j.neuroimage.2007.03.032; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Thiel CM, 2001, J NEUROSCI, V21, P6846, DOI 10.1523/JNEUROSCI.21-17-06846.2001; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Vannini P, 2013, HUM BRAIN MAPP, V34, P1568, DOI 10.1002/hbm.22011; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; WechslerD, 2001, WECHSLER TEST ADULT; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	75	7	7	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2015	9	4					801	820		10.1007/s11682-014-9337-5			20	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX5PX	WOS:000365755500014	25481386				2022-02-06	
J	Kitzmuller, G; Ervik, B				Kitzmuller, Gabriele; Ervik, Bente			Female Spouses' Perceptions of the Sexual Relationship with Stroke-Affected Partners	SEXUALITY AND DISABILITY			English	Article						Female spouses; Merleau-Ponty; Norway; Phenomenological hermeneutics; Sexuality; Stroke	TRAUMATIC BRAIN-INJURY; EXPERIENCE; ISSUES; LIFE; REHABILITATION; ATTITUDES; HEALTH; MIDDLE	Sexuality is known to be important for couples' function after stroke. Although maintaining a satisfying sexual life has a positive influence on self-esteem and predicts overall quality of life, there has been little focus on healthy spouses' sexuality after stroke. The purpose of this Norwegian study is to provide an interpretation of the influence of stroke on female spouses' sexual relationship with their disabled partner after stroke. Sexuality is understood as an integral and inseparable part of a person's personality and a basic aspect of being human. A phenomenological hermeneutic approach inspired by Merleau-Ponty was chosen. Narrative interviews were conducted with twelve female spouses who had lived 3-25 years with their stroke ridden partner. The data analysis resulted in four main themes: Married to a "stranger"; The shift from partner to caregiver; Sexuality wrapped in silence; A void to live with. These themes highlighted the influence of the residual disabilities, emotional experiences and overall life changes on spouses' sexual life with their partner. Spouses experienced their partner as changed and sometimes as having become a stranger. The former mutual relationship was turned into a caregiver/care receiver relationship. Spouses felt they were confronted with emotional turmoil that interfered with their sexual life. Communication problems added to couples' difficulties and some spouses decided to end the frustrating sexual relationship with their partner. Although the spouses managed to find different coping strategies, the loss of a fulfilling sexual life added to their burden. Health professionals did not address sexuality. Specialized training programs are needed to increase professional awareness and competency regarding sexuality after stroke.	[Kitzmuller, Gabriele] Narvik Univ Coll, Dept Hlth & Soc, N-8505 Narvik, Norway; [Ervik, Bente] Univ Hosp Northern Norway, Dept Oncol, Tromso, Norway; [Ervik, Bente] Arctic Univ Norway, Univ Tromso, Dept Hlth & Care Sci, N-9019 Tromso, Norway		Kitzmuller, G (corresponding author), Narvik Univ Coll, Dept Hlth & Soc, Lodve Langesgt 2,Pb 385, N-8505 Narvik, Norway.	gk@hin.no		Kitzmuller, Gabriele/0000-0002-8528-6137	Narvik University College, Norway	This study was funded by Narvik University College, Norway.	Achten D, 2012, DISABIL REHABIL, V34, P1468, DOI 10.3109/09638288.2011.645994; Backstrom B, 2010, NURS INQ, V17, P257, DOI 10.1111/j.1440-1800.2010.00490.x; Basson R, 2000, J SEX MARITAL THER, V26, P51, DOI 10.1080/009262300278641; Baumeister RF., 2001, SOCIAL DIMENSION SEX; Bodnar L. Elizabeth, 2005, SEX RELATSH THER, V20, P225, DOI [10.1080/14681990500113229, DOI 10.1080/14681990500113229]; Bright FAS, 2011, TOP STROKE REHABIL, V18, P490, DOI 10.1310/tsr1805-490; Buschenfeld K, 2009, DISABIL REHABIL, V31, P1643, DOI 10.1080/09638280902736338; Calabro RS, 2011, INT J NEUROSCI, V121, P598, DOI 10.3109/00207454.2011.600647; Eriksson M, 2006, J CLIN NURS, V15, P324, DOI 10.1111/j.1365-2702.2006.01290.x; Ervik B, 2013, CANCER NURS, V36, pE7, DOI 10.1097/NCC.0b013e31824fe1ef; Esmail S, 2010, DISABIL REHABIL, V32, P1148, DOI 10.3109/09638280903419277; Farman J., 2004, STROKE REHABILITATIO, P533; Giaquinto S, 2003, J CLIN PSYCHIAT, V64, P302, DOI 10.4088/JCP.v64n0312; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Johnson B K, 1998, Health Care Women Int, V19, P553, DOI 10.1080/073993398246115; Kitzmuller G., 2012, CRISIS LOSS, V20, P339, DOI DOI 10.2190/IL.20.4.c; Kitzmuller G., 2012, THESIS; Korpelainen JT, 1999, STROKE, V30, P715, DOI 10.1161/01.STR.30.4.715; Laan E, 2008, FEM PSYCHOL, V18, P505, DOI 10.1177/0959353508095533; Leiblum SR, 1998, INT J IMPOT RES, V10, pS104; Lemieux L, 2001, SEX DISABIL, V19, P253, DOI 10.1023/A:1017953308761; Loehr J, 1997, J WOMENS HEALTH, V6, P451, DOI 10.1089/jwh.1997.6.451; McLaughlin J, 2005, SEX DISABIL, V23, P213, DOI 10.1007/s11195-005-8929-9; Merleau-Ponty M, 1994, KROPPENS FENOMENOLOG; Merleau-Ponty M., 2002, PHENOMENOLOGY PERCEP; Milligan MS, 2001, SEX DISABIL, V19, P91, DOI 10.1023/A:1010621705591; Mitchell-Pedersen S.L., 1994, IMPACR STROKE COUPLE; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Palmer S, 2003, REHABIL PSYCHOL, V48, P255, DOI 10.1037/0090-5550.48.4.255; Pich?, 2000, SEX RELATSH THER, V15, P381, DOI DOI 10.1080/713697433; Ratcliffe M., 2009, COMPANION PHENOMENOL, P329; Saunamaki N, 2010, J ADV NURS, V66, P1308, DOI 10.1111/j.1365-2648.2010.05260.x; Schmitz MA, 2010, TOP STROKE REHABIL, V17, P204, DOI 10.1310/tsr1703-204; Song H, 2011, NEUROREHABILITATION, V28, P143, DOI 10.3233/NRE-2011-0642; Stein J, 2013, DISABIL REHABIL, V35, P1842, DOI 10.3109/09638288.2012.754953; Stokes T, 2000, BRIT J FAM PLAN, V26, P89; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; van Manen M., 1997, RES LIVED EXPERIENCE, V2nd ed.; vanManen M, 1997, QUAL HEALTH RES, V7, P345, DOI 10.1177/104973239700700303; Watson J., 2000, MALE BODIES HLTH CUL; Westheimer R. K., 2005, HUMAN SEXUALITY PSYC; White Carole L, 2006, J Neurosci Nurs, V38, P354	43	7	7	0	20	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0146-1044	1573-6717		SEX DISABIL	Sex. Disabil.	DEC	2015	33	4					499	512		10.1007/s11195-015-9404-x			14	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	CW6TM	WOS:000365130800008					2022-02-06	
J	Miyazaki, H; Miyawaki, H; Satoh, Y; Saiki, T; Kawauchi, S; Sato, S; Saitoh, D				Miyazaki, Hiromi; Miyawaki, Hiroki; Satoh, Yasushi; Saiki, Takami; Kawauchi, Satoko; Sato, Shunichi; Saitoh, Daizoh			Thoracic shock wave injury causes behavioral abnormalities in mice	ACTA NEUROCHIRURGICA			English	Article						Shock waves; Thoracic injury; Hippocampus; Cognitive dysfunction	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SLICE CULTURES; CONTROLLED CORTICAL IMPACT; BLAST-INDUCED NEUROTRAUMA; RAT HIPPOCAMPUS; CELL-DEATH; MECHANISMS; EXPOSURE; MEMORY; MODEL	Mild traumatic brain injury (mTBI) is caused by complex mechanisms of systemic, local and cerebral responses to blast exposure. However, the molecular mechanisms of cognitive impairment after exposure to blast waves are not clearly known. We tested the hypothesis that thoracic injury induced functional and morphological impairment in the brain, leading to behavioral abnormalities. Mice were exposed to laser-induced shock waves (LISWs) impacting the thorax and assessed for behavioral outcome at 7 and 28 days post injury. Hippocampus and lung were collected for histopathological analysis and gene expression profiling after injury. Thoracic injury transiently decreased the heart rate, blood pressure, peripheral oxyhemoglobin saturation and cerebral blood flow immediately after LISW exposure. Although LISWs exposure caused pulmonary contusions, hemorrhage was not apparent in the brain. At 7 and 28 days after, the injured mice exhibited impaired short-term memory and depression-like behavior compared with controls. Histological assessments showed an increase in neuronal cell death after shock wave exposure, especially in the CA3 region of the hippocampus. Moreover, shock wave exposure altered the expression of functionally relevant genes in the hippocampus at 1 h and 1 day post injury. Our findings indicate that the LISW-induced thoracic injury with no direct impact on the brain affected the hippocampal gene expression and led to morphological alterations, resulting in behavioral abnormalities. Therefore, body protection may be extremely important in the effective prevention against blast-induced alterations in brain function.	[Miyazaki, Hiromi; Saiki, Takami; Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Tokorozawa, Saitama 3598513, Japan; [Miyawaki, Hiroki] Natl Def Med Coll Hosp, Dept Traumatol & Crit Care Med, Tokorozawa, Saitama 3598513, Japan; [Satoh, Yasushi] Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 3598513, Japan; [Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 3598513, Japan		Miyazaki, H (corresponding author), Natl Def Med Coll, Res Inst, Div Traumatol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	hiromyzk@ndmc.ac.jp			Research Promotion Program for Defense Medicine from the National Defense Medical College	This study was supported by the Research Promotion Program for Defense Medicine from the National Defense Medical College (D.S.).	Auer RN, 2002, GREENFIELDS NEUROPAT, V7th, P233; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Gotze S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-447; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031, DOI 10.1152/jn.2000.83.2.1031; Kujuro Y, 2010, P NATL ACAD SCI USA, V107, P8259, DOI 10.1073/pnas.0911446107; Lisowski P, 2013, J MOL NEUROSCI, V50, P33, DOI 10.1007/s12031-012-9850-1; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Podvin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024609; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Satoh Y, 2010, LASER SURG MED, V42, P313, DOI 10.1002/lsm.20899; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Takeo C, 2009, ENDOCR J, V56, P113, DOI 10.1507/endocrj.K08E-220; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	39	7	8	0	12	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2015	157	12					2111	2120		10.1007/s00701-015-2613-3			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CW4OV	WOS:000364971900012	26489739				2022-02-06	
J	Rezaei, S; Moghadam, AD; Khodadadi, N; Rahmatpour, P				Rezaei, Sajjad; Moghadam, Anoush Dehnadi; Khodadadi, Naeima; Rahmatpour, Pardis			Functional Independence Measure in Iran: A Confirmatory Factor Analysis and Evaluation of Ceiling and Floor Effects in Traumatic Brain Injury Patients	ARCHIVES OF TRAUMA RESEARCH			English	Article						Traumatic Brain Injury; Confirmatory Factor Analysis; Disability Evaluation	REHABILITATION; OUTCOMES	Background: The functional independence measure (FIM) is one of the most important assessment instruments for motor and cognitive dependence in rehabilitation medicine; however, there is little data about its confirmatory factor analysis (CFA) and ceiling/floor effects from other countries and also in Iranian patients. Objectives: The aim of this study was to evaluate a two-factor model (motor and cognitive independence as latent variables) and ceiling/floor effects for FIM in Iranian patients with traumatic brain injuries (TBI). Patients and Methods: In this cross-sectional study, 185 subacute TBI patients were selected from emergency and neurosurgery departments of Poursina Hospital (the largest trauma hospital in northern Iran, Rasht) using the consecutive sampling method and were assessed for functional independence. Results: The results of this study showed that the floor effect was not observed; however, ceiling effects were observed for the FIM total score and its subscales. The confirmatory factor analysis showed that the chi-square/df ratio was 2.8 for the two-factor structure and the fit indices for this structural model including root mean square error of approximation (RMSEA) = 0.099, normed fit index (NFI) = 0.96, tucker lewis index (TLI) = 0.97, comparative fit index (CFI) = 0.97 were close to standard indices. Conclusions: Although ceiling effects should be considered for rehabilitation targets, the two-factor model of FIM (motor and cognitive independence) has an eligible fitness for Iranian patients with TBI.	[Rezaei, Sajjad; Moghadam, Anoush Dehnadi; Khodadadi, Naeima] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran; [Moghadam, Anoush Dehnadi] Guilan Univ Med Sci, Department Anesthesiol, Rasht, Iran; [Moghadam, Anoush Dehnadi] Guilan Univ Med Sci, Intens Care Unit, Guilan Rd Trauma Res Ctr, Rasht, Iran; [Khodadadi, Naeima; Rahmatpour, Pardis] Guilan Univ Med Sci, Fac Nursing & Midwifery, Dept Nursing, Rasht, Iran		Rezaei, S (corresponding author), Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran.	Rezaei_psy@hotmail.com	Rahmatpour, Pardis/B-3021-2017; Rezaei, Sajjad/J-5086-2017	Rahmatpour, Pardis/0000-0003-4271-8101; Rezaei, Sajjad/0000-0001-7292-9669; Dehnadi Moghadam, Anoush/0000-0002-8408-2909	Road Trauma Research Center in Guilan University of Medical Sciences	This research project was financially supported by Road Trauma Research Center in Guilan University of Medical Sciences.	BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; Byrne B., 2012, MULTIVARIATE APPL SE; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chabok SY, 2012, ARCH TRAUMA RES, V1, P19, DOI 10.5812/atr.5289; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cohen ME, 2000, ARCH PHYS MED REHAB, V81, pS21, DOI 10.1053/apmr.2000.20620; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Granger CV., 1997, GUIDE UNIFORM DATA S; Heinemann AW, 1991, RATING SCALE ANAL FU; Hershkovitz A, 2007, ARCH PHYS MED REHAB, V88, P916, DOI 10.1016/j.apmr.2007.03.029; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kline R, 2010, PRINCIPLES PRACTICE, V3rd Edn; Kohler F, 2009, EUR J PHYS REHAB MED, V45, P479; Kucukdeveci AA, 2001, CLIN REHABIL, V15, P311, DOI 10.1191/026921501676877265; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Meyers L. S., 2006, APPL MULTIVARIATE RE; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Park EY, 2013, DISABIL REHABIL, V35, P1466, DOI 10.3109/09638288.2012.737082; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; Rezaei S, 2013, J IRANIAN SCI ANESTH, V82, P24; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stineman MG, 1997, ARCH PHYS MED REHAB, V78, P636, DOI 10.1016/S0003-9993(97)90430-5; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6	29	7	7	1	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	DEC	2015	4	4							e25363	10.5812/atr.25363			8	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	CV9VO	WOS:000364635800001	26848469	Green Submitted, Green Published, Bronze			2022-02-06	
J	Wu, Z; Gao, X; Chen, F; Tao, X; Cai, J; Guo, J; Chen, X; Tan, J; Yang, S				Wu, Z.; Gao, X.; Chen, F.; Tao, X.; Cai, J.; Guo, J.; Chen, X.; Tan, J.; Yang, S.			Chinese Pediatric Organ Donation With Scheduled Cardiac Arrest After Brain Death: A Novel China Classification Beyond Maastricht	TRANSPLANTATION PROCEEDINGS			English	Article							KIDNEY-TRANSPLANTATION; ADULT RECIPIENTS; DONORS; OUTCOMES; PROGRAM; IMPACT	Objective. Organ donation with scheduled cardiac arrest after brain death (s-DBCD) is a special category in China. This study was to evaluate the procedure of pediatric s-DBCD, graft quality, and clinical outcomes of single kidney transplantation. Methods. We retrospectively analyzed the data of 8 Chinese pediatric donors. Results. The death causes of the donors (age 4-12 years) were cerebral hypoxia after cardiopulmonary resuscitation (n = 1), intracranial vascular malformation (n = 1), severe traumatic brain injury (n = 3), and brain malignancy (n = 3). The functional warm ischemia time of the grafts was 18 (13-26) minutes. Sixteen kidneys were recovered using liver-kidney en bloc procurement after in situ perfusion. All kidneys had a length >7 cm and were transplanted to 3 adolescent and 13 adult recipients. Two cases of delayed graft function occurred. The patients had a median serum creatinine level of 97 (55-123) mu mol/L by the last visit. The median estimated glomerular filtration rate level was 85.4 (58-136) mL/min. Five episodes of biopsy-proven acute rejection occurred in 4 patients, which were reversed by methylprednisolone pulse therapy. Renal arterial stenosis was observed in 1 patient, which was cured by interventional balloon dilatation and stent implantation. Conclusion. Pediatric s-DBCD is feasible with acceptable graft quality. Single kidney transplantation with pediatric graft size >7 cm has good clinical outcomes.	[Wu, Z.; Gao, X.; Tao, X.; Cai, J.; Guo, J.; Chen, X.; Tan, J.; Yang, S.] Xiamen Univ, Dongfang Hosp, Fuzhou Gen Hosp, Organ Transplant Inst, Fuzhou, Peoples R China; [Chen, F.] Xiamen Univ, Dongfang Hosp, Fuzhou Gen Hosp, Dept Hepatobiliary Dis, Fuzhou, Peoples R China		Yang, S (corresponding author), 156 West Erhuan Rd, Fuzhou 350025, Peoples R China.	ysliang@medmail.com.cn	Tan, Ming-Jen/A-3862-2011	Tan, Ming-Jen/0000-0002-3583-1723; Wu, Zhixian/0000-0002-0708-6770; Chen, xiao dong/0000-0002-0150-0491	Science and Technology Project of Fujian Province [2015Y5007]	This study was supported by the Science and Technology Project of Fujian Province (grant 2015Y5007).	Abt P, 2006, TRANSPLANTATION, V82, P1708, DOI 10.1097/01.tp.0000254762.95625.d0; Antommaria AHM, 2009, JAMA-J AM MED ASSOC, V301, P1902, DOI 10.1001/jama.2009.637; Bresnahan BA, 2001, TRANSPLANTATION, V72, P256, DOI 10.1097/00007890-200107270-00016; Chamorro C, 2009, TRANSPL P, V41, P3473, DOI 10.1016/j.transproceed.2009.09.004; Chen GD, 2013, AM J TRANSPLANT, V13, P1323, DOI 10.1111/ajt.12190; Chinese Society of Organ Transplantation Chinese Medical Association, 2013, Hepatobiliary Pancreat Dis Int, V12, P234; Dagher NN, 2011, TRANSPLANTATION, V91, P765, DOI 10.1097/TP.0b013e31820cfd27; de Vries EE, 2010, CRIT CARE MED, V38, P249, DOI 10.1097/CCM.0b013e3181c025fd; Engstrom I, 2011, ACTA PAEDIATR, V100, P1172, DOI 10.1111/j.1651-2227.2011.02373.x; Ethics Committee American College of Critical Care Medicine, 2001, Crit Care Med, V29, P1826; Ferguson M, 2003, J PEDIATR GASTR NUTR, V37, P219, DOI 10.1097/00005176-200309000-00001; Gallinat A, 2013, PEDIATR TRANSPLANT, V17, P179, DOI 10.1111/petr.12049; Harrison CH, 2008, TRANSPL P, V40, P1044, DOI 10.1016/j.transproceed.2008.03.064; Huang JF, 2013, TRANSPLANTATION, V96, P5, DOI 10.1097/TP.0b013e3182985491; Huang JF, 2012, LANCET, V379, P862, DOI 10.1016/S0140-6736(11)61086-6; Jochmans I, 2011, CURR OPIN ORGAN TRAN, V16, P174, DOI 10.1097/MOT.0b013e3283446b31; Joffe AR, 2008, PEDIATRICS, V122, pE967, DOI 10.1542/peds.2008-1210; Kayler LK, 2012, TRANSPLANTATION, V93, P430, DOI 10.1097/TP.0b013e318241d57d; Kolovos NS, 2007, PEDIATR CRIT CARE ME, V8, P47, DOI 10.1097/01.pcc.0000256624.08878.40; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Mazor R, 2007, PEDIATRICS, V120, pE960, DOI 10.1542/peds.2006-3550; Peng Fenghua, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P204, DOI 10.11817/j.issn.1672-7347.2014.02.017; Pleacher KM, 2009, PEDIATR CRIT CARE ME, V10, P166, DOI 10.1097/PCC.0b013e318194800b; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x; Rostron AJ, 2008, TRANSPLANTATION, V85, P597, DOI 10.1097/TP.0b013e31816398dd; Sharma A, 2013, TRANSPLANTATION, V95, P1354, DOI 10.1097/TP.0b013e31828a9493; Singh RP, 2011, CLIN TRANSPLANT, V25, P255, DOI 10.1111/j.1399-0012.2010.01241.x; Sui WG, 2011, AM J TRANSPLANT, V11, P2247, DOI 10.1111/j.1600-6143.2011.03694.x; Sung RS, 2010, NAT REV NEPHROL, V6, P387, DOI 10.1038/nrneph.2010.40; Weber M, 2002, NEW ENGL J MED, V347, P248, DOI 10.1056/NEJMoa020274; Yuan Q, 2011, EXP CLIN TRANSPLANT, V9, P165	31	7	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	DEC	2015	47	10					2836	2840		10.1016/j.transproceed.2015.10.029			5	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	CZ9KM	WOS:000367416500008	26707298				2022-02-06	
J	Chow, JW; Stokic, DS				Chow, John W.; Stokic, Dobrivoje S.			Intersegmental coordination scales with gait speed similarly in men and women	EXPERIMENTAL BRAIN RESEARCH			English	Article						Locomotion; Biomechanics; Motor control; Planar covariation; Gait speed	INTER-JOINT COORDINATION; TRAUMATIC BRAIN-INJURY; WALKING SPEED; HUMAN LOCOMOTION; BILATERAL COORDINATION; LIMB COORDINATION; STROKE PATIENTS; MUSCLE-ACTIVITY; SWING PHASE; ADULTS	We applied principal component analysis (PCA) to thigh, shank, and foot elevation angles to examine the impact of speed on intra-limb coordination during gait. The specific aims were to (1) determine speed-related changes in segment loadings on three principal components (PCs) and (2) examine differences between men and women. The subjects (26 women, 21 men) walked overground at five self-selected paces (very slow, slow, normal, fast, very fast). PCA yielded percent variation (PV) explained by each PC and thigh, shank, and foot loadings on PC1-PC3. These parameters were regressed against the speed normalized to body height (BH/s) to derive individual and aggregate slopes and P values, separately for men and women. PV1 increased with speed, whereas PV2 and PV3 decreased (all P < 0.001). The loadings of thigh and foot segments on PC1 increased with speed (0.14 and 0.04 per BH/s, P < 0.001, respectively), and the loading of shank decreased (-0.10, P < 0.001). Compared to PC1, the changes in segment loadings on PC3 were the opposite (thigh -0.18, shank 0.09, foot -0.04 per BH/s, P < 0.001). The changes in segment loadings on PC2 were inconsistent and generally small. The only significance (P = 0.006), albeit a minor difference between men and women, was in the slope of thigh loading on PC2 (-0.005 +/- A 0.019 and 0.015 +/- A 0.026 per BH/s, respectively). We conclude that intersegmental coordination during gait scales with speed, with the greatest impact on the thigh segment, but no differently between men and women.	[Chow, John W.; Stokic, Dobrivoje S.] Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS 39216 USA		Chow, JW (corresponding author), Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, 1350 East Woodrow Wilson Dr, Jackson, MS 39216 USA.	jchow@mmrcrehab.org		Stokic, Dobrivoje/0000-0002-1891-5730	Wilson Research Foundation, Jackson, MS, USA	We are grateful to Mark Hemleben and L. Anthony Smith for their assistance. This work was supported in part by the Wilson Research Foundation, Jackson, MS, USA.	Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bejek Z, 2006, KNEE SURG SPORT TR A, V14, P612, DOI 10.1007/s00167-005-0005-6; Besier TF, 2009, J BIOMECH, V42, P898, DOI 10.1016/j.jbiomech.2009.01.032; Bianchi L, 1998, J NEUROPHYSIOL, V79, P2155, DOI 10.1152/jn.1998.79.4.2155; Bianchi L, 1998, PFLUG ARCH EUR J PHY, V436, P343, DOI 10.1007/s004240050642; Bleyenheuft C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P3, DOI 10.1016/j.rehab.2012.11.001; Bleyenheuft C, 2012, CLIN BIOMECH, V27, P568, DOI 10.1016/j.clinbiomech.2012.01.010; Bleyenheuft C, 2009, GAIT POSTURE, V30, P168, DOI 10.1016/j.gaitpost.2009.04.003; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; Bruening DA, 2015, GAIT POSTURE, V41, P540, DOI 10.1016/j.gaitpost.2014.12.011; CAVANAGH PR, 1975, J BIOMECH, V8, P337, DOI 10.1016/0021-9290(75)90086-X; Chau T, 2001, GAIT POSTURE, V13, P49, DOI 10.1016/S0966-6362(00)00094-1; Chiu SL, 2012, J BIOMECH, V45, P275, DOI 10.1016/j.jbiomech.2011.10.028; Cho SH, 2004, CLIN BIOMECH, V19, P145, DOI 10.1016/j.clinbiomech.2003.10.003; Chow JW, 2015, EXP BRAIN RES, V233, P125, DOI 10.1007/s00221-014-4099-2; Chow JW, 2010, BRAIN INJURY, V24, P1575, DOI 10.3109/02699052.2010.523053; Combs SA, 2013, CLIN BIOMECH, V28, P448, DOI 10.1016/j.clinbiomech.2013.02.001; Dan B, 2000, NEUROSCI LETT, V280, P175, DOI 10.1016/S0304-3940(00)00778-3; De Wit L, 2009, NEUROREHAB NEURAL RE, V23, P825, DOI 10.1177/1545968309337137; den Otter AR, 2004, GAIT POSTURE, V19, P270, DOI 10.1016/S0966-6362(03)00071-7; Donker SF, 2002, ACTA PSYCHOL, V110, P265, DOI 10.1016/S0001-6918(02)00037-9; Dubbeldam R, 2010, CLIN BIOMECH, V25, P796, DOI 10.1016/j.clinbiomech.2010.06.007; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Ghanavati T, 2014, IRAN REHABIL J, V12, P6; Ghanavati T, 2014, J BIOMECH, V47, P2300, DOI 10.1016/j.jbiomech.2014.04.038; Grasso R, 1999, EXP BRAIN RES, V126, P139, DOI 10.1007/s002210050724; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hicheur H, 2006, J NEUROPHYSIOL, V96, P1406, DOI 10.1152/jn.00289.2006; Hutin E, 2012, GAIT POSTURE, V36, P205, DOI 10.1016/j.gaitpost.2012.02.016; Hutin E, 2010, NEUROREHAB NEURAL RE, V24, P442, DOI 10.1177/1545968309354535; Ihlen EAF, 2014, J APPL PHYSIOL, V117, P189, DOI 10.1152/japplphysiol.00212.2014; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Ivanenko YP, 2006, J NEUROPHYSIOL, V95, P602, DOI 10.1152/jn.00767.2005; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Jonsdottir J, 2007, NEUROREHAB NEURAL RE, V21, P190, DOI 10.1177/1545968306290823; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Krasovsky T, 2014, GAIT POSTURE, V39, P378, DOI 10.1016/j.gaitpost.2013.08.011; Lacquaniti F, 1999, NEWS PHYSIOL SCI, V14, P168, DOI 10.1152/physiologyonline.1999.14.4.168; Laroche D, 2007, EXP BRAIN RES, V176, P85, DOI 10.1007/s00221-006-0597-1; LARSSON LE, 1980, SCAND J REHABIL MED, V12, P107; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Lythgo N, 2011, GAIT POSTURE, V33, P29, DOI 10.1016/j.gaitpost.2010.09.017; MacLellan MJ, 2010, EXP BRAIN RES, V202, P307, DOI 10.1007/s00221-009-2133-6; Murray M P, 1966, Am J Phys Med, V45, P8; OBERG T, 1994, J REHABIL RES DEV, V31, P199; PATLA AE, 1985, J MOTOR BEHAV, V17, P443; Plotnik M, 2013, GAIT POSTURE, V38, P864, DOI 10.1016/j.gaitpost.2013.04.011; Rinaldi LA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-53; Sainani KL, 2014, PM&R, V6, P275, DOI 10.1016/j.pmrj.2014.02.001; Schmitz A, 2009, J ELECTROMYOGR KINES, V19, P1085, DOI 10.1016/j.jelekin.2008.10.008; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Shemmell J, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-10; Singer JD, 2003, APPL LONGITUDINAL DA, P23; Sousa ASP, 2013, ARCH PHYS MED REHAB, V94, P2515, DOI 10.1016/j.apmr.2013.06.032; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	59	7	7	1	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	NOV	2015	233	11					3175	3185		10.1007/s00221-015-4386-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8MF	WOS:000363796200012	26195171				2022-02-06	
J	Gauvin-Lepage, J; Lefebvre, H; Malo, D				Gauvin-Lepage, Jerome; Lefebvre, Helene; Malo, Denise			Resilience in Families With Adolescents Suffering From Traumatic Brain Injuries	REHABILITATION NURSING			English	Article						Family resilience; traumatic brain injury; rehabilitation professionals	CHILDREN; INTERVENTIONS; TERM	Purpose: This study aims to coconstruct the building blocks for an intervention program to support family resilience in conjunction with families with an adolescent suffering from traumatic brain injury and rehabilitation professionals. Design: This is a qualitative and inductive study, supported by a collaborative research approach. Methods: Based on the complex intervention design and validation model, the investigator follows a three-stage data collection process: (1) identifying the building blocks of the intervention program in the eyes of families and rehabilitation professionals, (2) prioritizing, and (3) validating the building blocks with the same participants. Findings: After analyzing the data, the investigator identifies five encompassing themes as the building blocks of the intervention program. Conclusions/Clinical Relevance: This study offers promising avenues for practitioners and researchers in nursing and other fields with respect to the implementation of concrete strategies to support the resilience process of families facing particularly difficult times in their lives.	[Gauvin-Lepage, Jerome; Lefebvre, Helene; Malo, Denise] Univ Montreal, Fac Nursing, Montreal, PQ H3C 3J7, Canada; [Gauvin-Lepage, Jerome] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada		Gauvin-Lepage, J (corresponding author), Univ Montreal, Fac Nursing, Stn Downtown, Pavillon Marguerite Youville,Off 5088,POB 6128, Montreal, PQ H3C 3J7, Canada.	jerome.gauvin-lepage@umontreal.ca	Gauvin-Lepage, Jerome/AAD-6699-2020				Ahlert IA, 2012, AM ANN DEAF, V157, P391; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Bayat M, 2007, J INTELL DISABIL RES, V51, P702, DOI 10.1111/j.1365-2788.2007.00960.x; Campbell TL, 2003, J MARITAL FAM THER, V29, P263, DOI 10.1111/j.1752-0606.2003.tb01204.x; Chen HY, 2009, J CLIN NURS, V18, P174, DOI 10.1111/j.1365-2702.2008.02355.x; Chrisman SP, 2012, J ADOLESCENT HEALTH, V50, pS49, DOI 10.1016/j.jadohealth.2011.10.134; Cimon L., 2000, PARTENARIAT RECHERCH, P47; Cohen L, 2011, J SOC WORK PRACT, V25, P109, DOI 10.1080/02650533.2010.533754; Crotty M., 1998, FDN SOCIAL RES MEANI; Davila A., 2010, RECHERCHES QUALITATI, V29, P50; de Klerk H, 2011, J VISUAL IMPAIR BLIN, V105, P414, DOI 10.1177/0145482X1110500704; Denzin N.K., 2011, SAGE HDB QUALITATIVE; DePalma J A, 2001, Crit Care Nurs Q, V23, P42; Desgagne S., 1997, REV SCI ED, V23, P1; Desgagne S., 2007, RECHERCHE PARTICIPAT, P89; Desgagnu S., 2001, REV SCI ED, V27, DOI [10.7202/000305ar, DOI 10.7202/000305AR]; Earvolino-Ramirez M, 2007, NURS FORUM, V42, P73, DOI 10.1111/j.1744-6198.2007.00070.x; Francois N., 2005, ANNONCE HANDICAP ADO, P58; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Genest C., 2012, THESIS; Greeff AP, 2012, REHABIL NURS, V37, P97, DOI 10.1002/RNJ.00018; Greeff AP, 2011, OMEGA-J DEATH DYING, V63, P343, DOI 10.2190/OM.63.4.c; Greeff A, 2009, AM J FAM THER, V37, P114, DOI 10.1080/01926180802151919; Greeff AP, 2004, SOC INDIC RES, V68, P59, DOI 10.1023/B:SOCI.0000025569.95499.b5; Guba E., 1985, NATURALISTIC INQUIRY; Guba EG., 1989, 4 GENERATION EVALUAT; House LA, 2009, SPINAL CORD, V47, P882, DOI 10.1038/sc.2009.64; INSPQ, 2012, EV HOSP ATTR TRAUM C; Jonker L, 2009, J COMMUNITY PSYCHOL, V37, P859, DOI 10.1002/jcop.20337; Jourdan-Ionescu C., 2010, B PSYCHOL, V63, p[510, 449]; Khelia I, 2011, DEV HUMAIN HANDICAP, V19, P103; Laloua F., 2006, EVALUATION TROUBLES, P109; Lefebvre H., 2004, RECHERCHE SOINS INFI, V78, P14; Lefebvre H., 2002, FAMILLE SITUATION HA, P27; Lefebvre H., 2005, FRONTIERES, V17, P77; Lefebvre H., 2010, FRONTIERES, V22, P78; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Lefrancois R, 1997, NOUVELLES PRATIQUES, V10, P81, DOI [10.7202/301388ar, DOI 10.7202/301388AR]; Lobiondo-Wood G, 2009, NURSING RES CANADA M, V2nd ed.; LOISELLE CG, 2007, METHODES RECHERCHE S; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Miles M. B., 2003, ANAL DONNEES QUALITA; Mullin WJ, 2008, J FAM SOC WORK, V11, P424, DOI 10.1080/10522150802424565; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Neuman W.L., 2006, SOCIAL RES METHODS Q; Pelchat D, 2004, APPRENDRE ENSEMBLE P; Ross KA, 2011, BRAIN INJURY, V25, P1206, DOI 10.3109/02699052.2011.609519; Schwandt T, 2007, SAGE DICT QUALITATIV; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tsai MC, 2012, J ADOLESCENT HEALTH, V50, pS51, DOI 10.1016/j.jadohealth.2011.10.138; Tusaie Kathleen, 2004, Holist Nurs Pract, V18, P3; van Meijel B, 2004, J ADV NURS, V48, P84; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Walsh F., 2006, STRENGTHENING FAMILY; West C, 2012, J CLIN NURS, V21, P3532, DOI 10.1111/j.1365-2702.2012.04271.x; West C, 2011, COLLEGIAN, V18, P3, DOI 10.1016/j.colegn.2010.08.004; Wright L.M., 2013, NURSES FAMILIES GUID, V6; Wu HC, 2011, J CLIN NURS, V20, P1906, DOI 10.1111/j.1365-2702.2010.03664.x	59	7	7	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	NOV-DEC	2015	40	6					368	377		10.1002/rnj.204			10	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	DA9NH	WOS:000368135700005	25772208	Bronze			2022-02-06	
J	Li, J; Wei, LF; Xu, BY; Zhang, XJ; Wang, SS				Li, Jun; Wei, Liangfeng; Xu, Bingyang; Zhang, Xiaojun; Wang, Shousen			Risk factors and early diagnosis of cerebral venous sinus occlusion secondary to traumatic brain injury	NEUROLOGY INDIA			English	Article						Cerebral venous sinus occlusion; risk factor; skull fracture; traumatic brain injury	BLUNT HEAD TRAUMA; SKULL FRACTURE; CT VENOGRAPHY; THROMBOSIS	Objective: This study was designed to investigate the risk factors of, and the strategy for early diagnosis of cerebral venous sinus occlusion (CVSO) secondary to traumatic brain injury. Materials and Methods: The clinical data of 240 consecutive patients were analyzed retrospectively. The clinical symptoms were observed and imaging was carried out. The risk factors of CVSO were evaluated with logistic regression analysis. Early diagnosis of CVSO was established based on the clinical and imaging features. Results: Forty patients were diagnosed to be having CVSO according to the findings of computerized tomographic venogram (CTV) and magnetic resonance venogram (MRV). They were classified into three sub-types (thrombosis occlusion type, compression type, and mixed type). A skull fracture crossing the sinus (odds ratio [OR] =8.026; 95% confidence interval [CI]: 3.107-20.734) and an epidural hematoma crossing the sinus (OR = 3.062; 95% CI: 1.355-6.921) were risk factors associated with CVSO, and the former played a more significant role. The female gender (OR = 0.306; 95% CI: 1.715-61.943) was the risk factor for the thrombosis occlusion type of CVSO. An epidural hematoma crossing the sinus (OR = 5.653; 95% CI: 1.767-18.084) was the risk factor of the compression type of CVSO. The past medical history of deep vein thrombosis (DVT) (OR = 11.276; 95% CI: 1.315-96.664) combined with a skull fracture and epidural hematoma crossing the sinus were risk factors for the mixed type of CVSO. Conclusions: Paying close attention to the past medical history of DVT, skull fracture, and the imaging finding of an epidural hematoma that crosses the sinus are necessary for the early diagnosis of CVSO. CTV and MRV help in making an early diagnosis of CVSO.	[Li, Jun; Wei, Liangfeng; Xu, Bingyang; Zhang, Xiaojun; Wang, Shousen] Fujian Med Univ, Fuzhou Gen Hosp, Dept Neurosurg, Fuzhou 350025, Peoples R China		Wang, SS (corresponding author), Fujian Med Univ, Fuzhou Gen Hosp, Dept Neurosurg, 156 Xierhuanbei Rd, Fuzhou 350025, Peoples R China.	13405990495@163.com			Key Project of Fujian Province Science and Technology Plans [2010Y0043]	This work was supported by Key Project of Fujian Province Science and Technology Plans (No. 2010Y0043).	Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; AMEEN AA, 1981, J NEUROL NEUROSUR PS, V44, P220, DOI 10.1136/jnnp.44.3.220; Bishop FS, 2009, J NEUROSURG, V111, P17, DOI 10.3171/2009.2.JNS08491; Brors M, 2001, NEURORADIOLOGY, V43, P144, DOI 10.1007/PL00006045; Chen JJ, 2014, CURR EYE RES, V40, P1; Daligic A, 2008, TURK NEUROSURG, V18, P70; Fahim DK, 2011, NEUROSURGERY, V68, pE1756, DOI 10.1227/NEU.0b013e3182171439; Forbes JA, 2010, J NEUROSURG-PEDIATR, V6, P23, DOI 10.3171/2010.3.PEDS09441; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Geisbusch C, 2014, NERVENARZT, V85, P211, DOI 10.1007/s00115-013-4000-8; Hinnell C, 2012, CAN J NEUROL SCI, V39, P74, DOI 10.1017/S0317167100012725; Ipema HJ, 2012, ANN PHARMACOTHER, V46, P97, DOI 10.1345/aph.1Q383; Jiang BD, 2009, J CLIN NEUROL, V22, P33; Lakhkar Bhavana, 2010, J Emerg Trauma Shock, V3, P73, DOI 10.4103/0974-2700.58658; Lindvall P, 2013, CASE REP NEUROL, V5, P168, DOI 10.1159/000355394; Majima Nozomi, 2013, Masui, V62, P410; Rivkin MA, 2014, ACTA NEUROCHIR, V156, P999, DOI 10.1007/s00701-014-2025-9; Satoh H, 2000, NEUROL MED-CHIR, V40, P361, DOI 10.2176/nmc.40.361; Sen WS, 2014, CHIN J BRAIN DIS REH, V4, P1; Sun Y, 2009, CHINESE MED J-PEKING, V122, P2428, DOI 10.3760/cma.j.issn.0366-6999.2009.20.006; Wang WH, 2006, CHIN J CLIN NEUROSUR, V11, P327; Yuen HW, 2005, ANN ACAD MED SINGAP, V34, P639; Zhu XJ, 2006, J NEUROL NEUROREHABI, V3, P196; 李聪慧, 2010, [中华神经外科杂志, Chinese Journal of Neurosurgery], V26, P526	24	7	9	0	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2015	63	6					881	888		10.4103/0028-3886.170067			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX4UL	WOS:000365695700015	26588621				2022-02-06	
J	Onyekwulu, FA; Anya, SU				Onyekwulu, F. A.; Anya, S. U.			Pattern of admission and outcome of patients admitted into the Intensive Care Unit of University of Nigeria Teaching Hospital Enugu: A 5-year review	NIGERIAN JOURNAL OF CLINICAL PRACTICE			English	Article						Admission; Intensive Care Unit; outcome	STAY	Objective: The objective was to determine the pattern of admission and outcome of patients in the Intensive Care Unit (ICU) of University of Nigeria Teaching Hospital (UNTH), Enugu, Nigeria. Materials and Methods: A retrospective review of all patients admitted into the general ICU at UNTH from 2008 to 2012. Data were collected from the ICU admission and discharge registers, and data analysis was done using Microsoft Excel 2007. Results: A total of 766 patients were admitted during the period, consisting of 501 (65.4%) males and 265 (34.6%) females. Ages ranged from 1-day to 89 years with a mean age of 38.2 +/- 18.2 years. The most common cases admitted were neurosurgical patients of which there were 316 (41.2%). Patients admitted as a result of critical incidents in anesthesia formed the lowest number of cases admitted 10 (1.3%). Of the 316 neurosurgical cases, 224 (70.9%) were due to severe traumatic brain injury (TBI). An overall admission of 92.4% (207) was for severe TBI due to motor-vehicular accident (MVA). The average length of stay was < 24 h to 72 days with a mean of 4.9 +/- 3.2 days. A total of 16.7% (128) patients received invasive mechanical ventilation during their stay in ICU. Only 15% (34 patients) of all the cases of severe TBI patients received invasive mechanical ventilation. Mortality rate was 34.6% in this study. Conclusion: The highest number of admissions into the ICU was for severe TBI following MVA. Developing a viable trauma team and separately equipped neurosurgical ICU with adequately trained and motivated staff will help improve the outcome of patients.	[Onyekwulu, F. A.; Anya, S. U.] Univ Nigeria, Teaching Hosp, Dept Anaesthesia, Ituku Ozalla, Enugu State, Nigeria		Onyekwulu, FA (corresponding author), Univ Nigeria, Teaching Hosp, Dept Anaesthesia, Ituku Ozalla, Enugu State, Nigeria.	faonyekwulu@yahoo.com					Adenekan AT, 2009, AFR J ANAESTH INT CA, V9, P5; Arabi Y, 2004, INT J QUAL HEALTH C, V16, P149, DOI 10.1093/intqhc/mzh025; BJORNEBOE M, 1955, LANCET, V2, P901; Bolaji BO, 2005, SOUTH AFR J ANAESTH, V11, P146, DOI 10.1080/22201173.2005.10872416; Chalya PL, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-61; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hinds CJ, 1996, A CONCISE TXB, P1; Isamade E S, 2007, Niger J Clin Pract, V10, P156; Jacobs P, 2004, INTENS CARE MED, V30, P660, DOI 10.1007/s00134-003-2123-2; Khush KK, 2005, CAN J CARDIOL, V21, P1041; LASSEN HCA, 1953, LANCET, V264, P37; Mato CN., 2009, S AM J CRIT CARE, V25, P10; Oji A, 1987, W AFR J MED, V6, P91; Oke D A, 2001, Niger Postgrad Med J, V8, P179; Oyegunle AO, 1997, AFR J ANAESTH INTENS, V3, P41; Population Division of the Department of Economics and Social Affairs of the United Nations Secretariat, 2013, WORLD POP PROSP 2012, V1, P29; Waters DA, 1952, CARE CRITICALLY 3 PA, P274; Williams TA, 2010, BRIT J ANAESTH, V104, P459, DOI 10.1093/bja/aeq025; Wunsch H, 2010, CRIT CARE MED, V38, P65	20	7	7	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1119-3077			NIGER J CLIN PRACT	Niger. J. Clin. Pract.	NOV-DEC	2015	18	6					775	779		10.4103/1119-3077.163291			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM2GF	WOS:000376164400012	26289516				2022-02-06	
J	Camilleri, JA; Reid, AT; Muller, VI; Grefkes, C; Amunts, K; Eickhoff, SB				Camilleri, Julia A.; Reid, Andrew T.; Mueller, Veronika I.; Grefkes, Christian; Amunts, Katrin; Eickhoff, Simon B.			Multi-modal imaging of neural correlates of motor speed performance in the trail making test	FRONTIERS IN NEUROLOGY			English	Article						trail-making test; motor speed; inferior frontal sulcus; voxel-based morphometry; resting state fMRI; meta-analytic connectivity modeling; structural covariance; probabilistic tractography	STATE FUNCTIONAL CONNECTIVITY; SUBJECT DIFFUSION DATA; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; CORTICAL THICKNESS; SPATIAL STATISTICS; VOXELWISE ANALYSIS; NETWORKS; CORTEX; COVARIANCE	The assessment of motor and executive functions following stroke or traumatic brain injury is a key aspect of impairment evaluation and used to guide further therapy. In clinical routine, such assessments are largely dominated by pen-and-paper tests. While these provide standardized, reliable, and ecologically valid measures of the individual level of functioning, rather little is yet known about their neurobiological underpinnings. Therefore, the aim of this study was to investigate brain regions and their associated networks that are related to upper extremity motor function, as quantified by the motor speed subtest of the trail making test (TMT-MS). Whole-brain voxel-based morphometry and whole-brain tract-based spatial statistics were used to investigate the association between TMT-MS performance with gray-matter volume (GMV) and white-matter integrity, respectively. While results demonstrated no relationship to local white-matter properties, we found a significant correlation between TMT-MS performance and GMV of the lower bank of the inferior frontal sulcus, a region associated with cognitive processing, as indicated by assessing its functional profile by the BrainMap database. Using this finding as a seed region, we further examined and compared networks as reflected by resting state connectivity, meta-analytic connectivity modeling, structural covariance, and probabilistic tractography. While differences between the different approaches were observed, all approaches converged on a network comprising regions that overlap with the multiple-demand network. Our data therefore indicate that performance may primarily depend on executive function, thus suggesting that motor speed in a more naturalistic setting should be more associated with executive rather than primary motor function. Moreover, results showed that while there were differences between the approaches, a convergence indicated that common networks can be revealed across highly divergent methods.	[Camilleri, Julia A.; Reid, Andrew T.; Mueller, Veronika I.; Amunts, Katrin; Eickhoff, Simon B.] Inst Neurosci & Med INM 1, Res Ctr Julich, Julich, Germany; [Camilleri, Julia A.; Mueller, Veronika I.; Eickhoff, Simon B.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Grefkes, Christian] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Amunts, Katrin] Univ Dusseldorf, C&O Vogt Inst Brain Res, Dusseldorf, Germany		Camilleri, JA (corresponding author), Inst Neurosci & Med INM 1, Res Ctr Julich, Julich, Germany.	j.camilleri@fz-juelich.de	Grefkes, Christian/H-3972-2013; Reid, Andrew/I-6769-2019; Reid, Andrew/O-4359-2015; Eickhoff, Simon B./K-2061-2013; Amunts, Katrin/I-3470-2013	Grefkes, Christian/0000-0002-1656-720X; Reid, Andrew/0000-0002-0523-926X; Reid, Andrew/0000-0002-0523-926X; Eickhoff, Simon B./0000-0001-6363-2759; Muller, Veronika/0000-0003-4382-3181; Amunts, Katrin/0000-0001-5828-0867	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [EI 816/4-1, LA 3071/3-1, EI 816/6-1]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH074457]; European UnionEuropean Commission [604102]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH074457] Funding Source: NIH RePORTER	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, EI 816/4-1, LA 3071/3-1; EI 816/6-1.), the National Institute of Mental Health (R01-MH074457), and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 604102 (Human Brain Project).	Albaugh MD, 2013, NEUROIMAGE, V71, P42, DOI 10.1016/j.neuroimage.2012.12.071; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Andersson JLR, 2007, NONLINEAR REGISTRATI; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; Cieslik EC, 2015, NEUROSCI BIOBEHAV R, V48, P22, DOI 10.1016/j.neubiorev.2014.11.003; Clos M, 2014, NEUROIMAGE, V99, P269, DOI 10.1016/j.neuroimage.2014.05.030; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2011, NEUROIMAGE, V57, P938, DOI 10.1016/j.neuroimage.2011.05.021; Eickhoff SB, 2011, CLIN EEG NEUROSCI, V42, P107, DOI 10.1177/155005941104200211; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Fagiolo G, 2008, BRIT J RADIOL, V81, P250, DOI 10.1259/bjr/12956156; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox PT, 2014, ANNU REV NEUROSCI, V37, P409, DOI 10.1146/annurev-neuro-062012-170320; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Godefroy O, 2002, NEUROPSYCHOLOGIA, V40, P2234, DOI 10.1016/S0028-3932(02)00109-4; Godefroy O, 2010, CEREBROVASC DIS, V29, P508, DOI 10.1159/000297968; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hardwick RM, 2015, NEUROIMAGE, V123, P114, DOI 10.1016/j.neuroimage.2015.08.024; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hoffstaedter F, 2014, HUM BRAIN MAPP, V35, P2741, DOI 10.1002/hbm.22363; Jakobs O, 2012, NEUROIMAGE, V60, P2389, DOI 10.1016/j.neuroimage.2012.02.037; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kauranen K, 1996, PERCEPT MOTOR SKILL, V82, P515, DOI 10.2466/pms.1996.82.2.515; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Laird AR, 2013, NEUROIMAGE, V80, P505, DOI 10.1016/j.neuroimage.2013.04.073; Laird Angela R, 2011, BMC Res Notes, V4, P349, DOI 10.1186/1756-0500-4-349; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lawrie SM, 2000, PSYCHOL MED, V30, P433, DOI 10.1017/S0033291799001816; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Muller VI, 2015, BRAIN STRUCT FUNCT, V220, P2401, DOI 10.1007/s00429-014-0797-6; Muller VI, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00268; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Raghavan Preeti, 2007, Curr Treat Options Cardiovasc Med, V9, P221; Reid AT, 2016, BRAIN STRUCT FUNCT, V221, P2589, DOI 10.1007/s00429-015-1060-5; Rigoli D, 2012, DEV MED CHILD NEUROL, V54, P1025, DOI 10.1111/j.1469-8749.2012.04403.x; Roski C, 2014, BRAIN STRUCT FUNCT, V219, P707, DOI 10.1007/s00429-013-0530-x; Rottschy C, 2013, BRAIN STRUCT FUNCT, V218, P1551, DOI 10.1007/s00429-012-0476-4; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Staines WR, 2001, NEUROLOGY, V56, P401, DOI 10.1212/WNL.56.3.401; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Yoldemir B, 2014, I S BIOMED IMAGING, P250, DOI 10.1109/ISBI.2014.6867856	67	7	7	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 27	2015	6								219	10.3389/fneur.2015.00219			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CV0KE	WOS:000363938800001	26579066	gold, Green Published			2022-02-06	
J	Batty, R; Francis, A; Thomas, N; Hopwood, M; Ponsford, J; Johnston, L; Rossell, S				Batty, Rachel; Francis, Andrew; Thomas, Neil; Hopwood, Malcolm; Ponsford, Jennie; Johnston, Lisa; Rossell, Susan			Executive dysfunction in psychosis following traumatic brain injury (PFTBI)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychology; Executive dysfunction; Traumatic brain injury; Psychosis; Schizophrenia	NEUROPSYCHOLOGICAL STATUS RBANS; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE REMEDIATION; REPEATABLE BATTERY; ATTENTION DEFICITS; AXONAL INJURY; HEAD-INJURY; SCHIZOPHRENIA; DISORDER; PREDICTORS	Introduction: Executive dysfunction is well established in patients with traumatic brain injury and in schizophrenia (SCZ). However, assessments of executive function in psychosis following traumatic brain injury (PFTBI) are limited and inconsistent, and often do not reflect the deficits demonstrated in patients with traumatic brain injury (TBI) or SCZ. We sought to determine the extent of executive dysfunction in PFTBI relative to three comparison cohorts. Method: Measures of executive function were administered to dually diagnosed patients with PFTBI (n = 10) including tests of mental inhibition and switching, processing speed, and attention: the Stroop Task, Trail Making Test (TMT), and the Attention subtest of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Demographically comparable patients with TBI (n = 10), SCZ (n = 23), and healthy controls (n = 23) underwent an identical battery. Results: Significant executive dysfunction was evident in patients with PFTBI on all measures. Relative to all three comparison cohorts patients with PFTBI performed most poorly. Conclusions: These data present novel evidence of substantially impaired executive function across four task types in PFTBI and suggest that TBI and psychosis have an additive influence on executive function deficits. Treatment programs requiring substantial executive engagement are not suitable for patients dually diagnosed with PFTBI.	[Batty, Rachel; Thomas, Neil; Rossell, Susan] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr BPsyC, Melbourne, Vic, Australia; [Batty, Rachel; Thomas, Neil; Rossell, Susan] MAPrc, Melbourne, Vic, Australia; [Batty, Rachel; Francis, Andrew] RMIT Univ, Bundoora, Vic, Australia; [Hopwood, Malcolm] Univ Melbourne, Dept Psychiat, Albert Rd Clin, Melbourne, Vic, Australia; [Ponsford, Jennie; Johnston, Lisa] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia		Batty, R (corresponding author), Brain & Psychol Sci Res Ctr, Neuroimaging Facil, POB 218, Hawthorn, Vic 3122, Australia.	rachel.ann.batty@gmail.com	Thomas, Neil/H-6268-2016	Thomas, Neil/0000-0001-7006-6361; Rossell, Susan/0000-0002-7415-8252; Batty, Rachel A/0000-0001-6413-5332	Austin Hospital Research Foundation [2-1372]	This work was supported by the Austin Hospital Research Foundation [grant number 2-1372].	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Ashley MJ, 2012, NEUROREHABILITATION, V31, P31, DOI 10.3233/NRE-2012-0772; Bagney A, 2013, PSYCHOPATHOLOGY, V46, P241, DOI 10.1159/000342345; BAMRAH JS, 1991, BRIT J PSYCHIAT, V158, P117, DOI 10.1192/bjp.158.1.117; Batty R., 2015, PSYCHIAT RES, DOI [10.1016/j.psychres.2015.03.040i, DOI 10.1016/J.PSYCHRES.2015.03.040I]; Batty RA, 2013, BRAIN IMPAIR, V14, P21, DOI 10.1017/BrImp.2013.10; Bell M, 2009, SCHIZOPHRENIA BULL, V35, P738, DOI 10.1093/schbul/sbm169; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Breton F, 2011, NEUROPSYCHOLOGIA, V49, P203, DOI 10.1016/j.neuropsychologia.2010.11.019; Carter JD, 2010, SCHIZOPHR RES, V122, P104, DOI 10.1016/j.schres.2010.03.019; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Contreras N, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/863203; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fine EM, 2008, AM J GERIAT PSYCHIAT, V16, P366, DOI 10.1097/JGP.0b013e3181629957; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Frascarelli M, 2015, PSYCHIAT RES-NEUROIM, V231, P103, DOI 10.1016/j.pscychresns.2014.10.017; FRITH CD, 1979, BRIT J PSYCHIAT, V134, P225, DOI 10.1192/bjp.134.3.225; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Garety P, 1997, BRIT J PSYCHIAT, V171, P420, DOI 10.1192/bjp.171.5.420; Gogos A, 2010, AUST NZ J PSYCHIAT, V44, P220, DOI 10.3109/00048670903446882; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Henik Avishai, 2004, Behav Cogn Neurosci Rev, V3, P42, DOI 10.1177/1534582304263252; Hutton SB, 1998, PSYCHOL MED, V28, P463, DOI 10.1017/S0033291797006041; Joshua N, 2009, SCHIZOPHR RES, V114, P84, DOI 10.1016/j.schres.2009.05.029; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krabbendam L, 2003, PSYCHOPHARMACOLOGY, V169, P376, DOI 10.1007/s00213-002-1326-5; Krawczyk DC, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00062; Kubicki M, 2009, BRAIN IMAGING BEHAV, V3, P191, DOI 10.1007/s11682-009-9061-8; Kurtz MM, 2009, SCHIZOPHR RES, V107, P267, DOI 10.1016/j.schres.2008.10.014; Kurtz MM, 2001, NEUROPSYCHOL REV, V11, P197, DOI 10.1023/A:1012953108158; Langdon R, 2014, COGN NEUROPSYCHIATRY, V19, P241, DOI 10.1080/13546805.2013.854198; Laws KR, 2008, PSYCHIAT RES, V160, P8, DOI 10.1016/j.psychres.2007.06.004; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; McGurk SR, 2006, ADM POLICY MENT HLTH, V33, P598, DOI 10.1007/s10488-006-0070-2; McGurk SR, 2009, SCHIZOPHRENIA BULL, V35, P319, DOI 10.1093/schbul/sbn182; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Medalia A, 2009, NEUROPSYCHOL REV, V19, P353, DOI 10.1007/s11065-009-9097-y; Michie PT, 2000, AUST NZ J PSYCHIAT, V34, pS74, DOI 10.1080/000486700226; MILLER EM, 1994, PERS INDIV DIFFER, V17, P803, DOI 10.1016/0191-8869(94)90049-3; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moritz S, 2014, CLIN PSYCHOL REV, V34, P358, DOI 10.1016/j.cpr.2014.04.004; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; Must Anita, 2011, Neuropsychopharmacol Hung, V13, P211; Nelson H.E., 1982, NATL ADULT READING T; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P160, DOI 10.1093/schbul/10.2.160; Perlstein WM, 1998, NEUROPSYCHOLOGY, V12, P414, DOI 10.1037/0894-4105.12.3.414; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Raffard S, 2012, BRAIN COGNITION, V79, P60, DOI 10.1016/j.bandc.2012.01.008; Rajji TK, 2010, J CLIN PSYCHOPHARM, V30, P431, DOI 10.1097/JCP.0b013e3181e69060; Randolph C., 1998, REPEATABLE BATTERY A; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Savla GN, 2012, SCHIZOPHRENIA BULL, V38, P760, DOI 10.1093/schbul/sbq149; Smith GL, 1998, J ABNORM PSYCHOL, V107, P390, DOI 10.1037/0021-843X.107.3.390; TEASDALE G, 1974, LANCET, V2, P81; Thomas N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-198; Vega U, 2005, SCHIZOPHR RES, V78, P107, DOI 10.1016/j.schres.2005.05.012; Weiss EM, 2007, PSYCHIAT RES-NEUROIM, V154, P31, DOI 10.1016/j.pscychresns.2006.04.009; WYKES T, 1994, BRIT J PSYCHIAT, V165, P486, DOI 10.1192/bjp.165.4.486; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855; Zayat E, 2011, PSYCHIAT RES, V187, P1, DOI 10.1016/j.psychres.2010.11.011; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	81	7	8	2	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 21	2015	37	9					917	930		10.1080/13803395.2015.1068279			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CQ5LZ	WOS:000360647100002	26332172				2022-02-06	
J	Herrera-Melero, MC; Egea-Guerrero, JJ; Vilches-Arenas, A; Rincon-Ferrari, MD; Flores-Cordero, JM; Leon-Carrion, J; Murillo-Cabezas, F				Herrera-Melero, M. C.; Egea-Guerrero, J. J.; Vilches-Arenas, A.; Rincon-Ferrari, M. D.; Flores-Cordero, J. M.; Leon-Carrion, J.; Murillo-Cabezas, F.			Acute predictors for mortality after severe TBI in Spain: Gender differences and clinical data	BRAIN INJURY			English	Article						Death; emergency care; gender; head injury; neurocritical care; outcome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SAN-DIEGO-COUNTY; HEAD-INJURY; INTRACRANIAL-PRESSURE; DEATH DEVELOPMENT; PROGNOSTIC VALUE; PROGESTERONE; EPIDEMIOLOGY; OUTCOMES; HYPOTENSION	Objective: The main objective of this study is to determine whether gender affects global mortality and functional outcome after severe traumatic brain injury (TBI).Methods: This retrospective cohort study included 629 patients with severe TBI (14.9% female) admitted to the ICU of a university hospital. Patients were split into gender groups to study potential differences in global mortality and functional outcome at ICU discharge and 6 months post-trauma using the GOS. The following variables were analysed: age, intracranial injury, injury mechanism, injury severity, factors contributing to secondary brain injury, monitoring level, treatment, complications, length of stay in the ICU and cause of death.Results: No differences were found between gender groups in neuromonitoring level or surgical procedures. Women had higher APACHE II scores, a higher incidence of pre-hospital hypotension, anaemia and transfusion and higher mortality rates in the ICU (OR=1.74; 95% CI=1.09-2.77) and 6 months post-trauma (OR=1.65; 95% CI=1.02-2.67). There were no significant differences in functional outcome at ICU discharge or 6 months post-injury. The multivariate analysis did not show gender as an independent predictive factor in mortality after severe TBI.Conclusion: In this study, gender was not found to be an independent predictor for poorer outcome after severe TBI.	[Herrera-Melero, M. C.; Egea-Guerrero, J. J.; Rincon-Ferrari, M. D.; Flores-Cordero, J. M.; Murillo-Cabezas, F.] Virgen Rocio Univ Hosp, Neurocrit Care Unit, Seville 41013, Spain; [Egea-Guerrero, J. J.; Vilches-Arenas, A.; Murillo-Cabezas, F.] Univ Seville, IBiS CSIC, Seville, Spain; [Vilches-Arenas, A.] Univ Seville, Dept Prevent Med & Publ Hlth, Seville, Spain; [Leon-Carrion, J.] Univ Seville, Human Neuropsychol Lab, Ctr Brain Injury Rehabil CRECER, Seville, Spain		Egea-Guerrero, JJ (corresponding author), Virgen Rocio Univ Hosp, Neurocrit Care Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.	juanjoegea@hotmail.com	Egea-Guerrero, Juan Jose JJ/P-5080-2014; Vilches-Arenas, Angel/C-1167-2015; Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016	Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Vilches-Arenas, Angel/0000-0003-2197-3760; 			[Anonymous], 2012, ADV TRAUM LIF SUPP D, P9; Arellano-Orden V, 2011, NEUROCRIT CARE, V14, P18, DOI 10.1007/s12028-010-9441-3; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Croce MA, 2002, J TRAUMA, V53, P889, DOI 10.1097/00005373-200211000-00013; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Egea-Guerrero JJ, 2012, TRANSPL P, V44, P2050, DOI 10.1016/j.transproceed.2012.07.070; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Hernandez-Tejedor A, 2008, MED INTENSIVA, V32, P337, DOI 10.1016/S0210-5691(08)76211-9; JEFFREYS RV, 1981, LANCET, V2, P459; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Marin-Caballos AJ, 2008, MED INTENSIVA, V32, P81, DOI 10.1016/S0210-5691(08)70912-4; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Murillo F, 1996, SEVERE TRAUMATIC BRA, P1; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Mushkudiani NA, 2001, ARCH SURG-CHICAGO, V136, P1118; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schoeneberg C, 2013, CRIT CARE, V17, DOI 10.1186/cc13132; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	41	7	7	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1439	1444		10.3109/02699052.2015.1071428			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200007	26305856				2022-02-06	
J	Li, YY; Sun, Y; Li, J; Wang, Z; Lin, YZ; Tang, L; Xia, DD; Zheng, TZ; Yang, XH; Sha, L; Sun, CK				Li, Yuyuan; Sun, Yang; Li, Jian; Wang, Zhe; Lin, Yongzhong; Tang, Ling; Xia, Dandan; Zheng, Tiezheng; Yang, Xiaohan; Sha, Li; Sun, C. K.			Changes of ubiquitin C-terminal hydrolase-L1 levels in serum and urine of patients with white matter lesions	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Ubiquitin C-terminal hydrolase-L1; UCH-L1; Biomarkers; Serum; Urine; White matter lesions; WMLs	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; BIOMARKERS; DISEASE; PATHOLOGY; UCH-L1; L1; ABNORMALITIES; METASTASES	Objectives: Ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) has been established as a potential biomarker of neuronal damage. There is not much information about the effects of white matter lesions (WMLs) on serum and urine UCH-L1 levels in white matter disease patients. This study was aimed to assess whether serum or urine UCH-L1 levels are a reliable marker of brain damage in patients with WMLs. Design and methods: Serum and urine levels of UCH-L1 were assessed in 125 patients with dizziness, hypertension, type 2 diabetes mellitus, or dyslipidemia. Of these 125 patient cases, 41 showed periventricular WMLs (P-WMLs), 46 showed subcortical WMLs (S-WMLs), and 38 displayed no well-defined WMLs (controls). Results: Serum UCH-L1 levels were significantly different between the WML group and controls (p < 0.05). Further subgroup analysis proved that serum UCH-L1 levels in participants with S-WMLs were significantly increased when compared with controls (p < 0.001), but there was no significant differences between controls and patients with P-WMLs (p > 0.05). However, urine levels of UCH-L1 were similar between these three groups (p > 0.05). In addition, multivariate analysis showed that increased serum UCH-L1 levels were independently associated with the severity of WMLs using Fazekas scale (beta = 0.432, p < 0.001). Conclusions: These findings suggest that serum UCH-L1 levels may serve as a novel biomarker for neuronal damage from WMLs, especially S-WMLs. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Yuyuan; Sun, Yang; Tang, Ling; Xia, Dandan; Zheng, Tiezheng; Yang, Xiaohan; Sun, C. K.] Dalian Med Univ, Liaoning Prov Key Lab Cerebral Dis, Inst Brain Disorders, Dalian 116044, Peoples R China; [Li, Jian] Dalian Univ, Xinhua Hosp, Dept Orthopaed, Dalian 116021, Peoples R China; [Wang, Zhe] Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Dalian 116011, Peoples R China; [Lin, Yongzhong] Dalian Med Univ, Affiliated Hosp 2, Dept Neurol, Dalian 116023, Peoples R China; [Sha, Li] Dalian Med Univ, Dept Psychol, Dalian 116044, Peoples R China		Li, YY (corresponding author), Dalian Med Univ, Liaoning Prov Key Lab Brain Dis, Inst Brain Disorders, Dalian, Peoples R China.	liyuyuan831221@163.com; cksun110@vip.sina.com			National Science and Technology Major Project of China [2012ZX009503001-003]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61302030, 30950025]; Science and Technology Project of Liaoning Province of China [2010225009]; Educational Commission of Liaoning Province of China [L2012320]	This work was supported by the National Science and Technology Major Project of China (No. 2012ZX009503001-003), the National Natural Science Foundation of China (No. 61302030 and No. 30950025), the Science and Technology Project of Liaoning Province of China (No. 2010225009), and the Educational Commission of Liaoning Province of China (No. L2012320).	Altinbas A, 2013, J NEUROL SCI, V334, P77, DOI 10.1016/j.jns.2013.07.2512; Amlien IK, 2013, RADIOLOGY, V266, P295, DOI 10.1148/radiol.12120319; Annweiler C, 2014, EUR J NEUROL, V21, P1436, DOI 10.1111/ene.12511; Bjerke M, 2014, DEMENT GER COGN D EX, V4, P385, DOI 10.1159/000366119; Bohnen NI, 2011, NAT REV NEUROL, V7, P229, DOI 10.1038/nrneurol.2011.21; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Brouns R, 2010, CLIN CHEM, V56, P451, DOI 10.1373/clinchem.2009.134122; Cabuk B, 2011, TURK NEUROSURG, V21, P352, DOI 10.5137/1019-5149.JTN.4119-11.1; Chan PC, 2011, CLIN BIOCHEM, V44, P1168, DOI 10.1016/j.clinbiochem.2011.06.018; Contu VR, 2014, J NEUROCHEM, V130, P826, DOI 10.1111/jnc.12762; de Groot JC, 2000, ANN NEUROL, V47, P145; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Delano-Wood L, 2008, STROKE, V39, P794, DOI 10.1161/STROKEAHA.107.502534; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Diomedi-Camassei F, 2005, NEPHROL DIAL TRANSPL, V20, P2714, DOI 10.1093/ndt/gfi124; Dobson R, 2013, ACTA NEUROL SCAND, V128, P321, DOI 10.1111/ane.12119; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fernandez-Andujar M, 2014, NEUROBIOL AGING, V35, P1103, DOI 10.1016/j.neurobiolaging.2013.10.087; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Giurgiutiu D. V., 2014, J NEUROINTERV SURG; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Guglielmotto M, 2012, AGING CELL, V11, P834, DOI 10.1111/j.1474-9726.2012.00854.x; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Huang C C, 1995, Parkinsonism Relat Disord, V1, P53, DOI 10.1016/1353-8020(95)00013-V; Israelsson H, 2012, ACTA NEUROL SCAND, V125, P163, DOI 10.1111/j.1600-0404.2011.01520.x; Lee AL, 2002, BIPOLAR DISORD, V4, P117, DOI 10.1034/j.1399-5618.2002.01144.x; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Li YJ, 2013, EPILEPSY RES, V103, P205, DOI 10.1016/j.eplepsyres.2012.08.001; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Mazzone PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007242; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8; Nezu T, 2013, J NEUROL, V260, P2642, DOI 10.1007/s00415-013-7040-x; Ogama N, 2014, J AM MED DIR ASSOC, V15, P36, DOI 10.1016/j.jamda.2013.11.004; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Pfeffer M, 2012, NEUROBIOL AGING, V33, P393, DOI 10.1016/j.neurobiolaging.2010.02.019; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Ren CH, 2013, BRAIN RES, V1540, P84, DOI 10.1016/j.brainres.2013.09.051; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Senn R, 2014, CEREBROVASC DIS, V38, P395, DOI 10.1159/000366470; Stewart A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.02.049; Strickland AL, 2014, CURR NEUROVASC RES, V11, P242, DOI 10.2174/1567202611666140530130327; Tarawneh R, 2015, JAMA NEUROL, V72, P656, DOI 10.1001/jamaneurol.2015.0202; Targosz-Gajniak M, 2009, J NEUROL SCI, V283, P79, DOI 10.1016/j.jns.2009.02.314; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Wallin A, 2000, EUR NEUROL, V44, P229, DOI 10.1159/000008242; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630	50	7	7	4	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2015	357	1-2					215	221		10.1016/j.jns.2015.07.033			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS5SQ	WOS:000362138800036	26232084				2022-02-06	
J	Lin, BS; Wang, CC; Chang, MH; Chio, CC				Lin, Bor-Shyh; Wang, Che-Chuan; Chang, Ming-Hsien; Chio, Chung-Ching			Evaluation of traumatic brain injury by optical technique	BMC NEUROLOGY			English	Article						Deoxyhemoglobin; Infarction volume; Near-infrared spectroscopy; Oxyhemoglobin; Traumatic brain injury; Triphenyltetrazolium chloride	NEAR-INFRARED SPECTROSCOPY; INTRACRANIAL HEMATOMAS; CEREBRAL OXYGENATION; BLOOD-VOLUME; HEMOGLOBIN; ISCHEMIA; INFANTS	Background: Traumatic brain injury (TBI), usually due to brain shaking or impact, affects the normal brain function and may lead to severe disability or even death. However, there is paucity of information regarding changes in the physiologic state of humans or animals after brain shaking. Methods: In this study, near-infrared spectroscopy (NIRS) was used to continuously monitor the concentration change of oxy-hemoglobin (HbO2) and deoxy-hemoglobin (HbR) to understand changes in the physiological state during and after brain shaking. Laser Doppler flowmetry was also used to monitor changes in cerebral blood flow under TBI to supplement the investigation. Triphenyltetrazolium chloride (TTC) staining was used to monitor changes of infarction volume corresponding to different impact strengths. Result: The experimental results indicated that concentration changes of HbO2 and total-hemoglobin (HbT) were significantly related to the impact strength. The infarction volume was also significantly related to the impact strength. Conclusion: Therefore, the non-invasive monitoring of concentration changes in HbO2, HbR, and HbT using NIRS may have a clinical application for the evaluation of TBI.	[Lin, Bor-Shyh; Chang, Ming-Hsien] Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Tainan 710, Taiwan; [Wang, Che-Chuan] Natl Chiao Tung Univ, Inst Photon Syst, Tainan 710, Taiwan; [Lin, Bor-Shyh] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Che-Chuan; Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Div Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan		Wang, CC (corresponding author), Natl Chiao Tung Univ, Inst Photon Syst, 901 Zhonghua Rd, Tainan 710, Taiwan.	wangchechuan@gmail.com			Agenzia Italiana del Farmaco	This project proposal was approved and funded (announcement year 2006) by "Agenzia Italiana del Farmaco" as part of the project AREA "Pharmacoepidemiological studies aimed at defining the benefit-risk profile of treatments and the impact of strategies for improving the appropriateness of drug use. TOPIC: Studies on pharmacological treatments of chronic headache". Dr. Sarchielli had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis	Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Crespi F, 2005, J NEUROSCI METH, V145, P11, DOI 10.1016/j.jneumeth.2004.11.016; Crespi F, 1997, NEUROSCI LETT, V230, P77, DOI 10.1016/S0304-3940(97)00479-5; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Merzagora AC, 2011, J INNOV OPT HEAL SCI, V4, P251, DOI 10.1142/S1793545811001551; Noble KA, 2010, J PERIANESTH NURS, V25, P242, DOI 10.1016/j.jopan.2010.05.008; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P591, DOI 10.1089/neu.1995.12.591; Stankovic M R, 2000, J Matern Fetal Med, V9, P142; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Vernieri F, 1999, EUR NEUROL, V41, P159, DOI 10.1159/000008041; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wahr JA, 1996, J CARDIOTHOR VASC AN, V10, P406, DOI 10.1016/S1053-0770(96)80107-8; Wolf T, 1997, J CEREBR BLOOD F MET, V17, P950, DOI 10.1097/00004647-199709000-00004; Wu PJ, 2013, IEEE ENG MED BIO, P2412, DOI 10.1109/EMBC.2013.6610025; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8	27	7	7	1	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	OCT 14	2015	15								202	10.1186/s12883-015-0465-3			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT3LJ	WOS:000362707900001	26467307	Green Published, gold			2022-02-06	
J	Gaewsky, JP; Weaver, AA; Koya, B; Stitzel, JD				Gaewsky, James P.; Weaver, Ashley A.; Koya, Bharath; Stitzel, Joel D.			Driver Injury Risk Variability in Finite Element Reconstructions of Crash Injury Research and Engineering Network (CIREN) Frontal Motor Vehicle Crashes	TRAFFIC INJURY PREVENTION			English	Article; Proceedings Paper	59th Annual Scientific Conference of the Association for the Advancement of Automotive Medicine (AAAM)	OCT 04-07, 2015	philadelphia, PA			finite element modeling; human body model; Latin hypercube; occupant position; THUMS; variation	PULMONARY CONTUSION; BODY MODEL; PREDICTION; METRICS; VALIDATION; OCCUPANT; IMPACTS	Objective: A 3-phase real-world motor vehicle crash (MVC) reconstruction method was developed to analyze injury variability as a function of precrash occupant position for 2 full-frontal Crash Injury Research and Engineering Network (CIREN) cases.Method: Phase I: A finite element (FE) simplified vehicle model (SVM) was developed and tuned to mimic the frontal crash characteristics of the CIREN case vehicle (Camry or Cobalt) using frontal New Car Assessment Program (NCAP) crash test data. Phase II: The Toyota HUman Model for Safety (THUMS) v4.01 was positioned in 120 precrash configurations per case within the SVM. Five occupant positioning variables were varied using a Latin hypercube design of experiments: seat track position, seat back angle, D-ring height, steering column angle, and steering column telescoping position. An additional baseline simulation was performed that aimed to match the precrash occupant position documented in CIREN for each case. Phase III: FE simulations were then performed using kinematic boundary conditions from each vehicle's event data recorder (EDR). HIC15, combined thoracic index (CTI), femur forces, and strain-based injury metrics in the lung and lumbar vertebrae were evaluated to predict injury.Results: Tuning the SVM to specific vehicle models resulted in close matches between simulated and test injury metric data, allowing the tuned SVM to be used in each case reconstruction with EDR-derived boundary conditions. Simulations with the most rearward seats and reclined seat backs had the greatest HIC15, head injury risk, CTI, and chest injury risk. Calculated injury risks for the head, chest, and femur closely correlated to the CIREN occupant injury patterns. CTI in the Camry case yielded a 54% probability of Abbreviated Injury Scale (AIS) 2+ chest injury in the baseline case simulation and ranged from 34 to 88% (mean = 61%) risk in the least and most dangerous occupant positions. The greater than 50% probability was consistent with the case occupant's AIS 2 hemomediastinum. Stress-based metrics were used to predict injury to the lower leg of the Camry case occupant. The regional-level injury metrics evaluated for the Cobalt case occupant indicated a low risk of injury; however, strain-based injury metrics better predicted pulmonary contusion. Approximately 49% of the Cobalt occupant's left lung was contused, though the baseline simulation predicted 40.5% of the lung to be injured.Conclusions: A method to compute injury metrics and risks as functions of precrash occupant position was developed and applied to 2 CIREN MVC FE reconstructions. The reconstruction process allows for quantification of the sensitivity and uncertainty of the injury risk predictions based on occupant position to further understand important factors that lead to more severe MVC injuries.	[Gaewsky, James P.; Weaver, Ashley A.; Koya, Bharath; Stitzel, Joel D.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Gaewsky, James P.; Weaver, Ashley A.; Koya, Bharath; Stitzel, Joel D.] Wake Forest Univ, Sch Biomed Engn & Sci, Virginia Tech, Winston Salem, NC 27109 USA		Weaver, AA (corresponding author), 575 Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	asweaver@wakehealth.edu	Stitzel, Joel/B-4045-2012; Koya, Bharath/ABA-2613-2021; Weaver, Ashley/ABB-5845-2021	Stitzel, Joel/0000-0001-9762-3033; Weaver, Ashley/0000-0002-4383-0106	Toyota's Collaborative Safety Research Center	Funding for this project was provided by Toyota's Collaborative Safety Research Center. Views expressed are those of the authors and do not represent the views of any of the sponsors. Computations were performed on the Wake Forest University DEAC Cluster, a centrally managed resource with support provided in part by the University, and the Blacklight system at the Pittsburgh Supercomputing Center (PSC).	AAAM, 1998, ABBR INJ SCAL AIS 19; Anderson G., 2013, SCALIA SAFETY ENG; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; Beillas P, 1999, 43 STAPP CAR CRASH C; Belwadi A, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005684; Danelson KA, 2015, TRAFFIC INJ PREV, V16, P627, DOI 10.1080/15389588.2014.995266; Danelson Kerry A, 2011, Ann Adv Automot Med, V55, P217; Danelson KA, 2011, AVIAT SPACE ENVIR MD, V82, P79, DOI 10.3357/ASEM.2861.2011; Danelson Kerry A, 2009, Ann Adv Automot Med, V53, P271; Eppinger R, 1999, DEV IMPR INJ CRIT AS; Forman Jason L, 2012, Ann Adv Automot Med, V56, P109; Gayzik FS, 2011, BIOMECH MODEL MECHAN, V10, P505, DOI 10.1007/s10237-010-0251-5; Gayzik FS, 2007, STAPP CAR CRASH JO, V51, P189; Golman AJ, 2015, COMPUT METHOD BIOMEC, V18, P1044, DOI 10.1080/10255842.2013.869319; Golman AJ, 2014, ACCIDENT ANAL PREV, V64, P1, DOI 10.1016/j.aap.2013.10.026; GOMEZ MA, 2002, ACCIDENTAL INJURY BI, P206; Hayashi S, 2008, STAPP CAR C, V52, P363; Iraeus J, 2014, TRAFFIC INJ PREV, V15, pS88, DOI 10.1080/15389588.2014.933477; Iraeus Johan, 2013, Ann Adv Automot Med, V57, P183; Kayanja Mark M, 2004, Spine J, V4, P76, DOI 10.1016/j.spinee.2003.07.003; Kuppa S, 2001, 17 ESV C AMST NETH J; Mroz K, 2010, IRCOBI C HANN GERM S; NHTSA, 2014, TRAFF SAF FACTS 2012; *NHTSA, 1995, 201 FMVSS; Poulard D, 2015, J BIOMECH, V48, P636, DOI 10.1016/j.jbiomech.2014.12.050; Reed MP, 1999, SAE TECHNICAL PAPER; Ruan J., 2003, STAPP CAR CRASH J, V47, P299; Shigeta K, 2009, 21 ESV C STUTTG GERM; Society of Automotive Engineers, 1980, J224 COLL DEF CLASS; Sprague MA, 2004, INT J NUMER METH ENG, V60, P2467, DOI 10.1002/nme.1054; Stitzel Joel D, 2002, Stapp Car Crash J, V46, P81; Stocki R., 2005, Computer Assisted Mechanics and Engineering Sciences, V12, P393; Takhounts EG, 2008, STAPP CAR C, V52, P1; Vavalle NA, 2013, ANN BIOMED ENG, V41, P497, DOI 10.1007/s10439-012-0684-3; Weaver AA, 2013, ACCIDENT ANAL PREV, V50, P223, DOI 10.1016/j.aap.2012.04.013; Wilcox RK, 2004, EUR SPINE J, V13, P481, DOI 10.1007/s00586-003-0625-9	36	7	7	1	22	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	OCT 8	2015	16			2	SI		S124	S131		10.1080/15389588.2015.1061666			8	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Transportation	CS8IN	WOS:000362330800017	26436221				2022-02-06	
J	Chen, H; Cao, HL; Chen, SW; Guo, Y; Gao, WW; Tian, HL; Xue, LX				Chen, Hao; Cao, He-Li; Chen, Shi-Wen; Guo, Yan; Gao, Wen-Wei; Tian, Heng-Li; Xue, Li-Xia			Neuroglobin and Nogo-a as biomarkers for the severity and prognosis of traumatic brain injury	BIOMARKERS			English	Article						Biomarker; neuroglobin; Nogo-A; prognosis; traumatic brain injury	DOWN-REGULATION; EXPRESSION; OUTCOMES; IMPACT; MICE; RAT; MODELS; SCALE	Objective: To identify the early changes of serum neuroglobin and Nogo-A concentrations and the relations to traumatic brain injury (TBI) severity and prognosis.Methods: Serum samples were obtained and analyzed from 34 patients with TBI within the first 96h after injury. Comparative analysis combined with Glasgow Coma Scale (GCS) scores and the 6-month prognosis of these patients was performed.Results: Significant correlations were found between peak serum neuroglobin and Nogo-A concentrations and a patient's GCS score on admission (p<0.001). The mean peak serum neuroglobin and Nogo-A concentrations were both significantly higher in patients with an unfavorable outcome at 6 months after injury (p<0.05).Conclusions: Serum neuroglobin and Nogo-A levels could be suggested as biomarkers for predicting TBI severity and prognosis.	[Chen, Hao; Cao, He-Li; Chen, Shi-Wen; Guo, Yan; Gao, Wen-Wei; Tian, Heng-Li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China; [Xue, Li-Xia] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai 200030, Peoples R China		Xue, LX (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, 600 Yishan Rd, Shanghai 200030, Peoples R China.	dr.xue@126.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271383]; Shanghai Jiao Tong University Affiliated Sixth People's Hospital foundation [1462, 1583]	Funding for this study was provided by National Nature Science Foundation of China (81271383), and Shanghai Jiao Tong University Affiliated Sixth People's Hospital foundation (1462 and 1583).	[Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Li Zhen-Yan, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P697; Lin Xin, 2010, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V26, P39; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Mahmood A, 2014, BRAIN RES, V1542, P41, DOI 10.1016/j.brainres.2013.10.045; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Shang AJ, 2012, NEUROL RES, V34, P588, DOI 10.1179/1743132812Y.0000000052; Shang AJ, 2012, NEUROL SCI, V33, P551, DOI 10.1007/s10072-011-0772-4; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Yang JF, 2013, J SURG RES, V182, pE69, DOI 10.1016/j.jss.2012.11.010; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67	25	7	10	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1354-750X	1366-5804		BIOMARKERS	Biomarkers	OCT 3	2015	20	6-7					495	501		10.3109/1354750X.2015.1094138			7	Biotechnology & Applied Microbiology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Toxicology	CX4EM	WOS:000365651700019	26472601				2022-02-06	
J	Khan, UR; Bhatti, JA; Shamim, MS; Zia, N; Razzak, JA; Jooma, R				Khan, Uzma R.; Bhatti, Junaid A.; Shamim, M. Shahzad; Zia, Nukhba; Razzak, Junaid A.; Jooma, Rashid			Clothing-related motorcycle injuries in Pakistan: findings from a surveillance study	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						clothing; South Asia; female; injury; pillion riders; motorcycle; Pakistan; scarf; dupatta	ACCIDENTAL STRANGULATION; DUPATTA; SCARF; RICKSHAW; KARACHI; DEATHS	This study aims to assess the burden and patterns of clothing-related motorcycle injuries in Karachi, Pakistan. Data were extracted from an ongoing traffic injury surveillance system. In three years (2007-2009), out of 99155 road traffic injury cases there were 986 (0.9%) cases of clothing-related motorcycle injuries. Most cases were females (73.9%) and pillion riders (80.6%). The crashes involving clothing-related injuries were mostly single vehicle (98.5%), and largely resulted in injuries to the external body (60.3%), limbs (51.0%), head (41.5%) and face (35.9%). One-third of injuries were either moderate (26.7%) or severe (10.2%) while 10 (1.01%) deaths were reported. Female gender (11.4%), age 45years (19.4%), pillion riding (11.3%) and crashes occurring at intersections (12.3%) were more likely to result in moderate or severe injury as compared to other users (P < 0.001). Injuries due to entanglement of loose fitting clothing in motorcycles are not uncommon in Karachi. Awareness campaigns for prevention of such injuries may involve promotion of appropriate dressing for motorcycle riding including close wrapping of clothes and encouraging installations of covers on the rear wheels and drive chains.	[Khan, Uzma R.; Bhatti, Junaid A.; Shamim, M. Shahzad; Zia, Nukhba; Razzak, Junaid A.; Jooma, Rashid] Aga Khan Univ, Dept Emergency Med, Karachi, Pakistan; [Bhatti, Junaid A.] Douglas Hosp, Res Ctr, Montreal, PQ, Canada; [Bhatti, Junaid A.] Publ Hlth Solut Pakistan Pvt Ltd, Lahore, Pakistan; [Razzak, Junaid A.] Aman Healthcare Serv, Karachi, Sindh, Pakistan; [Jooma, Rashid] Rd Traff Injury Res & Prevent Ctr, Karachi, Pakistan		Jooma, R (corresponding author), Aga Khan Univ, Dept Emergency Med, Karachi, Pakistan.	rashid.jooma@aku.edu	Razzak, Junaid/ABE-3549-2020	Razzak, Junaid/0000-0003-0735-9094; Jooma, Rashid/0000-0001-6627-3245	Fogarty International Center of the United States National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43-TW007-292]; Indus Motor Company Ltd.; World Health Organisation Regional Office for the Eastern Mediterranean Region; Aman Foundation	U.R. Khan and J. A. Razzak were partially supported through the "Johns Hopkins-Pakistan International Collaborative Trauma and Injury Research Training program", [grant number D43-TW007-292] from the Fogarty International Center of the United States National Institutes of Health. The content is solely the responsibility of the authors and do not represent the views of Fogarty or NIH.; The Road Traffic Injury Research and Prevention Centre, in its first three years of functioning, was in part supported by grants from Indus Motor Company Ltd., the World Health Organisation Regional Office for the Eastern Mediterranean Region and the Aman Foundation. Funding agencies had no inputs in study design, conduct, analyses, interpretations of results and decision to submit manuscripts.	Agarwal A, 2008, SPINE J, V8, P703, DOI 10.1016/j.spinee.2008.01.005; Aggarwal NK, 1998, MED SCI LAW, V38, P263, DOI 10.1177/002580249803800315; Agrawal A, 2009, J FORENSIC LEG MED, V16, P350, DOI 10.1016/j.jflm.2009.01.004; Bhatti Junaid A, 2011, BMC Res Notes, V4, P75, DOI 10.1186/1756-0500-4-75; Chiu CK, 2010, EUR J TRAUMA EMERG S, V36, P180, DOI 10.1007/s00068-009-8212-3; DSouza LG, 1996, FOOT ANKLE INT, V17, P170, DOI 10.1177/107110079601700310; Ghaffar A, 2004, PUBLIC HEALTH, V118, P211, DOI 10.1016/j.puhe.2003.05.003; Gowens PA, 2003, EMERG MED J, V20, P391, DOI 10.1136/emj.20.4.391; Gupta BD, 2004, MED SCI LAW, V44, P359, DOI 10.1258/rsmmsl.44.4.359; HABAL MB, 1971, NEW ENGL J MED, V284, P734; Hasan A., 2011, EXPLORATION POTENTIA; Jain V, 2008, INJURY, V39, P334, DOI 10.1016/j.injury.2007.09.008; Kaur Manpreet, 2010, Anesth Essays Res, V4, P120, DOI 10.4103/0259-1162.73522; Khan I, 2008, ACAD EMERG MED, V15, P384, DOI 10.1111/j.1553-2712.2008.00049.x; Khan U., 2011, J EPIDEMIOLOGY CO S1, V65, P63; Kohli A, 1996, FORENSIC SCI INT, V78, P7, DOI 10.1016/0379-0738(95)01843-3; Krishnan R, 1994, World Health Forum, V15, P186; Peden M., 2004, WORLD REPORT ROAD TR; Razzak JA, 1998, INT J EPIDEMIOL, V27, P866, DOI 10.1093/ije/27.5.866; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Segers MJM, 1997, INJURY, V28, P267, DOI 10.1016/S0020-1383(97)00006-5; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; Shetty Mahabalesh, 2006, J Clin Forensic Med, V13, P148, DOI 10.1016/j.jcfm.2005.11.001; Siddiqui Arshad A, 2006, J Coll Physicians Surg Pak, V16, P152; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Vaidya SV, 2012, INDIAN J ORTHOP, V46, P239, DOI 10.4103/0019-5413.93690; Verma SK, 2005, MED SCI LAW, V45, P47, DOI 10.1258/rsmmsl.45.1.47; Zine K. U., 2011, J INDIAN ACAD FORENS, V33, P267	28	7	7	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.	OCT 2	2015	22	4					308	313		10.1080/17457300.2014.908221			6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CS3JT	WOS:000361970300003	24881928				2022-02-06	
J	Camp, CL; O'Driscoll, SW				Camp, Christopher L.; O'Driscoll, Shawn W.			Transbrachialis Buttonholing of the Radial Head as a Cause for Irreducible Radiocapitellar Dislocation: A Case Report	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						radiocapitellar dislocation; pulled elbow; nursemaid elbow; brachialis; radial head	PULLED ELBOW; CHILDREN	Background: Isolated dislocation of the radial head is an uncommon injury among pediatric patients. Although closed reduction may be successful, some patients require open reduction with or without soft-tissue repair or reconstruction. If the radiocapitellar joint is not properly reduced, the long-term complications of pain, stiffness, neuropathy, and dysplasia can result from chronic radial head dislocation. Methods: While performing a cartwheel, a 13-year-old gymnast sustained a radiocapitellar dislocation that was unable to be reduced by closed means and failed 2 attempts at open reduction. Ultimately, the radial head was determined to have translated anterior to the brachialis muscle during the dislocation and subsequently buttonholed through the muscle as the elbow was flexed and rotated. It remained suspended by the brachialis tendon, preventing anatomic reduction. Once the radial head was delivered from this tendinous sling, anatomic restoration of the radiocapitellar joint was obtained. Results: Ultimately, the patient was able to return to full, unrestricted activity. At 9 months following surgery, she denied pain, and the elbow was stable upon examination. Elbow range of motion was 5 to 130 degrees with 80 and 90 degrees of pronation and supination respectively. Conclusions: This represents the first reported case of suspension transbrachialis buttonholing of the radial head in the brachialis tendon as a cause of initially irreducible radiocapitellar dislocation. When evaluating patients with persistent anterior subluxation or dislocation of the radial head, this etiology should be considered.	[O'Driscoll, Shawn W.] Mayo Clin & Mayo Fdn, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Ctr Sports Med, Rochester, MN 55905 USA		O'Driscoll, SW (corresponding author), Mayo Clin & Mayo Fdn, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.	odriscoll.shawn@mayo.edu					Armstrong R D, 1987, Orthop Rev, V16, P104; Belangero WD, 2007, INT ORTHOP, V31, P151, DOI 10.1007/s00264-006-0153-4; Blonna D, 2010, AM J SPORT MED, V38, P2509, DOI 10.1177/0363546510376727; BONATUS T, 1995, J ORTHOP TRAUMA, V9, P441, DOI 10.1097/00005131-199505000-00014; Brown D, 2009, ORTHOP NURS, V28, P161, DOI 10.1097/NOR.0b013e3181ada779; CHOUNG W, 1995, J PEDIATR ORTHOPED, V15, P454, DOI 10.1097/01241398-199507000-00008; Corella F, 2010, J PEDIATR ORTHOP B, V19, P304, DOI 10.1097/BPB.0b013e3283339a1b; De Boeck H, 2000, CLIN ORTHOP RELAT R, P215; HOLSTNIELSEN F, 1984, J HAND SURG-AM, V9A, P572, DOI 10.1016/S0363-5023(84)80112-4; Horii E, 2002, J BONE JOINT SURG AM, V84A, P1183, DOI 10.2106/00004623-200207000-00014; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; Krul M, 2012, COCHRANE DB SYST REV, V1; Oka K, 2010, CLIN ORTHOP RELAT R, V468, P2410, DOI 10.1007/s11999-010-1283-y; ONER FC, 1993, J BONE JOINT SURG BR, V75, P577, DOI 10.1302/0301-620X.75B4.8331112; TRIANTAFYLLOU SJ, 1992, CLIN ORTHOP RELAT R, P153; Upasani VV, 2011, J SHOULDER ELB SURG, V20, pE14, DOI 10.1016/j.jse.2010.11.025; VEENSTRA KM, 1993, ACTA ORTHOP SCAND, V64, P224, DOI 10.3109/17453679308994576; Yoshihara Y, 2002, J TRAUMA, V53, P984, DOI 10.1097/00005373-200211000-00028	19	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	OCT-NOV	2015	35	7					E67	E71					5	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	DD0BW	WOS:000369586300001	26090978				2022-02-06	
J	Gibson, TJ; Bedford, EM; Chancellor, NM; Limon, G				Gibson, Troy J.; Bedford, Elisabeth M.; Chancellor, Natalie M.; Limon, Georgina			Pathophysiology of free-bullet slaughter of horses and ponies	MEAT SCIENCE			English	Article						Equine; Slaughter; Rifle; Behaviour; Pathophysiology	CATTLE SHOT; HEAD; BALLISTICS; EUTHANASIA; MECHANISMS; AMMUNITION; INJURY	Forty-six equines were observed during routine commercial slaughter in an abattoir. The animals were shot once with a.22 calibre long rifle with hollow point rounds. Indicators of sensibility/insensibility were evaluated immediately after the shot (prior to exsanguination) and the resulting pathophysiology of free-bullet injury was assessed. All animals were rendered immediately insensible, with only one pony showing signs of a shallow depth of concussion, with an intermittently positive palpebral reflex but no other signs of brainstem function. All animals (100%) had some degree of damage to the structures of the brainstem or lobes of the cerebrums, while 41 (89%) had damage to the thalamus/hypothalamus. The bullet in one pony missed the brain but still caused mild damage to the thalamus, midbrain, pons and cerebellum, this animal had no signs of sensibility. The findings confirm that free-bullet shooting is an effective dispatch method for horses and ponies. (C) 2015 The Authors. Published by Elsevier Ltd.	[Gibson, Troy J.; Bedford, Elisabeth M.; Chancellor, Natalie M.; Limon, Georgina] Royal Vet Coll, Dept Prod & Populat Hlth, Hatfield AL9 7TA, Herts, England		Gibson, TJ (corresponding author), Royal Vet Coll, Dept Prod & Populat Hlth, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	tgibson@rvc.ac.uk	Gibson, Troy/AAA-8687-2019	Gibson, Troy/0000-0002-1242-2695	Humane Slaughter Association Dorothy Sidley Memorial Scholarship	Elisabeth M. Bedford was supported by a Humane Slaughter Association Dorothy Sidley Memorial Scholarship.	Aarabi B, 2005, HEAD INJURY PATHOPHY, P384; Anderson R, 2005, HEAD INJURY PATHOPHY, P26; Atkinson S, 2013, ANIM WELFARE, V22, P473, DOI 10.7120/09627286.22.4.473; Bell Y, 2013, VET REC, V173, DOI 10.1136/vr.101636; BLACKMORE DK, 1985, VET REC, V116, P36, DOI 10.1136/vr.116.2.36; BLACKMORE DK, 1979, VET REC, V105, P372, DOI 10.1136/vr.105.16.372; Cooney KA, 2012, VET EUTHANASIA TECHN, P136, DOI [10.1002/9781118704585, DOI 10.1002/9781118704585]; FAOSTAT, 2015, ONL DAT FAO UN; Farjo LA, 1997, INJURY, V28, P12; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; Finnie JW, 1997, AUST VET J, V75, P204, DOI 10.1111/j.1751-0813.1997.tb10067.x; FRICKER C, 1981, FLEISCHWIRTSCHAFT, V61, P124; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2009, NEW ZEAL VET J, V57, P77, DOI 10.1080/00480169.2009.36882; Gibson TJ, 2015, J APPL ANIM WELF SCI, V18, P222, DOI 10.1080/10888705.2014.980579; Gibson TJ, 2015, MEAT SCI, V100, P227, DOI 10.1016/j.meatsci.2014.10.022; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Gregory NG, 2009, MEAT SCI, V81, P178, DOI 10.1016/j.meatsci.2008.07.016; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; GREGORY NG, 1991, OUTLOOK AGR, V20, P95, DOI 10.1177/003072709102000207; HIRSCH CS, 1975, J NEUROSURG, V42, P530, DOI 10.3171/jns.1975.42.5.0530; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; HSA, 2005, HUM KILL LIV US FIR; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; Leadon DP, 2013, IRISH VET J, V66, DOI 10.1186/2046-0481-66-20; Machado M., 2013, Brazilian Journal of Veterinary Pathology, V6, P102; Millar GI, 2000, VET REC, V146, P754, DOI 10.1136/vr.146.26.754; O'Mahony PJ, 2013, QJM-INT J MED, V106, P595, DOI 10.1093/qjmed/hct087; Oehmichen M, 2004, FORENSIC SCI INT, V146, P111, DOI 10.1016/j.forsciint.2004.06.023; Oehmichen M, 2000, J NEUROTRAUM, V17, P155, DOI 10.1089/neu.2000.17.155; Oehmichen M., 2009, FORENSIC NEUROPATHOL, P116; Schiffer KJ, 2014, ANIM WELFARE, V23, P479, DOI 10.7120/09627286.23.4.479; Svendsen O, 2008, VET REC, V162, P90, DOI 10.1136/vr.162.3.90; Thomson DU, 2013, AM J VET RES, V74, P1385, DOI 10.2460/ajvr.74.11.1385; Wise J., 2013, BMJ BRIT MED J, V346	35	7	8	0	48	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	OCT	2015	108						120	124		10.1016/j.meatsci.2015.06.007			5	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	CO4ZB	WOS:000359168300020	26093383	hybrid, Green Accepted			2022-02-06	
J	Kallakuri, S; Purkait, HS; Dalavayi, S; VandeVord, P; Cavanaugh, JM				Kallakuri, Srinivasu; Purkait, Heena S.; Dalavayi, Satya; VandeVord, Pamela; Cavanaugh, John M.			Blast overpressure induced axonal injury changes in rat brainstem and spinal cord	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Axonal injury; blast overpressure; brainstem; neurofilament-light chain; spinal cord; traumatic brain injury		Introduction: Blast induced neurotrauma has been the signature wound in returning soldiers from the ongoing wars in Iraq and Afghanistan. Of importance is understanding the pathomechansim(s) of blast overpressure (OP) induced axonal injury. Although several recent animal models of blast injury indicate the neuronal and axonal injury in various brain regions, animal studies related to axonal injury in the white matter (WM) tracts of cervical spinal cord are limited. Objective: The purpose of this study was to assess the extent of axonal injury in WM tracts of cervical spinal cord in male Sprague Dawley rats subjected to a single insult of blast OP. Materials and Methods: Sagittal brainstem sections and horizontal cervical spinal cord sections from blast and sham animals were stained by neurofilament light (NF-L) chain and beta amyloid precursor protein immunocytochemistry and observed foraxonal injury changes. Results: Observations from this preliminary study demonstrate axonal injury changes in the form of prominent swellings, retraction bulbs, and putative signs of membrane disruptions in the brainstem and cervical spinal cord WM tracts of rats subjected to blast OP Conclusions: Prominent axonal injury changes following the blast OP exposure in brainstem and cervical spinal WM tracts underscores the need for careful evaluation of blast induced injury changes and associated symptoms. NF-L immunocytochemistry can be considered as an additional tool to assess the blast OP induced axonal injury.	[Kallakuri, Srinivasu; Purkait, Heena S.; Dalavayi, Satya; VandeVord, Pamela; Cavanaugh, John M.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA		Kallakuri, S (corresponding author), Dept Biomed Engn, 818 W Hancock, Detroit, MI 48201 USA.	skallakuri@wayne.edu			North American Spine Society; United States Office of Naval Research Award [N000140810585]	North American Spine Society, United States Office of Naval Research Award N000140810585.	Andary MT, 1997, CLIN J PAIN, V13, P244, DOI 10.1097/00002508-199709000-00010; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ihling C, 2001, CIRCULATION, V104, P864, DOI 10.1161/hc3301.094742; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Povhshock JT, 1996, ACTA NEUROCHIR S, V66, P81; Povhshock JT, 1997, J NEUROPATHOL EXP NE, V56, P347; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Sveilov SI, 2012, FRONT NEUROL, V3, P15; Sveilov SI, 2009, J NEUROTRAUM, V26, P913; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wang YQ, 2010, INJURY, V41, P707, DOI 10.1016/j.injury.2009.12.003; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	44	7	7	0	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT-DEC	2015	6	4					481	487		10.4103/0976-3147.169767			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3W7R	WOS:000218657400006	26752889	Green Published, gold			2022-02-06	
J	Kruppa, C; Konigshausen, M; Schildhauer, TA; Dudda, M				Kruppa, Christiane; Koenigshausen, Matthias; Schildhauer, Thomas A.; Dudda, Marcel			Isolated pediatric radial head and neck fractures. A rare injury. Analysis and follow up of 19 patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						radial head; radial neck; pediatric; nonunion; crossunion; radial head excision; childhood; ESIN	PERCUTANEOUS REDUCTION; MONTEGGIA LESION; CLOSED REDUCTION; PROXIMAL RADIUS; DISPLACED FRACTURES; CHILDREN; DISLOCATION; PROGNOSIS; FIXATION; ULNA	Purpose: Isolated pediatric radial head and neck fractures are rare. In recent literature, their incidence is estimated to be around 1% of all fractures. High rates of complications are reported. Beside non-operative treatment, head fractures are treated with k-wires, mini-screws or polypins, whereas neck fractures are treated more and more with elastic stable intramedullary nailing (ESIN). Purpose of the study was to evaluate the operative management, complications and clinical outcomes of these injuries. Methods: Retrospective analysis between 2002 and 2014. 19 children with isolated radial head and neck fractures were treated in our institution. Age averaged 11 years (range 6-16). Operative treatment with elastic stable intramedullary nailing (ESIN) was performed in 13 patients, in one patient with an additional k-wire; two screw, two k-wire and one polypin fixation was performed in the others. One child was treated non-operatively. Results: Follow up averaged 19 months (2-89). Initial complications occurred in nine children such as fracture dislocation (1), nonunion (1), malunion (1), elbow ankylosis (1), infection (1), crossunion (2), intraarticular screw penetration (1) and radial nerve irritation (1). ESIN lead a complication rate of 36%, mini-screw fixation and k-wire fixation showed a complication rate of 100%. All children (100%) with an open reduction maneuver and 36% children with closed or percutaneous reduction developed a complication. Secondary surgeries included ESIN removal and k-wire fixation (1), open arthrolysis (1), debridement (1), removal of crossunion (1), radial head removal plus arthrolysis (3) and screw removal (1). Subsequently 74% (14) children showed a free or < 20 degrees limited range of motion on final follow up. Implant removal was performed after an average of 8 weeks (5-12). Three patients were transferred to our surgical department after a complication following initial treatment. Excluding these, an overall complication rate of 37.5% was noted. Conclusions: Radial head injuries in children are rare. In this population, neck fractures occur more frequently. If conservative treatment is not possible, ESIN seems to be a simple and protective procedure for neck fractures; polypins or screws can be used for complicated radial head fractures. Complications occur frequently after open reduction. If closed reduction and internal fixation is possible, range of motion can be completely restored. (C) 2015 Elsevier Ltd. All rights reserved.	[Kruppa, Christiane; Koenigshausen, Matthias; Schildhauer, Thomas A.; Dudda, Marcel] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Gen & Trauma Surg, Bochum, Germany		Kruppa, C (corresponding author), BG Univ Klinikum Bergmannsheil Bochum, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.	Christiane.Kruppa@ruhr-uni-bochum.de		Schildhauer, Thomas/0000-0002-3232-9869			BERNSTEIN SM, 1993, J PEDIATR ORTHOPED, V13, P85, DOI 10.1097/01241398-199301000-00017; Blount W, 1955, FRACTURES CHILDREN; Chambers H, 2001, ROCKWOOD WILKINS FRA, P483; Chotel F, 2004, J PEDIATR ORTHOP B, V13, P268, DOI 10.1097/01.bpb.0000111050.85604.f1; Cossio A, 2014, INJURY, V45, pS80, DOI 10.1016/j.injury.2014.10.028; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Erickson M, 2010, ROCKWOOD WILKINS FRA, P405; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; Falciglia F, 2014, J PEDIATR ORTHOPED, V34, P756, DOI 10.1097/BPO.0000000000000299; FIELDING JW, 1964, J BONE JOINT SURG AM, V46, P1277, DOI 10.2106/00004623-196446060-00014; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; FRASER KE, 1995, J BONE JOINT SURG AM, V77A, P782, DOI 10.2106/00004623-199505000-00016; GAO GX, 1984, CHINESE MED J-PEKING, V97, P893; GASTON SR, 1953, AM J SURG, V85, P266, DOI 10.1016/0002-9610(53)90608-4; Hassle M, 1991, Unfallchirurgie, V17, P24, DOI 10.1007/BF02588173; HENRIKSON B, 1969, ACTA ORTHOP SCAND, V40, P246, DOI 10.3109/17453676908989505; Hilgert RE, 2002, UNFALLCHIRURG, V105, P116, DOI 10.1007/s001130100336; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314, DOI 10.1302/0301-620X.32B3.314; JONES E R L, 1971, Journal of Bone and Joint Surgery British Volume, V53, P429; JUDET J, 1952, ANN CHIR, V16, P1377; Kamineni S, 2002, J BONE JOINT SURG AM, V84A, P745, DOI 10.2106/00004623-200205000-00007; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66, DOI 10.1302/0301-620X.71B1.2915009; Koslowsky TC, 2006, J SHOULDER ELB SURG, V15, P119, DOI 10.1016/j.jse.2004.12.002; Landin L A, 1983, Acta Orthop Scand Suppl, V202, P1; Leung AG, 2000, J PEDIATR ORTHOPED, V20, P7; Lewis RW, 1937, SURG GYNECOL OBSTET, V64, P1079; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; Metaizeau JP, 2005, INJURY, V36, pA75, DOI 10.1016/j.injury.2004.12.016; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Neher CG, 2003, J PEDIATR ORTHOPED, V23, P626, DOI 10.1097/01241398-200309000-00009; Nenopoulos SR, 2009, J PEDIATR ORTHOP B, V18, P252, DOI 10.1097/BPB.0b013e3283153f7e; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; Patterson RF, 1934, J BONE JOINT SURG, V16, P695; PESUDO JV, 1982, CLIN ORTHOP RELAT R, P215; Powell RS, 2002, J ORTHOP TRAUMA, V16, P737, DOI 10.1097/00005131-200211000-00010; Pring Maya E, 2012, J Pediatr Orthop, V32 Suppl 1, pS14, DOI 10.1097/BPO.0b013e31824b251d; Radomisli TE, 1998, CLIN ORTHOP RELAT R, P30; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760, DOI 10.1302/0301-620X.74B5.1527130; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; STRONG ML, 1989, ORTHOPEDICS, V12, P1577; Subasi M, 2015, INJURY, V46, pS14, DOI 10.1016/j.injury.2015.05.026; Tan Bryan Hsi Ming, 2011, J Orthop Surg (Hong Kong), V19, P209; Tarallo L, 2013, J ORTHOP TRAUMATOL, V14, P291, DOI 10.1007/s10195-013-0252-0; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; Ugutmen E, 2010, J PEDIATR ORTHOP B, V19, P289, DOI 10.1097/BPB.0b013e32833918a0; Ursei Monica, 2006, Acta Orthop Belg, V72, P131; VAHVANEN V, 1978, ACTA ORTHOP SCAND, V49, P32, DOI 10.3109/17453677809005720; Vocke AK, 1998, UNFALLCHIRURG, V101, P287, DOI 10.1007/s001130050270; Vocke AK, 1998, J PEDIATR ORTHOP B, V7, P217, DOI 10.1097/01202412-199807000-00007; von Laer L, 1997, ORTHOPADE, V26, P1030, DOI 10.1007/PL00003358; von Laer L, 2004, PEDIAT FRACTURES DIS; Vostal O, 1970, Acta Chir Orthop Traumatol Cech, V37, P294; Waters PM, 2001, J PEDIATR ORTHOPED, V21, P570, DOI 10.1097/00004694-200109000-00003; Wedge JH RD, 1982, JBJS BR, P64; Weigel B, 2005, PRAXISBUCH UNFALLCHI; Woods G W, 1973, J Sports Med, V1, P43; WRAY CC, 1989, INJURY, V20, P241, DOI 10.1016/0020-1383(89)90126-5; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	64	7	8	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2015	46			4			S10	S16		10.1016/S0020-1383(15)30013-9			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CU9ZH	WOS:000363905200003	26542853				2022-02-06	
J	Russo, CR; Lathan, CE				Russo, C. R.; Lathan, C. E.			An Evaluation of the Consistency and Reliability of the Defense Automated Neurocognitive Assessment Tool	APPLIED PSYCHOLOGICAL MEASUREMENT			English	Article						reliability; cognitive assessment; screening; traumatic brain injury; concussion; sports concussion; CNT	TEST-RETEST RELIABILITY; MEANINGFUL CHANGE; PERFORMANCE; ERROR	A durable, portable, and field-hardened computerized neurocognitive test (CNT) called the Defense Automated Neurobehavioral Assessment (DANA) tool was recently developed to provide a practical means to conduct neurological and psychological assessment in situ. The psychometric properties of the DANA have been previously described. This present work discusses the test-retest reliability of the DANA Rapid test battery, as administered to a homogeneous population of U.S. Air Force Academy football team players (N = 162) across the duration of the season. The intraclass correlation coefficient (ICC) metric of the DANA is compared with that from two different CNTs recently reported in Cole et al., and the implications of using the metric to interpret comparative test reliability among different CNTs are discussed.	[Russo, C. R.; Lathan, C. E.] AnthroTronix Inc, Silver Spring, MD 20910 USA		Russo, CR (corresponding author), AnthroTronix Inc, 8737 Colesville Rd,Suite L203, Silver Spring, MD 20910 USA.	clementina.russo@atinc.com			AnthroTronix Inc.; U.S. Navy Bureau of Medicine and Surgery (BUMED)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by AnthroTronix Inc. and the U.S. Navy Bureau of Medicine and Surgery (BUMED).	Baumgartner T.A., 2000, MEAS PHYS EDUC EXERC, V4, P175, DOI [DOI 10.1207/S15327841MPEE0403_3, https://doi.org/10.1207/S15327841Mpee0403_3]; BAUMGARTNER TA, 1969, RES QUART, V40, P222, DOI 10.1080/10671188.1969.10616664; Bedard M, 2000, EXP AGING RES, V26, P353, DOI 10.1080/036107300750015741; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruggemans EF, 1997, J CLIN EXP NEUROPSYC, V19, P543, DOI 10.1080/01688639708403743; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Christie A, 2010, MEAS PHYS EDUC EXERC, V14, P164, DOI 10.1080/1091367X.2010.495549; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Denegar C.R., 1993, J SPORT REHABIL, V2, P35, DOI 10.1123/jsr.2.1.35.; ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777; FELDT LS, 1958, RES QUART, V29, P279, DOI 10.1080/10671188.1958.10762021; Hopkins WG, 2000, SPORTS MED, V30, P375, DOI [DOI 10.2165/00007256-200030050-00006, 10.2165/00007256-200030050-00006]; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; KROLL W, 1962, RES QUART, V33, P313, DOI 10.1080/10671188.1962.10613207; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Learmonth YC, 2013, MULT SCLER J, V19, P1784, DOI 10.1177/1352458513483890; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Moritz S, 2003, APPL NEUROPSYCHOL, V10, P115, DOI 10.1207/S15324826AN1002_07; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Salarian A., 2008, ICC ANOVA; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stratford PW, 1997, PHYS THER, V77, P745, DOI 10.1093/ptj/77.7.745; Streiner DL, 1995, MEASUREMENT SCALES P; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; [No title captured]	29	7	7	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0146-6216	1552-3497		APPL PSYCH MEAS	Appl. Psychol. Meas.	OCT	2015	39	7					566	572		10.1177/0146621615577361			7	Social Sciences, Mathematical Methods; Psychology, Mathematical	Social Science Citation Index (SSCI)	Mathematical Methods In Social Sciences; Psychology	CQ7PQ	WOS:000360796500005	29881027	Green Published			2022-02-06	
J	Ozen, LJ; Fernandes, MA; Clark, AJ; Roy, EA				Ozen, Lana J.; Fernandes, Myra A.; Clark, Amanda J.; Roy, Eric A.			Evidence of cognitive decline in older adults after remote traumatic brain injury: an exploratory study	AGING NEUROPSYCHOLOGY AND COGNITION			English	Article						Trail Making Test; aging; Stroop Test; attention; concussion	CLOSED-HEAD INJURY; WORKING-MEMORY; AGE-DIFFERENCES; ALZHEIMERS-DISEASE; TASK-COORDINATION; EXECUTIVE CONTROL; RISK FACTOR; ATTENTION; CONCUSSION; STRATEGIES	Separate bodies of literature indicate that a history of a traumatic brain injury (TBI) and natural aging may result in overlapping cognitive profiles, yet little is known about their combined effect. We predicted that a remote TBI would compound normal age-related cognitive decline, particularly affecting executive function. Neuropsychological task performance was compared between a group of older adults who sustained a TBI in their distant past (N=9) and a group of older adults with no history of head injury (N=15). While all participants scored in the normal range on the Mini-Mental State Examination, the TBI group scored lower than the non-TBI group. Also, in line with predictions, the TBI group made more errors on measures of executive functioning compared to the non-TBI group (the Trail Making B test and the incongruent condition of the Stroop Test), but performed similarly on all tasks with little executive requirements. Findings from this exploratory study indicate that a past TBI may put older adults at a higher risk for exacerbated age-related cognitive decline compared to older adults with no history of TBI.	[Ozen, Lana J.; Fernandes, Myra A.; Clark, Amanda J.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Roy, Eric A.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada		Ozen, LJ (corresponding author), Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada.	ozenl@tbh.net			Natural Sciences and Engineering Research Council (NSERC) postgraduate scholarshipsNatural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery grantsNatural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by Natural Sciences and Engineering Research Council (NSERC) postgraduate scholarships to LJO and AJC, and NSERC Discovery grants to MAF and EAR.	Aben B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00301; Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Bopp KL, 2007, J GERONTOL B-PSYCHOL, V62, pP239, DOI 10.1093/geronb/62.5.P239; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Brink JM, 1999, J GERONTOL B-PSYCHOL, V54, pP30, DOI 10.1093/geronb/54B.1.P30; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryan J, 2000, J CLIN EXP NEUROPSYC, V22, P40, DOI 10.1076/1380-3395(200002)22:1;1-8;FT040; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Clark AJ, 2012, BEHAV RES METHODS, V44, P558, DOI 10.3758/s13428-011-0154-0; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC, 1987, CALIFORNIA VERBAL LE; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; Ettlin TM, 2000, CLIN REHABIL, V14, P260, DOI 10.1191/026921500669635136; Folstein M. F., 1998, COMPENDIUM NEUROPSYC, P65; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Glass JM, 2000, PSYCHOL AGING, V15, P571, DOI 10.1037/0882-7974.15.4.571; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HARTLEY AA, 1993, PSYCHOL AGING, V8, P371, DOI 10.1037/0882-7974.8.3.371; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; Hill BD, 2012, APPL NEUROPSYCH-ADUL, V19, P198, DOI 10.1080/09084282.2011.643960; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Madden DJ, 1996, PSYCHOL AGING, V11, P454, DOI 10.1037/0882-7974.11.3.454; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Ozen LJ, 2010, J INT NEUROPSYCH SOC, V16, P556, DOI 10.1017/S1355617710000202; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Plude DJ, 1986, PSYCHOL AGING, V1, P4, DOI 10.1037/0882-7974.1.1.4; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Prull MW, 2000, HDB AGING COGNITION, V2., P91; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Reitan R, 1985, HALSTEAD REITAN NEUR; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Spielberger CD, 1970, MANUAL STATE TRAIT A; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Verhaeghen P, 1998, PSYCHOL AGING, V13, P120, DOI 10.1037/0882-7974.13.1.120; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Westcott MC, 2005, BRAIN INJURY, V19, P1261, DOI 10.1080/02699050500150104	80	7	7	1	32	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1382-5585	1744-4128		AGING NEUROPSYCHOL C	Aging Neuropsychol. Cogn.	SEP 3	2015	22	5					517	533		10.1080/13825585.2014.993584			17	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	CK5VZ	WOS:000356295400001	25532692				2022-02-06	
J	Hinton-Bayre, AD				Hinton-Bayre, Anton Dominic			Normative Versus Baseline Paradigms for Detecting Neuropsychological Impairment Following Sports-Related Concussion	BRAIN IMPAIRMENT			English	Article						Athlete; neurocognitive; mild traumatic brain injury; reliable change	TEST-RETEST RELIABILITY; RELIABLE CHANGE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; IMPACT; MANAGEMENT; JACOBSON; ZURICH	Objective: Obtaining baseline neuropsychological (NP) data to assist management of sports-related concussion has been considered the standard of care. The validity of this approach has been questioned, with suggestions that post-concussion testing alone will suffice. The present study compared the sensitivity of baseline and normative paradigms in the setting of sports-related concussion. Method: Baseline NP data were collected for 194 Australian rugby league athletes on a brief battery of paper-and-pencil NP tests. During competition, 27 athletes sustaining concussion referred from a sports physician were retested within two days of injury. Twenty-six uninjured controls were assessed at similar intervals. The baseline paradigm was assessed using a reliable change index for pre- and post-concussion scores. The normative paradigm was assessed comparing the post-concussion score to a normative mean. Results: The baseline paradigm was consistently more sensitive to negative change following concussion than the normative paradigm when using continuous data, despite reasonable agreement. However, when data were categorised as 'impaired' or 'not-impaired', using either 68% or 90% confidence intervals, the difference between paradigms failed to reach significance. Comparison of ROC curves for both paradigms found superior overall classification for one test and the composite score using baseline comparison data. Conclusions: Despite being a time and resource intensive process, the baseline paradigm as a repeated-measures design may be more sensitive than the between-subjects design of the normative paradigm for detecting changes following concussion. Further work is required to determine the validity of normative assessment in sports-related concussion.	[Hinton-Bayre, Anton Dominic] Univ Western Australia, Sch Surg, Crawley, WA 6009, Australia		Hinton-Bayre, AD (corresponding author), Univ Western Australia, Sch Surg M507, Ear Sci Ctr, 35 Stirling Highway, Crawley, WA 6009, Australia.	anton.hb@hotmail.com					Cohen R. J., 2012, PSYCHOL TESTING ASSE; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P755, DOI 10.1076/jcen.20.5.755.1132; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hinton-Bayre AD, 2012, CLIN J SPORT MED, V22, P105, DOI 10.1097/JSM.0b013e318248a526; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; Holdnak J.A., 2013, WAIS 4 WMS 4 ACS ADV; Howell D.C., 2010, STAT METHODS PSYCHOL, V7th ed; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Maassen GH, 2004, J INT NEUROPSYCH SOC, V10, P888, DOI 10.1017/S1355617704106097; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCSWEENY AJ, 1993, CLIN NEUROPSYCHOL, V7, P460; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; SPEER DC, 1992, J CONSULT CLIN PSYCH, V60, P402, DOI 10.1037/0022-006X.60.3.402; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	30	7	7	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2015	16	2					80	89		10.1017/BrImp.2015.14			10	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CV0MJ	WOS:000363944500002					2022-02-06	
J	Moreau, WJ; Nabhan, DC; Walden, T				Moreau, William J.; Nabhan, Dustin C.; Walden, Taylor			Sport Concussion Knowledge and Clinical Practices: A Survey of Doctors of Chiropractic With Sports Certification	JOURNAL OF CHIROPRACTIC MEDICINE			English	Article						Brain concussion; Chiropractic		Objective: The purpose of this study is to describe the knowledge base and clinical practices regarding concussion by sports-certified doctors of chiropractic. Methods: A21-item survey was distributed to the 312 attendees of the 2014 American Chiropractic Board of Sports Physicians Sports Sciences Symposium. Results were measured by frequency analysis and descriptive statistics for all surveys completed by sports-certified chiropractors. Results: Seventy-six surveys were returned by sports-certified doctors of chiropractic. All (N = 76) 100% of respondents believe that the evaluation of concussion should be performed by a health care provider with training in concussion. The respondents actively assess and manage concussion in adults (96%), adolescents (95%), and children (75%). A majority (79%) of respondents believe that the Sideline Concussion Assessment Tool-3 represents a current standard of care for the sideline evaluation of the athlete who possibly has sustained a sport concussion. Most respondents agreed or strongly agreed that manual therapies may be appropriate in certain circumstances in adults (80%) and minors (80%). Conclusion: This cross section of certified sports chiropractors strongly believes that the evaluation of concussion should be performed by a health care provider with specific training in concussion. A high percentage of the sports-certified chiropractors who responded assess and manage sport concussion in their practice, and many of them endorse the use of the Sideline Concussion Assessment Tool-3 as a sideline assessment tool. (C) 2015 National University of Health Sciences.	[Moreau, William J.; Nabhan, Dustin C.; Walden, Taylor] United States Olymp Comm, Colorado Springs, CO USA; [Moreau, William J.] Southern Calif Univ Hlth Sci, Whittier, CA USA		Nabhan, DC (corresponding author), 7795 Julynn Rd, Colorado Springs, CO 80919 USA.	nabhandc@gmail.com					Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; [Anonymous], 2001, NONF TRAUM BRAIN INJ; [Anonymous], 2009, J ORTHOP SPORT PHYS, V39, P364; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; CDC, IMPL RET PLAY LEARN; Chaibi A, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-67; Chaibi A, 2012, J HEADACHE PAIN, V13, P351, DOI 10.1007/s10194-012-0436-7; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Conidi Francis X, 2014, Neurol Clin Pract, V4, P153; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Ferrara Michael S., 2001, J Athl Train, V36, P145; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gordon KE, 2014, BRAIN INJURY, V28, P311, DOI 10.3109/02699052.2013.862740; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herring SA, 2011, MED SCI SPORTS EXERC, V43, P2412; Herzog MM, 2014, P AM AC PED NAT C EX; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moreau W., 2005, 2005 ACBSP SPORTS SC; Moreau WJ, 2013, J CHIROPR MED, V12, P269, DOI 10.1016/j.jcm.2013.07.002; NASN, 2013, NASN SCH NURSE, V28, P110; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Reneker JC, 2014, BR J SPORTS MED; Schneider KJ, 2013, BRIT J SPORT MED, V47, pe1; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343	36	7	7	0	4	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0899-3467	1556-3715		J CHIROPR MED	J. Chiropr. Med.	SEP	2015	14	3					169	175		10.1016/j.jcm.2015.08.003			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V03DM	WOS:000213718100003	26778930	Green Published			2022-02-06	
J	Ortiz, F; Gutierrez, R				Ortiz, Franco; Gutierrez, Rafael			Entorhinal cortex lesions result in adenosine-sensitive high frequency oscillations in the hippocampus	EXPERIMENTAL NEUROLOGY			English	Article						Entorhinal cortex; CA3; Dentate gyrus; Ripples; Fast ripples; High frequency oscillations; Cortical trauma; Adenosine	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; IN-VITRO; GAMMA OSCILLATIONS; GABAERGIC NEURONS; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; PERFORANT PATH; LIMBIC SYSTEM; BEHAVING RAT	Entorhinal cortex (EC) projections to the hippocampus run along the perforant path and activate the hippocampal area CA3 and the dentate gyrus (DG), which, in turn, drives CA3. Because cortical trauma damages the source of inputs to the hippocampus, we hypothesize that such an event can be reflected in immediate alterations of the hippocampal oscillatory activity. We here explore whether acute, localized disruption of EC-EC connectivity is involved in the generation or modulation of high frequency oscillations (HFOs) in the hippocampus. We conducted in vitro electrophysiological recordings in CA3 and DG of combined EC-hippocampal transversal slices prepared from intact brains and from brains with a spatially defined, transversal cut of the EC made in situ, 2 h before in vitro recordings commenced. We also determined if pharmacological manipulations of the adenosine system modulated the fast oscillatory activity. EC-hippocampal slices prepared from brains, in which a transversal lesion of the EC was uni- or bilaterally conducted in situ, displayed spontaneous epileptiform events with superimposed ripples (150-250 Hz) and fast ripples (>250 Hz), whereas those obtained from non-lesioned brains did not have spontaneous HFOs. However, in the latter, high frequency stimulation applied to the perforant path produced ripple activity in area CA3. Spontaneous fast ripples were prevented by conducting the slicing procedure and incubating the slices both in a Na+-free medium and in a low Ca++-high Mg++ medium for an hour before recording commenced, under normal Na+ concentration. Activation of A(1), but not A(2), receptors produced a strong inhibition of the incidence and spectral power of fast ripples but did not change their intrinsic frequency. Our data show that the disruption of EC-to-EC connections can immediately disinhibit hippocampal CA3 area to generate HFOs on top of epileptiform events, probably constituting an irritating focus long before overt epileptic activity can be detected behaviorally. Therefore, the activation of the adenosinergic system can possibly be regarded as an immediate intervention strategy to avoid epileptogenesis. (C) 2015 Elsevier Inc. All rights reserved.	[Ortiz, Franco; Gutierrez, Rafael] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Pharmacobiol, Mexico City 14330, DF, Mexico; [Ortiz, Franco] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico		Gutierrez, R (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Pharmacobiol, Calzada Tenorios 235, Mexico City 14330, DF, Mexico.	rafagut@cinvestav.mx			Consejo Nacional de Ciencia y Tecnologia (CONACYT), MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [1020/193/10 FON.INST.-29-10, 166712]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT)	This work was supported by grant 1020/193/10 FON.INST.-29-10 and 166712 to RG from Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. We thank Dr. Mario Trevino for help in the development of computational programs for analysis, Prof. Uwe Heinemann, Prof. Detlev Boison, Prof. Francisco Velasco and the reviewers for helpful comments on earlier versions of the manuscript. We thank Mr. Benjamin Munoz for excellent technical assistance. FO is a PhD student supported by a scholarship from CONACYT.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Andersson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070699; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Boison D, 2007, DRUG NEWS PERSPECT, V20, P607, DOI 10.1358/dnp.2007.20.10.1181353; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Cunha RA, 1996, N-S ARCH PHARMACOL, V353, P261, DOI 10.1007/BF00168627; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; De Guzman P, 2004, NEUROSCIENCE, V123, P875, DOI 10.1016/j.neuroscience.2003.11.013; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; DU F, 1993, EPILEPSY RES, V16, P223, DOI 10.1016/0920-1211(93)90083-J; DU F, 1995, J NEUROSCI, V15, P6301; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; Dzhala VI, 2003, J NEUROSCI, V23, P7873; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Franco L.M., 2015, BRAIN STRUCT FUNCT; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; GERMROTH P, 1989, BRAIN RES, V494, P187, DOI 10.1016/0006-8993(89)90162-5; Gutierrez R, 2000, J NEUROPHYSIOL, V84, P3088, DOI 10.1152/jn.2000.84.6.3088; Gutierrez R, 2002, J NEUROPHYSIOL, V87, P2562, DOI 10.1152/jn.2002.87.5.2562; HEINEMANN U, 1992, EPILEPSY RES, P273; Hernandez-Ortega K, 2012, J NEUROSCI RES, V90, P2116, DOI 10.1002/jnr.23106; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Jiruska P, 2010, BRAIN, V133, P1380, DOI 10.1093/brain/awq070; JONES RSG, 1988, J NEUROPHYSIOL, V59, P1476, DOI 10.1152/jn.1988.59.5.1476; Krook-Magnuson E, 2015, J PHYSIOL-LONDON, V593, P2379, DOI 10.1113/JP270056; Levesque M, 2011, NEUROBIOL DIS, V42, P231, DOI 10.1016/j.nbd.2011.01.007; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lopes LV, 2002, NEUROSCIENCE, V112, P319, DOI 10.1016/S0306-4522(02)00080-5; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; PARE D, 1992, J NEUROSCI, V12, P1867; Patel J, 2013, J NEUROSCI, V 33, P17029, DOI 10.1523/JNEUROSCI.2036-13.2013; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Rebola N, 2003, BRAIN RES, V987, P49, DOI 10.1016/S0006-8993(03)03247-5; Rebola N, 2003, EUR J NEUROSCI, V18, P820, DOI 10.1046/j.1460-9568.2003.02815.x; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schulz SB, 2012, NEUROPHARMACOLOGY, V62, P914, DOI 10.1016/j.neuropharm.2011.09.024; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Turner DA, 1998, PROG NEUROBIOL, V55, P537, DOI 10.1016/S0301-0082(98)00019-7; Viereckel T, 2013, HIPPOCAMPUS, V23, P323, DOI 10.1002/hipo.22104; Vivar C, 2012, EUR J NEUROSCI, V35, P76, DOI 10.1111/j.1460-9568.2011.07930.x; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9	53	7	7	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2015	271						319	328		10.1016/j.expneurol.2015.06.009			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT2JG	WOS:000362627200033	26072121				2022-02-06	
J	Shuaib, W; Tiwana, MH; Chokshi, FH; Johnson, JO; Bedi, H; Khosa, F				Shuaib, W.; Tiwana, M. H.; Chokshi, F. H.; Johnson, J. O.; Bedi, H.; Khosa, F.			Utility of CT head in the acute setting: value of contrast and non-contrast studies	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Contrast CT; Non-contrast CT; Atraumatic; Radiation; Cost-effective; Acute setting; CT head	CRANIAL COMPUTED-TOMOGRAPHY; PATIENT; ENHANCEMENT; HISTORY; HEALTH; RISK	Introduction To examine the added diagnostic value of emergent contrast enhanced CT head (CECTH) in patients who present to the emergency department (ED) with acute non-traumatic symptoms referable to the brain, and to assess the financial implications of CECTH in the emergent setting. Materials and methods We queried healthcare data for head CTs ordered by our ED between January 2008 and December 2010. Those who presented to the ED with non-traumatic neurologic disturbances were included. All traumatic head injury cases were excluded. Two board certified radiologists with fellowship training who were blinded to patient history and physical findings, independently reviewed all non-contrast computed tomography of the head (NCTH) and CECTH images. CECTH's were read following abnormal NCTH's, and findings were recorded as normal or abnormal. Results In our investigation, 379 patients-210 (55 %) females and 169 (45 %) males-met the inclusion criteria. Common indications for head CT included: headache 183 (48 %); dizziness 73 (19 %); altered mental status 49 (13 %); and seizure 38 (10 %). The mean age of study subjects was 47 (+/- 29) years. Two hundred sixty-one (69 %) of all patients scanned showed no abnormality. One hundred eighteen (31 %) of 379 patients had abnormal scans. We encountered 1 abnormal CECTH on which NCTH was normal. Cost of CECTH was $465 and NCTH was $385. Conclusion Head CT in ED non-traumatic neurological presentations with CECTH is not generally indicated and represents a calculable cost savings in the management of these patients.	[Shuaib, W.; Johnson, J. O.; Khosa, F.] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Emergency Radiol, Atlanta, GA 30308 USA; [Tiwana, M. H.] Emory Clin Res Inst, Atlanta, GA USA; [Chokshi, F. H.] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Neuroradiol, Atlanta, GA 30308 USA; [Bedi, H.] Tufts Univ, Sch Med, Dept Radiol, Div Neuroradiol, Boston, MA 02111 USA		Shuaib, W (corresponding author), Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Emergency Radiol, 550 Peachtree St NE, Atlanta, GA 30308 USA.	waqas.shuaib@emory.edu		Khosa, Faisal/0000-0001-5681-7683			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Affleck A, 2013, CAN J EMERG MED, V15, P359; Aragon-Ching JB, 2007, CLIN CANCER RES, V13, P1644, DOI 10.1158/1078-0432.CCR-07-0096; Davenport MS, 2013, RADIOLOGY, V268, P719, DOI 10.1148/radiol.13122276; de Araujo P, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-25; Demaerel P, 1998, EUR RADIOL, V8, P1447, DOI 10.1007/s003300050572; DEMAEREL P, 1995, LANCET, V345, P389, DOI 10.1016/S0140-6736(95)90376-3; Elicker BM, 2006, AM J ROENTGENOL, V186, P1651, DOI 10.2214/AJR.05.0407; Fakhran S, 2013, AM J NEURORADIOL, V34, P1077, DOI 10.3174/ajnr.A3325; Hill RG, 2013, AM J EMERG MED, V31, P1591, DOI 10.1016/j.ajem.2013.06.028; Horowitz SH, 2007, MED CLIN N AM, V91, P21, DOI 10.1016/j.mcna.2006.10.002; KUNKEL RS, 1979, HEADACHE, V19, P122, DOI 10.1111/j.1526-4610.1979.hed1903122.x; Masdeu J C, 2000, Radiology, V215 Suppl, P487; Mebust Donald, 2013, Perm J, V17, pe120, DOI 10.7812/TPP/12-137; REINUS WR, 1994, ANN EMERG MED, V23, P1271, DOI 10.1016/S0196-0644(94)70351-5; Rothrock SG, 1997, ACAD EMERG MED, V4, P654, DOI 10.1111/j.1553-2712.1997.tb03756.x; Sarwar A, 2013, ACAD RADIOL, V20, P519, DOI 10.1016/j.acra.2012.10.001; Savji N, 2013, J AM COLL CARDIOL, V61, P1736, DOI 10.1016/j.jacc.2013.01.054; Shuaib W, 2014, IRISH J MED SCI, V183, P151, DOI 10.1007/s11845-013-0999-6; Shuaib W, 2013, J RADIOL RAD THER, V1, P1003; Shuaib W, 2014, INT J CANC THER ONCO, V2, DOI 10.14319/ijcto.0204.3; Shuaib W, 2014, EMERG RADIOL, V21, P159, DOI 10.1007/s10140-013-1177-x; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; WOOD LP, 1990, NEURORADIOLOGY, V32, P261, DOI 10.1007/BF00593043	25	7	7	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	SEP	2015	184	3					631	635		10.1007/s11845-014-1191-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0ZQ	WOS:000363248800018	25173368				2022-02-06	
J	Timler, D; Dworzynski, MJ; Szarpak, L; Gaszynska, E; Dudek, K; Galazkowski, R				Timler, Dariusz; Dworzynski, Michal J.; Szarpak, Lukasz; Gaszynska, Ewelina; Dudek, Krzysztof; Galazkowski, Robert			Head Trauma in Elderly Patients: Mechanisms of Injuries and CT Findings	ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						elderly; head trauma; loss of consciousness; emergency department; computed tomography	BRAIN INJURY; CONSCIOUSNESS; MORTALITY; AMNESIA	Background. Head injuries in elderly people are a common cause of hospitalization at emergency departments. This group of patients is at high risk of post-traumatic intracranial pathology, which is diagnosed by computed tomography (CT) scanning of the head. Objectives. The aim of this study was to determine the incidence and outcomes of head trauma in older people in different scenarios, on the basis of CT scan findings. Material and Methods. The study involved a retrospective analysis of medical records of patients treated in the Emergency Department of Copernicus Memorial Hospital in Lodz, Poland, between the years 2010-2012. Patients above 75 years old whose diagnoses were coded with ICD-10 codes S00-S09 were included in the study. The patients' age, gender, the mechanism and cause of injury, their Glasgow Coma Scale (GCS) score at admission and the results of their head CTs were analyzed. Results. A total of 301 patients were included in the analysis. Intracranial abnormalities caused by trauma were detected in 24 patients (8%). Transient loss of consciousness (TLOC) was a cause of injury in 44 patients (14.6%) and was related to an increased risk of an abnormal CT scan result (OR 4.6, 95% CI, 1.2-18.4, p < 0.003). Other mechanisms related to an increased risk of post-traumatic intracranial pathology were high-energy mechanisms of injury and unexplained falls. Conclusions. Ground-level falls are the most frequent mechanism of head trauma in older people. One of the most commonly identified mechanisms of a fall is TLOC. Head injuries due to TLOC entailed a high risk of intracranial pathology in the elderly population. The risk of trauma-related positive CT scans in patients with unexplained falls is high, and is similar to that observed in patients with TLOC. The highest risk of trauma-related positive CT scans is observed in patients who have suffered a high-energy trauma.	[Timler, Dariusz] Med Univ Lodz, Dept Emergency Med & Disaster Med, Lodz, Poland; [Timler, Dariusz; Dworzynski, Michal J.] Copernicus Mem Hosp Lodz, Dept Emergency Med, Pabianicka 62, PL-93513 Lodz, Poland; [Szarpak, Lukasz] Med Univ Warsaw, Dept Emergency Med, Warsaw, Poland; [Gaszynska, Ewelina] Med Univ Lodz, Dept Hyg & Hlth Promot, Lodz, Poland; [Dudek, Krzysztof] Wroclaw Med Univ, Dept Emergency Med, Wroclaw, Poland; [Galazkowski, Robert] Med Univ Warsaw, Dept Emergency Med Serv, Warsaw, Poland		Timler, D (corresponding author), Copernicus Mem Hosp Lodz, Dept Emergency Med, Pabianicka 62, PL-93513 Lodz, Poland.	sor55@wp.pl	Szarpak, Lukasz/N-5222-2018; Timler, Dariusz/S-9720-2016; Galazkowski, Robert/X-2593-2018; Gaszynska, Ewelina/S-9946-2016	Szarpak, Lukasz/0000-0002-0973-5455; Timler, Dariusz/0000-0002-5415-5660; Galazkowski, Robert/0000-0002-7205-2219; Gaszynska, Ewelina/0000-0001-7568-3502			Ammirati F, 2001, Ital Heart J, V2, P38; Barrett TW, 2009, AM J EMERG MED, V27, P428, DOI 10.1016/j.ajem.2008.03.025; Bartoletti A, 2008, EUR HEART J, V29, P618, DOI 10.1093/eurheartj/ehm563; Berecki-Gisolf J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075255; Bhat PK, 2014, J EMERG MED, V46, P1, DOI 10.1016/j.jemermed.2013.04.064; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Chiara M, 2013, CURR GERONTOL GERIAT, DOI [10.1155/2013/928603, DOI 10.1155/2013/928603.EPUB]; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Dupre CM, 2014, J STROKE CEREBROVASC, V23, P374, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.015; Fedorowski A, 2011, EUR J EPIDEMIOL, V26, P537, DOI 10.1007/s10654-011-9578-1; Furtan S, 2013, ANEST RATOW, V7, P449; Gajek Jacek, 2003, Kardiol Pol, V58, P294; Gajek J, 2011, ADV CLIN EXP MED, V20, P305; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Mitra B, 2013, MED J AUSTRALIA, V199, P807, DOI 10.5694/mja13.11314; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; O'Dwyer C, 2011, EUROPACE, V13, P1040, DOI 10.1093/europace/eur069; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Parry SW, 2005, J AM COLL CARDIOL, V45, P1840, DOI 10.1016/j.jacc.2005.02.060; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Servadei F, 2002, NEUROEPIDEMIOLOGY, V21, P297, DOI 10.1159/000065523; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Zysko D, 2013, SIGNA VITAE, V8, P58; Zysko D, 2012, KARDIOL POL, V70, P148	26	7	8	0	1	WROCLAW MEDICAL UNIV	WROCLAW	UL K MARCINKOWSKIEGO 2-6, WROCLAW, 50-368, POLAND	1899-5276	2451-2680		ADV CLIN EXP MED	Adv. Clin. Exp. Med.	SEP-OCT	2015	24	6					1045	1050		10.17219/acem/27565			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DB4UG	WOS:000368508500016	26771978	gold, Green Submitted			2022-02-06	
J	Toth, A; Schmalfuss, I; Heaton, SC; Gabrielli, A; Hannay, HJ; Papa, L; Brophy, GM; Wang, KKW; Buki, A; Schwarcz, A; Hayes, RL; Robertson, CS; Robicsek, SA				Toth, Arnold; Schmalfuss, Ilona; Heaton, Shelley C.; Gabrielli, Andrea; Hannay, H. Julia; Papa, Linda; Brophy, Gretchen M.; Wang, Kevin K. W.; Bueki, Andras; Schwarcz, Attila; Hayes, Ronald L.; Robertson, Claudia S.; Robicsek, Steven A.			Lateral Ventricle Volume Asymmetry Predicts Midline Shift in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						computed tomography; ventricle; traumatic brain injury; midline shift	HEAD-INJURY; CLASSIFICATION; VALIDATION; CT; TOMOGRAPHY; DIAGNOSIS; CISTERNS; MODERATE	Midline shift following severe traumatic brain injury (sTBI) detected on computed tomography (CT) scans is an established predictor of poor outcome. We hypothesized that lateral ventricular volume (LVV) asymmetry is an earlier sign of developing asymmetric intracranial pathology than midline shift. This retrospective analysis was performed on data from 84 adults with blunt sTBI requiring a ventriculostomy who presented to a Level I trauma center. Seventy-six patients underwent serial CTs within 3 h and an average of three scans within the first 10 d of sTBI. Left and right LVVs were quantified by computer-assisted manual volumetric measurements. LVV ratios (LVR) were determined on the admission CT to evaluate ventricular asymmetry. The relationship between the admission LVR value and subsequent midline shift development was tested using receiver operating characteristic (ROC) analysis, and odds ratio (OR) and relative risk tests. Sixty patients had no >5 mm midline shift on the initial admission scan. Of these, 15 patients developed it subsequently (16 patients already had >5 mm midline shift on admission scans). For >5 mm midline shift development, admission LVR of >1.67 was shown to have a sensitivity of 73.3% and a specificity of 73.3% (area under the curve=0.782; p<0.0001). LVR of >1.67 as exposure yielded an OR of 7.56 (p<0.01), and a risk ratio of 4.42 (p<0.01) for midline shift development as unfavorable outcome. We propose that LVR captures LVV asymmetry and is not only related to, but also predicts the development of midline shift already at admission CT examination. Lateral ventricles may have a higher "compliance" than midline structures to developing asymmetric brain pathology. LVR analysis is simple, rapidly accomplished and may allow earlier interventions to attenuate midline shift and potentially improve ultimate outcomes.	[Toth, Arnold; Bueki, Andras; Schwarcz, Attila] Univ Pecs, Dept Neurosurg, H-7623 Pecs, Hungary; [Schmalfuss, Ilona] Univ Florida, Dept Radiol, Gainesville, FL 32610 USA; [Heaton, Shelley C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Gabrielli, Andrea] Univ Florida, Dept Anesthesiol & Crit Care, Gainesville, FL USA; [Robicsek, Steven A.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Robicsek, Steven A.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Schmalfuss, Ilona] North Florida South Georgia Vet Adm, Gainesville, FL USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Orlando, FL USA; [Brophy, Gretchen M.] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci & Neurosurg, Richmond, VA USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, McKnight Brain Inst, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Toth, A (corresponding author), Univ Pecs, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary.	prsarn@gmail.com		Hannay, H. Julia/0000-0001-7023-912X; Wang, Kevin/0000-0002-9343-6473; Brophy, Gretchen/0000-0002-4749-2693	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS052831]; European UnionEuropean Commission; State of Hungary; European Social Fund in the framework of National Excellence Program [TAMOP-4.2.4.A/2-11/1-2012-0001]; Hungarian Scientific Research Found OTKA- KOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [109132]; Bolyai ScholarshipHungarian Academy of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052831] Funding Source: NIH RePORTER	This study was funded by NIH R01 NS052831. A.T. was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/2-11/1-2012-0001 National Excellence Program. A.S. was funded by a grant of Hungarian Scientific Research Found OTKA- K 109132 and Bolyai Scholarship. No competing financial interests exist.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schoonjans F, 1995, COMPUT METH PROG BIO, V48, P257, DOI 10.1016/0169-2607(95)01703-8; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; ZWEIG MH, 1993, CLIN CHEM, V39, P561	21	7	7	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1307	1311		10.1089/neu.2014.3696			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500004	25752227	Green Published			2022-02-06	
J	Wu, C; Melnikow, J; Dinh, T; Holmes, JF; Gaona, SD; Bottyan, T; Paterniti, D; Nishijima, DK				Wu, Clayton; Melnikow, Joy; Dinh, Tu; Holmes, James F.; Gaona, Samuel D.; Bottyan, Thomas; Paterniti, Debora; Nishijima, Daniel K.			Patient Admission Preferences and Perceptions	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							INTENSIVE-CARE-UNIT; TRAUMATIC INTRACRANIAL HEMORRHAGE; ADULT PATIENTS; VISITATION POLICIES; PROSPECTIVE COHORT; WAITING TIME; US ICUS; EMERGENCY; STATES; PROTOCOL	Introduction: Understanding patient perceptions and preferences of hospital care is important to improve patients' hospitalization experiences and satisfaction. The objective of this study was to investigate patient preferences and perceptions of hospital care, specifically differences between intensive care unit (ICU) and hospital floor admissions. Methods: This was a cross-sectional survey of emergency department (ED) patients who were presented with a hypothetical scenario of a patient with mild traumatic brain injury (TBI). We surveyed their preferences and perceptions of hospital care related to this scenario. A closed-ended questionnaire provided quantitative data on patient preferences and perceptions of hospital care and an open-ended questionnaire evaluated factors that may not have been captured with the closed-ended questionnaire. Results: Out of 302 study patients, the ability for family and friends to visit (83%), nurse availability (80%), and physician availability (79%) were the factors most commonly rated "very important," while the cost of hospitalization (62%) and length of hospitalization (59%) were the factors least commonly rated " very important." When asked to choose between the ICU and the floor if they were the patient in the scenario, 33 patients (10.9%) choose the ICU, 133 chose the floor (44.0%), and 136 (45.0%) had no preference. Conclusion: Based on a hypothetical scenario of mild TBI, the majority of patients preferred admission to the floor or had no preference compared to admission to the ICU. Humanistic factors such as the availability of doctors and nurses and the ability to interact with family appear to have a greater priority than systematic factors of hospitalization, such as length and cost of hospitalization or length of time in the ED waiting for an in-patient bed.	[Wu, Clayton; Dinh, Tu; Holmes, James F.; Gaona, Samuel D.; Bottyan, Thomas; Nishijima, Daniel K.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Melnikow, Joy; Paterniti, Debora] Univ Calif Davis, Sch Med, Ctr Hlth Care Policy & Res, Sacramento, CA 95817 USA		Nishijima, DK (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 4150 V St PSSB,2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu					Azoulay E, 2004, CRIT CARE MED, V32, P1832, DOI 10.1097/01.CCM.0000139693.88931.59; Bobrovitz N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-98; BRETT AS, 1987, ARCH INTERN MED, V147, P133, DOI 10.1001/archinte.147.1.133; Das AM, 2008, CRIT CARE, V12, DOI 10.1186/cc6878; Davidson Judy E, 2013, Ann Am Thorac Soc, V10, P152, DOI 10.1513/AnnalsATS.201301-006PS; Eddy David M., 1990, JAMA-J AM MED ASSOC, V263, P3081; Egol A, 1999, CRIT CARE MED, V27, P633; Gooch RA, 2014, JAMA-J AM MED ASSOC, V311, P567, DOI 10.1001/jama.2013.283800; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Ishoo E, 1999, OTOLARYNG HEAD NECK, V121, P263, DOI 10.1016/S0194-5998(99)70182-8; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; KRAISS LW, 1995, AM J SURG, V169, P512, DOI 10.1016/S0002-9610(99)80207-4; Liu V, 2013, CRIT CARE, V17, DOI 10.1186/cc12677; McAdam JL, 2013, CRIT CARE, V17, DOI 10.1186/cc12763; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RON A, 1989, ARCH INTERN MED, V149, P338, DOI 10.1001/archinte.149.2.338; Sinuff T, 2004, CRIT CARE MED, V32, P1588, DOI 10.1097/01.CCM.0000130175.38521.9F; Soremekun OA, 2011, ACAD EMERG MED, V18, P1262, DOI 10.1111/j.1553-2712.2011.01226.x; Stickney CA, 2014, J PEDIATR-US, V164, P402, DOI 10.1016/j.jpeds.2013.09.037; Thompson DA, 1996, ANN EMERG MED, V28, P652, DOI 10.1016/S0196-0644(96)70089-6; Thompson DA, 1996, ANN EMERG MED, V28, P657, DOI 10.1016/S0196-0644(96)70090-2; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC	26	7	7	0	6	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	SEP	2015	16	5					707	714		10.5811/westjem.2015.7.27458			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	DH9LP	WOS:000373117900017	26587095	gold, Green Published			2022-02-06	
J	Wu, MF; Zhang, SQ; Gu, R; Liu, JB; Li, Y; Zhu, QS				Wu, Min-fei; Zhang, Shu-quan; Gu, Rui; Liu, Jia-bei; Li, Ye; Zhu, Qing-san			Transplantation of erythropoietin gene-modified neural stem cells improves the repair of injured spinal cord	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; spinal cord injury; neural stem cells; erythropoietin; motor function; subarachnoid cavity; transplantation; injury; recovery; neural regeneration	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; ELECTRICAL-STIMULATION; RATS; RECEPTOR; REGENERATION; TRANSECTION	The protective effects of erythropoietin on spinal cord injury have not been well described. Here, the eukaryotic expression plasmid pcDNA3.1 human erythropoietin was transfected into rat neural stem cells cultured in vitro. A rat model of spinal cord injury was established using a free falling object. In the human erythropoietin-neural stem cells group, transfected neural stem cells were injected into the rat subarachnoid cavity, while the neural stem cells group was injected with non-transfected neural stem cells. Dulbecco's modified Eagle's medium/F12 medium was injected into the rats in the spinal cord injury group as a control. At 1-4 weeks post injury, the motor function in the rat lower limbs was best in the human erythropoietin-neural stem cells group, followed by the neural stem cells group, and lastly the spinal cord injury group. At 72 hours, compared with the spinal cord injury group, the apoptotic index and Caspase-3 gene and protein expressions were apparently decreased, and the bcl-2 gene and protein expressions were noticeably increased, in the tissues surrounding the injured region in the human erythropoietin-neural stem cells group. At 4 weeks, the cavities were clearly smaller and the motor and somatosensory evoked potential latencies were remarkably shorter in the human erythropoietin-neural stem cells group and neural stem cells group than those in the spinal cord injury group. These differences were particularly obvious in the human erythropoietin-neural stem cells group. More CM-Dil-positive cells and horseradish peroxidase-positive nerve fibers and larger amplitude motor and somatosensory evoked potentials were found in the human erythropoietin-neural stem cells group and neural stem cells group than in the spinal cord injury group. Again, these differences were particularly obvious in the human erythropoietin-neural stem cells group. These data indicate that transplantation of erythropoietin gene-modified neural stem cells into the subarachnoid cavity to help repair spinal cord injury and promote the recovery of spinal cord function better than neural stem cell transplantation alone. These findings may lead to significant improvements in the clinical treatment of spinal cord injuries.	[Wu, Min-fei] Jilin Univ, Hosp 2, Dept Orthoped, Changchun 130023, Jilin Province, Peoples R China; [Zhang, Shu-quan] Tianjin Nankai Hosp, Dept Orthoped, Tianjin, Peoples R China; [Gu, Rui; Liu, Jia-bei; Li, Ye; Zhu, Qing-san] Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun 130023, Jilin Province, Peoples R China		Gu, R (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun 130023, Jilin Province, Peoples R China.	fandiliucl@126.com			Science and Technology Development Program of Jilin Province of China [2011084]	This study was supported by the Science and Technology Development Program of Jilin Province of China, No. 2011084.	Abbasnia K, 2015, ANAT CELL BIOL, V48, P104, DOI 10.5115/acb.2015.48.2.104; Chang RM, 2014, INFLAMM RES, V63, P675, DOI 10.1007/s00011-014-0740-6; Cohen SP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1748; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Du X, 2015, BIOTECH HISTOCHEM, V90, P384, DOI 10.3109/10520295.2014.988751; Ercan E, 2014, ACTA HISTOCHEM, V116, P117, DOI 10.1016/j.acthis.2013.06.007; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Grimm C, 2006, ADV EXP MED BIOL, V588, P119; Hasnan N, 2013, MED SCI SPORT EXER, V45, P1131, DOI 10.1249/MSS.0b013e3182805d5a; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Kim HJ, 2012, GENE THER, V19, P513, DOI 10.1038/gt.2011.137; Kristal B, 2008, ISR MED ASSOC J, V10, P266; Lai DM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0516-y; Li WC, 2014, INT J NEUROSCI, V124, P585, DOI 10.3109/00207454.2013.864289; Li WC, 2013, INT J NEUROSCI, V123, P240, DOI 10.3109/00207454.2012.755181; Lu PG, 2012, NEUROL RES, V34, P944, DOI 10.1179/1743132812Y.0000000096; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Maiese K, 2015, NEURAL REGEN RES, V10, P518, DOI 10.4103/1673-5374.155427; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Recio AC, 2012, J SPINAL CORD MED, V35, P58, DOI 10.1179/2045772311Y.0000000044; Ren LQ, 2013, NEUROSCIENCE, V236, P31, DOI 10.1016/j.neuroscience.2012.12.063; Seo TB, 2013, J NEUROTRAUM, V30, P1053, DOI 10.1089/neu.2012.2693; Smithason S, 2013, ACTA NEUROCHIR SUPPL, V115, P253, DOI 10.1007/978-3-7091-1192-5_45; Ung RV, 2008, EUR J NEUROSCI, V28, P2231, DOI 10.1111/j.1460-9568.2008.06508.x; Van Steenwinckel J, 2008, PAIN, V137, P66, DOI 10.1016/j.pain.2007.08.014; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Verstraete S, 2014, ACTA ANAESTH SCAND, V58, P1233, DOI 10.1111/aas.12394; Wang D, 2013, NEURAL REGEN RES, V8, P677, DOI 10.3969/j.issn.1673-5374.2013.08.001; Wang D, 2011, NEURAL REGEN RES, V6, P725, DOI 10.3969/j.issn.1673-5374.2011.10.001; Wu YW, 2015, DEV MED CHILD NEUROL, V57, P34, DOI 10.1111/dmcn.12730; Yang Chao, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P976; Yi CL, 2005, ZHONGHUA SHIYAN WAIK, V22, P984; Zhong Q, 2013, INVEST OPHTH VIS SCI, V54, P3941, DOI 10.1167/iovs.13-11598	34	7	8	0	13	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	SEP	2015	10	9					1483	1490		10.4103/1673-5374.165521			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CT2IK	WOS:000362625000035	26604911	gold, Green Published			2022-02-06	
J	Al Brashdi, YH; Albayram, MS				Al Brashdi, Yahya H.; Albayram, Mehmet S.			Reversible restricted-diffusion lesion representing transient intramyelinic cytotoxic edema in a patient with traumatic brain injury	NEURORADIOLOGY JOURNAL			English	Article						Traumatic brain injury; reversible diffusion restriction; cytotoxic edema		We report this case to increase the awareness of magnetic resonance imaging (MRI) features of reversible white matter abnormalities in diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps in a patient with traumatic brain injury (TBI). An eight-year-old girl, who was hit by a truck, was brought to the emergency department by the emergency medical service (EMS). Eleven days later, she experienced cognitive impairment requiring MRI evaluation. DWI and ADC maps showed restricted diffusion in the white matter of the corpus callosum, peri-atrial white matter, and in the right centrum semiovale. There were no significant hemorrhagic foci in these regions, which showed complete resolution on follow up DWI MRI 13 days later. This reported case revealed TBI-related transient reversible intramyelinic cytotoxic edema.	[Al Brashdi, Yahya H.; Albayram, Mehmet S.] Alberta Childrens Prov Gen Hosp, 2888 Shaganapi Trail NW, Calgary, AB T3B 6A8, Canada		Al Brashdi, YH (corresponding author), Alberta Childrens Prov Gen Hosp, 2888 Shaganapi Trail NW, Calgary, AB T3B 6A8, Canada.	albrashdi.yhs@gmail.com		Albayram, Mehmet Sait/0000-0001-9111-6815			Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Moritani T, 2005, AM J NEURORADIOL, V26, P216; Muccio CF, 2009, BRAIN INJURY, V23, P466, DOI 10.1080/02699050902841912; Muttikkal TJE, 2008, NEURORADIOL J, V21, P817, DOI 10.1177/197140090802100611; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2	6	7	8	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.	AUG	2015	28	4					409	412		10.1177/1971400915598071			4	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	CU3NJ	WOS:000363431800007	26306930	Green Published			2022-02-06	
J	Coritsidis, G; Diamond, N; Rahman, A; Solodnik, P; Lawrence, K; Rhazouani, S; Phalakornkul, S				Coritsidis, George; Diamond, Nechama; Rahman, Aleef; Solodnik, Paul; Lawrence, Kayode; Rhazouani, Salwa; Phalakornkul, Suganda			Hypertonic saline infusion in traumatic brain injury increases the incidence of pulmonary infection	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Hypertonic saline; Infection; Neurocritical care; Pneumonia; Traumatic brain injury	CEREBRAL EDEMA; HEAD-INJURY; INTRACRANIAL-PRESSURE; BARRIER PERMEABILITY; FLUID MANAGEMENT; RESUSCITATION; HYPERNATREMIA; SECONDARY; CHILDREN; THERAPY	We aimed to investigate the incidence of electrolyte abnormalities, acute kidney injury (AKI), deep venous thrombosis (DVT) and infections in patients with traumatic brain injury (TBI) treated with hypertonic saline (HTS) as osmolar therapy. We retrospectively studied 205 TBI patients, 96 with HIS and 109 without, admitted to the surgical/trauma intensive care unit between 2006 and 2012. Hemodynamics, electrolytes, length of stay (LOS), acute physiological assessment and chronic health evaluation II (APACHE II), injury severity scores (ISS) and mortality were tabulated. Infection, mechanical ventilation, DVT and AKI incidence were reviewed. HTS was associated with increased LOS and all infections (p = 0.0001). After correction for the Glasgow coma scale (GCS) and ventilator need, pulmonary infections (p = 0.001) and LOS remained higher with HTS (p = 0.0048). HTS did not result in increased blood pressure, DVT, AKI or neurological benefits. HTS significantly increased the odds for all infections, most specifically pulmonary infections, in patients with GCS < 8. Due to these findings, HTS in TBI should be administered with caution regardless of acuity. (C) 2015 Elsevier Ltd. All rights reserved.	[Coritsidis, George; Diamond, Nechama; Rahman, Aleef; Phalakornkul, Suganda] Elmhurst Hosp Ctr, Mt Sinai Sch Med, Dept Surg, Surg Trauma Intens Care Unit, Elmhurst, NY 11373 USA; [Coritsidis, George; Lawrence, Kayode] Elmhurst Hosp Ctr, Mt Sinai Sch Med, Div Nephrol, Dept Med, Elmhurst, NY 11373 USA; [Solodnik, Paul] Elmhurst Hosp Ctr, Dept Radiol, Elmhurst, NY 11373 USA; [Rhazouani, Salwa] Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY 11373 USA		Coritsidis, G (corresponding author), Elmhurst Hosp Ctr, Mt Sinai Sch Med, Dept Surg, Surg Trauma Intens Care Unit, 79-01 Broadway, Elmhurst, NY 11373 USA.	coritsg@nychhc.org		Rahman, Aleef/0000-0002-7610-4549			Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Coritsidis G, 2009, CRIT CARE MED, V37, pA1; Coritsidis GN, 2007, CRIT CARE MED, V35, pA66; Davenport A, 2008, HEMODIAL INT, V12, P307, DOI 10.1111/j.1542-4758.2008.00271.x; De Petris L, 2001, EUR J PEDIATR, V160, P71, DOI 10.1007/s004310000631; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hauer EM, 2011, CRIT CARE MED, V39, P1766, DOI 10.1097/CCM.0b013e318218a390; Heuer JF, 2011, INTENS CARE MED, V37, P1182, DOI 10.1007/s00134-011-2232-2; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Hoorn EJ, 2008, NEPHROL DIAL TRANSPL, V23, P1562, DOI 10.1093/ndt/gfm831; Kahle KT, 2013, J CLIN NEUROSCI, V20, P30, DOI 10.1016/j.jocn.2012.10.004; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Murphy CV, 2009, CHEST, V136, P102, DOI 10.1378/chest.08-2706; O'Donoghue SD, 2009, ANAESTHESIA, V64, P514, DOI 10.1111/j.1365-2044.2008.05857.x; Pelosi P, 2011, CRIT CARE, V15, DOI 10.1186/cc10259; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	31	7	14	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2015	22	8					1332	1337		10.1016/j.jocn.2015.02.025			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN4GZ	WOS:000358389900022	26055957				2022-02-06	
J	Griffin, GD				Griffin, Gerald Dieter			Stroke, mTBI, infection, antibiotics and beta blockade: Connecting the dots	MEDICAL HYPOTHESES			English	Article; Proceedings Paper	CIOMR (NATO) Congress	2012	Copenhagen, DENMARK	CIOMR, NATO			TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; ADRENERGIC-RECEPTORS; TDP-43; DEATH; MILD; RISK	Several themes supported by a robust literature are addressed in this clinical translational review and research paper: (1) the inadequate standard of care for minimal traumatic brain injury (mTBI)/concussion when compared to stroke because diagnosis and care for mTBI/concussion are based primarily on a symptom only framework; (2) the treatment of stroke (brain injury) infection with select antibiotics; (3) the use of beta blockade in stroke (brain injury). The various etiologies of brain injury appear to coalesce to common endpoints: potential neuronal demise, cognitive and functional losses, immune suppression and infection. The use of principles patterned after 'Koch's Postulates' (show/prove the presence of infection/illness/disease, treat until resolved, and prove objectively that the disease/illness is gone/healed/cured) appears to be marginalized in establishing a diagnosis and recovery from mTBI/TBI. The pathways of immune system interactions in stroke (brain injury) and infection are briefly discussed. The suggestion of combined specific antibiotic and beta blockade for ischemic stroke (brain injury) and mTBI is advanced for treatment and expeditious further study. Stroke is considered a brain injury in this paper. Stroke is also considered and recommended as a study model for mTBI therapy because of their common end points from brain damage. It is suggested that potential transfer or translation of therapy for stroke may be useful in mTBI. (C) 2015 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Griffin, Gerald Dieter] Univ Pacific, Sch Pharm & Hlth Sci, Stockton, CA 95211 USA		Griffin, GD (corresponding author), 123 Forest Ave, Pacific Grove, CA 93950 USA.	k6md@aol.com	Griffin, Gerald Dieter/R-7186-2019				Anstead MI, 1998, AM J RESP CRIT CARE, V157, P990, DOI 10.1164/ajrccm.157.3.9704071; Appel SH, 2010, MUSCLE NERVE, V42, P851, DOI 10.1002/mus.21939; Castillo J, 1998, STROKE, V27, P2204; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Dau B, 2009, J REHABIL RES DEV, V46, P673, DOI 10.1682/JRRD.2008.09.0113; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Emsley Hedley C. A., 2010, Infectious Disorders - Drug Targets, V10, P91; Fassbender K, 1997, J LAB CLIN MED, V130, P535, DOI 10.1016/S0022-2143(97)90131-1; Grabska K, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/691348; Greenwald BD, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/469475; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; LANDMANN R, 1992, EUR J CLIN INVEST, V22, P30; LENNARD TWJ, 1993, P NUTR SOC, V52, P85, DOI 10.1079/PNS19930040; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; MAISEL AS, 1989, CLIN PHARMACOL THER, V46, P429, DOI 10.1038/clpt.1989.161; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; McCrea M, 2001, J ATHL TRAINING, V36, P274; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Paciaroni M, 2004, EUR NEUROL, V51, P162, DOI 10.1159/000077663; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smrcka M, 2007, BRATISL MED J, V108, P144; Suberville S, 1996, EUR J IMMUNOL, V26, P2601, DOI 10.1002/eji.1830261110; Weimar C, 2012, NAT REV NEUROL, V8, P305, DOI 10.1038/nrneurol.2012.91; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706	38	7	8	0	9	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	AUG	2015	85	2					224	229		10.1016/j.mehy.2015.05.005			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Research & Experimental Medicine	CN5KQ	WOS:000358468600024	26045369	hybrid			2022-02-06	
J	King, PR; Beehler, GP; Wade, MJ				King, Paul R.; Beehler, Gregory P.; Wade, Michael J.			Self-Reported Pain and Pain Management Strategies Among Veterans With Traumatic Brain Injury: A Pilot Study	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ENDURING FREEDOM VETERANS; PREVALENCE; POLYTRAUMA; HEADACHES; SYMPTOMS	Reports of chronic pain such as headache, back and neck pain, and other musculoskeletal conditions are common among veterans with history of traumatic brain injury (TBI). This pilot study investigates self-reported pain and pain management strategies in a sample of veterans in postacute recovery from TBI. Participants included 24 outpatients with history of mild-to-moderate TBI who completed a series of self-report measures by mail, including the Pain Outcomes Questionnaire, the Pain Symptom Survey pain scale, and a detailed background survey. Seventy-nine percent of veterans surveyed reported frequent experiences with pain, typically headache, lower back, and joint pain of moderate severity. Two-thirds reported multiple pain locations, and more than half reported multiple concurrent mental health concerns, most frequently depression and post-traumatic stress disorder. Several different pain self-management strategies were identified with highly variable effects, though better perceived pain outcomes were reported with regular use of exercise and antidepressants. Many participants identified significant concerns regarding reinjury. Results suggest that opportunity exists for mental health professionals to address common anxieties pertaining to reinjury and to deliver concurrent interventions for chronic pain and affective disturbance.	[King, Paul R.; Beehler, Gregory P.] VA Western New York Healthcare Syst, Ctr Integrated Healthcare, Buffalo, NY 14215 USA; [Beehler, Gregory P.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Buffalo, NY 14214 USA; [Beehler, Gregory P.] SUNY Buffalo, Sch Nursing, Buffalo, NY 14214 USA; [Wade, Michael J.] Syracuse VA Med Ctr, Ctr Integrated Healthcare, Syracuse, NY 13204 USA		King, PR (corresponding author), VA Western New York Healthcare Syst, Ctr Integrated Healthcare, Buffalo, NY 14215 USA.				VA Center for Integrated Healthcare pilot grant program; VA Office of Academic AffiliationsUS Department of Veterans Affairs; Advanced Fellowship Program in Mental Illness Research and Treatment; Center for Integrated Healthcare/VA Western New York Healthcare System at Buffalo	Research reported in this manuscript was supported by the VA Center for Integrated Healthcare pilot grant program. Preparation of this manuscript was supported by the VA Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, and the Center for Integrated Healthcare/VA Western New York Healthcare System at Buffalo.	Clark ME, 2003, J REHABIL RES DEV, V40, P381, DOI 10.1682/JRRD.2003.09.0381; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; U. S. Department of Veterans Affairs, VA CONS C PRACT REC; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	18	7	9	0	8	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2015	180	8					863	868		10.7205/MILMED-D-14-00472			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ3TE	WOS:000360524800011	26226528	Bronze			2022-02-06	
J	Le, D; Shafi, S; Gwirtz, P; Bennett, M; Reeves, R; Callender, L; Dunklin, C; Cleveland, S				Le, David; Shafi, Shahid; Gwirtz, Patricia; Bennett, Monica; Reeves, Rustin; Callender, Librada; Dunklin, Cynthia; Cleveland, Samantha			Effect of Obesity on Motor Functional Outcome of Rehabilitating Traumatic Brain Injury Patients	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article							INPATIENT REHABILITATION; ARTHROPLASTY	Objective The aim of this study was to determine the association between obesity and functional motor outcome of patients undergoing inpatient rehabilitation after traumatic brain injury. Design This retrospective study at an urban acute inpatient rehabilitation center screened data from 761 subjects in the Traumatic Brain Injury Model System who were admitted from January 2010 to September 2013. Inclusion criteria consisted of age of 18 years or older and an abnormal Functional Independence Measure motor score. Body mass index was used to determine obesity in the study population. Patients with a body mass index of 30.0 kg/m(2) or greater were considered obese. Results A total of 372 subjects met the criteria for inclusion in the study. Of these, 54 (13.2%) were obese. Both obese and nonobese patients showed similar improvement in Functional Independence Measure motor score (mean [SD], 30.4 [12.8] for the obese patients, P = 0.115, and 27.3 [13.1] for the nonobese patients). The mean (SD) Functional Independence Measure motor scores at discharge for the obese and nonobese patients were 63.0 (12.6) and 62.3 (10.1) (P = 0.6548), respectively. Conclusions Obesity had no adverse impact on motor functional outcomes of the traumatic brain injury patients who underwent inpatient rehabilitation. Therefore, obesity should not be considered an obstacle in inpatient rehabilitation after traumatic brain injury, if patients are able to participate in necessary therapy.	[Le, David; Gwirtz, Patricia; Reeves, Rustin] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Shafi, Shahid; Bennett, Monica] Baylor Univ, Med Ctr, Dallas, TX USA; [Callender, Librada; Dunklin, Cynthia; Cleveland, Samantha] Baylor Inst Rehabil, Dallas, TX USA		Shafi, S (corresponding author), Ctr Clin Effectiveness, Baylor Scott & White Hlth, 8080 Cent Expressway,Suite 500, Dallas, TX 75206 USA.				Department of Education, National Institute on Disability and Rehabilitation Research, Traumatic Brain Injury Model Systems [H133A120098]	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research grant number H133A120098, Traumatic Brain Injury Model Systems. The contents of this report do not necessarily represent the policy of the Department of Education, and endorsement by the federal government should not be assumed. Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	[Anonymous], TRAUM BRAIN INJ; [Anonymous], BMI CHILDR TEENS; [Anonymous], TRAUM BRAIN INJ MOD; [Anonymous], BMI AD; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Centers for Disease Control and Prevention, AD OB FACTS; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Cournan M, 2011, REHABIL NURS, V36, P111, DOI 10.1002/j.2048-7940.2011.tb00075.x; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Stenson KW, 2011, ARCH PHYS MED REHAB, V92, P384, DOI 10.1016/j.apmr.2010.07.235; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Vincent HK, 2008, OBESITY, V16, P130, DOI 10.1038/oby.2007.10; Vincent HK, 2007, OBESITY, V15, P522, DOI 10.1038/oby.2007.551; Vincent HK, 2012, AM J PHYS MED REHAB, V91, P1051, DOI 10.1097/PHM.0b013e31825f1b19	14	7	7	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2015	94	8					627	632		10.1097/PHM.0000000000000222			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CN0RU	WOS:000358121900006	25299535				2022-02-06	
J	Shah, SU; Martinho, N; Socha, M; Reis, CP; Gibaud, S				Shah, Shefaat Ullah; Martinho, Nuno; Socha, Marie; Reis, Catarina Pinto; Gibaud, Stephane			Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor	EXPERT OPINION ON DRUG DELIVERY			English	Article						chitosan; Crohn's disease; glutathione; nitric oxide; Ussing chamber	TRAUMATIC BRAIN-INJURY; NASAL DELIVERY SYSTEM; IN-VITRO EVALUATION; N-ACETYLATION; NANOPARTICLES; ABSORPTION; RELEASE; NITROSOTHIOLS; CHEMISTRY; POLYMERS	Objectives: The aim of this work is to synthesize a novel stable and biodegradable nitric oxide (NO) donor polymer based on a chitosan backbone. This polymer needed to be linked to glutathione (GSH), which was nitrosated in a second step. This polymer has been developed as an' NO delivery platform that could be further evaluated for an oral delivery in Crohn's disease. Methods: The new polymer (named S-nitrosoglutathione-oligosaccharide-chitosan or SNOC) was obtained using a two-step procedure involving the linkage of GSH to chitosan via an amidine reaction followed by a postnitrosation with NaNO2. The GSH linkage was assessed using NMR, FTIR and an Ellman's test, whereas the final NO amount was determined by the Griess and Saville method. Results: Polymers with different numbers of NO groups were obtained (159.04 +/- 64.16 mu mol/g of polymer for SNOC G1 and 525.08 +/- 151.35 iirnolig of polymer for SNOC G2) depending on the procedure used for production. When tested in an Ussing chamber, SNOC G2 had a sustained release of NO and nitrites for at least 6 h. Conclusion: We believe that this type of polymer is adapted for the development of various formulations, including microparticles.	[Shah, Shefaat Ullah; Martinho, Nuno; Socha, Marie; Gibaud, Stephane] Univ Lorraine, Fac Pharm, EA 3452, CITHEFOR, F-54000 Nancy, France; [Martinho, Nuno; Reis, Catarina Pinto] Univ Lusofona Humanidades & Tecnol, CBIOS, Lab Nanosci & Biomed Nanotechnol, P-1749024 Lisbon, Portugal		Gibaud, S (corresponding author), Univ Lorraine, Fac Pharm, EA 3452, CITHEFOR, 5 Rue Albert Lebrun, F-54000 Nancy, France.	stephane.gibaud@univ-lorraine.fr	Reis, Catarina Pinto/M-8132-2013; iMed.ULisboa, NanoBB/B-5393-2014; SOCHA, Marie/D-3425-2016; GIBAUD, Stephane/F-2650-2010	Reis, Catarina Pinto/0000-0002-1046-4031; SOCHA, Marie/0000-0002-9913-9090; GIBAUD, Stephane/0000-0003-3594-0601	University of Gomal (Pakistan)	SU Shah received a scholarship from the University of Gomal (Pakistan). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Al-Sa'doni H, 2000, CLIN SCI, V98, P507, DOI 10.1042/CS19990267; ALLAN GG, 1995, CARBOHYD RES, V277, P273, DOI 10.1016/0008-6215(95)00208-B; Aspden TJ, 1996, EUR J PHARM SCI, V4, P23, DOI 10.1016/0928-0987(95)00026-7; Atyabi F, 2008, CARBOHYD POLYM, V74, P59, DOI 10.1016/j.carbpol.2008.01.015; BAXTER A, 1992, INT J BIOL MACROMOL, V14, P166, DOI 10.1016/S0141-8130(05)80007-8; Bernkop-Schnurch A, 1998, J CONTROL RELEASE, V50, P215, DOI 10.1016/S0168-3659(97)00136-3; Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Carini M, 2004, LIFE SCI, V74, P3291, DOI 10.1016/j.lfs.2003.11.018; Cheadle GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069042; Everett TR, 2014, BRIT J CLIN PHARMACO, V78, P660, DOI 10.1111/bcp.12379; Friedman AJ, 2008, NITRIC OXIDE-BIOL CH, V19, P12, DOI 10.1016/j.niox.2008.04.003; Furuhashi S, 2012, INT J ONCOL, V40, P807, DOI 10.3892/ijo.2011.1243; Gao H, 2010, ASIAN J PHARMACODYN, V10, P137; Georgii JL, 2011, J TISSUE ENG REGEN M, V5, P612, DOI 10.1002/term.353; Giustarini D, 2008, METHOD ENZYMOL, V440, P361, DOI 10.1016/S0076-6879(07)00823-3; Griess P., 1879, Berichte der deutschen chemischen Gesellschaft, V12, P426, DOI DOI 10.1002/CBER.187901201117; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450; Jin XF, 2011, CARBOHYD POLYM, V86, P51, DOI 10.1016/j.carbpol.2011.03.050; Kafedjiiski K, 2005, PHARM RES-DORDR, V22, P1480, DOI 10.1007/s11095-005-6248-6; Kafedjiiski K, 2007, INT J PHARMACEUT, V343, P48, DOI 10.1016/j.ijpharm.2007.04.019; Katsumi H, 2005, J PHARMACOL EXP THER, V314, P1117, DOI 10.1124/jpet.105.087429; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kumar V, 2010, MOL PHARMACEUT, V7, P291, DOI 10.1021/mp900245h; LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4; Loh JW, 2010, TOXICOL APPL PHARM, V249, P148, DOI 10.1016/j.taap.2010.08.029; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Maxwell S, 1999, LANCET, V354, P338, DOI 10.1016/S0140-6736(05)75246-6; MOORE GK, 1980, INT J BIOL MACROMOL, V2, P115, DOI 10.1016/0141-8130(80)90040-9; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Moustafine RI, 2008, EUR J PHARM BIOPHARM, V70, P215, DOI 10.1016/j.ejpb.2008.04.008; Parent M, 2013, CURR PHARM ANAL, V9, P31; RISEMAN JEF, 1958, CIRCULATION, V17, P22, DOI 10.1161/01.CIR.17.1.22; Sakloetsakun D, 2009, BIOMATERIALS, V30, P6151, DOI 10.1016/j.biomaterials.2009.07.060; Saremi S, 2011, INT J NANOMED, V6, P119, DOI 10.2147/IJN.S15500; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Schulz K, 1999, NITRIC OXIDE-BIOL CH, V3, P225, DOI 10.1006/niox.1999.0226; Servetnyk Z, 2011, EXP MOL PATHOL, V90, P79, DOI 10.1016/j.yexmp.2010.10.005; Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439; Yoo JW, 2010, J BIOMED MATER RES A, V92A, P1233, DOI 10.1002/jbm.a.32434; Yousefpour P, 2011, DARU, V19, P367	46	7	7	1	52	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1742-5247	1744-7593		EXPERT OPIN DRUG DEL	Expert Opin. Drug Deliv.	AUG	2015	12	8					1209	1223		10.1517/17425247.2015.1028916			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CO2HF	WOS:000358976100002	25804290				2022-02-06	
J	Villa, F; Colombo, K; Pastore, V; Locatelli, F; Molteni, E; Galbiati, S; Galbiati, S; Strazzer, S				Villa, Federica; Colombo, Katia; Pastore, Valentina; Locatelli, Federica; Molteni, Erika; Galbiati, Sara; Galbiati, Susanna; Strazzer, Sandra			LOCFAS-Assessed Evolution of Cognitive and Behavioral Functioning in a Sample of Pediatric Patients With Severe Acquired Brain Injury in the Postacute Phase	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric; coma; persistent vegetative state; brain injuries; rehabilitation	PERSISTENT VEGETATIVE STATE; MINIMALLY CONSCIOUS STATE; EARLY REHABILITATION; STIMULATION; COMA; CHILDREN; EPIDEMIOLOGY; DISORDERS; PREDICTORS; AMANTADINE	We studied 86 patients with severe acquired brain injuries of different etiology, aged 0 to 18 years, in a condition of vegetative state or minimally conscious state. During neurorehabilitation, we administered the Level of Cognitive Functioning Assessment Scale every 2 weeks in order to describe and compare the progressive improvement in their cognitive-behavioral functioning and responsiveness in different etiologies. Patients with traumatic brain injury showed more favorable clinical outcomes. The higher the level of functioning at the first evaluation, the better the outcome, and the higher the Glasgow Coma Scale score, the higher the Level of Cognitive Functioning Assessment Scale level reached at the end of hospitalization. Patients with an apparently stable clinical picture, too, showed a change in their ability to interact with the environment. This study underlines the importance of an individualized and early cognitive-behavioral intervention protocol that can reveal minimal and fluctuating responses.	[Villa, Federica; Colombo, Katia; Pastore, Valentina; Locatelli, Federica; Molteni, Erika; Galbiati, Sara; Galbiati, Susanna; Strazzer, Sandra] Eugenio Medea Sci Inst, Bosisio Parini, Lecco, Italy		Pastore, V (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, Lecco, Italy.	valentina.pastore@bp.lnf.it	Molteni, Erika/P-4564-2016; Colombo, Katia/ABE-5754-2020; Galbiati, Sara/AAA-7115-2020; Galbiati, Susanna/AAH-6883-2019; FEDERICA, LOCATELLI/AAA-5601-2020; Strazzer, Sandra/AAH-5712-2019; Pastore, Valentina/AAH-6831-2019	Molteni, Erika/0000-0001-7773-8140; Colombo, Katia/0000-0002-5390-106X; Galbiati, Sara/0000-0001-6810-359X; Galbiati, Susanna/0000-0001-7209-4251; FEDERICA, LOCATELLI/0000-0002-8243-5483; Strazzer, Sandra/0000-0001-8414-6565; Pastore, Valentina/0000-0002-3170-3070	Scientific Institute "E. Medea" [56 L 289/2002]; Scientific Institute "E. Medea"	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Project ex art. 56 L 289/2002. Fondi anno 2005. Scientific Institute "E. Medea" awarded to Sandra Strazzer as Principal Investigator; Ricerca corrente 2010-2012. Scientific Institute "E. Medea" awarded to SS as principal investigator.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2003, Clin Med (Lond), V3, P249; Ashwal S, 2003, BRAIN DEV-JPN, V25, P535, DOI 10.1016/S0387-7604(03)00095-0; Ashwal Stephen, 2002, Semin Pediatr Neurol, V9, P19, DOI 10.1053/spen.2002.30334; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Di Stefano C, 2012, BRAIN INJURY, V26, P1250, DOI 10.3109/02699052.2012.667588; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Eifert B, 2013, ARCH PHYS MED REHAB, V94, P1924, DOI 10.1016/j.apmr.2013.03.030; Flannery J, 2001, J Neurosci Nurs, V33, P50; Flannery J, 1998, Rehabil Nurs, V23, P88; Flannery J, 2003, MEASUREMENT NURSING, P34; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giovannetti AM, 2012, SCI WORLD J, DOI 10.1100/2012/232149; GOUVIER WD, 1986, INT J CLIN NEUROPSYC, V8, P1; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Hoffmann B, 2002, ACT NEUR S, V79, P33; Jorgensen H S, 1997, Ugeskr Laeger, V159, P4093; Jorgensen H S, 1997, Ugeskr Laeger, V159, P4089; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kerr ZY, 2014, N C MED J, V75, P8; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; Lotze M, 2011, J REHABIL MED, V43, P230, DOI 10.2340/16501977-0653; Mazzucchi A, 1997, RIABILITAZIONE NEURO; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Pagani M, 2014, J NEUROL, V261, P1144, DOI 10.1007/s00415-014-7309-8; Persel CS, 1997, BRAIN INJURY, V11, P751; Rosenthal M, 1999, REHABILITATION ADULT; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Sen AN, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.4.FOCUS1096; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; TEASDALE G, 1974, LANCET, V2, P81; Tunks E, 1995, TERAPIA COGNITIVO CO; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Whyte J, 2007, AM J PHYS MED REHAB, V86, P86, DOI 10.1097/PHM.0b013e31802f0434; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193; [No title captured]	49	7	7	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2015	30	9					1125	1134		10.1177/0883073814553798			10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CN0BN	WOS:000358076900002	25370863				2022-02-06	
J	Waterford, SD; Williams, M; Siegert, CJ; Fisichella, PM; Lebenthal, A				Waterford, Stephen D.; Williams, Mallory; Siegert, Charles J.; Fisichella, P. Marco; Lebenthal, Abraham			Trauma education in a state of emergency: a curriculum-based analysis	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Education; Curriculum; Medical school	SENIOR MEDICAL-STUDENTS; INJURY	Background: Trauma is the leading cause of death from ages 1-44-y in the United States and the fifth leading cause of death overall, but there are few studies quantifying trauma education in medical school. This study reviews curriculum hours devoted to trauma education at a northeastern medical school. Materials and methods: We reviewed the preclinical curriculum at a northeastern medical school affiliated with three adult and two pediatric level I trauma centers verified by the American College of Surgeons. We reviewed curricular hours and we categorized them according to the leading ten causes of death in the United States. We also compared the number of educational hours devoted to trauma to other leading causes of death. Results: The total amount of time devoted to trauma education in the first 2 y of medical school was 6.5 h. No lectures were given on the fundamentals of trauma management, traumatic brain injury, or chest or abdominal trauma. The most covered topic was heart disease (128 h), followed by chronic lower respiratory disease (80 h). Curricular time for heart disease, chronic lower respiratory disease, cancer, diabetes, renal disease, and influenza and pneumonia far exceeded that devoted to trauma, after adjusting for the mortality burden of these diseases (P < 0.05 for all). Conclusions: Our study demonstrates that trauma education at a northeastern medical school is nearly absent. With the large burden of trauma and rise in mass casualty incidence, the preclinical curriculum might not be sufficient to expose students to the fundamentals of trauma management. A broader multi-institutional study may shed more insight on these curricular deficiencies in trauma education and detect if these deficiencies are widespread nationally. Published by Elsevier Inc.	[Waterford, Stephen D.] Massachusetts Gen Hosp, Dept Gen Surg, Boston, MA 02114 USA; [Williams, Mallory] US Army, Joint Task Force Bravo, Soto Cano Air Base, Honduras; [Siegert, Charles J.; Fisichella, P. Marco; Lebenthal, Abraham] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Siegert, Charles J.; Fisichella, P. Marco; Lebenthal, Abraham] Boston VA Healthcare Syst, Boston, MA USA; [Siegert, Charles J.; Lebenthal, Abraham] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA		Lebenthal, A (corresponding author), Brigham & Womens Hosp, Dept Surg, Div Thorac Surg, 75 Francis St, Boston, MA 02115 USA.	alebenthal@partners.org	Williams, Mallory/ABC-2484-2020; Williams, Mallory/AAQ-2862-2021				ALI J, 1995, J TRAUMA, V38, P687, DOI 10.1097/00005373-199505000-00002; Ali J, 2002, J TRAUMA, V52, P847, DOI 10.1097/00005373-200205000-00005; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1; Finkelstein EA, 2006, ASS INCIDENCE EC BUR; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Gunst Mark, 2010, Proc (Bayl Univ Med Cent), V23, P349; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Mock CN, 2005, INJURY, V36, P725, DOI 10.1016/j.injury.2004.12.044; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Murray C. J., 1996, GLOBAL HLTH STAT COM; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Peden M., 2002, INJURY CHART BOOK GR; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; TRUNKEY DD, 1982, SURGERY, V92, P123; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	15	7	7	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2015	197	2					236	239		10.1016/j.jss.2015.03.002			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CK3CZ	WOS:000356095100004	25937566				2022-02-06	
J	Sandel, N; Henry, LC; French, J; Lovell, MR				Sandel, Natalie; Henry, Luke C.; French, Jonathan; Lovell, Mark R.			Parent Perceptions of Their Adolescent Athlete's Concussion: A Preliminary Retrospective Study	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						parent; athlete; symptoms; concussion; neurocognitive	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; TEST-RETEST RELIABILITY; TENSOR IMAGING FINDINGS; IMPACT TEST BATTERY; STATES HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; CONSTRUCT-VALIDITY; ONLINE VERSION; SYMPTOMS	Parent reports of their adolescent athletes' recovery from concussion are often considered by clinicians, but limited research has explored the factors (i.e., athletes' symptoms and neurocognitive performance) predicting parents' perceptions of athletes' recovery and how these factors relate to previous research on athletes' self-perceptions of recovery. The current study included 67 athletes aged 12 to 18 years old (M=14.69 years, SD=1.67) who were evaluated for a sports-related concussion within 6 months postinjury and were accompanied by a parent to their evaluation. Athletes and parents were asked to rate athletes' percent "back to normal" (i.e., perception of recovery), and athletes completed Immediate Post-Concussion Assessment and Cognitive Testing and symptom reports on the Post-Concussion Symptom Scale. Results of a multiple regression for athletes' total symptom score and neurocognitive performance (Verbal Memory, Visual Memory, Visuomotor Speed, and Reaction Time) was significant and accounted for 47.9% of the variance in parents' perceptions of recovery with total symptoms as the only significant predictor. A stepwise regression for symptom clusters (somatic, cognitive, sleep, and neuropsychiatric) demonstrated that somatic complaints were the most predictive of parents' perceptions. Parents' and athletes' perceptions are predicted by athletes' somatic symptoms, rather than athletes' performance on objective assessments.	[Sandel, Natalie] Widener Univ, Inst Grad Clin Psychol, Chester, PA 19013 USA; [Henry, Luke C.; French, Jonathan] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA USA; [Lovell, Mark R.] ImPACT Applicat Inc, Pittsburgh, PA USA		Sandel, N (corresponding author), Widener Univ, Inst Grad Clin Psychol, One Univ Pl, Chester, PA 19013 USA.	nksandel@mail.widener.edu	Meijer, Anna/K-5118-2016				Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	36	7	7	0	38	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2015	4	3					211	216		10.1080/21622965.2013.850692			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CK6OM	WOS:000356347400009	25257693				2022-02-06	
J	Al-Ozairi, A; McCullagh, S; Feinstein, A				Al-Ozairi, Abdullah; McCullagh, Scott; Feinstein, Anthony			Predicting Posttraumatic Stress Symptoms Following Mild, Moderate, and Severe Traumatic Brain Injury: The Role of Posttraumatic Amnesia	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							PERSISTENT POSTCONCUSSIVE SYMPTOMS; FEAR EXTINCTION; DISORDER; QUESTIONNAIRE; CONCUSSION; DEPRESSION; AVOIDANCE; SEQUELAE; ANXIETY; HEALTH	Objective: To explore the relation between posttraumatic amnesia (PTA) and posttraumatic stress symptoms in traumatic brain injury. Design: Single-site prospective cohort study. Participants: A total of 1114 individuals between the ages of 18 and 65 years with a traumatic brain injury seen on average 3 months following injury. Participants were divided into 4 groups according to their duration of PTA: less than 1 hour; 1 to 24 hours; 24 hours to 1 week; and more than 1 week. Main Measures: Glasgow Coma Scale, PTA, computed tomographic brain scan abnormalities, Impact of Event Scale, the 28-item General Health Questionnaire, and Rivermead Postconcussion Disorder Questionnaire. Results: The duration of PTA less than 1 hour was associated with more avoidant (P < .01) and intrusive (P < .001) posttraumatic stress symptoms and more anxiety according to the General Health Questionnaire (P < .01) than other groups. Regression analysis identified PTA and 3 concussive symptoms (light sensitivity, noise intolerance, and difficulties concentrating) as independent predictors of intrusive posttraumatic stress symptoms. Conclusion: Our data, representative of the full range of traumatic brain injury severity, indicate that a brief duration of PTA is a significant risk factor for the development of posttraumatic stress disorder symptoms. The persistence of certain symptoms of postconcussion disorder adds to the risk by possibly acting as a trigger for reminders of the traumatic event.	[Al-Ozairi, Abdullah; McCullagh, Scott; Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Dept Neuropsychiat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada		Al-Ozairi, A (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Neuropsychiat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	abs.al.ozairi@utoronto.ca					Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bomyea J, 2012, CLIN PSYCHOL REV, V32, P630, DOI 10.1016/j.cpr.2012.06.008; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; FEINSTEIN A, 1991, PSYCHOL MED, V21, P85, DOI 10.1017/S0033291700014689; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Graham BM, 2011, AM J PSYCHIAT, V168, P1255, DOI 10.1176/appi.ajp.2011.11040557; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Norman GR, 2008, BIOSTATISTICS BARE E, P393; Pochard F, 2011, B ACAD NATL MED, V195, P385; Pochard F, 2011, B ACAD NAT MED PARIS, V195, P377, DOI 10.1016/S0001-4079(19)32096-5; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Tull MT, 2004, J NERV MENT DIS, V192, P754, DOI 10.1097/01.nmd.0000144694.30121.89; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	39	7	7	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					283	289		10.1097/HTR.0000000000000043			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JA	WOS:000357944700007	24816155				2022-02-06	
J	Brown, JC; Viljoen, W; Lambert, MI; Readhead, C; Fuller, C; Van Mechelen, W; Verhagen, E				Brown, James C.; Viljoen, Wayne; Lambert, Mike I.; Readhead, Clint; Fuller, Chelsea; Van Mechelen, Willem; Verhagen, Evert			The economic burden of time-loss injuries to youth players participating in week-long rugby union tournaments	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Football; Football/economics; Football/economics/cost analysis; Football/injuries (MeSH terms)	SPORTS INJURIES; CONSENSUS STATEMENT; PHYSICAL-ACTIVITY; NEW-ZEALAND; COSTS; PREVENTION; CONCUSSION; SEVERITY; HEALTH; CLAIMS	Objectives: Rugby Union ("rugby") is a popular sport with high injury risk. Burden of injury is described by the incidence and severity of injury. However reports have ignored the monetary cost of injuries. Therefore the aim of this study was to describe the monetary cost associated with youth rugby injuries. Design: This descriptive study quantified medical treatments of injured players at the South African Rugby Union Youth tournaments in 2011/2012 and the days of work parents missed as a result of the injuries. A health insurer used these data to calculate associated costs. Methods: Legal guardians of the 421 injured players were contacted telephonically on a weekly basis until they returned to play. Treatments costs were estimated in South African Rands based on 2013 insurance rates and converted to US$ using purchasing power parities. Results: Of the 3652 players, 2% (n = 71) sought medical care after the tournament. For these players, average treatment costs were high (US$731 per player, 95% CI: US$425-US$1096), with fractures being the most expensive type of injury. Players with medical insurance had higher costs (US$937, 95% CI: US$486-US$1500) than those without (US$220, 95% CI: US$145-US$302). Conclusions: Although a minority of players sought follow-up treatment after the tournaments, the cost of these injuries was high. Players without medical insurance having lower costs may indicate that these players did not receive adequate treatment for their injuries. Injury prevention efforts should consider injuries with high costs and the treatment of players without medical insurance. (C) 2014 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Brown, James C.; Lambert, Mike I.; Fuller, Chelsea; Van Mechelen, Willem] Univ Cape Town, UCT MRC Res Unit Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Brown, James C.; Van Mechelen, Willem] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Viljoen, Wayne; Readhead, Clint] South African Rugby Union, Cape Town, South Africa		Brown, JC (corresponding author), Univ Cape Town, UCT MRC Res Unit Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	jamesbrown06@gmail.com	Verhagen, Evert/A-1502-2013; Brown, James Craig/H-7637-2019	Verhagen, Evert/0000-0001-9227-8234; Brown, James Craig/0000-0002-7778-7783; Lambert, Michael/0000-0001-8979-1504; Viljoen, Wayne/0000-0002-9432-6153; van Mechelen, Willem/0000-0001-7136-6382			Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Brown JC, 2012, S AFR J SPORTS MED, V24, P49; Collard DCM, 2011, BRIT J SPORT MED, V45, P1058, DOI 10.1136/bjsm.2010.082545; de Loes M, 2000, SCAND J MED SCI SPOR, V10, P90, DOI 10.1034/j.1600-0838.2000.010002090.x; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; King D, 2011, INT J SPORTS MED, V32, P287, DOI 10.1055/s-0030-1270486; King DA, 2010, BRIT J SPORT MED, V44, P1016, DOI 10.1136/bjsm.2009.064683; King DA, 2009, BRIT J SPORT MED, V43, P595, DOI 10.1136/bjsm.2009.061481; King DA, 2011, J SCI MED SPORT, V14, P126, DOI 10.1016/j.jsams.2010.10.001; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Patricios JS, 2011, S AFR J SPORTS MED, V22, P88; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Schmikli SL, 2009, CLIN J SPORT MED, V19, P101, DOI 10.1097/JSM.0b013e31819b9ca3; Steyn K, 2008, SAMJ S AFR MED J, V98, P376; vanMechelen W, 1997, SPORTS MED, V24, P176, DOI 10.2165/00007256-199724030-00006; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	22	7	9	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2015	18	4					394	399		10.1016/j.jsams.2014.06.015			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CL3HL	WOS:000356840900007	25138043				2022-02-06	
J	Damkliang, J; Considine, J; Kent, B; Street, M				Damkliang, Jintana; Considine, Julie; Kent, Bridie; Street, Maryann			Using an evidence-based care bundle to improve Thai emergency nurses' knowledge of care for patients with severe traumatic brain injury	NURSE EDUCATION IN PRACTICE			English	Article						Emergency nursing; Brain injury; Trauma; Neurotrauma; Care bundle; Evidence-based practice; Thailand	VENTILATOR-ASSOCIATED PNEUMONIA; EVIDENCE-BASED GUIDELINES; HEAD-INJURY; IMPACT; SEPSIS; EPIDEMIOLOGY; PREVENTION; MANAGEMENT; EUROPE; STROKE	There is known variation in Thai nurses' knowledge regarding the best available evidence for care of patients with severe traumatic brain injury. The purpose of this study was to examine the impact of an evidence-based care bundle on Thai emergency nurses' knowledge regarding management of patients with severe traumatic brain injury. A pre-test/post-test design was used. The study intervention was an evidence-based care bundle for initial nursing management of patients with severe traumatic brain injury. Data were collected from 31 Registered Nurses using multiple choice questions. Results revealed a statistically significant improvement in overall knowledge scores after care bundle implementation (p < 0.001). There were statistically significant improvements in five areas of knowledge: understanding of target end-tidal carbon dioxide levels (p < 0.001), implications of hypocapnia in severe traumatic brain injury (p = 0.01), implications of hypercapnia in severe traumatic brain injury (p = 0.02), importance of maintaining head and neck in neutral position (p = 0.05), and administration of sedatives and analgesics in severe traumatic brain injury (p = 0.01). This study suggested that implementation of an evidence-based care bundle improved emergency nurses' knowledge regarding management of patients with severe traumatic brain injury. (C) 2015 Elsevier Ltd. All rights reserved.	[Damkliang, Jintana] Deakin Univ, Sch Nursing & Midwifery, Burwood, Vic 3125, Australia; [Damkliang, Jintana] Prince Songkla Univ, Fac Nursing, Hat Yai, Thailand; [Considine, Julie; Street, Maryann] Deakin Univ, Nursing & Midwifery Res Ctr, Eastern Hlth, Burwood, Vic 3125, Australia; [Considine, Julie; Street, Maryann] Ctr Qual & Patient Safety Res, Melbourne, Vic, Australia; [Kent, Bridie] Univ Plymouth, Sch Nursing & Midwifery, Plymouth PL4 8AA, Devon, England		Damkliang, J (corresponding author), Deakin Univ, Sch Nursing & Midwifery, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	jdamklia@deakin.edu.au; julie.considine@deakin.edu.au; bridie.kent@plymouth.ac.uk; maryann.street@deakin.edu.au	Street, Maryann/A-2709-2010	Street, Maryann/0000-0002-5615-141X; Considine, Julie/0000-0003-3801-2456	Faculty of Nursing, Prince of Songkla University, Thailand	This study is an unfunded PhD study. Ms Damkliang is supported by a scholarship from Faculty of Nursing, Prince of Songkla University, Thailand. The authors wish to thank the following people for their assistance with survey development: Praphun Somporn, MD; Kesinee Sae-Heng, MD; Sorajanee Kanchanaprapas, MD; and Assistant Professor Luppana Kitrungrote and thank the nurse who participated in this study.	Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; Blot SI, 2007, INTENS CARE MED, V33, P1463, DOI 10.1007/s00134-007-0705-0; Brain Trauma Foundation (BTF), 2007, GUID PREH MAN TRAUM; BTF-Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Bureau of Epidemiology (BOE) Ministry of Public Health Thailand, 2007, SEV INJ DUE TRANSP A; Bureau of Policy and Strategy (BOPS) Ministry of Public Health Thailand, 2011, HLTH STAT INF; Considine Julie, 2005, Nurs Health Sci, V7, P199; Considine J, 2013, AUSTRALAS EMERG NURS, V16, P10, DOI 10.1016/j.aenj.2012.11.001; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Damkliang J, 2014, AUSTRALAS EMERG NURS, V17, P152, DOI 10.1016/j.aenj.2014.05.005; Damkliang J, 2013, AUSTRALAS EMERG NURS, V16, P127, DOI 10.1016/j.aenj.2013.09.001; Douglas B, 2011, EMERGENCY TRAUMA CAR, P1169; El-Khatib MF, 2010, AM J CRIT CARE, V19, P272, DOI 10.4037/ajcc2009131; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Guembe M, 2012, EUR J CLIN MICROBIOL, V31, P2799, DOI 10.1007/s10096-012-1630-x; Harper JP, 2007, J EMERG NURS, V33, P202, DOI 10.1016/j.jen.2006.11.002; Kendall-Gallagher D, 2009, AM J CRIT CARE, V18, P106, DOI 10.4037/ajcc2009487; Kuan WS, 2013, EUR J EMERG MED, V20, P344, DOI 10.1097/MEJ.0b013e32835c2ba3; Labeau S, 2008, J HOSP INFECT, V70, P180, DOI 10.1016/j.jhin.2008.06.027; MacLeod JBA, 2011, WORLD J SURG, V35, P9, DOI 10.1007/s00268-010-0810-z; Madden C, 2006, NURS EDUC TODAY, V26, P218, DOI 10.1016/j.nedt.2005.10.003; McCartan DP, 2008, BRAIN INJURY, V22, P305, DOI 10.1080/02699050801995124; McCarthy C, 2013, INT J CHRONIC OBSTR, V8, P605, DOI 10.2147/COPD.S52883; McCreanor JE, 2012, THORAX, V67, pA183, DOI 10.1136/thoraxjnl-2012-202678.363; McNett M, 2010, AM J CRIT CARE, V19, P250, DOI 10.4037/ajcc2009293; Mittal R, 2009, EMERG MED J, V26, P513, DOI 10.1136/emj.2009.072041; Moceri JT, 2014, J EMERG NURS, V40, P6, DOI 10.1016/j.jen.2012.04.014; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; National Institute of Clinical Studies (NICS), 2009, EM DEP STROK TRANS I; New Zealand Guidelines Group (NZGG), 2007, TRAUM BRAIN INJ DIAG; Nguyen HB, 2011, CRIT CARE, V15, DOI 10.1186/cc10469; NICE, 2014, HEAD INJ TRIAG ASS I; Nolan JP, 2008, RESUSCITATION, V76, P161, DOI 10.1016/j.resuscitation.2007.12.005; Pemberton J, 2013, AM J SURG, V205, P119, DOI 10.1016/j.amjsurg.2012.08.004; Price Ann M, 2003, Nurs Crit Care, V8, P126, DOI 10.1046/j.1478-5153.2003.00019.x; Rello J, 2010, INTENS CARE MED, V36, P773, DOI 10.1007/s00134-010-1841-5; Resar R, 2012, IHI INNOVATION SERIE; Robb E., 2010, BR MED J OVERSEAS RE, V340; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sedwick Mary Beth, 2012, Crit Care Nurse, V32, P41, DOI 10.4037/ccn2012964; SIGN, 2009, EARL MAN PAT HEAD IN; Smith Fiona C, 2010, Nurse Educ Pract, V10, P101, DOI 10.1016/j.nepr.2009.04.003; Sodhi K, 2013, J INFECT PUBLIC HEAL, V6, P269, DOI 10.1016/j.jiph.2013.02.004; Somporn P., 2011, NEUROL SURG, V2, P36; Subramanian P, 2013, SINGAP MED J, V54, P281, DOI 10.11622/smedj.2013109; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tippett Jane, 2004, Accid Emerg Nurs, V12, P39, DOI 10.1016/S0965-2302(03)00064-X; Tromp M, 2010, INT J NURS STUD, V47, P1464, DOI 10.1016/j.ijnurstu.2010.04.007; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Waltz CF, 2010, MEASUREMENT NURSING, V4th; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; Weeraratne JI, 2010, MED J AUSTRALIA, V193, P381, DOI 10.5694/j.1326-5377.2010.tb03962.x; Wong F W, 2000, Crit Care Nurse, V20, P18; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	61	7	8	0	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-5953			NURSE EDUC PRACT	Nurse Educ. Pract.	JUL	2015	15	4					284	292		10.1016/j.nepr.2015.03.007			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CN9YM	WOS:000358807100006	25866359	Green Published			2022-02-06	
J	Dharmadhikari, S; Romito, LM; Dzemidzic, M; Dydak, U; Xu, J; Bodkin, CL; Manchanda, S; Byrd, KE				Dharmadhikari, Shalmali; Romito, Laura M.; Dzemidzic, Mario; Dydak, Ulrike; Xu, Jun; Bodkin, Cynthia L.; Manchanda, Shalini; Byrd, Kenneth E.			GABA and glutamate levels in occlusal splint-wearing males with possible bruxism	ARCHIVES OF ORAL BIOLOGY			English	Article						MRS; Bruxism; Anxiety; Metabolites; GABA; Pathophysiology	POSTTRAUMATIC-STRESS-DISORDER; RESTLESS LEGS SYNDROME; GAMMA-AMINOBUTYRIC-ACID; TRAUMATIC BRAIN-INJURY; SLEEP BRUXISM; TEMPOROMANDIBULAR DISORDERS; PREFRONTAL CORTEX; PAIN SENSITIVITY; RECEPTOR-BINDING; FEARFUL FACES	Objective: The inhibitory neurotransmitter gamma-aminobutyric acid (GABA) plays an important role in the pathophysiology of anxiety behavioural disorders such as panic disorder and post-traumatic stress disorder and is also implicated in the manifestation of tooth-grinding and clenching behaviours generally known as bruxism. In order to test whether the stress-related behaviours of tooth-grinding and clenching share similar underlying mechanisms involving GABA and other metabolites as do anxiety-related behavioural disorders, we performed a Magnetic Resonance Spectroscopy (MRS) study for accurate, in vivo metabolite quantification in anxiety-related brain regions. Design: MRS was performed in the right hippocampus and right thalamus involved in the hypothalamic-pituitary-adrenal axis system, together with a motor planning region (dorsal anterior cingulate cortex/pre-supplementary motor area) and right dorsolateral prefrontal cortex (DLPFC). Eight occlusal splint-wearing men (OCS) with possible tooth-grinding and clenching behaviours and nine male controls (CON) with no such behaviour were studied. Results: Repeated-measures ANOVA showed significant Group x Region interaction for GABA+ (p = 0.001) and glutamate (Glu) (p = 0.031). Between-group post hoc ANOVA showed significantly lower levels of GABA+ (p = 0.003) and higher levels of Glu (p = 0.002) in DLPFC of OCS subjects. These GABA+ and Glu group differences remained significant (GABA+, p = 0.049; Glu, p = 0.039) after the inclusion of anxiety as a covariate. Additionally, GABA and Glu levels in the DLPFC of all subjects were negatively related (Pearson's r = -0.75, p = 0.003). Conclusions: These findings indicate that the oral behaviours of tooth-grirfding and clenching, generally known as bruxism, may be associated with disturbances in brain GABAergic and glutamatergic systems. (c) 2015 Elsevier Ltd. All rights reserved.	[Dharmadhikari, Shalmali; Dydak, Ulrike] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Romito, Laura M.; Byrd, Kenneth E.] Indiana Univ Sch Med, Dept Oral Biol, Indianapolis, IN 46202 USA; [Dzemidzic, Mario; Bodkin, Cynthia L.; Manchanda, Shalini] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Dharmadhikari, Shalmali; Dzemidzic, Mario; Dydak, Ulrike; Xu, Jun] Indiana Univ Sch Med, Dept Radiol, Indianapolis, IN 46202 USA; [Byrd, Kenneth E.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Bodkin, Cynthia L.; Manchanda, Shalini] Indiana Univ Sch Med, Indiana Univ Hlth Sleep Disorders Ctr, Indianapolis, IN 46202 USA		Byrd, KE (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, MS 5035,635 Barnhill Dr, Indianapolis, IN 46202 USA.	shdharma@iupui.edu; lromitoc@iu.edu; mdzemidz@iupui.edu; udydak@iupui.edu; jx3@iupui.edu; cbodkin@iupui.edu; smanchan@iu.edu; kbyrd@iupui.edu	Dharmadhikari, Shalmali/AAD-4772-2020	Dharmadhikari, Shalmali/0000-0001-6225-2172	Dept. of Anatomy & Cell Biology, Indiana University School of Medicine; Oral Health Research Institute, Indiana University School of Dentistry; American Equilibration Society [2005-002, 2012-001, 2012-002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES020529] Funding Source: NIH RePORTER	Research supported by Dept. of Anatomy & Cell Biology, Indiana University School of Medicine; Oral Health Research Institute, Indiana University School of Dentistry; and American Equilibration Society grants #2005-002, #2012-001, #2012-002 all to KEB.	Ahlberg J, 2004, COMMUNITY DENT ORAL, V32, P307, DOI 10.1111/j.1600-0528.2004.00163.x; Albouy G, 2013, HIPPOCAMPUS, V23, P985, DOI 10.1002/hipo.22183; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059490; Allen RP, 2013, NEUROLOGY, V80, P2028, DOI 10.1212/WNL.0b013e318294b3f6; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS; Anglin RE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.107; Baba K, 2005, J OROFAC PAIN, V19, P226; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Burris JL, 2010, J AM DENT ASSOC, V141, P22, DOI 10.14219/jada.archive.2010.0017; Byrd KE, 2009, J ORAL REHABIL, V36, P346, DOI 10.1111/j.1365-2842.2009.01947.x; Cameron OG, 2007, ARCH GEN PSYCHIAT, V64, P793, DOI 10.1001/archpsyc.64.7.793; Chen WH, 2005, J CLIN NEUROSCI, V12, P161, DOI 10.1016/j.jocn.2004.07.007; Cho S, 2012, J COGNITIVE NEUROSCI, V24, P1849, DOI 10.1162/jocn_a_00246; Chowdhury FA, 2015, J MAGN RESON IMAGING, V41, P694, DOI 10.1002/jmri.24611; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Denkova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014150; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Edden RAE, 2007, MAGN RESON MED, V58, P1276, DOI 10.1002/mrm.21383; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Ferreira LS, 2011, REV ODONTOL UNESP, V40, P143; Ganon-Elazar E, 2013, PSYCHONEUROENDOCRINO, V38, P1675, DOI 10.1016/j.psyneuen.2013.01.014; Gerstner GE, 2012, J DENT RES, V91, P485, DOI 10.1177/0022034512443366; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Goddard AW, 2004, AM J PSYCHIAT, V161, P2186, DOI 10.1176/appi.ajp.161.12.2186; Hasler G, 2008, ARCH GEN PSYCHIAT, V65, P1166, DOI 10.1001/archpsyc.65.10.1166; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HICKS RA, 1990, MED HYPOTHESES, V33, P239, DOI 10.1016/0306-9877(90)90134-Z; Hojo A, 2007, INT J PROSTHODONT, V20, P251; Huynh N, 2006, J SLEEP RES, V15, P339, DOI 10.1111/j.1365-2869.2006.00536.x; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jones BE, 2000, PRINCIPLES PRACTICE, P134; Kato T, 2010, SLEEP MED CLIN, V5, P9, DOI 10.1016/j.jsmc.2009.09.003; Keefe F J, 1988, J Craniomandib Disord, V2, P181; Kight M, 1999, HEALTH PSYCHOL, V18, P177, DOI 10.1037/0278-6133.18.2.177; Koyano K, 2008, J ORAL REHABIL, V35, P495, DOI 10.1111/j.1365-2842.2008.01880.x; Laberge L, 2000, PEDIATRICS, V106, P67, DOI 10.1542/peds.106.1.67; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lavigne GJ, 2008, J ORAL REHABIL, V35, P476, DOI 10.1111/j.1365-2842.2008.01881.x; LAVIGNE GJ, 1994, SLEEP, V17, P739; Lavigne GJ, 2001, CLIN NEUROPHARMACOL, V24, P145, DOI 10.1097/00002826-200105000-00005; Lavigne GJ, 1997, SLEEP, V20, P290; Lavigne GJ, 2005, SLEEP BRUXISM PRINCI; Lobbezoo F, 2006, J ORAL REHABIL, V33, P152, DOI 10.1111/j.1365-2842.2006.01542.x; Lobbezoo F, 2013, J ORAL REHABIL, V40, P2, DOI 10.1111/joor.12011; Lobbezoo F, 1997, MOVEMENT DISORD, V12, P73, DOI 10.1002/mds.870120113; Lobbezoo F, 2001, J ORAL REHABIL, V28, P1085, DOI 10.1046/j.1365-2842.2001.00839.x; Lobbezoo F, 2001, J OROFAC PAIN, V15, P340; Lobbezoo F, 1996, J DENT RES, V75, P1804, DOI 10.1177/00220345960750101401; Lobbezoo Frank, 1997, Journal of Orofacial Pain, V11, P15; Long Z, 2013, PROG NEURO-PSYCHOPH, V44, P131, DOI 10.1016/j.pnpbp.2013.01.020; Maddock R.J., 2012, CURR TOP BEHAV NEURO; Manfredini D, 2005, J ORAL REHABIL, V32, P584, DOI 10.1111/j.1365-2842.2005.01462.x; Manfredini D, 2003, CRANIO, V21, P279, DOI 10.1080/08869634.2003.11746263; Manfredini D, 2009, J OROFAC PAIN, V23, P153; MCCREARY CP, 1991, PAIN, V44, P29, DOI 10.1016/0304-3959(91)90143-L; Meletti S, 2004, NEUROLOGY, V62, P2306, DOI 10.1212/WNL.62.12.2306; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mongini F, 2007, PAIN, V131, P106, DOI 10.1016/j.pain.2006.12.017; Ohayon MM, 2001, CHEST, V119, P53, DOI 10.1378/chest.119.1.53; Park JW, 2010, INT J ORAL MAX SURG, V39, P968, DOI 10.1016/j.ijom.2010.06.003; Peers PV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00024; Petit D, 2007, PEDIATRICS, V119, pE1016, DOI 10.1542/peds.2006-2132; PINGITORE G, 1991, J PROSTHET DENT, V65, P443, DOI 10.1016/0022-3913(91)90240-W; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ranjan S, 2006, INT J NEUROPSYCHOPH, V9, P485, DOI 10.1017/S1461145705005985; Raphael KG, 2012, J AM DENT ASSOC, V143, P1223, DOI 10.14219/jada.archive.2012.0068; Raphael KG, 2003, J ORAL REHABIL, V30, P17, DOI 10.1046/j.1365-2842.2003.01117.x; Rosso IM, 2013, DEPRESS ANXIETY; Schmitz TW, 2010, J NEUROSCI, V30, P14750, DOI 10.1523/JNEUROSCI.2687-10.2010; Sjoholm TT, 1996, CLIN AUTON RES, V6, P37, DOI 10.1007/BF02291404; Smith MT, 2009, SLEEP, V32, P779, DOI 10.1093/sleep/32.6.779; Tosun T, 2003, INT J ORAL MAX IMPL, V18, P286; Van Cauter E., 2005, PRINCIPLES PRACTICE, P266; Winocur E, 2003, J OROFAC PAIN, V17, P99; Wong D, 2011, BRAIN RES, V1383, P206, DOI 10.1016/j.brainres.2011.01.096	85	7	8	1	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	JUL	2015	60	7					1021	1029		10.1016/j.archoralbio.2015.03.006			9	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CK3KK	WOS:000356114800007	25889171	Green Accepted, Green Submitted			2022-02-06	
J	Harvey, J; Hux, K				Harvey, Judy; Hux, Karen			Text-to-speech accommodations for the reading challenges of adults with traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; reading; text-to-speech technology	COMPUTER SPEECH; COMPREHENSION; STUDENTS; INSTRUCTION; DISORDERS; CHILDREN; BENEFITS; AVERAGE; READERS; RATES	Objective: This study's purpose was two-fold: (a) to confirm differences in silent reading rates of individuals with and without traumatic brain injury (TBI) and (b) to determine the effect of text-to-speech (TTS) on reading comprehension and efficiency by individuals with TBI. Design and methods: Ten adults with severe TBI answered comprehension questions about written passages presented in three conditions: reading only (RO), listening to ITS presentation only (LO) or reading and listening to TTS simultaneously (RL). The researchers compared reading rate, comprehension accuracy and comprehension rate (efficiency) across conditions. Results: Analysis revealed significantly slower silent reading rates for the participants with TBI than for readers without TBI (n=75). Also, participants with TBI achieved higher comprehension accuracy for factual than inferential questions; however, no significant main effect for comprehension accuracy emerged across reading conditions. In contrast, using comprehension rate as the dependent measure, analysis confirmed a significant main effect for reading condition and question type; post-hoc pairwise comparisons revealed that the RL condition yielded higher comprehension rate scores than the RO condition. Conclusions: As a group, adults with TBI appear to benefit in reading efficiency when simultaneously listening to and reading written passages; however, differences exist that reinforce the importance of individualizing treatment.	[Harvey, Judy; Hux, Karen] Univ Nebraska, Barkley Mem Ctr, Lincoln, NE 68583 USA		Harvey, J (corresponding author), Univ Nebraska, Barkley Mem Ctr 276, Lincoln, NE 68583 USA.	judy.harvey@unl.edu	Hux, Karen/AAQ-2078-2020				ABELSON AG, 1983, PERCEPT MOTOR SKILL, V57, P567, DOI 10.2466/pms.1983.57.2.567; Aldrich EM, 2012, CAN J SCH PSYCHOL, V27, P291, DOI 10.1177/0829573512455016; Anderson-Inman L, 2007, READ RES QUART, V42, P153, DOI 10.1598/RRQ.42.1.8; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Balajthy E., 2005, READING ONLINE, V8, P1; Brown J, 1993, NELSON DENNY READING; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Cook L. G., 2011, SIG 2 PERSPECTIVES N, V21, P33, DOI DOI 10.1044/NNSLD21.1.33; Dietz A, 2009, APHASIOLOGY, V23, P1053, DOI 10.1080/02687030802635832; Elkind J, 1996, ANN DYSLEXIA, V46, P159, DOI 10.1007/BF02648175; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Freeland JT, 2000, PSYCHOL SCHOOLS, V37, P415, DOI 10.1002/1520-6807(200009)37:5<415::AID-PITS2>3.3.CO;2-C; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Griffiths GG, 2013, THESIS U OREGON EUGE; Hale AD, 2005, PSYCHOL SCHOOLS, V42, P39, DOI 10.1002/pits.20027; Harvey J, 2013, BRAIN INJURY, V27, P1388, DOI 10.3109/02699052.2013.823649; Hecker L, 2002, ANN DYSLEXIA, V52, P243, DOI 10.1007/s11881-002-0015-8; Hiebert EH, 2012, LIT RES INSTR, V51, P110, DOI 10.1080/19388071.2010.531887; Higgins EL, 2004, ANN DYSLEXIA, V54, P365, DOI 10.1007/s11881-004-0017-9; Kertesz A., 2007, WAB R W APHASIA BATT; LEONG CK, 1995, LEARN DISABILITY Q, V18, P101, DOI 10.2307/1511198; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; LOVETT MW, 1994, BRAIN LANG, V47, P117, DOI 10.1006/brln.1994.1045; Manset-Williamson G, 2008, INT J SPEC EDUC, V23, P123; Matthias J, 2004, NEUROPSYCHOLOGY, V21, P212; Montali J, 1996, J LEARN DISABIL, V29, P271, DOI 10.1177/002221949602900305; Moorman A, 2010, LEARN DISABIL-MULTI, V16, P41; My Byline Media, READ FORM FREE READ; NICHOLAS LE, 1986, J SPEECH HEAR DISORD, V51, P82, DOI 10.1044/jshd.5101.82; NICHOLAS LE, 1987, J SPEECH HEAR DISORD, V52, P358, DOI 10.1044/jshd.5204.358; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Northcutt E, 1996, GED COMPLETE PREPARA; OLSON R, 1986, BEHAV RES METH INSTR, V18, P93, DOI 10.3758/BF03201007; Palinscar AS., 1984, COGNITION INSTRUCT, V1, P117, DOI [DOI 10.1207/S1532690XCI0102_1, 10.1207/s1532690xci0102_1]; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REITSMA P, 1988, READ RES QUART, V23, P219, DOI 10.2307/747803; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rockowitz M, 2001, BARRONS PREPARE GED; ROSE TL, 1984, LEARN DISABILITY Q, V7, P39, DOI 10.2307/1510259; Schmitt A. J., 2009, J EVIDENCE BASED PRA, V10, P95; Schmitt AJ, 2011, PSYCHOL SCHOOLS, V48, P37, DOI 10.1002/pits.20540; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sohlberg MM, 2014, AM J SPEECH-LANG PAT, V23, P160, DOI 10.1044/2013_AJSLP-12-0005; Stewart MA, 2011, PETERSONS MASTER GED; Tuiman J, 1974, READING RES Q, V2, P206; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; Van Slyke C, 2005, KAPLAN GED; Westby C. E., 2005, LANGUAGE READING DIS, P157; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Williams JR, 1998, HUM FAC ERG SOC P, P1447; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	52	7	7	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					888	897		10.3109/02699052.2015.1022878			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800014	25955116				2022-02-06	
J	Lien, E; Andersen, G; Bao, YD; Gordish-Dressman, H; Skranes, JS; Blackman, JA; Vik, T				Lien, Espen; Andersen, Guro; Bao, Yongde; Gordish-Dressman, Heather; Skranes, Jon S.; Blackman, James A.; Vik, Torstein			Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E	ACTA PAEDIATRICA			English	Article						apoE; APOE; Cerebral palsy; Regulation of apoE synthesis; rs59007384 polymorphism	E GENOTYPE; ALZHEIMERS-DISEASE; BRAIN-INJURY; CHILDREN; ASSOCIATION; APOE; NEUROPATHOLOGY; NORWAY; TARGET	AimApolipoprotein E (apoE) influences repair and other processes in the brain, and the apoE4 variant is a risk factor for Alzheimer's disease and for prolonged recovery following traumatic brain injury. We previously reported that specific single nucleotide polymorphisms in the APOE or TOMM40 genes affecting the structure and production of apoE were associated with epilepsy, more impaired hand function and gastrostomy tube feeding in children with cerebral palsy (CP). This study explored how various combinations of the same polymorphisms may affect these clinical manifestations. MethodsSuccessful DNA analyses of APOE and TOMM40 were carried out on 227 children. The CP Register of Norway provided details of gross and fine motor function, epilepsy and gastrostomy tube feeding. Possible associations between these clinical manifestations and various combinations of the APOE epsilon 2, epsilon 3 or epsilon 4 alleles and of the rs59007384 polymorphism in the TOMM40 gene were explored. ResultsEpilepsy, impaired fine motor function and gastrostomy tube feeding were less common in children carrying the combination of rs59007384 GG and APOE epsilon 2 or epsilon 3 than in children with other combinations. ConclusionOur findings suggest that specific combinations of genes influence the structure and production of apoE differently and affect the clinical manifestations of CP.	[Lien, Espen; Skranes, Jon S.; Vik, Torstein] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, N-7491 Trondheim, Norway; [Lien, Espen] Univ Trondheim Hosp, Dept Pediat, St Olavs Hosp, Trondheim, Norway; [Andersen, Guro] Cerebral Palsy Register Norway, Vestfold Hosp Trust, Tonsberg, Norway; [Bao, Yongde] Univ Virginia, Sch Med, DNA Sci Core, Charlottesville, VA 22908 USA; [Gordish-Dressman, Heather] George Washington Univ, Sch Med & Hlth Sci, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20052 USA; [Blackman, James A.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Blackman, James A.] Cerebral Palsy Int Res Fdn, New York, NY USA		Lien, E (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, N-7491 Trondheim, Norway.	espen.lien@ntnu.no			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03HD058625, R03HD065926]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Center for Medical Rehabilitation Research [R03HD65826, R24HD050846]; University of Virginia Children's Hospital; University of Virginia Pratt Research Fund; Health Authority of Central Norway; Norwegian University of Science and Technology, NTNU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050846, R01HD065826] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD065926, R03HD058625] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (R03HD058625 and R03HD065926), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Center for Medical Rehabilitation Research (R03HD65826 and R24HD050846), University of Virginia Children's Hospital Grant-in-Aid, University of Virginia Pratt Research Fund, the Health Authority of Central Norway and the Norwegian University of Science and Technology, NTNU. The funders have not been involved in any part of the study.	Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Bekris LM, 2012, J HUM GENET, V57, P18, DOI 10.1038/jhg.2011.123; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Blackman JA, 2009, J PEDIATR REHAB MED, V2, P67, DOI 10.3233/PRM-2009-0063; Blackman JA, 2010, DEV MED CHILD NEUROL, V52, P600, DOI 10.1111/j.1469-8749.2009.03476.x; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Dahlseng MO, 2012, ACTA PAEDIATR, V101, P92, DOI 10.1111/j.1651-2227.2011.02412.x; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Kuroda MM, 2007, PEDIATRICS, V119, P306, DOI 10.1542/peds.2006-1083; Lien E, 2014, EUR J PAEDIATR NEURO, V18, P591, DOI 10.1016/j.ejpn.2014.04.003; Lien E, 2013, DEV MED CHILD NEUROL, V55, P372, DOI 10.1111/dmcn.12086; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; McMichael GL, 2008, HUM GENET, V124, P411, DOI 10.1007/s00439-008-0564-y; O'Callaghan ME, 2009, HUM GENET, V126, P149, DOI 10.1007/s00439-009-0638-5; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Stoknes M, 2012, EUR J PAEDIATR NEURO, V16, P56, DOI 10.1016/j.ejpn.2011.10.004; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002	21	7	8	3	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	JUL	2015	104	7					701	706		10.1111/apa.12983			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CK7ZK	WOS:000356456300019	25703783	Green Accepted			2022-02-06	
J	Lin, YP; Jiang, RC; Zhang, JN				Lin, Yun-peng; Jiang, Rong-cai; Zhang, Jian-ning			Stability of rat models of fluid percussion-induced traumatic brain injury: comparison of three different impact forces	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; fluid percussion; impact force; pressure curve; head fixed; impact peak; animal models; neural regeneration	WHITE-MATTER; CELL LOSS; POSITION	Fluid percussion-induced traumatic brain injury models have been widely used in experimental research for years. In an experiment, the stability of impaction is inevitably affected by factors such as the appearance of liquid spikes. Management of impact pressure is a crucial factor that determines the stability of these models, and direction of impact control is another basic element. To improve experimental stability, we calculated a pressure curve by generating repeated impacts using a fluid percussion device at different pendulum angles. A stereotactic frame was used to control the direction of impact. We produced stable and reproducible models, including mild, moderate, and severe traumatic brain injury, using the MODEL01-B device at pendulum angles of 6 degrees, 11 degrees and 13 degrees, with corresponding impact force values of 1.0 +/- 0.11 atm (101.32 +/- 11.16 kPa), 2.6 +/- 0.16 atm (263.44 +/- 16.21 kPa), and 3.6 +/- 0.16 atm (364.77 +/- 16.21 kPa), respectively. Behavioral tests, hematoxylin-eosin staining, and magnetic resonance imaging revealed that models for different degrees of injury were consistent with the clinical properties of mild, moderate, and severe craniocerebral injuries. Using this method, we established fluid percussion models for different degrees of injury and stabilized pathological features based on precise power and direction control.	[Lin, Yun-peng; Jiang, Rong-cai; Zhang, Jian-ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Lin, Yun-peng; Jiang, Rong-cai; Zhang, Jian-ning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Lin, Yun-peng; Jiang, Rong-cai; Zhang, Jian-ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Lin, Yun-peng; Jiang, Rong-cai; Zhang, Jian-ning] Variat & Regenerat Nervous Syst, Tianjin Key Lab Injuries, Tianjin, Peoples R China; [Lin, Yun-peng] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.	jianningzhang@hotmail.com			International Science and Technology Cooperation Projects of China [2011DFG33430]	This work was supported by a grant from the International Science and Technology Cooperation Projects of China, No. 2011DFG33430.	Allen TC, 1992, LAB METHODS HISTOTEC, P53; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Griesbach GS, 2013, J NEUROTRAUM, V30, P281, DOI 10.1089/neu.2012.2616; Hawkins BE, 2013, BRAIN RES, V1496, P28, DOI 10.1016/j.brainres.2012.12.027; LINDGREN S, 1967, J TRAUM, V7, P493, DOI 10.1097/00005373-196707000-00001; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; Lusardi TA, 2012, EXP NEUROL, V234, P161, DOI 10.1016/j.expneurol.2011.12.026; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2012, J NEUROSURG, V118, P381; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Schwartzkroin PA, 2010, EPILEPSY RES, V92, P74, DOI 10.1016/j.eplepsyres.2010.08.009; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Yamashita Shin, 2011, Kurume Medical Journal, V58, P47; Yan H, 2012, CURR EYE RES, V37, P941, DOI 10.3109/02713683.2012.691599	26	7	7	0	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUL	2015	10	7					1088	1094		10.4103/1673-5374.160100			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CN9OK	WOS:000358778500024	26330831	Green Published, gold			2022-02-06	
J	Mackenzie, A; Fountain, R; Alfred, D; Combs, D				Mackenzie, Amy; Fountain, Rebecca; Alfred, Danita; Combs, Dennis			Quality of Life and Adaptation for Traumatic Brain Injury Survivors: Assessment of the Disability Centrality Model	JOURNAL OF REHABILITATION			English	Article							PSYCHOSOCIAL ADAPTATION; COPING STRATEGIES; SOCIAL SUPPORT; NEEDS; SATISFACTION; INDIVIDUALS; ADULTS; PARTICIPATION; DEPRESSION; SERVICES	The purpose of this research was to assess the applicability of the Disability Centrality Model (DCM) to traumatic brain injury (TBI) survivors living in the community and to gain information about their important needs. The DCM is a model of adaptation for patients living with chronic disease and disability. Satisfaction, control, TBI related impact and domain importance across ten life domains affect adaptation in the context of quality of life (QOL). The method was a single-stage design, employing a prospective, cross-sectional survey of TBI survivors, beyond a year post injury, aged 18-65 years with histories of moderate to severe TBI. These survivors responded to an online survey for collection of data, mostly recruited from brain injury support groups across the United States. One hundred twenty-five eligible participants returned the surveys. The primary data collection instruments included the Disability Centrality Scale (DCS), the powerful needs scale, and measures of QOL and level of adjustment. Findings revealed that satisfaction and control mediated the effect of TBI on QOL and that importance moderated the effect of satisfaction on QOL. However, in this sample of TBI survivors, powerful needs did not significantly affect QOL. The findings showed DCM is an appropriate model for predicting QOL and adaptation in TBI survivors. The most important unmet needs identified by TBI survivors were increasing income, improving memory and problem solving, and fulfilling needs for intimacy	[Mackenzie, Amy; Fountain, Rebecca; Alfred, Danita; Combs, Dennis] Univ Texas Tyler, Tyler, TX 75799 USA		Mackenzie, A (corresponding author), Univ Texas Tyler, 3900 Univ Blvd, Tyler, TX 75799 USA.	Arny@SynergyLCC.com					Aloni R, 2007, SEX DISABIL, V25, P125, DOI 10.1007/s11195-007-9047-7; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Andrews F. M., 1976, SOCIAL INDICATORS WE; Andrews F. M., 1991, MEASURES PERSONALITY, P61; ANDREWS FM, 1974, SOC INDIC RES, V1, P1, DOI 10.1007/BF00286419; ANDREWS FM, 1976, SOC INDIC RES, V3, P1, DOI 10.1007/BF00286161; ANDREWS FM, 1980, SOC INDIC RES, V8, P127, DOI 10.1007/BF00286474; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Armed Forces Health Surveillance Center, 2011, DOD WORLDW NUMB TRAU; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P1, DOI 10.1201/9781439849828; ATHELSTAN GT, 1979, REHABIL COUNS BULL, V22, P311; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bennett JA, 2000, RES NURS HEALTH, V23, P415, DOI 10.1002/1098-240X(200010)23:5<415::AID-NUR8>3.0.CO;2-H; Bishop M, 2005, J REHABIL, V71, P5; Bishop M., 2009, UNDERSTANDING PSYCHO, P521; Bishop M, 2007, J REHABIL, V73, P3; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Centers for Disease Control, 2014, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention (CDC), 2009, TRAUMATIC BRAIN INJU; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Devins G M, 1994, Adv Ren Replace Ther, V1, P251; DEVINS GM, 1984, INT J PSYCHIAT MED, V13, P327, DOI 10.2190/5DCP-25BV-U1G9-9G7C; Donnelly JP, 2005, BRAIN INJURY, V19, P1077, DOI 10.1080/02699050500110728; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fields A., 2000, DISCOVERING STAT USI; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Hsieh CM, 2003, SOC INDIC RES, V61, P227, DOI 10.1023/A:1021354132664; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; MacDonald SE, 2009, PUBLIC HEALTH NURS, V26, P95, DOI 10.1111/j.1525-1446.2008.00758.x; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Strom TQ, 2007, BRAIN INJURY, V21, P1137, DOI 10.1080/02699050701687334; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; WHO, 2002, ENV HLTH EM DIS PRAC; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Xiong Y, 2010, DISCOV MED, V10, P434	59	7	7	0	5	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	JUL-SEP	2015	81	3					9	20					12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	CS9CN	WOS:000362386800002					2022-02-06	
J	Palombo, DJ; Kapson, HS; Lafleche, G; Vasterling, JJ; Marx, BP; Franz, M; Verfaellie, M				Palombo, Daniela J.; Kapson, Heather S.; Lafleche, Ginette; Vasterling, Jennifer J.; Marx, Brian P.; Franz, Molly; Verfaellie, Mieke			Alterations in Autobiographical Memory for a Blast Event in Operation Enduring Freedom and Operation Iraqi Freedom Veterans With Mild Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						mild traumatic brain injury; autobiographical memory; coherence	POSTTRAUMATIC-STRESS-DISORDER; OEF/OIF VETERANS; MENTAL-HEALTH; SELF-REPORT; NARRATIVES; COHERENCE; SYMPTOMS; OUTCOMES; AMNESIA; MODEL	Objective: Although loss of consciousness associated with moderate or severe traumatic brain injury (TBI) is thought to interfere with encoding of the TBI event, little is known about the effects of mild TBI (mTBI), which typically involves only transient disruption in consciousness. Method: Blast-exposed Afghanistan and Iraq War veterans were asked to recall the blast event. Participants were stratified based on whether the blast was associated with probable mTBI (n = 50) or not (n = 25). Narratives were scored for organizational structure (i.e., coherence) using the Narrative Coherence Coding Scheme (Reese et al., 2011) and episodic recollection using the Autobiographical Interview Coding Procedures (Levine et al., 2002). Results: The mTBI group produced narratives that were less coherent but contained more episodic details than those of the no-TBI group. Conclusion: These results suggest that mTBI interferes with the organizational quality of memory in a manner that is independent of episodic detail generation.	[Palombo, Daniela J.; Kapson, Heather S.; Lafleche, Ginette; Franz, Molly; Verfaellie, Mieke] Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA; [Palombo, Daniela J.; Lafleche, Ginette; Vasterling, Jennifer J.; Marx, Brian P.; Verfaellie, Mieke] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Kapson, Heather S.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Vasterling, Jennifer J.; Marx, Brian P.] Vet Affairs Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA		Palombo, DJ (corresponding author), Vet Affairs Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	palombo@bu.edu	Marx, Brian/AAK-5072-2020	Palombo, Daniela/0000-0001-8082-3522; Verfaellie, Mieke/0000-0001-5535-4584	United States Department of Veterans Affairs, Office of Rehabilitation Research & Development Grant [IO1RX000216]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Veterans AffairsUS Department of Veterans Affairs [I01RX000216] Funding Source: NIH RePORTER	This research was supported by United States Department of Veterans Affairs, Office of Rehabilitation Research & Development Grant IO1RX000216 awarded to Mieke Verfaellie. Daniela J. Palombo was supported by the Canadian Institutes of Health Research. The authors thank Meredith Charney, Keely Burke, Elizabeth Race, and Matthew Grilli.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Berntsen D, 2014, CLIN PSYCHOL SCI, V2, P174, DOI 10.1177/2167702613496241; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brewin CR, 2001, INT REV PSYCHIATR, V13, P159, DOI 10.1080/09540260120074019; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Dougal S, 2007, PSYCHON B REV, V14, P423, DOI 10.3758/BF03194083; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; First M., 1995, STRUCTURED CLIN INTE, V9, P92; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jelinek L, 2009, J ABNORM PSYCHOL, V118, P288, DOI 10.1037/a0015633; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; MARTEL Y, 2001, LIFE PI; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nadel Lynn, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/90472; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Race E, 2015, CORTEX, V63, P271, DOI 10.1016/j.cortex.2014.09.004; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Reese E, 2011, J COGN DEV, V12, P424, DOI 10.1080/15248372.2011.587854; Rubin DC, 2011, CONSCIOUS COGN, V20, P857, DOI 10.1016/j.concog.2010.03.018; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schmolck H, 2000, PSYCHOL SCI, V11, P39, DOI 10.1111/1467-9280.00212; Sharot T, 2007, P NATL ACAD SCI USA, V104, P389, DOI 10.1073/pnas.0609230103; Shiromani P, 2009, POSTTRAUMATIC STRESS, P105, DOI DOI 10.1007/978-1-60327-329-9_5; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x	43	7	7	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2015	29	4					543	549		10.1037/neu0000198			7	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CL5CA	WOS:000356976200005	25893970	Green Accepted			2022-02-06	
J	Pieper, P; Garvan, C				Pieper, Pam; Garvan, Cynthia			Concordance of Child and Parent Reports of Health-Related Quality of Life in Children With Mild Traumatic Brain or Non-Brain Injuries and in Uninjured Children: Longitudinal Evaluation	JOURNAL OF PEDIATRIC HEALTH CARE			English	Article						Agreement; concordance; health-related quality of life; longitudinal; mild traumatic brain injury; PedsQL	GENERIC CORE SCALES; MULTIDIMENSIONAL FATIGUE SCALE; PEDIATRIC CANCER; AGE SUBGROUPS; SELF-REPORT; RELIABILITY; VALIDITY; PROXY; PEDSQL(TM)-4.0; AGREEMENT	Introduction: This study aimed to determine (a) concordance between parents' and children's perceptions of health-related quality of life (HRQoL) for children who sustained a mild traumatic brain injury or a mild non-brain injury or who were uninjured at baseline and at 1, 3, 6, and 12 months postinjury; (b) test-retest reliability of the Pediatric Quality of Life Inventory Generic Core and Cognitive Functioning Scales in the uninjured group; and (c) which, if any, variables predicted parity in child/parent dyad responses. Methods: This longitudinal study included 103 child/parent dyads in three groups. Each child and parent completed Pediatric Quality of Life Inventory questionnaires within 24 hours of injury and at months 1, 3, 6, and 12 postinjury. Results: Child/parent HRQoL concordance was generally poor. The variables for age, gender, and study group were not found to be response-parity predictors. Discussion: Inclusion of child and parent perceptions provides a more comprehensive picture of the child's HRQoL, increasing provider awareness of related health care needs. J Pediatr Health Care. (2015) 29, 343-351.	[Pieper, Pam; Garvan, Cynthia] Univ Florida, Coll Nursing, Jacksonville, FL 32209 USA; [Pieper, Pam] Univ Florida, Coll Med, Jacksonville, FL USA		Pieper, P (corresponding author), Univ Florida, Coll Nursing, 653 W 8th St,L-4, Jacksonville, FL 32209 USA.	pam.pieper@jax.ufl.edu			American Pediatric Surgical Nurses Association; Florida Nurses Association	This research was supported by grants from the American Pediatric Surgical Nurses Association and the Florida Nurses Association.	Ardon MS, 2012, ARCH PHYS MED REHAB, V93, P641, DOI 10.1016/j.apmr.2011.11.023; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; Davis E, 2007, QUAL LIFE RES, V16, P863, DOI 10.1007/s11136-007-9187-3; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Eiser C, 2013, EUR J PEDIATR, V172, P1299, DOI 10.1007/s00431-013-2049-9; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabbe BJ, 2010, J TRAUMA, V69, P1578, DOI 10.1097/TA.0b013e3181f8fd5f; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Glaser AW, 1997, QUAL LIFE RES, V6, P43; Jokovic A, 2004, QUAL LIFE RES, V13, P1297, DOI 10.1023/B:QURE.0000037480.65972.eb; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Oladeji Oluwabunmi, 2007, Pediatr Phys Ther, V19, P296, DOI 10.1097/PEP.0b013e31815a12ef; Parsons SK, 2012, QUAL LIFE RES, V21, P915, DOI 10.1007/s11136-011-9986-4; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Rebok G, 2001, QUAL LIFE RES, V10, P59, DOI 10.1023/A:1016693417166; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Ungar WJ, 2006, SOC SCI MED, V63, P2354, DOI 10.1016/j.socscimed.2006.06.016; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Varni JW, 1998, J BEHAV MED, V21, P179, DOI 10.1023/A:1018779908502; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428	30	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5245	1532-656X		J PEDIATR HEALTH CAR	J. Pediatr. Health Care	JUL-AUG	2015	29	4					343	351		10.1016/j.pedhc.2015.01.008			9	Health Policy & Services; Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing; Pediatrics	CR7NJ	WOS:000361536900015	25747790				2022-02-06	
J	Willmott, C; Spitz, G; Ponsford, JL				Willmott, Catherine; Spitz, Gershon; Ponsford, Jennie L.			Predictors of productivity outcomes for secondary and tertiary students following traumatic brain injury	BRAIN INJURY			English	Article						Education; employment; outcomes; productivity; traumatic brain injury	POSTTRAUMATIC AMNESIA; RETURN; EMPLOYMENT; DURATION; WORK	Primary objective: This prospective longitudinal study aimed to identify rates and predictors of productivity outcomes (educational or vocational) at 1 year post-injury in young people studying prior to sustaining a traumatic brain injury (TBI). Methods and procedures: A total of n = 145 with complicated mild-severe injuries, studying at secondary (45.2%) or tertiary (54.8%) levels pre-injury, participated. Mean age at injury = 18.6 years (SD = 3.29) and mean duration of PTA = 21.9 days (SD = 27.18). Pre-injury demographic (gender, age, level of study, living situation), injury related (severity, physical injuries) and concurrent post-injury (independence in ADLs and self-reported cognitive, behavioural, emotional sequelae) predictors were entered into logistic regressions. Main outcomes: Of those participants categorized as 'productive' (79.3%), 60% were studying, with 40% employed. Participants with longer PTA and those with reduced initiative and self-centredness were less likely to be 'productive'. The overall relationship between PTA and productivity appeared to be linear in nature, with PTA duration of more than 80 days, reducing the probability of being productive at 1 year to 50%. Conclusions: PTA duration and behavioural sequelae were the strongest predictors of productivity in those studying prior to injury. Allied health supports should be targeted towards reducing the impact of and compensating for barriers such as reduced initiative in order to maximize productive outcomes in this group.	[Willmott, Catherine; Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3168, Australia; [Willmott, Catherine; Spitz, Gershon; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Willmott, C (corresponding author), Monash Univ, Faculty Med Nursing & Hlth Sci, Sch Psychol Sci, Monash Psychol Ctr, Bldg 1-270 Ferntree Gully Rd,Notting Hill, Melbourne, Vic 3168, Australia.	catherine.willmott@monash.edu	Willmott, Catherine/AAA-5105-2019; Spitz, Gershon/H-7755-2014	Willmott, Catherine/0000-0001-8517-9035; Spitz, Gershon/0000-0002-7810-1480	Victorian Government Transport Accident Commission (TAC), through Institute for Safety, Compensation and Recovery Research (ISCRR)	This project was funded by the Victorian Government Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR). The authors report no conflicts of interest.	*ABS, 2007, AUSTR SOC TRENDS; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; O'Rance L., 2007, DISABILITY AUSTR ACQ; Ponsford J., 2013, TRAUMATIC BRAIN INJU, P192; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Tate R, 2011, FINAL REPORT LIFETIM, P1; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014	25	7	7	0	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					929	936		10.3109/02699052.2015.1022882			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800019	25962924				2022-02-06	
J	Batty, R; Francis, A; Thomas, N; Hopwood, M; Ponsford, J; Johnston, L; Rossell, S				Batty, Rachel; Francis, Andrew; Thomas, Neil; Hopwood, Malcolm; Ponsford, Jennie; Johnston, Lisa; Rossell, Susan			Verbal fluency, clustering, and switching in patients with psychosis following traumatic brain injury (PFTBI)	PSYCHIATRY RESEARCH			English	Article						Phonemic fluency; Semantic fluency; Neuropsychology; Schizophrenia; Head-injury; Language	CATEGORY FLUENCY; SCHIZOPHRENIC-PATIENTS; SEMANTIC MEMORY; DISPROPORTIONATE IMPAIRMENT; BIPOLAR DISORDER; HEALTHY-ADULTS; HEAD-INJURY; PERFORMANCE; LANGUAGE; DELUSIONS	Verbal fluency in patients with psychosis following traumatic brain injury (PFTBI) has been reported as comparable to healthy participants. This finding is counterintuitive given the prominent fluency impairments demonstrated post-traumatic brain injury (TBI) and in psychotic disorders, e.g. schizophrenia. We investigated phonemic (executive) fluency (3 letters: 'F' 'A' and 'S'), and semantic fluency (1 category: fruits and/or vegetables) in four matched groups; PFTBI (N=10), TB! (N=10), schizophrenia (N=23), and healthy controls (N=23). Words produced (minus perseverations and errors), and clustering and switching scores were compared for the two fluency types across the groups. The results confirmed that PFTBI patients do show impaired fluency, aligned with existing evidence in TBI and schizophrenia. PFTBI patients produced the least amount of words on the phonemic fluency ('A') trial and total score, and demonstrated reduced switching on both phonemic and semantic tasks. No significant differences in clustering performance were found. Importantly, the pattern of results suggested that PFTBI patients share deficits with their brain-injured (primarily executive), and psychotic (executive and semantic), counterparts, and that these are exacerbated by their dual-diagnosis. These findings add to a very limited literature by providing novel evidence of the nature of fluency impairments in dually-diagnosed PFTBI. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Batty, Rachel; Thomas, Neil; Rossell, Susan] Swinburne Univ Technol, Fac Hlth Arts & Design, Brain & Psychol Sci Res Ctr BPsyC, Melbourne, Vic, Australia; [Batty, Rachel; Thomas, Neil; Rossell, Susan] MAPrc, Melbourne, Vic, Australia; [Batty, Rachel; Francis, Andrew] RMIT Univ, Bundoora, Vic, Australia; [Hopwood, Malcolm] Univ Melbourne, Dept Psychiat, Albert Rd Clin, Melbourne, Vic, Australia; [Ponsford, Jennie; Johnston, Lisa] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Rossell, Susan] St Vincents Hosp, Psychiat, Melbourne, Vic, Australia		Batty, R (corresponding author), Brain & Psychol Sci Res Ctr, Neuroimaging Facil, POB 218, Hawthorn, Vic 3122, Australia.	rachel.ann.batty@gmail.com	Thomas, Neil/H-6268-2016	Thomas, Neil/0000-0001-7006-6361; Batty, Rachel A/0000-0001-6413-5332; Rossell, Susan/0000-0002-7415-8252	Austin Hospital Research Foundation [2-1372]; Australian Postgraduate AwardAustralian Government	This research was supported by the Austin Hospital Research Foundation (M.H., Grant number 2-1372), and an Australian Postgraduate Award. There are no conflicts of interest to declare.	[Anonymous], 1999, WECHSLER ABBREVIATED; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; BAMRAH JS, 1991, BRIT J PSYCHIAT, V158, P117, DOI 10.1192/bjp.158.1.117; Batty RA, 2013, BRAIN IMPAIR, V14, P21, DOI 10.1017/BrImp.2013.10; Bokat CE, 2003, SCHIZOPHR RES, V64, P73, DOI 10.1016/S0920-9964(02)00282-7; Bowie CR, 2004, ARCH CLIN NEUROPSYCH, V19, P289, DOI 10.1016/S0887-6177(03)00041-6; Bozikas VP, 2005, SCHIZOPHR RES, V74, P51, DOI 10.1016/j.schres.2004.05.001; Chen RYL, 2000, AUST NZ J PSYCHIAT, V34, P43, DOI 10.1046/j.1440-1614.2000.00647.x; Covington MA, 2005, SCHIZOPHR RES, V77, P85, DOI 10.1016/j.schres.2005.01.016; DeLisi LE, 2001, SCHIZOPHRENIA BULL, V27, P481, DOI 10.1093/oxfordjournals.schbul.a006889; Elvevag B, 2002, PSYCHOL MED, V32, P909, DOI 10.1017/S0033291702005597; Elvevag B, 2001, SCHIZOPHR RES, V51, P119, DOI 10.1016/S0920-9964(00)00053-0; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; First M., 2002, BIOMETRICS RES; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Gogos A, 2010, AUST NZ J PSYCHIAT, V44, P220, DOI 10.3109/00048670903446882; Gouzoulis-Mayfrank E, 2003, SCHIZOPHR RES, V65, P65, DOI 10.1016/S0920-9964(03)00066-5; Green S. A., 2005, USING SPSS WINDOWS M; GROSSMAN M, 1981, BRAIN LANG, V12, P313, DOI 10.1016/0093-934X(81)90022-5; Harrison JE, 2000, BRIT J CLIN PSYCHOL, V39, P181, DOI 10.1348/014466500163202; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; IBM Corporation, 2011, IBM STAT SOFTW PACK, V19; Jurado MA, 1997, NEUROPSYCHOLOGIA, V35, P635, DOI 10.1016/S0028-3932(96)00112-1; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kosmidis MH, 2005, PSYCHIAT RES, V134, P233, DOI 10.1016/j.psychres.2005.02.003; Kremen WS, 2003, J INT NEUROPSYCH SOC, V9, P79, DOI 10.1017/S1355617703910095; Landro NI, 2008, PSYCHIAT CLIN NEUROS, V62, P653, DOI 10.1111/j.1440-1819.2008.01864.x; Langdon R, 2014, COGN NEUROPSYCHIATRY, V19, P241, DOI 10.1080/13546805.2013.854198; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Levy DL, 2010, J NEUROLINGUIST, V23, P176, DOI 10.1016/j.jneuroling.2009.08.003; MARTIN RC, 1990, NEUROPSYCHOLOGIA, V28, P823, DOI 10.1016/0028-3932(90)90006-A; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moore DJ, 2006, SCHIZOPHR RES, V87, P254, DOI 10.1016/j.schres.2006.06.005; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Mummery CJ, 2000, ANN NEUROL, V47, P36; Neill E, 2014, COGN NEUROPSYCHIATRY, V19, P81, DOI 10.1080/13546805.2013.807233; Nelson H.E., 1982, NATL ADULT READING T; O'Bryant SE, 2004, APPL NEUROPSYCHOL, V11, P210; Ojeda N, 2008, SCHIZOPHR RES, V101, P225, DOI 10.1016/j.schres.2007.12.483; Ojeda N, 2010, J NERV MENT DIS, V198, P286, DOI 10.1097/NMD.0b013e3181d61748; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Rossell SL, 2006, SCHIZOPHR RES, V82, P135, DOI 10.1016/j.schres.2005.10.013; Rossell SL, 2006, SCHIZOPHR RES, V82, P121, DOI 10.1016/j.schres.2005.11.001; Rossell SL, 1999, J CLIN EXP NEUROPSYC, V21, P629, DOI 10.1076/jcen.21.5.629.865; Rossell SL, 2010, EUR ARCH PSY CLIN N, V260, P571, DOI 10.1007/s00406-010-0101-6; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Sumiyoshi C, 2005, SCHIZOPHR RES, V74, P91, DOI 10.1016/j.schres.2004.05.011; Sumiyoshi C, 2001, PSYCHIAT RES, V105, P187, DOI 10.1016/S0165-1781(01)00345-6; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; van Beilen M, 2004, SCHIZOPHR RES, V69, P267, DOI 10.1016/j.schres.2003.09.007; Vinogradov S, 2003, SCHIZOPHR RES, V59, P269, DOI 10.1016/S0920-9964(02)00200-1; Vogel AP, 2009, J PSYCHOLINGUIST RES, V38, P459, DOI 10.1007/s10936-009-9100-z; Zakzanis K.K., 2011, J CLIN EXPT NEUROPSY, V5, P1; Zakzanis KK, 2000, NEUROPSY NEUROPSY BE, V13, P239; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	68	7	7	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	JUN 30	2015	227	2-3					152	159		10.1016/j.psychres.2015.03.040			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CK0GU	WOS:000355884500004	25910419				2022-02-06	
J	Brayer, SW; Ketcham, S; Zou, HC; Hurwitz, M; Henderson, C; Fuletra, J; Kumar, K; Skidmore, E; Thiels, E; Wagner, AK				Brayer, Samuel W.; Ketcham, Scott; Zou, Huichao; Hurwitz, Max; Henderson, Christopher; Fuletra, Jay; Kumar, Krishma; Skidmore, Elizabeth; Thiels, Edda; Wagner, Amy K.			Developing a Clinically Relevant Model of Cognitive Training After Experimental Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; cognitive training; implicit learning and memory; Morris water maze; controlled cortical impact	MORRIS WATER MAZE; EXPLICIT MEMORY; RATS; IMPLICIT; REHABILITATION; NAVIGATION; LESIONS; HIPPOCAMPUS; ACQUISITION; PERFORMANCE	Background. Following traumatic brain injury (TBI), clinical cognitive training paradigms harness implicit and explicit learning and memory systems to improve function; however, these systems are differentially affected by TBI, highlighting the need for an experimental TBI model that can test efficacy of cognitive training approaches. Objectives. To develop a clinically relevant experimental cognitive training model using the Morris water maze (MWM) wherein training on implicitly learned task components was provided to improve behavioral performance post-TBI. Methods. Eighty-one adult male rats were divided by injury status (controlled cortical impact [CCI]/Sham), non-spatial cognitive training (CogTrained/No-CogTrained), and extra-maze cues (Cued/Non-Cued) during MWM testing. Platform latencies, thigmotaxis, and search strategies were assessed during MWM trials. Results. Cognitive training was associated with improved platform latencies, reduced thigmotaxis, and more effective search strategy use for Sham and CCI rats. In the Cued and Non-Cued MWM paradigm, there were no differences between CCI/CogTrained and Sham/No-CogTrained groups. During novel testing conditions, CogTrained groups applied implicitly learned knowledge/skills; however, sham-cued CogTrained/rats better incorporated extramaze cues into their search strategy than the CCI-Cued group. Cognitive training had no effects on contusion size or hippocampal cell survival. Conclusions. The results provide evidence that CCI-CogTrained rats that learned the nonspatial components of the MWM task applied these skills during multiple conditions of the place-learning task, thereby mitigating cognitive deficits typically associated with this injury model. The results show that a systematic application of clinically relevant constructs associated with cognitive training paradigms can be used with experimental TBI to affect place learning.	[Brayer, Samuel W.; Ketcham, Scott; Hurwitz, Max; Henderson, Christopher; Fuletra, Jay; Kumar, Krishma] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Zou, Huichao; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Skidmore, Elizabeth] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA 15213 USA; [Thiels, Edda] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, Kaufmann Bldg,Suite 202,3471 Fifth Ave, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Ketcham, Scott/0000-0002-5231-4111	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD071728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD071728] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by National Institutes of Health Grant 1R21HD071728.	Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Devan BD, 1999, J NEUROSCI, V19, P2789; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Glinsky E. L., 1992, J HEAD TRAUMA REHAB, V7, P1; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Graziano A, 2003, J NEUROSCI METH, V130, P33, DOI 10.1016/S0165-0270(03)00187-0; Guillazo-Blanch G, 2002, NEUROBIOL LEARN MEM, V78, P406, DOI 10.1006/nlme.2002.4073; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Jay JR, 2007, J NEUROSCI METH, V163, P235, DOI 10.1016/j.jneumeth.2007.03.008; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Ramos JMJ, 2010, NEUROBIOL LEARN MEM, V93, P506, DOI 10.1016/j.nlm.2010.01.008; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stokes ME, 2000, CATEGORICAL DATA ANA; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2013, NEUROBIOL LEARN MEM, V106, P71, DOI 10.1016/j.nlm.2013.07.006; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Whishaw IQ, 1997, HIPPOCAMPUS, V7, P361, DOI 10.1002/(SICI)1098-1063(1997)7:4<361::AID-HIPO2>3.0.CO;2-M; WHISHAW IQ, 1995, J NEUROSCI, V15, P5779; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363	38	7	7	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2015	29	5					483	495		10.1177/1545968314550367			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CJ3WI	WOS:000355414600010	25239938	Green Accepted			2022-02-06	
J	Hassanzadeh, K; Nikzaban, M; Moloudi, MR; Izadpanah, E				Hassanzadeh, Kambiz; Nikzaban, Mehrnoush; Moloudi, Mohammad Raman; Izadpanah, Esmael			Effect of selegiline on neural stem cells differentiation: a possible role for neurotrophic factors	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Neurotrophic factors; NSCs; Selegiline	CULTURED MOUSE ASTROCYTES; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; FUNCTIONAL RECOVERY; GROWTH-FACTOR; BRAIN; RAT; EXPRESSION; TRANSPLANTATION	Objective(s): The stimulation of neural stem cells (NSCs) differentiation into neurons has attracted great attention in management of neurodegenerative disease and traumatic brain injury. It has been reported that selegiline could enhance the morphologic differentiation of embryonic stem cells. Therefore this study aimed to investigate the effects of selegiline on NSCs differentiation with focus on the role of neurotrophic factor gene expression. Materials and Methods: The NSCs were isolated from lateral ventricle of C57 mice brain. The cells were exposed to selegiline in nano to micromolar concentrations for 24 hr or 72 hr. In order to assay the effect of selegiline on NSCs differentiation into neurons, astrocytes and oligodendrocytes, immunocytochemical techniques were utilized. Samples were exposed to specific antibodies against neurons (13 tubulin), astrocytes (GFAP) and oligodendrocytes (OSP). The expression of BDNF, NGF and NT3 genes was investigated using Real-Time PCR. Results: Our findings revealed that selegiline increased NSCs differentiation into neurons at 10(-7) and 10(-8) M and decreased the differentiation into astrocytes at 10(-9), while oligodendrocyte did not significantly change in any of the used concentrations. In addition data analyses showed that selegiline increased BDNF, NGF and NT3 gene expression at 24 hr, but did not change them in the other time of exposure (72 hr) except 10(-7) M concentration of selegiline, which increased NT3 expression. Conclusion: Our results indicate selegiline induced the differentiation of NSCs into neurons and in this context the role of neurotrophic factors is important and should be considered.	[Hassanzadeh, Kambiz; Nikzaban, Mehrnoush; Moloudi, Mohammad Raman; Izadpanah, Esmael] Kurdistan Univ Med Sci, Cellular & Mol Res Ctr, Sanandaj, Iran; [Hassanzadeh, Kambiz; Moloudi, Mohammad Raman; Izadpanah, Esmael] Kurdistan Univ Med Sci, Dept Physiol & Pharmacol, Sanandaj, Iran		Izadpanah, E (corresponding author), Kurdistan Univ Med Sci, Dept Physiol & Pharmacol, Fac Med, Sanandaj, Iran.	eizadpanah2000@yahoo.com	Hassanzadeh, K/Q-1241-2016; Izadpanah, Esmael/Q-2559-2016; Moloudi, Mohammad Raman/C-3150-2016	Hassanzadeh, K/0000-0002-8737-312X; Moloudi, Mohammad Raman/0000-0003-2883-5213; Izadpanah, Esmael/0000-0001-8090-906X	Deputy of Research of Kurdistan University of Medical Sciences	The authors would like to thank Deputy of Research of Kurdistan University of Medical Sciences for financial supports.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Esmaeili F, 2006, REJUV RES, V9, P475, DOI 10.1089/rej.2006.9.475; Fathi F, 2007, J IRAN ANATOM SCI, V19, P81; Feng ZQ, 2009, NEUROSCI LETT, V462, P213, DOI 10.1016/j.neulet.2009.07.008; Franchi S, 2012, PAIN, V153, P850, DOI 10.1016/j.pain.2012.01.008; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gyarfas T, 2010, CELL MOL NEUROBIOL, V30, P361, DOI 10.1007/s10571-009-9458-3; Huang F, 2013, NEUROREPORT, V24, P101, DOI 10.1097/WNR.0b013e32835c93c5; Izadpanah E, 2010, YAKHTEH, V12, P411; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kitani K, 2002, MECH AGEING DEV, V123, P1087, DOI 10.1016/S0047-6374(01)00392-X; KNOLL J, 1983, ACTA NEUROL SCAND, V68, P57, DOI 10.1111/j.1600-0404.1983.tb01517.x; KOUTSILIERI E, 1994, EUR J PHARM-MOLEC PH, V269, pR3, DOI 10.1016/0922-4106(94)90048-5; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Liang P, 2006, CHINESE MED J-PEKING, V119, P1331, DOI 10.1097/00029330-200608020-00003; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038243; Lu CB, 2001, NEUROBIOL DIS, V8, P194, DOI 10.1006/nbdi.2000.0377; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Macias MY, 2006, EXP NEUROL, V201, P335, DOI 10.1016/j.expneurol.2006.04.035; Magyar K, 2004, NEUROTOXICOLOGY, V25, P233, DOI 10.1016/S0161-813X(03)00102-5; Mizuta I, 2001, NEUROSCI LETT, V310, P117, DOI 10.1016/S0304-3940(01)02098-5; Mizuta I, 2000, BIOCHEM BIOPH RES CO, V279, P751, DOI 10.1006/bbrc.2000.4037; Ohta K, 2010, J NEUROL SCI, V291, P12, DOI 10.1016/j.jns.2010.01.013; Parvizpour A, 2013, PHARMACOL REP, V65, P593, DOI 10.1016/S1734-1140(13)71036-3; Semkova I, 1996, EUR J PHARMACOL, V315, P19, DOI 10.1016/S0014-2999(96)00593-6; Shimazu S, 2003, LIFE SCI, V72, P2785, DOI 10.1016/S0024-3205(03)00191-7; Tamm C, 2006, J NEUROCHEM, V97, P69, DOI 10.1111/j.1471-4159.2006.03718.x; Tang YP, 1998, J NEUROSCI RES, V53, P593; Tatton WG, 1996, NEUROLOGY, V47, pS171, DOI 10.1212/WNL.47.6_Suppl_3.171S; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Yang ZY, 2013, J BIOMED MATER RES A, V101, P599, DOI 10.1002/jbm.a.34331; Yi X, 2011, NEUROENDOCRINOL LETT, V32, P705; Zhu JM, 2011, J INT MED RES, V39, P488, DOI 10.1177/147323001103900216; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	36	7	7	0	2	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JUN	2015	18	6					548	554					7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	CO2PH	WOS:000358998500004	26221478				2022-02-06	
J	Kara, H; Akinci, M; Degirmenci, S; Bayir, A; Ak, A				Kara, Hasan; Akinci, Murat; Degirmenci, Selim; Bayir, Aysegul; Ak, Ahmet			Traumatic pneumorrhachis: 2 cases and review of the literature	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							AIR	The presence of air in the spinal canal is known as pneumorrhachis (PNR), aerorachia, intraspinal pneumocele, pneumosaccus, pneumomyelogra, or intraspinal air. Pneumorrhachis may be iatrogenic, traumatic, and nontraumatic. We treated 2 patients who had posttraumatic PNR in the cervical spine region after stab injuries. Case 1 was a 31-year-old man who was stabbed in the C5 to C6 region. He had muscle weakness (3/5) and numbness on the right side of the body. Brain computed tomographic (CT) scan showed pneumocephalus, and cervical CT scan showed PNR at the C6 level. Treatment included observation, and symptoms and weakness improved within 7 days. Case 2 was a 40-year-old man who was stabbed in the C3 to C4 region. He hadmuscle weakness (1/5) and numbness on the left side of the body. Brain CT scan showed pneumocephalus, and cervical CT scan showed PNR at the C3 level. Cerebrospinal fluid drainage persisted, and he was treated with surgical repair of a dural laceration. Muscle strength improved. In summary, PNR is a rare condition that usually is treated nonoperatively. However, surgical treatment may be indicated for persistent neurologic symptoms or signs; the air detected in the spinal canal with radiographic imaging may be associated with an active cerebrospinal fluid leak and may cause spinal compression.	[Kara, Hasan; Akinci, Murat; Degirmenci, Selim; Bayir, Aysegul; Ak, Ahmet] Selcuk Univ, Fac Med, Dept Emergency Med, Konya, Turkey		Kara, H (corresponding author), Selcuk Univ, Fac Med, Dept Emergency Med, Konya, Turkey.	hasankara42@gmail.com					Bilsky MH, 2001, ANN THORAC SURG, V71, P455, DOI 10.1016/S0003-4975(00)02339-0; Cayli SR, 2003, BRIT J NEUROSURG, V17, P72, DOI 10.3109/02688690309177976; Chibbaro S, 2005, SURG NEUROL, V64, P80, DOI 10.1016/j.surneu.2004.09.047; Chun BJ, 2009, SPINE, V34, pE979, DOI 10.1097/BRS.0b013e3181b03ecb; Fujisawa H, 1998, ACTA NEUROCHIR, V140, P287, DOI 10.1007/s007010050097; Gelalis ID, 2011, SPINE J, V11, P153, DOI 10.1016/j.spinee.2010.12.010; Goh BKP, 2005, J TRAUMA, V58, P875, DOI 10.1097/01.TA.0000158249.77176.9A; Kim KR, 2014, POLYM-KOREA, V38, P38, DOI 10.7317/pk.2014.38.1.38; Krishnam, 2003, ANAESTHESIA, V58, P292, DOI 10.1046/j.1365-2044.2003.306721.x; NEWBOLD RG, 1987, AM J ROENTGENOL, V148, P615, DOI 10.2214/ajr.148.3.615; Oertel MF, 2006, EUR SPINE J OFF P S5, V15, P636, DOI [DOI 10.1007/S00586-006-0160-6, 10.1007/s00586-006-0160-6]	11	7	7	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2015	33	6							861.e1	10.1016/j.ajem.2014.12.040			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CL0AS	WOS:000356601400050	25595271				2022-02-06	
J	Mills, B; Rowhani-Rahbar, A; Simonetti, JA; Vavilala, MS				Mills, Brianna; Rowhani-Rahbar, Ali; Simonetti, Joseph A.; Vavilala, Monica S.			Facility Characteristics and Inhospital Pediatric Mortality after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hospital mortality; facility characteristics; National Trauma Data Bank; pediatrics; regional variation; TBI	CENTER DESIGNATION; LEVEL I; DATA-BANK; OUTCOMES; CHILDREN; TIME; GUIDELINES; MANAGEMENT; SURVIVAL; CENTERS	More than 500,000 children sustain a traumatic brain injury (TBI) each year. Previous studies have described significant variation in inhospital mortality after pediatric TBI. The aim of this study was to identify facility-level characteristics independently associated with 30-day inhospital mortality after pediatric severe TBI. We hypothesized that, even after accounting for patient-level characteristics associated with mortality, the characteristics of facilities where patients received care would be associated with inhospital mortality. Using data from the National Trauma Data Bank from 2009-2012, we identified a cohort of 6707 pediatric patients hospitalized with severe TBI in 391 facilities and investigated their risk of 30-day inhospital mortality. Pre-specified facility-level characteristics (trauma certification level, teaching status, census region, facility size, nonprofit status, and responsibility for pediatric trauma care) were added to a Poisson regression model that accounted for patient-level characteristics associated with mortality. In multivariable analyses, patients treated in facilities located in the Midwest (risk ratio [RR]=1.42; 95% confidence interval [CI] 1.12-1.81) and South (RR=1.39; 95% CI: 1.12-1.72) regions had higher likelihoods of 30-day inhospital mortality compared with patients treated in the Northeast. Other facility-level characteristics were not found to be significant. To our knowledge, this is one of the largest investigations to identify regional variation in inhospital mortality after pediatric severe TBI in a national sample after accounting for individual and other facility-level characteristics. Further investigations to help explain this variation are needed to inform evidence-based decision-making for pediatric severe TBI care across different settings.	[Mills, Brianna; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, 1959 NE Pacific St,Hlth Sci Bldg F-250,Box 35723, Seattle, WA 98195 USA; [Mills, Brianna; Rowhani-Rahbar, Ali; Simonetti, Joseph A.; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Simonetti, Joseph A.; Vavilala, Monica S.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Mills, B (corresponding author), Univ Washington, Dept Epidemiol, 1959 NE Pacific St,Hlth Sci Bldg F-250,Box 35723, Seattle, WA 98195 USA.	brmills@uw.edu		Mills, Brianna/0000-0002-6632-9592; Rowhani-Rahbar, Ali/0000-0002-2705-4485	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24 HD042828, T32 HD007543] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-03] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007543, R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER		ACS Committee on Trauma, INSP QUAL FAQ; Alkhoury F, 2011, AM SURGEON, V77, P277; American College of Surgeons Committee on Trauma, 2013, NAT TRAUM DAT BANK D; American College of Surgeons Committee on Trauma, 2013, NAT TRAUM DAT BANK 2; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bratton SL, 2005, J PEDIATR-US, V147, P355, DOI 10.1016/j.jpeds.2005.05.008; Centers for Diseases Control and Prevention, MULT CAUS DEATH 1999; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Faul M, 2010, TRAUMATIC BRAIN INJU; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; Glance LG, 2012, J AM COLL SURGEONS, V215, P372, DOI 10.1016/j.jamcollsurg.2012.03.018; Goldhagen J, 2005, PEDIATRICS, V116, pE746, DOI 10.1542/peds.2005-0366; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hartman M, 2008, PEDIATRICS, V122, pE172, DOI 10.1542/peds.2007-3399; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS3, DOI 10.1097/PCC.0b013e31823f437e; Koike S, 2011, RESUSCITATION, V82, P863, DOI 10.1016/j.resuscitation.2011.02.007; Mullins RJ, 2006, J TRAUMA, V60, P691, DOI 10.1097/01.ta.0000210454.92078.89; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; StataCorp, 2011, STAT STAT SOFTW REL; Swaroop Mamta, 2013, J Emerg Trauma Shock, V6, P16, DOI 10.4103/0974-2700.106320; United States Census Bureau, 2010, MAP US CENS BUR GEOG; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wilde ET, 2012, EMERG MED J, V29, P415, DOI 10.1136/emj.2010.109736	30	7	7	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					841	846		10.1089/neu.2014.3733			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700009	25654233	Green Published			2022-02-06	
J	Proctor, SP; Nieto, K; Heaton, KJ; Dillon, CC; Schlegel, RE; Russell, ML; Vincent, AS				Proctor, Susan P.; Nieto, Kenneth; Heaton, Kristin J.; Dillon, Caitlin C.; Schlegel, Robert E.; Russell, Michael L.; Vincent, Andrea S.			Neurocognitive Performance and Prior Injury Among US Department of Defense Military Personnel	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; COGNITIVE IMPAIRMENT; SCREENING TOOL; REACTION-TIME; CONCUSSION; AFGHANISTAN; MANAGEMENT; DEPLOYMENT; UTILITY	This study examined the neurocognitive performance of U.S. military personnel completing the Automated Neuropsychological Assessment Metrics (version 4) TBI Military (ANAM4 TBI-MIL) battery as part of the Department of Defense Neurocognitive Functional Assessment Program. Descriptive analyses utilizing the ANAM4TBI Military Performance Database were performed. We examined ANAM Composite Score (ACS) differences between five injury subgroups (no injury, brain injury with current symptoms, brain injury without current symptoms, nonbrain injury with current symptoms, and nonbrain injury without current symptoms) using general linear mixed modeling. Almost 11% (70,472/641,285) reported brain injury in the 4 years before assessment. The ACS differed significantly by injury group (p < 0.0001). In comparison to the no injury group, those reporting brain injury with current symptoms (d = -0.44) and nonbrain injury with current symptoms (d = -0.24) demonstrated significantly reduced ACS scores (p < 0.0001) indicative of reduced neurocognitive proficiency. In this population-based study of U.S. military personnel, neurocognitive performance was significantly associated with reported injury within the past 4 years among those experiencing current symptoms. Occupational programs focusing on prospective brain health of injured population groups are warranted.	[Proctor, Susan P.; Nieto, Kenneth; Heaton, Kristin J.; Dillon, Caitlin C.] US Army, Environm Med Res Inst, Mil Performance Div, Natick, MA 01760 USA; [Proctor, Susan P.; Heaton, Kristin J.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Schlegel, Robert E.; Russell, Michael L.] US Army, Off Surg Gen, Neurocognit Assessment Branch, Ft Sam Houston, TX 78234 USA; [Russell, Michael L.] Dept Vet Affairs Ctr Excellence Res Returning War, Waco, TX 76711 USA; [Vincent, Andrea S.] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA		Proctor, SP (corresponding author), US Army, Environm Med Res Inst, Mil Performance Div, Kansas St,Bldg 42, Natick, MA 01760 USA.				U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-1-0021]	We thank the staff at the U.S. Army Office of the Surgeon General, Neurocognitive Assessment Branch, as well as the DoD Defense Manpower Data Center for their support in this project. Funding for this project has been provided by the U.S. Army Medical Research and Materiel Command to the U.S. Army Research Institute of Environmental Medicine and through award #W81XWH-08-1-0021 (PI: SP Proctor) to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	Baker M, 2013, CROAT MED J, V54, P417, DOI 10.3325/cmj.2013.54.417; Bellinger DC, 2004, ENVIRON RES, V95, P394, DOI 10.1016/j.envres.2003.07.013; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Committee on Gulf War and Health, 2009, BRAIN INJ VET LONG T, V7; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Department of Defense, 2013, 649013 DEP DEF; Department of Defense, 2008, MEM BAS PRED NEUR FU; Games P. A., 1976, J EDUC STAT, V1, P113, DOI DOI 10.2307/1164979; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hannay HJ, 2004, NEUROPSYCHOLOGY ASSE, P113; Hutchison M, 2012, J CLIN SPORT PSYCHOL, V6, P336, DOI 10.1123/jcsp.6.4.336; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Markoff J., 2013, NY TIMES; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; NEEDLEMAN HL, 1982, NEW ENGL J MED, V306, P367; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Todd KH, 1996, ANN EMERG MED, V27, P439, DOI 10.1016/S0196-0644(96)70226-3; *US GOV ACC OFF, 2008, GAO08615; Vasterling JJ, 2011, J INT NEUROPSYCH SOC, V17, P1, DOI 10.1017/S1355617710001116; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427	39	7	7	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUN	2015	180	6					660	669		10.7205/MILMED-D-14-00298			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5WM	WOS:000355563400015	26032381				2022-02-06	
J	Nikolaev, YA; Dosen, PJ; Laver, DR; van Helden, DF; Hamill, OP				Nikolaev, Yury A.; Dosen, Peter J.; Laver, Derek R.; van Helden, Dirk F.; Hamill, Owen P.			Single mechanically-gated cation channel currents can trigger action potentials in neocortical and hippocampal pyramidal neurons	BRAIN RESEARCH			English	Article						Brain; Mechanically-gated; Cation channels; Triggered; Action potentials	MECHANOSENSITIVE ION CHANNELS; CENTRAL-NERVOUS-SYSTEM; PATCH-CLAMP RECORDINGS; ACTIVATED CHANNELS; CORTICAL-NEURONS; SKELETAL-MUSCLE; XENOPUS OOCYTES; BRAIN-SLICES; WHOLE-CELL; STEM-CELLS	The mammalian brain is a mechanosensitive organ that responds to different mechanical forces ranging from intrinsic forces implicated in brain morphogenesis to extrinsic forces that can cause concussion and traumatic brain injury. However, little is known of the mechanosensors that transduce these forces. In this study we use cell-attached patch recording to measure single mechanically-gated (MG) channel currents and their affects on spike activity in identified neurons in neonatal mouse brain slices. We demonstrate that both neocortical and hippocampal pyramidal neurons express stretch-activated MG cation channels that are activated by suctions of similar to 25 mm Hg, have a single channel conductance for inward current of 50-70 PS and show weak selectivity for alkali metal cations (i.e., Na+<K+<Cs+). Significantly, single MG channel currents activated on the soma trigger spiking/action potentials in both neocortical and hippocampal pyramidal neurons. Not all neuron types studied here expressed MG channel currents. In particular, locus coeruleus and cerebellar Purkinje neurons showed no detectable MG channel activity. Moreover their robust rhythmic spike activity was resistant to mechanical modulation. Our observation that a single MG channel current can trigger spiking predicates the need for reassessment of the long held view that the impulse output of central neurons depends only upon their intrinsic voltage-gated channels and/or their integrated synaptic input. (C) 2015 Elsevier B.V. All rights reserved.	[Nikolaev, Yury A.; Dosen, Peter J.; Laver, Derek R.; van Helden, Dirk F.; Hamill, Owen P.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2308, Australia; [Nikolaev, Yury A.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Hamill, Owen P.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA		Hamill, OP (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	ohamill@utmb.edu			University of Newcastle	We thank Dr. Boris Martinac for reading an early version of the manuscript and his critical comments. We also thank Dr. Alan Brichta for generously providing us with the IR camera. The specific project was supported by a visiting fellowship to O.H. from the University of Newcastle.	Alcami P, 2012, J NEUROSCI, V32, P3118, DOI 10.1523/JNEUROSCI.5371-11.2012; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Bayly PV, 2014, J MECH BEHAV BIOMED, V29, P568, DOI 10.1016/j.jmbbm.2013.02.018; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; de Oliveira RB, 2010, NEUROSCIENCE, V170, P166, DOI 10.1016/j.neuroscience.2010.06.028; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FR, 1976, J PHYSIOL-LONDON, V259, P665, DOI 10.1113/jphysiol.1976.sp011488; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Glatz M., 2004, CLIN NEUOPHYSIOL, V115, P4; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Hamill O. P., 2014, PATCH CLAMP TECHNIQU, P1; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardie RC, 2012, SCIENCE, V338, P260, DOI 10.1126/science.1222376; Jang Hyun-Jun, 2013, Advances in Biological Regulation, V53, P51, DOI 10.1016/j.jbior.2012.09.008; JOHANSSON S, 1994, P NATL ACAD SCI USA, V91, P1761, DOI 10.1073/pnas.91.5.1761; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Kim KX, 2013, J GEN PHYSIOL, V142, P493, DOI 10.1085/jgp.201311068; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lee JC, 2014, J MOL HISTOL, V45, P497, DOI 10.1007/s10735-014-9578-z; Llinas RR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00320; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; LYNCH JW, 1989, BIOPHYS J, V55, P755, DOI 10.1016/S0006-3495(89)82874-7; Ma X, 2011, BBA-BIOMEMBRANES, V1808, P2789, DOI 10.1016/j.bbamem.2011.07.049; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Maroto R, 2012, CHANNELS, V6, P290, DOI 10.4161/chan.21063; Martinac B, 2002, P NATL ACAD SCI USA, V99, P4308, DOI 10.1073/pnas.072632899; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Prager-Khoutorsky M, 2014, NEURON, V83, P866, DOI 10.1016/j.neuron.2014.07.023; Rodriguez-Molina VM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000319; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; Sherrington CS, 1906, INTEGRATIVE ACTION N; Silberberg SD, 1997, J PHYSIOL-LONDON, V505, P551, DOI 10.1111/j.1469-7793.1997.551ba.x; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Soria B, 2013, J MEMBRANE BIOL, V246, P215, DOI 10.1007/s00232-012-9523-6; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; TAGLIETTI V, 1988, J PHYSIOL-LONDON, V407, P311, DOI 10.1113/jphysiol.1988.sp017417; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vasquez I, 2012, J PHYSIOL-LONDON, V590, P6167, DOI 10.1113/jphysiol.2012.240044; Wester JC, 2013, J COMPUT NEUROSCI, V35, P1, DOI 10.1007/s10827-012-0436-2; Wu G, 1998, PFLUG ARCH EUR J PHY, V435, P572, DOI 10.1007/s004240050554; Xu G., 2010, J BIOMECH ENG, V132	63	7	8	1	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 22	2015	1608						1	13		10.1016/j.brainres.2015.02.051			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG8YH	WOS:000353601100001	25765154				2022-02-06	
J	Hamill, V; Barry, SJE; McConnachie, A; McMillan, TM; Teasdale, GM				Hamill, Victoria; Barry, Sarah J. E.; McConnachie, Alex; McMillan, Thomas M.; Teasdale, Graham M.			Mortality from Head Injury over Four Decades in Scotland	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; time; Scotland; mortality; epidemiology; road traffic accidents	TRAUMATIC BRAIN-INJURY; FALL-INDUCED INJURIES; OLDER-ADULTS; EPIDEMIOLOGY; PREVENTION; TRENDS; IMPACT	Although the causes of head injury, the population at risk, and approaches to prevention and treatment are continually evolving, there is little information about how these are reflected in patterns of mortality over time. We used population-based comprehensive data uniquely available in Scotland to investigate changes in the total numbers of deaths from 1974 to 2012, as well as the rates of head injury death, from different causes, overall and in relation to age and gender. Total mortality fell from an annual average of 503 to 339 with a corresponding annual decrease in rate from 9.6 to 6.4 per 100,000 population, the decline substantially occurring between 1974 and 1990. Deaths in children fell strikingly, but rose in older people. Deaths in males fell to a greater extent than females, but remained at a higher rate overall. Initially, a transport accident accounted for most deaths, but these fell by 80%, from 325 per year to 65 per year over the 39-year period. Deaths from falling and all other causes did not decline, coming to outnumber transport accident deaths by 1998, which accounts for the overall absence of change in total mortality in recent years. In order to reduce mortality in the future, more-effective measures to prevent falls are needed and these strategies will vary in younger adults (where alcohol is often a factor), as well as in older adults where infirmity can be a cause. In addition, measures to sustain reductions in transport accidents need to be maintained and further developed.	[Hamill, Victoria; Barry, Sarah J. E.; McConnachie, Alex] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow G12 0XH, Lanark, Scotland; [McMillan, Thomas M.; Teasdale, Graham M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland		Teasdale, GM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	Graham.Teasdale@glasgow.ac.uk		Hamill, Victoria/0000-0001-8800-5102; Barry, Sarah J.E./0000-0003-3039-8729	Cooke bequest; Chief Scientist Office [CZH/4/674] Funding Source: researchfish	The authors are extremely grateful to Frank Dixon from the NRS for providing the numbers of head injury deaths defined and segmented in various ways, as well as for advising on how the data had been coded. We are grateful for financial support from the Cooke bequest to the University of Glasgow.	Adekoya N., 2002, SURVEILLANCE TRAUMAT; [Anonymous], 2011, NAT STAT PUBL SCOTL; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Division of Medical Sciences Committee on Trauma and Committee on Shock, 1966, ACC DEATH DIS NEGL D; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; Faul M, 2010, TRAUMATIC BRAIN INJU; Harrell Jr FE, 2014, HMISC HARRELL MISCEL; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; R Core Team, 2012, R LANG ENV STAT COMP; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/	18	7	7	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					689	703		10.1089/neu.2014.3670			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200004	25335097	Green Accepted			2022-02-06	
J	Haselwood, BA; La Belle, JT				Haselwood, Brittney A.; La Belle, Jeffrey T.			Development of electrochemical methods to enzymatically detect traumatic brain injury biomarkers	BIOSENSORS & BIOELECTRONICS			English	Article						Norepinephrine; Traumatic brain injury; Impedance; Point-of-care technology; Electrochemistry; Enzyme	ASCORBIC-ACID; CATECHOLAMINES; CHROMATOGRAPHY; MANAGEMENT; PLASMA	As awareness of traumatic brain injury (TBI) increases, the need to detect mild forms and distinguish between the different severities of TBI becomes more apparent. The goal of this work is to develop a point-of-care sensor to detect whole blood biomarkers for rapid and sensitive diagnosis of TBI severity. Presented herein is the enzymatic detection of norepinephrine through the use of immobilization chemistry and impedance techniques. Sustained elevation of norepinephrine concentrations in the blood has been correlated to negative long-term outcomes in TBI cases, often resulting in permanent cognitive or physical deficits. Novel analysis techniques have been used to identify an optimal binding frequency (371.1 Hz) of norepinephrine to the immobilized enzyme on a gold disk electrode. This form of analysis yielded a logarithmic fit characterized by exceptional responsivity (20.89 Omega/pgmL(-1)), reproducibility (R-2=0.96), and lower limit of detection (98 pg/mL) first in purified samples, then in rabbit whole blood solutions. Once the optimal binding frequency was determined, the preliminary use of an impedance-time technique was attempted in this work. This technique more closely resembles the amperometric detection method used in commercial self-monitoring blood glucose meters, allowing for continuous or instantaneous measurement of blood borne biomarkers without compromising sensitivity. Future directions include exploration of simultaneous multi-marker detection with the impedance-time technique and experimentation with novel mesoporous materials to filter large blood components. Published by Elsevier B.V.	[Haselwood, Brittney A.; La Belle, Jeffrey T.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [La Belle, Jeffrey T.] Mayo Clin Arizona, Sch Med, Scottsdale, AZ 85259 USA		La Belle, JT (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, 501 E Tyler Mall, Tempe, AZ 85287 USA.	JEFFREY.LABELLE@asu.edu			School of Biological and Heath Systems Engineering at Arizona State University	This work was supported by the School of Biological and Heath Systems Engineering at Arizona State University.	Adamson TL, 2012, ANALYST, V137, P4179, DOI 10.1039/c2an35645g; Atta NF, 2010, ANAL BIOCHEM, V400, P78, DOI 10.1016/j.ab.2010.01.001; CDC/NCHS National Hospital Discharge Survey, 2010, NAT HOSP DISCH SURV; Chamoun RB, 2009, EUROPEAN CRITICAL CA, P47; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Daniel J, 2010, IEEE SENSOR, P2259, DOI 10.1109/ICSENS.2010.5690713; Fairchild A. B., 2009, CME ICME INT C, P1; Ghindilis AL, 2009, ELECTROANAL, V21, P1459, DOI 10.1002/elan.200904549; Gonzalez S.I., 2012, BIOSENS J, V1, P1, DOI [10.4303/bj/235493, DOI 10.4303/BJ/235493]; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Kim YR, 2010, BIOSENS BIOELECTRON, V25, P2366, DOI 10.1016/j.bios.2010.02.031; Kumar A, 2011, J CHROMATOGR A, V1218, P3854, DOI 10.1016/j.chroma.2011.04.034; La Belle JT, 2007, BIOSENS BIOELECTRON, V23, P428, DOI 10.1016/j.bios.2007.07.013; La Belle JT, 2013, METHODS, V61, P39, DOI 10.1016/j.ymeth.2013.04.015; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; Mayo Clinic Laboratories, TEST UD CATPO CATECH; National Center for Injury Prevention and Control, 2003, DROP; Prasad BB, 2009, BIOCHEM ENG J, V44, P232, DOI 10.1016/j.bej.2008.12.013; Raggi MA, 1999, J CHROMATOGR B, V730, P201, DOI 10.1016/S0378-4347(99)00213-3; Salim A, 2009, AM SURGEON, V75, P25; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tsunoda M, 2009, ANAL BIOANAL CHEM, V394, P947, DOI 10.1007/s00216-009-2685-0; Upadhyay P, 2000, J IMMUNOL METHODS, V244, P133, DOI 10.1016/S0022-1759(00)00262-3	25	7	10	0	46	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	MAY 15	2015	67				SI		752	756		10.1016/j.bios.2014.09.032			5	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	CC1BT	WOS:000350076900109	25248324	Green Submitted			2022-02-06	
J	Chen, MM; Zhao, GW; He, P; Jiang, ZL; Xi, X; Xu, SH; Ma, DM; Wang, Y; Li, YC; Wang, GH				Chen, Miao-Miao; Zhao, Guang-Wei; He, Peng; Jiang, Zheng-Lin; Xi, Xin; Xu, Shi-Hui; Ma, Dong-Ming; Wang, Yong; Li, Yong-Cai; Wang, Guo-Hua			Improvement in the neural stem cell proliferation in rats treated with modified "Shengyu" decoction may contribute to the neurorestoration	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Rat; Traumatic brain injury; Neurorestoration; "Shengyu" decoction; Medicinal herbs; Traditional medicine	TRAUMATIC BRAIN-INJURY; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; HIPPOCAMPAL NEUROGENESIS; PROMOTES PROLIFERATION; ADULT NEUROGENESIS; GINSENOSIDE RG1; MICE; EXPRESSION; ISCHEMIA	Ethnopharmacological relevance: "Shengyu" decoction, a traditional Chinese medicine, has been used to treat diseases with deficit in "qi" and "blood". The modified "Shengyu" decoction (MSD) used in the present study was designed to treat traumatic brain injury (TB!) on the basis of the "Shengyu" decoction, in which additional four herbs were added. Many ingredients in these herbs have been demonstrated to be effective for the treatment of brain injury. The present study was performed to evaluate the neurorestorative effect and the underlying mechanisms of MSD on the rat brain after a TBI. Materials and methods: TBI was induced in the right cerebral cortex of adult rats using Feeney's weight-drop method. Intragastrical administration of MSD (1.0 ml/200 g) was begun 6 h after TBI. The neurological functions and neuronal loss in the cortex and hippocampus were determined. The levels of nerve growth-related factors GDNF, NGF, NCAM, TN-C, and Nogo-A and the number of GFAP(+)/GDNF(+), BrdU(+)/nestin(+), BrdU(+)/NeuN(+) immunoreactive cells in the brain ipsilateral to TBI were also measured. Moreover, the influences of MSD on these variables were observed at the same time. Results: We found that treatment with MSD in TBI rats ameliorated the neurological functions and alleviated neuronal loss. MSD treatment elevated the expression of GDNF, NGF, NCAM, and TN-C, and inhibited the expression of Nogo-A. Moreover, MSD treatment increased the number of GFAP(+)/GDNF(+), BrdU(+)/nestin(+), and BrdU(+)/NeuN(+) immunoreactive cells in the cortex and hippocampus. Conclusion: The present results suggest that MSD treatment in TBI rats could improve the proliferation of neural stem/progenitor cells and differentiation into neurons, which may facilitate neural regeneration and tissue repair and thus contribute to the recovery of neurological functions. These effects of modified "Shengyu" decoction may provide a foundation for the use of MSD as a prescription of medicinal herbs in the traditional medicine to treat brain injuries in order to improve the neurorestoration. (C) 2015 Elsevier Ireland Ltd..All rights reserved.	[Chen, Miao-Miao; Zhao, Guang-Wei; Jiang, Zheng-Lin; Wang, Guo-Hua] Nantong Univ, Dept Neurophysiol & Neuropharmacol, Inst Naut Med, Nantong 226019, Jiangsu, Peoples R China; [Chen, Miao-Miao; Zhao, Guang-Wei; Jiang, Zheng-Lin; Wang, Guo-Hua] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226019, Jiangsu, Peoples R China; [He, Peng; Xu, Shi-Hui; Ma, Dong-Ming; Li, Yong-Cai] Peoples Hosp Ningxia, Dept Neurosurg, Ningxia 750021, Peoples R China; [Xi, Xin; Wang, Yong] Peoples Hosp Nantong, Dept Neurosurg & Chinese Med, Nantong 226001, Jiangsu, Peoples R China; [Zhao, Guang-Wei] Peoples Hosp Gaocheng, Dept Neurol, Shijiazhuang 052160, Hebei, Peoples R China		Jiang, ZL (corresponding author), Nantong Univ, Dept Neurophysiol & Neuropharmacol, Inst Naut Med, 9 Seyuan Rd, Nantong 226019, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn; yclee7833@hotmail.com			Natural Science Foundation of Ningxia [NZ10178]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071614, 81372131]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundation of Ningxia (Grant NZ10178), and the authors were also supported partly by grants from the National Natural Science Foundation of China (81071614 and 81372131) and by project funding from the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Abaskharoun M, 2010, ASN NEURO, V2, DOI 10.1042/AN20100001; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Boutin C, 2009, EUR J NEUROSCI, V30, P1209, DOI 10.1111/j.1460-9568.2009.06928.x; Chang H. M., 2001, PHARM APPL CHINESE M; Chiu SC, 2009, J MOL MED, V87, P1179, DOI 10.1007/s00109-009-0528-2; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dong HY, 2014, MOLECULES, V19, P5634, DOI 10.3390/molecules19055634; Duan SR, 2010, NEUROL RES, V32, P835, DOI 10.1179/016164109X12581096870159; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Guo GQ, 2010, SCI CHINA LIFE SCI, V53, P653, DOI 10.1007/s11427-010-3106-5; Hannila SS, 1999, J NEUROBIOL, V39, P51, DOI 10.1002/(SICI)1097-4695(199904)39:1<51::AID-NEU5>3.3.CO;2-K; Hu BY, 2014, J ETHNOPHARMACOL, V155, P1243, DOI 10.1016/j.jep.2014.07.009; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Ji Y.B., 2005, PHARM APPL COMPOUND; Leker RR, 2009, EXPERT OPIN BIOL TH, V9, P1117, DOI 10.1517/14712590903130558; Liang W, 2010, BRAIN RES, V1357, P19, DOI 10.1016/j.brainres.2010.07.091; Liu G.S., 2004, SECRET BOOK ORCHID C, V3; Liu JW, 2007, J NAT PROD, V70, P1329, DOI 10.1021/np070135j; Meiners S, 1999, J NEUROSCI, V19, P8443; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rigato F, 2002, J NEUROSCI, V22, P6596; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shen LH, 2004, NEUROL RES, V26, P422, DOI 10.1179/016164104225016047; Shen LH, 2007, NEUROL RES, V29, P270, DOI 10.1179/016164107X159144; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Tian YM, 2010, NEUROSCI LETT, V474, P26, DOI 10.1016/j.neulet.2010.02.066; Tohda C, 2006, BRIT J PHARMACOL, V149, P532, DOI 10.1038/sj.bjp.0706865; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011; Wang ZJ, 2006, CHEM-BIOL INTERACT, V159, P58, DOI 10.1016/j.cbi.2005.09.003; Wu Q., 1957, CORRECTION DRUGS PRE, V3; Xiao XL, 2010, NEUROL RES, V32, P547, DOI 10.1179/174313209X414533; Xin JW, 2013, CURR NEUROVASC RES, V10, P304, DOI 10.2174/15672026113109990023; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP; Zhang XH, 2013, NEURAL REGEN RES, V8, P2256, DOI 10.3969/j.issn.1673-5374.2013.24.005; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Zheng GQ, 2011, J ETHNOPHARMACOL, V133, P724, DOI 10.1016/j.jep.2010.01.064	50	7	10	2	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	MAY 13	2015	165						9	19		10.1016/j.jep.2015.02.037			11	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	CG8YX	WOS:000353602700002	25704929				2022-02-06	
J	Challenor, M; Doig, RO; Fuller, P; Giacci, M; Bartlett, C; Wale, CH; Cozens, GS; Hool, L; Dunlop, S; Iyer, KS; Rodger, J; Fitzgerald, M				Challenor, Michael; Doig, Ryan O'Hare; Fuller, Paula; Giacci, Marcus; Bartlett, Carole; Wale, Celeste H.; Cozens, Greg S.; Hool, Livia; Dunlop, Sarah; Iyer, K. Swaminathan; Rodger, Jennifer; Fitzgerald, Melinda			Prolonged glutamate excitotoxicity increases GluR1 immunoreactivity but decreases mRNA of GluR1 and associated regulatory proteins in dissociated rat retinae in vitro	BIOCHIMIE			English	Article						Glutamate excitotoxicity; AMPA receptor; Calcium; Cornichon; Retina	PERMEABLE AMPA RECEPTORS; DELAYED CALCIUM DEREGULATION; AKAP79 SIGNALING COMPLEX; TRAUMATIC BRAIN-INJURY; LIGAND-BINDING CORE; GANGLION-CELLS; SYNAPTIC PLASTICITY; GENE-EXPRESSION; NMDA RECEPTOR; SPINAL-CORD	Glutamate excitotoxicity contributes to damage following injury to the central nervous system via mechanisms including changes in the expression of receptors, calcium overload, oxidative stress and cell death. Excitotoxicity is triggered by glutamate binding to receptors, including calcium permeable AMPA receptors, which can be upregulated under injury conditions. However, the transcriptional response of AMPA receptor regulatory proteins to excitotoxic conditions is unknown. Here, we use real-time quantitative PCR (RT-qPCR), to determine the effect of prolonged glutamate excitotoxicity on the expression of mRNA encoding for GluR1 and AMPA receptor regulatory proteins in dissociated rat retinal cultures that include neuronal (retinal ganglion cell (RGCs)) and glial (Muller) cell populations. mRNA levels of GluR1 and regulators of the GluR1 subunit of AMPA receptors, including Sap97, Cnih2 and Cnih3, decreased following 6, 24 and 48 h incubation with 5 mM glutamate: related regulators not associated with GluR1 were unaffected. In contrast, GluR1 protein, assessed immunohistochemically, was increased in both RGCs and Muller cells after 24 h glutamate exposure: western blotting analysis was inconclusive. Reductions in mRNA of GluR1 and associated regulators occurred prior to cell death, which was first detected at 24 h, and substantial by 48 h. Exposure to glutamate acutely increased the intracellular calcium concentration in the cultures and by 24 h, reactive oxygen species were increased. Our data suggest a negative feedback mechanism in retinal cells, that down-regulates transcription of genes encoding GluR1 regulatory proteins in response to glutamate exposure. Despite this mechanism, GluR1 protein levels remain increased, and are associated with increased reactive species and cell death. Therapeutic strategies targeting calcium permeable AMPA receptors should take into account that increases in GluR1 protein are not necessarily associated with increases in associated mRNA levels over time. (C) 2015 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.	[Challenor, Michael; Doig, Ryan O'Hare; Fuller, Paula; Giacci, Marcus; Bartlett, Carole; Dunlop, Sarah; Rodger, Jennifer; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Nedlands, WA 6009, Australia; [Challenor, Michael; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, Nedlands, WA 6009, Australia; [Doig, Ryan O'Hare; Wale, Celeste H.; Cozens, Greg S.; Hool, Livia] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Hool, Livia] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Nedlands, WA 6009, Australia.	Lindy.fitzgerald@uwa.edu.au	Hool, Livia C/H-5059-2014; Rodger, Jennifer/H-5735-2014; Doig, Ryan O'Hare/AAG-7585-2019; Fitzgerald, Melinda/C-4235-2011	Hool, Livia C/0000-0001-7758-5252; Rodger, Jennifer/0000-0003-3413-4229; Fitzgerald, Melinda/0000-0002-4823-8179; Giacci, Marcus/0000-0002-8330-678X; Dunlop, Sarah/0000-0002-1306-3962	University, State and Commonwealth Governments; Graduate Research School of The University of Western Australia; Australian Research CouncilAustralian Research Council; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1061791]	The authors acknowledge the facilities and the scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments. In particular, the acquisition of confocal slice images was performed with the professional assistance of Mr. John Murphy. The authors would also like to acknowledge Prof. Roberto Cappai (bio21 institute of the University of Melbourne) for helpful discussions. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. Michael Challenor acknowledges the Graduate Research School of The University of Western Australia for funding in the form of an Australian Postgraduate Award Scholarship. The authors acknowledge funding from the Australian Research Council and the National Health and Medical Research Council (APP1061791).	Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002; Alsbo CW, 2001, BRAIN RES, V894, P101, DOI 10.1016/S0006-8993(01)01985-0; Araujo IM, 2010, NEUROCHEM RES, V35, P1966, DOI 10.1007/s11064-010-0323-z; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barnstable C J, 1993, Curr Opin Neurobiol, V3, P520, DOI 10.1016/0959-4388(93)90050-9; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; Brockie PJ, 2013, NEURON, V80, P129, DOI 10.1016/j.neuron.2013.07.028; Chang PKY, 2012, EUR J NEUROSCI, V35, P1908, DOI 10.1111/j.1460-9568.2012.08165.x; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Coombs ID, 2009, NEUROSCIENCE, V162, P656, DOI 10.1016/j.neuroscience.2009.01.004; Coombs ID, 2012, J NEUROSCI, V32, P9796, DOI 10.1523/JNEUROSCI.0345-12.2012; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; D'Onofrio PM, 2013, ACTA PHARMACOL SIN, V34, P91, DOI 10.1038/aps.2012.165; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Fleming JJ, 2010, NAT CHEM BIOL, V6, P89, DOI [10.1038/NCHEMBIO.298, 10.1038/nchembio.298]; FRANK L, 1995, ACTA NEUROL SCAND, V92, P337; Friedman LK, 2010, INT J DEV NEUROSCI, V28, P195, DOI 10.1016/j.ijdevneu.2009.11.002; Furukawa T, 2003, J NEUROTRAUM, V20, P269, DOI 10.1089/089771503321532851; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Gill R, 2002, J PHARMACOL EXP THER, V302, P940, DOI 10.1124/jpet.102.034322; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Grunder T, 2000, INVEST OPHTH VIS SCI, V41, P3600; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hack I, 2001, EUR J NEUROSCI, V13, P15, DOI 10.1046/j.1460-9568.2001.01357.x; Harmel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030681; Hartwick ATE, 2008, J PHYSIOL-LONDON, V586, P3425, DOI 10.1113/jphysiol.2008.154609; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jackson AC, 2009, NATURE, V458, P585, DOI 10.1038/458585a; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Johnson CM, 1997, J NEUROSCI, V17, P6189; Jones RS, 2014, J NEUROSCI, V34, P656, DOI 10.1523/JNEUROSCI.1140-13.2014; Jones RS, 2012, NEURON, V75, P467, DOI 10.1016/j.neuron.2012.05.030; Jones TL, 2004, J PHARMACOL EXP THER, V310, P223, DOI 10.1124/jpet.103.064741; KELLER BU, 1992, EMBO J, V11, P891, DOI 10.1002/j.1460-2075.1992.tb05127.x; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Kondo M, 2000, EUR J NEUROSCI, V12, P2812, DOI 10.1046/j.1460-9568.2000.00167.x; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lalo U, 2011, BBA-MOL CELL RES, V1813, P992, DOI 10.1016/j.bbamcr.2010.09.007; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Mauric V, 2013, MOL CELL NEUROSCI, V56, P10, DOI 10.1016/j.mcn.2013.02.001; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Nicoll RA, 2013, NEUROPHARMACOLOGY, V74, P18, DOI 10.1016/j.neuropharm.2013.02.010; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Orlandi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025350; Otori Y, 1998, INVEST OPHTH VIS SCI, V39, P972; PAN ZH, 1995, J NEUROSCI, V15, P2668; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Parpura V, 2012, CROAT MED J, V53, P518, DOI 10.3325/cmj.2012.53.518; Pei WM, 2009, BIOCHEMISTRY-US, V48, P3767, DOI 10.1021/bi8015907; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; PENG YW, 1995, NEUROSCIENCE, V66, P483, DOI 10.1016/0306-4522(94)00569-Q; POW DV, 1994, NEUROSCIENCE, V60, P355, DOI 10.1016/0306-4522(94)90249-6; Qin P, 1996, BRAIN RES, V710, P303, DOI 10.1016/0006-8993(95)01476-4; Rauen T, 1998, CELL TISSUE RES, V291, P19; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sargoy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084507; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Sauvageau E, 2014, TRAFFIC, V15, P383, DOI 10.1111/tra.12148; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sorkin LS, 1999, NEUROREPORT, V10, P3523, DOI 10.1097/00001756-199911260-00011; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Takahashi M, 1998, J PHARMACOL EXP THER, V284, P467; Tasken K, 1998, GENOMICS, V50, P378, DOI 10.1006/geno.1998.5326; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turpaev KT, 2002, BIOCHEMISTRY-MOSCOW+, V67, P281, DOI 10.1023/A:1014819832003; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; VAUGHN JE, 1981, J COMP NEUROL, V197, P113, DOI 10.1002/cne.901970109; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Vorwerk CK, 2004, BRAIN RES BULL, V62, P485, DOI 10.1016/S0361-9230(03)00075-3; Vorwerk CK, 1996, INVEST OPHTH VIS SCI, V37, P1618; Wang AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091288; Ward MW, 2000, J NEUROSCI, V20, P7208; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xia Y, 2006, J NEUROSCI, V26, P5028, DOI 10.1523/JNEUROSCI.0169-06.2006; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yu ZF, 2002, NEUROBIOL DIS, V11, P199, DOI 10.1006/nbdi.2002.0530	109	7	7	0	9	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0300-9084	1638-6183		BIOCHIMIE	Biochimie	MAY	2015	112						160	171		10.1016/j.biochi.2015.03.008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH4NC	WOS:000354009200017	25792422	Green Submitted			2022-02-06	
J	Hu, Y; Wu, Y; Tian, KL; Lan, D; Chen, XY; Xue, MY; Liu, LM; Li, T				Hu, Yi; Wu, Yue; Tian, Kunlun; Lan, Dan; Chen, Xiangyun; Xue, Mingying; Liu, Liangming; Li, Tao			Identification of ideal resuscitation pressure with concurrent traumatic brain injury in a rat model of hemorrhagic shock	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Hemorrhagic shock; Resuscitation; Ideal blood pressure; Rats	HYPERTONIC SALINE RESUSCITATION; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; FLUID RESUSCITATION; PERMISSIVE HYPOTENSION; CEREBRAL EDEMA; ANIMAL-MODEL; OXYGEN; DAMAGE; TRIAL	Background: Traumatic brain injury (TBI) is often associated with uncontrolled hemorrhagic shock (UHS), which contributes significantly to the mortality of severe trauma. Studies have demonstrated that permissive hypotension resuscitation improves the survival for uncontrolled hemorrhage. What the ideal target mean arterial pressure (MAP) is for TBI with UHS remains unclear. Methods: With the rat model of TBI in combination with UHS, we investigated the effects of a series of target resuscitation pressures (MAP from 50-90 mm Hg) on animal survival, brain perfusion, and organ function before hemorrhage controlled. Results: Rats in 50-, 60-, and 70-mm Hg target MAP groups had less blood loss and less fluid requirement, a better vital organ including mitochondrial function and better cerebral blood flow, and animal survival (8, 6, and 7 of 10, respectively) than 80- and 90-mm Hg groups. The 70-mm Hg group had a better cerebral blood flow and cerebral mitochondrial function than in 50- and 60-mm Hg groups. In contrast, 80- and 90-mm Hg groups resulted in an excessive hemodilution, a decreased blood flow, an increased brain water content, and more severe cerebral edema. Conclusions: A 50-mm Hg target MAP is not suitable for the resuscitation of TBI combined with UHS. A 70 mm Hg of MAP is the ideal target resuscitation pressure for this trauma, which can keep sufficient perfusion to the brain and keep good organ function including cerebral mitochondrial function. (C) 2015 Elsevier Inc. All rights reserved.	[Hu, Yi; Wu, Yue; Tian, Kunlun; Lan, Dan; Chen, Xiangyun; Xue, Mingying; Liu, Liangming; Li, Tao] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res,Dept 2, Chongqing 400042, Peoples R China; [Hu, Yi] Third Mil Med Univ, Daping Hosp, Dept Anesthesiol, Chongqing 400042, Peoples R China		Li, T (corresponding author), Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res,Dept 2, Chongqing 400042, Peoples R China.	lt200132@163.com			Natural Scientific Foundation of Chongqing (Chongqing, China) [CSTC2011JJJQ0019]; Major State Basic Research Program (Beijing, China)National Basic Research Program of China [2012CB518101]	This work was supported by Natural Scientific Foundation of Chongqing for Distinguished Young Scholars (CSTC2011JJJQ0019; Chongqing, China) and Major State Basic Research Program (2012CB518101; Beijing, China).	Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, pS1; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Campion EM, 2013, J TRAUMA ACUTE CARE, V75, pS221, DOI 10.1097/TA.0b013e318299d59b; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dar DE, 2010, SHOCK, V34, P75, DOI 10.1097/SHK.0b013e3181ce2cbc; De Visscher G, 2005, J NEUROTRAUM, V22, P793; FALK JL, 1995, CRIT CARE MED, V23, P4, DOI 10.1097/00003246-199501000-00003; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GUNNAR W, 1988, SURGERY, V103, P398; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; James HE, 2006, ACT NEUR S, V96, P125; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P457, DOI 10.1097/TA.0b013e3182a9ea44; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li T, 2012, ANESTHESIOLOGY, V116, P1288, DOI 10.1097/ALN.0b013e318256f09d; Li T, 2012, ANESTHESIOLOGY, V116, P103, DOI 10.1097/ALN.0b013e31823de24f; Li T, 2011, ANESTHESIOLOGY, V114, P111, DOI 10.1097/ALN.0b013e3181fe3fe7; Liu LM, 2013, ANESTHESIOLOGY, V119, P379, DOI 10.1097/ALN.0b013e31829b3804; Makley AT, 2010, J TRAUMA, V68, P305, DOI 10.1097/TA.0b013e3181cb4472; Matsushita M, 1997, J COMP NEUROL, V377, P251, DOI 10.1002/(SICI)1096-9861(19970113)377:2<251::AID-CNE7>3.0.CO;2-2; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Myburgh J, 2007, NEW ENGL J MED, V357, P874; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sondeen JL, 2011, TRANSFUSION, V51, P779, DOI 10.1111/j.1537-2995.2010.02928.x; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Trunkey D D, 2001, Emerg Med Serv, V30, P93; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wang F, 2006, ACTA MED BONGBU CHIN, V31, P575	44	7	7	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY 1	2015	195	1					284	293		10.1016/j.jss.2015.01.038			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CE9CA	WOS:000352139900037	25703162				2022-02-06	
J	Lin, CW; Huang, YP; Pan, SL				Lin, Chia-Wei; Huang, Ya-Ping; Pan, Shin-Liang			Spinal Cord Injury Is Related to an Increased Risk of Multiple Sclerosis: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study	JOURNAL OF NEUROTRAUMA			English	Article						spinal cord injury; multiple sclerosis; propensity score; risk factors	CENTRAL-NERVOUS-SYSTEM; AUTOIMMUNE-DISEASE; HEALTH-INSURANCE; HEAD-INJURY; STRESS; TRAUMA; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; SMOKING; TAIWAN	Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system (CNS). Trauma to the CNS has been postulated to play a role in triggering CNS autoimmune disease. Although the association between traumatic brain injury and MS has been suggested in previous studies, epidemiological data on the association between spinal cord injury (SCI) and MS is still lacking. The aim of the present population-based, propensity score-matched, longitudinal follow-up study was therefore to investigate whether patients with SCI were at a higher risk of developing MS. A total of 11,913 subjects ages between 20 and 90 years with at least two ambulatory visits with the principal diagnosis of SCI in 2001 were enrolled in the SCI group. We used a logistic regression model that included age, sex, pre-existing comorbidities, and socioeconomic status as covariates to compute the propensity score. The non-SCI group consisted of 59,565 propensity score-matched, randomly sampled subjects without SCI. Stratified Cox proportional hazard regression with patients matched by propensity score was used to estimate the effect of SCI on the risk of developing subsequent MS. During follow-up, five subjects in the SCI group and four in the non-SCI group developed MS. The incidence rates of MS were 17.60 (95% confidence interval [CI], 5.71-41.0) per 100,000 person-years in the SCI group and 2.82 (95% CI, 0.77-7.22) per 100,000 person-years in the non-SCI group. Compared with the non-SCI group, the hazard ratio of MS for the SCI group was 8.33 (95% CI, 1.99-34.87, p=0.0037). Our study therefore shows that patients with SCI have an increased risk of developing MS.	[Lin, Chia-Wei; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei 100, Taiwan; [Huang, Ya-Ping] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Yun Lin Branch, Yunlin, Taiwan; [Pan, Shin-Liang] Natl Taiwan Univ, Dept Phys Med & Rehabil, Coll Med, Taipei 100, Taiwan		Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, 7 Chung Shan S Rd, Taipei 100, Taiwan.	panslcb@gmail.com		lin, chiawei/0000-0002-6577-0116; PAN, SHIN-LIANG/0000-0001-6451-4666	Department of Health, Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]; Ministry of Science and Technology, Executive Yuan, Republic of China [MOST 103-2314-B-002-009]	This work was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health, Executive Yuan, Republic of China, and grant MOST 103-2314-B-002-009 from the Ministry of Science and Technology, Executive Yuan, Republic of China. No competing financial interests exist.	Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; BUFILL E, 1995, J NEUROL NEUROSUR PS, V58, P577, DOI 10.1136/jnnp.58.5.577; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dekaban GA, 2009, J CLIN INVEST, V119, P2881, DOI 10.1172/JCI40839; Goldacre MJ, 2006, J NEUROL NEUROSUR PS, V77, P351, DOI 10.1136/jnnp.2005.077693; GRANT I, 1989, J NEUROL NEUROSUR PS, V52, P8, DOI 10.1136/jnnp.52.1.8; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068314; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Kil K, 1999, J NEUROIMMUNOL, V98, P201, DOI 10.1016/S0165-5728(99)00057-0; Kotzamani D, 2012, NEUROLOGY, V78, P1728, DOI 10.1212/WNL.0b013e31825830a9; KURLAND LT, 1994, ANN NEUROL, V36, pS33, DOI 10.1002/ana.410360711; KURTZKE JF, 1991, NEUROEPIDEMIOLOGY, V10, P1, DOI 10.1159/000110240; Liu RL, 2006, J IMMUNOL, V176, P5247, DOI 10.4049/jimmunol.176.9.5247; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Migliorini CE, 2009, SPINAL CORD, V47, P783, DOI 10.1038/sc.2009.43; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Nielsen MS, 2003, SPINAL CORD, V41, P296, DOI 10.1038/sj.sc.3101427; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Parsons LS, 2004, PERFORMING 1 N CASE; Pfleger CCH, 2009, MULT SCLER J, V15, P294, DOI 10.1177/1352458508099475; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; POSER CM, 1994, CLIN NEUROL NEUROSUR, V96, P103, DOI 10.1016/0303-8467(94)90042-6; Poser CM, 2000, ARCH NEUROL-CHICAGO, V57, P1074, DOI 10.1001/archneur.57.7.1074; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; Thompson AJ, 2008, MULT SCLER, V14, pS153; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; WARREN S, 1982, J CHRON DIS, V35, P821, DOI 10.1016/0021-9681(82)90047-9; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004	39	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2015	32	9					655	659		10.1089/neu.2014.3723			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CH0LN	WOS:000353711500005	25545758	Green Published			2022-02-06	
J	Vandresen, S; Franca, LM; Alcantara, J; Nogueira, LC; de Brito, TM; Lopes, L; Mesquita, F; Vanzeler, ML; Bertoldo, DB; Dias, PG; Colla, ARS; Hoeller, A; Duzzioni, M; Rodrigues, ALS; de Lima, TCM; Tasca, CI; Viola, GG				Vandresen-Filho, Samuel; Franca, Lucas Moreira; Alcantara-Junior, Jose; Nogueira, Lucas Caixeta; de Brito, Thiago Marques; Lopes, Lousa; Mesquita Junior, Fernando; Vanzeler, Maria Luzinete; Bertoldo, Daniela Bohn; Dias, Paula Gomes; Colla, Andre R. S.; Hoeller, Alexandre; Duzzioni, Marcelo; Rodrigues, Ana Lucia S.; de Lima, Thereza C. M.; Tasca, Carla Ines; Viola, Giordano Gubert			Statins enhance cognitive performance in object location test in albino Swiss mice: Involvement of beta-adrenoceptors	PHYSIOLOGY & BEHAVIOR			English	Article						Spatial memory; Statins; Rodent; Exploratory behavior; Ethology; Strain	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL CELL-DEATH; PREVENTS VASCULAR HYPOREACTIVITY; COA REDUCTASE INHIBITORS; RECOGNITION MEMORY; OXIDATIVE STRESS; NITRIC-OXIDE; NORADRENERGIC ACTIVATION; GLUTAMATE UPTAKE; UP-REGULATION	Statins are inhibitors of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, thereby inhibiting cell synthesis of cholesterol and isoprenoids. Moreover, several studies have been evaluating pleiotropic effects of statins, mainly because they present neuroprotective effects in various pathological conditions. However, knowledge about behavioral effects of statins per se is relatively scarce. Considering these facts, we aimed to analyze behavioral responses of atorvastatin or simvastatin-treated mice in the open field test, elevated plus maze and object location test. Atorvastatin treatment for 7 consecutive days at 1 mg/kg or 10 mg/1kg (v.o.) or simvastatin 10 mg/kg or 20 mg/kg enhanced cognitive performance in object location test when compared to control group (saline-treated mice). Simvastatin effects on mice performance in the object location test was abolished by post-training infusion of the beta-adrenoceptor antagonist propranolol. Atorvastatin and simvastatin did not change the behavioral response in open field and elevated plus-maze (EPM) tests in any of the used doses. These data demonstrate the positive effects of both statins in cognitive processes in mice, without any alteration in locomotor parameters in the open field test or anxiolytic-like behavior in EPM. In conclusion, we demonstrate that atorvastatin and simvastatin per se improve the cognitive performance in a rodent model of spatial memory and this effect is related to beta-adrenergic receptors modulation. (C) 2015 Elsevier Inc. All rights reserved.	[Vandresen-Filho, Samuel; Colla, Andre R. S.; Rodrigues, Ana Lucia S.; Tasca, Carla Ines; Viola, Giordano Gubert] Univ Fed Santa Catarina, Programa Posgrad Neurociencias, Florianopolis, SC, Brazil; [Vandresen-Filho, Samuel; Franca, Lucas Moreira; Alcantara-Junior, Jose; Nogueira, Lucas Caixeta; de Brito, Thiago Marques; Lopes, Lousa; Mesquita Junior, Fernando; Vanzeler, Maria Luzinete] Univ Fed Mato Grosso, Dept Ciencias Basicas Saude, Cuiaba, MT, Brazil; [Bertoldo, Daniela Bohn; Dias, Paula Gomes; Rodrigues, Ana Lucia S.; Tasca, Carla Ines] Univ Fed Santa Catarina, Dept Bioquim, BR-88040900 Florianopolis, SC, Brazil; [Dias, Paula Gomes] Univ Fed Santa Catarina, Lab Genet Comportamento, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil; [Hoeller, Alexandre; Duzzioni, Marcelo; de Lima, Thereza C. M.] Univ Fed Santa Catarina, Dept Farmacol, Ctr Ciencias Biol, Florianopolis, SC, Brazil; [Viola, Giordano Gubert] Univ Fed Sergipe, Programa Posgrad Ciencias Fisiol, Sao Cristovao, SE, Brazil		Viola, GG (corresponding author), Univ Fed Sergipe, Programa Posgrad Ciencias Fisiol, Dept Fisiol, Sao Cristovao, SE, Brazil.	giorgviola@gmail.com	Duzzioni, Marcelo/C-6797-2015; Tasca, Carla Ines/AAB-8287-2019; Rodrigues, Ana Lucia/P-6869-2015; Lima, Thereza CM/C-6812-2015; de Lima, Thereza Christina Monteiro/AAH-9402-2019; Hoeller, Alexandre Ademar/F-2823-2013	Tasca, Carla Ines/0000-0002-3414-6150; Rodrigues, Ana Lucia/0000-0001-6285-8780; Lima, Thereza CM/0000-0002-3253-7350; Hoeller, Alexandre Ademar/0000-0001-7526-1502; Marques de Brito, Thiago/0000-0001-8786-1150	CAPES-BrasilCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq-BrasilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC)Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)	This work was supported by the CAPES-Brasil, CNPq-Brasil and Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC).	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Barsegyan A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00160; Binder S, 2012, NEUROBIOL LEARN MEM, V97, P213, DOI 10.1016/j.nlm.2011.12.004; Branchi Igor, 2004, Ann Ist Super Sanita, V40, P231; Castro AA, 2013, BRAIN RES, V1513, P103, DOI 10.1016/j.brainres.2013.03.029; Cespedes-Rubio A, 2010, J NEUROSCI RES, V88, P3621, DOI 10.1002/jnr.22511; Chen MJ, 2007, LIFE SCI, V81, P1280, DOI 10.1016/j.lfs.2007.09.003; Clements JD, 2007, VASC PHARMACOL, V46, P52, DOI 10.1016/j.vph.2006.06.009; Crispim CF, 2012, COMPUT BIOL MED, V42, P257, DOI 10.1016/j.compbiomed.2011.12.002; Dornelles A, 2007, NEUROBIOL LEARN MEM, V88, P137, DOI 10.1016/j.nlm.2007.01.005; Douma TN, 2011, PSYCHOPHARMACOLOGY, V216, P537, DOI 10.1007/s00213-011-2245-0; Escobar C, 2008, VASC HEALTH RISK MAN, V4, P525; Farmer JA, 2000, DRUG SAFETY, V23, P197, DOI 10.2165/00002018-200023030-00003; Gaur Vaibhav, 2011, Inflammopharmacology, V19, P205, DOI 10.1007/s10787-010-0068-y; HANDLEY SL, 1984, N-S ARCH PHARMACOL, V327, P1, DOI 10.1007/BF00504983; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Kandasamy K, 2011, SHOCK, V36, P76, DOI 10.1097/SHK.0b013e31821a4002; Kou JH, 2010, BRAIN RES, V1356, P102, DOI 10.1016/j.brainres.2010.07.102; Kurinami H, 2008, INT J MOL MED, V21, P531; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Lee ST, 2008, J NEUROCHEM, V104, P1190, DOI 10.1111/j.1471-4159.2007.05044.x; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Ludka F.K., 2012, EUR NEUROPSYCHOPHARM; Ludka FK, 2014, PHARMACOL BIOCHEM BE, V122, P253, DOI 10.1016/j.pbb.2014.04.005; Maggo S, 2012, EUR J PHARMACOL, V674, P287, DOI 10.1016/j.ejphar.2011.11.006; Mans RA, 2010, NEUROSCIENCE, V166, P435, DOI 10.1016/j.neuroscience.2009.12.062; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; Metais C, 2014, J ALZHEIMERS DIS, V39, P315, DOI 10.3233/JAD-130257; Okamura N, 2011, NEUROPSYCHOPHARMACOL, V36, P744, DOI 10.1038/npp.2010.207; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Pleiner J, 2004, CIRCULATION, V110, P3349, DOI 10.1161/01.CIR.0000147774.90396.ED; Pugh SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106905; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; Rayatnia F, 2011, EUR J PHARMACOL, V666, P122, DOI 10.1016/j.ejphar.2011.05.017; Reiss AB, 2007, DRUGS, V67, P2111, DOI 10.2165/00003495-200767150-00001; Renshaw PF, 2009, PHARMACOL BIOCHEM BE, V92, P88, DOI 10.1016/j.pbb.2008.10.017; Rodgers RJ, 1996, PHARMACOL BIOCHEM BE, V54, P41, DOI 10.1016/0091-3057(95)02156-6; Roozendaal B, 2008, NEUROBIOL LEARN MEM, V90, P576, DOI 10.1016/j.nlm.2008.06.010; Roozendaal B, 2007, PROG BRAIN RES, V167, P79, DOI 10.1016/S0079-6123(07)67006-X; Sparks DL, 2006, ACTA NEUROL SCAND, V114, P78, DOI 10.1111/j.1600-0404.2006.00689.x; Tramontina AC, 2011, J NEURAL TRANSM, V118, P1641, DOI 10.1007/s00702-011-0680-z; Vandresen S, 2013, NEUROCHEM INT, V62, P948, DOI 10.1016/j.neuint.2013.03.002; Vaughan CJ, 2003, AM J CARDIOL, V91, p23B, DOI 10.1016/S0002-9149(02)03270-8; Viola GG, 2010, PHYSIOL BEHAV, V99, P17, DOI 10.1016/j.physbeh.2009.10.003; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Waters DD, 2005, AM J CARDIOL, V96, p69F, DOI 10.1016/j.amjcard.2005.06.028; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Young-Xu Y, 2003, J AM COLL CARDIOL, V42, P690, DOI 10.1016/S0735-1097(03)00785-X; Zhang YY, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S40405	54	7	8	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	MAY 1	2015	143						27	34		10.1016/j.physbeh.2015.02.024			8	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	CE7RU	WOS:000352040300004	25700896	hybrid			2022-02-06	
J	Arya, A; Meena, R; Sethy, NK; Das, M; Sharma, M; Bhargava, K				Arya, A.; Meena, R.; Sethy, N. K.; Das, M.; Sharma, M.; Bhargava, K.			NAP (davunetide) protects primary hippocampus culture by modulating expression profile of antioxidant genes during limiting oxygen conditions	FREE RADICAL RESEARCH			English	Article						antioxidant; free radicals; hippocampus	VASOACTIVE-INTESTINAL-PEPTIDE; INDUCED OXIDATIVE STRESS; NEUROPROTECTIVE PEPTIDE; HYPOXIA; INJURY; BRAIN; VIP; RECEPTORS; CORTEX; ADNP	Hypoxia is a well-known threat to neuronal cells and triggers the pathophysiological syndromes in extreme environments such as high altitudes and traumatic conditions such as stroke. Among several prophylactic molecules proven suitable for ameliorating free radical damage, NAP (an octapeptide with initial amino acids: asparagine/N, alanine/A, and proline/P) can be considered superlative, primarily due to its high permeability into brain through blood-brain barrier and observed activity at femtomolar concentrations. Several mechanisms of action of NAP have been hypothesized for its protective role during hypoxia, yet any distinct mechanism is unknown. Oxidative stress is advocated as the leading event in hypoxia; we, therefore, investigated the regulation of key antioxidant genes to understand the regulatory role of NAP in providing neuroprotection. Primary neuronal culture of rat was subjected to cellular hypoxia by limiting the oxygen concentration to 0.5% for 72 h and observing the prophylactic efficacies of 15fM NAP by conventional cell death assays using flow cytometry. We performed real-time quantitative polymerase chain reaction to comprehend the regulatory mechanism. Further, we validated the significantly regulated candidates by enzyme assays and immunoblotting. In the present study, we report that NAP regulates a major clad of cellular antioxidants and there is an involvement of more than one route of action in neuroprotection during hypoxia.	[Arya, A.; Meena, R.; Sethy, N. K.; Sharma, M.; Bhargava, K.] Def Res & Dev Org, Def Inst Physiol & Allied Sci, Peptide & Prote Div, Delhi 110054, India; [Das, M.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India		Bhargava, K (corresponding author), Def Res & Dev Org, Def Inst Physiol & Allied Sci, Peptide & Prote Div, Lucknow Rd, Delhi 110054, India.	manishks77@gmail.com; kalpanab2006@gmail.com	Sethy, Niroj/L-9817-2019; Arya, Aditya/Y-5527-2019	Sethy, Niroj/0000-0003-0675-1481; Arya, Aditya/0000-0002-9629-2532; Arya, Aditya/0000-0002-8747-3462	Council of Scientific and Industrial Research (CSIR), Government of IndiaCouncil of Scientific & Industrial Research (CSIR) - India	The authors would like to acknowledge Ms. Ankita Yadava and Ms. Anamika Gangwar for support in preparation of this manuscript. Aditya Arya is a recipient of Senior Research Fellowship (SRF) from Council of Scientific and Industrial Research (CSIR), Government of India.	Alcalay RN, 2004, NEUROSCI LETT, V361, P128, DOI 10.1016/j.neulet.2003.12.005; Arya A, 2013, INT J NANOMED, V8, P4507, DOI 10.2147/IJN.S53032; Ashur-Fabian O, 2001, NEUROSCI LETT, V307, P167, DOI 10.1016/S0304-3940(01)01954-1; Bartsch P, 2013, NEW ENGL J MED, V369, P1666, DOI 10.1056/NEJMc1309747; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Fleming SM, 2011, MOL CELL NEUROSCI, V46, P597, DOI 10.1016/j.mcn.2010.12.011; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gold M, 2012, NEUROPSYCH DIS TREAT, V8, P85, DOI 10.2147/NDT.S12518; Gozes I, 2003, J MOL NEUROSCI, V20, P315, DOI 10.1385/JMN:20:3:315; Gozes I, 2002, J MOL NEUROSCI, V19, P167, DOI 10.1007/s12031-002-0028-0; Gozes I, 2000, ANN NY ACAD SCI, V921, P115; Gozes I, 2001, TRENDS NEUROSCI, V24, P700, DOI 10.1016/S0166-2236(00)01931-7; Gozes I, 2011, CURR PHARM DESIGN, V17, P1040, DOI 10.2174/138161211795589373; Jarskog LF, 2013, NEUROPSYCHOPHARMACOL, V38, P1245, DOI 10.1038/npp.2013.23; Javitt DC, 2012, SCHIZOPHR RES, V136, P25, DOI 10.1016/j.schres.2011.11.001; Leker RR, 2002, STROKE, V33, P1085, DOI 10.1161/01.STR.0000014207.05597.D7; Maiti P, 2006, NEUROCHEM INT, V49, P709, DOI 10.1016/j.neuint.2006.06.002; Morimoto BH, 2013, EXPERT REV CLIN PHAR, V6, P483, DOI 10.1586/17512433.2013.827403; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Oz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051458; Roach RC, 2001, J EXP BIOL, V204, P3161; Said SI, 1999, TRENDS PHARMACOL SCI, V20, P132, DOI 10.1016/S0165-6147(98)01275-9; Sharma NK, 2011, PEPTIDES, V32, P1217, DOI 10.1016/j.peptides.2011.03.016; Sharma NK, 2013, J PROTEOMICS, V79, P277, DOI 10.1016/j.jprot.2012.12.020; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zawilska JB, 2005, J MOL NEUROSCI, V25, P215, DOI 10.1385/JMN:25:3:215; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1	34	7	7	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	APR	2015	49	4					440	452		10.3109/10715762.2015.1011153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF6YT	WOS:000352703600007	25727410				2022-02-06	
J	Bamzar, R; Ceccato, V				Bamzar, Roya; Ceccato, Vania			The nature and the geography of elderly injuries in Sweden	GEOJOURNAL			English	Article						Elderly injury; Geography of fall; Spatial patterns; Seasonal temperature variation	TRAUMATIC BRAIN-INJURY; HIP FRACTURE INCIDENCE; RISK-FACTORS; NORTHERN SWEDEN; OLDER-PEOPLE; FALLS; POPULATION; COMMUNITY; HOME; EPIDEMIOLOGY	This study assesses the nature and the geography of elderly injuries in Sweden. The most dominant types of accidents affecting the elderly in their homes and near environments are identified by using county-specific data from 2001 to 2010 followed by a correlation analysis of possible environmental factors underlying patterns of falls among the elderly. Geographical information systems are used to map rates by type. Slipping, tripping and stumbling are the causes of more than half of cases of elderly falls in Sweden, and is more typical in the Northern counties. Findings also show there has been a rise in rates of elderly falls since 2001 in most of the Southern counties, especially in Ostergotland and Skane Counties. Population age and gender affect the ecology of geography of fall rates and counties experiencing long cold winters tend to show higher rates of indoor falls than those with warmer temperature across the year. The article finalizes with a discussion of the results and implication for future research.	[Bamzar, Roya; Ceccato, Vania] KTH Royal Inst Technol, Stockholm, Sweden		Bamzar, R (corresponding author), KTH Royal Inst Technol, Stockholm, Sweden.	bamzar@kth.se					Alptekin F, 2008, INJURY, V39, P535, DOI 10.1016/j.injury.2007.02.042; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Anthamatten P., 2011, INTRO HLTH GEOGRAPHY; Baldwin R L, 1996, J Gerontol Nurs, V22, P14; Bardin MG, 2012, BRAZ J PHYS THER, V16, P275, DOI 10.1590/S1413-35552012005000033; Beauchet O, 2008, J AM GERIATR SOC, V56, P1265, DOI 10.1111/j.1532-5415.2008.01766.x; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; BERGSTRALH EJ, 1990, J BONE MINER RES, V5, P371, DOI 10.1002/jbmr.5650050410; Berleen G., 2004, HEALTHIER ELDERLY PO; Bjorgul K, 2007, INT ORTHOP, V31, P665, DOI 10.1007/s00264-006-0251-3; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Bulajic-Kopjar M, 2000, Inj Prev, V6, P16, DOI 10.1136/ip.6.1.16; CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; Chan WC, 2012, INJURY PREV, V18, P303, DOI 10.1136/injuryprev-2011-040068; Chen XL, 2011, ARCH GERONTOL GERIAT, V53, pE183, DOI 10.1016/j.archger.2010.08.012; Connell BR, 1997, ARCH PHYS MED REHAB, V78, P179, DOI 10.1016/S0003-9993(97)90261-6; Craven R, 1986, J Gerontol Nurs, V12, P27; Ekman R, 2005, INJURY PREV, V11, P29, DOI 10.1136/ip.2003.005074; Ekman R, 2001, ACCIDENT ANAL PREV, V33, P793, DOI 10.1016/S0001-4575(00)00093-2; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Evci ED, 2006, TOHOKU J EXP MED, V209, P291, DOI 10.1620/tjem.209.291; FALCH JA, 1993, BONE, V14, P643, DOI 10.1016/8756-3282(93)90086-P; Finsen V, 2004, CLIN ORTHOP RELAT R, P173, DOI 10.1097/01.blo.0000111886.01667.79; French DD, 2007, BRIT J CLIN PHARMACO, V63, P238, DOI 10.1111/j.1365-2125.2006.02798.x; Furugren L, 2007, SCAND J PUBLIC HEALT, V35, P11, DOI 10.1080/14034940600733925; GABELL A, 1985, ERGONOMICS, V28, P965, DOI 10.1080/00140138508963219; GRIFFIN MR, 1992, AM J EPIDEMIOL, V136, P1378, DOI 10.1093/oxfordjournals.aje.a116450; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; HOLMBERG S, 1987, CLIN ORTHOP RELAT R, P32; Isaacs B, 1985, Clin Geriatr Med, V1, P513; JACOBSEN SJ, 1991, AM J EPIDEMIOL, V133, P996, DOI 10.1093/oxfordjournals.aje.a115819; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; JOHNELL O, 1992, AGE AGEING, V21, P32, DOI 10.1093/ageing/21.1.32; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; LAU EMC, 1995, AUST J PUBLIC HEALTH, V19, P76; Lehtola S, 2006, ARCH GERONTOL GERIAT, V42, P217, DOI 10.1016/j.archger.2005.07.002; Levy AR, 1998, EPIDEMIOLOGY, V9, P172, DOI 10.1097/00001648-199803000-00012; Lin HC, 2006, OSTEOPOROSIS INT, V17, P795, DOI 10.1007/s00198-005-0060-3; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; LUUKINEN H, 1994, J CLIN EPIDEMIOL, V47, P843, DOI 10.1016/0895-4356(94)90187-2; Mackenzie L, 2002, OTJR-OCCUP PART HEAL, V22, P143, DOI 10.1177/153944920202200403; MANNING DP, 1982, BRIT MED J, V284, P508, DOI 10.1136/bmj.284.6314.508-c; Mirchandani S, 2005, ORTHOPEDICS, V28, P149, DOI 10.3928/0147-7447-20050201-17; Motel A, 2000, ZWEITE LEBENSHALFTE, P124; Neutel CI, 1996, AGE AGEING, V25, P273, DOI 10.1093/ageing/25.4.273; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P509, DOI 10.2105/AJPH.85.4.509; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Oswald F., 2005, HOME IDENTITY LATE L, P21; Parry SW, 2001, POSTGRAD MED J, V77, P103, DOI 10.1136/pmj.77.904.103; Petridou ET, 2008, J AGING HEALTH, V20, P159, DOI 10.1177/0898264307310467; Prudham D, 1981, Age Ageing, V10, P141; RALIS ZA, 1981, BRIT MED J, V282, P603, DOI 10.1136/bmj.282.6264.603; RALIS ZA, 1986, BRIT MED J, V293, P484, DOI 10.1136/bmj.293.6545.484; Reinsch S., 1993, PHYS OCCUPATIONAL TH, V11, P1; Rosenbloom S., 2000, ECMT REPORT TRANSPOR; ROWE SM, 1993, INT ORTHOP, V17, P139; SATTIN RW, 1990, AM J EPIDEMIOL, V131, P1028, DOI 10.1093/oxfordjournals.aje.a115594; Saveman BI, 2011, SCAND J CARING SCI, V25, P185, DOI 10.1111/j.1471-6712.2010.00810.x; Schyllander J, 2010, SKADOR BLAND ALDRE S; Scott VJ, 1999, CAN J PUBLIC HEALTH, V90, P343, DOI 10.1007/BF03404525; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46, DOI 10.1111/j.1532-5415.1991.tb05905.x; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; STEWART RB, 1992, J AM GERIATR SOC, V40, P1217, DOI 10.1111/j.1532-5415.1992.tb03645.x; TENO J, 1990, J AM GERIATR SOC, V38, P1321, DOI 10.1111/j.1532-5415.1990.tb03455.x; Tideiksaar R, 1996, GERIATRICS, V51, P43; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1207, DOI 10.1111/j.1532-5415.1995.tb07395.x; Torstensson G., 2011, FORSLAG TILL NATIONE; Verghese J, 2008, ARCH PHYS MED REHAB, V89, P100, DOI 10.1016/j.apmr.2007.08.129; Vitry AI, 2010, ARCH GERONTOL GERIAT, V50, pE1, DOI 10.1016/j.archger.2009.04.004; Wagert PV, 2009, ARCH GERONTOL GERIAT, V49, P390, DOI 10.1016/j.archger.2008.12.005; Wahl H.-W., 2010, SAGE HDB SOCIAL GERO, P111, DOI DOI 10.4135/9781446200933.N8; WALLER JA, 1978, ACCIDENT ANAL PREV, V10, P21, DOI 10.1016/0001-4575(78)90005-2; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; World Health Organization World Health Organization. Ageing and Life course Unit, 2008, WHO GLOB REP FALLP; YASUMURA S, 1994, AGE AGEING, V23, P323, DOI 10.1093/ageing/23.4.323; Yiannakoulias N, 2003, SOC SCI MED, V57, P2065, DOI 10.1016/S0277-9536(03)00081-9; Ytterstad B, 1999, Int J Circumpolar Health, V58, P84	83	7	7	1	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0343-2521	1572-9893		GEOJOURNAL	GeoJournal	APR	2015	80	2					279	299		10.1007/s10708-014-9552-z			21	Geography	Emerging Sources Citation Index (ESCI)	Geography	DA2HL	WOS:000367615800020					2022-02-06	
J	Baos, S; Sheehan, K; Culliford, L; Pike, K; Ellis, L; Parry, AJ; Stoica, S; Ghorbel, MT; Caputo, M; Rogers, CA				Baos, Sarah; Sheehan, Karen; Culliford, Lucy; Pike, Katie; Ellis, Lucy; Parry, Andrew J.; Stoica, Serban; Ghorbel, Mohamed T.; Caputo, Massimo; Rogers, Chris A.			Normothermic Versus Hypothermic Cardiopulmonary Bypass in Children Undergoing Open Heart Surgery (Thermic-2): Study Protocol for a Randomized Controlled Trial	JMIR RESEARCH PROTOCOLS			English	Article						pediatrics; cardiac surgery; cardiopulmonary bypass; temperature; hypothermia; normothermia; clinical trials; randomized	TRAUMATIC BRAIN-INJURY; PEDIATRIC CARDIAC-SURGERY; FIBRILLARY ACIDIC PROTEIN; PERFUSION TEMPERATURE; INFLAMMATORY RESPONSE; CLINICAL-EXPERIENCE; SYSTEMIC PERFUSION; BLOOD CARDIOPLEGIA; RENAL INJURY; SERUM	Background: During open heart surgery, patients are connected to a heart-lung bypass machine that pumps blood around the body ("perfusion") while the heart is stopped. Typically the blood is cooled during this procedure ("hypothermia") and warmed to normal body temperature once the operation has been completed. The main rationale for "whole body cooling" is to protect organs such as the brain, kidneys, lungs, and heart from injury during bypass by reducing the body's metabolic rate and decreasing oxygen consumption. However, hypothermic perfusion also has disadvantages that can contribute toward an extended postoperative hospital stay. Research in adults and small randomized controlled trials in children suggest some benefits to keeping the blood at normal body temperature throughout surgery ("normothermia"). However, the two techniques have not been extensively compared in children. Objective: The Thermic-2 study will test the hypothesis that the whole body inflammatory response to the nonphysiological bypass and its detrimental effects on different organ functions may be attenuated by maintaining the body at 35 degrees C-37 degrees C (normothermic) rather than 28 degrees C (hypothermic) during pediatric complex open heart surgery. Methods: This is a single-center, randomized controlled trial comparing the effectiveness and acceptability of normothermic versus hypothermic bypass in 141 children with congenital heart disease undergoing open heart surgery. Children having scheduled surgery to repair a heart defect not requiring deep hypothermic circulatory arrest represent the target study population. The co-primary clinical outcomes are duration of inotropic support, intubation time, and postoperative hospital stay. Secondary outcomes are in-hospital mortality and morbidity, blood loss and transfusion requirements, pre-and post-operative echocardiographic findings, routine blood gas and blood test results, renal function, cerebral function, regional oxygen saturation of blood in the cerebral cortex, assessment of genomic expression changes in cardiac tissue biopsies, and neuropsychological development. Results: A total of 141 patients have been successfully randomized over 2 years and 10 months and are now being followed-up for 1 year. Results will be published in 2015. Conclusions: We believe this to be the first large pragmatic study comparing clinical outcomes during normothermic versus hypothermic bypass in complex open heart surgery in children. It is expected that this work will provide important information to improve strategies of cardiopulmonary bypass perfusion and therefore decrease the inevitable organ damage that occurs during nonphysiological body perfusion.	[Baos, Sarah; Culliford, Lucy; Pike, Katie; Ellis, Lucy; Rogers, Chris A.] Univ Bristol, Bristol Royal Infirm, Sch Clin Sci, Clin Trials & Evaluat Unit, Bristol BS2 8HW, Avon, England; [Sheehan, Karen; Parry, Andrew J.; Stoica, Serban; Caputo, Massimo] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Div Women & Children, Bristol, Avon, England; [Parry, Andrew J.; Ghorbel, Mohamed T.] Univ Hosp Bristol NHS Fdn Trust, Bristol Heart Inst, Bristol, Avon, England		Rogers, CA (corresponding author), Univ Bristol, Bristol Royal Infirm, Sch Clin Sci, Clin Trials & Evaluat Unit, Level 7 Queens Bldg, Bristol BS2 8HW, Avon, England.	chris.rogers@bristol.ac.uk		Caputo, Massimo/0000-0001-7508-0891; Sheehan, Karen/0000-0003-1606-8184	National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0514-10114] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K025643/1] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K025643/1] Funding Source: UKRI		Anttila V, 2004, J THORAC CARDIOV SUR, V127, P1781, DOI 10.1016/j.jtcvs.2004.01.037; Birdi I, 1999, EUR J CARDIO-THORAC, V16, P540, DOI 10.1016/S1010-7940(99)00301-2; Birdi I, 1997, J THORAC CARDIOV SUR, V114, P475, DOI 10.1016/S0022-5223(97)70196-X; Birdi I, 1996, ANN THORAC SURG, V61, P1573, DOI 10.1016/0003-4975(96)00092-6; Birdi I, 1999, CARDIOVASC SURG, V7, P369, DOI 10.1016/S0967-2109(98)00150-1; Birdi I, 1996, ANN THORAC SURG, V61, P118, DOI 10.1016/0003-4975(95)00881-0; Cakir H, 2013, J CARDIOVASC SURG, V54, P397; Caputo M, 2005, ANN THORAC SURG, V80, P982, DOI 10.1016/j.athoracsur.2005.03.062; Caputo M, 2011, J THORAC CARDIOV SUR, V142, P1114, DOI 10.1016/j.jtcvs.2011.08.008; Che ML, 2010, NEPHRON CLIN PRACT, V115, pE66, DOI 10.1159/000286352; Durandy Y, 2002, J THORAC CARDIOV SUR, V123, P194, DOI 10.1067/mtc.2001.120005; Durandy Y, 2007, J THORAC CARDIOV SUR, V133, P241, DOI 10.1016/j.jtcvs.2006.10.004; Durandy YD, 2006, ASAIO J, V52, P539, DOI 10.1097/01.mat.0000242597.92625.e9; Edmunds L H, 1994, CARDIOPULMONARY BYPA; Eggum R, 2008, ANN THORAC SURG, V85, P611, DOI 10.1016/j.athoracsur.2007.10.062; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Gazzolo Diego, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P108; Ho KM, 2011, CARDIOVASC THER, V29, P260, DOI 10.1111/j.1755-5922.2009.00114.x; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Korkman M., 2007, NEPSY 2; Lenkin AI, 2013, INTERACT CARDIOV TH, V16, P595, DOI 10.1093/icvts/ivt016; LICHTENSTEIN SV, 1992, LANCET, V339, P1305; Lonnivorotov VV, 2014, J CARDIOTHOR VASC AN, V28, P295, DOI 10.1053/j.jvca.2013.03.009; MENASCHE P, 1994, J THORAC CARDIOV SUR, V107, P293; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Modi P, 2004, J THORAC CARDIOV SUR, V128, P67, DOI 10.1016/j.jtcvs.2003.11.071; MOORE FD, 1988, ANN SURG, V208, P95, DOI 10.1097/00000658-198807000-00014; OHATA T, 1995, ASAIO J, V41, pM288, DOI 10.1097/00002480-199507000-00014; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Poncelet AJ, 2011, EUR J CARDIO-THORAC, V40, P1384, DOI 10.1016/j.ejcts.2011.03.047; Pouard P, 2006, EUR J CARDIO-THORAC, V30, P695, DOI 10.1016/j.ejcts.2006.07.032; Rasmussen BS, 2007, J CARDIOTHOR VASC AN, V21, P191, DOI 10.1053/j.jvca.2006.02.030; Rasmussen LS, 2001, J CARDIOTHOR VASC AN, V15, P563, DOI 10.1053/jcan.2001.26532; REGRAGUI IA, 1995, ANN THORAC SURG, V60, P160; Stocker CF, 2011, J THORAC CARDIOV SUR, V142, P174, DOI 10.1016/j.jtcvs.2011.01.059; Tang ATM, 1999, EUR J CARDIO-THORAC, V15, P717, DOI 10.1016/S1010-7940(99)00081-0; Ti Yun-Xing, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P385; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wagner FMJ, 2001, CARDIOL YOUNG, V11, P532, DOI 10.1017/S1047951101000774; Wyckoff T, 2012, J CARDIOTHOR VASC AN, V26, P340, DOI 10.1053/j.jvca.2012.01.001; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	43	7	7	0	10	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	APR-JUN	2015	4	2							e59	10.2196/resprot.4338			12	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CQ8SB	WOS:000360877600008	26007621	Green Published, gold, Green Submitted			2022-02-06	
J	Ding, J; Ding, ZG; Yuan, F; Guo, JY; Chen, H; Gao, WW; Wang, R; Gu, Y; Chen, J; Guo, Y; Tian, HL				Ding, Jun; Ding, Zhengang; Yuan, Fang; Guo, Jianyi; Chen, Hao; Gao, Wenwei; Wang, Ren; Gu, Yi; Chen, Jiong; Guo, Yan; Tian, Hengli			Proteomics analysis after traumatic brain injury in rats: the search for potential biomarkers	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						traumatic brain injury; biomarkers; proteomics; two-dimensional gel electrophoresis; mass spectrometry	PYRUVATE-KINASE M2; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; SERUM BIOMARKERS; PEDIATRIC TBI; PROTEIN; S100B; RESPONSES; HYPOXIA; MODELS	Many studies of protein expression after traumatic brain injury (TBI) have identified biomarkers for diagnosing or determining the prognosis of TBI. In this study, we searched for additional protein markers of TBI using a fluid perfusion impact device to model TBI in S-D rats. Two-dimensional gel electrophoresis and mass spectrometry were used to identify differentially expressed proteins. After proteomic analysis, we detected 405 and 371 protein spots within a pH range of 3-10 from sham-treated and contused brain cortex, respectively. Eighty protein spots were differentially expressed in the two groups and 20 of these proteins were identified. This study validated the established biomarkers of TBI and identified potential biomarkers that could be examined in future work.	[Ding, Jun; Yuan, Fang; Guo, Jianyi; Chen, Hao; Gao, Wenwei; Wang, Ren; Gu, Yi; Chen, Jiong; Guo, Yan; Tian, Hengli] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China; [Ding, Zhengang] Chinese Med Hosp Huangdao Dist Jiaonan, Dept Neurosurg, Jiaonan 266406, Shandong, Peoples R China		Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China.	tianhlsh@126.com			National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271383, 81471245]; Shanghai Science and Technique Committee [13411951401]; Shanghai Municipal Health Bureau project [20114242]	National Nature and Science Foundation of China (grant no. 81271383, 81471245), the Shanghai Science and Technique Committee (grant no. 13411951401) and the Shanghai Municipal Health Bureau project (grant no. 20114242).	Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Barberan S, 2011, EUR J NEUROSCI, V34, P1737, DOI 10.1111/j.1460-9568.2011.07891.x; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bera TK, 2002, P NATL ACAD SCI USA, V99, P6997, DOI 10.1073/pnas.102187299; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bersano A, 2006, NEUROLOGY, V67, P2211, DOI 10.1212/01.wnl.0000249150.98891.d1; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Centers for Disease Control and Prevention, TBI OUTC CONS; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Namikawa K, 1998, MOL BRAIN RES, V55, P315, DOI 10.1016/S0169-328X(98)00012-6; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Park D, 2012, J NEUROSCI RES, V90, P461, DOI 10.1002/jnr.22769; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70	29	7	7	0	7	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	APR	2015	73	4					342	349		10.1590/0004-282X20150006			8	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CI5IA	WOS:000354787600012	25992526	gold, Green Submitted			2022-02-06	
J	Greenhow, A; East, J				Greenhow, Annette; East, Jocelyn			Custodians of the Game: Ethical Considerations for Football Governing Bodies in Regulating Concussion Management	NEUROETHICS			English	Article						Regulation; Concussion; Professional football; Ethics	OF-INTEREST; SPORT; INJURY; LEAGUE	Concussion in professional football is a topic that has generated a significant amount of interest for many years, partly due in recent times to the filing of the class-action litigation and the uncapped compensation injury fund and settlement involving 4,500 retired professional players and the National Football League (NFL). The proceedings claimed that the NFL, as the governing body of American football, failed in its duty to protect players' health during their professional playing careers by exposing players to risks of repetitive concussions and actively concealing links to potential long-term consequences. The NFL litigation sharpened the focus on the fundamental regulatory, governance and ethical considerations for football governing bodies, as self-regulated organisations, when governing the delicate balance between the dynamics of contact and collision sports, entertainment and player-health considerations. It also raised questions about public accountability and responsibilities to all levels of the sport through a framework of public health ethics. The NFL litigation and Congressional hearings have led to changes within the NFL and its regulatory and governance responses. A case study of the NFL responses to concussion in the sport of American football can provide insight into concussion regulation. Australian football governing bodies can align their regulatory and governance responses to concussion within their sports with the aim to avoid similar accusations, and circumvent a more coercive form of intervention.	[Greenhow, Annette] Bond Univ, Fac Law, Robina, Qld, Australia; [East, Jocelyn] Univ Ottawa, Ottawa, ON, Canada		Greenhow, A (corresponding author), Bond Univ, Fac Law, Univ Dr, Robina, Qld, Australia.	agreenho@bond.edu.au		Greenhow, Annette/0000-0003-2167-2634			Australian Football League Medical Officers' Association, 2013, AFL GUID MAN CONC AF; Black J., 2002, AUSTR J LEGAL PHILOS, P1; Carroll Linda, 2012, CONCUSSION CRISIS AN; Centers for Disease Control and Prevention, 2013, CONC SPORT; Chin Lee Lee, 2009, SBS WORLD NEWS AUSTR; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Dashnaw Matthew, 2012, NEUROSURG FOCUS, V33, P9; Doherty A, 2013, J SPORT MANAGE, V27, P1, DOI 10.1123/jsm.27.1.1; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Freiberg Arie, 2010, TOOLS REGULATION; Gee D, 2008, J PUBLIC HEALTH POL, V29, P474, DOI 10.1057/jphp.2008.31; Goldberg D. S., 2013, OP ED PUBL INT NFL C; Goldberg DS, 2013, J LEGAL MED, V34, P157, DOI 10.1080/01947648.2013.800792; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Guay D, 1993, CULTURE SPORTIVE; Hanna Joseph, 2014, LAWINSPORT; Healey D, 2012, ECON LABOUR RELAT RE, V23, P39, DOI 10.1177/103530461202300303; Hecht Alexandra, 2002, SETON HALL J SPORT L, P36; Hecht Alexandra, 2002, SETON HALL J SPORT L, P27; Heiner Jennifer, 2008, SETON HALL J SPORTS, V18; Kaplan Daniel, 2010, SPORTS BUSINESS 0405; King T, 2013, J SCI MED SPORT, V16, P302, DOI 10.1016/j.jsams.2012.09.003; Magnusson Roger, 1994, MONASH U LAW REV, V20, P214; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; Mitten Matthew J., 2010, TULANE LAW REV, V85, P269; Mitten Matthew J., 2005, SAINT LOUIS U LAW J, P211; Murthy Anjali, B NUY HOSP JOINT DIS, P56; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Opie Hayden, 1995, SPORTS PHYSIOTHERAPY; Parker C., 2002, OPEN CORPORATION EFF; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Patricios JS, 2014, BRIT J SPORT MED, V48, P71, DOI 10.1136/bjsports-2013-093285; Pearce JMS, 2008, EUR NEUROL, V59, P113, DOI 10.1159/000111872; Polsky Scott, 2011, CONT HLTH LAW POLICY, V14, P503; Pritchard Greg, 2012, THE AGE; Scott, 2001, PUBLIC LAW, P329; Sherry E, 2007, CORP GOV-INT J BUS S, V7, P267, DOI 10.1108/14720700710756544; Sparrow Malcolm K., 2000, REGULATORY CRAFT CON; Stewart B, 2011, SPORT MANAG REV, V14, P237, DOI 10.1016/j.smr.2011.02.001; Walshaw Nick, 2011, NRL PLAYERS DONATE B; Westerman Pauline, LEGISPRUDENCE, VIV, P225	43	7	7	1	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1874-5490	1874-5504		NEUROETHICS-NETH	Neuroethics	APR	2015	8	1					65	82		10.1007/s12152-014-9216-1			18	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	CH2UZ	WOS:000353881500008					2022-02-06	
J	Morbitzer, KA; Jordan, JD; Rhoney, DH				Morbitzer, Kathryn A.; Jordan, J. Dedrick; Rhoney, Denise H.			Vancomycin Pharmacokinetic Parameters in Patients with Acute Brain Injury Undergoing Controlled Normothermia, Therapeutic Hypothermia, or Pentobarbital Infusion	NEUROCRITICAL CARE			English	Article						Vancomycin; Pharmacokinetics; Controlled normothermia; Therapeutic hypothermia; Pentobarbital infusion; Acute brain injury	AUGMENTED RENAL CLEARANCE; CREATININE CLEARANCE; COMPLICATIONS; MIDAZOLAM; METABOLISM; MECHANISMS	Therapeutic strategies that cause an alteration in patient temperature, such as controlled normothermia (CN), therapeutic hypothermia (TH), and pentobarbital infusion (PI), are often used to manage complications caused by acute brain injury. The purpose of this study was to evaluate pharmacokinetic (PK) parameters of vancomycin in patients with acute brain injury undergoing temperature modulation. This was a retrospective cohort study of adult patients with acute brain injury admitted between May 2010 and March 2014 who underwent CN, TH, or PI and received vancomycin. Predicted PK parameters based on population data were compared with calculated PK parameters based on serum concentrations. Seventeen CN patients and 10 TH/PI patients met inclusion criteria. Traumatic brain injury and aneurysmal subarachnoid hemorrhage accounted for the majority of admitting diagnoses. In the CN group, the median dose was 16.7 (15.5-18.4) mg/kg. The median calculated elimination rate constant [0.155 (0.108-0.17) vs. 0.103 (0.08-0.142) hr(-1); p = 0.04] was significantly higher than the predicted value. The median measured trough concentration [8.9 (7.7-11.1) vs. 17.1 (10.8-22.3) upsilon g/mL; p = 0.004] was significantly lower than predicted. In the TH/PI group, the median dose was 15.4 (14.7-17.2) mg/kg. No significant differences were found between the median calculated and predicted elimination rate constant [0.107 (0.097-0.109) vs. 0.112 (0.102-0.127) hr(-1); p = 0.41] and median measured and predicted trough concentration [14.2 (12.7-17.1) vs. 13.1 (11-17.8) upsilon g/mL; p = 0.71]. Patients who underwent TH/PI did not exhibit PK alterations when compared to predicted PK parameters based on population data, while patients who underwent CN experienced PK alterations favoring an increased elimination of vancomycin.	[Morbitzer, Kathryn A.; Rhoney, Denise H.] Univ N Carolina, UNC Eshelman Sch Pharm, Div Practice Adv & Clin Educ, Chapel Hill, NC 27599 USA; [Jordan, J. Dedrick] Univ N Carolina, Sch Med, Dept Neurol & Neurosurg, Chapel Hill, NC 27599 USA		Rhoney, DH (corresponding author), Univ N Carolina, UNC Eshelman Sch Pharm, Div Practice Adv & Clin Educ, 115 Beard Hall,Campus Box 7574, Chapel Hill, NC 27599 USA.	drhoney@unc.edu		Jordan, Dedrick/0000-0002-0706-9583			Ambrose P.J., 2004, BASIC CLIN PHARMACOK, P451; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; Cook AM, 2013, NEUROCRIT CARE, V19, pS238; Empey PE, 2013, CRIT CARE MED, V41, P2379, DOI 10.1097/CCM.0b013e318292316c; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; MATZKE GR, 1984, ANTIMICROB AGENTS CH, V25, P433, DOI 10.1128/AAC.25.4.433; Mercer JM, 2010, PHARMACOTHERAPY, V30, P654, DOI 10.1592/phco.30.7.654; Naidech AM, 2009, NEUROCRIT CARE, V10, P11, DOI 10.1007/s12028-008-9148-x; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; SAWYER WT, 1983, AM J HOSP PHARM, V40, P2175, DOI 10.1093/ajhp/40.12.2175; Scott BNV, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-68; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Wurtz R, 1997, CLIN INFECT DIS, V25, P112, DOI 10.1086/514505; Zeiner A, 2004, RESUSCITATION, V60, P253, DOI 10.1016/j.resuscitation.2003.11.006; Zhou JQ, 2011, EXPERT OPIN DRUG MET, V7, P803, DOI 10.1517/17425255.2011.574127	29	7	7	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2015	22	2					258	264		10.1007/s12028-014-0079-4			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CD9VK	WOS:000351447100012	25330755				2022-02-06	
J	Neto, AP; Zanco, N; Lolatto, DCJ; Moreira, PSA; Dromboski, T				Neto, Angelo Polizel; Zanco, Natalia; Lolatto, Danielly C. J.; Moreira, Paulo S. A.; Dromboski, Tiago			Economic losses caused by injuries in carcasses of cattle slaughtered in northern Mato Grosso, Brazil	PESQUISA VETERINARIA BRASILEIRA			Portuguese	Article						Economic losses; injuries; carcasses; cattle; animal well-being; transport; concussions; pre-slaughter management	TRANSPORT	This study evaluates the economic losses caused by lesions during shipping and pre- management in cattle slaughtered in Mato Grosso, Brazil. From 1,021 carcasses evaluated, 433 (42.4%) presented injuries caused hrough transportation and pre-slaughter management. Lesion frequency varied significantly with shipping times (P<0.05). Animals transported for up to 2 hours presented 1,82 lesion/carcass. In turn, animals transported 2 to 8 hours exhibited 2.05 lesion/carcass, what however did not differ statistically from the number of lesions in animals transported for more than 8 hours (2.07 lesion/carcass; P>0.05). Injured animals presented up to six lesions, although most (96.9%) had up to four lesions. Cattle transported for more than 2 hours presented more lesions than animals shipped for less than 2 hours (P<0.05). Most lesions were obsetrved on the loin (50.35% of lesions), followed by the rump (36.38%). Total weight loss of animals accounted for 115.76 kg, Annual economic losses in a midsized slaughterhouse were estimated at R$ 200,000 by lesions caused during transport and pre-slaughter management of cattle.	[Neto, Angelo Polizel; Zanco, Natalia; Lolatto, Danielly C. J.; Moreira, Paulo S. A.; Dromboski, Tiago] Univ Fed Mato Grosso, Inst Ciencias Saude, BR-78557267 Sinop, MT, Brazil		Neto, AP (corresponding author), Univ Fed Mato Grosso, Inst Ciencias Saude, Ave Alexandre Ferronato 1200, BR-78557267 Sinop, MT, Brazil.	polizelneto@ufmt.br		Dombroski, Tiago/0000-0001-8226-8147			Andrade E.N., 2007, THESIS 1NESP B3T1CAT; [Anonymous], 2014, SIST INF GER SERV IN; [Anonymous], 2011, REB BOV NAC CRESC 2; Ferreira J.L., 2010, MED VET, V8; Gallo C, 2001, ARCH MED VET, V33, P43, DOI 10.4067/S0301-732X2001000100005; Grandin T, 1997, J ANIM SCI, V75, P249; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA-IBGE, 2014, IND IBGE EST PROD PE; Paranhos da Costa M.J.R., 2002, AN 5 C RAC ZEB ABCZ, P170; Renner R.M., 2005, FATORES QUE AFETAM C; Roca R.O., 2002, ABATE HUMANITARIO BO; Romero M.P., 2012, REVTA MED VET ZOOTEC, V17, P1; SAS Institute, 2002, SAS SYST WIND REL 9; Souza A.A., 2007, PERDAS EC DEVIDO MAN	13	7	8	0	3	REVISTA PESQUISA VETERINARIA BRASILEIRA	RIO JANEIRO	EMBRAPA-SAUDE ANIMAL, KM47 SEROPEDICA, 23851-970 RIO JANEIRO, BRAZIL	0100-736X	1678-5150		PESQUI VET BRASIL	Pesqui. Vet. Bras.	APR	2015	35	4					324	328		10.1590/S0100-736X2015000400002			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	CM5RC	WOS:000357745300002		gold, Green Published			2022-02-06	
J	Spiegel, DP; Lague-Beauvais, M; Sharma, G; Farivar, R				Spiegel, Daniel P.; Lague-Beauvais, Maude; Sharma, Gaurav; Farivar, Reza			Inter-hemispheric wave propagation failures in traumatic brain injury are indicative of callosal damage	VISION RESEARCH			English	Article						Traumatic brain injury; Corpus callosum; Vision; Binocular rivalry; Visual deficit; Intra-hemispheric	DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; CORPUS-CALLOSUM; INTERHEMISPHERIC-TRANSFER; CHILDREN	Approximately 3.2-5.3 million Americans live with the consequences of a traumatic brain injury (TBI), making TBI one of the most common causes of disability in the world. Visual deficits often accompany TBI but physiological and anatomical evidence for injury in mild TBI is lacking. Axons traversing the corpus callosum are particularly vulnerable to TBI. Hemifield representations of early visual areas are linked by bundles of fibers that together cross the corpus callosum while maintaining their topographic relations. Given the increased vulnerability of the long visual axons traversing the corpus callosum, we hypothesized that inter-hemispheric transmission for vision will be impaired following mild TBI. Using the travelling wave paradigm (Wilson, Blake, & Lee 2001), we measured inter-hemispheric transmission in terms of both speed and propagation failures in 14 mild TBI patients and 14 age-matched controls. We found that relative to intra-hemispheric waves, inter-hemispheric waves were faster and that the interhemispheric propagation failures were more common in TBI patients. Furthermore, the transmission failures were topographically distributed, with a bias towards greater failures for transmission across the upper visual field. We discuss the results in terms of increased local inhibition and topographically-selective axonal injury in mild TBI. (C) 2015 Elsevier Ltd. All rights reserved.	[Spiegel, Daniel P.; Lague-Beauvais, Maude; Farivar, Reza] McGill Univ, Traumat Brain Injury Program, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Lague-Beauvais, Maude] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Spiegel, Daniel P.; Sharma, Gaurav; Farivar, Reza] McGill Univ, Dept Ophthalmol, McGill Vis Res Unit, Montreal, PQ H3A 2T5, Canada		Spiegel, DP (corresponding author), Dept Ophthalmol, McGill Vis Res Unit, 687 Pine Ave West,Rm H4-14, Montreal, PQ H3A 1A1, Canada.	daniel.spiegel@mcgill.ca; reza.farivar@mcgill.ca	Farivar, Reza/AAA-5762-2020	Lague-Beauvais, Maude/0000-0002-0773-0343	Research Institute of the McGill University Health Center grant; Psychological Health and Traumatic Brain Injury Research Program of the U.S. Department of Defense [W81XWH-14-1-0320]; Research Institute of the McGill University Health Center grant; Psychological Health and Traumatic Brain Injury Research Program of the U.S. Department of Defense [W81XWH-14-1-0320]	We thank Dr. Erhan Genc for providing us MATLAB code for the task. This research was funded by the Research Institute of the McGill University Health Center grant and by the Psychological Health and Traumatic Brain Injury Research Program of the U.S. Department of Defense under award W81XWH-14-1-0320. Views and opinions of, and endorsements by the author(s) do not reflect those of the US Army or the Department of Defense. There are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.	Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRYSBAERT M, 1994, BEHAV BRAIN RES, V64, P151, DOI 10.1016/0166-4328(94)90127-9; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Genc E, 2015, CEREB CORTEX, V25, P1499, DOI 10.1093/cercor/bht342; Genc E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00161; Genc E, 2011, CURR BIOL, V21, P1494, DOI 10.1016/j.cub.2011.08.003; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Gunton KB, 2012, CURR OPIN OPHTHALMOL, V23, P400, DOI 10.1097/ICU.0b013e3283567276; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; ISHIAI S, 1993, NEUROLOGY, V43, P106, DOI 10.1212/WNL.43.1_Part_1.106; Joanette Y., 1989, INT J CLIN NEUROPSYC; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller SM, 2010, P NATL ACAD SCI USA, V107, P2664, DOI 10.1073/pnas.0912149107; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Saenz M, 2010, NEUROIMAGE, V52, P1224, DOI 10.1016/j.neuroimage.2010.05.060; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Schuett S, 2013, CORTEX, V49, P1001, DOI 10.1016/j.cortex.2012.04.008; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Van Loon AM, 2013, CURRENT BIOL; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066	33	7	7	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		A				38	44		10.1016/j.visres.2015.02.020			7	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	CF9ZV	WOS:000352927300004	25752746	Bronze			2022-02-06	
J	Tasi, YC; Chin, TY; Chen, YJ; Huang, CC; Lee, SL; Wu, TY				Tasi, Yun-Chieh; Chin, Ting-Yu; Chen, Ying-Ju; Huang, Chun-Chih; Lee, Shou-Lun; Wu, Tzong-Yuan			Potential Natural Products for Alzheimer's Disease: Targeted Search Using the Internal Ribosome Entry Site of Tau and Amyloid-beta Precursor Protein	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						memantine; amyloid precursor protein; tau; Alzheimer's disease; internal ribosome entry sites; bi-cistronic	NMDA RECEPTOR ANTAGONISTS; TRAUMATIC BRAIN-INJURY; MESSENGER-RNA; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; DENDRITIC SPINES; DEFICIENT MICE; MEMANTINE; TRANSLATION	Overexpression of the amyloid precursor protein (APP) and the hyperphosphorylation of the tau protein are vital in the understanding of the cause of Alzheimer's disease (AD). As a consequence, regulation of the expression of both APP and tau proteins is one important approach in combating AD. The APP and tau proteins can be targeted at the levels of transcription, translation and protein structural integrity. This paper reports the utilization of a bi-cistronic vector containing either APP or tau internal ribosome entry site (IRES) elements flanked by -galactosidase gene (cap-dependent) and secreted alkaline phosphatase (SEAP) (cap-independent) to discern the mechanism of action of memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist. Results indicate that memantine could reduce the activity of both the APP and tau IRES at a concentration of similar to 10 M (monitored by SEAP activity) without interfering with the cap-dependent translation as monitored by the -galactosidase assay. Western blot analysis of the tau protein in neuroblastoma (N2A) and rat hippocampal cells confirmed the halting of the expression of the tau proteins. We also employed this approach to identify a preparation named NB34, extracts of Boussingaultia baselloides (madeira-vine) fermented with Lactobacillus spp., which can function similarly to memantine in both IRES of APP and Tau. The water maze test demonstrated that NB34 could improve the spatial memory of a high fat diet induced neurodegeneration in apolipoprotein E-knockout (ApoE(-/-)) mice. These results revealed that the bi-cistronic vector provided a simple, and effective platform in screening and establishing the mechanistic action of potential compounds for the treatment and management of AD.	[Tasi, Yun-Chieh] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Chin, Ting-Yu; Chen, Ying-Ju; Wu, Tzong-Yuan] Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan 32032, Taiwan; [Huang, Chun-Chih] New Bellus Enterprise Co Ltd, Tainan 72042, Taiwan; [Lee, Shou-Lun] China Med Univ, Dept Biol Sci & Technol, Taichung 40402, Taiwan; [Chin, Ting-Yu; Wu, Tzong-Yuan] Chung Yuan Christian Univ, Program & Ctr Nanosci Technol, Taoyuan 32032, Taiwan		Lee, SL (corresponding author), China Med Univ, Dept Biol Sci & Technol, Taichung 40402, Taiwan.	yun9350751@hotmail.com; tychin@cycu.edu.tw; assam217@yahoo.com.tw; john@newbellus.com.tw; sllee@mail.cmu.edu.tw; tywu@cycu.edu.tw		Chin, Ting-Yu/0000-0001-5492-1794	Ministry of Science and Technology (NSC) [102-2632-M-033-001-MY3];  [E10200049-092]	This research was supported by Grants from the Conventional Industry Technology Development (E10200049-092) and the Ministry of Science and Technology (NSC 102-2632-M-033-001-MY3).	Alley GM, 2010, J NEUROSCI RES, V88, P143, DOI 10.1002/jnr.22172; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Ando K, 2011, AM J PATHOL, V178, P803, DOI 10.1016/j.ajpath.2010.10.034; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Chen YJ, 2008, ACTA PHARMACOL SIN, V29, P1327, DOI 10.1111/j.1745-7254.2008.00876.x; Chen YJ, 2005, BIOCHEM BIOPH RES CO, V335, P616, DOI 10.1016/j.bbrc.2005.07.116; Cheng HH, 2009, J NEUROSCI RES, V87, P460, DOI 10.1002/jnr.21852; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Choi RCY, 2010, J ALZHEIMERS DIS, V19, P795, DOI 10.3233/JAD-2010-1293; Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108; Combs CK, 1998, DEV BRAIN RES, V107, P143; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Danysz W, 1997, NEUROSCI BIOBEHAV R, V21, P455, DOI 10.1016/S0149-7634(96)00037-1; Deshpande A, 2008, FASEB J, V22, P2357, DOI 10.1096/fj.07-096909; Domier LL, 2003, J GEN VIROL, V84, P415, DOI 10.1099/VIR.0.18781-0; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Gilling KE, 2009, NEUROPHARMACOLOGY, V56, P866, DOI 10.1016/j.neuropharm.2009.01.012; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Han GC, 2013, J ALZHEIMERS DIS, V35, P373, DOI 10.3233/JAD-121963; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jackson CE, 2008, ALZHEIMERS DEMENT, V4, pS137, DOI 10.1016/j.jalz.2007.10.008; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Krugers HJ, 1997, NEUROREPORT, V8, P2505, DOI 10.1097/00001756-199707280-00018; Lee JC, 2005, BIOTECHNOL BIOENG, V90, P656, DOI 10.1002/bit.20440; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Nakamura S, 2006, EUR J PHARMACOL, V548, P115, DOI 10.1016/j.ejphar.2006.07.049; NOTHIAS F, 1995, NEUROSCIENCE, V66, P707, DOI 10.1016/0306-4522(94)00598-Y; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Petersen RB, 2007, J ALZHEIMERS DIS, V11, P143; Prince M., 2009, WORLD ALZHEIMER REPO; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Qiu ZH, 2003, J NEUROIMMUNOL, V139, P51, DOI 10.1016/S0165-5728(03)00158-9; Ray B, 2010, NEUROSCI LETT, V470, P1, DOI 10.1016/j.neulet.2009.11.016; Reus GZ, 2010, BRAIN RES BULL, V81, P585, DOI 10.1016/j.brainresbull.2009.11.013; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rogawski MA, 2003, CNS DRUG REV, V9, P275, DOI 10.1111/j.1527-3458.2003.tb00254.x; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; Seeman P, 2008, SYNAPSE, V62, P149, DOI 10.1002/syn.20472; STEWARD O, 1982, J NEUROSCI, V2, P284; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Takashima A, 2009, J ALZHEIMERS DIS, V17, P729, DOI 10.3233/JAD-2009-1090; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; TERRY RD, 1964, AM J PATHOL, V44, P269; Tiedge H, 1996, J NEUROSCI, V16, P7171; Veinbergs I, 1999, NEUROSCIENCE, V91, P401, DOI 10.1016/S0306-4522(98)00602-2; Veo BL, 2009, J ALZHEIMERS DIS, V16, P271, DOI 10.3233/JAD-2009-0978; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu TY, 2011, TAIWAN J OBSTET GYNE, V50, P131, DOI 10.1016/j.tjog.2011.04.004; Wu TY, 2009, TAIWAN J OBSTET GYNE, V48, P273, DOI 10.1016/S1028-4559(09)60303-X; Zetterberg H, 2010, EXP GERONTOL, V45, P23, DOI 10.1016/j.exger.2009.08.002; Zhang Yao, 2009, Pathophysiology, V16, P311, DOI 10.1016/j.pathophys.2009.02.003; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	73	7	7	0	16	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	APR	2015	16	4					8789	8810		10.3390/ijms16048789			22	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	CH4YO	WOS:000354040400131	25903151	Green Published, Green Submitted, gold			2022-02-06	
J	Uemura, M; Ishiguro, H				Uemura, Makoto; Ishiguro, Hiroshi			Freezing behavior of adherent neuron-like cells and morphological change and viability of post-thaw cells	CRYOBIOLOGY			English	Article						Nerve cells; Freezing; Thawing; Ice crystals; Microscopic behavior; Morphology; Neurites; Cytoskeleton; Cell viability	NERVE GROWTH-FACTOR; INTRACELLULAR ICE FORMATION; TRAUMATIC BRAIN-INJURY; STRETCH-INJURY; DIRECTIONAL SOLIDIFICATION; PHEOCHROMOCYTOMA CELLS; AXON DEGENERATION; CRYOPRESERVATION; RAT; PRINCIPLES	Freezing of nerve cells forming a neuronal network has largely been neglected, despite the fact that the cryopreservation of nerve cells benefits the study of cells in the areas of medicine and poison screening. Freezing of nerve cells is also attractive for studying cell morphology because of the characteristic long, thread-like neurites extending from the cell body. In the present study, freezing of neuron-like cells adhering to the substrate (differentiated PC12 cells), in physiological saline, was investigated in order to understand the fundamental freezing and thawing characteristics of nerve cells with neurites. The microscopic freezing behavior of cells under different cooling rates was observed. Next, the post-thaw morphological changes in the cells, including the cytoskeleton, were investigated and post-thaw cell viability was evaluated by dye exclusion using propidium iodide. Two categories of morphological changes, beading and shortening of the neurites, were found and quantified. Also, the morphological changes of neurites due to osmotic stress from sodium chloride were studied to gain a better understanding of causation. The results showed that morphological changes and cell death were promoted with a decrease in end temperature during freezing. (C) 2015 Elsevier Inc. All rights reserved.	[Uemura, Makoto; Ishiguro, Hiroshi] Kyushu Inst Technol, Dept Biol Funct & Engn, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan		Ishiguro, H (corresponding author), Kyushu Inst Technol, Dept Biol Funct & Engn, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan.	ishiguro@life.kyutech.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [21360098, 24360083, 23 9393]	This work was supported by Grant-in-Aid for Scientific Research #21360098 and #24360083 (to H.I) and JSPS Fellows #23 9393 (to M.U.) from the Japan Society for the Promotion of Science.	Al-Noori S, 2000, NEUROSCIENCE, V101, P337, DOI 10.1016/S0306-4522(00)00384-5; Bakhach J, 2009, ORGANOGENESIS, V5, P119, DOI 10.4161/org.5.3.9583; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Day JG, 2008, MOL BIOTECHNOL, V40, P202, DOI 10.1007/s12033-008-9099-7; FRODL EM, 1994, BRAIN RES, V647, P286, DOI 10.1016/0006-8993(94)91328-5; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; GASTER RN, 1971, ARCH SURG-CHICAGO, V103, P378; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; He Xiaoming, 2011, Open Biomed Eng J, V5, P47, DOI 10.2174/1874120701105010047; Hsu M, 2014, J NEURAL TRANSM, V121, P15, DOI 10.1007/s00702-013-1077-y; ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059; Ishiguro H, 2008, INT J HEAT MASS TRAN, V51, P5642, DOI 10.1016/j.ijheatmasstransfer.2008.04.019; Javois L.C., 1999, IMMUNOCYTOCHEMICAL M; JENSEN S, 1984, J COMP NEUROL, V227, P558, DOI 10.1002/cne.902270407; JENSEN S, 1987, CRYOBIOLOGY, V24, P120, DOI 10.1016/0011-2240(87)90014-9; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; JOSHI HC, 1985, J CELL BIOL, V101, P697, DOI 10.1083/jcb.101.3.697; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Liu XY, 2001, APPL PHYS LETT, V79, P39, DOI 10.1063/1.1384007; Ma W, 2006, NEUROSCI LETT, V403, P84, DOI 10.1016/j.neulet.2006.04.064; Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410; Markin VS, 1999, BIOPHYS J, V76, P2852, DOI 10.1016/S0006-3495(99)77439-4; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; MCGRATH JJ, 1975, CRYOBIOLOGY, V12, P540, DOI 10.1016/0011-2240(75)90048-6; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; Nakayama Y, 2001, J NEUROTRAUM, V18, P545, DOI 10.1089/089771501300227341; Ochs S, 1997, PROG NEUROBIOL, V52, P391, DOI 10.1016/S0301-0082(97)00022-1; Paynter SJ, 2008, BRAIN RES BULL, V75, P1, DOI 10.1016/j.brainresbull.2007.08.004; Pichugin Y, 2006, CRYOBIOLOGY, V52, P228, DOI 10.1016/j.cryobiol.2005.11.006; PIKE CJ, 1992, NEUROREPORT, V3, P769, DOI 10.1097/00001756-199209000-00012; RUBINSKY B, 1985, CRYOBIOLOGY, V22, P55, DOI 10.1016/0011-2240(85)90008-2; RUKENSTEIN A, 1983, BRAIN RES, V263, P177, DOI 10.1016/0006-8993(83)91218-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SOUZU H, 1978, BIOPHYS J, V23, P89, DOI 10.1016/S0006-3495(78)85435-6; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; TSUKADA Y, 1994, BIOL PHARM BULL, V17, P370; Uchida T., 2007, CRYOBIOL CRYOTECHNOL, V53, P161; Yamazaki M, 2006, NEUROSCI LETT, V393, P222, DOI 10.1016/j.neulet.2005.09.068; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Zhmakin AI, 2008, PHYS-USP+, V51, P231, DOI 10.1070/PU2008v051n03ABEH006449	48	7	8	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0011-2240	1090-2392		CRYOBIOLOGY	Cryobiology	APR	2015	70	2					122	135		10.1016/j.cryobiol.2015.01.006			14	Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Physiology	CF6NR	WOS:000352673900007	25645578				2022-02-06	
J	Wang, YB; Wang, XY; Le Bitoux, MA; Wagnieres, G; Vandenbergh, H; Gonzalez, M; Ris, HB; Perentes, JY; Krueger, T				Wang, Yabo; Wang, Xingyu; Le Bitoux, Marie-Aude; Wagnieres, Georges; Vandenbergh, Hubert; Gonzalez, Michel; Ris, Hans-Beat; Perentes, Jean Y.; Krueger, Thorsten			Fluence Plays a Critical Role on the Subsequent Distribution of Chemotherapy and Tumor Growth Delay in Murine Mesothelioma Xenografts Pre-Treated by Photodynamic Therapy	LASERS IN SURGERY AND MEDICINE			English	Article						photodynamic therapy; drug/light conditions; tumor response; mesothelioma lipoplatin (R)	NEAR-INFRARED LIGHT; LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; TERM NEUROLOGICAL DEFICITS; ADULT HEAD MODEL; TRANSCRANIAL LASER; OPTICAL-PROPERTIES; EMBOLIC STROKES; ISCHEMIC-STROKE; MICE	Background: The pre-conditioning of tumor vessels by low-dose photodynamic therapy (L-PDT) was shown to enhance the distribution of chemotherapy in different tumor types. However, how light dose affects drug distribution and tumor response is unknown. Here we determined the effect of L-PDT fluence on vascular transport in human mesothelioma xenografts. The best L-PDT conditions regarding drug transport were then combined with Lipoplatin (R) to determine tumor response. Methods: Nude mice bearing dorsal skinfold chambers were implanted with H-Meso1 cells. Tumors were treated by Visudyne (R)-mediated photodynamic therapy with 100 mW/cm(2) fluence rate and a variable fluence (5, 10, 30, and 50 J/cm(2)). FITC-Dextran (FITC-D) distribution was assessed in real time in tumor and normal tissues. Tumor response was then determined with best L-PDT conditions combined to Lipoplatin (R) and compared to controls in luciferase expressing H-Meso1 tumors by size and whole body bioluminescence assessment (n = 7/group). Results: Tumor uptake of FITC-D following L-PDT was significantly enhanced by 10-fold in the 10 J/cm(2) but not in the 5, 30, and 50 J/cm(2) groups compared to controls. Normal surrounding tissue uptake of FITC-D following L-PDT was significantly enhanced in the 30 J/cm(2) and 50 J/cm(2) groups compared to controls. Altogether, the FITC-D tumor to normal tissue ratio was significantly higher in the 10 J/cm(2) group compared others. Tumor growth was significantly delayed in animals treated by 10 J/cm2-L-PDT combined to Lipoplatin (R) compared to controls. Conclusions: Fluence of L-PDT is critical for the optimal distribution and effect of subsequently administered chemotherapy. These findings have an importance for the clinical translation of the vascular L-PDT concept in the clinics. Lasers Surg. Med. 47:323-330, 2015. (C) 2015 Wiley Periodicals, Inc.	[Wang, Yabo; Wang, Xingyu; Gonzalez, Michel; Ris, Hans-Beat; Perentes, Jean Y.; Krueger, Thorsten] CHU Vaudois, Ecole Polytech Fed Lausanne, Dept Thorac & Vasc Surg, CH-1011 Lausanne, Switzerland; [Le Bitoux, Marie-Aude] CHU Vaudois, Ecole Polytech Fed Lausanne, Dept Pathol, CH-1011 Lausanne, Switzerland; [Wagnieres, Georges; Vandenbergh, Hubert] Ecole Polytech Fed Lausanne, Dept Chem, Lausanne, Switzerland		Krueger, T (corresponding author), Serv Chirurg Thorac & Vasc, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	Jean.Perentes@chuv.ch; Thorsten.Krueger@chuv.ch	Krueger, Thorsten/AAK-1780-2021	gonzalez, michel/0000-0001-8705-4279; Wagnieres, Georges/0000-0002-9082-3099			Alcantara CC, 2013, LASER SURG MED, V45, P246, DOI 10.1002/lsm.22129; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Assis L, 2012, LASER SURG MED, V44, P726, DOI 10.1002/lsm.22077; Bashkatov AN, 2006, P SOC PHOTO-OPT INS, V6163; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Custo A, 2006, APPL OPTICS, V45, P4747, DOI 10.1364/AO.45.004747; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Frigo L, 2010, PHOTOMED LASER SURG, V28, pS151, DOI 10.1089/pho.2008.2475; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Hamblin M., 2007, P SOC PHOTO-OPT INS, P1; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Houreld NN, 2010, LASER SURG MED, V42, P494, DOI 10.1002/lsm.20812; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Komel'kova L V, 2004, Patol Fiziol Eksp Ter, P15; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Lopes-Martins RAB, 2007, CURR RHEUMATOL REV, V3, P147, DOI 10.2174/157339707780619421; Lychagov VV, 2006, EXPT STUDY NIR TRANS; McCarthy TJ, 2010, PHOTOMED LASER SURG, V28, P663, DOI 10.1089/pho.2009.2581; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Novoselova EG, 2006, PHOTODERMATOL PHOTO, V22, P33, DOI 10.1111/j.1600-0781.2006.00191.x; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8; Tata DB, 2011, LASER PHOTONICS REV, V5, P1, DOI 10.1002/lpor.200900032; Trimmer PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-26; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Wu XJ, 2012, LASER SURG MED, V44, P227, DOI 10.1002/lsm.22004; Yip KK, 2011, NEUROSCIENCE, V190, P301, DOI 10.1016/j.neuroscience.2011.06.022; Young AER, 2000, BRIT J ANAESTH, V84, P38, DOI 10.1093/oxfordjournals.bja.a013379; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	42	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	APR	2015	47	4					323	330		10.1002/lsm.22329			8	Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology; Surgery	CG4DN	WOS:000353233100006	25639847				2022-02-06	
J	Davidsson, J; Risling, M				Davidsson, Johan; Risling, Marten			Characterization of pressure distribution in penetrating traumatic brain injuries	FRONTIERS IN NEUROLOGY			English	Article						penetrating traumatic brain injuries; TBI; pressure; experimental	RAT	Severe impacts to the head commonly lead to localized brain damage. Such impacts may also give rise to temporary pressure changes that produce secondary injuries in brain volumes distal to the impact site. Monitoring pressure changes in a clinical setting is difficult; detailed studies into the effect of pressure changes in the brain call for the development and use of animal models. The aim of this study is to characterize the pressure distribution in an animal model of penetrating traumatic brain injuries (pTBI). This data may be used to validate mathematical models of the animal model and to facilitate correlation studies between pressure changes and pathology. Pressure changes were measured in rat brains while subjected to pTBI for a variety of different probe velocities and shapes; pointy, blunt, and flat. Experiments on ballistic gel samples were carried out to study the formation of any temporary cavities. In addition, pressure recordings from the gel experiments were compared to values recorded in the animal experiments. The pTBI generated short lasting pressure changes in the brain tissue; the pressure in the contralateral ventricle (CLV) increased to 8 bar followed by a drop to 0.4 bar when applying flat probes. The pressure changes in the periphery of the probe, in the Cisterna Magna, and the spinal canal, were significantly less than those recorded in the CLV or the vicinity of the skull base. Highspeed videos of the gel samples revealed the formation of spherically shaped cavities when flat and spherical probes were applied. Pressure changes in the gel were similar to those recorded in the animals, although amplitudes were lower in the gel samples. We concluded cavity expansion rate rather than cavity size correlated with pressure changes in the gel or brain secondary to probe impact. The new data can serve as validation data for finite element models of the trauma model and the animal and to correlate physical measurements with secondary injuries.	[Davidsson, Johan] Chalmers Univ Technol, Appl Mech, SE-41296 Gothenburg, Sweden; [Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden		Davidsson, J (corresponding author), Chalmers Univ Technol, Dept Appl Mech, SE-41296 Gothenburg, Sweden.	johan.davidsson@chalmers.se	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514	Karolinska InstituteKarolinska Institutet; Swedish Ministry of Defence and Chalmers Area of Advance, Transport	The study was funded by Karolinska Institute, the Swedish Ministry of Defence and Chalmers Area of Advance, Transport. We thank Maria Angeria for excellent technical assistance.	Andersson RWG, 2000, THESIS U ADELAIDE AD; Berlin R, 1976, Acta Chir Scand Suppl, V459, P1; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Coupland RM, 2000, TRAUMA, V2, P1, DOI [DOI 10.1191/146040800675614143, 10.1191/146040800675614143]; Holbourn AHS, 1943, LANCET, V2, P438; Jacobo A-M, 2014, INT J AUTOMOTIVE ENG, V5, P31; Janzon B., 1983, THESIS U GOTHENBURG; Jussila J, 2004, FORENSIC SCI INT, V141, P91, DOI 10.1016/j.forsciint.2003.11.036; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Mitchell AS, 2005, EUR J NEUROSCI, V22, P973, DOI 10.1111/j.1460-9568.2005.04199.x; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling M, 2006, 8 INT NEUR S ROTT; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Tikka S., 1989, THESIS, p3a; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	20	7	7	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 13	2015	6								51	10.3389/fneur.2015.00051			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8CW	WOS:000363769800002	25821445	Green Published, gold			2022-02-06	
J	Lepach, AC; Pauls, F; Petermann, F				Lepach, Anja C.; Pauls, Franz; Petermann, Franz			Executive Functioning and Visual Working Memory	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						visual spatial memory; executive function; WMS-IV; cognitive control; visual working memory	COGNITIVE CONTROL; ATTENTION; COMPONENT; CAPACITY; PERFORMANCE; INHIBITION; LOAD	The matter of modality is controversially discussed in the context of working memory (WM). There is evidence that modality-specific processes are accompanied by amodal processes to some extent. We investigated the relationship between executive-functioning tasks and visual WM (VWM) and were especially interested in the issue of amodal processes. Our correlational analyses suggest modality-independent relations of the tasks. We also aimed to quantify to what extent executive functioning is meaningful for VWM performances. We therefore estimated the relationship between executive tasks and VWM performances in a healthy (n=710) and a clinical traumatic brain injury sample (n=151) as well as in the combined total sample. The results indicate a substantial relevance of the verbal task for VWM performances in the total and the clinical sample but a low relevance in the healthy sample. These results could support assumptions of resource-depending differences in the relations of executive functioning and VWM but need further validation due to limitations of our study.	[Lepach, Anja C.; Pauls, Franz; Petermann, Franz] Univ Bremen, Ctr Clin Psychol & Rehabil, D-28359 Bremen, Germany		Lepach, AC (corresponding author), Univ Bremen, Ctr Clin Psychol & Rehabil, Grazer Str 6, D-28359 Bremen, Germany.	alepach@uni-bremen.de					Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Baddeley A.D., 2006, WORKING MEMORY ED, P1, DOI [10.1016/B978-012554465-8/50003-X, DOI 10.1016/B978-012554465-8/50003-X]; Badre D, 2011, TOP COGN SCI, V3, P217, DOI 10.1111/j.1756-8765.2011.01141.x; Belopolsky AV, 2009, ACTA PSYCHOL, V132, P124, DOI 10.1016/j.actpsy.2009.01.002; Bledowski C, 2010, BEHAV BRAIN RES, V214, P172, DOI 10.1016/j.bbr.2010.05.041; Brady TF, 2011, J VISION, V11, DOI 10.1167/11.5.4; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Colom R, 2008, INTELLIGENCE, V36, P584, DOI 10.1016/j.intell.2008.01.002; Cooper RP, 2010, TOP COGN SCI, V2, P598, DOI 10.1111/j.1756-8765.2010.01110.x; Cowan N., 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Cowan N, 2010, CURR DIR PSYCHOL SCI, V19, P51, DOI 10.1177/0963721409359277; de Bruijn ERA, 2008, CORTEX, V44, P580, DOI 10.1016/j.cortex.2007.09.003; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fougnie D, 2010, J VISION, V10, DOI 10.1167/10.12.27; Gohier B, 2009, J AFFECT DISORDERS, V116, P100, DOI 10.1016/j.jad.2008.10.028; Grandjean J, 2011, BRAIN COGNITION, V77, P237, DOI 10.1016/j.bandc.2011.08.004; Hester R, 2005, MEM COGNITION, V33, P221, DOI 10.3758/BF03195311; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kim JH, 2004, SCHIZOPHR RES, V68, P173, DOI 10.1016/S0920-9964(03)00150-6; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Krumm S, 2008, LEARN INDIVID DIFFER, V18, P248, DOI 10.1016/j.lindif.2007.08.002; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lee K., 2009, PSYCHOL TEST ASSESS, V51, P403; Lepach AC, 2012, Z NEUROPSYCHOL, V23, P123, DOI 10.1024/1016-264X/a000070; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loomis JM, 2012, ATTEN PERCEPT PSYCHO, V74, P1260, DOI 10.3758/s13414-012-0311-2; Mackie MA, 2013, BRAIN COGNITION, V82, P301, DOI 10.1016/j.bandc.2013.05.004; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morton J. B., 2010, TOP COGN SCI, V3, P212; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Pauls F, 2013, MEMORY, V21, P857, DOI 10.1080/09658211.2013.765892; Pauls F, 2013, J CLIN EXP NEUROPSYC, V35, P702, DOI 10.1080/13803395.2013.820257; Penades R, 2005, PSYCHIAT RES, V133, P81, DOI 10.1016/j.psychres.2004.09.005; Petermann F, 2012, WECHSLER MEMORY SCAL; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schoneck N, 2013, Z NEUROPSYCHOL, V24, P89, DOI 10.1024/1016-264X/a000091; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Staufenbiel T., 2001, COR EXE VERSION 1 1; Stopford CL, 2012, CORTEX, V48, P429, DOI 10.1016/j.cortex.2010.12.002; Unsworth N., 2009, PSYCHOL SCI Q, V9, P637, DOI DOI 10.3758/PBR.16.5.931; Unsworth N, 2010, J MEM LANG, V62, P392, DOI 10.1016/j.jml.2010.02.001; Wechsler D., 2009, WECHSLER MEMORY SCAL; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396	47	7	7	1	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2015	22	2					100	107		10.1080/23279095.2013.860603			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CC5DR	WOS:000350379400004	25072205				2022-02-06	
J	Broternarkle, RA; Resnick, B; Michaels, K; Morton, P; Wells, C				Broternarkle, Rebecca A.; Resnick, Barbara; Michaels, Kathleen; Morton, Patricia; Wells, Chris			Length of hospital stay and discharge disposition in older trauma patients	GERIATRIC NURSING			English	Article						Older adults; Trauma; Length of Stay; Discharge Disposition; Pain; Therapy	INTENSIVE-CARE-UNIT; BRAIN-INJURY; OF-STAY; GENDER-DIFFERENCES; INSURANCE STATUS; MOBILIZATION PROTOCOL; OCCUPATIONAL-THERAPY; POSTOPERATIVE PAIN; FUNCTIONAL DECLINE; HIP FRACTURE	As the number of older adults increases and life expectancies are increasing, more incidences of traumatic injury are expected in this population. In this study, the relationships between demographic variables, pain, days from admission to therapy evaluation, length of stay and discharge disposition were examined in 132 older adults who had experienced a traumatic event. Results showed that significant relationships existed between pain, age, comorbidities, injury severity and days from admission to therapy evaluation and length of stay; those with less pain, greater age and had more days between admission and when the first therapy evaluation occurred had longer lengths of stay. In addition, demographic variables, overall length of stay and pain intensity during therapy were associated with discharge location; for longer lengths of stay and higher pain, older trauma patients were less likely to be discharged to home. (C) 2015 Elsevier Inc. All rights reserved.	[Broternarkle, Rebecca A.; Resnick, Barbara; Michaels, Kathleen] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Morton, Patricia] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA; [Wells, Chris] Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Broternarkle, RA (corresponding author), Univ Maryland, Sch Nursing, 655 West Lombard St, Baltimore, MD 21201 USA.	Rbrot001@son.umaryland.edu					Banerjee A, 2011, CURR OPIN ANESTHESIO, V24, P195, DOI 10.1097/ACO.0b013e3283445382; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Birmingham J, 2008, PROF CASE MANAG, V13, P7; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Buurman BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026951; Byrne B., 2001, STRUCTURAL EQUATION; Catananti C, 2010, SURG ONCOL, V19, P140, DOI 10.1016/j.suronc.2009.11.010; Centers for Medicare and Medicaid Services, 2007, MED COV SKILL NURS F; Chan LYL, 2009, ANAESTH INTENS CARE, V37, P773, DOI 10.1177/0310057X0903700511; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Chen AF, 2012, J ARTHROPLASTY, V27, P851, DOI 10.1016/j.arth.2012.01.011; Claridge JA, 2006, J TRAUMA, V60, P178, DOI 10.1097/01.ta.0000198804.74514.0c; Clark DE, 2013, PHYS THER, V93, P186, DOI 10.2522/ptj.20110417; Croce MA, 2002, J TRAUMA, V53, P889, DOI 10.1097/00005373-200211000-00013; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dinh MM, 2013, ANZ J SURG, V83, P60, DOI 10.1111/j.1445-2197.2012.06177.x; Enderlin CA, 2013, GERIATR NURS, V34, P47, DOI 10.1016/j.gerinurse.2012.08.003; Evans DC, 2012, J AM GERIATR SOC, V60, P1465, DOI 10.1111/j.1532-5415.2012.04075.x; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Feldt K S, 2000, Pain Manag Nurs, V1, P13, DOI 10.1053/jpmn.2000.5831; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Frontera JA, 2011, NEUROCRIT CARE, V14, P260, DOI 10.1007/s12028-010-9418-2; Gagliese L, 2005, PAIN, V117, P412, DOI 10.1016/j.pain.2005.07.004; Gagliese L, 2003, PAIN, V103, P11, DOI 10.1016/S0304-3959(02)00327-5; Gannon CJ, 2002, J AM COLL SURGEONS, V195, P11, DOI 10.1016/S1072-7515(02)01187-0; Garcia AE, 2012, J ORTHOP TRAUMA, V26, P620, DOI 10.1097/BOT.0b013e3182695416; Garzon-Serrano J, 2011, PM&R, V3, P307, DOI 10.1016/j.pmrj.2010.12.022; Grabowski DC, 2011, J HEALTH ECON, V30, P675, DOI 10.1016/j.jhealeco.2011.05.014; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Gregg SC, 2010, MED HLTH R I, V93, P115; Gregson J, 2001, J NUTR EDUC, V33, pS4, DOI 10.1016/S1499-4046(06)60065-1; Grossman MD, 2012, J TRAUMA ACUTE CARE, V72, P1181, DOI 10.1097/TA.0b013e31824d0e6d; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Hall SF, 2006, J CLIN EPIDEMIOL, V59, P849, DOI 10.1016/j.jclinepi.2005.11.013; Harada ND, 2000, MED CARE, V38, P1119, DOI 10.1097/00005650-200011000-00006; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang HT, 2013, J CLIN NURS, V22, P1322, DOI 10.1111/jocn.12055; Inaba K, 2003, J TRAUMA, V54, P486, DOI 10.1097/01.TA.0000051588.05542.D6; Jette DU, 2009, PHYS THER, V89, P1158, DOI 10.2522/ptj.20080338; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Juliano Karen, 2011, HSS J, V7, P16, DOI 10.1007/s11420-010-9167-y; Kamel HK, 2003, J GERONTOL A-BIOL, V58, P1042; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Kress John P, 2009, Crit Care Med, V37, pS442, DOI 10.1097/CCM.0b013e3181b6f9c0; Lefaivre KA, 2009, J BONE JOINT SURG BR, V91B, P922, DOI 10.1302/0301-620X.91B7.22446; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Li SF, 2001, ANN EMERG MED, V38, P644, DOI 10.1067/mem.2001.119849; Lim HJ, 2007, J TRAUMA, V63, P902, DOI 10.1097/01.ta.0000240110.14909.71; Lord RK, 2013, CRIT CARE MED, V41, P717, DOI 10.1097/CCM.0b013e3182711de2; Maramba PJ, 2004, J NURS CARE QUAL, V19, P123, DOI 10.1097/00001786-200404000-00009; Masley PM, 2011, PHYS THER, V91, P906, DOI 10.2522/ptj.20100296; Mason SE, 2009, HEALTH SOC WORK, V34, P8, DOI 10.1093/hsw/34.1.8; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; McMahon DJ, 1996, WORLD J SURG, V20, P1113, DOI 10.1007/s002689900170; Mehta SS, 2010, PAIN MED, V11, P1516, DOI 10.1111/j.1526-4637.2010.00950.x; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Mudge AM, 2010, J GERONTOL A-BIOL, V65, P863, DOI 10.1093/gerona/glq069; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; *NAT CTR INJ PREV, 2009, CDC INJ RES AG 2009; National Trauma Data Bank, 2012, NAT TRAUM DAT BANK 2; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Newell MA, 2009, J TRAUMA, V67, P337, DOI 10.1097/TA.0b013e3181add08b; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Niven DJ, 2012, AM J SURG, V204, P151, DOI 10.1016/j.amjsurg.2012.02.014; O'Brien L, 2012, AM J OCCUP THER, V66, P431, DOI 10.5014/ajot.2012.003137; Oldmeadow LB, 2006, ANZ J SURG, V76, P607, DOI 10.1111/j.1445-2197.2006.03786.x; Oyetunji T, 2010, J SURG RES, V159, P627, DOI 10.1016/j.jss.2009.08.026; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peschman J, 2011, J TRAUMA, V70, P1331, DOI 10.1097/TA.0b013e31821693e2; Phillips JT, 1984, W VA L REV, V87, P13; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Resnick B, 2013, OLDER TRAUMA P UNPUB; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; SACCO WJ, 1993, J TRAUMA, V35, P538, DOI 10.1097/00005373-199310000-00007; Sacks GD, 2011, J TRAUMA, V71, P1011, DOI 10.1097/TA.0b013e3182092c27; Scheetz LJ, 2005, J NURS SCHOLARSHIP, V37, P361, DOI 10.1111/j.1547-5069.2005.00062.x; Scheetz LJ, 2005, RES NURS HEALTH, V28, P198, DOI 10.1002/nur.20075; Schmelkin L.P., 1991, MEASUREMENT DESIGN A; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shapiro MJ, 2001, ACAD EMERG MED, V8, P78, DOI 10.1111/j.1553-2712.2001.tb00560.x; Shepperd S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub3; Smith BA, 2010, PHYS THER, V90, P693, DOI 10.2522/ptj.20090164; Society for Hospital Medicine, 2004, DISCH DISP FACT SHEE; Soles GLS, 2011, J ORTHOP TRAUMA, V25, pS61, DOI 10.1097/BOT.0b013e31821b8a3b; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; US Census Bureau, 2010, NEXT 4 DEC OLD POP U; Wellman SS, 2011, CURR REV MUSCULOSKE, V4, P84, DOI 10.1007/s12178-011-9091-x	93	7	7	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4572	1528-3984		GERIATR NURS	Geriatr. Nurs.	MAR-APR	2015	36	2		S			S3	S9		10.1016/j.gerinurse.2015.02.016			7	Geriatrics & Gerontology; Gerontology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Nursing	CG3LW	WOS:000353182700002	25858517				2022-02-06	
J	Hashikawa, AN; Newton, MF; Cunningham, RM; Stevens, MW				Hashikawa, Andrew N.; Newton, Manya F.; Cunningham, Rebecca M.; Stevens, Martha W.			Unintentional injuries in child care centers in the United States: A systematic review	JOURNAL OF CHILD HEALTH CARE			English	Article						Accident and emergency; childhood; pediatric	PRESCHOOL-CHILDREN; SAFETY REGULATIONS; PLAYGROUND HAZARDS; INFECTIOUS-DISEASE; PASSENGER SAFETY; HEALTH; EPIDEMIOLOGY; IMPACT; PREVENTION; PROGRAMS	The study systematically reviewed all types of unintentional injury and injury prevention research studies occurring within child care centers in the United States. A total of 2 reviewers searched 11 electronic databases to identify 53 articles meeting inclusion criteria. No studies used trauma registries or randomized control trials. Data were not pooled for further analysis because studies lacked standardized definitions for injury, rates, severity, exposure, and demographics. The following child care center injury rates were reported: (0.25-5.31 injuries per 100,000 child-hours); (11.3-18 injuries per 100 children per year); (6-49 injuries per 1000 child-years); (2.5-8.29 injuries per child-year); (2.6-3.3 injuries per child); (3.3-6.3 injuries per 100 observations); (635-835 medically attended injuries per year per 100,000 children and 271-364 child care center playground injuries per year per 100,000 children); and (3.8 injuries per child per 2000 exposure hours). Child care center injury rates were comparable to injury rates published for schools, playground, and summer camp. Most injuries were minor, while most severe injuries (fractures and concussions) were falls from playground structures. Future studies need to use standardized injury definitions and injury severity scales, focus efforts on preventing severe playground injuries in child care centers, and report child care parameters for inclusion in national injury databases.	[Hashikawa, Andrew N.; Newton, Manya F.; Cunningham, Rebecca M.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Stevens, Martha W.] Johns Hopkins Sch Med, Baltimore, MD USA		Hashikawa, AN (corresponding author), Childrens Emergency Serv, Dept Emergency Med, 24 Frank Lloyd Wright Suite H-3200, Ann Arbor, MI 48105 USA.	Hashikawa.andrew@gmail.com					AAP (Am. Acad. Pediatr.). APHA (Am. Public Health Assoc.) NRCKIDS (Natl. Resour. Cent. Health Saf. Child Care Early Educ.), 2011, CAR OUR CHILDR NAT H; ADDISS DG, 1994, AM J PUBLIC HEALTH, V84, P1161, DOI 10.2105/AJPH.84.7.1161; Alkon A, 2000, Inj Prev, V6, P214, DOI 10.1136/ip.6.3.214; ALKON A, 1994, PEDIATRICS, V94, P1043; Alkon A, 1999, ARCH PEDIAT ADOL MED, V153, P1248, DOI 10.1001/archpedi.153.12.1248; Alkon A, 2009, ACAD PEDIATR, V9, P366, DOI 10.1016/j.acap.2009.05.005; [Anonymous], 1988, MMWR-MORBID MORTAL W, V37, P629; ARONSON SS, 1980, PEDIATRICS, V65, P318, DOI 10.1542/peds.65.2.318; ARONSON SS, 1983, YOUNG CHILDREN, V38, P19; Atkinson AM, 1963, THESIS U WISCONSIN M; BASSOFF BZ, 1991, PUBLIC HEALTH REP, V106, P523; Bitner SO, 1964, YOUNG CHILDREN, V19, P194; Borse N, 2009, FAM COMMUNITY HEALTH, V32, P189, DOI 10.1097/01.FCH.0000347986.44810.59; BRISS PA, 1995, ARCH PEDIAT ADOL MED, V149, P906, DOI 10.1001/archpedi.1995.02170210080014; BRISS PA, 1994, PEDIATRICS, V93, P364; Browning K S, 1996, Inj Prev, V2, P202, DOI 10.1136/ip.2.3.202; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P329; CHANG A, 1989, PEDIATRICS, V83, P272; CHANG A, 1985, PEDIATRICS, V76, P425; Chang BA, 2002, INJ PREV, V8, P284, DOI 10.1136/ip.8.4.284; Cradock ALI, 2010, J PHYS ACT HEALTH, V7, pS108, DOI 10.1123/jpah.7.s1.s108; Cummings P, 1996, Inj Prev, V2, P105, DOI 10.1136/ip.2.2.105; Currie J, 2004, J HEALTH ECON, V23, P25, DOI 10.1016/j.jhealeco.2003.07.004; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; DAVIS WS, 1988, AM J DIS CHILD, V142, P386; Dowd MD, 2002, CRIT CARE MED, V30, pS385, DOI 10.1097/00003246-200211001-00002; ELARDO R, 1987, AM J ORTHOPSYCHIAT, V57, P60, DOI 10.1111/j.1939-0025.1987.tb03509.x; Elardo R, 1989, EARLY CHILDHOOD RES, V4, P89; Federer SS, 1964, YOUNG CHILDREN, V19, P188; Fiene R., 2002, 13 INDICATORS QUALIT; FULLER EM, 1948, AM J ORTHOPSYCHIAT, V18, P708, DOI 10.1111/j.1939-0025.1948.tb05134.x; GARRARD J, 1988, AM J DIS CHILD, V142, P643, DOI 10.1001/archpedi.1988.02150060077037; Goldlust E, 2009, INJURY PREV, V15, P413, DOI 10.1136/ip.2008.020487; Gordon RA, 2007, DEMOGRAPHY, V44, P307, DOI 10.1353/dem.2007.0011; GRATZ R, 1992, CHILDRENS HLTH CARE, V21, P239; Gratz R R, 1992, J Pediatr Health Care, V6, P256, DOI 10.1016/0891-5245(92)90024-X; HARTMAN EE, 1966, J LANCET, V86, P22; Heymann SJ, 1999, AM J PUBLIC HEALTH, V89, P502, DOI 10.2105/AJPH.89.4.502; Heymann SJ, 1999, ARCH PEDIAT ADOL MED, V153, P870, DOI 10.1001/archpedi.153.8.870; Heymann SJ, 1996, PEDIATRICS, V98, P226; Huber, 1996, EDUC TREAT CHILD, V19, P46; KENDALL ED, 1986, REV INFECT DIS, V8, P651; KENDRICK AS, 1994, PEDIATRICS, V94, P1108; Kotch J B, 1997, Inj Prev, V3, P267, DOI 10.1136/ip.3.4.267; Kotch JB, 2003, INJURY PREV, V9, P220, DOI 10.1136/ip.9.3.220; KRENZELOK EP, 1981, AM J PUBLIC HEALTH, V71, P750, DOI 10.2105/AJPH.71.7.750; LANDMAN PF, 1987, AM J DIS CHILD, V141, P292, DOI 10.1001/archpedi.1987.04460030070027; Lee E J, 1990, J Pediatr Health Care, V4, P18; LELAND NL, 1993, AM J DIS CHILD, V147, P826, DOI 10.1001/archpedi.1993.02160320028014; LELAND NL, 1994, J DEV BEHAV PEDIATR, V15, P402; Mack M, 2001, INJURY CONTROL SAFET, V8, P45; McClure RJ, 1996, ACCIDENT ANAL PREV, V28, P443, DOI 10.1016/0001-4575(96)00012-7; Nadel FM, 2010, OPEN PEDIAT MED J, V4, P14; National Survey of Children's Health, 2007, DAT RES CTR; Newton MF, 2008, JAMA-J AM MED ASSOC, V300, P1914, DOI 10.1001/jama.300.16.1914; OCONNOR MAS, 1992, AM J PREV MED, V8, P14, DOI 10.1016/S0749-3797(18)30857-2; Perez H, 2011, CHILD YOUTH CARE FOR, V40, P151, DOI 10.1007/s10566-010-9128-0; Polinder S, 2005, PEDIATRICS, V116, pE810, DOI 10.1542/peds.2005-1035; Price S S, 1999, J Dent Hyg, V73, P135; RUNYAN CW, 1991, AM J PUBLIC HEALTH, V81, P981, DOI 10.2105/AJPH.81.8.981; SACKS JJ, 1990, AM J PUBLIC HEALTH, V80, P986, DOI 10.2105/AJPH.80.8.986; SACKS JJ, 1989, JAMA-J AM MED ASSOC, V262, P1641, DOI 10.1001/jama.262.12.1641; SACKS JJ, 1992, AM J PUBLIC HEALTH, V82, P429, DOI 10.2105/AJPH.82.3.429; SACKS JJ, 1995, AM J PUBLIC HEALTH, V85, P266, DOI 10.2105/AJPH.85.2.266; Schwebel DC, 2006, J PEDIATR PSYCHOL, V31, P184, DOI 10.1093/jpepsy/jsj007; Schwebel DC, 2006, J PEDIATR PSYCHOL, V31, P152, DOI 10.1093/jpepsy/jsj001; Shope TR, 2005, PEDIATR REV, V26, P86, DOI 10.1542/pir.26-3-86; Snow CW, 1992, EARLY CHILDHOOD ED J, V19, P28; SOLOMONS HC, 1982, CHILD HEALTH CARE, V10, P90; STRAUMANRAYMOND K, 1993, J SCHOOL HEALTH, V63, P254, DOI 10.1111/j.1746-1561.1993.tb06136.x; Taras H L, 1993, J Community Health, V18, P261, DOI 10.1007/BF01321787; Tinsworth D. K., 2001, SPECIAL STUDY INJURI; Turner W, 1993, CHILDRENS HLTH CARE, V22, P73, DOI DOI 10.1207/S15326888CHC2201_; Ulione M S, 1997, J Pediatr Nurs, V12, P148, DOI 10.1016/S0882-5963(97)80072-3; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898; Waibel R, 2003, J SCHOOL HEALTH, V73, P167, DOI 10.1111/j.1746-1561.2003.tb03597.x; WASSERMAN RC, 1989, J PEDIATR-US, V114, P591, DOI 10.1016/S0022-3476(89)80700-0; Wrigley J, 2005, AM SOCIOL REV, V70, P729, DOI 10.1177/000312240507000501; ZIGLER E, 2009, TRAGEDY CHILD CARE A	79	7	7	3	16	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1367-4935	1741-2889		J CHILD HEALTH CARE	J. Child Health Care	MAR	2015	19	1					93	105		10.1177/1367493513501020			13	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	CD7VI	WOS:000351302500010	24092867				2022-02-06	
J	Lynch, JM; Anderson, M; Benton, B; Green, SS				Lynch, James M.; Anderson, Megan; Benton, Brooke; Green, Sue Stanley			The Gaming of Concussions: A Unique Intervention in Postconcussion Syndrome	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; computer glasses; gaming glasses	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; VISUALLY SENSITIVE MIGRAINE; MINOR HEAD-INJURY; HIGH-SCHOOL; TINTED SPECTACLES; SYMPTOM SCALE; KING-DEVICK; BASE-LINE; RECOVERY	Objective: To present the case of 2 adolescent high school student-athletes who developed postconcussion syndrome with protracted and limiting visual complaints that markedly affected academic, social, and athletic activity for a year after the onset of symptoms. Both had significant improvement soon after a unique intervention was administered. Background: A 14-year-old female soccer and softball player sustained 2 concussions in the same week. She had persistent symptoms for a year that affected her grades and precluded athletic participation. A 15-year-old male football player sustained a concussion during an altercation with 2 other male adolescents. He continued to have symptoms 1 year later, with a marked decrease in academic performance and restriction from athletics. Both adolescents reported blurry vision, photophobia, and associated headache as significant components of the postconcussion syndrome. Differential Diagnosis: Concussion, postconcussion syndrome, skull fracture, subdural hematoma, epidural hematoma, second-impact syndrome, and visually sensitive migraine. Treatment: Both patients were advised to obtain computer gaming glasses to use throughout the day. The female patient was diligent in her use of the glasses, with marked lessening of symptoms. The male patient was less accepting of the glasses but did report lessening of symptoms when using the glasses. Uniqueness: We hypothesized that postconcussion syndrome with marked visual complaints would respond to and improve with decreased stimulation of the visual system. This was attempted with the addition of computer gaming glasses. Both adolescent athletes responded well to the filtering of visual stimuli by off-the-shelf computer gaming glasses. Conclusions: Postconcussion syndrome is a persistent condition with a myriad of symptoms. Two young athletes developed postconcussion syndrome with prominent visual symptoms that lasted a year. The addition of computer gaming glasses markedly lessened symptoms in both patients.	[Lynch, James M.; Anderson, Megan; Green, Sue Stanley] Florida Southern Coll, Lakeland, FL 33801 USA; [Benton, Brooke] Lakeland Christian High Sch, Lakeland, FL USA		Lynch, JM (corresponding author), Florida Southern Coll, 111 Lake Hollingsworth Dr, Lakeland, FL 33801 USA.	jlynch@flsouthern.edu		Lynch, James/0000-0001-9761-5180			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Daum Kent M, 2004, Optometry, V75, P33, DOI 10.1016/S1529-1839(04)70009-3; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Evans BJW, 2002, OPHTHAL PHYSL OPT, V22, P130, DOI 10.1046/j.1475-1313.2002.00017.x; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Kirkwood MW, 2012, CLIN J SPORT MED, V22, P383, DOI 10.1097/JSM.0b013e31826396fc; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Okumura A, 2004, NEW ENGL J MED, V351, P403, DOI 10.1056/NEJM200407223510424; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Takahashi Y, 2001, NEUROLOGY, V57, P1767, DOI 10.1212/WNL.57.10.1767; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wilkins AJ, 2002, CEPHALALGIA, V22, P711, DOI 10.1046/j.1468-2982.2002.00362.x; Wilkins AJ, 1999, SEIZURE-EUR J EPILEP, V8, P444, DOI 10.1053/seiz.1999.0337; World Health Organization, 1992, ICD 10 CLASSIFICATIO	44	7	7	0	19	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2015	50	3					270	276		10.4085/1062-6050-49.3.78			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CQ8AM	WOS:000360828300006	25347238	Green Published			2022-02-06	
J	Mansoor, S; Afshar, M; Barrett, M; Smith, GS; Barr, EA; Lissauer, ME; McCurdy, MT; Murthi, SB; Netzer, G				Mansoor, Sahar; Afshar, Majid; Barrett, Matthew; Smith, Gordon S.; Barr, Erik A.; Lissauer, Matthew E.; McCurdy, Michael T.; Murthi, Sarah B.; Netzer, Giora			Acute respiratory distress syndrome and outcomes after near hanging	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							ACUTE LUNG INJURY; PULMONARY-EDEMA; PROGNOSTIC-FACTORS; RISK-FACTORS; TRAUMA; MANAGEMENT; EMERGENCY; MORTALITY; ACCIDENT; ETIOLOGY	Purpose: The purpose of this study is to assess the case rate of acute respiratory distress syndrome (ARDS) after near hanging and the secondary outcomes of traumatic and/or anoxic brain injury and death. Risk factors for the outcomes were assessed. Method: The method is a single-center, state wide retrospective cohort study of consecutive patients admitted between August 2002 and September 2011, with a primary diagnosis of nonjudicial "hanging injury." Results: Of 56 patients, 73% were male. The median age was 31 (Interquartile range (IQR), 16-56). Upon arrival, 9% (5/56) did not have a pulse, and 23% (13/56) patients were intubated. The median Glasgow Coma Scale (GCS) was 13 (IQR, 3-15); 14% (8/56) had a GCS = 3. Acute respiratory distress syndrome developed in 9% (5/56) of patients. Traumatic anoxic brain injury resulted in 9% (5/56) of patients. The in-hospital case fatality was 5% (3/56). Lower median GCS (3 [IQR, 3-7] vs 14 [IQR, 3-15]; P = .0003) and intubation in field or in trauma resuscitation unit (100% [5/5] vs 16% [8/51]; P = .0003) were associated with ARDS development. Risk factors of death were GCS = 3 (100% [3/3] vs 9% [5/53]; P = .002), pulselessness upon arrival of emergency medical services (100% [3/3] vs 4% [2/53]; P < .001], and abnormal neurologic imaging (50% [1/2] vs zero; P = .04). Conclusions: The ARDS case rate after near hanging is similar to the general trauma population. Low GCS and intubation are associated with increased risk of ARDS development. The rate of traumatic and/or anoxic brain injury in this population is low. (C) 2014 Elsevier Inc. All rights reserved.	[Mansoor, Sahar] Univ Virginia, Sch Med, Div Pulm & Crit Care Med, Charlottesville, VA 22903 USA; [Afshar, Majid; McCurdy, Michael T.; Netzer, Giora] Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Barrett, Matthew] Christiana Care Hlth Syst, Div Pulm & Crit Care Med, Newark, DE USA; [Barrett, Matthew] Christiana Care Hlth Syst, Dept Emergency Med, Newark, DE USA; [Smith, Gordon S.; Barr, Erik A.; Netzer, Giora] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Lissauer, Matthew E.] Rutgers Robert Wood Johnson Med Sch, Dept Surg, Div Acute Care Surg, New Brunswick, NJ USA; [McCurdy, Michael T.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Murthi, Sarah B.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Mansoor, S (corresponding author), Univ Virginia, Sch Med, Div Pulm & Crit Care Med, POB 800546, Charlottesville, VA 22903 USA.	smansoor.sahar@gmail.com	Afshar, Majid/AAD-8365-2019; McCurdy, Michael/T-5518-2019	Afshar, Majid/0000-0002-6368-4652; McCurdy, Michael/0000-0001-5319-0475; Smith, Gordon/0000-0002-2911-3071; Lissauer, Matthew/0000-0002-6008-9778	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1AA018313-01A1, F32AA022553-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018313, F32AA022553] Funding Source: NIH RePORTER	This research was supported in part by National Institutes of Health grants 1RO1AA018313-01A1 (GSS) and F32AA022553-01 (MA).	Ackland GL, 2005, CHEST, V127, P1867, DOI 10.1378/chest.127.5.1867-a; Afshar M, 2014, J TRAUMA ACUTE CARE, V76, P1447, DOI 10.1097/TA.0000000000000238; Albergaria Viviane Ferreira, 2008, Rev. Bras. Anestesiol., V58, P391; Azzam HC, 2009, J AM MED INFORM ASSN, V16, P503, DOI 10.1197/jamia.M3120; Baker SP, 2013, AM J PREV MED, V44, P146, DOI 10.1016/j.amepre.2012.10.010; Berdai AM, 2013, AM J CASE REP, V14, P350, DOI 10.12659/AJCR.889415; BERLYNE N, 1968, BRIT J PSYCHIAT, V114, P411, DOI 10.1192/bjp.114.509.411; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; FERSTENFELD JE, 1975, AM J MED, V58, P709, DOI 10.1016/0002-9343(75)90508-2; FISCHMAN CM, 1977, CHEST, V71, P225, DOI 10.1378/chest.71.2.225; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Garg T, 2007, INTERNET J ANESTHESI, V17; Hanna SJ, 2004, INJURY, V35, P253, DOI 10.1016/S0020-1383(03)00110-4; Howell MA, 1996, J ACCID EMERG MED, V13, P135; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Kaki A, 1997, CAN J ANAESTH, V44, P445, DOI 10.1007/BF03014468; Koenig HC, 2011, CRIT CARE MED, V39, P98, DOI 10.1097/CCM.0b013e3181feb4a0; Kumar M, 2009, INDIAN J ANAESTH, V53, P355; Martin MJ, 2005, AM J SURG, V190, P836, DOI 10.1016/j.amjsurg.2005.05.051; Matsuyama T, 2004, AM J EMERG MED, V22, P207, DOI 10.1016/j.ajem.2004.02.012; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Miller PR, 2002, AM SURGEON, V68, P845; MOSS G, 1972, J TRAUM, V12, P885, DOI 10.1097/00005373-197210000-00009; MOSS G, 1971, Surgical Forum (Chicago), V22, P211; MOSS G, 1973, AM J SURG, V126, P37, DOI 10.1016/S0002-9610(73)80090-X; Nair Shalini, 2009, Indian J Med Sci, V63, P53; Oswalt C E, 1977, Rev Surg, V34, P364; Peixoto Aldo José, 2002, Rev. Bras. Anestesiol., V52, P335, DOI 10.1590/S0034-70942002000300009; Penney DJ, 2002, RESUSCITATION, V54, P27, DOI 10.1016/S0300-9572(02)00050-3; Petitjean C, 1975, Ann Anesthesiol Fr, V16 Spec No 2-3, P57; PETTY TL, 1971, CHEST, V60, P233, DOI 10.1378/chest.60.3.233; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Salim A, 2006, INJURY, V37, P435, DOI 10.1016/j.injury.2005.12.013; Sinha A, 2008, INDIAN J PEDIATR, V75, P1075, DOI 10.1007/S12098-008-0091-9; Solhi H, 2012, J EMERG MED, V43, P599, DOI 10.1016/j.jemermed.2011.09.035; Stromgren E, 1946, ACTA PSYCH NEUROL, V21, P753, DOI 10.1111/j.1600-0447.1946.tb07310.x; Trujillo MH, 2007, HEART LUNG, V36, P364, DOI 10.1016/j.hrtlng.2006.10.005; Van Kooy MA, 2000, AM FAM PHYSICIAN, V62, P401; Viswanathan S, 2012, J TRAUMA ACUTE CARE, V72, P297, DOI 10.1097/TA.0b013e3182191298; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watanabe M, 2000, Nihon Kokyuki Gakkai Zasshi, V38, P797	43	7	8	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAR	2015	33	3					359	362		10.1016/j.ajem.2014.12.001			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CE6GP	WOS:000351935100009	25596627	Green Accepted			2022-02-06	
J	Urbanczyk, CA; Palmeri, ML; Bass, CR				Urbanczyk, Caryn A.; Palmeri, Mark L.; Bass, Cameron R.			MATERIAL CHARACTERIZATION OF IN VIVO AND IN VITRO PORCINE BRAIN USING SHEAR WAVE ELASTICITY	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Ultrasound; Shear wave elasticity; Acoustic radiation force; Brain stiffness; Intracranial pressure; Confinement	MAGNETIC-RESONANCE ELASTOGRAPHY; MECHANICAL-PROPERTIES; HEAD-INJURY; TISSUE; BEHAVIOR; SPEED; PATHOPHYSIOLOGY; COMPRESSION; STIFFNESS; MODELS	Realistic computer simulation of closed head trauma requires accurate mechanical properties of brain tissue, ideally in vivo. A substantive deficiency of most existing experimental brain data is that properties were identified through in vitro mechanical testing. This study develops a novel application of shear wave elasticity imaging to assess porcine brain tissue shear modulus in vivo. Shear wave elasticity imaging is a quantitative ultrasound technique that has been used here to examine changes in brain tissue shear modulus as a function of several experimental and physiologic parameters. Animal studies were performed using two different ultrasound transducers to explore the differences in physical response between closed skull and open skull arrangements. In vivo intracranial pressure in four animals was varied over a relevant physiologic range (2-40 mmHg) and was correlated with shear wave speed and stiffness estimates in brain tissue. We found that stiffness does not vary with modulation of intracranial pressure. Additional in vitro porcine specimens (n = 14) were used to investigate variation in brain tissue stiffness with temperature, confinement, spatial location and transducer orientation. We observed a statistically significant decrease in stiffness with increased temperature (23%) and an increase in stiffness with decreasing external confinement (22-37%). This study determined the feasibility of using shear wave elasticity imaging to characterize porcine brain tissue both in vitro and in vivo. Our results underline the importance of temperature-and skull-derived boundary conditions to brain stiffness and suggest that physiologic ranges of intracranial pressure do not significantly affect in situ brain tissue properties. Shear wave elasticity imaging allowed for brain material properties to be experimentally characterized in a physiologic setting and provides a stronger basis for assessing brain injury in computational models. (C) 2015 World Federation for Ultrasound in Medicine & Biology.	[Urbanczyk, Caryn A.; Palmeri, Mark L.; Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA		Urbanczyk, CA (corresponding author), Duke Univ, 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.	caryn.urbanczyk@duke.edu	Palmeri, Mark L/B-7167-2015	Palmeri, Mark L/0000-0001-8995-0050	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB002132] Funding Source: NIH RePORTER; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB002132] Funding Source: Medline		Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; ARBOGAST KB, 1997, P 41 STAPP CAR CRASH, P293; Bass CR, 2007, SPINE, V32, pE436, DOI 10.1097/BRS.0b013e3180b7fa58; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bilston LE, 2001, BIORHEOLOGY, V38, P335; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brands D W, 2000, Stapp Car Crash J, V44, P249; Carlson LC, 2014, ULTRASOUND OBST GYN, V43, P452, DOI 10.1002/uog.12555; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Doherty JR, 2013, IEEE T ULTRASON FERR, V60, P685, DOI 10.1109/TUFFC.2013.2617; Fahey BJ, 2008, IEEE T ULTRASON FERR, V55, P1095, DOI 10.1109/TUFFC.2008.762; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Gennarelli TA, 1992, J EMERGENCY MED, V11, P5; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Hsu SJ, 2007, ULTRASOUND MED BIOL, V33, P1706, DOI 10.1016/j.ultrasmedbio.2007.05.009; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P11; Li CP, 2009, ULTRASOUND MED BIOL, V35, P1615, DOI 10.1016/j.ultrasmedbio.2009.05.011; LOUPAS T, 1995, IEEE T ULTRASON FERR, V42, P689, DOI 10.1109/58.393111; Mace E, 2011, IEEE T MED IMAGING, V30, P550, DOI 10.1109/TMI.2010.2079940; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Munkeby BH, 2004, J MAGN RESON IMAGING, V20, P8, DOI 10.1002/jmri.20084; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rose J. L., 2004, ULTRASONIC WAVES SOL; Rotemberg V, 2012, PHYS MED BIOL, V57, P329, DOI 10.1088/0031-9155/57/2/329; Rotemberg V, 2013, J BIOMECH, V46, P1875, DOI 10.1016/j.jbiomech.2013.04.027; Rouze NC, 2010, IEEE T ULTRASON FERR, V57, P2662, DOI 10.1109/TUFFC.2010.1740; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Svensson WE, 2006, BREAST CANC ONLINE, V9, P1, DOI [DOI 10.1017/S1470903106002835, 10.1017/S1470903106002835]; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Dommelen J. A. W., 2009, V2, P249; Vappou J, 2006, J RHEOL, V50, P531, DOI 10.1122/1.2207187; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; VINK R, 1988, J BIOL CHEM, V263, P757; Wang MH, 2010, ULTRASOUND MED BIOL, V36, P802, DOI 10.1016/j.ultrasmedbio.2010.02.007; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhai L, 2012, ULTRASOUND MED BIOL, V38, P50, DOI 10.1016/j.ultrasmedbio.2011.10.002	59	7	7	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	MAR	2015	41	3					713	723		10.1016/j.ultrasmedbio.2014.10.019			11	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CB6RF	WOS:000349753600010	25683220	Green Accepted			2022-02-06	
J	Goldshmit, Y; Frisca, F; Kaslin, J; Pinto, AR; Tang, JKKY; Pebay, A; Pinkas-Kramarski, R; Currie, PD				Goldshmit, Y.; Frisca, F.; Kaslin, J.; Pinto, A. R.; Tang, J. -K. K. Y.; Pebay, A.; Pinkas-Kramarski, R.; Currie, P. D.			DECREASED ANTI-REGENERATIVE EFFECTS AFTER SPINAL CORD INJURY IN SPRY4-/- MICE	NEUROSCIENCE			English	Article						spry4(-/-); astrocytes; inflammation; spinal cord injury	FIBROBLAST-GROWTH-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; SPROUTY PROTEINS; GLIAL-CELLS; ACTIVATION; EXPRESSION; DIFFERENTIATION; NEUROGENESIS; GLIOSIS	Previously, we have demonstrated a role for fibroblast growth factor (Fgf) in spinal cord regeneration in both zebrafish and mouse. We have shown that exogenous Fgf2 treatment attenuates astrocytic gliosis and induces glia cells to become progenitors that undergo neurogenesis as well as differentiating into bipolar astrocytes that support axonal regeneration (Goldshmit et al., 2012, 2014). One of the downstream signaling target genes of Fgf is spry4, which acts as a feedback inhibitor for Fgf signaling. In this study we examined the effects of increased endogenous Fgf signaling, in spry4(-/-) mice, on the early events that occur after spinal cord injury (SCI). We demonstrate that in spry4(-/-) mice inflammatory responses, such as tumor necrosis factor a (TNF alpha) secretion and macrophage/neutrophil invasion into the lesion site are reduced. In addition, astrocytic gliosis is attenuated and neuronal survival is increased. These results further support a pro-regenerative role of Fgf after SCI, and suggest that increased endogenous Fgf signaling after SCI may contribute to functional recovery and therefore presents this pathway as a target for new therapy development. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Goldshmit, Y.; Frisca, F.; Kaslin, J.; Pinto, A. R.; Tang, J. -K. K. Y.; Currie, P. D.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Goldshmit, Y.; Pinkas-Kramarski, R.] Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Frisca, F.; Pebay, A.] Univ Melbourne, Dept Ophthalmol, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia		Goldshmit, Y (corresponding author), Monash Univ, Level 1,Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia.	yona.goldshmit@med.monash.edu.au; peter.currie@monash.edu	Pinto, Alexander/AAF-5556-2021	Pinto, Alexander/0000-0001-6421-4970; Pinkas-Kramarski, Ronit/0000-0002-1000-369X; Pebay, Alice/0000-0002-7408-9453; Kaslin, Jan/0000-0002-6207-1889; Currie, Peter/0000-0001-8874-8862	National Health and Medical Research Council of Australia Principal Research FellowshipNational Health and Medical Research Council of Australia; State Government of Victoria; Australian Federal GovernmentAustralian Government	This work was supported by a National Health and Medical Research Council of Australia Principal Research Fellowship to P.D.C. The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government.	Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; Alsina FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032087; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Faedo A, 2010, J NEUROSCI, V30, P4015, DOI 10.1523/JNEUROSCI.0307-10.2010; Fukaya T, 2014, BIOCHEM BIOPH RES CO, V447, P471, DOI 10.1016/j.bbrc.2014.04.012; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2014, BRAIN BEHAV, V4, P187, DOI 10.1002/brb3.172; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hausott B, 2012, HIPPOCAMPUS, V22, P434, DOI 10.1002/hipo.20910; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kasai M, 2014, J NEUROTRAUMA; Kim WR, 2012, NEUROSCI LETT, V513, P155, DOI 10.1016/j.neulet.2012.02.023; Kolar MK, 2014, STEM CELLS DEV, V23, P1659, DOI 10.1089/scd.2013.0416; Kundi S, 2013, NEUROSCI RES, V76, P1, DOI 10.1016/j.neures.2013.03.013; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Macaya DJ, 2013, BIOMATERIALS, V34, P3591, DOI 10.1016/j.biomaterials.2012.12.050; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ohori Y, 2006, J NEUROSCI, V26, P11948, DOI 10.1523/JNEUROSCI.3127-06.2006; Pinto AR, 2013, J IMMUNOL METHODS, V393, P74, DOI 10.1016/j.jim.2013.03.012; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rottlaender A, 2011, IMMUNOLOGY, V133, P370, DOI 10.1111/j.1365-2567.2011.03450.x; Ruffini F, 2001, GENE THER, V8, P1207, DOI 10.1038/sj.gt.3301523; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steliga A, 2013, FOLIA NEUROPATHOL, V51, P203, DOI 10.5114/fn.2013.37704; Suzuki-Hirano A, 2005, DEVELOPMENT, V132, P257, DOI 10.1242/dev.01581; Taniguchi K, 2009, CANCER SCI, V100, P1648, DOI 10.1111/j.1349-7006.2009.01214.x; Taniguchi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005467; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; Wachter B, 2010, CELL TISSUE RES, V342, P147, DOI 10.1007/s00441-010-1061-x; Wang YH, 2014, GENE EXPR PATTERNS, V15, P61, DOI 10.1016/j.gep.2014.04.004; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	47	7	8	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 26	2015	287						104	112		10.1016/j.neuroscience.2014.12.020			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA2SZ	WOS:000348759100011	25541251				2022-02-06	
J	Loov, C; Nadadhur, AG; Hillered, L; Clausen, F; Erlandsson, A				Loov, Camilla; Nadadhur, Aishwarya G.; Hillered, Lars; Clausen, Fredrik; Erlandsson, Anna			Extracellular Ezrin: A Novel Biomarker for Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						moesin; ERM; phospho-ERM; actin; extracellular proteins	CONTROLLED CORTICAL IMPACT; DENDRITIC CELL-RECEPTOR; ERM PROTEINS; MOESIN; MEMBRANE; BINDING; MECHANISM; CERAMIDE; RADIXIN; MODEL	Traumatic brain injury (TBI) is a heterogeneous disease, and the discovery of diagnostic and prognostic TBI biomarkers is highly desirable in order to individualize patient care. We have previously published a study in which we identified possible TBI biomarkers by mass spectrometry 24 h after injury in a cell culture model. Ezrin-radixin-moesin (ERM) proteins were found abundantly in the medium after trauma, and in the present study we have identified extracellular ezrin as a possible biomarker for brain trauma by analyzing cell culture medium from injured primary neurons and glia and by measuring ezrin in cerebrospinal fluid (CSF) from both rats and humans. Our results show that extracellular ezrin concentration was substantially increased in cell culture medium after injury, but that the intracellular expression of the protein remained stable over time. Controlled cortical impact injured rats showed an increased amount of ezrin in CSF at both day 3 and day 7 after trauma. Moreover, ezrin was present in all ventricular CSF samples from seven humans with severe TBI. In contrast to intracellular ezrin, which is distinctly activated following TBI, extracellular ezrin is nonphosphorylated. This is the first report of extracellular ERM proteins in human and experimental models of TBI, providing a scientific foundation for further assessment of ezrin as a potential biomarker.	[Loov, Camilla; Nadadhur, Aishwarya G.; Hillered, Lars; Clausen, Fredrik] Univ Uppsala Hosp, Div Neurosurg, Dept Neurosci, Uppsala, Sweden; [Erlandsson, Anna] Uppsala Univ, Dept Publ Hlth & Caring Sci, Rudbeck Lab, SE-75185 Uppsala, Sweden		Erlandsson, A (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Rudbeck Lab, Dag Hammarskjolds 20, SE-75185 Uppsala, Sweden.	Anna.Erlandsson@pubcare.uu.se		Hillered, Lars/0000-0002-2808-9292; G Nadadhur, Aishwarya/0000-0003-0468-9135; Clausen, Fredrik/0000-0003-3592-4417	Swedish Medical Society; Tore Nilsson Foundation; Selander Foundation; Uppsala University Hospital	This study was supported by the Swedish Medical Society, the Tore Nilsson Foundation, the Selander Foundation, and Uppsala University Hospital.	BERRYMAN M, 1993, J CELL SCI, V105, P1025; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Jayasundar JJ, 2012, J BIOL CHEM, V287, P37119, DOI 10.1074/jbc.M112.380972; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Takamatsu H, 2007, BLOOD, V109, P2514, DOI 10.1182/blood-2006-07-036715; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	22	7	7	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2015	32	4					244	251		10.1089/neu.2014.3517			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB0KN	WOS:000349314900005	25087457				2022-02-06	
J	Pan, YQ; Yu, LJ; Lei, WJ; Guo, YX; Wang, JF; Yu, HR; Tang, Y; Yang, JQ				Pan, Yongquan; Yu, Lijuan; Lei, Wenjuan; Guo, Yuanxin; Wang, Jianfeng; Yu, Huarong; Tang, Yong; Yang, Junqing			Beraprost sodium protects against chronic brain injury in aluminum-overload rats	BEHAVIORAL AND BRAIN FUNCTIONS			English	Article						Chronic brain injury; Beraprost sodium; PGI2 level; PGIS; IP receptor	ALZHEIMERS-DISEASE; IP RECEPTOR; EXPRESSION; ISCHEMIA; NAPROXEN; MODEL	Background: Aluminum overload can cause severe brain injury and neurodegeneration. Previous studies suggest that prostacyclin synthase (PGIS) expression and prostacyclin receptor (IP) activation are beneficial for treatment of acute traumatic and ischemic brain injury. However, the potential value of PGIS/IP signaling pathway to chronic brain injury is still unclear. In this study, we investigated the change of PGIS/IP signaling pathway and the effect of beraprost sodium (BPS) on chronic brain injury in chronic aluminum-overload rats. Methods: Rat model of chronic cerebral injury was established by chronic intragastric administration of aluminum gluconate(Al3+ 200 mg/kg per day, 5d a week for 20 weeks). The methods of ELISA, qRT-PCR and Western blotting were used to detect the PGI2 level and the PGIS and IP mRNA and protein levels in hippocampi of chronic aluminum-overload rats, respectively. Rat hippocampal superoxide dismutase (SOD) activity and malondialdehyde (MDA) content also were measured. The effects of BPS (6, 12 and 24 mu g.kg(-1)) on brain injury in chronic aluminum-overload rats were evaluated. Results: Compared with the control group, PGIS mRNA expression, PGI2 level, and the IP mRNA and protein expressions significantly increased in hippocampi of chronic aluminum-overload rats. Administration of BPS significantly improved spatial learning and memory function impairment and hippocampal neuron injury induced by chronic aluminum overload in rats. Meanwhile, administration of BPS resulted in a decrease of PGI2 level and downregulation of PGIS and IP expressions in a dose-dependent manner. Aluminum overload also caused a decrease of SOD activity and an increase of MDA content. Administration of BPS significantly blunted the decrease of SOD activity and the increase of MDA content induced by aluminum overload in rats. Conclusions: BPS has a significant neuroprotective effect on chronic brain injury induced by aluminum overload in rats. Remodeling the balance of PGIS/IP signaling pathway and inhibition of oxidative stress involve in the neuroprotective mechanism of BPS in aluminum-overload rats. The PGIS/IP signaling pathway is a potential therapeutic strategy for chronic brain injury patients.	[Pan, Yongquan; Yu, Lijuan; Lei, Wenjuan; Guo, Yuanxin; Wang, Jianfeng; Yang, Junqing] Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China; [Pan, Yongquan] Chongqing Med Univ, Lab Anim Ctr, Chongqing 400016, Peoples R China; [Yu, Huarong; Tang, Yong] Chongqing Med Univ, Dept Basic Coll, Chongqing 400016, Peoples R China; [Yang, Junqing] Chongqing Med Univ, Dept Pharmacol, Chongqing 400010, Peoples R China		Yang, JQ (corresponding author), Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	1139627371@qq.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30672211, 81070972]	This work was supported by grants from the Natural Science Foundation of China (No. 30672211, and 81070972). The authors also thank Ms Rong Jiang for her help of HE staining.	Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014; Budson AE, 2009, NEUROLOGIST, V15, P71, DOI 10.1097/NRL.0b013e318188040d; Dobson CB, 1998, TOXICOL APPL PHARM, V152, P145, DOI 10.1006/taap.1998.8489; Fang YC, 2006, J CEREBR BLOOD F MET, V26, P491, DOI 10.1038/sj.jcbfm.9600205; Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023; Frisardi V, 2010, J ALZHEIMERS DIS, V20, P17, DOI 10.3233/JAD-2009-1340; Hoozemans JJM, 2001, ACTA NEUROPATHOL, V101, P2, DOI 10.1007/s004010000251; KAINOH M, 1993, PHARMACOL RES, V28, P249, DOI 10.1006/phrs.1993.1128; Kuang G, 2012, PPAR RES, V2012, DOI 10.1155/2012/209794; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Pan YQ, 2010, NEURAL REGEN RES, V5, P1634, DOI 10.3969/j.issn.1673-5374.2010.21.006; Saleem S, 2010, NEUROSCIENCE, V170, P317, DOI 10.1016/j.neuroscience.2010.06.060; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Su Qiang, 2009, Zhongguo Yaolixue Yu Dulixue Zazhi, V23, P6, DOI 10.3867/j.issn.1000-3002.2009.01.002; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Tsai MJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649809; WILLS MR, 1983, LANCET, V2, P29; Yu LJ, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-6	22	7	7	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1744-9081		BEHAV BRAIN FUNCT	Behav. Brain Funct.	FEB 7	2015	11								6	10.1186/s12993-014-0051-7			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CB5YD	WOS:000349703000001	25888780	Green Published, gold			2022-02-06	
J	Tyler, CW; Likova, LT; Mineff, KN; Elsaid, AM; Nicholas, SC				Tyler, Christopher W.; Likova, Lora T.; Mineff, Kristyo N.; Elsaid, Anas M.; Nicholas, Spero C.			Consequences of traumatic brain injury for human vergence dynamics	FRONTIERS IN NEUROLOGY			English	Article						oculomotor dynamics; vergence; binocular eye movements; convergence; divergence; traumatic brain injury	VISUAL FUNCTION; EYE	Purpose: Traumatic brain injury involving loss of consciousness has focal effects in the human brainstem, suggesting that it may have particular consequences for eye movement control. This hypothesis was investigated by measurements of vergence eye movement parameters. Methods: Disparity vergence eye movements were measured for a population of 123 normally sighted individuals, 26 of whom had suffered diffuse traumatic brain injury (dTBI) in the past, while the remainder served as controls. Vergence tracking responses were measured to sinusoidal disparity modulation of a random-dot field. Disparity vergence step responses were characterized in terms of their dynamic parameters separately for the convergence and divergence directions. Results: The control group showed notable differences between convergence and divergence dynamics. The dTBI group showed significantly abnormal vergence behavior on many of the dynamic parameters. Conclusion:The results support the hypothesis that occult injury to the oculomotor control system is a common residual outcome of dTBI.	[Tyler, Christopher W.; Likova, Lora T.; Mineff, Kristyo N.; Elsaid, Anas M.; Nicholas, Spero C.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; [Tyler, Christopher W.] City Univ London, Div Optometry, Sch Hlth Sci, London EC1V 0HB, England		Tyler, CW (corresponding author), Smith Kettlewell Eye Res Inst, 2318 Fillmore St, San Francisco, CA 94115 USA.	cwt@ski.org			CDMRPUnited States Department of Defense [DM 102524]	Supported by CDMRP DM 102524.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; HUNG GK, 1994, INVEST OPHTH VIS SCI, V35, P3486; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P339, DOI 10.1113/jphysiol.1961.sp006812; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tyler CW, 2013, PROC SPIE, V8651, DOI 10.1117/12.2012253; Tyler CW, 2012, J VISION, V12, DOI 10.1167/12.11.21; United States Government Accountability Office, 2008, VA HEALTHC MILD TRAU; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0	17	7	7	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 3	2015	5								282	10.3389/fneur.2014.00282			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU7XA	WOS:000363753900001	25691880	gold, Green Accepted, Green Published			2022-02-06	
J	Alkemade, N; Bowden, SC; Salzman, L				Alkemade, Nathan; Bowden, Stephen C.; Salzman, Louis			Scoring Correction for MMPI-2 Hs Scale with Patients Experiencing a Traumatic Brain Injury: A Test of Measurement Invariance	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; MMPI-2; Measurement invariance; Assessment; Correction procedures	MULTIPHASIC PERSONALITY INVENTORY-2; FACTORIAL INVARIANCE; PSYCHIATRIC-DISORDERS; FIT INDEXES; HEAD TRAUMA; SENSITIVITY; SPECIFICITY; DEPRESSION; IMPACT	It has been suggested that MMPI-2 scoring requires removal of some items when assessing patients after a traumatic brain injury (TBI). Gass (1991. MMPI-2 interpretation and closed head injury: Acorrection factor. Psychological assessment, 3, 27-31) proposed a correction procedure in line with the hypothesis that MMPI-2 endorsement may be affected by symptoms of TBI. This study assessed the validity of the Gass correction procedure. A sample of patients with a TBI (n = 242), and a random subset of the MMPI-2 normative sample (n = 1,786). The correction procedure implies a failure of measurement invariance across populations. This study examined measurement invariance of one of the MMPI-2 scales (Hs) that includes TBI correction items. A four-factor model of the MMPI-2 Hs items was defined. The factor model was found to meet the criteria for partial measurement invariance. Analysis of the change in sensitivity and specificity values implied by partial measurement invariance failed to indicate significant practical impact of partial invariance. Overall, the results support continued use of all Hs items to assess psychological well-being in patients with TBI.	[Alkemade, Nathan; Bowden, Stephen C.] Univ Melbourne, Parkville, Vic 3010, Australia; [Salzman, Louis] Royal Brisbane Hosp, Brisbane, Qld 4029, Australia		Alkemade, N (corresponding author), Univ Melbourne, Psychol Sci, Parkville, Vic 3010, Australia.	nathan.alkemade@unimelb.edu.au					Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; Arbisi PA, 1999, NEUROREHABILITATION, V13, P117; Bachna K, 1998, ARCH CLIN NEUROPSYCH, V13, P535; Bandalos DL, 2008, STRUCT EQU MODELING, V15, P211, DOI 10.1080/10705510801922340; Bontempo D., 2007, OXFORD HDB METHODS P, V1st, P153; Borsboom D, 2006, MED CARE, V44, pS176, DOI 10.1097/01.mlr.0000245143.08679.cc; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Butcher JN, 2006, MMPI 2 PRACTITIONERS; Byrne BM, 2010, INT J TEST, V10, P107, DOI 10.1080/15305051003637306; Byrne BM., 1998, STRUCTURAL EQUATION; Cheung GW, 1999, J MANAGE, V25, P1, DOI 10.1177/014920639902500101; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Davis PJ, 2000, PAIN MED, V1, P238, DOI 10.1046/j.1526-4637.2000.00032.x; Edwards DW, 2003, ASSESSMENT, V10, P222, DOI 10.1177/1073191103254491; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Friedman A.F., 2001, PSYCHOL ASSESSMENT M, V2nd ed.; Fujii D., 2005, PROGR SCHIZOPHRENIA; Gass C. S, 2009, OXFORD HDB PERSONALI; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Glassmire DM, 2003, ASSESSMENT, V10, P299, DOI 10.1177/1073191103256129; Glockner-Rist A, 2003, STRUCT EQU MODELING, V10, P544, DOI 10.1207/S15328007SEM1004_4; Graham J. R, 2006, MMPI 2 ASSESSING PER; Handel SF, 2007, PSYCHOSOMATICS, V48, P67, DOI 10.1176/appi.psy.48.1.67; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim ES, 2011, STRUCT EQU MODELING, V18, P212, DOI 10.1080/10705511.2011.557337; Kline R, 2010, PRINCIPLES PRACTICE, V3rd Edn; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LaChapelle DL, 2005, APPL NEUROPSYCHOL, V12, P143, DOI 10.1207/S15324826AN1203_4; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Lowry R, 2013, VASSARSTATS WEBSITE; MACCALLUM RC, 1993, PSYCHOL BULL, V114, P533, DOI 10.1037/0033-2909.114.3.533; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Millsap RE, 2004, PSYCHOL METHODS, V9, P93, DOI 10.1037/1082-989X.9.1.93; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Rayls K, 1997, ARCH CLIN NEUROPSYCH, V12, P390, DOI 10.1093/arclin/12.4.390a; Thomson B, 2004, INTERNAL REPLICABILI, P99; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Widaman K.F., 1997, SCI PREVENTION METHO, P281, DOI DOI 10.1037/10222-009; Wirth RJ, 2007, PSYCHOL METHODS, V12, P58, DOI 10.1037/1082-989X.12.1.58	48	7	7	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2015	30	1					39	48		10.1093/arclin/acu058			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CE6BA	WOS:000351919400004	25413486				2022-02-06	
J	Baker, A; Unsworth, CA; Lannin, NA				Baker, Anne; Unsworth, Carolyn A.; Lannin, Natasha A.			What information is provided in Australian emergency departments about fitness-to-drive after mild traumatic brain injury: A national survey	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						acute care; driving; mild traumatic brain injury (mTBI)	OCCUPATIONAL-THERAPY	Background/aimOccupational therapists work together with their medical and nursing colleagues to ensure that patients are able to return to safe and legal driving upon discharge from the emergency department after a range of illnesses and/or injuries. This study aimed to determine the type of information that is provided nationally in emergency departments to people after mild traumatic brain injury (mTBI), with respect to fitness-to-drive. MethodsCross-sectional electronic survey mailed to all emergency departments in Australia (N=110). Responses were invited from medical, nursing, and allied-health professionals. The survey asked respondents to comment about the existence and use of fitness-to-drive management guidelines, as well as their opinion on when clearance should be given to return to driving post injury. Results104 clinicians completed the survey; the majority of respondents were medical staff (n=46, 51%) followed by allied-health staff (n=23, 25%), with the highest response rate provided from Victoria (n=41, 45%). Just over one-third of respondents' emergency departments (n=34, 36%) recommended a period of no driving' after mTBI, and within these departments, this recommendation was usually provided by medical staff (n=25, 80%). Consensus was not displayed with respect to the safest time to return to driving after mTBI. Opinions from respondents strongly suggested that a review of fitness-to-drive management guidelines was required for mTBI patients (n=78, 88%). ConclusionNo consensus exists in the fitness-to-drive recommendations provided to patients after mTBI, and clinicians have reported the need for a review of fitness-to-drive management guidelines in Australian emergency departments. With their understanding about the complex interplay of the skills required for safe driving, occupational therapists are positioned to help guide the development of protocols in this area.	[Baker, Anne; Unsworth, Carolyn A.; Lannin, Natasha A.] La Trobe Univ, Dept Occupat Therapy, Fac Hlth Sci, Bundoora, Vic 3086, Australia; [Unsworth, Carolyn A.] Jonkoping Univ, Sch Hlth Sci, Dept Rehabil, Jonkoping, Sweden; [Lannin, Natasha A.] Alfred Hlth, Dept Occupat Therapy, Melbourne, Vic, Australia; [Lannin, Natasha A.] Univ Sydney, Sydney Med Sch, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia		Unsworth, CA (corresponding author), La Trobe Univ, Occupat Therapy Dept, Bundoora, Vic 3086, Australia.	c.unsworth@latrobe.edu.au	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345; Baker, Anne/0000-0002-3779-5463			Austroads, 2012, ASS FITN DRIV COMM P; Bottari C., 2012, REHABILITATION RES P, V2012, P9; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Cusick A, 2010, AUST OCCUP THER J, V57, P380, DOI 10.1111/j.1440-1630.2010.00874.x; Department of Motor Vehicles, 2013, DRIV SAF INF LAP CON; Dillman DA., 2007, MAIL INTERNET SURVEY; Hendriksen H, 2001, J ADV NURS, V36, P727, DOI 10.1046/j.1365-2648.2001.02038.x; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moore C, 2004, NZ MED J, V117, P1; Moss JE, 2002, MED J AUSTRALIA, V177, P435, DOI 10.5694/j.1326-5377.2002.tb04884.x; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Polgar S, 2008, INTRO RES HLTH SCI; PORTARE, 2009, HDB DIS DRIV ASS; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Unsworth CA, 2007, AUST OCCUP THER J, V54, P153, DOI 10.1111/j.1440-1630.2006.00617.x; World Health Organization, 2013, GLOB STAT REP ROAD S; [No title captured]	21	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	FEB	2015	62	1					50	55		10.1111/1440-1630.12172			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	CB0IF	WOS:000349308500007	25495155				2022-02-06	
J	Daley, MJ; Ali, S; Brown, CVR				Daley, Mitchell J.; Ali, Sadia; Brown, Carlos V. R.			Late Venous Thromboembolism Prophylaxis after Craniotomy in Acute Traumatic Brain Injury	AMERICAN SURGEON			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; LOW-DOSE HEPARIN; INTRACRANIAL HEMORRHAGE; COMPRESSION STOCKINGS; PULMONARY-EMBOLISM; PREVENTION; MORTALITY; SAFETY	The objective of this study is to compare rates of venous thromboembolism (VTE) in patients who receive enoxaparin prophylaxis compared with no enoxaparin prophylaxis after craniotomy for traumatic brain injury (TBI). This retrospective cohort evaluated all trauma patients admitted to a Level I trauma center from January 2006 to December 2011 who received craniotomy after acute TBI. Patients were excluded if developed VTE before administration of enoxaparin or they died within the first 72 hours of hospital admission. A total of 271 patients were included (enoxaparin prophylaxis, n = 45; no enoxaparin prophylaxis, n = 225). The median time until enoxaparin initiation was 11 +/- 1 days. There was no significant difference in the proportion of patients who developed a VTE when using enoxaparin prophylaxis compared with no enoxaparin prophylaxis (2 vs 4%; P = 0.65). Rates of deep vein thrombosis (2 vs 3%; P = 0.87) and pulmonary embolism (0 vs 1%; P = 0.99) were similar between treatment groups, respectively. Late enoxaparin prophylaxis did not demonstrate a protective effect for VTE. Given the overall low event rate, the administration of pharmacologic prophylaxis against VTE late in the treatment course may not be routinely warranted after craniotomy for acute TBI. Further investigation with early administration of enoxaparin is needed.	[Daley, Mitchell J.] Univ Med Ctr Brackenridge, Dept Pharmaceut Serv, Austin, TX 78701 USA; [Ali, Sadia; Brown, Carlos V. R.] Univ Med Ctr Brackenridge, Dept Trauma Serv, Austin, TX 78701 USA		Daley, MJ (corresponding author), Univ Med Ctr Brackenridge, Crit Care, Dept Pharm, 601 E 15th St, Austin, TX 78701 USA.	mjdaley@seton.org					Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; CERRATO D, 1978, J NEUROSURG, V49, P378, DOI 10.3171/jns.1978.49.3.0378; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Constantini S, 2001, J NEUROSURG, V94, P918, DOI 10.3171/jns.2001.94.6.0918; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Depew AJ, 2008, AM SURGEON, V74, P906; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Faul M, 2010, TRAUMATIC BRAIN INJU; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts William H, 2006, Hematology Am Soc Hematol Educ Program, P462; Gould MK, 2012, CHEST, V141, pS227S; Hamilton MG, 2011, NEUROSURGERY, V68, P571, DOI 10.1227/NEU.0b013e3182093145; Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; Kakkar AK, 2011, NEW ENGL J MED, V365, P2463, DOI 10.1056/NEJMoa1111288; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Melon E, 1987, ANESTHESIOLOGY, V75, pA214; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; Page RB, 2004, NEUROSURGERY, V54, P143, DOI 10.1227/01.NEU.0000097514.60813.1B; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027	25	7	10	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2015	81	2					207	211					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CI6TK	WOS:000354894700036	25642886				2022-02-06	
J	Elias, PZ; Spector, M				Elias, Paul Z.; Spector, Myron			Treatment of penetrating brain injury in a rat model using collagen scaffolds incorporating soluble Nogo receptor	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						penetrating brain injury; collagen scaffold; rat brain; Nogo receptor; traumatic brain injury; brain tissue engineering	SPINAL-CORD-INJURY; AXONAL REGENERATION; MOLECULAR-MECHANISMS; TAU-PROTEIN; IN-VITRO; MACROPHAGES; INFLAMMATION; OLIGODENDROCYTES; DEGENERATION; IMPLANTATION	Injuries and diseases of the central nervous system (CNS) have the potential to cause permanent loss of brain parenchyma, with severe neurological consequences. Cavitary defects in the brain may afford the possibility of treatment with biomaterials that fill the lesion site while delivering therapeutic agents. This study examined the treatment of penetrating brain injury (PBI) in a rat model with collagen biomaterials and a soluble Nogo receptor (sNgR) molecule. sNgR was aimed at neutralizing myelin proteins that hinder axon regeneration by inducing growth cone collapse. Scaffolds containing sNgR were implanted in the brains of adult rats 1 week after injury and analysed 4 weeks or 8 weeks later. Histological analysis revealed that the scaffolds filled the lesion sites, remained intact with open pores and were infiltrated with cells and extracellular matrix. Immunohistochemical staining demonstrated the composition of the cellular infiltrate to include macrophages, astrocytes and vascular endothelial cells. Isolated regions of the scaffold borders showed integration with surrounding viable brain tissue that included neurons and oligodendrocytes. While axon regeneration was not detected in the scaffolds, the cellular infiltration and vascularization of the lesion site demonstrated a modification of the injury environment with implications for regenerative strategies. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Elias, Paul Z.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Elias, Paul Z.; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA; [Spector, Myron] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA		Elias, PZ (corresponding author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151,Room D1-151,150 S Huntington Ave, Boston, MA 02130 USA.	pzelias@alum.mit.edu		Spector, Myron/0000-0003-3328-4858	US Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs	The research reported here was supported by the US Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service. We thank Dr. Daniel Lee and Dr. Paul Weinreb at Biogen Idec for generously providing the soluble Nogo receptor. We also thank Alix Weaver for assistance with H&E staining. No competing financial interests exist.	Agarwalla PK, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1038; ALLEN IV, 1982, INJURY, V14, P183, DOI 10.1016/0020-1383(82)90057-2; Assina R, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E3; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bolliet C, 2008, TISSUE ENG PART C-ME, V14, P207, DOI 10.1089/ten.tec.2008.0168; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Buss A, 2003, GLIA, V42, P424, DOI 10.1002/glia.10220; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Crompton KE, 2006, J MATER SCI-MATER M, V17, P633, DOI 10.1007/s10856-006-9226-6; Cuis Q, 2009, NEUROSCIENCE, V158, P1039; Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Elias PZ, 2012, J NEUROTRAUM, V29, P2086, DOI 10.1089/neu.2011.2181; Elias PZ, 2012, J MECH BEHAV BIOMED, V12, P63, DOI 10.1016/j.jmbbm.2012.03.014; Fitch MT, 1999, J NEUROSCI, V19, P8182; Frys EJ, 2007, NEURON, V53, P649; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Grandpre T, 2001, NEUROSCIENTIST, V7, P377, DOI 10.1177/107385840100700507; Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.actbio.2006.12.009; Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009; Hous S, 2005, J NEUROSCI METH, V148, P60; HUNT TK, 1984, SURGERY, V96, P48; Irving EA, 2001, ACTA NEUROPATHOL, V102, P627, DOI 10.1007/s004010100416; Jis B, 2005, EUR J NEUROSCI, V22, P587; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173; KNOWLSON GT, 1974, J NEUROL NEUROSUR PS, V37, P971, DOI 10.1136/jnnp.37.8.971; Ksiezak-Reding H, 2003, NEUROCHEM RES, V28, P1385, DOI 10.1023/A:1024952600774; Lees DH, 2003, NAT REV DRUG DISCOV, V2, P872; Lees J, 2006, TOXICOL APPL PHARM, V215, P64; Lees JK, 2004, J NEUROSCI, V24, P6209; Lis S, 2004, J NEUROSCI, V24, P10511; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Lus XC, 2011, J NEUROTRAUM, V28, P71; Lus XC, 2009, J NEUROTRAUM, V26, P141; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; MIGHELI A, 1988, J NEUROSCI, V8, P1846; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schwab JM, 2006, TRENDS MOL MED, V12, P293, DOI 10.1016/j.molmed.2006.05.001; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Vourc'h P, 2004, BRAIN RES REV, V45, P115, DOI 10.1016/j.brainresrev.2004.01.003; Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033; Weinreb PH, 2010, BIOTECHNOL APPL BIOC, V57, P31, DOI 10.1042/BA20100061; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Yaos C, 2008, BRAIN INJURY, V22, P723	67	7	8	0	20	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	FEB	2015	9	2					137	150		10.1002/term.1621			14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Engineering	AZ0RU	WOS:000347953100005	23038669				2022-02-06	
J	Fadiel, A; Song, J; Tivon, D; Hamza, A; Cardozo, T; Naftolin, F				Fadiel, A.; Song, J.; Tivon, D.; Hamza, A.; Cardozo, T.; Naftolin, Frederick			Phenytoin Is an Estrogen Receptor alpha-Selective Modulator That Interacts With Helix 12	REPRODUCTIVE SCIENCES			English	Article						Dilantin((R)); diphenylhydantoin; estradiol; estrogen receptors; epilepsy and computational molecular docking	TRAUMATIC BRAIN-INJURY; DRUG-DRUG INTERACTIONS; ANTIEPILEPTIC DRUGS; BONE HEALTH; BINDING; DOCKING; PROTEIN; WOMEN; LEVETIRACETAM; MECHANISMS	Rationale: Phenytoin (Dilantin((R)); DPH) is used to treat epilepsy but causes estrogen agonist-antagonist-like side effects. We investigated the interaction of phenytoin with estrogen receptors (ERs) and by computational molecular docking, ER competition binding, transcriptional assays, and biological actions, comparing outcomes with estradiol (E-2), estrone (E-1), and tamoxifen (TMX). Experimental: (1) The DPH docking to 3-dimensional crystal structures of the ER ligand-binding domain (LBD) showed a high degree of structural complementarity (-57.15 calculated energy units, approximating kcal/mol) with the ligand-binding pocket, including a contact at leucine (L540) in helix 12. Estrogen receptor showed slightly less favorable interactions (-54.27 kcal/mol), without contacting L450. Estradiol, E-1, and TMX contact points with ER and ER do not include L450. (2) Cellular actions: Incubation of cells transfected with ER or ER and a luciferase promoter phenytoin was several orders weaker than E-2 as an agonist through ER and had no effect through ER. However, phenytoin at clinical concentrations (10(-11) to 10(-6) mol/L) powerfully antagonized action of E-2 on ER-expressing cells. Similarly, phenytoin at clinically effective concentrations marginally induced alkaline phosphatase by ER- and ER-expressing endometrial cancer cells but at doses well below clinical effectiveness blocked E-2-induced alkaline phosphatase. (3) ER competition: In Scatchard plots comparing phenytoin with 17-estradiol against endometrial cancer cell cytosol E-2-alone more effectively displaced labeled E-2 than phenytoin, but phenytoin was approximately equimolar effective to E-2 in inhibiting E-2's displacement of the radiolabel, further confirming that phenytoin is a strong E-2 antagonist. Conclusions: At clinically effective concentrations, phenytoin is a strong ER cell antagonist but a many-fold weaker agonist. Although it interacts with ER LBD residues, phenytoin has no effects on ER-only expressing cells. Docking studies indicate phenytoin interacts with the ER LBD at the hinge of helix 12 and could thereby interfere with the entry of other ER ligands or with the mobility of helix 12, either of which actions could explain phenytoin's antagonism of ER-mediated E-2 actions. Our results suggest an explanation for the broad profile of phenytoin's actions and raise possibilities for the use of phenytoin or congeners in the clinical management of ER-dependent conditions.	[Fadiel, A.; Song, J.; Naftolin, Frederick] NYU, Dept Obstet & Gynecol, Sch Med, New York, NY 10014 USA; [Tivon, D.; Cardozo, T.] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10014 USA; [Hamza, A.] Univ Kentucky, Sch Pharm, Lexington, KY USA		Naftolin, F (corresponding author), NYU, Dept Obstet & Gynecol, Sch Med, 180 Varick St,Rm 627, New York, NY 10014 USA.	frederick.naftolin@nyumc.org		Fadiel Metwaly, Ahmed/0000-0002-5759-6891			ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R, 2001, CURR OPIN CHEM BIOL, V5, P375, DOI 10.1016/S1367-5931(00)00217-9; Arabaci T, 2014, ORAL DIS, V20, P294, DOI 10.1111/odi.12111; Bedell S, 2014, J STEROID BIOCHEM, V139, P225, DOI 10.1016/j.jsbmb.2012.12.004; Berga SL, 2013, REPROD SCI, V20, P1130, DOI 10.1177/1933719113497290; Bilezikian JP, 2009, J BONE MINER RES, V24, P373, DOI [10.1359/jbmr.090105, 10.1359/JBMR.090105]; Black JA, 2008, J NEUROL SCI, V274, P57, DOI 10.1016/j.jns.2008.04.001; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Buscaglia CA, 2007, PROTEINS, V66, P528, DOI 10.1002/prot.21266; Chlebowski RT, 2014, POL ARCH MED WEWN, V124, P191, DOI 10.20452/pamw.2190; Cornacchio ALP, 2011, J CAN DENT ASSOC, V77, P1; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Dreyfus J, 2003, STORY REMARKABLE MED; Eslami H, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3474951; Fernandez-Recio J, 2002, PROTEIN SCI, V11, P280, DOI 10.1110/ps.19202; Fernandez-Recio Juan, 2002, Pac Symp Biocomput, P552; FRANCIS J, 1992, MOL PHARMACOL, V42, P1097; Glass CK, 2000, GENE DEV, V14, P121; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; HARVEY SC, 1989, PROTEINS, V5, P78, DOI 10.1002/prot.340050109; Hines LE, 2011, AM J GERIATR PHARMAC, V9, P364, DOI 10.1016/j.amjopharm.2011.10.004; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Katritch V, 2007, J COMPUT AID MOL DES, V21, P549, DOI 10.1007/s10822-007-9138-7; Katzenellenbogen BS, 2001, ANN NY ACAD SCI, V949, P6; Khaira Ambar, 2008, J Assoc Physicians India, V56, P376; Kirmani BF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00170; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Kulak J, 2013, REPROD SCI, V20, P129, DOI 10.1177/1933719112463251; LITTLEFIELD BA, 1990, ENDOCRINOLOGY, V127, P2757, DOI 10.1210/endo-127-6-2757; Lugo L, 2014, MATURITAS, V77, P380, DOI 10.1016/j.maturitas.2014.01.016; MATTSON RH, 1986, JAMA-J AM MED ASSOC, V256, P238, DOI 10.1001/jama.256.2.238; McAuley JW, 2002, CLIN PHARMACOKINET, V41, P559, DOI 10.2165/00003088-200241080-00002; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Mocklinghoff S, 2010, CHEMBIOCHEM, V11, P2251, DOI 10.1002/cbic.201000532; Nakken KO, 2010, EXPERT OPIN DRUG SAF, V9, P561, DOI 10.1517/14740331003636475; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; O'Malley BW, 2012, MOL ENDOCRINOL, V26, P1646, DOI 10.1210/me.2012-1114; Oliva P, 2013, REPROD SCI, V20, P119, DOI 10.1177/1933719111431002; Pack AM, 2008, NEUROLOGY, V70, P1586, DOI 10.1212/01.wnl.0000310981.44676.de; Reyes CM, 2000, J MOL BIOL, V295, P1, DOI 10.1006/jmbi.1999.3319; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Siniscalchi A, 2013, EUR J PHARMACOL, V718, P10, DOI 10.1016/j.ejphar.2013.09.013; Svalheim S, 2011, ACTA NEUROL SCAND, V124, P89, DOI 10.1111/j.1600-0404.2011.01551.x; Vahabi Surena, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P167, DOI 10.1515/jbcpp-2013-0003; Vandenberg LN, 2013, REPROD TOXICOL, V38, P1, DOI 10.1016/j.reprotox.2013.02.002; West PJ, 2014, EPILEPSIA, V55, P214, DOI 10.1111/epi.12524; Yang M, 2012, BREAST CANCER RES TR, V134, P603, DOI 10.1007/s10549-012-2102-9; Pereira CAZ, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-7	54	7	8	0	23	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY		1933-7205		REPROD SCI	Reprod. Sci.	FEB	2015	22	2					146	155		10.1177/1933719114549853			10	Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Reproductive Biology	AZ0WO	WOS:000347963000003	25258361				2022-02-06	
J	Gee, SW; Karsies, TJ				Gee, Samantha W.; Karsies, Todd J.			Listeria meningitis-associated bradyarrhythmia treated with isoproterenol	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							CARDIAC-ARRHYTHMIAS; HEMORRHAGE; INJURY	In the setting of increased intracranial pressure (ICP), various rhythm disturbances have been associated, ranging from tachyarrhythmias to bradyarrhythmias with atrioventricular dissociation. Although most of these observations have been in patients with traumatic brain injuries, it is known that children with acute bacterial meningitis may also have severe intracranial hypertension. We present the case of a previously healthy 2-year-old boy diagnosed with listeria meningitis. Along with clinical signs suggestive of increased ICP and brainstem involvement, our patient had persistent bradyarrhythmia with hemodynamic compromise that was refractory to epinephrine and successfully managed with isoproterenol.	[Gee, Samantha W.; Karsies, Todd J.] Ohio State Univ, Nationwide Childrens Hosp, Sect Crit Care Med, Columbus, OH 43210 USA		Gee, SW (corresponding author), Nationwide Childrens Hosp, Sect Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA.	Samantha.Gee@nationwidechildrens.org	Karsies, Todd/O-9018-2019	Karsies, Todd/0000-0001-6822-6952			Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Grosse-Wortmann L, 2006, PEDIATR CARDIOL, V27, P286, DOI 10.1007/s00246-005-1248-1; Shapira MY, 1997, INT J CARDIOL, V62, P277, DOI 10.1016/S0167-5273(97)00260-X; STOBER T, 1988, STROKE, V19, P688, DOI 10.1161/01.STR.19.6.688; Young YR, 2007, NEUROCRIT CARE, V7, P238, DOI 10.1007/s12028-007-0059-z	5	7	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2015	33	2							306.e1	10.1016/j.ajem.2014.06.022			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CC6AW	WOS:000350447900042	25066909				2022-02-06	
J	Geri, G; Dumas, F; Chenevier-Gobeaux, C; Bougle, A; Daviaud, F; Morichau-Beauchant, T; Jouven, X; Mira, JP; Pene, F; Empana, JP; Cariou, M				Geri, Guillaume; Dumas, Florence; Chenevier-Gobeaux, Camille; Bougle, Adrien; Daviaud, Fabrice; Morichau-Beauchant, Tristan; Jouven, Xavier; Mira, Jean-Paul; Pene, Frederic; Empana, Jean-Philippe; Cariou, Main			Is Copeptin Level Associated With 1-Year Mortality After Out-of-Hospital Cardiac Arrest? Insights From the Paris Registry	CRITICAL CARE MEDICINE			English	Article						acute coronary syndrome; cardiac enzymes; copeptin; long-term follow-up; out-of-hospital cardiac arrest	ACUTE MYOCARDIAL-INFARCTION; TERMINAL PROVASOPRESSIN COPEPTIN; TRAUMATIC BRAIN-INJURY; PERCUTANEOUS CORONARY INTERVENTION; SUDDEN-DEATH SURVIVORS; HEART-FAILURE; CARDIOPULMONARY-RESUSCITATION; PROGNOSTIC MARKER; IMPLANTABLE DEFIBRILLATOR; THERAPEUTIC HYPOTHERMIA	Objectives: The availability of circulating biomarkers that helps to identify early out-of-hospital cardiac arrest survivors who are at increased risk of long-term mortality remains challenging. Our aim was to prospectively study the association between copeptin and 1-year mortality in patients with out-of-hospital cardiac arrest admitted in a tertiary cardiac arrest center. Design: Retrospective monocenter study. Setting: Tertiary cardiac arrest center in Paris, France. Patients: Copeptin was assessed at admission and day 3. Pre-and intrahospital factors associated with 1-year mortality were analyzed by multivariate Cox proportional analysis. Interventions: None. Measurements and Main Results: Two hundred ninety-eight consecutive out-of-hospital cardiac arrest patients (70.3% male; median age, 60.2 yr [49.9-71.4]) were admitted in a tertiary cardiac arrest center in Paris (France). After multivariate analysis, higher admission copeptin was associated with 1-year mortality with a threshold effect (hazard ratio 5(th vs 1st quintile) = 1.64- 95% Cl, 1.05-2.58; p = 0.03). Day 3 copeptiri was associated with 1-year mortality in a dose-dependent manner (hazard ratio(2nd vs 1st quintile) = 1.87;. 95% Cl, 1.00-3.49; p = 0.05; hazard ratio(3rd vs quintile) = 1.92; 95% Cl, 1.02-3.64; p = 0.04; hazard ratio(4th vs 1st quintile) = 2.12; 95% CI,-1.14-3.93; p = 0.02; and hazard ratio(5th vs 1st quintile) = 2.75; 95% Cl, 1.47-5.15; p < 0.01; p for trend < 0.01). For both admission and day 3 copeptin, association with 1-year mortality existed for out-of-hospital cardiac arrest of cardiac origin only (p for interaction = 0.05 and < 0.01, respectively). When admission and day 3 copeptin were mutually adjusted, only day 3 copeptin remained associated with 1-year mortality in a dose-dependent manner (p for trend = 0.01). Conclusion: High levels of copeptin were associated with 1-year mortality independently from prehospital and intrahospital risk factors, especially in out-of-hospital cardiac arrest of cardiac origin. Day 3 copeptin was superior to admission copeptin: this could permit identification of out-of-hospital cardiac. arrest survivors at increased risk of mortality and allow for close observation of such patients.	[Geri, Guillaume; Bougle, Adrien; Daviaud, Fabrice; Morichau-Beauchant, Tristan; Mira, Jean-Paul; Pene, Frederic; Cariou, Main] Hop Cochin, AP HP, Med Intens Care Unit, F-75674 Paris, France; [Geri, Guillaume; Dumas, Florence; Bougle, Adrien; Daviaud, Fabrice; Morichau-Beauchant, Tristan; Mira, Jean-Paul; Pene, Frederic; Cariou, Main] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France; [Geri, Guillaume; Dumas, Florence; Jouven, Xavier; Empana, Jean-Philippe; Cariou, Main] INSERM, Paris Cardiovasc Res Ctr, Sudden Death Expertise Ctr, U970, Paris, France; [Dumas, Florence] Hop Cochin, AP HP, Emergency Dept, F-75674 Paris, France; [Chenevier-Gobeaux, Camille] Hop Cochin, AP HP, Dept Automated Biol Diag, F-75674 Paris, France		Cariou, M (corresponding author), Hop Cochin, AP HP, Med Intens Care Unit, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	alain.cariou@cch.aphp.fr	Geri, Guillaume/F-4302-2015; Morichau-Beauchant, Tristan/AAK-9832-2020; Empana, Jean-Philippe/AAF-6923-2021	Morichau-Beauchant, Tristan/0000-0001-9890-4590; Empana, Jean-Philippe/0000-0002-1469-7772; Pene, Frederic/0000-0003-3639-3849	Institut National de la Sante et de la Recherche MedicaleInstitut National de la Sante et de la Recherche Medicale (Inserm); Societe de Reanimation de Langue Francaise; European Society of Intensive Care Medicine	Dr. Geri received support for the development of educational presentations from the Bristol Myers Squibb. His institution received support for travel from the Astellas. Dr. Chenevier-Gobeaux lectured for Biomerieux. Dr. Jouven's institution received grant support from the Institut National de la Sante et de la Recherche Medicale. Dr. Mira served as a board member for Merck Sharp & Dohme-Chibret (MSD) (board of AMARCAND study) and Laboratoire francais du fractionnement et des biotechnologies (LFB) (scientific committee); consulted for Astellas and Gilead; lectured for Astellas, LFB, Eli Lilly, and Brahms; and received support for the development of educational presentations from MSD. Dr. Pene lectured for the Roche. His institution received grant support from the Societe de Reanimation de Langue Francaise and European Society of Intensive Care Medicine. Dr. Empana consulted for the Lundbeck factory. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Annborn M, 2014, ACTA ANAESTH SCAND, V58, P428, DOI 10.1111/aas.12282; Bunch TJ, 2003, NEW ENGL J MED, V348, P2626, DOI 10.1056/NEJMoa023053; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Castren M, 2008, RESUSCITATION, V79, P193, DOI 10.1016/j.resuscitation.2008.07.007; Chelly J, 2012, RESUSCITATION, V83, P1444, DOI 10.1016/j.resuscitation.2012.08.321; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dumas F, 2012, J AM COLL CARDIOL, V60, P21, DOI 10.1016/j.jacc.2012.03.036; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; FASSBENDER K, 1994, STROKE, V25, P1105, DOI 10.1161/01.STR.25.6.1105; Gegenhuber A, 2007, J CARD FAIL, V13, P42, DOI 10.1016/j.cardfail.2006.09.004; Goldsmith SR, 2005, J AM COLL CARDIOL, V46, P1785, DOI 10.1016/j.jacc.2005.02.095; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Jarai R, 2011, AM J CARDIOL, V108, P1188, DOI 10.1016/j.amjcard.2011.06.024; Katan M, 2011, NEUROLOGY, V76, P563, DOI 10.1212/WNL.0b013e31820b75e6; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Keller T, 2010, J AM COLL CARDIOL, V55, P2096, DOI 10.1016/j.jacc.2010.01.029; Kelly D, 2008, J CARD FAIL, V14, P739, DOI 10.1016/j.cardfail.2008.07.231; Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503; Kotb A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096581; Latini R, 2011, J INTERN MED, V269, P160, DOI 10.1111/j.1365-2796.2010.02287.x; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Lin C, 2013, PEPTIDES, V42, P43, DOI 10.1016/j.peptides.2013.01.015; Lindner KH, 1996, HEART, V75, P145, DOI 10.1136/hrt.75.2.145; LINDNER KH, 1992, ANESTHESIOLOGY, V77, P662, DOI 10.1097/00000542-199210000-00008; Matsue Y, 2012, J AM COLL CARDIOL, V60, P908, DOI 10.1016/j.jacc.2012.03.070; Mongardon N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-45; NEGOVSKY VA, 1988, CRIT CARE MED, V16, P942, DOI 10.1097/00003246-198810000-00004; Neuhold S, 2008, J AM COLL CARDIOL, V52, P266, DOI 10.1016/j.jacc.2008.03.050; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; Ostadal P, 2012, CRIT CARE, V16, DOI 10.1186/cc11671; Reboldi G, 2014, HYPERTENSION, V63, P475, DOI 10.1161/HYPERTENSIONAHA.113.02089; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; von Haehling S, 2012, INT J CARDIOL, V162, P27, DOI 10.1016/j.ijcard.2011.12.105; Voors AA, 2009, EUR HEART J, V30, P1187, DOI 10.1093/eurheartj/ehp098; Wever EFD, 1996, CIRCULATION, V93, P489, DOI 10.1161/01.CIR.93.3.489; WEVER EFD, 1995, CIRCULATION, V91, P2195, DOI 10.1161/01.CIR.91.8.2195; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017	40	7	7	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2015	43	2					422	429		10.1097/CCM.0000000000000716			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2YX	WOS:000348096200019	25599466				2022-02-06	
J	Kahn, M; Williams, G				Kahn, Michelle; Williams, Gavin			Clinical Tests of Ankle Plantarflexor Strength Do Not Predict Ankle Power Generation During Walking	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Muscle Strength Testing; Gait; Ankle Plantarflexor Muscle; Traumatic Brain Injury	TRAUMATIC BRAIN-INJURY; MUSCLE STRENGTH; GAIT ANALYSIS; STROKE; JOINT; RELIABILITY; MOBILITY; REHABILITATION; DYNAMOMETRY; PROGRESSION	Objective: The aim of this study was to investigate the relationship between a clinical test of ankle plantarflexor strength and ankle power generation (APG) at push-off during walking. Design: This is a prospective cross-sectional study of 102 patients with traumatic brain injury. Outcome Measures: Handheld dynamometry was used to measure ankle plantarflexor strength. Three-dimensional gait analysis was performed to quantify ankle power generation at push-off during walking. Results: Ankle plantarflexor strength was only moderately correlated with ankle power generation at push-off (r = 0.43, P < 0.001; 95% confidence interval, 0.26-0.58). There was also a moderate correlation between ankle plantarflexor strength and self-selected walking velocity (r = 0.32, P = 0.002; 95% confidence interval, 0.13-0.48). Conclusions: Handheld dynamometry measures of ankle plantarflexor strength are only moderately correlated with ankle power generation during walking. This clinical test of ankle plantarflexor strength is a poor predictor of calf muscle function during gait in people with traumatic brain injury.	[Kahn, Michelle; Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Melbourne, Vic, Australia; [Williams, Gavin] La Trobe Univ, Melbourne, Vic, Australia		Kahn, M (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.			Williams, Gavin/0000-0003-2758-7473			Ada L, 2006, AUST J PHYSIOTHER, V52, P241, DOI 10.1016/S0004-9514(06)70003-4; Bohannon R, 2005, FIZYOTERAPI REHABILI, V16, P120; Bohannon RW, 2001, J PHYS THER SCI, V13, P1; Cohen J, 1977, STAT POWER ANAL BEHA; Daniels L, 1972, MUSCLE TESTING TECHN; Fosang A, 2006, GAIT POSTURE, V24, P406, DOI 10.1016/j.gaitpost.2005.09.015; Hakkinen K, 1985, SCAND J SPORTS SCI, V7, P65; Hof A.L., 1996, GAIT POSTURE, V4, P222; Kim C M, 2001, J Stroke Cerebrovasc Dis, V10, P265, DOI 10.1053/jscd.2001.123775; Kobayashi T, 2011, ISOKINET EXERC SCI, V19, P33, DOI 10.3233/IES-2011-0393; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; MacAvoy MC, 2007, J HAND SURG-AM, V32A, P149, DOI 10.1016/j.jhsa.2006.10.020; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McGinley JL, 2003, PHYS THER, V83, P146, DOI 10.1093/ptj/83.2.146; Moller M, 2005, KNEE SURG SPORT TR A, V13, P60, DOI 10.1007/s00167-003-0441-0; Moriello C, 2006, ARCH PHYS MED REHAB, V87, P1490, DOI 10.1016/j.apmr.2006.07.261; Morris SL, 2008, BRAIN INJURY, V22, P1030, DOI 10.1080/02699050802533775; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Simon SR, 2004, J BIOMECH, V37, P1869, DOI 10.1016/j.jbiomech.2004.02.047; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Sullivan KJ, 2011, PHYS THER, V91, P1892, DOI 10.2522/ptj.20110003; Teixeira-Salmela LF, 1999, ARCH PHYS MED REHAB, V80, P1211, DOI 10.1016/S0003-9993(99)90018-7; Thurman DA, 1999, TRAUMATIC BRAIN INJU, P1; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams G, 2014, AM J PHYS MED REHAB, V93, P511, DOI 10.1097/PHM.0000000000000058; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Winter D.A., 1991, BIOMECHANICS MOTOR C; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147	36	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2015	94	2					114	122		10.1097/PHM.0000000000000196			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CB3YK	WOS:000349565200008	25133620				2022-02-06	
J	Liu, YH; Shang, ZD; Chen, C; Lu, N; Liu, QF; Liu, M; Yan, J				Liu, Yu-He; Shang, Zhen-De; Chen, Chao; Lu, Nan; Liu, Qi-Feng; Liu, Ming; Yan, Jing			'Cool and quiet' therapy for malignant hyperthermia following severe traumatic brain injury: A preliminary clinical approach	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						traumatic brain injury; malignant hyperthermia; mild hypothermia; 'cool and quiet' therapy	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; HYPOTHERMIA; TEMPERATURE; GLUTAMATE; COMPLICATIONS; DEXAMETHASONE; METABOLISM; MECHANISMS	Malignant hyperthermia increases mortality and disability in patients with brain trauma. A clinical treatment for malignant hyperthermia following severe traumatic brain injury, termed 'cool and quiet' therapy by the authors of the current study, was investigated. Between June 2003 and June 2013, 110 consecutive patients with malignant hyperthermia following severe traumatic brain injury were treated using mild hypothermia (35-36 degrees C) associated with small doses of sedative and muscle relaxant. Physiological parameters and intracranial pressure were monitored, and the patients slowly rewarmed following the maintenance of mild hypothermia for 3-12 days. Consecutive patients who had undergone normothermia therapy were retrospectively analyzed as the control. In the mild hypothermia group, the recovery rate was 54.5%, the mortality rate was 22.7%, and the severe and mild disability rates were 11.8 and 10.9%, respectively. The mortality rate of the patients, particularly that of patients with a Glasgow Coma Scale (GCS) score of between 3 and 5 differed significantly between the hypothermia group and the normothermia group (P<0.05). The mortality of patients with a GCS score of between 6 and 8 was not significantly different between the two groups (P>0.05). The therapy using mild hypothermia with a combination of sedative and muscle relaxant was beneficial in decreasing the mortality of patients with malignant hyperthermia following severe traumatic brain injury, particularly in patients with a GCS score within the range 3-5 on admission. The therapy was found to be safe, effective and convenient. However, rigorous clinical trials are required to provide evidence of the effectiveness of 'cool and quiet' therapy for hyperthermia.	[Liu, Yu-He; Shang, Zhen-De; Chen, Chao; Lu, Nan; Liu, Qi-Feng; Liu, Ming; Yan, Jing] 88th Hosp PLA, Dept Neurosurg, Tai An 271000, Shandong, Peoples R China		Liu, YH (corresponding author), 88th Hosp PLA, Dept Neurosurg, 6 Dongcun,Hongmen Rd, Tai An 271000, Shandong, Peoples R China.	yuheliu123@yeah.net					Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Childs C, 2010, FRONT NEUROL, V146, P1; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, P3, DOI 10.1089/ther.2010.1500; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Groysman LI, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.4.FOCUS1154; HALLORAN LG, 1980, AM J SURG, V139, P44, DOI 10.1016/0002-9610(80)90228-7; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Maeda T, 1998, J NEUROTRAUM, V15, P655, DOI 10.1089/neu.1998.15.655; Mayumi H, 1997, ANN THORAC SURG, V63, P129; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; Mori K, 1998, NEUROL RES, V20, P719; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Wang CX, 2009, INT J STROKE, V4, P274, DOI 10.1111/j.1747-4949.2009.00317.x; Yokobori S, 2011, THER HYPOTHERMIA TEM, V1, P185, DOI 10.1089/ther.2011.0012	30	7	8	0	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	FEB	2015	9	2					464	468		10.3892/etm.2014.2130			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CB3CX	WOS:000349506900031	25574217	Green Published, gold			2022-02-06	
J	Mancuso, M; Magnani, N; Cantagallo, A; Rossi, G; Capitani, D; Galletti, V; Cardamone, G; Robertson, IH				Mancuso, Mauro; Magnani, Nadia; Cantagallo, Anna; Rossi, Giulia; Capitani, Donatella; Galletti, Vania; Cardamone, Giuseppe; Robertson, Ian Hamilton			Emotion Recognition Impairment in Traumatic Brain Injury Compared With Schizophrenia Spectrum Similar Deficits With Different Origins	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Emotion; Eye movements; Facial expression; Traumatic brain injury; Social cognition; Schizophrenia	FACIAL AFFECT RECOGNITION; SOCIAL COGNITION; EXECUTIVE FUNCTIONS; VISUAL SCANPATHS; NEURAL SYSTEMS; HIGH-RISK; PERCEPTION; METAANALYSIS; EXPRESSION; INDIVIDUALS	The aim of our study was to identify the common and separate mechanisms that might underpin emotion recognition impairment in patients with traumatic brain injury (TBI) and schizophrenia (Sz) compared with healthy controls (HCs). We recruited 21 Sz outpatients, 24 severe TBI outpatients, and 38 HCs, and we used eye-tracking to compare facial emotion processing performance. Both Sz and TBI patients were significantly poorer at recognizing facial emotions compared with HC. Sz patients showed a different way of exploring the Pictures of Facial Affects stimuli and were significantly worse in recognition of neutral expressions. Selective or sustained attention deficits in TBI may reduce efficient emotion recognition, whereas in Sz, there is a more strategic deficit underlying the observed problem. There would seem to be scope for adjustment of effective rehabilitative training focused on emotion recognition.	[Mancuso, Mauro; Rossi, Giulia] NHS, Neurol Rehabil Unit, Grosseto, Italy; [Magnani, Nadia; Cardamone, Giuseppe] NHS, Adult Mental Hlth Serv, Grosseto, Italy; [Cantagallo, Anna; Galletti, Vania] BrainCare, Padua, Italy; [Cantagallo, Anna] Univ Padua, Padua, Italy; [Capitani, Donatella] NHS, Grosseto, Italy; [Robertson, Ian Hamilton] Univ Dublin Trinity Coll, Sch Psychol, Dublin 2, Ireland; [Robertson, Ian Hamilton] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland		Mancuso, M (corresponding author), Via Scansanese 365, I-58100 Grosseto, Italy.	m.mancuso62@gmail.com	Mancuso, Mauro/J-6773-2018	Mancuso, Mauro/0000-0002-8451-9277; magnani, nadia/0000-0001-7486-8169; Robertson, Ian H/0000-0001-8637-561X			Addington J, 2008, BRIT J PSYCHIAT, V192, P67, DOI 10.1192/bjp.bp.107.039784; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Amann B, 2012, PSYCHOL MED, V23, P1; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bechi M, 2012, PSYCHIAT RES; Bediou B, 2007, NEUROPHYSIOL CLIN, V37, P77, DOI 10.1016/j.neucli.2007.04.001; Beedie SA, 2012, WORLD J BIOL PSYCHIA, V13, P200, DOI 10.3109/15622975.2011.566628; Beedie SA, 2011, J PSYCHIATR NEUROSCI, V36, P150, DOI 10.1503/jpn.090169; Biedermann F, 2012, CURR OPIN PSYCHIATR, V25, P71, DOI 10.1097/YCO.0b013e3283503624; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; CANCELLIERE AEB, 1990, BRAIN COGNITION, V13, P133, DOI 10.1016/0278-2626(90)90046-Q; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Di Mark L, 2009, NONVERBAL COMMUNICAT; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Ekman P., 1976, PICTURES FACIAL AFFE; Ekman Paul, 2003, UNMASKING FACE GUIDE; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Freedman D, 2011, INT J DEV NEUROSCI, V29, P237, DOI 10.1016/j.ijdevneu.2010.11.003; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Green MJ, 2001, BRIT J CLIN PSYCHOL, V40, P157, DOI 10.1348/014466501163607; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Habel U, 2010, SOC NEUROSCI-UK, V5, P92, DOI 10.1080/17470910903170269; Hanlon FM, 2011, NEUROIMAGE, V58, P1158, DOI 10.1016/j.neuroimage.2011.06.091; Hoofien D, 2001, BRAIN INJURY, V15, P189; Johnston PJ, 2010, SCHIZOPHRENIA BULL, V36, P680, DOI 10.1093/schbul/sbn136; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kee KS, 2006, SCHIZOPHR RES, V87, P228, DOI 10.1016/j.schres.2006.06.001; Keefe RSE, 2006, NEUROPSYCHOPHARMACOL, V31, P2033, DOI 10.1038/sj.npp.1301072; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim HS, 2010, SCHIZOPHR RES, V118, P81, DOI 10.1016/j.schres.2010.01.003; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Kucharska-Pietura K, 2005, BRIT J PSYCHIAT, V187, P523, DOI 10.1192/bjp.187.6.523; Li HJ, 2010, SCHIZOPHRENIA BULL, V36, P1029, DOI 10.1093/schbul/sbn190; Loughland CM, 2004, SCHIZOPHR RES, V67, P11, DOI 10.1016/S0920-9964(03)00094-X; Loughland CM, 2002, SCHIZOPHR RES, V55, P159, DOI 10.1016/S0920-9964(01)00186-4; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; Majani G, 1998, SAT P SATISFACTION P; Marwick K, 2008, BRIT MED BULL, V88, P43, DOI 10.1093/bmb/ldn035; Mathersul D, 2009, J CLIN EXP NEUROPSYC, V31, P278, DOI 10.1080/13803390802043619; Michalopoulou PG, 2008, BRIT J PSYCHIAT, V192, P191, DOI 10.1192/bjp.bp.106.032649; Morosini Pierluigi, 2003, Epidemiol Psichiatr Soc, V12, P53; Niendam TA, 2009, NEUROPSYCHOL REV, V19, P280, DOI 10.1007/s11065-009-9108-z; Orellana G, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-154; Palacios EM, 2012, CORTEX; Petroni A, 2011, NEUROSCI LETT, V505, P41, DOI 10.1016/j.neulet.2011.09.062; Pietersen CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001360; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Russell TA, 2007, NEUROPSYCHOLOGIA, V45, P107, DOI 10.1016/j.neuropsychologia.2006.04.026; Sasson N, 2007, NEUROPSYCHOLOGIA, V45, P2580, DOI 10.1016/j.neuropsychologia.2007.03.009; Sergi MJ, 2006, AM J PSYCHIAT, V163, P448, DOI 10.1176/appi.ajp.163.3.448; Silver H, 2004, PSYCHIAT RES, V128, P147, DOI 10.1016/j.psychres.2004.06.002; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spinnler H., 1987, J NEUROL SCI, V6, P6; Toh WL, 2011, COMPR PSYCHIAT, V52, P567, DOI 10.1016/j.comppsych.2010.12.005; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tremeau Fabien, 2006, Dialogues Clin Neurosci, V8, P59; van't Wout M, 2007, J NERV MENT DIS, V195, P758, DOI 10.1097/NMD.0b013e318142cc31; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wolf DH, 2011, PSYCHOPHARMACOLOGY, V218, P503, DOI 10.1007/s00213-011-2348-7	70	7	7	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	FEB	2015	203	2					87	95		10.1097/NMD.0000000000000245			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CA6EM	WOS:000349001900003	25602943				2022-02-06	
J	das Nair, R; Lincoln, NB; Ftizsimmons, D; Brain, N; Montgomery, A; Bradshaw, L; Drummond, A; Sackley, C; Newby, G; Thornton, J; Stapleton, S; Pink, A				das Nair, Roshan; Lincoln, Nadina B.; Ftizsimmons, Deborah; Brain, Nicola; Montgomery, Alan; Bradshaw, Lucy; Drummond, Avril; Sackley, Catherine; Newby, Gavin; Thornton, Jim; Stapleton, Sandip; Pink, Anthony			Rehabilitation of Memory following Brain Injury (ReMemBrIn): study protocol for a randomised controlled trial	TRIALS			English	Article						Traumatic brain injury; Memory; Cognitive rehabilitation; Randomised controlled trial; Cost-effectiveness	COGNITIVE REHABILITATION; NEUROLOGICAL DISABILITIES	Background: Impairments of memory are commonly reported by people with traumatic brain injuries (TBI). Such deficits are persistent, debilitating, and can severely impact quality of life. Currently, many do not routinely receive follow-up appointments for residual memory problems following discharge. Methods/Design: This is a multi-centre, randomised controlled trial investigating the clinical and cost-effectiveness of a group-based memory rehabilitation programme. Three hundred and twelve people with a traumatic brain injury will be randomised from four centres. Participants will be eligible if they had a traumatic brain injury more than 3 months prior to recruitment, have memory problems, are 18 to 69 years of age, are able to travel to one of our centres and attend group sessions, and are able to give informed consent. Participants will be randomised in clusters of 4 to 6 to the group rehabilitation intervention or to usual care. Intervention groups will receive 10 weekly sessions of a manualised memory rehabilitation programme, which has been developed in previous pilot studies. The intervention will include restitution strategies to retrain impaired memory functions and compensation strategies to enable participants to cope with their memory problems. All participants will receive a follow-up postal questionnaire and an assessment by a research assistant at 6 and 12 months post-randomisation. The primary outcome is the Everyday Memory Questionnaire at 6 months. Secondary outcomes include the Rivermead Behavioural Memory Test-3, General Health Questionnaire-30, health related quality of life, cost-effectiveness analysis determined by the EQ-5D and a service use questionnaire, individual goal attainment, European Brain Injury Questionnaire (patient and relative versions), and the Everyday Memory Questionnaire-relative version. The primary analysis will be based on intention to treat. A mixed-model regression analysis of the Everyday Memory Questionnaire at 6 months will be used to estimate the effect of the group memory rehabilitation programme. Discussion: The study will hopefully provide robust evidence regarding the clinical and cost-effectiveness of a group-based memory rehabilitation intervention for civilians and military personnel following TBI. We discuss our decision-making regarding choice of outcome measures and control group, and the unique challenges to recruiting people with memory problems to trials.	[das Nair, Roshan; Lincoln, Nadina B.] Univ Nottingham, Div Rehabil & Ageing, Queens Med Ctr, Nottingham NG7 2UH, England; [das Nair, Roshan] Nottingham Univ Hosp NHS Trust, Dept Clin Psychol & Neuropsychol, Nottingham NG7 2UH, England; [Ftizsimmons, Deborah] Swansea Univ, Swansea Ctr Hlth Econ, Coll Human & Hlth Sci, Swansea SA2 8PP, W Glam, Wales; [Brain, Nicola] Derby Hosp NHS Fdn Trust, Royal Derby Hosp, Derby DE22 3NE, England; [Montgomery, Alan; Bradshaw, Lucy; Thornton, Jim; Stapleton, Sandip] Queens Med Ctr, Nottingham Clin Trials Unit, Nottingham NG7 2UH, England; [Drummond, Avril] Univ Nottingham, Sch Nursing, Queens Med Ctr, Nottingham NG7 2UH, England; [Sackley, Catherine] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Newby, Gavin] Acquired Brain Injury Serv, Chester CH2 1HJ, Cheshire, England		das Nair, R (corresponding author), Univ Nottingham, Div Rehabil & Ageing, Queens Med Ctr, Nottingham NG7 2UH, England.	Roshan.nair@nottingham.ac.uk	Thornton, Jim/B-8336-2008	Thornton, Jim/0000-0001-9764-6876; das Nair, Roshan/0000-0001-8143-7893; Montgomery, Alan/0000-0003-0450-1606; sackley, catherine/0000-0002-8580-6622; Drummond, Avril/0000-0003-1220-8354	National Institute for Health Research Health Technology Assessment (NIHR HTA) ProgrammeNational Institute for Health Research (NIHR) [10/57/24]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [10/57/24] Funding Source: researchfish	This project is funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (10/57/24) and will be published in full in Health Technology Assessment.	Bauer DJ, MULTIVAR BEHAV RES; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; das Nair RD, 2007, COCHRANE DB SYST REV, V3; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; DASNAIR R, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002293.PUB2; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Ducharme JM, 2001, BRAIN INJURY, V15, P333, DOI 10.1080/02699050010005869; Finkelstein EA, 2006, INCIDENCE EC BURDEN, P202; Goldberg RJ, 1988, USERS GUIDE GEN HLTH; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Heath C, 1997, QUALITATIVE RES ACTI, P99; Jordan B, 1995, J LEARN SCI, V4, P39, DOI 10.1207/s15327809jls0401_2; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Mozzoni MP, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199602000-00003; Nair RD, 2008, THESIS U NOTTINGHAM; National Audit Office, 2005, NAT SERV FRAM LONG T; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; O'Brien MC, 2013, NEUROPSYCHOL REHABIL, V23, P321, DOI 10.1080/09602011.2012.753920; Ptak R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00057; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Skeel RL, 2001, REHABILITATION NEURO; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Syder D, 1993, SHEFFIELD SCREENING; Teasdale TW, BRAIN INJ; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williamson DJG, 1996, NEUROPSYCYHOLOGY CLI; Wilson B, 2010, J NEUROL NEUROSUR PS, V81, pE4, DOI 10.1136/jnnp.2010.217554.9; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, NEUROPSYCH REHAB	37	7	7	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	JAN 6	2015	16								6	10.1186/1745-6215-16-6			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AY9FH	WOS:000347854600001	25559090	Green Published, gold			2022-02-06	
J	Meyer, JE; Arnett, PA				Meyer, Jessica E.; Arnett, Peter A.			Changes in Symptoms in Concussed and Non-Concussed Athletes Following Neuropsychological Assessment	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							SPORTS; MANAGEMENT; REST	Collegiate athletes tested at baseline and post-concussion were administered a self-report measure of post-concussion symptoms pre- and post-testing. Athletes tested post-concussion were significantly more likely to demonstrate an increase in symptoms post-testing, suggesting that the cognitive exertion involved in neuropsychological assessment may exacerbate symptoms in some athletes.	[Meyer, Jessica E.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Meyer, JE (corresponding author), Penn State Univ, Dept Psychol, 372 Moore, University Pk, PA 16802 USA.	jem508@psu.edu					Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Randolph C, 2005, J ATHL TRAINING, V40, P139; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	10	7	7	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JAN 2	2015	40	1			SI		24	28		10.1080/87565641.2014.1001065			5	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CA6IR	WOS:000349015800005	25649776				2022-02-06	
J	Al-Dorzi, HM; Al-Humaid, W; Tamim, HM; Haddad, S; Aljabbary, A; Arifi, A; Arabi, YM				Al-Dorzi, Hasan M.; Al-Humaid, Waleed; Tamim, Hani M.; Haddad, Samir; Aljabbary, Ahmad; Arifi, Abdulaziz; Arabi, Yaseen M.			Anemia and Blood Transfusion in Patients with Isolated Traumatic Brain Injury	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							CEREBRAL OXYGENATION; CRITICALLY-ILL; CELL TRANSFUSION; OUTCOMES; PATHOPHYSIOLOGY; ERYTHROPOIETIN	Rationale. By reducing cerebral oxygen delivery, anemia may aggravate traumatic brain injury (TBI) secondary insult. This study evaluated the impact of anemia and blood transfusion on TBI outcomes. Methods. This was a retrospective cohort study of adult patients with isolated TBI at a tertiary-care intensive care unit from 1/1/2000 to 31/12/2011. Daily hemoglobin level and packed red blood cell (PRBC) transfusion were recorded. Patients with hemoglobin < 10 g/dL during ICU stay (anemic group) were compared with other patients. Results. Anemia was present on admission in two (2%) patients and developed in 48% during the first week with hemoglobin < 7 g/dL occurring in 3.0%. Anemic patients had higher admission Injury Severity Score and underwent more craniotomy (50% versus 13%, p < 0.001). Forty percent of them received PRBC transfusion (2.8 + 1.5 units per patient, median pretransfusion hemoglobin = 8.8 g/dL). Higher hospital mortality was associated with anemia (25% versus 6% for nonanemic patients, p = 0.01) and PRBC transfusion (38% versus 9% for nontransfused patients, p = 0.003). On multivariate analysis, only PRBC transfusion independently predicted hospital mortality (odds ratio: 6.8; 95% confidence interval: 1.1-42.3). Conclusions. Anemia occurred frequently after isolated TBI, but only PRBC transfusion independently predicted mortality.	[Al-Dorzi, Hasan M.; Haddad, Samir; Aljabbary, Ahmad; Arabi, Yaseen M.] King Abdul Aziz Med City, Dept Intens Care, Riyadh 11426, Saudi Arabia; [Al-Dorzi, Hasan M.; Al-Humaid, Waleed; Aljabbary, Ahmad; Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh 11426, Saudi Arabia; [Tamim, Hani M.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Epidemiol & Biostat, Riyadh 11426, Saudi Arabia; [Tamim, Hani M.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut 11072020, Lebanon; [Arifi, Abdulaziz] King Abdul Aziz Med City, Neurosurg Surg Dept, Riyadh 11426, Saudi Arabia		Al-Dorzi, HM (corresponding author), King Abdul Aziz Med City, Dept Intens Care, Riyadh 11426, Saudi Arabia.	aldorzih@yahoo.com	Arabi, Yaseen/ABF-3316-2020	Arabi, Yaseen/0000-0001-5735-6241; Al-Dorzi, Hasan M/0000-0002-3772-8949			Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CORWIN HL, 1995, CHEST, V108, P767, DOI 10.1378/chest.108.3.767; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hare GMT, 2008, ANESTH ANALG, V107, P1356, DOI 10.1213/ane.0b013e318184cfe9; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Malbrain MLNG, 2014, ANAESTH INTENSIVE TH, V46, P361, DOI 10.5603/AIT.2014.0060; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rodriquez RM, 2001, J CRIT CARE, V16, P36, DOI 10.1053/jcrc.2001.21795; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Simak J, 2006, TRANSFUS MED REV, V20, P1, DOI 10.1016/j.tmrv.2005.08.001; Taylor RW, 2006, CRIT CARE MED, V34, P2302, DOI 10.1097/01.CCM.0000234034.51040.7F; Tsai AG, 2004, TRANSFUSION, V44, P1626, DOI 10.1111/j.0041-1132.2004.04128.x; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; World health organization, 2008, WORLDWIDE PREVALENCE; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	28	7	9	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2015	2015								672639	10.1155/2015/672639			7	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	CV0SL	WOS:000363963100001	26605080	Green Published, Green Submitted, gold			2022-02-06	
J	Chhabra, R; Ruozi, B; Vilella, A; Belletti, D; Mangus, K; Pfaender, S; Sarowar, T; Boeckers, TM; Zoli, M; Forni, F; Vandelli, MA; Tosi, G; Grabrucker, AM				Chhabra, Resham; Ruozi, Barbara; Vilella, Antonietta; Belletti, Daniela; Mangus, Katharina; Pfaender, Stefanie; Sarowar, Tasnuva; Boeckers, Tobias Maria; Zoli, Michele; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni; Grabrucker, Andreas Martin			Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Blood brain barrier; brain; drug delivery; Nanoparticle (NP); Poly(D,L-lactide-co-glycolide) (PLGA); Zn2+; ZnSO4	DRUG-DELIVERY; BRAIN; TRANSCRIPTION; HOMEOSTASIS; INGESTION; PROTEIN; MTF-1; ACID	A dyshomeostasis of zinc ions has been reported for many psychiatric and neurodegenerative disorders including schizophrenia, attention deficit hyperactivity disorder, depression, autism, Parkinson's and Alzheimer's disease. Furthermore, alterations in zinc-levels have been associated with seizures and traumatic brain injury. Thus, altering zinc-levels within the brain is emerging as a new target for the prevention and treatment of psychiatric and neurological diseases. However, given the restriction of zinc uptake into the brain by the blood-brain barrier, methods for controlled regulation and manipulation of zinc concentrations within the brain are rare. Here, we performed in vivo studies investigating the possibility of brain targeted zinc delivery using zinc-loaded nanoparticles which are able to cross the blood-brain barrier. After injecting these nanoparticles, we analyzed the regional and time-dependent distribution of zinc and nanoparticles within the brain. Moreover, we evaluated whether the presence of zinc-loaded nanoparticles alters the expression of zinc sensitive genes and proteins such as metallothioneins and zinc transporters and quantified possible toxic effects. Our results show that zinc loaded g7 nanoparticles offer a promising approach as a novel non - invasive method to selectively enrich zinc in the brain within a small amount of time.	[Chhabra, Resham; Mangus, Katharina; Pfaender, Stefanie; Sarowar, Tasnuva; Grabrucker, Andreas Martin] Univ Ulm, WG Mol Anal Synaptopathies, Dept Neurol, Neuroctr, D-89081 Ulm, Germany; [Ruozi, Barbara; Belletti, Daniela; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni] Univ Modena & Reggio Emilia, Pharmaceut Technol, Dept Pharmaceut Sci, TeFarTI, I-41125 Modena, Italy; [Pfaender, Stefanie; Boeckers, Tobias Maria; Grabrucker, Andreas Martin] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany; [Vilella, Antonietta; Zoli, Michele] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, I-41125 Modena, Italy		Grabrucker, AM (corresponding author), Univ Ulm, WG Mol Anal Synaptopathies, Dept Neurol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	gtosi@unimore.it; andreas.grabrucker@uni-ulm.de	Zoli, Michele/C-8899-2016; VILELLA, ANTONIETTA/AAU-3373-2021; Vilella, Antonietta/AAF-2084-2019; Belletti, Daniela/L-5288-2016; Tosi, Giovanni/D-4547-2011	Zoli, Michele/0000-0002-8034-2849; Belletti, Daniela/0000-0003-2872-445X; Vilella, Antonietta/0000-0003-3820-0115; Tosi, Giovanni/0000-0001-8318-667X; Grabrucker, Andreas/0000-0003-0005-4810	Baustein 3.2 [L.SBN.0083]; Alzheimer's AssociationAlzheimer's Association [NIRG-12-235441]; PRIN grantMinistry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN); Vigoni grant	AMG is supported by Baustein 3.2 (L.SBN.0083) and the Alzheimer's Association (NIRG-12-235441). RC is a member of the International Graduate School Molecular Medicine at Ulm University. FF is supported by PRIN grant, GT is supported by Vigoni grant. The authors gratefully acknowledge the professional technical assistance of Renate Zienecker.	Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Bi YY, 2004, BIOCHEM J, V380, P695, DOI 10.1042/BJ20031677; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; Blanco MD, 1997, EUR J PHARM BIOPHARM, V43, P287, DOI 10.1016/S0939-6411(97)00056-8; Bobilya DJ, 1997, J TRACE ELEM MED BIO, V10, P918; Bondioli L, 2010, BIOMATERIALS, V31, P3395, DOI 10.1016/j.biomaterials.2010.01.049; Costantino L, 2005, J CONTROL RELEASE, V108, P84, DOI 10.1016/j.jconrel.2005.07.013; Davson H., 1996, PHYSL CSF BLOOD BRAI; EBADI M, 1986, BIOL TRACE ELEM RES, V11, P101, DOI 10.1007/BF02795528; Frederickson C. J., 1994, Biological Signals, V3, P127; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Grabrucker AM, 2014, DEV NEUROBIOL, V74, P136, DOI 10.1002/dneu.22089; Grabrucker Andreas M, 2011, Drug Deliv Lett, V1, P13; Grabrucker AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017851; Hagmeyer S, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00443; HOLM IE, 1988, HISTOCHEMISTRY, V89, P289, DOI 10.1007/BF00493154; JAARSMA D, 1990, J NEUROSCI METH, V35, P125, DOI 10.1016/0165-0270(90)90102-L; Jan HH, 2002, J NEUROCHEM, V83, P525, DOI 10.1046/j.1471-4159.2002.01093.x; JOSHI DP, 1979, ANAL CHIM ACTA, V104, P153, DOI 10.1016/S0003-2670(01)83825-3; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; KOZIK MB, 1980, FOL HISTOCH CYTOCHEM, V18, P201; KOZIK MB, 1979, ACTIV NERV SUPER, V21, P277; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Marger L, 2014, BIOCHEM PHARMACOL, V91, P426, DOI 10.1016/j.bcp.2014.08.002; McCormick NH, 2014, J MAMMARY GLAND BIOL, V19, P59, DOI 10.1007/s10911-013-9314-4; MURPHY JV, 1970, J AMER MED ASSOC, V212, P2119, DOI 10.1001/jama.212.12.2119; Nicolas J, 2013, CHEM SOC REV, V42, P1147, DOI 10.1039/c2cs35265f; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; PFEIFFER CC, 1982, BIOL PSYCHIAT, V17, P513; Pivovarova NB, 2014, J NEUROCHEM, V128, P592, DOI 10.1111/jnc.12489; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Sahni JK, 2011, J CONTROL RELEASE, V152, P208, DOI 10.1016/j.jconrel.2010.11.033; Shi NY, 2000, P NATL ACAD SCI USA, V97, P7567, DOI 10.1073/pnas.130187497; Smidt K, 2012, BIOMETALS, V25, P1, DOI 10.1007/s10534-011-9490-x; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Takeda A, 2001, BIOMETALS, V14, P343, DOI 10.1023/A:1012982123386; Tosi G, 2007, J CONTROL RELEASE, V122, P1, DOI 10.1016/j.jconrel.2007.05.022; Tosi G, 2008, EXPERT OPIN DRUG DEL, V5, P155, DOI 10.1517/17425247.5.2.155; Tosi G, 2014, J CONTROL RELEASE, V177, P96, DOI 10.1016/j.jconrel.2014.01.004; Tosi G, 2013, NANOMEDICINE-UK, V8, P1373, DOI [10.2217/NNM.12.172, 10.2217/nnm.12.172]; Tosi G, 2012, NANOMEDICINE-UK, V7, P365, DOI [10.2217/NNM.11.98, 10.2217/nnm.11.98]; Tosi G, 2011, NANOMEDICINE-UK, V6, P423, DOI [10.2217/NNM.11.11, 10.2217/nnm.11.11]; Vallee B L, 1992, Matrix Suppl, V1, P5; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vergoni AV, 2009, NANOMED-NANOTECHNOL, V5, P369, DOI 10.1016/j.nano.2009.02.005; White JF, 2003, EXP BIOL MED, V228, P639, DOI 10.1177/153537020322800601; Wong CP, 2012, MOL NUTR FOOD RES, V56, P77, DOI 10.1002/mnfr.201100511; Yasuda H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00129; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	50	7	7	3	17	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	8					1041	1053		10.2174/1871527314666150821111455			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CT1TH	WOS:000362583700012	26295815				2022-02-06	
J	Di Battista, A; Godfrey, C; Soo, C; Catroppa, C; Anderson, V				Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki			Does what we measure matter? Quality-of-life defined by adolescents with brain injury	BRAIN INJURY			English	Article						Adolescents/youth; mixed methods; quality-of-life; traumatic brain injury	INTERVIEWS; CHILDREN; TBI	Objectives: To determine if domains included in popular measurement systems (e.g. the Peds QL (TM)) reflect the adolescent survivor of a brain injury's sense of QoL and explore this relationship in reference to an emerging model of wellbeing in the adolescent with TBI. Methods: Mixed methods; adolescent QoL assessed using the PedsQL (TM) self-report and a semi-structured interview created by the lead author. Adolescent self-report was compared to adolescent narratives. Results: Ten adolescents participated. Adolescent PedsQL (TM) total was within normal limits. Adolescents reported that changes identified by the PedsQL were not important and did not impact on their sense of QoL. The importance on social components of QoL-as opposed to cognitive-provide additional support of the emerging model of wellbeing in adolescents with TBI. Conclusions: The PedsQL can identify changes post-TBI, but fails to consider whether these changes are relevant to the adolescent. Alternate methods of exploring QoL-which emphasize the interaction of social networks and friendships, should be considered to avoid an oblique view of QoL outcomes after TBI.	[Di Battista, Ashley] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy] Murdoch Childrens Res Inst, Dept Child Neuropsychol, Melbourne, Vic, Australia; [Catroppa, Cathy] Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Crit Care & Neurosci Res Melbourne, Melbourne, Vic, Australia		Di Battista, A (corresponding author), Hosp Sick Children, Dept Crit Care Med, 6th Floor,Black Wing,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ashley.dibattista@sickkids.ca	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Victorian Neurotrauma Initiative-fellowship; Australian National Health & Medical Research CouncilNational Health and Medical Research Council of Australia; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	The authors acknowledge: Victorian Government Operational Infrastructure Scheme; Victorian Neurotrauma Initiative-fellowship to CS; Australian National Health & Medical Research Council-fellowships to VA and CC; and Canadian Institutes of Health Research-Doctoral Research Award to AD.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson VA, 2010, J NEUROTRAUM, V27, P1; Apgar M, 1991, USING COMPUTERS QUAL; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; Cummins RA, 2005, J INTELL DISABIL RES, V49, P699, DOI 10.1111/j.1365-2788.2005.00738.x; Di Battista A., 2013, SPEAKING THEMSELVES, P208; Di Battista A, 2014, J REHABIL MED, V46, P975, DOI 10.2340/16501977-1883; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; HODGES K, 1993, J CHILD PSYCHOL PSYC, V34, P49, DOI 10.1111/j.1469-7610.1993.tb00967.x; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mason M., 2010, FORUM QUALITATIVE SO, V11, P8, DOI [10.17169/fqs-11.3.1428, DOI 10.17169/FQS-11.3.1428]; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; MEULI M, 1991, EUR J PEDIATR SURG, V1, P196, DOI 10.1055/s-2008-1042486; Padgett D. K., 1998, QUALITATIVE METHODS; Patton M.Q., 1990, QUALITATIVE EVALUATI; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Seidel J.V., 1998, QUALITATIVE DATA ANA; Smith A, 2003, QUALITATIVE PSYCHOL; TEASDALE G, 1974, LANCET, V2, P81; Varni J.W., 1998, PEDSQL MEASUREMENT M; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; World Health Organization, 2010, MEAS HLTH DIS MAN WH	30	7	7	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					573	582		10.3109/02699052.2014.989905			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000005	25642580				2022-02-06	
J	Hua, Y; Lin, SM; Gu, LX				Hua, Yi; Lin, Shengmao; Gu, Linxia			Relevance of Blood Vessel Networks in Blast-Induced Traumatic Brain Injury	COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE			English	Article							MECHANICAL-PROPERTIES; DYNAMIC-RESPONSE; MODEL	Cerebral vasculature is a complex network that circulates blood through the brain. However, the role of this networking effect in brain dynamics has seldom been inspected. This work is to study the effects of blood vessel networks on dynamic responses of the brain under blast loading. Voronoi tessellations were implemented to represent the network of blood vessels in the brain. The brain dynamics in terms of maximum principal strain (MPS), shear strain (SS), and intracranial pressure (ICP) were monitored and compared. Results show that blood vessel networks significantly affected brain responses. The increased MPS and SS were observed within the brain embedded with vessel networks, which did not exist in the case without blood vessel networks. It is interesting to observe that the alternation of the ICP response was minimal. Moreover, the vessel diameter and density also affected brain dynamics in both MPS and SS measures. This work sheds light on the role of cerebral vasculature in blast-induced traumatic brain injury.	[Hua, Yi; Lin, Shengmao; Gu, Linxia] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Gu, Linxia] Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA		Gu, LX (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	lgu@unl.edu	gu, linxia/A-5645-2013	gu, linxia/0000-0003-2637-0299	Edgerton Innovation Award at University of Nebraska-Lincoln College of Engineering	The authors gratefully acknowledge the financial support from the Edgerton Innovation Award at the University of Nebraska-Lincoln College of Engineering.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; DePalma RG, 2014, UNDERSTANDING TRAUMA, P413; Fischer H., 2007, US MILITARY CASUALTY; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Monson K. L., 2001, THESIS U CALIFORNIA; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Parnaik Yednesh, 2004, Stapp Car Crash J, V48, P259; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shreiber D. I, 1997, VIVO THRESHOLDS MECH; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	22	7	7	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1748-670X	1748-6718		COMPUT MATH METHOD M	Comput. Math. Method Med.		2015	2015								928236	10.1155/2015/928236			8	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	CT4HZ	WOS:000362768500001	26495036	Green Published, gold			2022-02-06	
J	Huang, TY; Ma, HP; Tsai, SH; Chiang, YH; Hu, CJ; Ou, JC				Huang, Ting-Yun; Ma, Hon-Ping; Tsai, Shin-Han; Chiang, Yung-Hsiao; Hu, Chaur-Jong; Ou, Juchi			Sleep Duration and Sleep Quality following Acute Mild Traumatic Brain Injury: A Propensity Score Analysis	BEHAVIOURAL NEUROLOGY			English	Article							CHINESE VERSION; INDEX; VALIDATION; INSOMNIA; ADULTS; DEPRESSION; DISORDERS; SOLDIERS; IMPACT; SAMPLE	Introduction. Mild traumatic brain injury (mTBI) has been widely studied and the effects of injury can be long termor even lifelong. This research aims to characterize the sleep problems of patients following acute mTBI. Methods. A total of 171 patients with mTBI within one month and 145 non-mTBI controls were recruited in this study. The questionnaire, Pittsburgh Sleep Quality Index (PSQI), was used to evaluate seven aspects of sleep problems. A propensity score method was used to generate a quasirandomized design to account for the background information, including gender, age, Beck's Anxiety Index, Beck's Depression Index, and Epworth Sleepiness Scale. The effect was evaluated via cumulative logit regression including propensity scores as a covariate. Results. Before adjustment, about 60% mTBI patients and over three quarters of control subjects had mild sleep disturbance while one third mTBI patients had moderate sleep disturbance. After adjusting by the propensity scores, the scores of sleep quality and duration were significant between mTBI and control groups. Conclusion. Our study supports that sleep problem is common in mTBI group. After adjusting the confounders by propensity score, sleep duration and subjective sleep quality are the most frequently reported problems in mTBI patients within one month after the injury.	[Huang, Ting-Yun; Ma, Hon-Ping; Tsai, Shin-Han; Ou, Juchi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei City 235, Taiwan; [Ma, Hon-Ping; Tsai, Shin-Han] Taipei Med Univ, Dept Emergency Med, Taipei 110, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Dept Neurosurg, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Canc, Translat Res Lab, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Dept Surg, Coll Med, Taipei 110, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City 235, Taiwan		Ou, JC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, 291 Zhongzheng Rd, New Taipei City 235, Taiwan.	juchi@tmu.edu.tw			 [NSC 98-2321-B-038-005-MY3];  [NSC 101-2321-B-038-005];  [103TMU-SHH-24];  [DOH 101-TD-B-111-003]	This study was supported by Grants NSC 98-2321-B-038-005-MY3, NSC 101-2321-B-038-005, 103TMU-SHH-24, and DOH 101-TD-B-111-003.	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, 1993, BECK ANXIETY INVENTO; Burkhalter H, 2010, SLEEP BIOL RHYTHMS, V8, P274, DOI 10.1111/j.1479-8425.2010.00473.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Cheng S.K.-W., 2002, CHINESE J CLIN PSYCH, V10, P4; Cole JC, 2006, SLEEP, V29, P112, DOI 10.1093/sleep/29.1.112; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Faul M, 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Kraus J, 1996, NEUROTRAUMA, P13; Lavigne GJ, 2011, CURR RHEUMATOL REP, V13, P535, DOI 10.1007/s11926-011-0209-3; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Magee CA, 2008, SLEEP BIOL RHYTHMS, V6, P222, DOI 10.1111/j.1479-8425.2008.00371.x; Marcus S, 2011, INFANT BEHAV DEV, V34, P26, DOI 10.1016/j.infbeh.2010.07.002; Mariman A, 2012, J PSYCHOSOM RES, V72, P111, DOI 10.1016/j.jpsychores.2011.11.004; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shen, 2002, TAIWANESE J PSYCHIAT, V16, P301, DOI DOI 10.1016/J.YEBEH.2015.01.019; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tomfohr LM, 2012, SLEEP MED REV, V16, P243, DOI 10.1016/j.smrv.2011.05.003; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Uhed T. W., 2000, PRINCIPLES PRACTICE, P1123; van Liempt S, 2013, PSYCHONEUROENDOCRINO, V38, P155, DOI 10.1016/j.psyneuen.2012.05.015; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	33	7	7	1	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								378726	10.1155/2015/378726			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CF2LG	WOS:000352378200001	25852234	Green Published, gold			2022-02-06	
J	Laxe, S; Cieza, A; Castano-Monsalve, B				Laxe, Sara; Cieza, Alarcos; Castano-Monsalve, Beatriz			Rehabilitation of traumatic brain injury in the light of the ICF	NEUROREHABILITATION			English	Article						Traumatic brain injury; ICF; TBI ICF Core Sets; functioning; disability	QUALITY-OF-LIFE; INTERNATIONAL-CLASSIFICATION; HEALTH ICF; FUNCTIONING DISABILITY; MULTIDISCIPLINARY TEAM; CORE SETS; IMPACT; PERSPECTIVE; UNIT; CARE	INTRODUCTION: Traumatic brain injury is a sudden and unexpected condition that gives rise to different impairments in body functions and structures leading to dramatic life changes, not only to the patient but also to his or her family and ultimately in the wider society. As a health strategy, rehabilitation aims to reduce disability and increasing the quality of life of those people that suffer from TBI but also to reduce the social burden associated with it. Functioning is the starting point of rehabilitation and the use of measurement instruments and classifications are commonly used tools for its definition. Within the endorsement of the ICF by WHO, there is now a classification and a conceptual framework for the description of functioning providing an opportunity of a full understanding of the experience of TBI. OBJECTIVE: This paper aims to identify the utility of ICF in TBI as well as bringing new challenges for further clinical practice and research. CONCLUSIONS: ICF has shown itself to be useful in the content comparison of measurement instruments. It has also been used to describe the functional profile of individuals with TBI in both acute and chronic phases making it possible to draw comparisons across other health conditions. Furthermore, the development of the TBI ICF Core Sets provided an item bank to describe not only functional status but also to set goals and plan interventions. Overall, we now have a potentially useful tool in rehabilitation of TBI that allows us to understand the full burden of traumatic brain injury.	[Laxe, Sara; Castano-Monsalve, Beatriz] Guttmann Inst Hosp Neurorehabil Adscript UAB, Brain Injury Unit, Barcelona, Spain; [Cieza, Alarcos] Univ Southampton, Southampton, Hants, England		Laxe, S (corresponding author), Guttmann Inst Hosp Neurorehabil Adscript UAB, Brain Injury Unit, Barcelona, Spain.	slaxe@guttmann.com					Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; [Anonymous], 1942, Proc R Soc Med, V35, P295; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Cieza A, 2008, EUR J PHYS REHAB MED, V44, P303; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Graves JM, 2013, J SAFETY RES, V45, P133, DOI 10.1016/j.jsr.2012.11.001; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS66, DOI 10.1016/j.apmr.2013.03.033; Hoffman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103082; Khan F, 2013, J REHABIL MED, V45, P434, DOI 10.2340/16501977-1132; Kohler F, 2012, J REHABIL MED, V44, P805, DOI 10.2340/16501977-1062; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kostanjsek N, 2011, DISABIL REHABIL, V33, P1475, DOI 10.3109/09638288.2010.527032; Kostanjsek N, 2011, DISABIL REHABIL, V33, P1281, DOI 10.3109/09638288.2010.526165; Laxe S, 2014, DISABIL REHABIL, V36, P82, DOI 10.3109/09638288.2013.780641; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Laxe S, 2011, NEUROREHABILITATION, V29, P99, DOI 10.3233/NRE-2011-0683; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Martinuzzi A, 2013, DISABIL REHABIL, V35, P1059, DOI 10.3109/09638288.2012.720347; Martinuzzi A, 2010, J REHABIL MED, V42, P49, DOI 10.2340/16501977-0468; Pachalska M, 2000, Ortop Traumatol Rehabil, V2, P109; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pinto RZ, 2012, J PHYSIOTHER, V58, P77, DOI 10.1016/S1836-9553(12)70087-5; Pistarini C, 2011, DISABIL REHABIL, V33, P2333, DOI 10.3109/09638288.2011.570414; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Rauch A, 2008, EUR J PHYS REHAB MED, V44, P329; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Tempest S, 2013, DISABIL REHABIL, V35, P1921, DOI 10.3109/09638288.2013.766272; Tempest S, 2012, DISABIL REHABIL, V34, P1686, DOI 10.3109/09638288.2012.658489; Verhoef J, 2008, CLIN REHABIL, V22, P23, DOI 10.1177/0269215507079845; Whyte J, 2012, ARCH PHYS MED REHAB, V93, pS101, DOI 10.1016/j.apmr.2011.11.040; World Health Organization:, WORLD REP DIS	41	7	7	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	1					37	43		10.3233/NRE-141189			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0OT	WOS:000349326700007	25547765				2022-02-06	
J	Li, T; Zhao, Y; Sun, YL; Li, K				Li, Ting; Zhao, Yue; Sun, Yunlong; Li, Kai			Effects of wavelength, beam type and size on cerebral low-level laser therapy by a Monte Carlo study on visible Chinese human	JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES			English	Article						Low level laser therapy; visible Chinese human; Monte Carlo simulation; beam; wavelength	OPTICAL-PROPERTIES; LIGHT THERAPY; STROKE	Low-level laser therapy (LLLT) has been clinically utilized for many indications in medicine requiring protection from cell/tissue death, stimulation of healing and repair of injuries, pain reduction, swelling and inflammation. Presently, the use of LLLT to treat stroke, traumatic brain injury and cognitive dysfunction are attracting growing interest. Near-infrared light is capable of penetrating into the cerebral cortex, allowing noninvasive treatments to be carried out with few treatment-related adverse events. Optimization of LLLT treatment effect is a crucial issue of this field; however, only a few experimental tests on mice for wavelength selection have been reported. We addressed this issue by low-cost, straightforward and quantitative comparisons on light dosage distribution within visible Chinese human head by Monte Carlo modeling of near-infrared light propagation. Optimized selection in wavelength, beam type and size were given based on comparisons among frequently used setups (i.e., wavelengths: 660, 810 and 980 nm; beam type: Gaussian and at beam; beam diameter: 2, 4 and 6 cm). This study provided an efficient way for guiding the optimization of LLLT setup and selection on wavelength, beam type and size for clinical brain LLLT.	[Li, Ting; Zhao, Yue; Sun, Yunlong; Li, Kai] Univ Elect Sci & Technol China, Sch Microelect & Solid State Elect, Chengdu 610054, Peoples R China		Li, T (corresponding author), Univ Elect Sci & Technol China, Sch Microelect & Solid State Elect, Chengdu 610054, Peoples R China.	liting@uestc.edu.cn			Research Start Fund [Y02002010]; Central University Basic Scientific Research Project Business Expenses [ZYGX2012J114]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61308114]	This study was supported by the Research Start Fund (Grant No. Y02002010), the Central University Basic Scientific Research Project Business Expenses (Grant No. ZYGX2012J114) and the National Natural Science Foundation of China (Grant No. 61308114). We highly appreciate the Britton Chance Center for Biomedical Photonics in providing VCH dataset in this study.	Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Demir O, 2009, ANAT REC, V292, P1953, DOI 10.1002/ar.20980; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hamblin MR, 2006, BIOM OPT 2006; Heng PA, 2006, CLIN ANAT, V19, P232, DOI 10.1002/ca.20314; Huang YY, 2010, SER MED PHYS BIOMED, P687; Huang YY, 2010, SER MED PHYS BIOMED, P717; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Li T., 2012, OPT SOC AM BIOM OPT; Li T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01358; Li T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3567085; Li T, 2010, J INNOV OPT HEAL SCI, V3, P91, DOI 10.1142/S1793545810000927; Naeser M. A., 2010, BIOS, P77512; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Rodrigo SM, 2009, PHOTOMED LASER SURG, V27, P929, DOI 10.1089/pho.2008.2306; Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003; Streeter J, 2006, IEEE LEOS ANN MTG, P665, DOI 10.1109/LEOS.2006.278888; Tafur J, 2010, PHOTOMED LASER SURG, V28, P23, DOI 10.1089/pho.2008.2373; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wu Q., 2010, P SOC PHOTO-OPT INS; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang GZ, 2008, PHYS MED BIOL, V53, P3697, DOI 10.1088/0031-9155/53/14/001; Zhang GZ, 2007, PHYS MED BIOL, V52, P7367, DOI 10.1088/0031-9155/52/24/011; Zhang GZ, 2008, HEALTH PHYS, V94, P118, DOI 10.1097/01.HP.0000285256.48498.b4; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x	30	7	7	1	21	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5458	1793-7205		J INNOV OPT HEAL SCI	J. Innov. Opt. Health Sci.	JAN	2015	8	1			SI				1540002	10.1142/S1793545815400027			9	Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Optics; Radiology, Nuclear Medicine & Medical Imaging	AY0QO	WOS:000347301800007		gold			2022-02-06	
J	Liu, ZM; Chen, QX; Tian, DF; Wang, L; Liu, BH; Zhang, SQ				Liu, Zaiming; Chen, Qianxue; Tian, Daofeng; Wang, Long; Liu, Baohui; Zhang, Shenqi			Clinical significance of dynamic monitoring by transcranial doppler ultrasound and intracranial pressure monitor after surgery of hypertensive intracerebral hemorrhage	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Hypertensive intracerebral hemorrhage; intracranial pressure monitoring; transcranial doppler ultrasound	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; TISSUE OXYGEN	The aim of this study was to investigate the surgical method of hypertensive intracerebral hemorrhage (HIH) and how to control the postoperative blood pressure. 96 HIH patients were performed the craniotomic hematoma dissection (CHD) and the hematoma-cavity drilling drainage (HCDD), respectively. Meanwhile, the intracranial pressure and mean arterial pressure of each patient were continuously monitored for 7 days, the postoperative 1st, 3rd, 7th and 14th-day average flow velocities and pulsatility indexes of the bilateral middle cerebral arteries were monitored. CHD exhibited the significant difference in the long-term quality of life (ADL classification 6 months later) of patients with hematoma >50 ml than HCDD; furthermore, the postoperative 1st, 3rd, 7th and 14th-day TCD parameter analysis revealed that CHD exhibited better results in relieving the intracranial pressure and improving the cerebral blood flow than HCDD, and the postoperative ICP and MAP monitoring towards all patients could effectively control the blood pressure and prevent the further bleeding. The patients with hematoma >50 ml should choose CHD, and all HIH patients should be routinely performed the ICP and MAP monitoring.	[Liu, Zaiming; Chen, Qianxue; Tian, Daofeng; Wang, Long; Liu, Baohui; Zhang, Shenqi] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430060, Hubei, Peoples R China		Chen, QX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430060, Hubei, Peoples R China.	qianxuechencn@163.com		Chen, Qianxue/0000-0002-9413-1030			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS38; Asgari S, 2011, PHYSIOL MEAS, V32, P1639, DOI 10.1088/0967-3334/32/10/011; Beseoglu K, 2014, NEURORADIOLOGY, V29, P987; Bullock MR, 2007, J NEUROTRAUM, V24, pvii; Edouard AR, 2005, BRIT J ANAESTH, V94, P216, DOI 10.1093/bja/aei034; Egido JA, 2000, REV NEUROLOGIA, V31, P179, DOI 10.33588/rn.3102.2000064; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kiphuth IC, 2013, EUR NEUROL, V70, P133, DOI 10.1159/000350815; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Maas AI, 2008, J TRAUMA, V65, P966, DOI 10.1097/TA.0b013e318184ee7b; Menzel M, 2003, J NEUROSURG ANESTH, V15, P33, DOI 10.1097/00008506-200301000-00006; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Romner B, 2013, NAT REV NEUROL, V9, P185, DOI 10.1038/nrneurol.2013.37; Ropper AE, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000428424.83867.87; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Speck V, 2011, NEUROCRIT CARE, V14, P208, DOI 10.1007/s12028-010-9459-6; Staykov D, 2011, NEUROSURGERY, V68, P1187, DOI 10.1227/NEU.0b013e31820c0274; Thompson BB, 2014, NEUROCRIT CARE, V10, P89; Thompson KM, 2007, MAYO CLIN PROC, V82, P987, DOI 10.4065/82.8.987; Zhang XQ, 2010, CHINESE MED J-PEKING, V123, P1246, DOI 10.3760/cma.j.issn.0366-6999.2010.10.003	24	7	11	0	4	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2015	8	7					11456	11462					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CR7UR	WOS:000361557500150	26379963				2022-02-06	
J	Parmar, S; Moore-Langston, S; Fredrickson, V; Kim, JM; Rastogi, R; Elmadoun, O; Ding, YC				Parmar, Sweena; Moore-Langston, Shannon; Fredrickson, Vance; Kim, Jung-Min; Rastogi, Radhika; Elmadoun, Omar; Ding, Yuchuan			Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke	CURRENT MEDICINAL CHEMISTRY			English	Article						Blood brain barrier; combination therapy; ethanol; ischemia; neuroprotection; normobaric oxygen therapy; oxidative stress; reperfusion; stroke	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; NORMOBARIC HYPEROXIA; HYPERBARIC-OXYGEN; NADPH OXIDASE; ALCOHOL-CONSUMPTION; OXIDATIVE STRESS; BLOOD-FLOW; CELL-DEATH	Currently, stroke researchers are racing to develop neuroprotective strategies that shield the brain from ischemia-induced injury. To date, neuroprotective agents that have shown promise in animal studies have failed in clinical trials. Since the pathophysiology of ischemic stroke exploits numerous pathways leading to cellular injury, a combination of neuroprotective agents may offer substantially better results than a single agent alone - by intervening in multiple mechanisms. In this paper, we consider an approach using combination therapy with normobaric oxygen (NBO) and ethanol. Studies indicate that NBO therapy improves tissue oxygenation, thereby reducing the extent of hypoxic injury and decelerating the development of tissue necrosis when administered early after stroke onset. Studies have also demonstrated that low to moderate levels of ethanol not only decrease the risk of stroke, but also reduce post-ischemic sequelae. This article reviews the history of NBO and ethanol therapies, their mechanisms of action, the results of key clinical trials, and the rationale for their use as a combination therapy in the context of stroke treatment.	[Parmar, Sweena; Moore-Langston, Shannon; Fredrickson, Vance; Kim, Jung-Min; Rastogi, Radhika; Elmadoun, Omar; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA		Ding, YC (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, 550 E Canfield, Detroit, MI 48201 USA.	yding@med.wayne.edu					Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; AGARDH CD, 1991, INT J DEV NEUROSCI, V9, P127, DOI 10.1016/0736-5748(91)90003-5; AGNER K, 1949, Q J STUD ALCOHOL, V9, P516; Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Alves OL, 2004, CURR PHARM DESIGN, V10, P2163, DOI 10.2174/1381612043384187; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asmaro K, 2013, CURR DRUG TARGETS, V14, P74, DOI 10.2174/138945013804806505; Avraham-Lubin Bat-Chen R, 2011, Front Neurol, V2, P23, DOI 10.3389/fneur.2011.00023; Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bainbridge W. S, 1913, TECHNIC INTRAABDOMIN; Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; Bennedbaek FN, 1997, EUR J ENDOCRINOL, V136, P240, DOI 10.1530/eje.0.1360240; Berry C, 2011, AM SURGEON, V77, P1416; Beynon C, 2007, NEUROSCI LETT, V425, P141, DOI 10.1016/j.neulet.2007.07.009; Block S. S., 1991, DISINFECTION STERILI, pxvi; Booth S, 2003, J ROY SOC MED, V96, P215, DOI 10.1258/jrsm.96.5.215; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burls A, 2011, EMERG MED J, V28, P917, DOI 10.1136/emj.2010.103564; Caicoya M, 1999, J CLIN EPIDEMIOL, V52, P677, DOI 10.1016/S0895-4356(98)00074-2; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Chiu EHH, 2006, ARCH NEUROL-CHICAGO, V63, P741, DOI 10.1001/archneur.63.5.741; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Demchenko IT, 2007, AM J PHYSIOL-LUNG C, V293, pL229, DOI 10.1152/ajplung.00450.2006; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fu P, 2013, NEUROSCI RES, V76, P93, DOI 10.1016/j.neures.2013.02.011; Fujiwara N, 2011, STROKE, V42, P1469, DOI 10.1161/STROKEAHA.110.593350; Fujiwara N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-79; Geng XK, 2013, BRAIN RES, V1531, P17, DOI 10.1016/j.brainres.2013.07.051; Geng XK, 2013, STROKE, V44, P1418, DOI 10.1161/STROKEAHA.111.000315; GILL JS, 1991, AM J MED, V90, P489, DOI 10.1016/0002-9343(91)80090-9; Grainge C, 2004, J ROY SOC MED, V97, P489, DOI 10.1258/jrsm.97.10.489; Hacke W, 2004, LANCET, V363, P768; He ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084602; Henninger N, 2007, J CEREBR BLOOD F MET, V27, P1632, DOI 10.1038/sj.jcbfm.9600463; Henninger N, 2006, EXP NEUROL, V201, P316, DOI 10.1016/j.expneurol.2006.04.011; Henninger N, 2009, J CEREBR BLOOD F MET, V29, P119, DOI 10.1038/jcbfm.2008.104; Hou HH, 2007, PHYSIOL MEAS, V28, P963, DOI 10.1088/0967-3334/28/8/017; Iscoe S, 2011, CRIT CARE, V15, DOI 10.1186/cc10229; ISO H, 1995, STROKE, V26, P767, DOI 10.1161/01.STR.26.5.767; JAMROZIK K, 1994, STROKE, V25, P51, DOI 10.1161/01.STR.25.1.51; Kajihara H, 2001, BRAIN RES, V909, P92, DOI 10.1016/S0006-8993(01)02640-3; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kim HY, 2005, ANN NEUROL, V57, P571, DOI 10.1002/ana.20430; Klatsky AL, 2001, AM J CARDIOL, V88, P703, DOI 10.1016/S0002-9149(01)01824-0; Kleindorfer D, 2009, STROKE, V40, P3580, DOI 10.1161/STROKEAHA.109.554626; Kochanski R., 2013, INNATE TOLERANCE CNS, P105; Kochanski R, 2013, J NEUROCHEM, V126, P113, DOI 10.1111/jnc.12169; KORNERBITENSKY N, 1995, AM J PHYS MED REHAB, V74, P9, DOI 10.1097/00002060-199501000-00003; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Lennox WG, 1932, J CLIN INVEST, V11, P1155, DOI 10.1172/JCI100470; Liao SL, 2003, NEUROREPORT, V14, P2089, DOI 10.1097/00001756-200311140-00016; Liu CS, 2012, STROKE, V43, P220, DOI 10.1161/STROKEAHA.111.625756; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Liu WL, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-22; Liu WL, 2008, J NEUROCHEM, V107, P1196, DOI 10.1111/j.1471-4159.2008.05664.x; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; Lo EH, 2008, BRIT J PHARMACOL, V153, pS396, DOI 10.1038/sj.bjp.0707626; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lucia S. P, 1963, HIST WINE THERAPY, pxviii; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Malarcher AM, 2001, STROKE, V32, P77, DOI 10.1161/01.STR.32.1.77; Malek M, 2013, EXP BRAIN RES, V224, P1, DOI 10.1007/s00221-012-3283-5; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michalski D, 2011, ACTA NEUROL SCAND, V123, P85, DOI 10.1111/j.1600-0404.2010.01363.x; Monzani F, 1997, CLIN ENDOCRINOL, V46, P9, DOI 10.1046/j.1365-2265.1997.d01-1752.x; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; New PW, 2006, NEUROEPIDEMIOLOGY, V26, P4, DOI 10.1159/000089536; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Osler W, 1898, PRINCIPLES PRACTICE, p[xvii, 1]; Padma MV, 2010, ANN INDIAN ACAD NEUR, V13, P284, DOI 10.4103/0972-2327.74203; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Patrick C. H., 1952, ALCOHOL CULTURE SOC, pxv; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Peng CY, 2013, NEUROL RES, V35, P790, DOI 10.1179/1743132813Y.0000000198; Phillis JW, 1998, NEUROSCI LETT, V244, P109, DOI 10.1016/S0304-3940(98)00139-6; Poli S, 2009, CURR MOL MED, V9, P227, DOI 10.2174/156652409787581619; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Qi ZF, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-2; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Saver JL, 2011, STROKE, V42, P2356, DOI 10.1161/STROKEAHA.111.619122; Schaffranietz L, 2000, Anaesthesiol Reanim, V25, P68; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; SHIINA S, 1991, CANCER, V68, P1524, DOI 10.1002/1097-0142(19911001)68:7<1524::AID-CNCR2820680711>3.0.CO;2-O; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Shinohara Y, 2006, CEREBROVASC DIS, V21, P271, DOI 10.1159/000091226; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; Singhal AB, 2008, STROKE, V39, P289, DOI 10.1161/STROKEAHA.107.511485; Singhal AB, 2007, STROKE, V38, P2851, DOI 10.1161/STROKEAHA.107.487280; Singhal AB, 2007, NEUROL RES, V29, P173, DOI 10.1179/016164107X181815; Singhal AB, 2006, INT J STROKE, V1, P191, DOI 10.1111/j.1747-4949.2006.00058.x; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Sun AY, 2001, ALCOHOL CLIN EXP RES, V25, p237S, DOI 10.1097/00000374-200105051-00038; Sun H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041716; Sun L, 2011, BRAIN RES, V1415, P103, DOI 10.1016/j.brainres.2011.07.064; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; Tang XN, 2012, NEUROL RES, V34, P338, DOI 10.1179/1743132812Y.0000000021; Tang XQ, 2010, BRAIN RES, V1348, P174, DOI 10.1016/j.brainres.2010.05.082; Tatarkova Z, 2011, NEUROCHEM RES, V36, P1475, DOI 10.1007/s11064-011-0473-7; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tikuisis P., 2006, ARCH SURG-CHICAGO, V141, P1192; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Volkow ND, 2006, NEUROIMAGE, V29, P295, DOI 10.1016/j.neuroimage.2005.07.004; VOLKOW ND, 1990, PSYCHIAT RES-NEUROIM, V35, P39, DOI 10.1016/S0165-1781(06)80006-5; Wang F, 2012, STROKE, V43, P205, DOI 10.1161/STROKEAHA.111.629576; Wang GJ, 2000, ALCOHOL CLIN EXP RES, V24, P822, DOI 10.1111/j.1530-0277.2000.tb02061.x; Wang Q, 2007, FREE RADICAL BIO MED, V43, P1048, DOI 10.1016/j.freeradbiomed.2007.06.018; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x; Willcox WH, 1910, BMJ-BRIT MED J, V1910, P1408; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang ZJ, 2010, EUR J APPL PHYSIOL, V108, P513, DOI 10.1007/s00421-009-1229-9; Yuan Y, 2012, NEUROL RES, V34, P373, DOI 10.1179/1743132812Y.0000000030; Yuan ZR, 2010, BRAIN RES, V1352, P248, DOI 10.1016/j.brainres.2010.07.010; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zeng XW, 2012, BRAIN RES, V1437, P127, DOI 10.1016/j.brainres.2011.12.012; Zhao HG, 2010, ALCOHOL CLIN EXP RES, V34, P1948, DOI 10.1111/j.1530-0277.2010.01284.x; Zhao YJ, 1998, ALCOHOL CLIN EXP RES, V22, P717, DOI 10.1097/00000374-199805000-00025	143	7	7	0	4	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2015	22	10					1194	1204		10.2174/0929867322666150114152945			11	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CD5WW	WOS:000351160400005	25620099				2022-02-06	
J	Prichep, LS; Naunheim, R; Bazarian, J; Mould, WA; Hanley, D				Prichep, Leslie S.; Naunheim, Rosanne; Bazarian, Jeffrey; Mould, W. Andrew; Hanley, Daniel			Identification of Hematomas in Mild Traumatic Brain Injury Using an Index of Quantitative Brain Electrical Activity	JOURNAL OF NEUROTRAUMA			English	Article						mild TBI (mTBI); neuroimaging; quantitative EEG (QEEG); traumatic hematomas; classifier function	MINOR HEAD-INJURY; NEAR-INFRARED SPECTROSCOPY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; GENETIC ALGORITHMS; FEATURE-SELECTION; CLASSIFICATION; DEVICE; REDUCTION; RULE	Rapid identification of traumatic intracranial hematomas following closed head injury represents a significant health care need because of the potentially life-threatening risk they present. This study demonstrates the clinical utility of an index of brain electrical activity used to identify intracranial hematomas in traumatic brain injury (TBI) presenting to the emergency department (ED). Brain electrical activity was recorded from a limited montage located on the forehead of 394 closed head injured patients who were referred for CT scans as part of their standard ED assessment. A total of 116 of these patients were found to be CT positive (CT+), of which 46 patients with traumatic intracranial hematomas (CT+) were identified for study. A total of 278 patients were found to be CT negative (CT-) and were used as controls. CT scans were subjected to quanitative measurements of volume of blood and distance of bleed from recording electrodes by blinded independent experts, implementing a validated method for hematoma measurement. Using an algorithm based on brain electrical activity developed on a large independent cohort of TBI patients and controls (TBI-Index), patients were classified as either positive or negative for structural brain injury. Sensitivity to hematomas was found to be 95.7% (95% CI=85.2, 99.5), specificity was 43.9% (95% CI=38.0, 49.9). There was no significant relationship between the TBI-Index and distance of the bleed from recording sites (F=0.044, p=0.833), or volume of blood measured F=0.179, p=0.674). Results of this study are a validation and extension of previously published retrospective findings in an independent population, and provide evidence that a TBI-Index for structural brain injury is a highly sensitive measure for the detection of potentially life-threatening traumatic intracranial hematomas, and could contribute to the rapid, quantitative evaluation and treatment of such patients.	[Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, Brain Res Labs, New York, NY USA; [Naunheim, Rosanne] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Bazarian, Jeffrey] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Mould, W. Andrew] Johns Hopkins Univ, Dept Clin Res, Baltimore, MD USA; [Hanley, Daniel] Johns Hopkins Univ, Sch Med, Div Brain Injury Outcomes, Baltimore, MD USA		Prichep, LS (corresponding author), Brain Res Labs, 462 First Ave,OBV Room 885, New York, NY 10016 USA.	leslie.prichep@nyumc.org		Hanley, Daniel/0000-0002-9536-4258	DoDUnited States Department of Defense [W911QY-12-C-0004]; BrainScope Co., Inc., Bethesda Maryland	The authors acknowledge the contributions of those who made this research possible, including the primary investigators and research technicians at all the clinical sites and the patients who volunteered. This research was supported in part by DoD contract #W911QY-12-C-0004, and by BrainScope Co., Inc., Bethesda Maryland, who granted expenses related to data acquisition.	de la Iglesia B, 2013, WIRES DATA MIN KNOWL, V3, P381, DOI 10.1002/widm.1106; DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jakob W., 1992, PARALLEL PROBLEM SOL; Jones G., 1993, SEARCHING DATABASES, P597; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kessel B, 2007, INJURY, V38, P1065, DOI 10.1016/j.injury.2007.05.009; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mitchell M., 1996, INTRO GENETIC ALGORI; Molina DK, 2007, J TRAUMA, V63, P625, DOI 10.1097/01.ta.0000236055.33085.77; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Syswerda G., 1991, P 4 INT C GEN ALG SA; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tomassini Marco, 1999, EVOLUTIONARY ALGORIT; United States Food and Drug Administration Center for Devices and Radiological Health, 2011, INFR MOD 1000 EV AUT; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091	35	7	7	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2015	32	1					17	22		10.1089/neu.2014.3365			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AX4JX	WOS:000346900100003	25054838	Green Published, Green Submitted			2022-02-06	
S	Reuter-Rice, K; Eads, JK; Berndt, SB; Bennett, E		Conley, YP		Reuter-Rice, Karin; Eads, Julia K.; Berndt, Suzanna Boyce; Bennett, Ellen			State of the Science of Pediatric Traumatic Brain Injury Biomarkers and Gene Association Studies	ANNUAL REVIEW OF NURSING RESEARCH, VOL 33: TRAUMATIC BRAIN INJURY	Annual Review of Nursing Research-Series		English	Article; Book Chapter							NEURON-SPECIFIC ENOLASE; COMMON DATA ELEMENTS; APOLIPOPROTEIN-E; CEREBROSPINAL-FLUID; SYSTEMS BIOLOGY; CHILDREN; S100B; SERUM; OUTCOMES; RECOMMENDATIONS	Objectives: Our objective is to review the most widely used biomarkers and gene studies reported in pediatric traumatic brain injury (TBI) literature, to describe their findings, and to discuss the discoveries and gaps that advance the understanding of brain injury and its associated outcomes. Ultimately, we aim to inform the science for future research priorities. Data sources: We searched PubMed, MEDLINE, CINAHL, and the Cochrane Database of Systematic Reviews for published English language studies conducted in the last 10 years to identify reviews and completed studies of biomarkers and gene associations in pediatric TBI. Of the 131 biomarker articles, only 16 were specific to pediatric TBI patients, whereas of the gene association studies in children with TBI, only four were included in this review. Conclusion: Biomarker and gene attributes are grossly understudied in pediatric TBI in comparison to adults. Although recent advances recognize the importance of biomarkers in the study of brain injury, the limited number of studies and genomic associations in the injured brain has shown the need for common data elements, larger sample sizes, heterogeneity, and common collection methods that allow for greater understanding of the injured pediatric brain. By building on to the consortium of interprofessional scientists, continued research priorities would lead to improved outcome prediction and treatment strategies for children who experience a TBI. Implications for nursing research: Understanding recent advances in biomarker and genomic studies in pediatric TBI is important because these advances may guide future research, collaborations, and interventions. It is also important to ensure that nursing is a part of this evolving science to promote improved outcomes in children with TBIs.	[Reuter-Rice, Karin; Berndt, Suzanna Boyce] Duke Univ, Sch Nursing, Durham, NC 27706 USA; [Eads, Julia K.] Duke Univ, Durham, NC USA; [Bennett, Ellen] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA		Reuter-Rice, K (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27706 USA.			Reuter-Rice, Karin/0000-0003-1501-8994	NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30NR014139] Funding Source: NIH RePORTER; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30 NR014139, 1P30 NR014139-01] Funding Source: Medline		Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Babcock L, 2013, PEDIATR EMERG CARE, V29, P458, DOI 10.1097/PEC.0b013e31828a202d; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Barr TL, 2011, BIOL RES NURS, V13, P140, DOI 10.1177/1099800410385671; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Faul M, 2010, TRAUMATIC BRAIN INJU; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Ghebranious N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni155; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2010, DEV NEUROSCI-BASEL, V32, P335, DOI 10.1159/000323016; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lo TYM, 2009, CHILD NERV SYST, V25, P47, DOI 10.1007/s00381-008-0723-4; Miller AC, 2012, J NEUROTRAUM, V29, P634, DOI 10.1089/neu.2011.1932; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Oh H, 2009, CRIT CARE NURSE, V29, P12, DOI 10.4037/ccn2009279; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Su E, 2012, NEUROCRIT CARE, V17, P401, DOI 10.1007/s12028-012-9767-0; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003	60	7	7	0	1	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2922-2; 978-0-8261-7162-7	ANNU REV NURS RES-SE			2015	33						185	217		10.1891/0739-6686.33.185			33	Nursing	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Nursing	BI5YI	WOS:000412973800007	25946386	Green Accepted			2022-02-06	
J	Schmidt, J; Fleming, J; Ownsworth, T; Lannin, NA				Schmidt, Julia; Fleming, Jennifer; Ownsworth, Tamara; Lannin, Natasha A.			Maintenance of treatment effects of an occupation-based intervention with video feedback for adults with TBI	NEUROREHABILITATION			English	Article						Cognition; traumatic brain injury; rehabilitation; occupational therapy; self-awareness; feedback; neuropsychology	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; UNDERSTANDING AWARENESS DEFICITS; COGNITIVE-BEHAVIOR THERAPY; IMPAIRED SELF-AWARENESS; REHABILITATION; QUESTIONNAIRE; MODERATE; TASK	BACKGROUND: Video feedback interventions have been found to improve self-awareness and occupational performance to a greater extent than other feedback interventions after traumatic brain injury (TBI). However, it is unclear whether the effects of video feedback are maintained over time. OBJECTIVE: To evaluate the maintenance of gains in self-awareness achieved with a video feedback intervention in people with TBI. METHODS: There were 32 participants with TBI and impaired self-awareness who had completed a randomized controlled trial with three feedback conditions (video plus verbal, verbal and experiential). Eight to ten weeks after the final feedback intervention session, a follow-up assessment was conducted. The primary outcome was maintenance of gains in online awareness measured by the number of errors made during a meal preparation task. Group outcomes were compared using an unstructured linear mixed regression model. RESULTS: The video plus verbal feedback group continued to demonstrate significantly greater gains in online awareness compared to the verbal feedback group (mean difference 20.6, 95% CI 8.8 to 32.3) and the experiential feedback group (mean difference 14.4, 95% CI 3.1 to 25.6). There was no significant impact of the interventions on participants' emotional status at the 8 to 10 week follow-up. CONCLUSIONS: A combination of video plus verbal feedback is an effective technique for achieving maintained gains in self-awareness in people with TBI.	[Schmidt, Julia] Australian Catholic Univ, Sch Allied Hlth, Sydney, NSW 2060, Australia; [Schmidt, Julia; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Schmidt, Julia] Royal Rehabil Ctr Sydney, Sydney, NSW, Australia; [Schmidt, Julia; Fleming, Jennifer] Metro South Hosp Hlth Serv, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Nathan, Qld 4111, Australia; [Lannin, Natasha A.] La Trobe Univ, Occupat Therapy, Melbourne, Vic, Australia; [Lannin, Natasha A.] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic, Australia; [Lannin, Natasha A.] Univ Sydney, Sydney Med Sch, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia		Schmidt, J (corresponding author), Australian Catholic Univ, 40 Edward St, Sydney, NSW 2060, Australia.	Julia.Schmidt@acu.edu.au	Lannin, Natasha A/A-4195-2013; Ownsworth, Tamara/ABB-6961-2021	Lannin, Natasha A/0000-0002-2066-8345; Ownsworth, Tamara/0000-0003-1835-7094; Schmidt, Julia/0000-0003-2004-4871	Occupational Therapists Board of Queensland; Wenkart Foundation, Australia; Cerebral Palsy Alliance, Australia	We thank the participants, their significant others, and therapists for their participation. This trial has been partially funded through a grant awarded by the Occupational Therapists Board of Queensland. At the time of this study, J. Schmidt was supported by a fellowship provided by the Wenkart Foundation, Australia and N. Lannin was supported by the Balnaves Fellowship provided by the Cerebral Palsy Alliance, Australia.	Alexy WD, 1983, COGNITIVE REHABILITA, V1, P8; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Barco PP, 1991, COGNITIVE REHABILITA, P129; Baum M.C., 1997, OCCUPATIONAL THERAPY; Baverman S. E., 1999, BRAIN INJURY, V13, P403; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Fleming J., 2014, INT HDB OCCUPATIONAL, V2nd; Fleming J., 2006, BRAIN IMPAIR, V7, P83, DOI [https://doi.org/10.1375/brim.7.2.83, DOI 10.1375/BRIM.7.2.83, 10.1375/brim.7.2.83]; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Manly T, 2014, UNDERSTANDING TRAUMA, P215; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth T, 2013, AM J OCCUP THER, V67, P336, DOI 10.5014/ajot.2013.007625; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2012, AUST OCCUP THER J, V59, P138, DOI 10.1111/j.1440-1630.2012.00998.x; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherer M, 2004, AWARENESS QUESTIONNA; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wechsler D., 2002, WAIS 3 WMS 3 TECHNIC	44	7	7	0	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	2					175	186		10.3233/NRE-151205			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CK9CW	WOS:000356539100003	25882200				2022-02-06	
S	Su, E; Bell, M		Laskowitz, D; Grant, G		Su, Erik; Bell, Michael			Diffuse Axonal Injury	TRANSLATIONAL RESEARCH IN TRAUMATIC BRAIN INJURY	Frontiers in Neuroscience-Series		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; CALPAIN-MEDIATED PROTEOLYSIS; C-TERMINAL HYDROLASE-L1; NEURON-SPECIFIC ENOLASE; NECROSIS-FACTOR-ALPHA; SEVERE HEAD-INJURY; WHITE-MATTER; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID		[Su, Erik] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Bell, Michael] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA		Su, E (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.		Su, Erik/AAG-9374-2019	Su, Erik/0000-0002-1054-308X			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adlard PA, 2000, ACTA NEUROPATHOL, V100, P183, DOI 10.1007/s004019900160; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Berger R, 2009, PEDIATR CRIT CARE ME, V10, P260, DOI 10.1097/PCC.0b013e31819a376d; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bochicchio GV, 2008, AM SURGEON, V74, P267; Bodjarian N, 1997, NEUROREPORT, V8, P3951, DOI 10.1097/00001756-199712220-00020; Bramlett HM, 2003, EXP NEUROL, V184, P27, DOI 10.1016/S0014-4886(03)00401-1; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 2000, J NEUROSCI, V20, P2825; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Cengiz P, 2008, PEDIATR CRIT CARE ME, V9, P524, DOI 10.1097/PCC.0b013e3181849dc9; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen YN, 2006, BIOCHEM BIOPH RES CO, V341, P1, DOI 10.1016/j.bbrc.2005.12.150; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FINK DJ, 1994, J NEUROCHEM, V63, P1782; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fujita M., 2011, J NEUROTRAUMA; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gaetz W, 2008, CLIN NEUROPHYSIOL, V119, P1923, DOI 10.1016/j.clinph.2008.04.291; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gieron MA, 1998, PEDIATR NEUROL, V19, P382, DOI 10.1016/S0887-8994(98)00072-1; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Grandpre T, 2001, NEUROSCIENTIST, V7, P377, DOI 10.1177/107385840100700507; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Holbourn AHS, 1943, LANCET, V2, P438; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Imaizumi T, 2003, J NEUROIMAGING, V13, P155, DOI 10.1177/1051228403251250; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones NR, 1998, J CLIN NEUROSCI, V5, P73, DOI 10.1016/S0967-5868(98)90207-7; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kita T, 2000, INT J LEGAL MED, V113, P221, DOI 10.1007/s004149900095; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kornek B, 2001, BRAIN, V124, P1114, DOI 10.1093/brain/124.6.1114; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kulbatski I, 2008, PROG HISTOCHEM CYTO, V43, P123, DOI 10.1016/j.proghi.2008.04.001; Laalo JP, 2014, BRAIN INJURY, V28, P66, DOI 10.3109/02699052.2013.857791; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Letournel F, 2006, NEUROSCIENCE, V137, P103, DOI 10.1016/j.neuroscience.2005.08.077; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; LUDWIN SK, 1990, ACTA NEUROPATHOL, V80, P184, DOI 10.1007/BF00308922; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mori S, 2013, ANNU REV BIOMED ENG, V15, P71, DOI 10.1146/annurev-bioeng-071812-152335; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Porto L, 2011, EUR J PAEDIATR NEURO, V15, P493, DOI 10.1016/j.ejpn.2011.06.004; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Raby CA, 1998, J NEUROCHEM, V71, P2505; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; ReiderGroswasser I, 1997, BRAIN INJURY, V11, P865, DOI 10.1080/026990597122936; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Richmond E., 2013, ENDOCRINE; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sarlls JE, 2009, NEUROIMAGE, V47, P1244, DOI 10.1016/j.neuroimage.2009.05.098; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Seledtsov VI, 2006, B EXP BIOL MED+, V142, P129, DOI 10.1007/s10517-006-0310-1; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Shin W., 2013, AM J NEURORADIOL; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Su E, 2012, NEUROCRIT CARE, V17, P401, DOI 10.1007/s12028-012-9767-0; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Sulaiman AM, 2011, J NEUROTRAUM, V28, P383, DOI 10.1089/neu.2010.1707; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; Sundaram NK, 2013, ENDOCRIN METAB CLIN, V42, P565, DOI 10.1016/j.ecl.2013.05.003; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tubbs RS, 2007, MED HYPOTHESES, V69, P1385, DOI 10.1016/j.mehy.2007.03.002; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Ueno H, 2009, BRAIN INJURY, V23, P291, DOI 10.1080/02699050902794855; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; Van Geel WJA, 2005, J IMMUNOL METHODS, V296, P179, DOI 10.1016/j.jim.2004.11.015; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto M, 2004, NEUROSCIENCE, V128, P163, DOI 10.1016/j.neuroscience.2004.06.026; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Yanagawa Y, 2009, J TRAUMA, V66, P162, DOI 10.1097/TA.0b013e3181469857; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049; Zheng WB, 2006, ANN C, V1, P1052; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	309	7	7	0	1	CRC PRESS-TAYLOR & FRANCIS GROUP	BOCA RATON	6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA	2154-5723		978-1-4665-8492-1; 978-1-4665-8491-4	FRONT NEUROSCI	Front. Neurosci.		2015	57						41	83			10.1201/b18959		43	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI2NN	WOS:000409469800005					2022-02-06	
J	Wong, B; Ong, BB; Milne, N				Wong, Brittany; Ong, Beng Beng; Milne, Nathan			The source of haemorrhage in traumatic basal subarachnoid haemorrhage	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Subarachnoid haemorrhage; Trauma; Vertebral artery; Post-mortem examination	VERTEBRAL ARTERY INJURY; TUNICA MEDIA; HYPEREXTENSION; RUPTURE; HEAD	Traumatic basal subarachnoid haemorrhage (TBSH) following trauma to the head, face or neck is well-established as a cause of death; however it remains a heavily disputed topic as the site of vascular injury is difficult to identify. Whilst many regions within the vasculature of the head and neck have been proposed as more susceptible to rupture, the vertebral artery remains the focal point of many investigations. We present a retrospective case review of TBSH in our forensic centre at Forensic and Scientific Services in Brisbane, Australia, from 2003 to 2011. Thirteen cases of TBSH were found, one case excluded due to vasculopathy. All decedents were male, the majority of which were involved in an altercation receiving blows to the head, face, or neck and were unconscious at the scene. All victims were under the influence of alcohol, drugs, or a combination thereof. External examination revealed injuries to the head, face, and neck in all cases. Various combinations of further examination techniques were used during the post-mortem examination including brain and/or cervical spine retention, CT imaging, and angiography. Vascular injury was identified in eight of the twelve cases, all of which occurred intracranially, with seven involving the vertebral artery. Histology was most reliable in identifying the rupture site and angiography failed to reveal a rupture site. The added benefits of histology over angiography are the ability to identify the microscopic architecture of the tear and to diagnose vasculopathy that may have rendered the individual more susceptible to TBSH. (C) 2014 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Wong, Brittany; Ong, Beng Beng; Milne, Nathan] Queensland Hlth Forens & Sci Serv, Coopers Plains, Qld 4108, Australia; [Ong, Beng Beng; Milne, Nathan] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Milne, Nathan] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia		Wong, B (corresponding author), Queensland Hlth Forens & Sci Serv, 39 Kessels Rd Coopers Plains, Coopers Plains, Qld 4108, Australia.	Brittany_Wong@health.qld.gov.au; Beng_Ong@health.qld.gov.au; Nathan_Milne@health.qld.gov.au			Royal College of Pathologists of Australasia	We would also like to thank The Royal College of Pathologists of Australasia for awarding the RCPA Scholarships in Pathology to BW to allow her to complete the paper.	Aggrawal A, 2006, J CLIN PATHOL, V59, P1000, DOI 10.1136/jcp.2005.030742; COAST GC, 1984, J CLIN PATHOL, V37, P1245, DOI 10.1136/jcp.37.11.1245; CONTOSTAVLOS D L, 1971, Journal of Forensic Sciences, V16, P40; CONTOSTAVLOS DL, 1995, FORENSIC SCI INT, V73, P61, DOI 10.1016/0379-0738(95)01700-3; DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; Ehrlich Edwin, 2008, Legal Medicine, V10, P171, DOI 10.1016/j.legalmed.2007.12.001; FARAG AM, 1988, FORENSIC SCI INT, V38, P275, DOI 10.1016/0379-0738(88)90173-9; Gray J, 1999, NY TIMES BK REV, P23; GROSS A, 1990, FORENSIC SCI INT, V45, P53, DOI 10.1016/0379-0738(90)90221-J; HARLAND WA, 1983, J CLIN PATHOL, V36, P1335, DOI 10.1136/jcp.36.12.1335; Johnson CP, 2000, FORENSIC SCI INT, V109, P169, DOI 10.1016/S0379-0738(99)00198-X; Johnson CP, 2001, J CLIN PATHOL, V54, P139, DOI 10.1136/jcp.54.2.139; JOHNSON P, 1995, FORENSIC SCI INT, V73, P75, DOI 10.1016/0379-0738(95)01701-1; Kaiser C, 2008, FORENSIC SCI INT, V182, pE15, DOI 10.1016/j.forsciint.2008.10.001; LEADBEATTER S, 1994, FORENSIC SCI INT, V67, P33, DOI 10.1016/0379-0738(94)90409-X; Lee CK, 2009, AM J FOREN MED PATH, V30, P134, DOI 10.1097/PAF.0b013e318187acb1; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; MIYAZAKI T, 1990, FORENSIC SCI INT, V47, P91, DOI 10.1016/0379-0738(90)90288-A; Opeskin K, 1998, AM J FOREN MED PATH, V19, P206, DOI 10.1097/00000433-199809000-00002; Pickup MJ, 2011, FORENSIC SCI MED PAT, V7, P192, DOI 10.1007/s12024-010-9205-6; Pollanen MS, 1996, AM J FOREN MED PATH, V17, P197, DOI 10.1097/00000433-199609000-00004; Ross JL, 2012, ACAD FORENSIC PATHOL, V2, P30; SIMONSEN J, 1984, FORENSIC SCI INT, V24, P57, DOI 10.1016/0379-0738(84)90152-X; Simonsen J, 1967, J Forensic Med, V14, P146	24	7	7	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	JAN	2015	29						18	23		10.1016/j.jflm.2014.09.012			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	AY2JX	WOS:000347417300004	25572079				2022-02-06	
J	Zhuang, LN; Xia, HM; Gu, Y; Derendorf, H; Li, YZ; Liu, CX				Zhuang, Luning; Xia, Huiming; Gu, Yuan; Derendorf, Hartmut; Li, Yazhuo; Liu, Changxiao			Theory and Application of Microdialysis in Pharmacokinetic Studies	CURRENT DRUG METABOLISM			English	Article						Locally delivery; microdialysis; pharmacokinetic; tissue homogenate	IN-VIVO MICRODIALYSIS; PLASMA-PROTEIN BINDING; TRAUMATIC BRAIN-INJURY; PERFORMANCE LIQUID-CHROMATOGRAPHY; CEREBRAL INTERSTITIAL FLUID; OPHTHALMIC DELIVERY-SYSTEM; RAT-BLOOD; OCULAR PHARMACOKINETICS; TRANSDERMAL ABSORPTION; INVIVO MICRODIALYSIS	The major aim of current pharmacokinetic studies is to investigate the drug absorption, disposition, metabolism and excretion in animals and humans. The time courses of plasma concentrations are usually characterized and linked to the pharmacodynamic effect to evaluate drug efficacy. However, under certain circumstance, site of action is located in tissues rather than in circulation, which requires direct measurement of tissue concentrations instead of plasma concentrations. Microdialysis is one of those techniques that have been demonstrated to be feasible for measurement of free drug concentration in many tissues, and is capable of being applied in most pharmacokinetic studies to enhance drug efficacy and reduce the unnecessary side effects. This paper reviews this technique from the perspective of theoretical background including the history of development, basic principle, components and their functions. Moreover, the relative recovery of microdialysis and the key factors are discussed, followed by calibration methods available to reduce the systemic bias. In addition, microdialysis is compared with conventional tissue sampling technique for superiorities and limitations. At last, the application of microdialysis in pharmacokinetic study is summarized, especially in assessment of drug efficacy and safety in different tissues. So far, microdialysis is a valuable tool in drug development and will play an unique role in a variety of pharmacokinetic and pharmacodynamic studies in future.	[Zhuang, Luning] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Zhuang, Luning; Derendorf, Hartmut] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA; [Xia, Huiming] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Gu, Yuan; Li, Yazhuo; Liu, Changxiao] Tianjin Inst Pharmaceut Res, Key Lab Drug Delivery Technol & Pharmacokinet, Tianjin 300193, Peoples R China		Zhuang, LN (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	zhuangada@gmail.com; liuchangxiao@vip.163.com			National Science & Technology Major Project of China [2012ZX09304002, 2012ZX09501001]; National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81430096]	This work was supported by the National Science & Technology Major Project of China (2012ZX09304002, 2012ZX09501001) and National Natural Science Foundation (81430096).	Aggarwal D, 2007, INT J PHARMACEUT, V338, P21, DOI 10.1016/j.ijpharm.2007.01.019; AULT JM, 1994, PHARMACEUT RES, V11, P1631, DOI 10.1023/A:1018922123774; Barbour A, 2009, ANTIMICROB AGENTS CH, V53, P2773, DOI 10.1128/AAC.01409-08; Beier H, 2007, EUR J PHARM SCI, V30, P75, DOI 10.1016/j.ejps.2006.10.005; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Benfeldt E, 1998, ACTA DERM-VENEREOL, V78, P274; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; Bergenheim AT, 2006, J NEURO-ONCOL, V80, P285, DOI 10.1007/s11060-006-9186-1; Bielecka-Grzela S, 2003, J CLIN PHARM THER, V28, P465, DOI 10.1046/j.0269-4727.2003.00516.x; BIGGS CS, 1992, BRAIN RES, V594, P138, DOI 10.1016/0006-8993(92)91038-G; Bourne JA, 2003, CLIN EXP PHARMACOL P, V30, P16, DOI 10.1046/j.1440-1681.2003.03789.x; Brunner M, 2000, LIFE SCI, V67, P977, DOI 10.1016/S0024-3205(00)00685-8; Buerger C, 2003, J CHROMATOGR B, V796, P155, DOI 10.1016/j.jchromb.2003.08.019; BUTTLER T, 1994, BIOTECHNOL BIOENG, V44, P322, DOI 10.1002/bit.260440309; Caricato A, 2006, INTENS CARE MED, V32, P325, DOI 10.1007/s00134-005-0015-3; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chaurasia CS, 2007, PHARM RES, V24, P1014, DOI 10.1007/s11095-006-9206-z; Chaurasia CS, 1999, BIOMED CHROMATOGR, V13, P317, DOI 10.1002/(SICI)1099-0801(199908)13:5<317::AID-BMC891>3.0.CO;2-I; Cheng FC, 2002, J CHROMATOGR A, V949, P35, DOI 10.1016/S0021-9673(01)01225-0; Chu Y, 2012, EUR J DRUG METAB PH, V37, P173, DOI 10.1007/s13318-012-0084-y; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; CMA A Harvard Apparatus Company, SPLI TUBL; Dahyot-Fizelier C, 2010, ANTIMICROB AGENTS CH, V54, P3502, DOI 10.1128/AAC.01725-09; DAILEY JW, 1992, J PHARMACOL EXP THER, V260, P533; Davies MI, 1996, LIFE SCI, V59, P1001, DOI 10.1016/0024-3205(96)00407-9; DAVIES MI, 1995, DRUG METAB DISPOS, V23, P1072; DEGUCHI Y, 1991, J PHARMACOBIO-DYNAM, V14, P483, DOI 10.1248/bpb1978.14.483; Dias C, 2002, CURR EYE RES, V25, P243, DOI 10.1076/ceyr.25.4.243.13488; Ding PT, 2000, BIOMED CHROMATOGR, V14, P141, DOI 10.1002/1099-0801(200005)14:3<141::AID-BMC937>3.0.CO;2-Z; DIX K, 1994, J PHARM SCI, V83, P1622, DOI 10.1002/jps.2600831119; EKBLOM M, 1992, PHARMACEUT RES, V9, P155, DOI 10.1023/A:1018960617549; Evrard PA, 1996, PHARMACEUT RES, V13, P18, DOI 10.1023/A:1016008712756; Feng MHR, 2001, EUR J DRUG METAB PH, V26, P123, DOI 10.1007/BF03190385; FPO IP Research & Communities, SYR PUMP; Frasca D, 2012, BRIT J ANAESTH, V109, P830, DOI 10.1093/bja/aes369; Gan L, 2010, INT J PHARMACEUT, V396, P179, DOI 10.1016/j.ijpharm.2010.06.015; Gao YA, 2010, DRUG DEV IND PHARM, V36, P1131, DOI 10.3109/03639041003680826; Garrison KE, 2002, EUR J PHARM SCI, V17, P1, DOI 10.1016/S0928-0987(02)00149-5; Gilinsky MA, 2001, J PHARMACEUT BIOMED, V24, P929, DOI 10.1016/S0731-7085(00)00562-8; Goren MZ, 2001, NEUROL SCI, V22, P297, DOI 10.1007/s10072-001-8171-x; Groth L, 1997, ANAL CHIM ACTA, V355, P75, DOI 10.1016/S0003-2670(97)81614-5; GUNARATNA PC, 1994, J PHARMACEUT BIOMED, V12, P1249, DOI 10.1016/0731-7085(94)00064-6; He HB, 2006, BIOL PHARM BULL, V29, P841, DOI 10.1248/bpb.29.841; HERNANDEZ L, 1986, LIFE SCI, V39, P2629, DOI 10.1016/0024-3205(86)90119-0; HERRERA AM, 1990, PHARMACEUT RES, V7, P1077, DOI 10.1023/A:1015955503708; HORAL M, 1995, EARLY HUM DEV, V42, P1, DOI 10.1016/0378-3782(95)01628-G; Huang CT, 1999, INT J PHARM, V182, P237, DOI 10.1016/S0378-5173(99)00079-4; Huang HF, 2008, J CHROMATOGR B, V874, P77, DOI 10.1016/j.jchromb.2008.09.005; Huang Y, 2001, J PHARM SCI, V90, P2088, DOI 10.1002/jps.1159; HURD YL, 1988, J NEUROCHEM, V51, P1314, DOI 10.1111/j.1471-4159.1988.tb03103.x; Hutschala D, 2007, ANN THORAC SURG, V84, P1605, DOI 10.1016/j.athoracsur.2007.06.052; IMPERATO A, 1984, J NEUROSCI, V4, P966; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; JANSSON PA, 1988, AM J PHYSIOL, V255, pE218, DOI 10.1152/ajpendo.1988.255.2.E218; Joukhadar C, 2005, CLIN PHARMACOKINET, V44, P895, DOI 10.2165/00003088-200544090-00002; Joukhadar C, 2001, EUR J CLIN PHARMACOL, V57, P211, DOI 10.1007/s002280100301; JUSTICE JB, 1993, J NEUROSCI METH, V48, P263, DOI 10.1016/0165-0270(93)90097-B; KALANT H, 1958, BIOCHEM J, V69, P99, DOI 10.1042/bj0690099; KENDRICK AH, 1988, Q J MED, V68, P615; KENDRICK KM, 1989, METHOD ENZYMOL, V168, P182; Kim A, 2008, ANTIMICROB AGENTS CH, V52, P3941, DOI 10.1128/AAC.00589-08; KORF J, 1985, J NEUROCHEM, V45, P1341, DOI 10.1111/j.1471-4159.1985.tb07198.x; KURATA N, 1995, RES COMMUN MOL PATH, V89, P45; LARSSON CI, 1991, LIFE SCI, V49, pPL73, DOI 10.1016/0024-3205(91)90082-M; LEVINE JE, 1989, METHODS ENZYMOL, V168, P166; Li X, 2008, INT J PHARMACEUT, V363, P177, DOI 10.1016/j.ijpharm.2008.07.017; Lin LC, 2004, J CHROMATOGR A, V1032, P125, DOI 10.1016/j.chroma.2003.08.077; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; LINHARES MC, 1992, ANAL CHEM, V64, P2831, DOI 10.1021/ac00046a029; Liu ZD, 2007, DRUG DEV IND PHARM, V33, P1327, DOI 10.1080/03639040701397241; Liu ZD, 2011, DRUG DEV IND PHARM, V37, P475, DOI 10.3109/03639045.2010.522193; Loscher W, 2007, EPILEPSIA, V48, P8, DOI 10.1111/j.1528-1167.2007.00993.x; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228; Lorentzen H, 1996, ANTIMICROB AGENTS CH, V40, P1785, DOI 10.1128/AAC.40.8.1785; LUDVIG N, 1995, ALCOHOL, V12, P417, DOI 10.1016/0741-8329(95)00012-G; Luer MS, 2004, NEUROL RES, V26, P312, DOI 10.1179/016164104225014012; Lydic R, 2002, SLEEP, V25, P617; Macha S, 2002, DRUG METAB DISPOS, V30, P670, DOI 10.1124/dmd.30.6.670; Macha S, 2001, EXP EYE RES, V72, P289, DOI 10.1006/exer.2000.0953; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Maia MBD, 1996, INT J CLIN PHARM TH, V34, P335; MAIDMENT NT, 1989, NEUROSCIENCE, V33, P549, DOI 10.1016/0306-4522(89)90407-7; Marchand S, 2005, ANTIMICROB AGENTS CH, V49, P2356, DOI 10.1128/AAC.49.6.2356-2361.2005; Masucci JA, 1998, J MASS SPECTROM, V33, P85, DOI 10.1002/(SICI)1096-9888(199801)33:1<85::AID-JMS612>3.0.CO;2-R; MATSUYAMA K, 1994, PHARMACEUT RES, V11, P684, DOI 10.1023/A:1018972112077; MATSUYAMA K, 1994, BIOL PHARM BULL, V17, P1395; McNay EC, 2013, JOVE-J VIS EXP, DOI 10.3791/4451; MENACHERRY S, 1992, ANAL CHEM, V64, P577, DOI 10.1021/ac00030a003; MINDERMANN T, 1993, J ANTIMICROB CHEMOTH, V31, P731, DOI 10.1093/jac/31.5.731; MOGHADDAM B, 1989, J NEUROCHEM, V53, P652, DOI 10.1111/j.1471-4159.1989.tb07383.x; Murakami T, 1998, J PHARM PHARMACOL, V50, P49, DOI 10.1111/j.2042-7158.1998.tb03304.x; Nakashima M, 1996, J PHARM PHARMACOL, V48, P1143, DOI 10.1111/j.2042-7158.1996.tb03910.x; NAKASHIMA M, 1994, BIOL PHARM BULL, V17, P1630; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; NEUMANN I, 1993, NEUROENDOCRINOLOGY, V58, P637, DOI 10.1159/000126604; OConnell MT, 1996, BRIT J CLIN PHARMACO, V42, P765, DOI 10.1046/j.1365-2125.1996.00505.x; Ooie T, 1997, DRUG METAB DISPOS, V25, P784; OSBORNE PG, 1990, J NEUROSCI METH, V34, P99, DOI 10.1016/0165-0270(90)90047-J; PALSMEIER RK, 1994, LIFE SCI, V55, P815, DOI 10.1016/0024-3205(94)00565-6; Patsalos PN, 1996, ACT NEUR S, V67, P59; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Poeppl W, 2012, INT J ANTIMICROB AG, V39, P343, DOI 10.1016/j.ijantimicag.2011.11.019; Price KE, 2005, J PHARMACEUT BIOMED, V38, P904, DOI 10.1016/j.jpba.2005.02.034; Rada P, 1998, ELECTROPHORESIS, V19, P2976, DOI 10.1002/elps.1150191629; Richards DA, 2007, AMINO ACIDS, V33, P429, DOI 10.1007/s00726-006-0480-1; Riley C.M., 1994, PHARM BIOMEDICAL APP, P193; Rittenhouse KD, 1999, PHARM RES-DORDR, V16, P736, DOI 10.1023/A:1018884826943; Rittenhouse KD, 2000, ADV DRUG DELIVER REV, V45, P229, DOI 10.1016/S0169-409X(00)00112-5; SAUERNHEIMER C, 1994, J PHARMACOL TOXICOL, V32, P149, DOI 10.1016/1056-8719(94)90068-X; Schwab M, 2003, ANNU REV PHARMACOL, V43, P285, DOI 10.1146/annurev.pharmtox.43.100901.140233; Schwalbe O., 2004, THESIS; SCOTT DO, 1993, PHARMACEUT RES, V10, P335, DOI 10.1023/A:1018971818689; SCOTT DO, 1990, J CHROMATOGR, V506, P461, DOI 10.1016/S0021-9673(01)91600-0; Shah VP, 1998, PHARMACEUT RES, V15, P167, DOI 10.1023/A:1011941929495; Shyr M H, 1999, Changgeng Yi Xue Za Zhi, V22, P246; Sood S, 2003, RESP PHYSIOL NEUROBI, V138, P205, DOI 10.1016/j.resp.2003.07.001; STAHLE L, 1991, LIFE SCI, V49, P1853, DOI 10.1016/0024-3205(91)90488-W; STAHLE L, 1993, J ACQ IMMUN DEF SYND, V6, P435; Stenken JA, 1998, J PHARM SCI, V87, P311, DOI 10.1021/js970288z; Strindberg L, 2000, SCAND J CLIN LAB INV, V60, P205, DOI 10.1080/003655100750044857; Tegeder I, 1999, CLIN PHARMACOL THER, V65, P357, DOI 10.1016/S0009-9236(99)70128-1; Tegeder I, 2002, CLIN PHARMACOL THER, V71, P153, DOI 10.1067/mcp.2002.121908; TIMMERMAN W, 1991, NEUROSCI LETT, V131, P93, DOI 10.1016/0304-3940(91)90344-S; Traunmuller F, 2007, ANTIMICROB AGENTS CH, V51, P3185, DOI 10.1128/AAC.00532-07; Tsai TH, 1996, J CHROMATOGR A, V730, P121, DOI 10.1016/0021-9673(95)00977-9; Tsai TH, 1998, J CHROMATOGR B, V720, P165, DOI 10.1016/S0378-4347(98)00435-6; Tsai TH, 2001, BRIT J PHARMACOL, V132, P1310, DOI 10.1038/sj.bjp.0703927; Tsai TH, 2000, J CHROMATOGR B, V738, P75, DOI 10.1016/S0378-4347(99)00492-2; UNGERSTEDT U, 1974, B SCHWEIZ AKAD MED, V30, P44; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Virtanen KA, 2002, DIABETES OBES METAB, V4, P60, DOI 10.1046/j.1463-1326.2002.00185.x; Waga J, 2000, ACTA OPHTHALMOL SCAN, V78, P369, DOI 10.1034/j.1600-0420.2000.078003369.x; WAGES SA, 1986, ANAL CHEM, V58, P1649, DOI 10.1021/ac00121a012; Ward KW, 1996, TOXICOL APPL PHARM, V140, P203, DOI 10.1006/taap.1996.0214; Watanabe H, 1996, SCAND J GASTROENTERO, V31, P1144, DOI 10.3109/00365529609036902; Wei G, 2006, BIOMED CHROMATOGR, V20, P67, DOI 10.1002/bmc.529; Wong PSH, 1999, RAPID COMMUN MASS SP, V13, P407, DOI 10.1002/(SICI)1097-0231(19990315)13:5<407::AID-RCM500>3.0.CO;2-I; WONG SL, 1993, J PHARMACOL EXP THER, V264, P899; Woo KL, 2008, J PHARMACEUT BIOMED, V48, P85, DOI 10.1016/j.jpba.2008.05.014; Woo KL, 2008, J PHARMACEUT BIOMED, V48, P20, DOI 10.1016/j.jpba.2008.04.019; Xue CF, 2011, J CHROMATOGR B, V879, P317, DOI 10.1016/j.jchromb.2010.12.016; Yang Z, 1997, PHARMACEUT RES, V14, P865, DOI 10.1023/A:1012191515035; Yokel RA, 1996, BIOL TRACE ELEM RES, V53, P193, DOI 10.1007/BF02784555; Zeitzer JM, 2006, SLEEP, V29, P455, DOI 10.1093/sleep/29.4.455; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X; Zhang YJ, 2011, J ETHNOPHARMACOL, V136, P129, DOI 10.1016/j.jep.2011.04.023; Zhao JL, 2004, J APPL PHYSIOL, V96, P628, DOI 10.1152/japplphysiol.00639.2003; Zhu T, 2003, J PHARM SCI, V92, P1947, DOI 10.1002/jps.10457	151	7	9	7	33	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-2002	1875-5453		CURR DRUG METAB	Curr. Drug Metab.		2015	16	10					919	931		10.2174/1389200216666150812124109			13	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CY0KU	WOS:000366095800007	26264199				2022-02-06	
J	Colton, K; Yang, S; Hu, PF; Chen, HH; Stansbury, LG; Scalea, TM; Stein, DM				Colton, K.; Yang, S.; Hu, P. F.; Chen, H. H.; Stansbury, L. G.; Scalea, T. M.; Stein, D. M.			Responsiveness to therapy for increased intracranial pressure in traumatic brain injury is associated with neurological outcome	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Intracranial pressure; Traumatic brain injury; Hypertonic saline; Hyperosmolar therapy	SEVERE HEAD-INJURY; PROGNOSTIC VALUE; HYPERTONIC SALINE; CEREBRAL HYPOPERFUSION; BRIEF EPISODES; IMPACT; HYPERTENSION; MANAGEMENT; ICP; TOMOGRAPHY	In patients with severe traumatic brain injury, increased intracranial pressure (ICP) is associated with poor functional outcome or death. Hypertonic saline (HTS) is a hyperosmolar therapy commonly used to treat increased ICP; this study aimed to measure initial patient response to HTS and look for association with patient outcome. Patients > 17 years old, admitted and requiring ICP monitoring between 2008 and 2010 at a large urban tertiary care facility were retrospectively enrolled. The first dose of hypertonic saline administered after admission for ICP > 19 mmHg was recorded and correlated with vital signs recorded at the bedside. The absolute and relative change in ICP at 1 and 2 h after HTS administration was calculated. Patients were stratified by mortality and long-term (>= 6 months) functional neurological outcome. We identified 46 patients who received at least 1 dose of HTS for ICP > 19, of whom 80% were male, mean age 34.4, with a median post-resuscitation GCS score of 6. All patients showed a significant decrease in ICP 1 h after HTS administration. Two hours post-administration, survivors showed a further decrease in ICP (43% reduction from baseline), while ICP began to rebound in non-survivors (17% reduction from baseline). When patients were stratified for long-term neurological outcome, results were similar, with a significant difference in groups by 2 h after HTS administration. In patients treated with HTS for intracranial hypertension, those who survived or had good neurological outcome, when compared to those who died or had poor outcomes, showed a significantly larger sustained decrease in ICP 2 h after administration. This suggests that even early in a patient's treatment, treatment responsiveness is associated with mortality or poor functional outcome. While this work is preliminary, it suggests that early failure to obtain a sustainable response to hyperosmolar therapy may warrant greater treatment intensity or therapy escalation. (C) 2014 Elsevier Ltd. All rights reserved.	[Colton, K.; Yang, S.; Hu, P. F.; Chen, H. H.; Stansbury, L. G.; Scalea, T. M.; Stein, D. M.] Univ Maryland, Sch Med, Shock Trauma Anesthesia Res Organized Res Ctr, Baltimore, MD 21201 USA; [Colton, K.; Yang, S.; Hu, P. F.; Chen, H. H.; Stansbury, L. G.; Scalea, T. M.; Stein, D. M.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Colton, K.] Duke Univ, Sch Med, Durham, NC USA		Colton, K (corresponding author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St,T1R52, Baltimore, MD 21201 USA.	Katharine.colton@duke.edu	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963	 [FA8650-11-2-6D06];  [FA8650-12-2-6D09];  [FA8650-13-2-6D15]	This study was funded in part by the grants FA8650-11-2-6D06, FA8650-12-2-6D09 and FA8650-13-2-6D15. Presented in part at Neurotrauma 2013, August 5, 2013, Nashville, TN.	BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Ditillo M, 2011, J TRAUMA, V71, P373; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Faul M, 2010, TRAUMATIC BRAIN INJU; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hartl R, 1997, ACT NEUR S, V70, P126; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Sorani MD, 2008, J NEUROTRAUM, V25, P291, DOI 10.1089/neu.2007.0411; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	33	7	7	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2014	45	12					2084	2088		10.1016/j.injury.2014.08.041			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CA1DB	WOS:000348652100049	25304159				2022-02-06	
J	Leung, J; Harvey, LA; Moseley, AM; Whiteside, B; Simpson, M; Stroud, K				Leung, Joan; Harvey, Lisa A.; Moseley, Anne M.; Whiteside, Bhavini; Simpson, Melissa; Stroud, Katarina			Standing with electrical stimulation and splinting is no better than standing alone for management of ankle plantarflexion contractures in people with traumatic brain injury: a randomised trial	JOURNAL OF PHYSIOTHERAPY			English	Article						Traumatic brain injury; Contracture; Splinting; Electrical stimulation; Stretch	IMPROVE MOTOR CONTROL; UPPER EXTREMITY; INTERRATER RELIABILITY; WRIST CONTRACTURE; MUSCLE STRENGTH; DAILY STRETCH; STROKE; SPASTICITY; RECOVERY; REHABILITATION	Question: Is a combination of standing, electrical stimulation and splinting more effective than standing alone for the management of ankle contractures after severe brain injury? Design: A multi-centre randomised trial with concealed allocation, assessor blinding and intention-to-treat analysis. Participants: Thirty-six adults with severe traumatic brain injury and ankle plantarflexion contractures. Intervention: All participants underwent a 6-week program. The experimental group received tilt table standing, electrical stimulation and ankle splinting. The control group received tilt table standing alone. Outcome measures: The primary outcome was passive ankle dorsiflexion with a 12 Nm torque. Secondary outcomes included: passive dorsiflexion with lower torques (3, 5, 7 and 9 Nm); spasticity; the walking item of the Functional Independence Measure; walking speed; global perceived effect of treatment; and perceived treatment credibility. Outcome measures were taken at baseline (Week 0), end of intervention (Week 6), and follow-up (Week 10). Results: The mean between-group differences (95% CI) for passive ankle dorsiflexion at Week 6 and Week 10 were -3 degrees (-8 to 2) and -1 degrees (-6 to 4), respectively, in favour of the control group. There was a small mean reduction of 1 point in spasticity at Week 6 (95% CI 0.1 to 1.8) in favour of the experimental group, but this effect disappeared at Week 10. There were no differences for other secondary outcome measures except the physiotherapists' perceived treatment credibility. Conclusion: Tilt table standing with electrical stimulation and splinting is not better than tilt table standing alone for the management of ankle contractures after severe brain injury. (C) 2014 Australian Physiotherapy Association. Published by Elsevier B.V.	[Leung, Joan; Stroud, Katarina] Royal Rehabil Ctr, Sydney, NSW, Australia; [Harvey, Lisa A.; Moseley, Anne M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Harvey, Lisa A.] Univ Sydney, Sydney Med Sch, Northern Clin Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Moseley, Anne M.] George Inst Global Hlth, Sydney, NSW, Australia; [Whiteside, Bhavini] Liverpool Hlth Serv, Liverpool, Merseyside, England; [Simpson, Melissa] Westmead Hosp, Sydney, NSW, Australia		Leung, J (corresponding author), Royal Rehabil Ctr Sydney, Brain Injury Unit, Sydney, NSW, Australia.	joan.leung@royalrehab.com.au	Leung, Joan/AAC-8623-2019	Leung, Joan/0000-0003-0888-558X; Harvey, Lisa A/0000-0002-4365-0236	Research Infrastructure Block Grants of the University of Sydney; Rehabilitation and Disability Research Grants of the Royal Rehabilitation Centre Sydney	The Rehabilitation and Disability Research Grants of the Royal Rehabilitation Centre Sydney, and the Research Infrastructure Block Grants of the University of Sydney.	Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; Ada L, 2003, BRAIN, V126, P724, DOI 10.1093/brain/awg066; Alon G, 2008, AM J PHYS MED REHAB, V87, P627, DOI 10.1097/PHM.0b013e31817fabc1; Bakhtiary AH, 2008, CLIN REHABIL, V22, P418, DOI 10.1177/0269215507084008; Bolton DAE, 2004, J NEUROL SCI, V223, P121, DOI 10.1016/j.jns.2004.05.005; BOWMAN BR, 1985, ANN BIOMED ENG, V13, P59, DOI 10.1007/BF02371250; Chan MKL, 2009, NEUROREHAB NEURAL RE, V23, P357, DOI 10.1177/1545968308326428; de Jong LD, 2013, J PHYSIOTHER, V59, P245, DOI 10.1016/S1836-9553(13)70201-7; de Kroon JR, 2005, J REHABIL MED, V37, P65, DOI 10.1080/16501970410024190; de Kroon JR, 2002, CLIN REHABIL, V16, P350, DOI 10.1191/0269215502cr504oa; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Fergusson D, 2007, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.BLO.0b013e3180308456; Glinsky J, 2007, PHYSIOTHER RES INT, V12, P175, DOI 10.1002/pri.375; Harvey L, 2003, SPINAL CORD, V41, P559, DOI 10.1038/sj.sc.3101486; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P1340, DOI 10.1053/apmr.2000.9168; Harvey LA, 2003, AUST J PHYSIOTHER, V49, P176, DOI 10.1016/S0004-9514(14)60237-3; Harvey L, 2006, AUST J PHYSIOTHER, V52, P251, DOI 10.1016/S0004-9514(06)70004-6; Horsley SA, 2007, AUST J PHYSIOTHER, V53, P239, DOI 10.1016/S0004-9514(07)70004-1; Katalinic OM, 2011, PHYS THER, V91, P11, DOI 10.2522/ptj.20100265; Kwah LK, 2012, J PHYSIOTHER, V58, P41, DOI 10.1016/S1836-9553(12)70071-1; Landau WM, 2002, ARCH NEUROL-CHICAGO, V59, P1453, DOI 10.1001/archneur.59.9.1453; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; Lannin NA, 2007, STROKE, V38, P111, DOI 10.1161/01.STR.0000251722.77088.12; Leung J, 2013, PHYSIOTHER CAN, V65, P223, DOI 10.3138/ptc.2012-29; Leung J, 2012, J PHYSIOTHER, V58, P231, DOI 10.1016/S1836-9553(12)70124-8; Lin ZL, 2011, J REHABIL MED, V43, P506, DOI 10.2340/16501977-0807; Malhotra S, 2011, CLIN REHABIL, V25, P184, DOI 10.1177/0269215510381620; Malhotra S, 2013, CLIN REHABIL, V27, P579, DOI 10.1177/0269215512464502; Moseley AM, 2008, CLIN REHABIL, V22, P406, DOI 10.1177/0269215507083795; Ng SSM, 2007, STROKE, V38, P2953, DOI 10.1161/STROKEAHA.107.490318; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Rosewilliam S, 2012, ARCH PHYS MED REHAB, V93, P1715, DOI 10.1016/j.apmr.2012.05.017; Sabut SK, 2011, NEUROREHABILITATION, V29, P393, DOI 10.3233/NRE-2011-0717; Sahin N, 2012, DISABIL REHABIL, V34, P151, DOI 10.3109/09638288.2011.593679; Shindo K, 2011, NEUROREHAB NEURAL RE, V25, P830, DOI 10.1177/1545968311408917; Stein RB, 2013, J CLIN NEUROPHYSIOL, V30, P66, DOI 10.1097/WNP.0b013e31827ed6bd; TARDIEU G, 1954, REV NEUROL, V91, P143; Taylor L, 2012, J CLIN NEUROPHYSIOL, V29, P237, DOI 10.1097/WNP.0b013e3182570f17; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Yan TB, 2005, STROKE, V36, P80, DOI 10.1161/01.STR.0000149623.24906.63	40	7	7	0	13	AUSTRALIAN PHYSIOTHERAPY ASSOC	ST KILDA	LEVEL 3, 201  FITZROY ST, ST KILDA, 3182, AUSTRALIA	1836-9553	1836-9561		J PHYSIOTHER	J. Physiother.	DEC	2014	60	4					201	208		10.1016/j.jphys.2014.09.007			8	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	AT4TY	WOS:000344936600004	25443650	gold			2022-02-06	
J	Miller, KE; Finn, JA; Newman, E				Miller, Katherine E.; Finn, Jacob A.; Newman, Elana			Are Communities Ready? Assessing Providers' Practices, Attitudes, and Knowledge About Military Personnel	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						veterans; community; competence; training; dissemination	MENTAL-HEALTH PROBLEMS; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PSYCHOLOGISTS ATTITUDES; VETERANS; IRAQ; AFGHANISTAN; CARE; PTSD; DISSEMINATION	One potential barrier to helping returning military personnel and their families is a lack of community providers skilled to help these groups. Although capacity and competence have expanded within the Department of Defense (DoD) and the Veterans Health Administration (VHA), it is unknown if community agencies have the interest, capacity, and competence to help service members, veterans, and their families postdeployment. This study used an online survey to examine the knowledge, common practices, attitudes, and training needs of community mental health providers, in order to determine if needs are adequately addressed. Assessment and treatment practices with veterans and service members varied greatly in community practices. Additional training opportunities are needed, particularly for helping military personnel with traumatic brain injuries and providing evidence-based practice. Furthermore, clinicians in the community need to systematically assess new clients for military service.	[Miller, Katherine E.; Finn, Jacob A.; Newman, Elana] Univ Tulsa, Tulsa, OK 74104 USA; [Newman, Elana] Univ Tulsa, Inst Trauma Advers & Injustice, Tulsa, OK 74104 USA; [Newman, Elana] Univ Tulsa, Dart Ctr Journalism & Trauma, Tulsa, OK 74104 USA		Newman, E (corresponding author), Univ Tulsa, Dept Psychol, 800 South Tucker Dr, Tulsa, OK 74104 USA.	elana-newman@utulsa.edu		Newman, Elana/0000-0003-2050-863X			Andrews K, 2006, HLTH CARE SURVEY DOD; Bass E, 2012, VET HLTH ADM TREATME; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Burdett H., 2012, ARMED FORCES SOC, P1, DOI [10.1177/0095327X12452033, DOI 10.1177/0095327X12452033]; Center for Public Policy and Social Research, 2008, CONN VET NEEDS ASS O; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veterans Affairs Office of Inspector General, 2012, 1200900168 DEP VET A; Dillman DA., 2007, MAIL INTERNET SURVEY; Epidemiology Program Post Deployment Health Strategic Healthcare Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2012, AN HLTH CAR UT OP EN; Foa EB, 2009, EFFECTIVE TREATMENTS, V2nd; Hoff RA, 1998, MED CARE, V36, P1524, DOI 10.1097/00005650-199811000-00002; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoshmand LT, 2007, J COMMUNITY PSYCHOL, V35, P171, DOI 10.1002/jcop.20141; Jameson JP, 2009, COMMUNITY MENT HLT J, V45, P463, DOI 10.1007/s10597-009-9230-7; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; McCarthy JF, 2010, PSYCHIAT SERV, V61, P1035, DOI 10.1176/ps.2010.61.10.1035; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Reger MA, 2008, MIL PSYCHOL, V20, P21, DOI 10.1080/08995600701753144; Rentz ED, 2006, TRAUMA VIOLENCE ABUS, V7, P93, DOI 10.1177/1524838005285916; SHEEHAN K, 2001, J COMPUTER MEDIATED; Sherman M. D., 2007, PSYCHOL NEEDS US MIL; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Stewart RE, 2012, PROF PSYCHOL-RES PR, V43, P100, DOI 10.1037/a0025694; Stirman SW, 2005, J CONSULT CLIN PSYCH, V73, P127, DOI 10.1037/0022-006X.73.1.127; Straits-Troster KA, 2011, PSYCHOL TRAUMA-US, V3, P283, DOI 10.1037/a0024645; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V720; U.S. Census Bureau, 2010, 2005 2009 AM COMM SU; U.S. Medicine Institute (USMI), 2005, CHANG MIL DIR CAR SY; van Minnen A, 2006, J TRAUMA STRESS, V19, P427, DOI 10.1002/jts.20146	36	7	7	0	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	DEC	2014	45	6			SI		398	404		10.1037/a0036774			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AX0HS	WOS:000346634200002					2022-02-06	
J	Morgan, WE; Morgan, CP				Morgan, William E.; Morgan, Clare P.			Chiropractic Care of a Patient With Neurogenic Heterotopic Ossification of the Anterior Longitudinal Ligament After Traumatic Brain Injury: A Case Report	JOURNAL OF CHIROPRACTIC MEDICINE			English	Article						Ossification; Heterotopic; Chiropractic; Military personnel; Brain injuries; Manipulation; Spinal		Objective: The purpose of this case report is to describe the use of chiropractic care for a patient with neurogenic heterotopic ossification of the anterior longitudinal ligament in the cervical spine and soft tissues of the right hip after a traumatic brain injury and right femur fracture. Clinical Features A 25-year-old military officer was referred to a hospital-based chiropractic clinic with complaints of pain and stiffness of the neck and back along with reduced respiratory excursions that began several months after a motor vehicle accident in which he had a traumatic brain injury. The patient had a fractured right femur from the accident, which had since been treated surgically, but had complications of heterotopic ossification in the soft tissues of the hip. His overall pain level was 3 of 10 on a verbal pain scale during use of oxycodone HCL/acetaminophen. Chest excursion was initially measured at.5 cm. Intervention and Outcome: With the intent to restore respiratory chest motion and to reduce the patient's back and neck pain, the patient was placed on a program of chiropractic and myofascial manipulation, exercise therapy, and respiratory therapy. After a year of care, the patient rated overall pain at 3 of 10 verbal pain scale level but was no longer takingmedications for pain and an increase in respiratory chest excursions measured at 3.5 cm. Conclusion: This case demonstrated that chiropractic treatment provided benefit to a patient with heterotopic ossification concurrent with musculoskeletal pain. (C) 2014 National University of Health Sciences	[Morgan, William E.; Morgan, Clare P.] Walter Reed Natl Mil Med Ctr, Phys Med & Rehabil Dept, Bethesda, MD 20814 USA		Morgan, WE (corresponding author), 11117 Innsbrook Way, Ijamsville, MD 21754 USA.	MorganDC@gmail.com					Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Bockenhauer SE, 2007, J AM OSTEOPATH ASSOC, V107, P191; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Chen Y, 2009, EUR SPINE J, V18, P1541, DOI 10.1007/s00586-009-1029-2; Czyrny J J, 1995, J Spinal Cord Med, V18, P194; Eid K, 2006, J BONE JOINT SURG BR, V88B, P1394, DOI 10.1302/0301-620X.88B10.17139; Epstein NE, 1999, J NEUROSURG, V90, P261, DOI 10.3171/spi.1999.90.2.0261; Estrores IM, 2004, J SPINAL CORD MED, V27, P434, DOI 10.1080/10790268.2004.11752233; Fijn R, 2003, PHARM WORLD SCI, V25, P138, DOI 10.1023/A:1024830213832; Forestier J, SPONDYLARTHRITE ANKY; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Garland GW, 1991, CLIN ORTHOP RELAT R, V263, P13; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Herd R, 2001, J BONE JOINT SURG BR, V83-B, P332; Hsieh JH, 2010, SPINE, V35, pE149, DOI 10.1097/BRS.0b013e3181bee8a7; Masi AT, 2005, CLIN EXP RHEUMATOL, V23, P760; Mestan MA, 2001, J MANIP PHYSIOL THER, V24, P296, DOI 10.1067/mmt.2001.114360; Mohan V, 2012, BANGLADESH J MED SCI, V11, P307, DOI 10.3329/bjms.v11i4.12602; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Potter BK, 2010, J BONE JOINT SURG AM, V92A, P74, DOI 10.2106/JBJS.J.00776; ROSSIER AB, 1973, PARAPLEGIA, V11, P36; Scherbel U, 2001, U PENN ORTHOP J, V14, P85; Singh RS, 2003, ARCH PHYS MED REHAB, V84, P1584, DOI 10.1053/S0003-9993(03)00347-2; Song J, 2006, NEUROSURGERY, V58, P913, DOI 10.1227/01.NEU.0000209936.46946.99; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	31	7	7	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0899-3467	1556-3715		J CHIROPR MED	J. Chiropr. Med.	DEC	2014	13	4					260	265		10.1016/j.jcm.2014.08.001			6	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V03CP	WOS:000213715800005	25435839	Green Published			2022-02-06	
J	Yoshida, K; Sawamura, D; Ogawa, K; Ikoma, K; Asakawa, K; Yamauchi, T; Sakai, S				Yoshida, Kazuki; Sawamura, Daisuke; Ogawa, Keita; Ikoma, Katsunori; Asakawa, Kiyoshi; Yamauchi, Taro; Sakai, Shinya			Flow Experience During Attentional Training Improves Cognitive Functions in Patients with Traumatic Brain Injury: An Exploratory Case Study	HONG KONG JOURNAL OF OCCUPATIONAL THERAPY			English	Article						attention deficit; Continuous Performance Test; Moss Attention Rating Scale; Symbol Digit Modalities Test; traumatic brain injury	REHABILITATION; RELIABILITY; PERFORMANCE; SCALE	Objective/Background: Flow is the holistic experience that occurs when an individual acts with total involvement. The objective of this study was to examine the effects of attention training that induces flow experience for patients with attention-deficit disorder after traumatic brain injury (TBI). Methods: A two-patient case report with a within-subject AB design was conducted. Two patients with attention deficit after TBI were recruited for attention training. Two types of video game tasks for attention training were created, one inducing flow (flow task) and the other not (control task). Patient A performed the flow task for 14 days after receiving general occupational therapy (OT) for 11 days. Patient B performed the flow task for 15 days after performing the control task for 10 days. We examined training effects using neuropsychological tests. The Flow State Scale for Occupational Tasks was administered to identify the patient's flow state. To evaluate the training effect, we used visual analysis, the two-standard deviation band method, and effect-size analyses. Results: Both Patient A and Patient B showed improvement on the Continuous Performance Test, Symbol Digit Modalities Test, and Moss Attention Rating Scale after the flow task. Patient B also showed improvement on the Trail Making Test. Conclusion: The results for Patient A suggested that the flow task was more effective than general OT for improving attention deficits. Moreover, the results for Patient B suggested that the flow task was more effective than the control task. Attention training inducing flow experience may thus facilitate improvement of attention. Copyright (C) 2015, Hong Kong Occupational Therapy Association. Published by Elsevier (Singapore) Pte Ltd. All rights reserved.	[Yoshida, Kazuki] Hokkaido Univ, Grad Sch Hlth Sci, Div Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Yoshida, Kazuki] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Occupat Therapy, Eniwa, Japan; [Sawamura, Daisuke] Hlth Sci Univ Hokkaido, Sch Rehabil Sci, Dept Occupat Therapy, Sapporo, Hokkaido, Japan; [Ogawa, Keita] Hokkaido Univ Hosp, Dept Rehabil, Sapporo, Hokkaido 060, Japan; [Ikoma, Katsunori] Hokkaido Univ, Dept Rehabil Med, Sapporo, Hokkaido 0600812, Japan; [Asakawa, Kiyoshi] Hosei Univ, Fac Intercultural Commun, Tokyo, Japan; [Yamauchi, Taro] Hokkaido Univ, Fac Hlth Sci, Human Ecol Lab, Sapporo, Hokkaido 0600812, Japan; [Sakai, Shinya] Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, Sapporo, Hokkaido 0600812, Japan		Sakai, S (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, N-12 W-5 Kita Ku, Sapporo, Hokkaido 0600812, Japan.	sakai@hs.hokudai.ac.jp	Sakai, Shinya/D-7474-2012; Sawamura, Daisuke/AAK-3975-2021	Sawamura, Daisuke/0000-0003-3180-3474	JSPSMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26750196]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25305003, 25101701] Funding Source: KAKEN	We thank the staff at Hokkaido University Hospital for their cooperation with patient data collection and intervention. This work was supported by JSPS Grants-in-Aid (26750196).	Busk PL., 1992, SINGLE CASE RES DESI, P187; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; Csikszentmihalyi M., 2000, BOREDOM ANXIETY; Csikszentmihalyi M., 2010, EFFORTLESS ATTENTION, P179, DOI DOI 10.7551/MITPRESS/9780262013840.003.0009; Csikszentmihalyi M., 1988, OPTIMAL EXPERIENCE P, P266; Danzl Megan M, 2012, J Allied Health, V41, P35; de Manzano O, 2013, NEUROIMAGE, V67, P1, DOI 10.1016/j.neuroimage.2012.10.072; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Klasen M, 2012, SOC COGN AFFECT NEUR, V7, P485, DOI 10.1093/scan/nsr021; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakamura J., 2002, HDB POSITIVE PSYCHOL, P89; NOURBAKHSH MR, 1994, PHYS THER, V74, P768, DOI 10.1093/ptj/74.8.768; Ottenbacher KJ., 1986, EVALUATING CLIN CHAN, P167; Pero S, 2006, BRAIN INJURY, V20, P1207, DOI 10.1080/02699050600983271; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Sawamura D, 2012, HIGHER BRAIN FUNCTIO, V33, P533; Schmidt M., 1996, REY AUDITORY VERBAL; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Scruggs T.E., 1986, BEHAV DISORDERS, V11, P260, DOI [https://doi.org/10.1177/019874298601100408, DOI 10.1177/019874298601100408]; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Takahashi T., 2008, JAPANESE J BEHAV ANA, V22, P49; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Ulrich M, 2014, NEUROIMAGE, V86, P194, DOI 10.1016/j.neuroimage.2013.08.019; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D, 1981, WECHSLER ADULT INTEL; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P966, DOI 10.1016/j.apmr.2007.12.031; Yoshida K, 2013, HONG KONG J OCCUP TH, V23, P54, DOI 10.1016/j.hkjot.2013.09.002	35	7	7	2	24	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1569-1861			HONG KONG J OCCUP TH	Hong Kong J. Occup. Ther.	DEC	2014	24	2					81	87		10.1016/j.hkjot.2015.01.001			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	CG3MJ	WOS:000353184000007		gold			2022-02-06	
J	Brody, AL; Okita, K; Shieh, J; Liang, LD; Hubert, R; Mamoun, M; Farahi, J; Mandelkern, MA				Brody, Arthur L.; Okita, Kyoji; Shieh, Jennifer; Liang, Lidia; Hubert, Robert; Mamoun, Michael; Farahi, Judah; Mandelkern, Mark A.			Radiation dosimetry and biodistribution of the translocator protein radiotracer [C-11]DAA1106 determined with PET/CT in healthy human volunteers	NUCLEAR MEDICINE AND BIOLOGY			English	Article						[C-11]DAA1106; Positron emission tomography; Dosimetry; Neuroinflammation; Translocator protein; Review	PERIPHERAL BENZODIAZEPINE-RECEPTOR; TRAUMATIC BRAIN-INJURY; LIGAND DAA1106 BINDS; HIGH-AFFINITY; MICROGLIAL ACTIVATION; IN-VIVO; ALZHEIMERS-DISEASE; RAT MODEL; NEUROINFLAMMATION; RADIOSYNTHESIS	Introduction: When microglia become activated (an integral part of neuroinflammation), cellular morphology changes and expression of translocator protein (TSPO) 18 kDa is increased. Over the past several years, [C-11] DAA1106 has emerged as a reliable radiotracer for labeling TSPO with high affinity during positron emission tomography (PET) scanning. While [C-11]DAA1106 PET scanning has been used in several research studies, a radiation dosimetry study of this radiotracer in humans has not yet been published. Methods: Twelve healthy participants underwent full body dynamic [C-11]DAA1106 PET scanning, with 8 sequential whole body scans (approximately 12 bed positions each), following a single injection. Regions of interest were drawn manually, and time activity curves (TACs) were obtained for 15 organs. OLINDA/EXM 1.1 was used to compute radiation,absorbed doses to the target organs, as well as effective dose (ED) and effective dose equivalent (EDE). Results: The ED and EDE were 4.06 +/- 0.58 mu Sv/MBq and 5.89 +/- 0.83 mu Sv/MBq, respectively. The highest absorbed doses were to the heart wall, kidney, liver, pancreas, and spleen. TACs revealed that peak dose rates are during the first scan (at 6 min) for all organs other than the urinary bladder wall, which had its peak dose rate during the fourth scan (at 30 min). Conclusions: The recently developed radiotracer [C-11]DAA1106 has its EDE and target-organ absorbed dose such that, for a single administration, its radiation dosimetry is well within the U.S. FDA guidelines for basic research studies in adults. This dose level implies that the dosimetry for multiple [C-11]DAA1106 scans within a given year also falls within FDA guidelines, and this favorable property makes this radiotracer suitable for examining microglial activation repeatedly over time, which may in the future be useful for longitudinal tracking of disease progression and monitoring of therapy response in conditions marked by neuroinflammation (e.g., head trauma and multiple sclerosis). Published by Elsevier Inc.	[Brody, Arthur L.; Okita, Kyoji; Shieh, Jennifer; Liang, Lidia; Hubert, Robert; Mamoun, Michael] VAGLAHS, Dept Res, Los Angeles, CA 90073 USA; [Brody, Arthur L.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Okita, Kyoji] Univ Calif Los Angeles, Lab Mol Imaging, Los Angeles, CA 90095 USA; [Farahi, Judah; Mandelkern, Mark A.] VAGLAHS, Dept Imaging, Los Angeles, CA 90073 USA; [Mandelkern, Mark A.] Univ Calif Irvine, Dept Phys, Irvine, CA 92697 USA		Brody, AL (corresponding author), 300 UCLA Med Plaza,Suite 2200, Los Angeles, CA 90095 USA.	abrody@ucla.edu			National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01 DA20872]; Tobacco-Related Disease Research ProgramUniversity of California System [19XT-0135]; Department of Veterans Affairs, Office of Research and Development (CSRD)US Department of Veterans Affairs [I01 CX000412]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA020872] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX000412] Funding Source: NIH RePORTER	This study was supported by the National Institute on Drug Abuse (A.L.B. [R01 DA20872]), the Tobacco-Related Disease Research Program (A.L.B. [19XT-0135]), and the Department of Veterans Affairs, Office of Research and Development (CSR&D Merit Review Award I01 CX000412 [A.L.B.]). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Anthony DC, 2013, MOL CELL NEUROSCI, V53, P1, DOI 10.1016/j.mcn.2012.11.005; Arlicot N, 2012, NUCL MED BIOL, V39, P570, DOI 10.1016/j.nucmedbio.2011.10.012; Brown AK, 2007, J NUCL MED, V48, P2072, DOI 10.2967/jnumed.107.044842; Chaki S, 1999, EUR J PHARMACOL, V371, P197, DOI 10.1016/S0014-2999(99)00118-1; Doorduin J, 2010, NUCL MED BIOL, V37, P9, DOI 10.1016/j.nucmedbio.2009.09.002; Doorduin J, 2008, CURR PHARM DESIGN, V14, P3297, DOI 10.2174/138161208786549443; Edison P, 2013, NEUROPSYCHOPHARMACOL, V38, P938, DOI 10.1038/npp.2012.255; Ellwardt E, 2014, EXP NEUROL IN PRESS; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Gulyas B, 2009, NEUROCHEM INT, V54, P28, DOI 10.1016/j.neuint.2008.10.001; Hirvonen J, 2010, EUR J NUCL MED MOL I, V37, P606, DOI 10.1007/s00259-009-1298-3; Iannaccone S, 2013, PARKINSONISM RELAT D, V19, P47, DOI 10.1016/j.parkreldis.2012.07.002; Kumar A, 2010, J NUCL MED, V51, P139, DOI 10.2967/jnumed.109.066472; Leung K, 2004, N 5 FLUORO 2 PHENOXY; Maeda J, 2004, SYNAPSE, V52, P283, DOI 10.1002/syn.20027; Okubo T, 2004, BIOORGAN MED CHEM, V12, P423, DOI 10.1016/j.bmc.2003.10.050; Probst KC, 2007, NUCL MED BIOL, V34, P439, DOI 10.1016/j.nucmedbio.2007.02.009; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Schuitemaker A, 2013, NEUROBIOL AGING, V34, P128, DOI 10.1016/j.neurobiolaging.2012.04.021; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Stabin MG, 2005, J NUCL MED, V46, P1023; Su ZJ, 2013, EUR J NUCL MED MOL I, V40, P1406, DOI 10.1007/s00259-013-2447-2; Surti S, 2007, J NUCL MED, V48, P471; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Takano A, 2010, INT J NEUROPSYCHOPH, V13, P943, DOI 10.1017/S1461145710000313; van der Aart J, 2012, NUCL MED BIOL, V39, P305, DOI 10.1016/j.nucmedbio.2011.08.005; Varrone A, 2013, EUR J NUCL MED MOL I, V40, P921, DOI 10.1007/s00259-013-2359-1; Venneti S, 2008, J NEUROPATH EXP NEUR, V67, P1001, DOI 10.1097/NEN.0b013e318188b204; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Venneti S, 2007, J NEUROCHEM, V102, P2118, DOI 10.1111/j.1471-4159.2007.04690.x; Verschuer JD, 2012, NUCL MED BIOL, V39, P742, DOI 10.1016/j.nucmedbio.2011.11.003; Wang M, 2012, APPL RADIAT ISOTOPES, V70, P965, DOI 10.1016/j.apradiso.2012.03.011; Wilson AA, 2000, NUCL MED BIOL, V27, P529, DOI 10.1016/S0969-8051(00)00132-3; Yasuno F, 2012, PSYCHIAT RES-NEUROIM, V203, P67, DOI 10.1016/j.pscychresns.2011.08.013; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang MR, 2003, NUCL MED BIOL, V30, P513, DOI 10.1016/S0969-8051(03)00016-7	38	7	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	NOV-DEC	2014	41	10					871	875		10.1016/j.nucmedbio.2014.07.004			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AR5HE	WOS:000343614800013	25156039	Green Published, Green Accepted			2022-02-06	
J	Cao, L; Bie, XH; Huo, S; Du, JB; Liu, L; Song, WQ				Cao, Lei; Bie, Xiaohua; Huo, Su; Du, Jubao; Liu, Lin; Song, Weiqun			Effects of diazepam on glutamatergic synaptic transmission in the hippocampal CA1 area of rats with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; fluid percussion injury; excitatory synaptic transmission; hippocampal CA1 pyramidal neurons; paired-pulse facilitation; miniature excitatory postsynaptic potential; gamma-aminobutyric acid; post-traumatic hyperactivity; intracellular recording; NSFC grant; neural regeneration	FLUID PERCUSSION INJURY; GABA(A) RECEPTOR; EPILEPSY; RECOVERY; MODELS; HYPEREXCITABILITY; INVOLVEMENT; ACTIVATION; SYNAPSES	The activity of the Schaffer collaterals of hippocampal CA3 neurons and hippocampal CA1 neurons has been shown to increase after fluid percussion injury Diazepam can inhibit the hyperexcitability of rat hippocampal neurons after injury, but the mechanism by which it affects excitatory synaptic transmission remains poorly understood. Our results showed that diazepam treatment significantly increased the slope of input-output curves in rat neurons after fluid percussion injury. Diazepam significantly decreased the numbers of spikes evoked by super stimuli in the presence of 15 mu mol/L bicuculline, indicating the existence of inhibitory pathways in the injured rat hippocampus. Diazepam effectively increased the paired-pulse facilitation ratio in the hippocampal CA1 region following fluid percussion injury, reduced miniature excitatory postsynaptic potentials, decreased action-potential-dependent glutamine release, and reversed spontaneous glutamine release. These data suggest that diazepam could decrease the fluid percussion injury-induced enhancement of excitatory synaptic transmission in the rat hippocampal CA1 area.	[Cao, Lei; Bie, Xiaohua] Xian Red Cross Hosp, Dept Funct Neurosurg, Xian, Shaanxi Provinc, Peoples R China; [Cao, Lei; Huo, Su; Du, Jubao; Liu, Lin; Song, Weiqun] Capital Med Univ, Dept Rehabil Med, Xuanwu Hosp, Beijing 100053, Peoples R China		Song, WQ (corresponding author), Capital Med Univ, Dept Rehabil Med, Xuanwu Hosp, Beijing 100053, Peoples R China.	songwq66@vip.163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201984]; Scientific Research Project of Shaanxi Provincial Health Department in China [2010E03]; Yulin Municipal Science and Technology Research and Development Project [Sf12-06]	This study was supported by the National Natural Science Foundation of China, No. 81201984; the Scientific Research Project of Shaanxi Provincial Health Department in China, No. 2010E03; and the Yulin Municipal Science and Technology Research and Development Project, No. Sf12-06.	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; Chen WG, 2013, NEURAL REGEN RES, V8, P169, DOI 10.3969/j.issn.1673-5374.2013.02.010; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Han Y, 2011, NEUROSCIENCE, V194, P234, DOI 10.1016/j.neuroscience.2011.07.068; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Liu XD, 2013, TALANTA, V106, P321, DOI 10.1016/j.talanta.2012.11.015; Long J, 2013, NEURAL REGEN RES, V8, P1491, DOI 10.3969/j.issn.1673-5374.2013.16.006; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Lusardi TA, 2012, EXP NEUROL, V234, P161, DOI 10.1016/j.expneurol.2011.12.026; Ma JY, 2014, BRAIN RES, V1563, P22, DOI 10.1016/j.brainres.2014.03.034; Manna SSS, 2011, BRAIN RES, V1425, P75, DOI 10.1016/j.brainres.2011.09.049; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Movsesyan VA, 2006, J NEUROTRAUM, V23, P117, DOI 10.1089/neu.2006.23.117; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Ooba S, 2008, NEUROSCI RES, V62, P195, DOI 10.1016/j.neures.2008.08.005; PALOMBI PS, 1992, J NEUROPHYSIOL, V67, P738, DOI 10.1152/jn.1992.67.3.738; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/NCHEMBIO.917, 10.1038/nchembio.917]; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rossetti F, 2012, NEUROTOXICOLOGY, V33, P500, DOI 10.1016/j.neuro.2012.02.010; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020	38	7	7	1	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	NOV	2014	9	21					1897	1901		10.4103/1673-5374.145357			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AW5OT	WOS:000346324900010	25558239	Green Published, gold			2022-02-06	
J	Dubowitz, H; Christian, CW; Hymel, K; Kellogg, ND				Dubowitz, Howard; Christian, Cindy W.; Hymel, Kent; Kellogg, Nancy D.			Forensic medical evaluations of child maltreatment: A proposed research agenda	CHILD ABUSE & NEGLECT			English	Article						Medical evaluation; Forensic; Research agenda; Child abuse and neglect	TRAUMATIC BRAIN-INJURY; UP SKELETAL SURVEYS; SEXUALLY-TRANSMITTED-DISEASES; PHYSICAL ABUSE; ADVOCACY CENTERS; YOUNG-CHILDREN; HEAD-INJURY; OSTEOGENESIS IMPERFECTA; HOUSEHOLD DYSFUNCTION; NEISSERIA-GONORRHOEAE	Physicians play an important role in the forensic evaluation of suspected child abuse and neglect. There has been considerable progress in the medical field, helping distinguish findings related to maltreatment from other conditions or circumstances. Nevertheless, important questions remain. This article covers several of these questions and proposes a research agenda concerning five main topics: sexual abuse, neglect, fractures, abusive head trauma, and physicians work in interdisciplinary settings. The suggestions are hardly inclusive, but offer suggestions the authors think are priorities, and ones that research could reasonably address. By providing some background to gaps in our knowledge, this paper should be of interest to a broader audience than just medical professionals. (C) 2014 Elsevier Ltd. All rights reserved.	[Dubowitz, Howard] Univ Maryland, Sch Med, College Pk, MD USA; [Christian, Cindy W.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hymel, Kent] Penn State Coll Med, State Coll, PA USA; [Kellogg, Nancy D.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA		Dubowitz, H (corresponding author), 520 West Lombard St, Baltimore, MD 21201 USA.			Hymel, Kent/0000-0002-1422-182X			Adams J A, 2001, J Pediatr Adolesc Gynecol, V14, P175, DOI 10.1016/S1083-3188(01)00126-7; Adams JA, 2012, CHILD ABUSE NEGLECT, V36, P383, DOI 10.1016/j.chiabu.2012.01.004; Anderst J., 2012, PEDIATRICS; Anderst J, 2009, CHILD ABUSE NEGLECT, V33, P481, DOI 10.1016/j.chiabu.2009.05.001; Asser SM, 1998, PEDIATRICS, V101, P625, DOI 10.1542/peds.101.4.625; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barnes Patrick D, 2007, Top Magn Reson Imaging, V18, P53, DOI 10.1097/RMR.0b013e3180d0a455; Bechtel K, 2008, PEDIATR EMERG CARE, V24, P442, DOI 10.1097/PEC.0b013e31817de11d; BELL TA, 1992, JAMA-J AM MED ASSOC, V267, P400, DOI 10.1001/jama.267.3.400; Bennett B. L., 2011, BMC RES NOTES; BENSON DE, 1991, CHILD ABUSE NEGLECT, V15, P57, DOI 10.1016/0145-2134(91)90090-Z; Berenson AB, 2002, J PEDIATR-US, V140, P600, DOI 10.1067/mpd.2002.123101; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bishop N, 2007, ARCH DIS CHILD, V92, P251, DOI 10.1136/adc.2006.106120; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Botash A. S., 2012, J PEDIAT; Byers PH, 2006, GENET MED, V8, P383, DOI 10.1097/01.gim.0000223557.54670.aa; Carroll D. M., 2007, J PERINATAL MED; Chapman T, 2010, PEDIATR RADIOL, V40, P1184, DOI 10.1007/s00247-009-1470-8; Christian CW, 2000, PEDIATRICS, V106, P100, DOI 10.1542/peds.106.1.100; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Cross TP, 2007, CHILD ABUSE NEGLECT, V31, P1031, DOI 10.1016/j.chiabu.2007.04.007; Cundy T., 2012, CALCIFIED TISSUE INT; Day Fiona, 2006, J Clin Forensic Med, V13, P55, DOI 10.1016/j.jcfm.2005.08.001; De Bellis M. D., 2002, PSYCHONEUROENDOCRINO; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; DeLago C, 2008, PEDIATRICS, V122, pE281, DOI 10.1542/peds.2008-0450; DePanfilis D., 2007, HDB CHILD PROTECTION, P121; Dong M, 2003, ARCH INTERN MED, V163, P1949, DOI 10.1001/archinte.163.16.1949; Dong M., 2004, CIRCULATION; Donohoe M, 2003, AM J FOREN MED PATH, V24, P239, DOI 10.1097/01.paf.0000083635.85457.97; Drubach LA, 2010, RADIOLOGY, V255, P173, DOI 10.1148/radiol.09091368; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Dubowitz H, 2004, CHILD MALTREATMENT, V9, P344, DOI 10.1177/1077559504269191; Dubowitz H, 2002, PEDIATRICS, V109, P1100, DOI 10.1542/peds.109.6.1100; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Durfee M., 2009, PEDIAT CLIN N AM; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Faller KC, 2007, CHILD ABUSE NEGLECT, V31, P1021, DOI 10.1016/j.chiabu.2007.09.001; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Flaherty EG, 2014, PEDIATRICS, V133, pE477, DOI 10.1542/peds.2013-3793; Gallion HR, 2009, J PEDIATR ADOL GYNEC, V22, P300, DOI 10.1016/j.jpag.2008.12.006; Gavril AR, 2012, PEDIATRICS, V129, P282, DOI 10.1542/peds.2011-0804; Gena M, 2007, WISC LAW REV, P701; Giardino AP, 2004, CHILD ABUSE NEGLECT, V28, P25, DOI 10.1016/j.chiabu.2003.05.003; Girardet R, 2011, PEDIATRICS, V128, P233, DOI 10.1542/peds.2010-3037; Girardet RG, 2009, PEDIATRICS, V124, P79, DOI 10.1542/peds.2008-2947; Golden MR, 2004, CLIN INFECT DIS, V39, P1387, DOI 10.1086/424880; Harper NS, 2013, PEDIATRICS, V131, pE672, DOI 10.1542/peds.2012-2608; Heppenstall-Heger A, 2003, PEDIATRICS, V112, P829, DOI 10.1542/peds.112.4.829; Hines DA, 2006, CHILD ABUSE NEGLECT, V30, P619, DOI 10.1016/j.chiabu.2005.11.008; Hochstadt NJ, 2006, CHILD WELFARE, V85, P653; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Ingram DM, 2001, PEDIATRICS, V107; Jackson SL, 2004, CHILD ABUSE NEGLECT, V28, P411, DOI 10.1016/j.chiabu.2003.09.020; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jones LM, 2007, CHILD ABUSE NEGLECT, V31, P1069, DOI 10.1016/j.chiabu.2007.07.003; Jones R, 2008, PEDIATRICS, V122, P259, DOI 10.1542/peds.2007-2312; Karandikar S., 2004, CHILD ABUSE REV, V13, P178, DOI DOI 10.1002/CAR.850; Katz C, 2012, CHILD ABUSE NEGLECT, V36, P753, DOI 10.1016/j.chiabu.2012.07.002; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keller KA, 2008, PEDIATR RADIOL, V38, P1210, DOI 10.1007/s00247-008-1001-z; Kellogg Nancy D, 2004, J Pediatr Adolesc Gynecol, V17, P331, DOI 10.1016/j.jpag.2004.07.006; Kemp A. M., 2006, CLIN RADIOLOGY; Kemp AM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1518; KendallTackett KA, 1996, CHILD ABUSE NEGLECT, V20, P161, DOI 10.1016/S0145-2134(95)00139-5; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Kistin CJ, 2011, ACAD PEDIATR, V11, P451, DOI 10.1016/j.acap.2011.08.002; Kistin CJ, 2010, PEDIATRICS, V126, P94, DOI 10.1542/peds.2009-3446; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Kleinman RE, 2007, AMBUL PEDIATR, V7, P278, DOI 10.1016/j.ambp.2007.03.005; Lane WG, 2007, CLIN ORTHOP RELAT R, P219, DOI 10.1097/BLO.0b013e31805c0849; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Laskey A. L., 2004, J PEDIAT; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Levi BH, 2006, CHILD ABUSE NEGLECT, V30, P345, DOI 10.1016/j.chiabu.2005.05.004; Levi BH, 2005, PEDIATRICS, V116, pE5, DOI 10.1542/peds.2004-2649; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Lucas-Herald A, 2012, PEDIATRICS, V130, P1116, DOI 10.1542/peds.2012-0462; Lyon TD, 2012, J CHILD SEX ABUS, V21, P19, DOI 10.1080/10538712.2012.642468; Lyons G., 2003, UTAH LAW REV, V1109, ple; Marlowe A, 2002, J MED GENET, V39, P382, DOI 10.1136/jmg.39.6.382; Marquardt ML, 2012, PEDIATRICS, V130, pE695, DOI 10.1542/peds.2011-1295; MCCANN J, 1993, PEDIATRICS, V91, P390; Miller A, 2009, CHILD ABUSE NEGLECT, V33, P12, DOI 10.1016/j.chiabu.2008.07.002; Moncada J, 2008, J CLIN MICROBIOL, V46, P1614, DOI 10.1128/JCM.02301-07; Narang S. K., 2012, J HLTH LAW POLICY, V11, P505; National Association of Children's Hospitals and Related Institutions, 2008, RESP CHILD MALTR CHI; Offer-Shechter S, 2000, EUR J EPIDEMIOL, V16, P53, DOI 10.1023/A:1007662708871; Onwuachi-Saunders C, 1999, Inj Prev, V5, P276; Palusci VJ, 2003, PEDIATR INFECT DIS J, V22, P618, DOI 10.1097/00006454-200307000-00010; Paterson CR, 2009, ACTA PAEDIATR, V98, P2008, DOI 10.1111/j.1651-2227.2009.01407.x; Perez-Rossello JM, 2010, AM J ROENTGENOL, V195, P744, DOI 10.2214/AJR.09.3364; PETERSON MC, 1992, WESTERN J MED, V156, P163; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Ravichandiran N, 2010, PEDIATRICS, V125, P60, DOI 10.1542/peds.2008-3794; Rintala MAM, 2005, CLIN INFECT DIS, V41, P1728, DOI 10.1086/498114; Robertson C. L., 2006, DEV NEUROSCIENCE; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Schachter J, 2006, J CLIN MICROBIOL, V44, P2512, DOI 10.1128/JCM.02620-05; Schilling S, 2011, PEDIATRICS, V127, P835, DOI 10.1542/peds.2010-0533; Shapiro RA, 2006, CURR OPIN OBSTET GYN, V18, P492, DOI 10.1097/01.gco.0000242950.09997.ca; Shore RM, 2013, PEDIATR RADIOL, V43, P152, DOI 10.1007/s00247-012-2536-6; SIEGEL RM, 1995, PEDIATRICS, V96, P1090; Sinclair KA, 2005, PEDIATRICS, V116, P815, DOI 10.1542/peds.2005-0652; Steiner RD, 1996, J PEDIATR-US, V128, P542, DOI 10.1016/S0022-3476(96)70367-0; Taylor MN, 2008, CLIN RADIOL, V63, P348, DOI 10.1016/j.crad.2007.07.022; Teicher MH, 2004, BIOL PSYCHIAT, V56, P80, DOI 10.1016/j.biopsych.2004.03.016; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Tuerkheimer D., 2009, WASHINGTON U LAW REV, V87; Wallacea GH, 2007, CHILD ABUSE NEGLECT, V31, P623, DOI 10.1016/j.chiabu.2006.12.010; Walsh WA, 2007, CHILD ABUSE NEGLECT, V31, P1053, DOI 10.1016/j.chiabu.2007.04.006; Webster DW, 2000, PEDIATRICS, V106, P1466, DOI 10.1542/peds.106.6.1466; Wei C, 2012, ACTA PAEDIATR, V101, P587, DOI 10.1111/j.1651-2227.2012.02640.x; Wesson D, 2000, J PEDIATR SURG, V35, P688, DOI 10.1053/jpsu.2000.5944; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; Woodside FC, 2013, T JEFFERSON LAW REV, V35, P103; Wootton-Gorges SL, 2008, CHILD ABUSE NEGLECT, V32, P659, DOI 10.1016/j.chiabu.2007.06.011; Young KL, 2006, ARCH PEDIAT ADOL MED, V160, P585, DOI 10.1001/archpedi.160.6.585; Zimmerman S, 2005, CHILD ABUSE NEGLECT, V29, P1075, DOI 10.1016/j.chiabu.2004.08.012; [No title captured]; [No title captured]	128	7	8	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	NOV	2014	38	11					1734	1746		10.1016/j.chiabu.2014.07.012			13	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	AW0CJ	WOS:000345957600002	25224781				2022-02-06	
J	Loyd, AM; Nightingale, RW; Song, Y; Luck, JF; Cutcliffe, H; Myers, BS; Bass, C				Loyd, Andre Matthew; Nightingale, Roger W.; Song, Yin; Luck, Jason F.; Cutcliffe, Hattie; Myers, Barry S.; Bass, Cameron 'Dale'			The response of the adult and ATD heads to impacts onto a rigid surface	ACCIDENT ANALYSIS AND PREVENTION			English	Article						ATD; Head impact; Hybrid III; Head injury; Traumatic brain injury; Q3	CRANIAL THICKNESS	Given the high incidence of TB!, head injury has been studied extensively using both cadavers and anthropomorphic test devices (ATDs). However, few studies have benchmarked the response of ATD heads against human data. Hence, the objective of this study is to investigate the response of adult and ATD heads in impact, and to compare adult Hybrid III head responses to the adult head responses. In this study, six adult human heads and seven ATD heads were used to obtain impact properties. The heads were dropped from both 15 cm and 30 cm onto five impact locations: right and left parietal, forehead, occiput and vertex. One set of drops were performed on the human heads and up to four sets were carried out on the ATD heads. For each drop, the head was placed into a fine net and positioned to achieve the desired drop height and impact location. The head was then released to allow free fall without rotation onto a flat aluminum 3/4 -inch thick platen. The platen was attached to a three-axis piezoelectric load cell to measure the impact force. The peak resultant acceleration, head impact criterion CHIC) and impact stiffness were calculated using the force/time curve and drop mass. No statistical differences were found between the adult human heads and the adult Hybrid III head for 15 cm and 30 cm impacts (p > 0.05). For the human heads, the mid-sagittal impact locations produced the highest HIC and peak acceleration values. The parietal impacts produced HICs and peak accelerations that were 26-48% lower than those from the mid-sagittal impacts. For the ATD heads, the acceleration and HIC values generally increased with represented age, except for the Q3, which produced HIC values up to higher than the other ATD heads. The impact responses of the adult Hybrid III onto different impact locations were found to adequately represent the impact stiffness of human adult head impacts from 30 cm and below onto a rigid surface. The Q3 dummy consistently produced the highest HIC values of the ATD heads, and produced higher acceleration and HIC values than the adult human heads as well, which is contrary to neonatal data demonstrating that the head acceleration increases with age. (C) 2014 Elsevier Ltd. All rights reserved.	[Loyd, Andre Matthew] Duke Univ, St Louis Pk, MN 55416 USA; [Nightingale, Roger W.; Luck, Jason F.; Cutcliffe, Hattie; Myers, Barry S.; Bass, Cameron 'Dale'] Duke Univ, Durham, NC 27708 USA; [Song, Yin] Duke Univ, Chapel Hill, NC 27514 USA		Loyd, AM (corresponding author), Duke Univ, 5680 West 35th St, St Louis Pk, MN 55416 USA.	Andre.M.Loyd@gmail.com; rwn@duke.edu; songniy@gmail.com; jfl1@duke.edu; hattie.cutcliffe@duke.edu; bsm@duke.edu; dale.bass@duke.edu	Nightingale, Roger W/D-2872-2011	Cutcliffe, Hattie/0000-0001-8456-1996			[Anonymous], 1995, SAEJ2221 EL INSTR SO; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Dibb AT, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127257; Faul M., 2010, TRAUMATIC BRAIN INJU, P71; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; [Fmvss F.M.C.S.], 1998, 208 FMVSS US DEP TRA, P719; Foster J., 1977, P STAPP CAR CRASH J; Getz B., 1960, ACTA MORPHOL NEERL S, V3, P221; Got C., 1978, P 22 STAPP CAR CRASH; Hodgson V. R., 1971, P 15 STAPP CAR CRASH, V15, P190; Hubbard R. P., 1973, STAPP CAR CRASH J, V18, P599; Hubbard R. P., 1974, P S HUM IMP RESP MEA, P129; Irwin A, 1997, STAPP CAR CRASH J, P261; ISHIDA H, 1990, HUM BIOL, V62, P389; Kleinberger M., 1998, NHTSA DOCKET, V4405, P12; Lynnerup N, 2001, FORENSIC SCI INT, V117, P45, DOI 10.1016/S0379-0738(00)00447-3; Melvin JW, 1995, SAE T, P1553; Mertz H J, 2001, Stapp Car Crash J, V45, P319; Mertz H.J., 1985, STAPP CAR CRASH C WA; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; Pintar F. A., 1990, STAPP CAR CRASH J, V34, P55; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Van-Ratingen M.R., 1997, P STAPP CAR CRASH C; Walker L. B., 1973, STAPP CAR CRASH C BO, P525; Yoganandan Narayan, 2004, Traffic Inj Prev, V5, P368, DOI 10.1080/15389580490510336; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	26	7	8	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2014	72						219	229		10.1016/j.aap.2014.06.022			11	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AR8SC	WOS:000343843700022	25086440				2022-02-06	
J	Rojo-Mota, G; Pedrero-Perez, EJ; De Leon, JMRS; Page, JCM				Rojo-Mota, Gloria; Pedrero-Perez, Eduardo J.; Maria Ruiz-Sanchez De Leon, Jose; Miangolarra Page, Juan Carlos			Assessment of motor and process skills in daily life activities of treated substance addicts	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						occupational therapy; motor skills; cognitive skills; AMPS; addiction; activities of daily living	TRAUMATIC BRAIN-INJURY; PERFORMANCE; DEMENTIA; ABILITY; DISABILITY; AWARENESS; STROKE; HOME	Aim: The purpose of this study was to apply the Assessment of Motor and Process Skills ( AMPS) in a sample of people in treatment for addictive behaviours and to study the results. Methods: The test was applied to a sample of 101 outpatients in treatment for addiction to substances. The results were studied in relation to gender, age, level of education, and variables related to addiction. Results: Motor and cognitive performance was negatively related to time of addiction and its severity. Sixty per cent of the sample reached suboptimal scores and 25% showed scores suggesting significant deterioration, especially with regard to cognitive processing skills. Conclusions: The AMPS seems to be a useful instrument to estimate the cognitive and motor impairment associated with addiction in daily life activities. The present work is the first to consider its applicability to drug users under treatment. The percentage of subjects affected and the magnitude of the observed impairment in the sample suggest the need to consider taking these deficits into account in treatment programmes and the convenience of incorporating functional rehabilitation as a basic element of the treatment of persons with addictions. Future studies should develop this instrument in larger samples, increasing the representativeness and generalizability of the results.	[Rojo-Mota, Gloria; Miangolarra Page, Juan Carlos] Univ Rey Juan Carlos Madrid, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Madrid, Spain; [Rojo-Mota, Gloria; Pedrero-Perez, Eduardo J.] Inst Addict, Madrid, Spain; [Maria Ruiz-Sanchez De Leon, Jose] Univ Complutense Madrid, Dept Basic Psychol Cognit Proc 2, Madrid, Spain; [Miangolarra Page, Juan Carlos] Univ Hosp Fuenlabrada, Madrid, Spain; [Miangolarra Page, Juan Carlos] Reg Minist Hlth, Madrid Hlth Serv SERMAS, Community Madrid, Madrid, Spain		Rojo-Mota, G (corresponding author), Inst Adicc, CAD San Blas 4, C Alcala 527, Madrid 28027, Spain.	gloriaroj@yahoo.es	Ruiz-Sanchez de Leon, Jose M./J-2593-2015; de Leon, Jose Maria Ruiz Sanchez/X-8963-2019; Pedrero-Perez, Eduardo Jose/P-8127-2015; Rojo-Mota, Gloria/P-3916-2016	Ruiz-Sanchez de Leon, Jose M./0000-0003-2834-0827; de Leon, Jose Maria Ruiz Sanchez/0000-0003-2834-0827; Pedrero-Perez, Eduardo Jose/0000-0002-3940-5609; Rojo-Mota, Gloria/0000-0003-0358-1181			Ahlstrom S, 2003, SCAND J OCCUP THER, V10, P88; Bernspang B, 1999, SCAND J OCCUP THER, V6, P101, DOI DOI 10.1080/110381299443681; Bjorkdahl A, 2006, CLIN REHABIL, V20, P1038, DOI 10.1177/0269215506071230; Bouwens SFM, 2008, DEMENT GERIATR COGN, V25, P81, DOI 10.1159/000111694; DOBLE SE, 1994, ARCH PHYS MED REHAB, V75, P843, DOI 10.1016/0003-9993(94)90107-4; EMCCDA. European Monitoring Center for Drug and Drug Addiction, 2011, 2011 ANN REP STAT DR; Fernandez Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V1; Fisher A.G, 1995, ASSESSMENT MOTOR PRO; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V2; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; GOLDMAN SL, 1997, BRIT J OCCUPATIONAL, V60, P77, DOI DOI 10.1177/030802269706000210; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hariz GM., 2002, SCAND J OCCUP THER, V9, P141; Hartgers C., 1995, EUR ADDICT RES, V1, P208, DOI DOI 10.1159/000259089; Hartman ML., 1999, SCAND J OCCUP THER, V6, P111; Hayase D, 2004, AUST OCCUP THER J, V51, P192, DOI [DOI 10.1046/J.1440-1630.2003.00425.X, DOI 10.1111/J.1440-1630.2004.00425.X]; Josman N, 2001, SCAND J OCCUP THER, V8, P193, DOI DOI 10.1080/110381201317166559; Katz EC, 2005, AM J DRUG ALCOHOL AB, V31, P359, DOI 10.1081/ADA-200056767; Kirkley K N, 1999, J Outcome Meas, V3, P53; Kizony R, 2002, OTJR-OCCUP PARTICI H, V22, P82, DOI 10.1177/153944920202200205; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lange B, 2009, AUST OCCUP THER J, V56, P89, DOI 10.1111/j.1440-1630.2007.00698.x; Linden A, 2005, ACTA NEUROL SCAND, V111, P48, DOI 10.1111/j.1600-0404.2004.00356.x; Liu KRY, 2007, ACTA NEUROL SCAND, V116, P91, DOI 10.1111/j.1600-0404.2007.00800.x; Mercier L, 2001, STROKE, V32, P2602, DOI 10.1161/hs1101.098154; Merritt B, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17339; NYGARD L, 1994, AM J OCCUP THER, V48, P689, DOI 10.5014/ajot.48.8.689; Oakley F, 1997, Int Psychogeriatr, V9, P197, DOI 10.1017/S1041610297004341; Ohman A, 2011, SCAND J OCCUP THER, V18, P133, DOI 10.3109/11038121003645993; Pedrero Perez EJ, 2011, COORD NEUROCIENCIA A, P395; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Rasch G., 1960, PROBABILISTIC MODELS; Rojo-Mota G, 2013, REV NEUROLOGIA, V56, P129, DOI 10.33588/rn.5603.2012628; Russo RN, 2009, DEV NEUROREHABIL, V12, P92, DOI 10.1080/17518420902783223; Three Star Press, 2005, ASSESSMENT MOTOR PRO; Waehrens Eva Ejlersen, 2007, Scand J Occup Ther, V14, P250, DOI 10.1080/11038120601182974; Zahr NM, 2010, NEUROPSYCHOL REV, V20, P280, DOI 10.1007/s11065-010-9141-y	38	7	8	0	16	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.	NOV	2014	21	6					458	464		10.3109/11038128.2014.922610			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AS6GI	WOS:000344362000007	25135612				2022-02-06	
J	Shannon, RJ; Timofeev, I; Nortje, J; Hutchinson, PJ; Carpenter, KLH				Shannon, Richard J.; Timofeev, Ivan; Nortje, Juergens; Hutchinson, Peter J.; Carpenter, Keri L. H.			Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						brain; human; microdialysis; pharmacokinetics; vigabatrin	GAMMA-VINYL-GABA; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; SEIZURE CONTROL; SERUM CONCENTRATIONS; ANTIEPILEPTIC DRUGS; AMINO-ACIDS; LEVELS RISE; CSF; INITIATION	AimsThe aims were to determine blood-brain barrier penetration and brain extracellular pharmacokinetics for the anticonvulsant vigabatrin (VGB; -vinyl--aminobutyric acid) in brain extracellular fluid and plasma from severe traumatic brain injury (TBI) patients, and to measure the response of -aminobutyric acid (GABA) concentration in brain extracellular fluid. MethodsSevere TBI patients (n = 10) received VGB (0.5g enterally, every 12h). Each patient had a cerebral microdialysis catheter; two patients had a second catheter in a different region of the brain. Plasma samples were collected 0.5h before and 2, 4 and 11.5h after the first VGB dose. Cerebral microdialysis commenced before the first VGB dose and continued through at least three doses of VGB. Controls were seven severe TBI patients with microdialysis, without VGB. ResultsAfter the first VGB dose, the maximum concentration of VGB (C-max) was 31.7(26.9-42.6)mol l(-1) (median and interquartile range for eight patients) in plasma and 2.41(2.03-5.94)mol l(-1) in brain microdialysates (nine patients, 11 catheters), without significant plasma-brain correlation. After three doses, median C-max in microdialysates increased to 5.22(4.24-7.14)mol l(-1) (eight patients, 10 catheters). Microdialysate VGB concentrations were higher close to focal lesions than in distant sites. Microdialysate GABA concentrations increased modestly in some of the patients after VGB administration. ConclusionsVigabatrin, given enterally to severe TBI patients, crosses the blood-brain barrier into the brain extracellular fluid, where it accumulates with multiple dosing. Pharmacokinetics suggest delayed uptake from the blood.	[Shannon, Richard J.; Timofeev, Ivan; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Nortje, Juergens; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Nortje, Juergens] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge CB2 0QQ, England		Shannon, RJ (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167 Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	rjs232@cam.ac.uk	Timofeev, Ivan/AAE-7019-2019	Carpenter, Keri/0000-0001-8236-7727; Timofeev, Ivan/0000-0002-1168-0393; Hutchinson, Peter/0000-0002-2796-1835	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390 ID 65883, G0600986 ID 79068]; Academy of Medical Sciences/Health Foundation; National Institute for Health Research Flexibility and Sustainability Fund; National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); Medical Research Council (Acute Brain Injury Programme Grant)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Codman Inc. grant; Evelyn Trust; MRC RESCUEicp trial grantUK Research & Innovation (UKRI)Medical Research Council UK (MRC); BP-TNK Kapitza Scholarship; British Journal of Anaesthesia/Royal College of Anaesthetists Fellowship; National Institute for Health Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277, G9439390, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G9439390, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013] Funding Source: researchfish	The authors gratefully acknowledge study support from the Medical Research Council (grant numbers G9439390 ID 65883 and G0600986 ID 79068) and the Academy of Medical Sciences/Health Foundation, and support for authors as follows: RJS, National Institute for Health Research Flexibility and Sustainability Fund; KLHC, National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme) and the Medical Research Council (Acute Brain Injury Programme Grant); IT, Codman Inc. grant, The Evelyn Trust grant, MRC RESCUEicp trial grant and BP-TNK Kapitza Scholarship; JN, British Journal of Anaesthesia/Royal College of Anaesthetists Fellowship; and PJH, National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). The authors thank Professors J. D. Pickard and M. Czosnyka for helpful comments with the manuscript. The authors also thank Mr I. Jalloh for assistance with patient demography and evaluation of computed tomography scans, and Ms L. Maskell for technical assistance with microdialysis and patient demography.	BENMENACHEM E, 1989, EPILEPSIA, V30, pS12, DOI 10.1111/j.1528-1157.1989.tb05826.x; BENMENACHEM E, 1989, BRIT J CLIN PHARMACO, V27, pS79, DOI 10.1111/j.1365-2125.1989.tb03466.x; Bouw MR, 2000, PHARMACEUT RES, V17, P1220, DOI 10.1023/A:1026414713509; Carpenter Keri L H, 2012, Acta Neurochir Suppl, V114, P271, DOI 10.1007/978-3-7091-0956-4_53; Crowe A, 2006, J DRUG TARGET, V14, P291, DOI 10.1080/10611860600720814; Dahyot-Fizelier C, 2013, ANTIMICROB AGENTS CH, V57, P2738, DOI 10.1128/AAC.02570-12; Dahyot-Fizelier C, 2010, ANTIMICROB AGENTS CH, V54, P3502, DOI 10.1128/AAC.01725-09; de Lange ECM, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-12; Duffull SB, 2011, BRIT J CLIN PHARMACO, V71, P807, DOI 10.1111/j.1365-2125.2010.03891.x; DURHAM SL, 1993, DRUG METAB DISPOS, V21, P480; Gratzfeld-Huesgen A, 1999, AGILENT TECHNOLOGIES; HAEGELE KD, 1986, CLIN PHARMACOL THER, V40, P581, DOI 10.1038/clpt.1986.227; HALONEN T, 1988, EPILEPSY RES, V2, P246, DOI 10.1016/0920-1211(88)90015-0; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; HOKE JF, 1993, J CLIN PHARMACOL, V33, P458, DOI 10.1002/j.1552-4604.1993.tb04688.x; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Knibbe CAJ, 2011, INT J PHARMACEUT, V415, P9, DOI 10.1016/j.ijpharm.2011.02.056; Lindberger M, 2003, THER DRUG MONIT, V25, P457, DOI 10.1097/00007691-200308000-00007; LIPPERT B, 1977, EUR J BIOCHEM, V74, P441, DOI 10.1111/j.1432-1033.1977.tb11410.x; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MENACHEM EB, 1988, EPILEPSY RES, V2, P96, DOI 10.1016/0920-1211(88)90025-3; PALFREYMAN MG, 1981, BIOCHEM PHARMACOL, V30, P817, DOI 10.1016/S0006-2952(81)80001-9; Petroff OAC, 1996, NEUROLOGY, V46, P1459, DOI 10.1212/WNL.46.5.1459; Petroff OAC, 1998, MOL NEUROBIOL, V16, P97, DOI 10.1007/BF02740605; Petroff OAC, 1996, NEUROLOGY, V47, P1567, DOI 10.1212/WNL.47.6.1567; Petroff OAC, 1996, J NEUROCHEM, V67, P2399; PITKANEN A, 1988, J NEUROL NEUROSUR PS, V51, P1395, DOI 10.1136/jnnp.51.11.1395; PITKANEN A, 1988, J NEUROL SCI, V88, P83, DOI 10.1016/0022-510X(88)90207-9; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; REY E, 1990, BRIT J CLIN PHARMACO, V30, P253, DOI 10.1111/j.1365-2125.1990.tb03772.x; REY E, 1992, CLIN PHARMACOKINET, V23, P267, DOI 10.2165/00003088-199223040-00003; RIEKKINEN PJ, 1989, BRIT J CLIN PHARMACO, V27, pS87, DOI 10.1111/j.1365-2125.1989.tb03467.x; Saransaari P, 1998, NEUROCHEM RES, V23, P563, DOI 10.1023/A:1022494921018; Schaeftlein A, 2014, EUR J PHARM SCI, V57, P68, DOI 10.1016/j.ejps.2013.11.004; SCHECHTER PJ, 1989, BRIT J CLIN PHARMACO, V27, pS19, DOI 10.1111/j.1365-2125.1989.tb03456.x; SCHECHTER PJ, 1984, NEUROLOGY, V34, P182, DOI 10.1212/WNL.34.2.182; SCHOUSBOE A, 1986, NEUROCHEM RES, V11, P1497, DOI 10.1007/BF00965769; Shannon RJ, 2013, J PHARMACOKINET PHAR, V40, P343, DOI 10.1007/s10928-013-9306-4; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tong X, 2009, EPILEPSIA, V50, P174, DOI 10.1111/j.1528-1167.2008.01863.x; Weiss J, 2003, J PHARMACOL EXP THER, V307, P262, DOI 10.1124/jpet.103.054197; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; Zhuang YL, 2006, CANCER RES, V66, P11305, DOI 10.1158/0008-5472.CAN-06-0929	46	7	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	NOV	2014	78	5					981	995		10.1111/bcp.12414			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AS4CY	WOS:000344222100006	24802902	Green Published, hybrid			2022-02-06	
J	Lasry, O; Marcoux, J				Lasry, Oliver; Marcoux, Judith			The use of intravenous Milrinone to treat cerebral vasospasm following traumatic subarachnoid hemorrhage	SPRINGERPLUS			English	Article						Traumatic brain injury; Subarachnoid hemorrhage; Vasospasm; Milrinone; Post-traumatic vasospasm	HEAD-INJURY; ARTERIES; COMA	Introduction: Traumatic subarachnoid hemorrhage (SAH) is a common intracranial lesion after traumatic brain injury (TBI). As in aneurysmal SAH, cerebral vasospasm is a common cause of secondary brain injury and is associated with the thickness of traumatic SAH. Unfortunately, there is limited literature on an effective treatment of this entity. The vasodilatory and inotropic agent, Milrinone, has been shown to be effective in treating vasospasm following aneurysmal SAH. The authors hypothesized that this agent could be useful and safe in treating vasospasm following tSAH. Case descriptions: Case reports of 2 TBI cases from a level 1 trauma centre with tSAH and whom developed delayed ischemic neurological deficits (DINDs) are presented. Intravenous Milrinone treatment was provided to each patient following the "Montreal Neurological Hospital Protocol". Discussion and evaluation: Both patients had an improvement in their DINDs following the treatment protocol. There were no complications of treatment and the Glasgow Outcome Scores of the patients ranged from 4 to 5. Conclusion: This is the first report of the use of intravenous Milrinone to treat cerebral vasospasm following traumatic SAH. This treatment option appeared to be safe and potentially useful at treating post-traumatic vasospasm. Prospective studies are necessary to establish Milrinone's clinical effectiveness in treating this type of cerebral vasospasm.	[Lasry, Oliver; Marcoux, Judith] McGill Univ, Dept Neurol & Neurosurg, Ctr Hlth, Montreal, PQ H3G 1A4, Canada		Marcoux, J (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Ctr Hlth, 1650 Cedar Ave,Room L7-516, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca					Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hayashida N, 1999, ANN THORAC SURG, V68, P1661, DOI 10.1016/S0003-4975(99)00716-X; JENNETT B, 1975, LANCET, V1, P480; KAKARIEKA A, 1995, CEREBROVASC DIS, V5, P403, DOI 10.1159/000107892; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Langham J, 2003, COCHRANE DB SYST REV; Lannes M, 2012, NEUROCRIT CARE, V16, P354, DOI 10.1007/s12028-012-9701-5; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lin TK, 2012, J TRAUMA ACUTE CARE, V73, P131, DOI 10.1097/TA.0b013e31824aff74; Newell D W, 1992, Clin Neurosurg, V39, P348; Nishuchi M, 2010, NEUROSURGERY, V66, P158, DOI 10.1227/01.NEU.0000363153.62579.FF; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TEASDALE G, 1974, LANCET, V2, P81; VARDIMAN AB, 1995, AM J NEURORADIOL, V16, P319; Vroom MB, 1996, BRIT J ANAESTH, V76, P122, DOI 10.1093/bja/76.1.122; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; Zubkov ZY, 2000, SURG NEUROL, V53, P126; Zurynski YA, 1998, J CLIN NEUROSCI, V5, P146, DOI 10.1016/S0967-5868(98)90028-5	25	7	10	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	OCT 27	2014	3								633	10.1186/2193-1801-3-633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4ED	WOS:000359112600001	25392803	gold, Green Published			2022-02-06	
J	Ji, XR; Zhang, W; Zhang, LH; Zhang, LC; Zhang, YL; Tang, PF				Ji, Xinran; Zhang, Wei; Zhang, Lihai; Zhang, Licheng; Zhang, Yiling; Tang, Peifu			Inhibition of p21-activated kinase 1 by IPA-3 attenuates secondary injury after traumatic brain injury in mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; PAK1; IPA-3; Brain edema; BBB disruption; Neurological functions	FACTOR-KAPPA-B; CEREBRAL-ARTERY OCCLUSION; ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; GENE-EXPRESSION; NADPH OXIDASE; PAK1; RATS; MODEL; MATRIX-METALLOPROTEINASE-9	The p21-activated kinase 1 (PAK1) is up-regulated in the brain following traumatic brain injury (TBI). Inhibition of PAK1 has been found to alleviate brain edema in a rat model of subarachnoid hemorrhage. Suppressing PAK1 activity might represent a novel therapeutics of attenuating secondary injury following TBI. Here we confirmed that the mRNA and protein levels of PAK1 and the protein level of p-PAK1 were significantly increased after inducing TBI in mice via M.A. Flierl's weight-drop model. A single intraperitoneal administration of IPA-3, a specific PAK1 inhibitor, immediately after TBI significantly reduced the protein level of p-PAK1, cleaved caspase-3 level, the number of apoptotic cells at the lesion sites of TBI mice. It also reduced brain water content and the blood-brain barrier permeability in TBI mice. Furthermore, the administration of IPA-3 significantly reduced the neurological severity score and increased the grip test score in TBI mice. Taken together, we demonstrate that PAK1 inhibition by IPA-3 may attenuate the secondary injury following TBI, suggesting it might be a promising neuroprotective strategy for preventing the development of secondary injury after TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Ji, Xinran; Zhang, Wei; Zhang, Lihai; Zhang, Licheng; Zhang, Yiling; Tang, Peifu] Peoples Liberat Army, Gen Hosp, Hosp 301, Beijing 100000, Peoples R China		Tang, PF (corresponding author), Peoples Liberat Army, Gen Hosp, Hosp 301, 28 Faxing Rd, Beijing 100000, Peoples R China.	ortho301@163.com		Tang, Peifu/0000-0003-4279-1704			Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arien-Zakay H., 2014, J NEUROTRAUMA; Arsenault D, 2013, J NEUROSCI, V33, P10729, DOI 10.1523/JNEUROSCI.1501-13.2013; Badolia R., 2014, PLATELETS; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; CORNELIUS C, 2013, ANTIOXID REDOX SIGNA; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Foryst-Ludwig A, 2000, J BIOL CHEM, V275, P39779, DOI 10.1074/jbc.M007617200; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Hayashi K, 2007, DEV NEUROBIOL, V67, P655, DOI 10.1002/dneu.20363; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Jang JW, 2014, J NEUROL SCI, V339, P75, DOI 10.1016/j.jns.2014.01.024; Karki P., 2014, MOL CELL ENDOCRINOL; Kuzelova K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092560; Leeds PR, 2014, ACS CHEM NEUROSCI; Li YJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-80; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Mitsios N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-93; Nassar NN, 2012, NEUROCHEM RES, V37, P614, DOI 10.1007/s11064-011-0651-7; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; Nikolic M, 2008, MOL NEUROBIOL, V37, P187, DOI 10.1007/s12035-008-8032-1; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roepstorff K, 2008, J BIOL CHEM, V283, P7983, DOI 10.1074/jbc.M708281200; Singhal R, 2012, ONCOTARGET, V3, P700, DOI 10.18632/oncotarget.587; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Wang J, 2012, METAB BRAIN DIS, V27, P159, DOI 10.1007/s11011-012-9282-1; Wong LLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068843; Yan J., 2013, STROKE; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290; You WC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/786242; Zegers M, 2008, INT REV CEL MOL BIO, V267, P253, DOI 10.1016/S1937-6448(08)00606-0; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhang T, 2012, CARDIOVASC RES, V93, P471, DOI 10.1093/cvr/cvr346; Zheng M., 2014, J MOL NEUROSCI; Zhou L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-15	46	7	7	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 17	2014	1585						13	22		10.1016/j.brainres.2014.08.026			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR8QS	WOS:000343840300002	25148711				2022-02-06	
J	Wei, M; Li, H; Shang, YG; Zhou, ZW; Zhang, JN				Wei, Ming; Li, Hong; Shang, Yanguo; Zhou, Ziwei; Zhang, Jianning			Increased CD147 (EMMPRIN) expression in the rat brain following traumatic brain injury	BRAIN RESEARCH			English	Article						CD147; MMP-9; Immunocytochemistry; Rat; Traumatic brain injury	MATRIX METALLOPROTEINASE INDUCER; FOCAL CEREBRAL-ISCHEMIA; IMMUNOGLOBULIN SUPERFAMILY; NEUTROPHIL ACCUMULATION; EPITHELIAL-CELLS; UP-REGULATION; BLOOD; BARRIER; INDUCTION; MATRIX-METALLOPROTEINASE-9	The extracellular matrix metalloproteinase inducer (EMMPRIN), or CD147, has been known to play a key regulatory role in vascular permeability and leukocyte activation by inducing the expression of matrix metalloproteinases (MMPs). The effects of traumatic brain injury on the expression of EMMPRIN remain poorly understood. In this study, we investigated changes in EMMPRIN expression in a rat model of fluid percussion injury (FPI) and examined the potential association between EMMPRIN and MMP-9 expression. Adult male rats were subjected to FPI. EMMPRIN expression was markedly up-regulated in the brain tissue surrounding the injured region 6-48 h after TBI, as measured by immunoblot and immunohistochemistry. EMMPRIN expression was localized to inflammatory cells. The increase in EMMPRIN expression was temporally correlated with an increase in MMP-9 levels. These data demonstrate, for the first time, changes in CD147 and MMP-9 expression following TBI. These data also suggest that CD147 and MMP-9 may play a role in vascular injuries after TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Wei, Ming; Li, Hong] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Tianjin 300211, Peoples R China; [Wei, Ming; Shang, Yanguo] Tianjin Huanhu Hosp, Tianjin 300060, Peoples R China; [Zhou, Ziwei; Zhang, Jianning] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Tianjin 300052, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@yeah.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772229]; Science Foundation of Tianjin Bureau of Public Health [2011KZ96]	This study was supported by the National Natural Science Foundation of China (grant number 30772229) and the Science Foundation of Tianjin Bureau of Public Health, (2011KZ96). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; Burggraf D, 2005, EUR J NEUROSCI, V22, P273, DOI 10.1111/j.1460-9568.2005.04187.x; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DeCastro R, 1996, J INVEST DERMATOL, V106, P1260, DOI 10.1111/1523-1747.ep12348959; Fan QW, 1998, NEUROSCI RES, V30, P53, DOI 10.1016/S0168-0102(97)00119-3; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Huet E, 2008, CONNECT TISSUE RES, V49, P175, DOI 10.1080/03008200802151722; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Jouneau S, 2011, RESPIROLOGY, V16, P705, DOI 10.1111/j.1440-1843.2011.01960.x; Kato N, 2009, J AM SOC NEPHROL, V20, P1565, DOI 10.1681/ASN.2008090957; Koga K, 2011, INT J ONCOL, V39, P657, DOI 10.3892/ijo.2011.1060; Lee Jee Youn, 2010, Exp Neurobiol, V19, P146, DOI 10.5607/en.2010.19.3.146; Marmorstein AD, 1998, J CELL BIOL, V142, P697, DOI 10.1083/jcb.142.3.697; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mattila OS, 2011, STROKE, V42, P3600, DOI 10.1161/STROKEAHA.111.632224; Menashi S, 2003, CANCER RES, V63, P7575; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nahalkova J, 2010, NEUROCHEM INT, V56, P67, DOI 10.1016/j.neuint.2009.09.003; Noguchi Y, 2003, J CLIN ENDOCR METAB, V88, P6063, DOI 10.1210/jc.2003-030457; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Seizer P, 2011, ARTERIOSCL THROM VAS, V31, P1377, DOI 10.1161/ATVBAHA.111.225771; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Tang Y, 2004, MOL CANCER RES, V2, P73; Wei M, 2012, J KOREAN MED SCI, V27, P291, DOI 10.3346/jkms.2012.27.3.291; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhu W, 2008, NEUROCHEM INT, V52, P1086, DOI 10.1016/j.neuint.2007.11.005	38	7	9	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 17	2014	1585						150	158		10.1016/j.brainres.2014.06.018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR8QS	WOS:000343840300015	24968091				2022-02-06	
J	McGuire, BE; Morrison, TG; Barker, LA; Morton, N; McBrinn, J; Caldwell, S; Wilson, CF; McCann, J; Carton, S; Delargy, M; Walsh, J				McGuire, Brian E.; Morrison, Todd G.; Barker, Lynne A.; Morton, Nicholas; McBrinn, Judith; Caldwell, Sheena; Wilson, Colin F.; McCann, John; Carton, Simone; Delargy, Mark; Walsh, Jane			Impaired self-awareness after traumatic brain injury: inter-rater reliability and factor structure of the Dysexecutive Questionnaire (DEX) in patients, significant others and clinicians	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						brain injury; dysexecutive; reliability; factor analysis; care giver	EXECUTIVE FUNCTIONS; IMPLICIT; DEFICITS; SAMPLE	Aims: This study sought to address two questions: (1) what is the inter-rater reliability of the Dysexecutive Questionnaire (DEX) when completed by patients, their significant others, and clinicians; and (2) does the factor structure of the DEX vary for these three groups? Methods: We obtained DEX ratings for 113 patients with an acquired brain injury from two brain injury services in the UK and two services in Ireland. We gathered data from two groups of raters "significant others" (DEX-SO) such as partners and close family members and "clinicians" (DEX-C), who were psychologists or rehabilitation physicians working closely with the patient and who were able to provide an opinion about the patient's level of everyday executive functioning. Intra-class correlation coefficients and their 95% confidence intervals were calculated between each of the three groups (self, significant other, clinician). Principal axis factor (PAF) analyses were also conducted for each of the three groups. Results: The factor analysis revealed a consistent one factor model for each of the three groups of raters. However, the inter-rater reliability analyses showed a low level of agreement between the self-ratings and the ratings of the two groups of independent raters. We also found low agreement between the significant others and the clinicians. Conclusion: Although there was a consistent finding of a single factor solution for each of the three groups, the low level of agreement between significant others and clinicians raises a question about the reliability of the DEX.	[McGuire, Brian E.; McBrinn, Judith; Walsh, Jane] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland; [Morrison, Todd G.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 0W0, Canada; [Barker, Lynne A.] Sheffield Hallam Univ, Dept Psychol, Sheffield S1 1WB, S Yorkshire, England; [Morton, Nicholas] Doncaster Rotherham & South Humber NHS Fdn Trust, Neurorehabil Serv, Doncaster, England; [Caldwell, Sheena; Wilson, Colin F.; McCann, John] Musgrave Pk Hosp, Reg Acquired Brain Injury Unit, Belfast, Antrim, North Ireland; [Carton, Simone; Delargy, Mark] Natl Rehabil Hosp, Dublin, Ireland		McGuire, BE (corresponding author), Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland.	Brian.mcguire@nuigalway.ie	Walsh, Jane/AAP-6870-2021	Walsh, Jane/0000-0001-5476-1348; Morrison, Todd/0000-0001-8033-3822			Amieva H, 2003, BRAIN COGNITION, V53, P129, DOI 10.1016/S0278-2626(03)00094-0; Bachmann LM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-50; Barker LA, 2010, NEUROPSYCHOLOGIA, V48, P2550, DOI 10.1016/j.neuropsychologia.2010.05.001; Barker LA, 2004, NEUROCASE, V10, P233, DOI 10.1080/13554790490495096; Barker LA, 2011, BRAIN INJURY, V25, P997, DOI 10.3109/02699052.2011.597046; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Caldwell S., 2014, IRISH J PSYCHOL, V35, P53, DOI [https://doi.org/10.1080/03033910.2014.921228, DOI 10.1080/03033910.2014.921228]; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; Costello A. B., 2005, PRACT ASSESS RES EVA, V10, P1, DOI DOI 10.7275/JYJ1-4868; Finch JF, 1997, J RES PERS, V31, P439, DOI 10.1006/jrpe.1997.2194; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hogan M, 2013, BRAIN INJURY, V27, P273, DOI 10.3109/02699052.2012.743177; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mooney B, 2006, APPL NEUROPSYCHOL, V13, P12, DOI 10.1207/s15324826an1301_2; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Philippi CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038413; Raspelli S., 2014, VALIDATING NEURO VR; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Wilson BA., 1997, BEHAV ASSESSMENT DYS; Winkens I, 2014, J HEAD TRAUMA REHAB, V29, P153, DOI 10.1097/HTR.0b013e31827d1500	28	7	8	5	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	OCT 10	2014	8								352	10.3389/fnbeh.2014.00352			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	AW0LS	WOS:000345984500001	25346668	Green Accepted, Green Published, gold			2022-02-06	
J	Alaeddini, A; Yang, K; Mao, HJ; Murat, A; Ankenman, B				Alaeddini, Adel; Yang, Kai; Mao, Haojie; Murat, Alper; Ankenman, Bruce			An Adaptive Sequential Experimentation Methodology for Expensive Response Surface Optimization - Case Study in Traumatic Brain Injury Modeling	QUALITY AND RELIABILITY ENGINEERING INTERNATIONAL			English	Article						adaptive sequential response surface optimization; simplex optimization; risk adjustment; fractional factorial design; central composite design (CCD)	AT-A-TIME; GLOBAL OPTIMIZATION; STEEPEST ASCENT; DESIGN; APPROXIMATION; ALGORITHM	The preset response surface designs often lack the ability to adapt the design based on the characteristics of application and experimental space so as to reduce the number of experiments necessary. Hence, they are not cost effective for applications where the cost of experimentation is high or when the experimentation resources are limited. In this paper, we present an adaptive sequential methodology for n-dimensional response surface optimization (n-dimensional adaptive sequential response surface methodology (N-ASRSM)) for industrial experiments with high experimentation cost, which requires high design optimization performance. We also develop a novel risk adjustment strategy for effectively considering the effect of noise into the design. The N-ASRSM is a sequential adaptive experimentation approach, which uses the information from previous experiments to design the subsequent experiment by simultaneously reducing the region of interest and identifying factor combinations for new experiments. Its major advantage is the experimentation efficiency such that, for a given response target, it identifies the input factor combination in less number of experiments than the classical response surface methodology designs. We applied N-ASRSM to the problem of traumatic brain injury modeling and compared the result with the conventional central composite design. Also, through extensive simulated experiments with different quadratic and nonlinear cases, we show that the proposed N-ASRSM method outperforms the classical response surface methodology designs and compares favorably with other sequential response surface methodologies in the literature in terms of both design optimality and experimentation efficiency. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Alaeddini, Adel] Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78230 USA; [Yang, Kai; Murat, Alper] Wayne State Univ, Dept Ind & Syst Engn, Detroit, MI 48202 USA; [Mao, Haojie] Wayne State Univ, Ctr Bioengn, Detroit, MI 48202 USA; [Ankenman, Bruce] Northwestern Univ, Dept Ind Engn & Management Sci, Evanston, IL 60208 USA		Alaeddini, A (corresponding author), Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78230 USA.	adel.alaeddini@utsa.edu	Mao, Haojie/Q-7514-2018; Ankenman, Bruce E/B-7453-2009	Mao, Haojie/0000-0002-7563-9234; 			Alaeddini A, 2013, QUAL RELIAB ENG INT, V29, P241, DOI 10.1002/qre.1306; Alaeddinis A, 2013, QUALITY REL IN PRESS; Alexandrov NM, 1998, STRUCT OPTIMIZATION, V15, P16, DOI 10.1007/BF01197433; AndereRendon J, 1997, J QUAL TECHNOL, V29, P451, DOI 10.1080/00224065.1997.11979796; Anderson BS, 2000, P 17 INT C MACH LEAR; BAZARAA MS, 1982, EUR J OPER RES, V11, P158, DOI 10.1016/0377-2217(82)90110-2; Box GEP, 1999, J QUAL TECHNOL, V31, P16; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; BOX GEP, 1957, ROY STAT SOC C-APP, V6, P81; Box GEP., 1960, TECHNOMETRICS, V2, P455, DOI [10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Boxs GEP, 2005, STAT EXPT DESIGN INN; Boxs GEP, 1969, EVOLUTIONARY OPERATI; Changs KH, 2012, INFORMS J C IN PRESS; Chen VCP, 2006, IIE TRANS, V38, P273, DOI 10.1080/07408170500232495; Czitrom V, 1999, AM STAT, V53, P126, DOI 10.2307/2685731; DRAPER NR, 1985, TECHNOMETRICS, V27, P173, DOI 10.2307/1268765; DUTTA SRK, 1977, MATH PROGRAM, V13, P140, DOI 10.1007/BF01584333; Fauls M, 2010, TRAUMATIC BRAIN INJU; Frey DD, 2006, J MECH DESIGN, V128, P1050, DOI 10.1115/1.2216733; Frey DD, 2006, TECHNOMETRICS, V48, P418, DOI 10.1198/004017006000000075; Frey DD, 2003, RES ENG DES, V14, P65, DOI 10.1007/s00163-002-0026-9; Friedmans M, 1947, SELECTED TECHNIQUES, P363; Ganos SE, 2004, 10 AIAA ISSMO MULT A; Gutmann HM, 2001, J GLOBAL OPTIM, V19, P201, DOI 10.1023/A:1011255519438; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Jones DR, 2001, J GLOBAL OPTIM, V21, P345, DOI 10.1023/A:1012771025575; Joshi S, 1998, COMPUT OPER RES, V25, P531, DOI 10.1016/S0305-0548(98)00014-8; KIEFER J, 1959, ANN MATH STAT, V30, P271, DOI 10.1214/aoms/1177706252; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; Kiefers J, 1961, 2 ANN MATH STAT, V32, P298; Kleijnen JPC, 2008, J SIMUL, V2, P19, DOI 10.1057/palgrave.jos.4250032; Kleijnen JPC, 2010, EUR J OPER RES, V202, P164, DOI 10.1016/j.ejor.2009.05.002; Kleijnen JPC, 2006, EUR J OPER RES, V170, P664, DOI 10.1016/j.ejor.2004.10.024; Kleijnen JPC, 2004, EUR J OPER RES, V159, P121, DOI 10.1016/S0377-2217(03)00414-4; Lemarechal C., 1989, HDB OPERATIONS RES M, P529, DOI DOI 10.1016/S0927-0507(89)01008-X; MADSEN K, 1978, MATH PROGRAM, V14, P208, DOI 10.1007/BF01588966; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Montgomerys DC, 2008, DESIGN ANAL EXPT; MOORE A, 1998, P 15 INT C MACH LEAR, P386; Myers RH, 1999, J QUAL TECHNOL, V31, P30; Myers RH, 2004, J QUAL TECHNOL, V36, P53, DOI 10.1080/00224065.2004.11980252; MYERS RH, 1989, TECHNOMETRICS, V31, P137, DOI 10.2307/1268813; Myerss RH, 1995, RESPONSE SURFACE MET; RENAUD JE, 1994, AIAA J, V32, P198, DOI 10.2514/3.11967; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rodriguez JF, 1998, STRUCT OPTIMIZATION, V15, P141, DOI 10.1007/BF01203525; Rodriguez JF, 2001, STRUCT MULTIDISCIP O, V22, P24, DOI 10.1007/s001580100122; Sanchez S. M., 2005, ACM Transactions on Modeling and Computer Simulation, V15, P362, DOI 10.1145/1113316.1113320; Sebers GAF, 2003, LINEAR REGRESSION AN; Simpson TW, 2004, STRUCT MULTIDISCIP O, V27, P302, DOI 10.1007/s00158-004-0389-9; Sobieszczanski-Sobieski J., 1988, 2 NASA AIR FORC S RE; SobieszczanskiSobieski J, 1997, STRUCT OPTIMIZATION, V14, P1, DOI 10.1007/BF01197554; SPENDLEY W, 1962, TECHNOMETRICS, V4, P441, DOI 10.2307/1266283; Standlers N, 2001, P 1 MIT C COMP FLUID; Tans PN, 2006, INTRO DATAMINING; Varian H., 2005, Mathematica Journal, V9, P768; VINCENT TL, 1992, J OPTIMIZ THEORY APP, V75, P501, DOI 10.1007/BF00940489; Walterss FS, 1991, SEQUENTIAL SIMPLEX O; Wang GG, 2003, J MECH DESIGN, V125, P210, DOI 10.1115/1.1561044; Wang GG, 2001, ENG OPTIMIZ, V33, P707, DOI 10.1080/03052150108940940	62	7	7	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0748-8017	1099-1638		QUAL RELIAB ENG INT	Qual. Reliab. Eng. Int.	OCT	2014	30	6			SI		767	793		10.1002/qre.1523			27	Engineering, Multidisciplinary; Engineering, Industrial; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Operations Research & Management Science	AQ1YF	WOS:000342580100001					2022-02-06	
J	Friese, RS; Wynne, J; Joseph, B; Hashmi, A; Diven, C; Pandit, V; O'Keeffe, T; Zangbar, B; Kulvatunyou, N; Rhee, P				Friese, R. S.; Wynne, J.; Joseph, B.; Hashmi, A.; Diven, C.; Pandit, V.; O'Keeffe, T.; Zangbar, B.; Kulvatunyou, N.; Rhee, P.			Age and mortality after injury: is the association linear?	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Geriatric trauma; Outcome is elderly trauma patients; Old age and mortality; Intensive care unit admission and old age	GERIATRIC TRAUMA PATIENTS; ELDERLY TRAUMA; FRAILTY; MANAGEMENT; OUTCOMES; SEVERITY; PATTERNS; SURVIVAL; DISEASE; OLD	Multiple studies have demonstrated a linear association between advancing age and mortality after injury. An inflection point, or an age at which outcomes begin to differ, has not been previously described. We hypothesized that the relationship between age and mortality after injury is non-linear and an inflection point exists. We performed a retrospective cohort analysis at our urban level I center from 2007 through 2009. All patients aged 65 years and older with the admission diagnosis of injury were included. Non-parametric logistic regression was used to identify the functional form between mortality and age. Multivariate logistic regression was utilized to explore the association between age and mortality. Age 65 years was used as the reference. Significance was defined as p < 0.05. A total of 1,107 patients were included in the analysis. One-third required intensive care unit (ICU) admission and 48 % had traumatic brain injury. 229 patients (20.6 %) were 84 years of age or older. The overall mortality was 7.2 %. Our model indicates that mortality is a quadratic function of age. After controlling for confounders, age is associated with mortality with a regression coefficient of 1.08 for the linear term (p = 0.02) and a regression coefficient of -0.006 for the quadratic term (p = 0.03). The model identified 84.4 years of age as the inflection point at which mortality rates begin to decline. The risk of death after injury varies linearly with age until 84 years. After 84 years of age, the mortality rates decline. These findings may reflect the varying severity of comorbidities and differences in baseline functional status in elderly trauma patients. Specifically, a proportion of our injured patient population less than 84 years old may be more frail, contributing to increased mortality after trauma, whereas a larger proportion of our injured patients over 84 years old, by virtue of reaching this advanced age, may, in fact, be less frail, contributing to less risk of death.	[Friese, R. S.; Wynne, J.; Joseph, B.; Hashmi, A.; Diven, C.; Pandit, V.; O'Keeffe, T.; Zangbar, B.; Kulvatunyou, N.; Rhee, P.] Univ Arizona, Coll Med, Div Trauma Crit Care Burn & Emergency Surg, Dept Surg, Tucson, AZ 85727 USA		Joseph, B (corresponding author), Univ Arizona, Coll Med, Div Trauma Crit Care Burn & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Zangbar, Bardiya/K-7147-2014	Zangbar, Bardiya/0000-0003-1215-1693			Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Andela RM, 2010, INT J NURS PRACT, V16, P14, DOI 10.1111/j.1440-172X.2009.01807.x; Arhinful E, 2011, J TRAUMA, V70, P616, DOI 10.1097/TA.0b013e31820d19ed; Bochicchio GV, 2006, WORLD J SURG, V30, P114, DOI 10.1007/s00268-005-0203-x; BROOS PLO, 1988, INT SURG, V73, P119; Caterino JM, 2010, AM J EMERG MED, V28, P151, DOI 10.1016/j.ajem.2008.10.027; Centers for Disease Control and Prevention (CDC), 2010, CAUS DEATH AG GROUP; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Department of Health & Human Services, 2011, ADM AG AG STAT; Fleischman RJ, 2010, J AM GERIATR SOC, V58, P1843, DOI 10.1111/j.1532-5415.2010.03065.x; Friese RS, 2006, CRIT CARE MED, V34, P1597, DOI 10.1097/01.CCM.0000217918.03343.AA; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Grossman M, 2003, J TRAUMA, V55, P26, DOI 10.1097/01.TA.0000072109.52351.0D; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76; Hastie T. J., 1990, GEN ADDITIVE MODELS; Holcomb JB, 2003, J AM COLL SURGEONS, V196, P549, DOI 10.1016/S1072-7515(02)01894-X; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Joseph B, 2014, J TRAUMA ACUTE CARE; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P196, DOI 10.1097/TA.0b013e3182a833ac; Joseph B, 2013, J SURG RES, V184, P541, DOI 10.1016/j.jss.2013.03.069; MACKENZIE EJ, 1989, J TRAUMA, V29, P757, DOI 10.1097/00005373-198906000-00011; Martin JT, 2010, AM SURGEON, V76, P65; Maxwell JG, 1998, AM SURGEON, V64, P826; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; Robinson TN, 2011, J AM COLL SURGEONS, V213, P37, DOI 10.1016/j.jamcollsurg.2011.01.056; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001	35	7	7	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2014	40	5					567	572		10.1007/s00068-014-0380-0			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AR9SL	WOS:000343916100009	26814513				2022-02-06	
J	Harrop, JS; Ghobrial, GM; Chitale, R; Krespan, K; Odorizzi, L; Fried, T; Maltenfort, M; Cohen, M; Vaccaro, A				Harrop, James S.; Ghobrial, George M.; Chitale, Rohan; Krespan, Kelly; Odorizzi, Laura; Fried, Tristan; Maltenfort, Mitchell; Cohen, Murray; Vaccaro, Alexander			Evaluating initial spine trauma response: Injury time to trauma center in PA, USA	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cranial; Epidemiology; Neurologic; SCI; Transportation; Trauma; Triage	CORD-INJURY; DIRECT TRANSPORT; BRAIN-INJURY; MANAGEMENT; MORTALITY; DECOMPRESSION; SYSTEM; IMPACT	Historical perceptions regarding the severity of traumatic spinal cord injury has led to considerable disparity in triage to tertiary care centers. This article retrospectively reviews a large regional trauma database to analyze whether the diagnosis of spinal trauma affected patient transfer timing and patterns. The Pennsylvania Trauma database was retrospectively reviewed. All acute trauma patient entries for level I and II centers were categorized for diagnosis, mechanism, and location of injury, analyzing transportation modality and its influence on time of arrival. A total of 1162 trauma patients were identified (1014 blunt injuries, 135 penetrating injuries and 12 other) with a mean transport time of 3.9 hours and a majority of patients arriving within 7 hours (>75%). Spine trauma patients had the longest mean arrival time (5.2 hours) compared to blunt trauma (4.2 hours), cranial neurologic injuries (4.35 hours), and penetrating injuries (2.13 hours, p < 0.0001). There was a statistically significant correlation between earlier arrivals and both cranial trauma (p = 0.0085) and penetrating trauma (p < 0.0001). The fastest modality was a fire rescue (0.93 hours) or police (0.63 hours) vehicle with Philadelphia County (1.1 hour) having the quickest arrival times. Most trauma patients arrived to a specialty center within 7 hours of injury. However subsets analysis revealed that spine trauma patients had the greatest transit times. Present research trials for spinal cord injuries suggest earlier intervention may lead to improved recovery. Therefore, it is important to focus on improvement of the transportation triage system for traumatic spinal patients. (C) 2014 Elsevier Ltd. All rights reserved.	[Harrop, James S.] Thomas Jefferson Univ Hosp, Dept Neurol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ Hosp, Dept Orthoped Surg, Philadelphia, PA 19107 USA		Harrop, JS (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurol, 909 Walnut St, Philadelphia, PA 19107 USA.	james.harrop@jefferson.edu			DePuy; Medtronics; Stryker Spine; Biomet Spine; Globus; Aesculap; Nuvasive; Cerapedics	Dr. Alex Vaccaro has Stock/Stock Option Ownership Interests in Spine Medica; Computational Biodynamics; Progressive Spinal Technologies; Spinology; Small Bone Innovations; NeuCore; Cross Current; Syndicom; In Vivo; Flagship Surgical; Advanced Spinal Intellectual Properties; Cytonics; Bonovo Orthopaedics; Electrocore; Gamma Spine; Location Based Intelligence; FlowPharma; R.S.I.; Replication Medica; Globus; K-2 Medical; Paradigm Spine; Stout Medical; Innovative Surgical Design; Spinicity; Rothman Institute and Related Properties. Dr Vaccaro also has receives royalty payments from DePuy; Medtronics; Stryker Spine; Biomet Spine; Globus; Aesculap; Nuvasive. He is involved with consulting/independent contracting for Gerson Lehrman Group; Guidepoint Global; Medacorp; Stout Medical; Innovative Surgical Design. He serves on scientific advisory board/board of directors/ committees including AO Spine; Innovative Surgical Design; Association of Collaborative Spine Research; Spinicity. He has an Institutional/Educational Grant from Stryker Spine; Nuvasive; Cerapedics.	Aguero-Valverde J, 2006, ACCIDENT ANAL PREV, V38, P618, DOI 10.1016/j.aap.2005.12.006; [Anonymous], J TRAUMA; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Cadotte David W, 2010, F1000 Med Rep, V2, P67, DOI 10.3410/M2-67; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2010, SPINE, V35, pS159, DOI 10.1097/BRS.0b013e3181f330f4; Furlan JC, 2013, J NEUROTRAUM, V30, P487, DOI 10.1089/neu.2012.2539; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; GERVIN AS, 1982, J TRAUMA, V22, P443, DOI 10.1097/00005373-198206000-00001; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Kelly DF, 2001, WORLD J SURG, V25, P1179; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; Petri R W, 1995, Prehosp Disaster Med, V10, P24; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Schiller MD, 2012, J CLIN NEUROSCI, V19, P1348, DOI 10.1016/j.jocn.2012.03.002; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; Sonmez E, 2013, SPINE, V38, P1253, DOI 10.1097/BRS.0b013e3182895587; Tariq UM, 2011, INTERACT CARDIOV TH, V12, P24, DOI 10.1510/icvts.2010.242750; van Middendorp JJ, 2012, SPINE J, V12, P540, DOI 10.1016/j.spinee.2012.06.007; Wilberger J CR, 2014, WHITE PAPER NEEDS AS, P1; Wilson J.R., 2013, WORLD NEUROSURG	24	7	7	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2014	21	10					1725	1729		10.1016/j.jocn.2014.03.011			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ0ML	WOS:000342477300013	24932590	Green Submitted			2022-02-06	
J	Korbakis, G; Bleck, T				Korbakis, Georgia; Bleck, Thomas			The Evolution of Neurocritical Care	CRITICAL CARE CLINICS			English	Article						Neurocritical care; Critical care; Neurology; Head trauma; Intracranial pressure	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; ARTIFICIAL-RESPIRATION; STEM ENCEPHALITIS; FLUID PRESSURE; CARDIAC-ARREST; HEAD; CONSENSUS; EFFICACY; PATIENT	Although neurocritical care as a subspecialty is a relatively young field of medicine, its origins can be traced back to ancient times. This article focuses on the progression of neurocritical care from prehistoric trepanation procedures, through the development of mechanical ventilation, management of increased intracranial pressure, and traumatic brain injury, to the establishment of the first "real" intensive care units, and finally to modern monitoring in neurocritical care, management of post-cardiac arrest patients, and the diagnosis of brain death. This article also focuses on the future direction of neurocritical care.	[Korbakis, Georgia; Bleck, Thomas] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Bleck, Thomas] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [Bleck, Thomas] Rush Univ, Med Ctr, Dept Anesthesiol, Chicago, IL 60612 USA; [Bleck, Thomas] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA		Korbakis, G (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 600 South Paulina St, Chicago, IL 60612 USA.	georgiakorbakis@gmail.com	Bleck, Thomas/D-3772-2009; Bleck, Thomas/R-2286-2019	Bleck, Thomas/0000-0002-8267-9787			Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; [Anonymous], 1995, Neurology, V45, P1012; [Anonymous], 1968, J AMER MED ASSOC, V205, P337; [Anonymous], 1976, Br Med J, V2, P1187; BAKER A B, 1971, Medical History, V15, P336; Baskett PJF, 2001, RESUSCITATION, V50, P17, DOI 10.1016/S0300-9572(01)00391-4; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BICKERSTAFF ER, 1957, BRIT MED J, V1, P1384, DOI 10.1136/bmj.1.5032.1384; Bordini AL, 2010, ARQ NEURO-PSIQUIAT, V68, P930, DOI 10.1590/S0004-282X2010000600019; Breasted J., 1930, E SMITH SURG PAPYRUS; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carey ME, 2011, J NEUROSURG, V114, P1495, DOI 10.3171/2011.1.JNS101259; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; de Lima Oliveira M, 2013, NEUROCRIT CARE; Di leva A, 2011, J NEUROSURG, V114, P1461; Drinker P, 1929, J CLIN INVEST, V7, P229, DOI 10.1172/JCI100226; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; ENGSTROM CG, 1954, BRIT MED J, V2, P666, DOI 10.1136/bmj.2.4889.666; Faul M, 2010, TRAUMATIC BRAIN INJU; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; FOREGGER R, 1957, ANESTHESIOLOGY, V18, P257, DOI 10.1097/00000542-195703000-00011; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Fremont-Smith F, 1927, ARCH NEURO PSYCHIATR, V18, P550, DOI 10.1001/archneurpsyc.1927.02210040057002; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Graus F, 2012, CURR OPIN NEUROL, V25, P795, DOI 10.1097/WCO.0b013e328359da15; Greenblatt SH, 1997, J NEUROSURG, V87, P964, DOI 10.3171/jns.1997.87.6.0964; Greer DM, 2008, NEUROLOGY, V70, P284, DOI 10.1212/01.wnl.0000296278.59487.c2; Grenvik A, 2009, CRIT CARE CLIN, V25, P239, DOI 10.1016/j.ccc.2008.11.001; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horsley JS, 1937, LANCET, V1, P141; HUGHES JT, 1988, PARAPLEGIA, V26, P71, DOI 10.1038/sc.1988.15; Ito M, 2008, J NEUROL, V255, P674, DOI 10.1007/s00415-008-0775-0; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; JAVID M, 1956, JAMA-J AM MED ASSOC, V160, P943, DOI 10.1001/jama.1956.02960460021006; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; KAUFMAN HH, 1993, J NEUROSURG, V78, P838, DOI 10.3171/jns.1993.78.5.0838; Kelly EC, 1949, CLASSICS NEUROLOGY; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Kinsman M, 2013, J HIST NEUROSCI, V22, P96, DOI 10.1080/0964704X.2012.671050; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Kshettry Varun R, 2007, Neurosurg Focus, V23, pE8; LASSEN HCA, 1954, P ROY SOC MED, V47, P67, DOI 10.1177/003591575404700119; LASSEN HCA, 1953, LANCET, V264, P37; Le Cat CN., 1751, PHIL T R SOC LOND, V157, P267; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; LEE R V, 1972, Journal of the History of Medicine and Allied Sciences, V27, P418; Lifshutz Jason, 2004, Neurosurg Focus, V16, pE5; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Mokin M, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.10.FOCUS13374; MOLLARET P., 1959, REV NEUROL [PARIS], V101, P3; Naidech AM, 2008, NEUROCRIT CARE, V9, P326, DOI 10.1007/s12028-008-9077-8; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; PRICE J L, 1962, Med Hist, V6, P67; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rahimi Scott Y, 2007, Neurosurg Focus, V23, pE14; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; ROGERS RM, 1972, CHEST, V62, P94, DOI 10.1378/chest.62.1.94; Rose F C, 1997, J Hist Neurosci, V6, P154; Rosengart MR, 2006, SURG CLIN N AM, V86, P1305, DOI 10.1016/j.suc.2006.09.004; Rosenthal ES, 2012, NEUROTHERAPEUTICS, V9, P24, DOI 10.1007/s13311-011-0101-x; RYDER HW, 1953, J LAB CLIN MED, V41, P428; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; SAFAR P, 1958, JAMA-J AM MED ASSOC, V167, P335, DOI 10.1001/jama.1958.72990200026008c; Sargent P, 1915, BRIT MED J, V1915, P537, DOI 10.1136/bmj.1.2830.537; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Shewmon DA, 2009, HASTINGS CENT REP, V39, P18; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Stuart RM, 2010, NEUROCRIT CARE, V13, P355, DOI 10.1007/s12028-010-9414-6; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Tabuteau GG, 1915, BRIT MED J, V1915, P501, DOI 10.1136/bmj.2.2857.501; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; TEASDALE G, 1974, LANCET, V2, P81; Tissue plasminogen activator for acute ischemic stroke, 1995, NEW ENGL J MED, V333, P1581, DOI [DOI 10.1056/NEJM199512143332401, 10.1056/NEJM199512143332401]; Trubuhovich Ronald V, 2006, Crit Care Resusc, V8, P157; Underwood E A, 1944, Proc R Soc Med, V37, P247; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vallejo-Manzur F, 2003, RESUSCITATION, V56, P3, DOI 10.1016/S0300-9572(02)00346-5; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wang VY, 2011, YOUMANS NEUROLOGICAL, P424; Wang X, 2013, CRIT CARE, V17, DOI 10.1186/cc12608; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; West JB, 2014, AM J PHYSIOL-LUNG C, V306, pL111, DOI 10.1152/ajplung.00310.2013; WIJDICKS EF, 1997, CLIN PRACTICE CRITIC; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2003, NEUROLOGY, V61, P970, DOI 10.1212/01.WNL.0000086804.18169.8D; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024; WISE BL, 1962, J NEUROSURG, V19, P1038, DOI 10.3171/jns.1962.19.12.1038; Zargaran A, 2013, INT J CARDIOL, V169, P233, DOI 10.1016/j.ijcard.2013.08.115	103	7	7	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	OCT	2014	30	4					657	+		10.1016/j.ccc.2014.06.001			16	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5IY	WOS:000343619800003	25257734				2022-02-06	
J	Needham, E; Zandi, MS				Needham, Ed; Zandi, Michael S.			Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia	JOURNAL OF NEUROLOGY			English	Article						Neuroimmunology; Schizophrenia; Psychosis; Alzheimer's disease; Traumatic brain injury; NMDAR encephalitis	D-ASPARTATE RECEPTOR; MICROGLIAL ACTIVATION; SYSTEMIC INFLAMMATION; ENCEPHALITIS; ANTIBODIES; IMMUNOPROTEASOME; PATHOPHYSIOLOGY; SEIZURES; ANTIGEN	In this update, we review recent advances in antibody-associated disorders of the central nervous system, and the immune mechanisms which may contribute to Alzheimer's disease, traumatic brain injury and schizophrenia. The field of neuroimmunology is rapidly developing and has concerned itself with an expanding portfolio of diseases. The core neuroimmunological diseases remain, multiple sclerosis, neuromyelitis optica, primary inflammatory and antibody-associated disorders of the central and peripheral nervous system (including Myasthenia Gravis and other disorders of neuromuscular junction and muscle, paraneoplastic syndromes, paraproteinaemic neuropathies), and the neurological involvement seen in systemic inflammatory diseases including lupus, sarcoidosis and vasculitis. But it is increasingly realised that immune mechanisms may contribute to the pathogenesis of degenerative diseases including Alzheimer's disease, traumatic brain disease and psychiatric diseases including schizophrenia and depression. These common and devastating disorders, often without effective disease-modifying therapies, are yet to be seen in a conventional neuroimmunology clinic, but the immune mechanisms identified have encouraged research into novel therapeutic approaches for them.	[Needham, Ed; Zandi, Michael S.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Zandi, Michael S.] NIHR Cambridge Biomed Res Ctr, Cambridge, England		Zandi, MS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0QQ, England.	msz20@cam.ac.uk	Zandi, Michael S/H-3444-2013	Zandi, Michael S/0000-0002-9612-9401; Needham, Edward/0000-0001-7042-7462			Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Angus-Leppan H, 2013, JAMA NEUROL, V70, P919, DOI 10.1001/jamaneurol.2013.2077; Armangue T, 2014, ANN NEUROL, V75, P317, DOI 10.1002/ana.24083; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Benros ME, 2014, BIOL PSYCHIAT, V75, P300, DOI 10.1016/j.biopsych.2013.09.023; Brenner T, 2013, EPILEPSIA, V54, P1028, DOI 10.1111/epi.12127; Brown JWL, 2014, J NEUROIMMUNOL, V271, P66, DOI 10.1016/j.jneuroim.2014.03.012; Bullmore ET, 2014, BIOL PSYCHIAT, V75, P260, DOI 10.1016/j.biopsych.2013.12.006; Carter CS, 2014, BIOL PSYCHIAT, V75, P258, DOI 10.1016/j.biopsych.2013.10.023; Carvajal-Gonzalez A, 2014, BRAIN, V137, P2178, DOI 10.1093/brain/awu142; Chang TS, 2013, JAMA NEUROL, V70, P1140, DOI 10.1001/jamaneurol.2013.3499; Chang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072921; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Coutinho E, 2014, BIOL PSYCHIAT, V75, P269, DOI 10.1016/j.biopsych.2013.07.040; De Tiege X, 2003, NEUROLOGY, V61, P241, DOI 10.1212/01.WNL.0000073985.71759.7C; Deakin J, 2014, BIOL PSYCHIAT, V75, P284, DOI 10.1016/j.biopsych.2013.07.018; Dodel R, 2013, LANCET NEUROL, V12, P233, DOI 10.1016/S1474-4422(13)70014-0; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Foltynie T, 2013, J NEUROL, V260, P1433, DOI 10.1007/s00415-013-6915-1; Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038; Girgis RR, 2014, BIOL PSYCHIAT, V75, P292, DOI 10.1016/j.biopsych.2013.12.002; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Granerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hacohen Y, 2014, MOVEMENT DISORD, V29, P90, DOI 10.1002/mds.25626; Hacohen Y, 2014, DEV MED CHILD NEUROL, V56, P190, DOI 10.1111/dmcn.12321; Harrison NA, 2014, BIOL PSYCHIAT, V76, P585, DOI 10.1016/j.biopsych.2014.01.005; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Huang BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091167; Hutchinson M, 2008, NEUROLOGY, V71, P1291, DOI 10.1212/01.wnl.0000327606.50322.f0; Irani SR, 2013, BRAIN, V136, P3151, DOI 10.1093/brain/awt212; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Khandaker GM, 2013, PSYCHOL MED, V43, P239, DOI 10.1017/S0033291712000736; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lozeron P, 2013, J NEUROL, V260, P2433, DOI 10.1007/s00415-013-6994-z; Mohammad SS, 2014, MOVEMENT DISORD, V29, P117, DOI 10.1002/mds.25623; Orre M, 2013, BRAIN, V136, P1415, DOI 10.1093/brain/awt083; Pathmanandavel K, 2015, BIOL PSYCHIAT, V77, P537, DOI 10.1016/j.biopsych.2014.07.014; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Petit-Pedrol M, 2014, LANCET NEUROL, V13, P276, DOI 10.1016/S1474-4422(13)70299-0; Pruss H, 2012, ANN NEUROL, V72, P902, DOI 10.1002/ana.23689; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rieckmann P, 2013, J NEUROL, V260, P462, DOI 10.1007/s00415-012-6656-6; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; ROZEMULLER JM, 1986, VIRCHOWS ARCH B, V51, P247, DOI 10.1007/BF02899034; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Trebst C, 2014, J NEUROL, V261, P1, DOI 10.1007/s00415-013-7169-7; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Vincent A, 2013, AUTOIMMUN REV, V12, P678, DOI 10.1016/j.autrev.2012.10.016; Weber KP, 2014, J NEUROL, V261, P1251, DOI 10.1007/s00415-013-7105-x; Zandi MS, 2013, BRAIN, V136, P2933, DOI 10.1093/brain/awt256; Zandi MS, 2011, J NEUROL, V258, P686, DOI 10.1007/s00415-010-5788-9; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	61	7	7	0	15	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	OCT	2014	261	10					2037	2042		10.1007/s00415-014-7473-x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR7JJ	WOS:000343755300030	25182699				2022-02-06	
J	Pardini, M; Krueger, F; Hodgkinson, CA; Raymont, V; Strenziok, M; Amore, M; Wassermann, EM; Goldman, D; Grafman, JH				Pardini, Matteo; Krueger, Frank; Hodgkinson, Colin A.; Raymont, Vanessa; Strenziok, Maren; Amore, Mario; Wassermann, Eric M.; Goldman, David; Grafman, Jordan H.			Aggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury	CNS SPECTRUMS			English	Article						Aggression; behavioral neurology; dopamine; prefrontal cortex; traumatic brain injury	NUCLEUS-ACCUMBENS DOPAMINE; FRONTOTEMPORAL DEMENTIA; REWARD ANTICIPATION; INVERTED-U; BEHAVIOR; RISPERIDONE; SINGLE; STIMULATION; HALOPERIDOL; ASSOCIATION	Objective. This study evaluated whether structural brain lesions modulate the relationship between pathological aggression and the dopaminergic system in traumatic brain injury (TBI). While converging evidence suggests that different areas of the prefrontal cortex modulate dopaminergic activity, to date no evidence exists of a modulation of endogenous dopaminergic tone by lesion localization in penetrating TBI (pTBI). Methods. This study included 141 male Caucasian veterans who suffered penetrating pTBI during their service in Vietnam and 29 healthy male Caucasian Vietnam veterans. Participants were genotyped for 3 functional single nucleotide polymorphisms (SNPs): dopamine receptor D1 (DRD1) rs686, dopamine receptor D2 (DRD2) rs4648317, and catechol-O-methyltransferase (COMT) Val158Met. Patients underwent brain CT scans and were divided into medial prefrontal cortex, lateral prefrontal cortex, and posterior cortex lesion groups. Long-term aggression levels were evaluated with the agitation/aggression subscale of the Neuropsychiatric Inventory. Results. Our data showed that carriers of more transcriptionally active DRD1 alleles compared to noncarriers demonstrated greater aggression levels due to medial prefrontal cortex lesions but reduced aggression levels due to lateral prefrontal cortex lesions independently of DRD2 rs4648317 or COMT Val158Met genotypes. Conclusions. Our results suggest that the relationship between pTBI-related aggression and the dopaminergic system is modulated by lesion location. Potentially lesion location could represent an easy-to-use, widely available, para-clinical marker to help in the development of an individualized therapeutic approach to pTBI-related pathological aggression.	[Pardini, Matteo; Amore, Mario] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mat, Genoa, Italy; [Pardini, Matteo] Univ Genoa, Magnet Resonance Res Ctr Nervous Syst Dis, Genoa, Italy; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank; Strenziok, Maren] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bethesda, MD 20892 USA; [Grafman, Jordan H.] Rehabil Inst Chicago, Chicago, IL 60611 USA		Grafman, JH (corresponding author), Rehabil Inst Chicago, Coleman Chair Phys Med & Rehabil, 345 East Super St, Chicago, IL 60611 USA.	jgrafman@northwestern.edu	Goldman, David/F-9772-2010; Wassermann, Eric M./AAC-9064-2020; Majid, Salma/AAT-2616-2020; Pardini, Matteo/F-8414-2010	Goldman, David/0000-0002-1724-5405; Wassermann, Eric M./0000-0003-0628-0210; Majid, Salma/0000-0002-1724-5405; Pardini, Matteo/0000-0002-4740-1982; Hodgkinson, Colin/0000-0002-5365-8119	U.S. National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); AKWO, Lavagna (Genoa) Italy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000301] Funding Source: NIH RePORTER	The work was supported by the U.S. National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the U.S. Army Medical Research and Material Command administrated by the Henry M Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government. M. P., F. K., and J.G. had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. M. P. thanks the nonprofit association AKWO, Lavagna (Genoa) Italy, for its unrestricted support.	AGUILAR MA, 1994, PHARMACOL BIOCHEM BE, V47, P753, DOI 10.1016/0091-3057(94)90185-6; Bakermans-Kranenburg MJ, 2011, ATTACH HUM DEV, V13, P253, DOI 10.1080/14616734.2011.562415; Blader JC, 2010, PEDIATRICS, V126, pE796, DOI 10.1542/peds.2010-0086; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Cohen MX, 2007, EUR J NEUROSCI, V26, P3652, DOI 10.1111/j.1460-9568.2007.05947.x; Comai S, 2012, J CLIN PSYCHOPHARM, V32, P83, DOI 10.1097/JCP.0b013e31823f8770; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; Couppis MH, 2008, PSYCHOPHARMACOLOGY, V197, P449, DOI 10.1007/s00213-007-1054-y; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; de Almeida J, 2008, PROG BRAIN RES, V172, P101, DOI 10.1016/S0079-6123(08)00905-9; DeYoung CG, 2006, ARCH GEN PSYCHIAT, V63, P1410, DOI 10.1001/archpsyc.63.12.1410; Diekhof EK, 2012, HUM BRAIN MAPP, V33, P2768, DOI 10.1002/hbm.21398; Floresco SB, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00062; Fowler S B, 1995, J Neurosci Nurs, V27, P119; Fukui N, 2011, MOL PSYCHIATR, V16, P356, DOI 10.1038/mp.2010.37; Goedhard LE, 2006, J CLIN PSYCHIAT, V67, P1013, DOI 10.4088/JCP.v67n0702; Hamidovic A, 2009, EXP CLIN PSYCHOPHARM, V17, P374, DOI 10.1037/a0017840; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Huang W, 2008, HUM GENET, V123, P133, DOI 10.1007/s00439-007-0453-9; Huey ED, 2006, NEUROLOGY, V66, P17, DOI 10.1212/01.wnl.0000191304.55196.4d; Huey ED, 2008, J CLIN PSYCHIAT, V69, P1981, DOI 10.4088/JCP.v69n1219a; JASKIW GE, 1990, BRAIN RES, V534, P321, DOI 10.1016/0006-8993(90)90149-6; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Miczek KA, 1989, PHARM TOXICOLOGY AMP; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Rodriguez-Arias M, 1998, EUR NEUROPSYCHOPHARM, V8, P95, DOI 10.1016/S0924-977X(97)00051-5; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Takahata R, 2000, J NEUROCHEM, V75, P1775, DOI 10.1046/j.1471-4159.2000.0751775.x; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TIDEY JW, 1992, BEHAV PHARMACOL, V3, P553; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Volavka J, 2004, ANN NY ACAD SCI, V1036, P393, DOI 10.1196/annals.1330.023; Wong TM, 2011, NEUROLOGY, V76, P1032, DOI 10.1212/WNL.0b013e318211c3fd; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95	46	7	7	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1092-8529	2165-6509		CNS SPECTRUMS	CNS Spectr.	OCT	2014	19	5					382	390		10.1017/S1092852914000108			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	AT0JC	WOS:000344621600005	24618367	Green Accepted			2022-02-06	
J	Fievisohn, EM; Sajja, VSSS; VandeVord, PJ; Hardy, WN				Fievisohn, Elizabeth M.; Sajja, Venkata Siva Sai Sujith; VandeVord, Pamela J.; Hardy, Warren N.			Evaluation of Impact-Induced Traumatic Brain Injury in the Gottingen Minipig Using Two Input Modes	TRAFFIC INJURY PREVENTION			English	Article						minipig; immunohistochemistry; traumatic brain injury; proton magnetic resonance spectroscopy	MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; HEAD-INJURY; GLUTAMATE/GLUTAMINE	Objectives: Two novel injury devices were used to characterize impact-induced traumatic brain injury (TBI). One imparts pure translation, and the other produces combined translation and rotation. The objective of this study was to evaluate the neuropathology associated with two injury devices using proton magnetic resonance spectroscopy (H-1-MRS) to quantify metabolic changes and immunohistochemistry (IHC) to evaluate axonal damage in the corpus callosum. Methods: Young adult female Gottingen minipigs were exposed to impact-induced TBI with either the translation-input injury device or the combined-input injury device (n = 11/group). Sham animals were treated identically except for the injury event (n = 3). The minipigs underwent H-1-MRS scans prior to injury (baseline), approximately 1h after injury, and 24h post injury, at which point the brains were extracted for IHC. Metabolites of interest include glutamate (Glu), glutamine (Gln), N-acetylaspartate (NAA), N-acetylaspartylglutamate (NAAG), and gamma-aminobutyric acid (GABA). Repeated measures analysis of variance with a least significant difference post hoc test were used to compare the three time points. IHC was performed on paraffin-embedded sections of the corpus callosum with light and heavy neurofilament antibodies. Stained pixel percentages were compared between shams and 24-h survival animals. Results: For the translation-input group (27.5-70.1g), 16 significant metabolite differences were found. Three of these include a significant increase in Gln, both 1h and 24h postinjury, and an increase in GABA 24h after injury. For the combined-input group (40.1-95.9g; 1,014.5-3,814.9 rad/s(2); 7.2-10.8 rad/s), 20 significant metabolite differences were found. Three of these include a significant increase in Glu, an increase in the ratio Glu/Gln, and an increase in the ratio Glu/NAAG 24h after injury. The IHC analysis revealed significant increases in light and heavy neurofilament for both groups 24h after injury. Conclusions: Only five metabolite differences were similar between the input modes, most of which are related to inflammation or myelin disruption. The observed metabolite differences indicate important dissimilarities. For the translation-input group, an increase in Gln and GABA suggests a response in the GABA shunt system. For the combined-input group, an increase in Glu, Glu/Gln, and Glu/NAAG suggests glutamate excitotoxicity. Importantly, both of these input modes lead to similar light and heavy neurofilament damage, which indicates axonal disruption. Identifying neuropathological changes that are unique to different injury mechanisms is critical in defining the complexity of TBI and can lead to improved prevention strategies and the development of effective drug therapies.	[Fievisohn, Elizabeth M.; Sajja, Venkata Siva Sai Sujith; VandeVord, Pamela J.; Hardy, Warren N.] Virginia Polytech Inst & State Univ, Ctr Injury Biomech, Sch Biomed Engn & Sci, Virginia Tech Wake Forest Univ, Blacksburg, VA 24061 USA; [VandeVord, Pamela J.] Salem VA Med Ctr, Res & Dev Serv, Salem, VA USA		Fievisohn, EM (corresponding author), Virginia Tech Wake Forest Univ, Ctr Injury Biomech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	lizf87@vt.edu	McNeil, Elizabeth/J-2972-2019; Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501; McNeil, Elizabeth/0000-0003-3439-3722	National Highway Traffic Safety Administration [DTNH22-09-H-00242]	This project was funded in part by the National Highway Traffic Safety Administration under award DTNH22-09-H-00242. The views in this article are those of the authors and not the sponsor.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Cox IJ, 1996, PROG BIOPHYS MOL BIO, V65, P45, DOI 10.1016/S0079-6107(96)00006-5; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Faul M, 2010, TRAUMATIC BRAIN INJU; Fievisohn Elizabeth M, 2012, Biomed Sci Instrum, V48, P126; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; Maheshwari SR, 2000, SEMIN ULTRASOUND CT, V21, P434, DOI 10.1016/S0887-2171(00)90036-2; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; Moore Gregory J, 2002, Psychopharmacol Bull, V36, P5; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Parnaik Y, 2004, STAPP CAR CRASH J, V48, P1; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Ramonet D, 2004, HIPPOCAMPUS, V14, P586, DOI 10.1002/hipo.10188; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Society of Automotive Engineers, 2007, SAEJ2111; SWANSON LW, 1995, TRENDS NEUROSCI, V18, P471, DOI 10.1016/0166-2236(95)92766-J; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; UNTERHARNSCHEIDT F, 1969, TEX REP BIOL MED, V27, P127; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366; Zhang Z, 2010, SYSTEMS BIOL DRUG DI	31	7	7	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	SEP 26	2014	15			1	SI		S81	S87		10.1080/15389588.2014.929670			7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	CI1AI	WOS:000354471600012	25307402				2022-02-06	
J	Yoganandan, N; Arun, MWJ; Halloway, DE; Pintar, FA; Maiman, DJ; Szabo, A; Rudd, RW				Yoganandan, Narayan; Arun, Mike W. J.; Halloway, Dale E.; Pintar, Frank A.; Maiman, Dennis J.; Szabo, Aniko; Rudd, Rodney W.			Crash Characteristics and Injury Patterns of Restrained Front Seat Occupants in Far-side Impacts	TRAFFIC INJURY PREVENTION			English	Article						motor vehicle injuries; restrained occupant; change in velocity; NASS-CDS; far-side crashes	BODY-MASS INDEX; RISK-FACTOR; OBESITY; MORTALITY; OUTCOMES; RESPONSES	Objective: The study was conducted to determine the association between vehicle-, crash-, and demographic-related factors and injuries to front seat far-side occupants in modern environments. Methods: Field data were obtained from the NASS-CDS database for the years 2009-2012. Inclusion factors included the following: adult restrained front outboard-seated occupants, no ejection or rollovers, and vehicle model years less than 10years old at the time of crash. Far-side crashes were determined by using collision deformation classification. Injuries were scored using the Abbreviated Injury Scale (AIS). Injuries (MAIS 2+, MAIS 3+, M denotes maximum score) were examined based on demographics, change in velocity, vehicle type, direction of force, extent zone, collision partner, and presence of another occupant in the front seat. Only weighted data were used in the analysis. Injuries to the head and face, thorax, abdomen, pelvis, and upper and lower extremity regions were studied. Odds ratios and upper and lower confidence intervals were estimated from multivariate analysis. Results: Out of 519,195 far-side occupants, 17,715 were MAIS 2+ and 4,387 were MAIS 3+ level injured occupants. The mean age, stature, total body mass, and body mass index (BMI) were 40.7years, 1.7m, 77.2kg, and 26.8kg/m(2), respectively. Of occupants with MAIS 2+ injuries, 51% had head and 19% had thorax injuries. Of occupants with MAIS 3+ injuries, 50% had head and 69% had thorax injuries. The cumulative distribution of changes in velocities at the 50th percentile for the struck vehicle for all occupants and occupants with MAIS 2+ and MAIS 3+ injuries were 19, 34, and 42km/h, respectively. Furthermore, 73% of MAIS 2+ injuries and 86% of MAIS 3+ injuries occurred at a change in velocity of 24km/h or greater. Odds of sustaining MAIS 2+ and MAIS 3+ injuries increased with each unit increase in change in velocity, stature, and age, with one exception. Odds of sustaining injuries were higher with the presence of an occupant in the front seat at the MAIS 3+ level, although it was reversed at the lower level. The extent zone of 3+ increased the odds compared to the extent zones of 1 to 2 at both MAIS 2+ and MAIS 3+ injuries. Odds ratios and confidence intervals are given. Conclusions: The findings are as follows: head and thorax are the more frequently injured body regions, and the prevalence of cranium injuries is similar at both injury severities; thoracic injuries are more prevalent at the MAIS 3+ level; the presence of another front seat occupant plays a role in MAIS 3+ trauma; injuries continue to occur at changes in velocity representative of side impact environments; and mean demographic factors are close to mid-size automotive anthropometry, indicating the need to pursue this line of study. Because data were gathered from only 4years, it would be important to include additional NASS-CDS database years, rescore injuries from previous years, and analyze other international databases to reinforce these findings for advancing safety for far-side occupants.	[Yoganandan, Narayan; Arun, Mike W. J.; Halloway, Dale E.; Pintar, Frank A.; Maiman, Dennis J.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Szabo, Aniko] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53226 USA; [Rudd, Rodney W.] NHTSA, US DOT, Washington, DC USA		Yoganandan, N (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA.	yoga@mcw.edu			National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8UL1TR000055]; US Department of Transportation [DTNH22-13-D-00290]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER	The study was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number 8UL1TR000055, and the US Department of Transportation DTNH22-13-D-00290. This material is the result of work supported with resources and the use of facilities at the Zablocki VA Medical Center, Milwaukee, Wisconsin and the Medical College of Wisconsin. All authors are part-time employees of the Zablocki VA Medical Center, Milwaukee, Wisconsin. Any views expressed in this article are those of the authors and not necessarily representative of the funding organizations.	Alban RF, 2006, AM SURGEON, V72, P966; Arbabi S, 2003, J TRAUMA, V54, P1090, DOI 10.1097/01.TA.0000064449.11809.48; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL; Augenstein J, 2000, Annu Proc Assoc Adv Automot Med, V44, P57; Augenstein J, 1999, P ANN C ASS, P139; Bostrom Ola, 2008, Ann Adv Automot Med, V52, P289; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; Chen YY, 2012, 811809 DOT HS; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Digges K, 2005, Annu Proc Assoc Adv Automot Med, V49, P185; Digges KH, 2006, P SAE C WARR PA SAE; Duane TM, 2006, J TRAUMA, V61, P1218, DOI 10.1097/01.ta.0000241022.43088.e1; Fildes B, 1994, CR134 FED OFF ROAD S; Fildes BN, 1991, PASSENGER CARS OCCUP; Forman Jason L, 2013, Stapp Car Crash J, V57, P343; Gabler HC, 2005, SAE T J PASSENGER CA, V114, P1; Gennarelli TA, 2002, HEAD INJURIES NEARSI; Kuppa Shashi, 2003, Stapp Car Crash J, V47, P189; Maltese Matthew R, 2002, Stapp Car Crash J, V46, P321; Mock CN, 2002, ACCIDENT ANAL PREV, V34, P221, DOI 10.1016/S0001-4575(01)00017-3; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Pintar F A, 2000, Annu Proc Assoc Adv Automot Med, V44, P149; Pintar Frank A, 2006, Annu Proc Assoc Adv Automot Med, V50, P199; Pintar FA, 2007, STAPP CAR CRASH JO, V51, P313; Spaine LA, 1996, INJURY, V27, P687, DOI 10.1016/S0020-1383(96)00136-2; Stitzel Joel D, 2007, Annu Proc Assoc Adv Automot Med, V51, P395; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Viano DC, 2008, TRAFFIC INJ PREV, V9, P59, DOI 10.1080/15389580701737645; Wang Stewart C, 2003, Annu Proc Assoc Adv Automot Med, V47, P545; Whitlock G, 2003, INT J EPIDEMIOL, V32, P147, DOI 10.1093/ije/dyg022; Yoganandan N, 2005, ACCIDENT ANAL PREV, V37, P495, DOI 10.1016/j.aap.2004.12.007; Yoganandan Narayan, 2005, Traffic Inj Prev, V6, P379, DOI 10.1080/15389580500256888; Yoganandan N, 2007, J BIOMECH, V40, P227, DOI 10.1016/j.jbiomech.2006.01.002; Yoganandan N, 2007, ACCIDENT ANAL PREV, V39, P22, DOI 10.1016/j.aap.2006.05.014; Yoganandan Narayan, 2013, Ann Adv Automot Med, V57, P197; Yoganandan N, 2013, ANN BIOMED ENG, V41, P2391, DOI 10.1007/s10439-013-0847-x; Yoganandan Narayan, 2011, Stapp Car Crash J, V55, P351; Yoganandan N, 2012, J BIOMECH, V45, P1546, DOI 10.1016/j.jbiomech.2012.03.002; Yoganandan Narayan, 2011, Ann Adv Automot Med, V55, P267; Yoganandan N, 2008, TRAFFIC INJ PREV, V9, P162, DOI 10.1080/15389580701775942; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104; Zein JG, 2005, ARCH SURG-CHICAGO, V140, P1130, DOI 10.1001/archsurg.140.11.1130-c	46	7	7	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	SEP 26	2014	15			1	SI		S27	S34		10.1080/15389588.2014.935771			8	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	CI1AI	WOS:000354471600005	25307394	Green Accepted			2022-02-06	
J	Raphael, I; Mahesula, S; Purkar, A; Black, D; Catala, A; Gelfond, JAL; Forsthuber, TG; Haskins, WE				Raphael, Itay; Mahesula, Swetha; Purkar, Anjali; Black, David; Catala, Alexis; Gelfond, Jonathon A. L.; Forsthuber, Thomas G.; Haskins, William E.			Microwave & Magnetic (M-2) Proteomics Reveals CNS-Specific Protein Expression Waves that Precede Clinical Symptoms of Experimental Autoimmune Encephalomyelitis	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; TANDEM MASS-SPECTROMETRY; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; PROGRESSIVE MULTIPLE-SCLEROSIS; SPECTRIN BREAKDOWN PRODUCTS; SYNAPSIN-I; GLUTAMATE NEUROTOXICITY; ERYTHROCYTE SPECTRIN; INTERFERON-GAMMA	Central nervous system-specific proteins (CSPs), transported across the damaged blood-brain-barrier (BBB) to cerebrospinal fluid (CSF) and blood (serum), might be promising diagnostic, prognostic and predictive protein biomarkers of disease in individual multiple sclerosis (MS) patients because they are not expected to be present at appreciable levels in the circulation of healthy subjects. We hypothesized that microwave & magnetic (M-2) proteomics of CSPs in brain tissue might be an effective means to prioritize putative CSP biomarkers for future immunoassays in serum. To test this hypothesis, we used M-2 proteomics to longitudinally assess CSP expression in brain tissue from mice during experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. Confirmation of central nervous system (CNS)-infiltrating inflammatory cell response and CSP expression in serum was achieved with cytokine ELISPOT and ELISA immunoassays, respectively, for selected CSPs. M-2 proteomics (and ELISA) revealed characteristic CSP expression waves, including synapsin-1 and alpha-II-spectrin, which peaked at day 7 in brain tissue (and serum) and preceded clinical EAE symptoms that began at day 10 and peaked at day 20. Moreover, M-2 proteomics supports the concept that relatively few CNS-infiltrating inflammatory cells can have a disproportionally large impact on CSP expression prior to clinical manifestation of EAE.	[Raphael, Itay; Mahesula, Swetha; Purkar, Anjali; Black, David; Catala, Alexis; Forsthuber, Thomas G.; Haskins, William E.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Gelfond, Jonathon A. L.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA		Haskins, WE (corresponding author), Univ Texas San Antonio, San Antonio, TX 78249 USA.	thomas.forsthuber@utsa.edu; weh.scholar@gmail.com		Raphael, Itay/0000-0002-7369-2752; /0000-0003-0692-7125	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [G12MD007591, NS52177, NS084201, NIH5U54RR022762-05]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG5011]; South Texas Center for Emerging Infectious Diseases; Cancer Therapy and Research Center at the University of Texas Health Science Center San Antonio, a National Cancer Institute-designated Cancer Center [NIHP30CA054174]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54RR022762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM060655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS084201, R01NS052177] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [G12MD007591] Funding Source: NIH RePORTER	This project was supported by National Institute of Health grants G12MD007591 (WEH, TGF), grants NS52177 and NS084201 (TGF), NIH5U54RR022762-05 (WEH), grant RG5011 from the National Multiple Sclerosis Society (TGF), and a fellowship of the South Texas Center for Emerging Infectious Diseases (IR). We thank the RCMI program and facilities at UTSA for assistance. The authors also acknowledge the support of the Cancer Therapy and Research Center at the University of Texas Health Science Center San Antonio, a National Cancer Institute-designated Cancer Center (NIHP30CA054174).	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; BAHMANYAR S, 1983, J NEUROIMMUNOL, V5, P191, DOI 10.1016/0165-5728(83)90009-7; BAINES AJ, 1986, NATURE, V319, P145, DOI 10.1038/319145a0; Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Cardali S, 2006, J Neurosurg Sci, V50, P25; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CLARK MB, 1994, BRAIN RES, V663, P223; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; DEBELLO WM, 1993, CELL, V74, P947, DOI 10.1016/0092-8674(93)90716-4; Dhib-Jalbut S, 2006, J NEUROIMMUNOL, V176, P198, DOI 10.1016/j.jneuroim.2006.03.027; Encinas JA, 1996, J IMMUNOL, V157, P2186; Fallarino F, 2010, NAT MED, V16, P897, DOI 10.1038/nm.2183; Farias AS, 2014, PROTEOMICS, V14, P467, DOI 10.1002/pmic.201300268; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; GOODMAN SR, 1983, CELL MOTIL CYTOSKEL, V3, P635, DOI 10.1002/cm.970030528; GOODMAN SR, 1984, AM J PHYSIOL, V247, pC61, DOI 10.1152/ajpcell.1984.247.1.C61; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; GOODMAN SR, 1989, BRAIN RES BULL, V23, P311, DOI 10.1016/0361-9230(89)90214-1; GOODMAN SR, 1986, BRAIN RES BULL, V16, P597, DOI 10.1016/0361-9230(86)90133-4; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Han MH, 2012, J EXP MED, V209, P1325, DOI 10.1084/jem.20101974; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HARTUNG HP, 1992, J NEUROIMMUNOL, V40, P197, DOI 10.1016/0165-5728(92)90134-7; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Heeger PS, 2000, J IMMUNOL, V164, P5771, DOI 10.4049/jimmunol.164.11.5771; Hofstetter HH, 2010, NEUROSCI LETT, V476, P150, DOI 10.1016/j.neulet.2010.04.018; Hu J, 2006, PROTEOMICS, V6, P4321, DOI 10.1002/pmic.200600026; Jaros Julian A J, 2013, Methods Mol Biol, V1002, P1, DOI 10.1007/978-1-62703-360-2_1; Klaver R, 2013, PRION, V7, P66, DOI 10.4161/pri.23499; Koutroukides TA, 2011, J SEP SCI, V34, P1621, DOI 10.1002/jssc.201100060; Kushnir MM, 2013, CLIN CHEM, V59, P982, DOI 10.1373/clinchem.2012.195594; Lassmann H, 1999, PHILOS T ROY SOC B, V354, P1635, DOI 10.1098/rstb.1999.0508; Lehmann S, 2013, CLIN CHEM LAB MED, V51, P919, DOI 10.1515/cclm-2012-0723; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mahesula S, 2012, ELECTROPHORESIS, V33, P3820, DOI 10.1002/elps.201200515; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Mateen FJ, 2012, LANCET NEUROL, V11, P484, DOI 10.1016/S1474-4422(12)70125-4; MUNOZ JJ, 1984, J NEUROIMMUNOL, V7, P91, DOI 10.1016/S0165-5728(84)80009-0; Neema M, 2007, NEUROTHERAPEUTICS, V4, P602, DOI 10.1016/j.nurt.2007.08.001; Nekrasova T, 2005, J IMMUNOL, V175, P2374, DOI 10.4049/jimmunol.175.4.2374; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OLSSON T, 1992, J NEUROIMMUNOL, V40, P211, DOI 10.1016/0165-5728(92)90135-8; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Ottens AK, 2005, ANAL CHEM, V77, P4836, DOI 10.1021/ac050478r; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; PETRUCCI TC, 1987, J CELL BIOL, V105, P1355, DOI 10.1083/jcb.105.3.1355; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Poonawalla AH, 2010, MULT SCLER J, V16, P1117, DOI 10.1177/1352458510374892; Raphael I, 2012, ELECTROPHORESIS, V33, P3810, DOI 10.1002/elps.201200200; REPASKY EA, 1982, CELL, V29, P821, DOI 10.1016/0092-8674(82)90444-5; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; RIEDERER BM, 1988, BRAIN RES BULL, V21, P607, DOI 10.1016/0361-9230(88)90200-6; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Robinson WH, 2003, CURR OPIN IMMUNOL, V15, P660, DOI 10.1016/j.coi.2003.09.015; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shive CL, 2000, EUR J IMMUNOL, V30, P2422, DOI 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H; SIKORSKI AF, 1991, J CELL BIOL, V114, P313, DOI 10.1083/jcb.114.2.313; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sosa RA, 2013, J IMMUNOL, V191, P5848, DOI 10.4049/jimmunol.1300771; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009; Sriskantharajah S, 2014, J IMMUNOL, V192, P3518, DOI 10.4049/jimmunol.1300172; Stabach PR, 2000, J BIOL CHEM, V275, P21385, DOI 10.1074/jbc.C000159200; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Thompson AJ, 1997, BRAIN, V120, P1085, DOI 10.1093/brain/120.6.1085; Tourdias T, 2013, NEUROTHERAPEUTICS, V10, P111, DOI 10.1007/s13311-012-0155-4; Veldhoen M, 2009, CURR OPIN IMMUNOL, V21, P606, DOI 10.1016/j.coi.2009.07.009; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; ZAGON IS, 1986, J NEUROSCI, V6, P2977; ZAGON IS, 1984, J NEUROSCI, V4, P3089	83	7	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 3	2014	4								6210	10.1038/srep06210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6EQ	WOS:000341442900001	25182730	Green Published, gold			2022-02-06	
J	Gaines, BA; Hansen, K; McKenna, C; McMahon, M; Meredith, JW; Mooney, DP; Snow, SK; Upperman, JS				Gaines, Barbara A.; Hansen, Kristine; McKenna, Chris; McMahon, Maria; Meredith, J. Wayne; Mooney, David P.; Snow, Sally K.; Upperman, Jeffrey S.		Childress Summit Pediat Trauma Soc	Report from the Childress Summit of the Pediatric Trauma Society, April 22-24, 2013	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article							POSTTRAUMATIC STRESS; INJURY; MORTALITY; CARE; DELIVERY; SURGEONS; OUTCOMES; CENTERS	The summit attendees were divided into four thematically focused work groups as follows: emergency medicine/critical care/resuscitation, general trauma, neurotrauma/traumatic brain injury, and trauma systems. Each work group identified strengths, weaknesses, opportunities, and threats specific to their topic before the summit convened. Once the summit began, each work group met in concurrent breakout sessions to identify challenges and opportunities to improve pediatric trauma care. The groups then reconvened; ideas from each group were shared and discussed among all participants. White papers generated by each group after the summit form the basis of this combined report. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Gaines, Barbara A.; McKenna, Chris] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Hansen, Kristine] Childrens Hosp Colorado, Aurora, CO USA; [McMahon, Maria; Mooney, David P.] Boston Childrens Hosp, Boston, MA USA; [Meredith, J. Wayne] Wake Forest Sch Med, Winston Salem, NC 27157 USA; [Snow, Sally K.] Cook Childrens Med Ctr, Ft Worth, TX USA; [Upperman, Jeffrey S.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA		Meredith, JW (corresponding author), Wake Forest Sch Med, Dept Surg, Med Ctr Blvd, Winston Salem, NC 27157 USA.	merediw@wakehealth.edu	Mooney, David/AAW-5132-2020		Childress Institute for Pediatric Trauma, Winston-Salem, NC	The Childress Summit of the Pediatric Trauma Society was supported by the Childress Institute for Pediatric Trauma, Winston-Salem, NC.	American College of Surgeons, NAT TRAUM DAT BANK 2; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Boudreaux ED, 2002, ANN EMERG MED, V40, P193, DOI 10.1067/mem.2002.124899; Curry JI, 2003, J PEDIATR SURG, V38, P556, DOI 10.1053/jpsu.2003.50121; Densmore JC, 2006, J PEDIATR SURG, V41, P92, DOI 10.1016/j.jpedsurg.2005.10.013; Durbin DR, 2011, PEDIATRICS, V127, pE1050, DOI 10.1542/peds.2011-0215; Durch JS, 1993, I MED REPORT EMERGEN; Fendya D, 2009, BEST PRACTICES GUIDE; Fuenfer MM, 2009, MIL MED, V174, P887, DOI 10.7205/MILMED-D-02-2308; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Hulka F, 1999, J TRAUMA, V47, pS85, DOI 10.1097/00005373-199909001-00019; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2006, EM CAR CHILDR GROW P; Kassam-Adams N, 2013, JAMA PEDIATR, V167, P1158, DOI 10.1001/jamapediatrics.2013.2741; Kassam-Adams N, 2011, J TRAUMA STRESS, V24, P252, DOI 10.1002/jts.20640; Kendrick D, 2012, COCHRANE DATABASE SY, V9; Lorch SA, 2010, PEDIATRICS, V126, P1182, DOI 10.1542/peds.2010-1119; Marsac ML, 2013, J PEDIATR PSYCHOL, V38, P1101, DOI 10.1093/jpepsy/jst053; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; Nance ML, 2009, ARCH PEDIAT ADOL MED, V163, P512, DOI 10.1001/archpediatrics.2009.65; Notrica DM, 2012, J TRAUMA ACUTE CARE, V73, P566, DOI 10.1097/TA.0b013e318265ca6f; Pediat Emergency Care Applied Res, 2003, ACAD EMERG MED, V10, P661; Petrosyan M, 2009, J TRAUMA, V67, pS114, DOI 10.1097/TA.0b013e3181ad3251; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Ramasamy A, 2010, INJURY, V41, P453, DOI 10.1016/j.injury.2009.11.012; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Watters W., 2008, AAOS NOW, V7; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642	27	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2014	77	3					504	509		10.1097/TA.0000000000000395			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AO2BJ	WOS:000341120200020		Bronze			2022-02-06	
J	Kim, TW; Kim, YW				Kim, Tea-Woo; Kim, Yong-Wook			Treadmill Sideways Gait Training with Visual Blocking for Patients with Brain Lesions	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Brain lesions; Treadmill training; Visual block	BODY-WEIGHT SUPPORT; MUSCLE-ACTIVITY; CHRONIC STROKE; FRONTAL PLANE; WALKING SPEED; BALANCE; REHABILITATION; PEOPLE; INFORMATION; LOCOMOTION	[Purpose] The aim of this study was to verify the effect of sideways treadmill training with and without visual blocking on the balance and gait function of patients with brain lesions. [Subjects] Twenty-four stroke and traumatic brain injury subjects participated in this study. They were divided into two groups: an experimental group (12 subjects) and a control group (12 subjects). [Methods] Each group executed a treadmill training session for 20 minutes, three times a week, for 6 weeks. The sideways gait training on the treadmill was performed with visual blocking by the experimental group and with normal vision by the control group. A Biodex Gait Trainer 2 was used to assess the gait function. It was used to measure walking speed, walking distance, step length, and stance time on each foot. The Five-Times-Sit-To-Stand test (FTSST) and Timed Up and Go test (TUG) were used as balance measures. [Results] The sideways gait training with visual blocking group showed significantly improved walking speed, walking distance, step length, and stance time on each foot after training; FTSST and TUG times also significantly improved after training in the experimental group. Compared to the control group, the experimental group showed significant increases in stance time on each foot. [Conclusion] Sideways gait training on a treadmill with visual blocking performed by patients with brain lesions significantly improved their balance and gait function.	[Kim, Tea-Woo] Jeonju Univ, Grad Sch, Dept Rehabil Sci, Jeonju Si, Jeollabuk Do, South Korea; [Kim, Yong-Wook] Jeonju Univ, Coll Med Sci, Dept Phys Therapy, Jeonju 560759, Jeonbuk Do, South Korea		Kim, YW (corresponding author), Jeonju Univ, Coll Med Sci, Dept Phys Therapy, 303 Cheonjam Ro, Jeonju 560759, Jeonbuk Do, South Korea.	ptkim@jj.ac.kr		Kim, Yongwook/0000-0002-0311-9766			Aaslund MK, 2008, GAIT POSTURE, V28, P303, DOI 10.1016/j.gaitpost.2008.01.011; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P274, DOI 10.1016/j.apmr.2003.06.016; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P268, DOI 10.1016/j.apmr.2003.06.017; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Faria CDCD, 2009, TOP STROKE REHABIL, V16, P196, DOI 10.1310/tsr1603-196; De Bujanda E, 2003, J REHABIL MED, V35, P259, DOI 10.1080/16501970310012428; Fujisawa H, 2006, CLIN REHABIL, V20, P340, DOI 10.1191/0269215506cr949oa; Hesse S, 2001, ARCH PHYS MED REHAB, V82, P1547, DOI 10.1053/apmr.2001.26607; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Januario F, 2010, DISABIL REHABIL, V32, P1775, DOI 10.3109/09638281003734433; Kim CM, 2004, GAIT POSTURE, V20, P140, DOI 10.1016/j.gaitpost.2003.07.002; Kim YW, 2013, J PHYS THER SCI, V25, P1279, DOI 10.1589/jpts.25.1279; Knikou M, 2002, EXP BRAIN RES, V143, P149, DOI 10.1007/s00221-001-0978-4; KREBS DE, 1992, PHYS THER, V72, P505, DOI 10.1093/ptj/72.7.505; Maguire C, 2010, CLIN REHABIL, V24, P37, DOI 10.1177/0269215509342335; Mercer VS, 2009, J GERIATR PHYS THER, V32, P6, DOI 10.1519/00139143-200932020-00003; Miller EW, 2002, PHYS THER, V82, P53, DOI 10.1093/ptj/82.1.53; Mohan U, 2013, ANN INDIAN ACAD NEUR, V16, P634, DOI 10.4103/0972-2327.120496; Neumann DA, 1996, PHYS THER, V76, P1320, DOI 10.1093/ptj/76.12.1320; Patterson SL, 2008, J REHABIL RES DEV, V45, P221, DOI 10.1682/JRRD.2007.02.0024; Pavawalla SP, 2006, J INT NEUROPSYCH SOC, V12, P802, DOI 10.1017/S135561770606098X; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; THORSTENSSON A, 1984, ACTA PHYSIOL SCAND, V121, P9, DOI 10.1111/j.1748-1716.1984.tb10452.x; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Yelnik AP, 2008, NEUROREHAB NEURAL RE, V22, P468, DOI 10.1177/1545968308315996; Zanetti C, 2007, EUR J APPL PHYSIOL, V100, P331, DOI 10.1007/s00421-007-0434-7	27	7	10	0	4	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	SEP	2014	26	9					1415	1418		10.1589/jpts.26.1415			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	AY3GC	WOS:000347471500020	25276026	Green Published, Green Submitted, gold			2022-02-06	
J	Proctor, JL; Fourney, WL; Leiste, UH; Fiskum, G				Proctor, Julie L.; Fourney, William L.; Leiste, Ulrich H.; Fiskum, Gary			Rat model of brain injury caused by under-vehicle blast-induced hyperacceleration	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Axonal injury; astrocyte; inflammation; internal capsule; cerebellum	OVERPRESSURE; MECHANISMS; SILVER	BACKGROUND: More than 300,000 US war fighters in Operations Iraqi and Enduring Freedom have sustained some form of traumatic brain injury (TBI), caused primarily by exposure to blasts. Many victims are occupants in vehicles that are targets of improvised explosive devices. These underbody blasts expose the occupants to vertical acceleration that can range from several to more than 1,000 G; however, it is unknown if blast-induced acceleration alone, in the absence of exposure to blast waves and in the absence of secondary impacts, can cause even mild TBI. METHODS: We approached this knowledge gap using rats secured to a metal platform that is accelerated vertically at either 20 G or 50 G in response to detonation of a small explosive (pentaerythritol tetranitrate) located at precise underbody standoff distances. All rats survived the blasts and were perfusion fixed for brain histology at 4 hours to 30 days later. RESULTS: Robust silver staining indicative of axonal injury was apparent throughout the internal capsule, corpus callosum, and cerebellum within 24 hours after blast exposure and was sustained for at least 7 days. Astrocyte activation, as measured morphologically with brains immunostained for glial fibrillary acidic protein, was also apparent early after the blast and persisted for at least 30 days. CONCLUSION: Exposure of rats to underbody blast-induced accelerations at either 20 G or 50 G results in histopathologic evidence of diffuse axonal injury and astrocyte activation but no significant neuronal death. The significance of these results is that they demonstrate that blast-induced vertical acceleration alone, in the absence of exposure to significant blast pressures, causes mild TBI. This unique animal model of TBI caused by underbody blasts may therefore be useful in understanding the pathophysiology of blast-induced mild TBI and for testing medical and engineering-based approaches toward mitigation. (J Trauma Acute Care Surg. 2014; 77: S83-S87. Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Proctor, Julie L.; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Proctor, Julie L.; Fiskum, Gary] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr STAR, Baltimore, MD 21201 USA; [Fourney, William L.; Leiste, Ulrich H.] Univ Maryland, Sch Engn, Dept Mech Engn, Baltimore, MD 21201 USA; [Fourney, William L.; Leiste, Ulrich H.] Univ Maryland, Ctr Energet Concepts Dev, Baltimore, MD 21201 USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 685 Baltimore St,534 MSTF, Baltimore, MD 21201 USA.	gfiskum@anes.umm.edu			US Air Force grant [FA8650-11-2-6D04]; US Army grant [W81XWH-13-1-0016]	There are no financial, consultant, institutional, or relationship conflicts declared by any author. This work was supported in part by US Air Force grant FA8650-11-2-6D04 and the US Army grant W81XWH-13-1-0016.	Cernak Ibolja, 1995, Magnesium Research, V8, P249; Fourney W. L., 2005, Fragblast, V9, P205, DOI 10.1080/13855140500431989; Fourney W. L., 2005, Fragblast, V9, P1; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Tenkova Tatyana I., 2007, V399, P31, DOI 10.1007/978-1-59745-504-6_3	18	7	7	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2014	77			2			S83	S87		10.1097/TA.0000000000000340			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AO2BL	WOS:000341120400006	25159367				2022-02-06	
J	Saigal, R; Batjer, HH; Ellenbogen, RG; Berger, MS				Saigal, Rajiv; Batjer, H. Hunt; Ellenbogen, Richard G.; Berger, Mitchel S.			Return to Play for Neurosurgical Patients	WORLD NEUROSURGERY			English	Article						Athlete; Craniotomy; Neurosurgical lesion; Return to play; Spine instrumentation; Sports; Survey	ARACHNOID CYST SECONDARY; CERVICAL-SPINE; HEADING INJURY; FOOTBALL; OUTCOMES; SPORTS; CORD	BACKGROUND: Concussion and sports-related cranial and spine injuries recently have garnered increased attention from the media, public, and sports' governing bodies. Although concussion has been well-studied, there are minimal data on return to play for structural neurosurgical lesions. OBJECTIVE: We aimed to study current neurosurgical practice on return to play for structural neurosurgical lesions in order to eventually establish guidelines for these athletes. METHODS: A survey was sent to all American Association of Neurological Surgeons members inviting them to submit information on athletes who presented with structural neurosurgical lesions. These included both operative and nonoperative lesions. Ten examples of relevant clinical scenarios were included. Neurosurgeons were surveyed about their practice of clearing these patients for return to play and about patient outcomes afterwards, including any clinical sequelae. Responses were tabulated and studied to search for trends in current practice. Nonstructural cases, such as concussion and cervical strain cases, were excluded. The Mann-Whitney U test was used to test for statistical difference in the time to return for spine versus cranial, instrumented versus noninstrumented spine, and pediatric versus adult cases. RESULTS: Ninety-eight respondents entered data on a total of 189 patients (118 surgical and 71 nonoperative/incidental). In the surgical category, 109 cases (41 cranial, 67 spine, and 1 peripheral nerve lesions) met inclusion criteria. There was a significant difference in time to return between spine (88% returned <= 6 months) versus cranial (50% returned >6 months, P < 0.001), noninstrumented (55% returned <= 3 months) versus instrumented spine (92% returned >3 months, P = 0.001), and adult (78% returned <= 6 months) versus pediatric cases (52% returned >6 months, P = 0.021). Fifty nonoperative/incidental cases met inclusion criteria; 94% of athletes returning to play with nonoperative lesions had no reported clinical sequelae. All nonsurgical and 81% of surgical respondents required deficit resolution before return to play. CONCLUSIONS: The results presented here are the first effort to study current practice on return to play for structural neurosurgical lesions. They establish an early foundation for neurosurgical guidelines on these patients.	[Saigal, Rajiv; Berger, Mitchel S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94107 USA; [Batjer, H. Hunt] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Saigal, R (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94107 USA.	saigalr@neurosurg.ucsf.edu					BAILES JE, 1991, NEUROSURGERY, V29, P491, DOI 10.1227/00006123-199110000-00001; Blount JP, 2004, NEUROSURGERY, V54, P1190, DOI 10.1227/01.NEU.0000119236.08000.49; Callaway GH, 1996, MED SCI SPORT EXER, V28, P1218, DOI 10.1097/00005768-199610000-00002; Cantu RC, 2013, CURR SPORT MED REP, V12, P14, DOI 10.1249/JSR.0b013e31827dc1fb; Cress M, 2013, NEUROSURGERY, V72, P716, DOI 10.1227/NEU.0b013e318285b3a4; Demetriades AK, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005710; HERZOG RJ, 1991, SPINE, V16, pS178, DOI 10.1097/00007632-199106001-00001; Hsu WK, 2011, SPINE, V36, P800, DOI 10.1097/BRS.0b013e3181e50651; Jamault V, 2013, NURSE PRACTITIONER, V38, P3; Jamault Vanessa, 2013, Nurse Pract, V38, P16, DOI 10.1097/01.NPR.0000425825.82811.ae; Kawanishi A, 1999, NEUROL MED-CHIR, V39, P231, DOI 10.2176/nmc.39.231; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maroon JC, 2013, NEUROSURGERY, V73, P103, DOI 10.1227/01.neu.0000429843.68836.91; Mayers LB, 2013, J NEUROPSYCH CLIN N, V25, P115, DOI 10.1176/appi.neuropsych.11120374; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; Petraglia Anthony L, 2012, Surg Neurol Int, V3, P126, DOI 10.4103/2152-7806.102351; Prabhu VC, 2002, NEUROSURGERY, V50, P195; TORG JS, 1993, AM J SPORT MED, V21, P640, DOI 10.1177/036354659302100502; Torg JS, 1991, CLIN J SPORT MED, V1, P12; Tsuzuki N, 2003, NEUROSURGERY, V53, P242, DOI 10.1227/01.NEU.0000072303.16102.E1; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vigil DV, 1998, CLIN J SPORT MED, V8, P234, DOI 10.1097/00042752-199807000-00013; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	24	7	7	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP-OCT	2014	82	3-4					485	491		10.1016/j.wneu.2014.06.043			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AQ6HV	WOS:000342912300098	25043128				2022-02-06	
J	Wang, W; Gao, J; Na, L; Jiang, HT; Xue, JF; Yang, ZJ; Wang, P				Wang, Wei; Gao, Jun; Na, Lei; Jiang, Hongtao; Xue, Jingfeng; Yang, Zhenjun; Wang, Pei			Craniocerebral injury promotes the repair of peripheral nerve injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; craniocerebral injury; peripheral nerve; sciatic nerve; sciatic nerve injury; nerve repair; horseradish peroxidase tracer technique; neural regeneration	TRAUMATIC BRAIN-INJURY; DORSAL-ROOT-GANGLIA; GROWTH-FACTOR; HEAD-INJURY; CALLUS FORMATION; FRACTURE; REGENERATION; RAT; EXPRESSION; RESECTION	The increase in neurotrophic factors after craniocerebral injury has been shown to promote fracture healing. Moreover, neurotrophic factors play a key role in the regeneration and repair of peripheral nerve. However, whether craniocerebral injury alters the repair of peripheral nerve injuries remains poorly understood. Rat injury models were established by transecting the left sciatic nerve and using a free-fall device to induce craniocerebral injury. Compared with sciatic nerve injury alone after 6-12 weeks, rats with combined sciatic and craniocerebral injuries showed decreased sciatic functional index, increased recovery of gastrocnemius muscle wet weight, recovery of sciatic nerve ganglia and corresponding spinal cord segment neuron morphologies, and increased numbers of horseradish peroxidase-labeled cells. These results indicate that craniocerebral injury promotes the repair of peripheral nerve injury.	[Wang, Wei; Wang, Pei] Chengde Med Coll, Affiliated Hosp, Dept Hand & Foot Surg, Chengde 067000, Hebei Province, Peoples R China; [Gao, Jun; Na, Lei; Jiang, Hongtao] Chengde Med Coll, Dept Postgrad, Chengde 067000, Hebei Province, Peoples R China; [Xue, Jingfeng; Yang, Zhenjun] Chengde Med Coll, Dept Anat, Chengde 067000, Hebei Province, Peoples R China		Wang, P (corresponding author), Chengde Med Coll, Affiliated Hosp, Dept Hand & Foot Surg, Chengde 067000, Hebei Province, Peoples R China.	cdgkwp@sina.com			Hebei Provincial Science and Technology Department in China [142777105D, 13277772D]	This study was supported by a grant from Hebei Provincial Science and Technology Department in China, No. 142777105D, 13277772D.	ARVIDSSON J, 1986, BRAIN RES, V373, P15, DOI 10.1016/0006-8993(86)90310-0; Cheng SA, 2006, ZHEJIANG YIXUE, V28, P353; De Souza AS, 2004, J NEUROTRAUM, V21, P627, DOI 10.1089/089771504774129955; [董玉珍 Dong Yuzhen], 2011, [重庆医学, Chongqing Medicine], V40, P2096; English AW, 2011, EUR J NEUROSCI, V33, P2265, DOI 10.1111/j.1460-9568.2011.07724.x; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GIBSON JMC, 1960, J BONE JOINT SURG BR, V42, P425; Gillardon F, 1996, BRAIN RES, V739, P244, DOI 10.1016/S0006-8993(96)00829-3; Hong A, 1999, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V13, P287; Khare G N, 1995, Indian J Med Sci, V49, P281; Liang AL, 2007, DISAN JUNYI DAXUE XU, V29, P717; Liu GH, 2012, ZHONGGUO ZUZHI GONGC, V16, P8721; Liu HW, 2013, NEURAL REGEN RES, V8, P3139, DOI 10.3969/j.issn.1673-5374.2013.33.008; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; MEAROW KM, 1994, J NEUROBIOL, V25, P127, DOI 10.1002/neu.480250205; MESULAM MM, 1977, NEUROSCI LETT, V5, P7, DOI 10.1016/0304-3940(77)90157-4; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Pan Shi-peng, 2009, Zhongguo Gu Shang, V22, P122; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; RISLING M, 1983, EXP NEUROL, V82, P568, DOI 10.1016/0014-4886(83)90081-X; SECKEL BR, 1984, PLAST RECONSTR SURG, V74, P173, DOI 10.1097/00006534-198408000-00001; Shen F, 2012, ZHONGGUO GU YU GUANJ, P601; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Wang G, 2013, ZHONGHUA XIANWEI WAI, V36, P558; Wang W, 2011, SHANDONG YIYAO, V51, P20; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1; Yan H, 2013, NEUROL RES, V35, P537, DOI 10.1179/1743132813Y.0000000201; Yang HL, 2012, ZHONGGUO XIANDAI YIX, V22, P44; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193; Yegiyants S, 2010, J CRANIOFAC SURG, V21, P998, DOI 10.1097/SCS.0b013e3181e17aef; Yu HL, 2014, NEUROSCI LETT, V566, P177, DOI 10.1016/j.neulet.2014.02.065; Zhang LC, 2013, MED HYPOTHESES, V81, P713, DOI 10.1016/j.mehy.2013.07.034; Zhao JP, 2014, YIXUE XINXI, V27, P154; Zhuang YF, 2013, ASIAN PAC J TROP MED, V6, P383, DOI 10.1016/S1995-7645(13)60043-7	36	7	7	0	15	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	SEP	2014	9	18					1703	1708		10.4103/1673-5374.141807			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AQ7AX	WOS:000342966100010	25374593	Green Published, gold			2022-02-06	
J	Xu, GZ; Li, W; Liu, KG; Wu, W; Lu, WC; Zhang, JF; Wang, MD				Xu, Gang-Zhu; Li, Wen; Liu, Kai-Ge; Wu, Wei; Lu, Wen-Chao; Zhang, Jun-Feng; Wang, Mao-De			Early Pressure Dressing for the Prevention of Subdural Effusion Secondary to Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Traumatic brain injury; decompressive craniectomy; subdural effusion; pressure dressing	COMPLICATIONS; HYGROMA; HYDROCEPHALUS	This study was performed to investigate the effect of early pressure dressing on the prevention of postoperative subdural effusion secondary to decompressive craniectomy (DC) in patients with severe traumatic brain injury (STBI). Patients with STBI who had undergone DC for refractory increased intracranial pressure between January 2008 and December 2011 (n = 169) were randomly divided into early pressure dressing (n = 82) and control (n = 87) groups. Early pressure dressing with an elastic bandage or general wrapping (control treatment) was applied 7 to 10 days after DC. Patients' age, sex, preoperative Glasgow Coma Scale score, incidence rate of subdural effusion, hospitalization time, and postoperative Glasgow Outcome Scale score were compared between groups. Intracranial pressure was measured immediately before and on the day after pressure dressing. No significant difference in age, sex, preoperative Glasgow Coma Scale score, or postoperative Glasgow Outcome Scale score was observed between groups (P > 0.05). Subdural effusion incidence rates were significantly lower in the early pressure dressing group than those in the control group (chi(2) = 5.449, P = 0.021), and a larger proportion of patients in the early pressure dressing group was hospitalized for 30 days or less (chi(2) = 5.245, P = 0.027). Early pressure dressing 7 to 10 days after DC, which is a noninvasive, simple procedure, reduced the incidence rate of subdural effusion and shortened hospitalization time after DC for STBI.	[Xu, Gang-Zhu; Wang, Mao-De] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China; [Xu, Gang-Zhu; Li, Wen; Liu, Kai-Ge; Wu, Wei; Lu, Wen-Chao; Zhang, Jun-Feng] Xian Med Coll, Affiliated Hosp, Dept Neurosurg, Xian, Peoples R China		Wang, MD (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	xgz917@126.com; maodewang@163.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; ARSALO A, 1977, CHILD BRAIN, V3, P79; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; FRENCH BN, 1978, SURG NEUROL, V9, P145; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; JENNETT B, 1975, LANCET, V1, P480; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kumar R, 2006, CHILD NERV SYST, V22, P1237, DOI 10.1007/s00381-006-0047-1; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MIZOI K, 1981, CHILD BRAIN, V8, P307; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SAKAI N, 1990, CHILD NERV SYST, V6, P447, DOI 10.1007/BF00302091; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; Su FW, 2008, J CLIN NEUROSCI, V15, P305, DOI 10.1016/j.jocn.2006.08.019; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Xiong NX, 2004, CHIN J CLIN NEUROSUR, V9, P427; Yang XF, 2010, ACTA NEUROCHIR, V152, P555, DOI 10.1007/s00701-009-0475-2; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	31	7	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2014	25	5					1836	1839		10.1097/SCS.0b013e3182a21056			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AP2VK	WOS:000341933600100	25072976				2022-02-06	
J	Brooks, BL; Sherman, EMS; Iverson, GL				Brooks, Brian L.; Sherman, Elisabeth M. S.; Iverson, Grant L.			Embedded Validity Indicators on CNS Vital Signs in Youth with Neurological Diagnoses	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Childhood neurologic disorders; Malingering; symptom validity testing; Assessment; Effort testing; Children	TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; TEST-PERFORMANCE; DIGIT SPAN; PEDIATRIC SAMPLE; CHILDREN; ADOLESCENTS; TOMM; DISORDERS; EPILEPSY	Computerized screening measures can provide valuable information on cognition. However, determining the validity of obtained data is critical for interpretation. The purpose of this study was to examine the embedded validity indicators on the CNS Vital Signs battery in a sample of youth with neurological diagnoses. The sample included 275 children and adolescents (mean = 13.9, SD = 3.0) with neurological disorders. Six out of seven subtests and six of the nine domain scores on CNS Vital Signs had fewer than 5% of the sample flagged as invalid on the embedded indicators. However, the Shifting Attention Test and its derived domain scores had higher rates of being flagged. Patients with one or more flagged scores (18% of sample) were younger and had lower intellectual abilities, psychomotor speed, verbal memory, and performance on other validity tests. Compared to stand-alone validity tests, CNS Vital Signs embedded validity indicators had low sensitivity. More research is needed with the embedded indicators in youth.	[Brooks, Brian L.; Sherman, Elisabeth M. S.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.; Sherman, Elisabeth M. S.] Univ Calgary, Dept Paediat, Fac Med, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.; Sherman, Elisabeth M. S.] Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Sherman, Elisabeth M. S.] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB, Canada; [Sherman, Elisabeth M. S.] Copeman Healthcare Ctr, Brain Hlth Program, Calgary, AB, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Calgary, AB, Canada; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Iverson, Grant L.] Copeman Healthcare Ctr, Vancouver, BC, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca		Iverson, Grant/0000-0001-7348-9570	Psychological Assessment Resources, Inc.; CNS Vital Signs; ImPACT Applications Systems	Collection of cognitive data was supported through in-kind support from the publisher of the CNS Vital Signs test (i.e., test credits). Drs Brooks and Sherman currently receive funding from another test publisher, Psychological Assessment Resources, Inc. Drs Brooks and Sherman receive book royalties from Oxford University Press. Dr Iverson has received past research support from CNS Vital Signs, ImPACT Applications Systems, and Psychological Assessment Resources, Inc. He has not received research support from a publishing company during the past 3 years. None of the authors, nor their families, have a financial interest in CNS Vital Signs.	Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Brooks B.L., 2012, PEDIAT FORENSIC NEUR; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone D. A., CHILD NEUROPSYCHOLOG; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; CNS Vital Signs, 2014, CNS VIT SIGNS TEST I; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gualtieri C. T., 2009, 20 ANN M AM NEUR ASS; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Loughan AR, 2014, APPL NEUROPSYCH-CHIL, V3, P26, DOI 10.1080/21622965.2012.670584; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Perna R, 2014, APPL NEUROPSYCH-CHIL, V3, P45, DOI 10.1080/21622965.2012.691067; Perna RB, 2013, CHILD NEUROPSYCHOL, V19, P438, DOI 10.1080/09297049.2012.731500; Rienstra A, 2010, ARCH CLIN NEUROPSYCH, V25, P371, DOI 10.1093/arclin/acq035; Rohling M, 2011, ARCH CLIN NEUROPSYCH, V26, P563; Saffer B. Y., 2013, J INT NEUROPSYCH SOC, V19, P131; SEIDEL WT, 1991, CLIN NEUROPSYCHOL, V5, P53; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063	44	7	8	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2014	29	5					422	431		10.1093/arclin/acu029			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AM6AZ	WOS:000339944200003	25034266	Bronze			2022-02-06	
J	Foerch, C; Pfeilschifter, W; Zeiner, P; Brunkhorst, R				Foerch, C.; Pfeilschifter, W.; Zeiner, P.; Brunkhorst, R.			Glial fibrillary acidic protein in patients with symptoms of acute stroke. Diagnostic marker of cerebral hemorrhage	NERVENARZT			German	Article						Ischemic stroke; Traumatic brain injury; Glioblastoma; Blood pressure; Predictive value of tests	TRAUMATIC BRAIN-INJURY; DIFFERENTIATING INTRACEREBRAL HEMORRHAGE; ACUTE ISCHEMIC-STROKE; SERUM S100B LEVELS; NEUROMYELITIS-OPTICA; BIOMARKER; METAANALYSIS; THERAPY; BLOOD; ACCURACY	Glial fibrillary acidic protein (GFAP) is a highly brain-specific protein that is expressed in large quantities in astrocytes and has important functions in terms of maintaining and stabilizing the cytoskeleton. Acute intracerebral hemorrhage leads to an immediate mechanical destruction of astroglial cells with the subsequent release of GFAP into the extracellular space and the bloodstream. On the other hand, necrosis, cytolysis and GFAP release does not occur before 6-12 h after symptom onset in ischemic stroke. Thus, in the early hours after stroke increased GFAP values could indicate intracerebral hemorrhage. This review article describes the underlying pathophysiology of the test and guides the reader through the available data. Potential implications regarding the prehospital triage of acute stroke patients are discussed, including the possibility to initiate hyperacute treatment, such as blood pressure reduction in patients with intracerebral hemorrhage. Other areas of interest for a potential GFAP test include traumatic brain injury and malignant gliomas.	[Foerch, C.; Pfeilschifter, W.; Zeiner, P.; Brunkhorst, R.] Klinikum Goethe Univ, Neurol Klin, D-60528 Frankfurt, Germany		Foerch, C (corresponding author), Klinikum Goethe Univ, Neurol Klin, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	foerch@em.uni-frankfurt.de					Aguilar MI, 2007, MAYO CLIN PROC, V82, P82, DOI 10.1016/s0025-6196(11)60970-1; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Brown TJ, 1993, CAN SOC FORENSIC SCI, V26, P69; Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Bukhari W, 2012, INT J MOL SCI, V13, P12970, DOI 10.3390/ijms131012970; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Gladstone DJ, 2009, STROKE, V40, P3841, DOI 10.1161/STROKEAHA.108.540377; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Husain H, 2012, J NEURO-ONCOL, V109, P123, DOI 10.1007/s11060-012-0874-8; Ilhan-Mutlu A, 2013, NEUROSURG REV, V36, P45, DOI 10.1007/s10143-012-0401-6; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; McMullan JT, 2010, INT J EMERG MED, V3, P127, DOI 10.1007/s12245-010-0177-9; Missler U, 1999, CLIN CHEM, V45, P138; Misu T, 2009, J NEUROL NEUROSUR PS, V80, P575, DOI 10.1136/jnnp.2008.150698; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Steiner T, 2006, STROKE, V37, P256, DOI 10.1161/01.STR.0000196989.09900.f8; Sun Y, 2013, SCAND J CLIN LAB INV, V73, P601, DOI 10.3109/00365513.2013.830326; Ting JY, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-45; Ting JY, 2011, INT J EMERG MED, V4, P1; Unden J, 2009, J NEUROL, V256, P72, DOI 10.1007/s00415-009-0054-8; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Whiteley W, 2012, INT J STROKE, V7, P435, DOI 10.1111/j.1747-4949.2012.00784.x; Woertgen C, 2002, ACT NEUR S, V81, P205; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x; Zhang J, 2013, NEUROL SCI, V34, P1887, DOI 10.1007/s10072-013-1541-3	41	7	11	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	AUG	2014	85	8					982	989		10.1007/s00115-014-4128-1			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	AN2EH	WOS:000340396300008	25057113				2022-02-06	
J	Kapoor, D; Singla, D; Singh, J; Jindal, R				Kapoor, Dheeraj; Singla, Deepak; Singh, Jasveer; Jindal, Rohit			Paroxysmal autonomic instability with dystonia (PAID) syndrome following cardiac arrest	SINGAPORE MEDICAL JOURNAL			English	Article						autonomic nervous system; brain injury; cardiac arrest; diffuse axonal injury; paroxysmal autonomic instability with dystonia	TRAUMATIC BRAIN-INJURY; DIENCEPHALIC SEIZURES; HEAD-INJURY; BROMOCRIPTINE; DYSAUTONOMIA; DYSFUNCTION; MANAGEMENT	Paroxysmal autonomic instability with dystonia (PAID) appears to be a unique syndrome following brain injury. It can echo many life-threatening conditions, making its early recognition and management a challenge for intensivists. A delay in early recognition and subsequent management may result in increased morbidity, which is preventable in affected patients. Herein, we report the case of a patient who was diagnosed with PAID syndrome following prolonged cardiac arrest, and discuss the pathophysiology, clinical presentation and management of this rare and under-recognised clinical entity.	[Kapoor, Dheeraj; Singla, Deepak; Singh, Jasveer] Govt Med Coll & Hosp, Dept Anaesthesia & Intens Care, Chandigarh, India; [Jindal, Rohit] Govt Med Coll & Hosp, Dept Orthopaed, Chandigarh, India		Kapoor, D (corresponding author), 1207,Sect 32 B, Chandigarh 160030, India.	kapoor.dheeraj72@gmail.com		Singla, Deepak/0000-0001-5238-6791			Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Bulakbasi N, 2000, TURK J MED SCI, V30, P571; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; CHIOLERO RL, 1989, CRIT CARE MED, V17, P328, DOI 10.1097/00003246-198904000-00006; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; GRANATO JE, 1983, ANN NEUROL, V14, P89, DOI 10.1002/ana.410140117; McEvoy GK, 1994, AHFS DRUG INFORMATIO, P1195; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; SILVER JK, 1994, ARCH PHYS MED REHAB, V75, P885, DOI 10.1016/0003-9993(94)90113-9	15	7	8	0	2	SINGAPORE MEDICAL ASSOC	SINGAPORE	2985 JALAN BUKIT MERAH, #02-2C, SMF BUILDING, SINGAPORE, SINGAPORE	0037-5675			SINGAP MED J	Singap. Med. J.	AUG	2014	55	8					E123	E125		10.11622/smedj.2013264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY5NS	WOS:000347619800003	25189311	Bronze, Green Published			2022-02-06	
J	Paxton, J; Chiaravalloti, N				Paxton, Jessica; Chiaravalloti, Nancy			Rule Monitoring Ability Predicts Event-Based Prospective Memory Performance in Individuals with TBI	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Memory for intentions; Executive functioning; Errors; Head injury; Retrospective memory; Prefrontal cortex	TRAUMATIC BRAIN-INJURY; ADULT AGE-DIFFERENCES; EXECUTIVE FUNCTIONS; RETROSPECTIVE COMPONENTS; PROCESSING SPEED; RETRIEVAL; ATTENTION; DEFICITS; INTENTIONS; AWARENESS	Numerous studies have demonstrated that prospective memory (PM) abilities are impaired following traumatic brain injury (TBI). PM refers to the ability to remember to complete a planned action following a delay. PM post-TBI has been shown to be related to performance on neuropsychological tests of executive functioning and retrospective episodic memory (RM). However, the relative influence of impairments in RM versus executive functioning on PM performance post-TBI remains uninvestigated. In the current study, PM and neuropsychological test performance were examined in 45 persons with a history of moderate to severe TBI at least 1 year before enrollment. Regression analyses examined the relative contributions of RM and executive functioning in the prediction of PM performance on the Rivermead Behavioral Memory Test (RBMT). Results indicated that scores on tests of delayed RM and rule monitoring (i.e., ability to avoid making errors on executive measures) were the strongest predictors of PM. When the interaction between RM impairment and rule monitoring was examined, a positive relationship between PM and rule monitoring was found only in TBI participants with impaired RM. Results suggest that PM performance is dependent upon rule monitoring abilities only when RM is impaired following TBI.	[Paxton, Jessica; Chiaravalloti, Nancy] Kessler Fdn, W Orange, NJ 07052 USA; [Paxton, Jessica; Chiaravalloti, Nancy] Rutgers State Univ, Dept Phys Med & Rehabil, Newark, NJ USA		Chiaravalloti, N (corresponding author), Kessler Fdn, 300 Execut Dr,Suite 70, W Orange, NJ 07052 USA.	nchiaravalloti@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute on Disability and Rehabilitation Research (N.D.C.) [H133A070037, H133P090009]	The authors acknowledge grant support from the National Institute on Disability and Rehabilitation Research (N.D.C., H133A070037 & H133P090009). However, these contents do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Government should not be assumed. The authors report no conflicts of interest.	Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Berkman ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040334; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Carey CL, 2008, NEUROPSYCHOLOGIA, V46, P1081, DOI 10.1016/j.neuropsychologia.2007.11.001; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delprado J, 2012, J INT NEUROPSYCH SOC, V18, P295, DOI 10.1017/S135561771100172X; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Denney DR, 2009, J INT NEUROPSYCH SOC, V15, P451, DOI 10.1017/S1355617709090730; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Martin M., 2003, INT J PSYCHOL, V38, P193; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Pavawalla SP, 2012, NEUROPSYCHOLOGY, V26, P91, DOI 10.1037/a0025866; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Possin KL, 2009, J INT NEUROPSYCH SOC, V15, P354, DOI 10.1017/S135561770909050X; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; Rajah MN, 2006, NEUROPSYCHOLOGIA, V44, P350, DOI 10.1016/j.neuropsychologia.2005.06.003; Raskin SA, 2012, NEUROPSYCHOL REHABIL, V22, P40, DOI 10.1080/09602011.2011.632908; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; SALTHOUSE TA, 1994, DEV PSYCHOL, V30, P240, DOI 10.1037/0012-1649.30.2.240; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P736, DOI 10.1037/a0018971; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652	64	7	8	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2014	20	7					673	683		10.1017/S1355617714000575			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	AN9QW	WOS:000340943800001	25068409				2022-02-06	
J	Steuer, E; Schaefer, ML; Belluscio, L				Steuer, Elizabeth; Schaefer, Michele L.; Belluscio, Leonardo			Using the Olfactory System as an In Vivo Model To Study Traumatic Brain Injury and Repair	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; APP; biomarker; circuit repair; mouse model; olfactory system; p75(NTR); regeneration; traumatic brain injury	AMYLOID PRECURSOR PROTEIN; FIBRILLARY ACIDIC PROTEIN; HEAD-INJURY; S-NITROSOGLUTATHIONE; SYNAPTIC PLASTICITY; SUBVENTRICULAR ZONE; FUNCTIONAL RECOVERY; CORTICAL CONTUSION; VOLUNTARY EXERCISE; CEREBRAL-ISCHEMIA	Loss of olfactory function is an early indicator of traumatic brain injury (TBI). The regenerative capacity and well-defined neural maps of the mammalian olfactory system enable investigations into the degeneration and recovery of neural circuits after injury. Here, we introduce a unique olfactory-based model of TBI that reproduces many hallmarks associated with human brain trauma. We performed a unilateral penetrating impact to the mouse olfactory bulb and observed a significant loss of olfactory sensory neurons (OSNs) in the olfactory epithelium (OE) ipsilateral to the injury, but not contralateral. By comparison, we detected the injury markers p75(NTR), beta-APP, and activated caspase-3 in both the ipsi- and contralateral OE. In the olfactory bulb (OB), we observed a graded cell loss, with ipsilateral showing a greater reduction than contralateral and both significantly less than sham. Similar to OE, injury markers in the OB were primarily detected on the ipsilateral side, but also observed contralaterally. Behavioral experiments measured 4 days after impact also demonstrated loss of olfactory function, yet following a 30-day recovery period, we observed a significant improvement in olfactory function and partial recovery of olfactory circuitry, despite the persistence of TBI markers. Interestingly, by using the M71-IRES-tauLacZ reporter line to track OSN organization, we further determined that inducing neural activity during the recovery period with intense odor conditioning did not enhance the recovery process. Together, these data establish the mouse olfactory system as a new model to study TBI, serving as a platform to understand neural disruption and the potential for circuit restoration.	[Steuer, Elizabeth; Schaefer, Michele L.; Belluscio, Leonardo] NINDS, Dev Neural Plast Sect, NIH, Bethesda, MD 20892 USA; [Steuer, Elizabeth; Schaefer, Michele L.; Belluscio, Leonardo] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Belluscio, L (corresponding author), NINDS, Dev Neural Plast Sect, Porter Neurosci Res Ctr, Bldg 35,Room 3E-410,35 Convent Dr,MSC 3703, Bethesda, MD 20892 USA.	belluscl@ninds.nih.gov			Center for Neuroscience and Regenerative Medicine (HJF) [60855-CNRM]; National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003116-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003116] Funding Source: NIH RePORTER	This work was supported by the Center for Neuroscience and Regenerative Medicine (HJF# 60855-CNRM) and the National Institute of Neurological Disorders and Stroke Intramural Research Program (ZIANS003116-02).	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; ALBERTS JR, 1971, PHYSIOL BEHAV, V6, P619, DOI 10.1016/0031-9384(71)90218-6; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Ardiles Y, 2007, EXP NEUROL, V207, P275, DOI 10.1016/j.expneurol.2007.06.022; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Chu GKT, 2007, NEUROSCIENCE, V148, P668, DOI 10.1016/j.neuroscience.2007.05.028; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Cummings DM, 2008, NEUROSCIENTIST, V14, P251, DOI 10.1177/1073858408315026; Cummings DM, 2010, J NEUROSCI, V30, P9172, DOI 10.1523/JNEUROSCI.1717-10.2010; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; EDWARDS DA, 1972, BEHAV BIOL, V7, P823, DOI 10.1016/S0091-6773(72)80174-3; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; FARBMAN AI, 1990, TRENDS NEUROSCI, V13, P362, DOI 10.1016/0166-2236(90)90017-5; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GIRAUD J C, 1957, Rev Otoneuroophtalmol, V29, P306; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; GREGG B, 1981, PHYSIOL BEHAV, V26, P1133, DOI 10.1016/0031-9384(81)90221-3; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jimenez D F, 1997, J Craniomaxillofac Trauma, V3, P8; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kikuchi K, 2009, BIOCHEM BIOPH RES CO, V390, P1121, DOI 10.1016/j.bbrc.2009.09.015; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kobayashi M, 2009, CHEM SENSES, V34, P573, DOI 10.1093/chemse/bjp038; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Liu JL, 1998, J NEUROSCI, V18, P7768; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; MACKAYSIM A, 1991, EUR J NEUROSCI, V3, P209, DOI 10.1111/j.1460-9568.1991.tb00081.x; Marks CA, 2006, J NEUROSCI, V26, P11257, DOI 10.1523/JNEUROSCI.2805-06.2006; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Papadopoulos MC, 2008, PROG BRAIN RES, V170, P589, DOI 10.1016/S0079-6123(08)00446-9; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roth P, 2000, Crit Care Nurs Q, V23, P14; Roth P., 2000, CRIT CARE NURS Q, V23, P65; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; STRITTMATTER SM, 1992, J NEUROBIOL, V23, P507, DOI 10.1002/neu.480230506; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Tang CH, 2012, PEPTIDES, V36, P39, DOI 10.1016/j.peptides.2012.04.014; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; Venero JL, 2013, DEV NEUROSCI-BASEL, V35, P88, DOI 10.1159/000346155; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang YX, 2013, J SURG RES, V182, P127, DOI 10.1016/j.jss.2012.07.071; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhao HQ, 1996, J NEUROBIOL, V30, P521, DOI 10.1002/(SICI)1097-4695(199608)30:4<521::AID-NEU7>3.0.CO;2-5	89	7	7	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1277	1291		10.1089/neu.2013.3296			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000005	24694002	Green Published			2022-02-06	
J	Falavigna, A; Medeiros, GS; Canabarro, CT; Barazzetti, DO; Marcon, G; Monteiro, GMC; Bossardi, JB; da Silva, PG; Teles, AR; Velho, MC; Ferrari, P				Falavigna, Asdrubal; Medeiros, Gregory Saraiva; Canabarro, Carolina Travi; Barazzetti, Daniel Ongaratto; Marcon, Grasiela; Carneiro Monteiro, Gabriela Massaro; Bossardi, Julia Berthold; da Silva, Pedro Guarise; Teles, Alisson Roberto; Velho, Maira Cristina; Ferrari, Priscila			How can we teach them about neurotrauma prevention ? Prospective and randomized "Pense Bem-Caxias do Sul" study with multiple interventions in preteens and adolescents Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						injury prevention; spinal cord injury; traumatic brain injury; Pense Bem project; ThinkFirst; trauma	INJURY PREVENTION; PROGRAM; KNOWLEDGE; SAFETY	Object. A previous study published by the authors showed that a single intervention could not change the baseline attitudes toward neurotrauma prevention. The present study was designed to evaluate the effectiveness of multiple interventions in modifying knowledge and attitudes for the prevention of neurotrauma in Brazilian preteens and adolescents. Methods. In a randomized controlled trial, fifth-year primary school (PS) and second-year high school (HS) students were divided into a control and 2 intervention (single/multiple) groups. The study was conducted in the following 8 stages: T1, questionnaire to measure baseline characteristics; T2, lecture on trauma prevention; T3, reapplying the questionnaire used in T1; T4, Traffic Department intervention; T5, a play about trauma and its consequences; T6, Fire Department intervention; T7, Emergency Medical Service intervention; and T8, reapplying the questionnaire used in T1 and T3. Positive answers were considered those affirming the use of safety devices "always or sometimes" and negative as "never" using safety devices. Results. The sample consisted of 535 students. Regarding attitudes, students in all groups at any stage of measurement showed protective behavior more than 95% of the time about seat belt use. There were only differences between attitudes in PS and HS students on T8 assessment concerning the use of safety equipment on bikes in the multiple-intervention group and concerning the use of safety equipment on skateboards and rollerblades in single-and multiple-intervention groups. These differences were caused mainly by the reduction in positive answers by the HS group, rather than by the increase in positive or protective answers by the PS group. However, there was no difference when the control and intervention groups were compared, independent of the attitudes or the student groups studied. The most important reason for not using protective devices was the belief that they would not get hurt. Conclusions. Multiple and different types of educational interventions, such as lectures, scenes from plays about trauma and its consequences, traffic and fire department intervention, and medical emergency intervention directed to preteens and adolescents from public and private schools did not modify most students' attitudes toward injury prevention.	[Falavigna, Asdrubal] Univ Caxias Sul, Dept Neurol & Neurosurg, BR-95040290 Caxias Do Sul, RS, Brazil; [Medeiros, Gregory Saraiva; Canabarro, Carolina Travi; Barazzetti, Daniel Ongaratto; Marcon, Grasiela; Carneiro Monteiro, Gabriela Massaro; Bossardi, Julia Berthold; da Silva, Pedro Guarise] Univ Caxias Sul, Liga Acad Multidisciplinar Neurol & Neurocirurgia, BR-95040290 Caxias Do Sul, RS, Brazil; [Teles, Alisson Roberto] Hosp Sao Jose, Complexo Hosp Santa Casa Misericordia Porto Alegr, Neurosurg Unit, Porto Alegre, RS, Brazil; [Velho, Maira Cristina] Hosp Beneficencia Portuguesa, Dept Neurosurg, Porto Alegre, RS, Brazil; [Ferrari, Priscila] Univ Caxias Sul, BR-95040290 Caxias Do Sul, RS, Brazil		Falavigna, A (corresponding author), Univ Caxias Sul, Dept Neurol & Neurosurg, Rua Gen Arcy da Rocha Nobrega 401-602, BR-95040290 Caxias Do Sul, RS, Brazil.	asdrubalmd@gmail.com	Medeiros, Gregory/AAL-8194-2021; Medeiros, Gregory S/F-1675-2013; Falavigna, Asdrubal/H-5123-2012; Teles, Alisson R./U-5661-2018	Falavigna, Asdrubal/0000-0002-0016-3198; Teles, Alisson R./0000-0003-2169-8156	Conselho Nacional de Pesquisa (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS); AOSpine Latin America	We acknowledge the contribution to the organization of the prevention activities by the local Traffic Department; Thiago de Moraes Gonzaga Foundation-"Vida Urgente," DRSUL Group; Regional Fire Department; Emergency Medical Service (SAMU); and Neurology and Neurosurgery. Multidisciplinary Academic League (LAMNN) of the University of Caxias do Sul. Furthermore, we acknowledge the support of Conselho Nacional de Pesquisa (CNPq), Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS), and AOSpine Latin America. We thank, especially, the directors, teachers and students of the schools enrolled in this study.	Babul S, 2007, Int J Inj Contr Saf Promot, V14, P109, DOI 10.1080/17457300701272474; BAKER SP, 1984, INJURY FACT BOOK; Bartolomeos K, 2012, FATAL INJURY SURVEIL; Borse NN, 2009, J SAFETY RES, V40, P71, DOI 10.1016/j.jsr.2009.01.002; Bruce Beth S, 2004, J Pediatr Nurs, V19, P121, DOI 10.1016/S0882-5963(03)00144-1; Eichel JD, 2001, J SCHOOL HEALTH, V71, P180, DOI 10.1111/j.1746-1561.2001.tb07312.x; Falavigna A, 2012, J NEUROSURG-PEDIATR, V9, P562, DOI 10.3171/2011.12.PEDS11169; Gonsaga Ricardo Alessandro Teixeira, 2012, Rev. Col. Bras. Cir., V39, P263; Jorge Maria Helena Prado de Mello, 2004, Rev. bras. epidemiol., V7, P228; Josse JM, 2006, INT J CIRCUMPOL HEAL, V65, P385; Laraque D, 1995, B NEW YORK ACAD MED, V72, P16; Mickalide A, 2012, PEDIATR CLIN N AM, V59, P1367, DOI 10.1016/j.pcl.2012.08.008; Ramsay LJ, 2003, PUBLIC HEALTH, V117, P404, DOI 10.1016/S0033-3506(03)00072-6; Salvarani CP, 2009, SURG NEUROL, V72, P6, DOI 10.1016/j.surneu.2007.10.008; SCHALL E, 1994, AM J PREV MED, V10, P30, DOI 10.1016/S0749-3797(18)30549-X; Shope JT, 2006, INJURY PREV, V12, P9, DOI 10.1136/ip.2006.011874; Vasconcellos EA, 1999, ACCIDENT ANAL PREV, V31, P319, DOI 10.1016/S0001-4575(98)00065-7; Wehner DE, 2005, J EMERG NURS, V31, P383, DOI 10.1016/j.jen.2005.06.001; Wesner ML, 2003, CAN J PUBLIC HEALTH, V94, P115, DOI 10.1007/BF03404583	19	7	7	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2014	14	1					94	100		10.3171/2014.3.PEDS13295			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	AJ8EM	WOS:000337935500014	24766306				2022-02-06	
J	Fujita, Y; Algarra, NN; Vavilala, MS; Prathep, S; Prapruettham, S; Sharma, D				Fujita, Yasuki; Algarra, Nelson N.; Vavilala, Monica S.; Prathep, Sumidtra; Prapruettham, Suchada; Sharma, Deepak			Intraoperative secondary insults during extracranial surgery in children with traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Secondary insults; Pediatric traumatic brain injury; Intraoperative; Anesthesia; Extracranial surgery	RISK-FACTORS; HYPOTENSION; HYPERGLYCEMIA; CRANIOTOMY; PREDICTORS; FIXATION; FRACTURE	Data on intraoperative secondary insults in pediatric traumatic brain injury (TBI) are limited. We examined intraoperative secondary insults during extracranial surgery in children with moderate-severe TBI and polytrauma and their association with postoperative head computed tomography (CT) scans, intracranial pressure (ICP), and therapeutic intensity level (TIL) scores 24 h after surgery. After IRB approval, we reviewed the records of children < 18 years with a Glasgow Coma Scale score < 13 who underwent extracranial surgery within 72 h of TBI. Definitions of secondary insults were as follows: systemic hypotension (SBP < 70 + 2 x age or 90 mmHg), cerebral hypotension (cerebral perfusion pressure < 40 mmHg), intracranial hypertension (ICP > 20 mmHg), hypoxia (oxygen saturation < 90 %), hypercarbia (end-tidal CO2 > 45 mmHg), hypocarbia (end-tidal CO2 < 30 mmHg without hypotension and in the absence of intracranial hypertension), hyperglycemia (blood glucose > 200 mg/dL), hyperthermia (temperature > 38 A degrees C), and hypothermia (temperature < 35 A degrees C). Data from 50 surgeries in 42 patients (median age 15.5 years, 25 males) revealed systemic hypotension during 78 %, hypocarbia during 46 %, and hypercarbia during 25 % surgeries. Intracranial hypertension occurred in 64 % and cerebral hypotension in 18 % surgeries with ICP monitoring (11/50). Hyperglycemia occurred during 17 % of the 29 surgeries with glucose monitoring. Cerebral hypotension and hypoxia were associated with postoperative intracranial hypertension (p = 0.02 and 0.03, respectively). We did not observe an association between intraoperative secondary insults and postoperative worsening of head CT scan or TIL score. Intraoperative secondary insults were common during extracranial surgery in pediatric TBI. Intraoperative cerebral hypotension and hypoxia were associated with postoperative intracranial hypertension. Strategies to prevent secondary insults during extracranial surgery in TBI are needed.	[Fujita, Yasuki; Vavilala, Monica S.; Prathep, Sumidtra; Prapruettham, Suchada; Sharma, Deepak] Univ Washington, Dept Anesthesiol, Seattle, WA 98104 USA; [Fujita, Yasuki; Vavilala, Monica S.; Prathep, Sumidtra; Prapruettham, Suchada; Sharma, Deepak] Univ Washington, Dept Pain Med, Seattle, WA 98104 USA; [Algarra, Nelson N.] Univ Kansas, Kansas City, KS USA; [Sharma, Deepak] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA		Sharma, D (corresponding author), Univ Washington, Harborview Med Ctr, 325 Ninth Ave,Box 359724, Seattle, WA 98104 USA.	dsharma@uw.edu					Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bienengraeber MW, 2005, VASC PHARMACOL, V42, P243, DOI 10.1016/j.vph.2005.02.005; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Centers for Disease Control and Prevention, 2013, TRAUMATIC BRAIN INJU; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chiaretti A, 2002, CHILD NERV SYST, V18, P54, DOI 10.1007/s00381-001-0533-4; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Dagal A, 2009, CURR OPIN ANESTHESIO, V22, P547, DOI 10.1097/ACO.0b013e32833020be; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1108, DOI 10.1038/sj.jcbfm.9600410; Larsen JKR, 2002, J NEUROSURG ANESTH, V14, P16, DOI 10.1097/00008506-200201000-00004; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements, 2013, TRAUM BRAIN INJ DAT; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Sharma Deepak, 2012, Anesthesiol Clin, V30, P333, DOI 10.1016/j.anclin.2012.04.003; Sharma D, 2012, J NEUROSURG ANESTH, V24, P178, DOI 10.1097/ANA.0b013e318254fb70; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Velmahos GC, 1998, AM J SURG, V176, P324, DOI 10.1016/S0002-9610(98)00208-6; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	28	7	7	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2014	30	7					1201	1208		10.1007/s00381-014-2353-3			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AK7TR	WOS:000338631100010	24429505				2022-02-06	
J	Jin, Y; Bouyer, J; Haas, C; Fischer, I				Jin, Ying; Bouyer, Julien; Haas, Christopher; Fischer, Itzhak			Behavioral and anatomical consequences of repetitive mild thoracic spinal cord contusion injury in the rat	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Behavioral analysis; Repeated CNS injury; Anatomical analysis	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; ALZHEIMERS-DISEASE; TRANSIENT QUADRIPLEGIA; CERVICAL NEURAPRAXIA; LOCOMOTOR RECOVERY; TEMPORAL WINDOW; CONCUSSION; STENOSIS; VULNERABILITY	Moderate and severe spinal cord contusion injuries have been extensively studied, yet much less is known about mild injuries. Mild contusions result in transient functional deficits, proceeding to near-complete recovery, but they may render the spinal cord vulnerable to future injuries. However, to date there have been no appropriate models to study the behavioral consequences, anatomical changes, and susceptibility of a mild contusion to repeated injuries, which may occur in children as well as adults during competitive sport activities. We have developed a novel mild spinal cord contusion injury model characterized by a sequence of transient functional deficits after the first injury and restoration to near-complete motor and sensory function, which is then followed up by a second injury. This model can serve not only to study the effects of repeated injuries on behavioral and anatomical changes, but also to examine the relationship between successive tissue damage and recovery of function. In the present study, we confirmed that mild thoracic spinal cord contusion, utilizing the NYU impactor device, resulted in localized tissue damage, characterized by a cystic cavity and peripheral rim of spared white matter at the injury epicenter, and rapid functional recovery to near-normal levels utilizing several behavioral tests. Repeated injury after 3 weeks, when functional recovery has been completed, resulted in worsening of both motor and sensory function, which did not recover to prior levels. Anatomical analyses showed no differences in the volumes of spared white matter, lesion, or cyst, but revealed modest extension of lesion area rostral to the injury epicenter as well as an increase in inflammation and apoptosis. These studies demonstrate that a mild injury model can be used to test efficacy of treatments for repeated injuries and may serve to assist in the formulation of policies and clinical practice regarding mild SCI injury and spinal concussion. (C) 2014 Elsevier Inc. All rights reserved.	[Jin, Ying; Bouyer, Julien; Haas, Christopher; Fischer, Itzhak] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA		Fischer, I (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	ifischer@drexelmed.edu	Fischer, Itzhak/D-1080-2012	Fischer, Itzhak/0000-0003-3187-8740	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1 NS055976]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS055976] Funding Source: NIH RePORTER	We thank Theresa Connors for her technical support. This work was supported by NIH grant (PO1 NS055976).	AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Andrews FJ, 2002, EMERG MED J, V19, P172, DOI 10.1136/emj.19.2.172; Bailes JE, 2005, J NEUROSURG-SPINE, V2, P11, DOI 10.3171/spi.2005.2.1.0011; Basso DM, 2002, RESTOR NEUROL NEUROS, V20, P189; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Brigham CD, 2013, SPINE, V38, P315, DOI 10.1097/BRS.0b013e31827973f6; BUNGE RP, 1993, ADV NEUROL, V59, P75; Cantu Robert V, 2005, Curr Sports Med Rep, V4, P27; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Collazos-Castro JE, 2006, J NEUROTRAUM, V23, P1, DOI 10.1089/neu.2006.23.1; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DOHRMANN GJ, 1972, J NEUROSURG, V36, P407, DOI 10.3171/jns.1972.36.4.0407; EPSTEIN JA, 1979, J NEUROSURG, V51, P362, DOI 10.3171/jns.1979.51.3.0362; Giza CC, 2001, J ATHL TRAINING, V36, P228; GRONWALL D, 1974, LANCET, V2, P1452; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Kobrine A I, 1975, Surg Neurol, V3, P261; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Loy DN, 2002, J NEUROSCI, V22, P315, DOI 10.1523/JNEUROSCI.22-01-00315.2002; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Maroon JC, 2007, J NEUROSURG-SPINE, V6, P356, DOI 10.3171/spi.2007.6.4.13; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Metz GAS, 2000, BRAIN RES, V883, P165, DOI 10.1016/S0006-8993(00)02778-5; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; NOGA BR, 1991, J NEUROSCI, V11, P1691; Onifer SM, 2011, NEUROTHERAPEUTICS, V8, P283, DOI 10.1007/s13311-011-0034-4; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RATHBONE D, 1992, J PEDIATR ORTHOPED, V12, P616; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SCHER AT, 1991, AM J SPORT MED, V19, P485, DOI 10.1177/036354659101900511; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; TORG JS, 1995, SPORTS MED, V20, P429, DOI 10.2165/00007256-199520060-00007; Torreman M, 1996, J NEUROSURG, V84, P663, DOI 10.3171/jns.1996.84.4.0663; Vaccaro Alexander R, 2002, Spine J, V2, P351; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; WAGNER FC, 1971, J NEUROSURG, V35, P272, DOI 10.3171/jns.1971.35.3.0272; WHISHAW IQ, 1992, BEHAV BRAIN RES, V52, P29, DOI 10.1016/S0166-4328(05)80322-5; Winder MJ, 2011, J NEUROSURG-SPINE, V14, P677, DOI 10.3171/2011.1.SPINE10345; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Yang FS, 1998, AM J PATHOL, V152, P379; Zhang YP, 2008, J NEUROTRAUM, V25, P1227, DOI 10.1089/neu.2007.0388; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	65	7	7	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2014	257						57	69		10.1016/j.expneurol.2014.04.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK1MU	WOS:000338180000007	24786492				2022-02-06	
J	Jones, N; Thandi, G; Fear, NT; Wessely, S; Greenberg, N				Jones, Norman; Thandi, Gursimran; Fear, Nicola T.; Wessely, Simon; Greenberg, Neil			The psychological effects of improvised explosive devices (IEDs) on UK military personnel in Afghanistan	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; PRIMARY-CARE; IRAQ; DEPLOYMENT; COMBAT; IMPAIRMENT; PREVALENCE; IMPACT	Objective To explore the psychological consequences of improvised explosive device (IED) exposure as IEDs have been the greatest threat to UK military personnel in Afghanistan though the mental health consequences of IED exposure are largely unknown. Method Deployed UK military personnel completed a survey while deployed in Afghanistan. Combat personnel and those dealing specifically with the IED threat were compared with all other deployed personnel; the relationship between IED exposure, general combat experiences, Post Traumatic Stress Disorder (PTSD) Checklist-Civilian Version (PCL-C) and General Health Questionnaire scores were evaluated. Results The response rate was 98% (n=2794). Half reported IED-related concerns, a third experienced exploding IEDs and a quarter gave medical aid to IED casualties. Combat and counter-IED threat personnel had higher levels of IED exposure than other deployed personnel. 18.8% of personnel who witnessed exploding IEDs scored positive for common mental disorder (General Health Questionnaire-12 scores >= 4) and 7.6% scored positive for probable PTSD symptoms (PTSD Checklist-Civilian Version scores >= 44). After adjusting for general combat exposure and other observed confounders, PTSD symptoms were associated with IED exposure whereas common mental disorder symptoms were not. IED exposure, IED-related concerns and functional impairment accumulated during deployment but functional impairment was related to factors other than IED exposure alone. Conclusions In Afghanistan, a substantial proportion of personnel were exposed to exploding IEDs however, the majority of exposed personnel were psychologically healthy. Psychological effects were similar for combat personnel and those dealing specifically with the IED threat but both groups were at greater psychological risk than other deployed personnel.	[Jones, Norman; Thandi, Gursimran; Fear, Nicola T.; Wessely, Simon; Greenberg, Neil] Acad Ctr Def Mental Hlth, Acad Dept Psychol Med, Inst Psychiat, Weston Educ Ctr, London SE5 9RJ, England		Jones, N (corresponding author), Acad Ctr Def Mental Hlth, Acad Dept Psychol Med, Inst Psychiat, Weston Educ Ctr, Cutcombe Rd, London SE5 9RJ, England.	Norman.Jones@kcl.ac.uk	Wessely, Simon C/A-8713-2008	greenberg, neil/0000-0003-4550-2971; Fear, Nicola/0000-0002-5792-2925; Wessely, Simon Charles/0000-0002-6743-9929	UK Ministry of Defence	UK Ministry of Defence.	[Anonymous], 2006, JOINT SERV PUBL, V570; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Buckman JEJ, 2011, OCCUP ENVIRON MED, V68, P69, DOI 10.1136/oem.2009.054692; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; COOPER CL, 1982, J OCCUP ENVIRON MED, V24, P653, DOI 10.1097/00043764-198209000-00009; COX D, 1983, BRIT J PSYCHOL, V74, P107, DOI 10.1111/j.2044-8295.1983.tb01847.x; Duma SJ, 2010, J TRAUMA STRESS, V23, P52, DOI 10.1002/jts.20484; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; FLORIAN V, 1995, J PERS SOC PSYCHOL, V68, P687, DOI 10.1037/0022-3514.68.4.687; Glicksohn J, 2000, PERS INDIV DIFFER, V28, P85, DOI 10.1016/S0191-8869(99)00083-5; Goldberg D., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Harvey SB, 2012, AM J EPIDEMIOL, V176, P1177, DOI 10.1093/aje/kws248; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Kolesar P, 2013, ANN OPER RES, V208, P451, DOI 10.1007/s10479-012-1126-1; Martin JK, 2009, DRAGONS CLAWS IMPROV; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Mulligan K, 2012, BRIT J PSYCHIAT, V201, P193, DOI 10.1192/bjp.bp.111.097527; Mulligan K, 2010, BRIT J PSYCHIAT, V197, P405, DOI 10.1192/bjp.bp.110.077263; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rachman S, 1982, J R Army Med Corps, V128, P100; Ramasamy A, 2009, J R Army Med Corps, V155, P265; Reger GM, 2011, J TRAUMA STRESS, V24, P93, DOI 10.1002/jts.20574; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rona RJ, 2009, J PSYCHIATR RES, V43, P649, DOI 10.1016/j.jpsychires.2008.09.006; Smith TC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-340; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Veliz C, 2010, INFANTRY, V99, P47; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Woodhead C, 2011, PSYCHOL MED, V41, P363, DOI 10.1017/S0033291710000759	35	7	7	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	JUL	2014	71	7					466	471		10.1136/oemed-2013-101903			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AJ7YP	WOS:000337918300003	24436060				2022-02-06	
J	Choi, JI; Kim, BJ; Ha, SK; Kim, SH; Lim, DJ; Kim, SD				Choi, Jong-Il; Kim, Bum-Joon; Ha, Sung-Kon; Kim, Se-Hoon; Lim, Dong-Jun; Kim, Sang-Dae			Comparison of subgroups based on hemorrhagic lesions between SWI and FLAIR in pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Pediatric traumatic brain injury; FLAIR; SWI; Hemorrhagic lesion	DIFFUSE AXONAL INJURY; INTENSIVE-CARE; HEAD-INJURY; CHILDREN; ADOLESCENTS; PREDICTORS; MRI	The purpose of this study was to investigate efficient ways to diagnose and predict clinical outcomes for childhood traumatic brain injury. Hemorrhagic signal intensities in nine brain regions were observed using axial fluid-attenuated inversion recovery (FLAIR) and susceptibility-weighted imaging (SWI). After having divided the subjects into mild presentation (GCS 14-15) and moderate-to-severe presentation groups (GCS a parts per thousand currency sign13), we divided the patients into three subgroups: Subgroup I, hemorrhagic foci observed only on SWI and not on FLAIR; Subgroup II, hemorrhagic foci observed on both SWI and FLAIR in the same brain regions; and Subgroup III, any cases with additional foci on SWI in other brain regions. We investigated the clinical course and compared lesion numbers and distributions of hemorrhagic lesions on SWI among the subgroups. Three clinical variables (hospitalization period in intensive care unit, total days of hospitalization, and outcome based on Pediatric Cerebral Performance Category Scale score) showed significant relevance to the three subgroups. Subgroup I showed the fewest lesions followed by Subgroups II and III, respectively. In all three subgroups, lesions were most abundant in cortical regions. Lesion in the thalamus, basal ganglia, corpus callosum, and brainstem was least in Subgroup I and gradually increased in Subgroups II and III. Such distinction was more significant in the moderate-to-severe group when compared with the mild group. In cases of pediatric traumatic brain injury, categorizing patients into one of the above three subgroups based on hemorrhagic lesions on SWI and FLAIR is a promising method for predicting patient's clinical outcome.	[Choi, Jong-Il; Kim, Bum-Joon; Ha, Sung-Kon; Kim, Se-Hoon; Lim, Dong-Jun; Kim, Sang-Dae] Korea Univ, Ansan Hosp, Dept Neurosurg, Ansan, South Korea; [Kim, Sang-Dae] Korea Univ, Coll Med, Dept Neurosurg, Ansan Hosp, Ansan, South Korea		Kim, SD (corresponding author), Korea Univ, Coll Med, Dept Neurosurg, Ansan Hosp, Ansan, South Korea.	neuron19@korea.ac.kr	Kim, Bum-Joon/T-7221-2017; Kim, Bum-Joon/AAU-1680-2021	Kim, Bum-Joon/0000-0002-3701-4030; Kim, Bum-Joon/0000-0002-3701-4030; Kim, Se-Hoon/0000-0002-1716-1375	Korea University School of Medicine, Republic of Korea [K0931341]	This study was supported by a grant of the Korea University School of Medicine, Republic of Korea, (K0931341).	Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Chalian M, 2011, J NEURORADIOLOGY, V38, P187, DOI 10.1016/j.neurad.2010.12.006; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; GEMKE RJBJ, 1993, J PEDIATR-US, V122, P325, DOI 10.1016/S0022-3476(06)80147-2; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Guerguerian AM, 2009, CURR OPIN PEDIATR, V21, P737, DOI 10.1097/MOP.0b013e328332d11c; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Kuzma BB, 2000, SURG NEUROL, V53, P400; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tsuchiya T, 1996, AM J NEURORADIOL, V17, P1081; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	25	7	7	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2014	30	6					1011	1019		10.1007/s00381-013-2349-4			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AH8NZ	WOS:000336396100005	24408783				2022-02-06	
J	Friedman, LS				Friedman, Lee S.			Complications associated with blood alcohol concentration following injury	ALCOHOL			English	Article						Alcohol; Ethanol; Complications; Heart failure; Renal failure; Mortality; Dose-response; Trauma	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; LENGTH-OF-STAY; ATTRIBUTABLE FRACTIONS; MYOCARDIAL-INFARCTION; ETHANOL INGESTION; MORTALITY; INTOXICATION; IMPACT; LEVEL	Alcohol increases the risk of injuring oneself and others. However, following an injury there appears to be a benefit to alcohol in mediating the body's response to a traumatic injury and reducing mortality. The physiological mechanism underlying this reported association is poorly understood. One approach to explaining the pathways by which alcohol affects acute mortality following a traumatic injury is to identify differential prevalence of medical complications associated with increased mortality. The goal of this study was to evaluate the association between blood alcohol concentration and complications subsequent to a traumatic injury that are associated with increased in-hospital mortality. This study involved a retrospective analysis of traumatic injuries occurring between 2000 and 2009 as reported by all level I and II trauma units in the state of Illinois. The study includes all patients with blood alcohol toxicological examination levels ranging from zero to 500 mg/c1L and meeting additional inclusion criteria (n = 84,974). A reduction in complications of cardiac and renal function by 23.5% and 30.0%, respectively, was attributable to blood alcohol concentration. In addition, blood alcohol concentration was associated with fewer cases of pneumothorax and convulsions. However, blood alcohol concentration continued to be positively associated with aspiration pneumonitis and acute pancreatitis in the final models. The net impact of alcohol following an injury is protective, largely attributable to a reduction in complications relating to cardiac and renal function. This study helps to explain the observed protective effect from blood alcohol concentrations in reducing in-hospital mortality after an injury, as reported in many studies. (C) 2014 Elsevier Inc. All rights reserved.	[Friedman, Lee S.] Univ Illinois, Sch Publ Hlth, Div Environm & Occupat Hlth Sci, Chicago, IL 60612 USA; [Friedman, Lee S.] Social Policy Res Inst, Skokie, IL 60076 USA		Friedman, LS (corresponding author), Univ Illinois, Sch Publ Hlth, 2121 W Taylor St, Chicago, IL 60612 USA.	lfried1@uic.edu	Friedman, Lee/G-9799-2011				*AG HEALTHC RES QU, 2008, PAT SAF IND TECHN SP; Allison P. D., 2002, J AM COLL CARDIOL, V50, pe1; Bau PFD, 2005, ALCOHOL, V37, P53, DOI 10.1016/j.alcohol.2005.10.034; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; CHERPITEL CJ, 1995, ACCIDENT ANAL PREV, V27, P651, DOI 10.1016/0001-4575(95)00011-N; Cherpitel CJ, 2003, ADDICTION, V98, P1277, DOI 10.1046/j.1360-0443.2003.00459.x; CHILD JS, 1979, CIRCULATION, V59, P120, DOI 10.1161/01.CIR.59.1.120; Choudhry MA, 2006, FRONT BIOSCI-LANDMRK, V11, P998, DOI 10.2741/1857; COLLINS R, 1995, LANCET, V345, P669; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; Dimick JB, 2003, J AM COLL SURGEONS, V196, P671, DOI 10.1016/S1072-7515(03)00122-4; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; EISENHOFER G, 1983, CLIN PHARMACOL THER, V34, P143, DOI 10.1038/clpt.1983.143; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fabbri A, 2002, EMERG MED J, V19, P210, DOI 10.1136/emj.19.3.210; Friedman LS, 2007, J OCCUP ENVIRON MED, V49, P401, DOI 10.1097/JOM.0b013e31803b9527; Friedman LS, 2012, ALCOHOL, V46, P769, DOI 10.1016/j.alcohol.2012.08.006; Glance LG, 2011, ANN SURG, V253, P811, DOI 10.1097/SLA.0b013e318211d872; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Gonzales RA, 1997, ALCOHOL HEALTH RES W, V21, P120; GOULD L, 1978, J ELECTROCARDIOL, V11, P11, DOI 10.1016/S0022-0736(78)80023-5; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Griffin R, 2009, J BURN CARE RES, V30, P395, DOI 10.1097/BCR.0b013e3181a28966; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Healey MA, 2002, ARCH SURG-CHICAGO, V137, P611, DOI 10.1001/archsurg.137.5.611; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Huseynova K, 2009, J AM COLL SURGEONS, V208, P547, DOI 10.1016/j.jamcollsurg.2009.01.002; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KELBAEK H, 1987, AM J CARDIOL, V59, P685, DOI 10.1016/0002-9149(87)91193-3; KELBAEK H, 1988, ALCOHOL ALCOHOLISM, V23, P211; KELLEY D, 1992, Journal of Burn Care and Rehabilitation, V13, P218, DOI 10.1097/00004630-199203000-00008; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MALHOTRA H, 1985, LANCET, V2, P584; Mann NC, 2006, ACAD EMERG MED, V13, P946, DOI 10.1197/j.aem.2006.04.019; Molina PE, 2004, ALCOHOL, V33, P217, DOI 10.1016/j.alcohol.2004.07.002; NEWSOME HH, 1988, J TRAUMA, V28, P1, DOI 10.1097/00005373-198801000-00001; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Osier T., 2012, ARCH SURG-CHICAGO, V147, P152; Phelan H, 2002, J TRAUMA, V52, P675, DOI 10.1097/00005373-200204000-00010; Phillips B, 2008, J TRAUMA, V64, P768, DOI 10.1097/TA.0b013e3181620152; Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04; RANDIN D, 1995, NEW ENGL J MED, V332, P1733, DOI 10.1056/NEJM199506293322601; RUBIN R, 1994, ALCOHOL CLIN EXP RES, V18, P105, DOI 10.1111/j.1530-0277.1994.tb00888.x; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Scirica BM, 2006, J AM COLL CARDIOL, V48, P37, DOI 10.1016/j.jacc.2006.02.052; Silber JH, 2005, MED CARE, V43, P122, DOI 10.1097/00005650-200502000-00005; Spaak J, 2008, AM J PHYSIOL-HEART C, V294, pH605, DOI 10.1152/ajpheart.01162.2007; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; Stubig T, 2012, ALCOHOL, V46, P681, DOI 10.1016/j.alcohol.2012.07.002; Tawakol A, 2004, AM J PHYSIOL-HEART C, V286, pH2468, DOI 10.1152/ajpheart.01207.2003; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; vandeBorne P, 1997, HYPERTENSION, V29, P1278, DOI 10.1161/01.HYP.29.6.1278; von Heymann C, 2002, J TRAUMA, V52, P95, DOI 10.1097/00005373-200201000-00017; Waikar S. S., 2012, HARRISONS PRINCIPLES, P2293; WALLIN G, 1983, AUTONOMIC FAILURE, P36; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Weathermon R, 1999, ALCOHOL RES HEALTH, V23, P40; World Health Organization, 2007, WHO COLL STUD ALC IN; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yaghoubian A, 2009, AM SURGEON, V75, P950; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	69	7	8	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0741-8329	1873-6823		ALCOHOL	Alcohol	JUN	2014	48	4					391	400		10.1016/j.alcohol.2014.01.008			10	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse; Pharmacology & Pharmacy; Toxicology	AI7LC	WOS:000337071100008	24835008				2022-02-06	
J	Hui, L; Shen, FZ; Chang, HG; Li, XS; Gao, GJ; Ma, JW				Hui, Lei; Shen, Fazheng; Chang, Haigang; Li, Xiangsheng; Gao, Guojun; Ma, Jiwei			Effects of ulinastatin on cerebral oxygen metabolism and CRP levels in patients with severe traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						ulinastatin; brain injury; cerebral oxygen metabolism; C-reactive protein	CARDIOPULMONARY BYPASS; MODEL	The aim of the present study was to investigate the effects of ulinastatin on cerebral oxygen metabolism and C-reactive protein (CRP) levels in patients with severe traumatic brain injury (sTBI). A total of 92 patients with sTBI, admitted to the First Affiliated Hospital of Xinxiang Medical University (Xinxiang, China), were randomly divided into control and observation groups. The control group received conventional therapy plus a placebo (0.9% sodium chloride), while the observation group were administered conventional therapy plus 200,000 units ulinastatin via intravenous injection twice a day for seven days. Arterial and jugular venous blood was collected for blood gas analysis. The jugular venous blood lactate (JVBL), jugular venous bulb oxygen saturation (SjvO(2)), arteriovenous oxygen content difference (AVDO(2)) and cerebral extraction of oxygen (CEO2) levels were measured on day 1, 3, 5 and 7, as well as the level of CRP in the peripheral blood. In the control group, the level of JVBL decreased as compared with the level at day 1, however, no statistically significant differences were observed (P>0.05). By contrast, the observation group exhibited a significant reduction in the level of JVBL (P<0.05), which was also significantly lower compared with the control group (P<0.05). Statistically significant differences were observed between the two groups with regard to SjvO(2), AVDO(2) and CEO2 on day 3,5 and 7. The CRP levels in the two groups increased and peaked on day 3. However, the CRP level in the observation group significantly decreased on day 5 (35.27 +/- 15.18 mg/l) and day 7 (22.65 +/- 10.48 mg/l), which was lower compared with the control group (56.19 +/- 13.24 mg/l and 47.36 +/- 15.73. mg/l, respectively); statistically significant differences were observed (P<0.05). Therefore, ulinastatin effectively improved cerebral oxygen metabolism and reduced the CRP level in patients with sTBI.	[Hui, Lei; Shen, Fazheng; Chang, Haigang; Li, Xiangsheng; Gao, Guojun; Ma, Jiwei] Xinxiang Med Univ, Affiliated Hosp 1, Dept Neurosurg, Weihui 453100, Henan, Peoples R China		Hui, L (corresponding author), Xinxiang Med Univ, Affiliated Hosp 1, Dept Neurosurg, 88 Jiankang Rd, Weihui 453100, Henan, Peoples R China.	leihuicn@163.com					Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Cao BP, 2013, ZHONGHUA SHEN JING W, V12, P244; Cao LJ, 2011, CHINESE J PHYSIOL, V54, P435, DOI [10.4077/CJP.2011.BAA058, 10.4077/CJP.2011.AMM058]; Faraco G, 2013, HYPERTENSION, V62, P759, DOI 10.1161/HYPERTENSIONAHA.113.01761; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Kamenskaya OV, 2013, KARDIOLOGIYA, V53, P49; Lee D.G., 2005, J KOREAN NEUROTRAUMA, V1, P57, DOI [10.13004/jknts.2005.1.1.57, DOI 10.13004/JKNTS.2005.1.1.57]; Lord LD, 2013, J CEREBR BLOOD F MET, V33, P1347, DOI 10.1038/jcbfm.2013.94; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Schmidt AT, 2013, BRAIN INJURY, V27, P1528, DOI 10.3109/02699052.2013.828851; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Tu Yue, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P677; Wang XH, 2013, ZHONGHUA GAN DAN WAI, V19, P544; Wang XC, 2013, PEDIATR ANESTH, V23, P209, DOI 10.1111/pan.12073; Xu CE, 2013, J CARDIOTHOR VASC AN, V27, P479, DOI 10.1053/j.jvca.2012.11.001	17	7	16	1	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2014	7	6					1683	1686		10.3892/etm.2014.1666			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AI0QX	WOS:000336555100043	24926366	Green Published, gold			2022-02-06	
J	Lemcke, J; Al-Zain, F; von der Brelie, C; Ebenau, M; Meier, U				Lemcke, Johannes; Al-Zain, Ferass; von der Brelie, Christian; Ebenau, Martina; Meier, Ullrich			The influence of coagulopathy on outcome after traumatic subdural hematoma: a retrospective single-center analysis of 319 patients	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						traumatic subdural hematoma; traumatic brain injury; coagulopathy; outcome	SEVERE BRAIN TRAUMA; HEAD-INJURY	The aim of this study was to identify the effects of coagulopathy on the outcome of patients with traumatic subdural hematoma (SDH). Based on a retrospective study, the records of all patients admitted between 2001 and 2007 to a large emergency hospital with acute SDH resulting from traumatic brain injury (TBI) were analyzed. An initial Glasgow coma score (GCS), clinical state, and Glasgow outcome score (GOS) were recorded for all patients. All computer assisted tomography and MRI scans obtained from patients were saved on an electronic storage device and were reviewed by a neurosurgeon and a neuroradiologist. The coagulation parameters were analyzed for all patients. Coagulopathy was defined as international normalized ratio more than 1.2 or partial thromboplastin time more than 37 s. One hundred and five women and 214 men aged between 1 and 100 years (mean 59 years) were included in the study. Patients with coagulopathy had a significantly worse outcome. Almost twice as many patients died in the coagulopathy group (mean GOS 3.10 +/- 1.46) than in the group without coagulopathy (mean GOS 2.16 +/- 1.45), (P < 0.001). In-hospital mortality is twice as frequent in patients with coagulopathy with traumatic SDH compared with noncoagulopathic patients, even if the initial severity of the TBI does not differ.	[Lemcke, Johannes; Al-Zain, Ferass; von der Brelie, Christian; Ebenau, Martina; Meier, Ullrich] Unfallkrankenhaus Berlin, Dept Neurosurg, D-12683 Berlin, Germany		Lemcke, J (corresponding author), Unfallkrankenhaus Berlin, Dept Neurosurg, Warener Str 7, D-12683 Berlin, Germany.	Johannes.lemcke@ukb.de		Lemcke, Johannes/0000-0002-8073-1625			Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Depreitere B, 2003, ACTA NEUROCHIR, V145, P541, DOI 10.1007/s00701-003-0020-7; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Leitgeb J, 2012, J TRAUMA ACUTE CARE, V72, P1263, DOI 10.1097/TA.0b013e318248ed83; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang K, 2013, NEUROL RES, V35, P642, DOI 10.1179/1743132813Y.0000000187; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	22	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	JUN	2014	25	4					353	359		10.1097/MBC.0000000000000042			7	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	AH2MZ	WOS:000335956900011	24784316				2022-02-06	
J	Nworah, U; Symes, L; Young, A; Langford, R				Nworah, Uchenna; Symes, Lene; Young, Anne; Langford, Rae			Afghanistan and Iraq War VETERANS' Health Care Needs and Their Underuse of Health Care Resources Implications for Psychiatric-Mental Health Nurses	JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES			English	Article							NATIONAL-GUARD SOLDIERS; HELP-SEEKING; PTSD; MASCULINITY; DEPLOYMENT; MILITARY; SERVICES; BARRIERS; INJURY; GENDER	U.S. Veterans who have served in the Afghanistan and Iraq wars have combat-related medical and mental health issues, notably posttraumatic stress disorder and traumatic brain injury, but underuse health care resources. To better understand their health care needs, resource use, and facilitators and barriers to seeking health care, a literature review was conducted. The results suggest high prevalence of mental and medical health issues and disproportionate use of quantitative research design that lacked approaches to understanding the psychosocial, cultural, and contextual factors that affect help-seeking by Veterans. Strategies to increase the likelihood that Veterans will seek needed health care, gaps in the literature, and the need for further research are discussed.	[Nworah, Uchenna] Texas Womans Univ, Houston, TX USA; [Nworah, Uchenna] Michael E DeBakey Vet Affairs VA Med Ctr, Houston, TX USA; [Symes, Lene; Young, Anne; Langford, Rae] Texas Womans Univ, Nelda C Stark Coll Nursing, Houston, TX USA		Nworah, U (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd, Houston, TX 77030 USA.	iunworah@sbcglobal.net					Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Bagalman E., 2011, SUICIDE PTSD SUBSTAN; Brown MC, 2011, J NERV MENT DIS, V199, P797, DOI 10.1097/NMD.0b013e31822fc9bf; Centers for Disease Control and Prevention, 2011, CD HLTH DISP IN REP; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Duck W., 2009, J AFRICAN AM STUDIES, V13, P283, DOI [10.1007/s12111-009-9097-2, DOI 10.1007/S12111-009-9097-2]; Green G, 2010, SOC SCI MED, V71, P1480, DOI 10.1016/j.socscimed.2010.07.015; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iversen AC, 2010, BRIT J PSYCHIAT, V197, P149, DOI 10.1192/bjp.bp.109.075762; Kehle SM, 2010, J TRAUMA STRESS, V23, P33, DOI 10.1002/jts.20480; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kirby AC, 2008, ADDICT BEHAV, V33, P1448, DOI 10.1016/j.addbeh.2008.05.007; Maguen S, 2012, J WOMENS HEALTH, V21, P666, DOI 10.1089/jwh.2011.3113; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Pietrzak RH, 2010, J PSYCHOSOM RES, V69, P441, DOI 10.1016/j.jpsychores.2010.07.002; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Randall MJ, 2012, MIL MED, V177, P11, DOI 10.7205/MILMED-D-11-00226; Reiber GE, 2010, J REHABIL RES DEV, V47, P275, DOI 10.1682/JRRD.2010.01.0009; Sareen J, 2010, PSYCHIAT SERV, V61, P50, DOI 10.1176/appi.ps.61.1.50; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Somnath S, 2007, RACIAL ETHNIC DISPAR; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Thompson VLS, 2009, AM J MENS HEALTH, V3, P6, DOI 10.1177/1557988307304630	28	7	7	0	13	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0279-3695	1938-2413		J PSYCHOSOC NURS MEN	J. Psychosoc. Nurs. Ment. Health Serv.	JUN	2014	52	6					42	49		10.3928/02793695-20140210-02			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	AK9QC	WOS:000338760700015	24530219				2022-02-06	
J	Polites, SF; Sebastian, AS; Habermann, EB; Iqbal, CW; Stuart, MJ; Ishitani, MB				Polites, Stephanie F.; Sebastian, Arjun S.; Habermann, Elizabeth B.; Iqbal, Corey W.; Stuart, Michael J.; Ishitani, Michael B.			Youth Ice Hockey Injuries Over 16 Years at a Pediatric Trauma Center	PEDIATRICS			English	Article						injury; pediatric; ice hockey; trauma; traumatic brain injury	ELECTRONIC SEARCH STRATEGIES; COMPUTED-TOMOGRAPHY; RISK-FACTORS; CONCUSSION; EPIDEMIOLOGY; SPLENECTOMY; VALIDATION; DERIVATION; CHILDHOOD; STATEMENT	BACKGROUND: Youth ice hockey is an exciting sport with growing participation in the United States. Updated assessment of injury patterns is needed to determine risk factors for severe injury and develop preventive efforts. The purpose of this study was to evaluate our experience as a level 1 pediatric trauma center in Minnesota treating injured youth ice hockey players. METHODS: Children <= 18 years old who presented to our institution from July 1997 to July 2013 with an injury sustained while participating in ice hockey were identified. Patient demographic information, injury characteristics, and outcomes including use of computed tomography, hospital admission, and procedures were obtained. Age- and gender-specific patterns were determined for injuries and outcomes. RESULTS: Over 16 years, 168 injuries in 155 children occurred, including 26 (15.5%) injuries in girls. Extremity injuries were most common, followed by traumatic brain injury. Injuries to the spine, face, and trunk were less common. Traumatic brain injury and injuries to the spine were most common in younger children <= 14 years old) and girls, whereas injuries to the face were most common in older players (>= 15 years old). Most injuries resulted from intentional contact. Admission to the hospital was needed in 65 patients, including 14 (8.3%) who needed intensive care. A major procedure was needed by 23.2% of patients because of their injuries. CONCLUSIONS: Youth ice hockey trauma can be severe, necessitating a thorough evaluation of injured children. Injury patterns are influenced by age and gender, providing an opportunity for targeted preventive efforts.	[Polites, Stephanie F.] Mayo Clin, Dept Surg, Rochester, MN 55901 USA; [Sebastian, Arjun S.; Stuart, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55901 USA; [Habermann, Elizabeth B.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55901 USA; [Iqbal, Corey W.] Mayo Clin, Dept Pediat Surg, Rochester, MN 55901 USA; [Ishitani, Michael B.] Childrens Mercy Hosp, Dept Surg, Kansas City, MO 64108 USA		Ishitani, MB (corresponding author), Mayo Clin, Coll Med, Div Pediat Surg, 200 1st SW, Rochester, MN 55901 USA.	ishitani.michael@mayo.edu		Habermann, Elizabeth/0000-0002-1140-003X			Alsara A, 2011, MAYO CLIN PROC, V86, P382, DOI 10.4065/mcp.2010.0802; American College of Surgeons, VER TRAUM CTR; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Blake Tracy, 2012, Clin J Sport Med, V22, P377, DOI 10.1097/JSM.0b013e31826038e0; Cusimano Michael D, 2011, Open Med, V5, pe57; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; DIAMOND LK, 1969, PEDIATRICS, V43, P886; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; EIN SH, 1977, ANN SURG, V185, P307, DOI 10.1097/00000658-197703000-00010; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Fenton SJ, 2004, J PEDIATR SURG, V39, P1877, DOI 10.1016/j.jpedsurg.2004.08.007; Gaines BA, 2002, CRIT CARE MED, V30, pS416, DOI 10.1097/00003246-200211001-00006; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris AW, 2012, CLIN J SPORT MED, V22, P455, DOI 10.1097/JSM.0b013e318259ed09; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Keightley M, 2013, INT J SPORTS MED, V34, P756, DOI 10.1055/s-0032-1327574; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; LAPRADE RF, 1995, AM J SPORT MED, V23, P773, DOI 10.1177/036354659502300624; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Minnesota Hockey, MINN HOCK YOUTH CLAS; Minnesota Hockey, REG NUMB; Nance ML, 2006, J TRAUMA, V61, P1389, DOI 10.1097/01.ta.0000244167.45002.58; Pearl RH, 2000, J PEDIATR SURG, V35, P167; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; REYNEN PD, 1994, AM J SPORT MED, V22, P167, DOI 10.1177/036354659402200203; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Streck CJ, 2012, J TRAUMA ACUTE CARE, V73, P371, DOI 10.1097/TA.0b013e31825840ab; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stuart MJ, 2000, SAFETY ICE HOCKEY; Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; The EAST Practice Management Guidelines Work Group, 2010, TRIAG TRAUM PAT; USA Hockey, GIRLS WOM HOCK; USA Hockey, 2012, US HOCK 2011 2012 AN; USA Hockey, 2011 2012 SEAS FIN R; USA Hockey, 2012, HEADS DONT DUCK; USA Hockey, BOD CHECK RUL PROP B	46	7	7	1	11	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2014	133	6					E1601	E1607		10.1542/peds.2013-3628			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AI8MY	WOS:000337172600016	24864187				2022-02-06	
J	Kwon, HG; Choi, BY; Kim, SH; Chang, CH; Jung, YJ; Do Lee, H; Jang, SH				Kwon, Hyeok Gyu; Choi, Byung Yeon; Kim, Seong Ho; Chang, Chul Hoon; Jung, Young Jin; Do Lee, Han; Jang, Sung Ho			Injury of the cingulurn in patients with putarninal hemorrhage: a diffusion tensor tractography study	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						cingulum; putaminal hemorrhage; cognitive function; diffusion tensor tractography; location of hematoma	TRAUMATIC BRAIN-INJURY; BASAL GANGLIA; INTRACEREBRAL HEMORRHAGE; CORTEX; PATHWAYS; CIRCUITS; CHILDREN; STROKE; BUNDLE; FORNIX	Objectives: Little is known about the pathophysiological mechanisms of cognitive impairment in patients with putaminal hemorrhage (PH). Using diffusion tensor tractography, we investigated injury of the cingulum in patients with PH. Methods: We recruited 63 patients with PH, who were classified according to three groups, based on integrity of the cingulum to the lower portion of the genu of the corpus callosum: group A; preserved integrity, group B; discontinuation of integrity in the affected hemisphere, and group C; discontinuation of integrity in both hemispheres. Results: Thirty four patients (54.0%) belonged to group A, 16 patients (25.4%) to group B, and the remaining 13 patients (20.6%) to group C. Regarding the Mini-Mental State Examination, significant differences were observed between group A and group C, and between group B and group C without significant difference between group A and group B (p < 0.05). In terms of the volume of hematoma, significant differences were observed among the three groups (p < 0.05). Regarding the most anterior point of the hematoma, significant differences were observed between group A and groups B and C (p < 0.05); in contrast, regarding the most point of hematoma, significant differences were observed between group C and groups A and B, respectively (p < 0.05). Conclusion: We found that the anterior cingulum is vulnerable to PH.Therefore, our results suggest the necessity for evaluation of the cingulum in patients with PH particularly if the hematoma is large or close to the anterior margin or midline of the brain.	[Kwon, Hyeok Gyu; Do Lee, Han; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Choi, Byung Yeon; Kim, Seong Ho; Chang, Chul Hoon; Jung, Young Jin] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Bogousslavsky J., 2001, STROKE SYNDROMES, DOI [10.1017/CBO9780511586521, DOI 10.1017/CBO9780511586521]; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Concha L, 2005, AM J NEURORADIOL, V26, P2267; DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496; Ghetti G, 2012, FRONT NEUROL NEUROSC, V30, P141, DOI 10.1159/000333617; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hochstenbach J, 1998, CLIN REHABIL, V12, P514, DOI 10.1191/026921598666870672; Hong JH, 2012, NEUROSURGERY, V70, P819, DOI 10.1227/NEU.0b013e3182367124; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Jang SH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00749; Jang SH, 2013, BRAIN IMAGING BEHAV, V7, P236, DOI 10.1007/s11682-013-9222-7; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; KWAK R, 1983, STROKE, V14, P493, DOI 10.1161/01.STR.14.4.493; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Martino J, 2013, BRAIN STRUCT FUNCT, V218, P105, DOI 10.1007/s00429-012-0386-5; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mendoza J., 2007, CLIN NEUROANATOMY NE; Rektor I, 2004, EXP BRAIN RES, V158, P289, DOI 10.1007/s00221-004-1901-6; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Seo JP, 2013, EUR NEUROL, V69, P236, DOI 10.1159/000345271; Shu Si-Yun, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P38; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Su CY, 2007, ARCH CLIN NEUROPSYCH, V22, P465, DOI 10.1016/j.acn.2007.01.025; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; van Huijzen, 2008, HUMAN CENTRAL NERVOU; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256	40	7	7	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 30	2014	8								366	10.3389/fnhum.2014.00366			6	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AM0OJ	WOS:000339544600001	24910606	Green Published, gold			2022-02-06	
J	Davoodi-Bojd, E; Chopp, M; Soltanian-Zadeh, H; Wang, SY; Ding, GL; Jiang, Q				Davoodi-Bojd, Esmaeil; Chopp, Michael; Soltanian-Zadeh, Hamid; Wang, Shiyang; Ding, Guangliang; Jiang, Quan			An Analytical Model for Estimating Water Exchange Rate in White Matter Using Diffusion MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AXON DIAMETER DISTRIBUTION; FIELD GRADIENT NMR; IN-VIVO; RESTRICTED DIFFUSION; SPIN-ECHO; STROKE; TENSOR; DIFFRACTION; FIBERS	Substantial effort is being expended on using micro-structural modeling of the white matter, with the goal of relating diffusion weighted magnetic resonance imaging (DWMRI) to the underlying structure of the tissue, such as axonal density. However, one of the important parameters affecting diffusion is the water exchange rate between the intra-and extra-axonal space, which has not been fully investigated and is a crucial marker of brain injury such as multiple sclerosis (MS), stroke, and traumatic brain injury (TBI). To our knowledge, there is no diffusion analytical model which includes the Water eXchange Rate (WXR) without the requirement of short gradient pulse (SGP) approximation. We therefore propose a new analytical model by deriving the diffusion signal for a permeable cylinder, assuming a clinically feasible pulse gradient spin echo (PGSE) sequence. Simulations based on Markov Random Walk confirm that the exchange parameter included in our model has a linear correlation (R-2>0.88) with the actual WXR. Moreover, increasing WXR causes the estimated values of diameter and volume fraction of the cylinders to increase and decrease, respectively, which is consistent with our findings from histology measurements in tissues near TBI regions. This model was also applied to the diffusion signal acquired from ex vivo brains of 14 male (10 TBI and 4 normal) rats using hybrid diffusion imaging. The estimated values of axon diameter and axonal volume fraction are in agreement with their corresponding histological measurements in normal brains, with 0.96 intra-class correlation coefficient value resulting from consistency analysis. Moreover, a significant increase (p = 0.001) in WXR and diameter and decrease in axonal volume fraction in the TBI boundary were detected in the TBI rats compared with the normal rats.	[Davoodi-Bojd, Esmaeil; Soltanian-Zadeh, Hamid] Univ Tehran, Sch Elect & Comp Engn, Tehran, Iran; [Davoodi-Bojd, Esmaeil; Chopp, Michael; Ding, Guangliang; Jiang, Quan] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael; Wang, Shiyang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Soltanian-Zadeh, Hamid] Henry Ford Hosp, Dept Radiol, Image Anal Lab, Detroit, MI 48202 USA		Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Ding, Guangliang/0000-0003-1286-5901	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS64134, RO1 AG037506, RO1 EB013227]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB013227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506] Funding Source: NIH RePORTER	This work was supported in part by NIH grants RO1 NS64134, RO1 AG037506, and RO1 EB013227. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2004, COMP Q BALL PASMRI S, V90; Aslund I, 2009, J MAGN RESON, V200, P291, DOI 10.1016/j.jmr.2009.07.015; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2005, MEASUREMENT AXON DIA, V842; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Avram L, 2004, J MAGN RESON, V169, P30, DOI 10.1016/j.jmr.2004.03.020; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; CALLAGHAN PT, 1995, J MAGN RESON SER A, V113, P53, DOI 10.1006/jmra.1995.1055; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; Callaghan PT, 2004, J CHEM PHYS, V120, P4032, DOI 10.1063/1.1642604; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; Davoodi-Bojd E, 2011, MAGN RESON IMAGING, V29, P1175, DOI 10.1016/j.mri.2011.07.006; Denk C, 2011, NMR BIOMED, V24, P246, DOI 10.1002/nbm.1581; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hagslatt H, 2003, J MAGN RESON, V161, P138, DOI 10.1016/S1090-7807(02)00039-3; Harkins KD, 2009, MAGN RESON MED, V62, P1414, DOI 10.1002/mrm.22155; Hwang SN, 2003, MAGNET RESON MED, V50, P373, DOI 10.1002/mrm.10536; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; KARGER J, 1988, ADV MAGN RESON, P1; Karimi-Ashtiani S, 2010, I S BIOMED IMAGING, P1149, DOI 10.1109/ISBI.2010.5490197; Komlosh ME, 2011, J MAGN RESON, V208, P128, DOI 10.1016/j.jmr.2010.10.014; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lasic S, 2011, MAGN RESON MED, V66, P356, DOI 10.1002/mrm.22782; Latt J, 2009, NMR BIOMED, V22, P619, DOI 10.1002/nbm.1376; Lawrenz M, 2010, J MAGN RESON, V202, P43, DOI 10.1016/j.jmr.2009.09.015; LEIBIG M, 1993, J PHYS A-MATH GEN, V26, P3349, DOI 10.1088/0305-4470/26/14/005; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Meier C, 2003, MAGN RESON MED, V50, P500, DOI 10.1002/mrm.10557; Momot KI, 2011, EUR BIOPHYS J BIOPHY, V40, P81, DOI 10.1007/s00249-010-0629-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NEUMAN CH, 1974, J CHEM PHYS, V60, P4508, DOI 10.1063/1.1680931; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Price WS, 1998, BIOPHYS J, V74, P2259, DOI 10.1016/S0006-3495(98)77935-4; Sen PN, 2005, MAGN RESON IMAGING, V23, P215, DOI 10.1016/j.mri.2004.11.014; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Torres AM, 1998, MAGN RESON IMAGING, V16, P423, DOI 10.1016/S0730-725X(98)00005-8; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Xu JZ, 2007, PHYS MED BIOL, V52, pN111, DOI 10.1088/0031-9155/52/7/N01; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084; Zhou W, 2009, ANAL MODEL DIFFUSION, V263	61	7	7	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95921	10.1371/journal.pone.0095921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	WOS:000339614800012	24836290	Green Published, Green Submitted, gold			2022-02-06	
J	Seifi, M; Corteen, NL; van der Want, JJ; Metzger, F; Swinny, JD				Seifi, Mohsen; Corteen, Nicole L.; van der Want, Johannes J.; Metzger, Friedrich; Swinny, Jerome D.			Localization of NG2 immunoreactive neuroglia cells in the rat locus coeruleus and their plasticity in response to stress	FRONTIERS IN NEUROANATOMY			English	Article						OPC; noradrenaline; brainstem; glia; GABAA receptor	CORTICOTROPIN-RELEASING-FACTOR; ACTIVATES NORADRENERGIC NEURONS; PROGENITOR CELLS; WHITE-MATTER; IN-VIVO; OLIGODENDROCYTE LINEAGE; POSTNATAL-DEVELOPMENT; NG2-POSITIVE CELLS; GLIAL PROGENITORS; PIRIFORM CORTEX	The locus coeruleus (LC) nucleus modulates adaptive behavioral responses to stress and dysregulation of LC neuronal activity is implicated in stress-induced mental illnesses. The LC is composed primarily of noradrenergic neurons together with various glial populations. A neuroglia cell-type largely unexplored within the LC is the NG2 cell. NG2 cells serve primarily as oligodendrocyte precursor cells throughout the brain. However, some NG2 cells are in synaptic contact with neurons suggesting a role in information processing. The aim of this study was to neurochemically and anatomically characterize NG2 cells within the rat LC. Furthermore, since NG2 cells have been shown to proliferate in response to traumatic brain injury, we investigated whether such NG2 cells plasticity also occurs in response to emotive insults such as stress. Immunohistochemistry and confocal microscopy revealed that NG2 cells were enriched within the pontine region occupied by the LC. Close inspection revealed that a sub-population of NG2 cells were located within unique indentations of LC noradrenergic somata and were immunoreactive for the neuronal marker NeuN whilst NG2 cell processes formed close appositions with clusters immunoreactive for the inhibitory synaptic marker proteins gephyrin and the GABA-A receptor alpha3-subunit, on noradrenergic dendrites. In addition, LC NG2 cell processes were decorated with vesicular glutamate transporter 2 immunoreactive puncta. Finally, 10 days of repeated restraint stress significantly increased the density of NG2 cells with in the LC. The study demonstrates that NG2 IR cells are integral components of the LC cellular network and they exhibit plasticity as a result of emotive challenges.	[Seifi, Mohsen; Corteen, Nicole L.; Swinny, Jerome D.] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Portsmouth PO1 2DT, Hants, England; [van der Want, Johannes J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [van der Want, Johannes J.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Metzger, Friedrich] F Hoffmann La Roche Ltd, DTA Neurosci, Pharma Res & Early Dev, Basel, Switzerland		Swinny, JD (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.	jerome.swinny@port.ac.uk	van der Want, Johannes/AAA-8058-2019	van der Want, Johannes/0000-0002-7485-4434; Seifi, Mohsen/0000-0002-5795-4409; Swinny, Jerome/0000-0002-8194-5481			Affaticati P, 2011, CELL DEATH DIFFER, V18, P99, DOI 10.1038/cdd.2010.79; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Armstrong CL, 2009, J COMP NEUROL, V517, P524, DOI 10.1002/cne.22167; Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; ASTONJONES G, 1980, BRAIN RES, V195, P215, DOI 10.1016/0006-8993(80)90880-X; Ballantyne D, 2004, RESP PHYSIOL NEUROBI, V143, P199, DOI 10.1016/j.resp.2004.07.018; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BEZIN L, 1994, J NEUROSCI, V14, P7486; Bolos M, 2013, CELL MOL LIFE SCI, V70, P2787, DOI 10.1007/s00018-013-1300-x; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Corteen NL, 2011, EUR J NEUROSCI, V34, P250, DOI 10.1111/j.1460-9568.2011.07740.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Dhabhar FS, 1997, NEUROENDOCRINOLOGY, V65, P360, DOI 10.1159/000127196; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Friedmann E, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.009; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Gensert JM, 2001, J NEUROBIOL, V48, P75, DOI 10.1002/neu.1043.abs; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Harro J, 2001, BRAIN RES REV, V38, P79, DOI 10.1016/S0165-0173(01)00082-0; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; INOUE T, 1993, PROG NEURO-PSYCHOPH, V17, P161; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; Jedema HP, 2004, J NEUROSCI, V24, P9703, DOI 10.1523/JNEUROSCI.2830-04.2004; Jiang P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3196; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Kida H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068877; Korber C, 2012, MOL CELL NEUROSCI, V50, P250, DOI 10.1016/j.mcn.2012.05.006; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Lin G, 2009, J NEUROSCI RES, V87, P3390, DOI 10.1002/jnr.22065; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Nair R, 2013, J CELL BIOL, V200, P61, DOI 10.1083/jcb.201207113; NAKAMURA S, 1987, J NEUROPHYSIOL, V58, P510, DOI 10.1152/jn.1987.58.3.510; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; OLSCHOWKA JA, 1981, J HISTOCHEM CYTOCHEM, V29, P271, DOI 10.1177/29.2.7019303; Palenski TL, 2013, LAB INVEST, V93, P646, DOI 10.1038/labinvest.2013.55; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Reynolds R, 1997, J NEUROSCI RES, V47, P455, DOI 10.1002/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Sharma V, 2012, J CEREBR BLOOD F MET, V32, P2055, DOI 10.1038/jcbfm.2012.107; Shipley MT, 1996, J COMP NEUROL, V365, P56, DOI 10.1002/(SICI)1096-9861(19960129)365:1<56::AID-CNE5>3.0.CO;2-I; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Stanic D, 2010, J COMP NEUROL, V518, P770, DOI 10.1002/cne.22226; Swinny JD, 2010, INT J NEUROPSYCHOPH, V13, P515, DOI 10.1017/S146114570999037X; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; Travagli RA, 1996, J NEUROPHYSIOL, V75, P2029, DOI 10.1152/jn.1996.75.5.2029; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Valentino R J, 1998, Adv Pharmacol, V42, P781; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; VALENTINO RJ, 1993, ANN NY ACAD SCI, V697, P173, DOI 10.1111/j.1749-6632.1993.tb49931.x; VALENTINO RJ, 1992, NEUROSCIENCE, V48, P689, DOI 10.1016/0306-4522(92)90412-U; VALENTINO RJ, 1983, BRAIN RES, V270, P363, DOI 10.1016/0006-8993(83)90615-7; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208	75	7	7	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5129			FRONT NEUROANAT	Front. Neuroanat.	MAY 14	2014	8								31	10.3389/fnana.2014.00031			14	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	AH2JW	WOS:000335948300001	24860436	Green Published, gold			2022-02-06	
J	Duraski, SA; Lovell, L; Roth, EJ				Duraski, Sylvia A.; Lovell, Linda; Roth, Elliot J.			Nutritional Intake, Body Mass Index, and Activity in Postacute Traumatic Brain Injury: A Preliminary Study	REHABILITATION NURSING			English	Article						rehabilitation; Brain injury; practice implications	MODERATE	Purpose In the United States, traumatic brain injury (TBI) remains a serious health problem contributing to lifelong disability. Little has been written about nutrition problems experienced postrehabilitation discharge. Our objective was to describe the nutrition and weight management characteristics of TBI survivors after discharge from rehabilitation and to identify characteristics of individuals at risk for weight control issues. Method/Design Twenty-six TBI survivors admitted to a freestanding rehabilitation hospital were followed for 1 year postdischarge. Data on height, weight, disability rating, diet and activity were collected at admission, 3, 6, 9 and 12 months after discharge. Findings Approximately 30% of the participants showed an increasing body mass index from discharge to 1-year follow up. Two patients had more complete long-term data and are highlighted. Conclusion/Clinical Relevance The case studies provide insight into the need for rehabilitation nurses to provide nutrition education to TBI survivors that will accommodate changes in lifestyle and activity after discharge.	[Duraski, Sylvia A.] Rehabil Inst Chicago, Brain Injury Med & Rehabil Program, Chicago, IL 60611 USA; [Lovell, Linda] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Roth, Elliot J.] Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Chicago, IL 60611 USA		Duraski, SA (corresponding author), Rehabil Inst Chicago, Brain Injury Med & Rehabil Program, 345 E Super St,Room 1178, Chicago, IL 60611 USA.	sduraski@ric.org			Spastic Paralysis Research Foundation, Illinois-Eastern Iowa District of Kiwanis International	Funding for this study was provided by the Spastic Paralysis Research Foundation, Illinois-Eastern Iowa District of Kiwanis International.	Agha Amar, 2005, Am J Med, V118, P1416; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Gerend MA, 2009, J ADOLESCENT HEALTH, V44, P84, DOI 10.1016/j.jadohealth.2008.06.014; Ha EJ, 2009, J NUTR EDUC BEHAV, V41, P103, DOI 10.1016/j.jneb.2008.07.001; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Perel P, 2006, COCHRANE DB SYST REV, V4, P1; U.S. Department of Agriculture and U.S. Department of Health and Human Services (USDA and DHHS), 2010, DIET GUID AM; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wright J, 2000, DISABILITY RATING SC; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668	16	7	7	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	MAY	2014	39	3					140	146		10.1002/rnj.138			7	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	AG7ET	WOS:000335581600005	24443322				2022-02-06	
J	Hernandez, CL; Elliott, TR; Berry, JW; Underhill, AT; Fine, PR; Lai, MHC				Hernandez, Caitlin L.; Elliott, Timothy R.; Berry, Jack W.; Underhill, Andrea T.; Fine, Philip R.; Lai, Mark H. C.			Trajectories of Life Satisfaction Five Years After Medical Discharge for Traumatically Acquired Disability	REHABILITATION PSYCHOLOGY			English	Article						life satisfaction; trauma; burns; spinal cord injury; family	SPINAL-CORD-INJURY; SET-POINT MODEL; QUALITY-OF-LIFE; BRAIN-INJURY; BURN INJURY; MARITAL-STATUS; FOLLOW-UP; ADAPTATION; HAPPINESS; INDIVIDUALS	Objectives: We studied the predictive impact of family satisfaction, marital status, and functional impairment on the trajectories of life satisfaction over the first 5 years following medical treatment for traumatic spinal cord injury, burns, or interarticular fractures (total N = 662). It was anticipated that fewer functional impairments, being married, and greater family satisfaction would predict higher life satisfaction trajectories. Method: The Functional Independence Measure, the Family Satisfaction Scale, and the Life Satisfaction Index were administered 12, 24, 48, and 60 months postdischarge. Results: Trajectory modeling revealed that greater functional impairment significantly predicted lower life satisfaction, regardless of injury type. However, this association diminished when marital status and family satisfaction were entered into the models. Greater family satisfaction and being married predicted greater life satisfaction across time. Moreover, there was no evidence for increases in life satisfaction trajectories over time: Trajectories were stable across time for all injury groups. Conclusions: Results suggest that being married and greater family satisfaction promote life satisfaction among those who traumatically acquire disability, and these beneficial effects may be more salient than the degree of functional impairment imposed by the condition.	[Hernandez, Caitlin L.; Elliott, Timothy R.; Lai, Mark H. C.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Berry, Jack W.] Samford Univ, Dept Psychol, Birmingham, AL USA; [Underhill, Andrea T.; Fine, Philip R.] Univ Alabama Birmingham, Injury Control Res Ctr, Birmingham, AL USA		Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA.	telliott@tamu.edu	Lai, Hok Chio/K-9386-2019; Elliott, Timothy R./I-5301-2012	Lai, Hok Chio/0000-0002-9196-7406; Elliott, Timothy R./0000-0002-6608-7714			ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; Askay S. W., 2010, HDB REHABILITATION P, P107; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Bond T, 2001, APPL RASCH MODEL FUN; Boyce CJ, 2011, PSYCHOL SCI, V22, P1397, DOI 10.1177/0956797611421790; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corry N, 2009, INT REV PSYCHIATR, V21, P539, DOI 10.3109/09540260903343901; de Groot S, 2009, J REHABIL MED, V41, P382, DOI 10.2340/16501977-0346; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; Dijkers MPJM, 2005, J REHABIL RES DEV, V42, P87, DOI 10.1682/JRRD.2004.08.0100; Dunn D.S., 2009, OXFORD HDB POSITIVE, P650, DOI [DOI 10.1093/OXFORDHB/9780195187243.013.0062, 10.1093/oxfordhb/9780195187243.013.0062]; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; EnglandKennedy ES, 2011, SOC SCI MED, V73, P1222, DOI 10.1016/j.socscimed.2011.07.006; Erosa NA, 2014, BRIT J HEALTH PSYCH, V19, P688, DOI 10.1111/bjhp.12063; Frederick S., 1999, WELL BEING FDN HEDON, P302; Freedman VA, 2012, SOC SCI MED, V74, P588, DOI 10.1016/j.socscimed.2011.10.018; Fujita F, 2005, J PERS SOC PSYCHOL, V88, P158, DOI 10.1037/0022-3514.88.1.158; Gibran NS, 2013, J BURN CARE RES, V34, P361, DOI 10.1097/BCR.0b013e31828cb249; Holavanahalli RK, 2006, J BURN CARE RES, V27, P703, DOI 10.1097/01.BCR.0000238085.87863.81; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Kalpinski RJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/102570; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Klein MB, 2011, J BURN CARE RES, V32, P66, DOI 10.1097/BCR.0b013e318203336a; Klinge K, 2009, J ADV NURS, V65, P2274, DOI 10.1111/j.1365-2648.2009.05138.x; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Lucas RE, 2007, J PERS SOC PSYCHOL, V92, P717, DOI 10.1037/0022-3514.92.4.717; Lucas RE, 2007, CURR DIR PSYCHOL SCI, V16, P75, DOI 10.1111/j.1467-8721.2007.00479.x; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Mausbach BT, 2011, CLIN PSYCHOL REV, V31, P900, DOI 10.1016/j.cpr.2011.04.004; McDowell I, 2006, MEASURING HLTH GUIDE; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Olson D. H., 1983, CIRCUMPLEX MODEL SYS; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Patterson DR, 2000, J BURN CARE REHABIL, V21, P490, DOI 10.1097/00004630-200021060-00004; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Powdthavee N, 2009, SOC SCI MED, V69, P1834, DOI 10.1016/j.socscimed.2009.09.023; Putzke JD, 2001, J CLIN PSYCHOL MED S, V8, P101, DOI 10.1023/A:1009555910604; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Rogers B., 2000, SCI PSYCHOSOCIAL PRO, V13, P41; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Snijders T. A. B., 1994, SOCIOLOGICAL METHODS, V18, P237; Snijders TAB., 2012, MULTILEVEL ANAL INTR; Underhill AT, 2004, J REHABIL RES DEV, V41, P603, DOI 10.1682/JRRD.2003.06.0094; van Leeuwen CMC, 2012, DISABIL REHABIL, V34, P76, DOI 10.3109/09638288.2011.587089; Vaux A., 2000, SOCIAL SUPPORT THEOR; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/001316402128775085; Wilson, 1982, FAMILY INVENTORIES I, P25; [No title captured]	57	7	7	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2014	59	2					183	192		10.1037/a0035887			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AJ7SQ	WOS:000337897800009	24611918				2022-02-06	
J	Kairy, D; Lehoux, P; Vincent, C				Kairy, Dahlia; Lehoux, Pascale; Vincent, Claude			Exploring routine use of telemedicine through a case study in rehabilitation	REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article						Telemedicine; rehabilitation; patient care team; spinal cord injuries; brain injuries; Canada	CLINICAL ROUTINES; TECHNOLOGY; TELEHEALTH; HEALTH; SUCCESS; IMPLEMENTATION; ORGANIZATIONS; NORMALIZATION; INFORMATION; COMMUNITY	Objective. This study examines how telerehabilitation becomes part of existing and new clinical routines and identifies factors that enable or constrain its routine use. Methods. An in-depth case study of a telemedicine program in rehabilitation implemented between an urban specialized rehabilitation center and a rural regional rehabilitation center was conducted. Using a conceptual framework based on Giddens' theory of structuration, a qualitative analysis was carried out using four data sources: focus groups and phone interviews (with health professionals, managers, and patients and their family members); telerehabilitation video recordings; and project documents (e.g., proposals, requests for funding, summaries, agendas of meetings, operating procedures, patient handouts, and tools for clinicians). Results. In two rehabilitation programs for 1) patients who sustained a traumatic brain injury and 2) those who sustained a spinal cord injury, telerehabilitation was successfully incorporated into routine clinical practices for activities such as interdisciplinary care plans. However, for specialized clinical consultations or long-term patient follow-up, telerehabilitation was not successfully incorporated. Factors that facilitated or prevented the integration of telerehabilitation in routine practices stemmed from both the structure (norms, rules, resources, and values) and the agent (e.g., users of telerehabilitation, including clinicians, managers, and patients and their families) and include 1) shared beliefs and assumptions held by patient care team members regarding the nature of the clinical activities, and the perceptions of patients and their family members; 2) clinical and organizational leadership; 3) extent and type of telerehabilitation use; 4) available resources; and 5) collaborations already in place or needing to be developed. Conclusions. This study provides empirical evidence of how telerehabilitation activities may become integrated into routine day-to-day clinical activities.	[Kairy, Dahlia] Univ Montreal, Fac Med, Sch Rehabil, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ H3C 3J7, Canada; [Lehoux, Pascale] Univ Montreal, Dept Hlth Adm, Inst Publ Hlth Res IRSPUM, Montreal, PQ, Canada; [Vincent, Claude] Univ Laval, Dept Rehabil, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada		Kairy, D (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ H3C 3J7, Canada.	dahlia.kairy@umontreal.ca	Lehoux, Pascale/M-9363-2013; Lehoux, Pascale/Q-6370-2019	Lehoux, Pascale/0000-0001-9482-1800; Lehoux, Pascale/0000-0001-9482-1800			BARLEY SR, 1986, ADMIN SCI QUART, V31, P78, DOI 10.2307/2392767; BARLEY SR, 1990, ADMIN SCI QUART, V35, P61, DOI 10.2307/2393551; Broens THF, 2007, J TELEMED TELECARE, V13, P303, DOI 10.1258/135763307781644951; Cardno EJ, 2000, J TELEMED TELECARE, V6, P6, DOI 10.1258/1357633001935644; de Bont A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-47; DESANCTIS G, 1994, ORGAN SCI, V5, P121, DOI 10.1287/orsc.5.2.121; Giddens A., 1984, CONSTITUTION SOC OUT; Greenhalgh T, 2013, SOC SCI MED, V93, P86, DOI 10.1016/j.socscimed.2013.05.036; Harrison R, 2002, J TELEMED TELECARE, V8, P39, DOI 10.1258/135763302320301948; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; Krueger R.A., 1998, MODERATING FOCUS GRO; Lehoux P, 2002, SOC SCI MED, V54, P889, DOI 10.1016/S0277-9536(01)00063-6; May C, 2003, J AM MED INFORM ASSN, V10, P596, DOI 10.1197/jamia.M1145; May C, 2003, J TELEMED TELECARE, V9, pS25; May C, 2003, SOC SCI MED, V57, P697, DOI 10.1016/S0277-9536(02)00419-7; May CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-131; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Moehr JR, 2006, INT J MED INFORM, V75, P755, DOI 10.1016/j.ijmedinf.2005.11.001; Murray E, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-6; NOORANI H, 2001, 14 CAN COORD OFF HLT; Orlikowski WJ, 1991, INFORM SYST RES, V2, P143, DOI 10.1287/isre.2.2.143; Orlikowski WJ, 2001, MIS QUART, V25, P145, DOI 10.2307/3250927; ORLIKOWSKI WJ, 1992, ORGAN SCI, V3, P398, DOI 10.1287/orsc.3.3.398; Paul DL, 2000, TELEMEDICINE STUDY V; PICOT J, 2000, TELEHEALTH IND CANAD; Pluye P, 2004, HEALTH PROMOT INT, V19, P489, DOI 10.1093/heapro/dah411; Schein EH., 2004, ORG CULTURE LEADERSH, V3rd ed.; Sicotte C, 2003, METHOD INFORM MED, V42, P451; Wade VA, 2014, QUAL HEALTH RES, V24, P682, DOI 10.1177/1049732314528809; Wootton R, 2001, J TELEMED TELECARE, V7, P3, DOI 10.1258/1357633011937245; Yellowlees P, 2001, J TELEMED TELECARE, V7, P29, DOI 10.1258/1357633011937056; Yin RK, 2003, CASE STUDY RES DESIG	33	7	8	0	12	PAN AMER HEALTH ORGANIZATION	WASHINGTON	525 23RD ST NW, WASHINGTON, DC 20037 USA	1020-4989			REV PANAM SALUD PUBL	Rev. Panam. Salud Publica	MAY-JUN	2014	35	5-6					337	344					8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AP6FY	WOS:000342174200004	25211559				2022-02-06	
J	Lu, H; Lei, XY				Lu, Hong; Lei, Xiaoyan			The apparent diffusion coefficient does not reflect cytotoxic edema on the uninjured side after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injuries; blood-brain barrier; magnetic resonance imaging; apparent diffusion coefficient; intracranial edema; cytotoxic edema; vasogenic edema; pathology; NSFC grant; neural regeneration	CORTICAL IMPACT INJURY; AQUAPORIN-4 EXPRESSION; RAT; ASTROCYTES; CONTUSION; TISSUE; MODEL; TBI	After traumatic brain injury, vasogenic and cytotoxic edema appear sequentially on the involved side. Neuroimaging investigations of edema on the injured side have employed apparent diffusion coefficient measurements in diffusion tensor imaging. We investigated the changes occurring on the injured and uninjured sides using diffusion tensor imaging/apparent diffusion coefficient and histological samples in rats. We found that, on the injured side, that vasogenic edema appeared at 1 hour and intracellular edema appeared at 3 hours. Mixed edema was observed at 6 hours, worsening until 12-24 hours post-injury. Simultaneously, microglial cells proliferated at the trauma site. Apparent diffusion coefficient values increased at 1 hour, decreased at 6 hours, and increased at 12 hours. The uninjured side showed no significant pathological change at 1 hour after injury. Cytotoxic edema appeared at 3 hours, and vasogenic edema was visible at 6 hours. Cytotoxic edema persisted, but vasogenic edema tended to decrease after 12-24 hours. Despite this complex edema pattern on the uninjured side with associated pathologic changes, no significant change in apparent diffusion coefficient values was detected over the first 24 hours. Apparent diffusion coefficient values accurately detected the changes on the injured side, but did not detect the changes on the uninjured side, giving a false-negative result.	[Lu, Hong; Lei, Xiaoyan] Cent S Univ, Xiangya Sch Med, Dept Radiol, Affiliated Haikou Hosp, Haikou 570208, Hainan Province, Peoples R China		Lu, H (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Radiol, Affiliated Haikou Hosp, Haikou 570208, Hainan Province, Peoples R China.	cqluh@sohu.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160181]; International Cooperation Project of Hainan Province [Qiongke (2012) 65]	This project was supported by the National Natural Science Foundation of China, No. 81160181; the International Cooperation Project of Hainan Province, No. Qiongke (2012) 65.	Akiguchi I, 1998, ACTA NEUROPATHOL, V95, P78, DOI 10.1007/s004010050768; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferrier MC, 2007, NEOPLASIA, V9, P546, DOI 10.1593/neo.07289; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Hu H, 2012, NEURAL REGEN RES, V7, P1659, DOI 10.3969/j.issn.1673-5374.2012.21.009; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Lo Pizzo M, 2013, NEUROL SCI, V34, P1309, DOI 10.1007/s10072-012-1233-4; Lu H, 2011, CHINESE MED J-PEKING, V124, P3148, DOI 10.3760/cma.j.issn.0366-6999.2011.19.034; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Sabre L, 2013, SPINAL CORD, V51, P623, DOI 10.1038/sc.2013.41; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Stroop R, 1998, ACT NEUR S, V71, P303; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Xu Fang-jing-wei, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P234; [张曙光 Zhang Shuguang], 2010, [中华创伤杂志, Chinese Journal of Trauma], V26, P589	23	7	8	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2014	9	9					973	977		10.4103/1673-5374.133150			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AI7KH	WOS:000337068600013	25206920	Green Published, Green Submitted, gold			2022-02-06	
J	Godoy, DA; Alvarez, E; Manzi, R; Pinero, G; Di Napoli, M				Agustin Godoy, Daniel; Alvarez, Erica; Manzi, Ruben; Pinero, Gustavo; Di Napoli, Mario			The Physiologic Effects of Indomethacin Test on CPP and ICP in Severe Traumatic Brain Injury (sTBI)	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Head trauma; Intracranial hypertension; Intracranial pressure; Cerebral perfusion pressure; Critical care; Indomethacin	CEREBRAL-BLOOD-FLOW; ELEVATED INTRACRANIAL-PRESSURE; SEVERE HEAD-INJURY; PERFUSION-PRESSURE; ACUTE MANAGEMENT; METABOLISM; CYCLOOXYGENASE; HEMODYNAMICS; HYPERTENSION; OXYGENATION	Refractory intracranial hypertension (RICH) is associated with high mortality in severe traumatic brain injury (sTBI). Indomethacin (INDO) can decrease intracranial cerebral pressure (ICP) improving cerebral pressure perfusion (CPP). Our aim was to determine modifications in ICP and CPP following INDO in RICH secondary to sTBI. INDO was administered in a loading dose (0.8 mg/kg/15 min), followed by continuous 2-h infusion period (0.5 mg/kg/h). Clinical outcome was assessed at 30 days according to Glasgow Outcome Scale (GOS). Differences in ICP and CPP values were assessed using repeated-measures ANOVA. Receiver operating characteristic curve (AUC) was used for discrimination in predicting 30-day survival and good functional outcome (GOS 4 or 5). Analysis of INDO safety profile was also conducted. Thirty-two patients were included. Median GCS score was 6 (interquartile range: 4-7). The most frequent CT finding was the evacuated mass lesion (EML) according to Marshall classification (28.1 %). Mortality rate was 34.4 %. Within 15 min of INDO infusion, ICP decreased (Delta%: -54.6 %; P < 0.0001), CPP increased (Delta%: +44.0 %; P < 0.0001), and the remaining was stable during the entire infusion period. Patients with good outcome (n = 12) showed a greater increase of CPP during INDO test (P = 0.028). CPP response to INDO test discriminated moderately well surviving patients (AUC = 0.751; P = 0.0098) and those with good functional recovery (AUC = 0.763; P = 0.0035) from those who died and from those with worse functional outcome, respectively. No adverse events were observed. INDO appears effective in reducing ICP and improving CPP in RICH. INDO test could be a useful tool in identifying RICH patients with favorable outcome. Future studies are needed.	[Agustin Godoy, Daniel; Alvarez, Erica; Manzi, Ruben] Sanatorio Pasteur, Neurocrit Care Unit, San Fernando Valle Catam, Argentina; [Agustin Godoy, Daniel] Hosp San Juan Bautista, Intens Care Unit, RA-4700 San Fernando Valle Catam K, Argentina; [Pinero, Gustavo] Hosp Municipal Leonidas Lucero, Intens Care Unit, Bahia Blanca, Buenos Aires, Argentina; [Di Napoli, Mario] San Camillo de Lellis Gen Hosp, Neurol Serv, Rieti, Italy; [Di Napoli, Mario] SMDN Ctr Cardiovasc Med & Cerebrovasc Dis Prevent, Neurol Sect, I-67039 Sulmona, AQ, Italy		Godoy, DA (corresponding author), Hosp San Juan Bautista, Intens Care Unit, Chacabuco 675, RA-4700 San Fernando Valle Catam K, Argentina.	dagodoytorres@yahoo.com.ar; mariodinapoli@katamail.com	Di Napoli, Mario/J-6418-2014; Di Napoli, Mario/H-3475-2019	Di Napoli, Mario/0000-0001-9609-4926; Di Napoli, Mario/0000-0001-9609-4926			BIESTRO AA, 1995, J NEUROSURG, V83, P627, DOI 10.3171/jns.1995.83.4.0627; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Bruhn H, 2001, J MAGN RESON IMAGING, V13, P325, DOI 10.1002/jmri.1047; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clemmesen JO, 1997, HEPATOLOGY, V26, P1423; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dahl B, 1996, ACTA NEUROCHIR, V138, P265, DOI 10.1007/BF01411736; ERIKSSON S, 1983, ACTA PHYSIOL SCAND, V117, P203, DOI 10.1111/j.1748-1716.1983.tb07198.x; Gjedde A, 2005, J CEREB BLOOD FLOW M, V25, P1183; Godoy DA, 2005, ACTA ANAESTH SCAND, V49, P1577, DOI 10.1111/j.1399-6576.2005.00885_49_10.x; Godoy DA, 2012, NEUROSURGERY, V71, P245, DOI 10.1227/NEU.0b013e318256b9f5; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; Imberti R, 2005, J NEUROSURG, V102, P455, DOI 10.3171/jns.2005.102.3.0455; Jensen K, 1996, J NEUROSURG ANESTH, V8, P111, DOI 10.1097/00008506-199604000-00002; JENSEN K, 1993, ACTA NEUROCHIR, V124, P114, DOI 10.1007/BF01401132; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Ling GSF, 2005, NEUROCRIT CARE, V2, P75, DOI 10.1385/NCC:2:1:075; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; MARKUS HS, 1994, STROKE, V25, P1760, DOI 10.1161/01.STR.25.9.1760; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; PICKARD J, 1980, BRAIN RES, V197, P425, DOI 10.1016/0006-8993(80)91127-0; PICKARD JD, 1977, EUR J PHARMACOL, V43, P343, DOI 10.1016/0014-2999(77)90040-1; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; QUINTANA A, 1988, EUR J PHARMACOL, V149, P385, DOI 10.1016/0014-2999(88)90674-7; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rasmussen M, 2005, ACTA ANAESTH SCAND, V49, P341, DOI 10.1111/j.1399-6576.2005.00647.x; Rasmussen M, 2004, ANAESTHESIA, V59, P229, DOI 10.1111/j.1365-2044.2004.03604.x; Roberts R G, 2002, Crit Care Resusc, V4, P271; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schumann P, 1996, NEUROSCI LETT, V220, P137, DOI 10.1016/S0304-3940(96)13210-9; Slavik RS, 1999, NEUROL RES, V21, P491; St Lawrence KS, 2003, MAGNET RESON MED, V50, P99, DOI 10.1002/mrm.10502; Stocchetti N, 1998, ACT NEUR S, V71, P162; TEASDALE G, 1974, LANCET, V2, P81; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; Upton RN, 2008, CLIN EXP PHARMACOL P, V35, P317, DOI 10.1111/j.1440-1681.2007.04818.x; Weigert G, 2008, INVEST OPHTH VIS SCI, V49, P1065, DOI 10.1167/iovs.07-0824; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zammit Christopher, 2013, Emerg Med Pract, V15, P1	48	7	7	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2014	20	2					230	239		10.1007/s12028-013-9924-0			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD0XA	WOS:000332956400008	24233815				2022-02-06	
J	Boerboom, W; Jacobs, EAC; Khajeh, L; van Kooten, F; Ribbers, GM; Heijenbrok-Kal, MH				Boerboom, Wendy; Jacobs, Esther A. C.; Khajeh, Ladbon; van Kooten, Fop; Ribbers, Gerard M.; Heijenbrok-Kal, Majanka H.			THE RELATIONSHIP OF COPING STYLE WITH DEPRESSION, BURDEN, AND LIFE DISSATISFACTION IN CAREGIVERS OF PATIENTS WITH SUBARACHNOID HAEMORRHAGE	JOURNAL OF REHABILITATION MEDICINE			English	Article						subarachnoid haemorrhage; caregiver; coping style	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; WORLD-FEDERATION; STROKE PATIENTS; FAMILY; INTERVENTION; DETERMINANTS; SATISFACTION; PARTNERS; OUTCOMES	Objective: To assess the relationship of coping style with depression, burden and life satisfaction in caregivers of patients with subarachnoid haemorrhage. Design: Cross-sectional study. Participants: Forty-one primary caregivers of patients with subarachnoid haemorrhage. Methods: Caregivers completed several questionnaires within the first year after subarachnoid haemorrhage. Coping style was assessed using the Utrecht Coping List, depression with the Goldberg Depression Scale (GDS), burden with the Sense of Competence Questionnaire, and life satisfaction with the Life Satisfaction Questionnaire. Results: Caregivers had a mean burden score of 37.8 (standard deviation (SD) = 7.4) and a life satisfaction score of 5.0 (SD = 0.6). Nine caregivers (23%) had depressive symptoms (GDS >= 2). A palliative coping style was positively associated with the presence of depressive symptoms (odds ratio (OR) = 1.45, p = 0.016). A passive coping style was positively related to burden (beta = 1.61, p = 0.024), adjusted for morbidity of the caregiver (beta = 11.90, p = 0.013), and inversely related to life satisfaction (beta =-0.10, p= 0.025). Conclusion: In caregivers of patients with subarachnoid haemorrhage palliative or passive coping styles are related to depressive symptoms, higher burden and life dissatisfaction. This implies that rehabilitation programmes for patients with subarachnoid haemorrhage should also include caregiver support programmes that focus on coping style.	[Boerboom, Wendy; Jacobs, Esther A. C.; Ribbers, Gerard M.; Heijenbrok-Kal, Majanka H.] Univ Med Ctr Rotterdam, Rijndam Rehabil Ctr, NL-3001 KD Rotterdam, Netherlands; [Boerboom, Wendy; Jacobs, Esther A. C.; Ribbers, Gerard M.; Heijenbrok-Kal, Majanka H.] Univ Med Ctr Rotterdam, Dept Rehabil Med, Erasmus MC, NL-3001 KD Rotterdam, Netherlands; [Khajeh, Ladbon; van Kooten, Fop] Univ Med Ctr Rotterdam, Dept Neurol, Erasmus MC, NL-3001 KD Rotterdam, Netherlands		Boerboom, W (corresponding author), Univ Med Ctr Rotterdam, RoNeRes Rotterdam Neurorehabil Res, Rijndam Rehabil Ctr, POB 23181, NL-3001 KD Rotterdam, Netherlands.	wboerboom@rijndam.nl	Ribbers, Gerard M/C-1454-2014; Ribbers, Gerard/N-3623-2019	Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	Johanna Kinderfonds [03.10.13-2003/0200]; Stichting BIO, The Netherlands	Financial support for this study was provided by: Johanna Kinderfonds (grant no 03.10.13-2003/0200) and Stichting BIO, The Netherlands.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bartolo M, 2010, J REHABIL MED, V42, P818, DOI 10.2340/16501977-0612; Boonstra AM, 2012, INT J REHABIL RES, V35, P153, DOI 10.1097/MRR.0b013e328352ab28; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Collin C, 1988, Int Disabil Stud, V10, P61; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gregorio GW, 2011, J REHABIL MED, V43, P190, DOI 10.2340/16501977-0633; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; HUTTER BO, 1994, ACTA NEUROCHIR, V127, P129, DOI 10.1007/BF01808755; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI 10.1136/bmj.328.7448.1099; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Mezue W, 2004, BRIT J NEUROSURG, V18, P135, DOI 10.1080/02688690410001680984; Noble AJ, 2008, J NEUROSURG, V109, P1027, DOI 10.3171/JNS.2008.109.12.1027; Oshiro EM, 1997, NEUROSURGERY, V41, P140, DOI 10.1097/00006123-199707000-00029; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Post MWM, 1998, SCAND J REHABIL MED, V30, P23; Pritchard C, 2001, BRIT J NEUROSURG, V15, P456, DOI 10.1080/02688690120097679; Reimer WJMSO, 1998, STROKE, V29, P373, DOI 10.1161/01.STR.29.2.373; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Schreurs P. J. G., 1993, UTRECHT COPING LIST; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Visser-Meily A, 2005, CEREBROVASC DIS, V20, P443, DOI 10.1159/000088983; Visser-Meily A, 2009, STROKE, V40, P1399, DOI 10.1161/STROKEAHA.108.516682; Visser-Meily JMA, 2004, CLIN REHABIL, V18, P601, DOI 10.1191/0269215504cr776oa	37	7	7	0	15	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2014	46	4					321	326		10.2340/16501977-1273			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AE7CR	WOS:000334154800005	24626873	gold, Green Submitted			2022-02-06	
J	Cralidis, A; Lundgren, K				Cralidis, Ann; Lundgren, Kristine			Component analysis of verbal fluency performance in younger participants with moderate-to-severe traumatic brain injury	BRAIN INJURY			English	Article						Clustering; phonemic verbal fluency; semantic verbal fluency; switching; Traumatic brain injury	CLOSED-HEAD INJURY; WORD FLUENCY; ALZHEIMERS-DISEASE; CATEGORY FLUENCY; PRACTICAL SCALE; NORMATIVE DATA; STRATEGY USE; TASKS; FAS; AGE	Primary objective: To investigate phonemic and semantic verbal fluency performance in a group of young adult participants with and without traumatic brain injury. Research design: Group comparison. Methods and procedures: Twenty-five participants with moderate-to-severe TBI and 25 participants with no brain damage (NBD) were given phonemic and semantic verbal fluency tasks. Responses were analysed quantitatively and qualitatively. Main outcomes and results: Young participants with moderate-to-severe TBI generated significantly fewer total correct words and sub-categories for both fluency conditions when compared to controls. The total number of correct words generated on the phonemic condition and for the semantic category of animals was positively correlated with the number of category switches produced during the task. Conclusions: While young participants with moderate-to-severe TBI produced fewer total correct words on both verbal fluency conditions in comparison to controls, these differences were greater on the phonemic condition. Participants with moderate-to-severe TBI switched less frequently on both fluency tasks and produced smaller cluster sizes only on the phonemic task in comparison to controls. These results are in contrast with previous investigations that have observed greater age-related declines on semantic tasks when compared to phonemic tasks.	[Cralidis, Ann] Longwood Univ, Dept Commun Sci & Disorders, Farmville, VA USA; [Lundgren, Kristine] Univ N Carolina, Dept Commun Sci & Disorders, Greensboro, NC 27412 USA		Cralidis, A (corresponding author), 315 W 3rd St,Off 105, Farmville, VA 23901 USA.	cralidisal@longwood.edu					Abwender DA, 2001, ASSESSMENT, V8, P323, DOI 10.1177/107319110100800308; ANDERSON JR, 1984, J EXP PSYCHOL LEARN, V10, P791, DOI 10.1037/0278-7393.10.4.791; Auriacombe S, 2001, AGING NEUROPSYCHOL C, V8, P98, DOI 10.1076/anec.8.2.98.841; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Bolla KI, 1998, CLIN NEUROPSYCHOL, V12, P482; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; Capitani E, 2009, NEUROPSYCHOLOGIA, V47, P423, DOI 10.1016/j.neuropsychologia.2008.09.016; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; CORDES AK, 1994, J SPEECH HEAR RES, V37, P264, DOI 10.1044/jshr.3702.264; Crossley M, 1997, J CLIN EXP NEUROPSYC, V19, P52, DOI 10.1080/01688639708403836; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Delis DC, DELIS KAPLAN EXECUTI; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Goldstein FC, 1996, NEUROPSYCHOLOGY, V10, P147; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; Haugrud N, 2010, AGING NEUROPSYCHOL C, V17, P220, DOI 10.1080/13825580903042700; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hughes DL, 2002, J CLIN EXP NEUROPSYC, V24, P642, DOI 10.1076/jcen.24.5.642.1002; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; JENNETT B, 1975, LANCET, V1, P480; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kave G, 2012, AGING NEUROPSYCHOL C, V19, P515, DOI 10.1080/13825585.2011.638975; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KOZORA E, 1995, CLIN NEUROPSYCHOL, V9, P313, DOI 10.1080/13854049508400495; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Leon SA, 2005, J REHABIL RES DEV, V42, P93, DOI 10.1682/JRRD.2003.12.0182; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Levin HS, 1982, NEUROBEHAVIORAL CONS, P279; MARSHALL JC, 1986, NEUROPSYCHOLOGIA, V24, P5, DOI 10.1016/0028-3932(86)90040-0; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MCGREGOR KK, 1992, J SPEECH HEAR RES, V35, P596, DOI 10.1044/jshr.3503.596; Newcombe F, 1969, MISSILE WOUNDS BRAIN, P145; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rather NB, 1992, J SPEECH HEAR RES, V35, P14; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; Sauzeon H, 2011, J ADULT DEV, V18, P144, DOI 10.1007/s10804-010-9107-6; Spreen O, 1991, COMPENDIUM NEUROPSYC, P442; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TOMER R, 1993, PERCEPT MOTOR SKILL, V76, P465, DOI 10.2466/pms.1993.76.2.465; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	53	7	7	0	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					456	464		10.3109/02699052.2014.896945			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900009	24678825				2022-02-06	
J	Goverover, Y; Chiaravalloti, ND; DeLuca, J				Goverover, Yael; Chiaravalloti, Nancy D.; DeLuca, John			Task meaningfulness and degree of cognitive impairment: Do they affect self-generated learning in persons with multiple sclerosis?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Self-generation; Generation effect; Memory; Learning; Multiple sclerosis	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; ALZHEIMER-TYPE; ADDED-PURPOSE; SOURCE MEMORY; REHABILITATION; ACQUISITION; MOVEMENT; DEMENTIA; CONTEXT	Self-generated learning has been shown to improve memory performance in persons with multiple sclerosis (MS), although little is known about the variables that influence its efficacy. This study examined whether task meaningfulness and degree of cognitive impairment influence the effectiveness of self-generation in improving learning and memory in MS. A mixed design with both a within-and between-subject factors was employed. The setting was a nonprofit rehabilitation research institution. Participants included 35 persons with MS with moderate to severe learning and memory impairments (SEVERE-MS), and 35 persons with little to no impairment (MILD-MS). Participants in both groups learned two types of tasks (functional everyday tasks and laboratory tasks), each in two learning conditions (Provided and Generated). Participants were required to recall the information immediately, 30 minutes, and 1 week following initial learning. Significantly more words were recalled from the generated condition relative to the provided condition. Additionally, self-generation was more effective in recall on the functional tasks compared to the laboratory tasks, consistent for both memory impaired and non-impaired participants. Self-generation may be influenced by variables such as task meaningfulness during learning and memory. In addition, type of task (functional versus laboratory) has a significant effect on memory. Implications for cognitive rehabilitation in MS are discussed.	[Goverover, Yael] NYU, Dept Occupat Therapy, New York, NY 10012 USA; [Goverover, Yael; Chiaravalloti, Nancy D.; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Chiaravalloti, Nancy D.; DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA		Goverover, Y (corresponding author), NYU, Dept Occupat Therapy, Steinhardt Sch Culture Educ & Human Dev, 35 West 4th St,11th Floor, New York, NY 10012 USA.	yg243@nyu.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG 3935A2/2]	This study supported by the National Multiple Sclerosis Society [grant number RG 3935A2/2]. Presented in part to the Consortium of Multiple Sclerosis Center, May 30-June 2, 2012, San Diego, CA and the International Neuropsychological Society, February 15-18, 2012, Montreal, CA.	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P875, DOI 10.3109/02699052.2012.655361; Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P63, DOI 10.1080/13803390601186957; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; BEATTY WW, 1988, ARCH NEUROL-CHICAGO, V45, P611, DOI 10.1001/archneur.1988.00520300029013; Beatty WW, 1995, J NEUROL REHABIL, V9, P167; BECKER JT, 1983, J NERV MENT DIS, V171, P617, DOI 10.1097/00005053-198310000-00005; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; BLOCH MW, 1989, AM J OCCUP THER, V43, P25, DOI 10.5014/ajot.43.1.25; BOWER GH, 1979, J RES PERS, V13, P420, DOI 10.1016/0092-6566(79)90005-9; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Czaja SJ, 2003, GERONTOLOGIST, V43, P9, DOI 10.1093/geront/43.suppl_1.9; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Demaree HA, 2000, J CLIN EXP NEUROPSYC, V22, P865, DOI 10.1076/jcen.22.6.865.961; Fasoli SE, 2002, OTJR-OCCUP PARTICI H, V22, P119, DOI 10.1177/153944920202200305; Ferguson JM, 1997, AM J OCCUP THER, V51, P508, DOI 10.5014/ajot.51.7.508; Fink F, 2010, MULT SCLER J, V16, P332, DOI 10.1177/1352458509356367; FISHER AG, 2001, ASSESSMENT MOTOR PRO; Fisk AD, 1996, AGING AND SKILLED PERFORMANCE, P1; Gonzalez-Nosti M, 2010, AM J ALZHEIMERS DIS, V25, P576, DOI 10.1177/1533317510382284; Goverover Y, 2008, ARCH PHYS MED REHAB, V89, P1514, DOI 10.1016/j.apmr.2007.11.059; Hsieh S, 1999, PERCEPT MOTOR SKILL, V89, P355, DOI 10.2466/PMS.89.6.355-367; KESSLER HR, 1992, INT J NEUROSCI, V62, P17, DOI 10.3109/00207459108999754; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Ma HI, 1999, AM J OCCUP THER, V53, P138, DOI 10.5014/ajot.53.2.138; Marsh EJ, 2001, MEM COGNITION, V29, P798, DOI 10.3758/BF03196409; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Patten Scott B, 2012, Int J MS Care, V14, P2, DOI 10.7224/1537-2073-14.1.2; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith ML, 1996, NEUROPSYCHOLOGIA, V34, P553, DOI 10.1016/0028-3932(95)00139-5; Souliez L, 1996, CORTEX, V32, P347, DOI 10.1016/S0010-9452(96)80056-6; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Thomson P, 2006, CAMBRIDGE INTRO LIT, P1, DOI [10.2277/ 0521542510, 10.1002/14651858.CD004431.pub2]; Trombly CA, 1999, AM J OCCUP THER, V53, P333, DOI 10.5014/ajot.53.4.333; vanWieringen PCW, 1996, HUM MOVEMENT SCI, V15, P315, DOI 10.1016/0167-9457(95)00048-8; Weber E, 2012, J INT NEUROPSYCH SOC, V18, P128, DOI 10.1017/S135561771100124X; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]	54	7	7	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR	2014	24	2					155	171		10.1080/09602011.2013.868815			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AI9BG	WOS:000337220800001	24438052				2022-02-06	
J	Gutenbrunner, C; Liebl, ME; Reisshauer, A; Schwarzkopf, SR; Korallus, C; Ziegenthaler, H; Smolenski, UC; Egen, C; Glaesener, JJ				Gutenbrunner, C.; Liebl, M. E.; Reisshauer, A.; Schwarzkopf, S. R.; Korallus, C.; Ziegenthaler, H.; Smolenski, U. C.; Egen, C.; Glaesener, J. -J.			Rethinking Rehabilitation Medicine - The Profile of the Specialist in Physical and Rehabilitation Medicine (PRM)	PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN			German	Article						Rehabilitationsdiagnostik; Rehabilitationssteuerung; funktionale Gesundheit; Physikalische und -Rehabilitative Medizin; diagnostics and assessment in rehabilitation; rehabilitation plan; physical and rehabilitation medicine; functioning	CONCEPTUAL DESCRIPTION; INTERNATIONAL CLASSIFICATION; POSITION PAPER; HEALTH; MODEL; PATHOPHYSIOLOGY; IMPLEMENTATION; COMPETENCE; DISABILITY; FIELD	New developments in medicine will change the way medical specialties define themselves. Such developments might be the increased knowledge in medicine and changes in epidemiology of diseases. Such changes and the recent developments in the theoretical model of functioning and disability significantly influenced the professional practice of Physical and Rehabilitation Medicine (PRM). This article describes the field of competence of PRM specialists and demonstrates its consequences using clinical cases. Due to international definitions PRM specialists treat patients with a wide range of health conditions and functional problems. In Germany the most common symptoms are musculoskeletal problems, chronic pain syndromes, diseases of the nervous system and psychosocial problems. In hospitals the most common indications are severe functional problems after injury and complex surgery, stroke, traumatic brain injury and spinal cord injury. In acute rehabilitation the focus is on the consequences and risks of immobilisation, such as muscular atrophy, critical-Illness-neuropathia, severe deconditioning, cerebral dysfunction incl. dysphagia, contractures, pain and spasticity Diagnostics in PRM includes the diagnosis of the underlying pathology, and the assessment of quality and intensity of functional problems, activity limitations and participation restrictions. Another area is the assessment of relevant contextual factors including both environmental and personal factors.Like in other medical specialties in PRM the detailed planning of therapies and rehabilitation interventions is crucial for a successful treatment. Due to the high variability of rehabilitation goals in PRM a wide spectrum of interventions is used (medication, physical modalities, rehabilitation interventions, supportive devices and assistive technologies, patient education and social support). Another main principle is the interdisciplinary and multi-professional co-operation of the PRM specialist. PRM doctors are working in acute setting, in-patient, day-clinic and outpatient rehabilita-tion services. All in all in Germany the medical specialty of PRM is well established and had a dynamic development. The need for coordinated rehabilitation interventions based on medical assessment and social analysis is growing. This is the case for the "classical" post-acute and long-term rehabilitation, but also in hospitals and in outpatient services. center dot	[Gutenbrunner, C.; Korallus, C.; Egen, C.] Hannover Med Sch, Klin Rehabil Med, D-30625 Hannover, Germany; [Liebl, M. E.; Reisshauer, A.] Charite Univ Med Berlin, Arbeitsbereich Phys Med & Rehabil, Berlin, Germany; [Schwarzkopf, S. R.] Klinikum Nurnberg, Klin & Inst Phys & Rehabil Med & Nat Heilverfahre, Nurnberg, Germany; [Ziegenthaler, H.] Moritz Klin GmbH & Co KG, Reha Zentrum Brandverletzte, Bad Klosterlausnitz, Germany; [Smolenski, U. C.] Univ Klinikum Jena, Inst Physiotherapie, Jena, Germany; [Glaesener, J. -J.] Berufsgenossenschaftliches Unfallkrankenhaus, Zentrum Rehabil Med, Hamburg, Germany		Gutenbrunner, C (corresponding author), Hannover Med Sch, Klin Rehabil Med, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gutenbrunner.christoph@mh-hannover.de		Gutenbrunner, Christoph/0000-0002-6522-1942; Liebl, Max Emanuel/0000-0002-6608-4281			AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Balluer K, 2013, GESUNDHEITSWESEN, V75, P848, DOI 10.1055/s-0033-1337995; Bethge M, 2010, PATIENTENORIENTIERUN; Beyer J, POSITIONSPAPIER FACH; BKK Gesundheitsreport, 2012, BKK GES; Bundesarztekammer, 2013, MUST; Clade H, 2010, RHEINISCHES ARZTEBL, V11, P23; Dannenberg A, 2009, RV AKTUELL, V9, P283; Dillmann U, 1994, Schmerz, V8, P100, DOI 10.1007/BF02530415; DRV Bund, 2009, RAHM MED REH GES REN; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Egen C, 2014, ENTWICKLUNG BUNDESEI; Geissner E., 1996, SCHMERZEMPFINDUNGS S; Gerbershagen HU., 1996, ANTIDEPRESSIVA ALS A, P71; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Gummesson C, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-11; Gutenbrunner C, 2011, PHYS MED REHAB KUROR, V21, P234, DOI 10.1055/s-0031-1286326; Gutenbrunner C., 2011, Annals of Physical and Rehabilitation Medicine, V54, P298, DOI 10.1016/j.rehab.2011.05.001; Gutenbrunner C, 2010, Ann Phys Rehabil Med, V53, P593, DOI 10.1016/j.rehab.2010.10.005; GUTENBRUNNER C, 2006, EURA MEDICOPHYS, V42, P287; Gutenbrunner C, 2010, REV SOC PORTUGESA ME, V19, P5; Gutenbrunner C, 2013, J REHABIL MED, V45, P1, DOI 10.2340/16501977-1094; Gutenbrunner C, 2011, J REHABIL MED, V43, P760, DOI 10.2340/16501977-0866; Gutenbrunner C, 2011, AM J PHYS MED REHAB, V90, P521, DOI 10.1097/PHM.0b013e31822473dc; Gutenbrunner C, 2010, J REHABIL MED, V42, P206, DOI 10.2340/16501977-0513; Hubert W, 2006, KLIN REHABILITATION; Janig W, 2002, SCHMERZ, V16, P429, DOI 10.1007/s00482-002-0187-5; Kohlmann T, 1996, Rehabilitation (Stuttg), V35, pI; Maihofner C, 2007, FORTSCHR NEUROL PSYC, V75, P331, DOI 10.1055/s-2006-944310; Mau W, 2004, PHYS MED REHAB KUROR, V14, P308, DOI 10.1055/s-2004-828395; Meyer T, 2008, REIHE REHABILITATION; Meyer T, 2011, J REHABIL MED, V43, P765, DOI 10.2340/16501977-0865; Neumann V, 2010, J REHABIL MED, V42, P4, DOI 10.2340/16501977-0483; Niemier K, 2012, FUNKTIONELLE SCHMERZ; Organisation for Economic Cooperation and Development (OECD), 2010, INT CLASS HLTH ACC I; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rentsch HP, 2003, DISABIL REHABIL, V25, P411, DOI 10.1080/0963828031000069717; Schafer T, 2013, KRANKENHAUS REPORT 2, P111; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Seidel EJ, 2013, PHYS REHABILITATIVE; Stucki G, 1996, Z RHEUMATOL, V55, P40; Stucki G, 2007, J REHABIL MED, V39, P286, DOI 10.2340/16501977-0044; Tarau L, 2009, CHRONISCHER SCHMERZ; Treede RD, 2011, PRAKTISCHE SCHMERZTH; Ward AB, 2007, J REHABIL MED, V39, P3; Ward AB, 2012, J REHABIL MED, V44, P289, DOI 10.2340/16501977-0960; Ward AB, 2010, J REHABIL MED, V42, P417, DOI 10.2340/16501977-0565; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wille R, 2002, PERSPEKTIVEN INTERDI, P73; World Health Organisation, 1980, INT CLASS IMP DIS HA; World Health Organizatio, 2001, INT CLASS FUNCT DIS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann Z, 2004, ORTHOPADE, V33, P515, DOI 10.1007/s00132-004-0646-z	55	7	7	0	35	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0940-6689	1439-085X		PHYS MED REHAB KUROR	Physik. Med. Rehabilitationsmed. Kurort.	APR	2014	24	2					62	74		10.1055/s-0034-1368786			13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AF8UR	WOS:000334991600002					2022-02-06	
J	Hamalanen, P; Rosti-Otajarvi, E				Hamalanen, Paivi; Rosti-Otajarvi, Eija			Is neuropsychological rehabilitation effective in multiple sclerosis?	NEURODEGENERATIVE DISEASE MANAGEMENT			English	Article							COGNITIVE REHABILITATION; WORKING-MEMORY; MS PATIENTS; IMPAIRMENT; INTERVENTION; ATTENTION; DEFICITS; PEOPLE; PERFORMANCE; DYSFUNCTION	Cognitive deficits are common symptoms in multiple sclerosis (MS), and evident even in the early stages of the disease. Cognitive functions most frequently affected are information processing, memory and learning, and attention. Deficits may have a multidimensional impact on quality of life by weakening the ability to work, impairing social functioning and increasing the strain of the caregiver. To date, no effective pharmacological treatment for cognitive decline has been established, although there is some evidence suggesting that disease-modifying therapies may help to preserve cognitive function. Neuropsychological rehabilitation aims at alleviation of the negative effects of cognitive impairments and has been found to be effective in patients with stroke and traumatic brain injury. This paper discusses the evidence on neuropsychological rehabilitation in MS based on a recent systematic literature review and suggests a model for alleviating the effects of cognitive impairments in MS. The preliminary research evidence on the effects of neuropsychological rehabilitation in MS is positive: rehabilitation may have favorable effects on patients' cognitive performance and coping with cognitive impairments. In clinical practice, the diagnostics and treatment of cognitive impairments should be improved. Neuropsychological rehabilitation should be an important part of a rehabilitation regimen in MS.	[Hamalanen, Paivi] Masku Neurol Rehabil Ctr, POB 15, FI-21251 Tampere, Finland; [Rosti-Otajarvi, Eija] Tampere Univ Hosp, Dept Neurol & Rehabil, FIN-33521 Tampere, Finland		Hamalanen, P (corresponding author), Masku Neurol Rehabil Ctr, POB 15, FI-21251 Tampere, Finland.	paivi.hamalainen@ms-liitto.fi					Amato MP, 2014, MULT SCLER J, V20, P91, DOI 10.1177/1352458513501571; Amato Maria Pia, 2008, Expert Rev Neurother, V8, P1585, DOI 10.1586/14737175.8.10.1585; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Barten LJ, 2010, DRUG DES DEV THER, V4, P343, DOI 10.2147/DDDT.S9331; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Benedict RHB, 2000, MULT SCLER, V6, P391, DOI 10.1177/135245850000600606; Bonnet MC, 2006, J NEUROL SCI, V251, P23, DOI 10.1016/j.jns.2006.08.002; BOWEN A, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003586.PUB2; Brissart H, 2013, NEUROCASE, V19, P553, DOI 10.1080/13554794.2012.701644; Calabrese P, 2006, J NEUROL, V253, P10, DOI 10.1007/s00415-006-1103-1; Cerasa A, 2013, NEUROREHAB NEURAL RE, V27, P284, DOI 10.1177/1545968312465194; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Chiaravalloti ND, 2012, EXPERT REV NEUROTHER, V12, P755, DOI [10.1586/ern.12.68, 10.1586/ERN.12.68]; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; DeLuca J, 2005, ISS CLIN COGN NEUROP, P37; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; Feinstein A, 2007, CLINICAL NEUROPSYCHIATRY OF MULTIPLE SCLEROSIS, 2ND EDITION, P1, DOI 10.1017/CBO9780511543760; Filippi M, 2010, NEUROL SCI, V31, P231, DOI 10.1007/s10072-010-0367-5; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Fink F, 2010, MULT SCLER J, V16, P1148, DOI 10.1177/1352458510375440; Flavia M, 2010, J NEUROL SCI, V288, P101, DOI 10.1016/j.jns.2009.09.024; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1166, DOI 10.1016/j.neuropsychologia.2005.10.006; Hildebrandt H, 2007, RESTOR NEUROL NEUROS, V25, P33; JENNEKENSSCHINKEL A, 1990, J NEUROL SCI, V99, P229, DOI 10.1016/0022-510X(90)90158-J; JONSSON A, 1993, ACTA NEUROL SCAND, V88, P394, DOI 10.1111/j.1600-0404.1993.tb05366.x; Khan F, 2007, DISABIL REHABIL, V29, P1241, DOI 10.1080/01443610600964141; Kotterba S, 2003, EUR NEUROL, V50, P160, DOI 10.1159/000073057; Kujala P, 1997, BRAIN, V120, P289, DOI 10.1093/brain/120.2.289; Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Langdon DW, 1999, MULT SCLER J, V5, P94, DOI 10.1177/135245859900500205; Leavitt VM, 2014, BRAIN IMAGING BEHAV, V8, P394, DOI 10.1007/s11682-012-9183-2; Lincoln NB, 2008, MULT SCLER, V14, P123, DOI 10.1177/1352458507080467; Lincoln NB, 2002, J NEUROL NEUROSUR PS, V72, P93, DOI 10.1136/jnnp.72.1.93; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; Mantynen A, 2014, MULT SCLER J, V20, P99, DOI 10.1177/1352458513494487; MARIANI C, 1991, J NEUROL, V238, P395, DOI 10.1007/BF00319859; Mattioli F, 2012, MULT SCLER RELAT DIS, V1, P168, DOI 10.1016/j.msard.2012.06.004; Mendoza RJ, 2001, NEUROREHAB NEURAL RE, V15, P9, DOI 10.1177/154596830101500102; Mendozzi L, 1998, ITAL J NEUROL SCI, V19, pS431, DOI 10.1007/BF00539601; Nair R, 2012, COCHRANE DB SYST REV, V3; Nair RD, 2007, COCHRANE DB SYST REV, V3; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Parisi L, 2014, BRAIN IMAGING BEHAV, V8, P387, DOI 10.1007/s11682-012-9160-9; Penner IK, 2007, MULT SCLER, V13, P1161, DOI 10.1177/1352458507079267; Rogers JM, 2007, J CLIN NEUROSCI, V14, P919, DOI 10.1016/j.jocn.2007.02.006; Rosti E, 2007, J INT NEUROPSYCH SOC, V13, P791, DOI 10.1017/S1355617707071019; Rosti-Otajarvi E, 2013, J NEUROL SCI, V334, P154, DOI 10.1016/j.jns.2013.08.017; Rosti-Otajarvi E, 2013, J NEUROL SCI, V334, P106, DOI 10.1016/j.jns.2013.07.2520; Rosti-Otajarvi EM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub3; Shatil E, 2010, NEUROREHABILITATION, V26, P143, DOI 10.3233/NRE-2010-0546; Solari A, 2004, J NEUROL SCI, V222, P99, DOI 10.1016/j.jns.2004.04.027; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; Stuifbergen AK, 2012, CLIN REHABIL, V26, P882, DOI 10.1177/0269215511434997; Sumowski JF, 2009, J CLIN EXP NEUROPSYC, V31, P913, DOI 10.1080/13803390902740643; Tesar N, 2005, WIEN KLIN WOCHENSCHR, V117, P747, DOI 10.1007/s00508-005-0470-4; Thomson P, 2006, CAMBRIDGE INTRO LIT, P1, DOI [10.2277/ 0521542510, 10.1002/14651858.CD004431.pub2]; Vogt A, 2008, NEUROL REHABILITATIO, V14, P93; Vogt A, 2009, RESTOR NEUROL NEUROS, V27, P225, DOI 10.3233/RNN-2009-0473; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Zivadinov R, 2001, J NEUROL NEUROSUR PS, V70, P773, DOI 10.1136/jnnp.70.6.773	64	7	7	0	4	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1758-2024	1758-2032		NEURODEGENER DIS MAN	Neurodegener. Dis. Manag.	APR	2014	4	2					147	154		10.2217/NMT.14.8			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V4M7C	WOS:000219071900010	24832032				2022-02-06	
J	Schulz, CM; Skrzypczak, M; Raith, S; Hinzmann, D; Krautheim, V; Heuser, F; Mayer, V; Kreuzer, C; Himsl, M; Holl, M; Lipp, C; Kochs, EF; Wagner, KJ				Schulz, Christian M.; Skrzypczak, Matthias; Raith, Stefan; Hinzmann, Dominik; Krautheim, Veronika; Heuser, Fabian; Mayer, Valentin; Kreuzer, Christoph; Himsl, Meike; Holl, Michael; Lipp, Christina; Kochs, Eberhard F.; Wagner, Klaus J.			High-fidelity Human Patient Simulators Compared with Human Actors in an Unannounced Mass-Casualty Exercise	PREHOSPITAL AND DISASTER MEDICINE			English	Article						disaster medicine; mass-casualty incident; patient simulation; triage		High-fidelity simulators (HFSs) have been shown to prompt critical actions at a level equal to that of trained human actors (HAs) and increase perceived realism in intrahospital mass-casualty incident (MCI) exercises. For unannounced prehospital MCI exercises, however, no data are available about the feasibility of incorporating HFSs. This case report describes the integration of HFSs in such an unannounced prehospital MCI drill with HAs and provides data about the differences concerning triage, treatment, and transport of HFSs and HAs with identical injury patterns. For this purpose, 75 actors and four high-fidelity simulators were subdivided into nine groups defined by a specific injury pattern. Four HFSs and six HAs comprised a group suffering from traumatic brain injury and blunt abdominal trauma. Triage results, times for transport, and number of diagnostic and therapeutic tasks were recorded. Means were compared by t test or one-way ANOVA. Triage times and results did not differ between actors and simulators. The number of diagnostic (1.25, SD = 0.5 in simulators vs 3.5, SD = 1.05 in HAs; P =.010) and therapeutic tasks (2.0, SD = 1.6 in simulators vs 4.8, SD = 0.4 in HAs; P =.019) were significantly lower in simulators. Due to difficulties in treating and evacuating the casualties from the site of the accident in a timely manner, all simulators died. Possible causal factors and strategies are discussed, with the aim of increasing the utility of simulators in emergency medicine training.	[Schulz, Christian M.; Skrzypczak, Matthias; Hinzmann, Dominik; Krautheim, Veronika; Heuser, Fabian; Mayer, Valentin; Kreuzer, Christoph; Himsl, Meike; Holl, Michael; Lipp, Christina; Kochs, Eberhard F.; Wagner, Klaus J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, Ismaninger Str 22, D-81675 Munich, Germany; [Raith, Stefan] Tech Univ Munich, Klinikum Rechts Isar, Clin Plast Surg & Hand Surg, Munich, Germany		Schulz, CM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, Ismaninger Str 22, D-81675 Munich, Germany.	c.m.schulz@lrz.tum.de			Department of Anesthesiology, Klinikum rechts der Isar, Technische Universitat Munchen	This research was funded by the Department of Anesthesiology, Klinikum rechts der Isar, Technische Universitat Munchen. Four wireless high-fidelity simulators were provided by Medical Education Technologies, Inc. (METI, Sarasota, Florida USA). The authors report no conflicts of interest.	Delooz H, 2007, EUR J EMERG MED, V14, P25, DOI 10.1097/01.mej.0000224432.43999.87; Fritz PZ, 2008, EMERG MED AUSTRALAS, V20, P1, DOI 10.1111/j.1742-6723.2007.01022.x; Gillett B, 2008, ACAD EMERG MED, V15, P1144, DOI 10.1111/j.1553-2712.2008.00198.x; Mayer V, 2013, MINERVA ANESTESIOL, V79, P264; McFetrich J, 2006, EMERG MED J, V23, P509, DOI 10.1136/emj.2005.030544; Perkins GD, 2007, RESUSCITATION, V73, P202, DOI 10.1016/j.resuscitation.2007.01.005; Schulz C, 2011, NOTFALL RETTUNGSMED, V14, P673, DOI 10.1007/s10049-011-1409-0; Schulz Christian M, 2011, BMC Res Notes, V4, P550, DOI 10.1186/1756-0500-4-550; SEFRIN P, 2003, DTSCH ARZTEBL, V100, pA2058; Ten Eyck RP, 2011, PEDIATR EMERG CARE, V27, P333, DOI 10.1097/PEC.0b013e3182131fe0; Vozenilek J, 2004, ACAD EMERG MED, V11, P1149, DOI 10.1197/j.aem.2004.08.003; Wallace D, 2010, RESUSCITATION, V81, P872, DOI 10.1016/j.resuscitation.2010.02.026	12	7	7	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	APR	2014	29	2					176	182		10.1017/S1049023X14000223			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	VG1BF	WOS:000445150200010	24650543				2022-02-06	
J	Falk, AC; Alm, A; Lindstrom, V				Falk, Ann-Charlotte; Alm, Annika; Lindstrom, Veronica			Has increased nursing competence in the ambulance services impacted on pre-hospital assessment and interventions in severe traumatic brain-injured patients?	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Pre-hospital management; Competence; Patient outcome	INTERNATIONAL EMS SYSTEMS; MORTALITY	Objective: Trauma is one of the most common causes of morbidity and mortality in modern society, and traumatic brain injuries (TBI) are the single leading cause of mortality among young adults. Pre-hospital acute care management has developed during recent years and guidelines have shown positive effects on the pre-hospital treatment and outcome for patients with severe traumatic brain injury. However, reports of impacts on improved nursing competence in the ambulance services are scarce. Therefore, the aim of this study was to investigate if increased nursing competence level has had an impact on pre-hospital assessment and interventions in severe traumatic brain-injured patients in the ambulance services. Method: A retrospective study was conducted. It included all severe TBI patients (>15 years of age) with a Glasgow Coma Score (GCS) of less than eight measured on admission to a level one trauma centre hospital, and requiring intensive care (ICU) during the years 2000-2009. Results: 651 patients were included, and between the years 2000-2005, 395 (60.7%) severe TBI patients were injured, while during 2006-2009, there were 256 (39.3%) patients. The performed assessment and interventions made at the scene of the injury and the mortality in hospital showed no significant difference between the two groups. However, the assessment of saturation was measured more frequently and length of stay in the ICU was significantly less in the group of TBI patients treated between 2006-2009. Conclusion: Greater competence of the ambulance personnel may result in better assessment of patient needs, but showed no impact on performed pre-hospital interventions or hospital mortality.	[Falk, Ann-Charlotte; Alm, Annika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, S-14183 Huddinge, Sweden; [Lindstrom, Veronica] Acad EMS Stockholm, Sodersjukhuset, Dept Clin Sci & Educ, Karolinska Inst, Stockholm, Sweden		Falk, AC (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alfred Nobels Alle 23, S-14183 Huddinge, Sweden.	ann-charlotte.falk@ki.se	Falk, Ann-Charlotte/ABA-1730-2020	Falk, Ann-Charlotte/0000-0003-2246-7894; Lindstrom, Veronica/0000-0003-1386-3203			Aiken LH, 2012, J NURS ADM S, V42, pS10; Aydin S, 2010, J TRAUMA, V69, P589, DOI 10.1097/TA.0b013e3181e74858; Bellander Bo-Michael, 2008, Lakartidningen, V105, P1834; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Black JJM, 2005, RESUSCITATION, V64, P21, DOI 10.1016/j.resuscitation.2004.10.004; Brain Trauma Foundation, 2007, J NEUROTRAUMA S, V24, pS1; Dunning J, 2004, EMERG MED J, V21, P404, DOI 10.1136/emj.2004.014944; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Health and clinicall exelence, 2007, HEAD INJ TRIAG ASS I; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Langhelle A, 2004, RESUSCITATION, V61, P9, DOI 10.1016/j.resuscitation.2003.12.008; Laudermilch DJ, 2010, J AM COLL SURGEONS, V210, P220, DOI 10.1016/j.jamcollsurg.2009.10.008; Marion Donald W, 2006, Prog Neurol Surg, V19, P171, DOI 10.1159/000095191; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Menon D, 2008, BMJ-BRIT MED J, V336, P397, DOI 10.1136/bmj.39461.616991.80; National board of Health and Welfare, 2012, SOC; Naylor MD, 2013, MED CARE, V51, pS6, DOI 10.1097/MLR.0b013e3182894848; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponzer CN, 2004, RESUSCITATION, V60, P239; Ringburg AN, 2007, J TRAUMA, V63, P258, DOI 10.1097/01.ta.0000240449.23201.57; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Stockholm County Council, 2012, STOCKH SPC AMB; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Suserud Bjorn-Ove, 2005, Nurs Crit Care, V10, P269, DOI 10.1111/j.1362-1017.2005.00129.x; TEASDALE G, 1974, LANCET, V2, P81	26	7	7	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 19	2014	22								20	10.1186/1757-7241-22-20			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AF5ZX	WOS:000334795200001	24641814	gold, Green Published			2022-02-06	
J	Edmed, SL; Sullivan, KA				Edmed, Shannon L.; Sullivan, Karen A.			The influence of injury cause, contact-sport participation, and personal knowledge on expectation of outcome from mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Expectation; Athlete; Mild traumatic brain injury; Concussion; Postconcussion syndrome	MINOR HEAD-INJURY; GOOD OLD DAYS; POSTCONCUSSION-SYNDROME; SYMPTOM EXPECTATION; ILLNESS PERCEPTIONS; RISK-FACTORS; CONCUSSION; RECOMMENDATIONS; CANADA	Objective: This study investigated the influence of injury cause, contact-sport participation, and prior knowledge of mild traumatic brain injury (mTBI) on injury beliefs and chronic symptom expectations of mTBI. Method: A total of 185 non-contact-sport players (non-CSPs) and 59 contact-sport players (CSPs) with no history of mTBI were randomly allocated to one of two conditions in which they read either a vignette depicting a sport-related mTBI (mTBI(sport)) or a motor-vehicle-accident-related mTBI (mTBI(MVA)). The vignettes were otherwise standardized to convey the same injury parameters (e.g., duration of loss of consciousness). After reading a vignette, participants reported their injury beliefs (i.e., perceptions of injury undesirability, chronicity, and consequences) and their expectations of chronic postconcussion syndrome (PCS) and posttraumatic stress disorder (PTSD) symptoms. Results: Non-CSPs held significantly more negative beliefs and expected greater PTSD symptomatology and greater PCS affective symptomatology from an mTBI(MVA) vignette thann mTBI(sport) vignette, but this difference was not found for CSPs. Unlike CSPs, non-CSPs who personally knew someone who had sustained an mTBI expected significantly less PCS symptomatology than those who did not. Despite these different results for non-CSPs and CSPs, overall, contact-sport participation did not significantly affect injury beliefs and symptom expectations from an mTBI(sport). Conclusions: Expectations of persistent problems after an mTBI are influenced by factors such as injury cause even when injury parameters are held constant. Personal knowledge of mTBI, but not contact sport participation, may account for some variability in mTBI beliefs and expectations. These factors require consideration when assessing mTBI outcome.	[Edmed, Shannon L.; Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Brisbane, Qld 4001, Australia; [Edmed, Shannon L.; Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Edmed, SL (corresponding author), Queensland Univ Technol, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	sl.edmed@connect.qut.edu.au		Edmed, Shannon/0000-0001-5550-9371			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Fox-Wasylyshyn SM, 2005, RES NURS HEALTH, V28, P488, DOI 10.1002/nur.20100; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Partridge B., 2013, NFL SETTLEMENT FAILS; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Suhr J. A., 2013, SECONDARY INFLUENCES, P182; Sullivan KA, 2014, J HEAD TRAUMA REHAB, V29, P54, DOI 10.1097/HTR.0b013e31828c708a; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P1255, DOI 10.1080/13854046.2012.735254; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Weathers F.W., 1993, ANN CONV INT SOC TRA; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	36	7	7	2	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 16	2014	36	3					221	235		10.1080/13803395.2013.877124			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AE5MG	WOS:000334032600001	24527996				2022-02-06	
J	Chien, WC; Chung, CH; Lai, CH; Chou, CH				Chien, Wu-Chien; Chung, Chi-Hsiang; Lai, Ching-Huang; Chou, Chiu-Hsuan			A retrospective population-based study of injury types among elderly in Taiwan	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						National Health Insurance Research Database; injury; falls; elderly; fractures	TRAUMATIC BRAIN-INJURY; HIP FRACTURE; OLDER WOMEN; SEVERITY; MORTALITY; MEN; AGE; HOSPITALIZATION; MECHANISMS; DISCHARGE	The aim of the article was to investigate the injury types and medical utilisations among patients more than 65 years in Taiwan. The data used in this study were obtained from the years 1997 to 2008 of the National Health Insurance Research Database (NHIRD). The patients with the age of 65 years and older as well as with ICM-9-CM discharge injury principal diagnoses 800-959 were included in this study. SPSS 18.0 was used for data analysis. The results showed that there were 518,601 older adults hospitalised because of injuries in the period of study. The average age among them was 76.1 years old and 51.7% of them were females. The common causes of injury were falls and motor vehicle accident. The average number of operations that patients received was one, and the average length of stay was 9.1 days. The total medical expenditure was over NT$ 28.9 billion, and the average expenditure was NT$ 55,738. The factors associated with deaths were sex, ages, co-morbidity disease, level of care, number of operations, length of stay, expenditure of medical care, injury types and causes of injury. This study concludes that in order to decrease the incident of injuries in elder patients, the education of preventing falls and traffic safety should be promoted continuously among elders.	[Chien, Wu-Chien; Lai, Ching-Huang; Chou, Chiu-Hsuan] Natl Def Med Ctr, Sch Publ Hlth, Taipei 11490, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Grad Inst Life Sci, Taipei 11490, Taiwan		Lai, CH (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, 161,Sect 6,Min Chuan East Rd, Taipei 11490, Taiwan.	lgh@mail.ndmctsgh.edu.tw	Lai, Ching-Huang/ABF-9274-2021; Chung, Chi-Hsiang/AAY-3386-2021				Bergstrom U, 2008, OSTEOPOROSIS INT, V19, P1267, DOI 10.1007/s00198-007-0549-z; Bureau of Health Promotion Department of Health ROC (Taiwan), 2009, ELD HLTH PROM PROGR; Centers for Disease Control and Prevention, 2009, WEB BAS INJ STAT QUE; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; Chang F.C., 2003, TAIWAN J PUBLIC HLTH, V22, P492; Cheng H. J., 2010, COMP LENGTH HOSP STA; Chou M.-Y., 2007, TAIWAN GERIATRICS GE, V2, P225; Clark EM, 2012, AGE AGEING, V41, P46, DOI 10.1093/ageing/afr132; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dellinger AM, 2006, J SAFETY RES, V37, P519, DOI 10.1016/j.jsr.2006.10.001; Department of Health Executive Yuan ROC (Taiwan), 2009, DEATH STAT; Department of Statistics Ministry of Interior ROC (Taiwan), 2009, STRUCT POP; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Frost M, 2012, OSTEOPOROSIS INT, V23, P521, DOI 10.1007/s00198-011-1575-4; GREENSPAN SL, 1994, JAMA-J AM MED ASSOC, V271, P128, DOI 10.1001/jama.271.2.128; Huang S. J., 2003, J FORMOS MED ASSOC, V7, P860; Hung H. C., 2005, J FORMOS MED, V9, P29; Hwang HF, 2011, OSTEOPOROSIS INT, V22, P2385, DOI 10.1007/s00198-010-1446-4; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Langford J, 2008, TRAFFIC INJ PREV, V9, P278, DOI 10.1080/15389580801895210; Li Y. M., 2004, J FORMOS MED ASSOC, V8, P114; Li Y. M., 2003, TAIWAN ASS GERIATRIC, V49, P1; McMahon DJ, 1996, WORLD J SURG, V20, P1113, DOI 10.1007/s002689900170; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; MORI Y, 1995, ACCIDENT ANAL PREV, V27, P391, DOI 10.1016/0001-4575(94)00077-Y; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Oyetunji TA, 2012, J SURG RES, V173, P206, DOI 10.1016/j.jss.2011.05.003; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; Scheetz LJ, 2005, J NURS SCHOLARSHIP, V37, P361, DOI 10.1111/j.1547-5069.2005.00062.x; Scheetz LJ, 2005, RES NURS HEALTH, V28, P198, DOI 10.1002/nur.20075; Shinoda-Tagawa T, 2003, INJURY PREV, V9, P214, DOI 10.1136/ip.9.3.214; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Wang W. C., 2007, THESIS TAIPEI MED U; Yeh H-M, 2003, SHOW CHWAN MED J, V4, P113	34	7	8	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.	MAR 1	2014	21	1					3	8		10.1080/17457300.2012.717084			6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AE5YO	WOS:000334065400002	22924733				2022-02-06	
J	Cusimano, MD; Holmes, SA; Sawicki, C; Topolovec-Vranic, J				Cusimano, Michael D.; Holmes, Scott A.; Sawicki, Carolyn; Topolovec-Vranic, Jane			Assessing Aggression Following Traumatic Brain Injury: A Systematic Review of Validated Aggression Scales	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; aggression; assessment tools; neuropsychology; systematic review; traumatic brain injury	OVERT AGGRESSION; INTERRATER RELIABILITY; UNITED-STATES; VALIDITY; BEHAVIOR; QUALITY; PREVALENCE; INVENTORY; VIOLENCE; HEAD	Background: Every year, millions of people worldwide suffer traumatic brain injuries (TBIs). Aggressive behavior, a known psychological symptom following TBI, has been regarded as an obstacle toward rehabilitation. Having measures that accurately assess aggression during rehabilitation is critical toward proper evaluation. Objective: To undertake a systematic review of the validated scales used to assess aggression in the postacute stage (3 months) after sustaining a TBI in the adult population. A comprehensive search was performed and studies meeting the inclusion criteria were reviewed in full. Quality and validity of supporting articles were assessed via the Downs and Black and QUADAS checklists along with their supporting statistics. Results: A total of 1329 articles were reviewed from the literature. Thirty-two were reviewed in detail and 6 studies eventually passed the exclusion criteria. Of these, 6 neuropsychological scales were represented pertaining to the measurement of aggressive behavior; however, only 1 directly addressed the validity of their scale's aggression component. Conclusions: Further research is required to establish the validity of scales that specifically address aggression for use in the adult TBI population which could be used to support rehabilitation and social reintegration strategies.	[Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Li Ka Shing Knowledge Inst,Keenan Res Ctr,Div Neu, Toronto, ON M5B 1W8, Canada; [Holmes, Scott A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Sawicki, Carolyn] Univ Western Ontario, London, ON, Canada; [Topolovec-Vranic, Jane] St Michaels Hosp, Li Ka Shing Knowledge Inst, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada		Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Li Ka Shing Knowledge Inst,Keenan Res Ctr,Div Neu, Toronto, ON M5B 1W8, Canada.	injurypreven-tion@smh.toronto.on.ca	Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Cusimano, Michael/0000-0002-9989-0650; Sawicki, Carolyn/0000-0003-1149-9188	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neuro trauma Foundation; St Michael's Hospital Foundation	The authors represent the Canadian Brain Injury and Violence Research Team. This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and funding from the Ontario Neuro trauma Foundation and St Michael's Hospital Foundation.	Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Antonucci AS, 2006, PSYCHIAT RES-NEUROIM, V147, P213, DOI 10.1016/j.pscychresns.2005.05.016; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P1, DOI 10.1201/9781439849828; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Cusimano MD, 2010, NEUROSURGERY, V67, P1404, DOI 10.1227/NEU.0b013e3181f209f1; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Faul M, 2010, TRAUMATIC BRAIN INJU; Giles GM, 2007, BRAIN INJURY, V21, P505, DOI 10.1080/02699050701311729; Golden CJ, 1996, AGGRESS VIOLENT BEH, V1, P3, DOI 10.1016/1359-1789(95)00002-X; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GRAHAM JR, 1999, MMPI 2 ASSESSING PER; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Hollingworth W, 2006, ACAD RADIOL, V13, P803, DOI 10.1016/j.acra.2006.03.008; Johansson SH, 2008, BRAIN INJURY, V22, P999, DOI 10.1080/02699050802530573; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Mann R, 2009, SOC PSYCH PSYCH EPID, V44, P300, DOI 10.1007/s00127-008-0440-z; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McDowell I, 2006, MEASURING HLTH GUIDE; Nichols D. S., 2001, ESSENTIALS MMPI 2 AS; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Suris A, 2004, AGGRESS VIOLENT BEH, V9, P165, DOI 10.1016/S1359-1789(03)00012-0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; U.S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Watts R, 1999, BRAIN INJURY, V13, P113, DOI 10.1080/026990599121773; Weiner IB, 2008, HDB PERSONALITY ASSE; Weinfurt KP, 1999, QUAL LIFE RES, V8, P17, DOI 10.1023/A:1026411129270; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 1800, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; Zald D. H., 2006, ORBITOFRONTAL CORTEX	49	7	7	2	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					172	184		10.1097/HTR.0b013e31827c7d15			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600011	23407424				2022-02-06	
J	Gladen, A; Iaizzo, PA; Bischof, JC; Erdman, AG; Divani, AA				Gladen, Adam; Iaizzo, Paul A.; Bischof, John C.; Erdman, Arthur G.; Divani, Afshin A.			A Head and Neck Support Device for Inducing Local Hypothermia	JOURNAL OF MEDICAL DEVICES-TRANSACTIONS OF THE ASME			English	Article						hypothermia; cooling helmet; stroke; traumatic brain injury; neuroprotection	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; COLD SALINE INFUSION; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; INDUCTION; TEMPERATURE; NORMOTHERMIA; PERFUSION	The present work describes the design of a device/system intended to induce local mild hypothermia by simultaneously cooling a patient's head and neck. The therapeutic goal is to lower the head and neck temperatures to 33-35 degrees C, while leaving the core body temperature unchanged. The device works by circulating a cold fluid around the exterior of the head and neck. The head surface area is separated into five different cooling zones. Each zone has a cooling coil and can be independently controlled. The cooling coils are tightly wrapped concentric circles of tubing. This design allows for a dense packing of tubes in a limited space, while preventing crimping of the tubing and minimizing the fluid pressure head loss. The design in the neck region also has multiple tubes wrapping around the circumference of the patient's neck in a helix. Preliminary testing indicates that this approach is capable of achieving the design goal of cooling the brain tissue (at a depth of 2.5 cm from the scalp) to 35 degrees C within 30-40 min, without any pharmacologic or circulatory manipulation. In a comparison with examples of current technology, the device has shown the potential for improved cooling capability.	[Gladen, Adam; Bischof, John C.; Erdman, Arthur G.; Divani, Afshin A.] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA; [Iaizzo, Paul A.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Iaizzo, Paul A.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Bischof, John C.; Divani, Afshin A.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Divani, Afshin A.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Divani, Afshin A.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA		Divani, AA (corresponding author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.	divani@umn.edu		Gladen, Adam/0000-0003-1999-5389	Institute for Engineering and Medicine (IEM) Seed Grant Program, University of Minnesota, Minneapolis, MN	This study was supported in part by the Institute for Engineering and Medicine (IEM) Seed Grant Program, University of Minnesota, Minneapolis, MN.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Arcure Jess, 2009, J Spec Oper Med, V9, P22; Bergman T. L., 2011, INTRO HEAT TRANSFER, P298; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Carpenter M.B, 1996, CARPENTERS HUMAN NEU; Dae MW, 2003, STROKE, V34, P734, DOI 10.1161/01.STR.0000057461.56040.FE; Den Hertog H. M., 2009, COCHRANE DB SYST REV, V21; Denn BH, 2003, J BIOMECH ENG-T ASME, V125, P832, DOI [10.1115/1.16324991, 10.1115/1.1634991]; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Duz B, 2007, CRYOBIOLOGY, V55, P279, DOI 10.1016/j.cryobiol.2007.08.009; Faridar A., 2012, FRONT NEUROL, V2, P1; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Gunn A J, 2006, NeuroRx, V3, P154, DOI 10.1016/j.nurx.2006.01.007; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Hemmen TM, 2009, J NEUROTRAUM, V26, P387, DOI 10.1089/neu.2008.0574; Holman J., 2001, HEAT TRANSFER; Holzer M, 2008, EUR J ANAESTH, V25, P31, DOI 10.1017/S0265021507003274; Holzer M, 2005, CRIT CARE MED, V33, P1346, DOI 10.1097/01.CCM.0000166356.45902.A2; Hu WW, 2008, HIPPOCAMPUS, V18, P386, DOI 10.1002/hipo.20402; Janssen FEM, 2005, PHYS MED BIOL, V50, P4065, DOI 10.1088/0031-9155/50/17/010; Janssen FPEM, 2007, PHYSIOL MEAS, V28, P829, DOI 10.1088/0967-3334/28/8/006; KARIBE H, 1994, J NEUROSURG, V80, P112, DOI 10.3171/jns.1994.80.1.0112; Kollmar R, 2004, EXP NEUROL, V190, P204, DOI 10.1016/j.expneurol.2004.07.006; Konstas AA, 2007, J APPL PHYSIOL, V102, P1329, DOI 10.1152/japplphysiol.00805.2006; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Ku YTE, 1996, AM J PHYS MED REHAB, V75, P443, DOI 10.1097/00002060-199611000-00008; Lampe JW, 2007, EXPERT REV MED DEVIC, V4, P441, DOI 10.1586/17434440.4.4.441; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Luan XD, 2004, ACTA NEUROPATHOL, V107, P227, DOI 10.1007/s00401-003-0802-2; Lyden PD, 2006, INT J STROKE, V1, P9, DOI 10.1111/j.1747-4949.2005.00011.x; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; McKean S, 2009, AACN ADV CRIT CARE, V20, P343, DOI 10.4037/15597768-2009-4008; Neimark MA, 2008, J THEOR BIOL, V253, P333, DOI 10.1016/j.jtbi.2008.03.025; Nelson DA, 1998, EUR J APPL PHYSIOL O, V78, P353, DOI 10.1007/s004210050431; Pichon N, 2007, CRIT CARE, V11, DOI 10.1186/cc5956; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2004, CRIT CARE MED, V32, P313, DOI 10.1097/01.CCM.0000104936.28288.7A; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Schneider P. J., 1957, CONDUCTION HEAT TRAN, P250; Shitzer A., 1985, HEAT TRANSFER MED BI, P312; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; Xu XJ, 1999, J APPL PHYSIOL, V86, P265, DOI 10.1152/jappl.1999.86.1.265; XUE D, 1992, BRAIN RES, V587, P66, DOI 10.1016/0006-8993(92)91428-H; Yenari M, 2008, THERAPEUTIC HYPOTHER, P141; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Zhu L, 2008, HEAT TRANSFER ENG, V29, P284, DOI 10.1080/01457630701758062	51	7	7	0	11	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1932-6181	1932-619X		J MED DEVICES	J. Med. Devices	MAR	2014	8	1							011002	10.1115/1.4025448			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	298WM	WOS:000330355200002		Green Published			2022-02-06	
J	Jung, CS; Wispel, C; Zweckberger, K; Beynon, C; Hertle, D; Sakowitz, OW; Unterberg, AW				Jung, Carla S.; Wispel, Christian; Zweckberger, Klaus; Beynon, Christopher; Hertle, Daniel; Sakowitz, Oliver W.; Unterberg, Andreas W.			Endogenous Nitric-Oxide Synthase Inhibitor ADMA after Acute Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						asymmetric dimethylarginine; nitric oxide synthase; dimethylarginine dimethylaminohydrolases; protein-arginine methyltransferases; acute traumatic brain injury; controlled cortical impact	CORTICAL IMPACT INJURY; L-ARGININE INFUSION; SUBARACHNOID HEMORRHAGE; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE; CEREBRAL VASOSPASM; NEUROLOGICAL DEFICIT; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; RATS; EXPRESSION	Previous results on nitric oxide (NO) metabolism after traumatic brain injury (TBI) show variations in NO availability and controversial effects of exogenous nitric oxide synthase (NOS)-inhibitors. Furthermore, elevated levels of the endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) were reported in cerebro-spinal fluid (CSF) after traumatic subarachnoid hemorrhage (SAH). Therefore, we examined whether ADMA and the enzymes involved in NO- and ADMA-metabolism are expressed in brain tissue after TBI and if time-dependent changes occur. TBI was induced by controlled cortical impact injury (CCII) and neurological performance was monitored. Expression of NOS, ADMA, dimethylarginine dimethylaminohydrolases (DDAH) and protein-arginine methyltransferase 1 (PRMT1) was determined by immunostaining in different brain regions and at various time-points after CCII. ADMA and PRMT1 expression decreased in all animals after TBI compared to the control group, while DDAH1 and DDAH2 expression increased in comparison to controls. Furthermore, perilesionally ADMA is positively correlated with neuroscore performance, while DDAH1 and DDAH2 are negatively correlated. ADMA and its metabolizing enzymes show significant temporal changes after TBI and may be new targets in TBI treatment.	[Jung, Carla S.; Wispel, Christian; Zweckberger, Klaus; Beynon, Christopher; Hertle, Daniel; Sakowitz, Oliver W.; Unterberg, Andreas W.] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany		Jung, CS (corresponding author), Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany.	carla.jung@med.uni-heidelberg.de; christianwispel@gmx.de; klaus.zweckberger@med.uni-heidelberg.de; christopher.beynon@med.uni-heidelberg.de; daniel.hertle@med.uni-heidelberg.de; oliver.sakowitz@med.uni-heidelberg.de; andreas.unterberg@med.uni-heidelberg.de		Sakowitz, Oliver/0000-0003-3248-6335	German society of neurological surgeons (Stipendium Neurochirurgische Forschung der Deutschen Gesellschaft fur Neurochirurgie (DGNC))	This work was supported by a stipend of the German society of neurological surgeons (Stipendium Neurochirurgische Forschung der Deutschen Gesellschaft fur Neurochirurgie (DGNC)) awarded to C.S. Jung. We thank Rolf Warta for technical assistance in performing photography of immunostaining.	Akaike T, 1996, METHOD ENZYMOL, V268, P211; Amrouni D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016891; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Goksel HM, 2001, ACTA NEUROCHIR, V143, P277, DOI 10.1007/s007010170108; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Huk I, 1997, CIRCULATION, V96, P667; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jung CS, 2007, J NEUROSURG, V107, P945, DOI 10.3171/JNS-07/11/0945; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Linsky TW, 2012, BIOORGAN MED CHEM, V20, P5550, DOI 10.1016/j.bmc.2012.07.022; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Marten-Lobenhoffer J, 2007, J NEUROSCI METH, V164, P155, DOI 10.1016/j.jneumeth.2007.04.005; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Nandi M, 2012, ARTERIOSCL THROM VAS, V32, P2589, DOI 10.1161/ATVBAHA.112.300232; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Pluta RM, 2000, J NEUROSURG, V92, P121, DOI 10.3171/jns.2000.92.1.0121; Pluta RM, 2007, REV RECENT CLIN TRIA, V2, P59, DOI 10.2174/157488707779318062; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Thampatty BP, 2013, PEDIATR CRIT CARE ME, V14, P403, DOI 10.1097/PCC.0b013e31827212c0; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; VALLANCE P, 1992, LANCET, V339, P572; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049267; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	45	7	8	1	9	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2014	15	3					4088	4103		10.3390/ijms15034088			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AF0ZU	WOS:000334444700044	24663083	Green Submitted, Green Published, gold			2022-02-06	
J	Mylonas, AI; Poulakou-Rebelakou, EF; Androutsos, GI; Seggas, I; Skouteris, CA; Papadopoulou, EC				Mylonas, Anastassios I.; Poulakou-Rebelakou, Eleftheria-Fotini; Androutsos, Georgios I.; Seggas, Ioannis; Skouteris, Christos A.; Papadopoulou, Evangelia Chr			Oral and cranio-maxillofacial surgery in Byzantium	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Byzantium; Cranio-maxillofacial Surgery; Oral surgery	TIMES 324-1453 AD; SCIENTIFIC DESCRIPTIONS; PLASTIC-SURGERY	Introduction: Byzantine physicians (4th-7th and 8th-12th centuries A.D.), especially those interested in Surgery, developed a number of interesting concepts, views and opinions referring to the field now recognized as Oral and Cranio-maxillofacial Surgery and Pathology. Material and method: The original texts of Byzantine physicians, written in ancient Greek, and now preserved in the electronic platform Thesaurus Linguae Graecae, at the University of California, Irvine, CA, USA, were investigated in relation to Oral and Cranio-maxillofacial Surgery and Pathology. Results: The most eminent physicians of the Early (4th-7th century A.D.) and Middle (8th-12th century A.D.) Byzantine Period, in particular Oribasius Pergamenus, Aetius Amidenus, Alexander Trallianus, Theophilus Protospatharius, Paulus Aegineta, Meletius Monachos, and Leo Medicus, in their works deal with topographic and surgical anatomy of the head and neck, and a large list of related topics, including dentoalveolar surgery, oral and cervicofacial infections, trauma of viscerocranium and neurocranium as well as the biomechanics of traumatic brain injuries, temporomandibular joints dysfunction as a consequence of mandibular dislocation, surgical oncology and reconstructive surgery of the head and neck, oral pathology, surgical pathology of salivary glands, therapeutic management of facial nerve dysfunction, preprosthetic surgery, craniofacial surgery, and deformities of the facial skeleton involving anthropologic and craniometric observations. Clinical examination of patients presenting corresponding functional and esthetic problems is considered, using recognizable orthodontic and orthognathic surgical approaches. Finally, specific bandages of the head and neck are described, for treating traumatic injuries of the viscerocranium and neurocranium, diastasis of the cranial sutures, dislocations of the mandible (unilateral and bilateral), as well as inflammatory diseases of the parotids and the neck. Conclusions: Byzantine physicians had been particularly interested in various subjects of the mouth, jaws, face, and head and neck in general, in the frame of course of their general surgery practice. (C) 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Mylonas, Anastassios I.] Metropolitan Hosp, Dept Oral & Maxillofacial Surg, N Faliro 18547, Piraeus, Greece; [Mylonas, Anastassios I.; Poulakou-Rebelakou, Eleftheria-Fotini; Androutsos, Georgios I.] Univ Athens, Sch Med, Dept Hist & Philosophy, Athens, Greece; [Seggas, Ioannis] Univ Athens, Sch Med, Hippokrat Gen Hosp Athens, Dept Otorhinolaryngol 1, Athens, Greece; [Skouteris, Christos A.] Univ Michigan, Sch Dent, Dept Oral & Maxillofacial Surg Hosp Dent, Ann Arbor, MI 48109 USA; [Skouteris, Christos A.] Univ Michigan, Sch Med, Dept Surg, Div Oral & Maxillofacial Surg, Ann Arbor, MI USA; [Papadopoulou, Evangelia Chr] PD Marinopoulos Pharm, Athens, Greece		Mylonas, AI (corresponding author), Metropolitan Hosp, Dept Oral & Maxillofacial Surg, 9 Ethn Makariou Ave & 1 El Venizelou Str, N Faliro 18547, Piraeus, Greece.	draimylo@otenet.gr	Androutsos, Georges/AAA-3504-2020; Mylonas, Anastassios I./AAL-1391-2021				Bennett D, 2000, SOC HIST MED, V13, P279, DOI 10.1093/shm/13.2.279; Bliquez L., 1984, DUMBARTON OAKS PAPER, V38, P187; CASTIGLIONI A, 1947, HIST MED; Constantelos D J, 1999, Med Secoli, V11, P337; Cramer JA, 1963, ANECDOTA GRAECA CODD, V3, p[1, 5]; Eftychiadis AC, 1983, INTRO BYZANTINE THER, P288; Eftychiadis AC, 1983, INTRO BYZANTINE THER, P148; Ermerins FZ, 1840, LEO MEDICUS CONSPECT, p[80, 89]; Georgakopoulos K., 1998, ANCIENT GREEK PHYS; Greenhill GA, 1842, THEOPHILI PROTOSPATH, P1; Gurunluoglu R, 2001, PLAST RECONSTR SURG, V108, P2072, DOI 10.1097/00006534-200112000-00038; Heiberg JL, 1921, CORPUS MEDICORUM GRA, V2, P3; Heiberg JL, 1924, CORPUS MEDICORUM GRA, V2, P5; Lascaratos J, 2004, UROLOGY, V63, P806, DOI 10.1016/S0090-4295(03)00340-6; Lascaratos J, 1998, EUR J VASC ENDOVASC, V15, P110, DOI 10.1016/S1078-5884(98)80130-5; Lascaratos J, 1998, PLAST RECONSTR SURG, V102, P1274, DOI 10.1097/00006534-199809040-00061; Lascaratos J, 2000, WORLD J SURG, V24, P615, DOI 10.1007/s002689910100; Lascaratos J, 2000, OTOLARYNG HEAD NECK, V122, P579, DOI 10.1016/S0194-5998(00)70107-0; LASCARATOS J, 1988, DOC OPHTHALMOL, V68, P157; Lascaratos J, 1999, AM J OTOL, V20, P397; Lascaratos J, 2001, J VASC SURG, V33, P197, DOI 10.1067/mva.2001.107990; LASCARATOS J, 1991, DOC OPHTHALMOL, V77, P377, DOI 10.1007/BF00156978; Lascaratos JG, 2000, ANN OTO RHINOL LARYN, V109, P871, DOI 10.1177/000348940010900916; Lascaratos JG, 2004, NEUROSURGERY, V55, P214, DOI 10.1227/01.NEU.0000126883.25501.E3; Lascaratos JG, 2003, WORLD J SURG, V27, P1165, DOI 10.1007/s00268-003-7123-4; MARKETOS SG, 1994, BRIT J UROL, V74, P405, DOI 10.1111/j.1464-410X.1994.tb00413.x; Miller T S, 1999, Med Secoli, V11, P323; Miller TS, 1997, BIRTH HOSPITAL BYZAN, pxi; Miller TS, 1985, BIRTH HOSP BYZANTINE, P165; Mylonas AI, 2011, THESIS U ATHENS ATHE; Neuburger M, 1910, HIST MED, V1, P240; Neuburger M, 1910, HIST MED, V1, P302; Olivieri A, 1950, CORPUS MEDICORUM GRA, P403; PENTOGALOS GE, 1984, B HIST MED, V58, P99; Poulakou-Rebelakou E, 1992, THESIS ATHENS; PUSCHMANN T., 1878, A VONTRALLES, V2, P1879; Puschmann T, 1879, A VONTRALLES, V1-2, P3; Raeder J, 1933, CORPUS MEDICORUM GRA, V1-4, P4; Raeder J, 1926, ORIBASII SYNOPSIS EU; Raeder J, 1933, CORPUS MEDICORUM GRA, V4, P75; Raeder J, 1928, CORPUS MEDICORUM GRA, V1-4; Raeder J, 1931, CORPUS MEDICORUM GRA, V1-4, P4; Raeder J, 1926, CORPUS MEDICORUM GRA; Raeder J, 1929, CORPUS MEDICORUM GRA, p[4, 239, 298]; TEIMOURIAN B, 1983, AESTHET PLAST SURG, V7, P155, DOI 10.1007/BF01571338; Troianos S, 1995, THEMES OBSTET GYNAEC, V9, P309; Tsoukanelis AS, 1995, STOMATOLOGY WORLD AG, P171; Wellmann M, 1906, PEDANII DIOSECURIDS, V2, P217	48	7	7	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	MAR	2014	42	2					159	168		10.1016/j.jcms.2013.04.006			10	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	AB3HZ	WOS:000331683200011	23757286				2022-02-06	
J	Patel, KV; Brennan, KL; Davis, ML; Jupiter, DC; Brennan, ML				Patel, Kushal V.; Brennan, Kindyle L.; Davis, Matthew L.; Jupiter, Daniel C.; Brennan, Michael L.			High-energy Femur Fractures Increase Morbidity but not Mortality in Elderly Patients	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							FEMORAL-SHAFT FRACTURES; INJURY SEVERITY SCORE; TRAUMA PATIENTS; DEATHS; RISK; AGE	Trauma centers are projected to have an increase in the number of elderly patients with high-energy femur fractures. Greater morbidity and mortality have been observed in these patients. Further clarification regarding the impact of high-energy femur fractures is necessary in this population. Our purpose was to assess the influence of high-energy femur fractures on mortality and morbidity in patients 60 years and older. Specifically, we asked (1) if the presence of a high-energy femur fracture increases in-hospital, 6-month, and 1-year mortality in patients 60 years and older, and (2) if there is a difference in morbidity (number of complications, intensive care unit [ICU] and total hospital length of stay, discharge disposition, accompanying fractures, and surgical intervention) between patients 60 years and older with and without high-energy femur fractures. A retrospective review of 242 patients was performed. Patients with traumatic brain injury or spine injury with a neurologic deficit were excluded. A control group, including patients admitted secondary to high-energy trauma without femur fractures, was matched by gender and Injury Severity Score (ISS). In-hospital mortality, 6-month and 1-year mortality, complications, ICU and total hospital length of stay, discharge disposition, accompanying fractures, surgical intervention, and covariates were recorded. Statistical analyses using Fisher's exact test, ANOVA, Kaplan-Meier estimates, and Cox regression models were performed to show differences in mortality (in-hospital, 6-month, 1-year), complications, length of ICU and total hospital stay, discharge disposition, surgical intervention, and accompanying fractures between elderly patients with and without femur fractures. The average ages of the patients were 72.8 years (+/- A 9 years) in the femur fracture group and 71.8 years (+/- A 9 years) in the control group. Sex, age, ISS, and comorbidities were homogenous between groups. In-hospital (p = 0.45), 6-month (p = 0.79), and 1-year mortality (p = 0.55) did not differ in patients with and without high-energy femur fractures. Elderly patients with high-energy femur fractures had an increased number of complications (p = 0.029), longer total hospital length of stay (p = 0.039), were discharged more commonly to rehabilitation centers (p < 0.005), had more accompanying long bone fractures (p = 0.002), and were more likely to have surgery (p < 0.001). Average ICU length of stay was similar between the two groups (p = 0.17). High-energy femur fractures increased morbidity in patients 60 years and older; however, no increase in mortality was observed in our patients. Concomitant injuries may play a more critical role in this population. Additional studies are necessary to clarify the role of high-energy femur fracture mortality in this age group. Level III, therapeutic study. See the Instructions for Authors for a complete description of levels of evidence.	[Patel, Kushal V.; Brennan, Kindyle L.; Davis, Matthew L.; Jupiter, Daniel C.; Brennan, Michael L.] Scott & White Mem Hosp & Clin, Temple, TX 76508 USA		Patel, KV (corresponding author), Scott & White Mem Hosp & Clin, 2401 S 31st St, Temple, TX 76508 USA.	kpatel@sw.org					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bamvita JM, 2007, J TRAUMA, V63, P135, DOI 10.1097/TA.0b013e318068651d; Bonnevialle P, 2002, REV CHIR ORTHOP, V88, P41; Callaway DW, 2007, EMERG MED CLIN N AM, V25, P837, DOI 10.1016/j.emc.2007.06.005; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Copeland CE, 1998, J ORTHOP TRAUMA, V12, P315, DOI 10.1097/00005131-199806000-00003; Federal Interagency Forum on Aging-Related Statistics, AG STATS 2010 REP OL; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Grossman M, 2003, J TRAUMA, V55, P26, DOI 10.1097/01.TA.0000072109.52351.0D; Hannan EL, 2004, J TRAUMA, V56, P1297, DOI 10.1097/01.TA.0000075350.66739.53; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; KNUDSON MM, 1994, ARCH SURG-CHICAGO, V129, P448; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Nagy KK, 2000, J TRAUMA, V49, P190, DOI 10.1097/00005373-200008000-00003; Nork SE, 2003, CLIN ORTHOP RELAT R, P272, DOI 10.1097/01.blo.0000093919.26658.23; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; SCHWAB CW, 1992, ARCH SURG-CHICAGO, V127, P701; SMITH DP, 1990, SOUTHERN MED J, V83, P171, DOI 10.1097/00007611-199002000-00010; Soles GLS, 2011, J ORTHOP TRAUMA, V25, pS61, DOI 10.1097/BOT.0b013e31821b8a3b; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Streubel PN, 2011, CLIN ORTHOP RELAT R, V469, P1188, DOI 10.1007/s11999-010-1530-2; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; United Nations Department of Economic and Social Affairs Population Division, WORLD POP AG 2009; vanderSluis CK, 1996, J TRAUMA, V40, P78, DOI 10.1097/00005373-199601000-00015; Willett K, 2010, J TRAUMA, V69, P405, DOI 10.1097/TA.0b013e3181e6138a; Zarzaur BL, 2010, J TRAUMA, V69, P93, DOI 10.1097/TA.0b013e3181df6734	28	7	8	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAR	2014	472	3					1030	1035		10.1007/s11999-013-3349-0			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AA3ET	WOS:000330976400041	24166074	Green Published			2022-02-06	
J	Chamard, E; Henry, L; Boulanger, Y; Lassonde, M; Theoret, H				Chamard, Emilie; Henry, Luke; Boulanger, Yvan; Lassonde, Maryse; Theoret, Hugo			A Follow-Up Study of Neurometabolic Alterations in Female Concussed Athletes	JOURNAL OF NEUROTRAUMA			English	Article						female athletes; magnetic resonance spectroscopy; sport; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; SPORT-RELATED CONCUSSION; STATES HIGH-SCHOOL; SEX-DIFFERENCES; RECURRENT CONCUSSION; METABOLIC-CHANGES; SYMPTOMS; GLUTAMATE; RECOVERY	Athletes who sustain a concussion demonstrate a variety of symptoms and neuropsychological alterations that could be brought on by neurometabolic abnormalities. However, no study has yet investigated these aspects in female athletes using magnetic resonance spectroscopy. The present study investigated the neurometabolic and -psychological effects of a concussion in the acute (7-10 days postinjury) and chronic (6 months postinjury) phases after injury. Eleven female concussed athletes and 10 female control athletes were scanned at both time points in a 3T magnetic resonance imaging scanner. Neuropsychological and symptomatic evaluations were completed at each time point. Neuropsychological alterations and a higher severity of symptoms were found in the acute phase in concussed athletes, relative to controls, but showed recovery in the chronic phase. Concussed athletes showed neurometabolic impairment in prefrontal and motor cortices characterized by a pathological increase of glutamine/glutamate and creatine (Cr) only in the chronic phase. Also, a significant decrease in N-acetyl-aspartate/Cr ratio was observed in control athletes at the second time point. Concussed female athletes showed acute cognitive alterations and higher severity of symptoms that do not appear to be underlied by neurometabolic abnormalities, which are only present in the chronic postinjury phase.	[Chamard, Emilie; Henry, Luke; Lassonde, Maryse; Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lassonde, Maryse; Theoret, Hugo] CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Boulanger, Yvan] Univ Montreal, Ctr Hosp Univ, Montreal, PQ H3C 3J7, Canada		Theoret, H (corresponding author), Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit CERNEC, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec	This research was supported by grants from the Canadian Institutes of Health Research and the Fonds de la Recherche en Sante du Quebec.	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Braun CMJ, 2002, LATERALITY, V7, P97, DOI 10.1080/13576500143000212; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; King KG, 2008, RADIOLOGY, V249, P242, DOI 10.1148/radiol.2491071500; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lin A. P., 2010, 96 SCI ASS ANN M RAD; Lin AP, 2003, MAGN RESON MATER PHY, V16, P29, DOI 10.1007/s10334-003-0004-x; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maddock R.J., 2012, CURR TOP BEHAV NEURO; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P., 2013, PHYS THER SPORT, V14, P1, DOI DOI 10.1016/J.PTSP.2013.03.002; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Federation of State High School Associations, 2011, 2010 2011 HIGH SCH A; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Soreni N, 2006, MAGN RESON IMAGING, V24, P187, DOI 10.1016/j.mri.2005.10.027; Swartz MM, 2013, NEUROPHARMACOLOGY, V73, P111, DOI 10.1016/j.neuropharm.2013.05.020; Szentkuti A, 2004, J NEUROL, V251, P1345, DOI 10.1007/s00415-004-0540-y; Toga A.W., 2002, BRAIN MAPPING METHOD, Vsecond; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zgonc E., 2010, NCAA SPORTS SPONSORS; Zimmerman ME, 2008, NEUROLOGY, V70, P1594, DOI 10.1212/01.wnl.0000306314.77311.be; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	64	7	7	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					339	345		10.1089/neu.2013.3083			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600006	24053210				2022-02-06	
J	Bartonicek, J; Kozanek, M; Jupiter, JB				Bartonicek, Jan; Kozanek, Michal; Jupiter, Jesse B.			History of Operative Treatment of Forearm Diaphyseal Fractures	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Diaphyseal fractures; forearm; history; osteosynthesis	COMPRESSION-PLATE FIXATION; LONG BONES; RADIUS; ULNA; DISLOCATION; ADULTS; HEAD	Diaphyseal fractures of the forearm have accompanied humanity throughout its history. Nonsurgical techniques dominated the treatment for centuries, and complications including nonunion and malunion were common. The 19th century featured the recognition of distinct injury patterns. With the development of anesthesia and antisepsis, the operative treatment became widespread. In 1878, Heine described fixation of the diaphyseal nonunion of the distal ulna using an intramedullary ivory peg. Parkhill reported on the application of external fixation for forearm fractures in 1897-1898. Hansmann published the case of plate osteosynthesis of an acute fracture of the radius in 1886. In 1913, Schone published the technique of closed intramedullary fixation of diaphyseal fractures of the forearm using a silver wire. During the first 2 decades of the 20th century, plate osteosynthesis quickly spread across Europe and North America owing to the influence of Lambotte and Lane. After the World War II, plate osteosynthesis became the surgical treatment of choice for forearm diaphyseal fractures. (Copyright (C) 2014 by the American Society for Surgery of the Hand. All rights reserved.)	Charles Univ Prague, Fac Med 1, Dept Orthopaed Trauma, Prague, Czech Republic; [Jupiter, Jesse B.] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA; Harvard Combined Orthopaed Residency Program, Boston, MA USA		Jupiter, JB (corresponding author), Massachusetts Gen Hosp, Dept Orthopaed Surg, YAW 2,55 Fruit St, Boston, MA 02114 USA.	JJUPITER1@PARTNERS.ORG	Bartonicek, Jan/E-8217-2017	Bartonicek, Jan/0000-0002-2228-1443			ANDERSON LD, 1975, J BONE JOINT SURG AM, VA 57, P287, DOI 10.2106/00004623-197557030-00001; [Anonymous], 1983, CLIN ORTHOP RELAT RE, P3; [Anonymous], 1988, CLIN ORTHOP RELAT RE, V1, P2; Ashhurst APC, 1912, ANN SURG, V56, P631, DOI 10.1097/00000658-191210000-00009; Bartonicek J, 2010, ARCH ORTHOP TRAUM SU, V130, P1385, DOI 10.1007/s00402-010-1082-7; Beckman EH, 1912, SURG GYNECOL OBSTET, V14, P71; Bircher H, 1887, ARCH KLIN CHIR, P410; Blake JA, 1912, SURG GYNECOL OBSTET, V14, P338; BOHLER L, 1949, J BONE JOINT SURG AM, V31-A, P295, DOI 10.2106/00004623-194931020-00007; Bohler L, 1929, TECHNIK KNOCHENBRUCH; Bohler Lorenz, 1944, TECHNIK KNOCHENBRUCH; Bonnin J G, 1967, J Bone Joint Surg Br, V49, P4; BURWELL HN, 1964, J BONE JOINT SURG BR, V46, P404; Caden JG, 1961, J BONE JOINT SURG AM, P1115; CHAPMAN MW, 1989, J BONE JOINT SURG AM, V71A, P159, DOI 10.2106/00004623-198971020-00001; Cohn HR, 1931, J BONE JOINT SURG, P261; Danis R., 1932, TECHNIQUE OSTEOSYNTH; Dieffenbach JF, 1846, WOCHENSCHRIFTT GESAM, P727; Dieffenbach JF, 1846, WOCHENSCHRIFTT GESAM, P745; Dieffenbach JF, 1846, WOCHENSCHRIFTT GESAM, P761; DODGE HS, 1972, J BONE JOINT SURG AM, V54, P1167, DOI 10.2106/00004623-197254060-00003; Galeazzi R, 1935, ARCH ORTHOP UNFALLCH, V35, P557; Gross E., AO B SOMMER 1979; HACKETHAL KH, 1961, BUNDEL NAGELUNG; Hansmann H, 1886, VERH DTSCH GES CHIR, P134; Heine C, 1878, LANGENBECK ARCH SURG, P472; Helferich H, 1897, ATLAS GRUNDRISS TRAU; Henry A, 1945, EXTENSILE EXPOSURES; Henry A, 1926, BRIT J SURG, P506; Hey-Groves EW, 1918, BRIT J SURG, P203; Hey-Groves EW, 1921, MODERN METHODS TREAT; HEYGROVES EW, 1916, MODERN METHODS TREAT; Hicks JH, 1961, J BONE JOINT SURG BR, P680; KNIGHT RA, 1949, J BONE JOINT SURG AM, V31-A, P755, DOI 10.2106/00004623-194931040-00006; KONIG F, 1931, OPERATIVE CHIRURGIE; KUNTSCHER G, 1962, PRAXIS MARKNAGELUNG; Kuntscher Gerhard, 1945, TECHNIK MARKNAGELUNG; LAMBOTTE A, 1907, INTERVENTION OPERATO; Lambrinudi C, 1939, P ROY SOC MED, P153; Lane W A, 1905, Br Med J, V2, P1325; LANE WA, 1914, OPERATIVE TREATMENT; Lane WA., 1908, BMJ-BRIT MED J, P745; Le Vay D, 1990, HIST ORTHOPAEDICS; Leveuf J, 1925, TRAITEMENT FRACTURES; Lilienthal H, 1912, ANN SURG, V56, P185, DOI 10.1097/00000658-191207000-00017; Malgaigne J-F., 1847, TRAITE FRACTURES LUX; Malgaigne JF, 1855, DROP REF; MAREK FM, 1961, J BONE JOINT SURG AM, V43, P1099, DOI 10.2106/00004623-196143080-00003; Monteggia GB, 1814, I CHIRURGICHE, V4; Muller M.E., 1969, MANUAL OSTEOSYNTHESE; Muller ME, 1991, MANUAL INTERNAL FIXA; MULLER ME, 1977, MANUAL OSTEOSYNTHESE; Pare A., 1579, OEVRES AMBROISE PARE; Parkhill C, 1898, Ann Surg, V27, P553; Peltier L, 1990, FRACTURES HIST ICONO; Petit JL, 1723, TRAITE MALADIES OS; Riedinger F, 1881, ARCH KLIN CHIR, P985; RUSH LV, 1955, ATLAS RUSH PIN TECHN; SAGE FP, 1959, J BONE JOINT SURG AM, V41, P1489, DOI 10.2106/00004623-195941080-00010; SARGENT JP, 1965, J BONE JOINT SURG AM, VA 47, P1475, DOI 10.2106/00004623-196547080-00002; Schone G, 1913, MUNCH MED WSCHR, P2327; SMITH JEM, 1959, J BONE JOINT SURG BR, V41, P122, DOI 10.1302/0301-620X.41B1.122; Speed JS, 1940, J AMER MED ASSOC, V115, P1699, DOI 10.1001/jama.1940.02810460031008; Spinner RJ, 1998, J HAND SURG-AM, V23A, P135, DOI 10.1016/S0363-5023(98)80101-9; Thompson JE, 1918, ANN SURG, V68, P309, DOI 10.1097/00000658-191809000-00012; van Meter SD, 1911, J AMER MED ASSOC, V56, P863; Volkmann R, 1878, BEHANDLUNG COMPLICIE; [No title captured]; [No title captured]; [No title captured]	70	7	7	1	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	FEB	2014	39	2					335	342		10.1016/j.jhsa.2013.06.020			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AA3QX	WOS:000331008500019	24332651				2022-02-06	
J	Cerecedo-Lopez, CD; Kim-Lee, JH; Hernandez, D; Acosta, SA; Borlongan, CV				Cerecedo-Lopez, Christian D.; Kim-Lee, Jennifer H.; Hernandez, Diana; Acosta, Sandra A.; Borlongan, Cesar V.			Insulin-associated neuroinflammatory pathways as therapeutic targets for traumatic brain injury	MEDICAL HYPOTHESES			English	Article							SIGNALING CASCADE; OXIDATIVE STRESS; NITRIC-OXIDE; CD36; DAMAGE; EXACERBATION; INFLAMMATION; HOMEOSTASIS; ACTIVATION; RECEPTORS	Traumatic brain injury (TBI) is characterized by an abrupt blow or exchange of force against the head and can be categorized as mild, moderate, and severe. The secondary cell death after TBI displays ischemic-like patterns including neuroinflammation. The scavenger receptor cluster of differentiation (CD) 36 is a lipid-associated protein capable of transducing intracellular signals to promote inflammatory mechanisms within different cell types. Expression and activation of CD36 is closely related to dyslipidemia secondary to diabetes. Diabetes mellitus (DM) has been documented as a co-morbidity factor in TBI, in that patients with a history of diabetes present with more severe brain damage and slower recovery from TBI than non-diabetic patients. Indeed, a strict regulation of blood serum glucose by the use of insulin promotes a better outcome for TBI patients. Based on these recent findings, we now advance the hypothesis that CD36 via DM insulin-associated pathways is closely involved in TBI chronic pathology. (C) 2013 Elsevier Ltd. All rights reserved.	[Cerecedo-Lopez, Christian D.; Kim-Lee, Jennifer H.] Univ Anahuac Mexico Norte, Fac Ciencias Salud, Dept Neuroinmunol, Huixquilucan, Estado De Mexic, Mexico; [Cerecedo-Lopez, Christian D.; Kim-Lee, Jennifer H.; Hernandez, Diana; Acosta, Sandra A.; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg, Ctr Excellence Aging & Brain Repair, Tampa, FL USA		Borlongan, CV (corresponding author), 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS071956-01]; Department of DefenseUnited States Department of Defense [W81XWH1110634]; James and Esther King Foundation for Biomedical Research Program [1KG01-33966]; SanBio Inc.; Celgene Cellular TherapeuticsBristol-Myers SquibbCelgene Corporation; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	CVB is supported by NIH NINDS 1R01NS071956-01, Department of Defense W81XWH1110634, James and Esther King Foundation for Biomedical Research Program 1KG01-33966, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Campdelacreu J., 2012, NEUROLOGIA; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Cho S, 2009, J NEUROCHEM, V109, P126, DOI 10.1111/j.1471-4159.2009.05801.x; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Corrigan JD, 2010, J HEAD TRAUMA REHABI, V25; Doyle KP, 2012, ANN NEUROL, V71, P729, DOI 10.1002/ana.23579; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Faul M, 2010, TRAUMATIC BRAIN INJU; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Grebe A, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0313-z; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Gubata ME, J HEAD TRAUMA REHABI, V9000; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Hernandez-Avila M, 2012, DIABETES MELLITUS UR; Kaplan M, 2012, PHARMACOL THERAPEUT, V136, P175, DOI 10.1016/j.pharmthera.2012.08.002; Kim E, 2008, J NEUROSCI, V28, P4661, DOI 10.1523/JNEUROSCI.0982-08.2008; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kouadir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030756; Laird MD, 2013, GLIA; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Navazo MDP, 1996, ARTERIOSCL THROM VAS, V16, P1033, DOI 10.1161/01.ATV.16.8.1033; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rachmany L, 2012, AGE, V08, P1; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Santos MS, 1996, STROKE, V27, P941, DOI 10.1161/01.STR.27.5.941; Sheedy FJ, 2013, NAT IMMUNOL, V23, P10; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Snipelisky D, 2012, WORLD J CARDIOVASC D, V2, P20; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tamagno E, 2012, NEUROTOX RES, V22, P208, DOI 10.1007/s12640-011-9283-6; TANDON NN, 1989, J BIOL CHEM, V264, P7570; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Vale AM, 2013, J EXP MED, V210, P875, DOI 10.1084/jem.20121861; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Weykamp C, 2013, ANN LAB MED, V33, P393, DOI 10.3343/alm.2013.33.6.393; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yurdakan G, 2012, KAOHSIUNG J MED SCI, V28, P16, DOI 10.1016/j.kjms.2011.06.030; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771	61	7	7	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	FEB	2014	82	2					171	174		10.1016/j.mehy.2013.11.028			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AA3XO	WOS:000331028700011	24332562	Green Accepted			2022-02-06	
J	Chen, A; Chan, V; Zagorski, B; Parsons, D; Colantonio, A				Chen, Amy; Chan, Vincy; Zagorski, Brandon; Parsons, Daria; Colantonio, Angela			FACTORS ASSOCIATED WITH LIVING SETTING AT DISCHARGE FROM INPATIENT REHABILITATION AFTER ACQUIRED BRAIN INJURY IN ONTARIO, CANADA	JOURNAL OF REHABILITATION MEDICINE			English	Article						acquired brain injury; Andersen behavioral model; inpatient rehabilitation; International Classification of Diseases	FUNCTIONAL OUTCOMES; ACUTE-CARE; DESTINATION; LENGTH; STAY	Objective: This study examined factors associated with living setting of patients with acquired brain injury at discharge from inpatient rehabilitation. Design: Retrospective cohort design. Subjects/Patients: Cohort of patients first identified in acute care with a diagnostic code of traumatic or non-traumatic brain injury who also subsequently received inpatient rehabilitation in Ontario, Canada for fiscal years 2003/2004 to 2005/2006. Methods: Using logistic regression, we examined predisposing, need and enabling factors associated with living settings at discharge from inpatient rehabilitation (home/other versus residential care). Acute care and inpatient rehabilitation data were used. Results: The majority of patients (83%) were discharged home after inpatient rehabilitation. Among ABI patients, those with longer lengths of stay and patients living alone and in non-home settings at admission were significantly more likely to be living in a residential care setting at discharge. Conversely, patients with higher total function scores from the FIM (TM) Instrument and those receiving informal support at discharge were significantly less likely to be living in a residential care setting at discharge. Conclusion: Our findings suggest that informal support influences service utilization and provide evidence for its importance at discharge with respect to living in the community. Prior living arrangement and functional outcome at discharge significantly predicted discharge destination. Improving physical function and providing needed supports at discharge may be factors important to reduce the demand for residential care facilities.	[Chen, Amy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, Toronto, ON M5G 1V7, Canada; [Zagorski, Brandon] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Parsons, Daria] Ontario Neurotrauma Fdn, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Chan, Vincy/AAA-7813-2020	Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Toronto Rehabilitation InstituteUniversity of Toronto; University Health Network; Ministry of Health Long Term Care (MOHLTC); Saunderson Family Chair in Acquired Brain Injury Research; Canadian Institutes of Health Research Chair in Gender Work and Health [CGW-126580]	Funding for this study was obtained from the Ontario Neurotrauma Foundation, The Toronto Rehabilitation Institute, University Health Network, and a grant from the Ministry of Health Long Term Care (MOHLTC). We would like to thank the MOHLTC for providing us with data, the Canadian Institute for Health Information for advice on data quality and variables, and the Toronto Rehabilitation Institute Foundation. We would also like to thank Sandra Sokoloff for her assistance with formatting this manuscript. Dr. Colantonio received support through the Saunderson Family Chair in Acquired Brain Injury Research and a Canadian Institutes of Health Research Chair in Gender Work and Health (#CGW-126580).	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Buchanan Robert J, 2006, J Health Hum Serv Adm, V29, P360; Canadian Institute for Health Information, 2009, CIHI DAT QUAL STUD 2; Canadian Institute for Health Information, 2009, NAT REH REP SYST DAT; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COLANTONIO A, 1993, J GERONTOL, V48, pS261, DOI 10.1093/geronj/48.5.S261; Colantonio A, 2009, ABI DATASET PILOT PR; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Croxford R., 2006, CANADIAN I HLTH INFO; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Erwin PC, 2010, J HEALTH CARE POOR U, V21, P931, DOI 10.1353/hpu.0.0336; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Kim H, 2013, DISABIL REHABIL, V35, P2213, DOI 10.3109/09638288.2013.774063; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Peek MK, 2012, J GERONTOL B-PSYCHOL, V67, P755, DOI 10.1093/geronb/gbs081; Salter K, 2011, ASSESSMENT OUTCOMES; Sanderson CA, 2004, HLTH PSYCHOL; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Statistics Canada, 2010, PROJ POP AG GROUP AC; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Toronto ABI Network, 2012, DEF ACQ BRAIN INJ; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164; Worthington AD, 2006, CLIN REHABIL, V20, P79, DOI 10.1191/0269215506cr881oa; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe	32	7	7	0	9	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	FEB	2014	46	2					144	152		10.2340/16501977-1243			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AB7RP	WOS:000331988700007	24424354	gold, Green Submitted, Green Published			2022-02-06	
J	Cheng, QH; Yang, GT; Ma, JZ; Li, JH; Shan, Q				Cheng, Qinghong; Yang, Guangtian; Ma, Juanzhen; Li, Jianhua; Shan, Qi			Effects of different types of fluid resuscitation on hepatic mitochondria and apoptosis	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						mitochondrial membrane potential; hemorrhagic shock; apoptosis; succinate dehydrogenase; fluid resuscitation	TRAUMATIC BRAIN-INJURY; UNCONTROLLED HEMORRHAGIC-SHOCK; RAT MODEL; MICE; REQUIREMENTS; COAGULOPATHY; HYPOTHERMIA; DAMAGE	The aim of this study was to observe the effects of different types of fluid resuscitation on hepatic mitochondria and apoptosis in hemorrhagic shock, and the corresponding mechanisms. Forty rats were divided into five groups: Sham surgery (Sham group), shock (Shock group), Ringer's lactate resuscitation (RL group), hydroxyethyl starch resuscitation (HES group) and autologous blood resuscitation (BL group). A model of hemorrhagic shock was successfully induced in the latter four groups. The recovery objective was to maintain the mean arterial pressure (MAP) of the rats at 80 mmHg. Two hours after the end of the recovery experiment, fresh liver samples were examined in order to observe the changes in the morphology and mitochondrial membrane potential (Delta psi m). In addition, the levels of succinate dehydrogenase (SDH) activity were assessed, and a terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was conducted to evaluate the level of apoptosis in the liver cells. In the Shock, RL, HES and BL groups, mitochondrial ultrastructural damage in the liver cells, significant reductions in liver cell function, liver Delta psi m and SDH activity, and the apoptosis of hepatocytes were more apparent compared with those in the Sham group. In the BL group, compared with the RL and HES groups, the injuries to the mitochondrial ultrastructure and liver cell function were significantly reduced, the hepatic Delta psi m and SDH activity were significantly increased and the hepatocyte apoptosis index (AI) was significantly reduced (P<0.05). In conclusion, in a rat model of hemorrhagic shock, different methods of fluid resuscitation may improve the liver cells with regard to mitochondrial ultrastructure and function, the stability of liver Delta psi m, the activity of SDH and the inhibition of liver cell apoptosis. The results indicate that infusion with autologous blood followed by RL solution is a preferable method of fluid resuscitation compared with HES.	[Cheng, Qinghong; Ma, Juanzhen; Li, Jianhua; Shan, Qi] Shihezi Univ, Affiliated Hosp 1, Dept Intens Care Unit, Coll Med, Shihezi 832002, Xinjiang, Peoples R China; [Yang, Guangtian] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Emergency Med, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China		Yang, GT (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Emergency Dept, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.	guangtianyang@yeah.net					Balbino M, 2010, J TRAUMA, V68, P859, DOI 10.1097/TA.0b013e3181af69d3; Bennetts P, 2012, CRIT CARE MED, V40, pU150; Blasiole B, 2013, ANESTHESIOLOGY, V118, P649, DOI 10.1097/ALN.0b013e318280a42d; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Brotfain E, 2012, SHOCK, V38, P630, DOI 10.1097/SHK.0b013e318272d59f; Calzia E, 2012, SHOCK, V38, P685, DOI 10.1097/SHK.0b013e3182756a24; Drabek T, 2011, SHOCK, V35, P67, DOI 10.1097/SHK.0b013e3181e86f49; Duke MD, 2012, J TRAUMA ACUTE CARE, V73, P674, DOI 10.1097/TA.0b013e318265ce1f; Flaherty DC, 2010, MIL MED, V175, P166, DOI 10.7205/MILMED-D-09-00161; Guerci P, 2012, CLIN HEMORHEOL MICRO; Helling H, 2010, CLIN HEMORHEOL MICRO, V45, P295, DOI 10.3233/CH-2010-1309; Hubetamann Bjorn, 2011, J Emerg Trauma Shock, V4, P465, DOI 10.4103/0974-2700.86630; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Legrand M, 2010, ANESTHESIOLOGY, V112, P119, DOI 10.1097/ALN.0b013e3181c4a5e2; Maier S, 2009, J TRAUMA, V66, P337, DOI 10.1097/TA.0b013e31817dac66; Messmer C, 2012, AM J EMERG MED, V30, P1336, DOI 10.1016/j.ajem.2011.09.018; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Murao Y, 2009, J TRAUMA, V67, P975, DOI 10.1097/TA.0b013e3181b83b7a; Narasaki R, 2012, J THROMB HAEMOST, V10, P2618, DOI 10.1111/jth.12032; Nishi K, 2013, J TRAUMA ACUTE CARE, V74, P808, DOI 10.1097/TA.0b013e31827e1899; Pierce JD, 2011, MIL MED, V176, P336, DOI 10.7205/MILMED-D-09-00226; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Scultetus A, 2011, ARTIF CELL BLOOD SUB, V39, P59, DOI 10.3109/10731199.2010.501755; Seishi Y, 2012, SHOCK, V38, P153, DOI 10.1097/SHK.0b013e31825ad7cf; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Subeq YM, 2012, CYTOKINE, V60, P68, DOI 10.1016/j.cyto.2012.06.009; Taguchi K, 2011, J PHARMACOL EXP THER, V337, P201, DOI 10.1124/jpet.110.177832; White NJ, 2013, SHOCK, V39, P210, DOI 10.1097/SHK.0b013e31827fd62b; White NJ, 2010, RESUSCITATION, V81, P111, DOI 10.1016/j.resuscitation.2009.09.017; Yamamoto M, 2012, ARTIF CELL BLOOD SUB, V40, P179, DOI 10.3109/10731199.2011.637929	32	7	7	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	FEB	2014	7	2					335	342		10.3892/etm.2013.1447			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AC7EU	WOS:000332690900005	24396400	gold, Green Published, Green Submitted			2022-02-06	
J	Friedland, D; Brunton, I; Potts, J				Friedland, Daniel; Brunton, Isabel; Potts, Jacquie			Falls and Traumatic Brain Injury in Adults Under the Age of Sixty	JOURNAL OF COMMUNITY HEALTH			English	Article						Traumatic brain injury; Fall; Functional outcome; Community; Alcohol	TRENDS; RETURN	Falls are a significant cause of traumatic brain injury (TBI). There has been little research into falls resulting in a TBI in adults under the age of 60. The authors retrospectively analysed consecutive referrals to their community rehabilitation service between 2009 and 2012 in order to determine whether falls are a common cause of TBI in adults under 60, the different types of falls, the presence of alcohol at the time of the fall, and return to work following TBI. Falls accounted for 25 % of TBI. Ground-level falls and falls down stairs were the main causes of falls leading to TBI. Alcohol was present in 30 % of the falls. 44 % of individuals who had been working prior to their fall related-TBI had returned to work 1 year post-TBI. The authors conclude that falls amongst adults under sixty is an important cause of traumatic brain injury, and requires preventative and reduction strategies.	[Friedland, Daniel; Potts, Jacquie] Jacketts Field Rehabil Unit, ABI Team, Jacketts Field WD5 0PA, Abbots Langley, England; [Brunton, Isabel] Univ Hertfordshire, Dept Psychol, Hatfield AL10 9AB, Herts, England		Friedland, D (corresponding author), Jacketts Field Rehabil Unit, ABI Team, Jacketts Field WD5 0PA, Abbots Langley, England.	daniel.friedland@hchs.nhs.uk					CDC, INJ PREV CONTR TRAUM; Cook A, 2003, INJURY PREV, V9, P266, DOI 10.1136/ip.9.3.266; Crandall M, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P25; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Richardson T., 2001, CLIN NEUROPSYCHOLOGI; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P1, DOI 10.1007/978-0-387-76978-3; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Wei WL, 2010, BRAIN INJURY, V24, P1358, DOI 10.3109/02699052.2010.506635; Whitfield PC, 2009, HEAD INJURY: A MULTIDISCIPLINARY APPROACH, P1, DOI 10.1017/CBO9780511576515	15	7	7	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0094-5145	1573-3610		J COMMUN HEALTH	J. Community Health	FEB	2014	39	1					148	150		10.1007/s10900-013-9752-3			3	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	289BC	WOS:000329655100019	23963854				2022-02-06	
J	Hoover, S; Zottoli, TM; Grose-Fifer, J				Hoover, Steven; Zottoli, Tina M.; Grose-Fifer, Jillian			ERP correlates of malingered executive dysfunction	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Malingering; Neuropsychology; ERP; P300; P3a; Forensic psychology	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DETECTING SIMULATED AMNESIA; EVENT-RELATED POTENTIALS; AUDITORY ODDBALL TASK; CARD SORTING TEST; HEAD-INJURY; COGNITIVE IMPAIRMENT; PREFRONTAL CORTEX; MEMORY IMPAIRMENT; BRAIN POTENTIALS	Assessment of malingering has become an integral part of many neuropsychological evaluations, particularly in forensic settings. However, traditional malingering measures are known to be vulnerable to both manipulation and coaching. Consequently, recent research has attempted to identify physiological indices of cognitive functioning that are less susceptible to overt manipulation. While prior studies have explored the validity of physiological assessment of memory deficits, this study evaluates the effectiveness of a physiological measure of executive functioning. This study used EEG recording in conjunction with a three-stimulus oddball design to compare neural responses in simulated malingerers feigning cognitive deficits associated with traumatic brain injury (TBI) and controls. Specifically, the study explored the efficacy of an event-related potential (ERP) known as P3a, which is believed to be an index of frontal lobe executive processes, specifically the attentional orienting response. The results of this study demonstrated that simulated malingerers did not produce a P3a response that was significantly different from control participants. Furthermore, the P3a in simulated malingerers did not demonstrate any of the properties reported in prior studies with TBI patients. Not only were malingerers unable to produce a significant change in their basic orienting response, but the very process of attempting to employ additional strategies to appear impaired produced other physiological markers of deception. Therefore, the P3a component appeared to be unaffected by an individual's motivation or overt performance, which suggests that it may have potential for development as a physiological measure for differentiating between malingerers and those with genuine TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Hoover, Steven; Grose-Fifer, Jillian] CUNY, Grad Ctr, New York, NY 10016 USA; [Zottoli, Tina M.] St Josephs Coll New York, Dept Psychol, Brooklyn, NY 11205 USA; [Hoover, Steven; Grose-Fifer, Jillian] CUNY John Jay Coll Criminal Justice, Dept Psychol, New York, NY 10019 USA		Hoover, S (corresponding author), CUNY John Jay Coll Criminal Justice, Dept Psychol, 524 West 59th St, New York, NY 10019 USA.	shoover56@hotmail.com	Zottoli, Tina/ABI-7687-2020				Andersson S, 2008, BIPOLAR DISORD, V10, P888, DOI 10.1111/j.1399-5618.2008.00638.x; Barcelo F, 2003, BRAIN RES PROTOC, V11, P27, DOI 10.1016/S1385-299X(03)00013-8; Baving L, 2006, J NEURAL TRANSM, V113, P685, DOI 10.1007/s00702-005-0345-x; Ben-Shakhar G, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00342; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Centers for Disease Control Prevention (CDC), 2012, MAN PEOPL HAV TBI; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Daffner KR, 2000, BRAIN, V123, P927, DOI 10.1093/brain/123.5.927; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Ellwanger J, 1996, INT J PSYCHOPHYSIOL, V23, P9, DOI 10.1016/0167-8760(96)00035-9; Ellwanger J, 1999, J CLIN EXP NEUROPSYC, V21, P866, DOI 10.1076/jcen.21.6.866.850; Elting JW, 2008, BRAIN INJURY, V22, P870, DOI 10.1080/02699050802403581; Fabiani M, 1998, PSYCHOPHYSIOLOGY, V35, P698, DOI 10.1111/1469-8986.3560698; Fjell AM, 2007, HUM BRAIN MAPP, V28, P1098, DOI 10.1002/hbm.20335; Frederick R. I., 1997, VALIDITY INDICATOR P; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friedman D, 2008, AGING NEUROPSYCHOL C, V15, P95, DOI 10.1080/13825580701533769; Golden CJ, 1978, STROOP COLOR WORD TE; Greenberg S.A., 2003, HDB PSYCHOL, V11, P233; Hanagasi HA, 2002, COGNITIVE BRAIN RES, V14, P234, DOI 10.1016/S0926-6410(02)00110-6; HARRIS JC, 1998, DEV NEUROPSYCHIATRY, V2; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hu XQ, 2011, BRAIN RES, V1369, P149, DOI 10.1016/j.brainres.2010.10.106; Jay G.W., 2000, MINOR TRAUMATIC BRAI; Johnson R, 2003, BIOL PSYCHOL, V64, P217, DOI 10.1016/j.biopsycho.2003.07.006; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1017/S0048577298961479; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; McAllister TW, 2011, TXB TRAUMATIC BRAIN, P239; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McGrath RE, 2010, PSYCHOL BULL, V136, P450, DOI 10.1037/a0019216; Polich J, 2003, DETECTION CHANGE EVE, P83, DOI DOI 10.1007/978-1-4615-0294-4_; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; Proverbio AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059383; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; ROSENFELD JP, 1995, INT J PSYCHOPHYSIOL, V19, P1, DOI 10.1016/0167-8760(94)00057-L; Rosenfeld JP, 1998, INT J PSYCHOPHYSIOL, V28, P233; Ruff RM, 2008, PSYCHOL INJ LAW, V1, P122, DOI 10.1007/s12207-008-9010-7; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Tabachnick B. G., 2006, USING MULTIVARIATE S, V5th; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Tardif HP, 2000, INT J PSYCHOPHYSIOL, V36, P1, DOI 10.1016/S0167-8760(00)00083-0; Tardif HP, 2002, INT J PSYCHOPHYSIOL, V46, P147, DOI 10.1016/S0167-8760(02)00090-9; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Wronka E, 2008, ACTA NEUROBIOL EXP, V68, P362	63	7	7	2	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	FEB	2014	91	2					139	146		10.1016/j.ijpsycho.2013.12.009			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	AD0EM	WOS:000332907300008	24394183				2022-02-06	
J	Kearns, RD; Myers, B; Cairns, CB; Rich, PB; Hultman, CS; Charles, AG; Jones, SW; Schmits, GL; Skarote, MB; Holmes, JH; Cairns, BA				Kearns, Randy D.; Myers, Brent; Cairns, Charles B.; Rich, Preston B.; Hultman, C. Scott; Charles, Anthony G.; Jones, Samuel W.; Schmits, Grace L.; Skarote, Mary Beth; Holmes, James H.; Cairns, Bruce A.			Hospital Bioterrorism Planning and Burn Surge	BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE			English	Article							MASS CASUALTY; DISASTER; PREPAREDNESS; PRINCIPLES; FATALITIES; CAPACITY; FUTURE	On the morning of June 9, 2009, an explosion occurred at a manufacturing plant in Garner, North Carolina. By the end of the day, 68 injured patients had been evaluated at the 3 Level I trauma centers and 3 community hospitals in the Raleigh/Durham metro area (3 people who were buried in the structural collapse died at the scene). Approximately 300 employees were present at the time of the explosion, when natural gas being vented during the repair of a hot water heater ignited. The concussion from the explosion led to structural failure in multiple locations and breached additional natural gas, electrical, and ammonia lines that ran overhead in the 1-story concrete industrial plant. Intent is the major difference between this type of accident and a terrorist using an incendiary device to terrorize a targeted population. But while this disaster lacked intent, the response, rescue, and outcomes were improved as a result of bioterrorism preparedness. This article discusses how bioterrorism hospital preparedness planning, with an all-hazards approach, became the basis for coordinated burn surge disaster preparedness. This real-world disaster challenged a variety of systems, hospitals, and healthcare providers to work efficiently and effectively to manage multiple survivors. Burn-injured patients served as a focus for this work. We describe the response, rescue, and resuscitation provided by first responders and first receivers as well as efforts made to develop burn care capabilities and surge capacity.	[Kearns, Randy D.] Univ N Carolina, Sch Med, North Carolina Burn Disaster Program, Chapel Hill, NC USA; [Kearns, Randy D.] Univ N Carolina, Sch Med, EMS Performance Improvement Ctr, Chapel Hill, NC USA; [Myers, Brent] Wake Cty Emergency Med Serv, Raleigh, NC USA; [Myers, Brent; Cairns, Charles B.; Rich, Preston B.; Hultman, C. Scott; Charles, Anthony G.; Jones, Samuel W.; Cairns, Bruce A.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Rich, Preston B.] USAR, NC Task Force 8, Chapel Hill, NC USA; [Charles, Anthony G.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Jones, Samuel W.; Cairns, Bruce A.] NC Jaycee Burn Ctr, Chapel Hill, NC USA; [Schmits, Grace L.] NC Jaycee Burn Ctr, UNC Hosp & Healthcare, Chapel Hill, NC USA; [Skarote, Mary Beth] NC Off Emergency Med Serv, Hosp Preparedness Program, Raleigh, NC USA; [Holmes, James H.] Wake Forest Baptist Hlth Syst, WFBMC Burn Ctr, Winston Salem, NC USA; [Holmes, James H.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA		Kearns, RD (corresponding author), Univ N Carolina, Sch Med, Dept Surg, Burn Surge Disaster Program, CB 7600,101 Manning Dr, Chapel Hill, NC 27515 USA.	Randy_kearns@med.unc.edu	Kearns, Randy D./N-3748-2013	Kearns, Randy D./0000-0003-2037-0108	OPHPR CDC HHS [CDC-RFA-TP12-1201] Funding Source: Medline		Agency for Healthcare Research & Quality, 2004, ALTERED STANDARDS OF; Agency for Healthcare Research & Quality, 2006, PROVIDING MASS MEDIC; [Anonymous], 2012, HEALTHCARE PREPAREDN; Ashkenazi I, 2005, NEW ENGL J MED, V352, P2651; Baker MS, 2007, MIL MED, V172, P232, DOI 10.7205/MILMED.172.3.232; Barbera J A, 1993, Prehosp Disaster Med, V8, P349; Barillo DJ, 2005, J BURN CARE REHABIL, V26, P174, DOI 10.1097/01.BCR.0000155545.24253.45; Carag D., 2009, WNCN; Centers for Disease Control and Prevention, 2010, IN A MOMENTS NOTICE; Federal Emergency Management Agency, NATIONAL PLANNING SC; Glenshaw MT, 2007, DISASTER MED PUBLIC, V1, P27, DOI 10.1097/DMP.0b013e3180640cd7; Gostin LO, 2012, CRISIS STANDARDS OF; Hick JL, 2012, ANN EMERG MED, V59, P177, DOI 10.1016/j.annemergmed.2011.06.012; Hick JL, 2009, DISASTER MED PUBLIC, V3, pS59, DOI 10.1097/DMP.0b013e31819f1ae2; Howard J, 2008, MT SINAI J MED, V75, P65, DOI 10.1002/msj.20037; Jeng JC, 2006, J BURN CARE RES, V27, P612, DOI 10.1097/01.BCR.0000235469.31294.32; Kearns RD, 2014, J BURN CARE RES, V35, pE33, DOI 10.1097/BCR.0b013e318283b7d2; Kearns RD, 2014, J BURN CARE RES, V35, pE21, DOI 10.1097/BCR.0b013e3182853cf7; Kearns RD, 2014, J BURN CARE RES, V35, pE1, DOI 10.1097/BCR.0b013e31829afe25; Kearns Randy D, 2013, EMS World, V42, P43; Kearns RD, JOURNAL BURN CARE RE; Kearns RD, 2012, THE NORTH CAROLINA B; Kearns RD, 2014, NC BURN SURGE DISAST; Kearns RD, 2011, THESIS; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; McFee RB, 2004, VET HUM TOXICOL, V46, P347; Minnick B., 2009, WRAL COM; Murphy JK, 2004, J HEALTHC MANAG, V49, P227, DOI 10.1097/00115514-200407000-00005; Myers Brent, 2007, N C Med J, V68, P268; NC Division of Health Service Regulation, 2013, 2013 PROPOSED STATE; NC USAR Task Force 8, 2008, NC USAR TASK FORCE 8; North Carolina Office of Emergency Medical Services, NC EMS TRIAGE AND DE; Peleg K, 2003, ADV RENAL REPLACE TH, V10, P117, DOI 10.1053/jarr.2003.50019; Peleg K, 2011, ANN SURG, V253, P421, DOI 10.1097/SLA.0b013e318206bedf; Peleg K, 2009, JAMA-J AM MED ASSOC, V302, P565, DOI 10.1001/jama.2009.1119; Roth Paul B., 1996, Emergency Medicine Clinics of North America, V14, P371, DOI 10.1016/S0733-8627(05)70256-X; Turris SA, 2012, PREHOSP DISASTER MED, V27, P531, DOI 10.1017/S1049023X12001446; US Chemical Safety Board, 2010, FINAL REPORT; Wake County EMS, 2012, WAKE COUNTY EMS; Zoraster RM, 2007, PREHOSP DISASTER MED, V22, P224, DOI 10.1017/S1049023X00004714	40	7	7	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1538-7135	1557-850X		BIOSECUR BIOTERROR	Biosecur. Bioterror.	FEB 1	2014	12	1					20	28		10.1089/bsp.2013.0065			9	Public, Environmental & Occupational Health; International Relations	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; International Relations	AB0EA	WOS:000331463400003	24527874	Green Submitted, Green Published			2022-02-06	
J	Knapik, JJ; Steelman, R; Hoedebecke, K; Klug, KL; Rankin, S; Proctor, S; Graham, B; Jones, BH				Knapik, Joseph J.; Steelman, Ryan; Hoedebecke, Kyle; Klug, Kevin L.; Rankin, Shawn; Proctor, Stanley; Graham, Bria; Jones, Bruce H.			Risk Factors for Closed-Head Injuries During Military Airborne Operations	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article						wind speed; night; combat loads; temperature; aircraft; entanglements; T-10D parachute	TYPICAL PARACHUTE INJURIES; TRAUMATIC BRAIN-INJURY; CONCUSSION; JUMPS; SURVEILLANCE; SYSTEM; HELMET; COHORT; SCHOOL; SPORT	Introduction: One of the more serious adverse outcomes of military airborne operations is closed-head injuries. This investigation examined risk factors for closed-head injuries in an Army airborne infantry unit. Methods: Closed-head injuries were defined as energy exchanges in which the head contacted the ground or an object and the soldier sought medical care for external trauma, headache, loss of consciousness, or altered mental state. Injury data were obtained by investigators in the drop zone and diagnoses were confirmed by a physician. Operational data on potential injury risk factors were obtained from routine reports published by the infantry unit. Weather data were obtained using a pocket weather tracker. Results: There were 96,132 jumps resulting in 310 closed-head injuries for a crude incidence of 3.22/1000 jumps. In 98% of known cases the injury was associated with parachute landings. Multivariate logistic regression revealed that independent risk factors for closed-head injuries included night jumps, combat loads, higher wind speeds, higher temperatures, enlisted rank, and entanglements. Conclusions: This study identifies the current incidence and extrinsic risk factors for closed-head injuries during military airborne operations. Although it is necessary to conduct airborne training under realistic conditions, trainers and commanders should be aware of these risks and plan airborne operations accordingly.	US Army, Inst Publ Hlth, Aberdeen Proving Ground, MD 21010 USA; Womack Army Med Ctr, Ft Bragg, NC USA; Concurrent Technol Corp, Fayetteville, NC USA; Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA		Knapik, JJ (corresponding author), US Army, Inst Publ Hlth, ATTN MCHB IPDI, Aberdeen Proving Ground, MD 21010 USA.	joseph.knapik@us.army.mil			Defense Safety Oversight Council; Office of the Assistant Secretary of the Army (Installations, Energy and Environment); U.S. Army Public Health Command (USAPHC);  [W74V8H-04-D-0005]	For their assistance with this investigation we would like to thank Mr. Tyson Grier, LTC Robert Malsby, LTC Michael Sassano, COL Michael Smith, Dr. Ellen Segan, Mr. Tommy Brown, Mr. Earl Jefferson, CPT King Cooper, MSG Todd Winhoven, CW4 Thompson, CW3 Lewis, Mr. Nick Weidler, Mr. Terence (Sean) Hensey, and Mr Keith Colliver. Mr. Shane Hall served as our statistical consultant. This work was funded through the Defense Safety Oversight Council and the Office of the Assistant Secretary of the Army (Installations, Energy and Environment) and conducted under contract W74V8H-04-D-0005 Task 0517. This work was also supported in part by an appointment to the Knowledge Preservation Program at the U.S. Army Public Health Command (USAPHC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAPHC.	Babio GO, 2006, J TRAUMA, V60, P620, DOI 10.1097/01.ta.0000196868.74701.79; Barreto SM, 2000, SCAND J WORK ENV HEA, V26, P523, DOI 10.5271/sjweh.577; Bricknell MCM, 1999, OCCUP MED-OXFORD, V49, P17, DOI 10.1093/occmed/49.1.17; Craig SC, 1997, MIL MED, V162, P162, DOI 10.1093/milmed/162.3.162; ESSEXLOPRESTI P, 1946, BRIT J SURG, V34, P1, DOI 10.1002/bjs.18003413302; HADLEY AT, 1984, AVIAT SPACE ENVIR MD, V55, P65; HALLEL T, 1975, J TRAUMA, V15, P14; Hay ST, 2006, AUSTR DEFENSE FORCE, V7, P73; Hodge JG, 2005, J LAW MED ETHICS, V33; Hsieh AJ, 2009, ARLTR4764; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Ivins BJ, 2008, MIL MED, V173, P1168, DOI 10.7205/MILMED.173.12.1168; Jones BH, 1999, SPORTS MED, V27, P111, DOI 10.2165/00007256-199927020-00004; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Knapik JJ, 2003, AVIAT SPACE ENVIR MD, V74, P768; Knapik JJ, 12HF27GOED11 US ARM; Knapik JJ, 2008, AVIAT SPACE ENVIR MD, V79, P408, DOI 10.3357/ASEM.2218.2008; Knapik JJ, 2011, AVIAT SPACE ENVIR MD, V82, P797, DOI 10.3357/ASEM.3061.2011; Kragh JF, 1996, MIL MED, V161, P416, DOI 10.1093/milmed/161.7.416; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Lillywhite L P, 1991, J R Army Med Corps, V137, P115; Lord CD, 1944, J AMER MED ASSOC, V125, P1182, DOI 10.1001/jama.1944.02850350020006; Lord CD, 1944, J BONE JOINT SURG, V26, P547; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McEntire BJ, 2005, 200512 US ARM MED RE; Osler M, 2007, INT J EPIDEMIOL, V36, P212, DOI 10.1093/ije/dyl261; OTOOLE BI, 1990, ACCIDENT ANAL PREV, V22, P211, DOI 10.1016/0001-4575(90)90013-B; PIRSON J, 1985, AVIAT SPACE ENVIR MD, V56, P564; Richards G, 2003, WORLD WAR 2 TROOP TY; Watkins SJ, 2008, CDA0805 HER FDN; Whitlock G, 2003, J EPIDEMIOL COMMUN H, V57, P512, DOI 10.1136/jech.57.7.512	31	7	8	3	11	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	0095-6562	1943-4448		AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	FEB	2014	85	2					105	111		10.3357/ASEM.3788.2014			7	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	AD1MB	WOS:000332997000001	24597153				2022-02-06	
J	Molina, C; Kretzer, RM; Hu, NB; Umekoji, H; Cunningham, BW; Serhan, H				Molina, Camilo; Kretzer, Ryan M.; Hu, Nianbin; Umekoji, Hidemasa; Cunningham, Bryan W.; Serhan, Hassan			Comparative In Vitro Biomechanical Analysis of a Novel Posterior Cervical Fixation Technique Versus Conventional Posterior-based Constructs	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						posterior cervical fusion; biomechanics; lateral mass screws; laminar screws; spinal instrumentation	SPINAL STABILIZATION METHODS; LATERAL MASS SCREW; FUSION; MODEL; INSTRUMENTATION; ARTHRODESIS; CORPECTOMY; FRACTURES; INJURIES; PLATES	Study Design:Comparative in vitro, cadaveric biomechanical study.Objective:To compare the kinematic response of a new posterior cervical midline surgical technique versus that of conventional fixation techniques.Summary of Background Data:A new method was designed using alternating bilateral intralaminar screws connected with a single midline rod. This technique provides the theoretical benefits of less operative dissection and reduced implant cost, but the acute flexibility properties remain unknown. Using an in vitro cadaveric model, the study objective was to define the operative level(s) changes in multidirectional flexibility after posterior destabilization/reconstruction from C3 to C6.Methods:A 6 degree of freedom spine stimulator was used to test flexibility in 7 human cadaveric specimens. Flexion-extension, lateral bending, and axial rotation were tested in the intact condition, followed by destabilization by a simulated posterior column injury from C3 to C6. Specimens were then reconstructed from C3 to C6 and tested in the following sequence: sublaminar hook rod (SH), lateral mass screw rod (LMR), midline laminectomy from C3 to C6 with LMR (MLR), and midline posterior fixation from C3 to C6 (SMF). Range of motion (ROM) and neutral zone were quantified and analyzed.Results:Significant increases in ROM and neutral zone at C3 to C6 were found under all loading conditions for the destabilized condition and intact spine versus all other treatments (P<0.05). The conventional treatments: SH, LMR, and MLR resulted in significantly less ROM than the proposed SMF in flexion-extension and lateral bending (P<0.05). Axial rotation provided similar results; however, no differences were observed between the SH and SMF (P>0.05). Notably, LMR and MLR provided significantly more stability than SH in axial rotation (P<0.05).Conclusions:Data produced suggest that the new, midline rod fixation approach provides less biomechanical stability than conventional posterior cervical reconstruction techniques. In addition, the high incidence of laminar fracture during screw placement and close proximity of the screw trajectory and polyaxial heads to the dura suggest a practical limitation as well.	[Molina, Camilo; Kretzer, Ryan M.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Kretzer, Ryan M.; Hu, Nianbin; Umekoji, Hidemasa; Cunningham, Bryan W.] St Joseph Med Ctr, Orthopaed Spinal Res Lab, Towson, MD USA; [Serhan, Hassan] DePuy Spine, Raynham, MA 02767 USA; [Serhan, Hassan] Univ Toledo, Dept Bioengn, Toledo, OH 43606 USA		Serhan, H (corresponding author), DePuy Spine, Raynham, MA 02767 USA.	hserhan@its.jnj.com		Serhan, Hassan/0000-0003-4914-5027	DePuy Spine Inc., Raynham, MA.	Supported by DePuy Spine Inc., Raynham, MA.	ABDU WA, 1992, ORTHOPEDICS, V15, P287; AN HS, 1991, SPINE, V16, pS548, DOI 10.1097/00007632-199110001-00019; ANDERSON PA, 1991, SPINE, V16, pS72, DOI 10.1097/00007632-199103001-00012; BENZEL EC, 1989, J NEUROSURG, V70, P893, DOI 10.3171/jns.1989.70.6.0893; BOHLMAN HH, 1979, J BONE JOINT SURG AM, V61, P1119, DOI 10.2106/00004623-197961080-00001; Bransford RJ, 2011, J AM ACAD ORTHOP SUR, V19, P63, DOI 10.5435/00124635-201102000-00001; CAHILL DW, 1983, NEUROSURGERY, V13, P1; CALLAHAN RA, 1977, J BONE JOINT SURG AM, V59, P991, DOI 10.2106/00004623-197759080-00001; COE JD, 1989, SPINE, V14, P1122, DOI 10.1097/00007632-198910000-00016; Deen H Gordon, 2003, Spine J, V3, P489; ERRICO T, 1992, J SPINAL DISORD, V5, P459, DOI 10.1097/00002517-199212000-00011; GILL K, 1988, SPINE, V13, P813, DOI 10.1097/00007632-198807000-00018; HELLER JG, 1995, SPINE, V20, P2442, DOI 10.1097/00007632-199511001-00013; Horgan MA, 1999, NEUROSURGERY, V44, P1267, DOI 10.1097/00006123-199906000-00060; Hussain M, 2011, SPINE J, V11, P324, DOI 10.1016/j.spinee.2011.02.008; JEANNERET B, 1991, SPINE, V16, pS56, DOI 10.1097/00007632-199103001-00010; Kandziora Frank, 2005, Injury, V36 Suppl 2, pB36; Katonis P, 2011, J SPINAL DISORD TECH, V24, P415, DOI 10.1097/BSD.0b013e3182024c06; Korovessis P, 2001, EUR SPINE J, V10, P385, DOI 10.1007/s005860100245; Kwon BK, 2007, NEUROSURGERY, V60, P118, DOI 10.1227/01.NEU.0000249222.57709.59; Liu JK, 2001, NEUROSURG FOCUS, V10, P1; Merola Andrew A, 2002, Spine J, V2, P430, DOI 10.1016/S1529-9430(02)00461-8; MONTESANO PX, 1991, SPINE, V16, pS10, DOI 10.1097/00007632-199103001-00004; Mummaneni PV, 2002, NEUROSURG FOCUS, V12, P1; PAIT TG, 1995, J NEUROSURG, V82, P1011, DOI 10.3171/jns.1995.82.6.1011; PANJABI MM, 1995, SPINE, V20, P1122, DOI 10.1097/00007632-199505150-00003; Pateder Dhruv B, 2006, Spine J, V6, P40, DOI 10.1016/j.spinee.2005.04.010; ROYCAMILLE R, 1992, SPINE, V17, pS442; Sekhon LHS, 2005, J SPINAL DISORD TECH, V18, P297, DOI 10.1097/01.bsd.0000166640.23448.09; Shaw MN, 2011, J NEUROSURG-SPINE, V14, P719, DOI 10.3171/2011.1.SPINE10411; Singh K, 2003, SPINE, V28, P2352, DOI 10.1097/01.BRS.0000085344.22471.23; SUTTERLIN CE, 1988, SPINE, V13, P795, DOI 10.1097/00007632-198807000-00015; ULRICH C, 1991, SPINE, V16, pS4, DOI 10.1097/00007632-199103001-00003	33	7	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	FEB	2014	27	1					40	47		10.1097/BSD.0b013e31824e1f86			8	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	AH2ZM	WOS:000335990900011	22425888				2022-02-06	
J	Reinstrup, P; Ryding, E; Asgeirsson, B; Hesselgard, K; Unden, J; Romner, B				Reinstrup, Peter; Ryding, Erik; Asgeirsson, Bogi; Hesselgard, Karin; Unden, Johan; Romner, Bertil			Cerebral Blood Flow and Transcranial Doppler Sonography Measurements of CO2-Reactivity in Acute Traumatic Brain Injured Patients	NEUROCRITICAL CARE			English	Article						Brain trauma; CO2 reactivity; Traumatic brain injury; Cerebral blood flow (CBF); Transcranial Doppler sonography (TCD)	HEAD-INJURY; CARBON-DIOXIDE; NITROUS-OXIDE; VELOCITY; CIRCULATION; VASOSPASM; RESPONSES; ARTERY	Cerebral blood flow (CBF) measurements are helpful in managing patients with traumatic brain injury (TBI), and testing the cerebrovascular reactivity to CO2 provides information about injury severity and outcome. The complexity and potential hazard of performing CBF measurements limits routine clinical use. An alternative approach is to measure the CBF velocity using bedside, non-invasive, and transcranial Doppler (TCD) sonography. This study was performed to investigate if TCD is a useful alternative to CBF in patients with severe TBI. CBF and TCD flow velocity measurements and cerebrovascular reactivity to hypocapnia were simultaneously evaluated in 27 patients with acute TBI. Measurements were performed preoperatively during controlled normocapnia and hypocapnia in patients scheduled for hematoma evacuation under general anesthesia. Although the lack of statistical correlation between the calculated reactivity indices, there was a significant decrease in TCD-mean flow velocity and a decrease in CBF with hypocapnia. CBF and TCD do not seem to be directly interchangeable in determining CO2-reactivity in TBI, despite both methods demonstrating deviation in the same direction during hypocapnia. TCD and CBF measurements both provide useful information on cerebrovascular events which, although not interchangeable, may complement each other in clinical scenarios.	[Hesselgard, Karin; Romner, Bertil] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden; [Reinstrup, Peter; Asgeirsson, Bogi; Unden, Johan] Univ Lund Hosp, Dept Neuroanesthesia, S-22185 Lund, Sweden; [Ryding, Erik] Univ Lund Hosp, Dept Neurophysiol, S-22185 Lund, Sweden; [Reinstrup, Peter] Univ Lund Hosp, Dept Neurointens Care, S-22185 Lund, Sweden		Reinstrup, P (corresponding author), Univ Lund Hosp, Dept Neurointens Care, S-22185 Lund, Sweden.	peter.reinstrup@med.lu.se			Regionalt Forskningsstod	Supported by Grants from Regionalt Forskningsstod.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brauer P, 1998, J NEUROSURG ANESTH, V10, P80, DOI 10.1097/00008506-199804000-00003; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Giller CA, 1998, NEUROSURGERY, V42, P1076, DOI 10.1097/00006123-199805000-00077; HARDER DR, 1985, PFLUG ARCH EUR J PHY, V403, P402, DOI 10.1007/BF00589253; HARTMANN A, 1991, NEUROCHIRURGIA, V34, P6; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Marion D W, 1995, New Horiz, V3, P439; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; Moreno J A, 2000, Neurosurg Focus, V8, pe8; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Ng SC, 2002, ACTA NEUROCHIR S, V81, P25; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Poon WS, 2005, ACT NEUR S, V95, P9; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; REINSTRUP P, 1992, BRIT J ANAESTH, V69, P615, DOI 10.1093/bja/69.6.615; Reinstrup P, 2001, ANESTHESIOLOGY, V95, P1079, DOI 10.1097/00000542-200111000-00009; REINSTRUP P, 1994, ANESTHESIOLOGY, V81, P396, DOI 10.1097/00000542-199408000-00018; RISBERG J, 1977, STROKE, V8, P380, DOI 10.1161/01.STR.8.3.380; RISBERG J, 1975, STROKE, V6, P142, DOI 10.1161/01.STR.6.2.142; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; ROMNER B, 1991, British Journal of Neurosurgery, V5, P31, DOI 10.3109/02688699108998444; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x	28	7	9	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2014	20	1					54	59		10.1007/s12028-012-9727-8			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB2RI	WOS:000331639400008	22700360				2022-02-06	
J	Salomon-Estebanez, MA; Grau, G; Vela, A; Rodriguez, A; Morteruel, E; Castano, L; Rica, I				Salomon-Estebanez, M. A.; Grau, G.; Vela, A.; Rodriguez, A.; Morteruel, E.; Castano, L.; Rica, I.			Is routine endocrine evaluation necessary after paediatric traumatic brain injury?	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Hypopituitarism; Traumatic brain injury; Children; Pituitary gland; Endocrine investigations	PITUITARY-FUNCTION; POSTTRAUMATIC HYPOPITUITARISM; COMA SCALE; LONG-TERM; CHILDREN; DYSFUNCTION; PREVALENCE; ADOLESCENTS; ABNORMALITIES; CHILDHOOD	Background Traumatic brain injury (TBI) is a common event in childhood. It is a recognised cause of hypopituitarism both in adult and paediatric patients. Routine endocrine evaluation has been proposed for adult TBI-survivors; nevertheless, incongruous data have been reported in children. Aim The goal of this study was to describe the prevalence of pituitary dysfunction after TBI in a cohort of children. Material/subjects and methods This is a cross-sectional study comprising retrospective medical record review and prospective testing. Children with brain injury discharged from the Paediatric Intensive Care Unit from year 2004 to 2009 were recruited. Height and weight were recorded, systemic examination was performed and baseline pituitary function tests were undertaken. Provocative tests were performed only if abnormal basal levels were detected. Results Thirty-six patients were collected; the mean age at assessment was 7.2 years and the mean interval since injury 3.3 years. All patients had skull fracture or intracranial haemorrhage; 36.6 % of them had moderate to severe TBI. No abnormalities were found on examination. Low serum IGF 1 levels were detected in four patients and two patients had low serum cortisol levels with inappropriately normal plasma ACTH concentrations. No evidence of pituitary dysfunction was observed in these patients after clinical follow-up, repeated baseline hormone levels or dynamic function tests. Conclusions No endocrine sequelae have been detected in this population. The routine endocrine evaluation in children with mild to moderate TBI might not be justified, according to our findings.	[Salomon-Estebanez, M. A.; Grau, G.; Vela, A.; Rodriguez, A.; Rica, I.] Cruces Univ Hosp, Dept Paediat Endocrinol, Baracaldo 48903, Biscay, Spain; [Vela, A.; Castano, L.] CIBERER Ctr Biomed Network Res Rare Dis, Valencia, Spain; [Morteruel, E.] Cruces Univ Hosp, Paediat Intens Care Unit, Baracaldo 48903, Biscay, Spain; [Castano, L.] Cruces Univ Hosp, Endocrinol & Diabet Res Grp, Baracaldo 48903, Biscay, Spain; [Castano, L.; Rica, I.] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Barcelona, Spain		Rica, I (corresponding author), Cruces Univ Hosp, Dept Paediat Endocrinol, Plaza Cruces S-N, Baracaldo 48903, Biscay, Spain.	itxaso.ricaechevarria@osakidetza.net	Rica, Itxaso/E-7645-2012	Castano, Luis/0000-0003-0437-9401			Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; EDWARDS OM, 1986, MEDICINE, V65, P281; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Giordano R, 2008, CLIN ENDOCRINOL, V68, P935, DOI 10.1111/j.1365-2265.2007.03141.x; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Sobradillo B, 2004, CURVAS TABLAS CRECIM, P1; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	34	7	7	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	FEB	2014	37	2					143	148		10.1007/s40618-013-0020-2			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	AG1CD	WOS:000335151700006	24497213				2022-02-06	
J	Sanfilippo, F; Veenith, T; Santonocito, C; Vrettou, CS; Matta, BF				Sanfilippo, F.; Veenith, T.; Santonocito, C.; Vrettou, C. S.; Matta, B. F.			Liver function test abnormalities after traumatic brain injury: is hepato-biliary ultrasound a sensitive diagnostic tool?	BRITISH JOURNAL OF ANAESTHESIA			English	Article						critical care; imaging techniques; liver function; ultrasonography	ACUTE ACALCULOUS CHOLECYSTITIS; INTENSIVE-CARE-UNIT; GALLBLADDER ABNORMALITIES; SONOGRAPHY; CHOLESCINTIGRAPHY; ULTRASONOGRAPHY; DYSFUNCTION	Background. This study was to evaluate the usefulness of hepato-biliary ultrasound (HBUS) for the investigation of isolated liver function tests (LFTs) abnormalities. Methods. We retrospectively reviewed HBUS reports in traumatic brain injury (TBI) patients admitted to our tertiary neuro-critical care unit (NCCU; January 2005-June 2011). We included patients receiving an HBUS for isolated LFTs derangement, excluding pre-existing hepato-biliary diseases or trauma. We assessed the temporal profile of alanine aminotransferase (ALT), bilirubin (Bil), and alkaline phosphatase (ALP). Results. Of 511 patients, 58 received an HBUS. Of these, 47 were investigated for isolated LFTs derangement; HBUS always failed to identify a cause for these abnormalities. The HBUS was performed on day 18 (range 6-51) with the following mean values: 246 IU litre(-1) [ALT, 95% confidence interval (CI) 183-308], 24 mu mol litre(-1) (Bil, 95% CI 8-40), and 329 IU litre(-1) (ALP, 95% CI 267-390); only ALT (72, 95% CI 36-107) and ALP (73, 95% CI 65-81) were deranged from admission values (both P<0.01). At NCCU discharge, both ALT (160, 95% CI 118-202) and ALP (300, 95% CI 240-360) were higher than at admission (P<0.01). Compared with HBUS-day value, only ALT improved by NCCU discharge (P<0.05), while both were recovering by hospital discharge (ALT 83, 95% CI 59-107; ALP 216, 95% CI 181-251; P<0.01). At hospital discharge, ALP remained higher than at admission (P<0.01). Conclusions. In TBI patients, HBUS did not appear sensitive in detecting causes for isolated LFT abnormalities. Both ALT and ALP worsened and gradually recovered. Their abnormalities did not prevent NCCU discharge. ALP recovered more slowly than ALT. TBI and its complications, critical illness, and pharmacological strategies may explain the LFTs derangement.	[Sanfilippo, F.; Veenith, T.; Vrettou, C. S.; Matta, B. F.] Cambridge Univ Hosp NHS Fdn Trust, Dept Anaesthesia, Addenbrookes Hosp, Neurocrit Care Unit, Cambridge CB2 0QQ, England; [Sanfilippo, F.; Santonocito, C.] Oxford Univ Hosp, John Radcliffe Hosp, Oxford Heart Ctr, Oxford OX3 9DU, England		Sanfilippo, F (corresponding author), Oxford Univ Hosp, John Radcliffe Hosp, Oxford Heart Ctr, Oxford OX3 9DU, England.	filipposanfi@yahoo.it	Sanfilippo, Filippo/N-7045-2017; Veenith, Tonny/AAI-3067-2020; Veenith, Tonny V/A-9948-2010	Sanfilippo, Filippo/0000-0001-5144-0776; Veenith, Tonny/0000-0002-4125-8804; Veenith, Tonny V/0000-0002-4125-8804	National Institute of Academic Anaesthesia; Raymond Beverly Sackler studentship	T.V. was supported by clinical research training fellowship from National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2011, ANN ROY COLL SURG, V93, P81, DOI 10.1308/003588411X12851639107070; BILHARTZ L, 2002, SLEISENGER FORDTRANS, P1106; Birrer R, 2007, INTERNAL MED, V46, P1063, DOI 10.2169/internalmedicine.46.0059; Bjornsson E, 2008, ACTA NEUROL SCAND, V118, P281, DOI 10.1111/j.1600-0404.2008.01009.x; Boland GWL, 2000, AM J ROENTGENOL, V174, P973, DOI 10.2214/ajr.174.4.1740973; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chand N, 2007, HEPATOLOGY, V45, P230, DOI 10.1002/hep.21480; CRONEMUNZEBROCK W, 1990, ROFO FORTSCHR RONTG, V153, P379, DOI 10.1055/s-2008-1033399; Fuhrmann V, 2011, INTENS CARE MED, V37, P1302, DOI 10.1007/s00134-011-2248-7; Ghabril M, 2013, J CLIN GASTROENTEROL, V47, P553, DOI 10.1097/MCG.0b013e318276bf00; Grau T, 2007, CRIT CARE, V11, DOI 10.1186/cc5670; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; HINDS CJ, 2008, INTENSIVE CARE CONCI, P466; Huffman JL, 2010, CLIN GASTROENTEROL H, V8, P15, DOI 10.1016/j.cgh.2009.08.034; IMHOF M, 1992, WORLD J SURG, V16, P1160, DOI 10.1007/BF02067089; Kalimi R, 2001, J AM COLL SURGEONS, V193, P609, DOI 10.1016/S1072-7515(01)01092-4; Kalliafas S, 1998, AM SURGEON, V64, P471; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lescot T, 2012, ANESTHESIOLOGY, V117, P898, DOI 10.1097/ALN.0b013e318266c6df; Luyendyk JP, 2003, J PHARMACOL EXP THER, V307, P9, DOI 10.1124/jpet.103.054288; Mariat G, 2000, INTENS CARE MED, V26, P1658, DOI 10.1007/s001340000684; Molenat F, 1996, INTENS CARE MED, V22, P356, DOI 10.1007/BF01700459; Myrianthefs P, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/565617; Pelinka LE, 2003, J TRAUMA, V55, P323, DOI 10.1097/01.TA.0000054648.26933.21; PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS291, DOI 10.1111/j.1365-2125.1980.tb01812.x; Puc MM, 2002, AM SURGEON, V68, P65; SHEA JA, 1994, ARCH INTERN MED, V154, P2573, DOI 10.1001/archinte.154.22.2573; Theodorou P, 2009, BURNS, V35, P405, DOI 10.1016/j.burns.2008.08.003; Thomson SJ, 2009, INTENS CARE MED, V35, P1406, DOI 10.1007/s00134-009-1511-7; Yusoff IF, 2003, GASTROENTEROL CLIN N, V32, P1145, DOI 10.1016/S0889-8553(03)00090-6	30	7	8	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	FEB	2014	112	2					298	303		10.1093/bja/aet305			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	299ZE	WOS:000330433400013	24067331	Green Published, Bronze			2022-02-06	
J	Sartor-Glittenberg, C; Brickner, L				Sartor-Glittenberg, Cecelia; Brickner, Lori			A multidimensional physical therapy program for individuals with cerebellar ataxia secondary to traumatic brain injury: a case series	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Ataxia; brain injury; rock climbing		The purpose of this case series is to describe changes in impairments and activity limitations in three individuals with severe cerebellar ataxia from traumatic brain injury (TBI) who participated in a long-term, multidimensional physical therapy program. A secondary purpose is to document use of a climbing wall for these persons. Each of the individuals had a TBI, severe ataxia and was admitted to a transitional neuro-rehabilitation day treatment program. The first person, a 22-year-old, was 6 years post injury and had 127 individual physical therapy sessions over 12 months. The second person, a 16-year-old, was 5 months post injury and had 187 individual therapy sessions over 19 months. The third person, a 20-year-old, was 6 months post injury and had 89 individual therapy sessions over 23 months. An integrative treatment approach was used, and the individuals participated in activities to minimize ataxia and improve mobility. Each of them made gains in coordination, balance, balance confidence, endurance and mobility. The three individuals with cerebellar ataxia participated in a long-term, individualized, multidimensional physical therapy treatment program, and made improvements in all areas of impairment and activity limitations. This study reinforces the need for long-term, multidimensional physical therapy for individuals with ataxia.	[Sartor-Glittenberg, Cecelia] AT Still Univ, Phys Therapy Program, Arizona Sch Hlth Sci, Mesa, AZ 85206 USA; [Brickner, Lori] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA		Sartor-Glittenberg, C (corresponding author), AT Still Univ, Phys Therapy Program, Arizona Sch Hlth Sci, 5850 E, Mesa, AZ 85206 USA.	cglittenberg@atsu.edu					Anke S Marianne, 2011, REHABILITATION RESEA, V2011, P1; Armultlu K, 2013, INTERNATIONAL ENCYCL; Armutlu K, 2001, NEUROREHAB NEURAL RE, V15, P203, DOI 10.1177/154596830101500308; Balliet R, 1987, Int Rehabil Med, V8, P148; Bastian AJ, 1997, PHYS THER, V77, P672, DOI 10.1093/ptj/77.6.672; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Boyd LA, 2004, NEUROREHAB NEURAL RE, V18, P134, DOI 10.1177/0888439004269072; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Cernak K, 2008, PHYS THER, V88, P88, DOI 10.2522/ptj.20070134; Chong RKY, 1999, J GERONTOL A-BIOL, V54, pM122, DOI 10.1093/gerona/54.3.M122; DORDEL H J, 1987, International Journal of Rehabilitation Research, V10, P279, DOI 10.1097/00004356-198712005-00060; Dutton M, 2012, DUTTONS ORTHOPAEDIC, P791; Feld JA, 2001, NEUROREHAB NEURAL RE, V15, P239, DOI 10.1177/154596830101500312; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fulk GD, 2007, PHYSICAL REHABILITAT, P898; Gialanella B, 2005, Minerva Med, V96, P373; Gibson-Horn Cynthia, 2008, J Neurol Phys Ther, V32, P139, DOI 10.1097/NPT.0b013e318185558f; GillBody KM, 1997, PHYS THER, V77, P534, DOI 10.1093/ptj/77.5.534; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Highsmith MJ, 2010, INT J SPORTS MED, V31, P38, DOI 10.1055/s-0029-1239562; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Ilg W, 2009, NEUROLOGY, V73, P1823, DOI 10.1212/WNL.0b013e3181c33adf; Ilich M, METAHOLDS A ROCK CLI; Ioffe ME, 2007, CEREBELLUM, V6, P87, DOI 10.1080/14734220701216440; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; KABAT H, 1955, ARCH NEURO PSYCHIATR, V74, P375, DOI 10.1001/archneurpsyc.1955.02330160025005; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kelley MP, 1997, PSYCHIATR REHABIL J, V20, P61; Kendall HO, 1971, MUSCLES TESTING AND, P157; Kent-Braun JA, 1999, J APPL PHYSIOL, V87, P22, DOI 10.1152/jappl.1999.87.1.22; Lundy-Ekman L, 2007, NEUROSCIENCE FUNDAME, P261; Marsden J, 2011, CLIN REHABIL, V25, P195, DOI 10.1177/0269215510382495; Martin CL, 2009, CLIN REHABIL, V23, P15, DOI 10.1177/0269215508097853; MAURITZ KH, 1979, BRAIN, V102, P461, DOI 10.1093/brain/102.3.461; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Mermier CM, 1997, BRIT J SPORT MED, V31, P224, DOI 10.1136/bjsm.31.3.224; Morton SM, 2004, EXP BRAIN RES, V156, P149, DOI 10.1007/s00221-003-1776-y; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2012, PHYS THER, V92, P726, DOI 10.2522/ptj.20110157; National Institute of Neurological Disorders and Stroke, 2012, NINDS ATAXIAS AND CE; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Newton RA, 1989, PAPER PRESENTED AT T; Norkin CC, 2007, PHYSICAL REHABILITAT, P320; O'Sullivan SB, 2007, PHYSICAL REHABILITAT, P801; Oliveira CB, 2011, CLINICS, V66, P2043, DOI 10.1590/S1807-59322011001200008; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schmahmann JD, 2009, MOVEMENT DISORD, V24, P1820, DOI 10.1002/mds.22681; Schmitz TJ, 2007, PHYSICAL REHABILITAT, P198; Schmitz TJ, 2010, IMPROVING FUNCTIONAL, p[60, 77]; Shapira MY, 2001, ARCH PHYS MED REHAB, V82, P1283, DOI 10.1053/apmr.2001.25152; Sheel AW, 2004, BRIT J SPORT MED, V38, P355, DOI 10.1136/bjsm.2003.008169; Sheel AW, 2003, MED SCI SPORT EXER, V35, P1225, DOI 10.1249/01.MSS.0000074443.17247.05; Shumway-Cook A, 2007, MOTOR CONTROL TRANSL, P387; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL, P71; Sibley KM, 2011, PHYS THER, V91, P1583, DOI 10.2522/ptj.20110063; SLIWA JA, 1994, ARCH PHYS MED REHAB, V75, P355, DOI 10.1016/0003-9993(94)90042-6; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Springer Barbara A, 2007, J Geriatr Phys Ther, V30, P8; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Vaz DV, 2008, CLIN REHABIL, V22, P234, DOI 10.1177/0269215507081578; Vinci P, 2003, ARCH PHYS MED REHAB, V84, P762, DOI 10.1016/S0003-9993(03)04907-9; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158	70	7	7	1	21	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.	FEB	2014	30	2					138	148		10.3109/09593985.2013.819952			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	287EF	WOS:000329523100009	23886039				2022-02-06	
J	Vonder Haar, C; Smith, TR; French, EJ; Martens, KM; Jacobs, EA; Hoane, MR				Vonder Haar, Cole; Smith, Travis R.; French, Eric J.; Martens, Kris M.; Jacobs, Eric A.; Hoane, Michael R.			Simple tone discriminations are disrupted following experimental frontal traumatic brain injury in rats	BRAIN INJURY			English	Article						Animal models; controlled cortical impact; operant learning	DECISION-MAKING; HEAD-INJURY; LONG-TERM; DEFICITS; CORTEX; CONTINGENCIES; CHOICE; SENSITIVITY; IMPACT; TIME	Primary objective: To assess cognitive deficits in a rat model of brain injury. Research design: Cognitive deficits are some of the most pervasive and enduring symptoms of frontal traumatic brain injury (TBI) in human patients. In animal models, the assessment of cognitive deficits from TBI has primarily been limited to tests of spatial learning. Recently, simple discrimination performance has been shown to be sensitive to frontal brain damage. The current study provides a detailed characterization of deficits in a two-choice tone discrimination following a bilateral frontal controlled cortical impact injury. Methods and procedures: Rats were trained on a two-tone discrimination task in a standard operant chamber, then either a frontal brain injury was delivered or sham procedures performed. Following recovery, they were re-tested on the discrimination task and then tested on a reversal of the discrimination. Main outcomes and results: Frontal injury caused substantial deficits in responding and discrimination accuracy as well as an increase in side bias. Conclusions: Based on the outcomes seen in this study, discrimination and other operant tasks may provide a sensitive tool to assess the effect of therapeutic agents on cognitive deficits in animal models, which could lead to improved characterization of deficits and yield an improved assessment tool to aid in drug discovery.	[Vonder Haar, Cole; Martens, Kris M.; Hoane, Michael R.] So Illinois Univ, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Smith, Travis R.; French, Eric J.; Jacobs, Eric A.] So Illinois Univ, Dept Psychol, Operant Learning Lab, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657; Vonder Haar, Cole/0000-0001-7949-2068	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD061944-01, NS045647-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER	This work was supported by NIH grants HD061944-01 and NS045647-04. The authors have no financial interest in the outcome of this research.	Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; AXELROD BN, 1994, NEUROPSY NEUROPSY BE, V7, P20; BIEDERMA.I, 1970, J EXP PSYCHOL, V86, P434, DOI 10.1037/h0030163; Birrell JM, 2000, J NEUROSCI, V20, P4320; DAVISON MC, 1978, J EXP ANAL BEHAV, V29, P331, DOI 10.1901/jeab.1978.29-331; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Heinicke MR, 2013, BRAIN INJURY, V27, P48, DOI 10.3109/02699052.2012.722250; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 1997, BRAIN INJURY, V11, P125, DOI 10.1080/026990597123719; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mair RG, 1998, BEHAV NEUROSCI, V112, P772, DOI 10.1037/0735-7044.112.4.772; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schlund MW, 2001, BRAIN INJURY, V15, P1061, DOI 10.1080/02699050110086887; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swets J A, 2000, Psychol Sci Public Interest, V1, P1, DOI 10.1111/1529-1006.001; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walton ME, 2002, J NEUROSCI, V22, P10996; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	30	7	7	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					235	243		10.3109/02699052.2013.860473			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900013	24456061				2022-02-06	
J	Huang, J; Fleming, J; Pomery, NL; O'Gorman, JG; Chan, RCK; Shum, DHK				Huang, Jia; Fleming, Jennifer; Pomery, Nadine L.; O'Gorman, John G.; Chan, Raymond C. K.; Shum, David H. K.			Perceived importance of prospective memory failures in adults with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Prospective memory; Comprehensive assessment of prospective memory (CAPM)	RETROSPECTIVE MEMORY; EXECUTIVE FUNCTIONS; DAMAGE	Prospective memory (PM) is the ability to carry out an intended action in the future. Failures in PM are often observed as more frequent in individuals with traumatic brain injury (TBI) than controls. However, it remains unknown how individuals with TBI and their significant others perceive the importance of these PM problems. In the current study, four groups (38 TBI, 34 TBI-other, 34 controls, 31 control-other) were recruited to report on the perceived importance of PM failures using Part B of the Comprehensive Assessments of Prospective Memory (CAPM). Individuals with TBI perceived PM failures as being more important than did their significant others. Controls' ratings did not differ from their significant others. There were no statistically significant differences in rated importance for PM problems involving the basic activities of daily living (BADL) component and those involving the instrumental activities of daily living (IADL) component. Implications of the results are discussed in terms of the motivation of people with TBI.	[Huang, Jia; Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Fleming, Jennifer; Pomery, Nadine L.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Metro South Hosp & Hlth Serv, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [O'Gorman, John G.; Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Behav Basis Hlth Program, Brisbane, Qld 4111, Australia; [O'Gorman, John G.; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	j.fleming@uq.edu.au	Chan, Raymond CK/B-6717-2009; Shum, David/A-3914-2008	Chan, Raymond CK/0000-0002-3414-450X; Shum, David/0000-0002-4810-9262	Endeavor Research Fellowship; Australian Academy of Science	Preparation of this manuscript was partly supported by an Endeavor Research Fellowship awarded to Jia Huang and an Australian Academy of Science Scientific Visit to China Award to David Shum.	Chan RCK, 2010, NEUROPSYCHOL REHABIL, V20, P459, DOI 10.1080/09602010903425710; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; Cockburn J, 1996, J CLIN EXP NEUROPSYC, V18, P304, DOI 10.1080/01688639608408284; Cohen J., 2013, STAT POWER ANAL BEHA; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; McCauley SR, 2011, J CLIN EXP NEUROPSYC, V33, P639, DOI 10.1080/13803395.2010.547844; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Pavawalla SP, 2012, NEUROPSYCHOLOGY, V26, P91, DOI 10.1037/a0025866; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Umeda S, 2011, NEUROPSYCHOLOGIA, V49, P2178, DOI 10.1016/j.neuropsychologia.2011.03.036; Wang Y, 2011, PSYCHIAT RES, V189, P156, DOI 10.1016/j.psychres.2011.01.002; Waugh N, 1999, SELF REPORT YOUNG MI; Wilson B., 2005, CAMBRIDGE PROSPECTIV	22	7	8	0	9	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2014	24	1					61	70		10.1080/09602011.2013.854723			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	295GJ	WOS:000330104300003	24171841	Green Accepted			2022-02-06	
S	Acheson, DT; Geyer, MA; Risbrough, VB		Kumari, V; Bob, P; Boutros, NN		Acheson, D. T.; Geyer, M. A.; Risbrough, V. B.			Psychophysiology in the Study of Psychological Trauma: Where Are We Now and Where Do We Need to Be?	ELECTROPHYSIOLOGY AND PSYCHOPHYSIOLOGY IN PSYCHIATRY AND PSYCHOPHARMACOLOGY	Current Topics in Behavioral Neurosciences		English	Article; Book Chapter						Psychophysiology; PTSD; Startle; Heart rate variability; Electrodermal response; TBI	POSTTRAUMATIC-STRESS-DISORDER; HEART-RATE-VARIABILITY; IMPAIRED FEAR INHIBITION; PREPULSE INHIBITION; ACOUSTIC STARTLE; VIETNAM VETERANS; BRAIN-INJURY; EMERGENCY-DEPARTMENT; BASE-LINE; EXPOSED INDIVIDUALS	Posttraumatic stress disorder (PTSD) is a major public health concern, which has been seeing increased recent attention partly due to the wars in Iraq and Afghanistan. Historically, research attempting to understand the etiology and treatment of PTSD has made frequent use of psychophysiological measures of arousal as they provide a number of advantages in providing objective, non-self-report outcomes that are closely related to proposed neurobiological mechanisms and provide opportunity for cross-species translation. Further, the ongoing shift in classification of psychiatric illness based on symptom clusters to specific biological, physiological, and behavioral constructs, as outlined in the US National Institute of Mental Health (NIMH) Research Domain Criteria project (RDoC), promises that psychophysiological research will continue to play a prominent role in research on trauma-related illnesses. This review focuses on the current state of the knowledge regarding psychophysiological measures and PTSD with a focus on physiological markers associated with current PTSD symptoms, as well as markers of constructs thought to be relevant to PTSD symptomatology (safety signal learning, fear extinction), and psychophysiological markers of risk for developing PTSD following trauma. Future directions and issues for the psychophysiological study of trauma including traumatic brain injury (TBI), treatment outcome studies, and new wearable physiological monitoring technologies are also discussed.	[Acheson, D. T.; Geyer, M. A.; Risbrough, V. B.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr Mail Code 0804, La Jolla, CA 92093 USA; [Risbrough, V. B.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Geyer, M. A.] VA San Diego Healthcare Syst, Mental Illness Res Educ & Clin Ctr, San Diego, CA USA		Risbrough, VB (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr Mail Code 0804, La Jolla, CA 92093 USA.	vrisbrough@ucsd.edu			VA BLRD Merit Award [MH074697, MH042228]; NARSAD Young Investigator AwardNARSAD	This work was supported by MH074697, MH042228, VA BLR&D Merit Award, and a NARSAD Young Investigator Award.	Acheson D, 2013, PSYCHOPHARMACOLOGY, V229, P199, DOI 10.1007/s00213-013-3099-4; Acheson DT, 2012, NEUROPHARMACOLOGY, V62, P674, DOI 10.1016/j.neuropharm.2011.04.029; Adenauer H, 2010, PSYCHOPHYSIOLOGY, V47, P315, DOI 10.1111/j.1469-8986.2009.00940.x; Aerni A, 2004, AM J PSYCHIAT, V161, P1488, DOI 10.1176/appi.ajp.161.8.1488; Agorastos A, 2013, STRESS, V16, P300, DOI 10.3109/10253890.2012.751369; Ahmari SE, 2012, NEUROPSYCHOPHARMACOL, V37, P1216, DOI 10.1038/npp.2011.308; Andero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005656; ARGYLE N, 1991, J NERV MENT DIS, V179, P563, DOI 10.1097/00005053-199109000-00008; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Baker DG, 2009, MIL MED, V174, P773; Barkay G, 2012, PSYCHIAT RES-NEUROIM, V204, P155, DOI 10.1016/j.pscychresns.2012.08.007; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Billeci L, 2014, EAT WEIGHT DISORD; Blanchard E B, 1982, Psychiatr Q, V54, P220, DOI 10.1007/BF01064817; Blanchard EB, 2002, J TRAUMA STRESS, V15, P199, DOI 10.1023/A:1015299126858; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Bryant RA, 2000, J ABNORM PSYCHOL, V109, P341, DOI 10.1037/0021-843X.109.2.341; Buckley TC, 2004, J TRAUMA STRESS, V17, P163, DOI 10.1023/B:JOTS.0000022623.01190.f0; Buckley TC, 2001, PSYCHOSOM MED, V63, P585, DOI 10.1097/00006842-200107000-00011; BUTLER RW, 1990, AM J PSYCHIAT, V147, P1308; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Chang HA, 2013, PSYCHIAT INVEST, V10, P121, DOI 10.4306/pi.2013.10.2.121; Cohen H, 2000, PSYCHIAT RES, V96, P1, DOI 10.1016/S0165-1781(00)00195-5; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; Darwish A, 2011, SENSORS-BASEL, V11, P5561, DOI 10.3390/s110605561; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; de Quervain DJF, 2011, P NATL ACAD SCI USA, V108, P6621, DOI 10.1073/pnas.1018214108; Dunlop BW, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-240; Ehlers A, 2010, INT J PSYCHOPHYSIOL, V78, P27, DOI 10.1016/j.ijpsycho.2010.04.009; Ehring T, 2008, PSYCHIAT RES, V161, P67, DOI 10.1016/j.psychres.2007.08.014; Eraly SA, 2014, JAMA PSYCHIAT, V71, P423, DOI 10.1001/jamapsychiatry.2013.4374; Fukukawa Y, 2004, PSYCHOL AGING, V19, P346, DOI 10.1037/0882-7974.19.2.346; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Geracioti TD, 2008, PSYCHONEUROENDOCRINO, V33, P416, DOI 10.1016/j.psyneuen.2007.12.012; GEYER MA, 1987, SCHIZOPHRENIA BULL, V13, P643, DOI 10.1093/schbul/13.4.643; GEYER MA, 1982, PSYCHOPHYSIOLOGY, V19, P1, DOI 10.1111/j.1469-8986.1982.tb02589.x; GEYER MA, 1990, BRAIN RES BULL, V25, P485, DOI 10.1016/0361-9230(90)90241-Q; Glover EM, 2011, DEPRESS ANXIETY, V28, P1058, DOI 10.1002/da.20880; Gould NF, 2011, J CLIN PSYCHIAT, V72, P539, DOI 10.4088/JCP.09m05405blu; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Greenwood TA, 2013, AM J PSYCHIAT, V170, P521, DOI 10.1176/appi.ajp.2012.12020186; Greenwood TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029630; Grenier JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043586; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 1996, PSYCHIAT RES, V64, P169, DOI 10.1016/S0165-1781(96)02942-3; Grillon C, 1998, BIOL PSYCHIAT, V44, P1027, DOI 10.1016/S0006-3223(98)00034-1; Grillon C, 2008, EMOTION, V8, P410, DOI 10.1037/1528-3542.8.3.410; Grillon C, 2009, BIOL PSYCHIAT, V66, P47, DOI 10.1016/j.biopsych.2008.12.028; Guthrie RM, 2006, PSYCHOSOM MED, V68, P307, DOI 10.1097/01.psy.0000208629.67653.cc; Haaker J, 2013, P NATL ACAD SCI USA, V110, pE2428, DOI 10.1073/pnas.1303061110; Halberstadt AL, 2009, NEUROBIOL LEARN MEM, V92, P243, DOI 10.1016/j.nlm.2008.05.015; Heathers JAJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00177; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge EA, 2012, CNS NEUROSCI THER, V18, P21, DOI 10.1111/j.1755-5949.2010.00227.x; Holstein DH, 2010, J AFFECT DISORDERS, V126, P188, DOI 10.1016/j.jad.2010.02.122; Holt DJ, 2009, BIOL PSYCHIAT, V65, P455, DOI 10.1016/j.biopsych.2008.09.017; Jansen D.J., 2013, POSTTRAUMATIC STRESS; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Jovanovic T, 2011, PSYCHONEUROENDOCRINO, V36, P1540, DOI 10.1016/j.psyneuen.2011.04.008; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; Jovanovic T, 2009, INT J PSYCHOPHYSIOL, V71, P264, DOI 10.1016/j.ijpsycho.2008.10.007; Kamkwalala A, 2012, PSYCHOSOM MED, V74, P153, DOI 10.1097/PSY.0b013e318240803a; Kamphuis MH, 2007, MED SCI SPORT EXER, V39, P1693, DOI 10.1249/mss.0b013e3180f6109f; Kassam-Adams N, 2005, ARCH GEN PSYCHIAT, V62, P335, DOI 10.1001/archpsyc.62.3.335; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Khoury NM, 2012, J CLIN PSYCHIAT, V73, P849, DOI 10.4088/JCP.11m07316; Klumpers F, 2010, BIOL PSYCHIAT, V68, P1031, DOI 10.1016/j.biopsych.2010.09.006; Kohl S, 2013, J PSYCHIATR RES, V47, P445, DOI 10.1016/j.jpsychires.2012.11.018; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Kuhn E, 2006, J TRAUMA STRESS, V19, P735, DOI 10.1002/jts.20150; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Lipschitz DS, 2005, J AM ACAD CHILD PSY, V44, P807, DOI 10.1097/01.chi.0000166379.60769.b6; Lommen MJJ, 2013, BEHAV RES THER, V51, P63, DOI 10.1016/j.brat.2012.11.004; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Ludewig K, 2002, SCHIZOPHR RES, V55, P129, DOI 10.1016/S0920-9964(01)00198-0; Ludewig S, 2005, J PSYCHIATR NEUROSCI, V30, P37; Ludewig S, 2002, DEPRESS ANXIETY, V15, P55, DOI 10.1002/da.10026; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McGhee LL, 2009, J BURN CARE RES, V30, P92, DOI 10.1097/BCR.0b013e3181921f51; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2013, JAMA PSYCHIAT, V70, P608, DOI 10.1001/jamapsychiatry.2013.914; Minassian A, 2014, PSYCHOSOM MED, V76, P292, DOI 10.1097/PSY.0000000000000056; Moon E, 2013, CLIN PSYCHOPHARM NEU, V11, P137, DOI 10.9758/cpn.2013.11.3.137; Morgan CA, 1997, AM J PSYCHIAT, V154, P1076; MORGAN CA, 1995, PSYCHOPHARMACOLOGY, V117, P466, DOI 10.1007/BF02246220; Muraoka MY, 1998, J TRAUMA STRESS, V11, P473, DOI 10.1023/A:1024400628342; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; ORNITZ EM, 1989, AM J PSYCHIAT, V146, P866; ORR SP, 1993, BIOL PSYCHIAT, V33, P127, DOI 10.1016/0006-3223(93)90312-2; Orr SP, 2002, PSYCHIAT CLIN N AM, V25, P271, DOI 10.1016/S0193-953X(01)00007-7; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; PALLMEYER TP, 1986, BEHAV RES THER, V24, P645, DOI 10.1016/0005-7967(86)90059-8; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Pietrzak RH, 2013, JAMA PSYCHIAT, V70, P1199, DOI 10.1001/jamapsychiatry.2013.399; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; PITMAN RK, 1993, PSYCHIAT RES, V48, P107, DOI 10.1016/0165-1781(93)90035-F; Pitman RK, 2006, ANN NY ACAD SCI, V1071, P242, DOI 10.1196/annals.1364.019; Pittig A, 2013, INT J PSYCHOPHYSIOL, V87, P19, DOI 10.1016/j.ijpsycho.2012.10.012; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Pole N, 2009, BIOL PSYCHIAT, V65, P235, DOI 10.1016/j.biopsych.2008.07.015; Price M, 2014, J CONSULT CLIN PSYCH, V82, P336, DOI 10.1037/a0035537; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Rabinak CA, 2013, NEUROPHARMACOLOGY, V64, P396, DOI 10.1016/j.neuropharm.2012.06.063; Rajan Sonali, 2012, J Mob Technol Med, V1, P25; Raskind MA, 2013, AM J PSYCHIAT, V170, P1003, DOI 10.1176/appi.ajp.2013.12081133; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Risbrough VB, 2006, HORM BEHAV, V50, P550, DOI 10.1016/j.yhbeh.2006.06.019; Robison-Andrew EJ, 2014, J ANXIETY DISORD, V28, P358, DOI 10.1016/j.janxdis.2014.04.002; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Sahar T, 2001, BIOL PSYCHIAT, V49, P637, DOI 10.1016/S0006-3223(00)01045-3; Shah AJ, 2013, BIOL PSYCHIAT, V73, P1103, DOI 10.1016/j.biopsych.2013.01.019; Shalev AY, 1998, ARCH GEN PSYCHIAT, V55, P553, DOI 10.1001/archpsyc.55.6.553; SHALEV AY, 1992, ARCH GEN PSYCHIAT, V49, P870; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sijbrandij M, 2013, J PSYCHIATR RES, V47, P1991, DOI 10.1016/j.jpsychires.2013.09.008; Solovieff N, 2014, NEUROPSYCHOPHARMACOL, V39, P1872, DOI 10.1038/npp.2014.34; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Suendermann O, 2010, PSYCHOSOM MED, V72, P301, DOI 10.1097/PSY.0b013e3181d07db8; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089455; Swerdlow NR, 2006, NEUROPSYCHOPHARMACOL, V31, P2011, DOI 10.1038/sj.npp.1301043; Tharion WJ, 2013, J SPORT HUMAN PERFOR; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vrana SR, 2013, PSYCHOPHARMACOLOGY, V230, P477, DOI 10.1007/s00213-013-3181-y; Wentworth BA, 2013, CARDIOL REV, V21, P16, DOI 10.1097/CRD.0b013e318265343b; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Williamson Jon B., 2013, FRONTIERS NEUROENGIN, V6, P1; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zao JK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00370; Zatzick DF, 2005, BIOL PSYCHIAT, V57, P91, DOI 10.1016/j.biopsych.2004.10.005; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	144	7	7	0	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1866-3370		978-3-319-12769-9; 978-3-319-12768-2	CURR TOP BEHAV NEURO	Cur. Top. Behav. Neurosci.		2014	21						157	183		10.1007/7854_2014_346	10.1007/978-3-319-12769-9		27	Psychology, Biological; Neurosciences; Psychiatry	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Psychiatry	BO7NN	WOS:000525319000007	25158622				2022-02-06	
J	Fuller, G; Woodford, M; Lawrence, T; Coats, T; Lecky, F				Fuller, Gordon; Woodford, Maralyn; Lawrence, Thomas; Coats, Timothy; Lecky, Fiona			DO PROLONGED PRIMARY TRANSPORT TIMES FOR TRAUMATIC BRAIN INJURY PATIENTS RESULT IN DETERIORATING PHYSIOLOGY? A COHORT STUDY	PREHOSPITAL EMERGENCY CARE			English	Article						craniocerebral trauma; emergency medical services; patient transfer; physiology; trauma centers; trauma systems	GLASGOW COMA SCALE; RESPONSE-TIME; CARE; SURVIVAL; CHILDREN; ENGLAND	Background. Recent interest has focused on reorganizing emergency medical services (EMS) for traumatic brain injury (TBI) patients, with bypass of nonspecialist hospitals and direct transportation to distant neuroscience centers. Although this could expedite neurosurgery and neurocritical care, deteriorating physiology could be deleterious. Methods. We performed a multicenter cohort study examining adult patients with significant TBI enrolled in the English National Trauma Registry. The distributions and correlation of first recorded prehospital and emergency department (ED) vital signs were compared, and the effect of time on changes in vital signs was examined in bivariate and multivariate analyses. Results. A total of 7149 eligible patients were studied. No clinically significant differences were apparent between distributions of prehospital and ED vital signs. Moderate linear correlation was observed for field and ED pulse rate (r(2) = 0.34) and GCS values (Spearman's rho = 0.76), with weak correlation apparent for systolic blood pressure (r(2) = 0.28) and respiratory rate (r(2) = 0.28). Eight percent of cases' vital signs deteriorated in the prehospital interval; however, odds of deterioration in vital sign status did not vary significantly with duration of EMS interval. Conclusion. The similarity between prehospital and ED vital signs, and lack of association between EMS interval and physiological deterioration, may support a strategy of direct transportation of TBI cases to specialist centers. Further research is necessary to identify patients at risk from deterioration during bypass and to investigate effects on mortality.	[Fuller, Gordon; Woodford, Maralyn; Lawrence, Thomas] Manchester Acad Hlth Sci Ctr, Hlth Sci Res Grp, Trauma Audit & Res Network, Salford, Lancs, England; [Coats, Timothy] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Emergency Med Acad Grp,Accid & Emergency Dept, Leicester, Leics, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England		Fuller, G (corresponding author), Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Trauma Audit & Res Network, Hlth Sci Res Grp, Mayo Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	gor-donwfuller@doctors.net.uk	Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784; Lawrence, Thomas/0000-0003-3648-7634; Fuller, Gordon Ward/0000-0001-8532-3500	National Institute for Health ResearchNational Institute for Health Research (NIHR) [DRF-2011-04-050] Funding Source: researchfish; Department of HealthEuropean Commission [DRF-2011-04-050] Funding Source: Medline		American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP P, V7; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Blackwell TH, 2002, ACAD EMERG MED, V9, P288, DOI 10.1111/j.1553-2712.2002.tb01321.x; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Committee on Injury Scaling, 2005, ABBR INJ SCAL 2005 R; Department of Health, HOSP EP STAT; Di Bartolomeo S, 2007, INJURY, V38, P305, DOI 10.1016/j.injury.2006.10.005; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; Fuller G, J NEUROSURG ANESTHES, V23, P198; Houston R, 2012, EMERG MED J, V29, P309, DOI 10.1136/emj.2011.112110; IVATURY RR, 1987, J TRAUMA, V27, P1066, DOI 10.1097/00005373-198709000-00019; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Mackinnon A, 2010, J INTERN MED, V268, P586, DOI 10.1111/j.1365-2796.2010.02274.x; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Newgard CD, 2011, J AM COLL SURGEONS, V213, P709, DOI 10.1016/j.jamcollsurg.2011.09.012; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; O'Reilly GM, 2012, INJURY, V43, P1917, DOI 10.1016/j.injury.2012.07.185; Office for National Statistics, 2005, MORT STAT CAUS SEX A; Osterwalder Joseph J, 2002, Prehosp Disaster Med, V17, P75; Pons PT, 2005, ACAD EMERG MED, V12, P594, DOI 10.1197/j.aem.2005.02.013; Pons PT, 2002, J EMERG MED, V23, P43, DOI 10.1016/S0736-4679(02)00460-2; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sleat G, 2011, INJURY, V42, P838, DOI 10.1016/j.injury.2011.05.014; Smith RM, 2009, INJURY, V40, pS23, DOI 10.1016/j.injury.2009.10.033; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; SZKLO M, 2000, EPIDEMIOLOGY BASICS; Vondy A, 2011, EMERG MED J, V28, P250, DOI 10.1136/emj.2010.101022; Yates D, 1997, BRIT MED J, V315, P1321, DOI 10.1136/bmj.315.7119.1321	32	7	7	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN-MAR	2014	18	1					60	67		10.3109/10903127.2013.831507			8	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	270OO	WOS:000328328200009	24112033				2022-02-06	
J	Gendreau, A; de la Sablonniere, R				Gendreau, Anne; de la Sablonniere, Roxane			The cognitive process of identity reconstruction after the onset of a neurological disability	DISABILITY AND REHABILITATION			English	Article						Identity; spinal cord injury; temporal continuity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DUAL PROCESS MODEL; SELF-CONCEPT; EXPERIENCE; WELL; REHABILITATION; BEREAVEMENT; RESILIENCE; PREDICTORS; ADULTS	Purpose: Rehabilitation professionals and researchers underscore the impact of an acquired disability on identity. However, the cognitive process by which identity is transformed is understudied. The present study aims to explore the cognitive process by which personal identity is reconstructed following disability onset. Methods: A template organizing style of interpretation was used to perform a qualitative analysis based on the Cognitive-Developmental Model of Social Identity Integration (CDMSII) using interview data from 10 participants with traumatic brain injury or traumatic spinal cord injury. Results: As suggested by the CDMSII, following the accident, participants initially tend to emphasize distinctions between their pre- and post-injury conditions. Eventually, individuals are able to create cognitive connections between pre-injury self-knowledge and how they understand their new condition. Finally, in the last stage of the identity integration process, the various identity components are recognized as part of the self. Organizing data based on the three stages of this theory was found to resonate with participants and aided the comprehension of how every stage in the identity reconstruction process is intertwined with the need for continuity through life. Conclusions: The CDMSII offers a useful heuristic for understanding long-term identity reconstruction and the present research emphasizes the importance of a sense of continuity following disability onset.	[Gendreau, Anne] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [de la Sablonniere, Roxane] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada		Gendreau, A (corresponding author), Univ Quebec, Dept Psychol, CP 8888 Succursale Ctr Ville,Room DS-4929, Montreal, PQ H3C 3P8, Canada.	gendreau.anne@courrier.uqam.ca					Amiot CE, 2007, PERS SOC PSYCHOL REV, V11, P364, DOI 10.1177/1088868307304091; Bernier P, 1999, REV QUE PSYCHOL, V20, P111; Bluck S, 2005, SOC COGNITION, V23, P91, DOI 10.1521/soco.23.1.91.59198; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Breakwell, 1986, COPING THREATENED ID; Breakwell G., 1983, THREATENED IDENTITIE; Breakwell GM, 1993, PAPERS SOC REPRESENT, V2, P198, DOI DOI 10.1017/CB09781139136983.010; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Calhoun, 1995, TRAUMA TRANSFORMATIO; Chandler M. J., 2008, SELF CONTINUITY INDI, P213; Chun S, 2013, DISABIL REHABIL, V35, P11, DOI 10.3109/09638288.2012.687026; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Concha-Barrientos M, 2005, AM J IND MED, V48, P470, DOI 10.1002/ajim.20226; CORBIN J, 1987, RES SOCIOLOGY HLTH C, V6, P249, DOI DOI 10.1046/J.1365-2648.2001.01767.X; Cote J, 2006, IDENTITY, V6, P3, DOI 10.1207/s1532706xid0601_2; Crabtree B. F., 1999, DOING QUALITATIVE RE, V2, P163; Cummins R.A., 2002, J HAPPINESS STUD, V3, P37, DOI [10.1023/A:1015678915305, DOI 10.1023/A:1015678915305, 10.1023/A%3A1015678915305]; Diehl M, 2006, J ADULT DEV, V13, P10, DOI 10.1007/s10804-006-9001-4; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; FISCHER KW, 1980, PSYCHOL REV, V87, P477, DOI 10.1037/0033-295X.87.6.477; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Greenstein M, 2000, AM J PSYCHOTHER, V54, P486, DOI 10.1176/appi.psychotherapy.2000.54.4.486; Harter S., 1999, CONSTRUCTION SELF; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; HEWITT JP, 1991, SELF SOC SYMBOLIC IN; Hinkebein J. H., 2007, COPING CHRONIC ILLNE, P389, DOI DOI 10.1007/978-0-387-48670-3_18; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lucas RE, 2007, J PERS SOC PSYCHOL, V92, P717, DOI 10.1037/0022-3514.92.4.717; Mancini AD, 2006, J CLIN PSYCHOL, V62, P971, DOI 10.1002/jclp.20283; MARKUS H, 1987, ANNU REV PSYCHOL, V38, P299, DOI 10.1146/annurev.ps.38.020187.001503; Martz E, 2007, COPING CHRONIC ILLNE, P389; MAYER JD, 1982, J CONSULT CLIN PSYCH, V50, P604; Mayring P., 2007, FORUM QUAL SOC RES, V8; Murray CD, 2004, DISABIL REHABIL, V26, P808, DOI 10.1080/09638280410001696746; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pagan-Rodriguez R, 2010, EUR J HEALTH ECON, V11, P471, DOI 10.1007/s10198-009-0184-z; Preston Julia, 2013, NY TIMES; Rathbone CJ, 2008, MEM COGNITION, V36, P1403, DOI 10.3758/MC.36.8.1403; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; Rybarczyk BD, 2002, BODY IMAGE: A HANDBOOK OF THEORY, RESEARCH, AND CLINICAL PRACTICE, P387; Sani F., 2008, SELF CONTINUITY INDI; Seymour W., 2002, J OCCUP SCI, V9, P1135; Sharma S, 2010, PSYCHOL STUD, V55, P118, DOI DOI 10.1007/S12646-010-0011-8; Skell RL, 2000, BRAIN INJURY, V14, P705; Smith B, 2005, SOC SCI MED, V61, P1095, DOI 10.1016/j.socscimed.2005.01.011; Stergiou-Kita M, 2012, DISABIL REHABIL, V34, P179, DOI 10.3109/09638288.2011.591881; Stets JE, 2000, SOC PSYCHOL QUART, V63, P224, DOI 10.2307/2695870; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Stroebe M, 2010, OMEGA-J DEATH DYING, V61, P273, DOI 10.2190/OM.61.4.b; Watson N, 2002, DISABIL SOC, V17, P509, DOI 10.1080/09687590220148496; Weinreich P., 2003, ANAL IDENTITY CROSS; WHO, 2004, WORLD REPORT ROAD TR; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; YOSHIDA KK, 1993, SOCIOL HEALTH ILL, V15, P217, DOI 10.1111/1467-9566.ep11346888	57	7	7	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	19					1608	1617		10.3109/09638288.2013.859749			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AP6QH	WOS:000342201800005	24286233				2022-02-06	
S	Hatzfeld, JJ; Dukes, S; Bridges, E		Kelley, PW		Hatzfeld, Jennifer J.; Dukes, Susan; Bridges, Elizabeth			Innovations in the En Route Care of Combat Casualties	ANNUAL REVIEW OF NURSING RESEARCH, VOL 32: MILITARY AND VETERAN INNOVATIONS OF CARE	Annual Review of Nursing Research-Series		English	Article; Book Chapter							OPERATIONS ENDURING FREEDOM; OXYGEN-SATURATION PREDICTS; MILITARY TRAUMA SYSTEM; OF-THE-LITERATURE; IRAQI FREEDOM; BRAIN-INJURY; FLUID RESPONSIVENESS; PAIN MANAGEMENT; AIR TRANSPORT; SPINE SURGERY	The en route care environment is dynamic and requires constant innovation to ensure appropriate nursing care for combat casualties. Building on experiences in Iraq and Afghanistan, there have been tremendous innovations in the process of transporting patients, including the movement of patients with spinal injuries. Advances have also been made in pain management and noninvasive monitoring, particularly for trauma and surgical patients requiring close monitoring of their hemodynamic and perfusion status. In addition to institutionalizing these innovations, future efforts are needed to eliminate secondary insults to patients with traumatic brain injuries and technologies to provide closed-loop sedation and ventilation.	[Hatzfeld, Jennifer J.] US Air Force, Ft Detrick, MD 21702 USA; [Dukes, Susan] US Air Force, Sch Aerosp Med, Wright Patterson AFB, OH USA; [Bridges, Elizabeth] US Air Force, Headquarters US Air Force SG1N, Falls Church, VA USA; [Bridges, Elizabeth] Univ Washington, Sch Nursing, Seattle, WA 98195 USA		Hatzfeld, JJ (corresponding author), US Air Force, Ft Detrick, MD 21702 USA.						Aldington DJ, 2011, PHILOS T R SOC B, V366, P268, DOI 10.1098/rstb.2010.0214; Apodaca A, 2013, J TRAUMA ACUTE CARE, V75, pS157, DOI 10.1097/TA.0b013e318299da3e; Applegate R., 2013, 2013 ANN M INT AN RE; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P22; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P18; Arney D., 2010, CYB PHYS SYST ICCPS; Bailey JA, 2013, CURR OPIN CRIT CARE, V19, P569, DOI 10.1097/MCC.0000000000000037; Baulig W, 2013, EUR J ANAESTHESI S51, V30, P50; Beekley AC, 2010, J TRAUMA, V69, pS14, DOI 10.1097/TA.0b013e3181e42326; Beilman Greg J, 2009, World J Emerg Surg, V4, P25, DOI 10.1186/1749-7922-4-25; Berkow L, 2011, ANESTH ANALG, V113, P1396, DOI 10.1213/ANE.0b013e318230b425; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS388, DOI 10.1097/TA.0b013e31827548df; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS378, DOI 10.1097/TA.0b013e3182754900; Blair JA, 2012, SPINE J, V12, P824, DOI 10.1016/j.spinee.2011.09.012; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Bridges E, 2013, CRIT CARE MED S0, V41, pA67; Bridges E, 2012, AM J CRIT CARE, V21, pe84; Bridges E., 2011, CRITICAL CARE MED S, V39, P111; Bridges E, 2013, AM J NURS, V113, P42, DOI 10.1097/01.NAJ.0000429754.15255.eb; Bridges E, 2009, MIL MED, V174, P370, DOI 10.7205/MILMED-D-03-9607; Buckenmaier C, 2008, MILITARY ADV REGIONA; Buckenmaier CC, 2009, PAIN MED, V10, P1487, DOI 10.1111/j.1526-4637.2009.00731.x; Burggraf M., 2009, STO SHOCK C VIENN AU; Burns S, 2013, MED ACUPUNCT, V25, P48, DOI 10.1089/acu.2012.0933; Carter G, 1988, J Emerg Med, V6, P499, DOI 10.1016/0736-4679(88)90408-8; Carter G., J EMERGENCY MED, V6, P499; Carter TE, 2010, INT ANESTHESIOL CLIN, V48, P123, DOI 10.1097/AIA.0b013e3181dd4f33; Chairman of the Joint Chiefs of Staff, 2012, HLTH SERV SUPP JOINT; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Cohn SM, 2007, J TRAUMA, V62, P44, DOI 10.1097/TA.0b013e31802eb817; Convertino Victor A, 2007, J Gravit Physiol, V14, pP39; Convertino VA, 2008, J TRAUMA, V64, pS342, DOI 10.1097/TA.0b013e31816c82f4; Dukes S., 2013, MIL HLTH SYST RES S; Dukes SF, 2013, MIL MED, V178, P11, DOI 10.7205/MILMED-D-12-00177; Fang R, 2011, J TRAUMA, V71, pS91, DOI 10.1097/TA.0b013e3182218f97; Fang R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1043; Fast M, 2008, J EMERG NURS, V34, P301, DOI 10.1016/j.jen.2007.08.021; Fleming Mark, 2012, J Surg Orthop Adv, V21, P32; Gentry C., 2010, 116 ANN M AMSUS SOC; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Guyette FX, 2012, J TRAUMA ACUTE CARE, V72, P930, DOI 10.1097/TA.0b013e31823d0677; Hatzfeld J., 2013, 118 ANN M AMSUS SOC; Hickman B J, 2001, Air Med J, V20, P6, DOI 10.1016/S1067-991X(01)70002-8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holland SR, 2013, MIL MED, V178, P529, DOI 10.7205/MILMED-D-12-00286; Joint Theater Trauma System, 2013, MANAGEMENT PAIN ANXI; Joint Theater Trauma System, 2012, CERVICAL THORACOLUMB; Lyon RM, 2013, EMERG MED J, V30, P506, DOI 10.1136/emermed-2012-201411; Malchow RJ, 2008, CRIT CARE MED, V36, pS346, DOI 10.1097/CCM.0b013e31817e2fc9; Malsby RF, 2013, MIL MED, V178, P785, DOI 10.7205/MILMED-D-13-00047; Manring MM, 2009, CLIN ORTHOP RELAT R, V467, P2168, DOI 10.1007/s11999-009-0738-5; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; Mason PE, 2011, J EMERG MED, V41, P8, DOI 10.1016/j.jemermed.2008.06.032; Miller RD, 2011, ANESTH ANALG, V112, P858, DOI 10.1213/ANE.0b013e31820eecd1; Mok JM, 2013, SPINE J, V13, P1801, DOI 10.1016/j.spinee.2013.05.028; Moore FA, 2008, J TRAUMA, V64, P1010, DOI 10.1097/TA.0b013e31816a2417; Morrison JJ, 2013, ANN SURG, V257, P330, DOI 10.1097/SLA.0b013e31827eefcf; Nagra Michael, 2011, US Army Med Dep J, P51; Ninkovic J, 2013, AMINO ACIDS, V45, P9, DOI 10.1007/s00726-011-1163-0; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Patzkowski JC, 2012, SPINE J, V12, P791, DOI 10.1016/j.spinee.2011.10.001; Pfennig P., 2008, 79 ANN SCI M AER MED; Rasmussen TE, 2013, J TRAUMA ACUTE CARE, V75, pS105, DOI 10.1097/TA.0b013e3182a0707b; Ricks M., 2012, AIR FORCE TIMES 0602; Sandroni C, 2012, INTENS CARE MED, V38, P1429, DOI 10.1007/s00134-012-2621-1; Soller BR, 2012, J TRAUMA ACUTE CARE, V73, pS106, DOI 10.1097/TA.0b013e318260a928; Stojadinovic A, 2006, PAIN MED, V7, P330, DOI 10.1111/j.1526-4637.2006.00171.x; Vice Chairman of the Joint Chiefs of Staff, 2012, TACT CRIT CAR TRANSP; Wu JJ, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/713281	74	7	7	0	2	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2809-6; 978-0-8261-2807-2	ANNU REV NURS RES-SE			2014	32						41	62		10.1891/0739-6686.32.41			22	Nursing	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Nursing	BI5YJ	WOS:000412974700004	25222537				2022-02-06	
S	Henry, LC		Niranjan, A; Lunsford, LD		Henry, Luke C.			Understanding Concussive Injuries Using Investigational Imaging Methods	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; MILD HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; WORKING-MEMORY DYSFUNCTION; SPORTS-RELATED CONCUSSION; CENTRAL-NERVOUS-SYSTEM; DIFFUSE AXONAL INJURY; CEREBRAL-BLOOD-FLOW; COMPUTED-TOMOGRAPHY	Concussions have long been understood to be an invisible injury. Indeed, conventional imaging techniques [computed tomography and magnetic resonance imaging (MRI)] are largely ineffective in elucidating concussive injuries. More advanced techniques are being used experimentally to help delineate the underlying pathophysiology of concussive injuries on metabolic as well as ultrastructural levels. The current report reviews the data from several of these techniques including functional MRI, single-photon emission computed tomography, positron emission tomography, diffusion tensor imaging, and magnetic resonance spectroscopy. Each technique is briefly described, followed by a summary of the findings specific to concussive injuries. Overall, there is mounting evidence to suggest that each technique has utility in describing and explaining postinjury changes in the brain. Overall, concussive injuries are evident using the various aforementioned neuroimaging modalities and suggest at a minimum the concussed brain is different in the acute and subacute postinjury phases with several other studies suggesting that changes are persistent well beyond, especially in those patients with persistent symptoms. (C) 2014 S. Karger AG, Basel	Univ Pittsburgh, UPMC Sports Concuss Program, Pittsburgh, PA 15203 USA		Henry, LC (corresponding author), Univ Pittsburgh, UPMC Sports Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA.	henryl@upmc.edu					Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Abu-Judeh HH, 1998, J NUCL MED, V39, P1357; Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Barr M, 2005, HUMAN NERVOUS SYSTEM, P470; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GRAY BG, 1992, J NUCL MED, V33, P52; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hadel S, 2013, J MAGN RESON IMAGING, V38, P1480, DOI 10.1002/jmri.24123; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; ICHISE M, 1994, J NUCL MED, V35, P217; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jacobs A, 1996, J NUCL MED, V37, P1605; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Kandel ER, 2000, PRINCIPLES NEURAL SC, P1414; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCALLISTER TW, 1992, COMPR PSYCHIAT, V33, P296, DOI 10.1016/0010-440X(92)90036-P; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2008, ACTA NEUROCHIR SUPPL, V102, P247, DOI 10.1007/978-3-211-85578-2_47; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; TAYLOR DL, 1994, J NEUROCHEM, V62, P2349; Toga A.W., 2002, BRAIN MAPPING METHOD, Vsecond; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Umile EM, 1998, BRAIN INJURY, V12, P577; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Urazaev AK, 2001, NEUROSCIENCE, V106, P237, DOI 10.1016/S0306-4522(01)00270-6; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940	92	7	7	0	4	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						63	74		10.1159/000358763	10.1159/isbn.978-3-318-02649-8		12	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000007	24923393				2022-02-06	
J	Katz-Leurer, M; Zohar, N; Boum, A; Keren, O				Katz-Leurer, Michal; Zohar, Naama; Boum, Arava; Keren, Ofer			Monitoring changes in heart rate, as an indicator of the cardiovascular autonomic nervous function, among patients at the sub-acute phase post-brain damage during a physiotherapy session: A preliminary investigation	BRAIN INJURY			English	Article						Autonomic nervous system; heart rate variability; physiotherapy; stroke; traumatic brain injury	RATE-VARIABILITY; INJURY; STROKE	Objectives: To assess cardiovascular autonomic nervous system function of patients post-brain-injury in the sub-acute phase during a physiotherapy session (PTS). Participants: Fourteen patients post-ischaemic stroke and 11 post-severe traumatic brain injuries. Intervention: Continuous electrocardiogram recording at rest, during active cycling and during routine PTS. Main outcome measure: Heart rate (HR) and Heart rate variability (HRV) parameters included the standard deviation of all R-R intervals (SDNN), the square root of the mean squared differences of successive differences (RMSSD), the Low-frequency (LF) power, High-frequency (HF) power and the LF/HF ratio. Results: The median HR at rest was 76 bpm (interquartile range 61-81). Significant increments were noted during activities; median HR during cycling was 93 bpm, during the most intense activity 91 bpm (p-value<0.001). A significant decline in HRV parameters' median values during cycling and PTS was observed only among patients post-stroke. Conclusions: Among patients post-brain injury, HR increased significantly during PTS in different activities and varied positions; therefore, therapists should be aware and monitor HR frequently during training. In addition, HRV values were low at rest and did not respond to activity among patients post-TBI, compared with higher values at rest and some response among patients post-stroke. This may indicate that autonomic impairment post-brain insult is more likely a consequence of central nervous system damage and less likely a result of pre-event cardiovascular illness.	[Katz-Leurer, Michal; Keren, Ofer] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel; [Zohar, Naama; Boum, Arava] Chaim Sheba Med Ctr, Brain Injury Rehabil Dept, IL-52621 Tel Hashomer, Israel; [Keren, Ofer] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il		Ron Baum, Arava/0000-0002-8384-8626			Baert I, 2012, DISABIL REHABIL, V34, P574, DOI 10.3109/09638288.2011.613513; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Camm AJ, 1996, CIRCULATION, V93, P1043; Gage WH, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-41; Hassett LM, 2008, COCHRANE DB SYST REV, V2, P1; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; Lennon S, 2000, DISABIL REHABIL, V22, P833, DOI 10.1080/09638280050207884; Lincoln N B, 1989, Int Disabil Stud, V11, P149; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1378, DOI 10.1053/apmr.2002.35089; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; ROTH EJ, 1994, ARCH PHYS MED REHAB, V75, P94; Tinson D J, 1989, Int Disabil Stud, V11, P45; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; WOLFE CDA, 1991, STROKE, V22, P1242, DOI 10.1161/01.STR.22.10.1242	21	7	7	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					127	131		10.3109/02699052.2013.848381			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700016	24328738				2022-02-06	
J	Krause, MO; Kennedy, MRT; Nelson, PB				Krause, Miriam O.; Kennedy, Mary R. T.; Nelson, Peggy B.			Masking release, processing speed and listening effort in adults with traumatic brain injury	BRAIN INJURY			English	Article						Head injury; sentence repetition; speech processing	COCHLEAR IMPLANT USERS; HEARING-LOSS; HEAD-INJURY; EXECUTIVE FUNCTION; DIVIDED ATTENTION; SEX-DIFFERENCES; DEFICITS; MEMORY; PERCEPTION; CHILDREN	Purpose: This preliminary study explored differences between adults with and without traumatic brain injury (TBI) for speech processing accuracy, processing speed and effort in various conditions of interference. Methods: Ten adults with TBI and six adults without TBI participated. Speech processing was studied using sentence repetition in six listening conditions with different types of interference, including noise and two simultaneous talkers. Participants repeated sentences and rated effort. Participants also completed standardized tests of cognition, including working memory and processing speed measures. Results: Sentence repetition accuracy did not differ between groups. However, the TBI group demonstrated slower processing speed than the control group and also reported significantly greater effort in the two-talker condition. Faster processing speed was also correlated with higher accuracy in the two-talker condition. Conclusions: Results of this study show group similarities in repetition accuracy across listening conditions, but group differences in speed and effort. This preliminary finding, as well as the relationship between processing speed and repetition accuracy, suggests that it is only in the most complex listening conditions that the effects of brain injury may be detectable.	[Krause, Miriam O.] Bowling Green State Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA; [Kennedy, Mary R. T.; Nelson, Peggy B.] Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN USA		Krause, MO (corresponding author), Bowling Green State Univ, Dept Commun Sci & Disorders, 200 Hlth Ctr Bldg, Bowling Green, OH 43403 USA.	miriamk@bgsu.edu	Krause, Miriam/AAD-1197-2022	Krause, Miriam/0000-0002-6798-3991	University of Minnesota Graduate Research Partnership Program (GRPP)University of Minnesota System; Bryng Bryngleson Fund	The authors report no conflicts of interest. This research was funded by the University of Minnesota Graduate Research Partnership Program (GRPP) and the Bryng Bryngleson Fund.	Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bacon SP, 1998, J SPEECH LANG HEAR R, V41, P549, DOI 10.1044/jslhr.4103.549; Body R., 1999, BRAIN DAM B; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Clark H. M., 1995, AM J SPEECH-LANG PAT, V4, P143, DOI DOI 10.1044/1058-0360.0404.143; Delis D.C., 2000, CALIFORNIA VERBAL LE; Desjardins JL, 2011, THESIS SYRACUSE U, P1; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duffy JR., 2013, MOTOR SPEECH DISORDE; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Giraud AL, 2004, CEREB CORTEX, V14, P247, DOI 10.1093/cercor/bhg124; Girden E. R., 1992, ANOVA REPEATED MEASU; Gosselin PA, 2011, J SPEECH LANG HEAR R, V54, P944, DOI 10.1044/1092-4388(2010/10-0069); GUSTAFSSON HA, 1994, J ACOUST SOC AM, V95, P518, DOI 10.1121/1.408346; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Howells FM, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-39; IEEE, IEEE T AUDIO ELECTRO; Jansma JM, 2007, HUM BRAIN MAPP, V28, P431, DOI 10.1002/hbm.20297; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Keil K, 2002, APHASIOLOGY, V16, P305, DOI 10.1080/02687030143000654; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Koelewijn T, 2012, EAR HEARING, V33, P291, DOI 10.1097/AUD.0b013e3182310019; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Larsby B, 2005, INT J AUDIOL, V44, P131, DOI 10.1080/14992020500057244; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lorenzi C, 2006, INT J AUDIOL, V45, P487, DOI 10.1080/14992020600753213; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mather N., 2001, WOODCOCK JOHNSON 3 T; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McFadden D, 1998, DEV NEUROPSYCHOL, V14, P261, DOI 10.1080/87565649809540712; Murdoch BE, 2012, BRAIN INJURY, V26, P241, DOI 10.3109/02699052.2011.650664; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; Neff DL, 1996, J ACOUST SOC AM, V100, P2547, DOI 10.1121/1.417364; Nelson H.E., 1982, NATL ADULT READING T; Nelson PB, 2003, J ACOUST SOC AM, V113, P961, DOI 10.1121/1.1531983; Nelson PB, 2004, J ACOUST SOC AM, V115, P2286, DOI 10.1121/1.1703538; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [DOI 10.1044/1058-0360.0403.69, 10.1044/1058-0360.0403.69]; Noppeney U, 2004, J COGNITIVE NEUROSCI, V16, P702, DOI 10.1162/089892904323057399; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Oxenham AJ, 2003, J ACOUST SOC AM, V114, P1543, DOI 10.1121/1.1598197; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS59; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rajan R, 2008, NEUROSCIENCE, V154, P784, DOI 10.1016/j.neuroscience.2008.03.067; Rakerd B, 1996, EAR HEARING, V17, P97, DOI 10.1097/00003446-199604000-00002; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Robertson I., 1994, TEST EVERYDAY ATTENT; Sarampalis A, 2009, J SPEECH LANG HEAR R, V52, P1230, DOI 10.1044/1092-4388(2009/08-0111); Schneider BA, 2007, J AM ACAD AUDIOL, V18, P559, DOI 10.3766/jaaa.18.7.4; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TUN PA, 1992, PSYCHOL AGING, V7, P546, DOI 10.1037/0882-7974.7.4.546; Tun PA, 2012, AM J AUDIOL, V21, P344, DOI 10.1044/1059-0889(2012/12-0030); Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VELOSO K, 1990, J SPEECH HEAR RES, V33, P96, DOI 10.1044/jshr.3301.96; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; Waters G, 2005, MEMORY, V13, P403, DOI 10.1080/09658210344000459; Weschler D, 1997, WMS 3 WECHSLER MEMOR; Ziegler JC, 2011, J EXP CHILD PSYCHOL, V110, P362, DOI 10.1016/j.jecp.2011.05.001	77	7	7	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1473	1484		10.3109/02699052.2014.920520			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200017	24960589				2022-02-06	
J	Liu, TC				Liu, Tie-Cheng			Influence of Propofol, Isoflurane and Enflurance on Levels of Serum Interleukin-8 and Interleukin-10 in Cancer Patients	ASIAN PACIFIC JOURNAL OF CANCER PREVENTION			English	Article						Propofol; isoflurane; enflurance; tumor; traumatic inflammation; cytokines; interleukin-8; interleukin-10	PRO-INFLAMMATORY CYTOKINES; TRAUMATIC BRAIN-INJURY; ANTIINFLAMMATORY CYTOKINES; SURGICAL-PATIENTS; CARDIAC-SURGERY; GASTRIC-CANCER; BREAST-CANCER; ANESTHESIA; RATS; OXIDE	Objective: To observe the influence of propofol, isoflurane and enflurance on interleukin-8 (IL-8) and IL-10 levels in cancer patients. Methods: Ninety cancer patients with selective operation from March 2011 to May 2014 were randomly divided into group A (34 cases), group B (28 cases) and group C (28 cases). Intramuscular injections of scopine hydrochloride and phenobarbital sodium were routinely conducted to 3 groups. After general anesthesia was induced, tracheal intubations were given. During the maintenance of anesthesia, 0.5 similar to 1.0 mg/kg propofol was intravenously injected to group A discontinuously, while continuous suctions of isoflurane and enflurance were subsequently performed to group B and C correspondingly. Clinical outcomes, postoperative complications as well as serum IL-8 and IL-10 levels before operation (T0), at the time of skin incision (T1), 3 h after the beginning of the operation (T2) and 24 h (T3) and 72 h (T4) after the operation were observed among 3 groups. Results: Operations in all groups were successfully completed. The rates of surgery associated complications were 8.82% (3/34), 7.14% (2/28) and 7.14% (2/28) in group A, B and C, respectively, and there were no significant differences (P>0.05). Serum IL-8 and IL-10 levels increased gradually from the beginning of the operation and reached the peak at T3, and were evidently higher at each time point than at T0 (P<0.01). At T1, serum IL-8 and IL-10 levels had no significant differences among 3 groups (P>0.05), but the differences were significant at T2, T3 and T4 (P<0.05). Moreover, correlation analysis suggested that serum IL-8 level was in positive relation with IL-10 level (r=0.952, P<0.01). Conclusions: Propofol, which is better in inhibiting serum IL-8 secretion and improving IL-10 secretion than isoflurane and enflurance, can be regarded as a preferable anesthetic agent in inhibiting traumatic inflammatory responses.	Jilin Univ, Hosp 2, Dept Anesthesiol, Changchun, Jilin, Peoples R China		Liu, TC (corresponding author), Jilin Univ, Hosp 2, Dept Anesthesiol, Changchun, Jilin, Peoples R China.	liutiechengliutiecheng@126.com					Allahtavakoli M, 2011, BRAIN RES BULL, V85, P219, DOI 10.1016/j.brainresbull.2011.03.019; Baki ED, 2013, INFLAMMATION, V36, P1327, DOI 10.1007/s10753-013-9671-6; Cavalca V, 2008, ANESTHESIOLOGY, V108, P988, DOI 10.1097/ALN.0b013e318173efb4; Dermitzaki E, 2009, INT J OBSTET ANESTH, V18, P33, DOI 10.1016/j.ijoa.2008.07.005; Ekin A, 2013, REV BRAS ANESTESIOL, V63, P410, DOI [10.1016/j.bjan.2012.07.012, 10.1016/j.bjane.2012.07.013]; Franca EL, 2013, ASIAN PAC J CANCER P, V14, P6233, DOI 10.7314/APJCP.2013.14.11.6233; Gabel J, 2013, EUR J CARDIO-THORAC, V44, P506, DOI 10.1093/ejcts/ezt019; Gonzalez-Correa JA, 2008, N-S ARCH PHARMACOL, V376, P331, DOI 10.1007/s00210-007-0220-4; Guo JR, 2014, ASIAN PAC J CANCER P, V15, P467, DOI 10.7314/APJCP.2014.15.1.467; Hofstetter C, 2005, INT IMMUNOPHARMACOL, V5, P1519, DOI 10.1016/j.intimp.2005.04.008; Jawa Randeep S, 2011, J Intensive Care Med, V26, P3, DOI 10.1177/0885066610395678; Jin YW, 2013, EXP THER MED, V6, P781, DOI 10.3892/etm.2013.1194; Kma L, 2014, ASIAN PAC J CANCER P, V15, P2405, DOI 10.7314/APJCP.2014.15.6.2405; Kumakura S, 2013, MOL MED REP, V8, P1643, DOI 10.3892/mmr.2013.1745; Kusku A, 2014, REV BRAS ANESTESIOL, V64, P241, DOI [10.1016/j.bjane.2013.06.012, 10.1016/j.bjan.2013.06.013]; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Lisowska B, 2013, POSTEP HIG MED DOSW, V67, P761; Lopez-Astacio RA, 2012, FASEB J, V2012, plb835; Lu K, 2014, ASIAN PAC J CANCER P, V15, P1057, DOI 10.7314/APJCP.2014.15.2.1057; de Lima FM, 2011, LASER SURG MED, V43, P410, DOI 10.1002/lsm.21053; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; Mawhinney LJ, 2012, BRAIN RES, V1431, P23, DOI 10.1016/j.brainres.2011.11.004; Pandurangan AK, 2014, ASIAN PAC J CANCER P, V15, P551, DOI 10.7314/APJCP.2014.15.2.551; Reikeras O, 2010, INFLAMM RES, V59, P409, DOI 10.1007/s00011-010-0167-7; ?rnek, 2014, J EXP CLIN MED, V6, P83; Schilling T, 2011, ANESTHESIOLOGY, V115, P65, DOI 10.1097/ALN.0b013e318214b9de; Shen B, 2013, ASIAN PAC J CANCER P, V14, P5403, DOI 10.7314/APJCP.2013.14.9.5403; Soliman NA, 2014, ASIAN PAC J CANCER P, V15, P837, DOI 10.7314/APJCP.2014.15.2.837; Sun TS, 2011, INJURY, V42, P707, DOI 10.1016/j.injury.2011.01.010; Taniguchi T, 2002, CRIT CARE MED, V30, P904, DOI 10.1097/00003246-200204000-00032; Tylman M, 2011, MINERVA ANESTESIOL, V77, P275; Veenhof AAFA, 2011, INT J COLORECTAL DIS, V26, P53, DOI 10.1007/s00384-010-1056-9; Verit FF, 2013, ASIAN PAC J CANCER P, V14, P5589, DOI 10.7314/APJCP.2013.14.10.5589; Ward JL, 2011, J TRAUMA, V70, P1471, DOI 10.1097/TA.0b013e31821c38bd; Yang L, 2013, ASIAN PAC J CANCER P, V14, P7467, DOI 10.7314/APJCP.2013.14.12.7467; Yu DP, 2014, ASIAN PAC J CANCER P, V15, P2685, DOI 10.7314/APJCP.2014.15.6.2685; Zhao YH, 2013, ASIAN PAC J CANCER P, V14, P5513, DOI 10.7314/APJCP.2013.14.9.5513; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	38	7	7	0	5	ASIAN PACIFIC ORGANIZATION CANCER PREVENTION	GYEONGGI-DO	APJCP HEAD OFFICE, KOREAN NATL CANCER CENTER, 323 ILAN -RO, ILSANDONG-GU, GOYANG-SI, GYEONGGI-DO, 410-769, SOUTH KOREA	1513-7368			ASIAN PAC J CANCER P	Asian Pac. J. Cancer Prev.		2014	15	16					6703	6707		10.7314/APJCP.2014.15.16.6703			5	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	AR8NY	WOS:000343832900041	25169512	gold			2022-02-06	
J	Mahajan, HP; Spaeth, DM; Dicianno, BE; Brown, K; Cooper, RA				Mahajan, Harshal P.; Spaeth, Donald M.; Dicianno, Brad E.; Brown, Karl; Cooper, Rory A.			Preliminary evaluation of a variable compliance joystick for people with multiple sclerosis	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						fatigue; joystick; MS; multiple sclerosis; outcome measures; tremor filter; variable compliance joystick; virtual reality; wheelchair; wheelchair driving	WHEELCHAIR DRIVING PERFORMANCE; TRAUMATIC BRAIN-INJURY; ASSISTIVE TECHNOLOGY; POWERED WHEELCHAIR; TREMOR; INDIVIDUALS; SIMULATOR; MOBILITY; FATIGUE; DISABILITIES	Upper-limb fatigue is a common problem that may restrict people with multiple sclerosis (MS) from using their electric powered wheelchair effectively and for a long period of time. The objective of this research is to evaluate whether participants with MS can drive better with a variable compliance joystick (VCJ) and customizable algorithms than with a conventional wheelchair joystick. Eleven participants were randomly assigned to one of two groups. The groups used the VCJ in either compliant or noncompliant isometric mode and a standard algorithm, personally fitted algorithm, or personally fitted algorithm with fatigue adaptation running in the background in order to complete virtual wheelchair driving tasks. Participants with MS showed better driving performance metrics while using the customized algorithms than while using the standard algorithm with the VCJ. Fatigue adaptation algorithms are especially beneficial in improving overall task performance while using the VCJ in isometric mode. The VCJ, along with the personally fitted algorithms and fatigue adaptation algorithms, has the potential to be an effective input interface for wheelchairs.	[Mahajan, Harshal P.; Spaeth, Donald M.; Dicianno, Brad E.; Brown, Karl; Cooper, Rory A.] VA Pittsburgh Healthcare Syst, Human Engn Res Labs, Dept Vet Affairs VA Rehabil Res & Dev Ctr, Pittsburgh, PA 15206 USA; [Mahajan, Harshal P.; Cooper, Rory A.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA		Dicianno, BE (corresponding author), VA Pittsburgh Healthcare Syst, Human Engn Res Labs, 6425 Penn Ave,Suite 400, Pittsburgh, PA 15206 USA.	dicianno@pitt.edu	Dicanno, Brad/AAC-5918-2019	Dicanno, Brad/0000-0003-0738-0192	Department of Veteran Affairs (VA) Research and Development Office [B3287R]	This material was based on work supported by the Department of Veteran Affairs (VA) Research and Development Office (grant B3287R) and with the resources and facilities of HERL, VA Pittsburgh Healthcare System.	ACCOT J, 1997, FITTS LAW MODELS TRA, P295, DOI DOI 10.1145/258549.258760; AISEN ML, 1993, NEUROLOGY, V43, P1346, DOI 10.1212/WNL.43.7.1346; Alusi SH, 1999, J NEUROL NEUROSUR PS, V66, P131, DOI 10.1136/jnnp.66.2.131; [Anonymous], 2013, PROP DRIV CONTR; [Anonymous], 2013, MICR MIN JOYST; Beringhause S., 1989, P 12 ANN C REH TECHN, P41; Brienza DM, 1996, DISABIL REHABIL, V18, P123, DOI 10.3109/09638289609166029; Brown KW, 2006, THESIS U PITTSBURGH; Brown KW, 2007, P RESNA 30 ANN C REH; Cook A. M., 2002, ASSISTIVE TECHNOLOGI; Cooper RA, 2000, IEEE T CONTR SYST T, V8, P112, DOI 10.1109/87.817696; Cooper RA, 2002, MED ENG PHYS, V24, P703, DOI 10.1016/S1350-4533(02)00111-X; Dicianno BE, 2006, AM J PHYS MED REHAB, V85, P631, DOI 10.1097/01.phm.0000228519.54763.b4; Dicianno BE, 2012, AM J PHYS MED REHAB, V91, P823, DOI 10.1097/PHM.0b013e31825a1497; Dicianno Brad E, 2010, Phys Med Rehabil Clin N Am, V21, P79, DOI 10.1016/j.pmr.2009.07.013; Dicianno BE, 2009, J REHABIL RES DEV, V46, P269, DOI 10.1682/JRRD.2008.02.0022; Ding D, 2004, P RESNA 27 ANN C REH; Douglas SA, 1999, TESTING POINTING DEV, P215; Fay BT, 2002, MED ENG PHYS, V24, P375, DOI 10.1016/S1350-4533(02)00037-1; Fehr L, 2000, J REHABIL RES DEV, V37, P353; Feys P, 2001, J REHABIL RES DEV, V38, P235; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Guirand AS, 2011, AM J PHYS MED REHAB, V90, P992, DOI 10.1097/PHM.0b013e318228ca9f; GUO G, 2005, SAUDI J DISABIL REHA, V9, P212; Harrison CS, 2010, ASSIST TECHNOL, V22, P20, DOI 10.1080/10400430903520223; Hasdai A, 1998, AM J OCCUP THER, V52, P215, DOI 10.5014/ajot.52.3.215; International Organization for Standardization, 2000, 924192000 ISO; Ito T, 2009, JMTL, V2, P90, DOI DOI 10.1299/jmtl.2.90; Kim E, 2010, J REHABIL RES DEV, V47, P477, DOI 10.1682/JRRD.2009.09.0151; Mahajan H, 2011, ARCH PHYS MED REHAB, V92, P1298, DOI 10.1016/j.apmr.2011.03.011; Mahajan HP, 2013, J SPINAL CORD MED, V36, P322, DOI 10.1179/2045772313Y.0000000130; Mahajan HP, 2009, P RESNA 32 ANN C REH; Nho W, 2006, THESIS U PITTSBURGH; Noonan CW, 2002, NEUROLOGY, V58, P136, DOI 10.1212/WNL.58.1.136; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pithon T, 2009, TECHNOL DISABIL, V21, P1; Powell F, 1992, P RESNA 15 ANN C TOR, P304; Riley P O, 1987, J Rehabil Res Dev, V24, P99; Riviere CN, 1998, IEEE T BIO-MED ENG, V45, P839, DOI 10.1109/10.686791; Routhier F, 2003, DISABIL REHABIL, V25, P19, DOI 10.1080/09638280210151978; Schwid SR, 1999, NEUROLOGY, V53, P743, DOI 10.1212/WNL.53.4.743; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; Souza A, 2010, J REHABIL RES DEV, V47, P213, DOI 10.1682/JRRD.2009.07.0096; Spaeth DM, 2008, ARCH PHYS MED REHAB, V89, P996, DOI 10.1016/j.apmr.2007.11.030; Zhai S., 1999, P SIGCHI C HUM FACT, P466, DOI DOI 10.1145/302979.303133; Zifko UA, 2002, J NEUROL, V249, P983, DOI 10.1007/s00415-002-0765-6	46	7	7	0	8	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	6					951	961		10.1682/JRRD.2013.01.0023			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AT0OT	WOS:000344635900012	25356558	Bronze, Green Accepted			2022-02-06	
J	Mariotti, GV; Golfo, S				Mariotti, Gabriele Virzi; Golfo, Salvatore			Determination and analysis of the head and chest parameters by simulation of a vehicle-teenager impact	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF AUTOMOBILE ENGINEERING			English	Article						teenager; vehicle-pedestrian impact; head injury criterion; abbreviated injury scale; thoracic trauma index; 3 ms criterion	AERIAL MOVEMENT; PROTECTION	This paper reports the results of multi-body numerical simulation of a vehicle crash with a teenager pedestrian. A previous technique utilized for adult pedestrian impact is applied. The work starts with the determination of the masses for the various segments of the body of a teenager with a total mass of 45 kg and then switches to the construction of the dummy and the middle-class vehicle in the Visual Nastran environment. Simulations are performed for both frontal impacts and lateral impacts, when the vehicle is travelling at a constant speed and when the vehicle is braking, following the Euro NCAP rules on the subject. The results are analysed by calculating the values of the head injury criterion for the head and the values of the thoracic trauma index and 3 ms criterion for the chest; the injuries are assessed according to the current interpretation. Abbreviated injury scale curves are used to determine the dangerousness of the impact. Finally, the results are close to those obtained by applying the same technique to an adult pedestrian and other available data in the literature for an adult or a child.	[Mariotti, Gabriele Virzi; Golfo, Salvatore] Univ Palermo, I-90128 Palermo, Italy		Mariotti, GV (corresponding author), Univ Palermo, Dipartimento Ingn Chim, Viale Sci, I-90128 Palermo, Italy.	gabriele.virzimariotti@unipa.it	Mariotti, Gabriele Virzi'/AAE-6053-2019	Mariotti, Gabriele Virzi'/0000-0001-6110-1540			Anderson RWG, 2009, NONLINEAR DYNAM, V58, P199, DOI 10.1007/s11071-009-9471-6; Astori P, 1996, ASPETTI BIOMECCANICI; Bartalesi R, 2005, World Haptics Conference: First Joint Eurohaptics Conference and Symposium on Haptic Interfaces for Virutual Environment and Teleoperator Systems, Proceedings, P535; Bellavia G., 2009, MOTOR VEHICLE ENG AT, V62, P40; Bellavia G., 2009, AUTOMOTIVE ENG 21 SC, V62, P48; Bocchieri Robert T, 2009, Proceedings of the ASME Rail Transportation Division Fall Conference, P61; Carter E, 2005, GECCO 2005: Genetic and Evolutionary Computation Conference, Vols 1 and 2, P2113; Cizek V, 2005, MECCA, V3, P25; Depriester J, 2005, 19 INT TECHN C ENH S; Euro NCAP, 2004, ASS PROT BIOM LIM VE; European Experimental Vehicles Committee, 1994, 10 EEVC GROUP UN EC; European New Car Assessment Programme (Euro NCAP), 2004, CHILD PROT ASS PROT; European New Car Assessment Programme (Euro NCAP), 2009, ASS PROT PED TEST PR; Hall SJ, 2004, BASIC BIOMECHANICS; Han Y, 2012, SAFETY SCI, V50, P1304, DOI 10.1016/j.ssci.2011.12.002; Ishikawa H, 1993, 933129 SAE; Japan Automobile Research Institute, 2004, GRPS101 INF JAP AUT; KALEPS I, 1984, ERGONOMICS, V27, P1225, DOI 10.1080/00140138408963604; Kovanda J, 2001, SIMPACK US M 2001 BA; Kuppa S., 2004, INJURY CRITERIA SIDE; Le Veau BL, 1993, BIOMECCANICA MOVIMEN; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Marquis BP, 1995, ASME APPL MECH DIV, V210, P539; Masson C., 2007, 20 INT TECHN C ENH S; Masson C., 2005, 19 INT TECHN C ENH S, P05; NAHUM AM, 2001, ACCIDENTAL INJURY BI; Neilson ID., 1993, P IMECHE D, V207, P117; Pohlak M, 2008, PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE OF DAAAM BALTIC INDUSTRIAL ENGINEERING, PTS 1 AND 2, P123; PRASAD P., 1985, 851246 SAE, DOI [10.4271/851246, DOI 10.4271/851246]; Rodarius C., 2007, 20 INT TECHN C ENH S; Schmitt K.-U., 2007, TRAUMA BIOMECHANICS; Schneck DJ, 2008, BIOMECHANICS PRINCIP; Shen J, 2008, P I MECH ENG D-J AUT, V222, P25, DOI 10.1243/09544070JAUTO660; Shin MK, 2008, P I MECH ENG D-J AUT, V222, P2373, DOI 10.1243/09544070JAUTO788; Sulzer J, 2006, 2006012349 SAE; Svoboda J, 2005, 10 EAEC EUR AUT C BE, V3, P1095; Svoboda J, 2001, REPUBLIC; Van Rooij L, 2003, 18 INT TECHN C ENH S; Winter D.A., 1990, BIOMECHANICS MOTOR C, VVol. 1; Wood DP, 2005, P I MECH ENG D-J AUT, V219, P183, DOI 10.1243/095440705X6703; Xu J, 2009, INT J IMPACT ENG, V36, P783, DOI 10.1016/j.ijimpeng.2008.11.008; Yang J, 2005, 19 INT TECHN C ENH S; Yang J.K., 2000, J CRASH PREVENTION I, V2, P131, DOI [10.1080/10286580008902559, DOI 10.1080/10286580008902559]; YEADON MR, 1990, J BIOMECH, V23, P59, DOI 10.1016/0021-9290(90)90369-E; YEADON MR, 1990, J BIOMECH, V23, P67, DOI 10.1016/0021-9290(90)90370-I; YEADON MR, 1990, J BIOMECH, V23, P75, DOI 10.1016/0021-9290(90)90371-9; YEADON MR, 1990, J BIOMECH, V23, P85, DOI 10.1016/0021-9290(90)90372-A; Zhang WF, 2009, RELIAB ENG SYST SAFE, V94, P152, DOI 10.1016/j.ress.2008.02.024; [No title captured]	49	7	7	0	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4070	2041-2991		P I MECH ENG D-J AUT	Proc. Inst. Mech. Eng. Part D-J. Automob. Eng.	JAN	2014	228	1					3	20		10.1177/0954407013501487			18	Engineering, Mechanical; Transportation Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transportation	293HK	WOS:000329961800001					2022-02-06	
J	Rahimi, S; Bidabadi, E; Mashouf, M; Saadat, SMS; Rahimi, S				Rahimi, Sepide; Bidabadi, Elham; Mashouf, Mehryar; Saadat, Seyed Mohammad Seyed; Rahimi, Samane			Prognostic value of arterial blood gas disturbances for in-hospital mortality in pediatric patients with severe traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Acid-base imbalances; Child; Mortality; Traumatic brain injuries	SEVERE HEAD-INJURY; CEREBRAL ACID-BASE; SECONDARY INSULTS; CHILDREN; RESUSCITATION; HYPERGLYCEMIA	The aim of this study was to evaluate the changes of arterial blood gas as a secondary insult in children and young adults suffering from severe traumatic brain injury, and to assess the correlation, if any, with their in-hospital mortality. In this cross-sectional study, the medical data of all children and adolescents with severe head trauma admitted to the Rasht Poursina Hospital were reviewed between April 2006 and September 2011. Data including age, gender, GCS upon admission, arrival and daily ABG values for the first 3 days, results of brain CT scan, as well as in-hospital mortality rate were collected. A logistic regression model was used to determine the association between acid-base disturbance and in-hospital mortality after adjustment for potential confounding factors. Of the 108 patients, 75 % were male and 25 % were female; and 31.5 % of them died in the hospital. Univariate analysis showed a significantly higher risk of mortality in patients who developed mixed metabolic acidosis plus respiratory acidosis on their admission day (OR = 3.94, p = 0.012). Multiple logistic regression analysis demonstrated that mixed metabolic acidosis plus respiratory acidosis (OR = 3.81, 95 % CI = 1.18-12.27, p-value = 0.025) and GCS (OR = 0.457, 95 % CI = 0.31-0.65, p-value < 0.001) were two significant predictors of mortality, regardless of other confounding variables. The results of present study show that, in pediatric patients with severe head injuries, initial mixed metabolic acidosis plus respiratory acidosis and GCS are significant predictors of mortality, but other factors after adjustment for potential confounding factors had no prognostic effect.	[Rahimi, Sepide; Saadat, Seyed Mohammad Seyed; Rahimi, Samane] Guilan Univ Med Sci, Rasht, Iran; [Bidabadi, Elham] Guilan Univ Med Sci, Golsar 4165855695, Rasht, Iran; [Mashouf, Mehryar] Arya Hosp, Rasht, Iran		Bidabadi, E (corresponding author), Guilan Univ Med Sci, 15-135 Ave, Golsar 4165855695, Rasht, Iran.	mashoof@mail.com	Bidabadi, Elham/D-2879-2019	Seyed Saadat, Seyed Mohammad/0000-0001-8188-3455; Bidabadi, Elham/0000-0002-1067-3335; Seyedsaadat, Seyed Mohammad/0000-0002-8219-6144			ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Avarello JT, 2007, EMERG MED CLIN N AM, V25, P803, DOI 10.1016/j.emc.2007.06.013; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Eberhard LW, 2000, CRIT CARE MED, V28, P125, DOI 10.1097/00003246-200001000-00021; FACCO E, 1986, CHILD NERV SYST, V2, P67; Jones PA, 2008, ACTA NEUROCHIR SUPPL, V102, P81, DOI 10.1007/978-3-211-85578-2_16; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; KING LR, 1974, J NEUROSURG, V40, P617, DOI 10.3171/jns.1974.40.5.0617; Alvarez JML, 2011, MED INTENSIVA, V35, P331, DOI 10.1016/j.medin.2011.02.001; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Sahin Soner, 2005, Ulus Travma Acil Cerrahi Derg, V11, P336; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Subhas K, 2011, INTENS CARE MED, V12, P201; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; VICARIO SJ, 1983, ANN EMERG MED, V12, P145, DOI 10.1016/S0196-0644(83)80554-X; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; ZUPPING R, 1970, J NEUROSURG, V33, P498, DOI 10.3171/jns.1970.33.5.0498	30	7	7	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2014	156	1					187	192		10.1007/s00701-013-1929-0			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	281IE	WOS:000329093100028	24221122				2022-02-06	
B	Reece, RM; Savage, RC; Sugar, N		Reece, RM; Hanson, RF; Sargent, J		Reece, Robert M.; Savage, Ronald C.; Sugar, Naomi			Treatment of Physical Child Abuse	TREATMENT OF CHILD ABUSE: COMMON GROUND FOR MENTAL HEALTH, MEDICAL, AND LEGAL PRACTITIONERS, 2ND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; BLUNT ABDOMINAL-TRAUMA; NONOPERATIVE MANAGEMENT; PSYCHOLOGICAL-PROBLEMS; PEDIATRIC-PATIENTS; YOUNG-CHILDREN; DECISION RULE; HEAD-INJURY; BURN CARE; DYSFUNCTION		[Reece, Robert M.] Tufts Univ, Sch Med, Pediat, N Falmouth, MA 02540 USA; [Savage, Ronald C.] Int Pediat Brain Injury Assoc, Philadelphia, PA USA; [Sugar, Naomi] Univ Washington, Sch Med, Div Gen Pediat, Pediat, Seattle, WA USA		Reece, RM (corresponding author), Tufts Univ, Sch Med, Pediat, N Falmouth, MA 02540 USA.						American College of Surgeons, 2011, ATLS PROGR ADV TRAUM; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barnes PM, 2005, LANCET, V366, P234, DOI 10.1016/S0140-6736(05)66913-9; Baxter AL, 2008, CHILD ABUSE NEGLECT, V32, P838, DOI 10.1016/j.chiabu.2007.09.013; Bensard DD, 1996, J TRAUMA, V41, P476, DOI 10.1097/00005373-199609000-00015; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Bixby SD, 2008, SEMIN ROENTGENOL, V43, P72, DOI 10.1053/j.ro.2007.08.009; Blakeney Patricia, 1993, Journal of Burn Care and Rehabilitation, V14, P65, DOI 10.1097/00004630-199301000-00015; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Brosbe MS, 2011, J PEDIATR PSYCHOL, V36, P718, DOI 10.1093/jpepsy/jsq115; Canty TG, 1999, J TRAUMA, V46, P234, DOI 10.1097/00005373-199902000-00005; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chester DL, 2006, BURNS, V32, P222, DOI 10.1016/j.burns.2005.08.018; Chou R, 2005, DRUG CLASS REV SKELE; CROCE MA, 1995, ANN SURG, V221, P744, DOI 10.1097/00000658-199506000-00013; De Young AC, 2012, J CHILD PSYCHOL PSYC, V53, P56, DOI 10.1111/j.1469-7610.2011.02431.x; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Desai KM, 2003, J TRAUMA, V54, P640, DOI 10.1097/01.TA.0000056184.80706.9B; Dias MS, 2004, PEDIATR CLIN N AM, V51, P271, DOI 10.1016/S0031-3955(03)00211-6; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Duffy BJ, 2006, CLIN PEDIATR EMERG M, V7, P82, DOI 10.1016/j.cpem.2006.04.001; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; Eaton DK, 2011, MMWR SURVEILL SUMM, V61, P1, DOI DOI 10.2307/24806047; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Fitzgerald CL, 2011, J UROLOGY, V185, P1058, DOI [10.1016/j.juro.2010.10.045, 10.1590/S1677-55382011000300031]; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Hanson MD, 2008, J BURN CARE RES, V29, P730, DOI 10.1097/BCR.0b013e318184812e; Hartford C, 2007, TOTAL BURN CARE, P67; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hilmes MA, 2011, PEDIATR RADIOL, V41, P643, DOI 10.1007/s00247-010-1899-9; Huang T, 2007, TOTAL BURN CARE, P674; Jennet B, 1976, HDB CLIN NEUROLOGY, V24, P445; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kay M, 2009, CURR OPIN PEDIATR, V21, P651, DOI 10.1097/MOP.0b013e32832e2764; Kiankhooy A, 2010, J TRAUMA, V68, P526, DOI 10.1097/TA.0b013e3181d3e5b7; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Landolt MA, 2002, J TRAUMA, V53, P1146, DOI 10.1097/00005373-200212000-00019; Lane WG, 2012, CHILD ABUSE NEGLECT, V36, P142, DOI 10.1016/j.chiabu.2011.09.010; Lane WG, 2011, PEDIATRICS, V127, pE1400, DOI 10.1542/peds.2010-2096; LEDBETTER DJ, 1988, ARCH SURG-CHICAGO, V123, P1101; LeDoux J, 1998, BURNS, V24, P425, DOI 10.1016/S0305-4179(98)00038-2; LEONARD LG, 1982, J TRAUMA, V22, P420, DOI 10.1097/00005373-198205000-00013; Lind K., 2012, ANN PHYS REHABILI S1, V55, pe233; Lindberg D, 2009, PEDIATRICS, V124, P509, DOI 10.1542/peds.2008-2348; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Malhotra AK, 2000, ANN SURG, V231, P804, DOI 10.1097/00000658-200006000-00004; Martin-Herz SP, 2000, J BURN CARE REHABIL, V21, P458, DOI 10.1097/00004630-200021050-00016; Maternal and Child Health Bureau U.S. Department of Health and Human Services Health Resources and Services Administration, 2012, NAT SURV CHILDR SPEC; Mattix KD, 2007, J PEDIATR SURG, V42, P340, DOI 10.1016/j.jpedsurg.2006.10.006; Meyer WJ, 2004, J BURN CARE REHABIL, V25, P98, DOI 10.1097/01.BCR.0000107203.48726.67; Minns RA, 2005, CLIN DEV MED, P364; Mlcak RP, 2007, TOTAL BURN CARE, P81; Morgan W. F., 2012, UPTODATE; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Peters E, 2006, PEDIATR CRIT CARE ME, V7, P551, DOI 10.1097/01.PCC.0000244428.31624.AB; Pham TN, 2007, TOTAL BURN CARE, P119; Raissaki M, 2011, PEDIATR RADIOL, V41, P4, DOI 10.1007/s00247-010-1882-5; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Richardson D, 2002, EUR J NEUROL, V9, P17, DOI 10.1046/j.1468-1331.2002.0090s1017.x; Rorke-Adams L, 2009, CHILD ABUSE MED DIAG; Schonfeld D, 2012, CURR OPIN PEDIATR, V24, P314, DOI 10.1097/MOP.0b013e328352de97; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SERGHIOU MA, 2007, TOTAL BURN CARE, P620; Shapiro MB, 2000, J TRAUMA, V49, P969, DOI 10.1097/00005373-200011000-00033; Sheridan R, 2005, PEDIATR EMERG CARE, V21, P449, DOI 10.1097/01.pec.0000169438.29315.fe; Sheridan R. L., 1995, Journal of Burn Care and Rehabilitation, V16, P605, DOI 10.1097/00004630-199511000-00008; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Stoddard FJ, 2006, J AM ACAD CHILD PSY, V45, P87, DOI 10.1097/01.chi.0000184934.71917.3a; Su E., 2012, NEUROCRITICAL CARE; TEASDALE G, 1974, LANCET, V2, P81; Temiz A, 2012, WORLD J GASTROENTERO, V18, P1098, DOI 10.3748/wjg.v18.i10.1098; Trokel M, 2004, CHILD MALTREATMENT, V9, P111, DOI 10.1177/1077559503260310; Trokel M, 2006, PEDIATR EMERG CARE, V22, P700, DOI 10.1097/01.pec.0000238734.76413.d0; Umbreit EC, 2009, UROLOGY, V74, P579, DOI 10.1016/j.urology.2009.04.049; Warden GD, 2007, TOTAL BURN CARE, V3, P107, DOI [10.1016/B978-1-4160-3274-8.50012-X, DOI 10.1016/B978-1-4160-3274-8.50012-X]; Willebrand M, 2011, BURNS, V37, P1309, DOI 10.1016/j.burns.2011.08.003; Wood J, 2005, J TRAUMA, V59, P1203, DOI 10.1097/01.ta.0000196437.07011.b1	95	7	7	0	1	JOHNS HOPKINS UNIV PRESS	BALTIMORE	2715 N CHARLES ST, BALTIMORE, MD 21218-4319 USA			978-1-4214-1273-3; 978-1-4214-1274-0; 978-1-4214-1272-6				2014							190	207					18	Public, Environmental & Occupational Health; Medicine, Legal	Book Citation Index – Science (BKCI-S)	Public, Environmental & Occupational Health; Legal Medicine	BD6NU	WOS:000362429500021					2022-02-06	
J	Ryb, GE; Dischinger, PC; Auman, KM; Kufera, JA; Cooper, CC; Mackenzie, CF; Kane, RL				Ryb, Gabriel E.; Dischinger, Patricia C.; Auman, Kimberly M.; Kufera, Joseph A.; Cooper, Carnell C.; Mackenzie, Colin F.; Kane, Robert L.			S-100 beta does not predict outcome after mild traumatic brain injury	BRAIN INJURY			English	Article						Biomarker; mild TBI; post-concussive syndrome; S-100 beta; traumatic brain injury	POST-CONCUSSION SYMPTOMS; NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; PROTEIN S-100; SERUM S-100B; S100B LEVELS; MARKER; DAMAGE	Objective: To determine the usefulness of S-100 beta, a marker for central nervous system damage, in the prediction of long-term outcomes after mild traumatic brain injury (MTBI) Hypothesis: Mid-and long-term outcomes of MTBI (i.e. 3, 6 and 12 months post-injury and return-to-work or school (RTWS)) may be predicted based on pre-injury and injury factors as well as S-100 beta. Methods: MTBI subjects without abnormal brain computed tomography requiring intervention, focal neurological deficits, seizures, amnesia424 hours and severe or multiple injuries were recruited at a level I trauma centre. Admission S-100 beta measurements and baseline Concussion Symptom Checklist were obtained. Symptoms and RTWS were re-assessed at follow-up visits (3-10 days and 3, 6 and 12 months). Outcomes included number of symptoms and RTWS at follow-up. Chi-square tests, linear and logistic regression models were used and p<0.05 was considered statistically significant. Results: One hundred and fifty of 180 study subjects had S-100 beta results. Eleven per cent were unable to RTWS at 12 months. S-100 beta levels were not associated with post-concussive symptomatology at follow-up. In addition, no association was found between S-100 beta levels and RTWS. Conclusion: Amongst MTBI patients, S-100 beta levels are not associated with prolonged post-concussive syndrome or the inability to RTWS.	[Ryb, Gabriel E.; Dischinger, Patricia C.; Auman, Kimberly M.; Kufera, Joseph A.; Mackenzie, Colin F.] Univ Maryland, Sch Med, Natl Study Ctr Trauma & Emergency Med Syst, Baltimore, MD 21201 USA; [Ryb, Gabriel E.; Cooper, Carnell C.] Univ Maryland, Sch Med, Program Trauma, Baltimore, MD 21201 USA; [Ryb, Gabriel E.; Cooper, Carnell C.] Prince Georges Gen Hosp & Med Ctr, Trauma Serv, Cheverly, MD USA; [Kane, Robert L.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA		Ryb, GE (corresponding author), Natl Study Ctr Trauma & Emergency Med Syst, 110 South Paca St,Fourth Floor, Baltimore, MD 21201 USA.	rybgabriel@gmail.com			Department of Defense Peer Reviewed Medical Research Program (PRMRP) of the US Army Medical Research and Materiel Command (USAMRMC) Office of the Congressionally Directed Medical Research Programs (CDMRP) [PR023113]	The project this manuscript is based on was funded by Department of Defense Peer Reviewed Medical Research Program (PRMRP) of the US Army Medical Research and Materiel Command (USAMRMC) Office of the Congressionally Directed Medical Research Programs (CDMRP): (PR023113). Patricia Dischinger, Kimberly Auman, Joseph Kufera and Robert Kane all received salary support from this project. Gabriel Ryb, Carnell Cooper and Colin Mackenzie may have received salary support.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Bottiger BW, 2001, CIRCULATION, V103, P2694; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faul M, 2010, TRAUMATIC BRAIN INJU; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; McDowell I, 1996, PSYCHOL WELLBEING ME; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Reeves D, 1995, NCRFSR9501; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181	34	7	8	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1430	1435		10.3109/02699052.2014.919525			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200011	24911665				2022-02-06	
J	Tamplin, J; Baker, FA; Buttifant, M; Berlowitz, DJ				Tamplin, Jeanette; Baker, Felicity A.; Buttifant, Mary; Berlowitz, David J.			The Effect of Singing Training on Voice Quality for People With Quadriplegia	JOURNAL OF VOICE			English	Article						Voice quality; Intensity; Singing; Music therapy; Quadriplegia; Spinal cord injury	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; RESPIRATORY-FUNCTION; ATAXIC DYSARTHRIA; SPEECH; LUNG; PERTURBATION; DYSFUNCTION; PHONATIONS; ABDOMEN	Objectives. Despite anecdotal reports of voice impairment in quadriplegia, the exact nature of these impairments is not well described in the literature. This article details objective and subjective voice assessments for people with quadriplegia at baseline and after a respiratory-targeted singing intervention. Study Design. Randomized controlled trial. Methods. Twenty-four participants with quadriplegia were randomly assigned to a 12-week program of either a singing intervention or active music therapy control. Recordings of singing and speech were made at baseline, 6 weeks, 12 weeks, and 6 months postintervention. These deidentified recordings were used to measure sound pressure levels and assess voice quality using the Multidimensional Voice Profile and the Perceptual Voice Profile. Results. Baseline voice quality data indicated deviation from normality in the areas of breathiness, strain, and roughness. A greater percentage of intervention participants moved toward more normal voice quality in terms of jitter, shimmer, and noise-to-harmonic ratio; however, the improvements failed to achieve statistical significance. Conclusions. Subjective and objective assessments of voice quality indicate that quadriplegia may have a detrimental effect on voice quality; in particular, causing a perception of roughness and breathiness in the voice. The results of this study suggest that singing training may have a role in ameliorating these voice impairments.	[Tamplin, Jeanette; Baker, Felicity A.; Buttifant, Mary; Berlowitz, David J.] Univ Melbourne, Melbourne Conservatorium Mus, Mus Therapy Dept, Parkville, Vic 3010, Australia		Tamplin, J (corresponding author), Univ Melbourne, Melbourne Conservatorium Mus, Mus Therapy Dept, 151 Barry St, Parkville, Vic 3010, Australia.	jeanette.tamplin@unimelb.edu.au	Tamplin, Jeanette/AAR-2855-2021; Berlowitz, David/D-4939-2011	Tamplin, Jeanette/0000-0002-3623-033X; Berlowitz, David/0000-0003-2543-8722	Victorian Neurotrauma Initiative	This project was supported by the Victorian Neurotrauma Initiative.	Bailey EF, 2002, J SPEECH LANG HEAR R, V45, P89, DOI 10.1044/1092-4388(2002/007); BELLAIRE K, 1986, J COMMUN DISORD, V19, P271, DOI 10.1016/0021-9924(86)90033-X; Bibby JRL, 2008, HEAD NECK-J SCI SPEC, V30, P600, DOI 10.1002/hed.20750; Bielamowicz S, 1996, J SPEECH HEAR RES, V39, P126, DOI 10.1044/jshr.3901.126; Brookshire R. H., 2003, INTRO NEUROGENIC COM; Brown J.R., 1975, MOTOR SPEECH DISORDE; Brown R, 2006, RESP CARE, V51, P853; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; CHEN CF, 1990, PARAPLEGIA, V28, P81, DOI 10.1038/sc.1990.10; Cohen J., 2013, STAT POWER ANAL BEHA; Fairbanks G., 1960, VOICE ARTICULATION D; FITCH JL, 1990, J SPEECH HEAR DISORD, V55, P360, DOI 10.1044/jshd.5502.360; Grandas NF, 2005, ARCH PHYS MED REHAB, V86, P1631, DOI 10.1016/j.apmr.2005.02.006; Hixon T. J., 2005, EVALUATION MANAGEMEN; HIXON TJ, 1973, J SPEECH HEAR RES, V16, P78, DOI 10.1044/jshr.1601.78; HOIT JD, 1990, J SPEECH HEAR RES, V33, P798, DOI 10.1044/jshr.3304.798; Hoit JD, 2002, AM J SPEECH-LANG PAT, V11, P71, DOI 10.1044/1058-0360(2002/008); HORII Y, 1982, J SPEECH HEAR RES, V25, P12, DOI 10.1044/jshr.2501.12; Jacobson BH., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Juraimi A., 2005, SEMINARS SPEECH LANG, V24, P20; Kent R. D., 1996, AM J SPEECH LANGUAGE, V5, P7, DOI [10.1044/1058-0360.0503.07, DOI 10.1044/1058-0360.0503.07]; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; Kent RD, 2003, J COMMUN DISORD, V36, P281, DOI 10.1016/S0021-9924(03)00016-9; Kreiman J, 1998, J ACOUST SOC AM, V104, P1598, DOI 10.1121/1.424372; KREIMAN J, 1993, J SPEECH HEAR RES, V36, P21, DOI 10.1044/jshr.3601.21; Lodgemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; MacBean N, 2006, J MED SPEECH-LANG PA, V14, P167; McHenry M, 2000, LARYNGOSCOPE, V110, P1157, DOI 10.1097/00005537-200007000-00017; Nygren-Bonnier M, 2011, DISABIL REHABIL, V33, P530, DOI 10.3109/09638288.2010.505995; Oates J, 1998, J VOICE, V12, P500, DOI 10.1016/S0892-1997(98)80059-3; Oates JM, 1997, SOUND JUDGEMENT; Olsen WO, 1998, AM J AUDIOL, V7, P21; Prathanee Benjamas, 1994, Journal of the Medical Association of Thailand, V77, P639; Rosen CA, 2000, J VOICE, P14; Rosenbek J.C., 1985, CLIN MANAGEMENT NEUR, V2nd ed., P97; ROTH EJ, 1995, PARAPLEGIA, V33, P454, DOI 10.1038/sc.1995.99; Tamplin J., 2011, THERAPEUTIC VOICEWOR, P147; Tamplin J, 2013, ARCH PHYS MED REHAB, V94, P426, DOI 10.1016/j.apmr.2012.10.006; Tamplin J, 2011, ARCH PHYS MED REHAB, V92, P250, DOI 10.1016/j.apmr.2010.10.032; Thaut MH., 2005, RHYTHM MUSIC BRAIN S; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Wadsworth BM, 2012, ARCH PHYS MED REHAB, V93, P2189, DOI 10.1016/j.apmr.2012.06.010; WATSON P J, 1989, Journal of Voice, V3, P24, DOI 10.1016/S0892-1997(89)80118-3; Watson PJ, 2001, J SPEECH LANG HEAR R, V44, P751, DOI 10.1044/1092-4388(2001/059); YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398	45	7	7	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0892-1997	1873-4588		J VOICE	J. Voice	JAN	2014	28	1							128.e19	10.1016/j.jvoice.2013.08.017			8	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	284NN	WOS:000329326100021	24291444				2022-02-06	
J	Tokes, T; Varga, G; Garab, D; Nagy, Z; Fekete, G; Tuboly, E; Plangar, I; Man, I; Szabo, RE; Szabo, Z; Volford, G; Ghyczy, M; Kaszaki, J; Boros, M; Hideghety, K				Tokes, Tuende; Varga, Gabriella; Garab, Denes; Nagy, Zoltan; Fekete, Gabor; Tuboly, Eszter; Plangar, Imola; Man, Imola; Szabo, Rita Emilia; Szabo, Zoltan; Volford, Gabor; Ghyczy, Miklos; Kaszaki, Jozsef; Boros, Mihaly; Hideghety, Katalin			Peripheral inflammatory activation after hippocampus irradiation in the rat	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						Brain irradiation; radioprotection; cytokines; TNF-alpha; ATP; L-alpha-glycerylphosphorylcholine	TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; TNF RECEPTORS P55; CYTOKINE EXPRESSION; CEREBRAL-ISCHEMIA; ENRICHED DIET; MAST-CELLS; ALPHA; PHOSPHATIDYLCHOLINE	Purpose : To detect the possible biochemical signs of inflammatory activation in the peripheral circulation in a rodent model of hippocampus irradiation, and to examine the effects of L-alpha-glycerylphosphorylcholine (GPC) in this experimental protocol. Materials and methods : Anesthetized Sprague-Dawley rats were subjected to 40 Gy cobalt irradiation of both hemispheres of the hippocampus, with or without GPC treatment (50 mg/kg intravenously (i.v.), 5 min before the irradiation, n = 6, each). A third group (n = 6) served as saline-treated control. Blood samples were obtained 3 h after the end of irradiation in order to examine the changes in plasma histamine, tumor necrosis factor-alpha (TNF-alpha), interleukin 1-beta, interleukin 6 (IL-6) and interleukin 10 (IL-10); liver tissue samples were taken to determine adenosine triphosphate (ATP) concentrations. Results : The hepatic ATP levels were significantly declined, while plasma concentrations of circulating TNF-alpha, IL-6, IL-10 and histamine were significantly increased after hippocampus irradiation. GPC treatment significantly reduced the irradiation-induced release of cytokines and histamine, and the liver ATP level was maintained at the control value. Conclusions : Targeted brain irradiation produced measurable pro-and anti-inflammatory cytokine changes in the systemic circulation. GPC supplementation provides significant protection against irradiation-induced peripheral pro-inflammatory activation and ATP depletion.	[Tokes, Tuende; Varga, Gabriella; Garab, Denes; Tuboly, Eszter; Ghyczy, Miklos; Kaszaki, Jozsef; Boros, Mihaly] Univ Szeged, Inst Surg Res, H-6720 Szeged, Hungary; [Nagy, Zoltan; Fekete, Gabor; Man, Imola; Szabo, Rita Emilia; Szabo, Zoltan; Hideghety, Katalin] Univ Szeged, Dept Oncotherapy, H-6720 Szeged, Hungary; [Plangar, Imola] Univ Szeged, Dept Neurol, H-6720 Szeged, Hungary; [Volford, Gabor] Univ Szeged, Dept Radiol, H-6720 Szeged, Hungary		Boros, M (corresponding author), Univ Szeged, Sch Med, Inst Surg Res, Szokefalvi Nagy BU 6, H-6720 Szeged, Hungary.	boros.mihaly@med.u-szeged.hu			Orszagos Tudomanyos Kutatasi Alapprogram (OTKA; Hungarian Science Research Fund)Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [OTKA 75833, OTKA K104656]; Tarsadalmi Megujulas Operativ Program (TAMOP; Social Renewal Operational Programme) [TAMOP-4.2.2/B-10/1-2010-0012]; Tarsadalmi Megujulus Operativ Program Konvergencia Regio (TAMOP-KONV; Social Renewal Operational Programme - Regional Convergence) [TAMOP-4.2.2A-11/1-KONV-2012-0035]	The study was supported by the Orszagos Tudomanyos Kutatasi Alapprogram (OTKA; Hungarian Science Research Fund) OTKA 75833, OTKA K104656, Tarsadalmi Megujulas Operativ Program (TAMOP; Social Renewal Operational Programme) TAMOP-4.2.2/B-10/1-2010-0012, and Tarsadalmi Megujulus Operativ Program Konvergencia Regio (TAMOP-KONV; Social Renewal Operational Programme - Regional Convergence) TAMOP-4.2.2A-11/1-KONV-2012-0035.	AMENTA F, 1994, MECH AGEING DEV, V76, P49, DOI 10.1016/0047-6374(94)90007-8; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Chao W, 1995, J CLIN INVEST, V96, P2654, DOI 10.1172/JCI118331; Daigle JL, 2001, CANCER RES, V61, P8859; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ELHARIRI LM, 1992, J PHARM PHARMACOL, V44, P651, DOI 10.1111/j.2042-7158.1992.tb05487.x; Eros G, 2009, EUR SURG RES, V42, P40, DOI 10.1159/000167856; Gaber MW, 2003, INT J RADIAT BIOL, V79, P359, DOI 10.1080/0955300031000114738; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Han SK, 2006, INT J RADIAT BIOL, V82, P686, DOI 10.1080/09553000600930699; Hideghety K, 2013, INT J RADIAT BIOL, V89, P645, DOI 10.3109/09553002.2013.784424; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; Huaux F, 1999, AM J RESP CELL MOL, V21, P137, DOI 10.1165/ajrcmb.21.1.3570; Ishikado A, 2009, ATHEROSCLEROSIS, V205, P404, DOI 10.1016/j.atherosclerosis.2009.01.010; Kalifa C, 2005, J NEURO-ONCOL, V75, P279, DOI 10.1007/s11060-005-6752-x; Karger CP, 2002, RADIAT RES, V157, P617, DOI 10.1667/0033-7587(2002)157[0617:DRCATD]2.0.CO;2; Khuntia D, 2009, NEUROTHERAPEUTICS, V6, P487, DOI 10.1016/j.nurt.2009.04.009; Kirste S, 2011, CANCER-AM CANCER SOC, V117, P3788, DOI 10.1002/cncr.25945; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Linard C, 2003, AM J PHYSIOL-GASTR L, V285, pG556, DOI 10.1152/ajpgi.00094.2003; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Marquette C, 2003, INT J RADIAT BIOL, V79, P777, DOI 10.1080/09553000310001610998; Marshall JS, 1996, J CLIN INVEST, V97, P1122, DOI 10.1172/JCI118506; McBride WH, 1997, CURRENT CLIN TOPICS, P91; Meistrell ME, 1997, SHOCK, V8, P341; MOHANTY S, 1989, J NEUROL SCI, V90, P87, DOI 10.1016/0022-510X(89)90048-8; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moreno MD, 2003, CLIN THER, V25, P178; Munter MW, 1999, RADIOLOGY, V212, P475; Onishchenko L S, 2008, Neurosci Behav Physiol, V38, P49, DOI 10.1007/s11055-008-0007-1; Parnetti L, 2007, J NEUROL SCI, V257, P264, DOI 10.1016/j.jns.2007.01.043; RUAT M, 1990, P NATL ACAD SCI USA, V87, P1658, DOI 10.1073/pnas.87.5.1658; SANGIORGI GB, 1994, ANN NY ACAD SCI, V717, P253, DOI 10.1111/j.1749-6632.1994.tb12095.x; Shimada R, 2012, J CLIN NEUROSCI, V19, P447, DOI 10.1016/j.jocn.2011.06.033; Tokes T, 2011, SHOCK, V36, P458, DOI 10.1097/SHK.0b013e31822f36b0; Treede I, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-53; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Ward JL, 2011, J TRAUMA, V70, P1471, DOI 10.1097/TA.0b013e31821c38bd; Zhou DH, 2001, INT J RADIAT BIOL, V77, P763, DOI 10.1080/09553000110050047	43	7	7	0	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.	JAN	2014	90	1					1	6		10.3109/09553002.2013.836617			6	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	291YQ	WOS:000329869200001	23968122	Green Accepted			2022-02-06	
J	Ulfarsson, T; Lundgren-Nilsson, A; Blomstrand, C; Jakobsson, KE; Oden, A; Nilsson, M; Rosen, T				Ulfarsson, Trandur; Lundgren-Nilsson, Asa; Blomstrand, Christian; Jakobsson, Karl-Erik; Oden, Anders; Nilsson, Michael; Rosen, Thord			Ten-year mortality after severe traumatic brain injury in western Sweden: A case control study	BRAIN INJURY			English	Article						Death; outcome; traumatic brain injury	REACTION LEVEL SCALE; GLASGOW COMA SCALE; HEAD-INJURY; FOLLOW-UP; YOUNG-PEOPLE; REHABILITATION; ADULTS; DISABILITY; SURVIVAL; AGE	Primary objective: Life expectancy may be substantially reduced for many years after severe traumatic brain injury (TBI). This study investigated the patterns of the short-and long-term all-cause mortality and the rates of primary causes of death in patients with severe TBI. Subjects: This study was of 166 consecutive patients (6-82 years) with severe TBI admitted to Sahlgrenska University Hospital, Gothenburg, Sweden, from 1999-2002. The control group consisted of 809 subjects from the community, matched to the TBI cohort for age, gender and postcode area at the time of the injury. Methods: Survival outcome and cause of death were ascertained 10 years after the injury from the Swedish National Board of Health and Welfare register. The cumulative death rates and causes of death in cases and controls were compared. Results: The risk of death was increased for at least 10 years after severe TBI. The distribution of the causes of deaths differed between cases and controls in the first year of follow-up, but not between 1-year survivors and controls. Conclusion: Further research will be required to determine how to improve treatment so as to lower late mortality among survivors of severe TBI.	[Ulfarsson, Trandur; Lundgren-Nilsson, Asa; Blomstrand, Christian; Nilsson, Michael] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Ctr Brain Repair & Rehabil, SE-41345 Gothenburg, Sweden; [Ulfarsson, Trandur; Lundgren-Nilsson, Asa] Sahlgrens Univ Hosp, Dept Rehabil Med, Gothenburg, Sweden; [Jakobsson, Karl-Erik] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden; [Oden, Anders] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Nilsson, Michael] Hunter Med Res Inst, Newcastle, NSW, Australia; [Nilsson, Michael] Univ Newcastle, Newcastle, NSW 2300, Australia; [Rosen, Thord] Sahlgrens Univ Hosp, Dept Endocrinol, Gothenburg, Sweden		Ulfarsson, T (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, SE-41345 Gothenburg, Sweden.	trandur.ulfarsson@vgregion.se	NILSSON, MICHAEL/ABE-7821-2020	NILSSON, MICHAEL/0000-0002-8826-1621	Lansforsakringar Alliance; Swedish Government ALF Grants for Medical Research; Sten A. Olsson Foundation for Research and Culture	The authors report no conflicts of interest. A grant from the Lansforsakringar Alliance, the Swedish Government ALF Grants for Medical Research and the Sten A. Olsson Foundation for Research and Culture supported this study. Stephen Ordway (Golden Gate Biomedical Communications) provided much appreciated scientific writing assistance.	Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sherlock M, 2013, CURR OPIN ENDOCRINOL, V20, P314, DOI 10.1097/MED.0b013e328363184d; Socialstyrelsen S, 2013, CAUSES DEATH 2011; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	39	7	7	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1675	1681		10.3109/02699052.2014.947625			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600006	25207641				2022-02-06	
J	Vakil, E; Galon, CLR				Vakil, Eli; Galon, Carmit Lev-Ran			Baseline performance and learning rate of conceptual and perceptual skill-learning tasks: The effect of moderate to severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Skill learning; Traumatic brain injury; Tower of Hanoi Puzzle; Mirror reading; Conceptual; Perceptual	CLOSED-HEAD INJURY; DIVIDED ATTENTION; IMPLICIT MEMORY; TRENDS; TBI	Existing literature presents a complex and inconsistent picture of the specific deficiencies involved in skill learning following traumatic brain injury (TBI). In an attempt to address this difficulty, individuals with moderate to severe TBI (n = 29) and a control group (n = 29) were tested with two different skill-learning tasks: conceptual (i.e., Tower of Hanoi Puzzle, TOHP) and perceptual (i.e., mirror reading, MR). Based on previous studies of the effect of divided attention on these tasks and findings regarding the effect of TBI on conceptual and perceptual priming tasks, it was predicted that the group with TBI would show impaired baseline performance compared to controls in the TOHP task though their learning rate would be maintained, while both baseline performance and learning rate on the MR task would be maintained. Consistent with our predictions, overall baseline performance of the group with TBI was impaired in the TOHP test, while the learning rate was not. The learning rate on the MR task was preserved but, contrary to our prediction, response time of the group with TBI was slower than that of controls. The pattern of results observed in the present study was interpreted to possibly reflect an impairment of both the frontal lobes as well as that of diffuse axonal injury, which is well documented as being affected by TBI. The former impairment affects baseline performance of the conceptual learning skill, while the latter affects the overall slower performance of the perceptual learning skill.	[Vakil, Eli] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, IL-52900 Ramat Gan, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	vakile@mail.biu.ac.il			Israeli Ministry of Defense, Rehabilitation Department	This work was supported by the Israeli Ministry of Defense, Rehabilitation Department.	ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Beaunieux H, 2006, MEMORY, V14, P521, DOI 10.1080/09658210500477766; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; COHEN NJ, 1985, ANN NY ACAD SCI, V444, P54, DOI 10.1111/j.1749-6632.1985.tb37579.x; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; FERRARO FR, 1993, BRAIN COGNITION, V21, P163, DOI 10.1006/brcg.1993.1013; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Heaton SK, 1993, WISCONSIN CARD SORTI; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MOSCOVITCH M, 1994, ATTENTION PERFORM, V15, P619; Moscovitch M., 1994, NEUROPSYCHOLOGY, V8, P524; Mulligan NW, 1998, J EXP PSYCHOL LEARN, V24, P27, DOI 10.1037/0278-7393.24.1.27; MUTTER SA, 1994, J CLIN EXP NEUROPSYC, V16, P271, DOI 10.1080/01688639408402638; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Parkin A. J., 1993, J CLIN EXPT NEUROPSY, V8, P62; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Troyer AK, 1999, NEUROPSYCHOLOGY, V13, P467, DOI 10.1037/0894-4105.13.4.467; Troyer AK, 2000, CAN J EXP PSYCHOL, V54, P161, DOI 10.1037/h0087338; Vakil E, 1998, CORTEX, V34, P611, DOI 10.1016/S0010-9452(08)70518-5; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2004, J CLIN EXP NEUROPSYC, V26, P653, DOI 10.1080/13803390490504335; Vakil E, 2002, BRAIN COGNITION, V50, P304, DOI 10.1016/S0278-2626(02)00515-8; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; Vakil E, 1997, J Int Neuropsychol Soc, V3, P327; VAKIL E, 1997, J GERONTOL B-PSYCHOL, V52, P229; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	36	7	7	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2014	36	5					447	454		10.1080/13803395.2014.901299			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AJ3VJ	WOS:000337595700001	24742199				2022-02-06	
J	Vilke, A; Bilskiene, D; Saferis, V; Gedminas, M; Bieliauskaite, D; Tamasauskas, A; Macas, A				Vilke, Alina; Bilskiene, Diana; Saferis, Viktoras; Gedminas, Martynas; Bieliauskaite, Dalia; Tamasauskas, Arimantas; Macas, Andrius			Predictive value of early near-infrared spectroscopy monitoring of patients with traumatic brain injury	MEDICINA-LITHUANIA			English	Article						Traumatic brain injury; Near-infrared spectroscopy; Hospital mortality	CLASSIFICATION	Background and objective: Traumatic brain injury (TBI) is the leading cause of death and disability in young adults. Study aimed to define the predictive value of early near-infrared spectroscopy (NIRS) monitoring of TBI patients in a Lithuanian clinical setting. Materials and methods: Data of 61 patients was analyzed. Predictive value of early NIRS monitoring, computed tomography data and regular intensive care unit (ICU) parameters was investigated. Results: Twenty-six patients expressed clinically severe TBI; 14 patients deceased. Patients who survived expressed higher NIRS values at the periods of admission to operative room (75.4% +/- 9.8% vs. 71.0% +/- 20.5%; P = 0.013) and 1 h after admission to ICU (74.7% +/- 1.5% vs. 61.9% +/- 19.4%; P = 0.029). The NIRS values discriminated hospital mortality groups more accurately than admission GCS score, blood sugar or hemoglobin levels. Admission INR value and NIRS value at 1 h after admission to ICU were selected by discriminant analysis into the optimal set of features when classifying hospital mortality groups. Average efficiency of classification using this method was 88.9%. When rsO(2) values at 1 h after admission to ICU did not exceed 68.0% in the left hemisphere and 68.3% in the right hemisphere, the hazard ratio for death increased by 17.7 times (P < 0.01) and 5.1 times (P < 0.05), respectively. Conclusions: NIRS plays an important role in the clinical care of TBI patients. Regional brain saturation monitoring provides accurate predictive data, which can improve the allocation of scarce medical resources, set the treatment goals and alleviate the early communication with patients' relatives. (C) 2014 Lithuanian University of Health Sciences. Production and hosting by Elsevier Urban & Partner Sp. z o.o. All rights reserved.	[Vilke, Alina; Bilskiene, Diana; Gedminas, Martynas; Bieliauskaite, Dalia; Macas, Andrius] Lithuanian Univ Hlth Sci, Med Acad, Dept Anesthesiol, LT-50161 Kaunas, Lithuania; [Vilke, Alina; Tamasauskas, Arimantas] Lithuanian Univ Hlth Sci, Med Acad, Inst Neurosci, LT-50161 Kaunas, Lithuania; [Saferis, Viktoras] Lithuanian Univ Hlth Sci, Med Acad, Dept Phys Math & Biophys, LT-50161 Kaunas, Lithuania; [Tamasauskas, Arimantas] Lithuanian Univ Hlth Sci, Med Acad, Dept Neurosurg, LT-50161 Kaunas, Lithuania		Macas, A (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Dept Anesthesiol, Eiveniu 2, LT-50161 Kaunas, Lithuania.	andrius.macas@kaunoklinikos.lt			LSMU Science Foundation; LSMU Faculty of Medicine	Support for this study in form of supplying portion of optodes was received from LSMU Science Foundation and LSMU Faculty of Medicine.	Adelson P David, 2007, Clin Neurosurg, V54, P58; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Gill AS, 2011, J NEUROSURG, V114, P470, DOI 10.3171/2010.2.JNS091017; Joshi B, 2012, ANESTH ANALG, V114, P503, DOI 10.1213/ANE.0b013e31823d292a; Kurihara K, 2007, J APPL PHYSIOL, V103, P1326, DOI 10.1152/japplphysiol.01191.2006; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Pennekamp CWA, 2009, EUR J VASC ENDOVASC, V38, P539, DOI 10.1016/j.ejvs.2009.07.008; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Salim A, 2009, AM SURGEON, V75, P25; Smith M, 2009, ANESTH ANALG, V108, P1055, DOI 10.1213/ane.0b013e31819a0301; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266	22	7	9	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.		2014	50	5					263	268		10.1016/j.medici.2014.10.001			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1YO	WOS:000348705900002	25488161	gold			2022-02-06	
J	Waid-Ebbs, JK; Daly, J; Wu, SS; Berg, WK; Bauer, RM; Perlstein, WM; Crosson, B				Waid-Ebbs, J. Kay; Daly, Janis; Wu, Samuel S.; Berg, W. Keith; Bauer, Russell M.; Perlstein, William M.; Crosson, Bruce			Response to Goal Management Training in Veterans with blast-related mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injury; cognitive rehabilitation; combat Veterans; concussion; executive function; intervention; Operation Enduring Freedom; Operation Iraqi Freedom; Operation New Dawn; traumatic brain injury	COGNITIVE REHABILITATION; EXECUTIVE FUNCTION; FRONTAL-LOBE; PLANNING ABILITY; TOWER; BEHAVIOR; LONDON; TASK; DYSFUNCTION; VERSIONS	Veterans with blast-related mild traumatic brain injury (TBI) experience cognitive deficits that interfere with functional activities. Goal Management Training (GMT), which is a metacognitive intervention, offers an executive function rehabilitation approach that draws upon theories concerning goal processing and sustained attention. GMT has received empirical support in studies of patients with TBI but has not been tested in Veterans with blast-related mild TBI. GMT was modified from 7 weekly to 10 biweekly sessions. Participants included six combat Veterans who reported multiple blast exposures resulting in symptoms consistent with mild TBI. Group analysis showed a significant improvement in measures of executive function derived from performance on the computerized Tower of London. There were no significant changes on self/informant questionnaires of executive function, indicating a lack of generalization of improvement from the clinic to everyday activities. Overall, while the data indicate efficacy of GMT in the rehabilitation of combat Veterans with executive function deficits because of blast-related mild TBI, enhancement of generalization is needed.	[Waid-Ebbs, J. Kay; Daly, Janis; Bauer, Russell M.; Perlstein, William M.; Crosson, Bruce] Dept Vet Affairs VA Rehabil Res & Dev, Brain Rehabil Res Ctr, Gainesville, FL USA; [Daly, Janis] Univ Florida, Dept Phys Therapy Neurol & Biomed Engn, Gainesville, FL USA; [Wu, Samuel S.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Berg, W. Keith] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Bauer, Russell M.; Perlstein, William M.; Crosson, Bruce] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Crosson, Bruce] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Crosson, Bruce] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Crosson, Bruce] Ctr Excellence Visual & Neurocognit Rehabil, VA Rehabil Res & Dev, Atlanta, GA USA		Waid-Ebbs, JK (corresponding author), Malcom Randall VAMC, Mail Code 151-A,1601 SW Archer Rd, Gainesville, FL 32607 USA.	Julia.Waid-Ebbs@va.gov			Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B6700M]	This material was based on work supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service (award B6700M),. J. Kay Waid-Ebbs, Health Scientist, Brain Rehabilitation Research Center of Excellence, Gainesville, Florida.	Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Berg WK, 2010, BRAIN COGNITION, V72, P472, DOI 10.1016/j.bandc.2010.01.002; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Feldstein SN, 1999, CLIN NEUROPSYCHOL, V13, P303, DOI 10.1076/clin.13.3.303.1744; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; FISHER AG, 1997, ASSESSMENT MOTOR PRO; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Kaller CP, 2012, PSYCHOL ASSESSMENT, V24, P46, DOI 10.1037/a0025174; Kaller CP, 2004, COGNITIVE BRAIN RES, V20, P462, DOI 10.1016/j.cogbrainres.2004.04.002; Kazdin A., 1982, SINGLE CASE RES DESI; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Koeler R, 2011, I MED COMMITTEE COGN; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Krishnan M, 2012, CLIN NEUROPSYCHOL, V26, P951, DOI 10.1080/13854046.2012.708166; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Metzler-Baddeley C, 2010, APPL NEUROPSYCHOL, V17, P299, DOI 10.1080/09084282.2010.523394; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Robertson I., 1996, GOAL MANAGEMENT TRAI; Roth R.M., 2005, BRIEF BEHAV RATING I; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Sohlberg M., 2001, COGNITIVE REHABILITA; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; Sutterlin S, 2011, SOC NEUROSCI-UK, V6, P169, DOI 10.1080/17470919.2010.495883; Sweeney S, 2010, NEUROPSYCHOL REHABIL, V20, P239, DOI 10.1080/09602010903080531; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Todd J S, 1992, J Okla State Med Assoc, V85, P227; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Unterrainer JM, 2003, COGNITIVE BRAIN RES, V17, P675, DOI 10.1016/S0926-6410(03)00191-5; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Williams D, 2013, AUTISM RES, V6, P461, DOI 10.1002/aur.1311	53	7	7	3	9	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	10					1555	1566		10.1682/JRRD.2013.12.0266			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CE8AS	WOS:000352063700008	25860148	Bronze			2022-02-06	
J	Walker, WC; McDonald, SD; Franke, LM				Walker, William C.; McDonald, Scott D.; Franke, Laura Manning			Diagnostic accuracy of Posttraumatic Stress Disorder Checklist in blast-exposed military personnel	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injury; concussion; diagnostic criteria; diagnostic errors; dual diagnosis; explosive blast; investigative techniques; medical history taking; military injury; posttraumatic stress disorder; sensitivity; specificity	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; MILD TBI; PTSD; VALIDATION; CONCUSSION; SYMPTOMS; IRAQ; AFGHANISTAN; DEPLOYMENT	Researchers often extrapolate posttraumatic stress disorder (PTSD) status from PTSD Checklist (PCL) data. When doing so, cut points should be based on samples with similar characteristics. This study assessed PCL diagnostic accuracy and postconcussive symptom levels within 106 Iraq/Afghanistan war Veterans and servicemembers with recent blast exposure. Two definitions of PTSD were applied: (1) "strict" Diagnostic and Statistical Manual of Mental Health Disorders (DSM), 4th edition (DSM-IV) criteria and (2) "relaxed" DSM-IV criteria dropping the A2 criterion as per the DSM, 5th edition. Using a structured interview for PTSD, we found moderate agreement with the PCL. Under strict criteria, PTSD prevalence was 16%, PCL cut point was 66 at peak kappa, and mean Rivermead Postconcussion Questionnaire (RPQ) score trended higher for those with PTSD than for those without PTSD (35.5 +/- 11.2 vs 30.5 +/- 10.7, respectively; p = 0.08). Under relaxed criteria, PTSD prevalence was 26.4%, PCL cut point was 58 at peak kappa, and those with PTSD had higher RPQ scores than those without PTSD (36.4 +/- 11.2 vs 29.5 +/- 10.2, respectively; p = 0.003). Participants diagnosed with blast-related mild traumatic brain injury (n = 90) did not differ from those without mild traumatic brain injury (n = 16) in symptom scores. In conclusion, persons with combat-related blast exposure need higher than conventional PCL cut points and those with PTSD have more severe postconcussive-type symptoms than those without PTSD.	[Walker, William C.; McDonald, Scott D.; Franke, Laura Manning] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Def & Vet Brain Injury Ctr, Richmond, VA USA; [Walker, William C.; McDonald, Scott D.; Franke, Laura Manning] Hunter Holmes McGuire Dept Vet Affairs Med Ctr, Richmond, VA USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, MCV Stn, Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu			Congressionally Directed Medical Research ProgramsUnited States Department of Defense [W91ZSQ8118N620]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; VA, VHA, Office of Research and Development, and Rehabilitation Research and Development Career Development Award-2 [1IK2RX000703-01]	This material was based on work supported by the Congressionally Directed Medical Research Programs (award W91ZSQ8118N620) with some support from the Defense and Veterans Brain Injury Center. This material was also based on work supported in part by a VA, VHA, Office of Research and Development, and Rehabilitation Research and Development Career Development Award-2 (1IK2RX000703-01 to S. M.).	Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Calhoun PS, 2012, DEPRESS ANXIETY, V29, P1032, DOI 10.1002/da.22012; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fleiss JL, 1973, STAT METHODS RATES P; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jones JE, 2005, J NEUROPSYCH CLIN N, V17, P172, DOI 10.1176/appi.neuropsych.17.2.172; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Ochodo EA, 2013, CLIN CHEM, V59, P917, DOI 10.1373/clinchem.2013.206516; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pereda N, 2012, J TRAUMA STRESS, V25, P587, DOI 10.1002/jts.21736; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T., 2008, INVISIBLE WOUNDS WAR; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281	38	7	7	0	8	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	8					1203	1216		10.1682/JRRD.2013.12.0271			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CA2ZZ	WOS:000348776400004	25671462	Bronze			2022-02-06	
J	Wang, HYJ; Wu, HW; Tsai, PJ; Liu, CB; Zheng, ZF				Wang, Hay-Yan J.; Wu, Hsuan-Wen; Tsai, Ping-Ju; Liu, Cheng Bin; Zheng, Zhi-Fu			Matrix-assisted laser desorption/ionization mass spectrometry imaging of cardiolipins in rat organ sections	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						MALDI-mass spectrometry imaging; Cardiolipin; Mitochondria; Lipidomics	TRAUMATIC BRAIN-INJURY; ELECTROSPRAY-IONIZATION; OXIDATIVE LIPIDOMICS; HEPATOCYTE HETEROGENEITY; MALDI-MS; LIPIDS; IONS; METABOLISM; QUADRUPOLE; LIVER	Cardiolipin (CL) is a class of phospholipid tightly associated with the mitochondria functions and a prime target of oxidative stress. Peroxidation of CL dissociates its bound cytochrome C, a phenomenon that reflects oxidative stress sustained by the organ and a trigger for the intrinsic apoptotic pathway. However, CL distribution in normal organ tissues has yet to be documented. Fresh rat organs were snap-frozen, cut into cryosections that were subsequently desalted with ammonium acetate solution, and vacuum-dried. CL distribution in situ was determined using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) technique on sections sublimed with 2,5-dihydroxybenzoic acid. CL images in rat cardiac ventricular section showed a homogeneous distribution of a single m/z 1447.9 ion species that was confirmed as the (18:2)(4) CL by tandem mass spectrometry. The presence of low abundant (18:2)(3)(18:1) CL with the bulk (18:2)(4) CL in quadriceps femoris rendered the muscle CL exhibiting a slightly deviated isotopic pattern from that of cardiac muscle. In rat liver, MALDI-MSI unveiled three CL-containing mass ranges, each with a unique in situ distribution pattern. Co-registration of the CL ion images with its stained liver section image further revealed the association of CLs in each mass range with the functional zones in the liver parenchyma and suggests the participation of in situ CLs with localized hepatic functions such as oxidation, conjugation, and detoxification. The advances in CL imaging offer an approach with molecular accuracy to reveal potentially dysregulated metabolic machineries in acute and chronic diseased states.	[Wang, Hay-Yan J.; Wu, Hsuan-Wen; Tsai, Ping-Ju; Liu, Cheng Bin; Zheng, Zhi-Fu] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Tsai, Ping-Ju] Yuans Gen Hosp, Dept Surg, Kaohsiung 80249, Taiwan; [Liu, Cheng Bin] Vet Gen Hosp Kaohsiung, Dept Obstet & Gynecol, Kaohsiung 81362, Taiwan		Wang, HYJ (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan.	hyjwang@faculty.nsysu.edu.tw			National Scientific Council, Taiwan [NSC-99-2320-B-110-001-MY3]; Veterans General Hospital-Kaohsiung-National Sun Yat-Sen University Joint Research Consortium [VGHNSU101-002, VGHNSU 102 004]; "Aim for the Top University Plan" of National Sun Yat-Sen University, TaiwanMinistry of Education, Taiwan	This study was sponsored by National Scientific Council, Taiwan (grant No: NSC-99-2320-B-110-001-MY3), by Veterans General Hospital-Kaohsiung-National Sun Yat-Sen University Joint Research Consortium (grant No: VGHNSU101-002 and VGHNSU 102 004), and by "Aim for the Top University Plan" of National Sun Yat-Sen University, Taiwan. The authors acknowledge the generous support of Dr. Jentaie Shiea, Department of Chemistry, National Sun Yat-Sen University, Taiwan, for the use of MALDI-TOF/TOF instrument.	BASS NM, 1990, MOL CELL BIOCHEM, V98, P167; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Benard S, 1999, CHEM PHYS LIPIDS, V100, P115, DOI 10.1016/S0009-3084(99)00045-6; Berger A, 1993, Adv Food Nutr Res, V37, P259, DOI 10.1016/S1043-4526(08)60118-7; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/BIO.11.232, 10.4155/bio.11.232]; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Dannenberger D, 2010, CHEM PHYS LIPIDS, V163, P157, DOI 10.1016/j.chemphyslip.2009.10.011; Eibisch M, 2011, RAPID COMMUN MASS SP, V25, P2619, DOI 10.1002/rcm.5161; Fernandez JA, 2011, ANAL BIOANAL CHEM, V401, P29, DOI 10.1007/s00216-011-4696-x; Fournier I, 2008, EXPERT REV PROTEOMIC, V5, P413, DOI 10.1586/14789450.5.3.413; Franck J, 2009, MOL CELL PROTEOMICS, V8, P2023, DOI 10.1074/mcp.R800016-MCP200; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; Harkewicz R, 2011, ANNU REV BIOCHEM, V80, P301, DOI 10.1146/annurev-biochem-060409-092612; HAUSSINGER D, 1992, ENZYME, V46, P72; Hijmans BS, 2013, BIOCHIMIE, DOI [10.1016/j.biochi.2013.06.007, DOI 10.1016/J.BI0CHI.2013.06.007]; Hsieh Yunsheng, 2007, Journal of Pharmacological and Toxicological Methods, V55, P193, DOI 10.1016/j.vascn.2006.06.004; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P491, DOI 10.1016/j.jasms.2004.12.015; Hsu FF, 2006, J AM SOC MASS SPECTR, V17, P420, DOI 10.1016/j.jasms.2005.11.019; Hsu FF, 2006, J AM SOC MASS SPECTR, V17, P1146, DOI 10.1016/j.jasms.2006.04.024; JUNGERMANN K, 1982, HEPATOLOGY, V2, P385; JUNGERMANN K, 1992, ENZYME, V46, P33, DOI 10.1159/000468777; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kim J, 2013, J CHROMATOGR B, V912, P105, DOI 10.1016/j.jchromb.2012.10.036; Lapthorn C, 2013, MASS SPECTROM REV, V32, P43, DOI 10.1002/mas.21349; Maciel E, 2011, RAPID COMMUN MASS SP, V25, P316, DOI 10.1002/rcm.4866; Miyamura N, 2011, BIOCHEM BIOPH RES CO, V408, P120, DOI 10.1016/j.bbrc.2011.03.133; Murphy RC, 2011, BBA-MOL CELL BIOL L, V1811, P970, DOI 10.1016/j.bbalip.2011.04.012; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Prideaux B, 2012, J PROTEOMICS, V75, P4999, DOI 10.1016/j.jprot.2012.07.028; Ross M. H., 2003, HISTOLOGY TEXT ATLAS; SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Stevens A, 2005, HUMAN HISTOLOGY, V3rd; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Stubiger G, 2008, ANAL CHEM, V80, P1664, DOI 10.1021/ac7018766; Sugiura Y, 2010, J NEUROIMMUNE PHARM, V5, P31, DOI 10.1007/s11481-009-9162-6; Thomas A, 2012, ANAL CHEM, V84, P2048, DOI 10.1021/ac2033547; Tyurina YY, 2010, AM J PHYSIOL-LUNG C, V299, pL73, DOI 10.1152/ajplung.00035.2010; Wang HYJ, 2007, J AM SOC MASS SPECTR, V18, P567, DOI 10.1016/j.jasms.2006.10.023; Wang HYJ, 2012, ANAL BIOANAL CHEM, V404, P113, DOI 10.1007/s00216-012-6077-5; Wang HYJ, 2011, J LIPID RES, V52, P840, DOI 10.1194/jlr.D013060; Wattacheril J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057165; Wisztorski M, 2007, CURR PHARM DESIGN, V13, P3317, DOI 10.2174/138161207782360672; Wong SCC, 2009, EXPERT REV PROTEOMIC, V6, P123, DOI 10.1586/EPR.09.1; Yurkova IL, 2011, CHEM PHYS LIPIDS, V164, P393, DOI 10.1016/j.chemphyslip.2011.05.006; Yurkova R, 2009, CHEM PHYS LIPIDS, V158, P16, DOI 10.1016/j.chemphyslip.2008.09.005	51	7	7	1	46	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	JAN	2014	406	2					565	575		10.1007/s00216-013-7492-y			11	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	288QK	WOS:000329626600020	24317517				2022-02-06	
J	Wilson, MH; Kolias, AG; Hutchinson, PJ				Wilson, M. H.; Kolias, A. G.; Hutchinson, P. J.			Neurotrauma - a multidisciplinary disease	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; RANDOMIZED-CONTROLLED-TRIAL; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; INTUBATION; HEMORRHAGE; HEMATOMAS; IMPACT	Trauma is the most common cause of death for those in the under 45s (1). Traumatic brain injury (TBI) remains the cause of approximately half of the trauma deaths. Worldwide, trauma is increasing at epidemic proportions with the World Health Organization predicting road traffic accidents being the fifth most common cause of death and disability by 2030 (2). Primary injury (occurring at the time of impact) can only be reduced by public health policy and safety prevention measures. This has to be the main focus for resource-poor countries in which trauma is increasing so dramatically. Secondary injury (the brain insults that occur following the impact) includes, amongst other problems, hypoxia, hypotension, further injury from compression (e. g. expanding haematoma), intracranial hypertension, seizures and infection. The secondary insults following an impact can be prevented and minimised with high quality neurotrauma care. To achieve such an aim, a multidisciplinary approach requiring integrated prehospital, emergency, neurosurgical, intensive and rehabilitative care is required.	[Wilson, M. H.] Univ London Imperial Coll Sci Technol & Med, Dept Neurosurg, Traumat Brain Injury Ctr, London, England; [Wilson, M. H.] Queen Mary Univ London, Londons Air Ambulance, Royal London Hosp, London, England; [Wilson, M. H.; Kolias, A. G.; Hutchinson, P. J.] Royal Coll Surgeons England, British Neurotrauma Grp, Soc British Neurosurg, London WC2A 3PE, England; [Kolias, A. G.; Hutchinson, P. J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, A. G.; Hutchinson, P. J.] Univ Cambridge, Cambridge, England		Wilson, MH (corresponding author), Royal Coll Surgeons England, British Neurotrauma Grp, Soc British Neurosurg, London WC2A 3PE, England.	mark@rcsed.ac.uk		Kolias, Angelos/0000-0003-3992-0587; Wilson, Mark/0000-0002-2346-4911	Royal College of Surgeons of England Research Fellowship; NIHR Academic Clinical Fellowship; Sackler Studentship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Freemasons and the Rose-trees Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277, G0601025] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, 12/35/57] Funding Source: researchfish	MHW is an Emeritus Pre-Hospital care specialist with London's Air Ambulance. AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rose-trees Trust), an NIHR Academic Clinical Fellowship, and a Sackler Studentship. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the NIHR Cambridge Biomedical Research Centre. PJH has been appointed as the Surgical Specialty Lead for Neurosurgery, Royal College of Surgeons of England Clinical Research Initiative. MHW and AGK are members of the British Neurotrauma Group (BNTG). PJH is lead for the BNTG.	Andrews PJD, 2010, INTENS CARE MED, V36, P1990, DOI 10.1007/s00134-010-2031-1; Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Edwards P, 2005, LANCET, V365, P1957; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; KIRKMAN MA, 2013, J NEUROTRAUMA; Kolias AG, 2013, ACTA NEUROCHIR, V155, P187, DOI 10.1007/s00701-012-1531-x; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NCIPC (National Centre for Injury Prevention and Control), WEB BAS INJ STAT QUE; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Seeley HM, 2009, BRIT J NEUROSURG, V23, P530, DOI 10.1080/02688690903078874; *WHO, 2010, 2 GLOB STAT REP ROAD	19	7	7	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	JAN	2014	68	1					5	7		10.1111/ijcp.12246			3	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pharmacology & Pharmacy	271ET	WOS:000328375000004	24341298				2022-02-06	
J	Yu, HR; Wergedal, JE; Rundle, CH; Mohan, S				Yu, Hongrun; Wergedal, Jon E.; Rundle, Charles H.; Mohan, Subburaman			Reduced bone mass accrual in mouse model of repetitive mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						bone mineral content; bone mineral density; histology; histomorphometry; mice; micro-computed tomography; mild traumatic brain injury; torsion test; traumatic brain injury; weight drop model	HYPOTHALAMIC-PITUITARY DYSFUNCTION; HEAT-SHOCK-PROTEIN; PROFESSIONAL FOOTBALL; GENETIC-EVIDENCE; NEGATIVE IMPACT; MINERAL DENSITY; THYROID-HORMONE; I EXPRESSION; LONG-TERM; MICE	Traumatic brain injury (TBI) can affect bone by influencing the production/actions of pituitary hormones and neuropeptides that play significant regulatory roles in bone metabolism. Previously, we demonstrated that experimental TBI exerted a negative effect on the skeleton. Since mild TBI (mTBI) accounts for the majority of TBI cases, this study was undertaken to evaluate TBI effects using a milder impact model in female mice. Repetitive mTBI caused microhemorrhaging, astrocytosis, and increased anti-inflammatory protective actions in the brain of the impacted versus control mice 2 wk after the first impact. Serum levels of growth regulating insulin-like growth factor 1 (IGF-1) were reduced by 28.9%. Bone mass was reduced significantly in total body as well as individual skeletons. Tibial total cortical density was reduced by 7.0%, which led to weaker bones, as shown by a 31.3% decrease in femoral size adjusted peak torque. A 27.5% decrease in tibial trabecular bone volume per total volume was accompanied by a 34.3% (p = 0.07) decrease in bone formation rate (BFR) per total area. Based on our data, we conclude that repetitive mTBI exerted significant negative effects on accrual of both cortical and trabecular bone mass in mice caused by a reduced BFR.	Dept Vet Affairs Loma Linda HealthCare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA USA; Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA		Mohan, S (corresponding author), VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, 11201 Benton St 151, Loma Linda, CA 92357 USA.	Subburaman.mohan@va.gov			Rehabilitation Research and Development Merit Review Program of the VA [1RX000175]	This material was based on work supported by the Rehabilitation Research and Development Merit Review Program of the VA (grant 1RX000175) and performed at research facilities provided by the VA Loma Linda HealthCare System.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Bennetts JS, 2007, DEV DYNAM, V236, P843, DOI 10.1002/dvdy.21064; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Cao P, 2013, CNS NEUROSCI THER, V19, P337, DOI 10.1111/cns.12082; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Mohan S, 2005, J ENDOCRINOL, V185, P415, DOI 10.1677/joe.1.06141; MOHAN S, 1995, J CLIN ENDOCR METAB, V80, P637, DOI 10.1210/jc.80.2.637; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Shen W, 2004, EUR J NEUROSCI, V20, P2031, DOI 10.1111/j.1460-9568.2004.03681.x; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Thompson SW, 1966, SELECTED HISTOCHEMIC; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Venkatesh K, 2013, NEUROL INDIA, V61, P383, DOI 10.4103/0028-3886.117615; Xing WR, 2012, J BONE MINER RES, V27, P1067, DOI 10.1002/jbmr.1551; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735; Yu HR, 2013, STRESS, V16, P564, DOI 10.3109/10253890.2013.806908; Yu HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042684; Yu HR, 2012, CALCIFIED TISSUE INT, V91, P81, DOI 10.1007/s00223-012-9613-6; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	45	7	8	0	8	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	9					1427	1437		10.1682/JRRD.2014.04.0095			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CD1LN	WOS:000350836500009	25785491	Bronze			2022-02-06	
J	Gong, PP; Xu, XD; Shi, JL; Ni, LC; Huang, QF; Xia, L; Nie, DK; Lu, XJ; Chen, J; Shi, W				Gong, Peipei; Xu, Xide; Shi, Jinlong; Ni, Lanchun; Huang, Qingfeng; Xia, Liang; Nie, Dekang; Lu, Xiaojian; Chen, Jian; Shi, Wei			Phosphorylation of Mitogen- and Stress-Activated Protein Kinase-1 in Astrocytic Inflammation: A Possible Role in Inhibiting Production of Inflammatory Cytokines	PLOS ONE			English	Article							NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; NEURONAL APOPTOSIS; IN-VITRO; MSK1; MICROGLIA; LIPOPOLYSACCHARIDE; MAPK	Purpose: It is generally accepted that inflammation has a role in the progression of many central nervous system (CNS) diseases, although the mechanisms through which this occurs remain unclear. Among mitogen-activated protein kinase (MAPK) targets, mitogen-and stress-activated protein kinase (MSK1) has been thought to be involved in the pathology of inflammatory gene expression. In this study, the roles of MSK1 activation in neuroinflammation were investigated. Methods: The bacterial lipopolysaccharide (LPS)-induced brain injury model was performed on Sprague-Dawley rats. The dynamic expression changes and the cellular location of p-MSK1 in the brain cortex were detected by Western blot and immunofluorescence staining. The synthesis of inflammatory cytokines in astrocytes was detected by enzyme-linked immunosorbent assay (ELISA). Results: Phosphorylated MSK1 (p-MSK1 Thr-581) was induced significantly after intracerebral injection of LPS into the lateral ventricles of the rat brain. Specific upregulation of p-MSK1 in astrocytes was also observed in inflamed cerebral cortex. At 1 day after LPS stimulation, iNOS, TNF alpha expression, and the astrocyte marker glial fibrillary acidic protein (GFAP) were increased significantly. Also, in vitro studies indicated that the upregulation of p-MSK1 (Thr-581) may be involved in the subsequent astrocyte inflammatory process, following LPS challenge. Using an enzyme-linked immunosorbent assay (ELISA), it was confirmed that treatment with LPS in primary astrocytes stimulated the synthesis of inflammatory cytokines, through MAPKs signaling pathways. In cultured primary astrocytes, both knock-down of total MSK1 by small interfering RNAs (siRNA) or specific mutation of Thr-581 resulted in higher production of certain cytokines, such as TNF alpha and IL-6. Conclusions: Collectively, these results suggest that MSK1 phosphorylation is associated with the regulation of LPS-induced brain injury and possibly acts as a negative regulator of inflammation.	[Gong, Peipei; Xu, Xide; Shi, Jinlong; Ni, Lanchun; Huang, Qingfeng; Xia, Liang; Nie, Dekang; Lu, Xiaojian; Chen, Jian; Shi, Wei] Nantong Univ, Dept Neurosurg, Comprehens Surg Lab, Affiliated Hosp, Nantong, Jiangsu, Peoples R China		Chen, J (corresponding author), Nantong Univ, Dept Neurosurg, Comprehens Surg Lab, Affiliated Hosp, Nantong, Jiangsu, Peoples R China.	chenjian1107@126.com; shiwei1107@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070992]; Youth Fund of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201975]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009161, BK2010169]; Nature Science Foundation of China Ministry of Health [2010-2-025]; Key Project Nature Science Foundation of Jiangsu Colleges and Universities [11KJA310002]; Application Research Project of Nantong City [HS12030]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Grand of Nantong University for innovation talent	This work was supported by the National Natural Science Foundation of China (No. 81070992), the Youth Fund of the National Natural Science Foundation of China (81201975); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009161 and No. BK2010169); Nature Science Foundation of China Ministry of Health (2010-2-025); Key Project Nature Science Foundation of Jiangsu Colleges and Universities (No. 11KJA310002); Application Research Project of Nantong City (Grant No. HS12030); Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); The Grand of Nantong University for innovation talent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SM, 2000, ANN NY ACAD SCI, V917, P84; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cho IJ, 2009, INFLAMM RES, V58, P863, DOI 10.1007/s00011-009-0057-z; Dambach DM, 2005, CURR TOP MED CHEM, V5, P929, DOI 10.2174/1568026054985911; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Degos V, 2010, J NEURAL TRANSM, V117, P1009, DOI 10.1007/s00702-010-0411-x; Dihne M, 2001, BRAIN RES, V902, P178, DOI 10.1016/S0006-8993(01)02378-2; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Gonzalez MC, 2004, NEUROSCIENCE, V127, P251, DOI 10.1016/j.neuroscience.2004.04.057; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Grin'kina NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036475; Hu S, 1997, NEUROCHEM INT, V30, P427, DOI 10.1016/S0197-0186(96)00078-2; Jana M, 2005, FREE RADICAL BIO MED, V38, P655, DOI 10.1016/j.freeradbiomed.2004.11.021; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kim JH, 2012, CELL MOL BIOL, V58, P1780, DOI 10.1170/209; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kim YH, 2010, INT IMMUNOPHARMACOL, V10, P1560, DOI 10.1016/j.intimp.2010.09.007; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; MacKenzie KF, 2013, MOL CELL BIOL, V33, P1456, DOI 10.1128/MCB.01690-12; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; Niranjan R, 2010, FREE RADICAL RES, V44, P1304, DOI 10.3109/10715762.2010.501080; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Oliveira CS, 2008, INT J DEV NEUROSCI, V26, P355, DOI 10.1016/j.ijdevneu.2007.12.007; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pan WW, 2010, J BIOL CHEM, V285, P34348, DOI 10.1074/jbc.M110.109165; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	50	7	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81747	10.1371/journal.pone.0081747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	WOS:000328730300049	24349124	Green Submitted, Green Published, gold			2022-02-06	
J	Banham-Hall, N; Kothwal, K; Pipkin, J; Bentley, J; Dickens, GL				Banham-Hall, Nicola; Kothwal, Krishna; Pipkin, Jane; Bentley, Judith; Dickens, Geoffrey L.			Prevalence of low bone mineral density in inpatients with traumatic brain injury receiving neurobehavioural rehabilitation: a postoperative, observational study	PHYSIOTHERAPY			English	Article						Osteoporosis; Osteopenia; Bone mineral density; Quantitative ultrasound; Physiotherapy; Brain injury	CLINICAL RISK-FACTORS; POSTMENOPAUSAL WOMEN; AGGRESSIVE-BEHAVIOR; HIP FRACTURE; OSTEOPOROSIS; POPULATION; MEN; MANAGEMENT; EXERCISE; EPILEPSY	Background Osteoporosis is characterised by low bone mineral density (BMD) leading to an increased risk of fracture. Patients who have sustained a significant traumatic brain injury may have an increased risk of secondary reduced BMD as a result of immobility and other factors. Objectives To describe BMD in a cohort of patients recovering from traumatic brain injury, and to discuss the implications of the findings for physiotherapy practice. Design Prospective, observational. Setting Specialist, residential unit providing care for individuals with brain injury, many with a history of severe challenging behaviour. Participants Current inpatients (n = 51, 80% male) with the capacity to provide consent, as judged by their responsible clinician. The median age was 41 years (range 20 to 60 years), and the median time since the brain injury was sustained was 22 years (range 4 to 54 years). Methods Participants' BMD was measured at the radius and tibia using quantitative ultrasound. Various clinical and demographic details were collected. Results Participants had suboptimal BMD measurements that were generally low for their age and gender. Nine (18%) participants met the criteria for osteopenia measured at the radius, and 26 (51%) participants met criteria for osteoporosis or osteopenia measured at the tibia. Conclusions Some participants had reduced BMD, putting them at risk of fracture or of developing such risk in the future. This group is at particular risk because they frequently display challenging aggressive behaviours that may be met with responses including proportionate use of manual restraint. Physiotherapists should bear this increased risk in mind when devising exercise programmes assessing risk in neurobehavioural rehabilitation settings. (C) 2013 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.	[Banham-Hall, Nicola; Kothwal, Krishna; Pipkin, Jane; Bentley, Judith] St Andrews Healthcare, Kemsley Natl Brain Injury Rehabil Unit, Northampton, England; [Dickens, Geoffrey L.] Kings Coll London, Inst Psychiat, St Andrews Acad Ctr, Northampton NN1 5BW, England		Dickens, GL (corresponding author), Kings Coll London, Inst Psychiat, St Andrews Acad Ctr, Northampton NN1 5BW, England.	gdickens@standrew.co.uk	Dickens, Geoffrey L/I-1226-2019	Dickens, Geoffrey L/0000-0002-8862-1527	St Andrew's Healthcare	St Andrew's Healthcare.	Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barkmann R, 2000, J CLIN DENSITOM, V3, P1, DOI 10.1385/JCD:3:1:001; Berry Sarah D, 2008, Curr Osteoporos Rep, V6, P149, DOI 10.1007/s11914-008-0026-4; Blake GM, 1998, J CLIN DENSITOM, V1, P55, DOI 10.1385/JCD:1:1:55; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Damilakis J, 2003, INVEST RADIOL, V38, P207, DOI 10.1097/00004424-200304000-00004; Dickens G, 2011, J PSYCHIATR MENT HLT, V18, P586, DOI 10.1111/j.1365-2850.2011.01707.x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dontas I. A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P268; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fujimura R, 1997, J BONE MINER RES, V12, P656, DOI 10.1359/jbmr.1997.12.4.656; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; HALBREICH U, 1995, PSYCHOSOM MED, V57, P485, DOI 10.1097/00006842-199509000-00011; Howard L, 2007, BRIT J PSYCHIAT, V190, P129, DOI 10.1192/bjp.bp.106.023671; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P155, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Kirk JK, 2002, FAM MED, V34, P201; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Lee SH, 2010, J BONE MINER RES, V25, P369, DOI 10.1359/jbmr.090722; Lim LS, 2009, AM J PREV MED, V36, P366, DOI 10.1016/j.amepre.2009.01.013; Mattson RH, 2004, EPILEPSY BEHAV, V5, pS36, DOI 10.1016/j.yebeh.2003.11.030; McMillan TM, 2001, BRAIN DAM B, P257; Nayak S, 2006, ANN INTERN MED, V144, P832, DOI 10.7326/0003-4819-144-11-200606060-00009; Nelson HD., 2010, SCREENING OSTEOPOROS; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P507, DOI 10.1007/s00198-008-0720-1; Pinheiro MM, 2009, OSTEOPOROSIS INT, V20, P399, DOI 10.1007/s00198-008-0680-5; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Scottish Intercollegiate Guidelines Network, 2003, MAN OST SIGN GUID 71; Shekelle P, 2007, SCREENING MEN OSTEOP; SPSS Inc, 2009, PASW STAT VERS 18 0; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Stubbs B, 2009, INT PSYCHOGERIATR, V21, P180, DOI 10.1017/S1041610208007849; Trimpou P, 2010, EUR J RADIOL, V73, P360, DOI 10.1016/j.ejrad.2008.11.024; Valsamis HA, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-36; Weiss M, 2000, OSTEOPOROSIS INT, V11, P411, DOI 10.1007/s001980070108; Weiss M, 2000, OSTEOPOROSIS INT, V11, P688, DOI 10.1007/s001980070067; Whitney J, 2012, J AM MED DIR ASSOC, V13, P535, DOI 10.1016/j.jamda.2012.03.009; Wieck A, 2002, BRIT MED J, V324, P250, DOI 10.1136/bmj.324.7332.250; Willgoss TG, 2010, J CLIN NURS, V19, P2100, DOI 10.1111/j.1365-2702.2009.03174.x; World Health Organization, 1994, WHO TECHN REP SER, V843; World Health Organization, 2010, ICD 10 VERS 2010; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	45	7	7	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0031-9406	1873-1465		PHYSIOTHERAPY	Physiotherapy	DEC	2013	99	4					328	334		10.1016/j.physio.2012.12.009			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	252AW	WOS:000326977700011	23473387				2022-02-06	
J	Bardl, S; Bardl, M; Kornhuber, ME				Bardl, S.; Bardl, M.; Kornhuber, M. E.			Dog-Based Multi-Sensorial Therapy of a Patient with a "Persistent Vegetative State" - A Case Report	REHABILITATION			German	Article						coma vigile; persistent vegetative state; severe traumatic brain injury; animal-assisted therapy	ANIMAL-ASSISTED THERAPY	Aim: There is evidence that animal-assisted therapy can have beneficial effects in patients with cognitive disorders. In the present case study, the influence of animal-assisted therapy was to be investigated in a patient with most severe cerebral lesions. Methods: A 27 year old patient with a persistent vegetative state since 5 years after severe traumatic brain injury received long term treatment by 54 sessions of animal-assisted therapy. Results: During the course of the therapeutic interventions, the patient showed more and more signs of vegetative, emotional and motor reactions. The latter were increasingly target-bound and at last allowed a simple type of non-verbal communication. Conclusion: The present case indicates that animal-assisted therapy can be a reasonable option to treat patients with most severe cerebral lesions. Furthermore, the results illustrate that the usual diagnostic classification such as persistent vegetative state based on a neurological investigation alone may be questionable. Possible reasons for the impact of animal-assisted therapy are complex and comprise e.g. multiple sensory stimuli.	[Bardl, M.] Univ Klinikum Halle, Ausbildungszentrum Gesundheitsfachberufe, Halle, Germany; [Kornhuber, M. E.] Univ Halle Wittenberg, Neurol Klin & Poliklin, Witten, Germany		Kornhuber, ME (corresponding author), Univ Klinikum Halle Saale, Neurol Klin & Poliklin, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.	malte.kornhuber@medizin.uni-halle.de					Baars S, 2011, NERVENHEILKUNDE, V12, P961; Barker SB, 1998, PSYCHIATR SERV, V49, P797, DOI 10.1176/ps.49.6.797; FRANKL VE, 1966, AM J PSYCHOTHER, V20, P252, DOI 10.1176/appi.psychotherapy.1966.20.2.252; Hotz GA, 2006, BRAIN INJURY, V20, P879, DOI 10.1080/02699050600832635; International Association of Human-Animal Interaction Organizations (IAHAIO), 1998, PRAG DECL; Kongable L G, 1989, Arch Psychiatr Nurs, V3, P191; Kotchoubey B, 2005, NEUROPSYCHOL REHABIL, V15, P333, DOI 10.1080/09602010443000416; Lasa SM, 2008, EUR J PHYS REHAB MED, V44, P99; LEVINSON BM, 1965, PSYCHOL REP, V17, P695, DOI 10.2466/pr0.1965.17.3.695; Lombardi F., 2002, COCHRANE DB SYST REV, V2002, DOI DOI 10.1002/14651858.CD001427; McCulloch AJ, 1991, CALIFORNIA VET, V8, P13; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Poza J, 2012, MED ENG PHYS; Roger-Lakenbrink I, 2006, ROG LAK, p[22, 38, 87]; Samson K, 2010, ANN NEUROL, V67, pA9, DOI 10.1002/ana.22048; Schwarzkopf A, 2003, MENSCHEN BRAUCHEN TI, P106; Von Wild K, 2012, DTSCH ARZTEBLATT, V109, pA143; Zieger A, 2007, WACHKOMA, P4	18	7	7	0	20	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0034-3536	1439-1309		REHABILITATION	Rehabilitation	DEC	2013	52	6					399	405		10.1055/s-0033-1334915			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	270PK	WOS:000328330600006	24217875				2022-02-06	
J	Brazda, N; Voss, C; Estrada, V; Lodin, H; Weinrich, N; Seide, K; Muller, J; Muller, HW				Brazda, Nicole; Voss, Christian; Estrada, Veronica; Lodin, Homaira; Weinrich, Nils; Seide, Klaus; Mueller, Joerg; Mueller, Hans W.			A mechanical microconnector system for restoration of tissue continuity and long-term drug application into the injured spinal cord	BIOMATERIALS			English	Article						Spinal cord injury; Spinal surgery; Soft tissue biomechanics; Polymethylmethacrylate; Neuronal regeneration	REGENERATION; AXONS; RESECTION; RECOVERY; GROWTH; BRAIN; SCAR	Complete transection of the spinal cord leaves a gap of several mm which fills with fibrous scar tissue. Several approaches in rodent models have used tubes, foams, matrices or tissue implants to bridge this gap. Here, we describe a mechanical microconnector system (mMS) to re-adjust the retracted spinal cord stumps. The mMS is a multi-channel system of polymethylmethacrylate (PMMA), designed to fit into the spinal cord tissue gap after transection, with an outlet tubing system to apply negative pressure to the mMS thus sucking the spinal cord stumps into the honeycomb-structured holes. The stumps adhere to the microstructure of the mMS walls and remain in the mMS after removal of the vacuum. We show that the mMS preserves tissue integrity and allows axonal regrowth at 2, 5 and 19 weeks post lesion with no adverse tissue effects like in-bleeding or cyst formation. Preliminary assessment of locomotor function in the open field suggested beneficial effects of the mMS. Additional inner micro-channels enable local substance delivery into the lesion center via an attached osmotic minipump. We suggest that the mMS is a suitable device to adapt and stabilize the injured spinal cord after surgical resection of scar tissue (e.g., for chronic patients) or traumatic injuries with large tissue and bone damages. (C) 2013 Elsevier Ltd. All rights reserved.	[Brazda, Nicole; Estrada, Veronica; Lodin, Homaira; Mueller, Hans W.] Univ Dusseldorf, Mol Neurobiol Lab, D-40225 Dusseldorf, Germany; [Voss, Christian; Mueller, Joerg] Tech Univ Hamburg, Inst Microsyst Technol, D-21073 Hamburg, Germany; [Voss, Christian; Weinrich, Nils; Seide, Klaus] BG Trauma Hosp Hamburg, Dept Trauma Surg Orthopaed & Sports Traumatol, D-21033 Hamburg, Germany		Brazda, N (corresponding author), Univ Dusseldorf, Mol Neurobiol Lab, Moorenstr 5, D-40225 Dusseldorf, Germany.	Nicole.brazda@uni-duesseldorf.de			BMBF (German Federal Ministry for Education and Research)Federal Ministry of Education & Research (BMBF); DGUV (Deutsche Gesetzliche Unfallversicherung); German Research CouncilGerman Research Foundation (DFG); Comeback-Program of the Heinrich-Heine-University	This work was supported by the BMBF (German Federal Ministry for Education and Research), DGUV (Deutsche Gesetzliche Unfallversicherung), the German Research Council (Research Training Group 1033) and by the Comeback-Program of the Heinrich-Heine-University.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blesch Armin, 2012, Handb Clin Neurol, V109, P563, DOI 10.1016/B978-0-444-52137-8.00035-8; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chen KS, 2002, J MICROELECTROMECH S, V11, P264, DOI 10.1109/JMEMS.2002.1007405; Coulthard MG, 2012, AM J PATHOL, V181, P1493, DOI 10.1016/j.ajpath.2012.06.043; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Kruse F, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00026; Loverde JR, 2011, JOVE-J VIS EXP, DOI 10.3791/2753; Loverde JR, 2011, J NEUROTRAUM, V28, P2389, DOI 10.1089/neu.2010.1598; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Rasouli A, 2009, J ORTHOP RES, V27, P931, DOI 10.1002/jor.20793; Seif GI, 2007, J NEUROTRAUM, V24, P1513, DOI 10.1089/neu.2007.0323; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Suk S, 2002, SPINE, V27, P2374, DOI 10.1097/00007632-200211010-00012; Tomita K, 1997, SPINE, V22, P324, DOI 10.1097/00007632-199702010-00018; Wang MD, 2011, TISSUE ENG PART B-RE, V17, P177, DOI 10.1089/ten.teb.2010.0648; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]	27	7	7	0	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	DEC	2013	34	38					10056	10064		10.1016/j.biomaterials.2013.09.057			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	267JT	WOS:000328094600031	24090837				2022-02-06	
J	Kean, J; Malec, JF; Cooper, DB; Bowles, AO				Kean, Jacob; Malec, James F.; Cooper, Douglas B.; Bowles, Amy O.			Utility of the Mayo-Portland Adaptability Inventory-4 for Self-Reported Outcomes in a Military Sample With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Conference of the American-Congress-of-Rehabilitation-Medicine/American-Society-for-Neurorehabilitation	OCT 11-15, 2011	Atlanta, GA	Amer Congress Rehabil Med, Amer Soc Neurorehabilitat		Brain injuries; Military personnel; Outcome assessment (health care); Outcome and process assessment (health care); Psychometrics; Rehabilitation	PSYCHOMETRIC EVALUATION; DISORDER; STRESS; SYSTEM	Objective: To investigate the psychometric properties of the Mayo-Portland Adaptability Inventory-4 (MPAI-4) obtained by self-report in a large sample of active duty military personnel with traumatic brain injury (TBI). Design: Consecutive cohort who completed the MPAI-4 as a part of a larger battery of clinical outcome measures at the time of intake to an outpatient brain injury clinic. Setting: Medical center. Participants: Consecutively referred sample of active duty military personnel (N=404) who suffered predominantly mild (n=355), but also moderate (n=37) and severe (n=12), TBI. Interventions: Not applicable. Main Outcome Measure: MPAI-4 Results: Initial factor analysis suggested 2 salient dimensions. In subsequent analysis, the ratio of the first and second eigenvalues (6.84:1) and parallel analysis indicated sufficient unidimensionality in 26 retained items. Iterative Rasch analysis resulted in the rescaling of the measure and the removal of 5 additional items for poor fit. The items of the final 21-item Mayo-Portland Adaptability Inventory-military were locally independent, demonstrated monotonically increasing responses, adequately fit the item response model, and permitted the identification of nearly 5 statistically distinct levels of disability in the study population. Slight mistargeting of the population resulted in the global outcome, as measured by the Mayo-Portland Adaptability Inventory-military, tending to be less reflective of very mild levels of disability. Conclusions: These data collected in a relatively large sample of active duty service members with TBI provide insight into the ability of patients to self-report functional impairment and the distinct effects of military deployment on outcome, providing important guidance for the meaningful measurement of outcome in this population. Archives of Physical Medicine and Rehabilitation 2013;94:2417-24 (C) 2013 by the American Congress of Rehabilitation Medicine	[Kean, Jacob] Richard L Roudebush VA Med Ctr, VA Ctr Excellence Implementing Evidence Based Pra, Indianapolis, IN 46202 USA; [Kean, Jacob] Regenstrief Inst Hlth Care, Hlth Serv Res Ctr, Indianapolis, IN 46202 USA; [Kean, Jacob; Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Cooper, Douglas B.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, Ft Sam Houston, TX USA; [Bowles, Amy O.] San Antonio Mil Med Ctr, Dept Orthoped & Rehabil, Ft Sam Houston, TX USA		Kean, J (corresponding author), Richard L Roudebush VA Med Ctr, VA Ctr Excellence Implementing Evidence Based Pra, 1481 W 10th St,Mail Code 11H, Indianapolis, IN 46202 USA.	jacob.kean@gmail.com		Kean, Jacob/0000-0002-8577-0586			Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Cook IA, 2007, J PSYCHIATR RES, V41, P737, DOI 10.1016/j.jpsychires.2006.07.015; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Lorenzo-Seva U, 1999, MULTIVAR BEHAV RES, V34, P347, DOI 10.1207/S15327906MBR3403_3; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Rose M, 2009, QUAL LIFE RES, V18, P125, DOI 10.1007/s11136-008-9436-0; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TENBERGE JMF, 1991, PSYCHOMETRIKA, V56, P309, DOI 10.1007/BF02294464; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Concussion/mTBI Working Group, 2009, VA DOD EV BAS CLIN P; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Williams CA, 2004, J AM MED INFORM ASSN, V11, P249, DOI 10.1197/jamia.M1527; Willis G. B., 2004, COGNITIVE INTERVIEWI	19	7	7	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2013	94	12					2417	2424		10.1016/j.apmr.2013.08.006			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	264UD	WOS:000327905600014	23978374				2022-02-06	
J	Lee, SR; Metwalli, ZA; Yevich, SM; Whigham, CJ; Benndorf, G				Lee, Stephen R.; Metwalli, Zeyad A.; Yevich, Steven M.; Whigham, Cliff J.; Benndorf, Goetz			Variability in Evolution and Course of Gunshot Injuries to the Neck and Impact on Management A Case Report	INTERVENTIONAL NEURORADIOLOGY			English	Article						gunshot injury; pseudoaneurysm; arteriovenous fistula; endovascular treatment; conservative management	CAROTID-ARTERY INJURIES; PSEUDOANEURYSMS; ANEURYSMS; HEAD	This study reports the differences in evolution and course of multiple pseudoaneurysms (PAs) and an axillary arteriovenous fistula (AVF) after penetrating vascular trauma due to shotgun injury to the head and neck. We describe the unusual case of a young man who, following penetrating shotgun injuries to the head and neck, developed multiple PAs of the common carotid, vertebral and superficial temporal arteries as well as an axillary AVE Serial angio graphic follow-up studies documented differences in time of occurrence, evolution and course of these lesions. This allowed for tailored management using endovascular (AVF, superficial temporal artery PAs) and conservative (carotid and vertebral PAs) treatment. No complication occurred and complete cure of all lesions was achieved and documented after seven months. Time of occurrence, evolution and regression of penetrating. vascular injuries can differ significantly even in the same patient. Close angiographic follow-up helps not only detect a lesion with delayed occurrence, but also provides a practical basis for decision-making for optimal therapeutic management.	[Lee, Stephen R.; Metwalli, Zeyad A.; Yevich, Steven M.; Whigham, Cliff J.; Benndorf, Goetz] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA		Benndorf, G (corresponding author), Baylor Coll Med, Dept Radiol, One Baylor Plaza,BCM 360, Houston, TX 77030 USA.	benndorf@bcm.edu	Metwalli, Zeyad/AAF-6957-2020	Metwalli, Zeyad/0000-0003-0067-5115			ASENSIO JA, 1991, SURG CLIN N AM, V71, P267; Berne JD, 2008, J TRAUMA, V64, P398, DOI 10.1097/TA.0b013e31815eb788; Cox MW, 2007, J VASC SURG, V46, P1227, DOI 10.1016/j.jvs.2007.08.021; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954; Garg K, 2012, J VASC SURG, V55, P1618, DOI 10.1016/j.jvs.2011.12.054; Guillon B, 1999, NEUROLOGY, V53, P117, DOI 10.1212/WNL.53.1.117; Harrigan MR, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-11; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; Johnson ON, 2007, J CARDIOVASC SURG, V48, P581; Joo JY, 2005, J TRAUMA, V58, P1159, DOI 10.1097/01.TA.0000171550.01402.ED; Maras D, 2006, CARDIOVASC INTER RAD, V29, P958, DOI 10.1007/s00270-005-0367-7; PERRY MO, 1993, J VASC SURG, V17, P399, DOI 10.1016/0741-5214(93)90424-K; Yevich S, 2012, J NEUROINTERV SURG; Zhou W, 2006, J VASC SURG, V43, P493, DOI 10.1016/j.jvs.2005.11.023	15	7	7	0	2	EDIZIONI CENTAURO	BOLOGNA	VIA DEL PRATELLO, 8, 40122 BOLOGNA, ITALY	1591-0199			INTERV NEURORADIOL	Interv. Neuroradiol.	DEC	2013	19	4					489	495		10.1177/159101991301900414			7	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AQ2HF	WOS:000342605700014	24355155	Green Published			2022-02-06	
J	Wall, G; Turner, A; Clarke, R				Wall, Gemma; Turner, Alex; Clarke, Richard			Evaluation of neuropsychological rehabilitation following severe traumatic brain injury: A case report	NEUROCASE			English	Article						Traumatic brain injury; Rehabilitation; Recovery; Compensation; Quality of life	BEHAVIOR	This case study presents the evaluation of traumatic brain injury rehabilitation for Jane, a 35-year-old woman who sustained a severe traumatic brain injury (TBI). On-going rehabilitation addressed difficulties within a structured neuro-rehabilitative therapeutic milieu and was holistically evaluated. Results showed improvement in mood and quality of life and at the compensatory level for cognition. At the impairment level, many of the affected areas of cognition remained at least below predicted pre-morbid levels. This supports the view that although TBI impairments may be permanent, structured neuro-rehabilitation can be effective through external and compensatory aids. Recording this holistically contributes to evidencing this.	[Wall, Gemma] Salford Royal NHS Fdn Trust, Dept Clin Neuropsychol, Salford M6 8HD, Lancs, England; [Wall, Gemma] Oakwood Acquired Brain Injury Rehabil Serv, Leonard Cheshire Disabil, Stockport, Lancs, England; [Turner, Alex; Clarke, Richard] Pennine Care NHS Fdn Trust, Oldham, England		Wall, G (corresponding author), Salford Royal NHS Fdn Trust, Dept Clin Neuropsychol, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England.	gemma.wall@nhs.net					ALDERMAN N, 1994, NEUROPSYCHOL REHABIL, V4, P31, DOI 10.1080/09602019408401454; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; ANDERSON ND, 2003, HDB CLIN NEUROPSYCHO, P48; [Anonymous], 1999, WORLD HLTH REP MAK D; Assessment Programme, 2008, ASS PROGR, V25, P1; Benson DM, 2007, ACQUIRED BRAIN INJUR, P122; Benton AL, 1994, MULTILINGUAL APHASIA; Brain Injury Rehabilitation Trust, 2007, BIRT MENT INF PROC B; British Society of Rehabilitation Medicine, 2003, VOC REH WAY FORW; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone K. D., 2006, J COGNITIVE NEUROSCI, V51, P257; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; Hollows S. E., 1985, ADULT MEMORY INFORM; King N. S., 2004, HDB CLIN NEUROPSYCHO, P487; Knight C, 2008, NEUROPSYCHOL REHABIL, V18, P129, DOI 10.1080/09602010701822381; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Robertson I., 1994, TEST EVERYDAY ATTENT; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Snaith RP, 1994, HADS HOSP ANXIETY DE; Sohlberg M., 2001, COGNITIVE REHABILITA; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; TURNERSTOKES L, 2003, REHABILITATION FOLLO; Wallace SE, 2007, BRAIN INJURY, V21, P1371, DOI 10.1080/02699050701785088; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Wilson B. A., 2004, CLIN NEUROPSYCHOLOGY, P345; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Worthington A. D., 2003, CLIN PSYCHOL, V23, P14	42	7	8	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	DEC 1	2013	19	6					530	541		10.1080/13554794.2012.701642			12	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	239HL	WOS:000326013100002	22856554				2022-02-06	
J	Wang, JX; Hou, Y; Ruan, SP; Wang, J; Hu, XM				Wang, Jun-Xing; Hou, Yong; Ruan, Shan-Ping; Wang, Jie; Hu, Xiao-Ming			Plasma visfatin, a possible prognostic marker in aneurysmal subarachnoid hemorrhage	PEPTIDES			English	Article						Visfatin; Aneurysmal subarachnoid hemorrhage; Prognosis; Biomarker	COLONY-ENHANCING FACTOR; TRAUMATIC BRAIN-INJURY; PROTEIN; STROKE	Visfatin is linked to inflammation and associated with clinical outcomes of intracerebral hemorrhage. This study was designed to investigate whether visfatin might serve as a marker of severity and prognosis in aneurysmal subarachnoid hemorrhage. In this study, plasma visfatin levels of 172 consecutive patients and 172 sex and age-matched healthy subjects were determined using enzyme-linked immunosorbent assay. The recorded clinical outcomes included in-hospital mortality and 6-month mortality and unfavorable outcome (Glasgow Outcome Scale score of 1-3). Plasma visfatin level was substantially higher in patients than in healthy controls (92.1 +/- 20.5 ng/mL vs. 12.4 +/- 3.2 ng/mL; P < 0.001), was significantly associated with the World Federation of Neurological Surgeons (WFNS) score (r = 0.569, P < 0.001) and Fisher score (r = 0.657, P < 0.001), was an independent predictor of in-hospital mortality [odds ratio (OR), 1.378; 95% confidence interval (CI), 1.036-1.866; P = 0.002] and 6-month mortality (OR, 1.261; 95% CI, 1.018-1.745; P = 0.004) and unfavorable outcome (OR, 1.207; 95% CI, 1.012-1.682; P = 0.008) in multivariate logistic regression analysis and had high predictive value for in-hospital mortality [area under curve(AUC), 0.849; 95% CI, 0.787-0.899; P < 0.001] and 6-month mortality (AUC, 0.868; 95% CI, 0.808-0.915; P < 0.001) and unfavorable outcome (AUC, 0.859; 95% CI, 0.797-0.907; P < 0.001) using receiver operating characteristic curves. AUCs of visfatin were similar to those of WFNS score and Fisher score (all P > 0.05), but visfatin did not improve the predictive values of WFNS score and Fisher score (all P > 0.05). Thus, visfatin may be associated with clinical severity of aneurysmal subarachnoid hemorrhage and also have prognostic value for clinical outcomes. (C) 2013 Elsevier Inc. All rights reserved.	[Wang, Jun-Xing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310000, Zhejiang, Peoples R China; [Hou, Yong; Ruan, Shan-Ping; Wang, Jie; Hu, Xiao-Ming] Taizhou Hosp Zhejiang Prov, Dept Neurosurg, Linhai 317000, Peoples R China		Hou, Y (corresponding author), Taizhou Hosp Zhejiang Prov, Dept Neurosurg, 150 Ximen Rd, Linhai 317000, Peoples R China.	taizhouyonghou@163.com					Buldak RJ, 2013, J PHYSIOL PHARMACOL, V64, P377; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Chen J, 2012, PEPTIDES, V38, P8, DOI 10.1016/j.peptides.2012.08.016; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gu SJ, 2013, CLIN CHIM ACTA, V425, P85, DOI 10.1016/j.cca.2013.07.025; Huang Q, 2013, PEPTIDES, V39, P55, DOI 10.1016/j.peptides.2012.11.006; Inagawa T, 1997, SURG NEUROL, V47, P47, DOI 10.1016/S0090-3019(96)00370-9; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Velthuis BK, 1998, RADIOLOGY, V208, P423, DOI 10.1148/radiology.208.2.9680571; Weng JF, 2013, PEPTIDES, V40, P8, DOI 10.1016/j.peptides.2012.12.017	18	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	DEC	2013	50						8	12		10.1016/j.peptides.2013.09.016			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	259JU	WOS:000327524000002	24120704				2022-02-06	
J	Blizzard, CA; King, AE; Vickers, J; Dickson, T				Blizzard, Catherine A.; King, Anna E.; Vickers, James; Dickson, Tracey			Cortical Murine Neurons Lacking the Neurofilament Light Chain Protein Have an Attenuated Response to Injury In Vitro	JOURNAL OF NEUROTRAUMA			English	Article						axotomy; cytoskeleton; neurofilaments; sprouting; trauma	AMYLOID PRECURSOR PROTEIN; TRAUMATIC AXONAL INJURY; TRIPLET PROTEINS; ALPHA-INTERNEXIN; BRAIN-INJURY; INTERMEDIATE-FILAMENTS; CYTOPLASMIC DYNEIN; ALZHEIMERS-DISEASE; RAT NEOCORTEX; CNS NEURONS	Neurofilaments (NFs) have been proposed to have a significant role in attempted axonal regeneration following a variety of forms of injury. The NF triplet proteins of the central nervous system are comprised of light (NF-L), medium (NF-M) and heavy (NF-H) chains and are part of the type IV intermediate filament family. We sought to define the role of NF-L in the neuronal response to trauma and regeneration by examining the effect of total absence of the NF-L protein on neuronal maturation and response to axotomy. This study utilized an in vitro model comprising relatively mature cortical murine neurons derived from either wild-type embryonic (E15) mice or mice with a genetic knockout of NF-L (NF-L KO). Whilst NF-L KO neurons developed to relative maturity at a comparable rate to wild-type control neurons, NF-L KO neurons demonstrated relatively increased expression of -internexin and decreased expression of NF-M. Further, we demonstrate that -internexin co-immunoprecipitates with the NF binding protein NDel1 in NFL-KO cortical neurons in vitro. Following localized axotomy, NF-L KO neurons demonstrated reduced amyloid precursor protein accumulation in damaged neurites as well as a significant reduction in the number of axons regenerating (4.79+/-0.58 sprouts) in comparison to control preparations (10.47+/-1.11 sprouts) (p<0.05). These studies indicate that NFs comprising NF-L have a dynamic role in the reactive and regenerative changes in axons following injury.	[Blizzard, Catherine A.; King, Anna E.; Dickson, Tracey] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [King, Anna E.; Vickers, James] Univ Tasmania, Sch Med, Wicking Dementia Res & Educ Ctr, Hobart, Tas 7000, Australia		Dickson, T (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Med Sci Bldg,Liverpool St, Hobart, Tas 7000, Australia.	Tracey.Dickson@utas.edu.au	King, Anna/J-7927-2014; Vickers, James C/J-7464-2014	King, Anna/0000-0003-1792-0965; Vickers, James C/0000-0001-5671-4879; Blizzard, Catherine/0000-0002-8683-2937; Dickson, Tracey/0000-0002-9196-1661			Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Carter J, 1998, J BIOL CHEM, V273, P5101, DOI 10.1074/jbc.273.9.5101; Carter JE, 1997, NEUROREPORT, V8, P2225, DOI 10.1097/00001756-199707070-00027; Chang R, 2009, J MOL BIOL, V391, P648, DOI 10.1016/j.jmb.2009.06.045; Chansard M, 2011, CYTOSKELETON, V68, P540, DOI 10.1002/cm.20532; Chuckowree JA, 2004, NEUROSCIENTIST, V10, P280, DOI 10.1177/1073858404263511; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Chung RS, 2005, EXP NEUROL, V193, P481, DOI 10.1016/j.expneurol.2005.01.005; CLEVELAND DW, 1991, J CELL SCI, P85; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hall GF, 2000, CELL MOTIL CYTOSKEL, V46, P166, DOI 10.1002/1097-0169(200007)46:3<166::AID-CM2>3.0.CO;2-8; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; King CE, 2000, ALZHEIMERS REP, V3, P31; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Kirkcaldie MTK, 2002, J CHEM NEUROANAT, V24, P163, DOI 10.1016/S0891-0618(02)00043-1; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; McLean JR, 2005, GLIA, V52, P59, DOI 10.1002/glia.20218; Musgrove REJ, 2013, NEUROTOX RES, V23, P358, DOI 10.1007/s12640-012-9352-5; Neukirchen D, 2011, SEMIN CELL DEV BIOL, V22, P825, DOI 10.1016/j.semcdb.2011.08.007; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Pierce JES, 1996, J NEUROSCI, V16, P1083; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Roush W, 1997, SCIENCE, V276, P1971, DOI 10.1126/science.276.5321.1971; SCOTT D, 1985, J BIOL CHEM, V260, P736; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Szaro BG, 2010, TRENDS NEUROSCI, V33, P27, DOI 10.1016/j.tins.2009.10.002; Teo L, 2012, TRANSL NEUROSCI, V3, P181, DOI 10.2478/s13380-012-0023-z; Toth C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002014; VICKERS JC, 1992, NEUROSCIENCE, V49, P73, DOI 10.1016/0306-4522(92)90077-F; Walker KL, 2001, J NEUROSCI, V21, P9655, DOI 10.1523/JNEUROSCI.21-24-09655.2001; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yuan AD, 2003, J NEUROSCI, V23, P9452; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Zhang GX, 2011, J COMP NEUROL, V519, P3657, DOI 10.1002/cne.22673; Zhang GX, 2005, NEUROREHAB NEURAL RE, V19, P46, DOI 10.1177/1545968305274577; Zhang QG, 2009, TRAFFIC, V10, P1337, DOI 10.1111/j.1600-0854.2009.00945.x; Zhang ZX, 2002, J COMP NEUROL, V450, P144, DOI 10.1002/cne.10306; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	54	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2013	30	22					1908	1918		10.1089/neu.2013.2850			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	243PH	WOS:000326328400009	23802559				2022-02-06	
J	Morner, T; Malmsten, J; Bernodt, K; Lunneryd, SG				Morner, Torsten; Malmsten, Jonas; Bernodt, Karin; Lunneryd, Sven-Gunnar			A study on the effect of different rifle calibres in euthanisation of grey seals (Halichoerus grypus) in seal traps in the Baltic Sea	ACTA VETERINARIA SCANDINAVICA			English	Article						Seals; Halichoerus grypus; Euthanasia; Rifles; Shotgun; Calibres		Background: In recent years, the euthanasia of seals has been discussed internationally and concern has been raised regarding the use of rifles, the effect of different calibres, and which calibres are sufficient for humane euthanasia. This study therefore investigated the effect of different firearm calibres on euthanasia of grey seals (Halichoerus grypus) in traps, and provides information for the development and refinement of regulations for hunting seals in the wild. Findings: The effect of different calibres was studied in 19 seals shot in the head and neck at close range. All seals were necropsied and radiographed to characterize the injuries caused by the bullets. All tested calibres, 5.6 mm bullet diameter or larger, and.12 shotgun, were sufficiently effective to cause severe skull fractures, meningeal haemorrhages and instant death. Conclusions: Rifles with 5.6 mm bullet diameter or larger, and a.12 shotgun loaded with a slug fired at close range to the head and neck of grey seals all caused instant death and can therefore be recommended for hunting seals in the wild.	[Morner, Torsten; Malmsten, Jonas; Bernodt, Karin] Natl Vet Inst, Dept Pathol & Wildlife Dis, S-75189 Uppsala, Sweden; [Lunneryd, Sven-Gunnar] Swedish Univ Agr Sci, Dept Aquat Resources, S-45321 Lysekil, Sweden		Morner, T (corresponding author), Natl Vet Inst, Dept Pathol & Wildlife Dis, S-75189 Uppsala, Sweden.	torsten.morner@sva.se		Malmsten, Jonas/0000-0003-1868-3746	Swedish National Veterinary Institutes research program for wildlife; Program Seal and Fishery; Swedish Environmental Protection Agency (SEPA)	This work was supported by the Swedish National Veterinary Institutes research program for wildlife and by the Program Seal and Fishery with funding from Swedish Environmental Protection Agency (SEPA). The authors thank the staff from the Institute of Coastal Research and participating fishers for help with the fieldwork, and H. Kanbjer, J. Karevik and L. Hammarsten for technical assistance during the study and A. Neimane for comments on the manuscript.	Daoust PY, 2002, CAN VET J, V43, P687; Daoust PY, 200407237 DEP FISH O, P37; Greer L. L., 2006, Guidelines for euthanasia of nondomestic animals, P66; Hemmingsson M, 2008, FISH RES, V93, P357, DOI 10.1016/j.fishres.2008.06.013; Pellas S, 2009, TRAPPER, V3, P11; Westerberg H, 2006, P AM FISH SOC S, P1281	6	7	8	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0044-605X	1751-0147		ACTA VET SCAND	Acta Vet. Scand.	NOV 13	2013	55								79	10.1186/1751-0147-55-79			4	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	279IJ	WOS:000328953300001	24219864	Green Published, gold			2022-02-06	
J	Aggarwal, NK; Ford, E				Aggarwal, Neil Krishan; Ford, Elizabeth			The Neuroethics and Neurolaw of Brain Injury	BEHAVIORAL SCIENCES & THE LAW			English	Article							ETHICAL CONSIDERATIONS; UNIQUE CHALLENGES; CLINICAL-TRIALS; CONSENT; ISSUES; LEGAL; EPIDEMIOLOGY; CAPACITY; RECOMMENDATIONS; NEUROSCIENCE	Neuroethics and neurolaw are fields of study that involve the interface of neuroscience with clinical and legal decision-making. The past two decades have seen increasing attention being paid to both fields, in large part because of the advances in neuroimaging techniques and improved ability to visualize and measure brain structure and function. Traumatic brain injury (TBI), along with its acute and chronic sequelae, has emerged as a focus of neuroethical issues, such as informed consent for treatment and research, diagnostic and prognostic uncertainties, and the subjectivity of interpretation of data. The law has also more frequently considered TBI in criminal settings for exculpation, mitigation and sentencing purposes and in tort and administrative law for personal injury, disability and worker's compensation cases. This article provides an overview of these topics with an emphasis on the current challenges that the neuroscience of TBI faces in the medicolegal arena. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Aggarwal, Neil Krishan] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Aggarwal, Neil Krishan] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Ford, Elizabeth] Bellevue Hosp Ctr, New York, NY 10016 USA; [Ford, Elizabeth] NYU, Sch Med, New York, NY 10003 USA		Aggarwal, NK (corresponding author), New York State Psychiat Inst & Hosp, 1051 Riverside Dr,Unit 11, New York, NY 10032 USA.	aggarwa@nyspi.columbia.edu		Ford, Elizabeth/0000-0002-1186-036X			American Academy of Psychiatry and the Law, 2005, ETH GUID PRACT FOR P; American College of Radiology, 2012, AM COLL RAD ACR APPR; [Anonymous], 2010, 10 LEAD CAUS DEATH I; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2013, FLORIDA TIMES UNION; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Bernat J L, 1992, J Clin Ethics, V3, P176; Bernat JL, 2013, NAT REV NEUROL, V9, P164, DOI 10.1038/nrneurol.2013.12; Bernat JL, 2009, ANN NY ACAD SCI, V1157, P117, DOI 10.1111/j.1749-6632.2008.04124.x; Blume J. H., 1999, CORNELL LAW FACULTY; BULLER T, 2006, NEUROETHICS DEFINING, P51; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cope D. N., 1989, J HEAD TRAUMA REHAB, V4, P13; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CRANFORD RE, 1989, NEUROL CLIN, V7, P697, DOI 10.1016/S0733-8619(18)30384-0; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; DeJong G., 1989, J HEAD TRAUMA REHAB, V4, P1; Eggen J. M., 2012, COLUMBIA SCI TECHNOL, V13, P11; ENGLEHARDT H, 1986, FDN BIOETHICS; Erickson Steven K., 2012, HOUSTON J LAW POLICY, V11, P303; Farah Martha, 2010, NEUROETHICS INTRO RE, P137; Farah MJ, 2012, ANNU REV PSYCHOL, V63, P571, DOI 10.1146/annurev.psych.093008.100438; Farah MJ, 2005, TRENDS COGN SCI, V9, P34, DOI 10.1016/j.tics.2004.12.001; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Fins Joseph J, 2011, Trans Am Clin Climatol Assoc, V122, P336; Ford E., 2012, NEUROIMAGING FORENSI, P325; Gazzaniga M. S., 2005, SCI AM MIND, V16, P42; Gazzaniga M. S., 2006, NEUROETHICS DEFINING, P141, DOI DOI 10.1093/ACPROF:OSO/9780198567219.003.0010; Gever John, 2011, ABC NEWS; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Granacher R. P., 2012, NEUROIMAGING FORENSI, P325; Greene J, 2004, PHILOS T R SOC B, V359, P1775, DOI 10.1098/rstb.2004.1546; HAFFEY WJ, 1989, J HEAD TRAUMA REHAB, V4, P43, DOI DOI 10.1097/00001199-198903000-00007; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Illes J, 2005, AM J BIOETHICS, V5, P5, DOI 10.1080/15265160590923358; Illes J, 2002, BRAIN COGNITION, V50, P341, DOI 10.1016/S0278-2626(02)00522-5; Illes J., 2013, AJOB NEUROSCIENCE, V4, P1; Illes J, 2009, AM J BIOETHICS, V9, P1, DOI 10.1080/15265160903192557; International Conference on Behavioral Health and Traumatic Brain Injury, 2008, CLIN NEUROPSYCHOL, V23, P1283; Jedlicka P, 2005, TRENDS COGN SCI, V9, P172, DOI 10.1016/j.tics.2005.02.010; Jennings B, 2006, HASTINGS CENT REP, V36, P29, DOI 10.1353/hcr.2006.0026; Johnson-Greene D, 2010, J HEAD TRAUMA REHAB, V25, P145, DOI 10.1097/HTR.0b013e3181d8287d; Knoppers BM, 2005, AM J BIOETHICS, V5, P33, DOI 10.1080/15265160590960393; Kompanje EJO, 2005, ACTA NEUROCHIR, V147, P633, DOI 10.1007/s00701-005-0525-3; Kompanje EJ, 2007, PROG BRAIN RES, V161, P243, DOI 10.1016/S0079-6123(06)61017-0; Lamparello A., 2011, COLUMBIA HUM R LAW R, V42, P481; Langleben DD, 2013, PSYCHOL PUBLIC POL L, V19, P222, DOI 10.1037/a0028841; Lazarus Arthur, 2011, Physician Exec, V37, P6; Leuthner SR, 2001, J AGGRESS MALTREAT T, V5, P341; Levy N, 2008, NEUROETHICS-NETH, V1, P1, DOI 10.1007/s12152-008-9007-7; Levy Neil, 2011, AJOB Neurosci, V2, P3; Lux WE, 2007, NEUROTHERAPEUTICS, V4, P525, DOI 10.1016/j.nurt.2007.04.002; Mackenzie R, 2011, NEUROETHICS-NETH, V4, P103, DOI 10.1007/s12152-010-9074-4; Madder H, 2012, J MED ETHICS, V38, P662, DOI 10.1136/medethics-2012-100869; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Martelli MF, 1999, NEUROREHABILITATION, V13, P45; Matthes J, 2013, J HEAD TRAUMA REHAB, V28, P126, DOI 10.1097/HTR.0b013e31822cc3dd; Meisel A, 1996, ARCH INTERN MED, V156, P2521, DOI 10.1001/archinte.156.22.2521; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Mohamed AD, 2012, INT J NEUROPSYCHOPH, V15, P559, DOI 10.1017/S146114571100037X; Moreno JD, 2003, NAT REV NEUROSCI, V4, P149, DOI 10.1038/nrn1031; Moriarty JC, 2008, BEHAV SCI LAW, V26, P29, DOI 10.1002/bsl.795; Morse SJ, 2011, MERCER L REV, V62, P837; Morse SJ, 2012, NEUROIMAGING FORENSI, P341; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P75, DOI 10.1310/2M1U-71FQ-QV33-56PX; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Northoff G, 2009, CURR OPIN PSYCHIATR, V22, P565, DOI 10.1097/YCO.0b013e32832e088b; Nugent Kristen M., 2012, NEUROIMAGING FORENSI, P255; Pape TLB, 2004, J REHABIL RES DEV, V41, P155, DOI 10.1682/JRRD.2004.02.0155; Racine E, 2005, NAT REV NEUROSCI, V6, P159, DOI 10.1038/nrn1609; Rhode D. L., 1995, LEGAL ETHICS, P133; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roy D, 2012, NEUROETHICS-NETH, V5, P217, DOI 10.1007/s12152-011-9130-8; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Russo Michael B, 2010, Continuum (Minneap Minn), V16, P161, DOI 10.1212/01.CON.0000391462.98911.26; Sahakian BJ, 2011, J PSYCHOPHARMACOL, V25, P197, DOI 10.1177/0269881109106926; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schaffner K. F., 2002, NEUROETHICS MAPPING, P27; Schauer F, 2010, TRENDS COGN SCI, V14, P101, DOI 10.1016/j.tics.2009.12.004; Schleim S, 2012, INT J LAW PSYCHIAT, V35, P104, DOI 10.1016/j.ijlp.2012.01.001; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Shook J. R., 2012, AJOB NEUROSCI, V3, P3, DOI [DOI 10.1080/21507740.2012.712602, 10.1080/21507740.2012.712602.]; Shuman AG, 2011, J EMERG MED, V40, P229, DOI 10.1016/j.jemermed.2009.02.029; Sugarman J, 2009, RESUSCITATION, V80, P644, DOI 10.1016/j.resuscitation.2009.03.015; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson SK, 2007, AM J LAW MED, V33, P341, DOI 10.1177/009885880703300209; Tovino S. A., 2005, SCHOLARLY WORKS; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Ubel PA, 1997, ANN INTERN MED, V126, P74, DOI 10.7326/0003-4819-126-1-199701010-00010; Wachbroit R, 2008, AM J BIOETHICS, V8, P3, DOI 10.1080/15265160701828576; Wiebking C, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0351-x; Williams MA, 2006, NEUROLOGY, V66, P13, DOI 10.1212/01.wnl.0000190568.69950.11; Wood RL, 2009, J HEAD TRAUMA REHAB, V24, P88, DOI 10.1097/HTR.0b013e31819b118a; Wright DW, 2008, ANN EMERG MED, V51, P355, DOI 10.1016/j.annemergmed.2007.08.021; [No title captured]	100	7	7	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		789	802		10.1002/bsl.2086			14	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400008	24123245				2022-02-06	
J	Bhargava, D; Alalade, A; Ellamushi, H; Yeh, J; Hunter, R				Bhargava, Deepti; Alalade, Andrew; Ellamushi, Habib; Yeh, John; Hunter, Roger			Mitigating effects of external ventricular drain usage in the management of severe head injury	ACTA NEUROCHIRURGICA			English	Article						Severe traumatic brain injury; External ventricular drain; Cerebrospinal fluid drainage; Decompressive craniectomy; Barbiturate coma	CEREBROSPINAL-FLUID DRAINAGE	Cerebrospinal fluid (CSF) drainage has been variably employed to lower intracranial pressure (ICP) in patients with severe head injury. The efficacy of this manoeuvre remains under-explored (Brain Trauma Foundation Recommendation-optional treatment). This work seeks to report the results of CSF drainage via external ventricular drain (EVD) in severe head injury in comparison to other treatment options. Retrospective observational comparative study of all consecutive patients admitted to a major trauma centre with severe traumatic brain injury over a period of 12 months. Out of a total 139 patients, 33 had delayed elevation of ICP despite conventional medical therapy, 16 patients were treated with EVD insertion (4 placed under AxiEM image guidance [Medtronic]) and 17 received either decompressive craniectomy or barbiturate coma. Subsequently, two patients with decompression had further ICP elevation and needed EVD. Two patients with EVD had raised ICP-one underwent decompression and the other was treated with barbiturate coma. One patient with EVD developed infection, which was successfully treated. Patients treated with EVD had a lower risk of needing definitive treatment for ICP control, i.e. decompressive craniectomy or barbiturate coma. EVD was a safe and less invasive procedure, and achieved sustained control of ICP in this patient group.	[Bhargava, Deepti; Alalade, Andrew; Ellamushi, Habib; Yeh, John; Hunter, Roger] Royal London Hosp, Dept Neurosurg, London E1 1BB, England; [Bhargava, Deepti] Walton Ctr Neurol & Neurosurg, Dept Neurosurg, Liverpool, Merseyside, England		Bhargava, D (corresponding author), 2 Ward Close, Warrington WA5 8XY, Cheshire, England.	deeptibhargava7@gmail.com; alaladefolusho@yahoo.com; habib.ellamushi@bartsandthelondon.nhs.uk; john.yeh@bartsandthelondon.nhs.uk; rhunter96@yahoo.com	Alalade, Andrew/Y-9744-2019	Alalade, Andrew/0000-0002-5601-0502			Brain Trauma Foundation and American Association of Neurological Surgeons, GUID SURG MAN TRAUM; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Guyot LL, 1998, ACT NEUR S, V71, P47; Kerr ME, 2000, J NEUROSURG ANESTH, V12, P324, DOI 10.1097/00008506-200010000-00005; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20	6	7	8	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2013	155	11					2129	2132		10.1007/s00701-013-1735-8			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236QZ	WOS:000325815600017	23728500				2022-02-06	
J	Bouzat, P; Francony, G; Oddo, M; Payen, JF				Bouzat, P.; Francony, G.; Oddo, M.; Payen, J. -F.			Therapeutic hypothermia for severe traumatic brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Therapeutic hypothermia; Traumatic brain; Injury; Neuroprotection; Intracranial pressure	INTRACRANIAL-PRESSURE; MILD HYPOTHERMIA; HEAD-INJURY; TEMPERATURE; NORMOTHERMIA; OXYGENATION; MECHANISMS; RISK	Therapeutic hypothermia (TH) is considered a standard of care in the post-resuscitation phase of cardiac arrest. In experimental models of traumatic brain injury (TBI). TH was found to have neuroprotective properties. However, TH failed to demonstrate beneficial effects on neurological outcome in patients with TBI. The absence of benefits of TH uniformly applied in TBI patients should not question the use of TH as a second-tier therapy to treat elevated intracranial pressure. The management of all the practical aspects of TH is a key factor to avoid side effects and to optimize the potential benefit of TH in the treatment of intracranial hypertension. Induction of TH can be achieved with external surface cooling or with intra-vascular devices. The therapeutic target should be set at a 35 degrees C using brain temperature as reference, and should be maintained at least during 48 hours and ideally over the entire period of elevated intracranial pressure. The control of the rewarming phase is crucial to avoid temperature overshooting and should not exceed 1 degrees C/day. Besides its use in the management of intracranial hypertension, therapeutic cooling is also essential to treat hyperthermia in brain-injured patients. In this review, we will discuss the benefit-risk balance and practical aspects of therapeutic temperature management in TBI patients. (C) 2013 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Bouzat, P.; Francony, G.; Payen, J. -F.] CHU Grenoble, Hop A Michallon, F-38000 Grenoble, France; [Bouzat, P.; Payen, J. -F.] Univ Grenoble 1, F-38000 Grenoble, France; [Bouzat, P.; Payen, J. -F.] INSERM, U836, Inst Neurosci Grenoble, F-38000 Grenoble, France; [Oddo, M.] CHU Lausanne, Serv Med Intens Adulte, Lausanne, Switzerland		Bouzat, P (corresponding author), CHU Grenoble, Hop A Michallon, F-38000 Grenoble, France.	pbouzat@chu-grenoble.fr	Bouzat, Pierre/AAC-4105-2019; Oddo, Mauro/R-3370-2016; Bouzat, Pierre/L-6881-2014; Payen, Jean-Francois/L-6667-2014	Bouzat, Pierre/0000-0003-4667-6738; Oddo, Mauro/0000-0002-6155-2525; 			Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bouzat P, 2013, RESUSCITATION, P30, DOI DOI 10.1016/LRESUSCITATI0N.2013.05.014; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bruder N, 2009, ANN FR ANESTH, V28, P365, DOI 10.1016/j.annfar.2009.03.001; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Degos V, 2008, ANN FR ANESTH, V27, P1008, DOI 10.1016/j.annfar.2008.07.099; Francony G, 2009, ANN FR ANESTH, V28, P371, DOI 10.1016/j.annfar.2009.02.021; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jimbo H, 2000, NEUROL MED-CHIR, V40, P463, DOI 10.2176/nmc.40.463; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Kuwagata Y, 1999, J TRAUMA, V47, P666, DOI 10.1097/00005373-199910000-00010; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Phillips KF, 2013, EUR J PHARMACOL, V698, P186, DOI 10.1016/j.ejphar.2012.10.010; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Ringel F, 2006, NEUROSCI LETT, V398, P306, DOI 10.1016/j.neulet.2006.01.012; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc12686; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Seguin P, 2012, CRIT CARE, V16, DOI 10.1186/cc11465; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Simosa HF, 2007, AM SURGEON, V73, P461; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Wang H, 2006, ACTA NEUROCHIR, V148, P565, DOI 10.1007/s00701-006-0747-z; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	43	7	8	0	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	NOV	2013	32	11					787	791		10.1016/j.annfar.2013.09.004			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	287NC	WOS:000329547500012	24138767				2022-02-06	
J	Coelho, GR; Neto, BAF; Teixeira, CCD; Marinho, DS; Rangel, MLM; Garcia, JHP				Coelho, G. R.; Feitosa Neto, B. A.; Teixeira, C. C. de G.; Marinho, D. S.; Rangel, M. L. M.; Garcia, J. H. P.			Single-Center Transfusion Rate for 555 Consecutive Liver Transplantations: Impact of Two Eras	TRANSPLANTATION PROCEEDINGS			English	Article							INTRAOPERATIVE BLOOD-TRANSFUSION; ENDOTHELIAL-CELL APOPTOSIS; PLATELETS; SURVIVAL; DISEASE; SCORE	Orthotopic liver transplantation (OLT) is the treatment of choice for patients with acute or chronic end-stage liver disease, irresectable primary liver tumor, and metabolic disorders. Historically, OLT has been associated with considerable blood loss and the need for transfusions. However, over the years there has been reduction is need for blood products. The aim of this article was to compare two distinct eras for perioperative blood transfusion rate among patients undergoing OLT; Era I, 200 transplantations in 188 patients, and Era II, 355 transplantations in 339 patients. The donor mean age was 33.70 (Era I) versus 35.34 (Era II). Cause of death in both eras was traumatic brain injury followed by cerebral vascular accident. Organ recipient data showed a mean age of 48.87 (Era I) versus 46.49 (Era II). During Era I patients with Child B (56.8%) prevailed, followed by Child C (35.4%) and Child A (7.8%). In Era II also patients with Child B (53.1%) prevailed, followed by Child C (39.6%) and Child A (7.3%). The prevalence of hepatocellular carcinoma (HCC) during Era I was 9% (18) and in Era II 20% (71). The use of blood products in the perioperative period: was as follows packed red blood cells 1.76 (Era I) versus 0.57 (Era II) units; fresh frozen plasma 1.89 (Era I) versus 0.49 (Era II) units; platelets 2.16 (Era I) versus 0.28 (Era II) units; and cryoprecipitate 0.08 (Era I) versus 0.03 (Era II) units. OLT using the piggyback technique was performed with a transfusion rate below <30%, and it reduced blood loss and prevented severe hemodynamic instability.	[Coelho, G. R.; Feitosa Neto, B. A.; Teixeira, C. C. de G.; Marinho, D. S.; Rangel, M. L. M.; Garcia, J. H. P.] Univ Fed Ceara, Hosp Univ Walter Cantidio, Dept Surg, Fortaleza, Ceara, Brazil		Garcia, JHP (corresponding author), Rua Prof Costa Mendes 1608, BR-60416200 Fortaleza, Ceara, Brazil.	huygensgarcia@hotmail.com					Brazilian Association of Organ Transplants, 2011, NUM DAT ORG DON TRAN, P1; Cacciarelli TV, 1999, ARCH SURG-CHICAGO, V134, P25, DOI 10.1001/archsurg.134.1.25; Darwish A, 2011, CURR OPIN ORGAN TRAN, V16, P326, DOI 10.1097/MOT.0b013e328346dd36; de Boer MT, 2008, ANESTH ANALG, V106, P32, DOI 10.1213/01.ane.0000289638.26666.ed; Frasco PE, 2005, ANESTH ANALG, V101, P30, DOI 10.1213/01.ANE.0000155288.57914.0D; Hannaman MJ, 2011, TRANSPLANT REV-ORLAN, V25, P36, DOI 10.1016/j.trre.2010.10.004; Hendriks HGD, 2004, THESIS U GRONINGEN; Llado L, 2004, HPB (Oxford), V6, P69, DOI 10.1080/13651820310020756; Lucey M R, 1998, Transplantation, V66, P956, DOI 10.1097/00007890-199810150-00034; Maurer J, 2004, TRANSPLANTATION; Otte JB, 2002, PEDIATR TRANSPLANT, V6, P378, DOI 10.1034/j.1399-3046.2002.01082.x; Ozier Y, 2008, CURR OPIN ORGAN TRAN, V13, P304, DOI 10.1097/MOT.0b013e3282faa0dd; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; Roayaie K, 2007, LIVER TRANSPLANT, V13, pS36, DOI 10.1002/lt.21329; Saab S, 2003, LIVER TRANSPLANT, V9, P473, DOI 10.1053/jlts.2003.50090; Sanchez JCP, 1998, HEPATO-GASTROENTEROL, V45, P1026; Neto JS, 2010, LIVER TRANSPLANT, V16, P426, DOI 10.1002/lt.22000; Showstack J, 1999, JAMA-J AM MED ASSOC, V281, P1381, DOI 10.1001/jama.281.15.1381; Sindram D, 2000, GASTROENTEROLOGY, V118, P183, DOI 10.1016/S0016-5085(00)70427-6; Sindram D, 2001, FASEB J, V15, P1230, DOI 10.1096/fj.00-0554fje	20	7	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	NOV	2013	45	9					3305	3309		10.1016/j.transproceed.2013.07.062			5	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	248NY	WOS:000326709400032	24182806				2022-02-06	
J	Kis, M; Saunders, FW; Kis, M; Irrcher, I; Tator, CH; Bishop, PJ; ten Hove, MW				Kis, Mihaly; Saunders, Fraser W.; Kis, Mihaly; Irrcher, Isabella; Tator, Charles H.; Bishop, Patrick J.; ten Hove, Martin W.			A Method of Evaluating Helmet Rotational Acceleration Protection Using the Kingston Impact Simulator (KIS Unit)	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; head injury; hockey; sport injury prevention	COLLEGIATE FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; HEAD IMPACTS; BRAIN-INJURY; CONCUSSION; PERFORMANCE; BIOMECHANICS; STATEMENT; LOCATION	Objective:Helmet use is the primary form of head protection against traumatic brain injury. Although helmet designs have proven to be effective in reducing the incidence of skull fracture and major traumatic brain injury, there is little evidence that helmets protect against concussion. Linear and rotational accelerations are important mechanisms underlying concussion, yet current testing protocols do not account for rotational acceleration. Technical considerations have prevented a valid, accurate, and reproducible testing paradigm. Our objectives were to design a novel helmet-testing methodology that accurately and reliably measures rotational acceleration at injury-relevant impact forces, locations, and planes and to evaluate differences in rotational force protection in commercially available helmets.Setting:Laboratory study.Intervention:The Kingston Impact Simulator (KIS unit) was used to study 10 commercially available hockey helmets. The rotational acceleration force protection was measured in the horizontal, coronal, and sagittal planes at each of 12 predetermined impact locations.Results:Mean peak unhelmeted and helmeted accelerations at all impact locations and planes ranged from 63 to 28.6 g and from 26.8 to 8.0 g, respectively. The percent reduction in rotational acceleration for all test helmets ranged from 6.4% to 84%. Statistically significant differences in rotational acceleration between manufacturers and within a helmet brand were identified.Conclusions:KIS is a novel testing methodology that identifies rotation force protection within and between hockey helmet models and manufacturers at different impact location and planes. This information may be useful in improving future helmet design and construction to provide maximal protection against the forces causing concussion.	[Kis, Mihaly] Trillium Hlth Ctr, Dept Neurosurg, Mississauga, ON, Canada; [Saunders, Fraser W.] Queens Univ, Kingston Gen Hosp, Dept Neurosurg, Kingston, ON, Canada; [Irrcher, Isabella; ten Hove, Martin W.] Queens Univ, Hop Hotel Dieu, Dept Ophthalmol, Kingston, ON, Canada; [Tator, Charles H.] Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Tator, Charles H.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Bishop, Patrick J.] Univ Waterloo, Dept Kinesiol, Fac Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada		ten Hove, MW (corresponding author), Queens Univ, Dept Ophthalmol, Kingston, ON, Canada.	tenhove@queensu.ca			Harry Botterell Foundation for the Neurological Sciences Fund	Funding for the current study was provided by the Harry Botterell Foundation for the Neurological Sciences Fund.	Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Becker EB, 1998, BIOM HLTH R, V21, P113; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Bishop PE, 1979, PHYSICIAN SPORTSMED, V7, P10; Bishop PE, 1977, J SAFETY RES, V9, P8; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Denny Brown D, 1941, BRAIN, V64, P156; Dixon JL, 1989, CANADIAN STANDARDS A; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holburn AHS, 1943, LANCET, V245, P3; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; King AI, MILD TRAUM BRAIN INJ; Kis M, 2004, CAN J NEUROL SCI, V31, P499, DOI 10.1017/S031716710000370X; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; Meeuwisse Willem H, 2002, Clin J Sport Med, V12, P406; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mills N J, 1990, Br J Sports Med, V24, P55; National Operating Committee on Standards for Athletic Equipment, 2006, STAND LIN IMP TEST M; Patton D, 2011, BRIT J SPORT MED, V45, P318; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	44	7	7	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2013	23	6					470	477		10.1097/JSM.0b013e318295a80f			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	248VJ	WOS:000326732800010	24080785				2022-02-06	
J	Lv, P; Xue, P; Dong, J; Peng, H; Clewell, R; Wang, AP; Wang, Y; Peng, SQ; Qu, W; Zhang, Q; Andersen, ME; Pi, JB				Lv, Peng; Xue, Peng; Dong, Jian; Peng, Hui; Clewell, Rebecca; Wang, Aiping; Wang, Yue; Peng, Shuangqing; Qu, Weidong; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo			Keap1 silencing boosts lipopolysaccharide-induced transcription of interleukin 6 via activation of nuclear factor kappa B in macrophages	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						IL6; Nrf2; Keap1; IKK beta; NF-kappa B; Macrophage	TRAUMATIC BRAIN-INJURY; BINDING PROTEIN-BETA; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; ADAPTIVE RESPONSE; CANCER-CELLS; E3 LIGASE; IKK-BETA; NRF2	Interleukin-6 (IL6) is a multifunctional cytokine that regulates immune and inflammatory responses. Multiple transcription factors, including nuclear factor kappa B (NF-kappa B) and nuclear factor E2-related factor 2 (Nrf2), regulate IL6 transcription. Kelch-like ECH-associated protein 1 (Keap1) is a substrate adaptor protein for the Cullin 3-dependent E3 ubiquitin ligase complex, which regulates the degradation of many proteins, including Nrf2 and I kappa B kinase beta (IKK beta). Here, we found that stable knockdown of Keap1 (Keap1-KD) in RAW 264.7 (RAW) mouse macrophages and human monocyte THP-1 cells significantly increased expression of 116, and Nrf2-target genes, under basal and lipopolysaccharide (LPS, 0.001-0.1 mu g/ml)-challenged conditions. However, Nrf2 activation alone, by tert-butylhydroquinone treatment of RAW cells, did not increase expression of Il6. Compared to cells transduced with scrambled non-target negative control shRNA, Keap1-KD RAW cells showed enhanced protein levels of IKK beta and increased expression and phosphorylation of NF-kappa B p65 under non-stressed and LPS-treated conditions. Because the expression of 116 in Keap1-KD RAW cells was significantly attenuated by silencing of Ikk beta, but not Nrf2, it appears that stabilized IKK beta is responsible for the enhanced transactivation of 116 in Keap1-KD cells. This study demonstrated that silencing of Keap1 in macrophages boosts LPS-induced transcription of 116 via NF-kappa B activation. Given the importance of IL6 in the inflammatory response, the Keap1-IKK beta-NF-kappa B pathway may be a novel target for treatment and prevention of inflammation and associated disorders. (C) 2013 Elsevier Inc. All rights reserved.	[Lv, Peng; Wang, Aiping] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Lv, Peng; Wang, Aiping] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lv, Peng; Xue, Peng; Dong, Jian; Peng, Hui; Clewell, Rebecca; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo] Hamner Inst Hlth Sci, Inst Chem Safety Sci, Res Triangle Pk, NC 27709 USA; [Wang, Yue] Natl Inst Food & Drug Control, Inst Med Device Standardizat Adm, Beijing, Peoples R China; [Qu, Weidong] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China		Pi, JB (corresponding author), Hamner Inst Hlth Sci, Inst Chem Safety Sci, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.	jpi@thehamner.org	xue, peng/K-4159-2015; Andersen, Melvin/S-6646-2019	Andersen, Melvin/0000-0002-3894-4811; Peng, Hui/0000-0002-6933-4098; pi, Jingbo/0000-0003-0227-8041	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ES016005]; DOW Chemical Company; UnileverUnilever; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES016005] Funding Source: NIH RePORTER	This research was supported in part by NIH grant ES016005 (JP), DOW Chemical Company (MEA) and Unilever (RC, SP and MEA).	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Giudice A, 2010, METHODS MOL BIOL, V647, P37, DOI 10.1007/978-1-60761-738-9_3; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007; Nagai N, 2009, FREE RADICAL BIO MED, V47, P300, DOI 10.1016/j.freeradbiomed.2009.04.033; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Niture S.K, 2013, FREE RADIC BIOL MED; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Reddy NM, 2009, J IMMUNOL, V183, P4601, DOI 10.4049/jimmunol.0901754; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Soetikno V, 2013, MOL NUTR FOOD RES, V57, P1649, DOI 10.1002/mnfr.201200540; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Woods CG, 2009, TOXICOL APPL PHARM, V238, P27, DOI 10.1016/j.taap.2009.04.007; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113; Yang B, 2012, TOXICOL APPL PHARM, V264, P315, DOI 10.1016/j.taap.2012.09.012; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zhan LJ, 2012, FREE RADICAL BIO MED, V53, P758, DOI 10.1016/j.freeradbiomed.2012.05.041; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhao R, 2012, ENVIRON HEALTH PERSP, V120, P583, DOI 10.1289/ehp.1104580	49	7	8	1	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	NOV 1	2013	272	3					697	702		10.1016/j.taap.2013.07.012			6	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	241BM	WOS:000326141400015	23906629				2022-02-06	
J	McBride, WF; Crighton, AH; Wygant, DB; Granacher, RP				McBride, Willie F., III; Crighton, Adam H.; Wygant, Dustin B.; Granacher, Robert P., Jr.			It's Not All in Your Head (or at Least Your Brain): Association of Traumatic Brain Lesion Presence and Location with Performance on Measures of Response Bias in Forensic Evaluation	BEHAVIORAL SCIENCES & THE LAW			English	Article							MMPI-2 VALIDITY SCALES; TEST-SCORES; VALIDATION; INJURY; RBS; FAILURE; SEEKING	This study examined the relationship between lesion presence and localization and performance on measures of cognitive response bias, specifically in individuals purporting to have a traumatic brain injury. Ninety-two participants, all of whom were involved in workers' compensation or personal injury litigation, were administered an extensive neuropsychological battery, including neuroimaging (magnetic resonance imaging and computed tomography), at a neuropsychiatric clinic in Lexington, KY. Those with evidence of intracranial injury on neuroimaging findings were placed in the head injury lesion litigation group and were coded based on the anatomical location and type of intracranial injury. Results demonstrated no significant relationships between lesion location and performance on performance validity tests (PVTs), as well as the Response Bias Scale of the Minnesota Multiphasic Personality Inventory-2 Restructured Form. Given the lack of research concerning lesions and performance validity tests, this study addresses important questions about the validity of PVTs as specific measures of response bias in patients who have structural changes secondary to traumatic brain injury. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Granacher, Robert P., Jr.] Lexington Forens Neuropsychiat, Lexington, KY 40504 USA; [Granacher, Robert P., Jr.] Univ Kentucky, Coll Med, Lexington, KY 40504 USA; [McBride, Willie F., III; Crighton, Adam H.; Wygant, Dustin B.] Eastern Kentucky Univ, Richmond, KY 40475 USA		Granacher, RP (corresponding author), Lexington Forens Neuropsychiat, 1401 Harrodsburg Rd,Suite A400, Lexington, KY 40504 USA.	rgranacher@aol.com					Berry D. T. R., 2009, NEUROPSYCHOLOGY MALI; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Browndyke J. N., 2013, MILD TRAUMATIC BRAIN, P303; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll S., 1995, COST EXCESS MED CLAI; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Granacher R. P., 2012, NEUROIMAGING FORENSI, P43; Green, 2003, WORD MEMORY TEST; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; PALMER BW, 1995, CLIN NEUROPSYCHOL, V9, P68, DOI 10.1080/13854049508402060; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Tellegen, 2008, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wu TC, 2010, PSYCHOL INJ LAW, V3, P50, DOI 10.1007/s12207-010-9067-y; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042	34	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		779	788		10.1002/bsl.2083			10	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400007	24123205				2022-02-06	
J	Pepping, M; Brunings, J; Goldberg, M				Pepping, Mary; Brunings, Julie; Goldberg, Myron			Cognition, Cognitive Dysfunction, and Cognitive Rehabilitation in Multiple Sclerosis	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Cognition; Cognitive rehabilitation; Cognitive retraining; Multiple sclerosis; Cognitive dysfunction	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; NEUROPSYCHOLOGICAL ASSESSMENT; EXECUTIVE FUNCTIONS; WORKING-MEMORY; ATROPHY; IMPAIRMENT; MS; RECOMMENDATIONS; PREDICTION	This article focuses on approaches and techniques for effective cognitive rehabilitation with people who have multiple sclerosis (MS). The patterns of preserved versus disrupted neuropsychological functions are reviewed. The relevant brain anatomy and physiology that underlie the common neurocognitive and neurobehavioral changes are described. The essential role is highlighted of comprehensive neuropsychological, speech language pathology, and clinical evaluations in the design and refinements of cognitive retraining treatment. The functional impact of cognitive problems expected with MS is emphasized, accompanied by examples of cognitive retraining approaches used to manage them and improve day-to-day performance.	[Pepping, Mary; Goldberg, Myron] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Brunings, Julie] Univ Washington, Med Ctr, Rehabil Therapy Dept, Seattle, WA 98195 USA		Pepping, M (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 356490,1959 Northeast Pacific St, Seattle, WA 98195 USA.	mpepping@u.washington.edu					Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; BEATTY WW, 1989, ARCH NEUROL-CHICAGO, V46, P1113, DOI 10.1001/archneur.1989.00520460103020; Beatty WW, 1996, NEUROPSYCHOLOGY CLIN, P225; Benedict RHB, 2008, NEUROPSYCHOLOGY, V22, P432, DOI 10.1037/0894-4105.22.4.432; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bermel RA, 2002, ARCH NEUROL-CHICAGO, V59, P275, DOI 10.1001/archneur.59.2.275; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; DEsposito M, 1996, NEUROPSYCHOLOGY, V10, P51, DOI 10.1037/0894-4105.10.1.51; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Fazekas F, 1999, NEUROLOGY, V53, P448, DOI 10.1212/WNL.53.3.448; Fischer J.S., 2001, HDB MULTIPLE SCLEROS, V53, P233; Fisher E, 2012, NEUROLOGY, V79, P1748, DOI 10.1212/WNL.0b013e31827040b5; Flavia M, 2010, J NEUROL SCI, V288, P101, DOI 10.1016/j.jns.2009.09.024; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Hohol MJ, 1997, ARCH NEUROL-CHICAGO, V54, P1018, DOI 10.1001/archneur.1997.00550200074013; Huijbregts SCJ, 2006, J NEUROL SCI, V245, P187, DOI 10.1016/j.jns.2005.07.018; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Mattioli F, 2010, NEUROL SCI, V31, P271, DOI 10.1007/s10072-010-0373-7; Moriarty DM, 1999, AM J NEURORADIOL, V20, P1956; National Multiple Sclerosis Society, 2006, EXP OP PAP ASS MAN C; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; O'Connor Paul, 2002, Neurology, V59, pS1; Pepping Mary, 2005, Phys Med Rehabil Clin N Am, V16, P411, DOI 10.1016/j.pmr.2005.01.009; Pinkston J, 2008, TXB CLIN NEUROPSYCHO, P599; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; Rosti-Otajarvi EM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub2; Rovaris M, 2000, AM J NEURORADIOL, V21, P402; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Schoonheim MM, 2012, NEUROLOGY, V79, P1754, DOI 10.1212/WNL.0b013e3182703f46; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Vigeveno RM, 2012, J MAGN RESON IMAGING, V36, P1, DOI 10.1002/jmri.23578; Wallin MT, 2006, J REHABIL RES DEV, V43, P63, DOI 10.1682/JRRD.2004.09.0120	43	7	7	2	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2013	24	4					663	+		10.1016/j.pmr.2013.06.009			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	261QN	WOS:000327679800010	24314684				2022-02-06	
J	Yuksel, H; Yavuz, O; Is, M; Comunoglu, N; Uzum, G; Akyuz, F; Yildirim, HA				Yuksel, Hatice; Yavuz, Ozlem; Is, Merih; Comunoglu, Nil; Uzum, Gulay; Akyuz, Feyzullah; Yildirim, Hayriye Ak			Simvastatin reduces VEGF and NO levels in acute stages of experimental traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article						Simvastatin; Traumatic brain injury; Rat; VEGF; NO	ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; VASCULAR-PERMEABILITY; ISCHEMIC BRAIN; ANGIOGENESIS; BARRIER; RATS; HYPERPERMEABILITY; INCREASE; HYPOXIA	This study was undertaken to evaluate the effect of simvastatin, a cholesterol-lowering agent, on vascular endothelial growth factors (VEGFs), nitric oxide (NO) levels and neuroprotection, in rats with experimentally induced traumatic brain injury (TBI). Forty Wistar albino rats were categorized into four groups: sham operated (S), trauma (T), trauma + vehicle (T + V) and trauma + simvastatin (T + S). The T, T + V and T + S groups were subjected to TBI. The T + V group was administered vehicle [ethanol:saline (1/2)] and the T + S group was administered 1 mg/kg of simvastatin 3 h after the injury insult. Blood and brain tissue specimens were obtained 24 h after the trauma to measure VEGFs and NO levels and perform histopathological examinations. The histopathological injury scores of brain tissues were significantly higher in the T group, and simvastatin significantly prevented brain injury in the T + S group. In the T group, significant increases of VEGF levels in serum and brain tissues were noted, which were prevented with simvastatin treatment in the T + S group. The markedly high levels of NO in brain tissues of the T group were decreased by simvastatin treatment in the T + S group. It can be concluded that, as evidenced by histopathological findings, simvastatin treatment improves neuropathology in acute stages of TBI.	[Yuksel, Hatice] Dicle Univ, Fac Med, Dept Biochem, TR-21280 Diyarbakir, Turkey; [Yavuz, Ozlem] Balikesir Univ, Fac Med, Dept Biochem, Balikesir, Turkey; [Is, Merih] Dr Lutfi Kirdar Kartal Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Comunoglu, Nil] Haydarpasa Numune Training & Res Hosp, Dept Pathol, Istanbul, Turkey; [Uzum, Gulay] Istanbul Univ, Fac Med, Dept Physiol, Istanbul, Turkey; [Akyuz, Feyzullah] Duzce Ataturk State Hosp, Dept Neurosurg, Duzce, Turkey; [Yildirim, Hayriye Ak] Geyve State Hosp, Dept Biochem, Sakarya, Turkey		Yuksel, H (corresponding author), Dicle Univ, Fac Med, Dept Biochem, TR-21280 Diyarbakir, Turkey.	hkyuksel@gmail.com; oyavuz08@gmail.com; merihis@yahoo.com; nilustundag@yahoo.com; guzum@istanbul.edu.tr; feyz68@mynet.com; hsm2002@gmail.com	Comunoglu, Nil/AAX-8590-2021; , nil/AAA-6280-2020; Uzum, Gulay/AAE-3076-2020; Comunoglu, Nil Ustundag/AAU-7408-2020	comunoglu, nil/0000-0002-2319-1757			Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Essig M, 1998, J AM SOC NEPHROL, V9, P1377; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Genesca J, 2003, GUT, V52, P1054, DOI 10.1136/gut.52.7.1054; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Iseri S, 2007, TOXICOLOGY, V230, P256, DOI 10.1016/j.tox.2006.11.073; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Liao JK, 2005, CURR OPIN LIPIDOL, V16, P624, DOI 10.1097/01.mol.0000191913.16321.60; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAURO VF, 1993, CLIN PHARMACOKINET, V24, P195, DOI 10.2165/00003088-199324030-00002; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148; Schiessl Barbara, 2006, Archives of Gynecology and Obstetrics, V274, P150, DOI 10.1007/s00404-006-0149-8; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Wu HM, 1996, AM J PHYSIOL-HEART C, V271, pH2735, DOI 10.1152/ajpheart.1996.271.6.H2735; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhu XY, 2008, LIFE SCI, V83, P801, DOI 10.1016/j.lfs.2008.09.029	32	7	7	0	5	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	NOV	2013	34	11					1941	1946		10.1007/s10072-013-1411-z			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250OJ	WOS:000326861800009	23543392				2022-02-06	
J	Davenport, A				Davenport, Andrew			Changing the hemodialysis prescription for hemodialysis patients with subdural and intracranial hemorrhage	HEMODIALYSIS INTERNATIONAL			English	Article						Hemodialysis; cerebral edema; extradural; intracranial hemorrhage	RENAL REPLACEMENT THERAPY; TRAUMATIC BRAIN-INJURY; ACUTE KIDNEY INJURY; INTRACEREBRAL HEMORRHAGE; DIALYSIS PATIENTS; ILL PATIENTS; FAILURE; PRESSURE; COMPLICATIONS; HEMATOMA	Although continuous modalities of renal replacement therapy offer an advantage to the patient with compromised cerebral perfusion and intracranial hypertension, they are generally limited to the intensive care unit setting. Many hemodialysis patients admitted with strokes and subdural hematoma are managed on general wards. As such, these patients are generally treated by intermittent hemodialysis, and their dialysis prescription should be altered to minimize changes in serum osmolality, and fall in blood pressure during dialysis. Such patients require more frequent but shorter dialysis sessions, using minimally bioincompatible small surface area dialyzers with lower blood flows, in combination with higher sodium and cooled dialysate. In patients at risk of intracranial hemorrhage and those with invasive intracranial monitoring, systemic anticoagulants should be avoided, choosing no anticoagulation protocols or regional anticoagulants.	UCL, Sch Med, UCL Ctr Nephrol, London NW3 2PF, England		Davenport, A (corresponding author), UCL, Sch Med, UCL Ctr Nephrol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	andrewdavenport@nhs.net					ARIEFF AI, 1973, KIDNEY INT, V4, P177, DOI 10.1038/ki.1973.100; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P561; DAVENPORT A, 1989, AM J KIDNEY DIS, V14, P516, DOI 10.1016/S0272-6386(89)80153-2; DAVENPORT A, 1993, CRIT CARE MED, V21, P328, DOI 10.1097/00003246-199303000-00007; DAVENPORT A, 1989, INT J ARTIF ORGANS, V12, P703, DOI 10.1177/039139888901201107; DAVENPORT A, 1991, NEPHRON, V59, P449, DOI 10.1159/000186607; Davenport A, 2008, HEMODIAL INT, V12, P307, DOI 10.1111/j.1542-4758.2008.00271.x; Davenport A, 2007, CONTRIB NEPHROL, V156, P333, DOI 10.1159/000102124; Davenport Andrew, 2006, Hemodial Int, V10, P162; Davenport A, 2011, HEMODIAL INT, V15, pS37, DOI 10.1111/j.1542-4758.2011.00600.x; Davenport A, 2010, HEMODIAL INT, V14, pS27, DOI 10.1111/j.1542-4758.2010.00487.x; Davenport A, 2009, CLIN KIDNEY J, V2, P439, DOI 10.1093/ndtplus/sfp136; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Hsieh CY, 2010, AM J NEPHROL, V32, P31, DOI 10.1159/000312228; Huang BR, 2008, INTERN MED J, V38, P568, DOI 10.1111/j.1445-5994.2007.01536.x; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; JONES JG, 1992, NEPHROL DIAL TRANSPL, V7, P110, DOI 10.1093/oxfordjournals.ndt.a092078; LEONARD A, 1975, ANN INTERN MED, V82, P650, DOI 10.7326/0003-4819-82-5-650; Lin CM, 2008, ACTA NEUROCHIR SUPPL, V101, P141; Neumann HPH, 2012, CEREBROVASC DIS EXTR, V2, P71, DOI 10.1159/000342620; Ochiai H, 2010, RENAL FAILURE, V32, P923, DOI 10.3109/0886022X.2010.502279; Power A, 2010, NEPHROL DIAL TRANSPL, V25, P2272, DOI 10.1093/ndt/gfq013; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Sabsovich I, 2007, AM J CRIT CARE, V16, P82, DOI 10.4037/ajcc2007.16.1.82; Sandhu E, 2012, INT J ARTIF ORGANS, V35, P642, DOI 10.5301/ijao.5000114; Santoro A, 2008, NEPHROL DIAL TRANSPL, V23, P1415, DOI 10.1093/ndt/gfm730; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Selby NM, 2006, NEPHROL DIAL TRANSPL, V21, P1883, DOI 10.1093/ndt/gfl126; Seliger SL, 2003, J AM SOC NEPHROL, V14, P2623, DOI 10.1097/01.ASN.0000088722.56342.A8; Sood P, 2007, CLIN J AM SOC NEPHRO, V2, P956, DOI 10.2215/CJN.03781106; Stoves J, 2001, ARTIF ORGANS, V25, P1009, DOI 10.1046/j.1525-1594.2001.06703.x; Trinh-Trang-Tan MM, 2005, NEPHROL DIAL TRANSPL, V20, P1984, DOI 10.1093/ndt/gfh877; Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P2662, DOI 10.2215/CJN.04550511	33	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	OCT	2013	17			1	SI		S22	S27		10.1111/hdi.12085			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	284FY	WOS:000329302700004	24134327				2022-02-06	
J	Tsesis, S; Gruenbaum, BF; Ohayon, S; Boyko, M; Gruenbaum, SE; Shapira, Y; Weintraub, A; Zlotnik, A				Tsesis, Svetlana; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Boyko, Matthew; Gruenbaum, Shaun Even; Shapira, Yoram; Weintraub, Adi; Zlotnik, Alexander			The effects of estrogen and progesterone on blood glutamate levels during normal pregnancy in women	GYNECOLOGICAL ENDOCRINOLOGY			English	Article						Estrogen; glutamate; neuroprotection; pregnancy; progesterone	CLOSED-HEAD INJURY; SCAVENGING ACTIVITY; ALZHEIMERS-DISEASE; BRAIN-INJURY; FEMALE RATS; PLASMA; GONADOTROPIN; MECHANISMS; ESTRADIOL; DEMENTIA	The purpose of this study was to examine whether changes in estrogen and progesterone levels observed during normal pregnancy influence blood glutamate levels. One-hundred and sixteen pregnant women were divided into three groups based on gestational age: group 1 included women in their first trimester, group 2 included women in their second trimester, and group 3 included women in their third trimester. A single venous blood sample was collected and analyzed for concentrations of estrogen, progesterone, glutamate-pyruvate transaminase (GPT), glutamate-oxaloacetate transaminase (GOT), and glutamate. Concentrations of blood glutamate were significantly lower during the second trimester (p < 0.001) and third trimester (p < 0.001). Blood glutamate levels were inversely correlated with levels of estrogen and progesterone throughout pregnancy (p < 0.001). Levels of GOT and GPT remained stable during the course of pregnancy, apart from a moderate reduction in GPT during the third trimester. Increases in estrogen and progesterone levels during advanced stages of pregnancy were inversely correlated with maternal blood glutamate concentrations. Once a maximal blood glutamate-reducing effect was achieved, any additional estrogen and progesterone had a negligible effect on blood glutamate. This study demonstrates the glutamate-reducing effects of estrogen and progesterone, which is most likely not mediated by a GOT/GPT conversion mechanism.	[Tsesis, Svetlana; Ohayon, Sharon; Boyko, Matthew; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, Dept Anesthesiol & Gen Intens Care, IL-84105 Beer Sheva, Israel; [Tsesis, Svetlana; Ohayon, Sharon; Boyko, Matthew; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Fac Hlth Sci, Div Anesthesiol, Dept Anesthesiol & Crit Care, Beer Sheva, Israel; [Gruenbaum, Benjamin Fredrick; Gruenbaum, Shaun Even] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Weintraub, Adi] Ben Gurion Univ Negev, Soroka Med Ctr, Div Obstet & Gynecol, IL-84105 Beer Sheva, Israel; [Weintraub, Adi] Ben Gurion Univ Negev, Fac Hlth Sci, Div Obstet & Gynecol, Dept Obstet & Gynecol B, Beer Sheva, Israel		Zlotnik, A (corresponding author), Soroka Med Ctr, Div Anesthesiol, Dept Anesthesiol, Rager Blvd,POB 151, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	Weintraub, Adi Y./I-1245-2017	Weintraub, Adi Y./0000-0002-4239-8665; Boyko, Matthew/0000-0003-3116-1643			Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Liang Z, 2002, J NEUROCHEM, V80, P807, DOI 10.1046/j.0022-3042.2002.00779.x; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Slooter AJC, 1999, J NEUROL NEUROSUR PS, V67, P779, DOI 10.1136/jnnp.67.6.779; Sortino MA, 1996, BRAIN RES BULL, V41, P359, DOI 10.1016/S0361-9230(96)00199-2; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2007, P NATL ACAD SCI USA, V104, P7315, DOI 10.1073/pnas.0702450104; Thangaratinam S, 2011, ACTA OBSTET GYN SCAN, V90, P574, DOI 10.1111/j.1600-0412.2011.01112.x; TULCHINSKY D, 1973, AM J OBSTET GYNECOL, V117, P884, DOI 10.1016/0002-9378(73)90057-4; Veliskova J, 2000, EPILEPSIA, V41, pS30, DOI 10.1111/j.1528-1157.2000.tb01553.x; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P323, DOI 10.1097/ANA.0b013e3182299b15; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	30	7	7	0	7	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0951-3590			GYNECOL ENDOCRINOL	Gynecol. Endocrinol.	OCT	2013	29	10					912	916		10.3109/09513590.2013.813467			5	Endocrinology & Metabolism; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Obstetrics & Gynecology	216CJ	WOS:000324258500009	23862584				2022-02-06	
J	Waszynski, C; Veronneau, P; Massa, A; Levick, S; Brousseau, M; Therrien, K				Waszynski, Christine; Veronneau, Patricia; Massa, Angela; Levick, Sarah; Brousseau, Melissa; Therrien, Karyn			Decreasing Patient Agitation Using Individualized Therapeutic Activities	AMERICAN JOURNAL OF NURSING			English	Article						agitation; cognitive impairment; continuous observation; delirium; psychiatric disorder; suicidal ideation; therapeutic activity; traumatic brain injury	MUSIC-THERAPY; DEMENTIA; ADULTS; DEPRESSION; QUALITY	Hospitalized patients who are suffering from cognitive impairment, delirium, suicidal ideation, traumatic brain injury, or another behavior-altering condition are often placed under continuous observation by designated "sitters." These patients may become agitated, which can jeopardize their safety even when a sitter is present. This quality improvement project was based on the hypothesis that agitation can be decreased by engaging these patients in individualized therapeutic activities. The authors created a tool that allowed continuous observers to identify a patient's abilities and interests, and then offer such activities to the patient. Data were collected using a scale that measured patient agitation before, during, and after these activities. The authors found that during the activities, 73% of patients had decreased levels of agitation compared with baseline, and 64% remained less agitated for at least one hour afterward. The intervention appeared effective in reducing levels of agitation in selected patients who were receiving continuous observation on nonpsychiatric units at a large, urban level 1 trauma center. Many patients expressed gratitude for the diversion from their health issues. Further investigation into the effectiveness of this intervention and its impact on the use of medications or restraints is warranted.	[Waszynski, Christine] Hartford Hosp, Dept Geriatr Med, Hartford, CT 06115 USA; [Veronneau, Patricia; Massa, Angela; Levick, Sarah] Hartford Hosp, Dept Nursing, Hartford, CT 06115 USA; [Brousseau, Melissa] Hartford Hosp, Hartford, CT 06115 USA; [Therrien, Karyn] Porter & Chester Inst, Pract Nursing Program, Rocky Hill, CT USA; [Therrien, Karyn] Hartford Hosp, Parent Educ Program, Hartford, CT 06115 USA		Waszynski, C (corresponding author), Hartford Hosp, Dept Geriatr Med, Hartford, CT 06115 USA.	christine.waszynski@hhchealth.org					Bogner J, 2000, AGITATED BEHAV SCALE; Boswell D J, 2001, Qual Manag Health Care, V10, P10; Conedera F, 2007, DEMENTIA SERIES, pD4; Cooke M, 2010, J HEALTH PSYCHOL, V15, P765, DOI 10.1177/1359105310368188; Corrigan JD, 1996, AM J ALZHEIMERS DIS, V11, P20; Costa A, 2010, DIGEST LIVER DIS, V42, P871, DOI 10.1016/j.dld.2010.03.016; Engberg J, 2008, GERONTOLOGIST, V48, P442, DOI 10.1093/geront/48.4.442; Flaherty JH, 2011, J AM GERIATR SOC, V59, pS295, DOI 10.1111/j.1532-5415.2011.03678.x; Guetin S, 2009, DEMENT GERIATR COGN, V28, P36, DOI 10.1159/000229024; Han PM, 2010, DEMENT GERIATR COGN, V30, P540, DOI 10.1159/000321668; Harding AD, 2010, NURS ECON, V28, P330; Joint Commission, 2012, NAT PAT SAF GOALS EF; Lai HL, 2005, J ADV NURS, V49, P234, DOI 10.1111/j.1365-2648.2004.03281.x; Mosby, 2009, MOSBYS DICT MED NURS; Nadler-Moodie Marlene, 2009, Nurs Manage, V40, P43, DOI 10.1097/01.NUMA.0000359209.42026.e9; Nightingale F., 1859, NOTES NURSING WHAT I; Nilsson U, 2001, ACTA ANAESTH SCAND, V45, P812, DOI 10.1034/j.1399-6576.2001.045007812.x; Nilsson Ulrica, 2008, AORN J, V87, P780, DOI 10.1016/j.aorn.2007.09.013; Pratt Rosalie Rebollo, 2004, Phys Med Rehabil Clin N Am, V15, P827, DOI 10.1016/j.pmr.2004.03.004; Pratt RR, 2004, PHYS MED REH CLIN N, V15, pvi; Raglio Alfredo, 2010, Curr Aging Sci, V3, P242; Scherder EJA, 2010, INT PSYCHOGERIATR, V22, P1203, DOI 10.1017/S1041610210001493; Segatore M, 2001, Orthop Nurs, V20, P31, DOI 10.1097/00006416-200101000-00008; Shorters V., 2011, MENTAL HLTH PRACTICE, V15, P24; Tabloski PA, 1995, AM J ALZHEIMERS CARE, V10, P10, DOI DOI 10.1177/153331759501000105; The Joint Commission, 2007, 2007 NAT PAT SAF GOA; Ward-Smith P, 2009, AM J ALZHEIMERS DIS, V24, P450, DOI 10.1177/1533317509350153; Wood MJM, 2011, PSYCHO-ONCOLOGY, V20, P135, DOI 10.1002/pon.1722	28	7	7	2	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0002-936X	1538-7488		AM J NURS	Am. J. Nurs.	OCT	2013	113	10					32	39					8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	299BL	WOS:000330369500017	24037247				2022-02-06	
J	Zhang, LC; Zhang, LH; Mao, Z; Tang, PF				Zhang, Licheng; Zhang, Lihai; Mao, Zhi; Tang, Peifu			Semaphoring 3A: An association between traumatic brain injury and enhanced osteogenesis	MEDICAL HYPOTHESES			English	Article							RAT SPINAL-CORD; HETEROTOPIC OSSIFICATION; HEAD-INJURY; EXPRESSION	An accelerated speed of fracture-healing in patients with traumatic brain injury (TBI) is often encountered in clinical practice. However the mechanisms responsible for this phenomenon are remain unclear. After TBI, many cytokines have been reported change their expressions, suggest that the phenomenon of accelerated speed of fracture-healing may be associated with these cytokines. Semaphorin 3A is a secreted cytokine regulated by neural injury, and it is known to guide axon/dendrite growth and neuronal migration. Recent studies suggest that Semaphorin 3A is so far the only molecule that can regulate bone resorption and formation synchronously. However, a Semaphoring 3A which could perhaps induce enhanced osteogenesis under TBI condition has not yet been identified. Therefore, we presume that Semaphoring 3A may play a key role in accelerated fracture-healing under TBI condition, and these will make Sema3A as a promising potential therapeutic target for facilitating fracture healing. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.	[Zhang, Licheng; Zhang, Lihai; Mao, Zhi; Tang, Peifu] Chinese PIA Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China		Tang, PF (corresponding author), Chinese PIA Gen Hosp, Dept Orthopaed, 28 Fuzing Rd, Beijing 100853, Peoples R China.	pftang301@163.com		Tang, Peifu/0000-0003-4279-1704	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000796, 30973068]; PLA Postgraduate Medical School [11BCZ02]	This research project was supported by the National Natural Science Foundation of China (81000796; 30973068; 30973068) and the doctorial innovation fund of PLA Postgraduate Medical School (11BCZ02).	BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; da Paz AC, 2007, MED HYPOTHESES, V68, P67, DOI 10.1016/j.mehy.2006.06.035; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Fuller DA, 2013, J SHOULDER ELB SURG, V22, P52, DOI 10.1016/j.jse.2012.01.028; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; Hashimoto M, 2004, ACTA NEUROPATHOL, V107, P250, DOI 10.1007/s00401-003-0805-z; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; Togari A, 2000, BRAIN RES, V878, P204, DOI 10.1016/S0006-8993(00)02700-1; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4	13	7	9	0	13	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2013	81	4					713	714		10.1016/j.mehy.2013.07.034			2	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	243ZO	WOS:000326357100041	23932049				2022-02-06	
J	Dawson, DR; Anderson, ND; Binns, MA; Bottari, C; Damianakis, T; Hunt, A; Polatajko, HJ; Zwarenstein, M				Dawson, Deirdre R.; Anderson, Nicole D.; Binns, Malcolm A.; Bottari, Carolina; Damianakis, Thecla; Hunt, Anne; Polatajko, Helene J.; Zwarenstein, Merrick			Managing executive dysfunction following acquired brain injury and stroke using an ecologically valid rehabilitation approach: a study protocol for a randomized, controlled trial	TRIALS			English	Article						Cognitive orientation to daily occupational performance; Executive dysfunction; Occupational therapy; Rehabilitation; Strategy-training; Stroke; Traumatic brain injury	COGNITIVE REHABILITATION; ADULTS; INTERVENTIONS; PERFORMANCE	Background: We have been investigating an ecologically valid strategy-training approach to enable adults with executive dysfunction to attain everyday life goals. Here, we report the protocol of a randomized controlled trial of the effects of this training compared to conventional therapy in a sample of community-dwelling adults with acquired brain injury and/or stroke. Methods/design: We will recruit 100 community-dwelling survivors at least six months post-acquired brain injury or stroke who report executive dysfunction during a telephone interview, confirmed in pre-training testing. Following pre-training testing, participants will be randomized to the ecologically valid strategy training or conventional therapy and receive two one-hour sessions for eight weeks (maximum of 15 hours of therapy). Post-testing will occur immediately following the training and three months later. The primary outcome is self-reported change in performance on everyday life activities measured using the Canadian Occupational Performance Measure, a standardized, semi-structured interview. Secondary outcomes are objective measurement of performance change from videotapes of treatment session, Performance Quality Rating Scale; executive dysfunction symptoms, Behavioural Rating Inventory of Executive Function - Adult; participation in everyday life, Mayo-Portland Adaptability Inventory Participation Index; and ability to solve novel problems, Instrumental Activities of Daily Living Profile. Discussion: This study is of a novel approach to promoting improvements in attainment of everyday life goals through managing executive dysfunction using an ecologically valid strategy training approach, the Cognitive Orientation to daily Occupational Performance. This study compares the efficacy of this approach with that of conventional therapy. The approach has the potential to be a valuable treatment for people with chronic acquired brain injury and/or stroke.	[Dawson, Deirdre R.; Anderson, Nicole D.; Binns, Malcolm A.] Baycrest, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Dawson, Deirdre R.; Polatajko, Helene J.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre R.; Hunt, Anne; Polatajko, Helene J.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Bottari, Carolina] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ H2H 2N8, Canada; [Damianakis, Thecla] Univ Windsor, Sch Social Work, Windsor, ON N9B 3P4, Canada; [Damianakis, Thecla] Baycrest, Kunin Lunenfeld Appl & Evaluat Res Unit, Toronto, ON M6A 2E1, Canada; [Zwarenstein, Merrick] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6G 4X8, Canada		Dawson, DR (corresponding author), Baycrest, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	ddawson@research.baycrest.org	Binns, Malcolm/AAQ-9195-2020; Anderson, Nicole D/E-9101-2011; Dawson, Deirdre R/I-8882-2014; Zwarenstein, Merrick F/P-5210-2014	Binns, Malcolm/0000-0001-9998-6612; Anderson, Nicole D/0000-0002-5979-2220; Dawson, Deirdre R/0000-0001-7517-6121; Zwarenstein, Merrick F/0000-0003-0162-7027	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation Centre for Stroke Recovery (CSR); CIHRCanadian Institutes of Health Research (CIHR)	This study is supported by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation Centre for Stroke Recovery (CSR). Anne Hunt is supported by a Doctoral Research Award from the CIHR. The views expressed are those of the authors and not necessarily those of the CIHR or CSR. The authors are grateful to the following for their work in study co-ordination, recruitment, and testing participants: Pratika Bandari, Jie Chang, Alison Douglas, Yu Han, Nikoo Norouzian and Rebecca Wright. We are also thankful to Dr. David Streiner and Ms. Corinne Kagan who are serving as our Trial Steering Committee.	Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chung CSY, 2013, COCHRANE DB SYST REV, V4, P1; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Cohen J., 2013, STAT POWER ANAL BEHA; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fox E, 2008, EDUC PSYCHOL REV, V20, P373, DOI 10.1007/s10648-008-9079-2; Gillen G., 2009, COGNITIVE PERCEPTUAL; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Malec JF., MANUAL MAYO PORTLAND; Mandich, 2004, ENABLING OCCUPATION; Martini R, 1994, THESIS U W ONTARIO; Mayer RE, 2004, AM PSYCHOL, V59, P14, DOI 10.1037/0003-066X.59.1.14; McEwen SE, 2009, BRAIN INJURY, V23, P1041, DOI 10.3109/02699050903421107; Meichenbaum, 1977, COGNITIVE BEHAV MODI; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Pollock N, 1998, CANADIAN OCCUPATIONA; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Sewell L, 2005, CHEST, V128, P1194, DOI 10.1378/chest.128.3.1194; Smith A., 1978, SYMBOL DIGIT MODALIT; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Wechsler D, 1985, WECHSLER ADULT INTEL; World Health Organization, 2007, INT CLASS FUNCT DIS	41	7	7	0	43	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	SEP 22	2013	14								306	10.1186/1745-6215-14-306			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	228BA	WOS:000325158700004	24053695	Green Published, gold			2022-02-06	
J	Dai, DW; Yuan, Q; Sun, YF; Yuan, F; Su, ZP; Ding, J; Tian, HL				Dai, Dawei; Yuan, Qiang; Sun, Yinfeng; Yuan, Fang; Su, Zuopeng; Ding, Jun; Tian, Hengli			Impact of Thoracic Injury on Traumatic Brain Injury Outcome	PLOS ONE			English	Article							PULMONARY CONTUSION; HEAD-INJURY; COMPUTED-TOMOGRAPHY; SECONDARY INSULTS; RISK	Background: To assessed the significance of thoracic injury on the 30-day mortality and outcome of traumatic brain injury (TBI). Methods: TBI patients admitted to our department were retrospectively evaluated. We developed two prognostic models based on admission predictors with logistic regression analysis to assess the significance of thoracic injuries in determining the 30-day mortality and outcome. The internal validity of the models was evaluated with the bootstrap re-sampling technique. We also validated the models in an external series of 165 patients that collected from our center. Discriminative ability was evaluated with C statistic. Calibrative ability was assessed with the Hosmer-Lemeshow test (H-L test). Results: Among 505 TBI patients admitted, 102 (20.2%) had thoracic injuries. Patients with a PCS >= 6 had a 3.142 and 8.065 times higher odds of mortality and poor outcome compared with patients with a PCS <6, respectively. Any one-score increase of the TTS had a 1.193 times higher odds of a poor outcome (p = 0.017). The predictive model for mortality and 30-day functional outcome both had good accuracy (AUC: 0.875; 95% confidence interval [CI], 0.841-0.910 and AUC: 0.888; 95% CI, 0.860-0.916, respectively). Internal validation showed no over optimism in any of the two models' predictive C statistics (C statistic 0.872 for 30-day mortality and C statistic 0.884 for the 30-day neurological outcome). The external validation confirmed the discriminatory ability of these models (C statistic 0.949 (95% CI: 0.919-0.980) for 30-day mortality and C statistic 0.915 (95% CI: 0.868-0.963) for the 30-day neurological outcome). The calibration was also good for patients from the validation population (H-L test p>0.05). Conclusion: Thoracic injury diagnosed by CT has a negative impact on the 30-day mortality and functional outcome of TBI patients. The extent of PC and the TTS are the predictors for TBI outcome.	[Dai, Dawei; Yuan, Qiang; Yuan, Fang; Su, Zuopeng; Ding, Jun; Tian, Hengli] Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Sun, Yinfeng] Shanghai Jiao Tong Univ, Dept Hyperbar Oxygen, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China		Ding, J (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China.	djdjdoc@126.com; tianhlsh@126.com			National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271383]; Shanghai Science and Technique Committee [13411951400, 13411951401, 10JC1412500]	Grant support was provided by National Nature and Science Foundation of China (grant No. 81271383) and the Shanghai Science and Technique Committee (grant No. 13411951400, 13411951401 and 10JC1412500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese J, 2001, YB INTENSIVE CARE EM, P353; Allen GS, 1996, AM SURGEON, V62, P895; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Gayzik FS, 2007, STAPP CAR CRASH JO, V51, P189; Hamrick MC, 2009, AM SURGEON, V75, P1054; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; JOHNSON JA, 1986, J TRAUMA, V26, P695, DOI 10.1097/00005373-198608000-00002; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; Leone M, 2002, ANN FR ANESTH, V21, P50, DOI 10.1016/S0750-7658(01)00550-0; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Miller PR, 2001, J TRAUMA, V51, P223, DOI 10.1097/00005373-200108000-00003; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; PFENNINGER EG, 1991, ACTA ANAESTH SCAND, V35, P148, DOI 10.1111/j.1399-6576.1991.tb03263.x; Plurad D, 2007, J TRAUMA, V62, P631, DOI 10.1097/TA.0b013e31802bf009; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Steyerberg, 2019, CLIN PREDICTION MODE; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	24	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e74204	10.1371/journal.pone.0074204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	WOS:000324338200100	24019957	Green Published, gold, Green Submitted			2022-02-06	
J	Cheng, SX; Zhang, S; Sun, HT; Tu, Y				Cheng, Shi-Xiang; Zhang, Sai; Sun, Hong-Tao; Tu, Yue			Effects of Mild Hypothermia Treatment on Rat Hippocampal beta-Amyloid Expression Following Traumatic Brain Injury	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article							THERAPEUTIC HYPOTHERMIA; PROTEIN; COMBINATION; MECHANISMS; DISEASE; CELLS	Previous studies have reported that mild induced hypothermia (MIH) treatment has positive effects on traumatic brain injury (TBI) outcomes, which have recently been linked to beta-amyloid (A beta)-induced secondary brain injury (SBI) extent in hippocampal tissues. We therefore investigate the relationship between MIH treatment and expression of A beta and related proteins following TBI. Adult Sprague-Dawley rats were randomly divided into three equal groups (S: sham-operated, N: normothermia, and H: mild hypothermia). After TBI induced by fluid percussion, group N remained at normal temperature, and group H underwent MIH (32 degrees C) for 6 hours. Behavioral scale scores were then assessed. All rats were sacrificed 24 hours and hippocampal tissues were harvested, stained with hematoxylin and eosin. mRNA and protein expressions of A beta, beta-amyloid protein precursor (APP), and beta-secretase (BACE) were analyzed. Our results revealed significantly improved behavioral scale scores and the surviving neuron numbers were observed in group H compared to group N (p<0.05). Additionally, group N increased APP, A beta, and BACE levels compared to group S (all p<0.05). Reduced expression of APP-, A beta-, and BACE were apparent in group H compared to group N (all p<0.05). However, no statistically significant difference was observed between groups H and S in behavioral scale scores and the expression of APP-, A beta-, and BACE (p>0.05). In conclusion, MIH treatment significantly improves the survival of neuron and reduced A beta, BACE, and APP upregulation after TBI, which may provide a better understanding of the mechanisms by which hypothermia reduces SBI in TBI patients.	[Cheng, Shi-Xiang; Zhang, Sai; Sun, Hong-Tao; Tu, Yue] Chinese Peoples Armed Police Forces, Ctr Neurol & Neurosurg, Inst Traumat Brain Injury & Neurosci, Pingjin Hosp,Logist Coll, Tianjin 300162, Peoples R China		Zhang, S (corresponding author), Chinese Peoples Armed Police Forces, Ctr Neurol & Neurosurg, Inst Traumat Brain Injury & Neurosci, Pingjin Hosp,Logist Coll, Tianjin 300162, Peoples R China.	zhangsai718@yahoo.com; ytumail@gmail.com			National Natural Scientific Fund of China (NSFC)National Natural Science Foundation of China (NSFC) [31200809, 81271392]; Logistics College of the Chinese People's Armed Police Forces grant [FYZ201201, WYM201119]	This study was supported by grants from the National Natural Scientific Fund of China (NSFC No. 31200809, 81271392) and the Logistics College of the Chinese People's Armed Police Forces grant (FYZ201201, WYM201119).	Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brain Trauma Foundation American Association of Neurological Surgeons and Congress of Neurological Surgeons, 2008, J NEUROTRAUM, V2025, P2276; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Frampton WR, 2011, NEUROSURGERY, V164, P28; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lichtlen P, 2008, J NEUROCHEM, V104, P859, DOI 10.1111/j.1471-4159.2007.05064.x; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Okonkwo DO, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E1; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; SCALEA TM, 1994, CRIT CARE MED, V22, P1610; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1007/978-1-4939-8793-1_15; Song SS, 2012, CURR TREAT OPTION NE, V14, P541, DOI 10.1007/s11940-012-0201-x; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083	32	7	8	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	SEP 1	2013	3	3					132	139		10.1089/ther.2013.0005			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38PI	WOS:000209354900007	24066267	Green Published			2022-02-06	
J	King, NS; Kirwilliam, S				King, Nigel S.; Kirwilliam, Simon			The Nature of Permanent Post-concussion Symptoms after Mild Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						mild traumatic brain injury; permanent post-concussion symptoms	MINOR HEAD-INJURY; PERSISTENT POSTCONCUSSION SYNDROME; FOLLOW-UP; QUESTIONNAIRE; RECOVERY	Objective: Very few studies have examined permanent post-concussion symptoms (PCSs) after mild traumatic brain injury (MTBI). None have reported the nature of such symptoms. Our recent study was the first to report on a wide range of factors affecting PCSs in a representative sample of such patients. This paper presents the frequencies of the different PCSs experienced by this group and compares them with PCSs at earlier stages post injury. Method: One hundred consecutively referred patients to a Community Head Injury Service in Buckinghamshire, UK, for the treatment of long-term PCSs after MTBI were invited to participate in the original study. Those consenting to do so (n = 24, mean time post injury = 6.9 years) completed a Rivermead Post Concussion Symptoms Questionnaire. The frequency of the types of symptoms reported is presented. These are then contrasted with comparable PCS presentations at 7-10 days and 6 months post injury from two other studies. Results: Fatigue was reported by all long-term patients. Poor concentration, sleep disturbance, taking longer to think and irritability were the other most frequently endorsed permanent symptoms. The least reported were blurred/double vision, photophobia, nausea, headache and dizziness. A similar pattern was present in those at earlier stages post injury. Conclusions: The most common permanent PCSs may be those best conceptualised as the more cognitively and emotionally based symptoms, and the least common the more somatically based ones. There may be some consistency in the nature of PCSs reported over time.	[King, Nigel S.] Camborne Ctr, Community Head Injury Serv, Aylesbury HP21 7ET, Bucks, England; [King, Nigel S.] Univ Oxford, Oxford Inst Clin Psychol Training, Oxford OX3 7JX, England; [Kirwilliam, Simon] Charing Cross Hosp, Clin Hlth & Neuropsychol Team, London W6 8RF, England		King, NS (corresponding author), Univ Oxford, Oxford Inst Clin Psychol Training, Oxford OX3 7JX, England.	nigel.king@hmc.ox.ac.uk					Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Evans R. W., 1994, NEUROL CLIN, V1, P815; FEE CRA, 1988, ARCH EMERG MED, V5, P12; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jennett BFrankowskiR, 1990, HDB CLIN NEUROLOGY, V13, P1; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; King N. S., 2008, PSYCHOL APPROACHES R, P1; King N.S., 2010, BRAIN IMPAIR, V11, P225; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MANDEL S, 1989, POSTGRAD MED, V85, P213; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Nichols L., 2010, BRAIN INJURY, V24, P458; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478	32	7	8	1	25	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2013	14	2					235	242		10.1017/BrImp.2013.17			8	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222VU	WOS:000324760900003		Bronze			2022-02-06	
J	McCauley, SR; Wilde, EA; Moretti, P; MacLeod, MC; Pedroza, C; Drever, P; Fourwinds, S; Frisby, ML; Beers, SR; Scott, JN; Hunter, JV; Traipe, E; Valadka, AB; Okonkwo, DO; Zygun, DA; Puccio, AM; Clifton, GL				McCauley, Stephen R.; Wilde, Elisabeth A.; Moretti, Paolo; MacLeod, Marianne C.; Pedroza, Claudia; Drever, Pamala; Fourwinds, Sierra; Frisby, Melisa L.; Beers, Sue R.; Scott, James N.; Hunter, Jill V.; Traipe, Elfrides; Valadka, Alex B.; Okonkwo, David O.; Zygun, David A.; Puccio, Ava M.; Clifton, Guy L.			Neurological Outcome Scale for Traumatic Brain Injury: III. Criterion-Related Validity and Sensitivity to Change in the NABIS Hypothermia-II Clinical Trial	JOURNAL OF NEUROTRAUMA			English	Article						assessment tools; neuropsychology; outcome measures; recovery; traumatic brain injury	DISABILITY RATING-SCALE; CLOSED-HEAD INJURY; NOS-TBI; COMPUTERIZED-TOMOGRAPHY; PRACTICAL SCALE; RELIABILITY; RECOVERY; RECOMMENDATIONS; CLASSIFICATION; COMMUNITY	The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) is a measure assessing neurological functioning in patients with TBI. We hypothesized that the NOS-TBI would exhibit adequate concurrent and predictive validity and demonstrate more sensitivity to change, compared with other well-established outcome measures. We analyzed data from the National Acute Brain Injury Study: Hypothermia-II clinical trial. Participants were 16-45 years of age with severe TBI assessed at 1, 3, 6, and 12 months postinjury. For analysis of criterion-related validity (concurrent and predictive), Spearman's rank-order correlations were calculated between the NOS-TBI and the Glasgow Outcome Scale (GOS), GOS-Extended (GOS-E), Disability Rating Scale (DRS), and Neurobehavioral Rating Scale-Revised (NRS-R). Concurrent validity was demonstrated through significant correlations between the NOS-TBI and GOS, GOS-E, DRS, and NRS-R measured contemporaneously at 3, 6, and 12 months postinjury (all p < 0.0013). For prediction analyses, the multiplicity-adjusted p value using the false discovery rate was <0.015. The 1-month NOS-TBI score was a significant predictor of outcome in the GOS, GOS-E, and DRS at 3 and 6 months postinjury (all p < 0.015). The 3-month NOS-TBI significantly predicted GOS, GOS-E, DRS, and NRS-R outcomes at 6 and 12 months postinjury (all p < 0.0015). Sensitivity to change was analyzed using Wilcoxon's signed rank-sum test of subsamples demonstrating no change in the GOS or GOS-E between 3 and 6 months. The NOS-TBI demonstrated higher sensitivity to change, compared with the GOS (p < 0.038) and GOS-E (p < 0.016). In summary, the NOS-TBI demonstrated adequate concurrent and predictive validity as well as sensitivity to change, compared with gold-standard outcome measures. The NOS-TBI may enhance prediction of outcome in clinical practice and measurement of outcome in TBI research.	[McCauley, Stephen R.; Wilde, Elisabeth A.; MacLeod, Marianne C.; Frisby, Melisa L.] Baylor Coll Med, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; MacLeod, Marianne C.; Frisby, Melisa L.] Univ Texas Houston, Sch Med, Houston, TX USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Moretti, Paolo] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.; Traipe, Elfrides] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Moretti, Paolo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Moretti, Paolo] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Pedroza, Claudia] Univ Texas Houston, Sch Med, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Drever, Pamala; Clifton, Guy L.] Univ Texas Houston, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX USA; [Fourwinds, Sierra] Silverwind Res, La Veta, CO USA; [Beers, Sue R.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Beers, Sue R.] Univ Pittsburgh, Med Ctr, Childrens Hosp, Pittsburgh, PA USA; [Scott, James N.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Zygun, David A.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Hunter, Jill V.; Traipe, Elfrides] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Valadka, Alex B.] Seton Brain & Spine Inst, Austin, TX USA; [Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Zygun, David A.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada		McCauley, SR (corresponding author), Baylor Coll Med, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Institutes of Health (NIH)/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 43353]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	The authors extend their gratitude to the participants and their families whose cooperation and patience helped make this study possible. This study was supported, in part, by grant NS 43353 from the National Institutes of Health (NIH)/NINDS (Guy L. Clifton, principal investigator). The information in this article and the article itself has never been published either electronically or in print. None of the authors has any financial or other relationship(s) that could be construed as a conflict of interest with respect to the content of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIH.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; TEASDALE G, 1974, LANCET, V2, P81; Urbina S, 1997, PSYCHOL TESTING; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	26	7	7	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1506	1511		10.1089/neu.2013.2925			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800006	23617608	Green Published			2022-02-06	
J	McCrary, BF; Weaver, L; Marrs, K; Miller, RS; Dicks, C; Deru, K; Close, N; DeJong, M				McCrary, Brian F.; Weaver, Lindell; Marrs, Kevin; Miller, R. Scott; Dicks, Cheryl; Deru, Kayla; Close, Nicole; DeJong, Marla			Hyperbaric oxygen (HBO2) for post-concussive syndrome/chronic TBI Product summary	UNDERSEA AND HYPERBARIC MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; SKELETAL-MUSCLE; CLINICAL-TRIAL; WOUND MODEL; IN-VIVO; THERAPY; TOXICITY; GROWTH; ANGIOGENESIS		[McCrary, Brian F.; Marrs, Kevin; Miller, R. Scott] US Army Med Mat Dev Act, Ft Detrick, MD USA; [Weaver, Lindell; Deru, Kayla] Intermt LDS Hosp, Salt Lake City, UT USA; [Weaver, Lindell] Intermt Med Ctr, Murray, UT USA; [Dicks, Cheryl] Clin Res Management Inc, Ft Detrick, MD USA; [Close, Nicole] EmpiriStat Inc, Mt Airy, MD USA; [DeJong, Marla] US Air Force Sch Aerosp Med, Wright Patterson AFB, OH USA		McCrary, BF (corresponding author), US Army Med Mat Dev Act, Ft Detrick, MD USA.	mccrarymia@gmail.com					Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Allardet-Servent J, 2009, CRIT CARE MED, V37, P202, DOI 10.1097/CCM.0b013e31819261db; Anderson B Jr, 1978, Trans Am Ophthalmol Soc, V76, P116; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baffer DJ, 1985, HYPEREB OXYGEN REV, V6, P65; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barrett K, 1998, UNDERSEA HYPERBAR M, V25, P9; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Beard T, 2011, UHMS ANN SCI M FORT, P135; BECKMAN DL, 1982, LIFE SCI, V31, P45, DOI 10.1016/0024-3205(82)90399-X; Behnke AR, 1936, AM J PHYSIOL, V114, P436; BEREND N, 1984, PATHOLOGY, V16, P136, DOI 10.3109/00313028409059091; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boerema I, 1960, J CARDIOVASC SURG, V1, P133; Bonomo SR, 1998, UNDERSEA HYPERBAR M, V25, P211; Boykin Joseph V Jr, 2007, Adv Skin Wound Care, V20, P382, DOI 10.1097/01.ASW.0000280198.81130.d5; Buras JA, 2000, AM J PHYSIOL-CELL PH, V278, pC292, DOI 10.1152/ajpcell.2000.278.2.C292; Buras JA, 2006, CRIT CARE MED, V34, P2624, DOI 10.1097/01.CCM.0000239438.22758.E0; Butler F, 2008, PHYSIOLOGY AND MEDIC, P565; Capelli-Schellpfeffer M, 1996, UNDERSEA HYPERBARI S, V23, P81; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Clark J, 2003, OXYGEN PRESSURE BENN; Clark J, 2008, HYPERBARIC OXYGEN TH, P215; CLARK J, 2008, PHYSL MED HYPERBARIC, P527; CLARK JM, 1971, PHARMACOL REV, V23, P37; Conley J, 2003, UHMS ANN SCI M QUEB, V30, P260; Dekleva M, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.03.031; DELOSSANTOS R, 1987, AM REV RESPIR DIS, V136, P657, DOI 10.1164/ajrccm/136.3.657; Donat SM, 1998, J UROLOGY, V160, P1347, DOI 10.1016/S0022-5347(01)62533-3; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Ekanayake L., 2001, S PAC UNDERW MED SOC, V31, P16; Eltorai I, 1991, J HYPERBARIC MED, V6, P189; Evanger K, 2004, ACTA OPHTHALMOL SCAN, V82, P449, DOI 10.1111/j.1395-3907.2004.00290.x; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Feldmeier J, 2003, UNDERSEA HYPERBAR M, V30, P1; Feng J, 1998, WOUND REPAIR REGEN, V6, pA252; Fledelius HC, 2002, ACTA OPHTHALMOL SCAN, V80, P188, DOI 10.1034/j.1600-0420.2002.800213.x; Freiberger J, 2011, UHMS ANN SCI M FORT; Gesell L.B., 2008, HYPERBARIC OXYGEN TH; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, 2 INT S HYP OX CER P; GOLDINER PL, 1978, BRIT MED J, V1, P1664, DOI 10.1136/bmj.1.6128.1664; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Haldane JS, 1922, RESPIRATION; HAMMARLUND C, 1994, PLAST RECONSTR SURG, V93, P829, DOI 10.1097/00006534-199404000-00026; Hampson N, 2003, UNDERSEA HYPERBAR M, V30, P147; Haque WA, 1996, J AM COLL CARDIOL, V27, P353, DOI 10.1016/0735-1097(95)00474-2; Harch P, 2002, 2 INT S HYP OX CER P; Harch P, 2010, 8 WORLD C BRAIN INJ; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch Paul G, 2009, Cases J, V2, P6538, DOI 10.4076/1757-1626-2-6538; Harch PG, 1996, TXB HYPERBARIC MED, P480; Harch PG, 2004, TXB HYPERBARIC MED, P223; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P30; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HOHN DC, 1976, SURG FORUM, V27, P18; Hopf HW, 2005, WOUND REPAIR REGEN, V13, P558, DOI 10.1111/j.1524-475X.2005.00078.x; Hopf HW, 2008, PHYSL MED HYPERBARIC, P203; Howe S, 1995, UNDERSEA HYPER MED S, V22, P76; HUNT TK, 1994, PLAST RECONSTR SURG, V93, P834; HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561; Institute of Medicine, 2009, GULF WAR HLTH, V7, P400; JAY GD, 1995, ANN EMERG MED, V26, P707, DOI 10.1016/S0196-0644(95)70042-0; Johnsson AA, 1999, INT J ORAL MAX IMPL, V14, P699; KAYE D, 1967, P SOC EXP BIOL MED, V124, P1090, DOI 10.3181/00379727-124-31932; KAYE D, 1967, P SOC EXP BIOL MED, V124, P360; Keim L, 1997, CHEST S, V112, P918; Kindwall E, 2008, HYPERBARIC MED PRACT, P852; Kingston W, 2002, UNDERSEA HYPERBAR M, V29, P144; KINSEY VE, 1956, ARCH OPHTHALMOL-CHIC, V56, P481, DOI 10.1001/archopht.1956.00930040489001; Lambertsen C, 1980, MED PHYSL, V2, P1901; LAMBERTSEN CJ, 1978, EXTRAPULMONARY MANIF, P239; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; LYNE AJ, 1978, T OPHTHAL SOC UK, V98, P66; MADER JT, 1980, J INFECT DIS, V142, P915, DOI 10.1093/infdis/142.6.915; MARX RE, 1990, AM J SURG, V160, P519, DOI 10.1016/S0002-9610(05)81019-0; Mazariegos GV, 1999, LIVER TRANSPLANT SUR, V5, P429, DOI 10.1002/lt.500050518; McDonagh M, 2003, Evid Rep Technol Assess (Summ), P1; Milovanova TN, 2009, J APPL PHYSIOL, V106, P711, DOI 10.1152/japplphysiol.91054.2008; Myers A, 1984, 8 INT C; National Fire Protection Agency, 2005, NFPA 99 STAND HLTH C; Neubauer R, 1985, MED SUBACQUEA IPERBA, V5, P75; Neubauer R, 2002, 3 WORLD C NEUR REH V; Neubauer R, 2005, J AM PHYS SURG, V10, P58; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Neubauer RA, 1992, UNDERSEA BIOMED RES, V19, P66; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; PATZ A, 1952, AM J OPHTHALMOL, V35, P1248, DOI 10.1016/0002-9394(52)91140-9; Perdrizet G, 2007, UNDERSEA HYPERBAR M, V34, P246; PETERSON JE, 1970, ARCH ENVIRON HEALTH, V21, P165, DOI 10.1080/00039896.1970.10667215; Piantadosi CA, 1999, HYPERBARIC MED 1, P7; Piantadosi CA, 2008, PHYSL MED HYPERBARIC, P133; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; Pontani B, 1994, UNDERSEA HYPERBAR ME; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Roje Z, 2008, CROAT MED J, V49, P224, DOI 10.3325/cmj.2008.2.224; Ross ME, 1996, OPTOMETRY VISION SCI, V73, P487, DOI 10.1097/00006324-199607000-00006; SACKNER MA, 1975, ANN INTERN MED, V82, P40, DOI 10.7326/0003-4819-82-1-40; Sander AL, 2009, WOUND REPAIR REGEN, V17, P179, DOI 10.1111/j.1524-475X.2009.00455.x; Sawai T, 1996, J ORAL MAXIL SURG, V54, P975, DOI 10.1016/S0278-2391(96)90396-1; Sever C, 2010, ACTA ORTHOP TRAUMATO, V44, P403, DOI 10.3944/AOTT.2010.2340; Sheffield PJ, 2003, 14 INT C HYP MED, P312; Sheikh AY, 2000, ARCH SURG-CHICAGO, V135, P1293, DOI 10.1001/archsurg.135.11.1293; Shi XY, 2006, CHINESE MED J-PEKING, V119, P1978, DOI 10.1097/00029330-200612010-00007; Shupak A., 2008, PHYSL MED HYPERBARIC, P513; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; STRAUSS MB, 1983, J BONE JOINT SURG AM, V65, P656, DOI 10.2106/00004623-198365050-00011; TAKAHASHI M, 1992, CRIT CARE MED, V20, P1588, DOI 10.1097/00003246-199211000-00018; Thom SR, 2004, UNDERSEA HYPERBAR M, V31, P123; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Undersea and Hyperbaric Medical Society, 2003, HYP OX THER CHRON BR; UPTON PG, 1986, CANCER TREAT REP, V70, P503; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VOROSMARTI J, 1978, UNDERSEA BIOMED RES, V5, P243; Vote D, 2000, SERIAL PLASMA GLUCOS, P62; Waite C, 1967, BASIC STUDIES, VI, P18; Weaver LK, 2011, CRIT CARE MED, V39, P1784, DOI 10.1097/CCM.0b013e31821858d1; Weaver LK, 2009, J APPL PHYSIOL, V107, P336, DOI 10.1152/japplphysiol.91012.2008; Weaver LK, 1992, J HYPERBARIC MED, V7, P1; Wilkinson D, 2004, ARCH SURG-CHICAGO, V139, P1339, DOI 10.1001/archsurg.139.12.1339; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; ZAMBONI WA, 1992, ANN PLAS SURG, V28, P339, DOI 10.1097/00000637-199204000-00008; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53	134	7	7	0	14	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	SEP-OCT	2013	40	5					443	467					25	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	252YW	WOS:000327049800011	24224288				2022-02-06	
J	Norup, A; Kristensen, KS; Poulsen, I; Nielsen, CL; Mortensen, EL				Norup, Anne; Kristensen, Karin Spangsberg; Poulsen, Ingrid; Nielsen, Christina Lofvquist; Mortensen, Erik Lykke			CLINICALLY SIGNIFICANT CHANGES IN THE EMOTIONAL CONDITION OF RELATIVES OF PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY DURING SUB-ACUTE REHABILITATION	JOURNAL OF REHABILITATION MEDICINE			English	Article						emotional distress; anxiety; depression; relatives; sub-acute rehabilitation; traumatic brain injury; clinically significant change; reliable change index; functional improvement; SCL-90-R	SEVERE HEAD-INJURY; QUALITY-OF-LIFE; CAREGIVER BURDEN; FAMILY; DEPRESSION; PREDICTORS; SYMPTOMS; DISTRESS; SUPPORT; ADULTS	Objective: To investigate clinically significant change in the emotional condition of relatives of patients with severe traumatic brain injury during sub-acute rehabilitation. Methods: Participants were 62 pairs of relatives and patients. Relatives completed the anxiety and depression scales from the Symptom Checklist-90-R (SCL-90-R) when the patients were admitted to sub-acute rehabilitation and at discharge. Improvement in emotional condition was investigated using the following criteria: (i) statistically reliable improvement; and (ii) clinically significant change (CSC). Results: At admission, 53.2% and 58.1% of relatives had scores above cut-off values on the anxiety and depression scales, respectively. On the anxiety scale 69.7% of these experienced a reliable improvement according to the Reliable Change Index (RCI) and 45.5% also obtained CSC, as their end-point was below the cut-off value. On the depression scale the corresponding figures were 44.4% and 41.7%, respectively. When comparing relatives with and without CSC, we found that CSC in symptoms of anxiety was associated with significantly better functional improvement during rehabilitation and a shorter period of post-traumatic amnesia in the patients. Conclusion: Of the relatives who reported scores above cut-off values on the anxiety and depression scales at patient's admission, approximately 40% experienced CSC in anxiety and depression during the patient's rehabilitation. Relatives of patients experiencing improvement during inpatient rehabilitation are more likely to experience CSC in anxiety.	[Norup, Anne; Kristensen, Karin Spangsberg; Poulsen, Ingrid; Nielsen, Christina Lofvquist] Univ Hosp, Traumat Brain Injury Unit, Res Unit BRain Injury Rehabil, Dept Neurorehabil,Copenhagen RUBRIC, Glostrup, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark		Norup, A (corresponding author), Copenhagen Univ Hosp, Traumat Brain Injury Unit, Dept Neurorehabil, Glostrup, Denmark.	anne.norup@regionh.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Norup, Anne/0000-0002-5598-6116; Mortensen, Erik Lykke/0000-0002-6985-451X			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bech P, 2006, SCL 90 R MANUAL; Beck AT, 1987, BECK DEPRESSION INVE; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans C, 1998, EVID BAS MENT HLTH, V1, P70, DOI DOI 10.1136/EBMH.1.3.70; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Gunthert KC, 1999, J PERS SOC PSYCHOL, V77, P1087, DOI 10.1037/0022-3514.77.5.1087; Hagen C., 1972, LEVELS COGNITIVE FUN; Heck G, 2000, NEUROL REHABIL, V6, P125; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kross EK, 2008, CRIT CARE MED, V36, P1955, DOI 10.1097/CCM.0b013e31817616c0; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; MCCRAE RR, 1986, J PERS, V54, P385, DOI 10.1111/j.1467-6494.1986.tb00401.x; Norup A, 2013, J REHABIL MED, V45, P827, DOI 10.2340/16501977-1181; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Norup A, 2011, NEUROPSYCHOL REHABIL, V21, P306, DOI 10.1080/09602011.2011.558766; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Novack TA, 1991, J HEAD TRAUMA REHAB, V6, P69; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1985, J CLIN EXP NEUROPSYC, V7, P165; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rivera P, 2007, NEUROREHABILITATION, V22, P3; TEASDALE G, 1974, LANCET, V2, P81; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281	41	7	7	0	11	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					820	826		10.2340/16501977-1190			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500019	24002320	gold, Green Submitted			2022-02-06	
J	Perla, LY; Jackson, PD; Hopkins, SL; Daggett, MC; Van Horn, LJ				Perla, Lisa Y.; Jackson, Patricia D.; Hopkins, Sherry L.; Daggett, Margaret C.; Van Horn, Linda J.			Transitioning Home: Comprehensive Case Management for America's Heroes	REHABILITATION NURSING			English	Article						Rehabilitation; case management; head injury	POLYTRAUMA REHABILITATION; CARE	Purpose The conflicts in Afghanistan and Iraq, also known as Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn, have created unique challenges for rehabilitation teams, including nurse and social work case managers. Active duty service members, National Guard and Reservists have deployed in large numbers and as many as 20% have been exposed to blast injury, which can result in polytrauma and traumatic brain injury, the signature injury of the war, as well as psychological trauma, and painful musculoskeletal injuries. In addition, there are also documented emotional injuries associated with the constant stress of war and the frequency of exposure to the graphic scenes of war. Findings/Conclusions The Departments of Defense and Veterans Affairs work closely to provide comprehensive care coordination and case management for service members and veterans who have honorably served our country. This article describes the case management collaborative between Veterans Affairs and the Department of Defense that ensures service members and veterans receive their entitled healthcare services. Clinical Relevance The complex care needs of these returning service members require astute case management in addition to clinical care. This collaboration ensures the best life-long outcomes and will be discussed in detail in this article.	[Perla, Lisa Y.] Vet Affairs Cent Off, Dept Vet Affairs, Washington, DC USA; [Jackson, Patricia D.] Vet Affairs, Dept Vet Affairs, Lexington, KY USA; [Hopkins, Sherry L.] Vet Affairs, Dept Vet Affairs, Grand Isl, NE USA; [Daggett, Margaret C.] Vet Affairs, Dept Vet Affairs, Syracuse, NY USA; [Van Horn, Linda J.] Vet Affairs, Dept Vet Affairs, Albuquerque, NM USA		Perla, LY (corresponding author), Rehabil Serv 10P4R, Dept Vet Affairs, 810 Vermont Ave NW, Washington, DC 20420 USA.	lisa.perla@va.gov					Amdur D, 2011, SOC WORK HEALTH CARE, V50, P564, DOI 10.1080/00981389.2011.554275; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Carr DD, 2009, PROF CASE MANAG, V14, P121, DOI 10.1097/NCM.0b013e3181a774c3; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline. Management of Concussion/mTBI, 2009, VA DOD MEM AGR REG R; French LM, 2011, SOC WORK HEALTH CARE, V50, P501, DOI 10.1080/00981389.2011.582007; Gebhardt MC, 2011, REHABIL NURS, V36, P3, DOI 10.1002/j.2048-7940.2011.tb00059.x; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Kersbergen AL, 1996, NURS OUTLOOK, V44, P169, DOI 10.1016/S0029-6554(96)80037-6; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Outlaw B., 2009, VANGUARD         WIN; [Primary Care Management Module (PCMM) Department of Veterans Affairs], 2009, VHA HDB; PRIME, 2012, CAS MAN MIL CIV CAS; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P179, DOI 10.1016/j.apmr.2007.06.774; Tahan H A, 1998, Nurs Case Manag, V3, P55	17	7	7	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	SEP	2013	38	5			SI		231	239		10.1002/rnj.102			9	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	211GK	WOS:000323893800004	23720383				2022-02-06	
